PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"32166325","Response to Dr Braillon","Mueller S.","Alcohol Alcohol. 2020 Apr 16;55(3):338. doi: 10.1093/alcalc/agaa016.","Mueller S","Alcohol Alcohol","2020","2020/03/14","","","10.1093/alcalc/agaa016"
"32119727","[Disulfiram: history, controversies and its use today]","Pavlovsky F.","Vertex. 2019 Jul-Aug;XXX(146):272-286.","Pavlovsky F","Vertex","2019","2020/03/03","","",""
"32115477","[Pharmacological profile and clinical findings of nalmefene (Selincro(®)) for reducing alcohol consumption in patients with alcohol dependence]","Tadori Y.","Nihon Yakurigaku Zasshi. 2020;155(2):113-119. doi: 10.1254/fpj.19136.","Tadori Y","Nihon Yakurigaku Zasshi","2020","2020/03/03","","","10.1254/fpj.19136"
"31928246","Current pharmacotherapy for gambling disorder: a systematic review","Kraus SW, Etuk R, Potenza MN.","Expert Opin Pharmacother. 2020 Feb;21(3):287-296. doi: 10.1080/14656566.2019.1702969. Epub 2020 Jan 11.","Kraus SW","Expert Opin Pharmacother","2020","2020/01/14","","","10.1080/14656566.2019.1702969"
"31907913","[The pharmacological treatment of PTSD and alcohol use disorder: a systematic literature review]","Neven A, de Jong J, Pieterse BH.","Tijdschr Psychiatr. 2019;61(10):692-701.","Neven A","Tijdschr Psychiatr","2019","2020/01/08","","",""
"31883574","Naltrexone use in pregnancy: a time for change","Caritis SN, Venkataramanan R.","Am J Obstet Gynecol. 2020 Jan;222(1):1-2. doi: 10.1016/j.ajog.2019.08.041.","Caritis SN","Am J Obstet Gynecol","2020","2019/12/30","","","10.1016/j.ajog.2019.08.041"
"31876051","Response to 'Nalmefene in alcohol-dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption'","Higuchi S, Miyata H, Hayashi T.","Psychiatry Clin Neurosci. 2020 Mar;74(3):219-220. doi: 10.1111/pcn.12971. Epub 2020 Jan 25.","Higuchi S","Psychiatry Clin Neurosci","2020","2019/12/27","PMC7064995","","10.1111/pcn.12971"
"31868031","Safety of nalmefene for the treatment of alcohol use disorder: an update","López-Pelayo H, Zuluaga P, Caballeria E, Van den Brink W, Mann K, Gual A.","Expert Opin Drug Saf. 2020 Jan;19(1):9-17. doi: 10.1080/14740338.2020.1707802. Epub 2019 Dec 30.","López-Pelayo H","Expert Opin Drug Saf","2020","2019/12/24","","","10.1080/14740338.2020.1707802"
"31849032","Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release oxycodone surrounding sequestered naltrexone","Gimbel JS, Rauck RL, Bass A, Wilson J, Pixton G, Malhotra B, Wilson G, Wolfram G.","J Opioid Manag. 2019 Sep/Oct;15(5):417-427. doi: 10.5055/jom.2019.0530.","Gimbel JS","J Opioid Manag","2019","2019/12/19","","","10.5055/jom.2019.0530"
"31800513","The Advantages and Disadvantages of Medication-Assisted Treatment in Primary Care Offices","Padgett TM.","J Addict Nurs. 2019 Oct/Dec;30(4):238-241. doi: 10.1097/JAN.0000000000000305.","Padgett TM","J Addict Nurs","2019","2019/12/05","","","10.1097/JAN.0000000000000305"
"31758629","Commentary on Nunes et al. (2020): Blocked opioid use in antagonist treatment-time for cognitive and user-centered perspectives","Kunøe N.","Addiction. 2020 Feb;115(2):247-248. doi: 10.1111/add.14847. Epub 2019 Nov 22.","Kunøe N","Addiction","2020","2019/11/24","","","10.1111/add.14847"
"31752905","Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial","Hoffman KA, Baker R, Kunkel LE, Waddell EN, Lum PJ, McCarty D, Korthuis PT.","BMC Health Serv Res. 2019 Nov 21;19(1):862. doi: 10.1186/s12913-019-4721-x.","Hoffman KA","BMC Health Serv Res","2019","2019/11/23","PMC6868733","","10.1186/s12913-019-4721-x"
"31743335","Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment","Yedinak JL, Goedel WC, Paull K, Lebeau R, Krieger MS, Thompson C, Buchanan AL, Coderre T, Boss R, Rich JD, Marshall BDL.","PLoS Med. 2019 Nov 19;16(11):e1002963. doi: 10.1371/journal.pmed.1002963. eCollection 2019 Nov.","Yedinak JL","PLoS Med","2019","2019/11/20","PMC6863520","","10.1371/journal.pmed.1002963"
"31686778","Effect of hepatic and renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination as a bilayer tablet","Sun L, Yagoda S, Du Y, von Moltke L.","Drug Des Devel Ther. 2019 Aug 22;13:2941-2955. doi: 10.2147/DDDT.S205000. eCollection 2019.","Sun L","Drug Des Devel Ther","2019","2019/11/06","PMC6709789","","10.2147/DDDT.S205000"
"31591014","Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose","Bagley SM, Larochelle MR, Xuan Z, Wang N, Patel A, Bernson D, Silverstein M, Hadland SE, Land T, Samet JH, Walley AY.","Ann Emerg Med. 2020 Jan;75(1):29-38. doi: 10.1016/j.annemergmed.2019.07.030. Epub 2019 Oct 4.","Bagley SM","Ann Emerg Med","2020","2019/10/09","","","10.1016/j.annemergmed.2019.07.030"
"31573166","Opioid Use Disorder: Medical Treatment Options","Coffa D, Snyder H.","Am Fam Physician. 2019 Oct 1;100(7):416-425.","Coffa D","Am Fam Physician","2019","2019/10/02","","",""
"31553867","Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias?","Tortelly VD, De Mattos T, Fernandes LSA, Nunes BEM, Melo DF.","Dermatol Online J. 2019 Aug 15;25(8):13030/qt6j45h81f.","Tortelly VD","Dermatol Online J","2019","2019/09/26","","",""
"31546391","Hydrogels for diabetic eyes: Naltrexone loading, release profiles and cornea penetration","Alvarez-Rivera F, Serro AP, Silva D, Concheiro A, Alvarez-Lorenzo C.","Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110092. doi: 10.1016/j.msec.2019.110092. Epub 2019 Aug 15.","Alvarez-Rivera F","Mater Sci Eng C Mater Biol Appl","2019","2019/09/25","","","10.1016/j.msec.2019.110092"
"31543255","Medication-Assisted Treatment for Opioid-Use Disorder","Oesterle TS, Thusius NJ, Rummans TA, Gold MS.","Mayo Clin Proc. 2019 Oct;94(10):2072-2086. doi: 10.1016/j.mayocp.2019.03.029. Epub 2019 Sep 19.","Oesterle TS","Mayo Clin Proc","2019","2019/09/24","","","10.1016/j.mayocp.2019.03.029"
"31542477","Inhibition of naltrexone on relapse in methamphetamine self-administration and conditioned place preference in rats","Guo LK, Wang ZY, Lu GY, Wu N, Dong GM, Ma CM, Zhang RL, Song R, Li J.","Eur J Pharmacol. 2019 Dec 15;865:172671. doi: 10.1016/j.ejphar.2019.172671. Epub 2019 Sep 19.","Guo LK","Eur J Pharmacol","2019","2019/09/23","","","10.1016/j.ejphar.2019.172671"
"31539569","Changes in murine respiratory dynamics induced by aerosolized carfentanil inhalation: Efficacy of naloxone and naltrexone","Tuet WY, Pierce SA, Racine MC, Tressler J, McCranor BJ, Sciuto AM, Wong B.","Toxicol Lett. 2019 Nov;316:127-135. doi: 10.1016/j.toxlet.2019.09.012. Epub 2019 Sep 17.","Tuet WY","Toxicol Lett","2019","2019/09/21","","","10.1016/j.toxlet.2019.09.012"
"31532339","Optimising opioid substitution therapy in the prison environment","Alam F, Wright N, Roberts P, Dhadley S, Townley J, Webster R.","Int J Prison Health. 2019 Dec 5;15(4):293-307. doi: 10.1108/IJPH-12-2017-0061.","Alam F","Int J Prison Health","2019","2019/09/19","PMC6761913","","10.1108/IJPH-12-2017-0061"
"31526369","Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis","Palpacuer C, Hammas K, Duprez R, Laviolle B, Ioannidis JPA, Naudet F.","BMC Med. 2019 Sep 16;17(1):174. doi: 10.1186/s12916-019-1409-3.","Palpacuer C","BMC Med","2019","2019/09/19","PMC6747755","","10.1186/s12916-019-1409-3"
"31525821","Response to Darke et al. (2019): Circumstances of death of opioid users being treated with naltrexone","Streel E, Brewer C.","Addiction. 2020 Feb;115(2):384. doi: 10.1111/add.14826. Epub 2019 Nov 22.","Streel E","Addiction","2020","2019/09/17","","","10.1111/add.14826"
"31514182","The Blockade of µ1- and κ-Opioid Receptors in the Inferior Colliculus Decreases the Expression of Panic Attack-Like Behaviours Induced by Chemical Stimulation of the Dorsal Midbrain","Calvo F, Almada RC, da Silva JA, Medeiros P, da Silva Soares R Jr, de Paiva YB, Roncon CM, Coimbra NC.","Neuropsychobiology. 2019;78(4):218-228. doi: 10.1159/000502439. Epub 2019 Sep 12.","Calvo F","Neuropsychobiology","2019","2019/09/13","","","10.1159/000502439"
"31495374","Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks","Camenga DR, Colon-Rivera HA, Muvvala SB.","J Stud Alcohol Drugs. 2019 Jul;80(4):393-402.","Camenga DR","J Stud Alcohol Drugs","2019","2019/09/10","","",""
"31478970","Methamphetamine Use: A New Wave in the Opioid Crisis?","Fogger SA.","J Addict Nurs. 2019 Jul/Sep;30(3):219-223. doi: 10.1097/JAN.0000000000000298.","Fogger SA","J Addict Nurs","2019","2019/09/04","","","10.1097/JAN.0000000000000298"
"31463821","Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age","Kumar V, Lu H, Hard M, von Moltke L.","Drugs R D. 2019 Sep;19(3):277-287. doi: 10.1007/s40268-019-00280-5.","Kumar V","Drugs R D","2019","2019/08/30","PMC6738372","","10.1007/s40268-019-00280-5"
"31453628","Dominant Dystrophic Epidermolysis Bullosa Pruriginosa Responding to Naltrexone Treatment","Pallesen KAU, Lindahl KH, Bygum A.","Acta Derm Venereol. 2019 Nov 1;99(12):1195-1196. doi: 10.2340/00015555-3304.","Pallesen KAU","Acta Derm Venereol","2019","2019/08/28","","","10.2340/00015555-3304"
"31448846","Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study","Hermes G, Hyman SM, Fogelman N, Kosten TR, Sinha R.","Am J Addict. 2019 Nov;28(6):480-488. doi: 10.1111/ajad.12942. Epub 2019 Aug 26.","Hermes G","Am J Addict","2019","2019/08/27","","","10.1111/ajad.12942"
"31404891","Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy","Wang R, Zhang Y, Shan F.","Int Immunopharmacol. 2019 Oct;75:105785. doi: 10.1016/j.intimp.2019.105785. Epub 2019 Aug 9.","Wang R","Int Immunopharmacol","2019","2019/08/13","","","10.1016/j.intimp.2019.105785"
"31376396","Use of naltrexone in treating opioid use disorder in pregnancy","Towers CV, Katz E, Weitz B, Visconti K.","Am J Obstet Gynecol. 2020 Jan;222(1):83.e1-83.e8. doi: 10.1016/j.ajog.2019.07.037. Epub 2019 Jul 31.","Towers CV","Am J Obstet Gynecol","2020","2019/08/04","","","10.1016/j.ajog.2019.07.037"
"31369758","The influence of TRAIL, adiponectin and sclerostin alterations on bone loss in BDL-induced cirrhotic rats and the effect of opioid system blockade","Moradi M, Doustimotlagh AH, Dehpour AR, Rahimi N, Golestani A.","Life Sci. 2019 Sep 15;233:116706. doi: 10.1016/j.lfs.2019.116706. Epub 2019 Jul 29.","Moradi M","Life Sci","2019","2019/08/02","","","10.1016/j.lfs.2019.116706"
"31361869","Medications for management of opioid use disorder","Koehl JL, Zimmerman DE, Bridgeman PJ.","Am J Health Syst Pharm. 2019 Jul 18;76(15):1097-1103. doi: 10.1093/ajhp/zxz105.","Koehl JL","Am J Health Syst Pharm","2019","2019/07/31","","","10.1093/ajhp/zxz105"
"31356321","The Opioid Crisis: Treatment Efforts Exclude Inmates","Nelson R.","Am J Nurs. 2019 Aug;119(8):19-20. doi: 10.1097/01.NAJ.0000577412.52694.99.","Nelson R","Am J Nurs","2019","2019/07/30","","","10.1097/01.NAJ.0000577412.52694.99"
"31340204","Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial","Solli KK, Kunoe N, Latif ZE, Sharma-Haase K, Opheim A, Krajci P, Gaulen Z, Šaltytė Benth J, Tanum L.","Eur Addict Res. 2019;25(6):303-309. doi: 10.1159/000501931. Epub 2019 Jul 24.","Solli KK","Eur Addict Res","2019","2019/07/25","","","10.1159/000501931"
"31337235","Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases","Jfri A, Litvinov IV, Netchiporouk E.","J Cutan Med Surg. 2019 Jul/Aug;23(4):453-454. doi: 10.1177/1203475419843122.","Jfri A","J Cutan Med Surg","2019","2019/07/25","","","10.1177/1203475419843122"
"31329393","Low-dose naltrexone: a unique treatment for amyopathic dermatomyositis","Manudhane AP, Schrom KP, Ezaldein HH, Armile JA.","Dermatol Online J. 2019 Jun 15;25(6):13030/qt89b75552.","Manudhane AP","Dermatol Online J","2019","2019/07/23","","",""
"31314749","Cross-talk between Human Spinal Cord μ-opioid Receptor 1Y Isoform and Gastrin-releasing Peptide Receptor Mediates Opioid-induced Scratching Behavior","Liu XY, Ginosar Y, Yazdi J, Hincker A, Chen ZF.","Anesthesiology. 2019 Aug;131(2):381-391. doi: 10.1097/ALN.0000000000002776.","Liu XY","Anesthesiology","2019","2019/07/18","PMC7098053","NIHMS1562629","10.1097/ALN.0000000000002776"
"31298784","Nalmefene in alcohol-dependent patients with a high drinking risk: Randomized controlled trial","Miyata H, Takahashi M, Murai Y, Tsuneyoshi K, Hayashi T, Meulien D, Sørensen P, Higuchi S.","Psychiatry Clin Neurosci. 2019 Nov;73(11):697-706. doi: 10.1111/pcn.12914. Epub 2019 Aug 5.","Miyata H","Psychiatry Clin Neurosci","2019","2019/07/13","PMC6899457","","10.1111/pcn.12914"
"31267482","Naldemedine: A Review in Opioid-Induced Constipation","Blair HA.","Drugs. 2019 Jul;79(11):1241-1247. doi: 10.1007/s40265-019-01160-7.","Blair HA","Drugs","2019","2019/07/04","","","10.1007/s40265-019-01160-7"
"31238952","Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York","Neighbors CJ, Choi S, Healy S, Yerneni R, Sun T, Shapoval L.","Subst Abuse Treat Prev Policy. 2019 Jun 25;14(1):28. doi: 10.1186/s13011-019-0215-4.","Neighbors CJ","Subst Abuse Treat Prev Policy","2019","2019/06/27","PMC6593566","","10.1186/s13011-019-0215-4"
"31238066","Metformin antinociceptive effect in models of nociceptive and neuropathic pain is partially mediated by activation of opioidergic mechanisms","Augusto PSA, Braga AV, Rodrigues FF, Morais MI, Dutra MMGB, Batista CRA, Melo ISF, Costa SOAM, Goulart FA, Coelho MM, Machado RR.","Eur J Pharmacol. 2019 Sep 5;858:172497. doi: 10.1016/j.ejphar.2019.172497. Epub 2019 Jun 22.","Augusto PSA","Eur J Pharmacol","2019","2019/06/26","","","10.1016/j.ejphar.2019.172497"
"31216535","The Prescription of Anticraving Medication and its Economic Consequences","Holzbach R, Stammen G, Kirchhof U, Scherbaum N.","Eur Addict Res. 2019;25(5):224-228. doi: 10.1159/000500521. Epub 2019 Jun 19.","Holzbach R","Eur Addict Res","2019","2019/06/20","","","10.1159/000500521"
"31207909","Opioid-Mediated Astrocyte-Neuron Signaling in the Nucleus Accumbens","Corkrum M, Rothwell PE, Thomas MJ, Kofuji P, Araque A.","Cells. 2019 Jun 14;8(6):586. doi: 10.3390/cells8060586.","Corkrum M","Cells","2019","2019/06/19","PMC6628279","","10.3390/cells8060586"
"31206155","Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial","Roche DJO, Trela CJ, Argos M, Jasmine F, Kibriya MG, Ahsan H, King AC.","Alcohol Alcohol. 2019 Jan 9;54(5):559-565. doi: 10.1093/alcalc/agz046.","Roche DJO","Alcohol Alcohol","2019","2019/06/18","","","10.1093/alcalc/agz046"
"31188761","The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome","Chatzis P, Tziomalos K, Pratilas GC, Makris V, Sotiriadis A, Dinas K.","Folia Med (Plovdiv). 2018 Dec 1;60(4):512-520. doi: 10.2478/folmed-2018-0036.","Chatzis P","Folia Med (Plovdiv)","2018","2019/06/13","","","10.2478/folmed-2018-0036"
"31183560","A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting","Sato J, Tanaka R, Ishikawa H, Suzuki T, Shino M.","Support Care Cancer. 2020 Mar;28(3):1083-1088. doi: 10.1007/s00520-019-04884-0. Epub 2019 Jun 11.","Sato J","Support Care Cancer","2020","2019/06/12","","","10.1007/s00520-019-04884-0"
"31180972","Conquering the Craving: Treatment to Curb Alcohol Use Disorder","","J Christ Nurs. 2019 Jul/Sep;36(3):E49-E50. doi: 10.1097/CNJ.0000000000000631.","","J Christ Nurs","2019","2019/06/11","","","10.1097/CNJ.0000000000000631"
"31180959","Conquering the Craving: Treatment to Curb Alcohol Use Disorder","Umhau JC.","J Christ Nurs. 2019 Jul/Sep;36(3):148-156. doi: 10.1097/CNJ.0000000000000624.","Umhau JC","J Christ Nurs","2019","2019/06/11","","","10.1097/CNJ.0000000000000624"
"31160146","Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent","Lim AC, Ghahremani DG, Grodin EN, Green R, Bujarski S, Hartwell EE, Courtney KE, Hutchison K, Miotto K, Ray LA.","Drug Alcohol Depend. 2019 Jul 1;200:181-190. doi: 10.1016/j.drugalcdep.2019.02.028. Epub 2019 May 9.","Lim AC","Drug Alcohol Depend","2019","2019/06/05","PMC6760244","NIHMS1529321","10.1016/j.drugalcdep.2019.02.028"
"31134864","A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council","Otuonye IS, Banken R, Kumar VM, Pearson SD.","J Manag Care Spec Pharm. 2019 Jun;25(6):630-634. doi: 10.18553/jmcp.2019.25.6.630.","Otuonye IS","J Manag Care Spec Pharm","2019","2019/05/29","","","10.18553/jmcp.2019.25.6.630"
"31128231","A Response to: Challenges in Recruiting Patients to a Controlled Feasibility Study of a Drug for Opioid-Induced Constipation: Lessons From the Population With Advanced Cancer","Clark K, Allingham S, Phillips JL, Brown L, Currow DC.","J Pain Symptom Manage. 2019 Sep;58(3):e1-e2. doi: 10.1016/j.jpainsymman.2019.04.037. Epub 2019 May 22.","Clark K","J Pain Symptom Manage","2019","2019/05/26","","","10.1016/j.jpainsymman.2019.04.037"
"31117905","Treating Alcohol Use Disorder in U.S. Veterans: The Role of Traumatic Brain Injury","Jorge RE, Li R, Liu X, McGavin JK, Shorter DI, Acion L, Arndt S.","J Neuropsychiatry Clin Neurosci. 2019 Fall;31(4):319-327. doi: 10.1176/appi.neuropsych.18110250. Epub 2019 May 23.","Jorge RE","J Neuropsychiatry Clin Neurosci","2019","2019/05/24","","","10.1176/appi.neuropsych.18110250"
"31106994","Should Long-Acting Depot Intramuscular Naltrexone Be Prescribed Every 3 Weeks for Alcohol Use Disorder?","Luvisi J, Ahonen K, Sethi R.","Prim Care Companion CNS Disord. 2019 May 16;21(3):18l02351. doi: 10.4088/PCC.18l02351.","Luvisi J","Prim Care Companion CNS Disord","2019","2019/05/21","","","10.4088/PCC.18l02351"
"31095544","Dispensing of medication for alcohol use disorder; an examination of large databases in a New Zealand context","Beaglehole B, Foulds J, Mulder RT, Boden JM.","N Z Med J. 2019 May 17;132(1495):48-53.","Beaglehole B","N Z Med J","2019","2019/05/17","","",""
"31092063","Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity","Bello NT.","Expert Opin Drug Saf. 2019 Jul;18(7):549-552. doi: 10.1080/14740338.2019.1618268. Epub 2019 May 17.","Bello NT","Expert Opin Drug Saf","2019","2019/05/17","","","10.1080/14740338.2019.1618268"
"31089098","[Medical rehabilitation of patients with alcohol dependency at risk of parental rights deprivation]","Agibalova TV, Akhmetzyanov II, Khaeva RF, Udachina GL, Nedobylskiy OV, Orlova AV, Gurevich GL.","Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(3):65-69. doi: 10.17116/jnevro201911903165.","Agibalova TV","Zh Nevrol Psikhiatr Im S S Korsakova","2019","2019/05/16","","","10.17116/jnevro201911903165"
"31085781","Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt","Pramar YV, Mandal TK, Bostanian LA, Nguyen AT, Morris TC, Graves RA.","Int J Pharm Compd. 2019 Mar-Apr;23(2):157-162.","Pramar YV","Int J Pharm Compd","2019","2019/05/16","","",""
"31082666","Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort","Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP.","Drug Alcohol Depend. 2019 Jul 1;200:34-39. doi: 10.1016/j.drugalcdep.2019.02.031. Epub 2019 May 3.","Morgan JR","Drug Alcohol Depend","2019","2019/05/15","PMC6613830","NIHMS1530317","10.1016/j.drugalcdep.2019.02.031"
"31070927","Simultaneous Transdermal Delivery of Buprenorphine Hydrochloride and Naltrexone Hydrochloride by Iontophoresis","Cordery SF, Husbands SM, Bailey CP, Guy RH, Delgado-Charro MB.","Mol Pharm. 2019 Jun 3;16(6):2808-2816. doi: 10.1021/acs.molpharmaceut.9b00337. Epub 2019 May 22.","Cordery SF","Mol Pharm","2019","2019/05/10","","","10.1021/acs.molpharmaceut.9b00337"
"31051223","μ-Opioid receptor in the CA1 involves in tramadol and morphine cross state-dependent memory","Niknamfar S, Nouri Zadeh-Tehrani S, Sadat-Shirazi MS, Akbarabadi A, Rahimi-Movaghar A, Zarrindast MR.","Neurosci Lett. 2019 Jul 13;705:177-182. doi: 10.1016/j.neulet.2019.04.054. Epub 2019 Apr 30.","Niknamfar S","Neurosci Lett","2019","2019/05/04","","","10.1016/j.neulet.2019.04.054"
"31046072","Medication-Based Treatment to Address Opioid Use Disorder","Leshner AI, Dzau VJ.","JAMA. 2019 Jun 4;321(21):2071-2072. doi: 10.1001/jama.2019.5523.","Leshner AI","JAMA","2019","2019/05/03","","","10.1001/jama.2019.5523"
"31043682","Conjugate vaccine produces long-lasting attenuation of fentanyl vs. food choice and blocks expression of opioid withdrawal-induced increases in fentanyl choice in rats","Townsend EA, Blake S, Faunce KE, Hwang CS, Natori Y, Zhou B, Bremer PT, Janda KD, Banks ML.","Neuropsychopharmacology. 2019 Sep;44(10):1681-1689. doi: 10.1038/s41386-019-0385-9. Epub 2019 May 2.","Townsend EA","Neuropsychopharmacology","2019","2019/05/03","PMC6784909","","10.1038/s41386-019-0385-9"
"31039639","Explaining Naltrexone's Interference With Ketamine's Antidepressant Effect","Wang M, Kaplin A.","Am J Psychiatry. 2019 May 1;176(5):410-411. doi: 10.1176/appi.ajp.2019.19010044.","Wang M","Am J Psychiatry","2019","2019/05/02","","","10.1176/appi.ajp.2019.19010044"
"31038486","Neuroprotective effects of lipopolysaccharide and naltrexone co‑preconditioning in the photothrombotic model of unilateral selective hippocampal ischemia in rat","Hosseini SM, Golaghaei A, Nassireslami E, Naderi N, Pourbadie HG, Rahimzadegan M, Mohammadi S.","Acta Neurobiol Exp (Wars). 2019;79(1):73-85.","Hosseini SM","Acta Neurobiol Exp (Wars)","2019","2019/05/01","","",""
"31026862","Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study","Martinez D, Slifstein M, Matuskey D, Nabulsi N, Zheng MQ, Lin SF, Ropchan J, Urban N, Grassetti A, Chang D, Salling M, Foltin R, Carson RE, Huang Y.","Neuropsychopharmacology. 2019 Sep;44(10):1720-1727. doi: 10.1038/s41386-019-0398-4. Epub 2019 Apr 26.","Martinez D","Neuropsychopharmacology","2019","2019/04/27","PMC6785004","","10.1038/s41386-019-0398-4"
"31005380","Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery","Landau R.","Int J Obstet Anesth. 2019 Aug;39:105-116. doi: 10.1016/j.ijoa.2019.01.011. Epub 2019 Feb 10.","Landau R","Int J Obstet Anesth","2019","2019/04/22","","","10.1016/j.ijoa.2019.01.011"
"31002846","Low-dose naltrexone therapy in benign chronic pemphigus (Hailey-Hailey disease): A case series","Riquelme-Mc Loughlin C, Riera-Monroig J, Morgado-Carrasco D, Giavedoni P, Podlipnik S, Iranzo P, Mascaró JM Jr.","J Am Acad Dermatol. 2019 Aug;81(2):644-646. doi: 10.1016/j.jaad.2019.04.024. Epub 2019 Apr 16.","Riquelme-Mc Loughlin C","J Am Acad Dermatol","2019","2019/04/20","","","10.1016/j.jaad.2019.04.024"
"30991059","Sex differences in the effect of bupropion and naltrexone combination on alcohol drinking in mice","Zhou Y, Leri F, Low MJ, Kreek MJ.","Pharmacol Biochem Behav. 2019 Jun;181:28-36. doi: 10.1016/j.pbb.2019.04.004. Epub 2019 Apr 13.","Zhou Y","Pharmacol Biochem Behav","2019","2019/04/17","PMC6545156","NIHMS1527799","10.1016/j.pbb.2019.04.004"
"30976797","Naltrexone alters responses to social and physical warmth: implications for social bonding","Inagaki TK, Hazlett LI, Andreescu C.","Soc Cogn Affect Neurosci. 2019 May 31;14(5):471-479. doi: 10.1093/scan/nsz026.","Inagaki TK","Soc Cogn Affect Neurosci","2019","2019/04/13","PMC6545530","","10.1093/scan/nsz026"
"30970376","Effects of stimulation of mu opioid and nociceptin/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys","Flynn SM, Epperly PM, Davenport AT, Cami-Kobeci G, Husbands SM, Ko MC, Czoty PW.","Neuropsychopharmacology. 2019 Jul;44(8):1476-1484. doi: 10.1038/s41386-019-0390-z. Epub 2019 Apr 10.","Flynn SM","Neuropsychopharmacology","2019","2019/04/11","PMC6784996","","10.1038/s41386-019-0390-z"
"30959048","Delta-opioid receptor antagonist naltrindole reduces oxycodone addiction and constipation in mice","Yang PP, Yeh TK, Loh HH, Law PY, Wang Y, Tao PL.","Eur J Pharmacol. 2019 Jun 5;852:265-273. doi: 10.1016/j.ejphar.2019.04.009. Epub 2019 Apr 6.","Yang PP","Eur J Pharmacol","2019","2019/04/09","","","10.1016/j.ejphar.2019.04.009"
"30958613","Use of low-dose naltrexone in the treatment of severe Hailey-Hailey disease: One case report","Garayar Cantero M, Canseco Martín M, Aguado García Á, Ruiz-Sánchez D, Valtueña J, Manchado López P.","Dermatol Ther. 2019 May;32(3):e12892. doi: 10.1111/dth.12892. Epub 2019 Apr 22.","Garayar Cantero M","Dermatol Ther","2019","2019/04/09","","","10.1111/dth.12892"
"30957236","Methadone's effects on pentylenetetrazole-induced seizure threshold in mice: NMDA/opioid receptors and nitric oxide signaling","Kazemi Roodsari S, Bahramnejad E, Rahimi N, Aghaei I, Dehpour AR.","Ann N Y Acad Sci. 2019 Aug;1449(1):25-35. doi: 10.1111/nyas.14043. Epub 2019 Apr 7.","Kazemi Roodsari S","Ann N Y Acad Sci","2019","2019/04/09","","","10.1111/nyas.14043"
"30951167","Effects of opioid receptor stimulation and blockade on touch pleasantness: a double-blind randomised trial","Løseth GE, Eikemo M, Leknes S.","Soc Cogn Affect Neurosci. 2019 May 17;14(4):411-422. doi: 10.1093/scan/nsz022.","Løseth GE","Soc Cogn Affect Neurosci","2019","2019/04/06","PMC6523440","","10.1093/scan/nsz022"
"30940694","Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose","Krieter P, Gyaw S, Crystal R, Skolnick P.","J Pharmacol Exp Ther. 2019 Nov;371(2):409-415. doi: 10.1124/jpet.118.256115. Epub 2019 Apr 2.","Krieter P","J Pharmacol Exp Ther","2019","2019/04/04","PMC6863453","","10.1124/jpet.118.256115"
"30930116","Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts","Tanaka K, Kondo H, Hamamura K, Togari A.","Life Sci. 2019 May 1;224:232-240. doi: 10.1016/j.lfs.2019.03.069. Epub 2019 Mar 28.","Tanaka K","Life Sci","2019","2019/04/02","","","10.1016/j.lfs.2019.03.069"
"30922276","Optimal treatment of opioid induced constipation in daily clinical practice - an observational study","Neefjes ECW, van der Wijngaart H, van der Vorst MJDL, Ten Oever D, van der Vliet HJ, Beeker A, Rhodius CA, van den Berg HP, Berkhof J, Verheul HMW.","BMC Palliat Care. 2019 Mar 29;18(1):31. doi: 10.1186/s12904-019-0416-7.","Neefjes ECW","BMC Palliat Care","2019","2019/03/30","PMC6439982","","10.1186/s12904-019-0416-7"
"30917675","Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes","Trofimovitch D, Baumrucker SJ.","Am J Hosp Palliat Care. 2019 Oct;36(10):907-912. doi: 10.1177/1049909119838974. Epub 2019 Mar 27.","Trofimovitch D","Am J Hosp Palliat Care","2019","2019/03/29","","","10.1177/1049909119838974"
"30909326","Low Dose Naltrexone in Dermatology","Jaros J, Lio P.","J Drugs Dermatol. 2019 Mar 1;18(3):235-238.","Jaros J","J Drugs Dermatol","2019","2019/03/26","","",""
"30904005","Cardioprotective properties of opioid receptor agonists in rats with stress-induced cardiac injury","Prokudina ES, Maslov LN, Naryzhnaya NV, Tsibulnikov SY, Lishmanov YB, Madias JE, Oeltgen PR.","Physiol Res. 2019 Jun 30;68(3):375-384. doi: 10.33549/physiolres.933946. Epub 2019 Mar 22.","Prokudina ES","Physiol Res","2019","2019/03/25","","","10.33549/physiolres.933946"
"30894239","Exposure and response prevention therapy augmented with naltrexone in kleptomania: a controlled case study using galvanic skin response for monitoring","Olbrich S, Jahn I, Stengler K.","Behav Cogn Psychother. 2019 Sep;47(5):622-627. doi: 10.1017/S1352465819000213. Epub 2019 Mar 21.","Olbrich S","Behav Cogn Psychother","2019","2019/03/22","","","10.1017/S1352465819000213"
"30888948","Naltrexone Therapy for Hailey-Hailey Disease: Confirming My Addiction to Evidence-Based Medicine","Heymann WR.","Skinmed. 2019 Mar 19;17(1):44-45. eCollection 2019.","Heymann WR","Skinmed","2019","2019/03/20","","",""
"30888624","A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects","Sun L, McDonnell D, Yu M, Kumar V, von Moltke L.","Clin Drug Investig. 2019 May;39(5):477-484. doi: 10.1007/s40261-019-00775-8.","Sun L","Clin Drug Investig","2019","2019/03/20","","","10.1007/s40261-019-00775-8"
"30865232","Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials","Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J; Alcohol Clinical Trials Initiative (ACTIVE) Workgroup.","JAMA Psychiatry. 2019 Apr 1;76(4):374-381. doi: 10.1001/jamapsychiatry.2018.3079.","Falk DE","JAMA Psychiatry","2019","2019/03/14","PMC6450273","","10.1001/jamapsychiatry.2018.3079"
"30861062","Therapeutic Drug Monitoring and the Clinical Significance of Naltrexone Blood Levels at the Time of a First Drink: Relevance to the Sinclair Method","Umhau JC.","Alcohol Alcohol. 2019 Mar 1;54(2):192. doi: 10.1093/alcalc/agz014.","Umhau JC","Alcohol Alcohol","2019","2019/03/13","","","10.1093/alcalc/agz014"
"30852374","The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial","Jarvis BP, Holtyn AF, DeFulio A, Koffarnus MN, Leoutsakos JS, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.","Drug Alcohol Depend. 2019 Apr 1;197:220-227. doi: 10.1016/j.drugalcdep.2018.12.026. Epub 2019 Feb 14.","Jarvis BP","Drug Alcohol Depend","2019","2019/03/11","PMC6440824","NIHMS1523474","10.1016/j.drugalcdep.2018.12.026"
"30851171","Efficacy of naldemedine for the treatment of opioid-induced constipation: A meta-analysis","Esmadi M, Ahmad D, Hewlett A.","J Gastrointestin Liver Dis. 2019 Mar;28(1):41-46. doi: 10.15403/jgld.2014.1121.281.any.","Esmadi M","J Gastrointestin Liver Dis","2019","2019/03/10","","","10.15403/jgld.2014.1121.281.any"
"30848965","A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine","Kelty E, Joyce D, Hulse G.","Am J Drug Alcohol Abuse. 2019;45(3):285-291. doi: 10.1080/00952990.2018.1545131. Epub 2019 Mar 8.","Kelty E","Am J Drug Alcohol Abuse","2019","2019/03/09","","","10.1080/00952990.2018.1545131"
"30845818","Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia","Martin WF, Correll CU, Weiden PJ, Jiang Y, Pathak S, DiPetrillo L, Silverman BL, Ehrich EW.","Am J Psychiatry. 2019 Jun 1;176(6):457-467. doi: 10.1176/appi.ajp.2018.18030280. Epub 2019 Mar 8.","Martin WF","Am J Psychiatry","2019","2019/03/09","","","10.1176/appi.ajp.2018.18030280"
"30844223","Prescription Drug and Alcohol Use Disorders: Alcohol Use Disorder","Warren D.","FP Essent. 2019 Mar;478:30-42.","Warren D","FP Essent","2019","2019/03/08","","",""
"30844221","Prescription Drug and Alcohol Use Disorders: Opioid Use Disorder","Witt L, Butler F.","FP Essent. 2019 Mar;478:19-24.","Witt L","FP Essent","2019","2019/03/08","","",""
"30829214","Study on structural insight of the analysis of negative effects of opioids analgesics in naltrexone with TLR4 Mutations","Tariq I, Farhan A, Ashfaq UA, Qasim M, Rehman M, Humayun F, Shah M, Munir A, Masoud MS.","Pak J Pharm Sci. 2019 Jan;32(1(Supplementary)):345-351.","Tariq I","Pak J Pharm Sci","2019","2019/03/05","","",""
"30821019","Pharmacologic effects of naldemedine, a peripherally acting μ-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation","Kanemasa T, Koike K, Arai T, Ono H, Horita N, Chiba H, Nakamura A, Morioka Y, Kihara T, Hasegawa M.","Neurogastroenterol Motil. 2019 May;31(5):e13563. doi: 10.1111/nmo.13563. Epub 2019 Feb 28.","Kanemasa T","Neurogastroenterol Motil","2019","2019/03/02","PMC6850587","","10.1111/nmo.13563"
"30818989","Target Population, Dose, and Timing Considerations for Understanding Naltrexone's Subjective Effect: Response to Amiaz","Heifets BD, Williams NR, Blasey C, Sudheimer K, Rodriguez CI, Schatzberg AF.","Am J Psychiatry. 2019 Mar 1;176(3):251-252. doi: 10.1176/appi.ajp.2018.18111231r.","Heifets BD","Am J Psychiatry","2019","2019/03/02","","","10.1176/appi.ajp.2018.18111231r"
"30818986","Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism: Is It a Ketamine-Specific Effect?","Amiaz R.","Am J Psychiatry. 2019 Mar 1;176(3):250-251. doi: 10.1176/appi.ajp.2018.18111231.","Amiaz R","Am J Psychiatry","2019","2019/03/02","","","10.1176/appi.ajp.2018.18111231"
"30802531","Caenorhabditis elegans as a model system to identify therapeutics for alcohol use disorders","Katner SN, Bredhold KE, Steagall KB 2nd, Bell RL, Neal-Beliveau BS, Cheong MC, Engleman EA.","Behav Brain Res. 2019 Jun 3;365:7-16. doi: 10.1016/j.bbr.2019.02.015. Epub 2019 Feb 22.","Katner SN","Behav Brain Res","2019","2019/02/26","PMC6474658","NIHMS1523153","10.1016/j.bbr.2019.02.015"
"30801358","Suppression of Human Natural Killer Cells by Different Classes of Opioids","Maher DP, Walia D, Heller NM.","Anesth Analg. 2019 May;128(5):1013-1021. doi: 10.1213/ANE.0000000000004058.","Maher DP","Anesth Analg","2019","2019/02/26","PMC6726115","NIHMS1046100","10.1213/ANE.0000000000004058"
"30794760","Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients","Cicero TJ, Mendoza M, Cattaneo M, Dart RC, Mardekian J, Polson M, Roland CL, Schnoll SH, Webster LR, Park PW.","Postgrad Med. 2019 Apr;131(3):225-229. doi: 10.1080/00325481.2019.1585688. Epub 2019 Mar 19.","Cicero TJ","Postgrad Med","2019","2019/02/23","","","10.1080/00325481.2019.1585688"
"30770183","Minimal contribution of P-gp on the low brain distribution of naldemedine, a peripherally acting μ-opioid receptor antagonist","Watari R, Matsuda A, Ohnishi S, Hasegawa H.","Drug Metab Pharmacokinet. 2019 Apr;34(2):126-133. doi: 10.1016/j.dmpk.2018.12.002. Epub 2018 Dec 23.","Watari R","Drug Metab Pharmacokinet","2019","2019/02/17","","","10.1016/j.dmpk.2018.12.002"
"30764838","κ-Opioid receptor stimulation reduces palmitate-induced apoptosis via Akt/eNOS signaling pathway","Cui Y, Feng N, Gu X, Fu F, Li J, Guo H, Liu Y, Zhang S, Li J, Wang Y, Jia M, Yang L, Zhang F, Wang Y, Fan R, Pei J.","Lipids Health Dis. 2019 Feb 14;18(1):52. doi: 10.1186/s12944-019-0989-4.","Cui Y","Lipids Health Dis","2019","2019/02/16","PMC6376663","","10.1186/s12944-019-0989-4"
"30763385","Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study","Raknes G, Småbrekke L.","PLoS One. 2019 Feb 14;14(2):e0212460. doi: 10.1371/journal.pone.0212460. eCollection 2019.","Raknes G","PLoS One","2019","2019/02/15","PMC6375629","","10.1371/journal.pone.0212460"
"30758525","Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats","Waeiss RA, Knight CP, Hauser SR, Pratt LA, McBride WJ, Rodd ZA.","Psychopharmacology (Berl). 2019 Jun;236(6):1887-1900. doi: 10.1007/s00213-019-5174-y. Epub 2019 Feb 13.","Waeiss RA","Psychopharmacology (Berl)","2019","2019/02/14","PMC6606358","NIHMS1524878","10.1007/s00213-019-5174-y"
"30744686","Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions","Williams EC, Matson TE, Harris AHS.","Addict Sci Clin Pract. 2019 Feb 12;14(1):6. doi: 10.1186/s13722-019-0134-8.","Williams EC","Addict Sci Clin Pract","2019","2019/02/13","PMC6371480","","10.1186/s13722-019-0134-8"
"30722778","Adverse events and nocebo phenomena: treatment or disease specific?","Zis P, Sykioti P.","BMC Med. 2019 Feb 5;17(1):30. doi: 10.1186/s12916-019-1272-2.","Zis P","BMC Med","2019","2019/02/07","PMC6364393","","10.1186/s12916-019-1272-2"
"30712317","Variable response to low-dose naltrexone in patients with Darier disease: a case series","Boehmer D, Eyerich K, Darsow U, Biedermann T, Zink A.","J Eur Acad Dermatol Venereol. 2019 May;33(5):950-953. doi: 10.1111/jdv.15457. Epub 2019 Mar 5.","Boehmer D","J Eur Acad Dermatol Venereol","2019","2019/02/04","","","10.1111/jdv.15457"
"30701613","No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study","Latif ZE, Solli KK, Opheim A, Kunoe N, Benth JŠ, Krajci P, Sharma-Haase K, Tanum L.","Am J Addict. 2019 Feb;28(2):77-85. doi: 10.1111/ajad.12859. Epub 2019 Jan 31.","Latif ZE","Am J Addict","2019","2019/02/01","","","10.1111/ajad.12859"
"30695679","Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone","Oaks Z, Stage A, Middleton B, Faraone S, Johnson B.","Discov Med. 2018 Nov;26(144):197-206.","Oaks Z","Discov Med","2018","2019/01/30","","",""
"30691415","Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes","McLaughlin PJ, Sassani JW, Titunick MB, Zagon IS.","BMC Ophthalmol. 2019 Jan 28;19(1):35. doi: 10.1186/s12886-019-1044-y.","McLaughlin PJ","BMC Ophthalmol","2019","2019/01/30","PMC6348650","","10.1186/s12886-019-1044-y"
"30690502","Behavioral and Accumbal Responses During an Affective Go/No-Go Task Predict Adherence to Injectable Naltrexone Treatment in Opioid Use Disorder","Shi Z, Jagannathan K, Wang AL, Fairchild VP, Lynch KG, Suh JJ, Childress AR, Langleben DD.","Int J Neuropsychopharmacol. 2019 Mar 1;22(3):180-185. doi: 10.1093/ijnp/pyz002.","Shi Z","Int J Neuropsychopharmacol","2019","2019/01/29","PMC6403086","","10.1093/ijnp/pyz002"
"30690119","Possible involvement of the μ opioid receptor in the antinociception induced by sinomenine on formalin-induced nociceptive behavior in mice","Komatsu T, Katsuyama S, Takano F, Okamura T, Sakurada C, Tsuzuki M, Ogawa K, Kubota A, Morinaga O, Tabata K, Sakurada T.","Neurosci Lett. 2019 Apr 23;699:103-108. doi: 10.1016/j.neulet.2019.01.035. Epub 2019 Jan 25.","Komatsu T","Neurosci Lett","2019","2019/01/29","","","10.1016/j.neulet.2019.01.035"
"30684117","Medications for Treatment of Opioid Use Disorder among Persons Living with HIV","Fanucchi L, Springer SA, Korthuis PT.","Curr HIV/AIDS Rep. 2019 Feb;16(1):1-6. doi: 10.1007/s11904-019-00436-7.","Fanucchi L","Curr HIV/AIDS Rep","2019","2019/01/27","PMC6420833","NIHMS1010433","10.1007/s11904-019-00436-7"
"30681985","Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain","Navratilova E, Ji G, Phelps C, Qu C, Hein M, Yakhnitsa V, Neugebauer V, Porreca F.","Pain. 2019 Apr;160(4):824-832. doi: 10.1097/j.pain.0000000000001458.","Navratilova E","Pain","2019","2019/01/26","PMC6424634","NIHMS1012111","10.1097/j.pain.0000000000001458"
"30665272","County-level access to opioid use disorder medications in medicare Part D (2010-2015)","Abraham AJ, Adams GB, Bradford AC, Bradford WD.","Health Serv Res. 2019 Apr;54(2):390-398. doi: 10.1111/1475-6773.13113. Epub 2019 Jan 21.","Abraham AJ","Health Serv Res","2019","2019/01/22","PMC6407357","","10.1111/1475-6773.13113"
"30660628","Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats","Schwienteck KL, Faunce KE, Rice KC, Obeng S, Zhang Y, Blough BE, Grim TW, Negus SS, Banks ML.","Neuropharmacology. 2019 May 15;150:200-209. doi: 10.1016/j.neuropharm.2019.01.020. Epub 2019 Jan 18.","Schwienteck KL","Neuropharmacology","2019","2019/01/21","PMC6476319","NIHMS1519571","10.1016/j.neuropharm.2019.01.020"
"30660616","Opioid receptors inhibit the spinal AMPA receptor Ca(2+) permeability that mediates latent pain sensitization","Taylor BK, Sinha GP, Donahue RR, Grachen CM, Morón JA, Doolen S.","Exp Neurol. 2019 Apr;314:58-66. doi: 10.1016/j.expneurol.2019.01.003. Epub 2019 Jan 17.","Taylor BK","Exp Neurol","2019","2019/01/21","PMC6559354","NIHMS928164","10.1016/j.expneurol.2019.01.003"
"30652502","A meta-analysis of naldemedine for the treatment of opioid-induced constipation","Song X, Wang D, Qu X, Dong N, Teng S.","Expert Rev Clin Pharmacol. 2019 Feb;12(2):121-128. doi: 10.1080/17512433.2019.1570845. Epub 2019 Jan 24.","Song X","Expert Rev Clin Pharmacol","2019","2019/01/18","","","10.1080/17512433.2019.1570845"
"30650121","Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)","Prukop T, Stenzel J, Wernick S, Kungl T, Mroczek M, Adam J, Ewers D, Nabirotchkin S, Nave KA, Hajj R, Cohen D, Sereda MW.","PLoS One. 2019 Jan 16;14(1):e0209752. doi: 10.1371/journal.pone.0209752. eCollection 2019.","Prukop T","PLoS One","2019","2019/01/17","PMC6334894","","10.1371/journal.pone.0209752"
"30642329","Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis","Bolton M, Hodkinson A, Boda S, Mould A, Panagioti M, Rhodes S, Riste L, van Marwijk H.","BMC Med. 2019 Jan 15;17(1):10. doi: 10.1186/s12916-018-1242-0.","Bolton M","BMC Med","2019","2019/01/16","PMC6332608","","10.1186/s12916-018-1242-0"
"30628813","Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers","Green R, Bujarski S, Lim AC, Venegas A, Ray LA.","Exp Clin Psychopharmacol. 2019 Jun;27(3):257-264. doi: 10.1037/pha0000252. Epub 2019 Jan 10.","Green R","Exp Clin Psychopharmacol","2019","2019/01/11","PMC7227763","NIHMS1048329","10.1037/pha0000252"
"30626554","Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation","Zhang T, Han Z, Shi X, Zhao W, Wang Z, Zhang R, Xu B, Zhang M, Zhang Q, Xiao J, Zhu H, Zheng T, Fang Q.","Bioorg Med Chem. 2019 Feb 15;27(4):630-643. doi: 10.1016/j.bmc.2019.01.003. Epub 2019 Jan 4.","Zhang T","Bioorg Med Chem","2019","2019/01/11","","","10.1016/j.bmc.2019.01.003"
"30624551","Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder","Yoon G, Petrakis IL, Krystal JH.","JAMA Psychiatry. 2019 Mar 1;76(3):337-338. doi: 10.1001/jamapsychiatry.2018.3990.","Yoon G","JAMA Psychiatry","2019","2019/01/10","PMC6439824","","10.1001/jamapsychiatry.2018.3990"
"30615514","Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities","Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M.","Health Aff (Millwood). 2019 Jan;38(1):14-23. doi: 10.1377/hlthaff.2018.05162.","Mojtabai R","Health Aff (Millwood)","2019","2019/01/08","PMC6816341","NIHMS1055968","10.1377/hlthaff.2018.05162"
"30589980","Gender-related issues in the pharmacology of new anti-obesity drugs","Cataldi M, Muscogiuri G, Savastano S, Barrea L, Guida B, Taglialatela M, Colao A.","Obes Rev. 2019 Mar;20(3):375-384. doi: 10.1111/obr.12805. Epub 2018 Dec 27.","Cataldi M","Obes Rev","2019","2018/12/28","","","10.1111/obr.12805"
"30585906","Medication-assisted treatment for opioid use disorder","Kaplan L.","Nurse Pract. 2019 Mar;44(3):10-12. doi: 10.1097/01.NPR.0000550252.04526.79.","Kaplan L","Nurse Pract","2019","2018/12/27","","","10.1097/01.NPR.0000550252.04526.79"
"30582992","The uses of naltrexone in dermatologic conditions","Lee B, Elston DM.","J Am Acad Dermatol. 2019 Jun;80(6):1746-1752. doi: 10.1016/j.jaad.2018.12.031. Epub 2018 Dec 21.","Lee B","J Am Acad Dermatol","2019","2018/12/25","","","10.1016/j.jaad.2018.12.031"
"30582909","The antihyperalgesic effect of docosahexaenoic acid in streptozotocin-induced neuropathic pain in the rat involves the opioidergic system","Landa-Juárez AY, Pérez-Severiano F, Castañeda-Hernández G, Ortiz MI, Chávez-Piña AE.","Eur J Pharmacol. 2019 Feb 15;845:32-39. doi: 10.1016/j.ejphar.2018.12.029. Epub 2018 Dec 21.","Landa-Juárez AY","Eur J Pharmacol","2019","2018/12/25","","","10.1016/j.ejphar.2018.12.029"
"30573023","Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers","Lim AC, Roche DJO, Ray LA.","J Stud Alcohol Drugs. 2018 Nov;79(6):918-928. doi: 10.15288/jsad.2018.79.918.","Lim AC","J Stud Alcohol Drugs","2018","2018/12/22","PMC6308171","","10.15288/jsad.2018.79.918"
"30573022","Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs","Finlay AK, Wong JJ, Ellerbe LS, Rubinsky A, Gupta S, Bowe TR, Schmidt EM, Timko C, Burden JL, Harris AHS.","J Stud Alcohol Drugs. 2018 Nov;79(6):909-917. doi: 10.15288/jsad.2018.79.909.","Finlay AK","J Stud Alcohol Drugs","2018","2018/12/22","PMC6308173","NIHMS988731","10.15288/jsad.2018.79.909"
"30566177","Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study","Latif ZE, Šaltyte Benth J, Solli KK, Opheim A, Kunoe N, Krajci P, Sharma-Haase K, Tanum L.","JAMA Psychiatry. 2019 Feb 1;76(2):127-134. doi: 10.1001/jamapsychiatry.2018.3537.","Latif ZE","JAMA Psychiatry","2019","2018/12/20","PMC6439739","","10.1001/jamapsychiatry.2018.3537"
"30557444","Being Explicit About Decisions: Prescribe Medications for Opioid Use Disorder on the Basis of Proven Effectiveness, Not Beliefs","Barocas JA, Saitz R.","Ann Intern Med. 2019 Jan 15;170(2):127-128. doi: 10.7326/M18-3293. Epub 2018 Dec 18.","Barocas JA","Ann Intern Med","2019","2018/12/18","","","10.7326/M18-3293"
"30555162","Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice","Anderson RI, Lopez MF, Griffin WC, Haun HL, Bloodgood DW, Pati D, Boyt KM, Kash TL, Becker HC.","Neuropsychopharmacology. 2019 May;44(6):1084-1092. doi: 10.1038/s41386-018-0294-3. Epub 2018 Dec 11.","Anderson RI","Neuropsychopharmacology","2019","2018/12/18","PMC6461883","","10.1038/s41386-018-0294-3"
"30553825","Locomotor and anti-immobility effects of buprenorphine in combination with the opioid receptor modulator samidorphan in rats","Burke NN, Ferdousi M, Deaver DR, Finn DP, Roche M, Kelly JP.","Neuropharmacology. 2019 Mar 1;146:327-336. doi: 10.1016/j.neuropharm.2018.12.012. Epub 2018 Dec 13.","Burke NN","Neuropharmacology","2019","2018/12/17","","","10.1016/j.neuropharm.2018.12.012"
"30545521","Lack of Opioid System in the Antidepressant Actions of Ketamine","Zhang K, Hashimoto K.","Biol Psychiatry. 2019 Mar 15;85(6):e25-e27. doi: 10.1016/j.biopsych.2018.11.006. Epub 2018 Dec 10.","Zhang K","Biol Psychiatry","2019","2018/12/15","","","10.1016/j.biopsych.2018.11.006"
"30541348","Intermittent blockade of OGFr and treatment of autoimmune disorders","Zagon IS, McLaughlin PJ.","Exp Biol Med (Maywood). 2018 Dec;243(17-18):1323-1330. doi: 10.1177/1535370218817746. Epub 2018 Dec 12.","Zagon IS","Exp Biol Med (Maywood)","2018","2018/12/14","PMC6348594","","10.1177/1535370218817746"
"30539185","Simultaneous extraction of acidic and basic drugs via on-chip electromembrane extraction using a single-compartment microfluidic device","Zarghampour F , Yamini Y , Baharfar M , Faraji M .","Analyst. 2019 Feb 11;144(4):1159-1166. doi: 10.1039/c8an01668b.","Zarghampour F","Analyst","2019","2018/12/13","","","10.1039/c8an01668b"
"30522370","Pharmacotherapy for opioid addiction in community corrections","Schwartz RP, Mitchell MM, O'Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Gordon MS, Jaffe JH.","Int Rev Psychiatry. 2018 Oct;30(5):117-135. doi: 10.1080/09540261.2018.1524373. Epub 2018 Dec 6.","Schwartz RP","Int Rev Psychiatry","2018","2018/12/08","PMC6551322","NIHMS1514646","10.1080/09540261.2018.1524373"
"30522048","Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual","Soares WE 3rd, Wilson D, Gordon MS, Lee JD, Nunes EV, O'Brien CP, Shroff M, Friedmann PD.","Drug Alcohol Depend. 2019 Jan 1;194:482-486. doi: 10.1016/j.drugalcdep.2018.10.035. Epub 2018 Dec 3.","Soares WE 3rd","Drug Alcohol Depend","2019","2018/12/07","PMC6354576","NIHMS1006132","10.1016/j.drugalcdep.2018.10.035"
"30506845","The efficacy of smoking cessation interventions in low- and middle-income countries: a systematic review and meta-analysis","Akanbi MO, Carroll AJ, Achenbach C, O'Dwyer LC, Jordan N, Hitsman B, Bilaver LA, McHugh MC, Murphy R.","Version 2. Addiction. 2019 Apr;114(4):620-635. doi: 10.1111/add.14518. Epub 2019 Jan 2.","Akanbi MO","Addiction","2019","2018/12/04","PMC6411424","NIHMS1000141","10.1111/add.14518"
"30500427","Antagonism of μ-opioid receptors reduces sensation seeking-like behavior in mice","Sikora M, Skupio U, Jastrzebska K, Rodriguez Parkitna J, Przewlocki R.","Behav Brain Res. 2019 Feb 1;359:498-501. doi: 10.1016/j.bbr.2018.11.039. Epub 2018 Nov 27.","Sikora M","Behav Brain Res","2019","2018/12/01","","","10.1016/j.bbr.2018.11.039"
"30485854","Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary Care","Castera P, Stewart E, Großkopf J, Brotons C, Brix Schou M, Zhang D, Steiniger Brach B, Meulien D; on behalf of the PICASO Study Investigators.","Eur Addict Res. 2018;24(6):293-303. doi: 10.1159/000494692. Epub 2018 Nov 28.","Castera P","Eur Addict Res","2018","2018/11/29","","","10.1159/000494692"
"30484835","Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review","Ekelem C, Juhasz M, Khera P, Mesinkovska NA.","JAMA Dermatol. 2019 Feb 1;155(2):229-236. doi: 10.1001/jamadermatol.2018.4093.","Ekelem C","JAMA Dermatol","2019","2018/11/29","","","10.1001/jamadermatol.2018.4093"
"30482648","[Drugs that require a visa, principle of equity and quality of care]","Muquebil Ali Al Shaban Rodriguez OW, Barrio Nespereira A, Álvarez Casariego MT.","J Healthc Qual Res. 2018 Nov-Dec;33(6):370-371. doi: 10.1016/j.jhqr.2018.09.003. Epub 2018 Nov 24.","Muquebil Ali Al Shaban Rodriguez OW","J Healthc Qual Res","2018","2018/11/29","","","10.1016/j.jhqr.2018.09.003"
"30459362","C-Terminal Residue of Ultrashort Peptides Impacts on Molecular Self-Assembly, Hydrogelation, and Interaction with Small-Molecule Drugs","Chan KH, Lee WH, Ni M, Loo Y, Hauser CAE.","Sci Rep. 2018 Nov 20;8(1):17127. doi: 10.1038/s41598-018-35431-2.","Chan KH","Sci Rep","2018","2018/11/22","PMC6244206","","10.1038/s41598-018-35431-2"
"30452137","Tackling addiction in primary care","Grahan B.","Minn Med. 2017 May;100(3):32-33.","Grahan B","Minn Med","2017","2018/11/20","","",""
"30451013","Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials","Lam L, Anand S, Li X, Tse ML, Zhao JX, Chan EW.","Clin Toxicol (Phila). 2019 Apr;57(4):225-233. doi: 10.1080/15563650.2018.1529317. Epub 2018 Nov 17.","Lam L","Clin Toxicol (Phila)","2019","2018/11/20","","","10.1080/15563650.2018.1529317"
"30448421","Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat","Smith KL, Cunningham JI, Eyerman DJ, Dean RL 3rd, Deaver DR, Sanchez C.","Neuropharmacology. 2019 Mar 1;146:316-326. doi: 10.1016/j.neuropharm.2018.11.015. Epub 2018 Nov 15.","Smith KL","Neuropharmacology","2019","2018/11/19","","","10.1016/j.neuropharm.2018.11.015"
"30446313","Discovery of naldemedine: A potent and orally available opioid receptor antagonist for treatment of opioid-induced adverse effects","Inagaki M, Kume M, Tamura Y, Hara S, Goto Y, Haga N, Hasegawa T, Nakamura T, Koike K, Oonishi S, Kanemasa T, Kai H.","Bioorg Med Chem Lett. 2019 Jan 1;29(1):73-77. doi: 10.1016/j.bmcl.2018.11.007. Epub 2018 Nov 7.","Inagaki M","Bioorg Med Chem Lett","2019","2018/11/18","","","10.1016/j.bmcl.2018.11.007"
"30445275","Effects of time-varying changes in tobacco and alcohol use on depressive symptoms following pharmaco-behavioral treatment for smoking and heavy drinking","Lechner WV, Sidhu NK, Cioe PA, Kahler CW.","Drug Alcohol Depend. 2019 Jan 1;194:173-177. doi: 10.1016/j.drugalcdep.2018.09.030. Epub 2018 Nov 6.","Lechner WV","Drug Alcohol Depend","2019","2018/11/17","","","10.1016/j.drugalcdep.2018.09.030"
"30421743","[Use of drugs for alcohol use disorder in Norway 2004–16]","Heldal AT, Skurtveit S, Lobmaier PPK, Vederhus JK, Bramness JG.","Tidsskr Nor Laegeforen. 2018 Nov 8;138(18). doi: 10.4045/tidsskr.18.0383. Print 2018 Nov 13.","Heldal AT","Tidsskr Nor Laegeforen","2018","2018/11/14","","","10.4045/tidsskr.18.0383"
"30418735","Ethanol and Naltrexone Have Distinct Effects on the Lateral Nano-organization of Mu and Kappa Opioid Receptors in the Plasma Membrane","Tobin SJ, Wakefield DL, Terenius L, Vukojević V, Jovanović-Talisman T.","ACS Chem Neurosci. 2019 Jan 16;10(1):667-676. doi: 10.1021/acschemneuro.8b00488. Epub 2018 Nov 12.","Tobin SJ","ACS Chem Neurosci","2019","2018/11/13","","","10.1021/acschemneuro.8b00488"
"30403896","Morphine sulfate abuse-deterrent formulations for the treatment of chronic pain","Fanelli A, Sorella MC, Ghisi D.","Expert Rev Clin Pharmacol. 2018 Dec;11(12):1157-1162. doi: 10.1080/17512433.2018.1545573. Epub 2018 Nov 17.","Fanelli A","Expert Rev Clin Pharmacol","2018","2018/11/08","","","10.1080/17512433.2018.1545573"
"30401680","Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys","Maguire DR, Gerak LR, Woods JH, Husbands SM, Disney A, France CP.","J Pharmacol Exp Ther. 2019 Jan;368(1):88-99. doi: 10.1124/jpet.118.252353. Epub 2018 Nov 6.","Maguire DR","J Pharmacol Exp Ther","2019","2018/11/08","","","10.1124/jpet.118.252353"
"30384381","Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach","Sluiter RL, Kievit W, van der Wilt GJ, Schene AH, Teichert M, Coenen MJH, Schellekens A.","Eur Addict Res. 2018;24(5):245-254. doi: 10.1159/000494127. Epub 2018 Nov 1.","Sluiter RL","Eur Addict Res","2018","2018/11/02","PMC6492516","","10.1159/000494127"
"30384323","An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI","Maggio SE, Saunders MA, Nixon K, Prendergast MA, Zheng G, Crooks PA, Dwoskin LP, Bell RL, Bardo MT.","Drug Alcohol Depend. 2018 Dec 1;193:154-161. doi: 10.1016/j.drugalcdep.2018.09.008. Epub 2018 Oct 17.","Maggio SE","Drug Alcohol Depend","2018","2018/11/02","PMC6239925","NIHMS1510904","10.1016/j.drugalcdep.2018.09.008"
"30373394","State-of-the-art behavioral and pharmacological treatments for alcohol use disorder","Ray LA PhD, Bujarski S PhD, Grodin E PhD, Hartwell E PhD, Green R MA, Venegas A BS, Lim AC MA, Gillis A MD, Miotto K MD.","Am J Drug Alcohol Abuse. 2019;45(2):124-140. doi: 10.1080/00952990.2018.1528265. Epub 2018 Oct 29.","Ray LA PhD","Am J Drug Alcohol Abuse","2019","2018/10/31","PMC6430676","NIHMS1520410","10.1080/00952990.2018.1528265"
"30352669","Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science","Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS.","J Subst Abuse Treat. 2018 Dec;95:43-47. doi: 10.1016/j.jsat.2018.09.006. Epub 2018 Oct 2.","Finlay AK","J Subst Abuse Treat","2018","2018/10/25","PMC6209329","NIHMS990870","10.1016/j.jsat.2018.09.006"
"30351180","Absorption, distribution, metabolism, and excretion of radiolabeled naldemedine in healthy subjects","Ohnishi S, Fukumura K, Kubota R, Wajima T.","Xenobiotica. 2019 Sep;49(9):1044-1053. doi: 10.1080/00498254.2018.1536815. Epub 2019 Jan 4.","Ohnishi S","Xenobiotica","2019","2018/10/24","","","10.1080/00498254.2018.1536815"
"30348514","Pharmacokinetics and Short-term Safety of ALKS 3831, a Fixed-dose Combination of Olanzapine and Samidorphan, in Adult Subjects with Schizophrenia","Sun L, McDonnell D, von Moltke L.","Clin Ther. 2018 Nov;40(11):1845-1854.e2. doi: 10.1016/j.clinthera.2018.09.002. Epub 2018 Oct 20.","Sun L","Clin Ther","2018","2018/10/24","","","10.1016/j.clinthera.2018.09.002"
"30345640","Extended-release injectable naltrexone (XR-NTX): a response to clinical issues raised by Brewer & Streel","Jarvis BP, Holtyn AF, Subramaniam S, Tompkins DA, Oga EA, Bigelow G, Silverman K.","Addiction. 2019 Jan;114(1):189-190. doi: 10.1111/add.14462. Epub 2018 Oct 30.","Jarvis BP","Addiction","2019","2018/10/23","","","10.1111/add.14462"
"30345573","Long-acting naltrexone has long-acting benefits and 100% induction rates are not difficult to achieve","Brewer C, Streel E.","Addiction. 2019 Jan;114(1):188-189. doi: 10.1111/add.14448. Epub 2018 Oct 30.","Brewer C","Addiction","2019","2018/10/23","","","10.1111/add.14448"
"30336703","A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder","Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, Levin FR, Mariani JJ, Nunes EV.","Am J Psychiatry. 2019 Feb 1;176(2):129-137. doi: 10.1176/appi.ajp.2018.17070732. Epub 2018 Oct 19.","Sullivan MA","Am J Psychiatry","2019","2018/10/20","PMC6358483","NIHMS1007341","10.1176/appi.ajp.2018.17070732"
"30322803","A delta opioid receptor agonist, KNT-127, in the prelimbic medial prefrontal cortex attenuates glial glutamate transporter blocker-induced anxiety-like behavior in mice","Saitoh A, Soda A, Kayashima S, Yoshizawa K, Oka JI, Nagase H, Yamada M.","J Pharmacol Sci. 2018 Nov;138(3):176-183. doi: 10.1016/j.jphs.2018.09.009. Epub 2018 Sep 27.","Saitoh A","J Pharmacol Sci","2018","2018/10/17","","","10.1016/j.jphs.2018.09.009"
"30322454","New opioid receptor modulators and agonists","Kaye AD, Cornett EM, Patil SS, Gennuso SA, Colontonio MM, Latimer DR, Kaye AJ, Urman RD, Vadivelu N.","Best Pract Res Clin Anaesthesiol. 2018 Jun;32(2):125-136. doi: 10.1016/j.bpa.2018.06.009. Epub 2018 Jul 2.","Kaye AD","Best Pract Res Clin Anaesthesiol","2018","2018/10/17","","","10.1016/j.bpa.2018.06.009"
"30320880","Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence","Matzeu A, Terenius L, Martin-Fardon R.","Alcohol Clin Exp Res. 2018 Dec;42(12):2466-2478. doi: 10.1111/acer.13898. Epub 2018 Oct 28.","Matzeu A","Alcohol Clin Exp Res","2018","2018/10/16","PMC6286204","NIHMS992442","10.1111/acer.13898"
"30318564","Involvement of central opioid receptors in protective effects of methadone on experimental colitis in rats","Fakhraei N, Javadian N, Rahimian R, Nili F, Rahimi N, Hashemizadeh S, Dehpour AR.","Inflammopharmacology. 2018 Dec;26(6):1399-1413. doi: 10.1007/s10787-018-0538-1. Epub 2018 Oct 15.","Fakhraei N","Inflammopharmacology","2018","2018/10/16","","","10.1007/s10787-018-0538-1"
"30312327","Early life adversity diminishes the cortisol response to opioid blockade in women: Studies from the Family Health Patterns project","Lovallo WR, Acheson A, Vincent AS, Sorocco KH, Cohoon AJ.","PLoS One. 2018 Oct 12;13(10):e0205723. doi: 10.1371/journal.pone.0205723. eCollection 2018.","Lovallo WR","PLoS One","2018","2018/10/13","PMC6185842","","10.1371/journal.pone.0205723"
"30300800","Accounting for the uncounted: Physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder","Carroll KM, Nich C, Frankforter TL, Yip SW, Kiluk BD, DeVito EE, Sofuoglu M.","Drug Alcohol Depend. 2018 Nov 1;192:264-270. doi: 10.1016/j.drugalcdep.2018.08.019. Epub 2018 Oct 4.","Carroll KM","Drug Alcohol Depend","2018","2018/10/10","PMC6203294","NIHMS1509425","10.1016/j.drugalcdep.2018.08.019"
"30293449","Extended-release morphine sulfate and naltrexone hydrochloride (EMBEDA): naltrexone-associated withdrawal and abuse-related effects in patients with chronic pain and recreational opioid users","Setnik B, Sommerville KW, Pixton GC, Webster L.","Curr Med Res Opin. 2019 Mar;35(3):503-512. doi: 10.1080/03007995.2018.1533457. Epub 2018 Nov 20.","Setnik B","Curr Med Res Opin","2019","2018/10/09","","","10.1080/03007995.2018.1533457"
"30290204","Short term exposure to oxycodone alters the survival, proliferation and differentiation of rat embryonic neural stem cell in vitro","Wu G, Zhao X, Wang F, Tan R, Wang J, Li X, Chen C, An J, Lu H.","Brain Res Bull. 2018 Oct;143:66-72. doi: 10.1016/j.brainresbull.2018.09.019. Epub 2018 Oct 2.","Wu G","Brain Res Bull","2018","2018/10/06","","","10.1016/j.brainresbull.2018.09.019"
"30286124","The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma","Machado MC, da Costa-Neto JM, Portela RD, D'Assis MJMH, Martins-Filho OA, Barrouin-Melo SM, Borges NF, Silva FL, Estrela-Lima A.","PLoS One. 2018 Oct 4;13(10):e0204830. doi: 10.1371/journal.pone.0204830. eCollection 2018.","Machado MC","PLoS One","2018","2018/10/05","PMC6171873","","10.1371/journal.pone.0204830"
"30281924","Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects","Saiz-Rodríguez M, Ochoa D, Herrador C, Belmonte C, Román M, Alday E, Koller D, Zubiaur P, Mejía G, Hernández-Martínez M, Abad-Santos F.","Basic Clin Pharmacol Toxicol. 2019 Mar;124(3):321-329. doi: 10.1111/bcpt.13141. Epub 2018 Oct 30.","Saiz-Rodríguez M","Basic Clin Pharmacol Toxicol","2019","2018/10/04","","","10.1111/bcpt.13141"
"30280262","Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine","Kubota R, Fukumura K, Wajima T.","Pharm Res. 2018 Oct 2;35(11):225. doi: 10.1007/s11095-018-2501-7.","Kubota R","Pharm Res","2018","2018/10/04","PMC6182381","","10.1007/s11095-018-2501-7"
"30277930","Identifying and Treating Opioid Side Effects: The Development of Methylnaltrexone","Moss J.","Anesthesiology. 2019 Jan;130(1):142-148. doi: 10.1097/ALN.0000000000002428.","Moss J","Anesthesiology","2019","2018/10/03","","","10.1097/ALN.0000000000002428"
"30266003","A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder","Kohno M, Dennis LE, McCready H, Schwartz DL, Hoffman WF, Korthuis PT.","Drug Alcohol Depend. 2018 Nov 1;192:186-192. doi: 10.1016/j.drugalcdep.2018.07.045. Epub 2018 Sep 21.","Kohno M","Drug Alcohol Depend","2018","2018/09/29","PMC6200637","NIHMS992021","10.1016/j.drugalcdep.2018.07.045"
"30260366","Therapeutic Drug Monitoring of Naltrexone and 6β-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference Ranges","Brünen S, Bekier NK, Hiemke C, Korf F, Wiedemann K, Jahn H, Kiefer F.","Alcohol Alcohol. 2019 Jan 1;54(1):51-55. doi: 10.1093/alcalc/agy067.","Brünen S","Alcohol Alcohol","2019","2018/09/28","","","10.1093/alcalc/agy067"
"30257396","Broccoli sprouts produce abdominal antinociception but not spasmolytic effects like its bioactive metabolite sulforaphane","Guadarrama-Enríquez O, González-Trujano ME, Ventura-Martínez R, Rodríguez R, Ángeles-López GE, Reyes-Chilpa R, Baenas N, Moreno DA.","Biomed Pharmacother. 2018 Nov;107:1770-1778. doi: 10.1016/j.biopha.2018.09.010. Epub 2018 Sep 11.","Guadarrama-Enríquez O","Biomed Pharmacother","2018","2018/09/28","","","10.1016/j.biopha.2018.09.010"
"30251424","Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France","Chaignot C, Zureik M, Rey G, Dray-Spira R, Coste J, Weill A.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1239-1248. doi: 10.1002/pds.4635. Epub 2018 Sep 25.","Chaignot C","Pharmacoepidemiol Drug Saf","2018","2018/09/26","PMC6282718","","10.1002/pds.4635"
"30246915","Successful treatment of dermatomyositis with low-dose naltrexone","Tran T, Chen A, Worswick S.","Dermatol Ther. 2018 Nov;31(6):e12720. doi: 10.1111/dth.12720. Epub 2018 Sep 24.","Tran T","Dermatol Ther","2018","2018/09/25","","","10.1111/dth.12720"
"30238780","The use of naltrexone in pathological and problem gambling: A UK case series","Ward S, Smith N, Bowden-Jones H.","J Behav Addict. 2018 Sep 1;7(3):827-833. doi: 10.1556/2006.7.2018.89. Epub 2018 Sep 21.","Ward S","J Behav Addict","2018","2018/09/22","PMC6426388","","10.1556/2006.7.2018.89"
"30237513","Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist","Wang YH, Chai JR, Xu XJ, Ye RF, Zan GY, Liu GY, Long JD, Ma Y, Huang X, Xiao ZC, Dong H, Wang YJ.","Sci Rep. 2018 Sep 20;8(1):14087. doi: 10.1038/s41598-018-32568-y.","Wang YH","Sci Rep","2018","2018/09/22","PMC6148296","","10.1038/s41598-018-32568-y"
"30232543","Ameliorating the adverse cardiorespiratory effects of chemical immobilization by inducing general anaesthesia in sheep and goats: implications for physiological studies of large wild mammals","Izwan A, Snelling EP, Seymour RS, Meyer LCR, Fuller A, Haw A, Mitchell D, Farrell AP, Costello MA, Maloney SK.","J Comp Physiol B. 2018 Nov;188(6):991-1003. doi: 10.1007/s00360-018-1184-z. Epub 2018 Sep 19.","Izwan A","J Comp Physiol B","2018","2018/09/21","","","10.1007/s00360-018-1184-z"
"30212383","Sex differences in the effectiveness of buprenorphine to decrease rates of responding in rhesus monkeys","Schwienteck KL, Negus SS, Banks ML.","Behav Pharmacol. 2019 Jun;30(4):358-362. doi: 10.1097/FBP.0000000000000437.","Schwienteck KL","Behav Pharmacol","2019","2018/09/14","PMC6414288","NIHMS1504543","10.1097/FBP.0000000000000437"
"30211703","CE: Acute Pain Management for People with Opioid Use Disorder","Broglio K, Matzo M.","Am J Nurs. 2018 Oct;118(10):30-38. doi: 10.1097/01.NAJ.0000546378.81550.84.","Broglio K","Am J Nurs","2018","2018/09/14","","","10.1097/01.NAJ.0000546378.81550.84"
"30208470","Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder","Hadland SE, Bagley SM, Rodean J, Silverstein M, Levy S, Larochelle MR, Samet JH, Zima BT.","Version 2. JAMA Pediatr. 2018 Nov 1;172(11):1029-1037. doi: 10.1001/jamapediatrics.2018.2143.","Hadland SE","JAMA Pediatr","2018","2018/09/13","PMC6218311","NIHMS989582","10.1001/jamapediatrics.2018.2143"
"30207769","The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System","Clarke JG, Martin RA, Gresko SA, Rich JD.","Am J Public Health. 2018 Oct;108(10):1323-1325. doi: 10.2105/AJPH.2018.304666.","Clarke JG","Am J Public Health","2018","2018/09/13","PMC6137785","","10.2105/AJPH.2018.304666"
"30204703","Pregnancy and Naltrexone Pharmacotherapy","Jones CW, Terplan M.","Obstet Gynecol. 2018 Oct;132(4):923-925. doi: 10.1097/AOG.0000000000002864.","Jones CW","Obstet Gynecol","2018","2018/09/12","","","10.1097/AOG.0000000000002864"
"30197228","[Illogical association nalmefene and opioids: Analysis in the French pharmacovigilance database]","Favrelière S, Lafay-Chebassier C, Fauconneau B, Quillet A, Yéléhé-Okouma M, Montastruc F, Pérault-Pochat MC.","Therapie. 2019 Jun;74(3):369-374. doi: 10.1016/j.therap.2018.06.004. Epub 2018 Aug 3.","Favrelière S","Therapie","2019","2018/09/11","","","10.1016/j.therap.2018.06.004"
"30189347","Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders?","Pannemans J, Corsetti M.","Curr Opin Pharmacol. 2018 Dec;43:53-58. doi: 10.1016/j.coph.2018.08.008. Epub 2018 Sep 3.","Pannemans J","Curr Opin Pharmacol","2018","2018/09/07","","","10.1016/j.coph.2018.08.008"
"30188587","Evaluation of samidorphan, a μ-opioid antagonist, in a drug discrimination assay in rats","Sgro MP, Modlin DL, Deaver DR, Kallman MJ, Todtenkopf MS.","Drug Dev Res. 2018 Aug;79(5):234-238. doi: 10.1002/ddr.21437.","Sgro MP","Drug Dev Res","2018","2018/09/07","","","10.1002/ddr.21437"
"30180001","Integration of Medication-Assisted Treatment Information for Opioid Use Disorders Into a Graduate Nursing Curriculum","Kameg B, Kaufman R, Lindsay D, Mitchell AM.","J Addict Nurs. 2018 Jul/Sep;29(3):163-166. doi: 10.1097/JAN.0000000000000232.","Kameg B","J Addict Nurs","2018","2018/09/05","","","10.1097/JAN.0000000000000232"
"30173086","Pharmacotherapy for amphetamine dependence: A systematic review","Lee NK, Jenner L, Harney A, Cameron J.","Drug Alcohol Depend. 2018 Oct 1;191:309-337. doi: 10.1016/j.drugalcdep.2018.06.038. Epub 2018 Aug 22.","Lee NK","Drug Alcohol Depend","2018","2018/09/03","","","10.1016/j.drugalcdep.2018.06.038"
"30170259","Acute foot-shock stress decreased seizure susceptibility against pentylenetetrazole-induced seizures in mice: Interaction between endogenous opioids and cannabinoids","Shirzadian A, Ostadhadi S, Hassanipour M, Shafaroodi H, Khoshnoodi M, Haj-Mirzaian A, Sharifzadeh M, Amiri S, Ghasemi M, Dehpour AR.","Epilepsy Behav. 2018 Oct;87:25-31. doi: 10.1016/j.yebeh.2018.06.035. Epub 2018 Aug 28.","Shirzadian A","Epilepsy Behav","2018","2018/09/01","","","10.1016/j.yebeh.2018.06.035"
"30167705","Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review","Kranzler HR, Soyka M.","JAMA. 2018 Aug 28;320(8):815-824. doi: 10.1001/jama.2018.11406.","Kranzler HR","JAMA","2018","2018/09/01","","","10.1001/jama.2018.11406"
"30153752","Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism","Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, Hawkins J, Birnbaum J, Lyons DM, Rodriguez CI, Schatzberg AF.","Am J Psychiatry. 2018 Dec 1;175(12):1205-1215. doi: 10.1176/appi.ajp.2018.18020138. Epub 2018 Aug 29.","Williams NR","Am J Psychiatry","2018","2018/08/30","PMC6395554","NIHMS1505882","10.1176/appi.ajp.2018.18020138"
"30138015","Drinking goals and attainment in a naltrexone trial of young adult heavy drinkers","DeMartini KS, Foster DW, Corbin WR, Fucito LM, Romano D, Leeman RF, Kranzler HR, O'Malley SS.","J Consult Clin Psychol. 2018 Sep;86(9):765-774. doi: 10.1037/ccp0000323.","DeMartini KS","J Consult Clin Psychol","2018","2018/08/24","PMC6435339","NIHMS973305","10.1037/ccp0000323"
"30124761","Predictors of Daily Adherence to Naltrexone for Alcohol Use Disorder Treatment During a Mobile Health Intervention","Dermody SS, Wardell JD, Stoner SA, Hendershot CS.","Version 2. Ann Behav Med. 2018 Aug 16;52(9):787-797. doi: 10.1093/abm/kax053.","Dermody SS","Ann Behav Med","2018","2018/08/21","PMC6105286","NIHMS984464","10.1093/abm/kax053"
"30115121","Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)","Morley KC, Kranzler HR, Luquin N, Baillie A, Shanahan M, Trent R, Teesson M, Haber PS.","Trials. 2018 Aug 16;19(1):443. doi: 10.1186/s13063-018-2824-z.","Morley KC","Trials","2018","2018/08/18","PMC6097336","","10.1186/s13063-018-2824-z"
"30108159","In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder","Bidlack JM, Knapp BI, Deaver DR, Plotnikava M, Arnelle D, Wonsey AM, Fern Toh M, Pin SS, Namchuk MN.","J Pharmacol Exp Ther. 2018 Nov;367(2):267-281. doi: 10.1124/jpet.118.249839. Epub 2018 Aug 14.","Bidlack JM","J Pharmacol Exp Ther","2018","2018/08/16","","","10.1124/jpet.118.249839"
"30106494","Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial","Campbell ANC, Barbosa-Leiker C, Hatch-Maillette M, Mennenga SE, Pavlicova M, Scodes J, Saraiya T, Mitchell SG, Rotrosen J, Novo P, Nunes EV, Greenfield SF.","Am J Addict. 2018 Sep;27(6):465-470. doi: 10.1111/ajad.12784. Epub 2018 Aug 14.","Campbell ANC","Am J Addict","2018","2018/08/15","PMC6124662","NIHMS986423","10.1111/ajad.12784"
"30106489","Adherence to extended release naltrexone: Patient and treatment characteristics","Chang G, Crawford M, Pitts M, Schein AZ, Goodwin K, Enggasser JL.","Am J Addict. 2018 Sep;27(6):524-530. doi: 10.1111/ajad.12786. Epub 2018 Aug 14.","Chang G","Am J Addict","2018","2018/08/15","","","10.1111/ajad.12786"
"30097301","Telemedicine's Role in Addressing the Opioid Epidemic","Yang YT, Weintraub E, Haffajee RL.","Mayo Clin Proc. 2018 Sep;93(9):1177-1180. doi: 10.1016/j.mayocp.2018.07.001. Epub 2018 Aug 7.","Yang YT","Mayo Clin Proc","2018","2018/08/12","PMC6330237","NIHMS1004632","10.1016/j.mayocp.2018.07.001"
"30096639","Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study","Guterstam J, Jayaram-Lindström N, Berrebi J, Petrovic P, Ingvar M, Fransson P, Franck J.","Drug Alcohol Depend. 2018 Oct 1;191:91-97. doi: 10.1016/j.drugalcdep.2018.06.023. Epub 2018 Jul 26.","Guterstam J","Drug Alcohol Depend","2018","2018/08/11","","","10.1016/j.drugalcdep.2018.06.023"
"30092933","Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy","Harrison TK, Kornfeld H, Aggarwal AK, Lembke A.","Anesthesiol Clin. 2018 Sep;36(3):345-359. doi: 10.1016/j.anclin.2018.04.002. Epub 2018 Jul 11.","Harrison TK","Anesthesiol Clin","2018","2018/08/11","","","10.1016/j.anclin.2018.04.002"
"30086873","New treatment modalities for obesity","Grandone A, Di Sessa A, Umano GR, Toraldo R, Miraglia Del Giudice E.","Best Pract Res Clin Endocrinol Metab. 2018 Aug;32(4):535-549. doi: 10.1016/j.beem.2018.06.007. Epub 2018 Jun 25.","Grandone A","Best Pract Res Clin Endocrinol Metab","2018","2018/08/09","","","10.1016/j.beem.2018.06.007"
"30081338","Predictors of treatment initiation for alcohol use disorders in primary care","Watkins KE, Ober A, McCullough C, Setodji C, Lamp K, Lind M, Hunter SB, Chan Osilla K.","Drug Alcohol Depend. 2018 Oct 1;191:56-62. doi: 10.1016/j.drugalcdep.2018.06.021. Epub 2018 Jul 24.","Watkins KE","Drug Alcohol Depend","2018","2018/08/07","PMC6141324","NIHMS985773","10.1016/j.drugalcdep.2018.06.021"
"30076211","Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion","Abraham AD, Schattauer SS, Reichard KL, Cohen JH, Fontaine HM, Song AJ, Johnson SD, Land BB, Chavkin C.","J Neurosci. 2018 Sep 12;38(37):8031-8043. doi: 10.1523/JNEUROSCI.0653-18.2018. Epub 2018 Aug 3.","Abraham AD","J Neurosci","2018","2018/08/05","PMC6136151","","10.1523/JNEUROSCI.0653-18.2018"
"30075159","Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis","Erikson CM, Wei G, Walker BM.","Neuropharmacology. 2018 Sep 15;140:162-173. doi: 10.1016/j.neuropharm.2018.07.034. Epub 2018 Jul 31.","Erikson CM","Neuropharmacology","2018","2018/08/04","PMC6232846","NIHMS992932","10.1016/j.neuropharm.2018.07.034"
"30073637","Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial","Edelman EJ, Moore BA, Holt SR, Hansen N, Kyriakides TC, Virata M, Brown ST, Justice AC, Bryant KJ, Fiellin DA, Fiellin LE.","AIDS Behav. 2019 Jan;23(1):211-221. doi: 10.1007/s10461-018-2241-z.","Edelman EJ","AIDS Behav","2019","2018/08/04","PMC6476298","NIHMS1502587","10.1007/s10461-018-2241-z"
"30073490","Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone","Binswanger IA, Glanz JM.","Drug Saf. 2018 Oct;41(10):979-980. doi: 10.1007/s40264-018-0705-8.","Binswanger IA","Drug Saf","2018","2018/08/04","PMC6366853","NIHMS1502590","10.1007/s40264-018-0705-8"
"30073471","Life satisfaction and pain interference in spine surgery patients before and after surgery: comparison between on-opioid and opioid-naïve patients","Kuronen M, Kokki H, Nyyssönen T, Savolainen S, Kokki M.","Qual Life Res. 2018 Nov;27(11):3013-3020. doi: 10.1007/s11136-018-1961-x. Epub 2018 Aug 2.","Kuronen M","Qual Life Res","2018","2018/08/04","","","10.1007/s11136-018-1961-x"
"30068260","Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime","Molero Y, Zetterqvist J, Binswanger IA, Hellner C, Larsson H, Fazel S.","Am J Psychiatry. 2018 Oct 1;175(10):970-978. doi: 10.1176/appi.ajp.2018.17101112. Epub 2018 Aug 2.","Molero Y","Am J Psychiatry","2018","2018/08/03","PMC6169735","EMS79141","10.1176/appi.ajp.2018.17101112"
"30066134","Administration of a delta opioid receptor agonist KNT-127 to the basolateral amygdala has robust anxiolytic-like effects in rats","Sugiyama A, Yamada M, Saitoh A, Nagase H, Oka JI, Yamada M.","Psychopharmacology (Berl). 2018 Oct;235(10):2947-2955. doi: 10.1007/s00213-018-4984-7. Epub 2018 Jul 31.","Sugiyama A","Psychopharmacology (Berl)","2018","2018/08/02","","","10.1007/s00213-018-4984-7"
"30059816","Study characteristics influence the efficacy of substance abuse treatments: A meta-analysis of medications for alcohol use disorder","Klemperer EM, Hughes JR, Naud S.","Drug Alcohol Depend. 2018 Sep 1;190:229-234. doi: 10.1016/j.drugalcdep.2018.06.015. Epub 2018 Jul 24.","Klemperer EM","Drug Alcohol Depend","2018","2018/07/31","","","10.1016/j.drugalcdep.2018.06.015"
"30059574","A comparison between phase-III trials and a phase-IV study of nalmefene in alcohol use disorder patients. Is there a difference?","Barrio Giménez P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.","Adicciones. 2019 Sep 1;31(4):284-288. doi: 10.20882/adicciones.1046.","Barrio Giménez P","Adicciones","2019","2018/07/31","","","10.20882/adicciones.1046"
"30055046","Effects of the Opioid System Modulator, Samidorphan, on Measures of Alcohol Consumption and Patient-Reported Outcomes in Adults with Alcohol Dependence","O'Malley SS, Todtenkopf MS, Du Y, Ehrich E, Silverman BL.","Alcohol Clin Exp Res. 2018 Oct;42(10):2011-2021. doi: 10.1111/acer.13849. Epub 2018 Aug 13.","O'Malley SS","Alcohol Clin Exp Res","2018","2018/07/29","","","10.1111/acer.13849"
"30048644","Naltrexone and nalmefene attenuate cocaine place preference in male mice","Windisch KA, Reed B, Kreek MJ.","Neuropharmacology. 2018 Sep 15;140:174-183. doi: 10.1016/j.neuropharm.2018.07.025. Epub 2018 Jul 23.","Windisch KA","Neuropharmacology","2018","2018/07/27","","","10.1016/j.neuropharm.2018.07.025"
"30048283","Overview of Drugs Used to Treat Opioid Use Disorder","Aschenbrenner DS.","Am J Nurs. 2018 Aug;118(8):25. doi: 10.1097/01.NAJ.0000544161.29445.db.","Aschenbrenner DS","Am J Nurs","2018","2018/07/27","","","10.1097/01.NAJ.0000544161.29445.db"
"30042276","[A New Twist on the Administration of Naldemedine for Opioid-Induced Constipation in an Outpatient]","Shikada Y, Emi Y, Kometani T, Ochiai T, Fujii M, Noda Y, Kajiwara M, Ikeda M, Asonuma S, Mori M.","Gan To Kagaku Ryoho. 2018 Jul;45(7):1075-1079.","Shikada Y","Gan To Kagaku Ryoho","2018","2018/07/26","","",""
"30032950","High drug related mortality rates following prison release: Assessing the acceptance likelihood of a naltrexone injection and related concerns","Murphy PN, Mohammed F, Wareing M, Cotton A, McNeill J, Irving P, Jones S, Sharples L, Monk R, Elton P.","J Subst Abuse Treat. 2018 Sep;92:91-98. doi: 10.1016/j.jsat.2018.07.002. Epub 2018 Jul 4.","Murphy PN","J Subst Abuse Treat","2018","2018/07/24","","","10.1016/j.jsat.2018.07.002"
"30031019","Evaluation of alcohol use disorders pharmacotherapies in a new preclinical model of binge drinking","González-Marín MC, Lebourgeois S, Jeanblanc J, Diouf M, Naassila M.","Neuropharmacology. 2018 Sep 15;140:14-24. doi: 10.1016/j.neuropharm.2018.07.015. Epub 2018 Jul 19.","González-Marín MC","Neuropharmacology","2018","2018/07/22","","","10.1016/j.neuropharm.2018.07.015"
"30028058","Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone","Mannelli P, Swartz M, Wu LT.","Am J Addict. 2018 Sep;27(6):471-476. doi: 10.1111/ajad.12763. Epub 2018 Jul 20.","Mannelli P","Am J Addict","2018","2018/07/21","","","10.1111/ajad.12763"
"30021181","Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report","Muller G, Grieshaber R, Talley JF, Riepl M, Fellows D.","Int J Pharm Compd. 2018 Jul-Aug;22(4):270-278.","Muller G","Int J Pharm Compd","2018","2018/07/19","","",""
"30020107","Methylnaltrexone-Associated Bowel Perforation in Postoperative Opioid-Induced Constipation and Ogilvie Syndrome: A Case Report","Blackney KA, Kamdar NV, Liu CA, Edwards DA.","A A Pract. 2019 Jan 15;12(2):44-46. doi: 10.1213/XAA.0000000000000840.","Blackney KA","A A Pract","2019","2018/07/19","","","10.1213/XAA.0000000000000840"
"30012803","Extended-release naltrexone overlooked in opioid use disorders guideline","Rieb LM.","CMAJ. 2018 Jul 16;190(28):E862. doi: 10.1503/cmaj.69411.","Rieb LM","CMAJ","2018","2018/07/18","PMC6050113","","10.1503/cmaj.69411"
"30003479","Post-intervention Durability of Alcohol Care Management: 1-Year Follow-up of a Randomized Controlled Trial","Rotenberg JR, Leong SH, Maisto SA, McKay JR, Possemato K, Ingram E, Oslin DW.","J Gen Intern Med. 2018 Oct;33(10):1626-1628. doi: 10.1007/s11606-018-4567-7.","Rotenberg JR","J Gen Intern Med","2018","2018/07/14","PMC6153255","","10.1007/s11606-018-4567-7"
"30001114","Methylation Products of 6β- N-Heterocyclic Substituted Naltrexamine Derivatives as Potential Peripheral Opioid Receptor Modulators","Zheng Y, Obeng S, Wang H, Stevens DL, Komla E, Selley DE, Dewey WL, Akbarali HI, Zhang Y.","ACS Chem Neurosci. 2018 Dec 19;9(12):3028-3037. doi: 10.1021/acschemneuro.8b00234. Epub 2018 Jul 23.","Zheng Y","ACS Chem Neurosci","2018","2018/07/13","PMC6344324","NIHMS989182","10.1021/acschemneuro.8b00234"
"29979903","Methylnaltrexone bromide for the treatment of opioid-induced constipation","Mozaffari S, Nikfar S, Abdollahi M.","Expert Opin Pharmacother. 2018 Jul;19(10):1127-1135. doi: 10.1080/14656566.2018.1491549. Epub 2018 Jul 6.","Mozaffari S","Expert Opin Pharmacother","2018","2018/07/07","","","10.1080/14656566.2018.1491549"
"29972745","Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment","Saloner B, Stoller KB, Alexander GC.","N Engl J Med. 2018 Jul 5;379(1):4-6. doi: 10.1056/NEJMp1804059.","Saloner B","N Engl J Med","2018","2018/07/05","PMC6522243","NIHMS1022585","10.1056/NEJMp1804059"
"29958944","Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians","Dziedowiec E, Nayak SU, Gruver KS, Jennings T, Tallarida CS, Rawls SM.","Neuroscience. 2018 Aug 21;386:214-222. doi: 10.1016/j.neuroscience.2018.06.029. Epub 2018 Jun 27.","Dziedowiec E","Neuroscience","2018","2018/07/01","PMC6086122","NIHMS978171","10.1016/j.neuroscience.2018.06.029"
"29956220","Comment on ""Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence""","Silverman B, Bloomgren G, Jain P, Marcopul K, Silveira A, Fratantonio J, Sullivan M, Akerman S.","Drug Saf. 2018 Oct;41(10):991-993. doi: 10.1007/s40264-018-0691-x.","Silverman B","Drug Saf","2018","2018/06/30","PMC6153963","","10.1007/s40264-018-0691-x"
"29956219","Authors' Response to Silverman and Colleagues' Comment on ""Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence""","Dasgupta N, Saucier R, Wolfe D.","Drug Saf. 2018 Oct;41(10):995-997. doi: 10.1007/s40264-018-0692-9.","Dasgupta N","Drug Saf","2018","2018/06/30","","","10.1007/s40264-018-0692-9"
"29947607","Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder","Shi Z, Wang AL, Jagannathan K, Fairchild VP, O'Brien CP, Childress AR, Langleben DD.","J Psychiatry Neurosci. 2018 Jul;43(4):254-261. doi: 10.1503/jpn.170036.","Shi Z","J Psychiatry Neurosci","2018","2018/06/28","PMC6019353","","10.1503/jpn.170036"
"29941320","Managing unplanned severe opiate withdrawal after Vivitrol","Brewer C.","Am J Emerg Med. 2019 Feb;37(2):360. doi: 10.1016/j.ajem.2018.06.035. Epub 2018 Jun 19.","Brewer C","Am J Emerg Med","2019","2018/06/27","","","10.1016/j.ajem.2018.06.035"
"29940509","Noradrenaline induces peripheral antinociception by endogenous opioid release","Romero TRL, Soares Santos RR, Castor MGME, Petrocchi JA, Guzzo LS, Klein A, Duarte IDG.","Pharmacol Rep. 2018 Aug;70(4):784-788. doi: 10.1016/j.pharep.2018.02.020. Epub 2018 Feb 23.","Romero TRL","Pharmacol Rep","2018","2018/06/26","","","10.1016/j.pharep.2018.02.020"
"29930811","Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-O-sulfate in rats: Drug discrimination and physical dependence","Yadlapalli JSK, Bommagani SB, Mahelona RD, Wan A, Gannon BM, Penthala NR, Dobretsov M, Crooks PA, Fantegrossi WE.","Pharmacol Res Perspect. 2018 Jun 19;6(4):e00403. doi: 10.1002/prp2.403. eCollection 2018 Jul.","Yadlapalli JSK","Pharmacol Res Perspect","2018","2018/06/23","PMC6009770","","10.1002/prp2.403"
"29929596","Pruritus in Cutaneous T-Cell Lymphoma and Its Management","Serrano L, Martinez-Escala ME, Zhou XA, Guitart J.","Dermatol Clin. 2018 Jul;36(3):245-258. doi: 10.1016/j.det.2018.02.011.","Serrano L","Dermatol Clin","2018","2018/06/23","","","10.1016/j.det.2018.02.011"
"29913516","Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study","Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, Bagley SM, Liebschutz JM, Walley AY.","Ann Intern Med. 2018 Aug 7;169(3):137-145. doi: 10.7326/M17-3107. Epub 2018 Jun 19.","Larochelle MR","Ann Intern Med","2018","2018/06/19","PMC6387681","NIHMS1002372","10.7326/M17-3107"
"29912214","Pharmacological treatment of alcohol use disorder. Scientific evidence","Attilia F, Perciballi R, Rotondo C, Capriglione I, Iannuzzi S, Attilia ML, Vitali M, Alessandrini G, Scamporrino MCM, Fiore M, Ceccanti M; Interdisciplinary Study Group CRARL - SITAC - SIPaD - SITD - SIPDip.","Riv Psichiatr. 2018 May-Jun;53(3):123-127. doi: 10.1708/2925.29414.","Attilia F","Riv Psichiatr","2018","2018/06/19","","","10.1708/2925.29414"
"29910015","Developing an opioid use disorder treatment cascade: A review of quality measures","Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M.","J Subst Abuse Treat. 2018 Aug;91:57-68. doi: 10.1016/j.jsat.2018.06.001. Epub 2018 Jun 2.","Williams AR","J Subst Abuse Treat","2018","2018/06/19","PMC6039975","NIHMS975411","10.1016/j.jsat.2018.06.001"
"29909547","Modulation of Mg(2+) influx and cytoplasmic free Mg(2+) concentration in rat ventricular myocytes","Tashiro M, Inoue H, Konishi M.","J Physiol Sci. 2019 Jan;69(1):97-102. doi: 10.1007/s12576-018-0625-5. Epub 2018 Jun 16.","Tashiro M","J Physiol Sci","2019","2018/06/18","","","10.1007/s12576-018-0625-5"
"29907903","The Chemokine CCL4 (MIP-1β) Evokes Antinociceptive Effects in Mice: a Role for CD4(+) Lymphocytes and Met-Enkephalin","García-Domínguez M, Lastra A, Folgueras AR, Cernuda-Cernuda R, Fernández-García MT, Hidalgo A, Menéndez L, Baamonde A.","Mol Neurobiol. 2019 Mar;56(3):1578-1595. doi: 10.1007/s12035-018-1176-8. Epub 2018 Jun 15.","García-Domínguez M","Mol Neurobiol","2019","2018/06/17","","","10.1007/s12035-018-1176-8"
"29885638","Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy","Li Z, You Y, Griffin N, Feng J, Shan F.","Int Immunopharmacol. 2018 Aug;61:178-184. doi: 10.1016/j.intimp.2018.05.020. Epub 2018 Jun 7.","Li Z","Int Immunopharmacol","2018","2018/06/10","","","10.1016/j.intimp.2018.05.020"
"29878893","The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia","Cote B, Ross B, Fortner J, Rao D.","Int J Pharm Compd. 2018 May-Jun;22(3):252-256.","Cote B","Int J Pharm Compd","2018","2018/06/08","","",""
"29869799","Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care","Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P.","Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3.","Candy B","Cochrane Database Syst Rev","2018","2018/06/06","PMC6513061","","10.1002/14651858.CD006332.pub3"
"29866385","Patient predictors of substance use disorder treatment initiation in primary care","Ober AJ, Watkins KE, McCullough CM, Setodji CM, Osilla K, Hunter SB.","J Subst Abuse Treat. 2018 Jul;90:64-72. doi: 10.1016/j.jsat.2018.04.004. Epub 2018 Apr 28.","Ober AJ","J Subst Abuse Treat","2018","2018/06/06","PMC6336395","NIHMS967197","10.1016/j.jsat.2018.04.004"
"29859012","Effects of cannabidiol plus naltrexone on motivation and ethanol consumption","Viudez-Martínez A, García-Gutiérrez MS, Fraguas-Sánchez AI, Torres-Suárez AI, Manzanares J.","Br J Pharmacol. 2018 Aug;175(16):3369-3378. doi: 10.1111/bph.14380. Epub 2018 Jul 1.","Viudez-Martínez A","Br J Pharmacol","2018","2018/06/03","PMC6057893","","10.1111/bph.14380"
"29856969","κ-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK/Akt/eNOS signaling activation","Zhang S, Zhou Y, Zhao L, Tian X, Jia M, Gu X, Feng N, An R, Yang L, Zheng G, Li J, Guo H, Fan R, Pei J.","Eur J Pharmacol. 2018 Aug 15;833:100-108. doi: 10.1016/j.ejphar.2018.05.043. Epub 2018 May 30.","Zhang S","Eur J Pharmacol","2018","2018/06/02","","","10.1016/j.ejphar.2018.05.043"
"29847389","Opioid Use Disorders: Perioperative Management of a Special Population","Ward EN, Quaye AN, Wilens TE.","Anesth Analg. 2018 Aug;127(2):539-547. doi: 10.1213/ANE.0000000000003477.","Ward EN","Anesth Analg","2018","2018/05/31","PMC6523021","NIHMS1016752","10.1213/ANE.0000000000003477"
"29806872","Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trial","Solli KK, Latif ZE, Opheim A, Krajci P, Sharma-Haase K, Benth JŠ, Tanum L, Kunoe N.","Addiction. 2018 Oct;113(10):1840-1849. doi: 10.1111/add.14278. Epub 2018 Jun 22.","Solli KK","Addiction","2018","2018/05/29","","","10.1111/add.14278"
"29788886","Novel Pharmacotherapeutic Approaches in Treatment of Alcohol Addiction","Pakri Mohamed RM, Kumar J, Ahmad SU, Mohamed IN.","Curr Drug Targets. 2018;19(12):1378-1390. doi: 10.2174/1389450119666180523092534.","Pakri Mohamed RM","Curr Drug Targets","2018","2018/05/24","","","10.2174/1389450119666180523092534"
"29781884","Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial","Springer SA, Di Paola A, Barbour R, Azar MM, Altice FL.","J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):92-100. doi: 10.1097/QAI.0000000000001759.","Springer SA","J Acquir Immune Defic Syndr","2018","2018/05/22","PMC6092223","NIHMS966443","10.1097/QAI.0000000000001759"
"29778749","Injection Butorphanol dependence: A case report","Shah B, Gupta R, Sarkar S, Balhara YPS.","Asian J Psychiatr. 2018 Jun;35:45-46. doi: 10.1016/j.ajp.2018.05.008. Epub 2018 May 14.","Shah B","Asian J Psychiatr","2018","2018/05/21","","","10.1016/j.ajp.2018.05.008"
"29744741","Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes","AlRabiah H, Ahad A, Mostafa GAE, Al-Jenoobi FI.","Eur J Drug Metab Pharmacokinet. 2018 Dec;43(6):707-713. doi: 10.1007/s13318-018-0482-x.","AlRabiah H","Eur J Drug Metab Pharmacokinet","2018","2018/05/11","","","10.1007/s13318-018-0482-x"
"29729492","Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection","Azizi H, Mirzaeei H, Nasiri AA, Bazi A, Mirzapour A, Khatami M, Nahavandi KH, Azimi A, Yaghoobi H.","Exp Parasitol. 2018 Jun;189:66-71. doi: 10.1016/j.exppara.2018.04.015. Epub 2018 Apr 27.","Azizi H","Exp Parasitol","2018","2018/05/06","","","10.1016/j.exppara.2018.04.015"
"29710079","Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury","Kosten TR, Graham DP, Nielsen DA.","JAMA Psychiatry. 2018 Jun 1;75(6):642-648. doi: 10.1001/jamapsychiatry.2018.0101.","Kosten TR","JAMA Psychiatry","2018","2018/05/01","","","10.1001/jamapsychiatry.2018.0101"
"29706172","Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review","Maglione MA, Raaen L, Chen C, Azhar G, Shahidinia N, Shen M, Maksabedian E, Shanman RM, Newberry S, Hempel S.","J Subst Abuse Treat. 2018 Jun;89:28-51. doi: 10.1016/j.jsat.2018.03.001. Epub 2018 Mar 13.","Maglione MA","J Subst Abuse Treat","2018","2018/05/01","","","10.1016/j.jsat.2018.03.001"
"29689646","Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK","Wilding JPH.","Clin Obes. 2018 Jun;8(3):211-225. doi: 10.1111/cob.12248. Epub 2018 Apr 24.","Wilding JPH","Clin Obes","2018","2018/04/25","PMC6001483","","10.1111/cob.12248"
"29678127","A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States","Nuijten M, Marczewska A, Araujo Torres K, Rasouli B, Perugini M.","J Med Econ. 2018 Sep;21(9):835-844. doi: 10.1080/13696998.2018.1468334. Epub 2018 May 18.","Nuijten M","J Med Econ","2018","2018/04/22","","","10.1080/13696998.2018.1468334"
"29674251","Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial","Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA.","Drug Alcohol Depend. 2018 Jun 1;187:171-178. doi: 10.1016/j.drugalcdep.2018.02.023. Epub 2018 Apr 10.","Bisaga A","Drug Alcohol Depend","2018","2018/04/21","","","10.1016/j.drugalcdep.2018.02.023"
"29658501","[Anhedonia, depression, anxiety, and craving in opioid dependent patients stabilized on oral naltrexone or naltrexone implant]","Krupitsky EM, Zvartau EE, Blokhina EA, Verbitskaya EV, Wahlgren VY, Tsoy-Podosenin MV, Bushara NM, Burakov AM, Masalov DV, Romanova TN, Tiurina AA, Palatkin VY, Yaroslavtseva TS, Sulimov GY, Pecoraro A, Woody G.","Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(1. Vyp. 2):26-33. doi: 10.17116/jnevro20181181226-33.","Krupitsky EM","Zh Nevrol Psikhiatr Im S S Korsakova","2018","2018/04/17","","","10.17116/jnevro20181181226-33"
"29651781","Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?","Salwan AJ, Hagemeier NE, Harirforoosh S.","Clin Drug Investig. 2018 Jul;38(7):573-577. doi: 10.1007/s40261-018-0651-3.","Salwan AJ","Clin Drug Investig","2018","2018/04/14","","","10.1007/s40261-018-0651-3"
"29626646","Cirrhosis induced by bile duct ligation alleviates acetic acid intestinal damages in rats: Involvements of nitrergic and opioidergic systems","Rahimi N, Hassanipour M, Allahabadi NS, Sabbaghziarani F, Yazdanparast M, Dehpour A.","Pharmacol Rep. 2018 Jun;70(3):426-433. doi: 10.1016/j.pharep.2017.11.010. Epub 2017 Nov 22.","Rahimi N","Pharmacol Rep","2018","2018/04/08","","","10.1016/j.pharep.2017.11.010"
"29621905","Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder","Ragguett RM, Rong C, Rosenblat JD, Ho RC, McIntyre RS.","Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):475-482. doi: 10.1080/17425255.2018.1459564. Epub 2018 Apr 6.","Ragguett RM","Expert Opin Drug Metab Toxicol","2018","2018/04/07","","","10.1080/17425255.2018.1459564"
"29621475","Management of Opioid-Induced Constipation in Patients with Malignancy","Garcia JM, Shamliyan TA.","Am J Med. 2018 Sep;131(9):1041-1051.e3. doi: 10.1016/j.amjmed.2018.02.038. Epub 2018 Apr 2.","Garcia JM","Am J Med","2018","2018/04/06","","","10.1016/j.amjmed.2018.02.038"
"29617066","The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone","Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Feinberg L, Kassabian S, Storch B, Biederman J.","J Clin Psychiatry. 2018 Mar/Apr;79(2):17m11609. doi: 10.4088/JCP.17m11609.","Spencer TJ","J Clin Psychiatry","2018","2018/04/05","PMC6548180","NIHMS1014190","10.4088/JCP.17m11609"
"29607497","Low dose naltrexone for induction of remission in Crohn's disease","Parker CE, Nguyen TM, Segal D, MacDonald JK, Chande N.","Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD010410. doi: 10.1002/14651858.CD010410.pub3.","Parker CE","Cochrane Database Syst Rev","2018","2018/04/03","PMC6494424","","10.1002/14651858.CD010410.pub3"
"29605483","Severe opioid withdrawal precipitated by Vivitrol®","Wightman RS, Nelson LS, Lee JD, Fox LM, Smith SW.","Am J Emerg Med. 2018 Jun;36(6):1128.e1-1128.e2. doi: 10.1016/j.ajem.2018.03.052. Epub 2018 Mar 21.","Wightman RS","Am J Emerg Med","2018","2018/04/02","","","10.1016/j.ajem.2018.03.052"
"29602178","Ethanol Exposure History and Alcoholic Reward Differentially Alter Dopamine Release in the Nucleus Accumbens to a Reward-Predictive Cue","Fiorenza AM, Shnitko TA, Sullivan KM, Vemuru SR, Gomez-A A, Esaki JY, Boettiger CA, Da Cunha C, Robinson DL.","Alcohol Clin Exp Res. 2018 Jun;42(6):1051-1061. doi: 10.1111/acer.13636. Epub 2018 Apr 30.","Fiorenza AM","Alcohol Clin Exp Res","2018","2018/03/31","PMC5984156","NIHMS954969","10.1111/acer.13636"
"29589835","SNC80 and naltrindole modulate voltage-dependent sodium, potassium and calcium channels via a putatively delta opioid receptor-independent mechanism","Moravčíková L, Královičová J, Lacinová Ľ.","Gen Physiol Biophys. 2018 May;37(3):299-307. doi: 10.4149/gpb_2018009. Epub 2018 Mar 28.","Moravčíková L","Gen Physiol Biophys","2018","2018/03/29","","","10.4149/gpb_2018009"
"29565661","Impact of Medicaid Expansion on Access to Opioid Analgesic Medications and Medication-Assisted Treatment","Sharp A, Jones A, Sherwood J, Kutsa O, Honermann B, Millett G.","Am J Public Health. 2018 May;108(5):642-648. doi: 10.2105/AJPH.2018.304338. Epub 2018 Mar 22.","Sharp A","Am J Public Health","2018","2018/03/23","PMC5888053","","10.2105/AJPH.2018.304338"
"29561955","Salvinorin A preserves cerebral pial artery autoregulation after forebrain ischemia via the PI3K/AKT/cGMP pathway","Dong HP, Zhou W, Ma XX, He ZZ, Wang ZH.","Braz J Med Biol Res. 2018 Mar 15;51(5):e6714. doi: 10.1590/1414-431X20176714.","Dong HP","Braz J Med Biol Res","2018","2018/03/22","PMC5875901","","10.1590/1414-431X20176714"
"29560940","[The efficiency of the medical rehabilitation program with the use of injectable naltrexone for alcohol addicted patients who are at risk of parental rights deprivation]","Agibalova TV, Akhmetzyanov II, Khaeva RF, Udachina GL, Poplevchenkov KN, Orlova AV, Nedobylskiy OV.","Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(2):40-44. doi: 10.17116/jnevro20181182140-44.","Agibalova TV","Zh Nevrol Psikhiatr Im S S Korsakova","2018","2018/03/22","","","10.17116/jnevro20181182140-44"
"29560596","Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence","Saucier R, Wolfe D, Dasgupta N.","Drug Saf. 2018 Oct;41(10):981-988. doi: 10.1007/s40264-018-0653-3.","Saucier R","Drug Saf","2018","2018/03/22","","","10.1007/s40264-018-0653-3"
"29544869","Criminal justice continuum for opioid users at risk of overdose","Brinkley-Rubinstein L, Zaller N, Martino S, Cloud DH, McCauley E, Heise A, Seal D.","Addict Behav. 2018 Nov;86:104-110. doi: 10.1016/j.addbeh.2018.02.024. Epub 2018 Feb 24.","Brinkley-Rubinstein L","Addict Behav","2018","2018/03/17","","","10.1016/j.addbeh.2018.02.024"
"29535451","Effect of combined naltrexone and bupropion therapy on the brain's functional connectivity","Wang GJ, Zhao J, Tomasi D, Kojori ES, Wang R, Wiers CE, Caparelli EC, Volkow ND.","Version 2. Int J Obes (Lond). 2018 Nov;42(11):1890-1899. doi: 10.1038/s41366-018-0040-2. Epub 2018 Feb 23.","Wang GJ","Int J Obes (Lond)","2018","2018/03/15","PMC6107443","NIHMS916817","10.1038/s41366-018-0040-2"
"29528663","Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats","Sakloth F, Negus SS.","Exp Clin Psychopharmacol. 2018 Apr;26(2):195-204. doi: 10.1037/pha0000183. Epub 2018 Mar 12.","Sakloth F","Exp Clin Psychopharmacol","2018","2018/03/13","PMC5897164","NIHMS928126","10.1037/pha0000183"
"29523156","Low dose Naltrexone for induction of remission in inflammatory bowel disease patients","Lie MRKL, van der Giessen J, Fuhler GM, de Lima A, Peppelenbosch MP, van der Ent C, van der Woude CJ.","J Transl Med. 2018 Mar 9;16(1):55. doi: 10.1186/s12967-018-1427-5.","Lie MRKL","J Transl Med","2018","2018/03/11","PMC5845217","","10.1186/s12967-018-1427-5"
"29518316","Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists","Zhang X, Cui F, Chen H, Zhang T, Yang K, Wang Y, Jiang Z, Rice KC, Watkins LR, Hutchinson MR, Li Y, Peng Y, Wang X.","J Chem Inf Model. 2018 Apr 23;58(4):816-825. doi: 10.1021/acs.jcim.7b00717. Epub 2018 Apr 11.","Zhang X","J Chem Inf Model","2018","2018/03/09","PMC6700752","NIHMS1046395","10.1021/acs.jcim.7b00717"
"29509554","Methylnaltrexone for Neostigmine-Resistant Ogilvie Syndrome","Tahir M, Singh A, Amjad W.","Am J Ther. 2018 Nov/Dec;25(6):e727-e728. doi: 10.1097/MJT.0000000000000743.","Tahir M","Am J Ther","2018","2018/03/07","","","10.1097/MJT.0000000000000743"
"29508016","Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1","Tseng TC, Huang DY, Lai LC, Hwai H, Hsiao YW, Jhou JP, Chuang EY, Tzeng SJ.","J Mol Med (Berl). 2018 May;96(5):413-425. doi: 10.1007/s00109-018-1626-9. Epub 2018 Mar 5.","Tseng TC","J Mol Med (Berl)","2018","2018/03/07","","","10.1007/s00109-018-1626-9"
"29504554","New solvates of the drug naltrexone: protonation, conformation and interplay of synthons","Gonçalves KO, Ribeiro L, Oliveira CMA, Carvalho JF, Martins FT.","Acta Crystallogr C Struct Chem. 2018 Mar 1;74(Pt 3):274-282. doi: 10.1107/S2053229618001791. Epub 2018 Feb 6.","Gonçalves KO","Acta Crystallogr C Struct Chem","2018","2018/03/06","","","10.1107/S2053229618001791"
"29499274","Role of dorsal hippocampus κ opioid receptors in contextual aversive memory consolidation in rats","Vanz F, Bicca MA, Linartevichi VF, Giachero M, Bertoglio LJ, Monteiro de Lima TC.","Neuropharmacology. 2018 Jun;135:253-267. doi: 10.1016/j.neuropharm.2018.02.029. Epub 2018 Feb 27.","Vanz F","Neuropharmacology","2018","2018/03/03","","","10.1016/j.neuropharm.2018.02.029"
"29496608","Effects of mesyl salvinorin B alone and in combination with naltrexone on alcohol deprivation effect in male and female mice","Zhou Y, Crowley R, Prisinzano T, Kreek MJ.","Neurosci Lett. 2018 Apr 23;673:19-23. doi: 10.1016/j.neulet.2018.02.056. Epub 2018 Feb 26.","Zhou Y","Neurosci Lett","2018","2018/03/03","PMC6293468","NIHMS997978","10.1016/j.neulet.2018.02.056"
"29493836","Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry","Saxon AJ, Akerman SC, Liu CC, Sullivan MA, Silverman BL, Vocci FJ.","Addiction. 2018 Aug;113(8):1477-1487. doi: 10.1111/add.14199. Epub 2018 Apr 1.","Saxon AJ","Addiction","2018","2018/03/02","","","10.1111/add.14199"
"29489440","TRPM7 Mediates Mechanosensitivity in Adult Rat Odontoblasts","Won J, Vang H, Kim JH, Lee PR, Kang Y, Oh SB.","J Dent Res. 2018 Aug;97(9):1039-1046. doi: 10.1177/0022034518759947. Epub 2018 Feb 28.","Won J","J Dent Res","2018","2018/03/01","","","10.1177/0022034518759947"
"29486222","Naltrexone alters alcohol self-administration behaviors and hypothalamic-pituitary-adrenal axis activity in a sex-dependent manner in rats","Nieto SJ, Quave CB, Kosten TA.","Pharmacol Biochem Behav. 2018 Apr;167:50-59. doi: 10.1016/j.pbb.2018.02.003. Epub 2018 Feb 24.","Nieto SJ","Pharmacol Biochem Behav","2018","2018/02/28","PMC6011835","NIHMS947570","10.1016/j.pbb.2018.02.003"
"29483538","Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model","Wang F, Meng J, Zhang L, Johnson T, Chen C, Roy S.","Sci Rep. 2018 Feb 26;8(1):3596. doi: 10.1038/s41598-018-21915-8.","Wang F","Sci Rep","2018","2018/02/28","PMC5827657","","10.1038/s41598-018-21915-8"
"29482123","Therapeutic challenges in comorbid obsessive compulsive disorder with substance use","Jain S, Gupta T, Nebhinani N, Singhai K, Suthar N.","Asian J Psychiatr. 2018 Jan;31:127-128. doi: 10.1016/j.ajp.2018.02.005. Epub 2018 Feb 9.","Jain S","Asian J Psychiatr","2018","2018/02/27","","","10.1016/j.ajp.2018.02.005"
"29480453","Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?","Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.","Clin Drug Investig. 2018 Apr;38(4):387-388. doi: 10.1007/s40261-018-0625-5.","Barrio P","Clin Drug Investig","2018","2018/02/27","","","10.1007/s40261-018-0625-5"
"29479731","Severe central sleep apnoea associated with nalmefene: a case report","Khouri C, Arbib F, Revol B, Pepin JL, Tamisier R.","Br J Clin Pharmacol. 2018 May;84(5):1075-1076. doi: 10.1111/bcp.13547. Epub 2018 Feb 26.","Khouri C","Br J Clin Pharmacol","2018","2018/02/27","PMC5903229","","10.1111/bcp.13547"
"29479004","Neurokinin B receptor agonist and Dynorphin receptor antagonist stimulated luteinizing hormone secretion in fasted male rodents","Matsuzaki T, Tungalagsuvd A, Munkhzaya M, Iwasa T, Yano K, Mayila Y, Tokui T, Yanagihara R, Matsui S, Kato T, Kuwahara A, Irahara M.","Endocr J. 2018 Apr 26;65(4):485-492. doi: 10.1507/endocrj.EJ17-0136. Epub 2018 Feb 23.","Matsuzaki T","Endocr J","2018","2018/02/27","","","10.1507/endocrj.EJ17-0136"
"29476330","Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?","Braillon A, Taiebi F, Bernoussi A.","Clin Drug Investig. 2018 Apr;38(4):385-386. doi: 10.1007/s40261-018-0628-2.","Braillon A","Clin Drug Investig","2018","2018/02/25","","","10.1007/s40261-018-0628-2"
"29469239","Compulsive Sexual Behaviors Treated With Naltrexone Monotherapy","Camacho M, Moura AR, Oliveira-Maia AJ.","Prim Care Companion CNS Disord. 2018 Feb 15;20(1):17l02109. doi: 10.4088/PCC.17l02109.","Camacho M","Prim Care Companion CNS Disord","2018","2018/02/23","","","10.4088/PCC.17l02109"
"29460668","Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision","Chen DT, Ko TM, Allen AA, Bonnie RJ, Suratt CE, Appelbaum PS, Nunes EV, Friedmann PD, Lee JD, Gordon MS, McDonald R, Wilson D, Boney TY, Murphy SM, O'Brien CP.","J Empir Res Hum Res Ethics. 2018 Apr;13(2):160-172. doi: 10.1177/1556264618755243. Epub 2018 Feb 20.","Chen DT","J Empir Res Hum Res Ethics","2018","2018/02/21","PMC6693513","NIHMS932836","10.1177/1556264618755243"
"29450443","Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System","Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BDL, Alexander-Scott N, Boss R, Rich JD.","JAMA Psychiatry. 2018 Apr 1;75(4):405-407. doi: 10.1001/jamapsychiatry.2017.4614.","Green TC","JAMA Psychiatry","2018","2018/02/17","PMC5875331","","10.1001/jamapsychiatry.2017.4614"
"29441516","Detection of naltrexone and naltrexol in patients prescribed Embeda®","West R, Guevara M, Mikel C.","J Opioid Manag. 2017 May/Jun;13(3):139-140. doi: 10.5055/jom.2017.0380.","West R","J Opioid Manag","2017","2018/02/15","","","10.5055/jom.2017.0380"
"29438157","Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study","Roberts W, Shi JM, Tetrault JM, McKee SA.","J Addict Med. 2018 May/Jun;12(3):227-233. doi: 10.1097/ADM.0000000000000392.","Roberts W","J Addict Med","2018","2018/02/14","PMC5970035","NIHMS937513","10.1097/ADM.0000000000000392"
"29432333","Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review","Borodovsky JT, Levy S, Fishman M, Marsch LA.","J Addict Med. 2018 May/Jun;12(3):170-183. doi: 10.1097/ADM.0000000000000388.","Borodovsky JT","J Addict Med","2018","2018/02/13","PMC5970018","NIHMS933394","10.1097/ADM.0000000000000388"
"29431852","Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence","Anton RF, Latham PK, Voronin KE, Randall PK, Book SW, Hoffman M, Schacht JP.","Alcohol Clin Exp Res. 2018 Apr;42(4):751-760. doi: 10.1111/acer.13601. Epub 2018 Feb 12.","Anton RF","Alcohol Clin Exp Res","2018","2018/02/13","PMC5880727","NIHMS935311","10.1111/acer.13601"
"29420770","Rationale for Utilization of Obesity Pharmacotherapy in the Active Duty Population","Nadolsky KZ.","Mil Med. 2018 Mar 1;183(3-4):45-50. doi: 10.1093/milmed/usx074.","Nadolsky KZ","Mil Med","2018","2018/02/09","","","10.1093/milmed/usx074"
"29420073","Open-label pilot study of injectable naltrexone for cannabis dependence","Notzon DP, Kelly MA, Choi CJ, Pavlicova M, Mahony AL, Brooks DJ, Mariani JJ, Levin FR.","Am J Drug Alcohol Abuse. 2018;44(6):619-627. doi: 10.1080/00952990.2017.1423321. Epub 2018 Feb 8.","Notzon DP","Am J Drug Alcohol Abuse","2018","2018/02/09","PMC6082728","NIHMS947015","10.1080/00952990.2017.1423321"
"29419653","Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study","Webster LR, Nalamachu S, Morlion B, Reddy J, Baba Y, Yamada T, Arjona Ferreira JC.","Pain. 2018 May;159(5):987-994. doi: 10.1097/j.pain.0000000000001174.","Webster LR","Pain","2018","2018/02/09","PMC5916485","","10.1097/j.pain.0000000000001174"
"29415856","A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine","Marcus R, Bojko MJ, Mazhnaya A, Makarenko I, Filippovych S, Dvoriak S, Altice FL, Springer SA.","J Subst Abuse Treat. 2018 Mar;86:86-93. doi: 10.1016/j.jsat.2018.01.003. Epub 2018 Jan 5.","Marcus R","J Subst Abuse Treat","2018","2018/02/09","PMC5808584","NIHMS933633","10.1016/j.jsat.2018.01.003"
"29408463","Bupropion and naltrexone combination alters high fructose corn syrup self-administration and gene expression in rats","Levy A, Daniels S, Hudson R, Horman T, Flynn A, Zhou Y, Leri F.","Neuropharmacology. 2018 Jun;135:547-554. doi: 10.1016/j.neuropharm.2018.01.035.","Levy A","Neuropharmacology","2018","2018/02/07","","","10.1016/j.neuropharm.2018.01.035"
"29406802","Reply to Y. Yagi et al","Katakami N, Yokota T, Tada Y.","J Clin Oncol. 2018 Apr 1;36(10):1050. doi: 10.1200/JCO.2017.77.0925. Epub 2018 Feb 6.","Katakami N","J Clin Oncol","2018","2018/02/07","","","10.1200/JCO.2017.77.0925"
"29406801","Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer","Yagi Y, Kosugi K, Tanimoto T.","J Clin Oncol. 2018 Apr 1;36(10):1049-1050. doi: 10.1200/JCO.2017.76.9349. Epub 2018 Feb 6.","Yagi Y","J Clin Oncol","2018","2018/02/07","","","10.1200/JCO.2017.76.9349"
"29396985","Extended-release injectable naltrexone for opioid use disorder: a systematic review","Jarvis BP, Holtyn AF, Subramaniam S, Tompkins DA, Oga EA, Bigelow GE, Silverman K.","Addiction. 2018 Jul;113(7):1188-1209. doi: 10.1111/add.14180. Epub 2018 Mar 24.","Jarvis BP","Addiction","2018","2018/02/04","PMC5993595","NIHMS939858","10.1111/add.14180"
"29395188","Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial","Miranda R Jr, Treloar Padovano H, Gray JC, Wemm SE, Blanchard A.","Addict Behav. 2018 Aug;83:72-78. doi: 10.1016/j.addbeh.2018.01.009. Epub 2018 Jan 10.","Miranda R Jr","Addict Behav","2018","2018/02/04","PMC5964002","NIHMS937731","10.1016/j.addbeh.2018.01.009"
"29385430","The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study","Raknes G, Simonsen P, Småbrekke L.","J Crohns Colitis. 2018 May 25;12(6):677-686. doi: 10.1093/ecco-jcc/jjy008.","Raknes G","J Crohns Colitis","2018","2018/02/01","PMC5972567","","10.1093/ecco-jcc/jjy008"
"29377216","The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders","Patten DK, Schultz BG, Berlau DJ.","Pharmacotherapy. 2018 Mar;38(3):382-389. doi: 10.1002/phar.2086. Epub 2018 Feb 23.","Patten DK","Pharmacotherapy","2018","2018/01/30","","","10.1002/phar.2086"
"29373393","Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial","Springer SA, Di Paola A, Azar MM, Barbour R, Biondi BE, Desabrais M, Lincoln T, Skiest DJ, Altice FL.","J Acquir Immune Defic Syndr. 2018 May 1;78(1):43-53. doi: 10.1097/QAI.0000000000001634.","Springer SA","J Acquir Immune Defic Syndr","2018","2018/01/27","PMC5889326","NIHMS935648","10.1097/QAI.0000000000001634"
"29369967","Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain","Nation KM, De Felice M, Hernandez PI, Dodick DW, Neugebauer V, Navratilova E, Porreca F.","Pain. 2018 May;159(5):919-928. doi: 10.1097/j.pain.0000000000001167.","Nation KM","Pain","2018","2018/01/26","PMC5916844","NIHMS955773","10.1097/j.pain.0000000000001167"
"29364992","Implementation of a Process for Initiating Naltrexone in Patients Hospitalized for Alcohol Detoxification or Withdrawal","Stephens JR, Moore C, Stepanek KV, Garbutt JC, Starke B, Liles A, Jonas DE.","J Hosp Med. 2018 Apr;13(4):221-228. doi: 10.12788/jhm.2900. Epub 2018 Jan 24.","Stephens JR","J Hosp Med","2018","2018/01/25","","","10.12788/jhm.2900"
"29352328","Attenuation of serotonin-induced itch by sumatriptan: possible involvement of endogenous opioids","Haddadi NS, Foroutan A, Shakiba S, Afshari K, Ostadhadi S, Daneshpazhooh M, Dehpour AR.","Arch Dermatol Res. 2018 Mar;310(2):165-172. doi: 10.1007/s00403-018-1809-9. Epub 2018 Jan 19.","Haddadi NS","Arch Dermatol Res","2018","2018/01/21","","","10.1007/s00403-018-1809-9"
"29345864","Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features","Grant JE, Potenza MN, Kraus SW, Petrakis IL.","J Clin Psychiatry. 2017 Nov/Dec;78(9):e1299-e1306. doi: 10.4088/JCP.16m11220.","Grant JE","J Clin Psychiatry","2017","2018/01/19","","","10.4088/JCP.16m11220"
"29344611","Variable Response to Naltrexone in Patients With Hailey-Hailey Disease","Cao S, Lilly E, Chen ST.","JAMA Dermatol. 2018 Mar 1;154(3):362-363. doi: 10.1001/jamadermatol.2017.5463.","Cao S","JAMA Dermatol","2018","2018/01/19","PMC5885838","","10.1001/jamadermatol.2017.5463"
"29330156","Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys","Cornelissen JC, Obeng S, Rice KC, Zhang Y, Negus SS, Banks ML.","J Pharmacol Exp Ther. 2018 Apr;365(1):37-47. doi: 10.1124/jpet.117.246439. Epub 2018 Jan 12.","Cornelissen JC","J Pharmacol Exp Ther","2018","2018/01/14","PMC5830633","","10.1124/jpet.117.246439"
"29326369","Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment","Weinstock LB, Brook JB, Myers TL, Goodman B.","BMJ Case Rep. 2018 Jan 11;2018:bcr2017221405. doi: 10.1136/bcr-2017-221405.","Weinstock LB","BMJ Case Rep","2018","2018/01/13","PMC5778345","","10.1136/bcr-2017-221405"
"29325983","A Case of Delirium and Rhabdomyolysis in Severe Iatrogenic Opioid Withdrawal","Hanna J, Swetter S.","Psychosomatics. 2018 Jul-Aug;59(4):405-407. doi: 10.1016/j.psym.2017.12.002. Epub 2017 Dec 14.","Hanna J","Psychosomatics","2018","2018/01/13","","","10.1016/j.psym.2017.12.002"
"29324623","New Drugs 2018, part 1","Hussar DA.","Nursing. 2018 Feb;48(2):36-44. doi: 10.1097/01.NURSE.0000529803.83288.e1.","Hussar DA","Nursing","2018","2018/01/12","","","10.1097/01.NURSE.0000529803.83288.e1"
"29324253","A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices","Andraka-Christou B, Capone MJ.","Int J Drug Policy. 2018 Apr;54:9-17. doi: 10.1016/j.drugpo.2017.11.021. Epub 2018 Jan 8.","Andraka-Christou B","Int J Drug Policy","2018","2018/01/12","","","10.1016/j.drugpo.2017.11.021"
"29320915","Healthcare utilization and costs associated with treatment for opioid dependence","Shah A, Duncan M, Atreja N, Tai KS, Gore M.","J Med Econ. 2018 Apr;21(4):406-415. doi: 10.1080/13696998.2018.1427101. Epub 2018 Feb 1.","Shah A","J Med Econ","2018","2018/01/12","","","10.1080/13696998.2018.1427101"
"29314653","Identification of oxymorphone as decomposition product of the permitted drug methylnaltrexone","Sobolevsky T, Kucherova Y, Ahrens B.","Drug Test Anal. 2018 May;10(5):892-895. doi: 10.1002/dta.2353. Epub 2018 Feb 6.","Sobolevsky T","Drug Test Anal","2018","2018/01/10","","","10.1002/dta.2353"
"29314404","Commentary on Palpacuer et al. (2018): Do small effects on total alcohol consumption translate into clinical practice?","Donoghue K.","Addiction. 2018 Feb;113(2):238-239. doi: 10.1111/add.14081.","Donoghue K","Addiction","2018","2018/01/10","","","10.1111/add.14081"
"29308591","Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users","Setnik B, Schoedel K, Bartlett C, Dick C, Hakim N, Geoffroy P.","J Opioid Manag. 2017 Nov/Dec;13(6):449-464. doi: 10.5055/jom.2017.0421.","Setnik B","J Opioid Manag","2017","2018/01/09","","","10.5055/jom.2017.0421"
"29307283","Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis","Ludwig MD, Zagon IS, McLaughlin PJ.","Exp Biol Med (Maywood). 2018 Feb;243(4):361-369. doi: 10.1177/1535370217749830. Epub 2018 Jan 7.","Ludwig MD","Exp Biol Med (Maywood)","2018","2018/01/09","PMC6022923","","10.1177/1535370217749830"
"29297843","SHORT DURATION IMMOBILIZATION OF ATLANTIC WALRUS ( ODOBENUS ROSMARUS ROSMARUS) WITH ETORPHINE, AND REVERSAL WITH NALTREXONE","Ølberg RA, Kovacs KM, Bertelsen MF, Semenova V, Lydersen C.","J Zoo Wildl Med. 2017 Dec;48(4):972-978. doi: 10.1638/2016-0232R.1.","Ølberg RA","J Zoo Wildl Med","2017","2018/01/04","","","10.1638/2016-0232R.1"
"29294197","Advances in Pharmacotherapy Development: Human Clinical Studies","Litten RZ, Falk DE, Ryan ML, Fertig J, Leggio L.","Handb Exp Pharmacol. 2018;248:579-613. doi: 10.1007/164_2017_79.","Litten RZ","Handb Exp Pharmacol","2018","2018/01/03","","","10.1007/164_2017_79"
"29292291","Medication Treatment of Adolescent Opioid Use Disorder in Primary Care","Carney BL, Hadland SE, Bagley SM.","Pediatr Rev. 2018 Jan;39(1):43-45. doi: 10.1542/pir.2017-0153.","Carney BL","Pediatr Rev","2018","2018/01/03","PMC6163000","NIHMS989722","10.1542/pir.2017-0153"
"29290404","The effects of recurrent hypoglycaemia and opioid antagonists on the adrenal catecholamine synthetic capacity in a rat model of HAAF","Senthilkumaran M, Bobrovskaya L.","Auton Neurosci. 2018 Mar;210:76-80. doi: 10.1016/j.autneu.2017.12.004. Epub 2017 Dec 16.","Senthilkumaran M","Auton Neurosci","2018","2018/01/02","","","10.1016/j.autneu.2017.12.004"
"29273901","Systematic Review of Combined Pharmacotherapy for the Treatment of Alcohol Use Disorder in Patients Without Comorbid Conditions","Naglich AC, Lin A, Wakhlu S, Adinoff BH.","CNS Drugs. 2018 Jan;32(1):13-31. doi: 10.1007/s40263-017-0484-2.","Naglich AC","CNS Drugs","2018","2017/12/24","","","10.1007/s40263-017-0484-2"
"29273249","Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSAT","Friedmann PD, Dunn KE, Nunes EV, O'Brien CP.","J Subst Abuse Treat. 2018 Feb;85:31-33. doi: 10.1016/j.jsat.2017.11.008. Epub 2017 Nov 22.","Friedmann PD","J Subst Abuse Treat","2018","2017/12/24","","","10.1016/j.jsat.2017.11.008"
"29273103","Emerging Unconventional Therapies for Alopecia Areata","Atanaskova Mesinkovska N.","J Investig Dermatol Symp Proc. 2018 Jan;19(1):S32-S33. doi: 10.1016/j.jisp.2017.10.012.","Atanaskova Mesinkovska N","J Investig Dermatol Symp Proc","2018","2017/12/24","","","10.1016/j.jisp.2017.10.012"
"29268702","Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study","Ober AJ, Watkins KE, Hunter SB, Ewing B, Lamp K, Lind M, Becker K, Heinzerling K, Osilla KC, Diamant AL, Setodji CM.","BMC Fam Pract. 2017 Dec 21;18(1):107. doi: 10.1186/s12875-017-0673-6.","Ober AJ","BMC Fam Pract","2017","2017/12/23","PMC5740845","","10.1186/s12875-017-0673-6"
"29267844","Nalmefene attenuates malignant potential in colorectal cancer cell via inhibition of opioid receptor","Wu Q, Chen X, Wang J, Sun P, Weng M, Chen W, Sun Z, Zhu M, Miao C.","Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):156-163. doi: 10.1093/abbs/gmx131.","Wu Q","Acta Biochim Biophys Sin (Shanghai)","2018","2017/12/22","","","10.1093/abbs/gmx131"
"29265379","Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial","Ray LA, Green R, Roche DJO, Bujarski S, Hartwell EE, Lim AC, Rohrbaugh T, Ghahremani D, Hutchison K, Miotto K.","Alcohol Clin Exp Res. 2018 Mar;42(3):613-623. doi: 10.1111/acer.13586. Epub 2018 Feb 1.","Ray LA","Alcohol Clin Exp Res","2018","2017/12/22","PMC6086578","NIHMS930495","10.1111/acer.13586"
"29265141","To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane","Sader S , Anant K , Wu C .","Phys Chem Chem Phys. 2018 Jan 17;20(3):1724-1741. doi: 10.1039/c7cp06745c.","Sader S","Phys Chem Chem Phys","2018","2017/12/22","","","10.1039/c7cp06745c"
"29258346","The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol","Berkson BM, Calvo Riera F.","Integr Cancer Ther. 2018 Sep;17(3):986-993. doi: 10.1177/1534735417747984. Epub 2017 Dec 19.","Berkson BM","Integr Cancer Ther","2018","2017/12/21","PMC6142095","","10.1177/1534735417747984"
"29256094","Blocking of opioid receptors in experimental formaline-inactivated respiratory syncytial virus (FI-RSV) immunopathogenesis: from beneficial to harmful impacts","Salimi V, Mirzaei H, Ramezani A, Tahamtan A, Jamali A, Shahabi S, Golara M, Minaei B, Gharagozlou MJ, Mahmoodi M, Bont L, Shokri F, Mokhtari-Azad T.","Med Microbiol Immunol. 2018 Apr;207(2):105-115. doi: 10.1007/s00430-017-0531-0. Epub 2017 Dec 18.","Salimi V","Med Microbiol Immunol","2018","2017/12/20","","","10.1007/s00430-017-0531-0"
"29245103","Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration","Kelly MM, Reilly E, Quiñones T, Desai N, Rosenheck R.","Drug Alcohol Depend. 2018 Feb 1;183:111-117. doi: 10.1016/j.drugalcdep.2017.10.017. Epub 2017 Dec 2.","Kelly MM","Drug Alcohol Depend","2018","2017/12/16","","","10.1016/j.drugalcdep.2017.10.017"
"29244650","Pharmacotherapy for obesity: What you need to know","Bersoux S, Byun TH, Chaliki SS, Poole KG.","Cleve Clin J Med. 2017 Dec;84(12):951-958. doi: 10.3949/ccjm.84a.16094.","Bersoux S","Cleve Clin J Med","2017","2017/12/16","","","10.3949/ccjm.84a.16094"
"29241428","State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder","Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, Friedmann PD.","Psychiatr Serv. 2018 Apr 1;69(4):448-455. doi: 10.1176/appi.ps.201700196. Epub 2017 Dec 15.","Abraham AJ","Psychiatr Serv","2018","2017/12/16","PMC6703818","NIHMS1532327","10.1176/appi.ps.201700196"
"29224002","The Protective Effects of Κ-Opioid Receptor Stimulation in Hypoxic Pulmonary Hypertension Involve Inhibition of Autophagy Through the AMPK-MTOR Pathway","Zhou Y, Wang Y, Wang X, Tian X, Zhang S, Yang F, Guo H, Fan R, Feng N, Jia M, Gu X, Wang Y, Li J, Pei J.","Cell Physiol Biochem. 2017;44(5):1965-1979. doi: 10.1159/000485886. Epub 2017 Dec 8.","Zhou Y","Cell Physiol Biochem","2017","2017/12/11","","","10.1159/000485886"
"29222923","Co-Administration of Low-Dose Naltrexone and Bupropion Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats","Nicholson ER, Dilley JE, Froehlich JC.","Alcohol Clin Exp Res. 2018 Mar;42(3):571-577. doi: 10.1111/acer.13577. Epub 2018 Jan 22.","Nicholson ER","Alcohol Clin Exp Res","2018","2017/12/10","PMC5832575","NIHMS926130","10.1111/acer.13577"
"29220529","Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection","Hsu EA, Miller JL, Perez FA, Roth CL.","J Clin Endocrinol Metab. 2018 Feb 1;103(2):370-375. doi: 10.1210/jc.2017-02080.","Hsu EA","J Clin Endocrinol Metab","2018","2017/12/09","","","10.1210/jc.2017-02080"
"29210822","PERIPHERALLY ACTING MU-OPIOID RECEPTOR ANTAGONISTS","Martinez-Cox S, Espinosa K, Friece C, Rahman A.","Gastroenterol Nurs. 2017 Nov/Dec;40(6):517-522. doi: 10.1097/SGA.0000000000000326.","Martinez-Cox S","Gastroenterol Nurs","2017","2017/12/07","","","10.1097/SGA.0000000000000326"
"29193080","The non-peptidic δ-opioid receptor agonist Tan-67 mediates neuroprotection post-ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice","Min JW, Liu Y, Wang D, Qiao F, Wang H.","J Neurochem. 2018 Feb;144(3):336-347. doi: 10.1111/jnc.14265. Epub 2017 Dec 19.","Min JW","J Neurochem","2018","2017/12/02","PMC5775031","NIHMS923422","10.1111/jnc.14265"
"29190156","Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions","Chang DC, Klimas J, Wood E, Fairbairn N.","Am J Drug Alcohol Abuse. 2018;44(2):143-146. doi: 10.1080/00952990.2017.1399403. Epub 2017 Nov 30.","Chang DC","Am J Drug Alcohol Abuse","2018","2017/12/01","PMC5815926","NIHMS934678","10.1080/00952990.2017.1399403"
"29188799","Computational insights into the G-protein-biased activation and inactivation mechanisms of the μ opioid receptor","Cheng JX, Cheng T, Li WH, Liu GX, Zhu WL, Tang Y.","Acta Pharmacol Sin. 2018 Jan;39(1):154-164. doi: 10.1038/aps.2017.158. Epub 2017 Nov 30.","Cheng JX","Acta Pharmacol Sin","2018","2017/12/01","PMC5758664","","10.1038/aps.2017.158"
"29186083","Naldemedine (Symproic) for opioid-induced constipation","","Med Lett Drugs Ther. 2017 Dec 4;59(1535):196-198.","","Med Lett Drugs Ther","2017","2017/11/30","","",""
"29176446","Addressing unhealthy alcohol use among people living with HIV: recent advances and research directions","Edelman EJ, Williams EC, Marshall BDL.","Curr Opin Infect Dis. 2018 Feb;31(1):1-7. doi: 10.1097/QCO.0000000000000422.","Edelman EJ","Curr Opin Infect Dis","2018","2017/11/28","","","10.1097/QCO.0000000000000422"
"29174308","Effectiveness of extended release naltrexone to reduce alcohol cravings and use behaviors during treatment and at follow-up","Crèvecoeur-MacPhail D, Cousins SJ, Denering L, Kim T, Rawson RA.","J Subst Abuse Treat. 2018 Feb;85:105-108. doi: 10.1016/j.jsat.2017.11.004. Epub 2017 Nov 10.","Crèvecoeur-MacPhail D","J Subst Abuse Treat","2018","2017/11/28","","","10.1016/j.jsat.2017.11.004"
"29158012","A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers","Silverman BL, Martin W, Memisoglu A, DiPetrillo L, Correll CU, Kane JM.","Schizophr Res. 2018 May;195:245-251. doi: 10.1016/j.schres.2017.10.014. Epub 2017 Nov 20.","Silverman BL","Schizophr Res","2018","2017/11/22","","","10.1016/j.schres.2017.10.014"
"29156533","Serotonin induces peripheral antinociception via the opioidergic system","Diniz DA, Petrocchi JA, Navarro LC, Souza TC, Castor MGME, Duarte IDG, Romero TRL.","Biomed Pharmacother. 2018 Jan;97:1434-1437. doi: 10.1016/j.biopha.2017.11.048. Epub 2017 Dec 14.","Diniz DA","Biomed Pharmacother","2018","2017/11/22","","","10.1016/j.biopha.2017.11.048"
"29156182","Obesity Pharmacotherapy","Saunders KH, Umashanker D, Igel LI, Kumar RB, Aronne LJ.","Med Clin North Am. 2018 Jan;102(1):135-148. doi: 10.1016/j.mcna.2017.08.010.","Saunders KH","Med Clin North Am","2018","2017/11/21","","","10.1016/j.mcna.2017.08.010"
"29154368","Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes","Mann K, Roos CR, Hoffmann S, Nakovics H, Leménager T, Heinz A, Witkiewitz K.","Neuropsychopharmacology. 2018 Mar;43(4):891-899. doi: 10.1038/npp.2017.282. Epub 2017 Nov 20.","Mann K","Neuropsychopharmacology","2018","2017/11/21","PMC5809801","","10.1038/npp.2017.282"
"29150316","Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study","Smith-Bernardin S, Rowe C, Behar E, Geier M, Washington S, Santos GM, Euren J, Martin J, Gleghorn A, Coffin PO.","J Subst Abuse Treat. 2018 Feb;85:109-115. doi: 10.1016/j.jsat.2017.11.005. Epub 2017 Nov 8.","Smith-Bernardin S","J Subst Abuse Treat","2018","2017/11/19","","","10.1016/j.jsat.2017.11.005"
"29150200","Extended-release naltrexone: good but not a panacea","Lott DC.","Lancet. 2018 Jan 27;391(10118):283-284. doi: 10.1016/S0140-6736(17)32872-6. Epub 2017 Nov 14.","Lott DC","Lancet","2018","2017/11/19","","","10.1016/S0140-6736(17)32872-6"
"29150198","Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, Farkas S, Fishman M, Gauthier P, Hodgkins CC, King J, Lindblad R, Liu D, Matthews AG, May J, Peavy KM, Ross S, Salazar D, Schkolnik P, Shmueli-Blumberg D, Stablein D, Subramaniam G, Rotrosen J.","Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14.","Lee JD","Lancet","2018","2017/11/19","PMC5806119","NIHMS929299","10.1016/S0140-6736(17)32812-X"
"29148888","Tissue Residue Levels after Immobilization of Rocky Mountain Elk ( Cervus elaphus nelsoni) using a Combination of Nalbuphine, Medetomidine, and Azaperone Antagonized with Naltrexone, Atipamezole, and Tolazoline","Wolfe LL, Nol P, McCollum MP, Mays T, Wehtje ME, Lance WR, Fisher MC, Miller MW.","J Wildl Dis. 2018 Apr;54(2):362-365. doi: 10.7589/2017-06-132. Epub 2017 Nov 17.","Wolfe LL","J Wildl Dis","2018","2017/11/18","","","10.7589/2017-06-132"
"29146290","Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder","Wang AL, Lowen SB, Elman I, Shi Z, Fairchild VP, Bouril A, Gur RC, Langleben DD.","J Subst Abuse Treat. 2018 Feb;85:70-77. doi: 10.1016/j.jsat.2017.10.007. Epub 2017 Oct 18.","Wang AL","J Subst Abuse Treat","2018","2017/11/18","PMC6043353","NIHMS977702","10.1016/j.jsat.2017.10.007"
"29143398","A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control children","Kelty E, Hulse G.","Am J Addict. 2017 Dec;26(8):845-851. doi: 10.1111/ajad.12642. Epub 2017 Nov 16.","Kelty E","Am J Addict","2017","2017/11/17","","","10.1111/ajad.12642"
"29141667","More beds are not the answer: transforming detoxification units into medication induction centers to address the opioid epidemic","Friedmann PD, Suzuki J.","Addict Sci Clin Pract. 2017 Nov 15;12(1):29. doi: 10.1186/s13722-017-0092-y.","Friedmann PD","Addict Sci Clin Pract","2017","2017/11/17","PMC5688652","","10.1186/s13722-017-0092-y"
"29141653","Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial","Molfenter T, Knudsen HK, Brown R, Jacobson N, Horst J, Van Etten M, Kim JS, Haram E, Collier E, Starr S, Toy A, Madden L.","Implement Sci. 2017 Nov 15;12(1):135. doi: 10.1186/s13012-017-0665-x.","Molfenter T","Implement Sci","2017","2017/11/17","PMC5688699","","10.1186/s13012-017-0665-x"
"29141063","Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris","Strazzulla LC, Avila L, Lo Sicco K, Shapiro J.","J Drugs Dermatol. 2017 Nov 1;16(11):1140-1142.","Strazzulla LC","J Drugs Dermatol","2017","2017/11/16","","",""
"29134730","Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region","Drinovac Vlah V, Filipović B, Bach-Rojecky L, Lacković Z.","Eur J Pain. 2018 Mar;22(3):583-591. doi: 10.1002/ejp.1146. Epub 2017 Nov 13.","Drinovac Vlah V","Eur J Pain","2018","2017/11/15","","","10.1002/ejp.1146"
"29117992","Naltrexone/bupropion for obesity","","Drug Ther Bull. 2017 Nov;55(11):126-129. doi: 10.1136/dtb.2017.11.0550.","","Drug Ther Bull","2017","2017/11/10","","","10.1136/dtb.2017.11.0550"
"29105118","V1b Receptor Antagonist SSR149415 and Naltrexone Synergistically Decrease Excessive Alcohol Drinking in Male and Female Mice","Zhou Y, Rubinstein M, Low MJ, Kreek MJ.","Alcohol Clin Exp Res. 2018 Jan;42(1):195-205. doi: 10.1111/acer.13544. Epub 2017 Nov 28.","Zhou Y","Alcohol Clin Exp Res","2018","2017/11/07","PMC5750120","NIHMS918082","10.1111/acer.13544"
"29102059","On-chip pulsed electromembrane extraction as a new concept for analysis of biological fluids in a small device","Karami M, Yamini Y, Abdossalami Asl Y, Rezazadeh M.","J Chromatogr A. 2017 Dec 8;1527:1-9. doi: 10.1016/j.chroma.2017.10.049. Epub 2017 Oct 23.","Karami M","J Chromatogr A","2017","2017/11/06","","","10.1016/j.chroma.2017.10.049"
"29099849","Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study","Raknes G, Småbrekke L.","PLoS One. 2017 Nov 3;12(11):e0187423. doi: 10.1371/journal.pone.0187423. eCollection 2017.","Raknes G","PLoS One","2017","2017/11/04","PMC5669439","","10.1371/journal.pone.0187423"
"29097161","A behavioral and pharmacological characterization of palatable diet alternation in mice","Moore CF, Schlain GS, Mancino S, Sabino V, Cottone P.","Pharmacol Biochem Behav. 2017 Dec;163:1-8. doi: 10.1016/j.pbb.2017.10.013. Epub 2017 Oct 31.","Moore CF","Pharmacol Biochem Behav","2017","2017/11/04","PMC5911178","NIHMS919131","10.1016/j.pbb.2017.10.013"
"29092627","Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain","Murphy JA, Sheridan EA.","Ann Pharmacother. 2018 Apr;52(4):370-379. doi: 10.1177/1060028017739637. Epub 2017 Nov 2.","Murphy JA","Ann Pharmacother","2018","2017/11/03","","","10.1177/1060028017739637"
"29087821","Cost-Effectiveness of Nalmefene Added to Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol-Dependent Patients With High/Very High Drinking Risk Levels: A Microsimulation Model","Millier A, Laramée P, Rahhali N, Aballéa S, Daeppen JB, Rehm J, Toumi M.","J Stud Alcohol Drugs. 2017 Nov;78(6):867-876. doi: 10.15288/jsad.2017.78.867.","Millier A","J Stud Alcohol Drugs","2017","2017/11/01","","","10.15288/jsad.2017.78.867"
"29080351","Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking","Wang Y, Chen X, Hahn JA, Brumback B, Zhou Z, Miguez MJ, Cook RL.","Alcohol Clin Exp Res. 2018 Jan;42(1):128-134. doi: 10.1111/acer.13540. Epub 2017 Dec 5.","Wang Y","Alcohol Clin Exp Res","2018","2017/10/29","PMC5750086","NIHMS916788","10.1111/acer.13540"
"29080208","Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results","Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.","Clin Drug Investig. 2018 Feb;38(2):147-155. doi: 10.1007/s40261-017-0590-4.","Barrio P","Clin Drug Investig","2018","2017/10/29","","","10.1007/s40261-017-0590-4"
"29055281","Application of wavelet and Fuorier transforms as powerful alternatives for derivative spectrophotometry in analysis of binary mixtures: A comparative study","Hassan SA, Abdel-Gawad SA.","Spectrochim Acta A Mol Biomol Spectrosc. 2018 Feb 15;191:365-371. doi: 10.1016/j.saa.2017.08.039. Epub 2017 Aug 14.","Hassan SA","Spectrochim Acta A Mol Biomol Spectrosc","2018","2017/10/22","","","10.1016/j.saa.2017.08.039"
"29052613","Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence","Matzeu A, Kallupi M, George O, Schweitzer P, Martin-Fardon R.","Neuropsychopharmacology. 2018 Apr;43(5):1010-1020. doi: 10.1038/npp.2017.250. Epub 2017 Oct 20.","Matzeu A","Neuropsychopharmacology","2018","2017/10/21","PMC5854806","","10.1038/npp.2017.250"
"29042247","Murine genetic variance in muscarinic cholinergic receptor antagonism of sucrose and saccharin solution intakes in three inbred mouse strains","Bourie F, Olsson K, Iskhakov B, Buras A, Fazilov G, Shenouda M, Zhezherya J, Bodnar RJ.","Pharmacol Biochem Behav. 2017 Dec;163:50-56. doi: 10.1016/j.pbb.2017.10.007. Epub 2017 Oct 16.","Bourie F","Pharmacol Biochem Behav","2017","2017/10/19","","","10.1016/j.pbb.2017.10.007"
"29042208","Antiallodynic activity of leflunomide is partially inhibited by naltrexone and glibenclamide and associated with reduced production of TNF-α and CXCL-1","Brito AMS, Godin AM, Augusto PSA, Menezes RR, Melo ISF, Dutra MGMB, Costa SOAM, Goulart FA, Rodrigues FF, Ísis Morais M, Machado RR, Coelho MM.","Eur J Pharmacol. 2018 Jan 5;818:17-25. doi: 10.1016/j.ejphar.2017.10.026. Epub 2017 Oct 16.","Brito AMS","Eur J Pharmacol","2018","2017/10/19","","","10.1016/j.ejphar.2017.10.026"
"29041942","Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain","Weil AJ, Masters ET, Barsdorf AI, Bass A, Pixton G, Wilson JG, Wolfram G.","Health Qual Life Outcomes. 2017 Oct 17;15(1):202. doi: 10.1186/s12955-017-0749-y.","Weil AJ","Health Qual Life Outcomes","2017","2017/10/19","PMC5645978","","10.1186/s12955-017-0749-y"
"29040826","Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys","Moerke MJ, Banks ML, Cheng K, Rice KC, Negus SS.","Drug Alcohol Depend. 2017 Dec 1;181:85-93. doi: 10.1016/j.drugalcdep.2017.09.020. Epub 2017 Oct 13.","Moerke MJ","Drug Alcohol Depend","2017","2017/10/18","PMC5683900","NIHMS912408","10.1016/j.drugalcdep.2017.09.020"
"29037662","Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine","Ward M, Norman H, D'Souza MS.","Behav Brain Res. 2018 Feb 15;338:56-65. doi: 10.1016/j.bbr.2017.10.011. Epub 2017 Oct 14.","Ward M","Behav Brain Res","2018","2017/10/18","","","10.1016/j.bbr.2017.10.011"
"29024552","Current pharmacotherapies for obesity: A practical perspective","Golden A.","J Am Assoc Nurse Pract. 2017 Oct;29(S1):S43-S52. doi: 10.1002/2327-6924.12519.","Golden A","J Am Assoc Nurse Pract","2017","2017/10/13","","","10.1002/2327-6924.12519"
"29016275","Effectiveness of Psychoanalytic-Interactional Group Therapy vs. Behavioral Group Therapy in Routine Outpatient Treatment of Alcohol-Dependent Patients","Nyhuis PW, Niederhofer E, Scherbaum N, Schifano F, Bonnet U, Dembski N, Niederhofer A, Specka M, Tenbergen M.","Subst Use Misuse. 2018 Feb 23;53(3):426-431. doi: 10.1080/10826084.2017.1334065. Epub 2017 Oct 10.","Nyhuis PW","Subst Use Misuse","2018","2017/10/11","","","10.1080/10826084.2017.1334065"
"28991360","Low-dose naltrexone: a novel treatment for Hailey-Hailey disease","Campbell V, McGrath C, Corry A.","Br J Dermatol. 2018 May;178(5):1196-1198. doi: 10.1111/bjd.16045. Epub 2018 Feb 23.","Campbell V","Br J Dermatol","2018","2017/10/10","","","10.1111/bjd.16045"
"28983886","Opioid receptor antagonists in the treatment of pathological gambling","Coppola M, Mondola R.","J Opioid Manag. 2017 Jul/Aug;13(4):205-206. doi: 10.5055/jom.2017.0388.","Coppola M","J Opioid Manag","2017","2017/10/07","","","10.5055/jom.2017.0388"
"28978715","Minimum effective naltrexone dose to antagonise etorphine immobilisation and prevent the complications of renarcotisation in domestic goats","O'Dell JH, Kock MD, Thompson PN, Meyer LCR.","Vet Rec. 2017 Nov;181(18):481. doi: 10.1136/vr.104435. Epub 2017 Oct 4.","O'Dell JH","Vet Rec","2017","2017/10/06","","","10.1136/vr.104435"
"28971229","Role of the guanine nucleotide binding protein, Gα(o,) in the development of morphine tolerance and dependence","Lamberts JT, Rosenthal LD, Jutkiewicz EM, Traynor JR.","Psychopharmacology (Berl). 2018 Jan;235(1):71-82. doi: 10.1007/s00213-017-4742-2. Epub 2017 Oct 3.","Lamberts JT","Psychopharmacology (Berl)","2018","2017/10/04","PMC5819733","NIHMS910479","10.1007/s00213-017-4742-2"
"28968171","Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer","Katakami N, Harada T, Murata T, Shinozaki K, Tsutsumi M, Yokota T, Arai M, Tada Y, Narabayashi M, Boku N.","J Clin Oncol. 2017 Dec 1;35(34):3859-3866. doi: 10.1200/JCO.2017.73.0853. Epub 2017 Oct 2.","Katakami N","J Clin Oncol","2017","2017/10/03","","","10.1200/JCO.2017.73.0853"
"28960888","Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers","Fukumura K, Yokota T, Baba Y, Arjona Ferreira JC.","Clin Pharmacol Drug Dev. 2018 Jun;7(5):474-483. doi: 10.1002/cpdd.387. Epub 2017 Sep 27.","Fukumura K","Clin Pharmacol Drug Dev","2018","2017/09/30","","","10.1002/cpdd.387"
"28948482","Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy Subjects","Bond M, Rabinovich-Guilatt L, Selim S, Darwish M, Tracewell W, Robertson P Jr, Yang R, Malamut R, Colucci P, Ducharme MP, Spiegelstein O.","Clin Drug Investig. 2017 Dec;37(12):1153-1163. doi: 10.1007/s40261-017-0575-3.","Bond M","Clin Drug Investig","2017","2017/09/27","","","10.1007/s40261-017-0575-3"
"28947376","Antagonising TLR4-TRIF signalling before or after a low-dose alcohol binge during adolescence prevents alcohol drinking but not seeking behaviour in adulthood","Jacobsen JHW, Buisman-Pijlman FT, Mustafa S, Rice KC, Hutchinson MR.","Neuropharmacology. 2018 Jan;128:460-473. doi: 10.1016/j.neuropharm.2017.09.028. Epub 2017 Sep 22.","Jacobsen JHW","Neuropharmacology","2018","2017/09/27","","","10.1016/j.neuropharm.2017.09.028"
"28945940","Opioid receptors mediate inotropic and depressor effects of apelin in rats with 2K1C-induced chronic renovascular hypertension","Rostamzadeh F, Najafipour H, Yeganeh-Hajahmadi M, Joukar S.","Clin Exp Pharmacol Physiol. 2018 Feb;45(2):187-197. doi: 10.1111/1440-1681.12860. Epub 2017 Nov 28.","Rostamzadeh F","Clin Exp Pharmacol Physiol","2018","2017/09/26","","","10.1111/1440-1681.12860"
"28940866","Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate","Palpacuer C, Duprez R, Huneau A, Locher C, Boussageon R, Laviolle B, Naudet F.","Addiction. 2018 Feb;113(2):220-237. doi: 10.1111/add.13974. Epub 2017 Sep 20.","Palpacuer C","Addiction","2018","2017/09/24","","","10.1111/add.13974"
"28934264","Profiling molecular factors associated with pyknosis and developmental arrest induced by an opioid receptor antagonist and dihydroartemisinin in Plasmodium falciparum","Asahi H, Inoue SI, Niikura M, Kunigo K, Suzuki Y, Kobayashi F, Sendo F.","PLoS One. 2017 Sep 21;12(9):e0184874. doi: 10.1371/journal.pone.0184874. eCollection 2017.","Asahi H","PLoS One","2017","2017/09/22","PMC5608265","","10.1371/journal.pone.0184874"
"28918581","Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study","Guerdjikova AI, Walsh B, Shan K, Halseth AE, Dunayevich E, McElroy SL.","Adv Ther. 2017 Oct;34(10):2307-2315. doi: 10.1007/s12325-017-0613-9. Epub 2017 Sep 16.","Guerdjikova AI","Adv Ther","2017","2017/09/18","PMC5656719","","10.1007/s12325-017-0613-9"
"28910481","Carfentanil: A New and Often Unrecognized Threat","Cowles CE Jr, Mitchell J, Stepp JE, Bewley VZ.","J Spec Oper Med. 2017 Fall;17(3):120-122.","Cowles CE Jr","J Spec Oper Med","2017","2017/09/15","","",""
"28891834","Naltrexone for Self-Injury in Borderline Personality With Venlafaxine-Associated Hyponatremia","DeLucia B.","J Clin Psychopharmacol. 2017 Dec;37(6):743-745. doi: 10.1097/JCP.0000000000000781.","DeLucia B","J Clin Psychopharmacol","2017","2017/09/12","","","10.1097/JCP.0000000000000781"
"28890053","Intrastriatal Chromospheres' Transplant Reduces Nociception in Hemiparkinsonian Rats","Gómez-Paz A, Drucker-Colín R, Milán-Aldaco D, Palomero-Rivero M, Ambriz-Tututi M.","Neuroscience. 2018 Sep 1;387:123-134. doi: 10.1016/j.neuroscience.2017.08.052. Epub 2017 Sep 8.","Gómez-Paz A","Neuroscience","2018","2017/09/12","","","10.1016/j.neuroscience.2017.08.052"
"28885299","Correlates of Stigma Severity Among Persons Seeking Opioid Detoxification","Bozinoff N, Anderson BJ, Bailey GL, Stein MD.","J Addict Med. 2018 Jan/Feb;12(1):19-23. doi: 10.1097/ADM.0000000000000355.","Bozinoff N","J Addict Med","2018","2017/09/09","PMC5786480","NIHMS901631","10.1097/ADM.0000000000000355"
"28877518","Naltrexone in the Treatment of Broadly Defined Behavioral Addictions: A Review and Meta-Analysis of Randomized Controlled Trials","Mouaffak F, Leite C, Hamzaoui S, Benyamina A, Laqueille X, Kebir O.","Eur Addict Res. 2017;23(4):204-210. doi: 10.1159/000480539. Epub 2017 Sep 7.","Mouaffak F","Eur Addict Res","2017","2017/09/07","","","10.1159/000480539"
"28868795","Ultra-Low Doses of Naltrexone Enhance the Antiallodynic Effect of Pregabalin or Gabapentin in Neuropathic Rats","Pineda-Farias JB, Caram-Salas NL, Salinas-Abarca AB, Ocampo J, Granados-Soto V.","Drug Dev Res. 2017 Dec;78(8):371-380. doi: 10.1002/ddr.21409. Epub 2017 Sep 3.","Pineda-Farias JB","Drug Dev Res","2017","2017/09/05","","","10.1002/ddr.21409"
"28868576","Choice between delayed food and immediate opioids in rats: treatment effects and individual differences","Panlilio LV, Secci ME, Schindler CW, Bradberry CW.","Psychopharmacology (Berl). 2017 Nov;234(22):3361-3373. doi: 10.1007/s00213-017-4726-2. Epub 2017 Sep 4.","Panlilio LV","Psychopharmacology (Berl)","2017","2017/09/05","PMC5664176","NIHMS903882","10.1007/s00213-017-4726-2"
"28867062","Home-based delivery of XR-NTX in youth with opioid addiction","Vo HT, Burgower R, Rozenberg I, Fishman M.","J Subst Abuse Treat. 2018 Feb;85:84-89. doi: 10.1016/j.jsat.2017.08.007. Epub 2017 Aug 31.","Vo HT","J Subst Abuse Treat","2018","2017/09/05","","","10.1016/j.jsat.2017.08.007"
"28864261","The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle","Jacobsen JHW, Buisman-Pijlman FTA, Mustafa S, Rice KC, Hutchinson MR.","Brain Behav Immun. 2018 Jan;67:181-193. doi: 10.1016/j.bbi.2017.08.021. Epub 2017 Aug 30.","Jacobsen JHW","Brain Behav Immun","2018","2017/09/03","","","10.1016/j.bbi.2017.08.021"
"28857657","Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome","Rosa SG, Pesarico AP, Tagliapietra CF, da Luz SC, Nogueira CW.","J Psychopharmacol. 2017 Sep;31(9):1250-1262. doi: 10.1177/0269881117724353. Epub 2017 Aug 31.","Rosa SG","J Psychopharmacol","2017","2017/09/01","","","10.1177/0269881117724353"
"28850647","The Role of Pleasure Neurobiology and Dopamine in Mental Health Disorders","Worley J.","J Psychosoc Nurs Ment Health Serv. 2017 Sep 1;55(9):17-21. doi: 10.3928/02793695-20170818-09.","Worley J","J Psychosoc Nurs Ment Health Serv","2017","2017/08/30","","","10.3928/02793695-20170818-09"
"28850596","Harms associated with taking nalmefene for substance use and impulse control disorders: A systematic review and meta-analysis of randomised controlled trials","Johansen KGV, Tarp S, Astrup A, Lund H, Pagsberg AK, Christensen R.","PLoS One. 2017 Aug 29;12(8):e0183821. doi: 10.1371/journal.pone.0183821. eCollection 2017.","Johansen KGV","PLoS One","2017","2017/08/30","PMC5574613","","10.1371/journal.pone.0183821"
"28849104","Killing effect of methionine enkephalin on melanoma in vivo and in vitro","Wang DM, Jiao X, Plotnikoff NP, Griffin N, Qi RQ, Gao XH, Shan FP.","Oncol Rep. 2017 Oct;38(4):2132-2140. doi: 10.3892/or.2017.5918. Epub 2017 Aug 24.","Wang DM","Oncol Rep","2017","2017/08/30","PMC5652957","","10.3892/or.2017.5918"
"28847457","Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision","Allen AA, Chen DT, Bonnie RJ, Ko TM, Suratt CE, Lee JD, Friedmann PD, Gordon M, McDonald R, Murphy SM, Boney TY, Nunes EV, O'Brien CP.","J Subst Abuse Treat. 2017 Oct;81:66-72. doi: 10.1016/j.jsat.2017.07.015. Epub 2017 Aug 1.","Allen AA","J Subst Abuse Treat","2017","2017/08/30","PMC5849444","NIHMS948552","10.1016/j.jsat.2017.07.015"
"28844812","Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-α-induced depression model","Callaghan CK, Rouine J, Dean RL, Knapp BI, Bidlack JM, Deaver DR, O'Mara SM.","Brain Behav Immun. 2018 Jan;67:152-162. doi: 10.1016/j.bbi.2017.08.016. Epub 2017 Aug 24.","Callaghan CK","Brain Behav Immun","2018","2017/08/29","","","10.1016/j.bbi.2017.08.016"
"28841773","Adverse effects of subcutaneous, drug-releasing implants for the treatment of opioid drug addiction","Bal C, Rappersberger K, Posch C.","J Dtsch Dermatol Ges. 2017 Dec;15(12):1232-1234. doi: 10.1111/ddg.13319. Epub 2017 Aug 25.","Bal C","J Dtsch Dermatol Ges","2017","2017/08/26","","","10.1111/ddg.13319"
"28833225","The Glycine Receptor-A Functionally Important Primary Brain Target of Ethanol","Söderpalm B, Lidö HH, Ericson M.","Alcohol Clin Exp Res. 2017 Nov;41(11):1816-1830. doi: 10.1111/acer.13483. Epub 2017 Oct 13.","Söderpalm B","Alcohol Clin Exp Res","2017","2017/08/24","","","10.1111/acer.13483"
"28827047","High Drinking in the Dark (HDID) mice are sensitive to the effects of some clinically relevant drugs to reduce binge-like drinking","Crabbe JC, Ozburn AR, Metten P, Barkley-Levenson A, Schlumbohm JP, Spence SE, Hack WR, Huang LC.","Pharmacol Biochem Behav. 2017 Sep;160:55-62. doi: 10.1016/j.pbb.2017.08.002. Epub 2017 Aug 5.","Crabbe JC","Pharmacol Biochem Behav","2017","2017/08/23","PMC5603423","NIHMS900707","10.1016/j.pbb.2017.08.002"
"28818558","Current and emerging pharmacotherapies for obesity in Australia","Hocking S, Dear A, Cowley MA.","Obes Res Clin Pract. 2017 Sep-Oct;11(5):501-521. doi: 10.1016/j.orcp.2017.07.002. Epub 2017 Aug 14.","Hocking S","Obes Res Clin Pract","2017","2017/08/19","","","10.1016/j.orcp.2017.07.002"
"28810695","Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial","Webster LR, Michna E, Khan A, Israel RJ, Harper JR.","Pain Med. 2017 Aug 1;18(8):1496-1504. doi: 10.1093/pm/pnx148.","Webster LR","Pain Med","2017","2017/08/17","PMC5914419","","10.1093/pm/pnx148"
"28806638","Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine","Marcus R, Makarenko I, Mazhnaya A, Zelenev A, Polonsky M, Madden L, Filippovych S, Dvoriak S, Springer SA, Altice FL.","Drug Alcohol Depend. 2017 Oct 1;179:213-219. doi: 10.1016/j.drugalcdep.2017.07.010. Epub 2017 Aug 5.","Marcus R","Drug Alcohol Depend","2017","2017/08/15","PMC5599372","NIHMS898103","10.1016/j.drugalcdep.2017.07.010"
"28806388","Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine","Lescut C, Gaboriau L, Carton L, Rolland B.","J Clin Psychopharmacol. 2017 Oct;37(5):631-633. doi: 10.1097/JCP.0000000000000763.","Lescut C","J Clin Psychopharmacol","2017","2017/08/15","","","10.1097/JCP.0000000000000763"
"28798303","Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method","Wang YT, Chan YH.","Sci Rep. 2017 Aug 10;7(1):7828. doi: 10.1038/s41598-017-08224-2.","Wang YT","Sci Rep","2017","2017/08/12","PMC5552784","","10.1038/s41598-017-08224-2"
"28795846","A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment","Rudolf G, Walsh J, Plawman A, Gianutsos P, Alto W, Mancl L, Rudolf V.","Am J Drug Alcohol Abuse. 2018;44(3):302-309. doi: 10.1080/00952990.2017.1334209. Epub 2017 Aug 10.","Rudolf G","Am J Drug Alcohol Abuse","2018","2017/08/11","","","10.1080/00952990.2017.1334209"
"28780906","Screening, treatment initiation, and referral for substance use disorders","Bernstein SL, D'Onofrio G.","Addict Sci Clin Pract. 2017 Aug 7;12(1):18. doi: 10.1186/s13722-017-0083-z.","Bernstein SL","Addict Sci Clin Pract","2017","2017/08/08","PMC5545867","","10.1186/s13722-017-0083-z"
"28780411","Increased ethanol drinking in ""humanized"" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms","Henderson-Redmond AN, Lowe TE, Tian XB, Morgan DJ.","Brain Res Bull. 2018 Apr;138:12-19. doi: 10.1016/j.brainresbull.2017.07.017. Epub 2017 Aug 2.","Henderson-Redmond AN","Brain Res Bull","2018","2017/08/07","PMC5796878","NIHMS897256","10.1016/j.brainresbull.2017.07.017"
"28776489","Pharmacokinetic study of methylnaltrexone after single and multiple subcutaneous administrations in healthy Chinese subjects","Zhang D, Ma JY, Yang M, Deng M, Liu H.","Xenobiotica. 2018 Aug;48(8):804-808. doi: 10.1080/00498254.2017.1364449. Epub 2017 Aug 17.","Zhang D","Xenobiotica","2018","2017/08/05","","","10.1080/00498254.2017.1364449"
"28768314","Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease)","Ibrahim O, Hogan SR, Vij A, Fernandez AP.","JAMA Dermatol. 2017 Oct 1;153(10):1015-1017. doi: 10.1001/jamadermatol.2017.2445.","Ibrahim O","JAMA Dermatol","2017","2017/08/03","PMC5817587","","10.1001/jamadermatol.2017.2445"
"28768313","Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone","Albers LN, Arbiser JL, Feldman RJ.","JAMA Dermatol. 2017 Oct 1;153(10):1018-1020. doi: 10.1001/jamadermatol.2017.2446.","Albers LN","JAMA Dermatol","2017","2017/08/03","PMC5817589","","10.1001/jamadermatol.2017.2446"
"28768307","Repurposing Medications-Chicken Manure, Erectile Dysfunction, and Finding the Golden Needle in the Haystack of Absurdity","Stratman EJ.","JAMA Dermatol. 2017 Oct 1;153(10):969-970. doi: 10.1001/jamadermatol.2017.2447.","Stratman EJ","JAMA Dermatol","2017","2017/08/03","","","10.1001/jamadermatol.2017.2447"
"28766982","Featured Article: Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone","Ludwig MD, Zagon IS, McLaughlin PJ.","Exp Biol Med (Maywood). 2017 Sep;242(15):1524-1533. doi: 10.1177/1535370217724791. Epub 2017 Aug 2.","Ludwig MD","Exp Biol Med (Maywood)","2017","2017/08/03","PMC5648293","","10.1177/1535370217724791"
"28753481","Baclofen and naltrexone effects on alcohol self-administration: Comparison of treatment initiated during abstinence or ongoing alcohol access in baboons","Holtyn AF, Kaminski BJ, Weerts EM.","Drug Alcohol Depend. 2017 Oct 1;179:47-54. doi: 10.1016/j.drugalcdep.2017.06.019. Epub 2017 Jul 18.","Holtyn AF","Drug Alcohol Depend","2017","2017/07/29","PMC5599358","NIHMS893751","10.1016/j.drugalcdep.2017.06.019"
"28745668","[An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients]","Agibalova TV, Nedobylskiy OV, Poplevchenkov KN, Sirotko II, Shcherban AV, Tsarev SA.","Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(6):32-34. doi: 10.17116/jnevro20171176132-34.","Agibalova TV","Zh Nevrol Psikhiatr Im S S Korsakova","2017","2017/07/27","","","10.17116/jnevro20171176132-34"
"28745076","Effects of ICI204,448, naloxone methiodide and levocetirizine on the scratching behavior induced by a κ-opioid antagonist, nor-BNI, in ICR mice","Nakasone T, Wakuda H, Sugimoto Y, Kamei C.","Immunopharmacol Immunotoxicol. 2017 Oct;39(5):292-295. doi: 10.1080/08923973.2017.1354879. Epub 2017 Jul 26.","Nakasone T","Immunopharmacol Immunotoxicol","2017","2017/07/27","","","10.1080/08923973.2017.1354879"
"28742957","Gambling Disorder and Concurrent Alcohol Use Disorder Treated With Naltrexone","Lee JC, Takayesu AG.","Prim Care Companion CNS Disord. 2017 Jul 20;19(4):16l02082. doi: 10.4088/PCC.16l02082.","Lee JC","Prim Care Companion CNS Disord","2017","2017/07/26","","","10.4088/PCC.16l02082"
"28734107","Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial","Coffin PO, Santos GM, Hern J, Vittinghoff E, Santos D, Matheson T, Colfax G, Batki SL.","Addiction. 2018 Feb;113(2):268-278. doi: 10.1111/add.13950. Epub 2017 Aug 29.","Coffin PO","Addiction","2018","2017/07/23","PMC5760469","NIHMS895003","10.1111/add.13950"
"28733097","Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY.","J Subst Abuse Treat. 2018 Feb;85:90-96. doi: 10.1016/j.jsat.2017.07.001. Epub 2017 Jul 3.","Morgan JR","J Subst Abuse Treat","2018","2017/07/23","PMC5750108","NIHMS894082","10.1016/j.jsat.2017.07.001"
"28728646","Efficacy of Naltrexone for the Treatment of Alcohol Dependence in Latino Populations","López CM, Barr SC, Reid-Quiñones K, de Arellano MA.","J Stud Alcohol Drugs. 2017 May;78(4):629-634. doi: 10.15288/jsad.2017.78.629.","López CM","J Stud Alcohol Drugs","2017","2017/07/22","PMC5551667","","10.15288/jsad.2017.78.629"
"28700791","Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial","Dunn KE, Tompkins DA, Bigelow GE, Strain EC.","JAMA Psychiatry. 2017 Sep 1;74(9):885-893. doi: 10.1001/jamapsychiatry.2017.1838.","Dunn KE","JAMA Psychiatry","2017","2017/07/13","PMC5710234","","10.1001/jamapsychiatry.2017.1838"
"28687195","β2-Microglobulin elicits itch-related responses in mice through the direct activation of primary afferent neurons expressing transient receptor potential vanilloid 1","Andoh T, Maki T, Li S, Uta D.","Eur J Pharmacol. 2017 Sep 5;810:134-140. doi: 10.1016/j.ejphar.2017.07.007. Epub 2017 Jul 4.","Andoh T","Eur J Pharmacol","2017","2017/07/09","","","10.1016/j.ejphar.2017.07.007"
"28663110","Sucrose and naltrexone prevent increased pain sensitivity and impaired long-term memory induced by repetitive neonatal noxious stimulation: Role of BDNF and β-endorphin","Nuseir KQ, Alzoubi KH, Alhusban A, Bawaane A, Al-Azzani M, Khabour OF.","Physiol Behav. 2017 Oct 1;179:213-219. doi: 10.1016/j.physbeh.2017.06.015. Epub 2017 Jun 27.","Nuseir KQ","Physiol Behav","2017","2017/07/01","","","10.1016/j.physbeh.2017.06.015"
"28662966","Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives","Kutsumura N, Koyama Y, Nagumo Y, Nakajima R, Miyata Y, Yamamoto N, Saitoh T, Yoshida N, Iwata S, Nagase H.","Bioorg Med Chem. 2017 Aug 15;25(16):4375-4383. doi: 10.1016/j.bmc.2017.06.026. Epub 2017 Jun 15.","Kutsumura N","Bioorg Med Chem","2017","2017/07/01","","","10.1016/j.bmc.2017.06.026"
"28649993","κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition","Abraham AD, Fontaine HM, Song AJ, Andrews MM, Baird MA, Kieffer BL, Land BB, Chavkin C.","Neuropsychopharmacology. 2018 Jan;43(2):362-372. doi: 10.1038/npp.2017.133. Epub 2017 Jun 26.","Abraham AD","Neuropsychopharmacology","2018","2017/06/27","PMC5729556","","10.1038/npp.2017.133"
"28642209","Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results","Cook RL, Weber KM, Mai D, Thoma K, Hu X, Brumback B, Karki M, Bryant K, Rathore M, Young M, Cohen M.","Contemp Clin Trials. 2017 Sep;60:72-77. doi: 10.1016/j.cct.2017.06.012. Epub 2017 Jun 19.","Cook RL","Contemp Clin Trials","2017","2017/06/24","PMC5570613","NIHMS890828","10.1016/j.cct.2017.06.012"
"28640990","Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone","Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Biederman J.","J Clin Psychiatry. 2018 Jan/Feb;79(1):16m11012. doi: 10.4088/JCP.16m11012.","Spencer TJ","J Clin Psychiatry","2018","2017/06/23","PMC6438372","NIHMS1014187","10.4088/JCP.16m11012"
"28635181","Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption","Kallupi M, Shen Q, de Guglielmo G, Yasuda D, Journigan VB, Zaveri NT, Ciccocioppo R.","Addict Biol. 2018 Mar;23(2):585-595. doi: 10.1111/adb.12513. Epub 2017 Jun 21.","Kallupi M","Addict Biol","2018","2017/06/22","PMC5740020","NIHMS888760","10.1111/adb.12513"
"28628701","Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014","Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR.","Version 2. JAMA Pediatr. 2017 Aug 1;171(8):747-755. doi: 10.1001/jamapediatrics.2017.0745.","Hadland SE","JAMA Pediatr","2017","2017/06/20","PMC5649381","NIHMS911093","10.1001/jamapediatrics.2017.0745"
"28628699","Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder","Saloner B, Feder KA, Krawczyk N.","JAMA Pediatr. 2017 Aug 1;171(8):729-731. doi: 10.1001/jamapediatrics.2017.1269.","Saloner B","JAMA Pediatr","2017","2017/06/20","PMC6007012","NIHMS970846","10.1001/jamapediatrics.2017.1269"
"28609749","Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone","Kelty E, Hulse G.","Int J Drug Policy. 2017 Aug;46:54-60. doi: 10.1016/j.drugpo.2017.05.039. Epub 2017 Jun 10.","Kelty E","Int J Drug Policy","2017","2017/06/14","","","10.1016/j.drugpo.2017.05.039"
"28606631","Restraint stress enhances alcohol intake in adolescent female rats but reduces alcohol intake in adolescent male and adult female rats","Wille-Bille A, Ferreyra A, Sciangula M, Chiner F, Nizhnikov ME, Pautassi RM.","Behav Brain Res. 2017 Aug 14;332:269-279. doi: 10.1016/j.bbr.2017.06.004. Epub 2017 Jun 10.","Wille-Bille A","Behav Brain Res","2017","2017/06/14","","","10.1016/j.bbr.2017.06.004"
"28605827","Predischarge Injectable Versus Oral Naltrexone to Improve Postdischarge Treatment Engagement Among Hospitalized Veterans with Alcohol Use Disorder: A Randomized Pilot Proof-of-Concept Study","Busch AC, Denduluri M, Glass J, Hetzel S, Gugnani SP, Gassman M, Krahn D, Deyo B, Brown R.","Alcohol Clin Exp Res. 2017 Jul;41(7):1352-1360. doi: 10.1111/acer.13410. Epub 2017 Jun 12.","Busch AC","Alcohol Clin Exp Res","2017","2017/06/13","PMC5519139","NIHMS872156","10.1111/acer.13410"
"28604472","Perioperative Pain Management of a Patient Taking Naltrexone HCl/Bupropion HCl (Contrave): A Case Report","Ninh A, Kim S, Goldberg A.","A A Case Rep. 2017 Oct 15;9(8):224-226. doi: 10.1213/XAA.0000000000000573.","Ninh A","A A Case Rep","2017","2017/06/13","","","10.1213/XAA.0000000000000573"
"28589556","Characterization of functional μ opioid receptor turnover in rat locus coeruleus: an electrophysiological and immunocytochemical study","Medrano MC, Santamarta MT, Pablos P, Aira Z, Buesa I, Azkue JJ, Mendiguren A, Pineda J.","Br J Pharmacol. 2017 Aug;174(16):2758-2772. doi: 10.1111/bph.13901. Epub 2017 Jul 7.","Medrano MC","Br J Pharmacol","2017","2017/06/08","PMC5522999","","10.1111/bph.13901"
"28580486","The Role of Endogenous Opioid System in the Regulation of Heart Tolerance to Stress-Induced Damage","Lishmanov YB, Tsibul'nikov SY, Naryzhnaya NV, Korobov MV, Maslov LN.","Bull Exp Biol Med. 2017 May;163(1):25-27. doi: 10.1007/s10517-017-3729-7. Epub 2017 Jun 3.","Lishmanov YB","Bull Exp Biol Med","2017","2017/06/06","","","10.1007/s10517-017-3729-7"
"28576452","Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials","Hale M, Wild J, Reddy J, Yamada T, Arjona Ferreira JC.","Lancet Gastroenterol Hepatol. 2017 Aug;2(8):555-564. doi: 10.1016/S2468-1253(17)30105-X. Epub 2017 May 30.","Hale M","Lancet Gastroenterol Hepatol","2017","2017/06/04","","","10.1016/S2468-1253(17)30105-X"
"28576389","Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual","Soares WE 3rd, Wilson D, Rathlev N, Lee JD, Gordon M, Nunes EV, O'Brien CP, Friedmann PD.","J Subst Abuse Treat. 2018 Feb;85:66-69. doi: 10.1016/j.jsat.2017.05.009. Epub 2017 May 12.","Soares WE 3rd","J Subst Abuse Treat","2018","2017/06/04","","","10.1016/j.jsat.2017.05.009"
"28554659","Naloxegol, an opioid antagonist with reduced CNS penetration: Mode-of-action and human relevance for rat testicular tumours","Andersson H, Mitchard T, Johnson N, Floettmann E.","Toxicol Appl Pharmacol. 2017 Aug 15;329:85-95. doi: 10.1016/j.taap.2017.05.032. Epub 2017 May 26.","Andersson H","Toxicol Appl Pharmacol","2017","2017/05/31","","","10.1016/j.taap.2017.05.032"
"28553701","Opioid antagonists with minimal sedation for opioid withdrawal","Gowing L, Ali R, White JM.","Cochrane Database Syst Rev. 2017 May 29;5(5):CD002021. doi: 10.1002/14651858.CD002021.pub4.","Gowing L","Cochrane Database Syst Rev","2017","2017/05/30","PMC6481395","","10.1002/14651858.CD002021.pub4"
"28543191","Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women","Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ.","Pharmacotherapy. 2017 Jul;37(7):824-839. doi: 10.1002/phar.1958. Epub 2017 Jul 2.","Tran TH","Pharmacotherapy","2017","2017/05/26","","","10.1002/phar.1958"
"28541285","Endogenous opioids regulate social threat learning in humans","Haaker J, Yi J, Petrovic P, Olsson A.","Nat Commun. 2017 May 25;8:15495. doi: 10.1038/ncomms15495.","Haaker J","Nat Commun","2017","2017/05/26","PMC5458514","","10.1038/ncomms15495"
"28540656","Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study","Di Nicola M, De Filippis S, Martinotti G, De Risio L, Pettorruso M, De Persis S, Maremmani AGI, Maremmani I, di Giannantonio M, Janiri L.","Adv Ther. 2017 Jul;34(7):1636-1649. doi: 10.1007/s12325-017-0546-3. Epub 2017 May 24.","Di Nicola M","Adv Ther","2017","2017/05/26","","","10.1007/s12325-017-0546-3"
"28538998","More Treatments on Deck for Alcohol Use Disorder","Lyon J.","JAMA. 2017 Jun 13;317(22):2267-2269. doi: 10.1001/jama.2017.4760.","Lyon J","JAMA","2017","2017/05/25","","","10.1001/jama.2017.4760"
"28536981","A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates","Kelty E, Hulse G.","Drugs. 2017 Jul;77(11):1211-1219. doi: 10.1007/s40265-017-0763-8.","Kelty E","Drugs","2017","2017/05/25","","","10.1007/s40265-017-0763-8"
"28536980","A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls","Kelty E, Hulse G.","Drugs. 2017 Jul;77(11):1199-1210. doi: 10.1007/s40265-017-0762-9.","Kelty E","Drugs","2017","2017/05/25","","","10.1007/s40265-017-0762-9"
"28527855","Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison","Friedmann PD, Wilson D, Hoskinson R Jr, Poshkus M, Clarke JG.","J Subst Abuse Treat. 2018 Feb;85:45-48. doi: 10.1016/j.jsat.2017.04.010. Epub 2017 Apr 19.","Friedmann PD","J Subst Abuse Treat","2018","2017/05/22","PMC5648627","NIHMS878895","10.1016/j.jsat.2017.04.010"
"28527854","Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders","Chokron Garneau H, Venegas A, Rawson R, Ray LA, Glasner S.","J Subst Abuse Treat. 2018 Feb;85:34-37. doi: 10.1016/j.jsat.2017.05.004. Epub 2017 May 11.","Chokron Garneau H","J Subst Abuse Treat","2018","2017/05/22","PMC5681892","NIHMS878110","10.1016/j.jsat.2017.05.004"
"28526967","Update on Barriers to Pharmacotherapy for Opioid Use Disorders","Sharma A, Kelly SM, Mitchell SG, Gryczynski J, O'Grady KE, Schwartz RP.","Curr Psychiatry Rep. 2017 Jun;19(6):35. doi: 10.1007/s11920-017-0783-9.","Sharma A","Curr Psychiatry Rep","2017","2017/05/21","PMC7075636","NIHMS1552800","10.1007/s11920-017-0783-9"
"28511286","Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials","Witkiewitz K, Pearson MR, Hallgren KA, Maisto SA, Roos CR, Kirouac M, Wilson AD, Montes KS, Heather N.","Addiction. 2017 Dec;112(12):2112-2121. doi: 10.1111/add.13870. Epub 2017 Jun 26.","Witkiewitz K","Addiction","2017","2017/05/17","PMC5673549","NIHMS877029","10.1111/add.13870"
"28502630","New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology","Zádor F, Király K, Váradi A, Balogh M, Fehér Á, Kocsis D, Erdei AI, Lackó E, Zádori ZS, Hosztafi S, Noszál B, Riba P, Benyhe S, Fürst S, Al-Khrasani M.","Eur J Pharmacol. 2017 Aug 15;809:111-121. doi: 10.1016/j.ejphar.2017.05.024. Epub 2017 May 11.","Zádor F","Eur J Pharmacol","2017","2017/05/16","","","10.1016/j.ejphar.2017.05.024"
"28501906","Medication use for the treatment of diabetes in obese individuals","Wilding JPH.","Diabetologia. 2018 Feb;61(2):265-272. doi: 10.1007/s00125-017-4288-1. Epub 2017 May 14.","Wilding JPH","Diabetologia","2018","2017/05/15","PMC6448959","","10.1007/s00125-017-4288-1"
"28501425","The effects of kratom on restraint-stress-induced analgesia and its mechanisms of action","Vázquez López JL, Schild L, Günther T, Schulz S, Neurath H, Becker A.","J Ethnopharmacol. 2017 Jun 9;205:178-185. doi: 10.1016/j.jep.2017.05.008. Epub 2017 May 10.","Vázquez López JL","J Ethnopharmacol","2017","2017/05/15","","","10.1016/j.jep.2017.05.008"
"28500210","First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario","Spithoff S, Turner S, Gomes T, Martins D, Singh S.","Can Fam Physician. 2017 May;63(5):e277-e283.","Spithoff S","Can Fam Physician","2017","2017/05/14","PMC5429069","",""
"28493563","Nalmefene Prevents Alcohol-Induced Neuroinflammation and Alcohol Drinking Preference in Adolescent Female Mice: Role of TLR4","Montesinos J, Gil A, Guerri C.","Alcohol Clin Exp Res. 2017 Jul;41(7):1257-1270. doi: 10.1111/acer.13416. Epub 2017 Jun 5.","Montesinos J","Alcohol Clin Exp Res","2017","2017/05/12","","","10.1111/acer.13416"
"28483411","Naldemedine effective in treating opioid-induced constipation","Brower V.","Lancet Oncol. 2017 Jun;18(6):e306. doi: 10.1016/S1470-2045(17)30320-0. Epub 2017 May 5.","Brower V","Lancet Oncol","2017","2017/05/10","","","10.1016/S1470-2045(17)30320-0"
"28481727","Trends in Opioid Use Disorder Diagnoses and Medication Treatment Among Veterans With Posttraumatic Stress Disorder","Shiner B, Leonard Westgate C, Bernardy NC, Schnurr PP, Watts BV.","J Dual Diagn. 2017 Jul-Sep;13(3):201-212. doi: 10.1080/15504263.2017.1325033. Epub 2017 May 8.","Shiner B","J Dual Diagn","2017","2017/05/09","PMC6190703","NIHMS988226","10.1080/15504263.2017.1325033"
"28481169","A Comparison of Sexual Side Effects of Antidepressants With and Without Naltrexone","Thapa M, Petrakis I, Ralevski E.","J Dual Diagn. 2017 Jul-Sep;13(3):230-235. doi: 10.1080/15504263.2017.1326650. Epub 2017 May 8.","Thapa M","J Dual Diagn","2017","2017/05/09","","","10.1080/15504263.2017.1326650"
"28479011","Extended-release naltrexone for opioid use disorder started during or following incarceration","Lincoln T, Johnson BD, McCarthy P, Alexander E.","J Subst Abuse Treat. 2018 Feb;85:97-100. doi: 10.1016/j.jsat.2017.04.002. Epub 2017 Apr 6.","Lincoln T","J Subst Abuse Treat","2018","2017/05/09","","","10.1016/j.jsat.2017.04.002"
"28476269","Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs","Finlay AK, Ellerbe LS, Wong JJ, Timko C, Rubinsky AD, Gupta S, Bowe TR, Burden JL, Harris AHS.","J Subst Abuse Treat. 2017 Jun;77:38-43. doi: 10.1016/j.jsat.2017.03.005. Epub 2017 Mar 10.","Finlay AK","J Subst Abuse Treat","2017","2017/05/07","PMC5467688","NIHMS860148","10.1016/j.jsat.2017.03.005"
"28473233","Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone","Nunes EV, Gordon M, Friedmann PD, Fishman MJ, Lee JD, Chen DT, Hu MC, Boney TY, Wilson D, O'Brien CP.","J Subst Abuse Treat. 2018 Feb;85:49-55. doi: 10.1016/j.jsat.2017.04.016. Epub 2017 Apr 23.","Nunes EV","J Subst Abuse Treat","2018","2017/05/06","PMC5755382","NIHMS873646","10.1016/j.jsat.2017.04.016"
"28466424","Naldemedine: First Global Approval","Markham A.","Drugs. 2017 May;77(8):923-927. doi: 10.1007/s40265-017-0750-0.","Markham A","Drugs","2017","2017/05/04","","","10.1007/s40265-017-0750-0"
"28457152","Current Progress in Opioid Treatment","Woody GE.","Am J Psychiatry. 2017 May 1;174(5):414-416. doi: 10.1176/appi.ajp.2016.16121398.","Woody GE","Am J Psychiatry","2017","2017/05/02","","","10.1176/appi.ajp.2016.16121398"
"28449955","Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults","Jarvis BP, Holtyn AF, Berry MS, Subramaniam S, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.","J Subst Abuse Treat. 2018 Feb;85:38-44. doi: 10.1016/j.jsat.2017.04.012. Epub 2017 Apr 20.","Jarvis BP","J Subst Abuse Treat","2018","2017/04/29","PMC5650550","NIHMS872221","10.1016/j.jsat.2017.04.012"
"28445097","Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer","Katakami N, Oda K, Tauchi K, Nakata K, Shinozaki K, Yokota T, Suzuki Y, Narabayashi M, Boku N.","J Clin Oncol. 2017 Jun 10;35(17):1921-1928. doi: 10.1200/JCO.2016.70.8453. Epub 2017 Apr 26.","Katakami N","J Clin Oncol","2017","2017/04/27","","","10.1200/JCO.2016.70.8453"
"28440810","Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study","Jayaram-Lindström N, Guterstam J, Häggkvist J, Ericson M, Malmlöf T, Schilström B, Halldin C, Cervenka S, Saijo T, Nordström AL, Franck J.","Transl Psychiatry. 2017 Apr 25;7(4):e1104. doi: 10.1038/tp.2017.79.","Jayaram-Lindström N","Transl Psychiatry","2017","2017/04/26","PMC5416714","","10.1038/tp.2017.79"
"28438708","Psychopharmacological modulation of event-related potentials suggests that first-hand pain and empathy for pain rely on similar opioidergic processes","Rütgen M, Seidel EM, Pletti C, Riečanský I, Gartus A, Eisenegger C, Lamm C.","Neuropsychologia. 2018 Jul 31;116(Pt A):5-14. doi: 10.1016/j.neuropsychologia.2017.04.023. Epub 2017 Apr 21.","Rütgen M","Neuropsychologia","2018","2017/04/26","","","10.1016/j.neuropsychologia.2017.04.023"
"28409564","Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status","Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF.","Neuropsychopharmacology. 2017 Dec;42(13):2640-2653. doi: 10.1038/npp.2017.74. Epub 2017 Apr 14.","Schacht JP","Neuropsychopharmacology","2017","2017/04/15","PMC5686497","","10.1038/npp.2017.74"
"28408331","Evaluation of effect of minocycline on rewarding potential and alcohol relapse in place preference model in mice","Gajbhiye SV, Tripathi RK, Salve B, Petare A, Potey AV.","Neurosci Lett. 2017 May 10;649:28-33. doi: 10.1016/j.neulet.2017.04.007. Epub 2017 Apr 10.","Gajbhiye SV","Neurosci Lett","2017","2017/04/15","","","10.1016/j.neulet.2017.04.007"
"28404521","Diabetic complications in the cornea","Ljubimov AV.","Vision Res. 2017 Oct;139:138-152. doi: 10.1016/j.visres.2017.03.002. Epub 2017 Apr 28.","Ljubimov AV","Vision Res","2017","2017/04/14","PMC5660664","NIHMS867140","10.1016/j.visres.2017.03.002"
"28401564","A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment","Kahler CW, Cioe PA, Tzilos GK, Spillane NS, Leggio L, Ramsey SE, Brown RA, O'Malley SS.","Alcohol Clin Exp Res. 2017 Jun;41(6):1201-1211. doi: 10.1111/acer.13396. Epub 2017 May 7.","Kahler CW","Alcohol Clin Exp Res","2017","2017/04/13","PMC5485847","NIHMS868772","10.1111/acer.13396"
"28387833","Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia","Crombie KM, Brellenthin AG, Hillard CJ, Koltyn KF.","Pain Med. 2018 Jan 1;19(1):118-123. doi: 10.1093/pm/pnx058.","Crombie KM","Pain Med","2018","2017/04/08","PMC6454785","","10.1093/pm/pnx058"
"28385676","Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres","Andhariya JV, Shen J, Choi S, Wang Y, Zou Y, Burgess DJ.","J Control Release. 2017 Jun 10;255:27-35. doi: 10.1016/j.jconrel.2017.03.396. Epub 2017 Apr 4.","Andhariya JV","J Control Release","2017","2017/04/08","","","10.1016/j.jconrel.2017.03.396"
"28379861","Extended-Release Injectable Naltrexone (XR-NTX) With Intensive Psychosocial Therapy for Amphetamine-Dependent Persons Seeking Treatment: A Placebo-Controlled Trial","Runarsdottir V, Hansdottir I, Tyrfingsson T, Einarsson M, Dugosh K, Royer-Malvestuto C, Pettinati H, Khalsa J, Woody GE.","J Addict Med. 2017 May/Jun;11(3):197-204. doi: 10.1097/ADM.0000000000000297.","Runarsdottir V","J Addict Med","2017","2017/04/06","PMC5449233","NIHMS842039","10.1097/ADM.0000000000000297"
"28376679","Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder","Heal DJ, Hallam M, Prow M, Gosden J, Cheetham S, Choi YK, Tarazi F, Hutson P.","J Psychopharmacol. 2017 Jun;31(6):770-783. doi: 10.1177/0269881117699607. Epub 2017 Apr 5.","Heal DJ","J Psychopharmacol","2017","2017/04/06","","","10.1177/0269881117699607"
"28376659","Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention","Xie JY, De Felice M, Kopruszinski CM, Eyde N, LaVigne J, Remeniuk B, Hernandez P, Yue X, Goshima N, Ossipov M, King T, Streicher JM, Navratilova E, Dodick D, Rosen H, Roberts E, Porreca F.","Cephalalgia. 2017 Jul;37(8):780-794. doi: 10.1177/0333102417702120. Epub 2017 Apr 4.","Xie JY","Cephalalgia","2017","2017/04/06","PMC6085081","NIHMS981004","10.1177/0333102417702120"
"28374069","Mu and kappa opioid receptors of the periaqueductal gray stimulate and inhibit thermogenesis, respectively, during psychological stress in rats","Cristina-Silva C, Martins V, Gargaglioni LH, Bícego KC.","Pflugers Arch. 2017 Sep;469(9):1151-1161. doi: 10.1007/s00424-017-1966-2. Epub 2017 Apr 4.","Cristina-Silva C","Pflugers Arch","2017","2017/04/05","","","10.1007/s00424-017-1966-2"
"28373674","Early improvement in food cravings are associated with long-term weight loss success in a large clinical sample","Dalton M, Finlayson G, Walsh B, Halseth AE, Duarte C, Blundell JE.","Int J Obes (Lond). 2017 Aug;41(8):1232-1236. doi: 10.1038/ijo.2017.89. Epub 2017 Apr 4.","Dalton M","Int J Obes (Lond)","2017","2017/04/05","PMC5797930","","10.1038/ijo.2017.89"
"28371937","A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain","Webster LR, Yamada T, Arjona Ferreira JC.","Pain Med. 2017 Dec 1;18(12):2350-2360. doi: 10.1093/pm/pnw325.","Webster LR","Pain Med","2017","2017/04/04","PMC5914456","","10.1093/pm/pnw325"
"28370746","Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database","Raknes G, Småbrekke L.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):685-693. doi: 10.1002/pds.4201. Epub 2017 Mar 29.","Raknes G","Pharmacoepidemiol Drug Saf","2017","2017/04/04","PMC5485080","","10.1002/pds.4201"
"28363796","Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration","Wang Y, Zhou J, Liu X, Zhao L, Wang Z, Zhang X, Wang K, Wang L, Wang R.","Peptides. 2017 May;91:40-48. doi: 10.1016/j.peptides.2017.03.009. Epub 2017 Mar 29.","Wang Y","Peptides","2017","2017/04/02","","","10.1016/j.peptides.2017.03.009"
"28363231","[Management of adverse effects of opioid therapy]","Wirz S.","Z Gastroenterol. 2017 Apr;55(4):394-400. doi: 10.1055/s-0043-103348. Epub 2017 Mar 31.","Wirz S","Z Gastroenterol","2017","2017/04/01","","","10.1055/s-0043-103348"
"28363055","CARDIORESPIRATORY EFFECTS OF DEXMEDETOMIDINE-BUTORPHANOL-MIDAZOLAM (DBM): A FULLY REVERSIBLE ANESTHETIC PROTOCOL IN CAPTIVE AND SEMI-FREE-RANGING CHEETAHS (ACINONYX JUBATUS)","Woc Colburn AM, Murray S, Hayek LC, Marker L, Sanchez CR.","J Zoo Wildl Med. 2017 Mar;48(1):40-47. doi: 10.1638/2016-0042.1.","Woc Colburn AM","J Zoo Wildl Med","2017","2017/04/01","","","10.1638/2016-0042.1"
"28358754","Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence","Earley PH, Zummo J, Memisoglu A, Silverman BL, Gastfriend DR.","J Addict Med. 2017 May/Jun;11(3):224-230. doi: 10.1097/ADM.0000000000000302.","Earley PH","J Addict Med","2017","2017/03/31","PMC5457834","","10.1097/ADM.0000000000000302"
"28357460","Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder","Roche DJO, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA.","Psychopharmacology (Berl). 2017 Jul;234(13):1997-2007. doi: 10.1007/s00213-017-4607-8. Epub 2017 Mar 29.","Roche DJO","Psychopharmacology (Berl)","2017","2017/03/31","PMC5480611","NIHMS864050","10.1007/s00213-017-4607-8"
"28350226","Integration of Care in the Implementation of the Affordable Care Act: Changes in Treatment Services in a National Sample of Centers Treating Substance Use Disorders","Aletraris L, Roman PM, Pruett J.","J Psychoactive Drugs. 2017 Apr-Jun;49(2):132-140. doi: 10.1080/02791072.2017.1299263. Epub 2017 Mar 28.","Aletraris L","J Psychoactive Drugs","2017","2017/03/29","","","10.1080/02791072.2017.1299263"
"28347824","Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI","Maraschin JC, Almeida CB, Rangel MP, Roncon CM, Sestile CC, Zangrossi H Jr, Graeff FG, Audi EA.","Behav Brain Res. 2017 Jun 1;327:75-82. doi: 10.1016/j.bbr.2017.03.033. Epub 2017 Mar 24.","Maraschin JC","Behav Brain Res","2017","2017/03/29","","","10.1016/j.bbr.2017.03.033"
"28343423","Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians","Franchitto N, Jullian B, Salles J, Pelissier F, Rolland B.","Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):669-677. doi: 10.1080/17425255.2017.1312340. Epub 2017 Apr 3.","Franchitto N","Expert Opin Drug Metab Toxicol","2017","2017/03/28","","","10.1080/17425255.2017.1312340"
"28334661","Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community","Springer SA, Di Paola A, Azar MM, Barbour R, Krishnan A, Altice FL.","Drug Alcohol Depend. 2017 May 1;174:158-170. doi: 10.1016/j.drugalcdep.2017.01.026. Epub 2017 Mar 10.","Springer SA","Drug Alcohol Depend","2017","2017/03/24","PMC5407009","NIHMS859619","10.1016/j.drugalcdep.2017.01.026"
"28333660","Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients","Sturn KM, Collin M.","Int J Pharm Compd. 2016 May-Jun;20(3):197-201.","Sturn KM","Int J Pharm Compd","2016","2017/03/24","","",""
"28328148","Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders","Williams AR, Barbieri V, Mishlen K, Levin FR, Nunes EV, Mariani JJ, Bisaga A.","Am J Addict. 2017 Jun;26(4):319-325. doi: 10.1111/ajad.12527. Epub 2017 Mar 22.","Williams AR","Am J Addict","2017","2017/03/23","PMC5426981","NIHMS853955","10.1111/ajad.12527"
"28325149","Low Dose Naltrexone in the Treatment of Fibromyalgia","Metyas S, Chen CL, Yeter K, Solyman J, Arkfeld DG.","Curr Rheumatol Rev. 2018;14(2):177-180. doi: 10.2174/1573397113666170321120329.","Metyas S","Curr Rheumatol Rev","2018","2017/03/23","","","10.2174/1573397113666170321120329"
"28324705","More pain, more gain: Blocking the opioid system boosts adaptive cognitive control","van Steenbergen H, Weissman DH, Stein DJ, Malcolm-Smith S, van Honk J.","Psychoneuroendocrinology. 2017 Jun;80:99-103. doi: 10.1016/j.psyneuen.2017.03.002. Epub 2017 Mar 7.","van Steenbergen H","Psychoneuroendocrinology","2017","2017/03/22","","","10.1016/j.psyneuen.2017.03.002"
"28322465","Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine","Yéléhé-Okouma M, Martini H, Lemarié J, Labroca P, Petitpain N, Gibaja V, Paille F, Gillet P.","Fundam Clin Pharmacol. 2017 Oct;31(5):574-579. doi: 10.1111/fcp.12286. Epub 2017 May 9.","Yéléhé-Okouma M","Fundam Clin Pharmacol","2017","2017/03/22","","","10.1111/fcp.12286"
"28315644","Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits","Martin-Flores M, Singh B, Walsh CA, Brooks EP, Taylor L, Mitchell LM.","J Am Assoc Lab Anim Sci. 2017 Mar 1;56(2):155-159.","Martin-Flores M","J Am Assoc Lab Anim Sci","2017","2017/03/20","PMC5361040","",""
"28301250","Naltrexone in the treatment of binge eating disorder in a patient with severe alcohol use disorder: a case report","Leroy A, Carton L, Gomajee H, Bordet R, Cottencin O.","Am J Drug Alcohol Abuse. 2017 Sep;43(5):618-620. doi: 10.1080/00952990.2017.1298117. Epub 2017 Mar 16.","Leroy A","Am J Drug Alcohol Abuse","2017","2017/03/17","","","10.1080/00952990.2017.1298117"
"28300812","[A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine]","Kibitov АО, Krupitsky ЕМ, Blokhina ЕА, Verbitskaya ЕV, Brodyansky VМ, Alekseeva NP, Bushara NМ, Yaroslavtseva ТS, Palatkin VY, Masalov DV, Burakov АМ, Romanova ТN, Sulimov GY, Grinenko AY, Kosten Т, Nielsen D, Zvartau EE.","Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(11. Vyp. 2):36-48. doi: 10.17116/jnevro201611611236-48.","Kibitov АО","Zh Nevrol Psikhiatr Im S S Korsakova","2016","2017/03/17","","","10.17116/jnevro201611611236-48"
"28294136","Opioid Modulation of Value-Based Decision-Making in Healthy Humans","Eikemo M, Biele G, Willoch F, Thomsen L, Leknes S.","Neuropsychopharmacology. 2017 Aug;42(9):1833-1840. doi: 10.1038/npp.2017.58. Epub 2017 Mar 15.","Eikemo M","Neuropsychopharmacology","2017","2017/03/16","PMC5520785","","10.1038/npp.2017.58"
"28291693","Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer","Li G, Low PS.","Bioorg Med Chem Lett. 2017 May 1;27(9):2074-2078. doi: 10.1016/j.bmcl.2016.06.067. Epub 2016 Jun 28.","Li G","Bioorg Med Chem Lett","2017","2017/03/15","PMC5771650","NIHMS896308","10.1016/j.bmcl.2016.06.067"
"28291571","The Los Angeles County hub-and-provider network for promoting the sustained use of extended-release naltrexone (XR-NTX) in Los Angeles County (2010-2015)","Cousins SJ, Crèvecoeur-MacPhail D, Kim T, Rawson RA.","J Subst Abuse Treat. 2018 Feb;85:78-83. doi: 10.1016/j.jsat.2017.02.011. Epub 2017 Mar 11.","Cousins SJ","J Subst Abuse Treat","2018","2017/03/15","","","10.1016/j.jsat.2017.02.011"
"28277185","Changes in the incentive value of food after naltrexone treatment depend on a differential preference for a palatable food in male rats","Alvarado-Bañuelos M, Barrios De Tomasi E, Juárez J.","Nutr Neurosci. 2017 Sep;20(7):416-423. doi: 10.1080/1028415X.2016.1162389. Epub 2016 Mar 23.","Alvarado-Bañuelos M","Nutr Neurosci","2017","2017/03/10","","","10.1080/1028415X.2016.1162389"
"28275232","The differential effects of low and high doses of apelin through opioid receptors on the blood pressure of rats with renovascular hypertension","Yeganeh-Hajahmadi M, Najafipour H, Rostamzadeh F.","Hypertens Res. 2017 Aug;40(8):732-737. doi: 10.1038/hr.2017.28. Epub 2017 Mar 9.","Yeganeh-Hajahmadi M","Hypertens Res","2017","2017/03/10","","","10.1038/hr.2017.28"
"28274648","Extended-release naltrexone and drug treatment courts: Policy and evidence for implementing an evidence-based treatment","Robertson AG, Swartz MS.","J Subst Abuse Treat. 2018 Feb;85:101-104. doi: 10.1016/j.jsat.2017.02.016. Epub 2017 Feb 28.","Robertson AG","J Subst Abuse Treat","2018","2017/03/10","","","10.1016/j.jsat.2017.02.016"
"28267152","Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery","Savulich G, Riccelli R, Passamonti L, Correia M, Deakin JF, Elliott R, Flechais RS, Lingford-Hughes AR, McGonigle J, Murphy A, Nutt DJ, Orban C, Paterson LM, Reed LJ, Smith DG, Suckling J, Tait R, Taylor EM, Sahakian BJ, Robbins TW, Ersche KD.","Transl Psychiatry. 2017 Mar 7;7(3):e1054. doi: 10.1038/tp.2017.34.","Savulich G","Transl Psychiatry","2017","2017/03/08","PMC5416677","","10.1038/tp.2017.34"
"28263712","Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone","Zhou Y, Crowley RS, Ben K, Prisinzano TE, Kreek MJ.","Brain Res. 2017 May 1;1662:75-86. doi: 10.1016/j.brainres.2017.02.027. Epub 2017 Mar 2.","Zhou Y","Brain Res","2017","2017/03/07","PMC5398281","NIHMS859624","10.1016/j.brainres.2017.02.027"
"28247556","A Systematic Review of Naltrexone for Attenuating Alcohol Consumption in Women with Alcohol Use Disorders","Canidate SS, Carnaby GD, Cook CL, Cook RL.","Alcohol Clin Exp Res. 2017 Mar;41(3):466-472. doi: 10.1111/acer.13313. Epub 2017 Feb 3.","Canidate SS","Alcohol Clin Exp Res","2017","2017/03/02","PMC5572298","NIHMS838863","10.1111/acer.13313"
"28247526","Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals","Morris LS, Baek K, Tait R, Elliott R, Ersche KD, Flechais R, McGonigle J, Murphy A, Nestor LJ, Orban C, Passetti F, Paterson LM, Rabiner I, Reed L, Smith D, Suckling J, Taylor EM, Bullmore ET, Lingford-Hughes AR, Deakin B, Nutt DJ, Sahakian BJ, Robbins TW, Voon V; ICCAM Consortium.","Addict Biol. 2018 Jan;23(1):425-436. doi: 10.1111/adb.12503. Epub 2017 Feb 28.","Morris LS","Addict Biol","2018","2017/03/02","PMC5811832","","10.1111/adb.12503"
"28246654","Obesity Epidemic: Pharmaceutical Weight Loss","Curry SA.","R I Med J (2013). 2017 Mar 1;100(2):18-20.","Curry SA","R I Med J (2013)","2017","2017/03/02","","",""
"28246225","A 35-year-old woman with low mood and concerns about her alcohol use","Samokhvalov AV, Le Foll B.","CMAJ. 2017 Feb 27;189(8):E317-E318. doi: 10.1503/cmaj.160132.","Samokhvalov AV","CMAJ","2017","2017/03/02","PMC5325733","","10.1503/cmaj.160132"
"28240173","Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond","Ragia G, Manolopoulos VG.","Curr Pharm Biotechnol. 2017;18(3):221-230. doi: 10.2174/1389201018666170224105025.","Ragia G","Curr Pharm Biotechnol","2017","2017/02/28","","","10.2174/1389201018666170224105025"
"28239984","Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder","Murphy SM, Polsky D, Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Bonnie RJ, Gordon M, Chen DT, Boney TY, O'Brien CP.","Addiction. 2017 Aug;112(8):1440-1450. doi: 10.1111/add.13807. Epub 2017 Apr 12.","Murphy SM","Addiction","2017","2017/02/28","PMC5503784","NIHMS855713","10.1111/add.13807"
"28236511","Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?","Friedmann PD, Wilson D, Nunes EV, Hoskinson R Jr, Lee JD, Gordon M, Murphy SM, Bonnie RJ, Chen DT, Boney TY, O'Brien CP.","J Subst Abuse Treat. 2018 Feb;85:61-65. doi: 10.1016/j.jsat.2017.01.018. Epub 2017 Feb 22.","Friedmann PD","J Subst Abuse Treat","2018","2017/02/26","PMC5565721","NIHMS854175","10.1016/j.jsat.2017.01.018"
"28220511","Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore","Goh ET, Morgan MY.","Aliment Pharmacol Ther. 2017 Apr;45(7):865-882. doi: 10.1111/apt.13965. Epub 2017 Feb 20.","Goh ET","Aliment Pharmacol Ther","2017","2017/02/22","","","10.1111/apt.13965"
"28219609","Neuroscience in gambling policy and treatment: an interdisciplinary perspective","Yücel M, Carter A, Allen AR, Balleine B, Clark L, Dowling NA, Gainsbury SM, Goudriaan AE, Grant J, Hayes A, Hodgins D, van Holst R, Lattimore R, Livingstone C, Lorenzetti V, Lubman D, Murawski C, Parkes L, Petry N, Room R, Singh B, Thomas A, Townshend P, Youssef G, Hall W.","Lancet Psychiatry. 2017 Jun;4(6):501-506. doi: 10.1016/S2215-0366(16)30369-8. Epub 2017 Feb 15.","Yücel M","Lancet Psychiatry","2017","2017/02/22","","","10.1016/S2215-0366(16)30369-8"
"28216062","Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study","Quelch DR, Mick I, McGonigle J, Ramos AC, Flechais RSA, Bolstridge M, Rabiner E, Wall MB, Newbould RD, Steiniger-Brach B, van den Berg F, Boyce M, Østergaard Nilausen D, Breuning Sluth L, Meulien D, von der Goltz C, Nutt D, Lingford-Hughes A.","Biol Psychiatry. 2017 Jun 1;81(11):941-948. doi: 10.1016/j.biopsych.2016.12.029. Epub 2017 Jan 10.","Quelch DR","Biol Psychiatry","2017","2017/02/21","","","10.1016/j.biopsych.2016.12.029"
"28215953","Antagonist Treatment for Opioid Use Disorder","Silverman BL, Akerman SC.","Am J Med. 2017 Mar;130(3):e117. doi: 10.1016/j.amjmed.2016.08.048.","Silverman BL","Am J Med","2017","2017/02/21","","","10.1016/j.amjmed.2016.08.048"
"28192104","Practical Use of Pharmacotherapy for Obesity","Igel LI, Kumar RB, Saunders KH, Aronne LJ.","Gastroenterology. 2017 May;152(7):1765-1779. doi: 10.1053/j.gastro.2016.12.049. Epub 2017 Feb 10.","Igel LI","Gastroenterology","2017","2017/02/14","","","10.1053/j.gastro.2016.12.049"
"28187396","Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome","Zielińska M, Jarmuż A, Wasilewski A, Cami-Kobeci G, Husbands S, Fichna J.","Pharmacol Rep. 2017 Apr;69(2):350-357. doi: 10.1016/j.pharep.2016.12.001. Epub 2016 Dec 5.","Zielińska M","Pharmacol Rep","2017","2017/02/11","PMC5367634","NIHMS851009","10.1016/j.pharep.2016.12.001"
"28181957","Use of nalmefene in patients with comorbid borderline personality disorder and alcohol use disorder: a preliminary report","Martín-Blanco A, Patrizi B, Soler J, Gasol X, Elices M, Gasol M, Carmona C, Pascual JC.","Int Clin Psychopharmacol. 2017 Jul;32(4):231-234. doi: 10.1097/YIC.0000000000000170.","Martín-Blanco A","Int Clin Psychopharmacol","2017","2017/02/10","","","10.1097/YIC.0000000000000170"
"28176798","Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone","Mallik A, Chanda ML, Levitin DJ.","Sci Rep. 2017 Feb 8;7:41952. doi: 10.1038/srep41952.","Mallik A","Sci Rep","2017","2017/02/09","PMC5296903","","10.1038/srep41952"
"28168894","Effect of combined opioid receptor and α(2)-adrenoceptor blockade on anxiety and electrically evoked startle responses","Vo L, Drummond PD.","J Psychopharmacol. 2017 Jun;31(6):722-729. doi: 10.1177/0269881116689259. Epub 2017 Feb 7.","Vo L","J Psychopharmacol","2017","2017/02/08","","","10.1177/0269881116689259"
"28168885","Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit","Merchan C, Altshuler D, Papadopoulos J.","Ann Pharmacother. 2017 Mar;51(3):203-208. doi: 10.1177/1060028016677310. Epub 2016 Nov 13.","Merchan C","Ann Pharmacother","2017","2017/02/08","","","10.1177/1060028016677310"
"28163104","Age-dependent regulation of GABA transmission by kappa opioid receptors in the basolateral amygdala of Sprague-Dawley rats","Przybysz KR, Werner DF, Diaz MR.","Neuropharmacology. 2017 May 1;117:124-133. doi: 10.1016/j.neuropharm.2017.01.036. Epub 2017 Feb 3.","Przybysz KR","Neuropharmacology","2017","2017/02/07","PMC5386797","NIHMS851082","10.1016/j.neuropharm.2017.01.036"
"28161142","Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study","Jarvis BP, DeFulio A, Long L, Holtyn AF, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.","J Subst Abuse Treat. 2018 Feb;85:56-60. doi: 10.1016/j.jsat.2016.12.006. Epub 2016 Dec 24.","Jarvis BP","J Subst Abuse Treat","2018","2017/02/06","PMC5483192","NIHMS849734","10.1016/j.jsat.2016.12.006"
"28153651","Accelerated in vitro release testing method for naltrexone loaded PLGA microspheres","Andhariya JV, Choi S, Wang Y, Zou Y, Burgess DJ, Shen J.","Int J Pharm. 2017 Mar 30;520(1-2):79-85. doi: 10.1016/j.ijpharm.2017.01.050. Epub 2017 Jan 30.","Andhariya JV","Int J Pharm","2017","2017/02/04","","","10.1016/j.ijpharm.2017.01.050"
"28137730","Procedure for the Selection and Validation of a Calibration Model I-Description and Application","Desharnais B, Camirand-Lemyre F, Mireault P, Skinner CD.","J Anal Toxicol. 2017 May 1;41(4):261-268. doi: 10.1093/jat/bkx001.","Desharnais B","J Anal Toxicol","2017","2017/02/01","","","10.1093/jat/bkx001"
"28132696","Socioeconomic and geographic disparities in access to pharmacotherapy for alcohol dependence","Morley KC, Logge W, Pearson SA, Baillie A, Haber PS.","J Subst Abuse Treat. 2017 Mar;74:23-25. doi: 10.1016/j.jsat.2016.12.004. Epub 2016 Dec 23.","Morley KC","J Subst Abuse Treat","2017","2017/01/31","","","10.1016/j.jsat.2016.12.004"
"28130990","Psychiatric symptoms, quality of life, and HIV status among people using opioids in Saint Petersburg, Russia","Desrosiers A, Blokhina E, Krupitsky E, Zvartau E, Schottenfeld R, Chawarski M.","Drug Alcohol Depend. 2017 Mar 1;172:60-65. doi: 10.1016/j.drugalcdep.2016.12.007. Epub 2017 Jan 23.","Desrosiers A","Drug Alcohol Depend","2017","2017/01/29","PMC5408353","NIHMS845914","10.1016/j.drugalcdep.2016.12.007"
"28130086","The opioid antagonist, β-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice","Davis RL, Stevens CW, Thomas Curtis J.","Physiol Behav. 2017 May 1;173:52-60. doi: 10.1016/j.physbeh.2017.01.037. Epub 2017 Jan 24.","Davis RL","Physiol Behav","2017","2017/01/29","","","10.1016/j.physbeh.2017.01.037"
"28130024","Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion/Naltrexone (Contrave(®))","Singh PA, Cassel KP, Moscati RM, Eckersley D.","J Emerg Med. 2017 Apr;52(4):e111-e113. doi: 10.1016/j.jemermed.2016.11.034. Epub 2017 Jan 24.","Singh PA","J Emerg Med","2017","2017/01/29","","","10.1016/j.jemermed.2016.11.034"
"28118565","Computation-Assisted Molecularly Imprinted Polymer Synthesis for Extraction of Naltrexone from Urine Using Experimental Design and Determination by UPLC-DAD","Rahmani ME, Ansari M, Nateghi M, Kazemipour M.","J AOAC Int. 2017 May 1;100(3):700-711. doi: 10.5740/jaoacint.16-0226. Epub 2016 Dec 23.","Rahmani ME","J AOAC Int","2017","2017/01/25","","","10.5740/jaoacint.16-0226"
"28110513","Effect of methylnaltrexone and naloxone on esophageal motor function in man","Scarpellini E, Pauwels A, Vos R, Rommel N, Tack J.","Neurogastroenterol Motil. 2017 Mar;29(3). doi: 10.1111/nmo.12938. Epub 2017 Jan 22.","Scarpellini E","Neurogastroenterol Motil","2017","2017/01/23","","","10.1111/nmo.12938"
"28106937","Naltrexone for the treatment of comorbid tobacco and pornography addiction","Capurso NA.","Am J Addict. 2017 Mar;26(2):115-117. doi: 10.1111/ajad.12501. Epub 2017 Jan 20.","Capurso NA","Am J Addict","2017","2017/01/21","","","10.1111/ajad.12501"
"28092666","Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia","Corder G, Tawfik VL, Wang D, Sypek EI, Low SA, Dickinson JR, Sotoudeh C, Clark JD, Barres BA, Bohlen CJ, Scherrer G.","Nat Med. 2017 Feb;23(2):164-173. doi: 10.1038/nm.4262. Epub 2017 Jan 16.","Corder G","Nat Med","2017","2017/01/17","PMC5296291","NIHMS834527","10.1038/nm.4262"
"28068780","Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine","Sullivan M, Bisaga A, Pavlicova M, Choi CJ, Mishlen K, Carpenter KM, Levin FR, Dakwar E, Mariani JJ, Nunes EV.","Am J Psychiatry. 2017 May 1;174(5):459-467. doi: 10.1176/appi.ajp.2016.16050548. Epub 2017 Jan 10.","Sullivan M","Am J Psychiatry","2017","2017/01/11","PMC5411308","NIHMS835206","10.1176/appi.ajp.2016.16050548"
"28064151","Supervised Disulfiram's Superior Effectiveness in Alcoholism Treatment: Ethical, Methodological, and Psychological Aspects","Brewer C, Streel E, Skinner M.","Alcohol Alcohol. 2017 Mar 9;52(2):213-219. doi: 10.1093/alcalc/agw093.","Brewer C","Alcohol Alcohol","2017","2017/01/09","","","10.1093/alcalc/agw093"
"28061441","Activation of TRPM7 by naltriben enhances migration and invasion of glioblastoma cells","Wong R, Turlova E, Feng ZP, Rutka JT, Sun HS.","Oncotarget. 2017 Feb 14;8(7):11239-11248. doi: 10.18632/oncotarget.14496.","Wong R","Oncotarget","2017","2017/01/07","PMC5355261","","10.18632/oncotarget.14496"
"28061017","Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial","Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, Oden NL, Lindblad R, Sorensen JL, Arenas V, Ha D, Mandler RN, McCarty D; CTN-0055 CHOICES Investigators.","Addiction. 2017 Jun;112(6):1036-1044. doi: 10.1111/add.13753. Epub 2017 Feb 8.","Korthuis PT","Addiction","2017","2017/01/07","PMC5408318","NIHMS842023","10.1111/add.13753"
"28055135","A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking","Froehlich JC, Fischer SM, Nicholson ER, Dilley JE, Filosa NJ, Smith TN, Rademacher LC.","Alcohol Clin Exp Res. 2017 Mar;41(3):644-652. doi: 10.1111/acer.13326. Epub 2017 Feb 9.","Froehlich JC","Alcohol Clin Exp Res","2017","2017/01/06","PMC5332282","NIHMS841376","10.1111/acer.13326"
"28044452","Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats","Ghiassy B, Rahimi N, Javadi-Paydar M, Gharedaghi MH, Norouzi-Javidan A, Dehpour AR.","Can J Physiol Pharmacol. 2017 Jan;95(1):16-22. doi: 10.1139/cjpp-2016-0188. Epub 2016 Aug 7.","Ghiassy B","Can J Physiol Pharmacol","2017","2017/01/04","","","10.1139/cjpp-2016-0188"
"28039905","Ultraviolet A eye irradiation ameliorates colon carcinoma induced by azoxymethane and dextran sodium sulfate through β-endorphin and methionine-enkephalin","Hiramoto K, Yokoyama S, Yamate Y.","Photodermatol Photoimmunol Photomed. 2017 Mar;33(2):84-91. doi: 10.1111/phpp.12290. Epub 2017 Jan 19.","Hiramoto K","Photodermatol Photoimmunol Photomed","2017","2017/01/01","","","10.1111/phpp.12290"
"28034985","Psychosocial Influences on Exercise-Induced Hypoalgesia","Brellenthin AG, Crombie KM, Cook DB, Sehgal N, Koltyn KF.","Pain Med. 2017 Mar 1;18(3):538-550. doi: 10.1093/pm/pnw275.","Brellenthin AG","Pain Med","2017","2016/12/31","","","10.1093/pm/pnw275"
"28029718","A SMART data analysis method for constructing adaptive treatment strategies for substance use disorders","Nahum-Shani I, Ertefaie A, Lu XL, Lynch KG, McKay JR, Oslin DW, Almirall D.","Addiction. 2017 May;112(5):901-909. doi: 10.1111/add.13743. Epub 2017 Feb 18.","Nahum-Shani I","Addiction","2017","2016/12/29","PMC5431579","NIHMS839550","10.1111/add.13743"
"28026920","Method-of-use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity","Halseth A, Shan K, Walsh B, Gilder K, Fujioka K.","Obesity (Silver Spring). 2017 Feb;25(2):338-345. doi: 10.1002/oby.21726. Epub 2016 Dec 27.","Halseth A","Obesity (Silver Spring)","2017","2016/12/28","PMC5299461","","10.1002/oby.21726"
"28011389","Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment","Gordon MS, Vocci FJ, Fitzgerald TT, O'Grady KE, O'Brien CP.","Contemp Clin Trials. 2017 Feb;53:130-136. doi: 10.1016/j.cct.2016.12.015. Epub 2016 Dec 20.","Gordon MS","Contemp Clin Trials","2017","2016/12/25","PMC5274608","NIHMS839608","10.1016/j.cct.2016.12.015"
"27988274","Improving efficacy of the adjustable gastric band: studies of the use of adjuvant approaches in a rodent model","Stefanidis A, Man Lee CC, Brown WA, Oldfield BJ.","Surg Obes Relat Dis. 2017 Feb;13(2):291-304. doi: 10.1016/j.soard.2016.09.005. Epub 2016 Sep 14.","Stefanidis A","Surg Obes Relat Dis","2017","2016/12/19","","","10.1016/j.soard.2016.09.005"
"27987236","Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone","Naik S, Belfort-DeAguiar R, Sejling AS, Szepietowska B, Sherwin RS.","Diabetes Obes Metab. 2017 May;19(5):615-621. doi: 10.1111/dom.12855. Epub 2017 Feb 17.","Naik S","Diabetes Obes Metab","2017","2016/12/18","PMC6015737","NIHMS839781","10.1111/dom.12855"
"27955689","The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial","Gustafson DH Sr, Landucci G, McTavish F, Kornfield R, Johnson RA, Mares ML, Westergaard RP, Quanbeck A, Alagoz E, Pe-Romashko K, Thomas C, Shah D.","Trials. 2016 Dec 12;17(1):592. doi: 10.1186/s13063-016-1726-1.","Gustafson DH Sr","Trials","2016","2016/12/14","PMC5153683","","10.1186/s13063-016-1726-1"
"27936293","Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults","Jarvis BP, Holtyn AF, DeFulio A, Dunn KE, Everly JJ, Leoutsakos JS, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.","Addiction. 2017 May;112(5):830-837. doi: 10.1111/add.13724. Epub 2017 Feb 3.","Jarvis BP","Addiction","2017","2016/12/10","PMC5382098","NIHMS837546","10.1111/add.13724"
"27932062","Experiencing neonatal maternal separation increased pain sensitivity in adult male mice: Involvement of oxytocinergic system","Amini-Khoei H, Amiri S, Mohammadi-Asl A, Alijanpour S, Poursaman S, Haj-Mirzaian A, Rastegar M, Mesdaghinia A, Banafshe HR, Sadeghi E, Samiei E, Mehr SE, Dehpour AR.","Neuropeptides. 2017 Feb;61:77-85. doi: 10.1016/j.npep.2016.11.005. Epub 2016 Nov 30.","Amini-Khoei H","Neuropeptides","2017","2016/12/10","","","10.1016/j.npep.2016.11.005"
"27930926","Changes in coping behavior in a randomized controlled trial of concurrent treatment for PTSD and alcohol dependence","Zang Y, Yu J, Chazin D, Asnaani A, Zandberg LJ, Foa EB.","Behav Res Ther. 2017 Mar;90:9-15. doi: 10.1016/j.brat.2016.11.013. Epub 2016 Nov 24.","Zang Y","Behav Res Ther","2017","2016/12/09","","","10.1016/j.brat.2016.11.013"
"27927048","Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials","Harris SC, Morganroth J, Ripa SR, Thorn MD, Colucci S.","Postgrad Med. 2017 Jan;129(1):69-80. doi: 10.1080/00325481.2017.1270156.","Harris SC","Postgrad Med","2017","2016/12/09","","","10.1080/00325481.2017.1270156"
"27925265","Pentoxifylline besides naltrexone recovers morphine-induced inflammation in male reproductive system of rats by regulating Toll-like receptor pathway","Chehrei S, Moradi M, Ghiabi HR, Falahi M, Kaviani S, Ghanbari A.","Andrologia. 2017 Nov;49(9). doi: 10.1111/and.12749. Epub 2016 Dec 7.","Chehrei S","Andrologia","2017","2016/12/08","","","10.1111/and.12749"
"27922226","Naltrexone-Associated Acute Pancreatitis","Verma R.","Prim Care Companion CNS Disord. 2016 Nov 24;18(6). doi: 10.4088/PCC.16l01953.","Verma R","Prim Care Companion CNS Disord","2016","2016/12/07","","","10.4088/PCC.16l01953"
"27919103","Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review","Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, Chou R.","Ann Intern Med. 2017 Feb 21;166(4):268-278. doi: 10.7326/M16-2149. Epub 2016 Dec 6.","Korthuis PT","Ann Intern Med","2017","2016/12/06","PMC5504692","NIHMS870055","10.7326/M16-2149"
"27889007","Nalmefene for alcohol dependence: a NICE decision?","Naudet F, Fitzgerald N, Braillon A.","Lancet Psychiatry. 2016 Dec;3(12):1104-1105. doi: 10.1016/S2215-0366(16)30356-X.","Naudet F","Lancet Psychiatry","2016","2016/11/28","","","10.1016/S2215-0366(16)30356-X"
"27888590","Erythrocytes Membrane Alterations Reflecting Liver Damage in CCl₄-Induced Cirrhotic Rats: The Ameliorative Effect of Naltrexone","Sarhadi Kholari F, Dehpour AR, Nourbakhsh M, Doustimotlagh AH, Bagherieh M, Golestani A.","Acta Med Iran. 2016 Oct;54(10):631-639.","Sarhadi Kholari F","Acta Med Iran","2016","2016/11/27","","",""
"27875802","Urgency traits moderate daily relations between affect and drinking to intoxication among young adults","Bold KW, Fucito LM, DeMartini KS, Leeman RF, Kranzler HR, Corbin WR, O'Malley SS.","Drug Alcohol Depend. 2017 Jan 1;170:59-65. doi: 10.1016/j.drugalcdep.2016.10.035. Epub 2016 Nov 3.","Bold KW","Drug Alcohol Depend","2017","2016/11/23","PMC5183550","NIHMS831248","10.1016/j.drugalcdep.2016.10.035"
"27870313","Hypothalamic-specific proopiomelanocortin deficiency reduces alcohol drinking in male and female mice","Zhou Y, Rubinstein M, Low MJ, Kreek MJ.","Genes Brain Behav. 2017 Apr;16(4):449-461. doi: 10.1111/gbb.12362. Epub 2017 Jan 17.","Zhou Y","Genes Brain Behav","2017","2016/11/22","PMC5553441","NIHMS892186","10.1111/gbb.12362"
"27865015","Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes","Subbaraman MS, Metrik J, Patterson D, Swift R.","Addiction. 2017 Apr;112(4):685-694. doi: 10.1111/add.13693. Epub 2017 Jan 10.","Subbaraman MS","Addiction","2017","2016/11/20","PMC5339049","NIHMS831170","10.1111/add.13693"
"27860208","Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain","Rauck R, Slatkin NE, Stambler N, Harper JR, Israel RJ.","Pain Pract. 2017 Jul;17(6):820-828. doi: 10.1111/papr.12535. Epub 2017 Feb 10.","Rauck R","Pain Pract","2017","2016/11/19","","","10.1111/papr.12535"
"27842940","Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy","Mann K, Torup L, Sørensen P, Gual A, Swift R, Walker B, van den Brink W.","Eur Neuropsychopharmacol. 2016 Dec;26(12):1941-1949. doi: 10.1016/j.euroneuro.2016.10.008. Epub 2016 Nov 12.","Mann K","Eur Neuropsychopharmacol","2016","2016/11/16","","","10.1016/j.euroneuro.2016.10.008"
"27818236","A role for the mu opioid receptor in the antidepressant effects of buprenorphine","Robinson SA, Erickson RL, Browne CA, Lucki I.","Behav Brain Res. 2017 Feb 15;319:96-103. doi: 10.1016/j.bbr.2016.10.050. Epub 2016 Nov 3.","Robinson SA","Behav Brain Res","2017","2016/11/08","PMC5587126","NIHMS901612","10.1016/j.bbr.2016.10.050"
"27813192","Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice","Moslehi A, Nabavizadeh F, Zekri A, Amiri F.","Clin Exp Pharmacol Physiol. 2017 Feb;44(2):207-212. doi: 10.1111/1440-1681.12695.","Moslehi A","Clin Exp Pharmacol Physiol","2017","2016/11/05","","","10.1111/1440-1681.12695"
"27787293","Response to Dr Fiscella: Transparency and Debate are Essential to Improve Guidelines and Measures","Harris AH, Chen C, Weisner CM, Chalk M, Capoccia V, Thomas CP.","J Addict Med. 2016 Nov/Dec;10(6):453-454. doi: 10.1097/ADM.0000000000000264.","Harris AH","J Addict Med","2016","2016/10/28","PMC5117436","NIHMS812433","10.1097/ADM.0000000000000264"
"27787292","Guidelines and Quality Measures Should Reflect Evidence for Effectiveness of Naltrexone","Fiscella K.","J Addict Med. 2016 Nov/Dec;10(6):453. doi: 10.1097/ADM.0000000000000265.","Fiscella K","J Addict Med","2016","2016/10/28","","","10.1097/ADM.0000000000000265"
"27782295","Nitrergic and opioidergic systems affect radiographic density ‎and histomorphometric indices in bile-duct-ligated cirrhotic rats","Doustimotlagh AH, Dehpour AR, Etemad-Moghadam S, Alaeddini M, Kheirandish Y, Golestani A.","Histol Histopathol. 2017 Jul;32(7):743-749. doi: 10.14670/HH-11-836. Epub 2016 Oct 26.","Doustimotlagh AH","Histol Histopathol","2017","2016/10/27","","","10.14670/HH-11-836"
"27768385","Influence of Naltrexone/Bupropion Combination Treatment on Body Mass Index in Prader-Willi Syndrome Re: ""Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent"" by Puri et al","Hor A, Purtell L.","J Child Adolesc Psychopharmacol. 2016 Nov;26(9):854. doi: 10.1089/cap.2016.0073. Epub 2016 Oct 21.","Hor A","J Child Adolesc Psychopharmacol","2016","2016/10/22","","","10.1089/cap.2016.0073"
"27743985","Mu-opioid receptor inhibition decreases voluntary wheel running in a dopamine-dependent manner in rats bred for high voluntary running","Ruegsegger GN, Brown JD, Kovarik MC, Miller DK, Booth FW.","Neuroscience. 2016 Dec 17;339:525-537. doi: 10.1016/j.neuroscience.2016.10.020. Epub 2016 Oct 13.","Ruegsegger GN","Neuroscience","2016","2016/11/06","","","10.1016/j.neuroscience.2016.10.020"
"27736689","Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants","Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M.","J Affect Disord. 2017 Jan 15;208:6-14. doi: 10.1016/j.jad.2016.08.029. Epub 2016 Oct 1.","Mischoulon D","J Affect Disord","2017","2016/10/14","","","10.1016/j.jad.2016.08.029"
"27736318","Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury","Aceves M, Bancroft EA, Aceves AR, Hook MA.","J Neurotrauma. 2017 Mar 15;34(6):1164-1174. doi: 10.1089/neu.2016.4601. Epub 2016 Nov 4.","Aceves M","J Neurotrauma","2017","2016/10/14","PMC5359644","","10.1089/neu.2016.4601"
"27734745","Update on pharmacotherapy for treatment of opioid use disorder","Ayanga D, Shorter D, Kosten TR.","Expert Opin Pharmacother. 2016 Dec;17(17):2307-2318. doi: 10.1080/14656566.2016.1244529. Epub 2016 Oct 20.","Ayanga D","Expert Opin Pharmacother","2016","2016/10/14","","","10.1080/14656566.2016.1244529"
"27732121","Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release","Halpern B, Mancini MC.","Expert Opin Drug Saf. 2017 Jan;16(1):27-39. doi: 10.1080/14740338.2017.1247807. Epub 2016 Oct 24.","Halpern B","Expert Opin Drug Saf","2017","2016/10/13","","","10.1080/14740338.2017.1247807"
"27720326","Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization","Arnatt CK, Falls BA, Yuan Y, Raborg TJ, Masvekar RR, El-Hage N, Selley DE, Nicola AV, Knapp PE, Hauser KF, Zhang Y.","Bioorg Med Chem. 2016 Nov 15;24(22):5969-5987. doi: 10.1016/j.bmc.2016.09.059. Epub 2016 Sep 26.","Arnatt CK","Bioorg Med Chem","2016","2016/10/11","PMC5112769","NIHMS828991","10.1016/j.bmc.2016.09.059"
"27692188","A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri","Crits-Christoph P, Markell HM, Gibbons MB, Gallop R, Lundy C, Stringer M, Gastfriend DR.","J Subst Abuse Treat. 2016 Nov;70:50-57. doi: 10.1016/j.jsat.2016.07.014. Epub 2016 Aug 10.","Crits-Christoph P","J Subst Abuse Treat","2016","2016/10/04","","","10.1016/j.jsat.2016.07.014"
"27690505","Daily relations among affect, urge, targeted naltrexone, and alcohol use in young adults","Bold KW, Fucito LM, Corbin WR, DeMartini KS, Leeman RF, Kranzler HR, O'Malley SS.","Exp Clin Psychopharmacol. 2016 Oct;24(5):367-375. doi: 10.1037/pha0000090.","Bold KW","Exp Clin Psychopharmacol","2016","2016/10/04","PMC5111359","NIHMS816738","10.1037/pha0000090"
"27687743","Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependence","Nunes EV, Lee JD, Sisti D, Segal A, Caplan A, Fishman M, Bailey G, Brigham G, Novo P, Farkas S, Rotrosen J.","Contemp Clin Trials. 2016 Nov;51:34-43. doi: 10.1016/j.cct.2016.09.006. Epub 2016 Sep 28.","Nunes EV","Contemp Clin Trials","2016","2016/10/01","PMC5466164","NIHMS858611","10.1016/j.cct.2016.09.006"
"27678551","Choice between delayed food and immediate oxycodone in rats","Secci ME, Factor JA, Schindler CW, Panlilio LV.","Psychopharmacology (Berl). 2016 Dec;233(23-24):3977-3989. doi: 10.1007/s00213-016-4429-0. Epub 2016 Sep 28.","Secci ME","Psychopharmacology (Berl)","2016","2016/09/29","PMC5106336","NIHMS819714","10.1007/s00213-016-4429-0"
"27670755","A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study","Raknes G, Småbrekke L.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):136-142. doi: 10.1002/pds.4110. Epub 2016 Sep 26.","Raknes G","Pharmacoepidemiol Drug Saf","2017","2016/09/28","PMC5298009","","10.1002/pds.4110"
"27659699","Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals","Price RC, Christou NV, Backman SB, Stone L, Schweinhardt P.","Psychopharmacology (Berl). 2016 Dec;233(23-24):3869-3879. doi: 10.1007/s00213-016-4417-4. Epub 2016 Sep 22.","Price RC","Psychopharmacology (Berl)","2016","2016/09/24","","","10.1007/s00213-016-4417-4"
"27656031","Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala","Nygard SK, Hourguettes NJ, Sobczak GG, Carlezon WA, Bruchas MR.","J Neurosci. 2016 Sep 21;36(38):9937-48. doi: 10.1523/JNEUROSCI.0953-16.2016.","Nygard SK","J Neurosci","2016","2016/09/23","PMC5030354","","10.1523/JNEUROSCI.0953-16.2016"
"27647699","Prescription drug monitoring program data tracking of opioid addiction treatment outcomes in integrated dual diagnosis care involving injectable naltrexone","Sajid A, Whiteman A, Bell RL, Greene MS, Engleman EA, Chambers RA.","Am J Addict. 2016 Oct;25(7):557-64. doi: 10.1111/ajad.12441. Epub 2016 Sep 20.","Sajid A","Am J Addict","2016","2016/09/21","PMC5096257","","10.1111/ajad.12441"
"27646808","Corrections","","Am J Health Syst Pharm. 2016 Oct 1;73(19):1482. doi: 10.2146/cor160010.","","Am J Health Syst Pharm","2016","2016/09/21","","","10.2146/cor160010"
"27636677","Fibromyalgia","Johnson J, Sheth S.","J Pain Palliat Care Pharmacother. 2016 Sep;30(3):233-4. doi: 10.1080/15360288.2016.1204410. Epub 2016 Aug 16.","Johnson J","J Pain Palliat Care Pharmacother","2016","2016/09/17","","","10.1080/15360288.2016.1204410"
"27633982","Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness","Harris AH, Bowe T, Hagedorn H, Nevedal A, Finlay AK, Gidwani R, Rosen C, Kay C, Christopher M.","Addict Sci Clin Pract. 2016 Sep 15;11(1):15. doi: 10.1186/s13722-016-0063-8.","Harris AH","Addict Sci Clin Pract","2016","2016/09/17","PMC5025587","","10.1186/s13722-016-0063-8"
"27628064","Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study","Mori M, Ji Y, Kumar S, Ashikaga T, Ades S.","Int J Clin Oncol. 2017 Apr;22(2):397-404. doi: 10.1007/s10147-016-1041-6. Epub 2016 Sep 15.","Mori M","Int J Clin Oncol","2017","2016/09/16","","","10.1007/s10147-016-1041-6"
"27627782","Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial","Garbutt JC, Kampov-Polevoy AB, Kalka-Juhl LS, Gallop RJ.","JAMA Psychiatry. 2016 Oct 1;73(10):1056-1063. doi: 10.1001/jamapsychiatry.2016.2157.","Garbutt JC","JAMA Psychiatry","2016","2016/09/15","","","10.1001/jamapsychiatry.2016.2157"
"27613150","Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands","Zaaijer ER, Goudriaan AE, Koeter MW, Booij J, van den Brink W.","Subst Use Misuse. 2016 Dec 5;51(14):1905-11. doi: 10.1080/10826084.2016.1201117. Epub 2016 Sep 9.","Zaaijer ER","Subst Use Misuse","2016","2016/09/11","","","10.1080/10826084.2016.1201117"
"27609425","▼Nalmefene-time for last orders?","","Drug Ther Bull. 2016 Sep;54(9):97. doi: 10.1136/dtb.2016.9.0421.","","Drug Ther Bull","2016","2016/09/10","","","10.1136/dtb.2016.9.0421"
"27605628","Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons","Jamshidi RJ, Sullivan LC, Jacobs BA, Chavera TA, Berg KA, Clarke WP.","J Pharmacol Exp Ther. 2016 Nov;359(2):319-328. doi: 10.1124/jpet.116.235184. Epub 2016 Sep 7.","Jamshidi RJ","J Pharmacol Exp Ther","2016","2016/09/09","PMC5074480","","10.1124/jpet.116.235184"
"27600363","Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and alcoholic polysubstance-dependent populations during a monetary incentive delay task","Nestor LJ, Murphy A, McGonigle J, Orban C, Reed L, Taylor E, Flechais R, Paterson LM, Smith D, Bullmore ET, Ersche KD, Suckling J, Tait R, Elliott R, Deakin B, Rabiner I, Lingford-Hughes A, Nutt DJ, Sahakian B, Robbins TW; ICCAM Consortium.","Addict Biol. 2017 Nov;22(6):1576-1589. doi: 10.1111/adb.12444. Epub 2016 Sep 6.","Nestor LJ","Addict Biol","2017","2016/09/08","","","10.1111/adb.12444"
"27590609","Opioid system mediated anti-nociceptive effect of agomelatine in mice","Kasap M, Can ÖD.","Life Sci. 2016 Oct 15;163:55-63. doi: 10.1016/j.lfs.2016.08.031. Epub 2016 Aug 30.","Kasap M","Life Sci","2016","2016/09/04","","","10.1016/j.lfs.2016.08.031"
"27588701","Naltrexone increases negatively-valenced facial responses to happy faces in female participants","Meier IM, Bos PA, Hamilton K, Stein DJ, van Honk J, Malcolm-Smith S.","Psychoneuroendocrinology. 2016 Dec;74:65-68. doi: 10.1016/j.psyneuen.2016.08.022. Epub 2016 Aug 23.","Meier IM","Psychoneuroendocrinology","2016","2016/09/03","","","10.1016/j.psyneuen.2016.08.022"
"27578083","Cholestatic Itch Management","Mittal A.","Curr Probl Dermatol. 2016;50:142-8. doi: 10.1159/000446057. Epub 2016 Aug 23.","Mittal A","Curr Probl Dermatol","2016","2016/09/01","","","10.1159/000446057"
"27575825","What's in a number? Recommending practicality in the DATA 2000 patient limits","Barthwell AG, Young JM, Barnes MC, Kulkarni SR.","J Opioid Manag. 2016 Jul-Aug;12(4):243-50. doi: 10.5055/jom.2016.0339.","Barthwell AG","J Opioid Manag","2016","2016/08/31","","","10.5055/jom.2016.0339"
"27573565","Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer","Janku F, Johnson LK, Karp DD, Atkins JT, Singleton PA, Moss J.","Ann Oncol. 2016 Nov;27(11):2032-2038. doi: 10.1093/annonc/mdw317. Epub 2016 Aug 29.","Janku F","Ann Oncol","2016","2016/08/31","PMC6267944","","10.1093/annonc/mdw317"
"27567436","Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice","Alongkronrusmee D, Chiang T, van Rijn RM.","Drug Alcohol Depend. 2016 Oct 1;167:190-8. doi: 10.1016/j.drugalcdep.2016.08.017. Epub 2016 Aug 21.","Alongkronrusmee D","Drug Alcohol Depend","2016","2016/08/28","PMC5325684","NIHMS812092","10.1016/j.drugalcdep.2016.08.017"
"27565106","Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management","Fujioka K, Braverman-Panza J.","J Fam Pract. 2016 Jul;65(7 Suppl):S16-23.","Fujioka K","J Fam Pract","2016","2016/08/28","","",""
"27561742","Functional modulation on macrophage by low dose naltrexone (LDN)","Yi Z, Guo S, Hu X, Wang X, Zhang X, Griffin N, Shan F.","Int Immunopharmacol. 2016 Oct;39:397-402. doi: 10.1016/j.intimp.2016.08.015. Epub 2016 Aug 23.","Yi Z","Int Immunopharmacol","2016","2016/08/27","","","10.1016/j.intimp.2016.08.015"
"27550978","Medication-Assisted Treatment of Adolescents With Opioid Use Disorders","COMMITTEE ON SUBSTANCE USE AND PREVENTION.","Pediatrics. 2016 Sep;138(3):e20161893. doi: 10.1542/peds.2016-1893. Epub 2016 Aug 22.","COMMITTEE ON SUBSTANCE USE AND PREVENTION","Pediatrics","2016","2016/08/24","","","10.1542/peds.2016-1893"
"27545091","Nicotine enhancement and reinforcer devaluation: Interaction with opioid receptors","Kirshenbaum AP, Suhaka JA, Phillips JL, Voltolini de Souza Pinto M.","Pharmacol Biochem Behav. 2016 Nov-Dec;150-151:1-7. doi: 10.1016/j.pbb.2016.08.003. Epub 2016 Aug 19.","Kirshenbaum AP","Pharmacol Biochem Behav","2016","2016/11/06","","","10.1016/j.pbb.2016.08.003"
"27538675","Sweet taste pleasantness is modulated by morphine and naltrexone","Eikemo M, Løseth GE, Johnstone T, Gjerstad J, Willoch F, Leknes S.","Psychopharmacology (Berl). 2016 Oct;233(21-22):3711-3723. doi: 10.1007/s00213-016-4403-x. Epub 2016 Aug 18.","Eikemo M","Psychopharmacology (Berl)","2016","2016/08/20","","","10.1007/s00213-016-4403-x"
"27534932","Evaluation in alcohol use disorders - insights from the nalmefene experience","Naudet F, Palpacuer C, Boussageon R, Laviolle B.","BMC Med. 2016 Aug 18;14(1):119. doi: 10.1186/s12916-016-0664-9.","Naudet F","BMC Med","2016","2016/08/19","PMC4989362","","10.1186/s12916-016-0664-9"
"27531386","The µ-opioid system promotes visual attention to faces and eyes","Chelnokova O, Laeng B, Løseth G, Eikemo M, Willoch F, Leknes S.","Soc Cogn Affect Neurosci. 2016 Dec;11(12):1902-1909. doi: 10.1093/scan/nsw116. Epub 2016 Aug 16.","Chelnokova O","Soc Cogn Affect Neurosci","2016","2016/08/18","PMC5141966","","10.1093/scan/nsw116"
"27531058","Ampakine CX1942 attenuates opioid-induced respiratory depression and corrects the hypoxaemic effects of etorphine in immobilized goats (Capra hircus)","Haw AJ, Meyer LC, Greer JJ, Fuller A.","Vet Anaesth Analg. 2016 Sep;43(5):528-38. doi: 10.1111/vaa.12358. Epub 2016 Mar 1.","Haw AJ","Vet Anaesth Analg","2016","2016/08/18","","","10.1111/vaa.12358"
"27525968","Lithium attenuated the behavioral despair induced by acute neurogenic stress through blockade of opioid receptors in mice","Khaloo P, Sadeghi B, Ostadhadi S, Norouzi-Javidan A, Haj-Mirzaian A, Zolfagharie S, Dehpour AR.","Biomed Pharmacother. 2016 Oct;83:1006-1015. doi: 10.1016/j.biopha.2016.08.015. Epub 2016 Aug 12.","Khaloo P","Biomed Pharmacother","2016","2016/08/16","","","10.1016/j.biopha.2016.08.015"
"27521809","NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale","Lee JD, Nunes EV, Mpa PN, Bailey GL, Brigham GS, Cohen AJ, Fishman M, Ling W, Lindblad R, Shmueli-Blumberg D, Stablein D, May J, Salazar D, Liu D, Rotrosen J.","Contemp Clin Trials. 2016 Sep;50:253-64. doi: 10.1016/j.cct.2016.08.004. Epub 2016 Aug 10.","Lee JD","Contemp Clin Trials","2016","2016/08/14","PMC5416469","NIHMS816434","10.1016/j.cct.2016.08.004"
"27519154","Morphine amplifies mechanical allodynia via TLR4 in a rat model of spinal cord injury","Ellis A, Grace PM, Wieseler J, Favret J, Springer K, Skarda B, Ayala M, Hutchinson MR, Falci S, Rice KC, Maier SF, Watkins LR.","Brain Behav Immun. 2016 Nov;58:348-356. doi: 10.1016/j.bbi.2016.08.004. Epub 2016 Aug 9.","Ellis A","Brain Behav Immun","2016","2016/08/14","PMC5067205","NIHMS810302","10.1016/j.bbi.2016.08.004"
"27511893","Rearing environment differentially modulates cocaine self-administration after opioid pretreatment: A behavioral economic analysis","Hofford RS, Beckmann JS, Bardo MT.","Drug Alcohol Depend. 2016 Oct 1;167:89-94. doi: 10.1016/j.drugalcdep.2016.07.026. Epub 2016 Aug 3.","Hofford RS","Drug Alcohol Depend","2016","2016/08/12","PMC5037017","NIHMS808979","10.1016/j.drugalcdep.2016.07.026"
"27510425","Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis","Hermann D, Hirth N, Reimold M, Batra A, Smolka MN, Hoffmann S, Kiefer F, Noori HR, Sommer WH, Reischl G, la Fougère C, Mann K, Spanagel R, Hansson AC.","Neuropsychopharmacology. 2017 Feb;42(3):606-614. doi: 10.1038/npp.2016.145. Epub 2016 Aug 11.","Hermann D","Neuropsychopharmacology","2017","2016/08/12","PMC5240173","","10.1038/npp.2016.145"
"27509572","Making the Journey From Opioid and Heroin Addiction: One Map for the Clinical Nurse Specialist","","Clin Nurse Spec. 2016 Sep-Oct;30(5):E24. doi: 10.1097/NUR.0000000000000241.","","Clin Nurse Spec","2016","2016/08/11","","","10.1097/NUR.0000000000000241"
"27509560","Making the Journey from Opioid and Heroin Addiction: One Map for the Clinical Nurse Specialist","O'Malley PA.","Clin Nurse Spec. 2016 Sep-Oct;30(5):257-60. doi: 10.1097/NUR.0000000000000239.","O'Malley PA","Clin Nurse Spec","2016","2016/08/11","","","10.1097/NUR.0000000000000239"
"27503284","Comment on: ""Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence""","Braillon A.","Drug Saf. 2016 Nov;39(11):1151-1152. doi: 10.1007/s40264-016-0447-4.","Braillon A","Drug Saf","2016","2016/08/10","","","10.1007/s40264-016-0447-4"
"27498137","δ-Opioid receptors: Pivotal role in intermittent hypoxia-augmentation of cardiac parasympathetic control and plasticity","Estrada JA, Barlow MA, Yoshishige D, Williams AG Jr, Downey HF, Mallet RT, Caffrey JL.","Auton Neurosci. 2016 Jul;198:38-49. doi: 10.1016/j.autneu.2016.07.007. Epub 2016 Jul 25.","Estrada JA","Auton Neurosci","2016","2016/08/08","PMC5012543","NIHMS808281","10.1016/j.autneu.2016.07.007"
"27497768","Involvement of Opioid Receptors and α(2)-Adrenoceptors in Inhibitory Pain Modulation Processes: A Double-Blind Placebo-Controlled Crossover Study","Vo L, Hood S, Drummond PD.","J Pain. 2016 Nov;17(11):1164-1173. doi: 10.1016/j.jpain.2016.07.004. Epub 2016 Aug 4.","Vo L","J Pain","2016","2016/08/08","","","10.1016/j.jpain.2016.07.004"
"27495821","The Role of κ Opioid Receptor in Brain Ischemia","Chen C, Xi C, Liang X, Ma J, Su D, Abel T, Liu R.","Crit Care Med. 2016 Dec;44(12):e1219-e1225. doi: 10.1097/CCM.0000000000001959.","Chen C","Crit Care Med","2016","2016/08/07","PMC5203937","NIHMS839019","10.1097/CCM.0000000000001959"
"27487681","Même pas mal","Kapanci L, Langhart J, Lembo AB, Shore C, Steger VJ, Studer LB, Leiba J, Cosson P.","Rev Med Suisse. 2016 Jun 1;12(521):1113.","Kapanci L","Rev Med Suisse","2016","2016/08/05","","",""
"27480445","Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone","Roos CR, Mann K, Witkiewitz K.","Addict Biol. 2017 Nov;22(6):1528-1539. doi: 10.1111/adb.12427. Epub 2016 Aug 2.","Roos CR","Addict Biol","2017","2016/08/03","PMC5290305","NIHMS797545","10.1111/adb.12427"
"27477337","Naltrexone/Bupropion extended release-induced weight loss is independent of nausea in subjects without diabetes","Hong K, Herrmann K, Dybala C, Halseth AE, Lam H, Foreyt JP.","Clin Obes. 2016 Oct;6(5):305-12. doi: 10.1111/cob.12157. Epub 2016 Aug 1.","Hong K","Clin Obes","2016","2016/08/02","PMC5129540","","10.1111/cob.12157"
"27474249","Study on the molecular mechanism of antinociception induced by ghrelin in acute pain in mice","Liu FY, Zhang MM, Zeng P, Liu WW, Wang JL, Yang B, Dai Q, Wei J.","Peptides. 2016 Sep;83:1-7. doi: 10.1016/j.peptides.2016.07.006. Epub 2016 Jul 26.","Liu FY","Peptides","2016","2016/07/31","","","10.1016/j.peptides.2016.07.006"
"27472317","Distinct Effects of Nalmefene on Dopamine Uptake Rates and Kappa Opioid Receptor Activity in the Nucleus Accumbens Following Chronic Intermittent Ethanol Exposure","Rose JH, Karkhanis AN, Steiniger-Brach B, Jones SR.","Int J Mol Sci. 2016 Jul 27;17(8):1216. doi: 10.3390/ijms17081216.","Rose JH","Int J Mol Sci","2016","2016/07/30","PMC5000614","","10.3390/ijms17081216"
"27470429","A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence","Laramée P, Millier A, Brodtkorb TH, Rahhali N, Cristeau O, Aballéa S, Montgomery S, Steeves S, Toumi M, Rehm J.","Clin Drug Investig. 2016 Nov;36(11):945-956. doi: 10.1007/s40261-016-0442-7.","Laramée P","Clin Drug Investig","2016","2016/07/30","","","10.1007/s40261-016-0442-7"
"27469281","Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism","Froehlich JC, Fischer SM, Dilley JE, Nicholson ER, Smith TN, Filosa NJ, Rademacher LC.","Alcohol Clin Exp Res. 2016 Sep;40(9):1961-70. doi: 10.1111/acer.13157. Epub 2016 Jul 29.","Froehlich JC","Alcohol Clin Exp Res","2016","2016/07/30","PMC5297249","NIHMS798680","10.1111/acer.13157"
"27440072","Release Characteristics In Vitro and In Vivo of In Situ Gels for a Novel Peptide Compared with Low-Molecular-Weight Hydrophilic Drug","Zhang G, Hu J, Meng Q, Wang T, Yang X, Gao L, Quan D.","Curr Drug Deliv. 2017;14(1):47-53. doi: 10.2174/1567201813666160720105242.","Zhang G","Curr Drug Deliv","2017","2016/07/22","","","10.2174/1567201813666160720105242"
"27438908","Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe","Bramness JG, Mann K, Wurst FM.","Eur Addict Res. 2016;22(6):318-321. doi: 10.1159/000447965. Epub 2016 Jul 21.","Bramness JG","Eur Addict Res","2016","2016/07/21","","","10.1159/000447965"
"27436632","Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant","Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Wahlgren V, Tsoy-Podosenin M, Bushara N, Burakov A, Masalov D, Romanova T, Tyurina A, Palatkin V, Yaroslavtseva T, Pecoraro A, Woody G.","Am J Drug Alcohol Abuse. 2016 Sep;42(5):614-620. doi: 10.1080/00952990.2016.1197231. Epub 2016 Jul 19.","Krupitsky E","Am J Drug Alcohol Abuse","2016","2016/07/21","PMC5156574","NIHMS831589","10.1080/00952990.2016.1197231"
"27434137","Interest in Extended Release Naltrexone among Opioid Users","Sharma Haase K, Kunøe N, Opheim A, Gaulen Z, Njå AM, Latif ZE, Solli KK, Tanum L.","Eur Addict Res. 2016;22(6):301-305. doi: 10.1159/000447964. Epub 2016 Jul 20.","Sharma Haase K","Eur Addict Res","2016","2016/07/20","","","10.1159/000447964"
"27424012","Enhancement of Cisplatin Nephrotoxicity by Morphine and Its Attenuation by the Opioid Antagonist Naltrexone","Aminian A, Javadi S, Rahimian R, Dehpour AR, Asadi Amoli F, Moghaddas P, Ejtemaei Mehr S.","Acta Med Iran. 2016 Jul;54(7):422-9.","Aminian A","Acta Med Iran","2016","2016/07/18","","",""
"27419333","Pharmacotherapy for Adults with Alcohol Use Disorder","Salisbury-Afshar E.","Am Fam Physician. 2016 Jul 15;94(2):155-7.","Salisbury-Afshar E","Am Fam Physician","2016","2016/07/16","","",""
"27417446","Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation","Chokhavatia S, John ES, Bridgeman MB, Dixit D.","Drugs Aging. 2016 Aug;33(8):557-74. doi: 10.1007/s40266-016-0381-2.","Chokhavatia S","Drugs Aging","2016","2016/07/16","PMC5012150","","10.1007/s40266-016-0381-2"
"27412108","Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION)","Patel PB, Brett SJ, O'Callaghan D, Anjum A, Cross M, Warwick J, Gordon AC.","BMJ Open. 2016 Jul 13;6(7):e011750. doi: 10.1136/bmjopen-2016-011750.","Patel PB","BMJ Open","2016","2016/07/15","PMC4947806","","10.1136/bmjopen-2016-011750"
"27411969","Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies","Hendershot CS, Wardell JD, Samokhvalov AV, Rehm J.","Addict Biol. 2017 Nov;22(6):1515-1527. doi: 10.1111/adb.12425. Epub 2016 Jul 14.","Hendershot CS","Addict Biol","2017","2016/07/15","PMC6139429","","10.1111/adb.12425"
"27402770","Reductions in Alcohol Craving Following Naltrexone Treatment for Heavy Drinking","Helstrom AW, Blow FC, Slaymaker V, Kranzler HR, Leong S, Oslin D.","Alcohol Alcohol. 2016 Sep;51(5):562-6. doi: 10.1093/alcalc/agw038. Epub 2016 Jul 11.","Helstrom AW","Alcohol Alcohol","2016","2016/07/13","","","10.1093/alcalc/agw038"
"27401883","Naltrexone: A Pan-Addiction Treatment?","Aboujaoude E, Salame WO.","CNS Drugs. 2016 Aug;30(8):719-33. doi: 10.1007/s40263-016-0373-0.","Aboujaoude E","CNS Drugs","2016","2016/07/13","","","10.1007/s40263-016-0373-0"
"27394934","National trends in alcohol pharmacotherapy: Findings from an Australian claims database","Morley KC, Logge W, Pearson SA, Baillie A, Haber PS.","Drug Alcohol Depend. 2016 Sep 1;166:254-7. doi: 10.1016/j.drugalcdep.2016.06.027. Epub 2016 Jun 29.","Morley KC","Drug Alcohol Depend","2016","2016/07/11","","","10.1016/j.drugalcdep.2016.06.027"
"27392602","Evaluation of therapeutic effect of low dose naltrexone in experimentally-induced Crohn's disease in rats","Tawfik DI, Osman AS, Tolba HM, Khattab A, Abdel-Salam LO, Kamel MM.","Neuropeptides. 2016 Oct;59:39-45. doi: 10.1016/j.npep.2016.06.003. Epub 2016 Jun 22.","Tawfik DI","Neuropeptides","2016","2016/07/10","","","10.1016/j.npep.2016.06.003"
"27388713","Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-analysis - Comment to Naudet","Soyka M, Friede M, Schnitker J.","Pharmacopsychiatry. 2016 Nov;49(6):261-262. doi: 10.1055/s-0042-110494. Epub 2016 Jul 7.","Soyka M","Pharmacopsychiatry","2016","2016/07/09","","","10.1055/s-0042-110494"
"27388712","Comparing Nalmefene and Naltrexone in Alcohol Dependence: Is there a Spin?","Naudet F.","Pharmacopsychiatry. 2016 Nov;49(6):260-261. doi: 10.1055/s-0042-110493. Epub 2016 Jul 7.","Naudet F","Pharmacopsychiatry","2016","2016/07/09","","","10.1055/s-0042-110493"
"27379819","Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder","Mooney LJ, Hillhouse MP, Thomas C, Ang A, Sharma G, Terry G, Chang L, Walker R, Trivedi M, Croteau D, Sparenborg S, Ling W.","J Addict Med. 2016 Jul-Aug;10(4):236-43. doi: 10.1097/ADM.0000000000000218.","Mooney LJ","J Addict Med","2016","2016/07/06","PMC4969133","NIHMS773172","10.1097/ADM.0000000000000218"
"27379743","Investigating the KNDy Hypothesis in Humans by Coadministration of Kisspeptin, Neurokinin B, and Naltrexone in Men","Narayanaswamy S, Prague JK, Jayasena CN, Papadopoulou DA, Mizamtsidi M, Shah AJ, Bassett P, Comninos AN, Abbara A, Bloom SR, Veldhuis JD, Dhillo WS.","J Clin Endocrinol Metab. 2016 Sep;101(9):3429-36. doi: 10.1210/jc.2016-1911. Epub 2016 Jul 5.","Narayanaswamy S","J Clin Endocrinol Metab","2016","2016/07/06","PMC5010567","","10.1210/jc.2016-1911"
"27378550","Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans","Weber SC, Beck-Schimmer B, Kajdi ME, Müller D, Tobler PN, Quednow BB.","Transl Psychiatry. 2016 Jul 5;6(7):e850. doi: 10.1038/tp.2016.113.","Weber SC","Transl Psychiatry","2016","2016/07/06","PMC4969763","","10.1038/tp.2016.113"
"27353717","Bi-directional interplay between proximal and distal inputs to CA2 pyramidal neurons","Nasrallah K, Piskorowski RA, Chevaleyre V.","Neurobiol Learn Mem. 2017 Feb;138:173-181. doi: 10.1016/j.nlm.2016.06.024. Epub 2016 Jun 25.","Nasrallah K","Neurobiol Learn Mem","2017","2016/06/30","","","10.1016/j.nlm.2016.06.024"
"27338968","Opioid Use Disorders","Sharma B, Bruner A, Barnett G, Fishman M.","Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):473-87. doi: 10.1016/j.chc.2016.03.002. Epub 2016 Apr 9.","Sharma B","Child Adolesc Psychiatr Clin N Am","2016","2016/06/25","PMC4920977","NIHMS776910","10.1016/j.chc.2016.03.002"
"27333729","NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION","Matošić A, Marušić S, Vidrih B, Kovak-Mufić A, Cicin-Šain L.","Acta Clin Croat. 2016 Mar;55(1):134-50. doi: 10.20471/acc.2016.55.01.19.","Matošić A","Acta Clin Croat","2016","2016/06/24","","","10.20471/acc.2016.55.01.19"
"27328752","The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy","Fujioka K, Plodkowski R, O'Neil PM, Gilder K, Walsh B, Greenway FL.","Int J Obes (Lond). 2016 Sep;40(9):1369-75. doi: 10.1038/ijo.2016.67. Epub 2016 Jun 22.","Fujioka K","Int J Obes (Lond)","2016","2016/06/23","","","10.1038/ijo.2016.67"
"27323868","A new era of addiction treatment amplifies the stigma of disease and treatment for individuals with obesity","Alfaris N, Kyle TK, Nadai J, Stanford FC.","Int J Obes (Lond). 2016 Sep;40(9):1335-6. doi: 10.1038/ijo.2016.101. Epub 2016 Jun 21.","Alfaris N","Int J Obes (Lond)","2016","2016/06/22","PMC6103629","NIHMS984493","10.1038/ijo.2016.101"
"27312405","The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans","Courtney KE, Ghahremani DG, Ray LA.","Neuropsychopharmacology. 2016 Nov;41(12):2872-2881. doi: 10.1038/npp.2016.99. Epub 2016 Jun 17.","Courtney KE","Neuropsychopharmacology","2016","2016/06/18","PMC5061897","","10.1038/npp.2016.99"
"27302030","Propofol-medetomidine-ketamine total intravenous anaesthesia in thiafentanil-medetomidine-immobilized impala (Aepyceros melampus)","Buck RK, Meyer LRC, Stegmann GF, Kästner SBR, Kummrow M, Gerlach C, Fosgate GT, Zeiler GE.","Vet Anaesth Analg. 2017 Jan;44(1):138-143. doi: 10.1111/vaa.12402. Epub 2017 Feb 23.","Buck RK","Vet Anaesth Analg","2017","2016/06/16","","","10.1111/vaa.12402"
"27299618","Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis","Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S.","JAMA. 2016 Jun 14;315(22):2424-34. doi: 10.1001/jama.2016.7602.","Khera R","JAMA","2016","2016/06/15","PMC5617638","NIHMS907248","10.1001/jama.2016.7602"
"27296151","Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids","Tanda G, Mereu M, Hiranita T, Quarterman JC, Coggiano M, Katz JL.","Neuropsychopharmacology. 2016 Oct;41(11):2772-81. doi: 10.1038/npp.2016.91. Epub 2016 Jun 14.","Tanda G","Neuropsychopharmacology","2016","2016/06/15","PMC5026747","","10.1038/npp.2016.91"
"27283839","A Trial-Based Predictive Microsimulation Assessing the Public Health Benefits of Nalmefene and Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol Dependence","Laramée P, Millier A, Rahhali N, Cristeau O, Aballéa S, François C, Chalem Y, Toumi M, Rehm J.","Appl Health Econ Health Policy. 2016 Aug;14(4):493-505. doi: 10.1007/s40258-016-0248-z.","Laramée P","Appl Health Econ Health Policy","2016","2016/06/11","","","10.1007/s40258-016-0248-z"
"27282118","Injectable pharmacotherapy for opioid use disorders (IPOD)","Farabee D, Hillhouse M, Condon T, McCrady B, McCollister K, Ling W.","Contemp Clin Trials. 2016 Jul;49:70-7. doi: 10.1016/j.cct.2016.06.003. Epub 2016 Jun 6.","Farabee D","Contemp Clin Trials","2016","2016/06/11","PMC5550768","NIHMS797966","10.1016/j.cct.2016.06.003"
"27279602","Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy","Liu WM, Scott KA, Dennis JL, Kaminska E, Levett AJ, Dalgleish AG.","Int J Oncol. 2016 Aug;49(2):793-802. doi: 10.3892/ijo.2016.3567. Epub 2016 Jun 7.","Liu WM","Int J Oncol","2016","2016/06/10","","","10.3892/ijo.2016.3567"
"27273582","Multi-modal MRI classifiers identify excessive alcohol consumption and treatment effects in the brain","Cosa A, Moreno A, Pacheco-Torres J, Ciccocioppo R, Hyytiä P, Sommer WH, Moratal D, Canals S.","Addict Biol. 2017 Sep;22(5):1459-1472. doi: 10.1111/adb.12418. Epub 2016 Jun 8.","Cosa A","Addict Biol","2017","2016/06/09","","","10.1111/adb.12418"
"27269866","6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand","Williams DA, Zheng Y, David BG, Yuan Y, Zaidi SA, Stevens DL, Scoggins KL, Selley DE, Dewey WL, Akbarali HI, Zhang Y.","ACS Chem Neurosci. 2016 Aug 17;7(8):1120-9. doi: 10.1021/acschemneuro.6b00075. Epub 2016 Jun 15.","Williams DA","ACS Chem Neurosci","2016","2016/06/09","PMC5125022","NIHMS828990","10.1021/acschemneuro.6b00075"
"27262594","Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers","Fitzgerald N, Angus K, Elders A, de Andrade M, Raistrick D, Heather N, McCambridge J.","Addiction. 2016 Aug;111(8):1477-87. doi: 10.1111/add.13438. Epub 2016 Jun 5.","Fitzgerald N","Addiction","2016","2016/06/06","PMC5089629","","10.1111/add.13438"
"27261513","Severe tumefactive rebound of multiple sclerosis following fingolimod cessation","Salam S, Mihalova T, Siripurapu R.","BMJ Case Rep. 2016 Jun 3;2016:bcr2016215596. doi: 10.1136/bcr-2016-215596.","Salam S","BMJ Case Rep","2016","2016/06/05","PMC4904436","","10.1136/bcr-2016-215596"
"27261473","Cost-Effectiveness of Nalmefene: Exaggerated Expectations or Fallacy?","Naudet F, Granger B, Braillon A.","Alcohol Alcohol. 2016 Sep;51(5):623-4. doi: 10.1093/alcalc/agw029. Epub 2016 Jun 3.","Naudet F","Alcohol Alcohol","2016","2016/06/05","","","10.1093/alcalc/agw029"
"27253690","Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain","Davis MP.","Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):823-31. doi: 10.1080/17425255.2016.1191469. Epub 2016 Jun 7.","Davis MP","Expert Opin Drug Metab Toxicol","2016","2016/06/03","","","10.1080/17425255.2016.1191469"
"27238566","Nalmefene is effective at reducing alcohol seeking, treating alcohol-cocaine interactions and reducing alcohol-induced histone deacetylases gene expression in blood","Calleja-Conde J, Echeverry-Alzate V, Giné E, Bühler KM, Nadal R, Maldonado R, Rodríguez de Fonseca F, Gual A, López-Moreno JA.","Br J Pharmacol. 2016 Aug;173(16):2490-505. doi: 10.1111/bph.13526. Epub 2016 Jul 18.","Calleja-Conde J","Br J Pharmacol","2016","2016/05/31","PMC4959953","","10.1111/bph.13526"
"27236030","Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice","Halberstadt AL, Hyun J, Ruderman MA, Powell SB.","Pharmacol Biochem Behav. 2016 Sep;148:69-75. doi: 10.1016/j.pbb.2016.05.009. Epub 2016 May 26.","Halberstadt AL","Pharmacol Biochem Behav","2016","2016/05/29","PMC5662292","NIHMS796815","10.1016/j.pbb.2016.05.009"
"27235740","Endogenous opioids regulate glucocorticoid-dependent stress-coping strategies in mice","Szklarczyk K, Korostynski M, Golda S, Piechota M, Ficek J, Przewlocki R.","Neuroscience. 2016 Aug 25;330:121-37. doi: 10.1016/j.neuroscience.2016.05.034. Epub 2016 May 26.","Szklarczyk K","Neuroscience","2016","2016/05/29","","","10.1016/j.neuroscience.2016.05.034"
"27235620","Pharmacotherapy for Substance Use Disorders","Klein JW.","Med Clin North Am. 2016 Jul;100(4):891-910. doi: 10.1016/j.mcna.2016.03.011. Epub 2016 Apr 20.","Klein JW","Med Clin North Am","2016","2016/05/29","","","10.1016/j.mcna.2016.03.011"
"27226238","κ-Opioid Receptor Stimulation Improves Endothelial Function via Akt-stimulated NO Production in Hyperlipidemic Rats","Tian F, Zheng XY, Li J, Zhang SM, Feng N, Guo HT, Jia M, Wang YM, Fan R, Pei JM.","Sci Rep. 2016 May 26;6:26807. doi: 10.1038/srep26807.","Tian F","Sci Rep","2016","2016/05/27","PMC4881032","","10.1038/srep26807"
"27213949","Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial","Mooney ME, Schmitz JM, Allen S, Grabowski J, Pentel P, Oliver A, Hatsukami DK.","Clin Pharmacol Ther. 2016 Oct;100(4):344-52. doi: 10.1002/cpt.402. Epub 2016 Jun 20.","Mooney ME","Clin Pharmacol Ther","2016","2016/05/24","PMC5017904","NIHMS789138","10.1002/cpt.402"
"27211996","Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification","Uebelacker LA, Bailey G, Herman D, Anderson B, Stein M.","J Subst Abuse Treat. 2016 Jul;66:48-53. doi: 10.1016/j.jsat.2016.02.009. Epub 2016 Mar 9.","Uebelacker LA","J Subst Abuse Treat","2016","2016/05/24","PMC4892369","NIHMS786788","10.1016/j.jsat.2016.02.009"
"27211993","Access to Addiction Pharmacotherapy in Private Health Plans","Reif S, Horgan CM, Hodgkin D, Matteucci AM, Creedon TB, Stewart MT.","J Subst Abuse Treat. 2016 Jul;66:23-9. doi: 10.1016/j.jsat.2016.03.001. Epub 2016 Mar 14.","Reif S","J Subst Abuse Treat","2016","2016/05/24","PMC4879589","NIHMS768330","10.1016/j.jsat.2016.03.001"
"27211522","Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid users","Backonja M, Webster LR, Setnik B, Bass A, Sommerville KW, Matschke K, Malhotra BK, Wolfram G.","Am J Drug Alcohol Abuse. 2016 Sep;42(5):539-549. doi: 10.3109/00952990.2016.1167215. Epub 2016 May 21.","Backonja M","Am J Drug Alcohol Abuse","2016","2016/05/24","","","10.3109/00952990.2016.1167215"
"27192330","Gender differences in treatment and clinical characteristics among patients receiving extended release naltrexone","Herbeck DM, Jeter KE, Cousins SJ, Abdelmaksoud R, Crèvecoeur-MacPhail D.","J Addict Dis. 2016 Oct-Dec;35(4):305-314. doi: 10.1080/10550887.2016.1189659. Epub 2016 May 18.","Herbeck DM","J Addict Dis","2016","2016/05/19","","","10.1080/10550887.2016.1189659"
"27191857","Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder","Di Ciano P, Le Foll B.","PLoS One. 2016 May 18;11(5):e0155604. doi: 10.1371/journal.pone.0155604. eCollection 2016.","Di Ciano P","PLoS One","2016","2016/05/19","PMC4871457","","10.1371/journal.pone.0155604"
"27189967","Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant Mice","Oberdick J, Ling Y, Phelps MA, Yudovich MS, Schilling K, Sadee W.","J Pharmacol Exp Ther. 2016 Jul;358(1):22-30. doi: 10.1124/jpet.115.231902. Epub 2016 May 5.","Oberdick J","J Pharmacol Exp Ther","2016","2016/05/19","PMC4931874","","10.1124/jpet.115.231902"
"27184387","Neuroimaging the Effectiveness of Substance Use Disorder Treatments","Cabrera EA, Wiers CE, Lindgren E, Miller G, Volkow ND, Wang GJ.","J Neuroimmune Pharmacol. 2016 Sep;11(3):408-33. doi: 10.1007/s11481-016-9680-y. Epub 2016 May 16.","Cabrera EA","J Neuroimmune Pharmacol","2016","2016/05/18","","","10.1007/s11481-016-9680-y"
"27180088","The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings","Chandler RK, Finger MS, Farabee D, Schwartz RP, Condon T, Dunlap LJ, Zarkin GA, McCollister K, McDonald RD, Laska E, Bennett D, Kelly SM, Hillhouse M, Mitchell SG, O'Grady KE, Lee JD.","Contemp Clin Trials. 2016 May;48:166-72. doi: 10.1016/j.cct.2016.05.003. Epub 2016 May 11.","Chandler RK","Contemp Clin Trials","2016","2016/05/16","PMC5454801","NIHMS861910","10.1016/j.cct.2016.05.003"
"27178765","Extended-release naltrexone opioid treatment at jail reentry (XOR)","McDonald RD, Tofighi B, Laska E, Goldfeld K, Bonilla W, Flannery M, Santana-Correa N, Johnson CW, Leibowitz N, Rotrosen J, Gourevitch MN, Lee JD.","Contemp Clin Trials. 2016 Jul;49:57-64. doi: 10.1016/j.cct.2016.05.002. Epub 2016 May 10.","McDonald RD","Contemp Clin Trials","2016","2016/05/15","PMC5455014","NIHMS861904","10.1016/j.cct.2016.05.002"
"27171031","Unique action mechanisms of tramadol in global cerebral ischemia-induced mechanical allodynia","Matsuura W, Kageyama E, Harada S, Tokuyama S.","Neuroreport. 2016 Jun 15;27(9):699-704. doi: 10.1097/WNR.0000000000000600.","Matsuura W","Neuroreport","2016","2016/05/13","","","10.1097/WNR.0000000000000600"
"27159820","Nature and Treatment of Comorbid Alcohol Problems and Post Traumatic Stress Disorder Among American Military Personnel and Veterans","Allen JP, Crawford EF, Kudler H.","Alcohol Res. 2016;38(1):133-40.","Allen JP","Alcohol Res","2016","2016/05/10","PMC4872608","",""
"27157410","The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers","Shaker ME, Trawick BN, Mehal WZ.","Biochem Pharmacol. 2016 Jul 15;112:90-101. doi: 10.1016/j.bcp.2016.05.003. Epub 2016 May 6.","Shaker ME","Biochem Pharmacol","2016","2016/05/10","","","10.1016/j.bcp.2016.05.003"
"27137146","Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone","Gandelman K, Lamson M, Salageanu J, Bramson C, Matschke K, Malhotra B.","Clin Pharmacol Drug Dev. 2015 Sep;4(5):370-6. doi: 10.1002/cpdd.177. Epub 2015 Jan 22.","Gandelman K","Clin Pharmacol Drug Dev","2015","2016/05/04","","","10.1002/cpdd.177"
"27121539","Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)","Kunøe N, Opheim A, Solli KK, Gaulen Z, Sharma-Haase K, Latif ZE, Tanum L.","BMC Pharmacol Toxicol. 2016 Apr 28;17(1):18. doi: 10.1186/s40360-016-0061-1.","Kunøe N","BMC Pharmacol Toxicol","2016","2016/04/29","PMC4848871","","10.1186/s40360-016-0061-1"
"27113225","The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice","Wang Q, Long Y, Hang A, Zan GY, Shu XH, Wang YJ, Liu JG.","Psychopharmacology (Berl). 2016 Jun;233(12):2411-8. doi: 10.1007/s00213-016-4292-z. Epub 2016 Apr 26.","Wang Q","Psychopharmacology (Berl)","2016","2016/04/27","","","10.1007/s00213-016-4292-z"
"27109624","Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype","Ziauddeen H, Nestor LJ, Subramaniam N, Dodds C, Nathan PJ, Miller SR, Sarai BK, Maltby K, Fernando D, Warren L, Hosking LK, Waterworth D, Korzeniowska A, Win B, Richards DB, Vasist Johnson L, Fletcher PC, Bullmore ET.","Neuropsychopharmacology. 2016 Oct;41(11):2647-57. doi: 10.1038/npp.2016.60. Epub 2016 Apr 25.","Ziauddeen H","Neuropsychopharmacology","2016","2016/04/26","PMC5026731","","10.1038/npp.2016.60"
"27107723","Lipophilic nalmefene prodrugs to achieve a one-month sustained release","Gaekens T, Guillaume M, Borghys H, De Zwart LL, de Vries R, Embrechts RC, Vermeulen A, Megens AA, Leysen JE, Herdewijn P, Annaert PP, Atack JR.","J Control Release. 2016 Jun 28;232:196-202. doi: 10.1016/j.jconrel.2016.04.029. Epub 2016 Apr 21.","Gaekens T","J Control Release","2016","2016/04/25","","","10.1016/j.jconrel.2016.04.029"
"27079125","Synthesis and evaluation of novel opioid ligands with a C-homomorphinan skeleton","Ishikawa K, Mochizuki Y, Hirayama S, Nemoto T, Nagai K, Itoh K, Fujii H.","Bioorg Med Chem. 2016 May 15;24(10):2199-205. doi: 10.1016/j.bmc.2016.03.040. Epub 2016 Mar 25.","Ishikawa K","Bioorg Med Chem","2016","2016/04/16","","","10.1016/j.bmc.2016.03.040"
"27046656","High-Dose Naltrexone Treatment and Gender in Alcohol Dependence","Yoon G, Kim SW, Petrakis IL, Westermeyer J.","Clin Neuropharmacol. 2016 Jul-Aug;39(4):165-8. doi: 10.1097/WNF.0000000000000152.","Yoon G","Clin Neuropharmacol","2016","2016/04/06","","","10.1097/WNF.0000000000000152"
"27043121","Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine","Marks KR, Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR.","J Clin Psychopharmacol. 2016 Jun;36(3):213-21. doi: 10.1097/JCP.0000000000000488.","Marks KR","J Clin Psychopharmacol","2016","2016/04/05","PMC4837068","NIHMS760177","10.1097/JCP.0000000000000488"
"27038317","Influence of dynorphin on estradiol- and cervical stimulation-induced prolactin surges in ovariectomized rats","Stathopoulos AM, Helena CV, Cristancho-Gordo R, Gonzalez-Iglesias AE, Bertram R.","Endocrine. 2016 Aug;53(2):585-94. doi: 10.1007/s12020-016-0938-1. Epub 2016 Apr 1.","Stathopoulos AM","Endocrine","2016","2016/04/03","","","10.1007/s12020-016-0938-1"
"27028913","Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders","Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Boney TY, Hoskinson RA Jr, Wilson D, McDonald R, Rotrosen J, Gourevitch MN, Gordon M, Fishman M, Chen DT, Bonnie RJ, Cornish JW, Murphy SM, O'Brien CP.","N Engl J Med. 2016 Mar 31;374(13):1232-42. doi: 10.1056/NEJMoa1505409.","Lee JD","N Engl J Med","2016","2016/03/31","PMC5454800","NIHMS775620","10.1056/NEJMoa1505409"
"27028699","Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent","Puri MR, Sahl R, Ogden S, Malik S.","J Child Adolesc Psychopharmacol. 2016 May;26(4):403-4. doi: 10.1089/cap.2015.0240. Epub 2016 Mar 30.","Puri MR","J Child Adolesc Psychopharmacol","2016","2016/03/31","","","10.1089/cap.2015.0240"
"27021234","Mechanisms of pentazocine-induced ventilatory depression and antinociception in anesthetized rats","Kimura S, Ohi Y, Haji A.","J Pharmacol Sci. 2016 Mar;130(3):181-4. doi: 10.1016/j.jphs.2016.03.003. Epub 2016 Mar 11.","Kimura S","J Pharmacol Sci","2016","2016/03/30","","","10.1016/j.jphs.2016.03.003"
"27008037","A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here","Ling W.","J Neuroimmune Pharmacol. 2016 Sep;11(3):394-400. doi: 10.1007/s11481-016-9663-z. Epub 2016 Mar 23.","Ling W","J Neuroimmune Pharmacol","2016","2016/03/24","","","10.1007/s11481-016-9663-z"
"27001273","Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence","Lalanne L, Ayranci G, Filliol D, Gavériaux-Ruff C, Befort K, Kieffer BL, Lutz PE.","Addict Biol. 2017 Jul;22(4):1010-1021. doi: 10.1111/adb.12392. Epub 2016 Mar 22.","Lalanne L","Addict Biol","2017","2016/03/23","PMC5590636","NIHMS901865","10.1111/adb.12392"
"26990998","Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors","Korpi ER, Linden AM, Hytönen HR, Paasikoski N, Vashchinkina E, Dudek M, Herr DR, Hyytiä P.","Addict Biol. 2017 Jul;22(4):1022-1035. doi: 10.1111/adb.12393. Epub 2016 Mar 15.","Korpi ER","Addict Biol","2017","2016/03/19","","","10.1111/adb.12393"
"26976581","Truncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS","Marrone GF, Grinnell SG, Lu Z, Rossi GC, Le Rouzic V, Xu J, Majumdar S, Pan YX, Pasternak GW.","Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3663-8. doi: 10.1073/pnas.1523894113. Epub 2016 Mar 14.","Marrone GF","Proc Natl Acad Sci U S A","2016","2016/03/16","PMC4822618","","10.1073/pnas.1523894113"
"26972745","Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters","Zandberg LJ, Rosenfield D, Alpert E, McLean CP, Foa EB.","Behav Res Ther. 2016 May;80:1-9. doi: 10.1016/j.brat.2016.02.005. Epub 2016 Mar 3.","Zandberg LJ","Behav Res Ther","2016","2016/03/15","PMC4828304","NIHMS767565","10.1016/j.brat.2016.02.005"
"26962129","Company is blamed for early halt of trial into obesity treatment","Wise J.","BMJ. 2016 Mar 8;352:i1363. doi: 10.1136/bmj.i1363.","Wise J","BMJ","2016","2016/03/11","","","10.1136/bmj.i1363"
"26954413","Time-to-Event Analysis","Tolles J, Lewis RJ.","JAMA. 2016 Mar 8;315(10):1046-7. doi: 10.1001/jama.2016.1825.","Tolles J","JAMA","2016","2016/03/09","","","10.1001/jama.2016.1825"
"26954408","Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial","Nissen SE, Wolski KE, Prcela L, Wadden T, Buse JB, Bakris G, Perez A, Smith SR.","JAMA. 2016 Mar 8;315(10):990-1004. doi: 10.1001/jama.2016.1558.","Nissen SE","JAMA","2016","2016/03/09","","","10.1001/jama.2016.1558"
"26954405","Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion: A Study Interrupted","Sharfstein JM, Psaty BM.","JAMA. 2016 Mar 8;315(10):984-6. doi: 10.1001/jama.2016.1461.","Sharfstein JM","JAMA","2016","2016/03/09","","","10.1001/jama.2016.1461"
"26950234","Methylnaltrexone for the Treatment of Constipation in Critically Ill Children","López J, Fernández SN, Santiago MJ, Urbano J, González R, Fernández-Llamazares C, López-Herce J.","J Clin Gastroenterol. 2016 Apr;50(4):351-2. doi: 10.1097/MCG.0000000000000483.","López J","J Clin Gastroenterol","2016","2016/03/08","","","10.1097/MCG.0000000000000483"
"26948856","Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study","Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J.","Addiction. 2016 Aug;111(8):1416-27. doi: 10.1111/add.13375. Epub 2016 Apr 21.","Ling W","Addiction","2016","2016/03/08","PMC4940267","NIHMS767093","10.1111/add.13375"
"26928671","The G-protein biased partial κ opioid receptor agonist 6'-GNTI blocks hippocampal paroxysmal discharges without inducing aversion","Zangrandi L, Burtscher J, MacKay JP, Colmers WF, Schwarzer C.","Br J Pharmacol. 2016 Jun;173(11):1756-67. doi: 10.1111/bph.13474. Epub 2016 Apr 21.","Zangrandi L","Br J Pharmacol","2016","2016/03/02","PMC4867738","","10.1111/bph.13474"
"26928397","Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety","Litten RZ, Wilford BB, Falk DE, Ryan ML, Fertig JB.","Subst Abus. 2016 Apr-Jun;37(2):286-98. doi: 10.1080/08897077.2015.1133472.","Litten RZ","Subst Abus","2016","2016/03/02","","","10.1080/08897077.2015.1133472"
"26922659","Antagonist Models for Relapse Prevention and Reducing HIV Risk","Woody GE, Krupitsky E, Zvartau E.","J Neuroimmune Pharmacol. 2016 Sep;11(3):401-7. doi: 10.1007/s11481-016-9659-8. Epub 2016 Feb 27.","Woody GE","J Neuroimmune Pharmacol","2016","2016/02/29","","","10.1007/s11481-016-9659-8"
"26920817","Linkage to Primary Care for Persons First Receiving Injectable Naltrexone During Inpatient Opioid Detoxification","Stein MD, Risi MM, Bailey GL, Anderson BJ.","J Subst Abuse Treat. 2016 May;64:44-6. doi: 10.1016/j.jsat.2016.01.007. Epub 2016 Feb 23.","Stein MD","J Subst Abuse Treat","2016","2016/02/28","PMC4818184","NIHMS758264","10.1016/j.jsat.2016.01.007"
"26905901","The impact of treatment condition and the lagged effects of PTSD symptom severity and alcohol use on changes in alcohol craving","Kaczkurkin AN, Asnaani A, Alpert E, Foa EB.","Behav Res Ther. 2016 Apr;79:7-14. doi: 10.1016/j.brat.2016.02.001. Epub 2016 Feb 15.","Kaczkurkin AN","Behav Res Ther","2016","2016/02/25","PMC4801783","NIHMS762137","10.1016/j.brat.2016.02.001"
"26903543","Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse","Sushchyk S, Xi ZX, Wang JB.","J Pharmacol Exp Ther. 2016 May;357(2):248-57. doi: 10.1124/jpet.115.229542. Epub 2016 Feb 22.","Sushchyk S","J Pharmacol Exp Ther","2016","2016/02/24","PMC4851325","","10.1124/jpet.115.229542"
"26900888","Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research","Dowling NA, Merkouris SS, Lorains FK.","Addict Behav. 2016 Jul;58:21-30. doi: 10.1016/j.addbeh.2016.02.012. Epub 2016 Feb 10.","Dowling NA","Addict Behav","2016","2016/02/23","","","10.1016/j.addbeh.2016.02.012"
"26888328","μ Opioid receptor: novel antagonists and structural modeling","Kaserer T, Lantero A, Schmidhammer H, Spetea M, Schuster D.","Sci Rep. 2016 Feb 18;6:21548. doi: 10.1038/srep21548.","Kaserer T","Sci Rep","2016","2016/02/19","PMC4757823","","10.1038/srep21548"
"26887340","A Comparison of New Pharmacological Agents for the Treatment of Obesity","Nuffer W, Trujillo JM, Megyeri J.","Ann Pharmacother. 2016 May;50(5):376-88. doi: 10.1177/1060028016634351. Epub 2016 Feb 17.","Nuffer W","Ann Pharmacother","2016","2016/02/19","","","10.1177/1060028016634351"
"26883739","The interaction between morphine and propranolol in chemical and electrical seizure models of mice","Shafaroodi H, Khosravani E, Fakhrzad A, Moezi L.","Neurol Res. 2016 Feb;38(2):166-76. doi: 10.1080/01616412.2015.1136779. Epub 2016 Feb 26.","Shafaroodi H","Neurol Res","2016","2016/02/18","","","10.1080/01616412.2015.1136779"
"26879900","δ-Opioid receptor (DOR) signaling and reactive oxygen species (ROS) mediate intermittent hypoxia induced protection of canine myocardium","Estrada JA, Williams AG Jr, Sun J, Gonzalez L, Downey HF, Caffrey JL, Mallet RT.","Basic Res Cardiol. 2016 Mar;111(2):17. doi: 10.1007/s00395-016-0538-5. Epub 2016 Feb 15.","Estrada JA","Basic Res Cardiol","2016","2016/02/17","","","10.1007/s00395-016-0538-5"
"26879458","The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective","Brodtkorb TH, Bell M, Irving AH, Laramée P.","CNS Drugs. 2016 Feb;30(2):163-77. doi: 10.1007/s40263-016-0310-2.","Brodtkorb TH","CNS Drugs","2016","2016/02/17","","","10.1007/s40263-016-0310-2"
"26874684","Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing ΔF508-CFTR and G551D-CFTR","Huguet F, Calvez ML, Benz N, Le Hir S, Mignen O, Buscaglia P, Horgen FD, Férec C, Kerbiriou M, Trouvé P.","Cell Mol Life Sci. 2016 Sep;73(17):3351-73. doi: 10.1007/s00018-016-2149-6. Epub 2016 Feb 13.","Huguet F","Cell Mol Life Sci","2016","2016/02/15","","","10.1007/s00018-016-2149-6"
"26874330","Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans","Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J.","Int J Neuropsychopharmacol. 2016 Jul 5;19(7):pyw016. doi: 10.1093/ijnp/pyw016. Print 2016 Jul.","Maqueda AE","Int J Neuropsychopharmacol","2016","2016/02/14","PMC4966277","","10.1093/ijnp/pyw016"
"26869247","Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial","Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E.","Am J Psychiatry. 2016 May 1;173(5):499-508. doi: 10.1176/appi.ajp.2015.15070921. Epub 2016 Feb 12.","Fava M","Am J Psychiatry","2016","2016/02/13","","","10.1176/appi.ajp.2015.15070921"
"26867023","Identification and Treatment of New Inflammatory Triggers for Complex Regional Pain Syndrome: Small Intestinal Bacterial Overgrowth and Obstructive Sleep Apnea","Weinstock LB, Myers TL, Walters AS, Schwartz OA, Younger JW, Chopra PJ, Guarino AH.","A A Case Rep. 2016 May 1;6(9):272-6. doi: 10.1213/XAA.0000000000000292.","Weinstock LB","A A Case Rep","2016","2016/02/12","","","10.1213/XAA.0000000000000292"
"26860331","Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series","Caputo F, Maremmani AG, Addolorato G, Domenicali M, Zoli G, D'Amore A, Maremmani I, Bernardi M.","J Psychopharmacol. 2016 Apr;30(4):402-9. doi: 10.1177/0269881116629126. Epub 2016 Feb 9.","Caputo F","J Psychopharmacol","2016","2016/02/11","","","10.1177/0269881116629126"
"26860203","Early-Life Social Isolation Stress Increases Kappa Opioid Receptor Responsiveness and Downregulates the Dopamine System","Karkhanis AN, Rose JH, Weiner JL, Jones SR.","Neuropsychopharmacology. 2016 Aug;41(9):2263-74. doi: 10.1038/npp.2016.21. Epub 2016 Feb 10.","Karkhanis AN","Neuropsychopharmacology","2016","2016/02/11","PMC4946054","","10.1038/npp.2016.21"
"26856827","Escape Mutations in NS4B Render Dengue Virus Insensitive to the Antiviral Activity of the Paracetamol Metabolite AM404","van Cleef KW, Overheul GJ, Thomassen MC, Marjakangas JM, van Rij RP.","Antimicrob Agents Chemother. 2016 Mar 25;60(4):2554-7. doi: 10.1128/AAC.02462-15. Print 2016 Apr.","van Cleef KW","Antimicrob Agents Chemother","2016","2016/02/10","PMC4808173","","10.1128/AAC.02462-15"
"26851200","Modulation of nucleus accumbens connectivity by alcohol drinking and naltrexone in alcohol-preferring rats: A manganese-enhanced magnetic resonance imaging study","Dudek M, Canals S, Sommer WH, Hyytiä P.","Eur Neuropsychopharmacol. 2016 Mar;26(3):445-55. doi: 10.1016/j.euroneuro.2016.01.003. Epub 2016 Jan 26.","Dudek M","Eur Neuropsychopharmacol","2016","2016/02/07","","","10.1016/j.euroneuro.2016.01.003"
"26845589","Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis","Soyka M, Friede M, Schnitker J.","Pharmacopsychiatry. 2016 Mar;49(2):66-75. doi: 10.1055/s-0035-1565184. Epub 2016 Feb 4.","Soyka M","Pharmacopsychiatry","2016","2016/02/05","","","10.1055/s-0035-1565184"
"26839023","Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review","Mehta N, O'Connell K, Giambrone GP, Baqai A, Diwan S.","Postgrad Med. 2016;128(3):282-9. doi: 10.1080/00325481.2016.1149017. Epub 2016 Feb 23.","Mehta N","Postgrad Med","2016","2016/02/04","","","10.1080/00325481.2016.1149017"
"26833888","Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats","de Carvalho CR, Takahashi RN.","Addict Biol. 2017 May;22(3):742-751. doi: 10.1111/adb.12366. Epub 2016 Feb 1.","de Carvalho CR","Addict Biol","2017","2016/02/03","","","10.1111/adb.12366"
"26832998","Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients","Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I.","Drug Alcohol Depend. 2016 Mar 1;160:222-6. doi: 10.1016/j.drugalcdep.2016.01.013. Epub 2016 Jan 24.","Finlay AK","Drug Alcohol Depend","2016","2016/02/03","PMC4767599","NIHMS752771","10.1016/j.drugalcdep.2016.01.013"
"26825639","The Cost-Effectiveness of the Integration of Nalmefene within the UK Healthcare System Treatment Pathway for Alcohol Dependence","Laramée P, Bell M, Irving A, Brodtkorb TH.","Alcohol Alcohol. 2016 May;51(3):283-90. doi: 10.1093/alcalc/agv140. Epub 2016 Jan 28.","Laramée P","Alcohol Alcohol","2016","2016/01/31","","","10.1093/alcalc/agv140"
"26823295","Predictors of Continued Use of Extended-Released Naltrexone (XR-NTX) for Opioid-Dependence: An Analysis of Heroin and Non-Heroin Opioid Users in Los Angeles County","Cousins SJ, Radfar SR, Crèvecoeur-MacPhail D, Ang A, Darfler K, Rawson RA.","J Subst Abuse Treat. 2016 Apr;63:66-71. doi: 10.1016/j.jsat.2015.12.004. Epub 2015 Dec 29.","Cousins SJ","J Subst Abuse Treat","2016","2016/01/30","","","10.1016/j.jsat.2015.12.004"
"26820699","A delayed injection-site reaction in a patient receiving extended-release naltrexone","Ahamad K, Korthuis PT, Lum PJ, Johnson C, Wood E.","Subst Abus. 2016 Apr-Jun;37(2):278-80. doi: 10.1080/08897077.2016.1138919.","Ahamad K","Subst Abus","2016","2016/01/29","PMC5266530","NIHMS844378","10.1080/08897077.2016.1138919"
"26820059","Relapse prevention medications in community treatment for young adults with opioid addiction","Vo HT, Robbins E, Westwood M, Lezama D, Fishman M.","Subst Abus. 2016 Jul-Sep;37(3):392-397. doi: 10.1080/08897077.2016.1143435. Epub 2016 Jan 28.","Vo HT","Subst Abus","2016","2016/01/29","","","10.1080/08897077.2016.1143435"
"26817034","Coactivation of μ- and κ-Opioid Receptors May Mediate the Protective Effect of Testosterone on the Development of Temporomandibular Joint Nociception in Male Rats","Macedo CG, Fanton LE, Fischer L, Tambeli CH.","J Oral Facial Pain Headache. 2016 Winter;30(1):61-7. doi: 10.11607/ofph.1298.","Macedo CG","J Oral Facial Pain Headache","2016","2016/01/28","","","10.11607/ofph.1298"
"26814245","Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy","Hota D, Srinivasan A, Dutta P, Bhansali A, Chakrabarti A.","Pain Med. 2016 Apr;17(4):790-1. doi: 10.1093/pm/pnv009. Epub 2015 Dec 7.","Hota D","Pain Med","2016","2016/01/28","","","10.1093/pm/pnv009"
"26810044","Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential","Soyka M.","Expert Opin Pharmacother. 2016;17(4):619-26. doi: 10.1517/14656566.2016.1146689. Epub 2016 Feb 16.","Soyka M","Expert Opin Pharmacother","2016","2016/01/27","","","10.1517/14656566.2016.1146689"
"26808307","A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction","Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D.","Version 2. J Addict Med. 2016 Mar-Apr;10(2):93-103. doi: 10.1097/ADM.0000000000000193.","Dugosh K","J Addict Med","2016","2016/01/26","PMC4795974","NIHMS743456","10.1097/ADM.0000000000000193"
"26806780","Opioid neuroscience for addiction medicine: From animal models to FDA approval for alcohol addiction","Berrettini W.","Prog Brain Res. 2016;223:253-67. doi: 10.1016/bs.pbr.2015.07.030. Epub 2015 Oct 21.","Berrettini W","Prog Brain Res","2016","2016/01/26","","","10.1016/bs.pbr.2015.07.030"
"26801398","Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys","Saccone PA, Zelenock KA, Lindsey AM, Sulima A, Rice KC, Prinssen EP, Wichmann J, Woods JH.","J Pharmacol Exp Ther. 2016 Apr;357(1):17-23. doi: 10.1124/jpet.115.231134. Epub 2016 Jan 22.","Saccone PA","J Pharmacol Exp Ther","2016","2016/01/24","PMC4809320","","10.1124/jpet.115.231134"
"26798982","Opioid antagonists in broadly defined behavioral addictions: a narrative review","Piquet-Pessôa M, Fontenelle LF.","Expert Opin Pharmacother. 2016;17(6):835-44. doi: 10.1517/14656566.2016.1145660. Epub 2016 Feb 27.","Piquet-Pessôa M","Expert Opin Pharmacother","2016","2016/01/23","","","10.1517/14656566.2016.1145660"
"26796966","Opioids and social bonding: naltrexone reduces feelings of social connection","Inagaki TK, Ray LA, Irwin MR, Way BM, Eisenberger NI.","Soc Cogn Affect Neurosci. 2016 May;11(5):728-35. doi: 10.1093/scan/nsw006. Epub 2016 Jan 21.","Inagaki TK","Soc Cogn Affect Neurosci","2016","2016/01/23","PMC4847702","","10.1093/scan/nsw006"
"26795938","Therapist empathy, combined behavioral intervention, and alcohol outcomes in the COMBINE research project","Moyers TB, Houck J, Rice SL, Longabaugh R, Miller WR.","J Consult Clin Psychol. 2016 Mar;84(3):221-9. doi: 10.1037/ccp0000074. Epub 2016 Jan 21.","Moyers TB","J Consult Clin Psychol","2016","2016/01/23","PMC4760890","NIHMS745724","10.1037/ccp0000074"
"26780565","Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests","Huang P, Yakovleva T, Aldrich JV, Tunis J, Parry C, Liu-Chen LY.","Neurosci Lett. 2016 Feb 26;615:15-20. doi: 10.1016/j.neulet.2016.01.017. Epub 2016 Jan 15.","Huang P","Neurosci Lett","2016","2016/01/19","PMC4876075","NIHMS754347","10.1016/j.neulet.2016.01.017"
"26780488","Rapid Tolerance to Constipating Effects of Loperamide in Healthy Subjects","Kolbow J, Weitschies W, Siegmund W.","J Clin Pharmacol. 2016 Feb;56(2):248-9. doi: 10.1002/jcph.659.","Kolbow J","J Clin Pharmacol","2016","2016/01/19","","","10.1002/jcph.659"
"26780476","Association between a brief alcohol craving measure and drinking in the following week","McHugh RK, Fitzmaurice GM, Griffin ML, Anton RF, Weiss RD.","Addiction. 2016 Jun;111(6):1004-10. doi: 10.1111/add.13311. Epub 2016 Mar 18.","McHugh RK","Addiction","2016","2016/01/19","PMC4861663","NIHMS753142","10.1111/add.13311"
"26779860","Pharmacotherapy for mental health problems in people with intellectual disability","Ji NY, Findling RL.","Curr Opin Psychiatry. 2016 Mar;29(2):103-25. doi: 10.1097/YCO.0000000000000233.","Ji NY","Curr Opin Psychiatry","2016","2016/01/19","","","10.1097/YCO.0000000000000233"
"26773883","A stability-indicating HPLC method for simultaneous determination of morphine and naltrexone","Jafari-Nodoushan M, Barzin J, Mobedi H.","J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Feb 1;1011:163-70. doi: 10.1016/j.jchromb.2015.12.048. Epub 2015 Dec 28.","Jafari-Nodoushan M","J Chromatogr B Analyt Technol Biomed Life Sci","2016","2016/01/17","","","10.1016/j.jchromb.2015.12.048"
"26773164","Mixture of Alum--Naloxone and Alum--Naltrexone as a novel adjuvant elicits immune responses for Toxoplasma gondii lysate antigen in BALB /c mice","Khorshidvand Z, Shahabi S, Mohamadzade H, Daryani A, Hazrati Tappeh K.","Exp Parasitol. 2016 Mar;162:28-34. doi: 10.1016/j.exppara.2016.01.001. Epub 2016 Jan 7.","Khorshidvand Z","Exp Parasitol","2016","2016/01/17","","","10.1016/j.exppara.2016.01.001"
"26749217","Differentiating the Effect of an Opioid Agonist on Cardiac Repolarization From µ-Receptor-mediated, Indirect Effects on the QT Interval: A Randomized, 3-way Crossover Study in Healthy Subjects","Darpo B, Zhou M, Bai SA, Ferber G, Xiang Q, Finn A.","Clin Ther. 2016 Feb;38(2):315-26. doi: 10.1016/j.clinthera.2015.12.004. Epub 2015 Dec 31.","Darpo B","Clin Ther","2016","2016/01/11","","","10.1016/j.clinthera.2015.12.004"
"26742690","Molecular switches of the κ opioid receptor triggered by 6'-GNTI and 5'-GNTI","Cheng J, Sun X, Li W, Liu G, Tu Y, Tang Y.","Sci Rep. 2016 Jan 8;6:18913. doi: 10.1038/srep18913.","Cheng J","Sci Rep","2016","2016/01/09","PMC4705513","","10.1038/srep18913"
"26742523","Inhibitory Effect of Endomorphin-2 Binding to the μ-Opioid Receptor in the Rat Pre-Bötzinger Complex on the Breathing Activity","Qi J, Li H, Zhao TB, Lu YC, Zhang T, Li JL, Dong YL, Li YQ.","Mol Neurobiol. 2017 Jan;54(1):461-469. doi: 10.1007/s12035-015-9624-1. Epub 2016 Jan 7.","Qi J","Mol Neurobiol","2017","2016/01/09","","","10.1007/s12035-015-9624-1"
"26741052","Topical Application of Naltrexone to the Ocular Surface of Healthy Volunteers: A Tolerability Study","Liang D, Sassani JW, McLaughlin PJ, Zagon IS.","J Ocul Pharmacol Ther. 2016 Mar;32(2):127-32. doi: 10.1089/jop.2015.0070. Epub 2016 Jan 7.","Liang D","J Ocul Pharmacol Ther","2016","2016/01/08","","","10.1089/jop.2015.0070"
"26732226","[Hypersexuality and other impulse control disorders in Parkinson's disease]","Nelis EA, Berendse HW, van den Heuvel OA.","Ned Tijdschr Geneeskd. 2016;160:A9359.","Nelis EA","Ned Tijdschr Geneeskd","2016","2016/01/07","","",""
"26715052","Meta-analysis finds no evidence for efficacy of nalmefene in treating alcohol dependence","Mayor S.","BMJ. 2015 Dec 29;351:h6988. doi: 10.1136/bmj.h6988.","Mayor S","BMJ","2015","2015/12/31","","","10.1136/bmj.h6988"
"26714742","Clinical experience about an unexpected adverse event during nalmefene treatment in two patients with alcohol use disorder","Milano G, Zavan V, Natta WM, Martelli A, Mattioli F.","J Clin Pharm Ther. 2016 Feb;41(1):97-100. doi: 10.1111/jcpt.12345. Epub 2015 Dec 30.","Milano G","J Clin Pharm Ther","2016","2015/12/31","","","10.1111/jcpt.12345"
"26712376","Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice","Matsumoto K, Umemoto H, Mori T, Akatsu R, Saito S, Tashima K, Shibasaki M, Kato S, Suzuki T, Horie S.","Eur J Pharmacol. 2016 Jan 15;771:220-8. doi: 10.1016/j.ejphar.2015.12.033. Epub 2015 Dec 19.","Matsumoto K","Eur J Pharmacol","2016","2015/12/30","","","10.1016/j.ejphar.2015.12.033"
"26710657","Naltrexone alters the processing of social and emotional stimuli in healthy adults","Wardle MC, Bershad AK, de Wit H.","Soc Neurosci. 2016 Dec;11(6):579-91. doi: 10.1080/17470919.2015.1136355. Epub 2016 Jan 22.","Wardle MC","Soc Neurosci","2016","2015/12/30","PMC4958027","NIHMS771981","10.1080/17470919.2015.1136355"
"26702846","Opioid-induced constipation in chronic noncancer pain","Weber HC.","Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):11-7. doi: 10.1097/MED.0000000000000220.","Weber HC","Curr Opin Endocrinol Diabetes Obes","2016","2015/12/26","","","10.1097/MED.0000000000000220"
"26695349","Safety profile of extended-release morphine sulfate with sequestered naltrexone hydrochloride in older patients: pooled analysis of three clinical trials","Setnik B, Pixton GC, Webster LR.","Curr Med Res Opin. 2016;32(3):563-72. doi: 10.1185/03007995.2015.1131153. Epub 2016 Jan 26.","Setnik B","Curr Med Res Opin","2016","2015/12/24","","","10.1185/03007995.2015.1131153"
"26694529","Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials","Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F.","PLoS Med. 2015 Dec 22;12(12):e1001924. doi: 10.1371/journal.pmed.1001924. eCollection 2015 Dec.","Palpacuer C","PLoS Med","2015","2015/12/24","PMC4687857","","10.1371/journal.pmed.1001924"
"26679384","Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes","Apovian CM.","Future Cardiol. 2016 Mar;12(2):129-38. doi: 10.2217/fca.15.79. Epub 2015 Dec 18.","Apovian CM","Future Cardiol","2016","2015/12/19","","","10.2217/fca.15.79"
"26674372","Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men","Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL.","J Acquir Immune Defic Syndr. 2016 May 1;72(1):21-30. doi: 10.1097/QAI.0000000000000922.","Santos GM","J Acquir Immune Defic Syndr","2016","2015/12/18","PMC4837026","NIHMS743168","10.1097/QAI.0000000000000922"
"26669310","Mibefradil represents a new class of benzimidazole TRPM7 channel agonists","Schäfer S, Ferioli S, Hofmann T, Zierler S, Gudermann T, Chubanov V.","Pflugers Arch. 2016 Apr;468(4):623-34. doi: 10.1007/s00424-015-1772-7. Epub 2015 Dec 16.","Schäfer S","Pflugers Arch","2016","2015/12/17","","","10.1007/s00424-015-1772-7"
"26663237","The gender differences in the inhibitory action of UVB-induced melanocyte activation by the administration of tranexamic acid","Hiramoto K, Yamate Y, Sugiyama D, Takahashi Y, Mafune E.","Photodermatol Photoimmunol Photomed. 2016 May;32(3):136-45. doi: 10.1111/phpp.12231. Epub 2016 Jan 8.","Hiramoto K","Photodermatol Photoimmunol Photomed","2016","2015/12/15","","","10.1111/phpp.12231"
"26662031","Short-term UROD treatment on cerebral function in codeine-containing cough syrups dependent male individuals","Qiu YW, Jiang GH, Su HH, Lv XF, Ma XF, Tian JZ, Zhuo FZ.","Eur Radiol. 2016 Sep;26(9):2964-73. doi: 10.1007/s00330-015-4139-8. Epub 2015 Dec 10.","Qiu YW","Eur Radiol","2016","2015/12/15","","","10.1007/s00330-015-4139-8"
"26658085","Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting","Pélissier F, Rougé Bugat ME, Nubukpo P, Franchitto N.","J Clin Psychopharmacol. 2016 Feb;36(1):100-3. doi: 10.1097/JCP.0000000000000448.","Pélissier F","J Clin Psychopharmacol","2016","2015/12/15","","","10.1097/JCP.0000000000000448"
"26655695","Possible involvement of nitrergic and opioidergic systems in the modulatory effect of acute chloroquine treatment on pentylenetetrazol induced convulsions in mice","Hassanipour M, Shirzadian A, Boojar MM, Abkhoo A, Abkhoo A, Delazar S, Amiri S, Rahimi N, Ostadhadi S, Dehpour AR.","Brain Res Bull. 2016 Mar;121:124-30. doi: 10.1016/j.brainresbull.2015.11.020. Epub 2015 Dec 3.","Hassanipour M","Brain Res Bull","2016","2015/12/15","","","10.1016/j.brainresbull.2015.11.020"
"26654934","Extended-Release Naltrexone: A Qualitative Analysis of Barriers to Routine Use","Alanis-Hirsch K, Croff R, Ford JH 2nd, Johnson K, Chalk M, Schmidt L, McCarty D.","J Subst Abuse Treat. 2016 Mar;62:68-73. doi: 10.1016/j.jsat.2015.10.003. Epub 2015 Nov 6.","Alanis-Hirsch K","J Subst Abuse Treat","2016","2015/12/15","PMC4724460","NIHMS736073","10.1016/j.jsat.2015.10.003"
"26654213","Longitudinal findings from a randomized clinical trial of naltrexone for young adult heavy drinkers","DeMartini KS, Gueorguieva R, Leeman RF, Corbin WR, Fucito LM, Kranzler HR, O'Malley SS.","J Consult Clin Psychol. 2016 Feb;84(2):185-90. doi: 10.1037/ccp0000053. Epub 2015 Dec 14.","DeMartini KS","J Consult Clin Psychol","2016","2015/12/15","PMC4941818","NIHMS725290","10.1037/ccp0000053"
"26652895","Opioid antagonists block acetaldehyde-induced increments in dopamine neurons activity","Fois GR, Diana M.","Drug Alcohol Depend. 2016 Jan 1;158:172-6. doi: 10.1016/j.drugalcdep.2015.11.013. Epub 2015 Nov 22.","Fois GR","Drug Alcohol Depend","2016","2015/12/15","","","10.1016/j.drugalcdep.2015.11.013"
"26650429","Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis","Viscusi ER, Barrett AC, Paterson C, Forbes WP.","Reg Anesth Pain Med. 2016 Jan-Feb;41(1):93-8. doi: 10.1097/AAP.0000000000000341.","Viscusi ER","Reg Anesth Pain Med","2016","2015/12/10","PMC4684250","","10.1097/AAP.0000000000000341"
"26619775","Treatment of Compulsive Pornography Use With Naltrexone: A Case Report","Kraus SW, Meshberg-Cohen S, Martino S, Quinones LJ, Potenza MN.","Am J Psychiatry. 2015 Dec;172(12):1260-1. doi: 10.1176/appi.ajp.2015.15060843.","Kraus SW","Am J Psychiatry","2015","2015/12/02","","","10.1176/appi.ajp.2015.15060843"
"26603732","Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4","Wang X, Zhang Y, Peng Y, Hutchinson MR, Rice KC, Yin H, Watkins LR.","Br J Pharmacol. 2016 Mar;173(5):856-69. doi: 10.1111/bph.13394. Epub 2016 Feb 4.","Wang X","Br J Pharmacol","2016","2015/11/26","PMC4761092","","10.1111/bph.13394"
"26598763","What a waste!","","Prescrire Int. 2015 Oct;24(164):232.","","Prescrire Int","2015","2015/11/25","","",""
"26598003","Goshajinkigan reduces bortezomib-induced mechanical allodynia in rats: Possible involvement of kappa opioid receptor","Higuchi H, Yamamoto S, Ushio S, Kawashiri T, Egashira N.","J Pharmacol Sci. 2015 Nov;129(3):196-9. doi: 10.1016/j.jphs.2015.09.004. Epub 2015 Oct 30.","Higuchi H","J Pharmacol Sci","2015","2015/11/25","","","10.1016/j.jphs.2015.09.004"
"26594724","Naltrexone + bupropion (Mysimba). Too risky for only modest weight loss","","Prescrire Int. 2015 Oct;24(164):229-33.","","Prescrire Int","2015","2015/11/24","","",""
"26592537","Numerical simulation of iontophoresis in the drug delivery system","Filipovic N, Zivanovic M, Savic A, Bijelic G.","Comput Methods Biomech Biomed Engin. 2016;19(11):1154-9. doi: 10.1080/10255842.2015.1115021. Epub 2015 Nov 23.","Filipovic N","Comput Methods Biomech Biomed Engin","2016","2015/11/24","","","10.1080/10255842.2015.1115021"
"26590621","Should naltrexone be the first-line medicine to treat alcohol dependence in Aboriginal and Torres Strait Islander populations? An Australian perspective","Brett J, Ivers R, Doyle M, Lawrence L, Conigrave K.","Aust Fam Physician. 2015;44(11):815-9.","Brett J","Aust Fam Physician","2015","2015/11/23","","",""
"26589243","Effects of lisdexamfetamine in a rat model of binge-eating","Vickers SP, Hackett D, Murray F, Hutson PH, Heal DJ.","J Psychopharmacol. 2015 Dec;29(12):1290-307. doi: 10.1177/0269881115615107. Epub 2015 Nov 20.","Vickers SP","J Psychopharmacol","2015","2015/11/22","","","10.1177/0269881115615107"
"26583653","Effectiveness of Nalmefene in Binge Eating Disorder: A Case Report","Marazziti D, Piccinni A, Baroni S, DellʼOsso L.","J Clin Psychopharmacol. 2016 Feb;36(1):103-4. doi: 10.1097/JCP.0000000000000427.","Marazziti D","J Clin Psychopharmacol","2016","2015/11/20","","","10.1097/JCP.0000000000000427"
"26560326","Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system","Springer SA, Brown SE, Di Paola A, Altice FL.","Drug Alcohol Depend. 2015 Dec 1;157:158-65. doi: 10.1016/j.drugalcdep.2015.10.023. Epub 2015 Oct 28.","Springer SA","Drug Alcohol Depend","2015","2015/11/13","PMC4675147","NIHMS734231","10.1016/j.drugalcdep.2015.10.023"
"26546222","Naltrexone: Not Just for Opioids Anymore","Sudakin D.","J Med Toxicol. 2016 Mar;12(1):71-5. doi: 10.1007/s13181-015-0512-x.","Sudakin D","J Med Toxicol","2016","2015/11/08","PMC4781804","","10.1007/s13181-015-0512-x"
"26539578","[Alcohol use disorders in elderly people calls for treatment]","Wieben ES, Nielsen B, Nielsen AS, Andersen K.","Ugeskr Laeger. 2015 Apr 27;177(18):837-40.","Wieben ES","Ugeskr Laeger","2015","2015/11/06","","",""
"26525810","[Alcohol use disorders: current approaches to diagnosis and treatment]","Sivolap YP.","Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(9):23-27. doi: 10.17116/jnevro20151159123-27.","Sivolap YP","Zh Nevrol Psikhiatr Im S S Korsakova","2015","2015/11/04","","","10.17116/jnevro20151159123-27"
"26525620","[A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence]","Krupitsky EM, Blokhina EA, Zvartau EE, Verbitskaya VE, Bushara EM, Tiurina AA, Palatkin VY, Yaroslavtseva TS, Burakov AM, Masalov DV, Romanova TN, Grininko AY, Sinha R, Kosten T.","Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):39-46. doi: 10.17116/jnevro201511510139-46.","Krupitsky EM","Zh Nevrol Psikhiatr Im S S Korsakova","2015","2015/11/04","","","10.17116/jnevro201511510139-46"
"26514556","Alterations of naltrexone-induced conditioned place avoidance by pre-exposure to high fructose corn syrup or heroin in Sprague-Dawley rats","Daniels S, Marshall P, Leri F.","Psychopharmacology (Berl). 2016 Feb;233(3):425-33. doi: 10.1007/s00213-015-4121-9. Epub 2015 Oct 30.","Daniels S","Psychopharmacology (Berl)","2016","2015/10/31","","","10.1007/s00213-015-4121-9"
"26512740","Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity","Ali KF, Shukla AP, Aronne LJ.","Expert Rev Clin Pharmacol. 2016;9(1):27-34. doi: 10.1586/17512433.2016.1100072. Epub 2015 Oct 29.","Ali KF","Expert Rev Clin Pharmacol","2016","2015/10/30","","","10.1586/17512433.2016.1100072"
"26511777","Personality Predictors of Drinking Outcomes in Depressed Alcohol-Dependent Patients","Foulds JA, Mulder RT, Newton-Howes G, Adamson SJ, Boden JM, Sellman JD.","Alcohol Alcohol. 2016 May;51(3):296-301. doi: 10.1093/alcalc/agv122. Epub 2015 Oct 28.","Foulds JA","Alcohol Alcohol","2016","2015/10/30","","","10.1093/alcalc/agv122"
"26509454","[Low dose naltrexone for treatment of pain]","Plesner KB, Vægter HB, Handberg G.","Ugeskr Laeger. 2015 Oct 9;177(43):V03150248.","Plesner KB","Ugeskr Laeger","2015","2015/10/29","","",""
"26501171","Kappa-opioid antagonism impairs forebrain-dependent associative learning: A trace eyeblink conditioning study","Loh RM, Galvez R.","Behav Neurosci. 2015 Dec;129(6):692-700. doi: 10.1037/bne0000101. Epub 2015 Oct 26.","Loh RM","Behav Neurosci","2015","2015/10/27","","","10.1037/bne0000101"
"26500121","Morphine modulates the effects of histamine H1 and H3 receptors on seizure susceptibility in pentylenetetrazole-induced seizure model of mice","Amini-Khoei H, Rahimi-Balaei M, Amiri S, Haj-Mirzaian A, Hassanipour M, Shirzadian A, Gooshe M, Alijanpour S, Mehr SE, Dehpour AR.","Eur J Pharmacol. 2015 Dec 15;769:43-7. doi: 10.1016/j.ejphar.2015.10.034. Epub 2015 Oct 21.","Amini-Khoei H","Eur J Pharmacol","2015","2015/10/27","","","10.1016/j.ejphar.2015.10.034"
"26483076","Population pharmacokinetics of nalmefene in healthy subjects and its relation to μ-opioid receptor occupancy","Kyhl LE, Li S, Faerch KU, Soegaard B, Larsen F, Areberg J.","Br J Clin Pharmacol. 2016 Feb;81(2):290-300. doi: 10.1111/bcp.12805. Epub 2016 Jan 27.","Kyhl LE","Br J Clin Pharmacol","2016","2015/10/21","PMC4833148","","10.1111/bcp.12805"
"26476133","Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord","Komatsu T, Katsuyama S, Nagase H, Mizoguchi H, Sakurada C, Tsuzuki M, Sakurada S, Sakurada T.","Pharmacol Biochem Behav. 2016 Jan;140:68-74. doi: 10.1016/j.pbb.2015.10.010. Epub 2015 Oct 22.","Komatsu T","Pharmacol Biochem Behav","2016","2015/10/18","","","10.1016/j.pbb.2015.10.010"
"26474659","Biphalin protects against cognitive deficits in a mouse model of mild traumatic brain injury (mTBI)","Lesniak A, Pick CG, Misicka A, Lipkowski AW, Sacharczuk M.","Neuropharmacology. 2016 Feb;101:506-18. doi: 10.1016/j.neuropharm.2015.10.014. Epub 2015 Oct 22.","Lesniak A","Neuropharmacology","2016","2015/10/18","","","10.1016/j.neuropharm.2015.10.014"
"26467975","Retention in medication-assisted treatment for opiate dependence: A systematic review","Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C.","J Addict Dis. 2016;35(1):22-35. doi: 10.1080/10550887.2016.1100960. Epub 2015 Oct 14.","Timko C","J Addict Dis","2016","2015/10/16","PMC6542472","NIHMS1013457","10.1080/10550887.2016.1100960"
"26463904","[Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions]","Dahmke H, Kupferschmidt H, Kullak-Ublick GA, Weiler S.","Praxis (Bern 1994). 2015 Oct 14;104(21):1129-34. doi: 10.1024/1661-8157/a002160.","Dahmke H","Praxis (Bern 1994)","2015","2015/10/15","","","10.1024/1661-8157/a002160"
"26462331","The Effect of CRH, Dexamethasone and Naltrexone on the Mu, Delta and Kappa Opioid Receptor Agonist Binding in Lamb Hypothalamic-Pituitary-Adrenal Axis","Pierzchała-Koziec K, Dziedzicka-Wasylewska M, Oeltgen P, Zubel-Łojek J, Latacz A, Ocłon E.","Folia Biol (Krakow). 2015;63(3):187-93. doi: 10.3409/fb63_3.187.","Pierzchała-Koziec K","Folia Biol (Krakow)","2015","2015/10/15","","","10.3409/fb63_3.187"
"26460570","Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome","Zandberg LJ, Rosenfield D, McLean CP, Powers MB, Asnaani A, Foa EB.","J Consult Clin Psychol. 2016 Jan;84(1):43-56. doi: 10.1037/ccp0000052. Epub 2015 Oct 12.","Zandberg LJ","J Consult Clin Psychol","2016","2015/10/14","PMC4695374","NIHMS714303","10.1037/ccp0000052"
"26455758","Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders","Helton SG, Lohoff FW.","Psychiatry Res. 2015 Dec 15;230(2):121-9. doi: 10.1016/j.psychres.2015.09.019. Epub 2015 Sep 14.","Helton SG","Psychiatry Res","2015","2015/10/13","","","10.1016/j.psychres.2015.09.019"
"26449162","Effect of Naltrexone on photoperiodic regulation of testicular steroidogenesis in adult golden hamster, Mesocricetus auratus","Mukherjee A, Haldar C.","Gen Comp Endocrinol. 2016 Dec 1;239:89-96. doi: 10.1016/j.ygcen.2015.10.001. Epub 2015 Oct 9.","Mukherjee A","Gen Comp Endocrinol","2016","2015/10/10","","","10.1016/j.ygcen.2015.10.001"
"26439728","Opioid-Induced Constipation Part 2: Newer Therapies #295","Badke A, Rosielle DA.","J Palliat Med. 2015 Oct;18(10):893-4. doi: 10.1089/jpm.2015.0153.","Badke A","J Palliat Med","2015","2015/10/07","","","10.1089/jpm.2015.0153"
"26437315","Opioid Receptor Antagonists in the Treatment of Alcoholism","Serecigni JG.","Adicciones. 2015 Sep 29;27(3):214-30.","Serecigni JG","Adicciones","2015","2015/10/06","","",""
"26427671","Brain opioid and nociceptin receptors are involved in regulation of bombesin-induced activation of central sympatho-adrenomedullary outflow in the rat","Yawata T, Higashi Y, Shimizu T, Shimizu S, Nakamura K, Taniuchi K, Ueba T, Saito M.","Mol Cell Biochem. 2016 Jan;411(1-2):201-11. doi: 10.1007/s11010-015-2582-0. Epub 2015 Oct 1.","Yawata T","Mol Cell Biochem","2016","2015/10/03","","","10.1007/s11010-015-2582-0"
"26417092","Placebo analgesia and its opioidergic regulation suggest that empathy for pain is grounded in self pain","Rütgen M, Seidel EM, Silani G, Riečanský I, Hummer A, Windischberger C, Petrovic P, Lamm C.","Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):E5638-46. doi: 10.1073/pnas.1511269112. Epub 2015 Sep 28.","Rütgen M","Proc Natl Acad Sci U S A","2015","2015/09/30","PMC4611649","","10.1073/pnas.1511269112"
"26414784","Therapies in early development for the treatment of opiate addiction","Rodríguez-Arias M, Aguilar MA, Miñarro J.","Expert Opin Investig Drugs. 2015;24(11):1459-72. doi: 10.1517/13543784.2015.1086746. Epub 2015 Sep 28.","Rodríguez-Arias M","Expert Opin Investig Drugs","2015","2015/09/29","","","10.1517/13543784.2015.1086746"
"26410545","The T-peak-T-end interval as a marker of repolarization abnormality: a comparison with the QT interval for five different drugs","Bhuiyan TA, Graff C, Kanters JK, Nielsen J, Melgaard J, Matz J, Toft E, Struijk JJ.","Clin Drug Investig. 2015 Nov;35(11):717-24. doi: 10.1007/s40261-015-0328-0.","Bhuiyan TA","Clin Drug Investig","2015","2015/09/28","","","10.1007/s40261-015-0328-0"
"26406300","American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","Kampman K, Jarvis M.","J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166.","Kampman K","J Addict Med","2015","2015/09/26","PMC4605275","","10.1097/ADM.0000000000000166"
"26394517","[Pharmacological therapies for alcohol use disorder in Japan]","Yumoto Y, Higuchi S.","Nihon Rinsho. 2015 Sep;73(9):1536-9.","Yumoto Y","Nihon Rinsho","2015","2015/09/24","","",""
"26364383","[Reduction of consumption as the first goal of therapy]","Bruhn C.","Med Monatsschr Pharm. 2015 Apr;38(4):145-6.","Bruhn C","Med Monatsschr Pharm","2015","2015/09/15","","",""
"26363892","Comparing treatment policies with assistance from the structural nested mean model","Lu X, Lynch KG, Oslin DW, Murphy S.","Biometrics. 2016 Mar;72(1):10-9. doi: 10.1111/biom.12391. Epub 2015 Sep 13.","Lu X","Biometrics","2016","2015/09/14","PMC4789134","NIHMS728071","10.1111/biom.12391"
"26360669","Constipation: opioid antagonists in people prescribed opioids","Ahmedzai SH, Boland JW.","BMJ Clin Evid. 2015 Sep 11;2015:2407.","Ahmedzai SH","BMJ Clin Evid","2015","2015/09/12","PMC4566814","",""
"26356528","[Depression in alcohol addicted patients]","Ponizovskiy PA, Gofman AG.","Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(7):146-150. doi: 10.17116/jnevro201511571146-150.","Ponizovskiy PA","Zh Nevrol Psikhiatr Im S S Korsakova","2015","2015/09/11","","","10.17116/jnevro201511571146-150"
"26354994","Role of µ, κ, and δ opioid receptors in tibial inhibition of bladder overactivity in cats","Zhang Z, Slater RC, Ferroni MC, Kadow BT, Lyon TD, Shen B, Xiao Z, Wang J, Kang A, Roppolo JR, de Groat WC, Tai C.","J Pharmacol Exp Ther. 2015 Nov;355(2):228-34. doi: 10.1124/jpet.115.226845. Epub 2015 Sep 9.","Zhang Z","J Pharmacol Exp Ther","2015","2015/09/11","PMC4613954","","10.1124/jpet.115.226845"
"26350161","Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala","Kang-Park M, Kieffer BL, Roberts AJ, Siggins GR, Moore SD.","J Pharmacol Exp Ther. 2015 Nov;355(2):206-11. doi: 10.1124/jpet.115.225870. Epub 2015 Sep 8.","Kang-Park M","J Pharmacol Exp Ther","2015","2015/09/10","PMC4613963","","10.1124/jpet.115.225870"
"26349557","Clinical relevance of nalmefene versus placebo in alcohol treatment: reduction in mortality risk","Roerecke M, Sørensen P, Laramée P, Rahhali N, Rehm J.","J Psychopharmacol. 2015 Nov;29(11):1152-8. doi: 10.1177/0269881115602487. Epub 2015 Sep 8.","Roerecke M","J Psychopharmacol","2015","2015/09/10","PMC4623485","","10.1177/0269881115602487"
"26345338","Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial","Moheet A, Mangia S, Kumar A, Tesfaye N, Eberly LE, Bai Y, Kubisiak K, Seaquist ER.","J Diabetes Complications. 2015 Nov-Dec;29(8):1277-82. doi: 10.1016/j.jdiacomp.2015.08.004. Epub 2015 Aug 12.","Moheet A","J Diabetes Complications","2015","2015/09/09","PMC4871128","NIHMS780434","10.1016/j.jdiacomp.2015.08.004"
"26339899","A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling","Kovanen L, Basnet S, Castrén S, Pankakoski M, Saarikoski ST, Partonen T, Alho H, Lahti T.","Eur Addict Res. 2016;22(2):70-9. doi: 10.1159/000435876. Epub 2015 Sep 5.","Kovanen L","Eur Addict Res","2016","2015/09/05","","","10.1159/000435876"
"26329380","Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction","Diot C, Eiden C, Roussin A, Batisse A, Boucher A, Chavant F, Daveluy A, Donadieu-Rigole H, Peyrière H; réseau des centres français d’addictovigilance.","Eur J Clin Pharmacol. 2015 Dec;71(12):1539-40. doi: 10.1007/s00228-015-1931-y. Epub 2015 Sep 2.","Diot C","Eur J Clin Pharmacol","2015","2015/09/03","","","10.1007/s00228-015-1931-y"
"26325040","Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior","Váradi A, Marrone GF, Eans SO, Ganno ML, Subrath JJ, Le Rouzic V, Hunkele A, Pasternak GW, McLaughlin JP, Majumdar S.","ACS Chem Neurosci. 2015 Nov 18;6(11):1813-24. doi: 10.1021/acschemneuro.5b00153. Epub 2015 Sep 14.","Váradi A","ACS Chem Neurosci","2015","2015/09/02","PMC4651729","NIHMS735149","10.1021/acschemneuro.5b00153"
"26318102","Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus","Morgenweck J, Frankowski KJ, Prisinzano TE, Aubé J, Bohn LM.","Neuropharmacology. 2015 Dec;99:600-9. doi: 10.1016/j.neuropharm.2015.08.027. Epub 2015 Aug 25.","Morgenweck J","Neuropharmacology","2015","2015/08/31","PMC4739521","NIHMS720565","10.1016/j.neuropharm.2015.08.027"
"26314552","Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review","Agabio R, Pani PP, Preti A, Gessa GL, Franconi F.","Eur Addict Res. 2016;22(1):1-16. doi: 10.1159/000433579. Epub 2015 Aug 29.","Agabio R","Eur Addict Res","2016","2015/08/29","","","10.1159/000433579"
"26313157","Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects","Kolbow J, Modess C, Wegner D, Oswald S, Maritz MA, Rey H, Weitschies W, Siegmund W.","J Clin Pharmacol. 2016 Feb;56(2):239-45. doi: 10.1002/jcph.624. Epub 2015 Oct 20.","Kolbow J","J Clin Pharmacol","2016","2015/08/28","","","10.1002/jcph.624"
"26307636","Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens","Yan D, Weisshaar M, Lamb K, Chung HK, Lin MZ, Plemper RK.","Biochemistry. 2015 Sep 15;54(36):5589-604. doi: 10.1021/acs.biochem.5b00623. Epub 2015 Sep 1.","Yan D","Biochemistry","2015","2015/08/27","PMC4719150","NIHMS750583","10.1021/acs.biochem.5b00623"
"26305522","Abuse-deterrent opioid formulations","","Med Lett Drugs Ther. 2015 Aug 31;57(1476):119-21.","","Med Lett Drugs Ther","2015","2015/08/26","","",""
"26299956","A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners","Gordon MS, Kinlock TW, Vocci FJ, Fitzgerald TT, Memisoglu A, Silverman B.","J Subst Abuse Treat. 2015 Dec;59:52-8. doi: 10.1016/j.jsat.2015.07.005. Epub 2015 Jul 18.","Gordon MS","J Subst Abuse Treat","2015","2015/08/25","","","10.1016/j.jsat.2015.07.005"
"26295464","Nalmefene: A Novel Drug for an Old Disorder","Marazziti D, Presta S, Baroni S, Mungai F, Piccinni A, Mucci F, Dell'Osso L.","Curr Med Chem. 2015;22(27):3162-8. doi: 10.2174/0929867322666150821100538.","Marazziti D","Curr Med Chem","2015","2015/08/22","","","10.2174/0929867322666150821100538"
"26288469","Evaluation of acute effects of melatonin on ethanol drinking in ethanol naïve rats","Rather ZA, Chowta MN, Bolumbu G, Rakesh KB.","Indian J Pharmacol. 2015 Jul-Aug;47(4):383-7. doi: 10.4103/0253-7613.161259.","Rather ZA","Indian J Pharmacol","2015","2015/08/20","PMC4527058","","10.4103/0253-7613.161259"
"26280708","Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis","Roginsky G, Alexoff A, Ehrenpreis ED.","J Clin Gastroenterol. 2015 Oct;49(9):794-5. doi: 10.1097/MCG.0000000000000398.","Roginsky G","J Clin Gastroenterol","2015","2015/08/18","","","10.1097/MCG.0000000000000398"
"26268145","Oral operant ethanol self-administration in the absence of explicit cues, food restriction, water restriction and ethanol fading in C57BL/6J mice","Stafford AM, Anderson SM, Shelton KL, Brunzell DH.","Psychopharmacology (Berl). 2015 Oct;232(20):3783-95. doi: 10.1007/s00213-015-4040-9. Epub 2015 Aug 14.","Stafford AM","Psychopharmacology (Berl)","2015","2015/08/14","PMC4667783","NIHMS715460","10.1007/s00213-015-4040-9"
"26260605","Radioligand Binding Assay for an Exon 11-Associated Mu Opioid Receptor Target","Marrone GF, Majumdar S, Pasternak GW.","Methods Mol Biol. 2015;1335:241-9. doi: 10.1007/978-1-4939-2914-6_16.","Marrone GF","Methods Mol Biol","2015","2015/08/12","","","10.1007/978-1-4939-2914-6_16"
"26260061","Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals","Rasmussen DD, Kincaid CL, Froehlich JC.","Alcohol Clin Exp Res. 2015 Sep;39(9):1832-41. doi: 10.1111/acer.12828. Epub 2015 Aug 11.","Rasmussen DD","Alcohol Clin Exp Res","2015","2015/08/12","PMC4558320","NIHMS705774","10.1111/acer.12828"
"26257334","Maturational alterations in constitutive activity of medial prefrontal cortex kappa-opioid receptors in Wistar rats","Sirohi S, Walker BM.","J Neurochem. 2015 Nov;135(4):659-65. doi: 10.1111/jnc.13279. Epub 2015 Sep 11.","Sirohi S","J Neurochem","2015","2015/08/11","PMC4636924","NIHMS714559","10.1111/jnc.13279"
"26246443","The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description","Paterson LM, Flechais RS, Murphy A, Reed LJ, Abbott S, Boyapati V, Elliott R, Erritzoe D, Ersche KD, Faluyi Y, Faravelli L, Fernandez-Egea E, Kalk NJ, Kuchibatla SS, McGonigle J, Metastasio A, Mick I, Nestor L, Orban C, Passetti F, Rabiner EA, Smith DG, Suckling J, Tait R, Taylor EM, Waldman AD, Robbins TW, Deakin JF, Nutt DJ, Lingford-Hughes AR; ICCAM Platform.","J Psychopharmacol. 2015 Sep;29(9):943-60. doi: 10.1177/0269881115596155. Epub 2015 Aug 5.","Paterson LM","J Psychopharmacol","2015","2015/08/07","","","10.1177/0269881115596155"
"26226962","Mechanisms Involved in Guiding the Preference for Fat Emulsion Differ Depending on the Concentration","Sakamoto K, Matsumura S, Okafuji Y, Eguchi A, Lee S, Adachi S, Fujitani M, Tsuzuki S, Inoue K, Fushiki T.","J Nutr Sci Vitaminol (Tokyo). 2015;61(3):247-54. doi: 10.3177/jnsv.61.247.","Sakamoto K","J Nutr Sci Vitaminol (Tokyo)","2015","2015/08/01","","","10.3177/jnsv.61.247"
"26222044","Patient-reported quality of life in a randomized placebo-controlled trial of naltrexone/bupropion for obesity","Kolotkin RL, Chen S, Klassen P, Gilder K, Greenway FL.","Clin Obes. 2015 Oct;5(5):237-44. doi: 10.1111/cob.12108. Epub 2015 Jul 29.","Kolotkin RL","Clin Obes","2015","2015/07/30","","","10.1111/cob.12108"
"26220464","Dopamine D1 and opioid receptor antagonists differentially reduce the acquisition and expression of fructose-conditioned flavor preferences in BALB/c and SWR mice","Kraft TT, Yakubov Y, Huang D, Fitzgerald G, Natanova E, Sclafani A, Bodnar RJ.","Physiol Behav. 2015 Nov 1;151:213-20. doi: 10.1016/j.physbeh.2015.07.028. Epub 2015 Jul 26.","Kraft TT","Physiol Behav","2015","2015/07/30","PMC4648251","NIHMS712534","10.1016/j.physbeh.2015.07.028"
"26216791","[Who can really benefit from nalmefene? Independent evaluations vs experts with conflicts of interest]","Braillon A, Granger B.","Encephale. 2015 Sep;41(4):379-80. doi: 10.1016/j.encep.2015.06.001. Epub 2015 Jul 26.","Braillon A","Encephale","2015","2015/07/29","","","10.1016/j.encep.2015.06.001"
"26213378","A meta-analysis of the response of pathological hoarding to pharmacotherapy","Brakoulias V, Eslick GD, Starcevic V.","Psychiatry Res. 2015 Sep 30;229(1-2):272-6. doi: 10.1016/j.psychres.2015.07.019. Epub 2015 Jul 17.","Brakoulias V","Psychiatry Res","2015","2015/07/28","","","10.1016/j.psychres.2015.07.019"
"26203498","Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability","Turel AP, Oh KH, Zagon IS, McLaughlin PJ.","J Clin Psychopharmacol. 2015 Oct;35(5):609-11. doi: 10.1097/JCP.0000000000000373.","Turel AP","J Clin Psychopharmacol","2015","2015/07/24","","","10.1097/JCP.0000000000000373"
"26202376","Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis","Hammer LA, Waldner H, Zagon IS, McLaughlin PJ.","Exp Biol Med (Maywood). 2016 Jan;241(1):71-8. doi: 10.1177/1535370215596384. Epub 2015 Jul 22.","Hammer LA","Exp Biol Med (Maywood)","2016","2015/07/24","PMC4935426","","10.1177/1535370215596384"
"26201215","Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease","Hohl CM, Wong JK, Harlos MS.","J Palliat Care. 2015;31(2):124-6. doi: 10.1177/082585971503100209.","Hohl CM","J Palliat Care","2015","2015/07/24","","","10.1177/082585971503100209"
"26191654","Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques","Lee KM, Chiu KB, Didier PJ, Baker KC, MacLean AG.","Brain Behav Immun. 2015 Nov;50:288-297. doi: 10.1016/j.bbi.2015.07.017. Epub 2015 Jul 17.","Lee KM","Brain Behav Immun","2015","2015/07/21","PMC4631668","NIHMS711064","10.1016/j.bbi.2015.07.017"
"26189794","Role of thalamic nuclei in the modulation of Fos expression within the cerebral cortex during hypertonic saline-induced muscle nociception","Xiao Y, Lei J, Ye G, Xu H, You HJ.","Neuroscience. 2015 Sep 24;304:36-46. doi: 10.1016/j.neuroscience.2015.07.027. Epub 2015 Jul 17.","Xiao Y","Neuroscience","2015","2015/07/21","","","10.1016/j.neuroscience.2015.07.027"
"26188600","Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist","Meirsman AC, Le Merrer J, Pellissier LP, Diaz J, Clesse D, Kieffer BL, Becker JA.","Biol Psychiatry. 2016 Jun 1;79(11):917-27. doi: 10.1016/j.biopsych.2015.05.020. Epub 2015 Jun 6.","Meirsman AC","Biol Psychiatry","2016","2015/07/20","PMC4670823","NIHMS709255","10.1016/j.biopsych.2015.05.020"
"26188223","The efficacy and safety of the naltrexone/bupropion combination for the treatment of obesity: an update","Christou GA, Kiortsis DN.","Hormones (Athens). 2015 Jul-Sep;14(3):370-5. doi: 10.14310/horm.2002.1600.","Christou GA","Hormones (Athens)","2015","2015/07/19","","","10.14310/horm.2002.1600"
"26187456","The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone","Bisaga A, Sullivan MA, Glass A, Mishlen K, Pavlicova M, Haney M, Raby WN, Levin FR, Carpenter KM, Mariani JJ, Nunes EV.","Drug Alcohol Depend. 2015 Sep 1;154:38-45. doi: 10.1016/j.drugalcdep.2015.05.013. Epub 2015 Jul 8.","Bisaga A","Drug Alcohol Depend","2015","2015/07/19","PMC4536087","NIHMS706399","10.1016/j.drugalcdep.2015.05.013"
"26164674","Putting the brakes on the ""drive to eat"": Pilot effects of naltrexone and reward-based eating on food cravings among obese women","Mason AE, Laraia B, Daubenmier J, Hecht FM, Lustig RH, Puterman E, Adler N, Dallman M, Kiernan M, Gearhardt AN, Epel ES.","Eat Behav. 2015 Dec;19:53-6. doi: 10.1016/j.eatbeh.2015.06.008. Epub 2015 Jul 2.","Mason AE","Eat Behav","2015","2015/07/13","PMC4644449","NIHMS706447","10.1016/j.eatbeh.2015.06.008"
"26158698","A demonstration project implementing extended-release naltrexone in Los Angeles County","Cousins SJ, Denering L, Crèvecoeur-MacPhail D, Viernes J, Sugita W, Barger J, Kim T, Weimann S, Rawson RA.","Subst Abus. 2016;37(1):54-62. doi: 10.1080/08897077.2015.1052868. Epub 2015 Jul 9.","Cousins SJ","Subst Abus","2016","2015/07/10","","","10.1080/08897077.2015.1052868"
"26150678","Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation","Jones R, Prommer E, Backstedt D.","Am J Hosp Palliat Care. 2016 Nov;33(9):875-880. doi: 10.1177/1049909115593937. Epub 2015 Jul 6.","Jones R","Am J Hosp Palliat Care","2016","2015/07/08","","","10.1177/1049909115593937"
"26141191","The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice","Ripley TL, Sanchez-Roige S, Bullmore ET, Mugnaini M, Maltby K, Miller SR, Wille DR, Nathan P, Stephens DN.","Psychopharmacology (Berl). 2015 Sep;232(18):3431-41. doi: 10.1007/s00213-015-3995-x. Epub 2015 Jul 5.","Ripley TL","Psychopharmacology (Berl)","2015","2015/07/05","PMC4537503","","10.1007/s00213-015-3995-x"
"26122463","Species-specific lipophilicity of morphine antagonists","Mazák K, Hosztafi S, Noszál B.","Eur J Pharm Sci. 2015 Oct 12;78:1-7. doi: 10.1016/j.ejps.2015.06.026. Epub 2015 Jun 26.","Mazák K","Eur J Pharm Sci","2015","2015/07/01","","","10.1016/j.ejps.2015.06.026"
"26119641","Review of pharmacotherapy options for the management of obesity","Bragg R, Crannage E.","J Am Assoc Nurse Pract. 2016 Feb;28(2):107-15. doi: 10.1002/2327-6924.12279. Epub 2015 Jun 25.","Bragg R","J Am Assoc Nurse Pract","2016","2015/06/30","","","10.1002/2327-6924.12279"
"26110357","Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World","Parrino MW, Maremmani AG, Samuels PN, Maremmani I.","J Addict Dis. 2015;34(2-3):255-62. doi: 10.1080/10550887.2015.1059113.","Parrino MW","J Addict Dis","2015","2015/06/26","","","10.1080/10550887.2015.1059113"
"26108334","Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice","Navarro M, Carvajal F, Lerma-Cabrera JM, Cubero I, Picker MJ, Thiele TE.","Alcohol Clin Exp Res. 2015 Aug;39(8):1425-33. doi: 10.1111/acer.12774. Epub 2015 Jun 24.","Navarro M","Alcohol Clin Exp Res","2015","2015/06/26","PMC4515169","NIHMS690153","10.1111/acer.12774"
"26107099","Technology: Barriers to misuse","Dolgin E.","Nature. 2015 Jun 25;522(7557):S60-1. doi: 10.1038/522S60a.","Dolgin E","Nature","2015","2015/06/25","","","10.1038/522S60a"
"26107096","Pharmacotherapy: Quest for the quitting pill","Willyard C.","Nature. 2015 Jun 25;522(7557):S53-5. doi: 10.1038/522S53a.","Willyard C","Nature","2015","2015/06/25","","","10.1038/522S53a"
"26105136","Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors","Kissler JL, Walker BM.","Neuropsychopharmacology. 2016 Jan;41(2):560-7. doi: 10.1038/npp.2015.183. Epub 2015 Jun 24.","Kissler JL","Neuropsychopharmacology","2016","2015/06/25","PMC5130131","","10.1038/npp.2015.183"
"26105116","Naltrexone ER/Bupropion ER: A Review in Obesity Management","Greig SL, Keating GM.","Drugs. 2015 Jul;75(11):1269-80. doi: 10.1007/s40265-015-0427-5.","Greig SL","Drugs","2015","2015/06/25","","","10.1007/s40265-015-0427-5"
"26099536","Investigation of 7-benzylidenenaltrexone derivatives as a novel structural antitrichomonal lead compound","Kutsumura N, Nakajima R, Koyama Y, Miyata Y, Saitoh T, Yamamoto N, Iwata S, Fujii H, Nagase H.","Bioorg Med Chem Lett. 2015 Nov 1;25(21):4890-4892. doi: 10.1016/j.bmcl.2015.06.002. Epub 2015 Jun 10.","Kutsumura N","Bioorg Med Chem Lett","2015","2015/06/24","","","10.1016/j.bmcl.2015.06.002"
"26098729","Blocking opioids attenuates physical warmth-induced feelings of social connection","Inagaki TK, Irwin MR, Eisenberger NI.","Emotion. 2015 Aug;15(4):494-500. doi: 10.1037/emo0000088. Epub 2015 Jun 22.","Inagaki TK","Emotion","2015","2015/06/23","PMC4516568","NIHMS687910","10.1037/emo0000088"
"26097003","Intermittent-access binge consumption of sweet high-fat liquid does not require opioid or dopamine receptors in the nucleus accumbens","Lardeux S, Kim JJ, Nicola SM.","Behav Brain Res. 2015 Oct 1;292:194-208. doi: 10.1016/j.bbr.2015.06.015. Epub 2015 Jun 18.","Lardeux S","Behav Brain Res","2015","2015/06/23","PMC4558197","NIHMS705763","10.1016/j.bbr.2015.06.015"
"26092968","Influence of the A118G Polymorphism of the OPRM1 Gene and Exon 3 VNTR Polymorphism of the DRD4 Gene on Cigarette Craving After Alcohol Administration","Lechner WV, Knopik VS, McGeary JE, Spillane NS, Tidey JW, McKee SA, Metrik J, Leventhal AM, Rohsenow DJ, Kahler CW.","Nicotine Tob Res. 2016 May;18(5):632-6. doi: 10.1093/ntr/ntv136. Epub 2015 Jun 19.","Lechner WV","Nicotine Tob Res","2016","2015/06/21","PMC5896808","","10.1093/ntr/ntv136"
"26091546","Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain","Howland RH.","J Psychosoc Nurs Ment Health Serv. 2015 Jun;53(6):19-22. doi: 10.3928/02793695-20150526-02.","Howland RH","J Psychosoc Nurs Ment Health Serv","2015","2015/06/20","","","10.3928/02793695-20150526-02"
"26078009","Morphine Modulates Interleukin-4- or Breast Cancer Cell-induced Pro-metastatic Activation of Macrophages","Khabbazi S, Goumon Y, Parat MO.","Sci Rep. 2015 Jun 16;5:11389. doi: 10.1038/srep11389.","Khabbazi S","Sci Rep","2015","2015/06/17","PMC4468425","","10.1038/srep11389"
"26056031","Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus","Chen Z, Tang Y, Tao H, Li C, Zhang X, Liu Y.","Neuropharmacology. 2015 Oct;97:259-69. doi: 10.1016/j.neuropharm.2015.05.030. Epub 2015 Jun 6.","Chen Z","Neuropharmacology","2015","2015/06/10","","","10.1016/j.neuropharm.2015.05.030"
"26053024","The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients","François C, Rahhali N, Chalem Y, Sørensen P, Luquiens A, Aubin HJ.","PLoS One. 2015 Jun 8;10(6):e0129289. doi: 10.1371/journal.pone.0129289. eCollection 2015.","François C","PLoS One","2015","2015/06/09","PMC4460126","","10.1371/journal.pone.0129289"
"26051817","Opioid-dependent regulation of high and low fear responses in two inbred mouse strains","Szklarczyk K, Korostynski M, Cieslak PE, Wawrzczak-Bargiela A, Przewlocki R.","Behav Brain Res. 2015 Oct 1;292:95-101. doi: 10.1016/j.bbr.2015.06.001. Epub 2015 Jun 5.","Szklarczyk K","Behav Brain Res","2015","2015/06/09","","","10.1016/j.bbr.2015.06.001"
"26050313","[Mysimba, an American appetite suppressant and the logic of the single European market]","Nau JY.","Rev Med Suisse. 2015 Apr 15;11(470):890-1.","Nau JY","Rev Med Suisse","2015","2015/06/09","","",""
"26050241","Severe opioid withdrawal syndrome after a single dose of nalmefene","Donnerstag N, Schneider T, Lüthi A, Taegtmeyer A, Raetz Bravo A, Mehlig A.","Eur J Clin Pharmacol. 2015 Aug;71(8):1025-6. doi: 10.1007/s00228-015-1884-1. Epub 2015 Jun 7.","Donnerstag N","Eur J Clin Pharmacol","2015","2015/06/08","","","10.1007/s00228-015-1884-1"
"26049209","Naltrexone Facilitates Learning and Delays Extinction by Increasing AMPA Receptor Phosphorylation and Membrane Insertion","Kibaly C, Kam AY, Loh HH, Law PY.","Biol Psychiatry. 2016 Jun 1;79(11):906-16. doi: 10.1016/j.biopsych.2015.04.019. Epub 2015 May 2.","Kibaly C","Biol Psychiatry","2016","2015/06/08","PMC4630208","NIHMS687126","10.1016/j.biopsych.2015.04.019"
"26049060","Antagonism of κ opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence","Zan GY, Wang Q, Wang YJ, Liu Y, Hang A, Shu XH, Liu JG.","Behav Brain Res. 2015 Sep 15;291:334-341. doi: 10.1016/j.bbr.2015.05.053. Epub 2015 Jun 3.","Zan GY","Behav Brain Res","2015","2015/06/07","","","10.1016/j.bbr.2015.05.053"
"26048798","Naltrindole derivatives with fluorinated ethyl substituents on the 17-nitrogen as δ opioid receptor inverse agonists","Nemoto T, Iihara Y, Hirayama S, Iwai T, Higashi E, Fujii H, Nagase H.","Bioorg Med Chem Lett. 2015 Aug 1;25(15):2927-30. doi: 10.1016/j.bmcl.2015.05.038. Epub 2015 May 22.","Nemoto T","Bioorg Med Chem Lett","2015","2015/06/07","","","10.1016/j.bmcl.2015.05.038"
"26045511","Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice","Almatroudi A, Husbands SM, Bailey CP, Bailey SJ.","J Psychopharmacol. 2015 Jul;29(7):812-21. doi: 10.1177/0269881115586937. Epub 2015 Jun 4.","Almatroudi A","J Psychopharmacol","2015","2015/06/06","PMC5075030","NIHMS821198","10.1177/0269881115586937"
"26044906","The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking","Giuliano C, Goodlett CR, Economidou D, García-Pardo MP, Belin D, Robbins TW, Bullmore ET, Everitt BJ.","Neuropsychopharmacology. 2015 Dec;40(13):2981-92. doi: 10.1038/npp.2015.152. Epub 2015 Jun 5.","Giuliano C","Neuropsychopharmacology","2015","2015/06/06","PMC4864633","","10.1038/npp.2015.152"
"26044640","Mu opioid receptor modulation in the nucleus accumbens lowers voluntary wheel running in rats bred for high running motivation","Ruegsegger GN, Toedebusch RG, Will MJ, Booth FW.","Neuropharmacology. 2015 Oct;97:171-81. doi: 10.1016/j.neuropharm.2015.05.022. Epub 2015 Jun 1.","Ruegsegger GN","Neuropharmacology","2015","2015/06/06","","","10.1016/j.neuropharm.2015.05.022"
"26043235","The mu opioid receptor: A new target for cancer therapy?","Singleton PA, Moss J, Karp DD, Atkins JT, Janku F.","Cancer. 2015 Aug 15;121(16):2681-8. doi: 10.1002/cncr.29460. Epub 2015 Jun 4.","Singleton PA","Cancer","2015","2015/06/05","","","10.1002/cncr.29460"
"26037158","Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation","Moreno-Vicente R, Fernández-Nieva Z, Navarro A, Gascón-Crespí I, Farré-Albaladejo M, Igartua M, Hernández RM, Pedraz JL.","J Pharm Biomed Anal. 2015 Oct 10;114:105-12. doi: 10.1016/j.jpba.2015.04.044. Epub 2015 May 7.","Moreno-Vicente R","J Pharm Biomed Anal","2015","2015/06/04","","","10.1016/j.jpba.2015.04.044"
"26035084","Pharmacological interventions for drug-using offenders","Perry AE, Neilson M, Martyn-St James M, Glanville JM, Woodhouse R, Godfrey C, Hewitt C.","Cochrane Database Syst Rev. 2015 Jun 2;(6):CD010862. doi: 10.1002/14651858.CD010862.pub2.","Perry AE","Cochrane Database Syst Rev","2015","2015/06/03","","","10.1002/14651858.CD010862.pub2"
"26025420","Effect of norbinaltorphimine on ∆⁹-tetrahydrocannabinol (THC)-induced taste avoidance in adolescent and adult Sprague-Dawley rats","Flax SM, Wakeford AG, Cheng K, Rice KC, Riley AL.","Psychopharmacology (Berl). 2015 Sep;232(17):3193-201. doi: 10.1007/s00213-015-3970-6. Epub 2015 May 31.","Flax SM","Psychopharmacology (Berl)","2015","2015/05/31","PMC5551397","NIHMS880903","10.1007/s00213-015-3970-6"
"26022268","Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4","Bachtell R, Hutchinson MR, Wang X, Rice KC, Maier SF, Watkins LR.","CNS Neurol Disord Drug Targets. 2015;14(6):692-9. doi: 10.2174/1871527314666150529132503.","Bachtell R","CNS Neurol Disord Drug Targets","2015","2015/05/30","PMC5548122","NIHMS886575","10.2174/1871527314666150529132503"
"26021148","[Influence of nalmefene on psychosocial intervention in alcohol-dependent patients]","Favrod-Coune T.","Rev Med Suisse. 2015 Apr 1;11(468):792.","Favrod-Coune T","Rev Med Suisse","2015","2015/05/30","","",""
"26011742","Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users","Setnik B, Bramson C, Bass A, Levy-Cooperman N, Malhotra B, Matschke K, Sommerville KW, Wolfram G, Geoffroy P.","J Clin Pharmacol. 2015 Dec;55(12):1351-61. doi: 10.1002/jcph.552. Epub 2015 Jul 2.","Setnik B","J Clin Pharmacol","2015","2015/05/27","","","10.1002/jcph.552"
"26011641","Mediation of opioid analgesia by a truncated 6-transmembrane GPCR","Lu Z, Xu J, Rossi GC, Majumdar S, Pasternak GW, Pan YX.","J Clin Invest. 2015 Jul 1;125(7):2626-30. doi: 10.1172/JCI81070. Epub 2015 May 26.","Lu Z","J Clin Invest","2015","2015/05/27","PMC4563690","","10.1172/JCI81070"
"26010811","Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists","Selfridge BR, Wang X, Zhang Y, Yin H, Grace PM, Watkins LR, Jacobson AE, Rice KC.","J Med Chem. 2015 Jun 25;58(12):5038-52. doi: 10.1021/acs.jmedchem.5b00426. Epub 2015 Jun 5.","Selfridge BR","J Med Chem","2015","2015/05/27","PMC4634939","NIHMS733807","10.1021/acs.jmedchem.5b00426"
"26009787","Mechanisms of symptom reduction in a combined treatment for comorbid posttraumatic stress disorder and alcohol dependence","McLean CP, Su YJ, Foa EB.","J Consult Clin Psychol. 2015 Jun;83(3):655-61. doi: 10.1037/ccp0000024.","McLean CP","J Consult Clin Psychol","2015","2015/05/27","PMC4445454","NIHMS677721","10.1037/ccp0000024"
"26007645","The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice","Davis RL, Das S, Thomas Curtis J, Stevens CW.","Eur J Pharmacol. 2015 Sep 5;762:193-201. doi: 10.1016/j.ejphar.2015.05.040. Epub 2015 May 22.","Davis RL","Eur J Pharmacol","2015","2015/05/27","PMC4543532","NIHMS697751","10.1016/j.ejphar.2015.05.040"
"26005722","Mutations in the opioid growth factor receptor in human cancers alter receptor function","Kren NP, Zagon IS, McLaughlin PJ.","Int J Mol Med. 2015 Jul;36(1):289-93. doi: 10.3892/ijmm.2015.2221. Epub 2015 May 25.","Kren NP","Int J Mol Med","2015","2015/05/26","","","10.3892/ijmm.2015.2221"
"25993547","A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment","Rauck RL, Hale ME, Bass A, Bramson C, Pixton G, Wilson JG, Setnik B, Meisner P, Sommerville KW, Malhotra BK, Wolfram G.","Pain. 2015 Sep;156(9):1660-9. doi: 10.1097/j.pain.0000000000000230.","Rauck RL","Pain","2015","2015/05/21","","","10.1097/j.pain.0000000000000230"
"25992402","Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study","Weintraub D, Papay K, Xie SX.","Neurology. 2015 Mar 31;84(13):1386-7.","Weintraub D","Neurology","2015","2015/05/21","","",""
"25992401","Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study","Liang JW, Shanker VL, Groves M.","Neurology. 2015 Mar 31;84(13):1386-7.","Liang JW","Neurology","2015","2015/05/21","","",""
"25982086","Spinal and supraspinal N-methyl-D-aspartate and melanocortin-1 receptors contribute to a qualitative sex difference in morphine-induced hyperalgesia","Arout CA, Caldwell M, Rossi G, Kest B.","Physiol Behav. 2015 Aug 1;147:364-72. doi: 10.1016/j.physbeh.2015.05.006. Epub 2015 May 14.","Arout CA","Physiol Behav","2015","2015/05/19","","","10.1016/j.physbeh.2015.05.006"
"25973526","Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension","Bull J, Wellman CV, Israel RJ, Barrett AC, Paterson C, Forbes WP.","J Palliat Med. 2015 Jul;18(7):593-600. doi: 10.1089/jpm.2014.0362. Epub 2015 May 14.","Bull J","J Palliat Med","2015","2015/05/15","PMC4492709","","10.1089/jpm.2014.0362"
"25971593","Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs","Tejeda HA, Hanks AN, Scott L, Mejias-Aponte C, Hughes ZA, O'Donnell P.","Neuropsychopharmacology. 2015 Dec;40(13):2856-64. doi: 10.1038/npp.2015.138. Epub 2015 May 14.","Tejeda HA","Neuropsychopharmacology","2015","2015/05/15","PMC4864622","","10.1038/npp.2015.138"
"25967924","Laxatives for the management of constipation in people receiving palliative care","Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P.","Cochrane Database Syst Rev. 2015 May 13;2015(5):CD003448. doi: 10.1002/14651858.CD003448.pub4.","Candy B","Cochrane Database Syst Rev","2015","2015/05/14","PMC6956627","","10.1002/14651858.CD003448.pub4"
"25955964","Behavioral and neurochemical analysis of ongoing bone cancer pain in rats","Remeniuk B, Sukhtankar D, Okun A, Navratilova E, Xie JY, King T, Porreca F.","Version 2. Pain. 2015 Oct;156(10):1864-73. doi: 10.1097/j.pain.0000000000000218.","Remeniuk B","Pain","2015","2015/05/09","PMC4578982","NIHMS684751","10.1097/j.pain.0000000000000218"
"25947592","[We do not want more pills]","Kittilsen L.","Tidsskr Nor Laegeforen. 2015 May 5;135(8):743. doi: 10.4045/tidsskr.15.0095. eCollection 2015 May 5.","Kittilsen L","Tidsskr Nor Laegeforen","2015","2015/05/08","","","10.4045/tidsskr.15.0095"
"25938514","In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene","Xie X, Lin W, Xing C, Yang Y, Chi Q, Zhang H, Li Y, Li Z, Yang Y, Yang Z, Li M.","PLoS One. 2015 May 4;10(5):e0125953. doi: 10.1371/journal.pone.0125953. eCollection 2015.","Xie X","PLoS One","2015","2015/05/05","PMC4418713","","10.1371/journal.pone.0125953"
"25935714","Factors associated with willingness to take extended release naltrexone among injection drug users","Ahamad K, Milloy MJ, Nguyen P, Uhlmann S, Johnson C, Korthuis TP, Kerr T, Wood E.","Addict Sci Clin Pract. 2015 May 3;10:12. doi: 10.1186/s13722-015-0034-5.","Ahamad K","Addict Sci Clin Pract","2015","2015/05/04","PMC4636793","","10.1186/s13722-015-0034-5"
"25933795","Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers","Roche DJ, Bujarski S, Hartwell E, Green R, Ray LA.","Pharmacol Biochem Behav. 2015 Jul;134:92-8. doi: 10.1016/j.pbb.2015.04.013. Epub 2015 Apr 28.","Roche DJ","Pharmacol Biochem Behav","2015","2015/05/03","PMC4457679","NIHMS694229","10.1016/j.pbb.2015.04.013"
"25931433","Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial","Mason AE, Lustig RH, Brown RR, Acree M, Bacchetti P, Moran PJ, Dallman M, Laraia B, Adler N, Hecht FM, Daubenmier J, Epel ES.","Appetite. 2015 Aug;91:311-320. doi: 10.1016/j.appet.2015.04.062. Epub 2015 Apr 27.","Mason AE","Appetite","2015","2015/05/02","PMC4485926","NIHMS685108","10.1016/j.appet.2015.04.062"
"25928699","Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist","Shram MJ, Silverman B, Ehrich E, Sellers EM, Turncliff R.","J Clin Psychopharmacol. 2015 Jun;35(3):242-9. doi: 10.1097/JCP.0000000000000320.","Shram MJ","J Clin Psychopharmacol","2015","2015/05/01","PMC4415969","","10.1097/JCP.0000000000000320"
"25927665","Methylnaltrexone for Opioid-Induced Constipation in Children and Adolescents and Young Adults with Progressive Incurable Cancer at the End of Life","Flerlage JE, Baker JN.","J Palliat Med. 2015 Jul;18(7):631-3. doi: 10.1089/jpm.2014.0364. Epub 2015 Apr 30.","Flerlage JE","J Palliat Med","2015","2015/05/01","PMC4492591","","10.1089/jpm.2014.0364"
"25925946","Chronic Treatment with Naltrexone Prevents Memory Retention Deficits in Rats Poisoned with the Sarin Analog Diisopropylfluorophosphate (DFP) and Treated with Atropine and Pralidoxime","Brewer KL, Tran T, Meggs WJ.","J Med Toxicol. 2015 Dec;11(4):433-8. doi: 10.1007/s13181-015-0480-1.","Brewer KL","J Med Toxicol","2015","2015/05/01","PMC4675601","","10.1007/s13181-015-0480-1"
"25925715","Complexities of the mu opioid receptor","Berrettini W.","Biol Psychiatry. 2015 May 15;77(10):844-5. doi: 10.1016/j.biopsych.2015.03.011.","Berrettini W","Biol Psychiatry","2015","2015/05/01","","","10.1016/j.biopsych.2015.03.011"
"25921475","Medicaid coverage of medications to treat alcohol and opioid dependence","Mark TL, Lubran R, McCance-Katz EF, Chalk M, Richardson J.","J Subst Abuse Treat. 2015 Aug;55:1-5. doi: 10.1016/j.jsat.2015.04.009. Epub 2015 Apr 16.","Mark TL","J Subst Abuse Treat","2015","2015/04/30","","","10.1016/j.jsat.2015.04.009"
"25919978","Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial","Witkiewitz K, Vowles KE, McCallion E, Frohe T, Kirouac M, Maisto SA.","Addiction. 2015 Aug;110(8):1262-71. doi: 10.1111/add.12964. Epub 2015 Jun 3.","Witkiewitz K","Addiction","2015","2015/04/29","PMC4503502","NIHMS685331","10.1111/add.12964"
"25919941","Rutin antinociception involves opioidergic mechanism and descending modulation of ventrolateral periaqueductal grey matter in rats","Hernandez-Leon A, Fernández-Guasti A, González-Trujano ME.","Eur J Pain. 2016 Feb;20(2):274-83. doi: 10.1002/ejp.720. Epub 2015 Apr 27.","Hernandez-Leon A","Eur J Pain","2016","2015/04/29","","","10.1002/ejp.720"
"25918964","Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trial","Bress A, Kittles R, Wing C, Hooker SE Jr, King A.","Pharmacogenet Genomics. 2015 Jun;25(6):305-12. doi: 10.1097/FPC.0000000000000138.","Bress A","Pharmacogenet Genomics","2015","2015/04/29","PMC4413945","NIHMS670449","10.1097/FPC.0000000000000138"
"25911583","Primary afferent neurons express functional delta opioid receptors in inflamed skin","Brederson JD, Honda CN.","Brain Res. 2015 Jul 21;1614:105-11. doi: 10.1016/j.brainres.2015.04.023. Epub 2015 Apr 22.","Brederson JD","Brain Res","2015","2015/04/26","PMC4457631","NIHMS683467","10.1016/j.brainres.2015.04.023"
"25909320","Randomized controlled trial of a mobile phone intervention for improving adherence to naltrexone for alcohol use disorders","Stoner SA, Arenella PB, Hendershot CS.","PLoS One. 2015 Apr 24;10(4):e0124613. doi: 10.1371/journal.pone.0124613. eCollection 2015.","Stoner SA","PLoS One","2015","2015/04/25","PMC4409303","","10.1371/journal.pone.0124613"
"25907815","Baseline characteristics of patients predicting suitability for rapid naltrexone induction","Mogali S, Khan NA, Drill ES, Pavlicova M, Sullivan MA, Nunes E, Bisaga A.","Am J Addict. 2015 Apr;24(3):258-64. doi: 10.1111/ajad.12180.","Mogali S","Am J Addict","2015","2015/04/25","PMC4496800","NIHMS701450","10.1111/ajad.12180"
"25906771","Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis","McLaughlin PJ, McHugh DP, Magister MJ, Zagon IS.","BMC Immunol. 2015 Apr 24;16:24. doi: 10.1186/s12865-015-0093-0.","McLaughlin PJ","BMC Immunol","2015","2015/04/25","PMC4407783","","10.1186/s12865-015-0093-0"
"25901587","Methylnaltrexone for opioid-induced constipation in patients at the end of life","Santucci G, Battista V.","Int J Palliat Nurs. 2015 Apr;21(4):162, 164. doi: 10.12968/ijpn.2015.21.4.162.","Santucci G","Int J Palliat Nurs","2015","2015/04/23","","","10.12968/ijpn.2015.21.4.162"
"25901451","Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?","Nunes EV, Krupitsky E, Ling W, Zummo J, Memisoglu A, Silverman BL, Gastfriend DR.","J Addict Med. 2015 May-Jun;9(3):238-43. doi: 10.1097/ADM.0000000000000125.","Nunes EV","J Addict Med","2015","2015/04/23","PMC4450918","","10.1097/ADM.0000000000000125"
"25900872","Safety and tolerability of medications approved for chronic weight management","Fujioka K.","Obesity (Silver Spring). 2015 Apr;23 Suppl 1:S7-11. doi: 10.1002/oby.21094.","Fujioka K","Obesity (Silver Spring)","2015","2015/04/23","","","10.1002/oby.21094"
"25886539","Views about responsibility for alcohol addiction and negative evaluations of naltrexone","Johnson RA, Lukens JM, Kole JW, Sisti DA.","Subst Abuse Treat Prev Policy. 2015 Mar 8;10:10. doi: 10.1186/s13011-015-0004-7.","Johnson RA","Subst Abuse Treat Prev Policy","2015","2015/04/18","PMC4369079","","10.1186/s13011-015-0004-7"
"25884917","Types of skin afferent fibers and spinal opioid receptors that contribute to touch-induced inhibition of heart rate changes evoked by noxious cutaneous heat stimulation","Watanabe N, Piché M, Hotta H.","Mol Pain. 2015 Feb 12;11:4. doi: 10.1186/s12990-015-0001-x.","Watanabe N","Mol Pain","2015","2015/04/18","PMC4335417","","10.1186/s12990-015-0001-x"
"25881118","Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G","Lovallo WR, Enoch MA, Acheson A, Cohoon AJ, Sorocco KH, Hodgkinson CA, Vincent AS, Glahn DC, Goldman D.","Neuropsychopharmacology. 2015 Oct;40(11):2546-54. doi: 10.1038/npp.2015.101. Epub 2015 Apr 16.","Lovallo WR","Neuropsychopharmacology","2015","2015/04/17","PMC4569944","","10.1038/npp.2015.101"
"25881117","Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers","Haney M, Ramesh D, Glass A, Pavlicova M, Bedi G, Cooper ZD.","Neuropsychopharmacology. 2015 Oct;40(11):2489-98. doi: 10.1038/npp.2015.108. Epub 2015 Apr 16.","Haney M","Neuropsychopharmacology","2015","2015/04/17","PMC4569951","","10.1038/npp.2015.108"
"25876512","Mechanism Underlying the Analgesic Effect Exerted by Endomorphin-1 in the rat Ventrolateral Periaqueductal Gray","Chen T, Li J, Feng B, Hui R, Dong YL, Huo FQ, Zhang T, Yin JB, Du JQ, Li YQ.","Mol Neurobiol. 2016 Apr;53(3):2036-2053. doi: 10.1007/s12035-015-9159-5. Epub 2015 Apr 16.","Chen T","Mol Neurobiol","2016","2015/04/17","","","10.1007/s12035-015-9159-5"
"25861786","Targeting Itch with Ligands Selective for κ Opioid Receptors","Cowan A, Kehner GB, Inan S.","Handb Exp Pharmacol. 2015;226:291-314. doi: 10.1007/978-3-662-44605-8_16.","Cowan A","Handb Exp Pharmacol","2015","2015/04/12","","","10.1007/978-3-662-44605-8_16"
"25853862","Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo","Suzuki M, Chiwaki F, Sawada Y, Ashikawa M, Aoyagi K, Fujita T, Yanagihara K, Komatsu M, Narita M, Suzuki T, Nagase H, Kushima R, Sakamoto H, Fukagawa T, Katai H, Nakagama H, Yoshida T, Uezono Y, Sasaki H.","PLoS One. 2015 Apr 8;10(4):e0123407. doi: 10.1371/journal.pone.0123407. eCollection 2015.","Suzuki M","PLoS One","2015","2015/04/09","PMC4390307","","10.1371/journal.pone.0123407"
"25851485","Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","Stevenson M, Pandor A, Stevens JW, Rawdin A, Rice P, Thompson J, Morgan MY.","Pharmacoeconomics. 2015 Aug;33(8):833-47. doi: 10.1007/s40273-015-0272-0.","Stevenson M","Pharmacoeconomics","2015","2015/04/09","","","10.1007/s40273-015-0272-0"
"25841704","Extended-Release Naltrexone for Alcohol and Opioid Problems in Missouri Parolees and Probationers","Crits-Christoph P, Lundy C, Stringer M, Gallop R, Gastfriend DR.","J Subst Abuse Treat. 2015 Sep;56:54-60. doi: 10.1016/j.jsat.2015.03.003. Epub 2015 Mar 25.","Crits-Christoph P","J Subst Abuse Treat","2015","2015/04/06","","","10.1016/j.jsat.2015.03.003"
"25832297","Clinical relevance of as-needed treatment with nalmefene in alcohol-dependent patients","Aubin HJ, Reimer J, Nutt DJ, Bladström A, Torup L, François C, Chick J.","Eur Addict Res. 2015;21(3):160-8. doi: 10.1159/000371547. Epub 2015 Mar 31.","Aubin HJ","Eur Addict Res","2015","2015/04/03","","","10.1159/000371547"
"25825466","Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study","Galduróz JC, Ramos AC, Santos-Galduróz RF.","Neurology. 2015 Mar 31;84(13):1386-7. doi: 10.1212/WNL.0000000000001458.","Galduróz JC","Neurology","2015","2015/04/01","","","10.1212/WNL.0000000000001458"
"25819700","Naltrexone-facilitated buprenorphine discontinuation: a feasibility trial","Dakwar E, Kleber HD.","J Subst Abuse Treat. 2015 Jun;53:60-3. doi: 10.1016/j.jsat.2015.01.004. Epub 2015 Jan 15.","Dakwar E","J Subst Abuse Treat","2015","2015/03/31","","","10.1016/j.jsat.2015.01.004"
"25817230","High-dose pentazocine antagonizes the antinociception induced by high-dose morphine","Shu H, Wang Z, Ye F, Li Q, Dou Y, Lin Y, Huang W, Xiao X.","Life Sci. 2015 Jun 1;130:1-6. doi: 10.1016/j.lfs.2015.02.023. Epub 2015 Mar 25.","Shu H","Life Sci","2015","2015/03/31","","","10.1016/j.lfs.2015.02.023"
"25816931","Preoperative ultra-rapid opiate detoxification for the treatment of post-operative surgical pain","Blum JM, Biel SS, Hilliard PE, Jutkiewicz EM.","Med Hypotheses. 2015 Jun;84(6):529-31. doi: 10.1016/j.mehy.2015.02.008. Epub 2015 Mar 6.","Blum JM","Med Hypotheses","2015","2015/03/31","","","10.1016/j.mehy.2015.02.008"
"25810023","The effects of morphine and methylnaltrexone on gastrointestinal pain in healthy male participants","Brokjaer A, Olesen AE, Christrup LL, Dahan A, Drewes AM.","Neurogastroenterol Motil. 2015 May;27(5):693-704. doi: 10.1111/nmo.12545. Epub 2015 Mar 22.","Brokjaer A","Neurogastroenterol Motil","2015","2015/03/27","","","10.1111/nmo.12545"
"25808344","κ-Opioid receptors are involved in enhanced cardioprotection by combined fentanyl and limb remote ischemic postconditioning","Xu YC, Li RP, Xue FS, Cui XL, Wang SY, Liu GP, Yang GZ, Sun C, Liao X.","J Anesth. 2015 Aug;29(4):535-43. doi: 10.1007/s00540-015-1998-8. Epub 2015 Mar 26.","Xu YC","J Anesth","2015","2015/03/27","","","10.1007/s00540-015-1998-8"
"25805351","[Neurobiology of alcohol and pharmacological aspects of nalmefene]","Biggio G.","Riv Psichiatr. 2015 Jan-Feb;50(1):19-27. doi: 10.1708/1794.19530.","Biggio G","Riv Psichiatr","2015","2015/03/26","","","10.1708/1794.19530"
"25803343","Naltrexone extended-release plus bupropion extended-release for treatment of obesity","Yanovski SZ, Yanovski JA.","JAMA. 2015 Mar 24-31;313(12):1213-4. doi: 10.1001/jama.2015.1617.","Yanovski SZ","JAMA","2015","2015/03/25","PMC4993523","NIHMS810954","10.1001/jama.2015.1617"
"25801501","The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study","Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K.","Neuropsychopharmacology. 2015 Sep;40(10):2347-56. doi: 10.1038/npp.2015.83. Epub 2015 Mar 24.","Ray LA","Neuropsychopharmacology","2015","2015/03/25","PMC4538349","","10.1038/npp.2015.83"
"25793206","Comment on ""Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients""","Aghabiklooei A, Hassanian-Moghaddam H, Zamani N.","Biomed Res Int. 2015;2015:752902. doi: 10.1155/2015/752902. Epub 2015 Feb 22.","Aghabiklooei A","Biomed Res Int","2015","2015/03/21","PMC4352462","","10.1155/2015/752902"
"25787988","Men Who Have Sex With Men in Peru: Acceptability of Medication-Assisted Therapy for Treating Alcohol Use Disorders","Brown SE, Vagenas P, Konda KA, Clark JL, Lama JR, Gonzales P, Sanchez J, Duerr AC, Altice FL.","Version 2. Am J Mens Health. 2017 Jul;11(4):1269-1278. doi: 10.1177/1557988315576775. Epub 2015 Mar 17.","Brown SE","Am J Mens Health","2017","2015/03/20","PMC4573823","NIHMS696215","10.1177/1557988315576775"
"25781230","Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence","Wang AL, Elman I, Lowen SB, Blady SJ, Lynch KG, Hyatt JM, O'Brien CP, Langleben DD.","Transl Psychiatry. 2015 Mar 17;5(3):e531. doi: 10.1038/tp.2015.20.","Wang AL","Transl Psychiatry","2015","2015/03/18","PMC4354350","","10.1038/tp.2015.20"
"25775099","Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence","Jackson H, Mandell K, Johnson K, Chatterjee D, Vanness DJ.","Subst Abus. 2015;36(2):226-31. doi: 10.1080/08897077.2015.1010031. Epub 2015 Mar 16.","Jackson H","Subst Abus","2015","2015/03/17","PMC4470733","NIHMS694046","10.1080/08897077.2015.1010031"
"25774010","(+)-Naltrexone is neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest/cardiopulmonary resuscitation","Grace PM, Shimizu K, Strand KA, Rice KC, Deng G, Watkins LR, Herson PS.","Brain Behav Immun. 2015 Aug;48:115-22. doi: 10.1016/j.bbi.2015.03.005. Epub 2015 Mar 13.","Grace PM","Brain Behav Immun","2015","2015/03/17","PMC5548128","NIHMS881288","10.1016/j.bbi.2015.03.005"
"25773958","Chorionic morphine, naltrexone and pentoxifylline effect on hypophyso-gonadal hormones of male rats","Moradi M, Mahmoodi M, Raoofi A, Ghanbari A.","Bratisl Lek Listy. 2015;116(4):276-9. doi: 10.4149/bll_2015_053.","Moradi M","Bratisl Lek Listy","2015","2015/03/17","","","10.4149/bll_2015_053"
"25762676","κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake","Whitfield TW Jr, Schlosburg JE, Wee S, Gould A, George O, Grant Y, Zamora-Martinez ER, Edwards S, Crawford E, Vendruscolo LF, Koob GF.","J Neurosci. 2015 Mar 11;35(10):4296-305. doi: 10.1523/JNEUROSCI.1978-13.2015.","Whitfield TW Jr","J Neurosci","2015","2015/03/13","PMC4355200","","10.1523/JNEUROSCI.1978-13.2015"
"25761458","Recent Developments in Pharmacotherapy of Alcoholism","Soyka M, Lieb M.","Pharmacopsychiatry. 2015 Jul;48(4-5):123-35. doi: 10.1055/s-0035-1547237. Epub 2015 Mar 11.","Soyka M","Pharmacopsychiatry","2015","2015/03/13","","","10.1055/s-0035-1547237"
"25760804","Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial","Oslin DW, Leong SH, Lynch KG, Berrettini W, O'Brien CP, Gordon AJ, Rukstalis M.","JAMA Psychiatry. 2015 May;72(5):430-7. doi: 10.1001/jamapsychiatry.2014.3053.","Oslin DW","JAMA Psychiatry","2015","2015/03/12","","","10.1001/jamapsychiatry.2014.3053"
"25757673","Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients","Zaaijer ER, van Dijk L, de Bruin K, Goudriaan AE, Lammers LA, Koeter MW, van den Brink W, Booij J.","Psychopharmacology (Berl). 2015 Jul;232(14):2597-607. doi: 10.1007/s00213-015-3891-4. Epub 2015 Mar 12.","Zaaijer ER","Psychopharmacology (Berl)","2015","2015/03/12","PMC4480848","","10.1007/s00213-015-3891-4"
"25752019","[Acamprosate and naltrexone: similar efficacy for relapse]","Saitz R.","Rev Med Suisse. 2014 Dec 17;10(455):2437.","Saitz R","Rev Med Suisse","2014","2015/03/11","","",""
"25747924","Alcohol use disorders in pregnancy","DeVido J, Bogunovic O, Weiss RD.","Harv Rev Psychiatry. 2015 Mar-Apr;23(2):112-21. doi: 10.1097/HRP.0000000000000070.","DeVido J","Harv Rev Psychiatry","2015","2015/03/10","PMC4530607","NIHMS705835","10.1097/HRP.0000000000000070"
"25747921","Long-term course of opioid addiction","Hser YI, Evans E, Grella C, Ling W, Anglin D.","Harv Rev Psychiatry. 2015 Mar-Apr;23(2):76-89. doi: 10.1097/HRP.0000000000000052.","Hser YI","Harv Rev Psychiatry","2015","2015/03/10","","","10.1097/HRP.0000000000000052"
"25747920","Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","Connery HS.","Harv Rev Psychiatry. 2015 Mar-Apr;23(2):63-75. doi: 10.1097/HRP.0000000000000075.","Connery HS","Harv Rev Psychiatry","2015","2015/03/10","","","10.1097/HRP.0000000000000075"
"25743758","Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat","Verplaetse TL, Czachowski CL.","Psychopharmacology (Berl). 2015 Aug;232(15):2647-57. doi: 10.1007/s00213-015-3896-z. Epub 2015 Mar 7.","Verplaetse TL","Psychopharmacology (Berl)","2015","2015/03/07","PMC4504773","NIHMS670121","10.1007/s00213-015-3896-z"
"25742215","Naltrexone reduces heavy drinking in problem drinkers across the spectrum of dependence","Hester RK.","J Clin Psychiatry. 2015 Feb;76(2):e226-7. doi: 10.4088/JCP.14com09370.","Hester RK","J Clin Psychiatry","2015","2015/03/06","","","10.4088/JCP.14com09370"
"25742208","Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety","O'Malley SS, Corbin WR, Leeman RF, DeMartini KS, Fucito LM, Ikomi J, Romano DM, Wu R, Toll BA, Sher KJ, Gueorguieva R, Kranzler HR.","J Clin Psychiatry. 2015 Feb;76(2):e207-13. doi: 10.4088/JCP.13m08934.","O'Malley SS","J Clin Psychiatry","2015","2015/03/06","PMC4442987","NIHMS688261","10.4088/JCP.13m08934"
"25724154","Effects of ethanol on the pharmacokinetics of extended-release oxycodone with sequestered naltrexone (ALO-02)","Malhotra BK, Matschke K, Wang Q, Bramson C, Salageanu J.","Clin Drug Investig. 2015 Apr;35(4):267-74. doi: 10.1007/s40261-015-0278-6.","Malhotra BK","Clin Drug Investig","2015","2015/03/01","","","10.1007/s40261-015-0278-6"
"25716198","Enkephalin analog, cyclo[N(ε),N(β)-carbonyl-D-Lys(2),Dap(5)] enkephalinamide (cUENK6), inhibits the ethanol withdrawal-induced anxiety-like behavior in rats","Gibula-Bruzda E, Marszalek-Grabska M, Witkowska E, Izdebski J, Kotlinska JH.","Alcohol. 2015 May;49(3):229-36. doi: 10.1016/j.alcohol.2015.01.007. Epub 2015 Feb 3.","Gibula-Bruzda E","Alcohol","2015","2015/02/27","","","10.1016/j.alcohol.2015.01.007"
"25715171","OPRM1 genotype and naltrexone response in depressed alcohol-dependent patients","Foulds JA, Ton K, Kennedy MA, Adamson SJ, Mulder RT, Sellman JD.","Pharmacogenet Genomics. 2015 May;25(5):270-3. doi: 10.1097/FPC.0000000000000128.","Foulds JA","Pharmacogenet Genomics","2015","2015/02/26","","","10.1097/FPC.0000000000000128"
"25712671","Involvement of nitridergic and opioidergic pathways in the antinociception of gabapentin in the orofacial formalin test in mice","Miranda HF, Sierralta F, Lux S, Troncoso R, Ciudad N, Zepeda R, Zanetta P, Noriega V, Prieto JC.","Pharmacol Rep. 2015 Apr;67(2):399-403. doi: 10.1016/j.pharep.2014.10.018. Epub 2014 Nov 7.","Miranda HF","Pharmacol Rep","2015","2015/02/26","","","10.1016/j.pharep.2014.10.018"
"25703440","Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial","Lee JD, McDonald R, Grossman E, McNeely J, Laska E, Rotrosen J, Gourevitch MN.","Addiction. 2015 Jun;110(6):1008-14. doi: 10.1111/add.12894. Epub 2015 Apr 5.","Lee JD","Addiction","2015","2015/02/24","","","10.1111/add.12894"
"25697724","Qualitatively and quantitatively evaluating harm-reduction goal setting among chronically homeless individuals with alcohol dependence","Collins SE, Grazioli VS, Torres NI, Taylor EM, Jones CB, Hoffman GE, Haelsig L, Zhu MD, Hatsukami AS, Koker MJ, Herndon P, Greenleaf SM, Dean PE.","Addict Behav. 2015 Jun;45:184-90. doi: 10.1016/j.addbeh.2015.02.001. Epub 2015 Feb 8.","Collins SE","Addict Behav","2015","2015/02/21","PMC4452113","NIHMS665134","10.1016/j.addbeh.2015.02.001"
"25679122","A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression","Adamson SJ, Sellman JD, Foulds JA, Frampton CM, Deering D, Dunn A, Berks J, Nixon L, Cape G.","J Clin Psychopharmacol. 2015 Apr;35(2):143-9. doi: 10.1097/JCP.0000000000000287.","Adamson SJ","J Clin Psychopharmacol","2015","2015/02/14","","","10.1097/JCP.0000000000000287"
"25675975","Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial","Chen T, Powell CC.","Vet Ophthalmol. 2015 Nov;18(6):497-501. doi: 10.1111/vop.12255. Epub 2015 Feb 10.","Chen T","Vet Ophthalmol","2015","2015/02/14","","","10.1111/vop.12255"
"25664494","The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis","Donoghue K, Elzerbi C, Saunders R, Whittington C, Pilling S, Drummond C.","Addiction. 2015 Jun;110(6):920-30. doi: 10.1111/add.12875. Epub 2015 Mar 17.","Donoghue K","Addiction","2015","2015/02/10","","","10.1111/add.12875"
"25655226","Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-up","Leslie DL, Milchak W, Gastfriend DR, Herschman PL, Bixler EO, Velott DL, Meyer RE.","Am J Addict. 2015 Apr;24(3):265-70. doi: 10.1111/ajad.12182. Epub 2015 Feb 4.","Leslie DL","Am J Addict","2015","2015/02/07","","","10.1111/ajad.12182"
"25652768","Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme","van den Brink W, Strang J, Gual A, Sørensen P, Jensen TJ, Mann K.","Expert Opin Drug Saf. 2015 Apr;14(4):495-504. doi: 10.1517/14740338.2015.1011619. Epub 2015 Feb 4.","van den Brink W","Expert Opin Drug Saf","2015","2015/02/06","","","10.1517/14740338.2015.1011619"
"25647453","Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience","Grosshans M, Mutschler J, Kiefer F.","Int Clin Psychopharmacol. 2015 Jul;30(4):237-8. doi: 10.1097/YIC.0000000000000069.","Grosshans M","Int Clin Psychopharmacol","2015","2015/02/04","","","10.1097/YIC.0000000000000069"
"25643645","Low-dose naltrexone to prevent intolerable morphine adverse events: a forgotten remedy for a neglected, global clinical need","Raffaeli W, Indovina P.","Pain Med. 2015 Jun;16(6):1239-42. doi: 10.1111/pme.12704. Epub 2015 Feb 3.","Raffaeli W","Pain Med","2015","2015/02/04","","","10.1111/pme.12704"
"25639561","Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain","Beaudry H, Gendron L, Morón JA.","Eur J Neurosci. 2015 Apr;41(7):901--7. doi: 10.1111/ejn.12829. Epub 2015 Jan 9.","Beaudry H","Eur J Neurosci","2015","2015/02/03","PMC4390435","NIHMS649319","10.1111/ejn.12829"
"25637376","Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human","Rorick-Kehn LM, Witcher JW, Lowe SL, Gonzales CR, Weller MA, Bell RL, Hart JC, Need AB, McKinzie JH, Statnick MA, Suico JG, McKinzie DL, Tauscher-Wisniewski S, Mitch CH, Stoltz RR, Wong CJ.","Int J Neuropsychopharmacol. 2014 Oct 31;18(2):pyu036. doi: 10.1093/ijnp/pyu036.","Rorick-Kehn LM","Int J Neuropsychopharmacol","2014","2015/02/01","PMC4368892","","10.1093/ijnp/pyu036"
"25634851","Drug treatment of obesity: current status and future prospects","Kakkar AK, Dahiya N.","Eur J Intern Med. 2015 Mar;26(2):89-94. doi: 10.1016/j.ejim.2015.01.005. Epub 2015 Jan 26.","Kakkar AK","Eur J Intern Med","2015","2015/01/31","","","10.1016/j.ejim.2015.01.005"
"25625602","Dopamine D1 and opioid receptor antagonist-induced reductions of fructose and saccharin intake in BALB/c and SWR inbred mice","Kraft TT, Huang D, Natanova E, Lolier M, Yakubov Y, La Magna S, Warshaw D, Sclafani A, Bodnar RJ.","Pharmacol Biochem Behav. 2015 Apr;131:13-8. doi: 10.1016/j.pbb.2015.01.010. Epub 2015 Jan 24.","Kraft TT","Pharmacol Biochem Behav","2015","2015/01/28","","","10.1016/j.pbb.2015.01.010"
"25623409","Social network moderators of naltrexone and behavioral treatment effects on heavy drinking in the COMBINE study","Worley MJ, Witkiewitz K, Brown SA, Kivlahan DR, Longabaugh R.","Alcohol Clin Exp Res. 2015 Jan;39(1):93-100. doi: 10.1111/acer.12605.","Worley MJ","Alcohol Clin Exp Res","2015","2015/01/28","PMC4418469","NIHMS684718","10.1111/acer.12605"
"25623408","Extended release naltrexone for alcohol use disorders: quasi-experimental effects on mortality and subsequent detoxification episodes","Harris AH, Bowe T, Del Re AC, Finlay AK, Oliva E, Myrick HL, Rubinsky AD.","Alcohol Clin Exp Res. 2015 Jan;39(1):79-83. doi: 10.1111/acer.12597.","Harris AH","Alcohol Clin Exp Res","2015","2015/01/28","","","10.1111/acer.12597"
"25622123","Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study","Pal R, Mendelson JE, Flower K, Garrison K, Yount G, Coyle JR, Galloway GP.","J Addict Med. 2015 Mar-Apr;9(2):130-5. doi: 10.1097/ADM.0000000000000107.","Pal R","J Addict Med","2015","2015/01/27","PMC4375053","NIHMS649984","10.1097/ADM.0000000000000107"
"25620274","Comparison of dehydroepiandrosterone (DHEA) and pregnanolone with existing pharmacotherapies for alcohol abuse on ethanol- and food-maintained responding in male rats","Hulin MW, Lawrence MN, Amato RJ, Weed PF, Winsauer PJ.","Alcohol. 2015 Mar;49(2):127-38. doi: 10.1016/j.alcohol.2014.07.024. Epub 2015 Jan 6.","Hulin MW","Alcohol","2015","2015/01/27","PMC4514518","NIHMS658122","10.1016/j.alcohol.2014.07.024"
"25618226","Nonincretin drugs in later-stage development","Zimmerman MP, Mehr SR.","Am J Manag Care. 2014 Jan;20(1 Spec No.):E2.","Zimmerman MP","Am J Manag Care","2014","2015/01/26","","",""
"25609921","Letter to the editor: naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date","Buehler AM.","Drug Des Devel Ther. 2015 Jan 8;9:419-23. doi: 10.2147/DDDT.S77881. eCollection 2015.","Buehler AM","Drug Des Devel Ther","2015","2015/01/23","PMC4293294","","10.2147/DDDT.S77881"
"25607785","Metastatic hepatocellular carcinoma with paraneoplastic itch: effective treatment with naltrexone","Chia BK, Tey HL.","J Drugs Dermatol. 2014 Dec;13(12):1440.","Chia BK","J Drugs Dermatol","2014","2015/01/22","","",""
"25602580","Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial","Lee JD, Friedmann PD, Boney TY, Hoskinson RA Jr, McDonald R, Gordon M, Fishman M, Chen DT, Bonnie RJ, Kinlock TW, Nunes EV, Cornish JW, O'Brien CP.","Contemp Clin Trials. 2015 Mar;41:110-7. doi: 10.1016/j.cct.2015.01.005. Epub 2015 Jan 17.","Lee JD","Contemp Clin Trials","2015","2015/01/21","PMC4380547","NIHMS663856","10.1016/j.cct.2015.01.005"
"25593096","Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif","Frankowski KJ, Slauson SR, Lovell KM, Phillips AM, Streicher JM, Zhou L, Whipple DA, Schoenen FJ, Prisinzano TE, Bohn LM, Aubé J.","Bioorg Med Chem. 2015 Jul 15;23(14):3948-56. doi: 10.1016/j.bmc.2014.12.033. Epub 2014 Dec 23.","Frankowski KJ","Bioorg Med Chem","2015","2015/01/17","PMC4468036","NIHMS651599","10.1016/j.bmc.2014.12.033"
"25591636","[Injectable extended-release naltrexone for opioid dependence: an open label study of long-term safety and efficacy]","Krupitsky EM, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, Blokhina EA, Silverman BL.","Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(11):49-56.","Krupitsky EM","Zh Nevrol Psikhiatr Im S S Korsakova","2014","2015/01/17","","",""
"25591478","The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats","Kelsey JE, Verhaak AM, Schierberl KC.","Behav Brain Res. 2015 Apr 15;283:16-21. doi: 10.1016/j.bbr.2015.01.008. Epub 2015 Jan 13.","Kelsey JE","Behav Brain Res","2015","2015/01/17","","","10.1016/j.bbr.2015.01.008"
"25586403","Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats","Zaaijer ER, de Bruin K, la Fleur SE, Goudriaan AE, van den Brink W, Booij J.","J Psychopharmacol. 2015 Mar;29(3):344-8. doi: 10.1177/0269881114565380. Epub 2015 Jan 13.","Zaaijer ER","J Psychopharmacol","2015","2015/01/15","","","10.1177/0269881114565380"
"25581657","Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients","Spagnolo PA, Ramchandani VA, Schwandt ML, Zhang L, Blaine SK, Usala JM, Diamond KA, Phillips MJ, George DT, Momenan R, Heilig M.","Alcohol Clin Exp Res. 2014 Dec;38(12):3024-32. doi: 10.1111/acer.12581.","Spagnolo PA","Alcohol Clin Exp Res","2014","2015/01/13","PMC4293087","NIHMS631775","10.1111/acer.12581"
"25581305","Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys","Hutsell BA, Cheng K, Rice KC, Negus SS, Banks ML.","Addict Biol. 2016 Mar;21(2):360-73. doi: 10.1111/adb.12206. Epub 2015 Jan 8.","Hutsell BA","Addict Biol","2016","2015/01/13","PMC4496334","NIHMS666817","10.1111/adb.12206"
"25573369","Effects of β-endorphin on functional activity of mouse splenocytes under conditions of in vivo blockade of μ,δ-opioid receptors","Gein SV, Baeva TA, Nebogatikov VO.","Bull Exp Biol Med. 2015 Jan;158(3):356-60. doi: 10.1007/s10517-015-2761-8. Epub 2015 Jan 9.","Gein SV","Bull Exp Biol Med","2015","2015/01/10","","","10.1007/s10517-015-2761-8"
"25573119","Transformation of naltrexone into mesembrane and investigation of the binding properties of its intermediate derivatives to opioid receptors","Konoura K, Fujii H, Imaide S, Gouda H, Hirayama S, Hirono S, Nagase H.","Bioorg Med Chem. 2015 Feb 1;23(3):439-48. doi: 10.1016/j.bmc.2014.12.032. Epub 2014 Dec 24.","Konoura K","Bioorg Med Chem","2015","2015/01/10","","","10.1016/j.bmc.2014.12.032"
"25567476","Methylnaltrexone to prevent intrathecal morphine-induced pruritus after Caesarean delivery: a multicentre, randomized clinical trial","Paech M, Sng B, Ng L, Nathan E, Sia A, Carvalho B.","Br J Anaesth. 2015 Mar;114(3):469-76. doi: 10.1093/bja/aeu410. Epub 2015 Jan 7.","Paech M","Br J Anaesth","2015","2015/01/09","","","10.1093/bja/aeu410"
"25562928","[Nalmefene (Selincro) orally]","","J Pharm Belg. 2014 Dec;(4):51-2.","","J Pharm Belg","2014","2015/01/08","","",""
"25555621","Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone","Sullivan MA, Bisaga A, Glass A, Mishlen K, Pavlicova M, Carpenter KM, Mariani JJ, Levin FR, Nunes EV.","Drug Alcohol Depend. 2015 Feb 1;147:122-9. doi: 10.1016/j.drugalcdep.2014.11.028. Epub 2014 Dec 9.","Sullivan MA","Drug Alcohol Depend","2015","2015/01/04","PMC4435949","NIHMS652529","10.1016/j.drugalcdep.2014.11.028"
"25554995","Depression outcome in alcohol dependent patients: an evaluation of the role of independent and substance-induced depression and other predictors","Foulds JA, Douglas Sellman J, Adamson SJ, Boden JM, Mulder RT, Joyce PR.","J Affect Disord. 2015 Mar 15;174:503-10. doi: 10.1016/j.jad.2014.11.052. Epub 2014 Dec 5.","Foulds JA","J Affect Disord","2015","2015/01/03","","","10.1016/j.jad.2014.11.052"
"25554482","Prenatal exposure to vanilla or alcohol induces crawling after these odors in the neonate rat: The role of mu and kappa opioid receptor systems","Gaztañaga M, Aranda-Fernández PE, Chotro MG.","Physiol Behav. 2015 Sep 1;148:58-64. doi: 10.1016/j.physbeh.2014.12.046. Epub 2014 Dec 30.","Gaztañaga M","Physiol Behav","2015","2015/01/03","","","10.1016/j.physbeh.2014.12.046"
"25552382","Cellular localization and adaptive changes of the cardiac delta opioid receptor system in an experimental model of heart failure in rats","Treskatsch S, Feldheiser A, Shaqura M, Dehe L, Habazettl H, Röpke TK, Shakibaei M, Schäfer M, Spies CD, Mousa SA.","Heart Vessels. 2016 Feb;31(2):241-50. doi: 10.1007/s00380-014-0620-6. Epub 2015 Jan 1.","Treskatsch S","Heart Vessels","2016","2015/01/02","","","10.1007/s00380-014-0620-6"
"25547452","[κ-opioid receptor agonist U50, 488H attenuates myocardial ischemia-reperfusionvia modulating Toll-like receptor 4/nuclear factor-κB signaling in rat]","Cai W, Zhang Y, Li J, Wang J.","Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Oct;42(10):866-72.","Cai W","Zhonghua Xin Xue Guan Bing Za Zhi","2014","2014/12/31","","",""
"25542074","Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteers","Darwish M, Yang R, Tracewell W, Robertson P Jr, Bond M.","Clin Ther. 2015 Feb 1;37(2):390-401. doi: 10.1016/j.clinthera.2014.11.014. Epub 2014 Dec 24.","Darwish M","Clin Ther","2015","2014/12/28","","","10.1016/j.clinthera.2014.11.014"
"25539634","Approval of antiobesity drug is ""major regression for patients' safety,"" says health watchdog","Hawkes N.","BMJ. 2014 Dec 23;349:g7805. doi: 10.1136/bmj.g7805.","Hawkes N","BMJ","2014","2014/12/26","","","10.1136/bmj.g7805"
"25519680","An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A","Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D.","Orphanet J Rare Dis. 2014 Dec 18;9:199. doi: 10.1186/s13023-014-0199-0.","Attarian S","Orphanet J Rare Dis","2014","2014/12/19","PMC4311411","","10.1186/s13023-014-0199-0"
"25518754","Evaluation of opioid modulation in major depressive disorder","Ehrich E, Turncliff R, Du Y, Leigh-Pemberton R, Fernandez E, Jones R, Fava M.","Neuropsychopharmacology. 2015 May;40(6):1448-55. doi: 10.1038/npp.2014.330. Epub 2014 Dec 18.","Ehrich E","Neuropsychopharmacology","2015","2014/12/19","PMC4397403","","10.1038/npp.2014.330"
"25516200","The opioid system majorly contributes to preference for fat emulsions but not sucrose solutions in mice","Sakamoto K, Okahashi T, Matsumura S, Okafuji Y, Adachi S, Tsuzuki S, Inoue K, Fushiki T.","Biosci Biotechnol Biochem. 2015;79(4):658-63. doi: 10.1080/09168451.2014.991688. Epub 2014 Dec 17.","Sakamoto K","Biosci Biotechnol Biochem","2015","2014/12/18","","","10.1080/09168451.2014.991688"
"25498394","Inhibition of DOR prevents remifentanil induced postoperative hyperalgesia through regulating the trafficking and function of spinal NMDA receptors in vivo and in vitro","Wang C, Li Y, Wang H, Xie K, Shu R, Zhang L, Hu N, Yu Y, Wang G.","Brain Res Bull. 2015 Jan;110:30-9. doi: 10.1016/j.brainresbull.2014.12.001. Epub 2014 Dec 9.","Wang C","Brain Res Bull","2015","2014/12/16","","","10.1016/j.brainresbull.2014.12.001"
"25491744","Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy","Chumakov I, Milet A, Cholet N, Primas G, Boucard A, Pereira Y, Graudens E, Mandel J, Laffaire J, Foucquier J, Glibert F, Bertrand V, Nave KA, Sereda MW, Vial E, Guedj M, Hajj R, Nabirotchkin S, Cohen D.","Orphanet J Rare Dis. 2014 Dec 10;9:201. doi: 10.1186/s13023-014-0201-x.","Chumakov I","Orphanet J Rare Dis","2014","2014/12/11","PMC4279797","","10.1186/s13023-014-0201-x"
"25487784","German evaluation says new drug for alcohol dependence is no better than old one","Stafford N.","BMJ. 2014 Dec 8;349:g7544. doi: 10.1136/bmj.g7544.","Stafford N","BMJ","2014","2014/12/10","","","10.1136/bmj.g7544"
"25486403","Adoption of injectable naltrexone in U.S. substance use disorder treatment programs","Aletraris L, Bond Edmond M, Roman PM.","J Stud Alcohol Drugs. 2015 Jan;76(1):143-51.","Aletraris L","J Stud Alcohol Drugs","2015","2014/12/09","PMC4263776","",""
"25481857","K303⁶·⁵⁸ in the μ opioid (MOP) receptor is important in conferring selectivity for covalent binding of β-funaltrexamine (β-FNA)","DiMattio KM, Chen C, Shi L, Liu-Chen LY.","Eur J Pharmacol. 2015 Feb 5;748:93-100. doi: 10.1016/j.ejphar.2014.11.028. Epub 2014 Dec 4.","DiMattio KM","Eur J Pharmacol","2015","2014/12/08","PMC4314454","NIHMS646734","10.1016/j.ejphar.2014.11.028"
"25481453","Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers","Meyer AC, Miller ME, Sigmon SC.","Addict Behav. 2015 Mar;42:189-93. doi: 10.1016/j.addbeh.2014.11.006. Epub 2014 Nov 18.","Meyer AC","Addict Behav","2015","2014/12/08","PMC4272898","NIHMS648510","10.1016/j.addbeh.2014.11.006"
"25475959","The immunomodulation mediated by a delta-opioid receptor for [Met(5)]-enkephalin in oyster Crassostrea gigas","Liu Z, Zhou Z, Wang L, Jiang S, Wang W, Zhang R, Song L.","Dev Comp Immunol. 2015 Apr;49(2):217-24. doi: 10.1016/j.dci.2014.11.017. Epub 2014 Dec 2.","Liu Z","Dev Comp Immunol","2015","2014/12/06","","","10.1016/j.dci.2014.11.017"
"25460532","Narcotic-induced pain","Thapa SD, Schairer J.","Am J Med. 2015 Apr;128(4):e7-8. doi: 10.1016/j.amjmed.2014.10.044. Epub 2014 Nov 22.","Thapa SD","Am J Med","2015","2014/12/03","","","10.1016/j.amjmed.2014.10.044"
"25459893","Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase","Roche DJ, King AC.","Psychoneuroendocrinology. 2015 Feb;52:59-71. doi: 10.1016/j.psyneuen.2014.10.013. Epub 2014 Oct 30.","Roche DJ","Psychoneuroendocrinology","2015","2014/12/03","PMC4482338","NIHMS639595","10.1016/j.psyneuen.2014.10.013"
"25459104","Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine","Stoops WW, Pike E, Hays LR, Glaser PE, Rush CR.","Pharmacol Biochem Behav. 2015 Feb;129:45-50. doi: 10.1016/j.pbb.2014.11.018. Epub 2014 Nov 29.","Stoops WW","Pharmacol Biochem Behav","2015","2014/12/03","PMC4300270","NIHMS650689","10.1016/j.pbb.2014.11.018"
"25457129","Downregulation of spinal endomorphin-2 correlates with mechanical allodynia in a rat model of tibia cancer","Chen L, Wang K, Yang T, Wang W, Mei XP, Zhu C, Wang W, Zhang FX, Li YQ.","Neuroscience. 2015 Feb 12;286:151-61. doi: 10.1016/j.neuroscience.2014.11.049. Epub 2014 Nov 29.","Chen L","Neuroscience","2015","2014/12/03","","","10.1016/j.neuroscience.2014.11.049"
"25456560","Single- and multiple-dose pharmacokinetics of samidorphan, a novel opioid antagonist, in healthy volunteers","Turncliff R, DiPetrillo L, Silverman B, Ehrich E.","Clin Ther. 2015 Feb 1;37(2):338-48. doi: 10.1016/j.clinthera.2014.10.001. Epub 2014 Oct 29.","Turncliff R","Clin Ther","2015","2014/12/03","","","10.1016/j.clinthera.2014.10.001"
"25454365","[Benefits in reducing alcohol consumption: how nalmefene can help]","Bendimerad P, Blecha L.","Encephale. 2014 Dec;40(6):495-500. doi: 10.1016/j.encep.2014.10.012. Epub 2014 Nov 22.","Bendimerad P","Encephale","2014","2014/12/03","","","10.1016/j.encep.2014.10.012"
"25454364","[Place of the opioid system in biology and treatment of Alcohol Use Disorder]","Nubukpo P.","Encephale. 2014 Dec;40(6):457-67. doi: 10.1016/j.encep.2014.10.010. Epub 2014 Nov 22.","Nubukpo P","Encephale","2014","2014/12/03","","","10.1016/j.encep.2014.10.010"
"25449041","Hypoxia/ischemia a key player in early post stroke seizures: modulation by opioidergic and nitrergic systems","Gooshe M, Abdolghaffari AH, Aleyasin AR, Chabouk L, Tofigh S, Hassanzadeh GR, Payandemehr B, Partoazar A, Azizi Y, Dehpour AR.","Eur J Pharmacol. 2015 Jan 5;746:6-13. doi: 10.1016/j.ejphar.2014.11.005. Epub 2014 Nov 15.","Gooshe M","Eur J Pharmacol","2015","2014/12/03","","","10.1016/j.ejphar.2014.11.005"
"25446568","Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats","Sukhtankar DD, Lagorio CH, Ko MC.","Eur J Pharmacol. 2014 Dec 15;745:182-9. doi: 10.1016/j.ejphar.2014.10.029. Epub 2014 Oct 29.","Sukhtankar DD","Eur J Pharmacol","2014","2014/12/03","PMC4259829","NIHMS643312","10.1016/j.ejphar.2014.10.029"
"25446206","The opioid system contributes to the acquisition of reinforcement for dietary fat but is not required for its maintenance","Sakamoto K, Matsumura S, Okafuji Y, Eguchi A, Yoneda T, Mizushige T, Tsuzuki S, Inoue K, Fushiki T.","Physiol Behav. 2015 Jan;138:227-35. doi: 10.1016/j.physbeh.2014.11.001. Epub 2014 Nov 6.","Sakamoto K","Physiol Behav","2015","2014/12/03","","","10.1016/j.physbeh.2014.11.001"
"25445974","Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: fabrication, mechanical properties, mucoadhesion, tolerability and stability studies","Abdelkader H, Pierscionek B, Alany RG.","Int J Pharm. 2014 Dec 30;477(1-2):631-42. doi: 10.1016/j.ijpharm.2014.10.069. Epub 2014 Nov 4.","Abdelkader H","Int J Pharm","2014","2014/12/03","","","10.1016/j.ijpharm.2014.10.069"
"25445079","Posttraumatic stress disorder and alcohol dependence: does order of onset make a difference?","McLean CP, Su YJ, Foa EB.","J Anxiety Disord. 2014 Dec;28(8):894-901. doi: 10.1016/j.janxdis.2014.09.023. Epub 2014 Oct 16.","McLean CP","J Anxiety Disord","2014","2014/12/03","","","10.1016/j.janxdis.2014.09.023"
"25442314","Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery","Eldridge JA, Milewski M, Stinchcomb AL, Crooks PA.","Bioorg Med Chem Lett. 2014 Nov 15;24(22):5212-5. doi: 10.1016/j.bmcl.2014.09.072. Epub 2014 Oct 2.","Eldridge JA","Bioorg Med Chem Lett","2014","2014/12/03","PMC4254627","NIHMS632649","10.1016/j.bmcl.2014.09.072"
"25442002","A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice","Bilbao A, Robinson JE, Heilig M, Malanga CJ, Spanagel R, Sommer WH, Thorsell A.","Biol Psychiatry. 2015 May 15;77(10):850-8. doi: 10.1016/j.biopsych.2014.08.021. Epub 2014 Sep 8.","Bilbao A","Biol Psychiatry","2015","2014/12/03","","","10.1016/j.biopsych.2014.08.021"
"25434595","Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird","Rubio MA.","Endocrinol Nutr. 2014 Dec;61(10):501-4. doi: 10.1016/j.endonu.2014.11.002.","Rubio MA","Endocrinol Nutr","2014","2014/12/02","","","10.1016/j.endonu.2014.11.002"
"25421512","Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging","Mann K, Vollstädt-Klein S, Reinhard I, Leménager T, Fauth-Bühler M, Hermann D, Hoffmann S, Zimmermann US, Kiefer F, Heinz A, Smolka MN.","Alcohol Clin Exp Res. 2014 Nov;38(11):2754-62. doi: 10.1111/acer.12546.","Mann K","Alcohol Clin Exp Res","2014","2014/11/26","","","10.1111/acer.12546"
"25421416","[Low dose naltrexone in the treatment of dissociative symptoms]","Pape W, Wöller W.","Nervenarzt. 2015 Mar;86(3):346-51. doi: 10.1007/s00115-014-4015-9.","Pape W","Nervenarzt","2015","2014/11/26","","","10.1007/s00115-014-4015-9"
"25418525","Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out","Citrome L.","Int J Clin Pract. 2014 Dec;68(12):1401-5. doi: 10.1111/ijcp.12587.","Citrome L","Int J Clin Pract","2014","2014/11/25","","","10.1111/ijcp.12587"
"25417789","Brainstem opioidergic system is involved in early response to experimental SAH","Cetas JS, McFarlane R, Kronfeld K, Smitasin P, Liu JJ, Raskin JS.","Transl Stroke Res. 2015 Apr;6(2):140-7. doi: 10.1007/s12975-014-0378-2. Epub 2014 Nov 25.","Cetas JS","Transl Stroke Res","2015","2014/11/25","","","10.1007/s12975-014-0378-2"
"25415192","Delta opioid receptors: the link between exercise and cardioprotection","Borges JP, Verdoorn KS, Daliry A, Powers SK, Ortenzi VH, Fortunato RS, Tibiriçá E, Lessa MA.","PLoS One. 2014 Nov 21;9(11):e113541. doi: 10.1371/journal.pone.0113541. eCollection 2014.","Borges JP","PLoS One","2014","2014/11/22","PMC4240613","","10.1371/journal.pone.0113541"
"25410894","Genetic polymorphisms and response to medications for alcohol use disorders: a systematic review and meta-analysis","Jonas DE, Amick HR, Feltner C, Wines R, Shanahan E, Rowe CJ, Garbutt JC.","Pharmacogenomics. 2014 Sep;15(13):1687-700. doi: 10.2217/pgs.14.121.","Jonas DE","Pharmacogenomics","2014","2014/11/21","","","10.2217/pgs.14.121"
"25392958","Treatment of alcohol dependence: recent progress and reduction of consumption","Testino G, Leone S, Borro P.","Minerva Med. 2014 Dec;105(6):447-66.","Testino G","Minerva Med","2014","2014/11/14","","",""
"25387448","Cerebral Networks Linked to Itch-related Sensations Induced by Histamine and Capsaicin","Vierow V, Forster C, Vogelgsang R, Dörfler A, Handwerker HO.","Acta Derm Venereol. 2015 Jul;95(6):645-52. doi: 10.2340/00015555-2006.","Vierow V","Acta Derm Venereol","2015","2014/11/13","","","10.2340/00015555-2006"
"25381183","Alleviating waiting impulsivity and perseverative responding by μ-opioid receptor antagonism in two inbred mouse strains","Sanchez-Roige S, Ripley TL, Stephens DN.","Psychopharmacology (Berl). 2015 Apr;232(8):1483-92. doi: 10.1007/s00213-014-3786-9. Epub 2014 Nov 8.","Sanchez-Roige S","Psychopharmacology (Berl)","2015","2014/11/09","","","10.1007/s00213-014-3786-9"
"25375267","Neuroprotection of nalmefene for postoperative patients with spontaneous intracerebral hemorrhage","Zheng J, Li H, Guo R, Chen R, Lin S, Liu M, You C.","Int J Neurosci. 2015;125(12):918-23. doi: 10.3109/00207454.2014.985294. Epub 2014 Dec 3.","Zheng J","Int J Neurosci","2015","2014/11/07","","","10.3109/00207454.2014.985294"
"25372849","Contrave--a combination of bupropion and naltrexone for weight loss","","Med Lett Drugs Ther. 2014 Nov 10;56(1455):112-4.","","Med Lett Drugs Ther","2014","2014/11/06","","",""
"25359257","Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings","Fredriksson I, Jayaram-Lindström N, Wirf M, Nylander E, Nyström E, Jardemark K, Steensland P.","Neuropsychopharmacology. 2015 Mar 13;40(5):1130-40. doi: 10.1038/npp.2014.294.","Fredriksson I","Neuropsychopharmacology","2015","2014/11/01","PMC4367455","","10.1038/npp.2014.294"
"25347242","[Therapy in heroin addiction]","Hosztafi S, Fürst Z.","Neuropsychopharmacol Hung. 2014 Sep;16(3):127-40.","Hosztafi S","Neuropsychopharmacol Hung","2014","2014/10/28","","",""
"25346506","In with the old and out with the new? A comparison of the old and new binge drinking standards","Corbin WR, Zalewski S, Leeman RF, Toll BA, Fucito LM, O'Malley SS.","Alcohol Clin Exp Res. 2014 Oct;38(10):2657-63. doi: 10.1111/acer.12514.","Corbin WR","Alcohol Clin Exp Res","2014","2014/10/28","","","10.1111/acer.12514"
"25346505","Predictors of abstinence from heavy drinking during treatment in COMBINE and external validation in PREDICT","Gueorguieva R, Wu R, O'Connor PG, Weisner C, Fucito LM, Hoffmann S, Mann K, O'Malley SS.","Alcohol Clin Exp Res. 2014 Oct;38(10):2647-2656. doi: 10.1111/acer.12541.","Gueorguieva R","Alcohol Clin Exp Res","2014","2014/10/28","PMC4397985","NIHMS677602","10.1111/acer.12541"
"25335648","Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking","Fridberg DJ, Cao D, Grant JE, King AC.","Alcohol Clin Exp Res. 2014 Oct;38(10):2622-9. doi: 10.1111/acer.12513. Epub 2014 Oct 21.","Fridberg DJ","Alcohol Clin Exp Res","2014","2014/10/23","PMC4638321","NIHMS733984","10.1111/acer.12513"
"25325878","Role of naltrexone in management of behavioral outbursts in an adolescent male diagnosed with disruptive mood dysregulation disorder","Parmar A, Vats D, Parmar R, Aligeti M.","J Child Adolesc Psychopharmacol. 2014 Dec;24(10):594-5. doi: 10.1089/cap.2014.0072.","Parmar A","J Child Adolesc Psychopharmacol","2014","2014/10/18","","","10.1089/cap.2014.0072"
"25325292","Interaction of the adenosine A1 receptor agonist N6-cyclopentyladenosine and κ-opioid receptors in rat spinal cord nociceptive reflexes","Ramos-Zepeda GA, Herrero-Zorita C, Herrero JF.","Behav Pharmacol. 2014 Dec;25(8):741-9. doi: 10.1097/FBP.0000000000000091.","Ramos-Zepeda GA","Behav Pharmacol","2014","2014/10/18","","","10.1097/FBP.0000000000000091"
"25310199","Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study","Murphy BL, Ravichandran C, Babb SM, Cohen BM.","J Clin Psychopharmacol. 2014 Dec;34(6):749-51. doi: 10.1097/JCP.0000000000000222.","Murphy BL","J Clin Psychopharmacol","2014","2014/10/14","","","10.1097/JCP.0000000000000222"
"25307867","Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids","Goutier W, Kloeze M, McCreary AC.","Addict Biol. 2016 Mar;21(2):234-41. doi: 10.1111/adb.12190. Epub 2014 Oct 13.","Goutier W","Addict Biol","2016","2014/10/14","","","10.1111/adb.12190"
"25307594","Pharmacologic treatment of alcoholism","Anton RF, Schacht JP, Book SW.","Handb Clin Neurol. 2014;125:527-42. doi: 10.1016/B978-0-444-62619-6.00030-6.","Anton RF","Handb Clin Neurol","2014","2014/10/14","","","10.1016/B978-0-444-62619-6.00030-6"
"25302627","Excess mortality among opioid-using patients treated with oral naltrexone in Australia","Degenhardt L, Larney S, Kimber J, Farrell M, Hall W.","Drug Alcohol Rev. 2015 Jan;34(1):90-6. doi: 10.1111/dar.12205. Epub 2014 Oct 10.","Degenhardt L","Drug Alcohol Rev","2015","2014/10/11","","","10.1111/dar.12205"
"25297905","κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain","Megat S, Bohren Y, Doridot S, Gaveriaux-Ruff C, Kieffer BL, Freund-Mercier MJ, Yalcin I, Barrot M.","Br J Pharmacol. 2015 Feb;172(4):1034-44. doi: 10.1111/bph.12963. Epub 2014 Dec 1.","Megat S","Br J Pharmacol","2015","2014/10/10","PMC4314193","","10.1111/bph.12963"
"25294031","[Alcohol use disorders in elderly people calls for treatment]","Wieben ES, Nielsen B, Nielsen AS, Andersen K.","Ugeskr Laeger. 2014 Sep 8;176(37):V11130693.","Wieben ES","Ugeskr Laeger","2014","2014/10/09","","",""
"25287870","Decision to recommend drug to cut drink dependence proves controversial","Wise J.","BMJ. 2014 Oct 5;349:g6054. doi: 10.1136/bmj.g6054.","Wise J","BMJ","2014","2014/10/08","","","10.1136/bmj.g6054"
"25282750","[Drug therapy supports reduction of alcohol consumption]","Oetzel S.","Med Monatsschr Pharm. 2014 Sep;37(9):339-40.","Oetzel S","Med Monatsschr Pharm","2014","2014/10/07","","",""
"25271655","Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders","Park TW, Friedmann PD.","R I Med J (2013). 2014 Oct 1;97(10):20-4.","Park TW","R I Med J (2013)","2014","2014/10/02","PMC4406629","NIHMS677839",""
"25262980","Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice","Hwa LS, Shimamoto A, Kayyali T, Norman KJ, Valentino RJ, DeBold JF, Miczek KA.","Addict Biol. 2016 Jan;21(1):111-24. doi: 10.1111/adb.12189. Epub 2014 Sep 28.","Hwa LS","Addict Biol","2016","2014/09/30","PMC4377124","NIHMS627086","10.1111/adb.12189"
"25258511","Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date","Caixàs A, Albert L, Capel I, Rigla M.","Drug Des Devel Ther. 2014 Sep 18;8:1419-27. doi: 10.2147/DDDT.S55587. eCollection 2014.","Caixàs A","Drug Des Devel Ther","2014","2014/09/27","PMC4174046","","10.2147/DDDT.S55587"
"25251201","A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence","Pettinati HM, Kampman KM, Lynch KG, Dundon WD, Mahoney EM, Wierzbicki MR, O'Brien CP.","Am J Addict. 2014 Nov-Dec;23(6):591-7. doi: 10.1111/j.1521-0391.2014.12146.x. Epub 2014 Sep 22.","Pettinati HM","Am J Addict","2014","2014/09/25","","","10.1111/j.1521-0391.2014.12146.x"
"25245060","Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats","Leitl MD, Potter DN, Cheng K, Rice KC, Carlezon WA Jr, Negus SS.","Mol Pain. 2014 Sep 23;10:62. doi: 10.1186/1744-8069-10-62.","Leitl MD","Mol Pain","2014","2014/09/24","PMC4180532","","10.1186/1744-8069-10-62"
"25240704","Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community","Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA.","Contemp Clin Trials. 2014 Nov;39(2):256-68. doi: 10.1016/j.cct.2014.09.002. Epub 2014 Sep 18.","Di Paola A","Contemp Clin Trials","2014","2014/09/22","PMC4283549","NIHMS629218","10.1016/j.cct.2014.09.002"
"25239213","The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol","Dennis BB, Naji L, Bawor M, Bonner A, Varenbut M, Daiter J, Plater C, Pare G, Marsh DC, Worster A, Desai D, Samaan Z, Thabane L.","Syst Rev. 2014 Sep 19;3:105. doi: 10.1186/2046-4053-3-105.","Dennis BB","Syst Rev","2014","2014/09/21","PMC4171401","","10.1186/2046-4053-3-105"
"25230208","Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats","Guy EG, Fisher DC, Higgins GA, Fletcher PJ.","Behav Pharmacol. 2014 Dec;25(8):775-83. doi: 10.1097/FBP.0000000000000092.","Guy EG","Behav Pharmacol","2014","2014/09/18","","","10.1097/FBP.0000000000000092"
"25228120","A predictive microsimulation model to estimate the clinical relevance of reducing alcohol consumption in alcohol dependence","François C, Laramée P, Rahhali N, Chalem Y, Aballéa S, Millier A, Bineau S, Toumi M, Rehm J.","Eur Addict Res. 2014;20(6):269-84. doi: 10.1159/000362408. Epub 2014 Sep 16.","François C","Eur Addict Res","2014","2014/09/18","","","10.1159/000362408"
"25227627","The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model","Laramée P, Brodtkorb TH, Rahhali N, Knight C, Barbosa C, François C, Toumi M, Daeppen JB, Rehm J.","BMJ Open. 2014 Sep 16;4(9):e005376. doi: 10.1136/bmjopen-2014-005376.","Laramée P","BMJ Open","2014","2014/09/18","PMC4166142","","10.1136/bmjopen-2014-005376"
"25223901","Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit","Cunningham JW, Wiviott SD.","Clin Cardiol. 2014 Nov;37(11):693-9. doi: 10.1002/clc.22304. Epub 2014 Sep 15.","Cunningham JW","Clin Cardiol","2014","2014/09/17","PMC6649490","","10.1002/clc.22304"
"25217253","Epigenetic regulation of spinal cord gene expression controls opioid-induced hyperalgesia","Liang DY, Sun Y, Shi XY, Sahbaie P, Clark JD.","Mol Pain. 2014 Sep 12;10:59. doi: 10.1186/1744-8069-10-59.","Liang DY","Mol Pain","2014","2014/09/14","PMC4171542","","10.1186/1744-8069-10-59"
"25217046","Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds","Hendershot CS.","Addict Sci Clin Pract. 2014 Sep 13;9(1):20. doi: 10.1186/1940-0640-9-20.","Hendershot CS","Addict Sci Clin Pract","2014","2014/09/14","PMC4165632","","10.1186/1940-0640-9-20"
"25216068","Sexual performance and precontact 50-kHz ultrasonic vocalizations in WAG/Rij rats: effects of opioid receptor treatment","Bialy M, Strefnel M, Nikolaev-Diak A, Socha A, Nikolaev E, Boguszewski PM.","Epilepsy Behav. 2014 Oct;39:66-72. doi: 10.1016/j.yebeh.2014.08.003. Epub 2014 Sep 13.","Bialy M","Epilepsy Behav","2014","2014/09/13","","","10.1016/j.yebeh.2014.08.003"
"25198217","Evolving directions in obesity management","Aronne LJ.","J Fam Pract. 2014 Jul;63(7 Suppl):S27-33.","Aronne LJ","J Fam Pract","2014","2014/09/09","","",""
"25186835","Activation of κ-opioid receptor exerts the glucose-homeostatic effect in streptozotocin-induced diabetic mice","Shang Y, Guo F, Li J, Fan R, Ma X, Wang Y, Feng N, Yin Y, Jia M, Zhang S, Zhou J, Wang H, Pei J.","J Cell Biochem. 2015 Feb;116(2):252-9. doi: 10.1002/jcb.24962.","Shang Y","J Cell Biochem","2015","2014/09/05","","","10.1002/jcb.24962"
"25185350","Informed consent abandoned--patient given contraindicated drug","Gregg M, Martinez L, Samaritan G.","J Med Assoc Ga. 2014;103(2):22.","Gregg M","J Med Assoc Ga","2014","2014/09/05","","",""
"25183508","Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice","Moslehi A, Nabavizadeh F, Dehpour AR, Tavanga SM, Hassanzadeh G, Zekri A, Nahrevanian H, Sohanaki H.","Acta Physiol Hung. 2014 Sep;101(3):341-52. doi: 10.1556/APhysiol.101.2014.3.9.","Moslehi A","Acta Physiol Hung","2014","2014/09/04","","","10.1556/APhysiol.101.2014.3.9"
"25182664","Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans","Naganawa M, Zheng MQ, Nabulsi N, Tomasi G, Henry S, Lin SF, Ropchan J, Labaree D, Tauscher J, Neumeister A, Carson RE, Huang Y.","J Cereb Blood Flow Metab. 2014 Nov;34(11):1818-25. doi: 10.1038/jcbfm.2014.150. Epub 2014 Sep 3.","Naganawa M","J Cereb Blood Flow Metab","2014","2014/09/04","PMC4269759","","10.1038/jcbfm.2014.150"
"25178815","Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice","Falcon E, Maier K, Robinson SA, Hill-Smith TE, Lucki I.","Psychopharmacology (Berl). 2015 Mar;232(5):907-15. doi: 10.1007/s00213-014-3723-y. Epub 2014 Sep 3.","Falcon E","Psychopharmacology (Berl)","2015","2014/09/03","PMC4326609","NIHMS625278","10.1007/s00213-014-3723-y"
"25151304","Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle","Liu YP, Huang TS, Tung CS, Lin CC.","Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:81-90. doi: 10.1016/j.pnpbp.2014.08.007. Epub 2014 Aug 21.","Liu YP","Prog Neuropsychopharmacol Biol Psychiatry","2015","2014/08/25","","","10.1016/j.pnpbp.2014.08.007"
"25147168","Off-label uses of alvimopan and methylnaltrexone","Rodriguez RW.","Am J Health Syst Pharm. 2014 Sep 1;71(17):1450-5. doi: 10.2146/ajhp130632.","Rodriguez RW","Am J Health Syst Pharm","2014","2014/08/23","","","10.2146/ajhp130632"
"25134047","Employment-based reinforcement of adherence to oral naltrexone in unemployed injection drug users: 12-month outcomes","Dunn K, DeFulio A, Everly JJ, Donlin WD, Aklin WM, Nuzzo PA, Leoutsakos JM, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.","Psychol Addict Behav. 2015 Jun;29(2):270-6. doi: 10.1037/adb0000010. Epub 2014 Aug 18.","Dunn K","Psychol Addict Behav","2015","2014/08/19","PMC4339630","NIHMS663882","10.1037/adb0000010"
"25121147","Nalmefene. Alcohol dependence: no advance","","Prescrire Int. 2014 Jun;23(150):150-2.","","Prescrire Int","2014","2014/08/15","","",""
"25117849","Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers","Bujarski S, Ray LA.","Addict Behav. 2014 Dec;39(12):1723-9. doi: 10.1016/j.addbeh.2014.07.019. Epub 2014 Jul 22.","Bujarski S","Addict Behav","2014","2014/08/14","","","10.1016/j.addbeh.2014.07.019"
"25113330","[Therapy of prurigo nodularis]","Zeidler C, Ständer S.","Hautarzt. 2014 Aug;65(8):709-13. doi: 10.1007/s00105-014-2757-8.","Zeidler C","Hautarzt","2014","2014/08/13","","","10.1007/s00105-014-2757-8"
"25102328","A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept","Tek C, Ratliff J, Reutenauer E, Ganguli R, O'Malley SS.","J Clin Psychopharmacol. 2014 Oct;34(5):608-12. doi: 10.1097/JCP.0000000000000192.","Tek C","J Clin Psychopharmacol","2014","2014/08/08","PMC4149840","NIHMS609025","10.1097/JCP.0000000000000192"
"25101542","The effects of nucleus accumbens μ-opioid and adenosine 2A receptor stimulation and blockade on instrumental learning","Clissold KA, Pratt WE.","Behav Brain Res. 2014 Nov 1;274:84-94. doi: 10.1016/j.bbr.2014.07.047. Epub 2014 Aug 4.","Clissold KA","Behav Brain Res","2014","2014/08/08","PMC4181594","NIHMS620507","10.1016/j.bbr.2014.07.047"
"25100293","Overview of new antiobesity drugs","Hainer V.","Expert Opin Pharmacother. 2014 Oct;15(14):1975-8. doi: 10.1517/14656566.2014.946904. Epub 2014 Aug 6.","Hainer V","Expert Opin Pharmacother","2014","2014/08/08","","","10.1517/14656566.2014.946904"
"25098969","What happens when people discontinue taking medications? Lessons from COMBINE","Stout RL, Braciszewski JM, Subbaraman MS, Kranzler HR, O'Malley SS, Falk D; ACTIVE group.","Addiction. 2014 Dec;109(12):2044-52. doi: 10.1111/add.12700. Epub 2014 Sep 12.","Stout RL","Addiction","2014","2014/08/08","PMC4254710","NIHMS638949","10.1111/add.12700"
"25096956","Tolerability and safety of the new anti-obesity medications","Hainer V, Aldhoon-Hainerová I.","Drug Saf. 2014 Sep;37(9):693-702. doi: 10.1007/s40264-014-0206-3.","Hainer V","Drug Saf","2014","2014/08/07","","","10.1007/s40264-014-0206-3"
"25093831","Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene","Wieskopf JS, Pan YX, Marcovitz J, Tuttle AH, Majumdar S, Pidakala J, Pasternak GW, Mogil JS.","Pain. 2014 Oct;155(10):2063-70. doi: 10.1016/j.pain.2014.07.014. Epub 2014 Aug 2.","Wieskopf JS","Pain","2014","2014/08/06","PMC4372857","NIHMS618878","10.1016/j.pain.2014.07.014"
"25092049","Fabrication of a novel naltrexone biosensor based on a computationally engineered nanobiocomposite","Gholivand MB, Jalalvand AR, Paimard G, Goicoechea HC, Skov T, Farhadi R, Ghobadi S, Moradi N, Nasirian V.","Int J Biol Macromol. 2014 Sep;70:596-605. doi: 10.1016/j.ijbiomac.2014.07.028. Epub 2014 Aug 1.","Gholivand MB","Int J Biol Macromol","2014","2014/08/06","","","10.1016/j.ijbiomac.2014.07.028"
"25090615","Opposite effects of neuropeptide FF on central antinociception induced by endomorphin-1 and endomorphin-2 in mice","Wang ZL, Fang Q, Han ZL, Pan JX, Li XH, Li N, Tang HH, Wang P, Zheng T, Chang XM, Wang R.","PLoS One. 2014 Aug 4;9(8):e103773. doi: 10.1371/journal.pone.0103773. eCollection 2014.","Wang ZL","PLoS One","2014","2014/08/05","PMC4121275","","10.1371/journal.pone.0103773"
"25086835","Salsolinol, free of isosalsolinol, exerts ethanol-like motivational/sensitization effects leading to increases in ethanol intake","Quintanilla ME, Rivera-Meza M, Berrios-Cárcamo PA, Bustamante D, Buscaglia M, Morales P, Karahanian E, Herrera-Marschitz M, Israel Y.","Alcohol. 2014 Sep;48(6):551-9. doi: 10.1016/j.alcohol.2014.07.003. Epub 2014 Jul 14.","Quintanilla ME","Alcohol","2014","2014/08/04","","","10.1016/j.alcohol.2014.07.003"
"25070809","5-HTTLPR moderates naltrexone and psychosocial treatment responses in heavy drinking men who have sex with men","Chen AC, Davis CM, Kahler CW, Kuerbis AN, Covault J, Kranzler HR, Morgenstern J.","Alcohol Clin Exp Res. 2014 Sep;38(9):2362-8. doi: 10.1111/acer.12492. Epub 2014 Jul 28.","Chen AC","Alcohol Clin Exp Res","2014","2014/07/30","PMC4177453","NIHMS598195","10.1111/acer.12492"
"25069013","Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats","Avena NM, Bocarsly ME, Murray S, Gold MS.","Exp Clin Psychopharmacol. 2014 Oct;22(5):460-7. doi: 10.1037/a0037223. Epub 2014 Jul 28.","Avena NM","Exp Clin Psychopharmacol","2014","2014/07/29","","","10.1037/a0037223"
"25069012","A new look at risk-taking: using a translational approach to examine risk-taking behavior on the balloon analogue risk task","DeMartini KS, Leeman RF, Corbin WR, Toll BA, Fucito LM, Lejuez CW, O'Malley SS.","Exp Clin Psychopharmacol. 2014 Oct;22(5):444-52. doi: 10.1037/a0037421. Epub 2014 Jul 28.","DeMartini KS","Exp Clin Psychopharmacol","2014","2014/07/29","PMC4392709","NIHMS608551","10.1037/a0037421"
"25066321","Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors","Liang J, Olsen RW.","Acta Pharmacol Sin. 2014 Aug;35(8):981-93. doi: 10.1038/aps.2014.50.","Liang J","Acta Pharmacol Sin","2014","2014/07/29","PMC4125717","","10.1038/aps.2014.50"
"25065832","Involvement of μ- and δ-opioid receptor function in the rewarding effect of (±)-pentazocine","Mori T, Itoh T, Yoshizawa K, Ise Y, Mizuo K, Saeki T, Komiya S, Masukawa D, Shibasaki M, Suzuki T.","Addict Biol. 2015 Jul;20(4):724-32. doi: 10.1111/adb.12169. Epub 2014 Jul 27.","Mori T","Addict Biol","2015","2014/07/29","","","10.1111/adb.12169"
"25065344","Naltrexone as a diagnostic tool to distinguish between hyperandrogenemic and hypothalamic ovarian failure in females with congenital adrenal hyperplasia due to 21-hydroxylase-deficiency (CAH)","Böttcher B, Dörr HG, Wildt L.","Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:153-6. doi: 10.1016/j.ejogrb.2014.06.007. Epub 2014 Jun 24.","Böttcher B","Eur J Obstet Gynecol Reprod Biol","2014","2014/07/29","","","10.1016/j.ejogrb.2014.06.007"
"25052197","δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes","Liang J, Chao D, Sandhu HK, Yu Y, Zhang L, Balboni G, Kim DH, Xia Y.","Br J Pharmacol. 2014 Dec;171(23):5417-30. doi: 10.1111/bph.12857.","Liang J","Br J Pharmacol","2014","2014/07/24","PMC4294049","","10.1111/bph.12857"
"25046272","Peripheral opioid receptor blockade increases postoperative morphine demands--a randomized, double-blind, placebo-controlled trial","Jagla C, Martus P, Stein C.","Pain. 2014 Oct;155(10):2056-62. doi: 10.1016/j.pain.2014.07.011. Epub 2014 Jul 18.","Jagla C","Pain","2014","2014/07/22","","","10.1016/j.pain.2014.07.011"
"25041200","Commentary on Garbutt et al. (2014): Can we predict who benefits from naltrexone in the treatment of alcohol dependence?","Kranzler HR.","Addiction. 2014 Aug;109(8):1285-6. doi: 10.1111/add.12618.","Kranzler HR","Addiction","2014","2014/07/22","PMC4154559","NIHMS597758","10.1111/add.12618"
"25037206","Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study","Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D.","Neurology. 2014 Aug 26;83(9):826-33. doi: 10.1212/WNL.0000000000000729. Epub 2014 Jul 18.","Papay K","Neurology","2014","2014/07/20","PMC4155050","","10.1212/WNL.0000000000000729"
"25030485","Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing","Immonen JA, Zagon IS, McLaughlin PJ.","Exp Biol Med (Maywood). 2014 Oct;239(10):1300-9. doi: 10.1177/1535370214543061. Epub 2014 Jul 16.","Immonen JA","Exp Biol Med (Maywood)","2014","2014/07/18","","","10.1177/1535370214543061"
"25020077","A novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium berghei","Shahabi S, Azizi H, Mazloomi E, Tappeh KH, Seyedi S, Mohammadzadeh H.","Immunol Invest. 2014;43(7):653-66. doi: 10.3109/08820139.2014.914531. Epub 2014 Jul 14.","Shahabi S","Immunol Invest","2014","2014/07/15","","","10.3109/08820139.2014.914531"
"24978316","Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects","Le Naour M, Lunzer MM, Powers MD, Kalyuzhny AE, Benneyworth MA, Thomas MJ, Portoghese PS.","J Med Chem. 2014 Aug 14;57(15):6383-92. doi: 10.1021/jm500159d. Epub 2014 Jul 18.","Le Naour M","J Med Chem","2014","2014/07/01","PMC4136663","","10.1021/jm500159d"
"24973897","The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours","Kelly E, Mundell SJ, Sava A, Roth AL, Felici A, Maltby K, Nathan PJ, Bullmore ET, Henderson G.","Psychopharmacology (Berl). 2015 Jan;232(1):305-14. doi: 10.1007/s00213-014-3666-3. Epub 2014 Jun 29.","Kelly E","Psychopharmacology (Berl)","2015","2014/06/30","PMC4281354","","10.1007/s00213-014-3666-3"
"24973366","GI relief may come sooner than later for patients with chronic noncancer pain","Thompson CA.","Am J Health Syst Pharm. 2014 Jul 15;71(14):1153-5. doi: 10.2146/news140049.","Thompson CA","Am J Health Syst Pharm","2014","2014/06/29","","","10.2146/news140049"
"24970924","Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA","Grinnell SG, Majumdar S, Narayan A, Le Rouzic V, Ansonoff M, Pintar JE, Pasternak GW.","J Pharmacol Exp Ther. 2014 Sep;350(3):710-8. doi: 10.1124/jpet.114.213199. Epub 2014 Jun 26.","Grinnell SG","J Pharmacol Exp Ther","2014","2014/06/28","PMC4152881","","10.1124/jpet.114.213199"
"24968803","Operant nociception in nonhuman primates","Kangas BD, Bergman J.","Pain. 2014 Sep;155(9):1821-8. doi: 10.1016/j.pain.2014.06.010. Epub 2014 Jun 23.","Kangas BD","Pain","2014","2014/06/28","PMC4157960","NIHMS608022","10.1016/j.pain.2014.06.010"
"24967470","Off-label, low-dose naltrexone for refractory chronic low back pain","Ghai B, Bansal D, Hota D, Shah CS.","Pain Med. 2014 May;15(5):883-4. doi: 10.1111/pme.12345.","Ghai B","Pain Med","2014","2014/06/27","","","10.1111/pme.12345"
"24958228","Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex","Latagliata EC, Valzania A, Pascucci T, Campus P, Cabib S, Puglisi-Allegra S.","Psychopharmacology (Berl). 2014 Oct;231(21):4099-108. doi: 10.1007/s00213-014-3549-7. Epub 2014 Mar 29.","Latagliata EC","Psychopharmacology (Berl)","2014","2014/06/25","","","10.1007/s00213-014-3549-7"
"24949564","Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings","Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED.","Am J Drug Alcohol Abuse. 2015 Jan;41(1):35-44. doi: 10.3109/00952990.2014.927881. Epub 2014 Jun 20.","Ray LA","Am J Drug Alcohol Abuse","2015","2014/06/21","PMC4365972","NIHMS669941","10.3109/00952990.2014.927881"
"24944865","The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats","Funk D, Coen K, Lê AD.","Brain Behav. 2014 May;4(3):356-67. doi: 10.1002/brb3.222. Epub 2014 Feb 17.","Funk D","Brain Behav","2014","2014/06/20","PMC4055186","","10.1002/brb3.222"
"24936803","Hypothalamic-pituitary-adrenal axis response to oral naltrexone in alcoholics during early withdrawal","Besirli A, Eşel E, Özsoy S, Turan T.","Pharmacopsychiatry. 2014 Jul;47(4-5):151-5. doi: 10.1055/s-0034-1381983. Epub 2014 Jun 17.","Besirli A","Pharmacopsychiatry","2014","2014/06/18","","","10.1055/s-0034-1381983"
"24935915","A Bayesian mixed-treatment comparison meta-analysis of treatments for alcohol dependence and implications for planning future trials","DeSantis SM, Zhu H.","Med Decis Making. 2014 Oct;34(7):899-910. doi: 10.1177/0272989X14537558. Epub 2014 Jun 16.","DeSantis SM","Med Decis Making","2014","2014/06/18","PMC4318856","NIHMS594092","10.1177/0272989X14537558"
"24923251","Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist","Taylor AM, Roberts KW, Pradhan AA, Akbari HA, Walwyn W, Lutfy K, Carroll FI, Cahill CM, Evans CJ.","Br J Pharmacol. 2015 Jan;172(2):691-703. doi: 10.1111/bph.12810. Epub 2014 Sep 5.","Taylor AM","Br J Pharmacol","2015","2014/06/14","PMC4292979","","10.1111/bph.12810"
"24920732","Effects of peripheral and spinal κ-opioid receptor stimulation on the exercise pressor reflex in decerebrate rats","Copp SW, Stone AJ, Yamauchi K, Kaufman MP.","Am J Physiol Regul Integr Comp Physiol. 2014 Aug 1;307(3):R281-9. doi: 10.1152/ajpregu.00156.2014. Epub 2014 Jun 11.","Copp SW","Am J Physiol Regul Integr Comp Physiol","2014","2014/06/13","PMC4121628","","10.1152/ajpregu.00156.2014"
"24919534","Repeated stress exposure causes strain-dependent shifts in the behavioral economics of cocaine in rats","Groblewski PA, Zietz C, Willuhn I, Phillips PE, Chavkin C.","Addict Biol. 2015 Mar;20(2):297-301. doi: 10.1111/adb.12123. Epub 2014 Feb 15.","Groblewski PA","Addict Biol","2015","2014/06/13","PMC4448949","NIHMS693510","10.1111/adb.12123"
"24918835","Nalmefene and its use in alcohol dependence","Gual A, Bruguera P, López-Pelayo H.","Drugs Today (Barc). 2014 May;50(5):347-55. doi: 10.1358/dot.2014.50.5.2132323.","Gual A","Drugs Today (Barc)","2014","2014/06/12","","","10.1358/dot.2014.50.5.2132323"
"24905513","Opioid modulation of prolactin secretion induced by stress during late pregnancy. Role of ovarian steroids","Valdez SR, Pennacchio GE, Gamboa DF, de Di Nasso EG, Bregonzio C, Soaje M.","Pharmacol Rep. 2014 Jun;66(3):386-93. doi: 10.1016/j.pharep.2013.12.006. Epub 2014 Apr 3.","Valdez SR","Pharmacol Rep","2014","2014/06/07","","","10.1016/j.pharep.2013.12.006"
"24902873","Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use","Kelty E, Hayes L, O'Neil G, Kyle S, Jeffrey GP, O'Neil G, Hendrie D, Mukhtar A, Hulse G.","J Psychopharmacol. 2014 Aug;28(8):745-50. doi: 10.1177/0269881114536791. Epub 2014 Jun 5.","Kelty E","J Psychopharmacol","2014","2014/06/07","","","10.1177/0269881114536791"
"24891526","Novel orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome","Sałaga M, Polepally PR, Sobczak M, Grzywacz D, Kamysz W, Sibaev A, Storr M, Do Rego JC, Zjawiony JK, Fichna J.","J Pharmacol Exp Ther. 2014 Jul;350(1):69-78. doi: 10.1124/jpet.114.214239.","Sałaga M","J Pharmacol Exp Ther","2014","2014/06/04","","","10.1124/jpet.114.214239"
"24886878","Nalmefene reverses carfentanil-induced loss of righting reflex and respiratory depression in rats","Yong Z, Gao X, Ma W, Dong H, Gong Z, Su R.","Eur J Pharmacol. 2014 Sep 5;738:153-7. doi: 10.1016/j.ejphar.2014.05.044. Epub 2014 Jun 2.","Yong Z","Eur J Pharmacol","2014","2014/06/03","","","10.1016/j.ejphar.2014.05.044"
"24871705","Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers","Zacny JP, Wroblewski K, Coalson DW.","Psychopharmacology (Berl). 2015 Jan;232(1):63-73. doi: 10.1007/s00213-014-3637-8. Epub 2014 May 29.","Zacny JP","Psychopharmacology (Berl)","2015","2014/05/30","PMC4295206","NIHMS599937","10.1007/s00213-014-3637-8"
"24866991","Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord","Kao JH, Gao MJ, Yang PP, Law PY, Loh HH, Tao PL.","Br J Pharmacol. 2015 Jan;172(2):630-41. doi: 10.1111/bph.12790.","Kao JH","Br J Pharmacol","2015","2014/05/29","PMC4292974","","10.1111/bph.12790"
"24863033","Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat","Ciccocioppo R, Stopponi S, Economidou D, Kuriyama M, Kinoshita H, Heilig M, Roberto M, Weiss F, Teshima K.","Neuropsychopharmacology. 2014 Oct;39(11):2601-10. doi: 10.1038/npp.2014.113. Epub 2014 Jun 27.","Ciccocioppo R","Neuropsychopharmacology","2014","2014/05/28","PMC4207340","","10.1038/npp.2014.113"
"24858375","Wistar rats acquire and maintain self-administration of 20 % ethanol without water deprivation, saccharin/sucrose fading, or extended access training","Augier E, Flanigan M, Dulman RS, Pincus A, Schank JR, Rice KC, Kejun C, Heilig M, Tapocik JD.","Psychopharmacology (Berl). 2014 Dec;231(23):4561-8. doi: 10.1007/s00213-014-3605-3. Epub 2014 May 25.","Augier E","Psychopharmacology (Berl)","2014","2014/05/27","PMC4988093","NIHMS806651","10.1007/s00213-014-3605-3"
"24854219","Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies","Hartung DM, McCarty D, Fu R, Wiest K, Chalk M, Gastfriend DR.","J Subst Abuse Treat. 2014 Aug;47(2):113-21. doi: 10.1016/j.jsat.2014.03.007. Epub 2014 Apr 13.","Hartung DM","J Subst Abuse Treat","2014","2014/05/24","PMC4110954","NIHMS603325","10.1016/j.jsat.2014.03.007"
"24851030","Difference of the naltrexone's effects in social drinkers by spicy food preference","Lee JS, Kim SG, Jeong HJ, Kim JH, Yang YH, Jung WY.","J Korean Med Sci. 2014 May;29(5):714-8. doi: 10.3346/jkms.2014.29.5.714. Epub 2014 Apr 25.","Lee JS","J Korean Med Sci","2014","2014/05/23","PMC4024942","","10.3346/jkms.2014.29.5.714"
"24846619","Harm reduction with pharmacotherapy for homeless people with alcohol dependence: protocol for a randomized controlled trial","Collins SE, Saxon AJ, Duncan MH, Smart BF, Merrill JO, Malone DK, Jackson TR, Clifasefi SL, Joesch J, Ries RK.","Contemp Clin Trials. 2014 Jul;38(2):221-34. doi: 10.1016/j.cct.2014.05.008. Epub 2014 May 17.","Collins SE","Contemp Clin Trials","2014","2014/05/22","PMC4104260","NIHMS597220","10.1016/j.cct.2014.05.008"
"24844744","Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242","Naganawa M, Jacobsen LK, Zheng MQ, Lin SF, Banerjee A, Byon W, Weinzimmer D, Tomasi G, Nabulsi N, Grimwood S, Badura LL, Carson RE, McCarthy TJ, Huang Y.","Neuroimage. 2014 Oct 1;99:69-79. doi: 10.1016/j.neuroimage.2014.05.033. Epub 2014 May 17.","Naganawa M","Neuroimage","2014","2014/05/22","PMC4140089","NIHMS606459","10.1016/j.neuroimage.2014.05.033"
"24835677","Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information","Zhao X, Perez-Aguilar JM, Matsunaga F, Lerner M, Xi J, Selling B, Johnson AT Jr, Saven JG, Liu R.","Anesthesiology. 2014 Oct;121(4):866-75. doi: 10.1097/ALN.0000000000000308.","Zhao X","Anesthesiology","2014","2014/05/20","PMC4175066","NIHMS592230","10.1097/ALN.0000000000000308"
"24825644","Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC.","JAMA. 2014 May 14;311(18):1889-900. doi: 10.1001/jama.2014.3628.","Jonas DE","JAMA","2014","2014/05/15","","","10.1001/jama.2014.3628"
"24819092","Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking","Ong EW, Xue L, Olmstead MC, Cahill CM.","Br J Pharmacol. 2015 Jan;172(2):615-29. doi: 10.1111/bph.12761. Epub 2014 Jul 1.","Ong EW","Br J Pharmacol","2015","2014/05/14","PMC4292973","","10.1111/bph.12761"
"24817033","Potent inhibition of alcohol self-administration in alcohol-preferring rats by a κ-opioid receptor antagonist","Cashman JR, Azar MR.","J Pharmacol Exp Ther. 2014 Jul;350(1):171-80. doi: 10.1124/jpet.114.214262. Epub 2014 May 9.","Cashman JR","J Pharmacol Exp Ther","2014","2014/05/13","PMC4056268","","10.1124/jpet.114.214262"
"24815199","Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials","Nalamachu SR, Pergolizzi J, Taylor R Jr, Slatkin NE, Barrett AC, Yu J, Bortey E, Paterson C, Forbes WP.","Pain Pract. 2015 Jul;15(6):564-71. doi: 10.1111/papr.12218. Epub 2014 May 10.","Nalamachu SR","Pain Pract","2015","2014/05/13","","","10.1111/papr.12218"
"24813545","Use of naltrexone in ketamine dependence","Garg A, Sinha P, Kumar P, Prakash O.","Addict Behav. 2014 Aug;39(8):1215-6. doi: 10.1016/j.addbeh.2014.04.004. Epub 2014 Apr 13.","Garg A","Addict Behav","2014","2014/05/13","","","10.1016/j.addbeh.2014.04.004"
"24813527","Opioid receptors in the prelimbic cortex modulate restraint stress-induced cardiovascular responses in the rat","Fassini A, Scopinho AA, Resstel LB, Correa FM.","Neuropharmacology. 2014 Oct;85:367-74. doi: 10.1016/j.neuropharm.2014.04.019. Epub 2014 May 6.","Fassini A","Neuropharmacology","2014","2014/05/13","","","10.1016/j.neuropharm.2014.04.019"
"24812024","Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease","O'Malley SS, Wu R, Mayne ST, Jatlow PI.","Nicotine Tob Res. 2014 Aug;16(8):1145-9. doi: 10.1093/ntr/ntu067. Epub 2014 May 8.","O'Malley SS","Nicotine Tob Res","2014","2014/05/10","PMC4155425","","10.1093/ntr/ntu067"
"24809337","▼Nalmefene for alcohol dependence","","Drug Ther Bull. 2014 May;52(5):54-7. doi: 10.1136/dtb.2014.5.0252. Epub 2014 May 8.","","Drug Ther Bull","2014","2014/05/10","","","10.1136/dtb.2014.5.0252"
"24796820","Brief prenatal ethanol exposure alters behavioral sensitivity to the kappa opioid receptor agonist (U62,066E) and antagonist (Nor-BNI) and reduces kappa opioid receptor expression","Nizhnikov ME, Pautassi RM, Carter JM, Landin JD, Varlinskaya EI, Bordner KA, Werner DF, Spear NE.","Alcohol Clin Exp Res. 2014 Jun;38(6):1630-8. doi: 10.1111/acer.12416. Epub 2014 May 5.","Nizhnikov ME","Alcohol Clin Exp Res","2014","2014/05/07","","","10.1111/acer.12416"
"24796150","[Cutting-edge of medicine; the prospects of novel anti-obesity drugs]","Ueno H, Nakazato M.","Nihon Naika Gakkai Zasshi. 2014 Mar 10;103(3):753-9. doi: 10.2169/naika.103.753.","Ueno H","Nihon Naika Gakkai Zasshi","2014","2014/05/07","","","10.2169/naika.103.753"
"24785762","Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities: Abridged republication of a Cochrane systematic review","Gormez A, Rana F, Varghese S.","J Psychopharmacol. 2014 Jul;28(7):624-32. doi: 10.1177/0269881114531665. Epub 2014 Apr 30.","Gormez A","J Psychopharmacol","2014","2014/05/03","","","10.1177/0269881114531665"
"24785567","Ex vivo studies for the passive transdermal delivery of low-dose naltrexone from a cream; detection of naltrexone and its active metabolite, 6β-naltrexol, using a novel LC Q-ToF MS assay","Dodou K, Armstrong A, Kelly I, Wilkinson S, Carr K, Shattock P, Whiteley P.","Pharm Dev Technol. 2015;20(6):694-701. doi: 10.3109/10837450.2014.915569. Epub 2014 May 2.","Dodou K","Pharm Dev Technol","2015","2014/05/03","","","10.3109/10837450.2014.915569"
"24779575","Extended-release naltrexone and harm reduction counseling for chronically homeless people with alcohol dependence","Collins SE, Duncan MH, Smart BF, Saxon AJ, Malone DK, Jackson TR, Ries RK.","Subst Abus. 2015;36(1):21-33. doi: 10.1080/08897077.2014.904838. Epub 2015 Jan 22.","Collins SE","Subst Abus","2015","2014/05/01","","","10.1080/08897077.2014.904838"
"24777492","Detoxification treatments for opiate dependent adolescents","Minozzi S, Amato L, Bellisario C, Davoli M.","Cochrane Database Syst Rev. 2014 Apr 29;(4):CD006749. doi: 10.1002/14651858.CD006749.pub3.","Minozzi S","Cochrane Database Syst Rev","2014","2014/04/30","","","10.1002/14651858.CD006749.pub3"
"24773391","Synthesis of enantiopure 10-nornaltrexones in the search for Toll-like receptor 4 antagonists and opioid ligands","Selfridge BR, Deschamps JR, Jacobson AE, Rice KC.","J Org Chem. 2014 Jun 6;79(11):5007-18. doi: 10.1021/jo500568s. Epub 2014 May 6.","Selfridge BR","J Org Chem","2014","2014/04/30","PMC4059225","","10.1021/jo500568s"
"24770627","Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats","Henderson-Redmond A, Czachowski C.","Psychopharmacology (Berl). 2014 Nov;231(22):4309-21. doi: 10.1007/s00213-014-3571-9. Epub 2014 Apr 26.","Henderson-Redmond A","Psychopharmacology (Berl)","2014","2014/04/29","PMC4209193","NIHMS589786","10.1007/s00213-014-3571-9"
"24766397","Drug safety evaluation of naltrexone/bupropion for the treatment of obesity","Verpeut JL, Bello NT.","Expert Opin Drug Saf. 2014 Jun;13(6):831-41. doi: 10.1517/14740338.2014.909405. Epub 2014 Apr 28.","Verpeut JL","Expert Opin Drug Saf","2014","2014/04/29","","","10.1517/14740338.2014.909405"
"24763910","Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity","Murray E, Brouwer S, McCutcheon R, Harmer CJ, Cowen PJ, McCabe C.","Psychopharmacology (Berl). 2014 Nov;231(22):4323-35. doi: 10.1007/s00213-014-3573-7. Epub 2014 Apr 25.","Murray E","Psychopharmacology (Berl)","2014","2014/04/26","","","10.1007/s00213-014-3573-7"
"24758591","δ-Opioid receptors in the accumbens shell mediate the influence of both excitatory and inhibitory predictions on choice","Laurent V, Wong FL, Balleine BW.","Br J Pharmacol. 2015 Jan;172(2):562-70. doi: 10.1111/bph.12731. Epub 2014 Jul 1.","Laurent V","Br J Pharmacol","2015","2014/04/25","PMC4292968","","10.1111/bph.12731"
"24754973","Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss","Billes SK, Sinnayah P, Cowley MA.","Pharmacol Res. 2014 Jun;84:1-11. doi: 10.1016/j.phrs.2014.04.004. Epub 2014 Apr 19.","Billes SK","Pharmacol Res","2014","2014/04/24","","","10.1016/j.phrs.2014.04.004"
"24748657","Desensitization of functional µ-opioid receptors increases agonist off-rate","Williams JT.","Mol Pharmacol. 2014 Jul;86(1):52-61. doi: 10.1124/mol.114.092098. Epub 2014 Apr 18.","Williams JT","Mol Pharmacol","2014","2014/04/22","PMC4054003","","10.1124/mol.114.092098"
"24742304","Scalable production of highly sensitive nanosensors based on graphene functionalized with a designed G protein-coupled receptor","Lerner MB, Matsunaga F, Han GH, Hong SJ, Xi J, Crook A, Perez-Aguilar JM, Park YW, Saven JG, Liu R, Johnson AT.","Nano Lett. 2014 May 14;14(5):2709-14. doi: 10.1021/nl5006349. Epub 2014 Apr 21.","Lerner MB","Nano Lett","2014","2014/04/19","PMC4025580","","10.1021/nl5006349"
"24739358","Delta-opioid receptor blockade in the ventral pallidum increases perceived palatability and consumption of saccharin solution in rats","Inui T, Shimura T.","Behav Brain Res. 2014 Aug 1;269:20-7. doi: 10.1016/j.bbr.2014.04.005. Epub 2014 Apr 13.","Inui T","Behav Brain Res","2014","2014/04/18","","","10.1016/j.bbr.2014.04.005"
"24738071","Comment on ""Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients""","Kessler BD, Hoffman RS.","Biomed Res Int. 2014;2014:705754. doi: 10.1155/2014/705754. Epub 2014 Mar 11.","Kessler BD","Biomed Res Int","2014","2014/04/17","PMC3967808","","10.1155/2014/705754"
"24733235","Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings","Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED.","Psychopharmacology (Berl). 2014 Oct;231(19):3843-53. doi: 10.1007/s00213-014-3519-0. Epub 2014 Apr 15.","Ray LA","Psychopharmacology (Berl)","2014","2014/04/16","PMC4161630","NIHMS585933","10.1007/s00213-014-3519-0"
"24726844","Opioid/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test","Haj-Mirzaian A, Ostadhadi S, Kordjazy N, Dehpour AR, Ejtemaei Mehr S.","Eur J Pharmacol. 2014 Jul 15;735:26-31. doi: 10.1016/j.ejphar.2014.03.053. Epub 2014 Apr 13.","Haj-Mirzaian A","Eur J Pharmacol","2014","2014/04/15","","","10.1016/j.ejphar.2014.03.053"
"24725220","Light alcohol intake during adolescence induces alcohol addiction in a neurodevelopmental model of schizophrenia","Jeanblanc J, Balguerie K, Coune F, Legastelois R, Jeanblanc V, Naassila M.","Addict Biol. 2015 May;20(3):490-9. doi: 10.1111/adb.12146. Epub 2014 Apr 13.","Jeanblanc J","Addict Biol","2015","2014/04/15","","","10.1111/adb.12146"
"24725195","A role for kappa-, but not mu-opioid, receptor activation in acute food deprivation-induced reinstatement of heroin seeking in rats","Sedki F, Eigenmann K, Gelinas J, Schouela N, Courchesne S, Shalev U.","Addict Biol. 2015 May;20(3):423-32. doi: 10.1111/adb.12133. Epub 2014 Apr 13.","Sedki F","Addict Biol","2015","2014/04/15","","","10.1111/adb.12133"
"24724887","Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans","Arias AJ, Gelernter J, Gueorguieva R, Ralevski E, Petrakis IL.","Am J Addict. 2014 May-Jun;23(3):288-93. doi: 10.1111/j.1521-0391.2014.12102.x.","Arias AJ","Am J Addict","2014","2014/04/15","PMC4600600","NIHMS691551","10.1111/j.1521-0391.2014.12102.x"
"24711667","Wim van den Brink and colleagues reply to Des Spence and Alain Braillon","van den Brink W, Mann K, Gual A, Aubin HJ.","BMJ. 2014 Apr 7;348:g2605. doi: 10.1136/bmj.g2605.","van den Brink W","BMJ","2014","2014/04/09","","","10.1136/bmj.g2605"
"24706503","The effect of UGT2B7*2 polymorphism on the pharmacokinetics of OROS® hydromorphone in Taiwanese subjects","Vandenbossche J, Richards H, Francke S, Van Den Bergh A, Lu CC, Franc MA.","J Clin Pharmacol. 2014 Oct;54(10):1170-9. doi: 10.1002/jcph.305. Epub 2014 Apr 15.","Vandenbossche J","J Clin Pharmacol","2014","2014/04/08","","","10.1002/jcph.305"
"24704710","Naltrexone: a review of existing sustained drug delivery systems and emerging nano-based systems","Goonoo N, Bhaw-Luximon A, Ujoodha R, Jhugroo A, Hulse GK, Jhurry D.","J Control Release. 2014 Jun 10;183:154-66. doi: 10.1016/j.jconrel.2014.03.046. Epub 2014 Apr 2.","Goonoo N","J Control Release","2014","2014/04/08","","","10.1016/j.jconrel.2014.03.046"
"24699386","3-Methoxynaltrexone is not a selective antagonist for the acute psychomotor stimulating effects of heroin and 6-monoacetylmorphine in mice","Eriksen GS, Andersen JM, Boix F, Mørland J.","Pharmacol Biochem Behav. 2014 Jul;122:82-8. doi: 10.1016/j.pbb.2014.03.018. Epub 2014 Mar 31.","Eriksen GS","Pharmacol Biochem Behav","2014","2014/04/05","","","10.1016/j.pbb.2014.03.018"
"24697498","Drug effects on multiple and concurrent schedules of ethanol- and food-maintained behaviour: context-dependent selectivity","Ginsburg BC, Lamb RJ.","Br J Pharmacol. 2014 Jul;171(14):3499-510. doi: 10.1111/bph.12707.","Ginsburg BC","Br J Pharmacol","2014","2014/04/05","PMC4105936","","10.1111/bph.12707"
"24696081","Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse","Lê AD, Funk D, Lo S, Coen K.","Psychopharmacology (Berl). 2014 Oct;231(20):4019-29. doi: 10.1007/s00213-014-3541-2. Epub 2014 Apr 3.","Lê AD","Psychopharmacology (Berl)","2014","2014/04/04","PMC5357119","NIHMS849165","10.1007/s00213-014-3541-2"
"24695742","Naltrexone implant treatment for buprenorphine dependence--Mauritian case series","Jhugroo A, Ellayah D, Norman A, Hulse G.","J Psychopharmacol. 2014 Aug;28(8):800-3. doi: 10.1177/0269881114528592. Epub 2014 Apr 2.","Jhugroo A","J Psychopharmacol","2014","2014/04/04","","","10.1177/0269881114528592"
"24682505","Behavioural profile of exendin-4/naltrexone dose combinations in male rats during tests of palatable food consumption","Wright FL, Rodgers RJ.","Psychopharmacology (Berl). 2014 Sep;231(18):3729-44. doi: 10.1007/s00213-014-3507-4. Epub 2014 Feb 28.","Wright FL","Psychopharmacology (Berl)","2014","2014/04/01","","","10.1007/s00213-014-3507-4"
"24675031","Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors","Pacheco Dda F, Romero TR, Duarte ID.","Brain Res. 2014 May 8;1562:69-75. doi: 10.1016/j.brainres.2014.03.026. Epub 2014 Mar 24.","Pacheco Dda F","Brain Res","2014","2014/03/29","","","10.1016/j.brainres.2014.03.026"
"24674234","An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone","Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA.","J Subst Abuse Treat. 2014 Jul;47(1):35-40. doi: 10.1016/j.jsat.2014.02.008. Epub 2014 Mar 12.","Vagenas P","J Subst Abuse Treat","2014","2014/03/29","PMC4042403","NIHMS576139","10.1016/j.jsat.2014.02.008"
"24671340","Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study","van den Brink W, Sørensen P, Torup L, Mann K, Gual A; SENSE Study Group.","J Psychopharmacol. 2014 Aug;28(8):733-44. doi: 10.1177/0269881114527362. Epub 2014 Mar 26.","van den Brink W","J Psychopharmacol","2014","2014/03/28","","","10.1177/0269881114527362"
"24661324","Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence","Garbutt JC, Greenblatt AM, West SL, Morgan LC, Kampov-Polevoy A, Jordan HS, Bobashev GV.","Addiction. 2014 Aug;109(8):1274-84. doi: 10.1111/add.12557. Epub 2014 May 23.","Garbutt JC","Addiction","2014","2014/03/26","","","10.1111/add.12557"
"24659754","Naltrexone metabolism and concomitant drug concentrations in chronic pain patients","Liu JC, Ma JD, Morello CM, Atayee RS, Best BM.","J Anal Toxicol. 2014 May;38(4):212-7. doi: 10.1093/jat/bku019. Epub 2014 Mar 21.","Liu JC","J Anal Toxicol","2014","2014/03/25","","","10.1093/jat/bku019"
"24657279","Knockout subtraction autoradiography: a novel ex vivo method to detect heteromers finds sparse KOP receptor/DOP receptor heterodimerization in the brain","Yoo JH, Bailey A, Borsodi A, Tóth G, Matifas A, Kieffer BL, Kitchen I.","Eur J Pharmacol. 2014 May 15;731:1-7. doi: 10.1016/j.ejphar.2014.03.007. Epub 2014 Mar 18.","Yoo JH","Eur J Pharmacol","2014","2014/03/25","","","10.1016/j.ejphar.2014.03.007"
"24655631","Treatment of fetishism with naltrexone: a case report","Firoz K, Nidheesh Sankar V, Rajmohan V, Manoj Kumar G, Raghuram TM.","Asian J Psychiatr. 2014 Apr;8:67-8. doi: 10.1016/j.ajp.2013.11.006. Epub 2013 Dec 4.","Firoz K","Asian J Psychiatr","2014","2014/03/25","","","10.1016/j.ajp.2013.11.006"
"24650828","Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trials","Falk DE, Litten RZ, Anton RF, Kranzler HR, Johnson BA; Active Workgroup.","J Stud Alcohol Drugs. 2014 Mar;75(2):335-46. doi: 10.15288/jsad.2014.75.335.","Falk DE","J Stud Alcohol Drugs","2014","2014/03/22","PMC3965687","","10.15288/jsad.2014.75.335"
"24644335","Paediatric palliative care: intravenous methylnaltrexone relieves constipation","Yeomanson D, Chohan O, Mayer A.","BMJ Support Palliat Care. 2013 Mar;3(1):103-5. doi: 10.1136/bmjspcare-2012-000291. Epub 2012 Nov 2.","Yeomanson D","BMJ Support Palliat Care","2013","2014/03/20","","","10.1136/bmjspcare-2012-000291"
"24644334","Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation","Clark K, Rowett D, Robinson M, Currow DC.","BMJ Support Palliat Care. 2013 Mar;3(1):98-102. doi: 10.1136/bmjspcare-2012-000284. Epub 2012 Nov 15.","Clark K","BMJ Support Palliat Care","2013","2014/03/20","","","10.1136/bmjspcare-2012-000284"
"24635882","'Miracle cure' or 'liquid handcuffs': reporting on naltrexone and methadone in the Australian print media","Matthew-Simmons F, Ritter A.","Drug Alcohol Rev. 2014 Sep;33(5):506-14. doi: 10.1111/dar.12134. Epub 2014 Mar 18.","Matthew-Simmons F","Drug Alcohol Rev","2014","2014/03/19","","","10.1111/dar.12134"
"24633576","Activation of TRPM7 channels by small molecules under physiological conditions","Hofmann T, Schäfer S, Linseisen M, Sytik L, Gudermann T, Chubanov V.","Pflugers Arch. 2014 Dec;466(12):2177-89. doi: 10.1007/s00424-014-1488-0. Epub 2014 Mar 15.","Hofmann T","Pflugers Arch","2014","2014/03/18","","","10.1007/s00424-014-1488-0"
"24633528","Systematic review and meta-analysis of opioid antagonists for smoking cessation","David SP, Chu IM, Lancaster T, Stead LF, Evins AE, Prochaska JJ.","BMJ Open. 2014 Mar 14;4(3):e004393. doi: 10.1136/bmjopen-2013-004393.","David SP","BMJ Open","2014","2014/03/18","PMC3963070","","10.1136/bmjopen-2013-004393"
"24631297","C-Fos activation in the periaqueductal gray following acute morphine-3β-D-glucuronide or morphine administration","Arout CA, Caldwell M, McCloskey DP, Kest B.","Physiol Behav. 2014 May 10;130:28-33. doi: 10.1016/j.physbeh.2014.02.056. Epub 2014 Mar 11.","Arout CA","Physiol Behav","2014","2014/03/18","","","10.1016/j.physbeh.2014.02.056"
"24614808","Bad medicine: using surrogate markers","McNulty SJ, Williams P.","BMJ. 2014 Mar 10;348:g2012. doi: 10.1136/bmj.g2012.","McNulty SJ","BMJ","2014","2014/03/12","","","10.1136/bmj.g2012"
"24614566","Nalmefene in alcohol misuse: junk evaluation by the European Medicines Agency","Braillon A.","BMJ. 2014 Mar 10;348:g2017. doi: 10.1136/bmj.g2017.","Braillon A","BMJ","2014","2014/03/12","","","10.1136/bmj.g2017"
"24613828","δ-Opioid receptor activation reduces α-synuclein overexpression and oligomer formation induced by MPP(+) and/or hypoxia","Chen T, Li J, Chao D, Sandhu HK, Liao X, Zhao J, Wen G, Xia Y.","Exp Neurol. 2014 May;255:127-36. doi: 10.1016/j.expneurol.2014.02.022. Epub 2014 Mar 5.","Chen T","Exp Neurol","2014","2014/03/12","","","10.1016/j.expneurol.2014.02.022"
"24602802","Blockade of central delta-opioid receptors inhibits salt appetite in sodium-depleted rats","Nascimento AI, Ferreira HS, Cerqueira DR, Fregoneze JB.","Peptides. 2014 May;55:110-9. doi: 10.1016/j.peptides.2014.02.012. Epub 2014 Mar 3.","Nascimento AI","Peptides","2014","2014/03/08","","","10.1016/j.peptides.2014.02.012"
"24602363","Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial","Mannelli P, Wu LT, Peindl KS, Swartz MS, Woody GE.","Drug Alcohol Depend. 2014 May 1;138:83-8. doi: 10.1016/j.drugalcdep.2014.02.002. Epub 2014 Feb 15.","Mannelli P","Drug Alcohol Depend","2014","2014/03/08","PMC4017322","NIHMS574040","10.1016/j.drugalcdep.2014.02.002"
"24598474","Trichotillomania successfully treated with risperidone and naltrexone: a geriatric case report","Oravecz R, Štuhec M.","J Am Med Dir Assoc. 2014 Apr;15(4):301-2. doi: 10.1016/j.jamda.2014.01.007. Epub 2014 Mar 2.","Oravecz R","J Am Med Dir Assoc","2014","2014/03/07","","","10.1016/j.jamda.2014.01.007"
"24589346","Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review","Roy A, Roy M, Deb S, Unwin G, Roy A.","J Intellect Disabil Res. 2015 Apr;59(4):293-306. doi: 10.1111/jir.12122. Epub 2014 Mar 4.","Roy A","J Intellect Disabil Res","2015","2014/03/05","","","10.1111/jir.12122"
"24583747","Naltrexone therapy for Crohn's disease and ulcerative colitis","Weinstock LB.","J Clin Gastroenterol. 2014 Sep;48(8):742. doi: 10.1097/MCG.0000000000000093.","Weinstock LB","J Clin Gastroenterol","2014","2014/03/04","","","10.1097/MCG.0000000000000093"
"24583188","Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats","Grella SL, Funk D, Coen K, Li Z, Lê AD.","Behav Brain Res. 2014 May 15;265:188-97. doi: 10.1016/j.bbr.2014.02.029. Epub 2014 Feb 28.","Grella SL","Behav Brain Res","2014","2014/03/04","PMC4082245","NIHMS577776","10.1016/j.bbr.2014.02.029"
"24571193","The effect of methylnaltrexone on the side effects of intrathecal morphine after orthopedic surgery under spinal anesthesia","Zand F, Amini A, Asadi S, Farbood A.","Pain Pract. 2015 Apr;15(4):348-54. doi: 10.1111/papr.12185. Epub 2014 Feb 27.","Zand F","Pain Pract","2015","2014/02/28","","","10.1111/papr.12185"
"24560952","Evaluation of saccharin intake and expression of fructose-conditioned flavor preferences following opioid receptor antagonism in the medial prefrontal cortex, amygdala or lateral hypothalamus in rats","Malkusz DC, Bernal SY, Banakos T, Malkusz G, Mohamed A, Vongwattanakit T, Bodnar RJ.","Neurosci Lett. 2014 Apr 3;564:94-8. doi: 10.1016/j.neulet.2014.02.020. Epub 2014 Feb 20.","Malkusz DC","Neurosci Lett","2014","2014/02/25","","","10.1016/j.neulet.2014.02.020"
"24560438","A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence","Bisaga A, Sullivan MA, Glass A, Mishlen K, Carpenter KM, Mariani JJ, Levin FR, Nunes EV.","J Subst Abuse Treat. 2014 May-Jun;46(5):546-52. doi: 10.1016/j.jsat.2014.01.005. Epub 2014 Jan 17.","Bisaga A","J Subst Abuse Treat","2014","2014/02/25","PMC4007510","NIHMS558077","10.1016/j.jsat.2014.01.005"
"24558033","Low dose naltrexone for induction of remission in Crohn's disease","Segal D, Macdonald JK, Chande N.","Cochrane Database Syst Rev. 2014 Feb 21;(2):CD010410. doi: 10.1002/14651858.CD010410.pub2.","Segal D","Cochrane Database Syst Rev","2014","2014/02/22","","","10.1002/14651858.CD010410.pub2"
"24557083","Can alcohol dependent patients adhere to an 'as-needed' medication regimen?","Sinclair J, Chick J, Sørensen P, Kiefer F, Batel P, Gual A.","Eur Addict Res. 2014;20(5):209-17. doi: 10.1159/000357865. Epub 2014 Feb 15.","Sinclair J","Eur Addict Res","2014","2014/02/22","","","10.1159/000357865"
"24555641","Antinociceptive activity of methanolic extract of Muntingia calabura leaves: further elucidation of the possible mechanisms","Zakaria ZA, Mohd Sani MH, Cheema MS, Kader AA, Kek TL, Salleh MZ.","BMC Complement Altern Med. 2014 Feb 20;14:63. doi: 10.1186/1472-6882-14-63.","Zakaria ZA","BMC Complement Altern Med","2014","2014/02/22","PMC3941974","","10.1186/1472-6882-14-63"
"24551070","Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling","Zou JY, Crews FT.","PLoS One. 2014 Feb 14;9(2):e87915. doi: 10.1371/journal.pone.0087915. eCollection 2014.","Zou JY","PLoS One","2014","2014/02/20","PMC3925099","","10.1371/journal.pone.0087915"
"24550443","Opioid analgesics stop the development of clostridial gas gangrene","Chakravorty A, Awad MM, Hiscox TJ, Cheung JK, Choo JM, Lyras D, Rood JI.","J Infect Dis. 2014 Aug 1;210(3):483-92. doi: 10.1093/infdis/jiu101. Epub 2014 Feb 18.","Chakravorty A","J Infect Dis","2014","2014/02/20","","","10.1093/infdis/jiu101"
"24531208","Bad medicine: nalmefene in alcohol misuse","Spence D.","BMJ. 2014 Feb 14;348:g1531. doi: 10.1136/bmj.g1531.","Spence D","BMJ","2014","2014/02/18","","","10.1136/bmj.g1531"
"24526250","The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain","Younger J, Parkitny L, McLain D.","Clin Rheumatol. 2014 Apr;33(4):451-9. doi: 10.1007/s10067-014-2517-2. Epub 2014 Feb 15.","Younger J","Clin Rheumatol","2014","2014/02/15","PMC3962576","","10.1007/s10067-014-2517-2"
"24523233","Anticonvulsants for alcohol dependence","Pani PP, Trogu E, Pacini M, Maremmani I.","Cochrane Database Syst Rev. 2014 Feb 13;(2):CD008544. doi: 10.1002/14651858.CD008544.pub2.","Pani PP","Cochrane Database Syst Rev","2014","2014/02/14","","","10.1002/14651858.CD008544.pub2"
"24514570","Rewards of beauty: the opioid system mediates social motivation in humans","Chelnokova O, Laeng B, Eikemo M, Riegels J, Løseth G, Maurud H, Willoch F, Leknes S.","Mol Psychiatry. 2014 Jul;19(7):746-7. doi: 10.1038/mp.2014.1. Epub 2014 Feb 11.","Chelnokova O","Mol Psychiatry","2014","2014/02/12","","","10.1038/mp.2014.1"
"24512968","Opioid antagonists","Barnett V, Twycross R, Mihalyo M, Wilcock A.","J Pain Symptom Manage. 2014 Feb;47(2):341-52. doi: 10.1016/j.jpainsymman.2013.12.223.","Barnett V","J Pain Symptom Manage","2014","2014/02/12","","","10.1016/j.jpainsymman.2013.12.223"
"24511042","Metabolic treatment of cancer: intermediate results of a prospective case series","Schwartz L, Buhler L, Icard P, Lincet H, Steyaert JM.","Anticancer Res. 2014 Feb;34(2):973-80.","Schwartz L","Anticancer Res","2014","2014/02/11","","",""
"24508751","Role of NMDA, opioid and dopamine D1 and D2 receptor signaling in the acquisition of a quinine-conditioned flavor avoidance in rats","Rotella FM, Badalia A, Duenas SM, Hossain M, Saeed S, Touzani K, Sclafani A, Bodnar RJ.","Physiol Behav. 2014 Apr 10;128:133-40. doi: 10.1016/j.physbeh.2014.01.014. Epub 2014 Feb 6.","Rotella FM","Physiol Behav","2014","2014/02/11","","","10.1016/j.physbeh.2014.01.014"
"24503624","Nanoscale effects of ethanol and naltrexone on protein organization in the plasma membrane studied by photoactivated localization microscopy (PALM)","Tobin SJ, Cacao EE, Hong DW, Terenius L, Vukojevic V, Jovanovic-Talisman T.","PLoS One. 2014 Feb 4;9(2):e87225. doi: 10.1371/journal.pone.0087225. eCollection 2014.","Tobin SJ","PLoS One","2014","2014/02/08","PMC3913589","","10.1371/journal.pone.0087225"
"24503508","Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice","Dimattio KM, Yakovleva TV, Aldrich JV, Cowan A, Liu-Chen LY.","Neurosci Lett. 2014 Mar 20;563:155-9. doi: 10.1016/j.neulet.2014.01.022. Epub 2014 Feb 3.","Dimattio KM","Neurosci Lett","2014","2014/02/08","PMC4154496","NIHMS566122","10.1016/j.neulet.2014.01.022"
"24480726","Spinal ERK2 activation through δ2-opioid receptors contributes to nociceptive behavior induced by intrathecal injection of leucine-enkephalin","Komatsu T, Katsuyama S, Mizoguchi H, Sakurada C, Tsuzuki M, Sakurada S, Sakurada T.","Peptides. 2014 Apr;54:131-9. doi: 10.1016/j.peptides.2014.01.014. Epub 2014 Jan 27.","Komatsu T","Peptides","2014","2014/02/01","","","10.1016/j.peptides.2014.01.014"
"24477128","[L.S. Stavseth and colleagues reply]","Stavseth LS, Tanum L, Kunøe N.","Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):136-7. doi: 10.4045/tidsskr.13.1669.","Stavseth LS","Tidsskr Nor Laegeforen","2014","2014/01/31","","","10.4045/tidsskr.13.1669"
"24477127","[Violation of the Helsinki Declaration]","Ekgren JS.","Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):136. doi: 10.4045/tidsskr.13.1668.","Ekgren JS","Tidsskr Nor Laegeforen","2014","2014/01/31","","","10.4045/tidsskr.13.1668"
"24477126","[Registered opiate addicts in Norway]","Pedersen E.","Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):136. doi: 10.4045/tidsskr.13.1667.","Pedersen E","Tidsskr Nor Laegeforen","2014","2014/01/31","","","10.4045/tidsskr.13.1667"
"24471478","Long-term relapse of ultra-rapid opioid detoxification","Salimi A, Safari F, Mohajerani SA, Hashemian M, Kolahi AA, Mottaghi K.","J Addict Dis. 2014;33(1):33-40. doi: 10.1080/10550887.2014.882727.","Salimi A","J Addict Dis","2014","2014/01/30","","","10.1080/10550887.2014.882727"
"24464838","Cocaine- or stress-induced metaplasticity of LTP in the dorsal and ventral hippocampus","Keralapurath MM, Clark JK, Hammond S, Wagner JJ.","Hippocampus. 2014 May;24(5):577-90. doi: 10.1002/hipo.22250. Epub 2014 Feb 12.","Keralapurath MM","Hippocampus","2014","2014/01/28","","","10.1002/hipo.22250"
"24464531","Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users","Marks KR, Lile JA, Stoops WW, Rush CR.","Psychopharmacology (Berl). 2014 Jul;231(14):2741-50. doi: 10.1007/s00213-014-3449-x. Epub 2014 Jan 25.","Marks KR","Psychopharmacology (Berl)","2014","2014/01/28","PMC4074228","NIHMS575285","10.1007/s00213-014-3449-x"
"24456403","Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone","Vuoristo-Myllys S, Lipsanen J, Lahti J, Kalska H, Alho H.","Am J Drug Alcohol Abuse. 2014 Mar;40(2):103-10. doi: 10.3109/00952990.2013.853074. Epub 2014 Jan 23.","Vuoristo-Myllys S","Am J Drug Alcohol Abuse","2014","2014/01/25","","","10.3109/00952990.2013.853074"
"24455776","Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs)","Meng J, Meng Y, Plotnikoff NP, Youkilis G, Griffin N, Shan F.","Int Immunopharmacol. 2013 Dec;17(4):1084-9. doi: 10.1016/j.intimp.2013.10.012.","Meng J","Int Immunopharmacol","2013","2014/01/24","","","10.1016/j.intimp.2013.10.012"
"24437142","[New treatment options for alcohol dependence]","Müller CA, Heinz A.","MMW Fortschr Med. 2013 May 2;155(8):63-5. doi: 10.1007/s15006-013-0644-3.","Müller CA","MMW Fortschr Med","2013","2014/01/21","","","10.1007/s15006-013-0644-3"
"24432563","[Analgesic properties of morpholinoethylimidazobenzimidazole derivative RU-1205]","Spasov AA, Grechko OIu, Shtareva DM, Anisimova VA.","Eksp Klin Farmakol. 2013;76(9):15-8.","Spasov AA","Eksp Klin Farmakol","2013","2014/01/18","","",""
"24424425","A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone","Schmitz JM, Green CE, Stotts AL, Lindsay JA, Rathnayaka NS, Grabowski J, Moeller FG.","Drug Alcohol Depend. 2014 Mar 1;136:100-7. doi: 10.1016/j.drugalcdep.2013.12.015. Epub 2014 Jan 3.","Schmitz JM","Drug Alcohol Depend","2014","2014/01/16","PMC3944935","NIHMS553349","10.1016/j.drugalcdep.2013.12.015"
"24413399","Molecular control of δ-opioid receptor signalling","Fenalti G, Giguere PM, Katritch V, Huang XP, Thompson AA, Cherezov V, Roth BL, Stevens RC.","Nature. 2014 Feb 13;506(7487):191-6. doi: 10.1038/nature12944. Epub 2014 Jan 12.","Fenalti G","Nature","2014","2014/01/14","PMC3931418","NIHMS540532","10.1038/nature12944"
"24412802","Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain","Ellis A, Wieseler J, Favret J, Johnson KW, Rice KC, Maier SF, Falci S, Watkins LR.","J Pain. 2014 Apr;15(4):407-21. doi: 10.1016/j.jpain.2013.12.007. Epub 2014 Jan 9.","Ellis A","J Pain","2014","2014/01/14","PMC3972272","NIHMS555529","10.1016/j.jpain.2013.12.007"
"24411184","Methylnaltrexone in palliative care: further research is needed","Clark K, Currow DC.","J Pain Symptom Manage. 2014 Feb;47(2):e5-6. doi: 10.1016/j.jpainsymman.2013.11.004. Epub 2014 Jan 8.","Clark K","J Pain Symptom Manage","2014","2014/01/14","","","10.1016/j.jpainsymman.2013.11.004"
"24410326","Characterization of BU09059: a novel potent selective κ-receptor antagonist","Casal-Dominguez JJ, Furkert D, Ostovar M, Teintang L, Clark MJ, Traynor JR, Husbands SM, Bailey SJ.","ACS Chem Neurosci. 2014 Mar 19;5(3):177-84. doi: 10.1021/cn4001507. Epub 2014 Jan 28.","Casal-Dominguez JJ","ACS Chem Neurosci","2014","2014/01/14","PMC3963132","","10.1021/cn4001507"
"24402092","Uremic pruritus","Mettang T, Kremer AE.","Kidney Int. 2015 Apr;87(4):685-91. doi: 10.1038/ki.2013.454. Epub 2014 Jan 8.","Mettang T","Kidney Int","2015","2014/01/10","","","10.1038/ki.2013.454"
"24395718","Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin","Ghosh P, Brogden NK, Stinchcomb AL.","J Pharm Sci. 2014 Feb;103(2):652-60. doi: 10.1002/jps.23844. Epub 2014 Jan 6.","Ghosh P","J Pharm Sci","2014","2014/01/08","","","10.1002/jps.23844"
"24388844","Treatment of refractory vulvovaginal pruritus with naltrexone, a specific opiate antagonist","Böttcher B, Wildt L.","Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:115-6. doi: 10.1016/j.ejogrb.2013.12.010. Epub 2013 Dec 15.","Böttcher B","Eur J Obstet Gynecol Reprod Biol","2014","2014/01/07","","","10.1016/j.ejogrb.2013.12.010"
"24384538","Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community","Springer SA, Altice FL, Herme M, Di Paola A.","Contemp Clin Trials. 2014 Mar;37(2):209-18. doi: 10.1016/j.cct.2013.12.006. Epub 2013 Dec 31.","Springer SA","Contemp Clin Trials","2014","2014/01/04","PMC3992862","NIHMS558184","10.1016/j.cct.2013.12.006"
"24374748","Maternal isolation during the first two postnatal weeks affects novelty-induced responses and sensitivity to ethanol-induced locomotor activity during infancy","Fernández M, Fabio MC, Nizhnikov ME, Spear NE, Abate P, Pautassi RM.","Dev Psychobiol. 2014 Jul;56(5):1070-82. doi: 10.1002/dev.21192. Epub 2013 Dec 24.","Fernández M","Dev Psychobiol","2014","2013/12/31","","","10.1002/dev.21192"
"24363821","Naltrexone reverses ethanol-induced rat hippocampal and serum oxidative damage","Almansa I, Barcia JM, López-Pedrajas R, Muriach M, Miranda M, Romero FJ.","Oxid Med Cell Longev. 2013;2013:296898. doi: 10.1155/2013/296898. Epub 2013 Dec 1.","Almansa I","Oxid Med Cell Longev","2013","2013/12/24","PMC3864183","","10.1155/2013/296898"
"24358569","Giving laxatives safely and effectively","Daniels G, Daniels G.","Medsurg Nurs. 2013 Sep-Oct;22(5):290-6, 302.","Daniels G","Medsurg Nurs","2013","2013/12/24","","",""
"24353217","Pharmacological interventions for drug-using offenders","Perry AE, Neilson M, Martyn-St James M, Glanville JM, McCool R, Duffy S, Godfrey C, Hewitt C.","Cochrane Database Syst Rev. 2013 Dec 19;(12):CD010862. doi: 10.1002/14651858.CD010862.","Perry AE","Cochrane Database Syst Rev","2013","2013/12/20","","","10.1002/14651858.CD010862"
"24346745","The effect of naltrexone on sleep parameters in healthy male volunteers","Sramek J, Andry JM, Ding H, Riordan HJ, Leibowitz M, Cutler NR.","J Clin Psychopharmacol. 2014 Feb;34(1):167-8. doi: 10.1097/JCP.0b013e3182a607ff.","Sramek J","J Clin Psychopharmacol","2014","2013/12/19","","","10.1097/JCP.0b013e3182a607ff"
"24342569","Mu opioid receptor antagonism in the nucleus accumbens shell blocks consumption of a preferred sucrose solution in an anticipatory contrast paradigm","Katsuura Y, Taha SA.","Neuroscience. 2014 Mar 7;261:144-52. doi: 10.1016/j.neuroscience.2013.12.004. Epub 2013 Dec 14.","Katsuura Y","Neuroscience","2014","2013/12/18","PMC3956648","NIHMS559659","10.1016/j.neuroscience.2013.12.004"
"24333676","DOR(2)-selective but not DOR(1)-selective antagonist abolishes anxiolytic-like effects of the δ opioid receptor agonist KNT-127","Sugiyama A, Nagase H, Oka J, Yamada M, Saitoh A.","Neuropharmacology. 2014 Apr;79:314-20. doi: 10.1016/j.neuropharm.2013.11.021. Epub 2013 Dec 12.","Sugiyama A","Neuropharmacology","2014","2013/12/17","","","10.1016/j.neuropharm.2013.11.021"
"24327043","Therapy for posttraumatic stress and alcohol dependence--reply","Foa EB, McLean CP, Yusko D.","JAMA. 2013 Dec 11;310(22):2458-9. doi: 10.1001/jama.2013.282158.","Foa EB","JAMA","2013","2013/12/12","","","10.1001/jama.2013.282158"
"24327041","Therapy for posttraumatic stress and alcohol dependence","Najavits LM.","JAMA. 2013 Dec 11;310(22):2457-8. doi: 10.1001/jama.2013.282141.","Najavits LM","JAMA","2013","2013/12/12","","","10.1001/jama.2013.282141"
"24306132","Improved effect of the combination naltrexone/D-penicillamine in the prevention of alcohol relapse-like drinking in rats","Orrico A, Martí-Prats L, Cano-Cebrián MJ, Granero L, Polache A, Zornoza T.","J Psychopharmacol. 2014 Jan;28(1):76-81. doi: 10.1177/0269881113515063. Epub 2013 Dec 3.","Orrico A","J Psychopharmacol","2014","2013/12/06","","","10.1177/0269881113515063"
"24305833","Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake","Schlosburg JE, Whitfield TW Jr, Park PE, Crawford EF, George O, Vendruscolo LF, Koob GF.","J Neurosci. 2013 Dec 4;33(49):19384-92. doi: 10.1523/JNEUROSCI.1979-13.2013.","Schlosburg JE","J Neurosci","2013","2013/12/06","PMC3850049","","10.1523/JNEUROSCI.1979-13.2013"
"24299657","A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence","Larney S, Gowing L, Mattick RP, Farrell M, Hall W, Degenhardt L.","Drug Alcohol Rev. 2014 Mar;33(2):115-28. doi: 10.1111/dar.12095. Epub 2013 Dec 3.","Larney S","Drug Alcohol Rev","2014","2013/12/05","","","10.1111/dar.12095"
"24291355","A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade","Daubenmier J, Lustig RH, Hecht FM, Kristeller J, Woolley J, Adam T, Dallman M, Epel E.","Appetite. 2014 Mar;74:92-100. doi: 10.1016/j.appet.2013.11.014. Epub 2013 Nov 27.","Daubenmier J","Appetite","2014","2013/12/03","PMC4125886","NIHMS552807","10.1016/j.appet.2013.11.014"
"24289087","Antinociceptive activity of a synthetic oxopyrrolidine-based compound, ASH21374, and determination of its possible mechanisms","Zakaria ZA, Sani MH, Mohammat MF, Mansor NS, Shaameri Z, Kek TL, Salleh MZ, Hamzah AS.","Can J Physiol Pharmacol. 2013 Dec;91(12):1143-53. doi: 10.1139/cjpp-2013-0099. Epub 2013 Sep 16.","Zakaria ZA","Can J Physiol Pharmacol","2013","2013/12/03","","","10.1139/cjpp-2013-0099"
"24288728","Effects of naltrexone on firing activity of rat cortex neurons and its interactions with ethanol","Kozhechkin SN, Mednikova YS, Kolik LG.","Bull Exp Biol Med. 2013 Sep;155(5):639-42. doi: 10.1007/s10517-013-2214-1.","Kozhechkin SN","Bull Exp Biol Med","2013","2013/11/30","","","10.1007/s10517-013-2214-1"
"24285378","Synthesis of [15, 16- ³H] beta-funaltrexamine","Filer CN, Seguin RJ.","J Labelled Comp Radiopharm. 2013 May 15;56(5):310-1. doi: 10.1002/jlcr.3050. Epub 2013 Apr 24.","Filer CN","J Labelled Comp Radiopharm","2013","2013/11/29","","","10.1002/jlcr.3050"
"24257074","Central amygdala opioid transmission is necessary for increased high-fat intake following 24-h food deprivation, but not following intra-accumbens opioid administration","Parker KE, Johns HW, Floros TG, Will MJ.","Behav Brain Res. 2014 Mar 1;260:131-8. doi: 10.1016/j.bbr.2013.11.014. Epub 2013 Nov 17.","Parker KE","Behav Brain Res","2014","2013/11/22","PMC4451003","NIHMS692533","10.1016/j.bbr.2013.11.014"
"24252444","The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models","Moore CF, Protzuk OA, Johnson BA, Lynch WJ.","Pharmacol Biochem Behav. 2014 Jan;116:107-15. doi: 10.1016/j.pbb.2013.11.013. Epub 2013 Nov 16.","Moore CF","Pharmacol Biochem Behav","2014","2013/11/21","PMC3886549","NIHMS541988","10.1016/j.pbb.2013.11.013"
"24246244","Nalmefene for the treatment of alcohol dependence: a current update","Soyka M.","Int J Neuropsychopharmacol. 2014 Apr;17(4):675-84. doi: 10.1017/S1461145713001284. Epub 2013 Nov 18.","Soyka M","Int J Neuropsychopharmacol","2014","2013/11/20","","","10.1017/S1461145713001284"
"24244983","The role of methylnaltrexone in opioid-induced constipation","Hellwig TR, Pottebaum AA.","S D Med. 2013 Oct;66(10):425, 427.","Hellwig TR","S D Med","2013","2013/11/20","","",""
"24234803","Hydrogels composed of cyclodextrin inclusion complexes with PLGA-PEG-PLGA triblock copolymers as drug delivery systems","Khodaverdi E, Mirzazadeh Tekie FS, Hadizadeh F, Esmaeel H, Mohajeri SA, Sajadi Tabassi SA, Zohuri G.","AAPS PharmSciTech. 2014 Feb;15(1):177-188. doi: 10.1208/s12249-013-0051-1.","Khodaverdi E","AAPS PharmSciTech","2014","2013/11/16","PMC3909172","","10.1208/s12249-013-0051-1"
"24226324","[Long-acting naltrexone--a new way out of opiate addiction?]","Stavseth LS, Kunøe N, Tanum L.","Tidsskr Nor Laegeforen. 2013 Nov 12;133(21):2231-2. doi: 10.4045/tidsskr.13.1139.","Stavseth LS","Tidsskr Nor Laegeforen","2013","2013/11/15","","","10.4045/tidsskr.13.1139"
"24221826","Dopamine D1 and μ-opioid receptor antagonism blocks anticipatory 50 kHz ultrasonic vocalizations induced by palatable food cues in Wistar rats","Buck CL, Vendruscolo LF, Koob GF, George O.","Psychopharmacology (Berl). 2014 Mar;231(5):929-37. doi: 10.1007/s00213-013-3307-2. Epub 2013 Nov 13.","Buck CL","Psychopharmacology (Berl)","2014","2013/11/14","PMC3945412","NIHMS539967","10.1007/s00213-013-3307-2"
"24220019","Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism","Enoch MA.","Pharmacol Biochem Behav. 2014 Aug;123:17-24. doi: 10.1016/j.pbb.2013.11.001. Epub 2013 Nov 9.","Enoch MA","Pharmacol Biochem Behav","2014","2013/11/14","PMC4016188","NIHMS541074","10.1016/j.pbb.2013.11.001"
"24218151","Sustained release of naltrexone from poly(n-isopropylacrylamide) microgels","Kjøniksen AL, Calejo MT, Zhu K, Cardoso AM, de Lima MC, Jurado AS, Nyström B, Sande SA.","J Pharm Sci. 2014 Jan;103(1):227-34. doi: 10.1002/jps.23780. Epub 2013 Nov 11.","Kjøniksen AL","J Pharm Sci","2014","2013/11/13","","","10.1002/jps.23780"
"24218048","The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled pilot study","Taveira TH, Wu WC, Tschibelu E, Borsook D, Simonson DC, Yamamoto R, Langleben DD, Swift R, Elman I.","J Psychopharmacol. 2014 Apr;28(4):395-400. doi: 10.1177/0269881113509904. Epub 2013 Nov 11.","Taveira TH","J Psychopharmacol","2014","2013/11/13","","","10.1177/0269881113509904"
"24214100","Pharmacotherapy for trichotillomania","Rothbart R, Amos T, Siegfried N, Ipser JC, Fineberg N, Chamberlain SR, Stein DJ.","Cochrane Database Syst Rev. 2013 Nov 8;(11):CD007662. doi: 10.1002/14651858.CD007662.pub2.","Rothbart R","Cochrane Database Syst Rev","2013","2013/11/12","","","10.1002/14651858.CD007662.pub2"
"24206269","Sequestered naltrexone in sustained release morphine or oxycodone - a way to inhibit illicit use?","Raffa RB, Taylor R Jr, Pergolizzi JV Jr.","Expert Opin Drug Saf. 2014 Feb;13(2):181-90. doi: 10.1517/14740338.2013.841136. Epub 2013 Nov 11.","Raffa RB","Expert Opin Drug Saf","2014","2013/11/12","","","10.1517/14740338.2013.841136"
"24200890","Delta opioid receptor agonist BW373U86 attenuates post-resuscitation brain injury in a rat model of asphyxial cardiac arrest","Yang L, Zhao X, Sun M, Sun X, Yao L, Yu D, Ding Q, Gao C, Chai W.","Resuscitation. 2014 Feb;85(2):299-305. doi: 10.1016/j.resuscitation.2013.10.022. Epub 2013 Nov 5.","Yang L","Resuscitation","2014","2013/11/09","","","10.1016/j.resuscitation.2013.10.022"
"24184385","Dynorphins regulate the strength of social memory","Bilkei-Gorzo A, Mauer D, Michel K, Zimmer A.","Neuropharmacology. 2014 Feb;77:406-13. doi: 10.1016/j.neuropharm.2013.10.023. Epub 2013 Nov 1.","Bilkei-Gorzo A","Neuropharmacology","2014","2013/11/05","","","10.1016/j.neuropharm.2013.10.023"
"24176612","A prospective study of methylnaltrexone for opioid-induced constipation in advanced illness: should we use it or not?","Centeno C, Carranza O, Zuriarrain Y, Portela MA, Larumbe A, Canal J, Palomar C.","J Pain Symptom Manage. 2013 Nov;46(5):e1-3. doi: 10.1016/j.jpainsymman.2013.08.009.","Centeno C","J Pain Symptom Manage","2013","2013/11/02","","","10.1016/j.jpainsymman.2013.08.009"
"24172116","Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexone","Vuoristo-Myllys S, Lahti J, Alho H, Julkunen J.","J Stud Alcohol Drugs. 2013 Nov;74(6):894-901. doi: 10.15288/jsad.2013.74.894.","Vuoristo-Myllys S","J Stud Alcohol Drugs","2013","2013/11/01","","","10.15288/jsad.2013.74.894"
"24157490","Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala","Gilpin NW, Roberto M, Koob GF, Schweitzer P.","Neuropharmacology. 2014 Feb;77:294-302. doi: 10.1016/j.neuropharm.2013.10.005. Epub 2013 Oct 21.","Gilpin NW","Neuropharmacology","2014","2013/10/26","PMC3873141","NIHMS534098","10.1016/j.neuropharm.2013.10.005"
"24153411","A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers","Sigmon SC, Dunn KE, Saulsgiver K, Patrick ME, Badger GJ, Heil SH, Brooklyn JR, Higgins ST.","JAMA Psychiatry. 2013 Dec;70(12):1347-54. doi: 10.1001/jamapsychiatry.2013.2216.","Sigmon SC","JAMA Psychiatry","2013","2013/10/25","PMC4131728","NIHMS599500","10.1001/jamapsychiatry.2013.2216"
"24152140","Morphine intake and the effects of naltrexone and buprenorphine on the acquisition of methamphetamine intake","Eastwood EC, Phillips TJ.","Genes Brain Behav. 2014 Feb;13(2):226-35. doi: 10.1111/gbb.12100. Epub 2013 Nov 18.","Eastwood EC","Genes Brain Behav","2014","2013/10/25","PMC3976242","NIHMS536605","10.1111/gbb.12100"
"24145220","The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study","Grant JE, Odlaug BL, Schreiber LR, Kim SW.","J Clin Psychopharmacol. 2014 Feb;34(1):134-8. doi: 10.1097/JCP.0000000000000037.","Grant JE","J Clin Psychopharmacol","2014","2013/10/23","","","10.1097/JCP.0000000000000037"
"24144653","Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes","Hollander P, Gupta AK, Plodkowski R, Greenway F, Bays H, Burns C, Klassen P, Fujioka K; COR-Diabetes Study Group.","Diabetes Care. 2013 Dec;36(12):4022-9. doi: 10.2337/dc13-0234. Epub 2013 Oct 21.","Hollander P","Diabetes Care","2013","2013/10/23","PMC3836105","","10.2337/dc13-0234"
"24144240","Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity","Yuan Y, Zaidi SA, Elbegdorj O, Aschenbach LC, Li G, Stevens DL, Scoggins KL, Dewey WL, Selley DE, Zhang Y.","J Med Chem. 2013 Nov 27;56(22):9156-69. doi: 10.1021/jm4012214. Epub 2013 Nov 7.","Yuan Y","J Med Chem","2013","2013/10/23","PMC4373589","NIHMS672726","10.1021/jm4012214"
"24135337","Pharmacological characteristics of zolpidem-induced catalepsy in the rat","Mierzejewski P, Kolaczkowski M, Nowak N, Korkosz A, Scinska A, Sienkiewicz-Jarosz H, Samochowiec J, Kostowski W, Bienkowski P.","Neurosci Lett. 2013 Nov 27;556:99-103. doi: 10.1016/j.neulet.2013.10.011. Epub 2013 Oct 14.","Mierzejewski P","Neurosci Lett","2013","2013/10/19","","","10.1016/j.neulet.2013.10.011"
"24133661","KASL clinical practice guidelines: management of alcoholic liver disease","Korean Association for the Study of the Liver (KASL).","Clin Mol Hepatol. 2013 Sep;19(3):216-54. doi: 10.3350/cmh.2013.19.3.216. Epub 2013 Sep 30.","Korean Association for the Study of the Liver (KASL)","Clin Mol Hepatol","2013","2013/10/18","PMC3796673","","10.3350/cmh.2013.19.3.216"
"24132534","[Opiate induced constipation--mechanisms, relevance and treatment]","Müller-Lissner S.","Dtsch Med Wochenschr. 2013 Oct;138(43):2207-11. doi: 10.1055/s-0033-1349447. Epub 2013 Oct 16.","Müller-Lissner S","Dtsch Med Wochenschr","2013","2013/10/18","","","10.1055/s-0033-1349447"
"24126432","[Nalmefene: a novel pharmacotherapeutic option for alcoholism]","Soyka M.","Nervenarzt. 2014 May;85(5):578-82. doi: 10.1007/s00115-013-3843-3.","Soyka M","Nervenarzt","2014","2013/10/16","","","10.1007/s00115-013-3843-3"
"24126280","Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA","Mizoguchi H, Kon-No T, Watanabe H, Watanabe C, Yonezawa A, Sato T, Sakurada T, Sakurada S.","Peptides. 2013 Dec;50:139-44. doi: 10.1016/j.peptides.2013.10.003. Epub 2013 Oct 12.","Mizoguchi H","Peptides","2013","2013/10/16","","","10.1016/j.peptides.2013.10.003"
"24126206","An overview of problematic internet use","Spada MM.","Addict Behav. 2014 Jan;39(1):3-6. doi: 10.1016/j.addbeh.2013.09.007. Epub 2013 Oct 2.","Spada MM","Addict Behav","2014","2013/10/16","","","10.1016/j.addbeh.2013.09.007"
"24114428","On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination","Wright FL, Rodgers RJ.","Psychopharmacology (Berl). 2014 Feb;231(4):787-800. doi: 10.1007/s00213-013-3295-2. Epub 2013 Oct 11.","Wright FL","Psychopharmacology (Berl)","2014","2013/10/12","","","10.1007/s00213-013-3295-2"
"24113418","Involvement of spinal cord opioid mechanisms in the acute antinociceptive effect of hyperbaric oxygen in mice","Heeman JH, Zhang Y, Shirachi DY, Quock RM.","Brain Res. 2013 Dec 2;1540:42-7. doi: 10.1016/j.brainres.2013.09.050. Epub 2013 Oct 7.","Heeman JH","Brain Res","2013","2013/10/12","PMC3867933","NIHMS531144","10.1016/j.brainres.2013.09.050"
"24107112","Phase I study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence","Xuyi W, Juelu W, Xiaojun X, Haiyan L, Zheyuan L, Zhehui G, Guoming D, Gang L, Jin L, Wei H.","Am J Addict. 2014 Mar-Apr;23(2):162-9. doi: 10.1111/j.1521-0391.2013.12085.x. Epub 2013 Sep 20.","Xuyi W","Am J Addict","2014","2013/10/11","","","10.1111/j.1521-0391.2013.12085.x"
"24105441","Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment","Kuzmin A, Chefer V, Bazov I, Meis J, Ögren SO, Shippenberg T, Bakalkin G.","Transl Psychiatry. 2013 Oct 8;3(10):e310. doi: 10.1038/tp.2013.72.","Kuzmin A","Transl Psychiatry","2013","2013/10/10","PMC3818015","","10.1038/tp.2013.72"
"24090623","DSM IV axis II traits can influence compliance to treatment with oral naltrexone: a preliminary study on 30 opiate dependent patients","Streel E, Chenut C, Papageorgiou C, Verbanck P.","Addict Behav. 2014 Jan;39(1):321-4. doi: 10.1016/j.addbeh.2013.08.031. Epub 2013 Sep 8.","Streel E","Addict Behav","2014","2013/10/05","","","10.1016/j.addbeh.2013.08.031"
"24089691","Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients","Aghabiklooei A, Hassanian-Moghaddam H, Zamani N, Shadnia S, Mashayekhian M, Rahimi M, Nasouhi S, Ghoochani A.","Biomed Res Int. 2013;2013:903172. doi: 10.1155/2013/903172. Epub 2013 Sep 9.","Aghabiklooei A","Biomed Res Int","2013","2013/10/04","PMC3781921","","10.1155/2013/903172"
"24084045","Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain","Podolsky AT, Sandweiss A, Hu J, Bilsky EJ, Cain JP, Kumirov VK, Lee YS, Hruby VJ, Vardanyan RS, Vanderah TW.","Life Sci. 2013 Dec 18;93(25-26):1010-6. doi: 10.1016/j.lfs.2013.09.016. Epub 2013 Sep 29.","Podolsky AT","Life Sci","2013","2013/10/03","PMC3962292","NIHMS529870","10.1016/j.lfs.2013.09.016"
"24078107","Opioid receptor blockade and warmth-liking: effects on interpersonal trust and frontal asymmetry","Schweiger D, Stemmler G, Burgdorf C, Wacker J.","Soc Cogn Affect Neurosci. 2014 Oct;9(10):1608-15. doi: 10.1093/scan/nst152. Epub 2013 Sep 27.","Schweiger D","Soc Cogn Affect Neurosci","2014","2013/10/01","PMC4187277","","10.1093/scan/nst152"
"24066621","Impact of organic solvent additive on the integrity of plasma samples in bioanalysis by LC-MS/MS","Dicaire C, Mess JN, Furtado M, Bergeron A, Garofolo F.","Bioanalysis. 2013 Oct;5(19):2359-70. doi: 10.4155/bio.13.207.","Dicaire C","Bioanalysis","2013","2013/09/27","","","10.4155/bio.13.207"
"24063986","Analgesia induced by 2- or 100-Hz electroacupuncture in the rat tail-flick test depends on the anterior pretectal nucleus","Silva ML, Silva JR, Prado WA.","Life Sci. 2013 Nov 6;93(20):742-54. doi: 10.1016/j.lfs.2013.09.012. Epub 2013 Sep 21.","Silva ML","Life Sci","2013","2013/09/26","","","10.1016/j.lfs.2013.09.012"
"24063087","Comparison of two injectable immobilization combinations in Himalayan tahr (Hemitragus jemlahicus): medetomidine, ketamine, and atipamezole versus carfentanil, xylazine, naltrexone, and atipamezole","Rainwater KL, Valitutto MT, Kalk P, Moore RP, Sykes JM.","J Zoo Wildl Med. 2013 Sep;44(3):596-604. doi: 10.1638/2012-0140R1.1.","Rainwater KL","J Zoo Wildl Med","2013","2013/09/26","","","10.1638/2012-0140R1.1"
"24055076","Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonists","Zaidi SA, Arnatt CK, He H, Selley DE, Mosier PD, Kellogg GE, Zhang Y.","Bioorg Med Chem. 2013 Nov 1;21(21):6405-13. doi: 10.1016/j.bmc.2013.08.042. Epub 2013 Sep 4.","Zaidi SA","Bioorg Med Chem","2013","2013/09/24","PMC3831368","NIHMS522979","10.1016/j.bmc.2013.08.042"
"24053426","Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation","Milewski M, Paudel KS, Brogden NK, Ghosh P, Banks SL, Hammell DC, Stinchcomb AL.","Mol Pharm. 2013 Oct 7;10(10):3745-57. doi: 10.1021/mp400227e. Epub 2013 Sep 23.","Milewski M","Mol Pharm","2013","2013/09/24","PMC3848502","NIHMS526872","10.1021/mp400227e"
"24052453","A randomized clinical trial of alcohol care management delivered in Department of Veterans Affairs primary care clinics versus specialty addiction treatment","Oslin DW, Lynch KG, Maisto SA, Lantinga LJ, McKay JR, Possemato K, Ingram E, Wierzbicki M.","J Gen Intern Med. 2014 Jan;29(1):162-8. doi: 10.1007/s11606-013-2625-8. Epub 2013 Sep 20.","Oslin DW","J Gen Intern Med","2014","2013/09/21","PMC3889933","","10.1007/s11606-013-2625-8"
"24052307","Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence","Corder G, Doolen S, Donahue RR, Winter MK, Jutras BL, He Y, Hu X, Wieskopf JS, Mogil JS, Storm DR, Wang ZJ, McCarson KE, Taylor BK.","Science. 2013 Sep 20;341(6152):1394-9. doi: 10.1126/science.1239403.","Corder G","Science","2013","2013/09/21","PMC4440417","NIHMS673303","10.1126/science.1239403"
"24043724","Rapid opiate detoxification and antagonist induction under general anaesthesia or intravenous sedation is humane, sometimes essential and should always be an option. Three illustrative case reports involving diabetes and epilepsy and a review of the literature","Brewer C, de Jong C, Williams J.","J Psychopharmacol. 2014 Jan;28(1):67-75. doi: 10.1177/0269881113504835. Epub 2013 Sep 16.","Brewer C","J Psychopharmacol","2014","2013/09/18","","","10.1177/0269881113504835"
"24036398","Divergent short- and long-term effects of acute stress in object recognition memory are mediated by endogenous opioid system activation","Nava-Mesa MO, Lamprea MR, Múnera A.","Neurobiol Learn Mem. 2013 Nov;106:185-92. doi: 10.1016/j.nlm.2013.09.002. Epub 2013 Sep 11.","Nava-Mesa MO","Neurobiol Learn Mem","2013","2013/09/17","","","10.1016/j.nlm.2013.09.002"
"24033779","Commentary on Subbaraman et al. (2013) [corrected]: cravings as a mediator and moderator of drinking outcomes in the COMBINE Study","Anton RF.","Addiction. 2013 Oct;108(10):1745-6. doi: 10.1111/add.12328.","Anton RF","Addiction","2013","2013/09/17","","","10.1111/add.12328"
"24018540","Extended-release intramuscular naltrexone (VIVITROL®): a review of its use in the prevention of relapse to opioid dependence in detoxified patients","Syed YY, Keating GM.","CNS Drugs. 2013 Oct;27(10):851-61. doi: 10.1007/s40263-013-0110-x.","Syed YY","CNS Drugs","2013","2013/09/11","","","10.1007/s40263-013-0110-x"
"24014913","Involvement of opioid and monoaminergic pain pathways in Aegle marmelos induced analgesia in mice","Kothari S, Kushwah A, Kothari D.","Indian J Pharmacol. 2013 Jul-Aug;45(4):371-5. doi: 10.4103/0253-7613.115020.","Kothari S","Indian J Pharmacol","2013","2013/09/10","PMC3757606","","10.4103/0253-7613.115020"
"24008352","Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids","Leitl MD, Onvani S, Bowers MS, Cheng K, Rice KC, Carlezon WA Jr, Banks ML, Negus SS.","Neuropsychopharmacology. 2014 Feb;39(3):614-24. doi: 10.1038/npp.2013.236. Epub 2013 Sep 6.","Leitl MD","Neuropsychopharmacology","2014","2013/09/07","PMC3895239","","10.1038/npp.2013.236"
"23998986","Involvement of brain opioid receptors in the anti-allodynic effect of hyperbaric oxygen in rats with sciatic nerve crush-induced neuropathic pain","Gibbons CR, Liu S, Zhang Y, Sayre CL, Levitch BR, Moehlmann SB, Shirachi DY, Quock RM.","Brain Res. 2013 Nov 6;1537:111-6. doi: 10.1016/j.brainres.2013.08.050. Epub 2013 Aug 30.","Gibbons CR","Brain Res","2013","2013/09/04","PMC3827781","NIHMS521006","10.1016/j.brainres.2013.08.050"
"23986225","Topical treatment with the opioid antagonist naltrexone accelerates the remodeling phase of full-thickness wound healing in type 1 diabetic rats","Immonen JA, Zagon IS, Lewis GS, McLaughlin PJ.","Exp Biol Med (Maywood). 2013 Oct;238(10):1127-35. doi: 10.1177/1535370213502632. Epub 2013 Aug 28.","Immonen JA","Exp Biol Med (Maywood)","2013","2013/08/30","","","10.1177/1535370213502632"
"23984635","Unexpected side effect of methylnaltrexone","Stettler A, Zulian GB.","J Palliat Med. 2013 Oct;16(10):1168. doi: 10.1089/jpm.2013.0264. Epub 2013 Aug 28.","Stettler A","J Palliat Med","2013","2013/08/30","","","10.1089/jpm.2013.0264"
"23976952","Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters","Munro TA, Huang XP, Inglese C, Perrone MG, Van't Veer A, Carroll FI, Béguin C, Carlezon WA Jr, Colabufo NA, Cohen BM, Roth BL.","PLoS One. 2013 Aug 14;8(8):e70701. doi: 10.1371/journal.pone.0070701. eCollection 2013.","Munro TA","PLoS One","2013","2013/08/27","PMC3747596","","10.1371/journal.pone.0070701"
"23975038","Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice","Hwa LS, Kalinichev M, Haddouk H, Poli S, Miczek KA.","Psychopharmacology (Berl). 2014 Jan;231(2):333-43. doi: 10.1007/s00213-013-3245-z. Epub 2013 Aug 22.","Hwa LS","Psychopharmacology (Berl)","2014","2013/08/27","PMC3947346","NIHMS518617","10.1007/s00213-013-3245-z"
"23973647","Mechanisms underlying the antinociceptive effect of mangiferin in the formalin test","Izquierdo T, Espinosa de los Monteros-Zuñiga A, Cervantes-Durán C, Lozada MC, Godínez-Chaparro B.","Eur J Pharmacol. 2013 Oct 15;718(1-3):393-400. doi: 10.1016/j.ejphar.2013.08.004. Epub 2013 Aug 23.","Izquierdo T","Eur J Pharmacol","2013","2013/08/27","","","10.1016/j.ejphar.2013.08.004"
"23965295","Involvement of delta and mu opioid receptors in the acute and sensitized locomotor action of cocaine in mice","Kotlinska JH, Gibula-Bruzda E, Witkowska E, Izdebski J.","Peptides. 2013 Oct;48:89-95. doi: 10.1016/j.peptides.2013.08.009. Epub 2013 Aug 18.","Kotlinska JH","Peptides","2013","2013/08/23","","","10.1016/j.peptides.2013.08.009"
"23955905","A novel adjuvant, mixture of Alum and naltrexone, elicits humoral immune responses for excreted/secreted antigens of Toxoplasma gondii tachyzoites vaccine in Balb/c murine model","Tappeh KH, Khorshidvand Z, Shahabi S, Mohammadzadeh H.","Turkiye Parazitol Derg. 2013;37(2):92-6. doi: 10.5152/tpd.2013.22.","Tappeh KH","Turkiye Parazitol Derg","2013","2013/08/20","","","10.5152/tpd.2013.22"
"23953813","Different types of opioid receptors involved in the suppression of LH secretion in lactating sheep","Dobek E, Górski K, Romanowicz K, Misztal T.","Anim Reprod Sci. 2013 Sep;141(1-2):62-7. doi: 10.1016/j.anireprosci.2013.07.006. Epub 2013 Jul 25.","Dobek E","Anim Reprod Sci","2013","2013/08/20","","","10.1016/j.anireprosci.2013.07.006"
"23952195","Meta-analysis: pharmacological treatment of pathological gambling","Bartley CA, Bloch MH.","Expert Rev Neurother. 2013 Aug;13(8):887-94. doi: 10.1586/14737175.2013.814938. Epub 2013 Aug 16.","Bartley CA","Expert Rev Neurother","2013","2013/08/20","","","10.1586/14737175.2013.814938"
"23949908","Nalmefene: a review of its use in the treatment of alcohol dependence","Keating GM.","CNS Drugs. 2013 Sep;27(9):761-72. doi: 10.1007/s40263-013-0101-y.","Keating GM","CNS Drugs","2013","2013/08/17","","","10.1007/s40263-013-0101-y"
"23947734","Commentary on Krupitsky et al.(2013): Refuge from the streets--parked on methadone, or seeking shelter of a depot?","Bell J.","Addiction. 2013 Sep;108(9):1638-9. doi: 10.1111/add.12248.","Bell J","Addiction","2013","2013/08/17","","","10.1111/add.12248"
"23943543","Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin","Ghosh P, Lee D, Kim KB, Stinchcomb AL.","Pharm Res. 2014 Jan;31(1):148-59. doi: 10.1007/s11095-013-1147-8. Epub 2013 Aug 14.","Ghosh P","Pharm Res","2014","2013/08/15","PMC3870048","NIHMS515769","10.1007/s11095-013-1147-8"
"23936895","Assessing the subjective and physiological effects of intranasally administered crushed extended-release morphine formulations with and without a sequestered naltrexone core in recreational opioid users","Setnik B, Goli V, Levy-Cooperman N, Mills C, Shram M, Smith I.","Pain Res Manag. 2013 Jul-Aug;18(4):e55-62. doi: 10.1155/2013/952082.","Setnik B","Pain Res Manag","2013","2013/08/13","PMC3812195","","10.1155/2013/952082"
"23933468","The mesolimbic system participates in the naltrexone-induced reversal of sexual exhaustion: opposite effects of intra-VTA naltrexone administration on copulation of sexually experienced and sexually exhausted male rats","Garduño-Gutiérrez R, León-Olea M, Rodríguez-Manzo G.","Behav Brain Res. 2013 Nov 1;256:64-71. doi: 10.1016/j.bbr.2013.07.056. Epub 2013 Aug 8.","Garduño-Gutiérrez R","Behav Brain Res","2013","2013/08/13","","","10.1016/j.bbr.2013.07.056"
"23933210","Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice","Kishioka S, Kiguchi N, Kobayashi Y, Yamamoto C, Saika F, Wakida N, Ko MC, Woods JH.","Neurosci Lett. 2013 Sep 27;552:98-102. doi: 10.1016/j.neulet.2013.07.040. Epub 2013 Aug 7.","Kishioka S","Neurosci Lett","2013","2013/08/13","","","10.1016/j.neulet.2013.07.040"
"23932227","Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption","Robinson S, Bowe T, Harris AH.","J Subst Abuse Treat. 2013 Nov-Dec;45(5):475-7. doi: 10.1016/j.jsat.2013.06.009. Epub 2013 Aug 9.","Robinson S","J Subst Abuse Treat","2013","2013/08/13","PMC4013787","NIHMS523017","10.1016/j.jsat.2013.06.009"
"23925680","Naltrexone may block euphoria-like placebo effect","Samokhvalov AV, Gamaleddin I, Sproule B, Rehm J.","BMJ Case Rep. 2013 Aug 7;2013:bcr2013010098. doi: 10.1136/bcr-2013-010098.","Samokhvalov AV","BMJ Case Rep","2013","2013/08/09","PMC3762058","","10.1136/bcr-2013-010098"
"23925619","Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial","Foa EB, Yusko DA, McLean CP, Suvak MK, Bux DA Jr, Oslin D, O'Brien CP, Imms P, Riggs DS, Volpicelli J.","JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268.","Foa EB","JAMA","2013","2013/08/09","","","10.1001/jama.2013.8268"
"23925616","Treatment of comorbid substance dependence and posttraumatic stress disorder","Mills K.","JAMA. 2013 Aug 7;310(5):482-3. doi: 10.1001/jama.2013.8269.","Mills K","JAMA","2013","2013/08/09","","","10.1001/jama.2013.8269"
"23924756","Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues","Wang GJ, Tomasi D, Volkow ND, Wang R, Telang F, Caparelli EC, Dunayevich E.","Int J Obes (Lond). 2014 May;38(5):682-8. doi: 10.1038/ijo.2013.145. Epub 2013 Aug 8.","Wang GJ","Int J Obes (Lond)","2014","2013/08/09","PMC4010969","","10.1038/ijo.2013.145"
"23918871","Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer","Zagon IS, Porterfield NK, McLaughlin PJ.","Exp Biol Med (Maywood). 2013 Jun;238(6):589-99. doi: 10.1177/1535370213489492.","Zagon IS","Exp Biol Med (Maywood)","2013","2013/08/07","","","10.1177/1535370213489492"
"23916912","Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus","Brunetti L, Ferrante C, Orlando G, Recinella L, Leone S, Chiavaroli A, Di Nisio C, Shohreh R, Manippa F, Ricciuti A, Mollica A, Vacca M.","Peptides. 2013 Oct;48:83-8. doi: 10.1016/j.peptides.2013.07.021. Epub 2013 Aug 3.","Brunetti L","Peptides","2013","2013/08/07","","","10.1016/j.peptides.2013.07.021"
"23903243","Ethanol self-administration in rats responding under concurrent schedules for milk or ethanol plus milk","Paronis CA.","Behav Pharmacol. 2013 Sep;24(5-6):486-95. doi: 10.1097/FBP.0b013e328364c006.","Paronis CA","Behav Pharmacol","2013","2013/08/02","","","10.1097/FBP.0b013e328364c006"
"23891651","Morphine treatment selectively regulates expression of rat pituitary POMC and the prohormone convertases PC1/3 and PC2","Nie Y, Ferrini MG, Liu Y, Anghel A, Paez Espinosa EV, Stuart RC, Lutfy K, Nillni EA, Friedman TC.","Peptides. 2013 Sep;47:99-109. doi: 10.1016/j.peptides.2013.07.006. Epub 2013 Jul 26.","Nie Y","Peptides","2013","2013/07/30","PMC3787842","NIHMS510099","10.1016/j.peptides.2013.07.006"
"23890764","Quality of life in veterans with alcohol dependence and co-occurring mental illness","Ralevski E, Gianoli MO, McCarthy E, Petrakis I.","Addict Behav. 2014 Feb;39(2):386-91. doi: 10.1016/j.addbeh.2013.06.002. Epub 2013 Jun 13.","Ralevski E","Addict Behav","2014","2013/07/30","","","10.1016/j.addbeh.2013.06.002"
"23889334","Missing data in alcohol clinical trials: a comparison of methods","Hallgren KA, Witkiewitz K.","Alcohol Clin Exp Res. 2013 Dec;37(12):2152-60. doi: 10.1111/acer.12205. Epub 2013 Jul 24.","Hallgren KA","Alcohol Clin Exp Res","2013","2013/07/30","PMC4113114","NIHMS604999","10.1111/acer.12205"
"23889231","The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies","Litten RZ, Castle IJ, Falk D, Ryan M, Fertig J, Chen CM, Yi HY.","Alcohol Clin Exp Res. 2013 Dec;37(12):2128-37. doi: 10.1111/acer.12197. Epub 2013 Jul 24.","Litten RZ","Alcohol Clin Exp Res","2013","2013/07/30","PMC3823636","NIHMS480537","10.1111/acer.12197"
"23889161","Research opportunities for medications to treat alcohol dependence: addressing stakeholders' needs","Litten RZ, Falk D, Ryan M, Fertig J.","Alcohol Clin Exp Res. 2014 Jan;38(1):27-32. doi: 10.1111/acer.12193. Epub 2013 Jul 24.","Litten RZ","Alcohol Clin Exp Res","2014","2013/07/30","","","10.1111/acer.12193"
"23888749","[Pharmacological features of naltrexone and its use in the treatment of alcohol dependence]","Bieńkowski P.","Psychiatr Pol. 2013 Jan-Feb;47(1):117-26.","Bieńkowski P","Psychiatr Pol","2013","2013/07/30","","",""
"23888580","[Rapid opiate detoxification under anesthesia (RODA)]","Dubols N, Hallet C, Luppens D, Ansseau M, Charlier C.","Rev Med Liege. 2013 May-Jun;68(5-6):298-302.","Dubols N","Rev Med Liege","2013","2013/07/30","","",""
"23887471","[Alcohol dependence and mental adaptation disorders (the use of injectable extended-release naltrexone)]","Agibalova TV, Rychkova OV, Kuznetsov AG, Gurevich GL, Val'chuk DS, Petrov AD.","Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(6 Pt 2):63-8.","Agibalova TV","Zh Nevrol Psikhiatr Im S S Korsakova","2013","2013/07/27","","",""
"23881667","Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone","Rauck RL.","Drugs. 2013 Aug;73(12):1297-306. doi: 10.1007/s40265-013-0084-5.","Rauck RL","Drugs","2013","2013/07/25","","","10.1007/s40265-013-0084-5"
"23881605","Targeted opioid receptor antagonists in the treatment of alcohol use disorders","Niciu MJ, Arias AJ.","CNS Drugs. 2013 Oct;27(10):777-87. doi: 10.1007/s40263-013-0096-4.","Niciu MJ","CNS Drugs","2013","2013/07/25","PMC4600601","NIHMS509129","10.1007/s40263-013-0096-4"
"23881045","Abuse-related effects of µ-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure","Altarifi AA, Rice KC, Negus SS.","Behav Pharmacol. 2013 Sep;24(5-6):459-70. doi: 10.1097/FBP.0b013e328364c0bd.","Altarifi AA","Behav Pharmacol","2013","2013/07/25","PMC3864000","NIHMS535001","10.1097/FBP.0b013e328364c0bd"
"23880055","Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats","He SQ, Yang F, Perez FM, Xu Q, Shechter R, Cheong YK, Carteret AF, Dong X, Sweitzer SM, Raja SN, Guan Y.","Pain. 2013 Nov;154(11):2477-86. doi: 10.1016/j.pain.2013.07.023. Epub 2013 Jul 20.","He SQ","Pain","2013","2013/07/25","PMC3863910","NIHMS508391","10.1016/j.pain.2013.07.023"
"23877505","Chronic peripheral administration of kappa-opioid receptor antagonist advances puberty onset associated with acceleration of pulsatile luteinizing hormone secretion in female rats","Nakahara T, Uenoyama Y, Iwase A, Oishi S, Nakamura S, Minabe S, Watanabe Y, Deura C, Noguchi T, Fujii N, Kikkawa F, Maeda K, Tsukamura H.","J Reprod Dev. 2013 Oct;59(5):479-84. doi: 10.1262/jrd.2013-046. Epub 2013 Jul 22.","Nakahara T","J Reprod Dev","2013","2013/07/24","PMC3934117","","10.1262/jrd.2013-046"
"23877147","Use of methylnaltrexone to induce laxation in acutely injured patients with burns and necrotizing soft-tissue infections","Hewitt K, Lin H, Faraklas I, Morris S, Cochran A, Saffle J.","J Burn Care Res. 2014 Mar-Apr;35(2):e106-11. doi: 10.1097/BCR.0b013e31829b399d.","Hewitt K","J Burn Care Res","2014","2013/07/24","","","10.1097/BCR.0b013e31829b399d"
"23875623","Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone","Froehlich JC, Hausauer BJ, Rasmussen DD.","Alcohol Clin Exp Res. 2013 Oct;37(10):1763-70. doi: 10.1111/acer.12148. Epub 2013 Jul 22.","Froehlich JC","Alcohol Clin Exp Res","2013","2013/07/24","PMC3795831","NIHMS459525","10.1111/acer.12148"
"23873853","Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies","van den Brink W, Aubin HJ, Bladström A, Torup L, Gual A, Mann K.","Alcohol Alcohol. 2013 Sep-Oct;48(5):570-8. doi: 10.1093/alcalc/agt061. Epub 2013 Jul 19.","van den Brink W","Alcohol Alcohol","2013","2013/07/23","PMC3746807","","10.1093/alcalc/agt061"
"23856908","Targeting the opioid growth factor: opioid growth factor receptor axis for treatment of human ovarian cancer","Zagon IS, Donahue R, McLaughlin PJ.","Exp Biol Med (Maywood). 2013 May;238(5):579-87. doi: 10.1177/1535370213488483.","Zagon IS","Exp Biol Med (Maywood)","2013","2013/07/17","","","10.1177/1535370213488483"
"23855719","Adoption and diffusion of evidence-based addiction medications in substance abuse treatment","Heinrich CJ, Cummings GR.","Health Serv Res. 2014 Feb;49(1):127-52. doi: 10.1111/1475-6773.12093. Epub 2013 Jul 16.","Heinrich CJ","Health Serv Res","2014","2013/07/17","PMC3922470","","10.1111/1475-6773.12093"
"23853171","Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptors","Patkar KA, Wu J, Ganno ML, Singh HD, Ross NC, Rasakham K, Toll L, McLaughlin JP.","J Pharmacol Exp Ther. 2013 Sep;346(3):545-54. doi: 10.1124/jpet.113.206086. Epub 2013 Jul 12.","Patkar KA","J Pharmacol Exp Ther","2013","2013/07/16","","","10.1124/jpet.113.206086"
"23846544","Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract","Stolt AC, Schröder H, Neurath H, Grecksch G, Höllt V, Meyer MR, Maurer HH, Ziebolz N, Havemann-Reinecke U, Becker A.","Psychopharmacology (Berl). 2014 Jan;231(1):13-25. doi: 10.1007/s00213-013-3201-y. Epub 2013 Jul 12.","Stolt AC","Psychopharmacology (Berl)","2014","2013/07/13","","","10.1007/s00213-013-3201-y"
"23844255","δ-Opioid receptor activation rescues the functional TrkB receptor and protects the brain from ischemia-reperfusion injury in the rat","Tian X, Guo J, Zhu M, Li M, Wu G, Xia Y.","PLoS One. 2013 Jul 2;8(7):e69252. doi: 10.1371/journal.pone.0069252. Print 2013.","Tian X","PLoS One","2013","2013/07/12","PMC3699518","","10.1371/journal.pone.0069252"
"23834367","Pharmacologic treatment of opioid-induced constipation","Wang CZ, Yuan CS.","Expert Opin Investig Drugs. 2013 Oct;22(10):1225-7. doi: 10.1517/13543784.2013.819341. Epub 2013 Jul 9.","Wang CZ","Expert Opin Investig Drugs","2013","2013/07/10","","","10.1517/13543784.2013.819341"
"23827259","Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?","Sullivan MA, Bisaga A, Mariani JJ, Glass A, Levin FR, Comer SD, Nunes EV.","Drug Alcohol Depend. 2013 Nov 1;133(1):80-5. doi: 10.1016/j.drugalcdep.2013.05.030. Epub 2013 Jul 1.","Sullivan MA","Drug Alcohol Depend","2013","2013/07/06","PMC3955093","NIHMS502113","10.1016/j.drugalcdep.2013.05.030"
"23813295","Combining medical treatment and CBT in treating alcohol-dependent patients: effects on life quality and general well-being","Laaksonen E, Vuoristo-Myllys S, Koski-Jannes A, Alho H.","Alcohol Alcohol. 2013 Nov-Dec;48(6):687-93. doi: 10.1093/alcalc/agt053. Epub 2013 Jun 28.","Laaksonen E","Alcohol Alcohol","2013","2013/07/02","","","10.1093/alcalc/agt053"
"23810221","Pharmacotherapy for alcohol dependence: status of current treatments","Franck J, Jayaram-Lindström N.","Curr Opin Neurobiol. 2013 Aug;23(4):692-9. doi: 10.1016/j.conb.2013.05.005. Epub 2013 Jun 26.","Franck J","Curr Opin Neurobiol","2013","2013/07/02","","","10.1016/j.conb.2013.05.005"
"23805859","Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial","Tek C, Guloksuz S, Srihari VH, Reutenauer EL.","BMC Psychiatry. 2013 Jun 27;13:176. doi: 10.1186/1471-244X-13-176.","Tek C","BMC Psychiatry","2013","2013/06/29","PMC3702521","","10.1186/1471-244X-13-176"
"23802568","Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs","Arnold TS, Wittenburg LA, Powell CC.","Vet Ophthalmol. 2014 Sep;17(5):328-33. doi: 10.1111/vop.12079. Epub 2013 Jun 27.","Arnold TS","Vet Ophthalmol","2014","2013/06/28","","","10.1111/vop.12079"
"23802360","[Constipation management in palliative care]","Lötscher C, Ivanovi N, Fringer A.","Krankenpfl Soins Infirm. 2013;106(6):32-3.","Lötscher C","Krankenpfl Soins Infirm","2013","2013/06/28","","",""
"23791558","A novel, potent, oral active and safe antinociceptive pyrazole targeting kappa opioid receptors","Trevisan G, Rossato MF, Walker CI, Oliveira SM, Rosa F, Tonello R, Silva CR, Machado P, Boligon AA, Martins MA, Zanatta N, Bonacorso HG, Athayde ML, Rubin MA, Calixto JB, Ferreira J.","Neuropharmacology. 2013 Oct;73:261-73. doi: 10.1016/j.neuropharm.2013.06.011. Epub 2013 Jun 18.","Trevisan G","Neuropharmacology","2013","2013/06/25","","","10.1016/j.neuropharm.2013.06.011"
"23790742","Long-acting injectable depot naltrexone use in the Veterans' Health Administration: a national study","Marienfeld C, Iheanacho T, Issa M, Rosenheck RA.","Addict Behav. 2014 Feb;39(2):434-8. doi: 10.1016/j.addbeh.2013.05.006. Epub 2013 May 21.","Marienfeld C","Addict Behav","2014","2013/06/25","","","10.1016/j.addbeh.2013.05.006"
"23788174","Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis","McLaughlin PJ, Immonen JA, Zagon IS.","Exp Biol Med (Maywood). 2013 Jul;238(7):733-43. doi: 10.1177/1535370213492688. Epub 2013 Jun 20.","McLaughlin PJ","Exp Biol Med (Maywood)","2013","2013/06/22","","","10.1177/1535370213492688"
"23787819","Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism","Al-Hasani R, McCall JG, Foshage AM, Bruchas MR.","Neuropsychopharmacology. 2013 Nov;38(12):2484-97. doi: 10.1038/npp.2013.151. Epub 2013 Jun 21.","Al-Hasani R","Neuropsychopharmacology","2013","2013/06/22","PMC3799068","","10.1038/npp.2013.151"
"23782897","Overview and treatment of opioid-induced constipation","McCarberg BH.","Postgrad Med. 2013 Jul;125(4):7-17. doi: 10.3810/pgm.2013.07.2651. Epub 2013 Jun 19.","McCarberg BH","Postgrad Med","2013","2013/06/21","","","10.3810/pgm.2013.07.2651"
"23777539","Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone","Zagon IS, Sassani JW, Immonen JA, McLaughlin PJ.","Clin Exp Ophthalmol. 2014 Mar;42(2):159-68. doi: 10.1111/ceo.12144. Epub 2013 Jul 29.","Zagon IS","Clin Exp Ophthalmol","2014","2013/06/20","","","10.1111/ceo.12144"
"23775075","Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons","Schmid CL, Streicher JM, Groer CE, Munro TA, Zhou L, Bohn LM.","J Biol Chem. 2013 Aug 2;288(31):22387-98. doi: 10.1074/jbc.M113.476234. Epub 2013 Jun 17.","Schmid CL","J Biol Chem","2013","2013/06/19","PMC3829329","","10.1074/jbc.M113.476234"
"23766091","Methylnaltrexone for opioid-induced constipation in pediatric oncology patients","Rodrigues A, Wong C, Mattiussi A, Alexander S, Lau E, Dupuis LL.","Pediatr Blood Cancer. 2013 Oct;60(10):1667-70. doi: 10.1002/pbc.24615. Epub 2013 Jun 14.","Rodrigues A","Pediatr Blood Cancer","2013","2013/06/15","","","10.1002/pbc.24615"
"23761054","Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans","Brogden NK, Banks SL, Crofford LJ, Stinchcomb AL.","Pharm Res. 2013 Aug;30(8):1947-55. doi: 10.1007/s11095-013-1036-1. Epub 2013 Jun 13.","Brogden NK","Pharm Res","2013","2013/06/14","PMC3773937","NIHMS492795","10.1007/s11095-013-1036-1"
"23754134","Effects of the kappa opioid receptor antagonist, nor-binaltorphimine, on ethanol intake: impact of age and sex","Morales M, Anderson RI, Spear LP, Varlinskaya EI.","Dev Psychobiol. 2014 May;56(4):700-12. doi: 10.1002/dev.21137. Epub 2013 Jun 10.","Morales M","Dev Psychobiol","2014","2013/06/12","PMC4074415","NIHMS582536","10.1002/dev.21137"
"23752879","Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis","Ford AC, Brenner DM, Schoenfeld PS.","Am J Gastroenterol. 2013 Oct;108(10):1566-74; quiz 1575. doi: 10.1038/ajg.2013.169. Epub 2013 Jun 11.","Ford AC","Am J Gastroenterol","2013","2013/06/12","","","10.1038/ajg.2013.169"
"23751259","A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia","El-Hage N, Dever SM, Podhaizer EM, Arnatt CK, Zhang Y, Hauser KF.","AIDS. 2013 Sep 10;27(14):2181-90. doi: 10.1097/QAD.0b013e3283639804.","El-Hage N","AIDS","2013","2013/06/12","PMC3918492","NIHMS540643","10.1097/QAD.0b013e3283639804"
"23750742","Training and fidelity monitoring of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia: the IMPACT Effectiveness Trial","Connery H, Greenfield S, Livchits V, McGrady L, Patrick N, Lastimoso CS, Heney JH, Nelson AK, Shields A, Stepanova YP, Petrova LY, Anastasov OV, Novoseltseva OI, Shin SS.","Subst Use Misuse. 2013 Jun;48(9):784-92. doi: 10.3109/10826084.2013.793715. Epub 2013 Jun 10.","Connery H","Subst Use Misuse","2013","2013/06/12","PMC4010131","NIHMS511527","10.3109/10826084.2013.793715"
"23746430","Emerging pharmacotherapies for alcohol dependence: a systematic review focusing on reduction in consumption","Aubin HJ, Daeppen JB.","Drug Alcohol Depend. 2013 Nov 1;133(1):15-29. doi: 10.1016/j.drugalcdep.2013.04.025. Epub 2013 Jun 6.","Aubin HJ","Drug Alcohol Depend","2013","2013/06/11","","","10.1016/j.drugalcdep.2013.04.025"
"23746197","Methylnaltrexone use in a seventeen-month-old female with progressive cancer and rectal prolapse","Laubisch JE, Baker JN.","J Palliat Med. 2013 Nov;16(11):1486-8. doi: 10.1089/jpm.2012.0600. Epub 2013 Jun 7.","Laubisch JE","J Palliat Med","2013","2013/06/11","PMC3822361","","10.1089/jpm.2012.0600"
"23745947","Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid users","Setnik B, Sommerville K, Goli V, Han L, Webster L.","Pain Med. 2013 Aug;14(8):1173-86. doi: 10.1111/pme.12148. Epub 2013 Jun 7.","Setnik B","Pain Med","2013","2013/06/11","","","10.1111/pme.12148"
"23744347","Opioid antagonists for smoking cessation","David SP, Lancaster T, Stead LF, Evins AE, Prochaska JJ.","Cochrane Database Syst Rev. 2013 Jun 6;6(6):CD003086. doi: 10.1002/14651858.CD003086.pub3.","David SP","Cochrane Database Syst Rev","2013","2013/06/08","PMC4038652","NIHMS579848","10.1002/14651858.CD003086.pub3"
"23739600","[Pharmacogenetics and the treatment of addiction]","Schellekens A.","Ned Tijdschr Geneeskd. 2013;157(23):A5725.","Schellekens A","Ned Tijdschr Geneeskd","2013","2013/06/07","","",""
"23736314","Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers","Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D, Walker EA, Jones JD, Vosburg SK, Cooper ZD, Roux P, Sullivan MA, Manubay JM, Rubin E, Pines A, Berkower EL, Haney M, Foltin RW.","Neuropsychopharmacology. 2013 Nov;38(12):2427-38. doi: 10.1038/npp.2013.143. Epub 2013 Jun 5.","Comer SD","Neuropsychopharmacology","2013","2013/06/06","PMC3799062","","10.1038/npp.2013.143"
"23735301","Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication","van Cleef KW, Overheul GJ, Thomassen MC, Kaptein SJ, Davidson AD, Jacobs M, Neyts J, van Kuppeveld FJ, van Rij RP.","Antiviral Res. 2013 Aug;99(2):165-71. doi: 10.1016/j.antiviral.2013.05.011. Epub 2013 Jun 2.","van Cleef KW","Antiviral Res","2013","2013/06/06","","","10.1016/j.antiviral.2013.05.011"
"23732971","Monthly injectable naltrexone for pathological gambling","Yoon G, Kim SW.","Am J Psychiatry. 2013 Jun;170(6):682-3. doi: 10.1176/appi.ajp.2013.12111469.","Yoon G","Am J Psychiatry","2013","2013/06/05","","","10.1176/appi.ajp.2013.12111469"
"23731692","Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system","Gillett K, Harshberger E, Valdez GR.","Alcohol. 2013 Aug;47(5):359-65. doi: 10.1016/j.alcohol.2013.05.001. Epub 2013 May 31.","Gillett K","Alcohol","2013","2013/06/05","PMC3700612","NIHMS483581","10.1016/j.alcohol.2013.05.001"
"23731419","Medications for substance use disorders","Douaihy AB, Kelly TM, Sullivan C.","Soc Work Public Health. 2013;28(3-4):264-78. doi: 10.1080/19371918.2013.759031.","Douaihy AB","Soc Work Public Health","2013","2013/06/05","PMC3767185","NIHMS496118","10.1080/19371918.2013.759031"
"23729643","Opioid pharmacogenetics of alcohol addiction","Berrettini W.","Cold Spring Harb Perspect Med. 2013 Jul 1;3(7):a012203. doi: 10.1101/cshperspect.a012203.","Berrettini W","Cold Spring Harb Perspect Med","2013","2013/06/05","PMC3685876","","10.1101/cshperspect.a012203"
"23727404","The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice","Kitanaka J, Kitanaka N, Hall FS, Uhl GR, Fukushima Y, Sawai T, Watabe K, Kubo H, Takahashi H, Tanaka K, Nishiyama N, Tatsuta T, Morita Y, Takemura M.","Brain Res. 2013 Jul 19;1522:88-98. doi: 10.1016/j.brainres.2013.05.027. Epub 2013 May 28.","Kitanaka J","Brain Res","2013","2013/06/04","","","10.1016/j.brainres.2013.05.027"
"23721804","Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives","Zhang Y, Elbegdorj O, Yuan Y, Beletskaya IO, Selley DE.","Bioorg Med Chem Lett. 2013 Jul 1;23(13):3719-22. doi: 10.1016/j.bmcl.2013.05.027. Epub 2013 May 16.","Zhang Y","Bioorg Med Chem Lett","2013","2013/06/01","PMC3690547","NIHMS482593","10.1016/j.bmcl.2013.05.027"
"23721530","Naltrexone (50 mg) plus psychotherapy in alcohol-dependent patients: a meta-analysis of randomized controlled trials","Jarosz J, Miernik K, Wąchal M, Walczak J, Krumpl G.","Am J Drug Alcohol Abuse. 2013 May;39(3):144-60. doi: 10.3109/00952990.2013.796961.","Jarosz J","Am J Drug Alcohol Abuse","2013","2013/06/01","","","10.3109/00952990.2013.796961"
"23714324","Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial","King A, Cao D, Zhang L, Rueger SY.","Addiction. 2013 Oct;108(10):1836-44. doi: 10.1111/add.12261. Epub 2013 Jul 12.","King A","Addiction","2013","2013/05/30","PMC3775903","NIHMS487351","10.1111/add.12261"
"23713743","Effects of remifentanil on the esophagogastric junction and swallowing","Savilampi J, Ahlstrand R, Magnuson A, Wattwil M.","Acta Anaesthesiol Scand. 2013 Sep;57(8):1002-9. doi: 10.1111/aas.12134. Epub 2013 May 29.","Savilampi J","Acta Anaesthesiol Scand","2013","2013/05/30","","","10.1111/aas.12134"
"23713721","Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities","Healy JR, Bezawada P, Shim J, Jones JW, Kane MA, MacKerell AD Jr, Coop A, Matsumoto RR.","ACS Chem Neurosci. 2013 Sep 18;4(9):1256-66. doi: 10.1021/cn4000428. Epub 2013 Jun 11.","Healy JR","ACS Chem Neurosci","2013","2013/05/30","PMC3778426","","10.1021/cn4000428"
"23709323","A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients","Setnik B, Roland CL, Goli V, Sommerville K, Webster L.","J Opioid Manag. 2013 Mar-Apr;9(2):139-50. doi: 10.5055/jom.2013.0155.","Setnik B","J Opioid Manag","2013","2013/05/28","","","10.5055/jom.2013.0155"
"23701526","Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness","Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, Silverman BL.","Addiction. 2013 Sep;108(9):1628-37. doi: 10.1111/add.12208. Epub 2013 May 24.","Krupitsky E","Addiction","2013","2013/05/25","","","10.1111/add.12208"
"23697901","Behavioral characteristics and pharmacological manipulations of a nicotine-entrainable circadian oscillator","Gillman AG, Leffel JK, Kosobud AE, Timberlake W.","Chronobiol Int. 2013 Aug;30(7):855-69. doi: 10.3109/07420528.2013.782314. Epub 2013 May 22.","Gillman AG","Chronobiol Int","2013","2013/05/24","","","10.3109/07420528.2013.782314"
"23690227","Withdrawal syndrome caused by naltrexone in opioid abusers","Hassanian-Moghaddam H, Afzali S, Pooya A.","Hum Exp Toxicol. 2014 Jun;33(6):561-7. doi: 10.1177/0960327112450901. Epub 2013 May 20.","Hassanian-Moghaddam H","Hum Exp Toxicol","2014","2013/05/22","","","10.1177/0960327112450901"
"23689673","Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats","Walker BM, Kissler JL.","Neuropsychopharmacology. 2013 Oct;38(11):2278-85. doi: 10.1038/npp.2013.129. Epub 2013 May 21.","Walker BM","Neuropsychopharmacology","2013","2013/05/22","PMC3773679","","10.1038/npp.2013.129"
"23683793","Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia","Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Tsoy M, Wahlgren V, Burakov A, Masalov D, Romanova TN, Palatkin V, Tyurina A, Yaroslavtseva T, Sinha R, Kosten TR.","Drug Alcohol Depend. 2013 Oct 1;132(3):674-80. doi: 10.1016/j.drugalcdep.2013.04.021. Epub 2013 May 15.","Krupitsky E","Drug Alcohol Depend","2013","2013/05/21","PMC3971535","NIHMS481127","10.1016/j.drugalcdep.2013.04.021"
"23675763","An immunocytochemical-derived correlate for evaluating the bridging of heteromeric mu-delta opioid protomers by bivalent ligands","Yekkirala AS, Kalyuzhny AE, Portoghese PS.","ACS Chem Biol. 2013 Jul 19;8(7):1412-6. doi: 10.1021/cb400113d. Epub 2013 May 17.","Yekkirala AS","ACS Chem Biol","2013","2013/05/17","PMC5060010","NIHMS481929","10.1021/cb400113d"
"23675405","Ventral hippocampal kappa opioid receptors mediate the renewal of fear following extinction in the rat","Cole S, Richardson R, McNally GP.","PLoS One. 2013 May 10;8(5):e58701. doi: 10.1371/journal.pone.0058701. Print 2013.","Cole S","PLoS One","2013","2013/05/16","PMC3651202","","10.1371/journal.pone.0058701"
"23672966","Hormonal contraceptive use diminishes salivary cortisol response to psychosocial stress and naltrexone in healthy women","Roche DJ, King AC, Cohoon AJ, Lovallo WR.","Pharmacol Biochem Behav. 2013 Aug;109:84-90. doi: 10.1016/j.pbb.2013.05.007. Epub 2013 May 12.","Roche DJ","Pharmacol Biochem Behav","2013","2013/05/16","PMC3683955","NIHMS479283","10.1016/j.pbb.2013.05.007"
"23668624","Cravings as a mediator and moderator of drinking outcomes in the COMBINE study","Subbaraman MS, Lendle S, van der Laan M, Kaskutas LA, Ahern J.","Addiction. 2013 Oct;108(10):1737-44. doi: 10.1111/add.12238. Epub 2013 Jun 4.","Subbaraman MS","Addiction","2013","2013/05/15","PMC3916135","NIHMS535620","10.1111/add.12238"
"23649949","Long-term antinociception by electroacupuncture is mediated via peripheral opioid receptors in free-moving rats with inflammatory hyperalgesia","Wang Y, Hackel D, Peng F, Rittner HL.","Eur J Pain. 2013 Nov;17(10):1447-57. doi: 10.1002/j.1532-2149.2013.00325.x. Epub 2013 May 6.","Wang Y","Eur J Pain","2013","2013/05/08","","","10.1002/j.1532-2149.2013.00325.x"
"23644347","Controlled delivery of naltrexone by an intraoral device: in vivo study on human subjects","Paderni C, Campisi G, Schumacher A, Göttsche T, Giannola LI, De Caro V, Wolff A.","Int J Pharm. 2013 Aug 16;452(1-2):128-34. doi: 10.1016/j.ijpharm.2013.04.070. Epub 2013 May 2.","Paderni C","Int J Pharm","2013","2013/05/07","","","10.1016/j.ijpharm.2013.04.070"
"23637207","Role of the endogenous opioid system in modulation of urinary bladder activity by spinal nerve stimulation","Su X, Nickles A, Nelson DE.","Am J Physiol Renal Physiol. 2013 Jul 1;305(1):F52-60. doi: 10.1152/ajprenal.00090.2013. Epub 2013 May 1.","Su X","Am J Physiol Renal Physiol","2013","2013/05/03","PMC3725673","","10.1152/ajprenal.00090.2013"
"23633366","Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities","Rana F, Gormez A, Varghese S.","Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009084. doi: 10.1002/14651858.CD009084.pub2.","Rana F","Cochrane Database Syst Rev","2013","2013/05/02","","","10.1002/14651858.CD009084.pub2"
"23624641","Anger regulation style, anger arousal and acute pain sensitivity: evidence for an endogenous opioid ""triggering"" model","Burns JW, Bruehl S, Chont M.","J Behav Med. 2014 Aug;37(4):642-53. doi: 10.1007/s10865-013-9511-z. Epub 2013 Apr 28.","Burns JW","J Behav Med","2014","2013/04/30","PMC4180113","NIHMS473428","10.1007/s10865-013-9511-z"
"23624290","In vitro binding affinities of a series of flavonoids for μ-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice","Higgs J, Wasowski C, Loscalzo LM, Marder M.","Neuropharmacology. 2013 Sep;72:9-19. doi: 10.1016/j.neuropharm.2013.04.020. Epub 2013 Apr 26.","Higgs J","Neuropharmacology","2013","2013/04/30","","","10.1016/j.neuropharm.2013.04.020"
"23624288","The interaction of adenosine and morphine on pentylenetetrazole-induced seizure threshold in mice","Moezi L, Akbarian R, Niknahad H, Shafaroodi H.","Neuropharmacology. 2013 Sep;72:1-8. doi: 10.1016/j.neuropharm.2013.04.017. Epub 2013 Apr 25.","Moezi L","Neuropharmacology","2013","2013/04/30","","","10.1016/j.neuropharm.2013.04.017"
"23617468","Pharmacotherapy of amphetamine-type stimulant dependence: an update","Brensilver M, Heinzerling KG, Shoptaw S.","Drug Alcohol Rev. 2013 Sep;32(5):449-60. doi: 10.1111/dar.12048. Epub 2013 Apr 25.","Brensilver M","Drug Alcohol Rev","2013","2013/04/27","PMC4251965","NIHMS465161","10.1111/dar.12048"
"23605506","Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study","Parikh N, Goskonda V, Chavan A, Dillaha L.","Clin Drug Investig. 2013 Jun;33(6):391-400. doi: 10.1007/s40261-013-0079-8.","Parikh N","Clin Drug Investig","2013","2013/04/23","","","10.1007/s40261-013-0079-8"
"23604277","Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving","Soyka M.","Evid Based Ment Health. 2013 Aug;16(3):71. doi: 10.1136/eb-2013-101304. Epub 2013 Apr 20.","Soyka M","Evid Based Ment Health","2013","2013/04/23","","","10.1136/eb-2013-101304"
"23594453","Bernard Bihari, MD: low-dose naltrexone for normalizing immune system function","Bihari B.","Altern Ther Health Med. 2013 Mar-Apr;19(2):56-65.","Bihari B","Altern Ther Health Med","2013","2013/04/19","","",""
"23591123","Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats","Javadi-Paydar M, Ghiassy B, Ebadian S, Rahimi N, Norouzi A, Dehpour AR.","Behav Pharmacol. 2013 Jun;24(3):195-206. doi: 10.1097/FBP.0b013e3283618a8c.","Javadi-Paydar M","Behav Pharmacol","2013","2013/04/18","","","10.1097/FBP.0b013e3283618a8c"
"23590816","Therapies for obesity and medication-associated weight gain","Howland RH.","J Psychosoc Nurs Ment Health Serv. 2013 May;51(5):13-6. doi: 10.3928/02793695-20130411-01. Epub 2013 Apr 18.","Howland RH","J Psychosoc Nurs Ment Health Serv","2013","2013/04/18","","","10.3928/02793695-20130411-01"
"23590208","Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery","Ghosh P, Brogden NK, Stinchcomb AL.","Mol Pharm. 2013 Jun 3;10(6):2331-9. doi: 10.1021/mp3007083. Epub 2013 May 13.","Ghosh P","Mol Pharm","2013","2013/04/18","PMC3718312","NIHMS480682","10.1021/mp3007083"
"23590187","Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment","Pagar KP, Vavia PR.","Pharm Dev Technol. 2014 Jun;19(4):385-94. doi: 10.3109/10837450.2013.784334. Epub 2013 Apr 16.","Pagar KP","Pharm Dev Technol","2014","2013/04/18","","","10.3109/10837450.2013.784334"
"23584013","Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism","Krishnan-Sarin S, O'Malley S, Krystal JH.","Alcohol Res Health. 2008;31(4):400-7.","Krishnan-Sarin S","Alcohol Res Health","2008","2013/04/16","PMC3860468","",""
"23580015","Medications for unhealthy alcohol use: across the spectrum","O'Malley SS, O'Connor PG.","Alcohol Res Health. 2011;33(4):300-12.","O'Malley SS","Alcohol Res Health","2011","2013/04/13","PMC3860540","",""
"23577900","Aversion to injection limits acceptability of extended-release naltrexone among homeless, alcohol-dependent patients","Friedmann PD, Mello D, Lonergan S, Bourgault C, O'Toole TP.","Subst Abus. 2013;34(2):94-6. doi: 10.1080/08897077.2012.763083.","Friedmann PD","Subst Abus","2013","2013/04/13","PMC4394196","NIHMS677834","10.1080/08897077.2012.763083"
"23573810","Effects of naltrexone plus topiramate on ethanol self-administration and tyrosine hydroxylase gene expression changes","Navarrete F, Rubio G, Manzanares J.","Addict Biol. 2014 Sep;19(5):862-73. doi: 10.1111/adb.12058. Epub 2013 Apr 9.","Navarrete F","Addict Biol","2014","2013/04/12","","","10.1111/adb.12058"
"23572466","Smoking and opioid detoxification: behavioral changes and response to treatment","Mannelli P, Wu LT, Peindl KS, Gorelick DA.","Nicotine Tob Res. 2013 Oct;15(10):1705-13. doi: 10.1093/ntr/ntt046. Epub 2013 Apr 9.","Mannelli P","Nicotine Tob Res","2013","2013/04/11","PMC3768333","","10.1093/ntr/ntt046"
"23571420","Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study","Lukas SE, Lowen SB, Lindsey KP, Conn N, Tartarini W, Rodolico J, Mallya G, Palmer C, Penetar DM.","Neuroimage. 2013 Sep;78:176-85. doi: 10.1016/j.neuroimage.2013.03.055. Epub 2013 Apr 6.","Lukas SE","Neuroimage","2013","2013/04/11","","","10.1016/j.neuroimage.2013.03.055"
"23566774","Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study","DeSantis SM, Bandyopadhyay D, Baker NL, Randall PK, Anton RF, Prisciandaro JJ.","Drug Alcohol Depend. 2013 Sep 1;132(1-2):244-50. doi: 10.1016/j.drugalcdep.2013.02.013. Epub 2013 Apr 6.","DeSantis SM","Drug Alcohol Depend","2013","2013/04/10","PMC4025907","NIHMS521960","10.1016/j.drugalcdep.2013.02.013"
"23562264","A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence","Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group.","Eur Neuropsychopharmacol. 2013 Nov;23(11):1432-42. doi: 10.1016/j.euroneuro.2013.02.006. Epub 2013 Apr 3.","Gual A","Eur Neuropsychopharmacol","2013","2013/04/09","","","10.1016/j.euroneuro.2013.02.006"
"23561653","Pharmacotherapies for treating opioid use disorder","Nguyen TA, Hahn JH, Strakowski SM.","CNS Spectr. 2013 Dec;18(6):289-95. doi: 10.1017/S1092852913000229. Epub 2013 Apr 8.","Nguyen TA","CNS Spectr","2013","2013/04/09","","","10.1017/S1092852913000229"
"23550625","Activation of PPARγ by pioglitazone potentiates the effects of naltrexone on alcohol drinking and relapse in msP rats","Stopponi S, de Guglielmo G, Somaini L, Cippitelli A, Cannella N, Kallupi M, Ubaldi M, Heilig M, Demopulos G, Gaitanaris G, Ciccocioppo R.","Alcohol Clin Exp Res. 2013 Aug;37(8):1351-60. doi: 10.1111/acer.12091. Epub 2013 Mar 29.","Stopponi S","Alcohol Clin Exp Res","2013","2013/04/05","","","10.1111/acer.12091"
"23549827","Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats","Lee H.","Yonsei Med J. 2013 May 1;54(3):763-71. doi: 10.3349/ymj.2013.54.3.763.","Lee H","Yonsei Med J","2013","2013/04/04","PMC3635624","","10.3349/ymj.2013.54.3.763"
"23549670","The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist","Tsuruda PR, Vickery RG, Long DD, Armstrong SR, Beattie DT.","Naunyn Schmiedebergs Arch Pharmacol. 2013 Jun;386(6):479-91. doi: 10.1007/s00210-013-0850-7. Epub 2013 Apr 4.","Tsuruda PR","Naunyn Schmiedebergs Arch Pharmacol","2013","2013/04/04","","","10.1007/s00210-013-0850-7"
"23546884","Treatment of Complex Regional Pain Syndrome (CRPS) using low dose naltrexone (LDN)","Chopra P, Cooper MS.","J Neuroimmune Pharmacol. 2013 Jun;8(3):470-6. doi: 10.1007/s11481-013-9451-y. Epub 2013 Apr 2.","Chopra P","J Neuroimmune Pharmacol","2013","2013/04/03","PMC3661907","","10.1007/s11481-013-9451-y"
"23544597","Endogenous opioids mediate the sexual inhibition but not the drug hypersensitivity induced by sexual satiation in male rats","Garduño-Gutiérrez R, Guadarrama-Bazante L, León-Olea M, Rodríguez-Manzo G.","Behav Neurosci. 2013 Jun;127(3):458-64. doi: 10.1037/a0032332. Epub 2013 Apr 1.","Garduño-Gutiérrez R","Behav Neurosci","2013","2013/04/03","","","10.1037/a0032332"
"23543091","The μ-opioid receptor and treatment response to naltrexone","Thorsell A.","Alcohol Alcohol. 2013 Jul-Aug;48(4):402-8. doi: 10.1093/alcalc/agt030. Epub 2013 Mar 29.","Thorsell A","Alcohol Alcohol","2013","2013/04/02","","","10.1093/alcalc/agt030"
"23542927","Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion","Tejeda HA, Counotte DS, Oh E, Ramamoorthy S, Schultz-Kuszak KN, Bäckman CM, Chefer V, O'Donnell P, Shippenberg TS.","Neuropsychopharmacology. 2013 Aug;38(9):1770-9. doi: 10.1038/npp.2013.76. Epub 2013 Mar 29.","Tejeda HA","Neuropsychopharmacology","2013","2013/04/02","PMC3717537","","10.1038/npp.2013.76"
"23542298","The clinical conundrum of perioperative pain management in patients with opioid dependence: lessons from two cases","Israel JS, Poore SO.","Plast Reconstr Surg. 2013 Apr;131(4):657e-8e. doi: 10.1097/PRS.0b013e31828277bd.","Israel JS","Plast Reconstr Surg","2013","2013/04/02","","","10.1097/PRS.0b013e31828277bd"
"23540350","Naltrexone and nalmefene: any meaningful difference?","Swift RM.","Biol Psychiatry. 2013 Apr 15;73(8):700-1. doi: 10.1016/j.biopsych.2013.03.002.","Swift RM","Biol Psychiatry","2013","2013/04/02","","","10.1016/j.biopsych.2013.03.002"
"23528353","Resistance to depression through interference of opioid and nitrergic systems in bile-duct ligated mice","Haj-Mirzaian A, Hamzeh N, Javadi-Paydar M, Abdollahzadeh Estakhri MR, Dehpour AR.","Eur J Pharmacol. 2013 May 15;708(1-3):38-43. doi: 10.1016/j.ejphar.2013.03.013. Epub 2013 Mar 23.","Haj-Mirzaian A","Eur J Pharmacol","2013","2013/03/27","","","10.1016/j.ejphar.2013.03.013"
"23523991","Effect of naloxone on ischemic acute kidney injury in the mouse","Mutoh J, Ohsawa M, Hisa H.","Neuropharmacology. 2013 Aug;71:10-8. doi: 10.1016/j.neuropharm.2013.03.001. Epub 2013 Mar 19.","Mutoh J","Neuropharmacology","2013","2013/03/26","","","10.1016/j.neuropharm.2013.03.001"
"23512167","The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity","Armstrong SR, Campbell CB, Richardson CL, Vickery RG, Tsuruda PR, Long DD, Hegde SS, Beattie DT.","Naunyn Schmiedebergs Arch Pharmacol. 2013 Jun;386(6):471-8. doi: 10.1007/s00210-013-0844-5. Epub 2013 Mar 13.","Armstrong SR","Naunyn Schmiedebergs Arch Pharmacol","2013","2013/03/21","","","10.1007/s00210-013-0844-5"
"23503684","μ-opioid receptors in the stimulation of mesolimbic dopamine activity by ethanol and morphine in Long-Evans rats: a delayed effect of ethanol","Valenta JP, Job MO, Mangieri RA, Schier CJ, Howard EC, Gonzales RA.","Psychopharmacology (Berl). 2013 Aug;228(3):389-400. doi: 10.1007/s00213-013-3041-9. Epub 2013 Mar 16.","Valenta JP","Psychopharmacology (Berl)","2013","2013/03/19","PMC3707954","NIHMS456816","10.1007/s00213-013-3041-9"
"23503545","Four-year follow-up study of pharmacological treatment in pathological gamblers","Rosenberg O, Dinur LK, Dannon PN.","Clin Neuropharmacol. 2013 Mar-Apr;36(2):42-5. doi: 10.1097/WNF.0b013e31828740ea.","Rosenberg O","Clin Neuropharmacol","2013","2013/03/19","","","10.1097/WNF.0b013e31828740ea"
"23499782","Effects of naltrexone on post-abstinence alcohol drinking in C57BL/6NCRL and DBA/2J mice","Tomie A, Azogu I, Yu L.","Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:240-7. doi: 10.1016/j.pnpbp.2013.03.002. Epub 2013 Mar 13.","Tomie A","Prog Neuropsychopharmacol Biol Psychiatry","2013","2013/03/19","PMC3713418","NIHMS465739","10.1016/j.pnpbp.2013.03.002"
"23499661","Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A","Drinovac V, Bach-Rojecky L, Matak I, Lacković Z.","Neuropharmacology. 2013 Jul;70:331-7. doi: 10.1016/j.neuropharm.2013.02.011. Epub 2013 Mar 13.","Drinovac V","Neuropharmacology","2013","2013/03/19","","","10.1016/j.neuropharm.2013.02.011"
"23494371","A FLIPR assay for evaluating agonists and antagonists of GPCR heterodimers","Harvey JH, van Rijn RM, Whistler JL.","Methods Mol Biol. 2013;995:43-54. doi: 10.1007/978-1-62703-345-9_4.","Harvey JH","Methods Mol Biol","2013","2013/03/16","PMC6428067","NIHMS1006734","10.1007/978-1-62703-345-9_4"
"23490304","Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia","Shin S, Livchits V, Connery HS, Shields A, Yanov S, Yanova G, Fitzmaurice GM, Nelson AK, Greenfield SF; Tomsk Tuberculosis Alcohol Working Group.","Addiction. 2013 Aug;108(8):1387-96. doi: 10.1111/add.12148. Epub 2013 May 13.","Shin S","Addiction","2013","2013/03/16","PMC3710528","NIHMS452634","10.1111/add.12148"
"23489381","Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity","Smith SR, Fujioka K, Gupta AK, Billes SK, Burns C, Kim D, Dunayevich E, Greenway FL.","Diabetes Obes Metab. 2013 Sep;15(9):863-6. doi: 10.1111/dom.12095. Epub 2013 Apr 5.","Smith SR","Diabetes Obes Metab","2013","2013/03/16","","","10.1111/dom.12095"
"23489253","Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial","Miranda R, Ray L, Blanchard A, Reynolds EK, Monti PM, Chun T, Justus A, Swift RM, Tidey J, Gwaltney CJ, Ramirez J.","Addict Biol. 2014 Sep;19(5):941-54. doi: 10.1111/adb.12050. Epub 2013 Mar 13.","Miranda R","Addict Biol","2014","2013/03/16","PMC3729253","NIHMS451048","10.1111/adb.12050"
"23484859","Opioid antagonists for pain","Taylor R Jr, Pergolizzi JV Jr, Porreca F, Raffa RB.","Expert Opin Investig Drugs. 2013 Apr;22(4):517-25. doi: 10.1517/13543784.2013.778973.","Taylor R Jr","Expert Opin Investig Drugs","2013","2013/03/15","","","10.1517/13543784.2013.778973"
"23483467","[Ingestion of anabolic steroids and ischaemic stroke. A clinical case report and review of the literature]","García-Esperón C, Hervás-García JV, Jiménez-González M, Pérez de la Ossa-Herrero N, Gomis-Cortina M, Dorado-Bouix L, López-Cancio Martinez E, Castaño-Duque CH, Millán-Torné M, Dávalos A.","Rev Neurol. 2013 Mar 16;56(6):327-31.","García-Esperón C","Rev Neurol","2013","2013/03/14","","",""
"23478431","Pharmacological treatment of constipation in palliative care","Clemens KE, Faust M, Jaspers B, Mikus G.","Curr Opin Support Palliat Care. 2013 Jun;7(2):183-91. doi: 10.1097/SPC.0b013e32835f1e17.","Clemens KE","Curr Opin Support Palliat Care","2013","2013/03/13","","","10.1097/SPC.0b013e32835f1e17"
"23473921","Co-activation of μ- and δ-opioid receptors elicits tolerance to morphine-induced ventilatory depression via generation of peroxynitrite","Young AP, Gruber RB, Discala JF, May WJ, McLaughlin D, Palmer LA, Lewis SJ.","Respir Physiol Neurobiol. 2013 May 1;186(3):255-64. doi: 10.1016/j.resp.2013.02.028. Epub 2013 Mar 5.","Young AP","Respir Physiol Neurobiol","2013","2013/03/12","PMC4451624","NIHMS686031","10.1016/j.resp.2013.02.028"
"23473323","Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity","Graziane NM, Polter AM, Briand LA, Pierce RC, Kauer JA.","Neuron. 2013 Mar 6;77(5):942-54. doi: 10.1016/j.neuron.2012.12.034.","Graziane NM","Neuron","2013","2013/03/12","PMC3632376","NIHMS450723","10.1016/j.neuron.2012.12.034"
"23470804","Rewarding effects of ethanol combined with low doses of morphine through dopamine D1 receptors","Ise Y, Mori T, Katayama S, Nagase H, Suzuki T.","J Nippon Med Sch. 2013;80(1):34-41. doi: 10.1272/jnms.80.34.","Ise Y","J Nippon Med Sch","2013","2013/03/09","","","10.1272/jnms.80.34"
"23467353","Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein","Lamberts JT, Smith CE, Li MH, Ingram SL, Neubig RR, Traynor JR.","Version 2. J Neurosci. 2013 Mar 6;33(10):4369-77. doi: 10.1523/JNEUROSCI.5470-12.2013.","Lamberts JT","J Neurosci","2013","2013/03/08","PMC3740968","NIHMS470995","10.1523/JNEUROSCI.5470-12.2013"
"23461013","[Effect of opioid receptor blockade on antibody response and proliferative response under stress conditions]","Geĭn SV, Sharav'eva IL.","Eksp Klin Farmakol. 2013;76(1):30-4.","Geĭn SV","Eksp Klin Farmakol","2013","2013/03/07","","",""
"23456431","Impact of opioid pharmacotherapy on arterial stiffness and vascular ageing: cross-sectional and longitudinal studies","Reece AS, Hulse GK.","Cardiovasc Toxicol. 2013 Sep;13(3):254-66. doi: 10.1007/s12012-013-9204-4.","Reece AS","Cardiovasc Toxicol","2013","2013/03/05","","","10.1007/s12012-013-9204-4"
"23455599","Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash","Wright FL, Rodgers RJ.","Psychopharmacology (Berl). 2013 Jul;228(2):291-307. doi: 10.1007/s00213-013-3036-6. Epub 2013 Mar 1.","Wright FL","Psychopharmacology (Berl)","2013","2013/03/05","","","10.1007/s00213-013-3036-6"
"23447620","Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure","Birdsong WT, Arttamangkul S, Clark MJ, Cheng K, Rice KC, Traynor JR, Williams JT.","Version 2. J Neurosci. 2013 Feb 27;33(9):4118-27. doi: 10.1523/JNEUROSCI.4187-12.2013.","Birdsong WT","J Neurosci","2013","2013/03/01","PMC3711766","NIHMS451103","10.1523/JNEUROSCI.4187-12.2013"
"23437926","Evidence for the involvement of descending pain-inhibitory mechanisms in the antinociceptive effect of hecogenin acetate","Gama KB, Quintans JS, Antoniolli AR, Quintans-Júnior LJ, Santana WA, Branco A, Soares MB, Villarreal CF.","J Nat Prod. 2013 Apr 26;76(4):559-63. doi: 10.1021/np3007342. Epub 2013 Feb 25.","Gama KB","J Nat Prod","2013","2013/02/27","","","10.1021/np3007342"
"23435273","Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response","Gueorguieva R, Wu R, Krystal JH, Donovan D, O'Malley SS.","Addict Behav. 2013 May;38(5):2119-27. doi: 10.1016/j.addbeh.2013.01.024. Epub 2013 Feb 4.","Gueorguieva R","Addict Behav","2013","2013/02/26","PMC3595348","NIHMS441992","10.1016/j.addbeh.2013.01.024"
"23434041","Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study","Iheanacho T, Issa M, Marienfeld C, Rosenheck R.","Drug Alcohol Depend. 2013 Sep 1;132(1-2):122-6. doi: 10.1016/j.drugalcdep.2013.01.016. Epub 2013 Feb 22.","Iheanacho T","Drug Alcohol Depend","2013","2013/02/26","","","10.1016/j.drugalcdep.2013.01.016"
"23426445","Avoiding narcotics in Crohn's disease","Jackson WE, Rizk M, Lashner BA.","J Clin Gastroenterol. 2013 Apr;47(4):293-5. doi: 10.1097/MCG.0b013e318278aeec.","Jackson WE","J Clin Gastroenterol","2013","2013/02/22","","","10.1097/MCG.0b013e318278aeec"
"23417751","Development of a codrug approach for sustained drug delivery across microneedle-treated skin","Ghosh P, Pinninti RR, Hammell DC, Paudel KS, Stinchcomb AL.","J Pharm Sci. 2013 May;102(5):1458-67. doi: 10.1002/jps.23469. Epub 2013 Feb 15.","Ghosh P","J Pharm Sci","2013","2013/02/19","","","10.1002/jps.23469"
"23408728","A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)","Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, Kim D, Dunayevich E; COR-II Study Group.","Obesity (Silver Spring). 2013 May;21(5):935-43. doi: 10.1002/oby.20309.","Apovian CM","Obesity (Silver Spring)","2013","2013/02/15","PMC3739931","","10.1002/oby.20309"
"23400047","The current situation of treatment systems for alcoholism in Korea","Kim JW, Lee BC, Kang TC, Choi IG.","J Korean Med Sci. 2013 Feb;28(2):181-9. doi: 10.3346/jkms.2013.28.2.181. Epub 2013 Jan 29.","Kim JW","J Korean Med Sci","2013","2013/02/13","PMC3565127","","10.3346/jkms.2013.28.2.181"
"23398292","Specific and nonspecific effects of naltrexone on goal-directed and habitual models of alcohol seeking and drinking","Hay RA, Jennings JH, Zitzman DL, Hodge CW, Robinson DL.","Alcohol Clin Exp Res. 2013 Jul;37(7):1100-10. doi: 10.1111/acer.12081. Epub 2013 Feb 7.","Hay RA","Alcohol Clin Exp Res","2013","2013/02/13","PMC3655078","NIHMS433308","10.1111/acer.12081"
"23398219","A retrospective assessment of the use of naltrexone implants for the treatment of problematic amphetamine use","Kelty E, Thomson K, Carlstein S, Sinclair R, Hulse G.","Am J Addict. 2013 Jan;22(1):1-6. doi: 10.1111/j.1521-0391.2013.00320.x.","Kelty E","Am J Addict","2013","2013/02/13","","","10.1111/j.1521-0391.2013.00320.x"
"23398164","The declining efficacy of naltrexone pharmacotherapy for alcohol use disorders over time: a multivariate meta-analysis","Del Re AC, Maisel N, Blodgett J, Finney J.","Alcohol Clin Exp Res. 2013 Jun;37(6):1064-8. doi: 10.1111/acer.12067. Epub 2013 Feb 7.","Del Re AC","Alcohol Clin Exp Res","2013","2013/02/13","PMC3657572","NIHMS431361","10.1111/acer.12067"
"23397604","Chemical neuroanatomical and psychopharmacological evidence that κ receptor-mediated endogenous opioid peptide neurotransmission in the dorsal and ventral mesencephalon modulates panic-like behaviour","da Silva JA, de Freitas RL, Eichenberger GC, Padovan CM, Coimbra NC.","Eur J Pharmacol. 2013 Jan 5;698(1-3):235-45. doi: 10.1016/j.ejphar.2012.07.038.","da Silva JA","Eur J Pharmacol","2013","2013/02/12","","","10.1016/j.ejphar.2012.07.038"
"23392920","Neuropsychopharmacological actions of taurine","Banerjee SP, Ragnauth A, Chan CY, Agovic MS, Sostris V, Jashanmal I, Vidal L, Friedman E.","Adv Exp Med Biol. 2013;775:3-18. doi: 10.1007/978-1-4614-6130-2_1.","Banerjee SP","Adv Exp Med Biol","2013","2013/02/09","","","10.1007/978-1-4614-6130-2_1"
"23391399","Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease","Kumar N, Garg N, Bailey A.","J Palliat Med. 2013 Feb;16(2):122-3. doi: 10.1089/jpm.2012.0452.","Kumar N","J Palliat Med","2013","2013/02/09","","","10.1089/jpm.2012.0452"
"23384483","Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving","Theberge FR, Li X, Kambhampati S, Pickens CL, St Laurent R, Bossert JM, Baumann MH, Hutchinson MR, Rice KC, Watkins LR, Shaham Y.","Biol Psychiatry. 2013 Apr 15;73(8):729-37. doi: 10.1016/j.biopsych.2012.12.019. Epub 2013 Feb 4.","Theberge FR","Biol Psychiatry","2013","2013/02/07","PMC3615146","NIHMS434104","10.1016/j.biopsych.2012.12.019"
"23380104","Naltrexone prevents delayed encephalopathy in rats poisoned with the sarin analogue diisopropylflurophosphate","Brewer KL, Troendle MM, Pekman L, Meggs WJ.","Am J Emerg Med. 2013 Apr;31(4):676-9. doi: 10.1016/j.ajem.2012.12.003. Epub 2013 Feb 4.","Brewer KL","Am J Emerg Med","2013","2013/02/06","","","10.1016/j.ajem.2012.12.003"
"23376103","Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes","Davis RL, Das S, Buck DJ, Stevens CW.","Neurochem Int. 2013 Mar;62(4):478-85. doi: 10.1016/j.neuint.2013.01.013. Epub 2013 Jan 31.","Davis RL","Neurochem Int","2013","2013/02/05","PMC3604055","NIHMS439175","10.1016/j.neuint.2013.01.013"
"23372103","Laxatives or methylnaltrexone for the management of constipation in palliative care patients","Brick N.","Clin J Oncol Nurs. 2013 Feb;17(1):91-2. doi: 10.1188/13.CJON.91-92.","Brick N","Clin J Oncol Nurs","2013","2013/02/02","","","10.1188/13.CJON.91-92"
"23370666","Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells","Obara G, Toyohira Y, Inagaki H, Takahashi K, Horishita T, Kawasaki T, Ueno S, Tsutsui M, Sata T, Yanagihara N.","J Pharmacol Sci. 2013;121(2):138-47. doi: 10.1254/jphs.12164fp. Epub 2013 Feb 1.","Obara G","J Pharmacol Sci","2013","2013/02/02","","","10.1254/jphs.12164fp"
"23364815","Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects","Green A, Kaul A, O'Shea J, Sharma E, Bennett L, Mullings EL, Munafò MR, Nutt DJ, Melichar JK, Donaldson LF.","J Psychopharmacol. 2013 Mar;27(3):265-75. doi: 10.1177/0269881112472567. Epub 2013 Jan 29.","Green A","J Psychopharmacol","2013","2013/02/01","","","10.1177/0269881112472567"
"23362164","β-endorphin-induced inhibition of vitellogenic follicular growth in the fish Oreochromis mossambicus: evidence for opioidergic mediation of ovarian stress response","Chabbi A, Ganesh CB.","J Exp Zool A Ecol Genet Physiol. 2013 Mar;319(3):156-65. doi: 10.1002/jez.1781. Epub 2013 Jan 29.","Chabbi A","J Exp Zool A Ecol Genet Physiol","2013","2013/01/31","","","10.1002/jez.1781"
"23361094","Effects of methylnaltrexone on guinea pig gastrointestinal motility","Anselmi L, Huynh J, Vegezzi G, Sternini C.","Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):279-86. doi: 10.1007/s00210-013-0833-8. Epub 2013 Jan 30.","Anselmi L","Naunyn Schmiedebergs Arch Pharmacol","2013","2013/01/31","PMC3657610","NIHMS440369","10.1007/s00210-013-0833-8"
"23359310","Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels","Younger J, Noor N, McCue R, Mackey S.","Arthritis Rheum. 2013 Feb;65(2):529-38. doi: 10.1002/art.37734.","Younger J","Arthritis Rheum","2013","2013/01/30","","","10.1002/art.37734"
"23356858","Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers","Harris AHS, Ellerbe L, Reeder RN, Bowe T, Gordon AJ, Hagedorn H, Oliva E, Lembke A, Kivlahan D, Trafton JA.","Psychol Serv. 2013 Nov;10(4):410-419. doi: 10.1037/a0030949. Epub 2013 Jan 28.","Harris AHS","Psychol Serv","2013","2013/01/30","","","10.1037/a0030949"
"23346966","Opioid system in the medial prefrontal cortex mediates binge-like eating","Blasio A, Steardo L, Sabino V, Cottone P.","Addict Biol. 2014 Jul;19(4):652-62. doi: 10.1111/adb.12033. Epub 2013 Jan 24.","Blasio A","Addict Biol","2014","2013/01/26","PMC3664255","NIHMS431519","10.1111/adb.12033"
"23336713","Effect of transcutaneous electrical stimulation on nociception and edema induced by peripheral serotonin","Santos CM, Francischi JN, Lima-Paiva P, Sluka KA, Resende MA.","Int J Neurosci. 2013 Jul;123(7):507-15. doi: 10.3109/00207454.2013.768244. Epub 2013 Mar 15.","Santos CM","Int J Neurosci","2013","2013/01/23","","","10.3109/00207454.2013.768244"
"23334174","Gastrointestinal dysmotility: evidence and clinical management","Chapman MJ, Nguyen NQ, Deane AM.","Curr Opin Clin Nutr Metab Care. 2013 Mar;16(2):209-16. doi: 10.1097/MCO.0b013e32835c1fa5.","Chapman MJ","Curr Opin Clin Nutr Metab Care","2013","2013/01/22","","","10.1097/MCO.0b013e32835c1fa5"
"23331881","Naltrexone in the treatment of opioid-dependent pregnant women: common ground","Jones HE, Chisolm MS, Jansson LM, Terplan M.","Addiction. 2013 Feb;108(2):255-6. doi: 10.1111/add.12071.","Jones HE","Addiction","2013","2013/01/22","","","10.1111/add.12071"
"23331880","Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research","Clark N, Verster A.","Addiction. 2013 Feb;108(2):253-5. doi: 10.1111/j.1360-0443.2012.04096.x.","Clark N","Addiction","2013","2013/01/22","","","10.1111/j.1360-0443.2012.04096.x"
"23331879","Is sustained release natrexone an option for heroin-dependent pregnant women?","Waal H.","Addiction. 2013 Feb;108(2):252-3. doi: 10.1111/j.1360-0443.2012.03940.x.","Waal H","Addiction","2013","2013/01/22","","","10.1111/j.1360-0443.2012.03940.x"
"23331878","Blocking endogenous opioids during development--do we understand the consequences?","White J.","Addiction. 2013 Feb;108(2):251-2. doi: 10.1111/j.1360-0443.2012.03914.x.","White J","Addiction","2013","2013/01/22","","","10.1111/j.1360-0443.2012.03914.x"
"23331877","Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?","Stitzer ML.","Addiction. 2013 Feb;108(2):249-50. doi: 10.1111/j.1360-0443.2012.03883.x.","Stitzer ML","Addiction","2013","2013/01/22","","","10.1111/j.1360-0443.2012.03883.x"
"23331876","An ethical framework for conducting research on pregnant, opioid-dependent women","McCullough LB, Chervenak FA, Coverdale JH.","Addiction. 2013 Feb;108(2):248-9. doi: 10.1111/j.1360-0443.2012.03865.x.","McCullough LB","Addiction","2013","2013/01/22","","","10.1111/j.1360-0443.2012.03865.x"
"23327357","Bioavailability of oral methylnaltrexone increases with a phosphatidylcholine-based formulation","Lin DH, Wang CZ, Qin LF, Xie XX, Wang JT, Gu M, McEntee E, Yuan CS.","Drug Dev Ind Pharm. 2014 Feb;40(2):186-91. doi: 10.3109/03639045.2012.753899. Epub 2013 Jan 18.","Lin DH","Drug Dev Ind Pharm","2014","2013/01/19","","","10.3109/03639045.2012.753899"
"23312429","Attributions of change and self-efficacy in a randomized controlled trial of medication and psychotherapy for problem drinking","Schaumberg K, Kuerbis A, Morgenstern J, Muench F.","Behav Ther. 2013 Mar;44(1):88-99. doi: 10.1016/j.beth.2012.07.001. Epub 2012 Jul 24.","Schaumberg K","Behav Ther","2013","2013/01/15","PMC3556396","NIHMS427000","10.1016/j.beth.2012.07.001"
"23302184","Letter to the Editor: Shopping frenzy induced by naltrexone--a paradoxical effect in bipolar disorder?","Losekam S, Kluge I, Nittel KS, Kircher T, Konrad C.","Psychol Med. 2013 Apr;43(4):895. doi: 10.1017/S0033291712003005. Epub 2013 Jan 10.","Losekam S","Psychol Med","2013","2013/01/11","","","10.1017/S0033291712003005"
"23300784","Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood","Farid WO, Lawrence AJ, Krstew EV, Tait RJ, Hulse GK, Dunlop SA.","PLoS One. 2012;7(12):e52812. doi: 10.1371/journal.pone.0052812. Epub 2012 Dec 26.","Farid WO","PLoS One","2012","2013/01/10","PMC3530485","","10.1371/journal.pone.0052812"
"23279646","Naltrexone does not affect isoflurane minimum alveolar concentration in cats","Brosnan RJ, Pypendop BH, Majewski-Tiedeken CR, Shilo-Benjamini Y, Ilkiw JE.","Vet Anaesth Analg. 2013 Mar;40(2):225-8. doi: 10.1111/vaa.12004. Epub 2012 Dec 24.","Brosnan RJ","Vet Anaesth Analg","2013","2013/01/03","PMC3573213","NIHMS424032","10.1111/vaa.12004"
"23265686","Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems","Benedetti F, Thoen W, Blanchard C, Vighetti S, Arduino C.","Pain. 2013 Mar;154(3):361-7. doi: 10.1016/j.pain.2012.11.007. Epub 2012 Nov 21.","Benedetti F","Pain","2013","2012/12/26","","","10.1016/j.pain.2012.11.007"
"23264316","An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult","Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Nagar S, Labhsetwar S, Sinclair N, Gould EM.","J Opioid Manag. 2012 Nov-Dec;8(6):383-93. doi: 10.5055/jom.2012.0138.","Pergolizzi JV Jr","J Opioid Manag","2012","2012/12/25","","","10.5055/jom.2012.0138"
"23252742","Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects","Weerts EM, Wand GS, Kuwabara H, Xu X, Frost JJ, Wong DF, McCaul ME.","Addict Biol. 2014 Jul;19(4):733-42. doi: 10.1111/adb.12022. Epub 2012 Dec 18.","Weerts EM","Addict Biol","2014","2012/12/21","PMC3638047","NIHMS425529","10.1111/adb.12022"
"23242099","Naltrexone-induced Nicolau syndrome masquerading as cutaneous abscess","Perli D, Martone C, Rapose A.","BMJ Case Rep. 2012 Dec 14;2012:bcr2012007785. doi: 10.1136/bcr-2012-007785.","Perli D","BMJ Case Rep","2012","2012/12/18","PMC4544998","","10.1136/bcr-2012-007785"
"23241479","Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependence","Kelty E, Ngo H, Hulse G.","Clin Trials. 2013 Feb;10(1):170-80. doi: 10.1177/1740774512467237. Epub 2012 Dec 14.","Kelty E","Clin Trials","2013","2012/12/18","","","10.1177/1740774512467237"
"23240906","A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm","Cordery SF, Taverner A, Ridzwan IE, Guy RH, Delgado-Charro MB, Husbands SM, Bailey CP.","Addict Biol. 2014 Jul;19(4):575-86. doi: 10.1111/adb.12020. Epub 2012 Dec 14.","Cordery SF","Addict Biol","2014","2012/12/18","","","10.1111/adb.12020"
"23237314","Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene","Mann K, Bladström A, Torup L, Gual A, van den Brink W.","Biol Psychiatry. 2013 Apr 15;73(8):706-13. doi: 10.1016/j.biopsych.2012.10.020. Epub 2012 Dec 11.","Mann K","Biol Psychiatry","2013","2012/12/15","","","10.1016/j.biopsych.2012.10.020"
"23231573","The effects of drinking goal on treatment outcome for alcoholism","Bujarski S, O'Malley SS, Lunny K, Ray LA.","J Consult Clin Psychol. 2013 Feb;81(1):13-22. doi: 10.1037/a0030886. Epub 2012 Dec 10.","Bujarski S","J Consult Clin Psychol","2013","2012/12/13","PMC4166539","NIHMS486593","10.1037/a0030886"
"23231446","Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study","Mann K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A, Berner M, Wodarz N, Heinz A, Smolka MN, Zimmermann US, Wellek S, Kiefer F, Anton RF; PREDICT Study Team.","Addict Biol. 2013 Nov;18(6):937-46. doi: 10.1111/adb.12012. Epub 2012 Dec 12.","Mann K","Addict Biol","2013","2012/12/13","","","10.1111/adb.12012"
"23226534","Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia","Ruger JP, Chawarski M, Mazlan M, Ng N, Schottenfeld R.","PLoS One. 2012;7(12):e50673. doi: 10.1371/journal.pone.0050673. Epub 2012 Dec 4.","Ruger JP","PLoS One","2012","2012/12/11","PMC3514172","","10.1371/journal.pone.0050673"
"23225130","Naltrexone treatment of kleptomania: a case report","Çetinay Aydın P, Belkız Güngör B, Gülseren L.","Turk Psikiyatri Derg. 2012 Winter;23(4):284-6.","Çetinay Aydın P","Turk Psikiyatri Derg","2012","2012/12/11","","",""
"23223834","Current status of co-occurring mood and substance use disorders: a new therapeutic target","Pettinati HM, O'Brien CP, Dundon WD.","Am J Psychiatry. 2013 Jan;170(1):23-30. doi: 10.1176/appi.ajp.2012.12010112.","Pettinati HM","Am J Psychiatry","2013","2012/12/11","PMC3595612","NIHMS445675","10.1176/appi.ajp.2012.12010112"
"23223282","Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake","Schindler AG, Messinger DI, Smith JS, Shankar H, Gustin RM, Schattauer SS, Lemos JC, Chavkin NW, Hagan CE, Neumaier JF, Chavkin C.","Version 2. J Neurosci. 2012 Dec 5;32(49):17582-96. doi: 10.1523/JNEUROSCI.3220-12.2012.","Schindler AG","J Neurosci","2012","2012/12/11","PMC3523715","NIHMS427293","10.1523/JNEUROSCI.3220-12.2012"
"23222260","Opioid receptors control viral replication in the airways","Salimi V, Hennus MP, Mokhtari-Azad T, Shokri F, Janssen R, Hodemaekers HM, Rygiel TP, Coenjaerts FE, Meyaard L, Bont L.","Crit Care Med. 2013 Jan;41(1):205-14. doi: 10.1097/CCM.0b013e31826767a8.","Salimi V","Crit Care Med","2013","2012/12/11","","","10.1097/CCM.0b013e31826767a8"
"23216641","Distinct susceptibility to inoculated melanoma and sensitivity to cancer pain in mouse lines with high and low sensitivity to stress","Sacharczuk M, Ragan AR, Szymanska H, Lesniak A, Sadowski B, Lipkowski AW.","J Environ Pathol Toxicol Oncol. 2012;31(2):167-77. doi: 10.1615/jenvironpatholtoxicoloncol.v31.i2.80.","Sacharczuk M","J Environ Pathol Toxicol Oncol","2012","2012/12/11","","","10.1615/jenvironpatholtoxicoloncol.v31.i2.80"
"23212389","Effect of food restriction on cocaine locomotor sensitization in Sprague-Dawley rats: role of kappa opioid receptors","Allen CP, Zhou Y, Leri F.","Psychopharmacology (Berl). 2013 Apr;226(3):571-8. doi: 10.1007/s00213-012-2930-7. Epub 2012 Dec 2.","Allen CP","Psychopharmacology (Berl)","2013","2012/12/06","","","10.1007/s00213-012-2930-7"
"23207598","Motility disorders of the colon and rectum","Gras B, Magge S, Bloom A, Lembo A.","Curr Opin Gastroenterol. 2013 Jan;29(1):66-71. doi: 10.1097/MOG.0b013e32835a80e7.","Gras B","Curr Opin Gastroenterol","2013","2012/12/05","","","10.1097/MOG.0b013e32835a80e7"
"23205722","Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users","Dunn KE, Defulio A, Everly JJ, Donlin WD, Aklin WM, Nuzzo PA, Leoutsakos JM, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.","Exp Clin Psychopharmacol. 2013 Feb;21(1):74-83. doi: 10.1037/a0030743. Epub 2012 Dec 3.","Dunn KE","Exp Clin Psychopharmacol","2013","2012/12/05","PMC3641088","NIHMS453494","10.1037/a0030743"
"23188075","Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study","Smith JP, Field D, Bingaman SI, Evans R, Mauger DT.","J Clin Gastroenterol. 2013 Apr;47(4):339-45. doi: 10.1097/MCG.0b013e3182702f2b.","Smith JP","J Clin Gastroenterol","2013","2012/11/29","PMC3586944","NIHMS409690","10.1097/MCG.0b013e3182702f2b"
"23186301","A randomized trial evaluating an mHealth system to monitor and enhance adherence to pharmacotherapy for alcohol use disorders","Stoner SA, Hendershot CS.","Addict Sci Clin Pract. 2012 Jun 8;7(1):9. doi: 10.1186/1940-0640-7-9.","Stoner SA","Addict Sci Clin Pract","2012","2012/11/29","PMC3507635","","10.1186/1940-0640-7-9"
"23183627","Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats","Kotlinska JH, Gibula-Bruzda E, Witkowska E, Chung NN, Schiller PW, Izdebski J.","Peptides. 2013 Jan;39:103-10. doi: 10.1016/j.peptides.2012.11.008. Epub 2012 Nov 23.","Kotlinska JH","Peptides","2013","2012/11/28","PMC3934762","NIHMS555849","10.1016/j.peptides.2012.11.008"
"23178563","Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test","Filho CB, Del Fabbro L, de Gomes MG, Goes AT, Souza LC, Boeira SP, Jesse CR.","Eur J Pharmacol. 2013 Jan 5;698(1-3):286-91. doi: 10.1016/j.ejphar.2012.11.003. Epub 2012 Nov 20.","Filho CB","Eur J Pharmacol","2013","2012/11/27","","","10.1016/j.ejphar.2012.11.003"
"23178527","Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models","Clapper JR, Athanacio J, Wittmer C, Griffin PS, D'Souza L, Parkes DG, Roth JD.","Eur J Pharmacol. 2013 Jan 5;698(1-3):292-8. doi: 10.1016/j.ejphar.2012.11.010. Epub 2012 Nov 21.","Clapper JR","Eur J Pharmacol","2013","2012/11/27","","","10.1016/j.ejphar.2012.11.010"
"23177384","Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial","King AC, Cao D, Zhang L, O'Malley SS.","Biol Psychiatry. 2013 May 1;73(9):924-30. doi: 10.1016/j.biopsych.2012.09.025. Epub 2012 Nov 22.","King AC","Biol Psychiatry","2013","2012/11/27","PMC3629005","NIHMS414987","10.1016/j.biopsych.2012.09.025"
"23166745","Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats","Rogala B, Li Y, Li S, Chen X, Kirouac GJ.","PLoS One. 2012;7(11):e49669. doi: 10.1371/journal.pone.0049669. Epub 2012 Nov 14.","Rogala B","PLoS One","2012","2012/11/21","PMC3498224","","10.1371/journal.pone.0049669"
"23159788","The cardiovascular effects of a chimeric opioid peptide based on morphiceptin and PFRTic-NH2","Li M, Zhou L, Ma G, Cao S, Dong S.","Peptides. 2013 Jan;39:89-94. doi: 10.1016/j.peptides.2012.10.014. Epub 2012 Nov 14.","Li M","Peptides","2013","2012/11/20","","","10.1016/j.peptides.2012.10.014"
"23159524","Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology","Mooney LJ, Nielsen S, Saxon A, Hillhouse M, Thomas C, Hasson A, Stablein D, McCormack J, Lindblad R, Ling W.","Contemp Clin Trials. 2013 Mar;34(2):196-204. doi: 10.1016/j.cct.2012.11.002. Epub 2012 Nov 16.","Mooney LJ","Contemp Clin Trials","2013","2012/11/20","PMC3760415","NIHMS430218","10.1016/j.cct.2012.11.002"
"23139366","Vasculoprotective effect of U50,488H in rats exposed to chronic hypoxia: role of Akt-stimulated NO production","Li J, Shi QX, Fan R, Zhang LJ, Zhang SM, Guo HT, Wang YM, Kaye AJ, Kaye AD, Bueno FR, Xu XZ, Yu SQ, Yi DH, Pei JM.","J Appl Physiol (1985). 2013 Jan 15;114(2):238-44. doi: 10.1152/japplphysiol.00994.2012. Epub 2012 Nov 8.","Li J","J Appl Physiol (1985)","2013","2012/11/10","","","10.1152/japplphysiol.00994.2012"
"23138934","Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception","Katsuyama S, Mizoguchi H, Kuwahata H, Komatsu T, Nagaoka K, Nakamura H, Bagetta G, Sakurada T, Sakurada S.","Eur J Pain. 2013 May;17(5):664-75. doi: 10.1002/j.1532-2149.2012.00242.x. Epub 2012 Nov 9.","Katsuyama S","Eur J Pain","2013","2012/11/10","","","10.1002/j.1532-2149.2012.00242.x"
"23135875","WYE-120318, a ring contraction product of methylnaltrexone, and structure revision of coniothyrione","Kong F, Zhu T, Pan W, Tsao R, Pagano TG, Nguyen B, Marquez B.","Magn Reson Chem. 2012 Dec;50(12):829-33. doi: 10.1002/mrc.3892. Epub 2012 Nov 8.","Kong F","Magn Reson Chem","2012","2012/11/09","","","10.1002/mrc.3892"
"23135529","Effects of estrogen and opioid blockade on blood pressure reactivity to stress in postmenopausal women","Allen AJ, McCubbin JA, Loveless JP, Helfer SG.","J Behav Med. 2014 Feb;37(1):94-101. doi: 10.1007/s10865-012-9468-3. Epub 2012 Nov 9.","Allen AJ","J Behav Med","2014","2012/11/09","","","10.1007/s10865-012-9468-3"
"23126554","Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking","Sabino V, Kwak J, Rice KC, Cottone P.","Alcohol Clin Exp Res. 2013 Apr;37(4):635-43. doi: 10.1111/acer.12008. Epub 2012 Nov 5.","Sabino V","Alcohol Clin Exp Res","2013","2012/11/07","PMC3567206","NIHMS408326","10.1111/acer.12008"
"23125072","Medications development for opioid abuse","Negus SS, Banks ML.","Cold Spring Harb Perspect Med. 2013 Jan 1;3(1):a012104. doi: 10.1101/cshperspect.a012104.","Negus SS","Cold Spring Harb Perspect Med","2013","2012/11/06","PMC3530034","","10.1101/cshperspect.a012104"
"23121581","Subsidised use of methylnaltrexone in Australia for palliative care","Rowett DS, Clark K, Robinson MK, Currow DC.","Med J Aust. 2012 Nov 5;197(9):492. doi: 10.5694/mja12.11398.","Rowett DS","Med J Aust","2012","2012/11/06","","","10.5694/mja12.11398"
"23118019","In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor","Casal-Dominguez JJ, Clark M, Traynor JR, Husbands SM, Bailey SJ.","J Psychopharmacol. 2013 Feb;27(2):192-202. doi: 10.1177/0269881112464828. Epub 2012 Oct 31.","Casal-Dominguez JJ","J Psychopharmacol","2013","2012/11/03","PMC4361741","NIHMS662961","10.1177/0269881112464828"
"23110786","The effect of naltrexone on the perception and distress in tinnitus: an open-label pilot study","Vanneste S, Azevedo A, De Ridder D.","Int J Clin Pharmacol Ther. 2013 Jan;51(1):5-11. doi: 10.5414/CP201754.","Vanneste S","Int J Clin Pharmacol Ther","2013","2012/11/01","","","10.5414/CP201754"
"23109863","Antinociceptive action of isolated mitragynine from Mitragyna Speciosa through activation of opioid receptor system","Shamima AR, Fakurazi S, Hidayat MT, Hairuszah I, Moklas MA, Arulselvan P.","Int J Mol Sci. 2012;13(9):11427-42. doi: 10.3390/ijms130911427. Epub 2012 Sep 12.","Shamima AR","Int J Mol Sci","2012","2012/10/31","PMC3472755","","10.3390/ijms130911427"
"23103774","Critical role of NMDA but not opioid receptors in the acquisition of fat-conditioned flavor preferences in rats","Dela Cruz JA, Bae VS, Icaza-Cukali D, Sampson C, Bamshad D, Samra A, Singh S, Khalifa N, Touzani K, Sclafani A, Bodnar RJ.","Neurobiol Learn Mem. 2012 Nov;98(4):341-7. doi: 10.1016/j.nlm.2012.10.007. Epub 2012 Oct 24.","Dela Cruz JA","Neurobiol Learn Mem","2012","2012/10/30","PMC3513665","NIHMS417492","10.1016/j.nlm.2012.10.007"
"23101980","Management of alcohol abuse","Albanese AP.","Clin Liver Dis. 2012 Nov;16(4):737-62. doi: 10.1016/j.cld.2012.08.006.","Albanese AP","Clin Liver Dis","2012","2012/10/30","","","10.1016/j.cld.2012.08.006"
"23101148","Recent advancements in drug treatment of obesity","Carter R, Mouralidarane A, Ray S, Soeda J, Oben J.","Clin Med (Lond). 2012 Oct;12(5):456-60. doi: 10.7861/clinmedicine.12-5-456.","Carter R","Clin Med (Lond)","2012","2012/10/30","PMC4953770","","10.7861/clinmedicine.12-5-456"
"23095430","The implications of tamper-resistant formulations for opioid rotation","Pappagallo M, Sokolowska M.","Postgrad Med. 2012 Sep;124(5):101-9. doi: 10.3810/pgm.2012.09.2588.","Pappagallo M","Postgrad Med","2012","2012/10/26","","","10.3810/pgm.2012.09.2588"
"23088328","Injectable and implantable sustained release naltrexone in the treatment of opioid addiction","Kunøe N, Lobmaier P, Ngo H, Hulse G.","Br J Clin Pharmacol. 2014 Feb;77(2):264-71. doi: 10.1111/bcp.12011.","Kunøe N","Br J Clin Pharmacol","2014","2012/10/24","PMC4014017","","10.1111/bcp.12011"
"23083028","Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome","Banga A, Connor DF.","J Child Adolesc Psychopharmacol. 2012 Oct;22(5):396-8. doi: 10.1089/cap.2012.0028.","Banga A","J Child Adolesc Psychopharmacol","2012","2012/10/23","","","10.1089/cap.2012.0028"
"23082827","Do manualized psychosocial interventions help reduce relapse among alcohol-dependent adults treated with naltrexone or placebo? A meta-analysis","Agosti V, Nunes EV, O'Shea D.","Am J Addict. 2012 Nov-Dec;21(6):501-7. doi: 10.1111/j.1521-0391.2012.00270.x. Epub 2012 Sep 21.","Agosti V","Am J Addict","2012","2012/10/23","","","10.1111/j.1521-0391.2012.00270.x"
"23077646","Combination treatment of hypothermia and mesenchymal stromal cells amplifies neuroprotection in primary rat neurons exposed to hypoxic-ischemic-like injury in vitro: role of the opioid system","Kaneko Y, Tajiri N, Su TP, Wang Y, Borlongan CV.","PLoS One. 2012;7(10):e47583. doi: 10.1371/journal.pone.0047583. Epub 2012 Oct 15.","Kaneko Y","PLoS One","2012","2012/10/19","PMC3471862","","10.1371/journal.pone.0047583"
"23075288","Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW.","Addiction. 2013 Feb;108(2):275-93. doi: 10.1111/j.1360-0443.2012.04054.x. Epub 2012 Oct 17.","Maisel NC","Addiction","2013","2012/10/19","PMC3970823","NIHMS558742","10.1111/j.1360-0443.2012.04054.x"
"23073726","Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics","Schaeffer T.","J Med Toxicol. 2012 Dec;8(4):400-7. doi: 10.1007/s13181-012-0270-y.","Schaeffer T","J Med Toxicol","2012","2012/10/18","PMC3550267","","10.1007/s13181-012-0270-y"
"23065849","Spinal cord stimulation reduces hypersensitivity through activation of opioid receptors in a frequency-dependent manner","Sato KL, King EW, Johanek LM, Sluka KA.","Eur J Pain. 2013 Apr;17(4):551-61. doi: 10.1002/j.1532-2149.2012.00220.x. Epub 2012 Oct 12.","Sato KL","Eur J Pain","2013","2012/10/16","","","10.1002/j.1532-2149.2012.00220.x"
"23063739","Effects of κ- and μ-opioid agonists on cholinergic neurotransmission and contraction in isolated bovine trachealis","Baroffio M, Crimi E, Rehder K, Brusasco V.","Respir Physiol Neurobiol. 2013 Jan 15;185(2):281-6. doi: 10.1016/j.resp.2012.10.001. Epub 2012 Oct 9.","Baroffio M","Respir Physiol Neurobiol","2013","2012/10/16","","","10.1016/j.resp.2012.10.001"
"23062049","Opioid dependence","Praveen KT, Law F, O'Shea J, Melichar J.","Am Fam Physician. 2012 Sep 15;86(6):565-6.","Praveen KT","Am Fam Physician","2012","2012/10/16","","",""
"23060515","Sufentanil citrate immobilization of Alaskan moose calves","Kreeger TJ, Kellie KA.","J Wildl Dis. 2012 Oct;48(4):1088-91. doi: 10.7589/2012-04-112.","Kreeger TJ","J Wildl Dis","2012","2012/10/13","","","10.7589/2012-04-112"
"23053608","Naltrexone attenuates stress-induced suppression of LH secretion in the pituitary gland in the Cichlid fish Oreochromis mossambicus: evidence for the opioidergic mediation of reproductive stress response","Ganesh CB, Chabbi A.","Fish Physiol Biochem. 2013 Jun;39(3):627-36. doi: 10.1007/s10695-012-9725-y. Epub 2012 Oct 6.","Ganesh CB","Fish Physiol Biochem","2013","2012/10/12","","","10.1007/s10695-012-9725-y"
"23045720","Gestational naltrexone ameliorates fetal ethanol exposures enhancing effect on the postnatal behavioral and neural response to ethanol","Youngentob SL, Kent PF, Youngentob LM.","Exp Biol Med (Maywood). 2012 Oct;237(10):1197-208. doi: 10.1258/ebm.2012.012132. Epub 2012 Oct 8.","Youngentob SL","Exp Biol Med (Maywood)","2012","2012/10/10","PMC3501531","NIHMS418012","10.1258/ebm.2012.012132"
"23036218","Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection","Mitchell MC, Memisoglu A, Silverman BL.","J Stud Alcohol Drugs. 2012 Nov;73(6):991-7. doi: 10.15288/jsad.2012.73.991.","Mitchell MC","J Stud Alcohol Drugs","2012","2012/10/06","","","10.15288/jsad.2012.73.991"
"23032071","Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues","Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S, Myrick H.","Neuropsychopharmacology. 2013 Feb;38(3):414-22. doi: 10.1038/npp.2012.195. Epub 2012 Oct 3.","Schacht JP","Neuropsychopharmacology","2013","2012/10/04","PMC3547192","","10.1038/npp.2012.195"
"23028524","GPR54-dependent stimulation of luteinizing hormone secretion by neurokinin B in prepubertal rats","Grachev P, Li XF, Lin YS, Hu MH, Elsamani L, Paterson SJ, Millar RP, Lightman SL, O'Byrne KT.","PLoS One. 2012;7(9):e44344. doi: 10.1371/journal.pone.0044344. Epub 2012 Sep 28.","Grachev P","PLoS One","2012","2012/10/03","PMC3460954","","10.1371/journal.pone.0044344"
"23019498","Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeys","Yekkirala AS, Banks ML, Lunzer MM, Negus SS, Rice KC, Portoghese PS.","ACS Chem Neurosci. 2012 Sep 19;3(9):720-7. doi: 10.1021/cn300049m. Epub 2012 Jul 5.","Yekkirala AS","ACS Chem Neurosci","2012","2012/09/29","PMC3447399","","10.1021/cn300049m"
"23013006","[Effect of mu- and kappa-opioid receptor antagonists on aggressiveness of male mice with repeated experience of aggression]","Bondar' NP.","Ross Fiziol Zh Im I M Sechenova. 2012 Jun;98(6):681-92.","Bondar' NP","Ross Fiziol Zh Im I M Sechenova","2012","2012/09/28","","",""
"23008452","Medications for adolescents and young adults with autism spectrum disorders: a systematic review","Dove D, Warren Z, McPheeters ML, Taylor JL, Sathe NA, Veenstra-VanderWeele J.","Pediatrics. 2012 Oct;130(4):717-26. doi: 10.1542/peds.2012-0683. Epub 2012 Sep 24.","Dove D","Pediatrics","2012","2012/09/26","PMC4074627","","10.1542/peds.2012-0683"
"23001479","Morphine induces hyperalgesia without involvement of μ-opioid receptor or morphine-3-glucuronide","Swartjes M, Mooren RA, Waxman AR, Arout C, van de Wetering K, den Hartigh J, Beijnen JH, Kest B, Dahan A.","Mol Med. 2012 Dec 6;18(1):1320-6. doi: 10.2119/molmed.2012.00244.","Swartjes M","Mol Med","2012","2012/09/25","PMC3521788","","10.2119/molmed.2012.00244"
"22999198","Pulsed electromembrane extraction: a new concept of electrically enhanced extraction","Rezazadeh M, Yamini Y, Seidi S, Esrafili A.","J Chromatogr A. 2012 Nov 2;1262:214-8. doi: 10.1016/j.chroma.2012.08.090. Epub 2012 Sep 3.","Rezazadeh M","J Chromatogr A","2012","2012/09/25","","","10.1016/j.chroma.2012.08.090"
"22985676","Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months","Lee JD, Grossman E, Huben L, Manseau M, McNeely J, Rotrosen J, Stevens D, Gourevitch MN.","J Subst Abuse Treat. 2012 Dec;43(4):458-62. doi: 10.1016/j.jsat.2012.08.012. Epub 2012 Sep 15.","Lee JD","J Subst Abuse Treat","2012","2012/09/19","","","10.1016/j.jsat.2012.08.012"
"22970525","[Between cider and cirrhosis]","Oberpichler-Schwenk H.","Med Monatsschr Pharm. 2012 Aug;35(8):271.","Oberpichler-Schwenk H","Med Monatsschr Pharm","2012","2012/09/14","","",""
"22967990","Double-dissociation of D1 and opioid receptor antagonism effects on the acquisition of sucrose-conditioned flavor preferences in BALB/c and SWR mice","Dym CT, Kraft TT, Bae VS, Yakubov Y, Touzani K, Sclafani A, Bodnar RJ.","Pharmacol Biochem Behav. 2012 Nov;103(1):26-32. doi: 10.1016/j.pbb.2012.07.018. Epub 2012 Aug 7.","Dym CT","Pharmacol Biochem Behav","2012","2012/09/13","PMC3444661","NIHMS399773","10.1016/j.pbb.2012.07.018"
"22967782","Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence","Aklin WM, Severtson SG, Umbricht A, Fingerhood M, Bigelow GE, Lejuez CW, Silverman K.","J Clin Psychiatry. 2012 Aug;73(8):e1056-61. doi: 10.4088/JCP.09m05807.","Aklin WM","J Clin Psychiatry","2012","2012/09/13","PMC3985274","NIHMS550694","10.4088/JCP.09m05807"
"22967443","[DADLE suppresses the proliferation of human liver cancer HepG2 cells by activation of PKC pathway and elevates the sensitivity to cis-diammine dichloridoplatium]","Tang B, DU J, Gao ZM, Liang R, Sun DG, Jin XL, Wang LM.","Zhonghua Zhong Liu Za Zhi. 2012 Jun;34(6):425-9.","Tang B","Zhonghua Zhong Liu Za Zhi","2012","2012/09/13","","",""
"22963992","Anxiolytic effects of ethanol are partially related to a reduced expression of adenylyl cyclase 5 but not to μ-opioid receptor activation in rat nucleus accumbens","Morales-Mulia M, Estrada-Camarena E, Amaya MI, Mejía-Mauríes S, Sollozo-Dupont I, Mengod G, de Gortari P.","Behav Brain Res. 2012 Dec 1;235(2):189-94. doi: 10.1016/j.bbr.2012.07.036. Epub 2012 Aug 9.","Morales-Mulia M","Behav Brain Res","2012","2012/09/12","","","10.1016/j.bbr.2012.07.036"
"22962958","Commentary on Kelty & Hulse (2012): is the comparison of mortality between patients prescribed implanted or oral naltrexone an unbiased and unconfounded comparison?","Hickman M, Degenhardt L, Farrell M, Hall W.","Addiction. 2012 Oct;107(10):1825-6. doi: 10.1111/j.1360-0443.2012.03966.x.","Hickman M","Addiction","2012","2012/09/12","","","10.1111/j.1360-0443.2012.03966.x"
"22960407","Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide","Li M, Zhou L, Ma G, Dong S.","Regul Pept. 2012 Nov 10;179(1-3):23-8. doi: 10.1016/j.regpep.2012.08.008. Epub 2012 Sep 4.","Li M","Regul Pept","2012","2012/09/11","","","10.1016/j.regpep.2012.08.008"
"22956800","Pain-facilitating medullary neurons contribute to opioid-induced respiratory depression","Phillips RS, Cleary DR, Nalwalk JW, Arttamangkul S, Hough LB, Heinricher MM.","J Neurophysiol. 2012 Nov;108(9):2393-404. doi: 10.1152/jn.00563.2012. Epub 2012 Sep 5.","Phillips RS","J Neurophysiol","2012","2012/09/08","PMC3545170","","10.1152/jn.00563.2012"
"22954510","Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol","Ashenhurst JR, Bujarski S, Ray LA.","Pharmacol Biochem Behav. 2012 Dec;103(2):253-9. doi: 10.1016/j.pbb.2012.08.019. Epub 2012 Aug 27.","Ashenhurst JR","Pharmacol Biochem Behav","2012","2012/09/08","PMC3683577","NIHMS409823","10.1016/j.pbb.2012.08.019"
"22951790","[Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial]","Krupitskiĭ EM, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Blokhina EA, Silverman BL.","Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(5 Pt 2):3-11.","Krupitskiĭ EM","Zh Nevrol Psikhiatr Im S S Korsakova","2012","2012/09/07","","",""
"22946873","Improving clinical outcomes for naltrexone as a management of problem alcohol use","Hulse GK.","Br J Clin Pharmacol. 2013 Nov;76(5):632-41. doi: 10.1111/j.1365-2125.2012.04452.x.","Hulse GK","Br J Clin Pharmacol","2013","2012/09/06","PMC3853523","","10.1111/j.1365-2125.2012.04452.x"
"22946581","An unusual case of Ogilvie syndrome in a pediatric oncology patient receiving palliative care after failed treatment with neostigmine","Johnson LM, Spraker HL, Coleman JL, Baker JN.","J Palliat Med. 2012 Sep;15(9):1042-6. doi: 10.1089/jpm.2011.0450.","Johnson LM","J Palliat Med","2012","2012/09/06","","","10.1089/jpm.2011.0450"
"22945623","Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence","Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Wahlgren V, Tsoy-Podosenin M, Bushara N, Burakov A, Masalov D, Romanova T, Tyurina A, Palatkin V, Slavina T, Pecoraro A, Woody GE.","Arch Gen Psychiatry. 2012 Sep;69(9):973-81. doi: 10.1001/archgenpsychiatry.2012.1a.","Krupitsky E","Arch Gen Psychiatry","2012","2012/09/05","PMC3614358","NIHMS449740","10.1001/archgenpsychiatry.2012.1a"
"22941847","Advantages of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules in pain management","Kapoor S.","J Opioid Manag. 2012 Jul-Aug;8(4):207. doi: 10.5055/jom.2012.0117.","Kapoor S","J Opioid Manag","2012","2012/09/04","","","10.5055/jom.2012.0117"
"22936083","Do opioid receptors play a role in the pathogenesis of the inflammatory response in acute pancreatitis?","Penido A, Coelho AM, Molan NT, Silva FP, D'Albuquerque LA, Machado MC.","Acta Cir Bras. 2012 Sep;27(9):600-5. doi: 10.1590/s0102-86502012000900002.","Penido A","Acta Cir Bras","2012","2012/09/01","","","10.1590/s0102-86502012000900002"
"22931520","Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?","Bannwarth B.","Drugs. 2012 Sep 10;72(13):1713-23. doi: 10.2165/11635860-000000000-00000.","Bannwarth B","Drugs","2012","2012/08/31","","","10.2165/11635860-000000000-00000"
"22929597","Modeling socially anhedonic syndromes: genetic and pharmacological manipulation of opioid neurotransmission in mice","Cinque C, Pondiki S, Oddi D, Di Certo MG, Marinelli S, Troisi A, Moles A, D'Amato FR.","Transl Psychiatry. 2012 Aug 28;2(8):e155. doi: 10.1038/tp.2012.83.","Cinque C","Transl Psychiatry","2012","2012/08/30","PMC3432195","","10.1038/tp.2012.83"
"22926596","Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women","King AC, Cao D, O'Malley SS, Kranzler HR, Cai X, deWit H, Matthews AK, Stachoviak RJ.","J Clin Psychopharmacol. 2012 Oct;32(5):630-6. doi: 10.1097/JCP.0b013e3182676956.","King AC","J Clin Psychopharmacol","2012","2012/08/29","PMC4640209","NIHMS733373","10.1097/JCP.0b013e3182676956"
"22918032","The mu-opioid receptor-selective peptide antagonists, antanal-1 and antanal-2, produce anticonvulsant effects in mice","Fichna J, Socała K, Nieoczym D, Gach K, Perlikowska R, Janecka A, Wlaź P.","Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:126-31. doi: 10.1016/j.pnpbp.2012.07.020. Epub 2012 Aug 11.","Fichna J","Prog Neuropsychopharmacol Biol Psychiatry","2013","2012/08/25","","","10.1016/j.pnpbp.2012.07.020"
"22914074","Role of µ-opioid receptor reserve and µ-agonist efficacy as determinants of the effects of µ-agonists on intracranial self-stimulation in rats","Altarifi AA, Miller LL, Negus SS.","Behav Pharmacol. 2012 Oct;23(7):678-92. doi: 10.1097/FBP.0b013e328358593c.","Altarifi AA","Behav Pharmacol","2012","2012/08/24","PMC3864003","NIHMS535005","10.1097/FBP.0b013e328358593c"
"22909206","Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone","Setiawan E, Pihl RO, Benkelfat C, Leyton M.","Pharmacogenomics. 2012 Jul;13(10):1161-72. doi: 10.2217/pgs.12.99.","Setiawan E","Pharmacogenomics","2012","2012/08/23","","","10.2217/pgs.12.99"
"22898437","Urge-specific and lifestyle coping strategies of alcoholics: relationships of specific strategies to treatment outcome","Dolan SL, Rohsenow DJ, Martin RA, Monti PM.","Drug Alcohol Depend. 2013 Feb 1;128(1-2):8-14. doi: 10.1016/j.drugalcdep.2012.07.010. Epub 2012 Aug 14.","Dolan SL","Drug Alcohol Depend","2013","2012/08/18","PMC3505227","NIHMS397866","10.1016/j.drugalcdep.2012.07.010"
"22894733","Analysis of naltrexone and its metabolite 6-beta-naltrexol in serum with high-performance liquid chromatography","Heinälä P, Lahti T, Sinclair D, Ariniemi K, Lillsunde P, Alho H.","BMC Res Notes. 2012 Aug 15;5:439. doi: 10.1186/1756-0500-5-439.","Heinälä P","BMC Res Notes","2012","2012/08/17","PMC3490825","","10.1186/1756-0500-5-439"
"22892944","[Relapse prevention in alcohol dependence: acamprosate and naltrexone as a combined pharmacological strategy]","Gahr M, Kölle MA, Schönfeldt-Lecuona C.","Nervenarzt. 2013 May;84(5):584-9. doi: 10.1007/s00115-012-3633-3.","Gahr M","Nervenarzt","2013","2012/08/16","","","10.1007/s00115-012-3633-3"
"22875830","A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence","Wee S, Vendruscolo LF, Misra KK, Schlosburg JE, Koob GF.","Sci Transl Med. 2012 Aug 8;4(146):146ra110. doi: 10.1126/scitranslmed.3003948.","Wee S","Sci Transl Med","2012","2012/08/10","PMC3448552","NIHMS403879","10.1126/scitranslmed.3003948"
"22873183","Maintenance medication for opiate addiction: the foundation of recovery","Bart G.","J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598.","Bart G","J Addict Dis","2012","2012/08/10","PMC3411273","NIHMS390074","10.1080/10550887.2012.694598"
"22866296","Elucidation of the mechanisms of membranotropic effects of RU-1203 on ionic channels of Lymnaea stagnalis neurons","Grechko OY, Spasov AA, Vislobokov AI, Ignatov YD, Anisimova VA.","Bull Exp Biol Med. 2012 Jul;153(3):301-4. doi: 10.1007/s10517-012-1700-1.","Grechko OY","Bull Exp Biol Med","2012","2012/08/07","","","10.1007/s10517-012-1700-1"
"22860172","ACS chemical neuroscience molecule spotlight on contrave","Mercer SL.","ACS Chem Neurosci. 2011 Sep 21;2(9):484-6. doi: 10.1021/cn200076y.","Mercer SL","ACS Chem Neurosci","2011","2012/08/04","PMC3369782","","10.1021/cn200076y"
"22841808","Antinociceptive properties of Micrurus lemniscatus venom","Leite dos Santos GG, Casais e Silva LL, Pereira Soares MB, Villarreal CF.","Toxicon. 2012 Nov;60(6):1005-12. doi: 10.1016/j.toxicon.2012.07.003. Epub 2012 Jul 24.","Leite dos Santos GG","Toxicon","2012","2012/07/31","","","10.1016/j.toxicon.2012.07.003"
"22833995","Microneedle delivery: clinical studies and emerging medical applications","Pettis RJ, Harvey AJ.","Ther Deliv. 2012 Mar;3(3):357-71. doi: 10.4155/tde.12.13.","Pettis RJ","Ther Deliv","2012","2012/07/27","","","10.4155/tde.12.13"
"22827928","The opioid placebo analgesia is mediated exclusively through μ-opioid receptor in rat","Zhang RR, Zhang WC, Wang JY, Guo JY.","Int J Neuropsychopharmacol. 2013 May;16(4):849-56. doi: 10.1017/S1461145712000673. Epub 2012 Jul 25.","Zhang RR","Int J Neuropsychopharmacol","2013","2012/07/26","","","10.1017/S1461145712000673"
"22818080","Investigation of 7-benzylidenenaltrexone derivatives as resistance reverser for chloroquine-resistant Plasmodium chabaudi","Miyata Y, Fujii H, Uenohara Y, Kobayashi S, Takeuchi T, Nagase H.","Bioorg Med Chem Lett. 2012 Aug 15;22(16):5174-6. doi: 10.1016/j.bmcl.2012.06.085. Epub 2012 Jul 1.","Miyata Y","Bioorg Med Chem Lett","2012","2012/07/24","","","10.1016/j.bmcl.2012.06.085"
"22817867","The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens","Steensland P, Fredriksson I, Holst S, Feltmann K, Franck J, Schilström B, Carlsson A.","Biol Psychiatry. 2012 Nov 15;72(10):823-31. doi: 10.1016/j.biopsych.2012.06.018. Epub 2012 Jul 18.","Steensland P","Biol Psychiatry","2012","2012/07/24","","","10.1016/j.biopsych.2012.06.018"
"22816021","Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists","Yuan Y, Li G, He H, Stevens DL, Kozak P, Scoggins KL, Mitra P, Gerk PM, Selley DE, Dewey WL, Zhang Y.","ACS Chem Neurosci. 2011 Jul 20;2(7):346-51. doi: 10.1021/cn2000348. Epub 2011 May 6.","Yuan Y","ACS Chem Neurosci","2011","2012/07/21","PMC3369747","","10.1021/cn2000348"
"22805601","Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating","Giuliano C, Robbins TW, Nathan PJ, Bullmore ET, Everitt BJ.","Neuropsychopharmacology. 2012 Nov;37(12):2643-52. doi: 10.1038/npp.2012.128. Epub 2012 Jul 18.","Giuliano C","Neuropsychopharmacology","2012","2012/07/19","PMC3473330","","10.1038/npp.2012.128"
"22803167","Effect of dehydroepiandrosterone sulfate on aldosterone level during stress exposures: role of μ-opioid receptors","Obut TA, Saryg SK, Ovsukova MV, Dementeva TU, Obut ET, Erdinieva TA.","Bull Exp Biol Med. 2012 Apr;152(6):696-8. doi: 10.1007/s10517-012-1609-8.","Obut TA","Bull Exp Biol Med","2012","2012/07/18","","","10.1007/s10517-012-1609-8"
"22784013","Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment","Kranzler HR, Armeli S, Covault J, Tennen H.","Addict Biol. 2013 Jan;18(1):193-201. doi: 10.1111/j.1369-1600.2012.00471.x. Epub 2012 Jul 11.","Kranzler HR","Addict Biol","2013","2012/07/13","PMC3473112","NIHMS380679","10.1111/j.1369-1600.2012.00471.x"
"22778191","Clinical safety of 1500 mg oral naltrexone overdose","Reece AS.","BMJ Case Rep. 2010 Sep 7;2010:bcr0420102871. doi: 10.1136/bcr.04.2010.2871.","Reece AS","BMJ Case Rep","2010","2012/07/11","PMC3028212","","10.1136/bcr.04.2010.2871"
"22776054","Effects of extended-release injectable naltrexone on self-injurious behavior in rhesus macaques (Macaca mulatta)","Kempf DJ, Baker KC, Gilbert MH, Blanchard JL, Dean RL, Deaver DR, Bohm RP Jr.","Comp Med. 2012 Jun;62(3):209-17.","Kempf DJ","Comp Med","2012","2012/07/11","PMC3364699","",""
"22771010","An efficient synthesis of 3-OBn-6β,14-epoxy-bridged opiates from naltrexone and identification of a related dual MOR inverse agonist/KOR agonist","Martin DJ, FitzMorris PE, Li B, Ayestas M, Sally EJ, Dersch CM, Rothman RB, Deveau AM.","Bioorg Med Chem Lett. 2012 Nov 15;22(22):6801-5. doi: 10.1016/j.bmcl.2012.06.056. Epub 2012 Jun 23.","Martin DJ","Bioorg Med Chem Lett","2012","2012/07/10","","","10.1016/j.bmcl.2012.06.056"
"22770638","Effects of acute stressors on itch- and pain-related behaviors in rats","Spradley JM, Davoodi A, Carstens MI, Carstens E.","Pain. 2012 Sep;153(9):1890-7. doi: 10.1016/j.pain.2012.05.032. Epub 2012 Jul 5.","Spradley JM","Pain","2012","2012/07/10","PMC3413756","NIHMS392209","10.1016/j.pain.2012.05.032"
"22770490","Methylnaltrexone for opioid-induced constipation in a pediatric oncology patient","Kissling KT, Mohassel LR, Heintz J.","J Pain Symptom Manage. 2012 Jul;44(1):e1-3. doi: 10.1016/j.jpainsymman.2012.04.001.","Kissling KT","J Pain Symptom Manage","2012","2012/07/10","","","10.1016/j.jpainsymman.2012.04.001"
"22766006","Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat","Bobeck EN, Haseman RA, Hong D, Ingram SL, Morgan MM.","J Pain. 2012 Aug;13(8):799-807. doi: 10.1016/j.jpain.2012.05.005. Epub 2012 Jul 3.","Bobeck EN","J Pain","2012","2012/07/07","PMC3958948","NIHMS391320","10.1016/j.jpain.2012.05.005"
"22764364","Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial","Tiihonen J, Krupitsky E, Verbitskaya E, Blokhina E, Mamontova O, Föhr J, Tuomola P, Kuoppasalmi K, Kiviniemi V, Zwartau E.","Am J Psychiatry. 2012 May;169(5):531-6. doi: 10.1176/appi.ajp.2011.11071121.","Tiihonen J","Am J Psychiatry","2012","2012/07/06","","","10.1176/appi.ajp.2011.11071121"
"22759074","Multivesicular liposomes for sustained release of naltrexone hydrochloride: design, characterization and in vitro/in vivo evaluation","Sun L, Wang T, Gao L, Quan D, Feng D.","Pharm Dev Technol. 2013 Jul-Aug;18(4):828-33. doi: 10.3109/10837450.2012.700934. Epub 2012 Jul 3.","Sun L","Pharm Dev Technol","2013","2012/07/05","","","10.3109/10837450.2012.700934"
"22749946","Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: the effects on immediate-early gene expression in the rat prefrontal cortex","Echeverry-Alzate V, Tuda-Arízcun M, Bühler KM, Santos Á, Giné E, Olmos P, Gorriti MÁ, Huertas E, Rodríguez de Fonseca F, López-Moreno JA.","Neuropharmacology. 2012 Nov;63(6):927-35. doi: 10.1016/j.neuropharm.2012.06.010. Epub 2012 Jun 28.","Echeverry-Alzate V","Neuropharmacology","2012","2012/07/04","","","10.1016/j.neuropharm.2012.06.010"
"22747544","Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?","Holzer P.","Curr Pharm Des. 2012;18(37):6010-20. doi: 10.2174/138161212803582388.","Holzer P","Curr Pharm Des","2012","2012/07/04","","","10.2174/138161212803582388"
"22747521","Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients","Langleben DD, Ruparel K, Elman I, Loughead JW, Busch EL, Cornish J, Lynch KG, Nuwayser ES, Childress AR, O'Brien CP.","Addict Biol. 2014 Mar;19(2):262-71. doi: 10.1111/j.1369-1600.2012.00462.x. Epub 2012 Jul 2.","Langleben DD","Addict Biol","2014","2012/07/04","","","10.1111/j.1369-1600.2012.00462.x"
"22736766","6'-Guanidinonaltrindole (6'-GNTI) is a G protein-biased κ-opioid receptor agonist that inhibits arrestin recruitment","Rives ML, Rossillo M, Liu-Chen LY, Javitch JA.","J Biol Chem. 2012 Aug 3;287(32):27050-4. doi: 10.1074/jbc.C112.387332. Epub 2012 Jun 26.","Rives ML","J Biol Chem","2012","2012/06/28","PMC3411045","","10.1074/jbc.C112.387332"
"22735633","The effects of κ-opioid receptor on stretch-induced electrophysiological changes in infarcted rat hearts","Xiu J, Liu J, Li H, Fu L, Ding D, Han D.","Am J Med Sci. 2013 Feb;345(2):129-35. doi: 10.1097/MAJ.0b013e31824ceba7.","Xiu J","Am J Med Sci","2013","2012/06/28","","","10.1097/MAJ.0b013e31824ceba7"
"22732665","Supraspinal antinociceptive effect of apelin-13 in a mouse visceral pain model","Lv SY, Qin YJ, Wang NB, Yang YJ, Chen Q.","Peptides. 2012 Sep;37(1):165-70. doi: 10.1016/j.peptides.2012.06.007. Epub 2012 Jun 23.","Lv SY","Peptides","2012","2012/06/27","","","10.1016/j.peptides.2012.06.007"
"22728209","Centrally administered apelin-13 induces depression-like behavior in mice","Lv SY, Qin YJ, Wang HT, Xu N, Yang YJ, Chen Q.","Brain Res Bull. 2012 Sep 1;88(6):574-80. doi: 10.1016/j.brainresbull.2012.06.003. Epub 2012 Jun 21.","Lv SY","Brain Res Bull","2012","2012/06/26","","","10.1016/j.brainresbull.2012.06.003"
"22723540","Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats","Kurbanov DB, Currie PJ, Simonson DC, Borsook D, Elman I.","J Psychopharmacol. 2012 Sep;26(9):1244-51. doi: 10.1177/0269881112450783. Epub 2012 Jun 21.","Kurbanov DB","J Psychopharmacol","2012","2012/06/23","","","10.1177/0269881112450783"
"22717418","Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers","Bass A, Stark JG, Pixton GC, Sommerville KW, Zamora CA, Leibowitz M, Rolleri R.","Clin Ther. 2012 Jul;34(7):1601-12. doi: 10.1016/j.clinthera.2012.05.009. Epub 2012 Jun 19.","Bass A","Clin Ther","2012","2012/06/22","","","10.1016/j.clinthera.2012.05.009"
"22710911","Novel object recognition as a facile behavior test for evaluating drug effects in AβPP/PS1 Alzheimer's disease mouse model","Zhang R, Xue G, Wang S, Zhang L, Shi C, Xie X.","J Alzheimers Dis. 2012;31(4):801-12. doi: 10.3233/JAD-2012-120151.","Zhang R","J Alzheimers Dis","2012","2012/06/20","","","10.3233/JAD-2012-120151"
"22691393","[Naltrexone and opiate substitutive treatment]","Dupouy J, Poutrain JC, Lapeyre-Mestre M.","Therapie. 2011 Nov-Dec;66(6):549-52. doi: 10.2515/therapie/2011072. Epub 2011 Dec 21.","Dupouy J","Therapie","2011","2012/06/14","","","10.2515/therapie/2011072"
"22687282","The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease","McLaughlin PJ, Zagon IS.","Biochem Pharmacol. 2012 Sep 15;84(6):746-55. doi: 10.1016/j.bcp.2012.05.018. Epub 2012 Jun 1.","McLaughlin PJ","Biochem Pharmacol","2012","2012/06/13","","","10.1016/j.bcp.2012.05.018"
"22683223","6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists","Yuan Y, Stevens DL, Braithwaite A, Scoggins KL, Bilsky EJ, Akbarali HI, Dewey WL, Zhang Y.","Bioorg Med Chem Lett. 2012 Jul 15;22(14):4731-4. doi: 10.1016/j.bmcl.2012.05.075. Epub 2012 May 26.","Yuan Y","Bioorg Med Chem Lett","2012","2012/06/12","PMC3395321","NIHMS384110","10.1016/j.bmcl.2012.05.075"
"22676570","The science and practice of medication-assisted treatments for opioid dependence","Pecoraro A, Ma M, Woody GE.","Subst Use Misuse. 2012 Jun-Jul;47(8-9):1026-40. doi: 10.3109/10826084.2012.663292.","Pecoraro A","Subst Use Misuse","2012","2012/06/09","","","10.3109/10826084.2012.663292"
"22676261","Pharmacotherapy for adolescent alcohol use disorder","Clark DB.","CNS Drugs. 2012 Jul 1;26(7):559-69. doi: 10.2165/11634330-000000000-00000.","Clark DB","CNS Drugs","2012","2012/06/09","","","10.2165/11634330-000000000-00000"
"22659976","Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner","Tejeda HA, Natividad LA, Orfila JE, Torres OV, O'Dell LE.","Psychopharmacology (Berl). 2012 Nov;224(2):289-301. doi: 10.1007/s00213-012-2752-7. Epub 2012 Jun 4.","Tejeda HA","Psychopharmacology (Berl)","2012","2012/06/05","PMC3482308","NIHMS402708","10.1007/s00213-012-2752-7"
"22642416","Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity","Munro TA, Berry LM, Van't Veer A, Béguin C, Carroll FI, Zhao Z, Carlezon WA Jr, Cohen BM.","BMC Pharmacol. 2012 May 29;12:5. doi: 10.1186/1471-2210-12-5.","Munro TA","BMC Pharmacol","2012","2012/05/31","PMC3411462","","10.1186/1471-2210-12-5"
"22640757","Advances in opioid antagonist treatment for opioid addiction","Ling W, Mooney L, Wu LT.","Psychiatr Clin North Am. 2012 Jun;35(2):297-308. doi: 10.1016/j.psc.2012.03.002. Epub 2012 Apr 10.","Ling W","Psychiatr Clin North Am","2012","2012/05/30","PMC4178977","NIHMS615689","10.1016/j.psc.2012.03.002"
"22628183","Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin","Milewski M, Pinninti RR, Stinchcomb AL.","J Pharm Sci. 2012 Aug;101(8):2777-86. doi: 10.1002/jps.23189. Epub 2012 May 24.","Milewski M","J Pharm Sci","2012","2012/05/26","","","10.1002/jps.23189"
"22624424","[Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification]","Jovanović T, Lazarević D, Nikolić G.","Vojnosanit Pregl. 2012 Apr;69(4):326-32. doi: 10.2298/vsp1204326j.","Jovanović T","Vojnosanit Pregl","2012","2012/05/26","","","10.2298/vsp1204326j"
"22623016","Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment","Stoops WW, Lofwall MR, Nuzzo PA, Craig LB, Siegel AJ, Walsh SL.","Psychopharmacology (Berl). 2012 Oct;223(4):427-38. doi: 10.1007/s00213-012-2739-4. Epub 2012 May 24.","Stoops WW","Psychopharmacology (Berl)","2012","2012/05/25","PMC3439600","NIHMS380999","10.1007/s00213-012-2739-4"
"22616317","Safety of EMBEda (morphine sulfate and naltrexone hydrochloride) extended-release capsules: review of postmarketing adverse events during the first year","Badalamenti VC, Buckley JW, Smith ET.","J Opioid Manag. 2012 Mar-Apr;8(2):115-25. doi: 10.5055/jom.2012.0104.","Badalamenti VC","J Opioid Manag","2012","2012/05/24","","","10.5055/jom.2012.0104"
"22612306","A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men","Morgenstern J, Kuerbis AN, Chen AC, Kahler CW, Bux DA Jr, Kranzler HR.","J Consult Clin Psychol. 2012 Oct;80(5):863-75. doi: 10.1037/a0028615. Epub 2012 May 21.","Morgenstern J","J Consult Clin Psychol","2012","2012/05/23","PMC3458143","NIHMS375961","10.1037/a0028615"
"22611701","[The use of different forms of naltrexone in the treatment of opioid dependence]","Krupitskiĭ EM, Zvartau EE, Blokhina EA, Woody G.","Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(11 Pt 2):66-72.","Krupitskiĭ EM","Zh Nevrol Psikhiatr Im S S Korsakova","2011","2012/05/23","","",""
"22596164","Structure of the δ-opioid receptor bound to naltrindole","Granier S, Manglik A, Kruse AC, Kobilka TS, Thian FS, Weis WI, Kobilka BK.","Nature. 2012 May 16;485(7398):400-4. doi: 10.1038/nature11111.","Granier S","Nature","2012","2012/05/19","PMC3523198","NIHMS370047","10.1038/nature11111"
"22596150","Structural biology: How opioid drugs bind to receptors","Filizola M, Devi LA.","Nature. 2012 May 16;485(7398):314-7. doi: 10.1038/485314a.","Filizola M","Nature","2012","2012/05/19","PMC3589518","NIHMS443198","10.1038/485314a"
"22595640","Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects","Abdelkader H, Wu Z, Al-Kassas R, Alany RG.","Int J Pharm. 2012 Aug 20;433(1-2):142-8. doi: 10.1016/j.ijpharm.2012.05.011. Epub 2012 May 14.","Abdelkader H","Int J Pharm","2012","2012/05/19","","","10.1016/j.ijpharm.2012.05.011"
"22594709","A 'miracle cure' misunderstood","Brewer C.","Addiction. 2012 Aug;107(8):1528. doi: 10.1111/j.1360-0443.2012.03912.x. Epub 2012 May 17.","Brewer C","Addiction","2012","2012/05/19","","","10.1111/j.1360-0443.2012.03912.x"
"22593047","κ-Opioid receptors within the nucleus accumbens shell mediate pair bond maintenance","Resendez SL, Kuhnmuench M, Krzywosinski T, Aragona BJ.","J Neurosci. 2012 May 16;32(20):6771-84. doi: 10.1523/JNEUROSCI.5779-11.2012.","Resendez SL","J Neurosci","2012","2012/05/18","PMC6622186","","10.1523/JNEUROSCI.5779-11.2012"
"22575752","Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models","Abdelkader H, Ismail S, Hussein A, Wu Z, Al-Kassas R, Alany RG.","Int J Pharm. 2012 Aug 1;432(1-2):1-10. doi: 10.1016/j.ijpharm.2012.04.063. Epub 2012 Apr 30.","Abdelkader H","Int J Pharm","2012","2012/05/12","","","10.1016/j.ijpharm.2012.04.063"
"22575744","Low-voltage electrically-enhanced microextraction as a novel technique for simultaneous extraction of acidic and basic drugs from biological fluids","Seidi S, Yamini Y, Rezazadeh M, Esrafili A.","J Chromatogr A. 2012 Jun 22;1243:6-13. doi: 10.1016/j.chroma.2012.04.050. Epub 2012 Apr 26.","Seidi S","J Chromatogr A","2012","2012/05/12","","","10.1016/j.chroma.2012.04.050"
"22575525","The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice","Nguyen AT, Marquez P, Hamid A, Kieffer B, Friedman TC, Lutfy K.","Eur J Pharmacol. 2012 Jul 5;686(1-3):50-4. doi: 10.1016/j.ejphar.2012.04.040. Epub 2012 May 2.","Nguyen AT","Eur J Pharmacol","2012","2012/05/12","PMC3367137","NIHMS374502","10.1016/j.ejphar.2012.04.040"
"22575355","Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project","Lovallo WR, King AC, Farag NH, Sorocco KH, Cohoon AJ, Vincent AS.","Psychoneuroendocrinology. 2012 Dec;37(12):1922-8. doi: 10.1016/j.psyneuen.2012.04.006. Epub 2012 May 8.","Lovallo WR","Psychoneuroendocrinology","2012","2012/05/12","PMC3449011","NIHMS376136","10.1016/j.psyneuen.2012.04.006"
"22551231","Simultaneous modeling of the impact of treatments on alcohol consumption and quality of life in the COMBINE study: a coupled hidden Markov analysis","Prisciandaro JJ, DeSantis SM, Bandyopadhyay D.","Alcohol Clin Exp Res. 2012 Dec;36(12):2141-9. doi: 10.1111/j.1530-0277.2012.01823.x. Epub 2012 May 2.","Prisciandaro JJ","Alcohol Clin Exp Res","2012","2012/05/04","PMC3416970","NIHMS365161","10.1111/j.1530-0277.2012.01823.x"
"22551036","Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes","Anton RF, Voronin KK, Randall PK, Myrick H, Tiffany A.","Alcohol Clin Exp Res. 2012 Nov;36(11):2000-7. doi: 10.1111/j.1530-0277.2012.01807.x. Epub 2012 May 2.","Anton RF","Alcohol Clin Exp Res","2012","2012/05/04","PMC3414671","NIHMS365141","10.1111/j.1530-0277.2012.01807.x"
"22549204","Sustained-release opiate blockers for treating heroin and amphetamine dependence","Penetar DM.","Am J Psychiatry. 2012 May;169(5):455-7. doi: 10.1176/appi.ajp.2012.12020210.","Penetar DM","Am J Psychiatry","2012","2012/05/03","","","10.1176/appi.ajp.2012.12020210"
"22546226","Cathepsin E induces itch-related response through the production of endothelin-1 in mice","Andoh T, Yoshida T, Lee JB, Kuraishi Y.","Eur J Pharmacol. 2012 Jul 5;686(1-3):16-21. doi: 10.1016/j.ejphar.2012.04.024. Epub 2012 Apr 21.","Andoh T","Eur J Pharmacol","2012","2012/05/02","","","10.1016/j.ejphar.2012.04.024"
"22542677","The role of mu-opioid receptor signaling in the dorsolateral periaqueductal gray on conditional and unconditional responding to threatening and aversive stimuli","Halladay LR, Blair HT.","Neuroscience. 2012 Aug 2;216:82-93. doi: 10.1016/j.neuroscience.2012.04.045. Epub 2012 Apr 25.","Halladay LR","Neuroscience","2012","2012/05/01","","","10.1016/j.neuroscience.2012.04.045"
"22541040","Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence","Fucito LM, Park A, Gulliver SB, Mattson ME, Gueorguieva RV, O'Malley SS.","Biol Psychiatry. 2012 Nov 15;72(10):832-8. doi: 10.1016/j.biopsych.2012.03.023. Epub 2012 Apr 26.","Fucito LM","Biol Psychiatry","2012","2012/05/01","PMC3410039","NIHMS367479","10.1016/j.biopsych.2012.03.023"
"22537770","Naltrindole inhibits human multiple myeloma cell proliferation in vitro and in a murine xenograft model in vivo","Mundra JJ, Terskiy A, Howells RD.","J Pharmacol Exp Ther. 2012 Aug;342(2):273-87. doi: 10.1124/jpet.112.194159. Epub 2012 Apr 26.","Mundra JJ","J Pharmacol Exp Ther","2012","2012/04/28","PMC3400794","","10.1124/jpet.112.194159"
"22534819","Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing","King CD, Goodin B, Kindler LL, Caudle RM, Edwards RR, Gravenstein N, Riley JL 3rd, Fillingim RB.","J Behav Med. 2013 Jun;36(3):315-27. doi: 10.1007/s10865-012-9424-2. Epub 2012 Apr 26.","King CD","J Behav Med","2013","2012/04/27","PMC3774309","NIHMS448293","10.1007/s10865-012-9424-2"
"22530908","Synthesis and biological evaluation of naloxone and naltrexone-derived hybrid opioids","Nassim BE, Wang ML.","Med Chem. 2012 Jul;8(4):683-9. doi: 10.2174/157340612801216193.","Nassim BE","Med Chem","2012","2012/04/26","","","10.2174/157340612801216193"
"22528547","Preparation and investigation of sustained drug delivery systems using an injectable, thermosensitive, in situ forming hydrogel composed of PLGA-PEG-PLGA","Khodaverdi E, Tekie FS, Mohajeri SA, Ganji F, Zohuri G, Hadizadeh F.","AAPS PharmSciTech. 2012 Jun;13(2):590-600. doi: 10.1208/s12249-012-9781-8. Epub 2012 Apr 18.","Khodaverdi E","AAPS PharmSciTech","2012","2012/04/25","PMC3364385","","10.1208/s12249-012-9781-8"
"22526543","Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on stress and drug-induced reinstatement of nicotine-conditioned place preference in mice","Jackson KJ, McLaughlin JP, Carroll FI, Damaj MI.","Psychopharmacology (Berl). 2013 Apr;226(4):763-8. doi: 10.1007/s00213-012-2716-y. Epub 2012 Apr 20.","Jackson KJ","Psychopharmacology (Berl)","2013","2012/04/25","PMC3821839","NIHMS522968","10.1007/s00213-012-2716-y"
"22525000","Trajectory analyses in alcohol treatment research","Chen J, Johnson BA, Wang XQ, O'Quigley J, Isaac M, Zhang D, Liu L.","Alcohol Clin Exp Res. 2012 Aug;36(8):1442-8. doi: 10.1111/j.1530-0277.2012.01748.x. Epub 2012 Apr 23.","Chen J","Alcohol Clin Exp Res","2012","2012/04/25","PMC3407320","NIHMS350150","10.1111/j.1530-0277.2012.01748.x"
"22515274","Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis","Chamorro AJ, Marcos M, Mirón-Canelo JA, Pastor I, González-Sarmiento R, Laso FJ.","Addict Biol. 2012 May;17(3):505-12. doi: 10.1111/j.1369-1600.2012.00442.x.","Chamorro AJ","Addict Biol","2012","2012/04/21","","","10.1111/j.1369-1600.2012.00442.x"
"22513524","Opioid modulation of facial itch- and pain-related responses and grooming behavior in rats","Spradley JM, Davoodi A, Carstens MI, Carstens E.","Acta Derm Venereol. 2012 Sep;92(5):515-20. doi: 10.2340/00015555-1364.","Spradley JM","Acta Derm Venereol","2012","2012/04/20","","","10.2340/00015555-1364"
"22511629","Spontaneous episodic decreased tear secretion in rats is related to opioidergic signaling pathways","Zagon IS, Campbell AM, Sassani JW, McLaughlin PJ.","Invest Ophthalmol Vis Sci. 2012 May 31;53(6):3234-40. doi: 10.1167/iovs.11-9051.","Zagon IS","Invest Ophthalmol Vis Sci","2012","2012/04/19","PMC3383188","","10.1167/iovs.11-9051"
"22494221","Acceptance of naltrexone by pregnant women enrolled in comprehensive drug addiction treatment: an initial survey","Jones HE.","Am J Addict. 2012 May-Jun;21(3):199-201. doi: 10.1111/j.1521-0391.2012.00229.x. Epub 2012 Apr 6.","Jones HE","Am J Addict","2012","2012/04/13","","","10.1111/j.1521-0391.2012.00229.x"
"22490239","Opioid receptor heteromers in analgesia","Costantino CM, Gomes I, Stockton SD, Lim MP, Devi LA.","Expert Rev Mol Med. 2012 Apr 10;14:e9. doi: 10.1017/erm.2012.5.","Costantino CM","Expert Rev Mol Med","2012","2012/04/12","PMC3805500","NIHMS444800","10.1017/erm.2012.5"
"22487769","κ opioid regulation of anxiety-like behavior during acute ethanol withdrawal","Valdez GR, Harshberger E.","Pharmacol Biochem Behav. 2012 Jul;102(1):44-7. doi: 10.1016/j.pbb.2012.03.019. Epub 2012 Apr 2.","Valdez GR","Pharmacol Biochem Behav","2012","2012/04/11","PMC3354014","NIHMS372542","10.1016/j.pbb.2012.03.019"
"22487087","Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use","Kelty E, Hulse G.","Addiction. 2012 Oct;107(10):1817-24. doi: 10.1111/j.1360-0443.2012.03910.x. Epub 2012 May 17.","Kelty E","Addiction","2012","2012/04/11","","","10.1111/j.1360-0443.2012.03910.x"
"22484111","Central kappa opioid receptors modulate salt appetite in rats","Nascimento AI, Ferreira HS, Saraiva RM, Almeida TS, Fregoneze JB.","Physiol Behav. 2012 Jun 25;106(4):506-14. doi: 10.1016/j.physbeh.2012.03.028. Epub 2012 Mar 29.","Nascimento AI","Physiol Behav","2012","2012/04/10","","","10.1016/j.physbeh.2012.03.028"
"22480625","Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?","Ramanathan S, Panksepp J, Johnson B.","Psychosomatics. 2012 Nov-Dec;53(6):591-4. doi: 10.1016/j.psym.2011.11.006. Epub 2012 Apr 4.","Ramanathan S","Psychosomatics","2012","2012/04/07","","","10.1016/j.psym.2011.11.006"
"22471668","Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research","Jones HE, Chisolm MS, Jansson LM, Terplan M.","Addiction. 2013 Feb;108(2):233-47. doi: 10.1111/j.1360-0443.2012.03811.x. Epub 2012 Apr 4.","Jones HE","Addiction","2013","2012/04/05","","","10.1111/j.1360-0443.2012.03811.x"
"22465615","Previous administration of naltrexone did not change synergism between paracetamol and tramadol in mice","Miranda HF, Noriega V, Prieto JC.","Pharmacol Biochem Behav. 2012 Jul;102(1):72-6. doi: 10.1016/j.pbb.2012.03.008. Epub 2012 Mar 20.","Miranda HF","Pharmacol Biochem Behav","2012","2012/04/03","","","10.1016/j.pbb.2012.03.008"
"22457501","δ-opioid receptor function in the dorsal striatum plays a role in high levels of ethanol consumption in rats","Nielsen CK, Simms JA, Li R, Mill D, Yi H, Feduccia AA, Santos N, Bartlett SE.","J Neurosci. 2012 Mar 28;32(13):4540-52. doi: 10.1523/JNEUROSCI.5345-11.2012.","Nielsen CK","J Neurosci","2012","2012/03/30","PMC6622068","","10.1523/JNEUROSCI.5345-11.2012"
"22451093","Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboons","Kaminski BJ, Duke AN, Weerts EM.","Psychopharmacology (Berl). 2012 Sep;223(1):55-66. doi: 10.1007/s00213-012-2688-y. Epub 2012 Mar 27.","Kaminski BJ","Psychopharmacology (Berl)","2012","2012/03/28","PMC3419300","NIHMS380620","10.1007/s00213-012-2688-y"
"22442070","Regulation of GABA and glutamate release from proopiomelanocortin neuron terminals in intact hypothalamic networks","Dicken MS, Tooker RE, Hentges ST.","Version 2. J Neurosci. 2012 Mar 21;32(12):4042-8. doi: 10.1523/JNEUROSCI.6032-11.2012.","Dicken MS","J Neurosci","2012","2012/03/24","PMC3321840","NIHMS365954","10.1523/JNEUROSCI.6032-11.2012"
"22440692","Ontogenetic differences in ethanol's motivational properties during infancy","Nizhnikov ME, Pautassi RM, Varlinskaya EI, Rahmani P, Spear NE.","Alcohol. 2012 May;46(3):225-34. doi: 10.1016/j.alcohol.2011.09.026. Epub 2012 Mar 21.","Nizhnikov ME","Alcohol","2012","2012/03/24","PMC3376757","NIHMS360106","10.1016/j.alcohol.2011.09.026"
"22439295","Medical treatment of alcohol dependence: a systematic review","Miller PM, Book SW, Stewart SH.","Int J Psychiatry Med. 2011;42(3):227-66. doi: 10.2190/PM.42.3.b.","Miller PM","Int J Psychiatry Med","2011","2012/03/24","PMC3632430","NIHMS451973","10.2190/PM.42.3.b"
"22437504","Structure of the human κ-opioid receptor in complex with JDTic","Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC.","Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939.","Wu H","Nature","2012","2012/03/23","PMC3356457","NIHMS356477","10.1038/nature10939"
"22429255","Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study","Bujarski S, MacKillop J, Ray LA.","Exp Clin Psychopharmacol. 2012 Jun;20(3):181-90. doi: 10.1037/a0027379. Epub 2012 Mar 19.","Bujarski S","Exp Clin Psychopharmacol","2012","2012/03/21","PMC3741097","NIHMS486585","10.1037/a0027379"
"22426027","Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease","Bosco D, Plastino M, Colica C, Bosco F, Arianna S, Vecchio A, Galati F, Cristiano D, Consoli A, Consoli D.","Clin Neuropharmacol. 2012 May-Jun;35(3):118-20. doi: 10.1097/WNF.0b013e31824d529b.","Bosco D","Clin Neuropharmacol","2012","2012/03/20","","","10.1097/WNF.0b013e31824d529b"
"22418875","Mouse model of touch-evoked itch (alloknesis)","Akiyama T, Carstens MI, Ikoma A, Cevikbas F, Steinhoff M, Carstens E.","J Invest Dermatol. 2012 Jul;132(7):1886-91. doi: 10.1038/jid.2012.52. Epub 2012 Mar 15.","Akiyama T","J Invest Dermatol","2012","2012/03/16","PMC3375351","NIHMS354659","10.1038/jid.2012.52"
"22415159","Endogenous opioid and cannabinoid mechanisms are involved in the analgesic effects of celecoxib in the central nervous system","Rezende RM, Paiva-Lima P, Dos Reis WG, Camêlo VM, Faraco A, Bakhle YS, Francischi JN.","Pharmacology. 2012;89(3-4):127-36. doi: 10.1159/000336346. Epub 2012 Mar 10.","Rezende RM","Pharmacology","2012","2012/03/15","","","10.1159/000336346"
"22413747","Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone","Gatti A, Sabato AF.","Clin Drug Investig. 2012 May 1;32(5):293-301. doi: 10.2165/11598000-000000000-00000.","Gatti A","Clin Drug Investig","2012","2012/03/15","","","10.2165/11598000-000000000-00000"
"22410963","A review of late-stage CNS drug candidates for the treatment of obesity","Heal DJ, Gosden J, Smith SL.","Int J Obes (Lond). 2013 Jan;37(1):107-17. doi: 10.1038/ijo.2012.26. Epub 2012 Mar 13.","Heal DJ","Int J Obes (Lond)","2013","2012/03/14","","","10.1038/ijo.2012.26"
"22404717","Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice","Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G.","Am J Drug Alcohol Abuse. 2012 May;38(3):187-99. doi: 10.3109/00952990.2011.653426. Epub 2012 Mar 12.","Sigmon SC","Am J Drug Alcohol Abuse","2012","2012/03/13","PMC4331107","NIHMS661048","10.3109/00952990.2011.653426"
"22392864","What cost weight loss?","Hiatt WR, Thomas A, Goldfine AB.","Circulation. 2012 Mar 6;125(9):1171-7. doi: 10.1161/CIRCULATIONAHA.111.023499.","Hiatt WR","Circulation","2012","2012/03/07","","","10.1161/CIRCULATIONAHA.111.023499"
"22392627","The effects of lobeline and naltrexone on methamphetamine-induced place preference and striatal dopamine and serotonin levels in adolescent rats with a history of maternal separation","Dimatelis JJ, Russell VA, Stein DJ, Daniels WM.","Metab Brain Dis. 2012 Sep;27(3):351-61. doi: 10.1007/s11011-012-9288-8. Epub 2012 Mar 4.","Dimatelis JJ","Metab Brain Dis","2012","2012/03/07","","","10.1007/s11011-012-9288-8"
"22389180","New pharmacological treatment strategies for relapse prevention","Spanagel R, Vengeliene V.","Curr Top Behav Neurosci. 2013;13:583-609. doi: 10.1007/7854_2012_205.","Spanagel R","Curr Top Behav Neurosci","2013","2012/03/06","","","10.1007/7854_2012_205"
"22386181","Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients","Sawh SB, Selvaraj IP, Danga A, Cotton AL, Moss J, Patel PB.","Mayo Clin Proc. 2012 Mar;87(3):255-9. doi: 10.1016/j.mayocp.2011.11.014.","Sawh SB","Mayo Clin Proc","2012","2012/03/06","PMC3498420","","10.1016/j.mayocp.2011.11.014"
"22385598","Management of postoperative ileus","Thompson M, Magnuson B.","Orthopedics. 2012 Mar;35(3):213-7. doi: 10.3928/01477447-20120222-08.","Thompson M","Orthopedics","2012","2012/03/06","","","10.3928/01477447-20120222-08"
"22384673","[Analgesic effect of corticotropin-releasing factor administered into midbrain periaqueductal grey matter]","Iarushkina NI, Bagaeva TR, Filaretova LP.","Ross Fiziol Zh Im I M Sechenova. 2011 Dec;97(12):1327-35.","Iarushkina NI","Ross Fiziol Zh Im I M Sechenova","2011","2012/03/06","","",""
"22361211","The cost-effectiveness of tailored, postal feedback on general practitioners' prescribing of pharmacotherapies for alcohol dependence","Navarro HJ, Shakeshaft A, Doran CM, Petrie DJ.","Drug Alcohol Depend. 2012 Aug 1;124(3):207-15. doi: 10.1016/j.drugalcdep.2012.01.007. Epub 2012 Feb 22.","Navarro HJ","Drug Alcohol Depend","2012","2012/02/25","","","10.1016/j.drugalcdep.2012.01.007"
"22357166","A single-dose, 3-way crossover pharmacokinetic comparison between immediate-release oxycodone hydrochloride with aversion technology (IRO-A, Oxecta), IRO-a with Niacin, and Oxycodone Hydrochloride (Roxicodone) in healthy adults under fasting conditions","Leibowitz MT, Zamora CA, Brzeczko AW, Stark JG.","Am J Ther. 2014 Mar-Apr;21(2):99-105. doi: 10.1097/MJT.0b013e3182456d9b.","Leibowitz MT","Am J Ther","2014","2012/02/24","","","10.1097/MJT.0b013e3182456d9b"
"22352278","[Six-month follow-up study of drug treatment for cannabis addiction: comparison study of four drugs]","Shoenfeld N, Bodnik D, Rosenberg O, Kotler M, Dannon P.","Harefuah. 2011 Dec;150(12):888-92, 937.","Shoenfeld N","Harefuah","2011","2012/02/23","","",""
"22343623","Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells","Kuzumaki N, Suzuki A, Narita M, Hosoya T, Nagasawa A, Imai S, Yamamizu K, Morita H, Nagase H, Okada Y, Okano HJ, Yamashita JK, Okano H, Suzuki T, Narita M.","Br J Cancer. 2012 Mar 13;106(6):1148-52. doi: 10.1038/bjc.2011.574. Epub 2012 Feb 16.","Kuzumaki N","Br J Cancer","2012","2012/02/21","PMC3304401","","10.1038/bjc.2011.574"
"22335183","Implementing evidence-based alcohol interventions in a resource-limited setting: novel delivery strategies in Tomsk, Russia","Shin SS, Livchits V, Nelson AK, Lastimoso CS, Yanova GV, Yanov SA, Mishustin SP, Connery HS, Greenfield SF.","Version 2. Harv Rev Psychiatry. 2012 Jan-Feb;20(1):58-67. doi: 10.3109/10673229.2012.649121.","Shin SS","Harv Rev Psychiatry","2012","2012/02/17","PMC3318976","NIHMS363267","10.3109/10673229.2012.649121"
"22333328","Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure","Kruse MI, Radnovich AJ, Kalapatapu RK, Mehdiyoun N, Chambers RA, Davidson D.","J Stud Alcohol Drugs. 2012 Mar;73(2):205-15. doi: 10.15288/jsad.2012.73.205.","Kruse MI","J Stud Alcohol Drugs","2012","2012/02/16","PMC3281980","","10.15288/jsad.2012.73.205"
"22328595","Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer","Donahue RN, McLaughlin PJ, Zagon IS.","Exp Biol Med (Maywood). 2012 Feb;237(2):167-77. doi: 10.1258/ebm.2011.011321. Epub 2012 Feb 10.","Donahue RN","Exp Biol Med (Maywood)","2012","2012/02/14","","","10.1258/ebm.2011.011321"
"22324565","Does session attendance by a supportive significant other predict outcomes in individual treatment for alcohol use disorders?","Hunter-Reel D, Witkiewitz K, Zweben A.","Alcohol Clin Exp Res. 2012 Jul;36(7):1237-43. doi: 10.1111/j.1530-0277.2011.01719.x. Epub 2012 Feb 10.","Hunter-Reel D","Alcohol Clin Exp Res","2012","2012/02/14","PMC3366157","NIHMS343430","10.1111/j.1530-0277.2011.01719.x"
"22320026","Opioid-dependent error processing","Fellows-Smith J.","J Opioid Manag. 2011 Nov-Dec;7(6):443-9.","Fellows-Smith J","J Opioid Manag","2011","2012/02/11","","",""
"22310470","Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations","Liang NC, Bello NT, Moran TH.","Int J Obes (Lond). 2013 Feb;37(2):272-8. doi: 10.1038/ijo.2012.16. Epub 2012 Feb 7.","Liang NC","Int J Obes (Lond)","2013","2012/02/08","PMC3383881","NIHMS350138","10.1038/ijo.2012.16"
"22302826","μ- and δ-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice","Laurent V, Leung B, Maidment N, Balleine BW.","J Neurosci. 2012 Feb 1;32(5):1875-83. doi: 10.1523/JNEUROSCI.4688-11.2012.","Laurent V","J Neurosci","2012","2012/02/04","PMC3742880","","10.1523/JNEUROSCI.4688-11.2012"
"22302505","A mixed non-homogeneous hidden Markov model for categorical data, with application to alcohol consumption","Maruotti A, Rocci R.","Stat Med. 2012 Apr 30;31(9):871-86. doi: 10.1002/sim.4478. Epub 2012 Feb 3.","Maruotti A","Stat Med","2012","2012/02/04","","","10.1002/sim.4478"
"22289023","Effects of methylnaltrexone in patients with narcotic bowel syndrome: a pilot observational study","Gibson PR, Morrison G.","Intern Med J. 2012 Aug;42(8):907-12. doi: 10.1111/j.1445-5994.2012.02726.x.","Gibson PR","Intern Med J","2012","2012/02/01","","","10.1111/j.1445-5994.2012.02726.x"
"22280332","Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives","Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.","Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. doi: 10.2174/1874473711205010052.","Mannelli P","Curr Drug Abuse Rev","2012","2012/01/28","PMC3496559","NIHMS412595","10.2174/1874473711205010052"
"22264217","The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects","Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.","Addict Biol. 2013 Jan;18(1):181-92. doi: 10.1111/j.1369-1600.2011.00430.x. Epub 2012 Jan 20.","Wand GS","Addict Biol","2013","2012/01/24","PMC3337889","NIHMS345339","10.1111/j.1369-1600.2011.00430.x"
"22263713","A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers","Coviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, Friedmann PD, Nunes EV, Kinlock TW, Gordon MS, Schwartz RP, Nuwayser ES, O'Brien CP.","Subst Abus. 2012;33(1):48-59. doi: 10.1080/08897077.2011.609438.","Coviello DM","Subst Abus","2012","2012/01/24","PMC3365863","NIHMS359077","10.1080/08897077.2011.609438"
"22263709","Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions","Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S, O'Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK; Mat Working Group Of CJ-Dats.","Subst Abus. 2012;33(1):9-18. doi: 10.1080/08897077.2011.611460.","Friedmann PD","Subst Abus","2012","2012/01/24","PMC3295578","NIHMS359080","10.1080/08897077.2011.611460"
"22263545","Conformational analysis of 6α- and 6β-naltrexol and derivatives and relationship to opioid receptor affinity","Bayron JA, Deveau AM, Stubbs JM.","J Chem Inf Model. 2012 Feb 27;52(2):391-5. doi: 10.1021/ci200405u. Epub 2012 Jan 20.","Bayron JA","J Chem Inf Model","2012","2012/01/24","","","10.1021/ci200405u"
"22261437","Early role of the κ opioid receptor in ethanol-induced reinforcement","Pautassi RM, Nizhnikov ME, Acevedo MB, Spear NE.","Physiol Behav. 2012 Mar 20;105(5):1231-41. doi: 10.1016/j.physbeh.2012.01.003. Epub 2012 Jan 11.","Pautassi RM","Physiol Behav","2012","2012/01/21","PMC3289852","NIHMS349647","10.1016/j.physbeh.2012.01.003"
"22256863","Pharmacogenetics of alcoholism: a clinical neuroscience perspective","Ray LA, Courtney KE, Bujarski S, Squeglia LM.","Pharmacogenomics. 2012 Jan;13(2):129-32. doi: 10.2217/pgs.11.173.","Ray LA","Pharmacogenomics","2012","2012/01/20","PMC3683583","NIHMS470018","10.2217/pgs.11.173"
"22249001","Naltrexone/bupropion: an investigational combination for weight loss and maintenance","Makowski CT, Gwinn KM, Hurren KM.","Obes Facts. 2011;4(6):489-94. doi: 10.1159/000335352. Epub 2011 Dec 15.","Makowski CT","Obes Facts","2011","2012/01/18","PMC6444555","","10.1159/000335352"
"22243563","Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans","Ranganathan M, Carbuto M, Braley G, Elander J, Perry E, Pittman B, Radhakrishnan R, Sewell RA, D'Souza DC.","Int J Neuropsychopharmacol. 2012 Oct;15(9):1251-64. doi: 10.1017/S1461145711001830. Epub 2012 Jan 16.","Ranganathan M","Int J Neuropsychopharmacol","2012","2012/01/17","","","10.1017/S1461145711001830"
"22242247","[Pharmacological treatment of amphetamine dependence still on unsafe basis]","Franck J.","Lakartidningen. 2011 Oct 9-15;108(45):2304-7.","Franck J","Lakartidningen","2011","2012/01/17","","",""
"22242243","[Good effect of drug therapy against alcoholism]","Söderpalm B.","Lakartidningen. 2011 Oct 9-15;108(45):2285-9.","Söderpalm B","Lakartidningen","2011","2012/01/17","","",""
"22240038","Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages","Franchi S, Moretti S, Castelli M, Lattuada D, Scavullo C, Panerai AE, Sacerdote P.","Brain Behav Immun. 2012 Mar;26(3):480-8. doi: 10.1016/j.bbi.2011.12.010. Epub 2012 Jan 5.","Franchi S","Brain Behav Immun","2012","2012/01/14","","","10.1016/j.bbi.2011.12.010"
"22234164","Alternatives to prokinetics to move the pylorus and colon","Pfab F, Nowak-Machen M, Napadow V, Fleckenstein J.","Curr Opin Clin Nutr Metab Care. 2012 Mar;15(2):166-73. doi: 10.1097/MCO.0b013e32834f3000.","Pfab F","Curr Opin Clin Nutr Metab Care","2012","2012/01/12","","","10.1097/MCO.0b013e32834f3000"
"22233189","The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal","Mannelli P, Peindl K, Wu LT, Patkar AA, Gorelick DA.","Am J Drug Alcohol Abuse. 2012 May;38(3):200-5. doi: 10.3109/00952990.2011.644003. Epub 2012 Jan 10.","Mannelli P","Am J Drug Alcohol Abuse","2012","2012/01/12","PMC3578306","NIHMS428331","10.3109/00952990.2011.644003"
"22232915","[Model of platelet activation as experimental test system for screening kappa-opioid receptor ligands]","Spasov AA, Grechko OIu, Anisimova VA.","Eksp Klin Farmakol. 2011;74(8):45-7.","Spasov AA","Eksp Klin Farmakol","2011","2012/01/12","","",""
"22230321","Synthesis, characterization and evaluation of computationally designed nanoparticles of molecular imprinted polymers as drug delivery systems","Rostamizadeh K, Vahedpour M, Bozorgi S.","Int J Pharm. 2012 Mar 15;424(1-2):67-75. doi: 10.1016/j.ijpharm.2011.12.054. Epub 2012 Jan 2.","Rostamizadeh K","Int J Pharm","2012","2012/01/11","","","10.1016/j.ijpharm.2011.12.054"
"22221277","Behavioral treatment + naltrexone reduces drug use and legal problems in the Republic of Georgia","Kirtadze I, Otiashvili D, O'Grady KE, Jones HE.","Am J Drug Alcohol Abuse. 2012 Mar;38(2):171-5. doi: 10.3109/00952990.2011.643996. Epub 2012 Jan 5.","Kirtadze I","Am J Drug Alcohol Abuse","2012","2012/01/07","PMC3413379","NIHMS393642","10.3109/00952990.2011.643996"
"22210742","Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward","Skibicka KP, Shirazi RH, Hansson C, Dickson SL.","Endocrinology. 2012 Mar;153(3):1194-205. doi: 10.1210/en.2011-1606. Epub 2011 Dec 30.","Skibicka KP","Endocrinology","2012","2012/01/03","","","10.1210/en.2011-1606"
"22209819","Gambling addiction","Bowden-Jones H, George S.","BMJ. 2011 Dec 30;343:d7789. doi: 10.1136/bmj.d7789.","Bowden-Jones H","BMJ","2011","2012/01/03","","","10.1136/bmj.d7789"
"22204802","Central corticotropin-releasing factor (CRF) may attenuate somatic pain sensitivity through involvement of glucocorticoids","Yarushkina NI, Bagaeva TR, Filaretova LP.","J Physiol Pharmacol. 2011 Oct;62(5):541-8.","Yarushkina NI","J Physiol Pharmacol","2011","2011/12/30","","",""
"22200548","Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system","Gao CJ, Niu L, Ren PC, Wang W, Zhu C, Li YQ, Chai W, Sun XD.","Neuroscience. 2012 Jan 27;202:352-62. doi: 10.1016/j.neuroscience.2011.11.060. Epub 2011 Dec 21.","Gao CJ","Neuroscience","2012","2011/12/28","","","10.1016/j.neuroscience.2011.11.060"
"22196236","Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neurons","Brailoiu GC, Deliu E, Hooper R, Dun NJ, Undieh AS, Adler MW, Benamar K, Brailoiu E.","Drug Alcohol Depend. 2012 Jun 1;123(1-3):277-81. doi: 10.1016/j.drugalcdep.2011.11.021. Epub 2011 Dec 21.","Brailoiu GC","Drug Alcohol Depend","2012","2011/12/27","PMC3321394","NIHMS346300","10.1016/j.drugalcdep.2011.11.021"
"22189052","Co-occurring marijuana use is associated with medication nonadherence and nonplanning impulsivity in young adult heavy drinkers","Peters EN, Leeman RF, Fucito LM, Toll BA, Corbin WR, O'Malley SS.","Addict Behav. 2012 Apr;37(4):420-6. doi: 10.1016/j.addbeh.2011.11.036. Epub 2011 Dec 3.","Peters EN","Addict Behav","2012","2011/12/23","PMC3288288","NIHMS345681","10.1016/j.addbeh.2011.11.036"
"22184124","Cys-27 variant of human δ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization","Leskelä TT, Lackman JJ, Vierimaa MM, Kobayashi H, Bouvier M, Petäjä-Repo UE.","J Biol Chem. 2012 Feb 10;287(7):5008-20. doi: 10.1074/jbc.M111.305656. Epub 2011 Dec 19.","Leskelä TT","J Biol Chem","2012","2011/12/21","PMC3281609","","10.1074/jbc.M111.305656"
"22180367","Delta opioid receptors contribute to the cardiorespiratory effects of biphalin in anesthetized rats","Wojciechowski P, Szereda-Przestaszewska M, Lipkowski AW.","Pharmacol Rep. 2011;63(5):1235-42. doi: 10.1016/s1734-1140(11)70644-2.","Wojciechowski P","Pharmacol Rep","2011","2011/12/20","","","10.1016/s1734-1140(11)70644-2"
"22173030","Inhibition of itch-related responses at spinal level in rats","Horvath G, Joo G, Kekesi G, Farkas I, Tuboly G, Petrovszki Z, Benedek G.","Acta Physiol Hung. 2011 Dec;98(4):480-90. doi: 10.1556/APhysiol.98.2011.4.12.","Horvath G","Acta Physiol Hung","2011","2011/12/17","","","10.1556/APhysiol.98.2011.4.12"
"22166127","Contributions of a relational psychoanalytic approach to dealing with the nonadherent psychiatric patient","Lev-Ran S, Nitzan U, Fennig S.","Bull Menninger Clin. 2011 Dec;75(4):281-94. doi: 10.1521/bumc.2011.75.4.281.","Lev-Ran S","Bull Menninger Clin","2011","2011/12/15","","","10.1521/bumc.2011.75.4.281"
"22150655","Management of constipation in patients receiving palliative care","Cayley WE Jr.","Am Fam Physician. 2011 Dec 1;84(11):1227-8.","Cayley WE Jr","Am Fam Physician","2011","2011/12/14","","",""
"22150002","Principles of psychoneuroendocrinoimmunotherapy of cancer","Lissoni P, Rovelli F.","Immunotherapy. 2012 Jan;4(1):77-86. doi: 10.2217/imt.11.158.","Lissoni P","Immunotherapy","2012","2011/12/14","","","10.2217/imt.11.158"
"22138236","Ethanol drinking-in-the-dark facilitates behavioral sensitization to ethanol in C57BL/6J, BALB/cByJ, but not in mu-opioid receptor deficient CXBK mice","Tarragón E, Baliño P, Aragon CM, Pastor R.","Pharmacol Biochem Behav. 2012 Mar;101(1):14-23. doi: 10.1016/j.pbb.2011.11.014. Epub 2011 Nov 25.","Tarragón E","Pharmacol Biochem Behav","2012","2011/12/06","","","10.1016/j.pbb.2011.11.014"
"22136373","Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice","Le Naour M, Lunzer MM, Powers MD, Portoghese PS.","J Med Chem. 2012 Jan 26;55(2):670-7. doi: 10.1021/jm200902v. Epub 2012 Jan 5.","Le Naour M","J Med Chem","2012","2011/12/06","PMC3438918","NIHMS342778","10.1021/jm200902v"
"22123184","6β-naltrexol, a peripherally selective opioid antagonist that inhibits morphine-induced slowing of gastrointestinal transit: an exploratory study","Yancey-Wrona J, Dallaire B, Bilsky E, Bath B, Burkart J, Webster L, Magiera D, Yang X, Phelps M, Sadee W.","Pain Med. 2011 Dec;12(12):1727-37. doi: 10.1111/j.1526-4637.2011.01279.x. Epub 2011 Nov 28.","Yancey-Wrona J","Pain Med","2011","2011/11/30","","","10.1111/j.1526-4637.2011.01279.x"
"22118653","[Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review]","Petrov I, Krogh J, Nordentoft M.","Ugeskr Laeger. 2011 Nov 28;173(48):3103-9.","Petrov I","Ugeskr Laeger","2011","2011/11/29","","",""
"22110284","YFa and analogs: investigation of opioid receptors in smooth muscle contraction","Kumar K, Goyal R, Mudgal A, Mohan A, Pasha S.","World J Gastroenterol. 2011 Oct 28;17(40):4523-31. doi: 10.3748/wjg.v17.i40.4523.","Kumar K","World J Gastroenterol","2011","2011/11/24","PMC3218144","","10.3748/wjg.v17.i40.4523"
"22108648","Early maternal separation affects ethanol-induced conditioning in a nor-BNI insensitive manner, but does not alter ethanol-induced locomotor activity","Pautassi RM, Nizhnikov ME, Fabio MC, Spear NE.","Pharmacol Biochem Behav. 2012 Jan;100(3):630-8. doi: 10.1016/j.pbb.2011.11.005. Epub 2011 Nov 13.","Pautassi RM","Pharmacol Biochem Behav","2012","2011/11/24","PMC3256748","NIHMS338368","10.1016/j.pbb.2011.11.005"
"22107877","Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice","Merlo LJ, Greene WM, Pomm R.","J Addict Med. 2011 Dec;5(4):279-83. doi: 10.1097/ADM.0b013e31821852a0.","Merlo LJ","J Addict Med","2011","2011/11/24","PMC3223377","NIHMS285798","10.1097/ADM.0b013e31821852a0"
"22106286","Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects","Majumdar S, Grinnell S, Le Rouzic V, Burgman M, Polikar L, Ansonoff M, Pintar J, Pan YX, Pasternak GW.","Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19778-83. doi: 10.1073/pnas.1115231108. Epub 2011 Nov 21.","Majumdar S","Proc Natl Acad Sci U S A","2011","2011/11/23","PMC3241767","","10.1073/pnas.1115231108"
"22098810","Drug treatment of obesity","Bray GA, Ryan DH.","Psychiatr Clin North Am. 2011 Dec;34(4):871-80. doi: 10.1016/j.psc.2011.08.013.","Bray GA","Psychiatr Clin North Am","2011","2011/11/22","","","10.1016/j.psc.2011.08.013"
"22091732","Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide","Ruger JP, Chawarski M, Mazlan M, Luekens C, Ng N, Schottenfeld R.","Health Serv Res. 2012 Apr;47(2):865-87. doi: 10.1111/j.1475-6773.2011.01335.x. Epub 2011 Oct 18.","Ruger JP","Health Serv Res","2012","2011/11/19","PMC3419893","","10.1111/j.1475-6773.2011.01335.x"
"22089316","Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence","Petrakis IL, Ralevski E, Desai N, Trevisan L, Gueorguieva R, Rounsaville B, Krystal JH.","Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. Epub 2011 Nov 16.","Petrakis IL","Neuropsychopharmacology","2012","2011/11/18","PMC3280636","","10.1038/npp.2011.283"
"22086665","Medication-assisted treatment research with criminal justice populations: challenges of implementation","Gordon MS, Kinlock TW, Miller PM.","Behav Sci Law. 2011 Nov-Dec;29(6):829-45. doi: 10.1002/bsl.1015.","Gordon MS","Behav Sci Law","2011","2011/11/17","PMC3243915","NIHMS341354","10.1002/bsl.1015"
"22079773","Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course","Bigelow GE, Preston KL, Schmittner J, Dong Q, Gastfriend DR.","Drug Alcohol Depend. 2012 Jun 1;123(1-3):57-65. doi: 10.1016/j.drugalcdep.2011.10.018. Epub 2011 Nov 12.","Bigelow GE","Drug Alcohol Depend","2012","2011/11/15","PMC3880792","NIHMS523730","10.1016/j.drugalcdep.2011.10.018"
"22078567","Structural basis for μ-opioid receptor binding and activation","Serohijos AW, Yin S, Ding F, Gauthier J, Gibson DG, Maixner W, Dokholyan NV, Diatchenko L.","Structure. 2011 Nov 9;19(11):1683-90. doi: 10.1016/j.str.2011.08.003.","Serohijos AW","Structure","2011","2011/11/15","PMC3217204","NIHMS319188","10.1016/j.str.2011.08.003"
"22074899","The role of endogenous dynorphin in ethanol-induced state-dependent CPP","Nguyen K, Tseng A, Marquez P, Hamid A, Lutfy K.","Behav Brain Res. 2012 Feb 1;227(1):58-63. doi: 10.1016/j.bbr.2011.10.035. Epub 2011 Oct 29.","Nguyen K","Behav Brain Res","2012","2011/11/15","PMC4701201","NIHMS745011","10.1016/j.bbr.2011.10.035"
"22067321","Kisspeptin signaling is indispensable for neurokinin B, but not glutamate, stimulation of gonadotropin secretion in mice","García-Galiano D, van Ingen Schenau D, Leon S, Krajnc-Franken MA, Manfredi-Lozano M, Romero-Ruiz A, Navarro VM, Gaytan F, van Noort PI, Pinilla L, Blomenröhr M, Tena-Sempere M.","Endocrinology. 2012 Jan;153(1):316-28. doi: 10.1210/en.2011-1260. Epub 2011 Nov 8.","García-Galiano D","Endocrinology","2012","2011/11/10","","","10.1210/en.2011-1260"
"22056608","Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats","Dean RL, Eyerman D, Todtenkopf MS, Turncliff RZ, Bidlack JM, Deaver DR.","Pharmacol Biochem Behav. 2012 Jan;100(3):530-7. doi: 10.1016/j.pbb.2011.10.019. Epub 2011 Oct 25.","Dean RL","Pharmacol Biochem Behav","2012","2011/11/08","","","10.1016/j.pbb.2011.10.019"
"22051215","Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review","Swift R, Oslin DW, Alexander M, Forman R.","J Stud Alcohol Drugs. 2011 Nov;72(6):1012-8. doi: 10.15288/jsad.2011.72.1012.","Swift R","J Stud Alcohol Drugs","2011","2011/11/05","","","10.15288/jsad.2011.72.1012"
"22046937","Opioid antagonists for the treatment of alcohol dependence","Yancey JR, Lumbad J.","Am Fam Physician. 2011 Nov 1;84(9):990-2.","Yancey JR","Am Fam Physician","2011","2011/11/04","","",""
"22045373","Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials","Slatkin NE, Lynn R, Su C, Wang W, Israel RJ.","J Pain Symptom Manage. 2011 Nov;42(5):754-60. doi: 10.1016/j.jpainsymman.2011.02.015.","Slatkin NE","J Pain Symptom Manage","2011","2011/11/03","","","10.1016/j.jpainsymman.2011.02.015"
"22034654","Reversal of morphine-induced urinary retention after methylnaltrexone","Garten L, Bührer C.","Arch Dis Child Fetal Neonatal Ed. 2012 Mar;97(2):F151-3. doi: 10.1136/archdischild-2011-300213. Epub 2011 Oct 27.","Garten L","Arch Dis Child Fetal Neonatal Ed","2012","2011/10/29","","","10.1136/archdischild-2011-300213"
"22033345","Delta-opioid receptor activation promotes mesenchymal stem cell survival via PKC/STAT3 signaling pathway","Higuchi S, Ii M, Zhu P, Ashraf M.","Circ J. 2012;76(1):204-12. doi: 10.1253/circj.cj-11-0309. Epub 2011 Oct 28.","Higuchi S","Circ J","2012","2011/10/29","","","10.1253/circj.cj-11-0309"
"22023056","Sensitivity to μ-opioid receptor-mediated anti-nociception is determined by cross-regulation between μ- and δ-opioid receptors at supraspinal level","Ballesta JJ, Cremades J, Rodríguez-Muñoz M, Garzón J, Faura CC.","Br J Pharmacol. 2012 May;166(1):309-26. doi: 10.1111/j.1476-5381.2011.01750.x.","Ballesta JJ","Br J Pharmacol","2012","2011/10/26","PMC3415656","","10.1111/j.1476-5381.2011.01750.x"
"22015431","Neuroprotective effects of remifentanil against transient focal cerebral ischemia in rats","Jeong S, Kim SJ, Jeong C, Lee S, Jeong H, Lee J, Yoo KY.","J Neurosurg Anesthesiol. 2012 Jan;24(1):51-7. doi: 10.1097/ANA.0b013e3182368d70.","Jeong S","J Neurosurg Anesthesiol","2012","2011/10/22","","","10.1097/ANA.0b013e3182368d70"
"22014186","Involvement of the beta-endorphin neurons of the hypothalamic arcuate nucleus in ethanol-induced place preference conditioning in mice","Pastor R, Font L, Miquel M, Phillips TJ, Aragon CM.","Alcohol Clin Exp Res. 2011 Nov;35(11):2019-29. doi: 10.1111/j.1530-0277.2011.01553.x. Epub 2011 Oct 20.","Pastor R","Alcohol Clin Exp Res","2011","2011/10/22","PMC4151392","NIHMS623571","10.1111/j.1530-0277.2011.01553.x"
"22005157","Dorsal hippocampal N-methyl-D-aspartate glutamatergic and δ-opioidergic systems modulate anxiety behaviors in rats in a noninteractive manner","Solati J.","Kaohsiung J Med Sci. 2011 Nov;27(11):485-93. doi: 10.1016/j.kjms.2011.06.011.","Solati J","Kaohsiung J Med Sci","2011","2011/10/19","","","10.1016/j.kjms.2011.06.011"
"22002175","Evaluation of naltrexone for dissociative symptoms in borderline personality disorder","Schmahl C, Kleindienst N, Limberger M, Ludäscher P, Mauchnik J, Deibler P, Brünen S, Hiemke C, Lieb K, Herpertz S, Reicherzer M, Berger M, Bohus M.","Int Clin Psychopharmacol. 2012 Jan;27(1):61-8. doi: 10.1097/YIC.0b013e32834d0e50.","Schmahl C","Int Clin Psychopharmacol","2012","2011/10/18","","","10.1097/YIC.0b013e32834d0e50"
"21998076","Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery","Anissian L, Schwartz HW, Vincent K, Vincent HK, Carpenito J, Stambler N, Ramakrishna T.","J Hosp Med. 2012 Feb;7(2):67-72. doi: 10.1002/jhm.943. Epub 2011 Oct 13.","Anissian L","J Hosp Med","2012","2011/10/15","","","10.1002/jhm.943"
"21997147","Arresting the development of morphine tolerance and dependence","Hales TG.","Br J Anaesth. 2011 Nov;107(5):653-5. doi: 10.1093/bja/aer294.","Hales TG","Br J Anaesth","2011","2011/10/15","","","10.1093/bja/aer294"
"21992933","Methylnaltrexone for treatment of acute colonic pseudo-obstruction","Weinstock LB, Chang AC.","J Clin Gastroenterol. 2011 Nov-Dec;45(10):883-4. doi: 10.1097/MCG.0b013e31821100ab.","Weinstock LB","J Clin Gastroenterol","2011","2011/10/14","","","10.1097/MCG.0b013e31821100ab"
"21991594","Low-dose naltrexone: tricking the body to heal itself","","Exp Biol Med (Maywood). 2011 Sep;236(9):vii-viii. doi: 10.1258/ebm.2011.011f08.","","Exp Biol Med (Maywood)","2011","2011/10/13","","","10.1258/ebm.2011.011f08"
"21988815","Use of naltrexone to antagonize high doses of remifentanil in cats: a dose-finding study","Pypendop BH, Brosnan RJ, Ilkiw JE.","Vet Anaesth Analg. 2011 Nov;38(6):594-7. doi: 10.1111/j.1467-2995.2011.00649.x.","Pypendop BH","Vet Anaesth Analg","2011","2011/10/13","","","10.1111/j.1467-2995.2011.00649.x"
"21970135","Adverse events in the removal of naltrexone implants","Sadleir PH, Gardner AI, Hennessy B.","Anaesth Intensive Care. 2011 Sep;39(5):895-8. doi: 10.1177/0310057X1103900515.","Sadleir PH","Anaesth Intensive Care","2011","2011/10/06","","","10.1177/0310057X1103900515"
"21967071","Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study","Matz J, Graff C, Vainio PJ, Kallio A, Højer AM, Struijk JJ, Kanters JK, Andersen MP, Toft E.","Clin Drug Investig. 2011 Nov 1;31(11):799-811. doi: 10.1007/BF03256919.","Matz J","Clin Drug Investig","2011","2011/10/05","","","10.1007/BF03256919"
"21964915","Determining the clinically important difference in visual analog scale scores in abuse liability studies evaluating novel opioid formulations","Eaton TA, Comer SD, Revicki DA, Trudeau JJ, van Inwegen RG, Stauffer JW, Katz NP.","Qual Life Res. 2012 Aug;21(6):975-81. doi: 10.1007/s11136-011-0012-7. Epub 2011 Oct 1.","Eaton TA","Qual Life Res","2012","2011/10/04","PMC3628592","NIHMS453830","10.1007/s11136-011-0012-7"
"21962974","Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats","Dhaher R, Toalston JE, Hauser SR, Bell RL, McKinzie DL, McBride WJ, Rodd ZA.","Alcohol. 2012 Feb;46(1):17-27. doi: 10.1016/j.alcohol.2011.08.011. Epub 2011 Oct 1.","Dhaher R","Alcohol","2012","2011/10/04","PMC4581853","NIHMS714038","10.1016/j.alcohol.2011.08.011"
"21960665","Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats","Braida D, Donzelli A, Martucci R, Capurro V, Sala M.","Int J Toxicol. 2011 Dec;30(6):650-61. doi: 10.1177/1091581811418538. Epub 2011 Sep 29.","Braida D","Int J Toxicol","2011","2011/10/01","","","10.1177/1091581811418538"
"21960180","Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence","Langleben DD, Busch EL, O'Brien CP, Elman I.","Psychopharmacology (Berl). 2012 Apr;220(3):559-64. doi: 10.1007/s00213-011-2503-1. Epub 2011 Sep 30.","Langleben DD","Psychopharmacology (Berl)","2012","2011/10/01","PMC3302938","NIHMS335730","10.1007/s00213-011-2503-1"
"21953882","Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors","Fichna J, Dicay M, Lewellyn K, Janecka A, Zjawiony JK, MacNaughton WK, Storr MA.","Inflamm Bowel Dis. 2012 Jun;18(6):1137-45. doi: 10.1002/ibd.21873. Epub 2011 Sep 26.","Fichna J","Inflamm Bowel Dis","2012","2011/09/29","","","10.1002/ibd.21873"
"21946895","OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence","Coller JK, Cahill S, Edmonds C, Farquharson AL, Longo M, Minniti R, Sullivan T, Somogyi AA, White JM.","Pharmacogenet Genomics. 2011 Dec;21(12):902-5. doi: 10.1097/FPC.0b013e32834c5445.","Coller JK","Pharmacogenet Genomics","2011","2011/09/28","","","10.1097/FPC.0b013e32834c5445"
"21940429","Opioidergic interactions between striatal projection neurons","Blomeley CP, Bracci E.","Version 2. J Neurosci. 2011 Sep 21;31(38):13346-56. doi: 10.1523/JNEUROSCI.1775-11.2011.","Blomeley CP","J Neurosci","2011","2011/09/24","PMC3781771","EMS36740","10.1523/JNEUROSCI.1775-11.2011"
"21925828","Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment","Gueorguieva R, Wu R, Donovan D, Rounsaville BJ, Couper D, Krystal JH, O'Malley SS.","Alcohol. 2012 Mar;46(2):121-31. doi: 10.1016/j.alcohol.2011.08.008. Epub 2011 Sep 17.","Gueorguieva R","Alcohol","2012","2011/09/20","PMC3266454","NIHMS326963","10.1016/j.alcohol.2011.08.008"
"21924845","Strategies for evaluating the economic value of drugs in alcohol dependence treatment","Schwappach D, Popova S, Mohapatra S, Patra J, Godinho A, Rehm J.","Drug Alcohol Depend. 2012 May 1;122(3):165-73. doi: 10.1016/j.drugalcdep.2011.08.026. Epub 2011 Sep 15.","Schwappach D","Drug Alcohol Depend","2012","2011/09/20","","","10.1016/j.drugalcdep.2011.08.026"
"21917593","Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats","McLaughlin PJ, Pothering CA, Immonen JA, Zagon IS.","Exp Biol Med (Maywood). 2011 Oct;236(10):1122-32. doi: 10.1258/ebm.2011.011163. Epub 2011 Sep 14.","McLaughlin PJ","Exp Biol Med (Maywood)","2011","2011/09/16","","","10.1258/ebm.2011.011163"
"21910569","Targeting opioid signaling in Crohn's disease: new therapeutic pathways","Zagon IS, McLaughlin PJ.","Expert Rev Gastroenterol Hepatol. 2011 Oct;5(5):555-8. doi: 10.1586/egh.11.62.","Zagon IS","Expert Rev Gastroenterol Hepatol","2011","2011/09/14","","","10.1586/egh.11.62"
"21909635","Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism","Robinson JE, Fish EW, Krouse MC, Thorsell A, Heilig M, Malanga CJ.","Psychopharmacology (Berl). 2012 Mar;220(1):215-24. doi: 10.1007/s00213-011-2469-z. Epub 2011 Sep 10.","Robinson JE","Psychopharmacology (Berl)","2012","2011/09/13","PMC3484369","NIHMS341283","10.1007/s00213-011-2469-z"
"21904098","Opioid titration and conversion in patients receiving morphine sulfate and naltrexone hydrochloride extended release capsules","Webster LR, Brewer R, Morris D, Cleveland JM, Setnik B.","Postgrad Med. 2011 Sep;123(5):155-64. doi: 10.3810/pgm.2011.09.2471.","Webster LR","Postgrad Med","2011","2011/09/10","","","10.3810/pgm.2011.09.2471"
"21903117","Chronic treatment with the opioid antagonist naltrexone favours the coupling of spinal cord μ-opioid receptors to Gαz protein subunits","Valdizán EM, Díaz A, Pilar-Cuéllar F, Lantero A, Mostany R, Villar AV, Laorden ML, Hurlé MA.","Neuropharmacology. 2012 Feb;62(2):757-64. doi: 10.1016/j.neuropharm.2011.08.029. Epub 2011 Aug 31.","Valdizán EM","Neuropharmacology","2012","2011/09/10","","","10.1016/j.neuropharm.2011.08.029"
"21902287","Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users","Webster LR, Johnson FK, Stauffer J, Setnik B, Ciric S.","Version 2. Drugs R D. 2011 Sep 1;11(3):259-75. doi: 10.2165/11593390-000000000-00000.","Webster LR","Drugs R D","2011","2011/09/10","PMC3586102","","10.2165/11593390-000000000-00000"
"21900886","Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study","Ray LA, Bujarski S, Chin PF, Miotto K.","Neuropsychopharmacology. 2012 Jan;37(2):445-55. doi: 10.1038/npp.2011.192. Epub 2011 Sep 7.","Ray LA","Neuropsychopharmacology","2012","2011/09/09","PMC3242306","","10.1038/npp.2011.192"
"21895762","Opioid-like antinociceptive effects of oral administration of a lectin purified from the seeds of Canavalia brasiliensis","de Freitas Pires A, Assreuy AM, Lopes ÉA, Celedônio NR, Soares CE, Rodrigues NV, Sousa PL, Benevides RG, Nagano CS, Cavada BS, Leal-Cardoso JH, Coelho-de-Souza AN, Santos CF.","Fundam Clin Pharmacol. 2013 Apr;27(2):201-9. doi: 10.1111/j.1472-8206.2011.00987.x. Epub 2011 Sep 5.","de Freitas Pires A","Fundam Clin Pharmacol","2013","2011/09/08","","","10.1111/j.1472-8206.2011.00987.x"
"21895714","Opioidergic modulation of ethanol self-administration in the ventral pallidum","Kemppainen H, Raivio N, Suo-Yrjo V, Kiianmaa K.","Alcohol Clin Exp Res. 2012 Feb;36(2):286-93. doi: 10.1111/j.1530-0277.2011.01611.x. Epub 2011 Sep 6.","Kemppainen H","Alcohol Clin Exp Res","2012","2011/09/08","","","10.1111/j.1530-0277.2011.01611.x"
"21887861","Low-dose naltrexone: harnessing the body's own chemistry to treat human ovarian cancer","","Exp Biol Med (Maywood). 2011 Jul;236(7):viii. doi: 10.1258/ebm.2011.011f07.","","Exp Biol Med (Maywood)","2011","2011/09/03","","","10.1258/ebm.2011.011f07"
"21880450","Quantitative determination of methylnaltrexone in human serum using liquid chromatography-tandem mass spectrometry","Oswald S, Schumacher G, Siegmund W.","J Pharm Biomed Anal. 2011 Dec 15;56(5):1079-84. doi: 10.1016/j.jpba.2011.08.016. Epub 2011 Aug 12.","Oswald S","J Pharm Biomed Anal","2011","2011/09/02","","","10.1016/j.jpba.2011.08.016"
"21878578","Randomized 5-treatment crossover study to assess the effects of external heat on serum fentanyl concentrations during treatment with transdermal fentanyl systems","Moore KT, Sathyan G, Richarz U, Natarajan J, Vandenbossche J.","J Clin Pharmacol. 2012 Aug;52(8):1174-85. doi: 10.1177/0091270011411710. Epub 2011 Aug 30.","Moore KT","J Clin Pharmacol","2012","2011/09/01","","","10.1177/0091270011411710"
"21876436","Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient","Lee JM, Mooney J.","Clin J Pain. 2012 May;28(4):338-41. doi: 10.1097/AJP.0b013e31822ad94c.","Lee JM","Clin J Pain","2012","2011/08/31","","","10.1097/AJP.0b013e31822ad94c"
"21874227","Activation of the δ-opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway","Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H, Wang L.","Int J Mol Med. 2011 Dec;28(6):1077-85. doi: 10.3892/ijmm.2011.784. Epub 2011 Aug 26.","Tang B","Int J Mol Med","2011","2011/08/30","","","10.3892/ijmm.2011.784"
"21872220","The effects of opioid receptor antagonists on electroacupuncture-produced anti-allodynia/hyperalgesia in rats with paclitaxel-evoked peripheral neuropathy","Meng X, Zhang Y, Li A, Xin J, Lao L, Ren K, Berman BM, Tan M, Zhang RX.","Brain Res. 2011 Sep 26;1414:58-65. doi: 10.1016/j.brainres.2011.08.004. Epub 2011 Aug 7.","Meng X","Brain Res","2011","2011/08/30","PMC3176966","NIHMS316919","10.1016/j.brainres.2011.08.004"
"21856478","Injectable extended-release naltrexone for opioid dependence","Throckmorton DC, Temple R, Rappaport BA, Roca R, Winchell CJ.","Lancet. 2011 Aug 20;378(9792):665-6; author reply 666. doi: 10.1016/S0140-6736(11)61332-9.","Throckmorton DC","Lancet","2011","2011/08/23","","","10.1016/S0140-6736(11)61332-9"
"21856477","Injectable extended-release naltrexone for opioid dependence","Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL.","Lancet. 2011 Aug 20;378(9792):665; author reply 666. doi: 10.1016/S0140-6736(11)61331-7.","Krupitsky E","Lancet","2011","2011/08/23","","","10.1016/S0140-6736(11)61331-7"
"21856476","Injectable extended-release naltrexone for opioid dependence","Woody GE, Metzger DS.","Lancet. 2011 Aug 20;378(9792):664-5; author reply 666. doi: 10.1016/S0140-6736(11)61330-5.","Woody GE","Lancet","2011","2011/08/23","","","10.1016/S0140-6736(11)61330-5"
"21856474","Promise of extended-release naltrexone is a red herring","Bart G.","Lancet. 2011 Aug 20;378(9792):663; author reply 663-4. doi: 10.1016/S0140-6736(11)61328-7.","Bart G","Lancet","2011","2011/08/23","","","10.1016/S0140-6736(11)61328-7"
"21850280","Bupropion/naltrexone fixed-dose combination for the treatment of obesity","Halpern B, Faria AM, Halpern A.","Drugs Today (Barc). 2011 Aug;47(8):575-81. doi: 10.1358/dot.2011.47.8.1617339.","Halpern B","Drugs Today (Barc)","2011","2011/08/19","","","10.1358/dot.2011.47.8.1617339"
"21844938","[Low dosage naltrexone]","Raknes G, Giverhaug T.","Tidsskr Nor Laegeforen. 2011 Aug 9;131(15):1415-6. doi: 10.4045/tidsskr.11.0651.","Raknes G","Tidsskr Nor Laegeforen","2011","2011/08/17","","","10.4045/tidsskr.11.0651"
"21844831","Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders","Lapham SC, McMillan GP.","J Addict Med. 2011 Sep;5(3):163-9. doi: 10.1097/ADM.0b013e3181eb3b89.","Lapham SC","J Addict Med","2011","2011/08/17","","","10.1097/ADM.0b013e3181eb3b89"
"21842273","Neuroprotective potential of biphalin, multireceptor opioid peptide, against excitotoxic injury in hippocampal organotypic culture","Kawalec M, Kowalczyk JE, Beresewicz M, Lipkowski AW, Zablocka B.","Neurochem Res. 2011 Nov;36(11):2091-5. doi: 10.1007/s11064-011-0568-1. Epub 2011 Aug 13.","Kawalec M","Neurochem Res","2011","2011/08/16","PMC3183243","","10.1007/s11064-011-0568-1"
"21841040","Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig","Wang YJ, Rasakham K, Huang P, Chudnovskaya D, Cowan A, Liu-Chen LY.","J Pharmacol Exp Ther. 2011 Nov;339(2):438-50. doi: 10.1124/jpet.111.183905. Epub 2011 Aug 12.","Wang YJ","J Pharmacol Exp Ther","2011","2011/08/16","PMC3199977","","10.1124/jpet.111.183905"
"21839129","Central administration of neuronostatin induces antinociception in mice","Yang AM, Ge WW, Lu SS, Yang SB, Su SF, Mi ZY, Chen Q.","Peptides. 2011 Sep;32(9):1893-901. doi: 10.1016/j.peptides.2011.07.010. Epub 2011 Aug 2.","Yang AM","Peptides","2011","2011/08/16","","","10.1016/j.peptides.2011.07.010"
"21836464","Characterization of the antinociceptive effects of the individual isomers of methadone after acute and chronic administrations","Morgan RW, Nicholson KL.","Behav Pharmacol. 2011 Sep;22(5-6):548-57. doi: 10.1097/FBP.0b013e328349ab0d.","Morgan RW","Behav Pharmacol","2011","2011/08/13","PMC3163453","NIHMS310517","10.1097/FBP.0b013e328349ab0d"
"21836460","Drug discrimination in pigeons trained to discriminate among morphine, U50488, a combination of these drugs, and saline","Wessinger WD, Li M, McMillan DE.","Behav Pharmacol. 2011 Sep;22(5-6):468-79. doi: 10.1097/FBP.0b013e328349ab6c.","Wessinger WD","Behav Pharmacol","2011","2011/08/13","PMC3158672","NIHMS310520","10.1097/FBP.0b013e328349ab6c"
"21823547","Current concepts in the management of opioid-induced constipation: a perfect review with an imperfect concept","Ruan X.","J Opioid Manag. 2011 May-Jun;7(3):167, 170; author reply 170-2. doi: 10.5055/jom.2011.0059.","Ruan X","J Opioid Manag","2011","2011/08/10","","","10.5055/jom.2011.0059"
"21818506","A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis","Herzog JL, Solomon JA, Draelos Z, Fleischer A Jr, Stough D, Wolf DI, Abramovits W, Werschler W, Green E, Duffy M, Rothaul A, Tansley R.","J Drugs Dermatol. 2011 Aug;10(8):853-60.","Herzog JL","J Drugs Dermatol","2011","2011/08/06","","",""
"21810165","Efficacy of subcutaneous methylnaltrexone in the treatment of opioid-induced constipation: a responder post hoc analysis","Michna E, Weil AJ, Duerden M, Schulman S, Wang W, Tzanis E, Zhang H, Yu D, Manley A, Randazzo B.","Pain Med. 2011 Aug;12(8):1223-30. doi: 10.1111/j.1526-4637.2011.01189.x. Epub 2011 Aug 2.","Michna E","Pain Med","2011","2011/08/04","","","10.1111/j.1526-4637.2011.01189.x"
"21808756","Compulsive buying treated with motivational interviewing and imaginal desensitization","Donahue CB, Odlaug BL, Grant JE.","Ann Clin Psychiatry. 2011 Aug;23(3):226-7.","Donahue CB","Ann Clin Psychiatry","2011","2011/08/03","","",""
"21807817","Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model","Donahue RN, McLaughlin PJ, Zagon IS.","Exp Biol Med (Maywood). 2011 Sep;236(9):1036-50. doi: 10.1258/ebm.2011.011121. Epub 2011 Aug 1.","Donahue RN","Exp Biol Med (Maywood)","2011","2011/08/03","","","10.1258/ebm.2011.011121"
"21804585","Trial watch: Nalmefene reduces alcohol use in phase III trial","","Nat Rev Drug Discov. 2011 Aug 1;10(8):566. doi: 10.1038/nrd3518.","","Nat Rev Drug Discov","2011","2011/08/02","","","10.1038/nrd3518"
"21803531","Effect of opioid receptor blockade on acetaldehyde self-administration and ERK phosphorylation in the rat nucleus accumbens","Peana AT, Muggironi G, Fois GR, Zinellu M, Vinci S, Acquas E.","Alcohol. 2011 Dec;45(8):773-83. doi: 10.1016/j.alcohol.2011.06.003. Epub 2011 Jul 31.","Peana AT","Alcohol","2011","2011/08/02","","","10.1016/j.alcohol.2011.06.003"
"21797892","Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone","Tetrault JM, Tate JP, McGinnis KA, Goulet JL, Sullivan LE, Bryant K, Justice AC, Fiellin DA; Veterans Aging Cohort Study Team.","Alcohol Clin Exp Res. 2012 Feb;36(2):318-24. doi: 10.1111/j.1530-0277.2011.01601.x. Epub 2011 Jul 28.","Tetrault JM","Alcohol Clin Exp Res","2012","2011/07/30","PMC3221963","NIHMS302772","10.1111/j.1530-0277.2011.01601.x"
"21787433","The effects of polyunsaturated fatty acids in alcohol dependence treatment--a double-blind, placebo-controlled pilot study","Fogaça MN, Santos-Galduróz RF, Eserian JK, Galduróz JC.","BMC Clin Pharmacol. 2011 Jul 26;11:10. doi: 10.1186/1472-6904-11-10.","Fogaça MN","BMC Clin Pharmacol","2011","2011/07/27","PMC3162484","","10.1186/1472-6904-11-10"
"21785483","Morphine sulfate and naltrexone hydrochloride extended-release capsules: naltrexone release, pharmacodynamics, and tolerability","Johnson F, Setnik B.","Pain Physician. 2011 Jul-Aug;14(4):391-406.","Johnson F","Pain Physician","2011","2011/07/26","","",""
"21785031","Use of pure opioid antagonists for management of opioid-induced pruritus","Miller JL, Hagemann TM.","Am J Health Syst Pharm. 2011 Aug 1;68(15):1419-25. doi: 10.2146/ajhp100475.","Miller JL","Am J Health Syst Pharm","2011","2011/07/26","","","10.2146/ajhp100475"
"21784323","How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatment","Campanella S, Petit G, Verbanck P, Kornreich C, Noel X.","Neurophysiol Clin. 2011 Jul;41(3):115-23. doi: 10.1016/j.neucli.2011.04.001. Epub 2011 May 26.","Campanella S","Neurophysiol Clin","2011","2011/07/26","","","10.1016/j.neucli.2011.04.001"
"21782353","Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial","DeFulio A, Everly JJ, Leoutsakos JM, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.","Drug Alcohol Depend. 2012 Jan 1;120(1-3):48-54. doi: 10.1016/j.drugalcdep.2011.06.023. Epub 2011 Jul 22.","DeFulio A","Drug Alcohol Depend","2012","2011/07/26","PMC3245785","NIHMS314611","10.1016/j.drugalcdep.2011.06.023"
"21775651","Involvement of the opioid system in the orexigenic and hedonic effects of melanin-concentrating hormone","Lopez CA, Guesdon B, Baraboi ED, Roffarello BM, Hétu M, Richard D.","Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R1105-11. doi: 10.1152/ajpregu.00076.2011. Epub 2011 Jul 20.","Lopez CA","Am J Physiol Regul Integr Comp Physiol","2011","2011/07/22","","","10.1152/ajpregu.00076.2011"
"21771602","Systemic opioid receptor antagonism blocks swim stress-induced retention impairment independently from CA1 and BLA opioidergic pathways","Rezvanfard M, Zarrindast MR, Ownegh V.","Life Sci. 2011 Aug 29;89(9-10):320-6. doi: 10.1016/j.lfs.2011.06.014. Epub 2011 Jul 7.","Rezvanfard M","Life Sci","2011","2011/07/21","","","10.1016/j.lfs.2011.06.014"
"21764311","Opioid δ₁ receptor antagonist 7-benzylidenenaltrexone as an effective resistance reverser for chloroquine-resistant Plasmodium chabaudi","Miyata Y, Fujii H, Osa Y, Kobayashi S, Takeuchi T, Nagase H.","Bioorg Med Chem Lett. 2011 Aug 15;21(16):4710-2. doi: 10.1016/j.bmcl.2011.06.085. Epub 2011 Jun 25.","Miyata Y","Bioorg Med Chem Lett","2011","2011/07/19","","","10.1016/j.bmcl.2011.06.085"
"21761950","Cost and utilization outcomes of opioid-dependence treatments","Baser O, Chalk M, Fiellin DA, Gastfriend DR.","Am J Manag Care. 2011 Jun;17 Suppl 8:S235-48.","Baser O","Am J Manag Care","2011","2011/07/19","","",""
"21761949","Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization","Bryson WC, McConnell J, Korthuis PT, McCarty D.","Am J Manag Care. 2011 Jun;17 Suppl 8(Suppl 8):S222-34.","Bryson WC","Am J Manag Care","2011","2011/07/19","PMC3556906","NIHMS346693",""
"21761948","Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence","Baser O, Chalk M, Rawson R, Gastfriend DR.","Am J Manag Care. 2011 Jun;17 Suppl 8:S222-34.","Baser O","Am J Manag Care","2011","2011/07/19","","",""
"21761946","Utilization patterns of extended-release naltrexone for alcohol dependence","Jan S, Gill P, Borawala AS.","Am J Manag Care. 2011 Jun;17 Suppl 8:S210-2.","Jan S","Am J Manag Care","2011","2011/07/19","","",""
"21757186","Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity","Potter DN, Damez-Werno D, Carlezon WA Jr, Cohen BM, Chartoff EH.","Biol Psychiatry. 2011 Oct 15;70(8):744-53. doi: 10.1016/j.biopsych.2011.05.021. Epub 2011 Jul 14.","Potter DN","Biol Psychiatry","2011","2011/07/16","PMC3186866","NIHMS312396","10.1016/j.biopsych.2011.05.021"
"21742445","Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care","Otiashvili D, Kirtadze I, O'Grady KE, Jones HE.","Drug Alcohol Depend. 2012 Jan 1;120(1-3):14-21. doi: 10.1016/j.drugalcdep.2011.06.012. Epub 2011 Jul 13.","Otiashvili D","Drug Alcohol Depend","2012","2011/07/12","PMC3377370","NIHMS305862","10.1016/j.drugalcdep.2011.06.012"
"21741968","Chromaffin cell transplant in spinal cord reduces secondary allodynia induced by formalin in the rat. Role of opioid receptors and α₂-adrenoceptors","Ambriz-Tututi M, Sánchez-González V, Drucker-Colín R.","Eur J Pharmacol. 2011 Oct 1;668(1-2):147-54. doi: 10.1016/j.ejphar.2011.06.030. Epub 2011 Jul 3.","Ambriz-Tututi M","Eur J Pharmacol","2011","2011/07/12","","","10.1016/j.ejphar.2011.06.030"
"21736895","The role of opioid antagonist efficacy and constitutive opioid receptor activity in the opioid withdrawal syndrome in mice","Navani DM, Sirohi S, Madia PA, Yoburn BC.","Pharmacol Biochem Behav. 2011 Oct;99(4):671-5. doi: 10.1016/j.pbb.2011.06.025. Epub 2011 Jun 29.","Navani DM","Pharmacol Biochem Behav","2011","2011/07/09","PMC3156320","NIHMS313733","10.1016/j.pbb.2011.06.025"
"21736885","Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats","Chartoff E, Sawyer A, Rachlin A, Potter D, Pliakas A, Carlezon WA.","Neuropharmacology. 2012 Jan;62(1):167-76. doi: 10.1016/j.neuropharm.2011.06.014. Epub 2011 Jun 29.","Chartoff E","Neuropharmacology","2012","2011/07/09","PMC3195851","NIHMS308178","10.1016/j.neuropharm.2011.06.014"
"21734650","Activation of μ-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie voles","Burkett JP, Spiegel LL, Inoue K, Murphy AZ, Young LJ.","Neuropsychopharmacology. 2011 Oct;36(11):2200-10. doi: 10.1038/npp.2011.117. Epub 2011 Jul 6.","Burkett JP","Neuropsychopharmacology","2011","2011/07/08","PMC3176565","","10.1038/npp.2011.117"
"21729744","Preparation and characterization of tri-block poly(lactide)-poly(ethylene glycol)-poly(lactide) nanogels for controlled release of naltrexone","Asadi H, Rostamizadeh K, Salari D, Hamidi M.","Int J Pharm. 2011 Sep 15;416(1):356-64. doi: 10.1016/j.ijpharm.2011.06.035. Epub 2011 Jun 25.","Asadi H","Int J Pharm","2011","2011/07/07","","","10.1016/j.ijpharm.2011.06.035"
"21725378","[Research on low dosage naltrexone]","Holmøy T.","Tidsskr Nor Laegeforen. 2011 Jul 1;131(13-14):1277-8. doi: 10.4045/tidsskr.11.0578.","Holmøy T","Tidsskr Nor Laegeforen","2011","2011/07/05","","","10.4045/tidsskr.11.0578"
"21724671","Adapting treatment to patient problems","O'Brien CP.","Am J Psychiatry. 2011 Jul;168(7):670-1. doi: 10.1176/appi.ajp.2011.11040594.","O'Brien CP","Am J Psychiatry","2011","2011/07/05","","","10.1176/appi.ajp.2011.11040594"
"21723199","Endogenous opioids released during non-nociceptive environmental stress induce latent pain sensitization Via a NMDA-dependent process","Le Roy C, Laboureyras E, Gavello-Baudy S, Chateauraynaud J, Laulin JP, Simonnet G.","J Pain. 2011 Oct;12(10):1069-79. doi: 10.1016/j.jpain.2011.04.011. Epub 2011 Jul 1.","Le Roy C","J Pain","2011","2011/07/05","","","10.1016/j.jpain.2011.04.011"
"21722680","The action of a synthetic derivative of Met5-enkephalin-Arg6-Phe7 on behavioral and endocrine responses","Csabafi K, Jászberényi M, Bagosi Z, Tóth G, Wollemann M, Telegdy G.","Peptides. 2011 Aug;32(8):1656-60. doi: 10.1016/j.peptides.2011.05.029. Epub 2011 Jun 22.","Csabafi K","Peptides","2011","2011/07/05","","","10.1016/j.peptides.2011.05.029"
"21719828","Sufentanil and xylazine immobilization of Rocky Mountain elk","Kreeger TJ, Huizenga M, Hansen C, Wise BL.","J Wildl Dis. 2011 Jul;47(3):638-42. doi: 10.7589/0090-3558-47.3.638.","Kreeger TJ","J Wildl Dis","2011","2011/07/02","","","10.7589/0090-3558-47.3.638"
"21718302","Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments","Elhabazi K, Trigo JM, Mollereau C, Moulédous L, Zajac JM, Bihel F, Schmitt M, Bourguignon JJ, Meziane H, Petit-demoulière B, Bockel F, Maldonado R, Simonin F.","Br J Pharmacol. 2012 Jan;165(2):424-35. doi: 10.1111/j.1476-5381.2011.01563.x.","Elhabazi K","Br J Pharmacol","2012","2011/07/02","PMC3268196","","10.1111/j.1476-5381.2011.01563.x"
"21716095","THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats","Wakley AA, Craft RM.","Behav Pharmacol. 2011 Sep;22(5-6):489-97. doi: 10.1097/FBP.0b013e328348ed22.","Wakley AA","Behav Pharmacol","2011","2011/07/01","","","10.1097/FBP.0b013e328348ed22"
"21715107","A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence","Bisaga A, Sullivan MA, Cheng WY, Carpenter KM, Mariani JJ, Levin FR, Raby WN, Nunes EV.","Drug Alcohol Depend. 2011 Dec 1;119(1-2):e23-9. doi: 10.1016/j.drugalcdep.2011.05.019. Epub 2011 Jun 28.","Bisaga A","Drug Alcohol Depend","2011","2011/07/01","PMC3199033","NIHMS300053","10.1016/j.drugalcdep.2011.05.019"
"21703826","In situ gelling hexagonal phases for sustained release of an anti-addiction drug","Phelps J, Bentley MV, Lopes LB.","Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):391-8. doi: 10.1016/j.colsurfb.2011.05.048. Epub 2011 Jun 1.","Phelps J","Colloids Surf B Biointerfaces","2011","2011/06/28","","","10.1016/j.colsurfb.2011.05.048"
"21696912","Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts","Finigan MW, Perkins T, Zold-Kilbourn P, Parks J, Stringer M.","J Subst Abuse Treat. 2011 Oct;41(3):288-93. doi: 10.1016/j.jsat.2011.04.003. Epub 2011 Jun 21.","Finigan MW","J Subst Abuse Treat","2011","2011/06/24","","","10.1016/j.jsat.2011.04.003"
"21696648","Opioid dependence","O'Shea J, Law F, Melichar J.","BMJ Clin Evid. 2009 Jul 24;2009:1015.","O'Shea J","BMJ Clin Evid","2009","2011/06/24","PMC2907824","",""
"21695393","Acupuncture alleviates the affective dimension of pain in a rat model of inflammatory hyperalgesia","Zhang Y, Meng X, Li A, Xin J, Berman BM, Lao L, Tan M, Ren K, Zhang RX.","Neurochem Res. 2011 Nov;36(11):2104-10. doi: 10.1007/s11064-011-0534-y. Epub 2011 Jun 22.","Zhang Y","Neurochem Res","2011","2011/06/23","PMC3581325","NIHMS442778","10.1007/s11064-011-0534-y"
"21693150","Induction of conditioned place preference and dopamine release by salsolinol in posterior VTA of rats: involvement of μ-opioid receptors","Hipólito L, Martí-Prats L, Sánchez-Catalán MJ, Polache A, Granero L.","Neurochem Int. 2011 Oct;59(5):559-62. doi: 10.1016/j.neuint.2011.04.014. Epub 2011 Jun 13.","Hipólito L","Neurochem Int","2011","2011/06/23","","","10.1016/j.neuint.2011.04.014"
"21689677","The response to naltrexone in ethanol-drinking rats depends on early environmental experiences","Daoura L, Nylander I.","Pharmacol Biochem Behav. 2011 Oct;99(4):626-33. doi: 10.1016/j.pbb.2011.06.004. Epub 2011 Jun 13.","Daoura L","Pharmacol Biochem Behav","2011","2011/06/22","","","10.1016/j.pbb.2011.06.004"
"21689063","Combination therapy with naltrexone and bupropion for obesity","Billes SK, Greenway FL.","Expert Opin Pharmacother. 2011 Aug;12(11):1813-26. doi: 10.1517/14656566.2011.591382. Epub 2011 Jun 21.","Billes SK","Expert Opin Pharmacother","2011","2011/06/22","","","10.1517/14656566.2011.591382"
"21685245","Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists","Mitra P, Venitz J, Yuan Y, Zhang Y, Gerk PM.","Drug Metab Dispos. 2011 Sep;39(9):1589-96. doi: 10.1124/dmd.111.038588. Epub 2011 Jun 17.","Mitra P","Drug Metab Dispos","2011","2011/06/21","PMC3164275","","10.1124/dmd.111.038588"
"21685240","Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin","Donahue RN, McLaughlin PJ, Zagon IS.","Exp Biol Med (Maywood). 2011 Jul;236(7):883-95. doi: 10.1258/ebm.2011.011096. Epub 2011 Jun 17.","Donahue RN","Exp Biol Med (Maywood)","2011","2011/06/21","","","10.1258/ebm.2011.011096"
"21683049","A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation","Abraham AJ, Knudsen HK, Roman PM.","J Stud Alcohol Drugs. 2011 Jul;72(4):669-77. doi: 10.15288/jsad.2011.72.669.","Abraham AJ","J Stud Alcohol Drugs","2011","2011/06/21","PMC3125890","","10.15288/jsad.2011.72.669"
"21679264","Examining naltrexone and alcohol effects in a minority population: results from an initial human laboratory study","Plebani JG, Oslin DW, Lynch KG.","Am J Addict. 2011 Jul-Aug;20(4):330-6. doi: 10.1111/j.1521-0391.2011.00138.x. Epub 2011 May 31.","Plebani JG","Am J Addict","2011","2011/06/18","PMC3124087","NIHMS293998","10.1111/j.1521-0391.2011.00138.x"
"21666232","Kappa opioid receptor localization and coupling to nitric oxide production in cells of the anterior chamber","Russell-Randall KR, Dortch-Carnes J.","Invest Ophthalmol Vis Sci. 2011 Jul 13;52(8):5233-9. doi: 10.1167/iovs.10-6613.","Russell-Randall KR","Invest Ophthalmol Vis Sci","2011","2011/06/14","PMC3176081","","10.1167/iovs.10-6613"
"21657861","Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study","Lipman AG, Karver S, Cooney GA, Stambler N, Israel RJ.","J Pain Palliat Care Pharmacother. 2011;25(2):136-45. doi: 10.3109/15360288.2011.573531.","Lipman AG","J Pain Palliat Care Pharmacother","2011","2011/06/11","","","10.3109/15360288.2011.573531"
"21651459","Opioid modulators for alcohol dependence","Hillemacher T, Heberlein A, Muschler MA, Bleich S, Frieling H.","Expert Opin Investig Drugs. 2011 Aug;20(8):1073-86. doi: 10.1517/13543784.2011.592139. Epub 2011 Jun 9.","Hillemacher T","Expert Opin Investig Drugs","2011","2011/06/10","","","10.1517/13543784.2011.592139"
"21647545","[Amisulpride for the treatment of alcohol dependence]","Flórez G, Saiz PA, García-Portilla P, Álvarez S, Nogueiras L, Bobes J.","Adicciones. 2011;23(2):149-56.","Flórez G","Adicciones","2011","2011/06/08","","",""
"21641219","Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons","Nagase H, Watanabe A, Nemoto T, Nakajima M, Hasebe K, Mochizuki H, Fujii H.","Bioorg Med Chem Lett. 2011 Jul 1;21(13):4023-6. doi: 10.1016/j.bmcl.2011.04.134. Epub 2011 May 5.","Nagase H","Bioorg Med Chem Lett","2011","2011/06/07","","","10.1016/j.bmcl.2011.04.134"
"21640148","Kinetics of skin resealing after insertion of microneedles in human subjects","Gupta J, Gill HS, Andrews SN, Prausnitz MR.","J Control Release. 2011 Sep 5;154(2):148-55. doi: 10.1016/j.jconrel.2011.05.021. Epub 2011 May 26.","Gupta J","J Control Release","2011","2011/06/07","PMC3164267","NIHMS300081","10.1016/j.jconrel.2011.05.021"
"21630515","Opioids in preclinical and clinical trials","Nagase H, Fujii H.","Top Curr Chem. 2011;299:29-62. doi: 10.1007/128_2010_74.","Nagase H","Top Curr Chem","2011","2011/06/02","","","10.1007/128_2010_74"
"21630510","Synthesis of novel basic skeletons derived from naltrexone","Nagase H, Fujii H.","Top Curr Chem. 2011;299:187-237. doi: 10.1007/128_2010_75.","Nagase H","Top Curr Chem","2011","2011/06/02","","","10.1007/128_2010_75"
"21616664","N,N'-Dialkylaminoalkylcarbonyl (DAAC) prodrugs and aminoalkylcarbonyl (AAC) prodrugs of 4-hydroxyacetanilide and naltrexone with improved skin permeation properties","Devarajan-Ketha H, Sloan KB.","Bioorg Med Chem Lett. 2011 Jul 1;21(13):4078-82. doi: 10.1016/j.bmcl.2011.04.118. Epub 2011 May 11.","Devarajan-Ketha H","Bioorg Med Chem Lett","2011","2011/05/28","","","10.1016/j.bmcl.2011.04.118"
"21606123","Treating constipation in palliative care: the impact of other factors aside from opioids","Clark K, Byfieldt N, Dawe M, Currow DC.","Am J Hosp Palliat Care. 2012 Mar;29(2):122-5. doi: 10.1177/1049909111409389. Epub 2011 May 23.","Clark K","Am J Hosp Palliat Care","2012","2011/05/25","","","10.1177/1049909111409389"
"21606111","Activation of κ opioid receptors increases intrinsic excitability of dentate gyrus granule cells","McDermott CM, Schrader LA.","J Physiol. 2011 Jul 15;589(Pt 14):3517-32. doi: 10.1113/jphysiol.2011.211623. Epub 2011 May 23.","McDermott CM","J Physiol","2011","2011/05/25","PMC3167115","","10.1113/jphysiol.2011.211623"
"21602598","Synergism between dexketoprofen and meloxicam in an orofacial formalin test was not modified by opioid antagonists","Gonzalez C, Zegpi C, Noriega V, Prieto JC, Miranda HF.","Pharmacol Rep. 2011;63(2):433-40. doi: 10.1016/s1734-1140(11)70509-6.","Gonzalez C","Pharmacol Rep","2011","2011/05/24","","","10.1016/s1734-1140(11)70509-6"
"21593282","Effects of alcohol on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules","Johnson FK, Ciric S, Boudriau S, Kisicki J, Stauffer J.","J Clin Pharmacol. 2012 May;52(5):747-56. doi: 10.1177/0091270011403740. Epub 2011 May 18.","Johnson FK","J Clin Pharmacol","2012","2011/05/20","","","10.1177/0091270011403740"
"21575016","Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence","Pettinati HM, Silverman BL, Battisti JJ, Forman R, Schweizer E, Gastfriend DR.","Alcohol Clin Exp Res. 2011 Oct;35(10):1804-11. doi: 10.1111/j.1530-0277.2011.01524.x. Epub 2011 May 16.","Pettinati HM","Alcohol Clin Exp Res","2011","2011/05/18","","","10.1111/j.1530-0277.2011.01524.x"
"21569055","Interaction between family history of alcoholism and Locus of Control in the opioid regulation of impulsive responding under the influence of alcohol","Altamirano LJ, Fields HL, D'Esposito M, Boettiger CA.","Alcohol Clin Exp Res. 2011 Nov;35(11):1905-14. doi: 10.1111/j.1530-0277.2011.01535.x. Epub 2011 May 13.","Altamirano LJ","Alcohol Clin Exp Res","2011","2011/05/17","PMC3158828","NIHMS285922","10.1111/j.1530-0277.2011.01535.x"
"21565223","The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions","Saitoh A, Sugiyama A, Nemoto T, Fujii H, Wada K, Oka J, Nagase H, Yamada M.","Behav Brain Res. 2011 Oct 1;223(2):271-9. doi: 10.1016/j.bbr.2011.04.041. Epub 2011 May 5.","Saitoh A","Behav Brain Res","2011","2011/05/14","","","10.1016/j.bbr.2011.04.041"
"21556092","[Naltrexone--high expectations to low dosages]","Raknes G, Giverhaug T.","Tidsskr Nor Laegeforen. 2011 May 6;131(8):844-6. doi: 10.4045/tidsskr.10.1126.","Raknes G","Tidsskr Nor Laegeforen","2011","2011/05/11","","","10.4045/tidsskr.10.1126"
"21555938","Dissociable effects of ultralow-dose naltrexone on tolerance to the antinociceptive and cataleptic effects of morphine","Tuerke KJ, Beninger RJ, Paquette JJ, Olmstead MC.","Behav Pharmacol. 2011 Sep;22(5-6):558-63. doi: 10.1097/FBP.0b013e3283474a56.","Tuerke KJ","Behav Pharmacol","2011","2011/05/11","","","10.1097/FBP.0b013e3283474a56"
"21554565","Naltrexone depot formulations for opioid and alcohol dependence: a systematic review","Lobmaier PP, Kunøe N, Gossop M, Waal H.","CNS Neurosci Ther. 2011 Dec;17(6):629-36. doi: 10.1111/j.1755-5949.2010.00194.x.","Lobmaier PP","CNS Neurosci Ther","2011","2011/05/11","PMC6493794","","10.1111/j.1755-5949.2010.00194.x"
"21550962","Understanding the effect of different assay formats on agonist parameters: a study using the µ-opioid receptor","Nickolls SA, Waterfield A, Williams RE, Kinloch RA.","J Biomol Screen. 2011 Aug;16(7):706-16. doi: 10.1177/1087057111406548. Epub 2011 May 5.","Nickolls SA","J Biomol Screen","2011","2011/05/10","","","10.1177/1087057111406548"
"21549821","Inhibitory effects of processed Aconiti tuber on morphine-induced conditioned place preference in rats","Wu G, Huang W, Zhang H, Li Q, Zhou J, Shu H.","J Ethnopharmacol. 2011 Jun 14;136(1):254-9. doi: 10.1016/j.jep.2011.04.041. Epub 2011 Apr 28.","Wu G","J Ethnopharmacol","2011","2011/05/10","","","10.1016/j.jep.2011.04.041"
"21549636","Investigation of structure, vibrational and NMR spectra of oxycodone and naltrexone: a combined experimental and theoretical study","Tavakol H, Esfandyari M, Taheri S, Heydari A.","Spectrochim Acta A Mol Biomol Spectrosc. 2011 Aug;79(3):574-82. doi: 10.1016/j.saa.2011.03.038. Epub 2011 Apr 2.","Tavakol H","Spectrochim Acta A Mol Biomol Spectrosc","2011","2011/05/10","","","10.1016/j.saa.2011.03.038"
"21536702","Prescription pain medication dependence","Dodrill CL, Helmer DA, Kosten TR.","Am J Psychiatry. 2011 May;168(5):466-71. doi: 10.1176/appi.ajp.2010.10020260.","Dodrill CL","Am J Psychiatry","2011","2011/05/04","","","10.1176/appi.ajp.2010.10020260"
"21531450","The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice","Donahue RN, McLaughlin PJ, Zagon IS.","Gynecol Oncol. 2011 Aug;122(2):382-8. doi: 10.1016/j.ygyno.2011.04.009. Epub 2011 Apr 30.","Donahue RN","Gynecol Oncol","2011","2011/05/03","","","10.1016/j.ygyno.2011.04.009"
"21529930","Concerns about injectable naltrexone for opioid dependence","Wolfe D, Carrieri MP, Dasgupta N, Wodak A, Newman R, Bruce RD.","Lancet. 2011 Apr 30;377(9776):1468-70. doi: 10.1016/S0140-6736(10)62056-9.","Wolfe D","Lancet","2011","2011/05/03","","","10.1016/S0140-6736(10)62056-9"
"21529928","Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL.","Lancet. 2011 Apr 30;377(9776):1506-13. doi: 10.1016/S0140-6736(11)60358-9.","Krupitsky E","Lancet","2011","2011/05/03","","","10.1016/S0140-6736(11)60358-9"
"21514668","Multiple opioid receptors mediate the hypotensive response induced by central 5-HT(3) receptor stimulation","Fregoneze JB, Oliveira EF, Ribeiro VF, Ferreira HS, De Castro E Silva E.","Neuropeptides. 2011 Jun;45(3):219-27. doi: 10.1016/j.npep.2011.03.004. Epub 2011 Apr 22.","Fregoneze JB","Neuropeptides","2011","2011/04/26","","","10.1016/j.npep.2011.03.004"
"21513688","Problem drinking and low-dose naltrexone-assisted opioid detoxification","Mannelli P, Peindl K, Patkar AA, Wu LT, Tharwani HM, Gorelick DA.","J Stud Alcohol Drugs. 2011 May;72(3):507-13. doi: 10.15288/jsad.2011.72.507.","Mannelli P","J Stud Alcohol Drugs","2011","2011/04/26","PMC3084365","","10.15288/jsad.2011.72.507"
"21502953","Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans","Rabiner EA, Beaver J, Makwana A, Searle G, Long C, Nathan PJ, Newbould RD, Howard J, Miller SR, Bush MA, Hill S, Reiley R, Passchier J, Gunn RN, Matthews PM, Bullmore ET.","Mol Psychiatry. 2011 Aug;16(8):826-35, 785. doi: 10.1038/mp.2011.29. Epub 2011 Apr 19.","Rabiner EA","Mol Psychiatry","2011","2011/04/20","PMC3142667","","10.1038/mp.2011.29"
"21493167","Electromembrane extraction of trace amounts of naltrexone and nalmefene from untreated biological fluids","Rezazadeh M, Yamini Y, Seidi S.","J Chromatogr B Analyt Technol Biomed Life Sci. 2011 May 1;879(15-16):1143-8. doi: 10.1016/j.jchromb.2011.03.043. Epub 2011 Mar 30.","Rezazadeh M","J Chromatogr B Analyt Technol Biomed Life Sci","2011","2011/04/16","","","10.1016/j.jchromb.2011.03.043"
"21491383","Oral naltrexone maintenance treatment for opioid dependence","Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.","Cochrane Database Syst Rev. 2011 Apr 13;2011(4):CD001333. doi: 10.1002/14651858.CD001333.pub4.","Minozzi S","Cochrane Database Syst Rev","2011","2011/04/15","PMC7045778","","10.1002/14651858.CD001333.pub4"
"21486473","Analgesic tone conferred by constitutively active mu opioid receptors in mice lacking β-arrestin 2","Lam H, Maga M, Pradhan A, Evans CJ, Maidment NT, Hales TG, Walwyn W.","Mol Pain. 2011 Apr 12;7:24. doi: 10.1186/1744-8069-7-24.","Lam H","Mol Pain","2011","2011/04/14","PMC3090352","","10.1186/1744-8069-7-24"
"21484425","Local kappa opioid receptor activation decreases temporomandibular joint inflammation","Chicre-Alcântara TC, Torres-Chávez KE, Fischer L, Clemente-Napimoga JT, Melo V, Parada CA, Tambeli CH.","Inflammation. 2012 Feb;35(1):371-6. doi: 10.1007/s10753-011-9329-1.","Chicre-Alcântara TC","Inflammation","2012","2011/04/13","","","10.1007/s10753-011-9329-1"
"21481651","Reliability and validity of a brief method to assess nociceptive flexion reflex (NFR) threshold","Rhudy JL, France CR.","J Pain. 2011 Jul;12(7):782-91. doi: 10.1016/j.jpain.2011.01.002. Epub 2011 Apr 9.","Rhudy JL","J Pain","2011","2011/04/13","PMC3130810","NIHMS268749","10.1016/j.jpain.2011.01.002"
"21474600","Naltrexone for severe self-harm behavior: a case report","Agarwal LJ, Berger CE, Gill L.","Am J Psychiatry. 2011 Apr;168(4):437-8. doi: 10.1176/appi.ajp.2010.10101493.","Agarwal LJ","Am J Psychiatry","2011","2011/04/09","","","10.1176/appi.ajp.2010.10101493"
"21471758","Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials","Yu CS, Chun HK, Stambler N, Carpenito J, Schulman S, Tzanis E, Randazzo B.","Dis Colon Rectum. 2011 May;54(5):570-8. doi: 10.1007/DCR.0b013e3182092bde.","Yu CS","Dis Colon Rectum","2011","2011/04/08","","","10.1007/DCR.0b013e3182092bde"
"21470065","Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing","Smith HS.","Expert Opin Pharmacother. 2011 May;12(7):1111-25. doi: 10.1517/14656566.2011.571205. Epub 2011 Apr 7.","Smith HS","Expert Opin Pharmacother","2011","2011/04/08","","","10.1517/14656566.2011.571205"
"21470064","Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond","Ruan X.","Expert Opin Pharmacother. 2011 May;12(7):999-1001. doi: 10.1517/14656566.2011.571208. Epub 2011 Apr 7.","Ruan X","Expert Opin Pharmacother","2011","2011/04/08","","","10.1517/14656566.2011.571208"
"21465551","The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease","Koprich JB, Fox SH, Johnston TH, Goodman A, Le Bourdonnec B, Dolle RE, DeHaven RN, DeHaven-Hudkins DL, Little PJ, Brotchie JM.","Mov Disord. 2011 Jun;26(7):1225-33. doi: 10.1002/mds.23631. Epub 2011 Apr 4.","Koprich JB","Mov Disord","2011","2011/04/06","","","10.1002/mds.23631"
"21458450","Nucleus accumbens facilitates nociception","Gear RW, Levine JD.","Exp Neurol. 2011 Jun;229(2):502-6. doi: 10.1016/j.expneurol.2011.03.021. Epub 2011 Mar 31.","Gear RW","Exp Neurol","2011","2011/04/05","PMC3100434","NIHMS290409","10.1016/j.expneurol.2011.03.021"
"21454917","Gabapentin combined with naltrexone for the treatment of alcohol dependence","Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK.","Am J Psychiatry. 2011 Jul;168(7):709-17. doi: 10.1176/appi.ajp.2011.10101436. Epub 2011 Mar 31.","Anton RF","Am J Psychiatry","2011","2011/04/02","PMC3204582","NIHMS329666","10.1176/appi.ajp.2011.10101436"
"21454318","Methylnaltrexone: treatment for opioid-induced constipation--not convinced yet","HaiNan Liu, Xiulu Ruan.","Am J Hosp Palliat Care. 2011 Jun;28(4):290; author reply 291. doi: 10.1177/1049909111402817. Epub 2011 Mar 30.","HaiNan Liu","Am J Hosp Palliat Care","2011","2011/04/02","","","10.1177/1049909111402817"
"21449706","Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres","Akala EO, Wiriyacoonkasem P, Pan G.","Drug Dev Ind Pharm. 2011 Jun;37(6):673-84. doi: 10.3109/03639045.2010.535540. Epub 2011 Mar 30.","Akala EO","Drug Dev Ind Pharm","2011","2011/04/01","PMC3786334","NIHMS365808","10.3109/03639045.2010.535540"
"21443939","Effect of surfactants and pH on naltrexone (NTX) permeation across buccal mucosa","Rai V, Tan HS, Michniak-Kohn B.","Int J Pharm. 2011 Jun 15;411(1-2):92-7. doi: 10.1016/j.ijpharm.2011.03.046. Epub 2011 Apr 4.","Rai V","Int J Pharm","2011","2011/03/30","PMC3103779","NIHMS289729","10.1016/j.ijpharm.2011.03.046"
"21443293","Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence","Hartzler B, Witkiewitz K, Villarroel N, Donovan D.","Psychol Addict Behav. 2011 Jun;25(2):269-78. doi: 10.1037/a0022869.","Hartzler B","Psychol Addict Behav","2011","2011/03/30","PMC3236109","NIHMS299064","10.1037/a0022869"
"21443039","Pruritus responsive to naltrexone in a patient with cholestatic liver disease","Mozer-Glassberg Y, Hojsak I, Zevit N, Shapiro R, Shamir R.","Isr Med Assoc J. 2011 Feb;13(2):111-2.","Mozer-Glassberg Y","Isr Med Assoc J","2011","2011/03/30","","",""
"21437991","Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study","Yoon G, Kim SW, Thuras P, Westermeyer J.","Hum Psychopharmacol. 2011 Mar;26(2):125-32. doi: 10.1002/hup.1183. Epub 2011 Mar 16.","Yoon G","Hum Psychopharmacol","2011","2011/03/26","","","10.1002/hup.1183"
"21434584","Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients","Mysels DJ, Vosburg SK, Benga I, Levin FR, Sullivan MA.","J Opioid Manag. 2011 Jan-Feb;7(1):47-53. doi: 10.5055/jom.2011.0048.","Mysels DJ","J Opioid Manag","2011","2011/03/26","PMC3111025","NIHMS295332","10.5055/jom.2011.0048"
"21429809","Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study","Michna E, Blonsky ER, Schulman S, Tzanis E, Manley A, Zhang H, Iyer S, Randazzo B.","J Pain. 2011 May;12(5):554-62. doi: 10.1016/j.jpain.2010.11.008. Epub 2011 Mar 22.","Michna E","J Pain","2011","2011/03/25","","","10.1016/j.jpain.2010.11.008"
"21427831","[Anesthetic considerations in a patient taking disulfiram and naltrexone for chronic alcoholism]","del Blanco Narciso BB, Orts Castro A, Calvo Vecino JM.","Rev Esp Anestesiol Reanim. 2011 Feb;58(2):128-9. doi: 10.1016/s0034-9356(11)70013-5.","del Blanco Narciso BB","Rev Esp Anestesiol Reanim","2011","2011/03/25","","","10.1016/s0034-9356(11)70013-5"
"21422164","Heteromerization of the μ- and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking","Milan-Lobo L, Whistler JL.","Version 2. J Pharmacol Exp Ther. 2011 Jun;337(3):868-75. doi: 10.1124/jpet.111.179093. Epub 2011 Mar 21.","Milan-Lobo L","J Pharmacol Exp Ther","2011","2011/03/23","PMC3097170","UKMS34918","10.1124/jpet.111.179093"
"21420495","Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation","Peiró AM, Climent L, Zapater P, Horga A, Horga JF.","Pharmacol Res. 2011 Jul;64(1):80-4. doi: 10.1016/j.phrs.2011.02.009. Epub 2011 Mar 21.","Peiró AM","Pharmacol Res","2011","2011/03/23","","","10.1016/j.phrs.2011.02.009"
"21419715","Morphine sensitization in the pentylenetetrazole-induced clonic seizure threshold in mice: role of nitric oxide and μ receptors","Shafaroodi H, Baradaran N, Moezi L, Dehpour S, Kabiri T, Dehpour AR.","Epilepsy Behav. 2011 Apr;20(4):602-6. doi: 10.1016/j.yebeh.2010.12.020. Epub 2011 Mar 21.","Shafaroodi H","Epilepsy Behav","2011","2011/03/23","","","10.1016/j.yebeh.2010.12.020"
"21415049","Enhancing acupuncture by low dose naltrexone","Hesselink JM, Kopsky DJ.","Acupunct Med. 2011 Jun;29(2):127-30. doi: 10.1136/aim.2010.003566. Epub 2011 Mar 17.","Hesselink JM","Acupunct Med","2011","2011/03/19","","","10.1136/aim.2010.003566"
"21410481","The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype","Setiawan E, Pihl RO, Cox SM, Gianoulakis C, Palmour RM, Benkelfat C, Leyton M.","Alcohol Clin Exp Res. 2011 Jun;35(6):1134-41. doi: 10.1111/j.1530-0277.2011.01446.x. Epub 2011 Mar 15.","Setiawan E","Alcohol Clin Exp Res","2011","2011/03/18","","","10.1111/j.1530-0277.2011.01446.x"
"21392099","Investigating the role of endogenous opioids and KATP channels in glycerol-induced acute renal failure","Sauriyal DS, Jaggi AS, Singh N, Muthuraman A.","Fundam Clin Pharmacol. 2012 Jun;26(3):347-55. doi: 10.1111/j.1472-8206.2011.00936.x. Epub 2011 Mar 11.","Sauriyal DS","Fundam Clin Pharmacol","2012","2011/03/12","","","10.1111/j.1472-8206.2011.00936.x"
"21386701","Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids","Stagg NJ, Mata HP, Ibrahim MM, Henriksen EJ, Porreca F, Vanderah TW, Philip Malan T Jr.","Anesthesiology. 2011 Apr;114(4):940-8. doi: 10.1097/ALN.0b013e318210f880.","Stagg NJ","Anesthesiology","2011","2011/03/10","PMC6345518","NIHMS274780","10.1097/ALN.0b013e318210f880"
"21386072","Study suggests gene may predict success of therapies for alcohol dependence","Kuehn BM.","JAMA. 2011 Mar 9;305(10):984-5. doi: 10.1001/jama.2011.270.","Kuehn BM","JAMA","2011","2011/03/10","","","10.1001/jama.2011.270"
"21385944","N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromers","Yekkirala AS, Lunzer MM, McCurdy CR, Powers MD, Kalyuzhny AE, Roerig SC, Portoghese PS.","Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5098-103. doi: 10.1073/pnas.1016277108. Epub 2011 Mar 8.","Yekkirala AS","Proc Natl Acad Sci U S A","2011","2011/03/10","PMC3064379","","10.1073/pnas.1016277108"
"21382667","Counselor attitudes toward the use of naltrexone in substance abuse treatment: a multi-level modeling approach","Abraham AJ, Rieckmann T, McNulty T, Kovas AE, Roman PM.","Addict Behav. 2011 Jun;36(6):576-583. doi: 10.1016/j.addbeh.2011.01.030. Epub 2011 Jan 28.","Abraham AJ","Addict Behav","2011","2011/03/09","PMC3070850","NIHMS270196","10.1016/j.addbeh.2011.01.030"
"21381712","Synthesis of (-)-homogalanthamine from naltrexone","Yamamoto N, Fujii H, Imaide S, Hirayama S, Nemoto T, Inokoshi J, Tomoda H, Nagase H.","J Org Chem. 2011 Apr 1;76(7):2257-60. doi: 10.1021/jo1022487. Epub 2011 Mar 7.","Yamamoto N","J Org Chem","2011","2011/03/09","","","10.1021/jo1022487"
"21380937","Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial","Smith JP, Bingaman SI, Ruggiero F, Mauger DT, Mukherjee A, McGovern CO, Zagon IS.","Dig Dis Sci. 2011 Jul;56(7):2088-97. doi: 10.1007/s10620-011-1653-7. Epub 2011 Mar 8.","Smith JP","Dig Dis Sci","2011","2011/03/08","PMC3381945","NIHMS373349","10.1007/s10620-011-1653-7"
"21377275","Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation","Roman PM, Abraham AJ, Knudsen HK.","Addict Behav. 2011 Jun;36(6):584-589. doi: 10.1016/j.addbeh.2011.01.032. Epub 2011 Jan 27.","Roman PM","Addict Behav","2011","2011/03/08","PMC3087632","NIHMS282288","10.1016/j.addbeh.2011.01.032"
"21376180","Resolution of opioid-induced postoperative ileus in a newborn infant after methylnaltrexone","Garten L, Degenhardt P, Bührer C.","J Pediatr Surg. 2011 Mar;46(3):e13-5. doi: 10.1016/j.jpedsurg.2010.10.015.","Garten L","J Pediatr Surg","2011","2011/03/08","","","10.1016/j.jpedsurg.2010.10.015"
"21371948","Voltammetry of naltrexone in commercial formulation and human body fluids: Quantification and pharmacokinetic studies","Ghoneim MM, El-Desoky HS, Abdel-Galeil MM.","Bioelectrochemistry. 2011 Jun;81(2):65-73. doi: 10.1016/j.bioelechem.2011.02.005. Epub 2011 Feb 21.","Ghoneim MM","Bioelectrochemistry","2011","2011/03/05","","","10.1016/j.bioelechem.2011.02.005"
"21366875","Sexual dysfunction among male patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence","Ramdurg S, Ambekar A, Lal R.","J Sex Med. 2012 Dec;9(12):3198-204. doi: 10.1111/j.1743-6109.2011.02219.x. Epub 2011 Mar 2.","Ramdurg S","J Sex Med","2012","2011/03/04","","","10.1111/j.1743-6109.2011.02219.x"
"21356425","Addiction treatment: level of care determination","Alam DA, Martorana A.","Prim Care. 2011 Mar;38(1):125-136. doi: 10.1016/j.pop.2010.11.009.","Alam DA","Prim Care","2011","2011/03/02","","","10.1016/j.pop.2010.11.009"
"21356418","Alcoholism: a modern look at an ancient illness","Carr GD.","Prim Care. 2011 Mar;38(1):9-21. doi: 10.1016/j.pop.2010.11.002.","Carr GD","Prim Care","2011","2011/03/02","","","10.1016/j.pop.2010.11.002"
"21352825","β-Endorphin inhibits phagocytic activity of lizard splenic phagocytes through μ receptor-coupled adenylate cyclase-protein kinase A signaling pathway","Kumar S, Ghorai SM, Rai U.","Gen Comp Endocrinol. 2011 May 1;171(3):301-8. doi: 10.1016/j.ygcen.2011.02.008. Epub 2011 Feb 23.","Kumar S","Gen Comp Endocrinol","2011","2011/03/01","","","10.1016/j.ygcen.2011.02.008"
"21348558","Comparison of healthcare utilization among patients treated with alcoholism medications","Mark TL, Montejano LB, Kranzler HR, Chalk M, Gastfriend DR.","Am J Manag Care. 2010;16(12):879-88.","Mark TL","Am J Manag Care","2010","2011/02/26","PMC4160801","NIHMS624972",""
"21338616","κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats","Nealey KA, Smith AW, Davis SM, Smith DG, Walker BM.","Neuropharmacology. 2011 Jul-Aug;61(1-2):35-42. doi: 10.1016/j.neuropharm.2011.02.012. Epub 2011 Feb 19.","Nealey KA","Neuropharmacology","2011","2011/02/23","PMC3955175","NIHMS572167","10.1016/j.neuropharm.2011.02.012"
"21328250","Oral naltrexone maintenance treatment for opioid dependence","Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.","Cochrane Database Syst Rev. 2011 Feb 16;(2):CD001333. doi: 10.1002/14651858.CD001333.pub3.","Minozzi S","Cochrane Database Syst Rev","2011","2011/02/18","","","10.1002/14651858.CD001333.pub3"
"21324329","Pharmacological investigations on adaptation in rats subjected to cold water immersion stress","Agrawal A, Jaggi AS, Singh N.","Physiol Behav. 2011 Jun 1;103(3-4):321-9. doi: 10.1016/j.physbeh.2011.02.014. Epub 2011 Feb 12.","Agrawal A","Physiol Behav","2011","2011/02/18","","","10.1016/j.physbeh.2011.02.014"
"21322147","[Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial]","Krupitskiĭ EM, Zvartau EE, Tsoĭ-Podosenin MV, Masalov DV, Burakov AM, Egorova VIu, Didenko TIu, Romanova TN, Ivanova EB, Bespalov AIu, Verbitskaia EV, Neznanov NG, Grineneko AIa, O'Brien C, Woody D.","Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Pt 2):44-54.","Krupitskiĭ EM","Zh Nevrol Psikhiatr Im S S Korsakova","2010","2011/02/16","","",""
"21320227","Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial","Everly JJ, DeFulio A, Koffarnus MN, Leoutsakos JM, Donlin WD, Aklin WM, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.","Addiction. 2011 Jul;106(7):1309-18. doi: 10.1111/j.1360-0443.2011.03400.x. Epub 2011 May 3.","Everly JJ","Addiction","2011","2011/02/16","PMC3107896","NIHMS278651","10.1111/j.1360-0443.2011.03400.x"
"21316152","Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic","Hough LB, Nalwalk JW, Yang J, Conroy JL, VanAlstine MA, Yang W, Gargano J, Shan Z, Zhang SZ, Wentland MP, Phillips JG, Knapp BI, Bidlack JM, Zuiderveld OP, Leurs R, Ding X.","Pain. 2011 Apr;152(4):878-87. doi: 10.1016/j.pain.2011.01.001.","Hough LB","Pain","2011","2011/02/15","PMC3065546","NIHMS275635","10.1016/j.pain.2011.01.001"
"21314752","Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone","O'Brien CP, Gastfriend DR, Forman RF, Schweizer E, Pettinati HM.","Am J Addict. 2011 Mar-Apr;20(2):106-12. doi: 10.1111/j.1521-0391.2010.00107.x. Epub 2010 Dec 28.","O'Brien CP","Am J Addict","2011","2011/02/15","PMC3895092","NIHMS253364","10.1111/j.1521-0391.2010.00107.x"
"21303476","The use of opioids in fibromyalgia","Ngian GS, Guymer EK, Littlejohn GO.","Int J Rheum Dis. 2011 Feb;14(1):6-11. doi: 10.1111/j.1756-185X.2010.01567.x. Epub 2010 Aug 23.","Ngian GS","Int J Rheum Dis","2011","2011/02/10","","","10.1111/j.1756-185X.2010.01567.x"
"21301935","Diclofenac enables prolonged delivery of naltrexone through microneedle-treated skin","Banks SL, Paudel KS, Brogden NK, Loftin CD, Stinchcomb AL.","Pharm Res. 2011 May;28(5):1211-9. doi: 10.1007/s11095-011-0372-2. Epub 2011 Feb 8.","Banks SL","Pharm Res","2011","2011/02/09","PMC3377386","NIHMS276470","10.1007/s11095-011-0372-2"
"21300053","Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice","Campillo A, Cabañero D, Romero A, García-Nogales P, Puig MM.","Eur J Pharmacol. 2011 Apr 25;657(1-3):89-96. doi: 10.1016/j.ejphar.2011.01.059. Epub 2011 Feb 4.","Campillo A","Eur J Pharmacol","2011","2011/02/09","","","10.1016/j.ejphar.2011.01.059"
"21293255","Involvement of the lateral amygdala in the antiallodynic and reinforcing effects of heroin in rats after peripheral nerve injury","Martin TJ, Buechler NL, Kim SA, Ewan EE, Xiao R, Childers SR.","Anesthesiology. 2011 Mar;114(3):633-42. doi: 10.1097/ALN.0b013e318209aba7.","Martin TJ","Anesthesiology","2011","2011/02/05","PMC3044784","NIHMS265861","10.1097/ALN.0b013e318209aba7"
"21291870","Opioid-like compound exerts anti-fibrotic activity via decreased hepatic stellate cell activation and inflammation","Day SA, Lakner AM, Moore CC, Yen MH, Clemens MG, Wu ES, Schrum LW.","Biochem Pharmacol. 2011 Apr 15;81(8):996-1003. doi: 10.1016/j.bcp.2011.01.015. Epub 2011 Feb 1.","Day SA","Biochem Pharmacol","2011","2011/02/05","","","10.1016/j.bcp.2011.01.015"
"21289167","Micro-opioid receptor activation in the basolateral amygdala mediates the learning of increases but not decreases in the incentive value of a food reward","Wassum KM, Cely IC, Balleine BW, Maidment NT.","Version 2. J Neurosci. 2011 Feb 2;31(5):1591-9. doi: 10.1523/JNEUROSCI.3102-10.2011.","Wassum KM","J Neurosci","2011","2011/02/04","PMC3081716","NIHMS270158","10.1523/JNEUROSCI.3102-10.2011"
"21286024","Morphine postconditioning attenuates ICAM-1 expression on endothelial cells","Min TJ, Kim JI, Kim JH, Noh KH, Kim TW, Kim WY, Lee YS, Park YC.","J Korean Med Sci. 2011 Feb;26(2):290-6. doi: 10.3346/jkms.2011.26.2.290. Epub 2011 Jan 24.","Min TJ","J Korean Med Sci","2011","2011/02/03","PMC3031017","","10.3346/jkms.2011.26.2.290"
"21272018","Intramuscular extended-release naltrexone: current evidence","Gastfriend DR.","Ann N Y Acad Sci. 2011 Jan;1216:144-66. doi: 10.1111/j.1749-6632.2010.05900.x.","Gastfriend DR","Ann N Y Acad Sci","2011","2011/01/29","","","10.1111/j.1749-6632.2010.05900.x"
"21266377","Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference","Laaksonen E, Lahti J, Sinclair JD, Heinälä P, Alho H.","Alcohol Alcohol. 2011 May-Jun;46(3):308-11. doi: 10.1093/alcalc/agq101. Epub 2011 Jan 25.","Laaksonen E","Alcohol Alcohol","2011","2011/01/27","","","10.1093/alcalc/agq101"
"21261434","Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence","Witkiewitz K, Bowen S, Donovan DM.","J Consult Clin Psychol. 2011 Feb;79(1):54-63. doi: 10.1037/a0022282.","Witkiewitz K","J Consult Clin Psychol","2011","2011/01/26","PMC3157314","NIHMS258450","10.1037/a0022282"
"21256121","Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis","Rahn KA, McLaughlin PJ, Zagon IS.","Brain Res. 2011 Mar 24;1381:243-53. doi: 10.1016/j.brainres.2011.01.036. Epub 2011 Jan 20.","Rahn KA","Brain Res","2011","2011/01/25","","","10.1016/j.brainres.2011.01.036"
"21254901","Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?","Katsiki N, Hatzitolios AI, Mikhailidis DP.","Ann Med. 2011 Jun;43(4):249-58. doi: 10.3109/07853890.2010.541490. Epub 2011 Jan 24.","Katsiki N","Ann Med","2011","2011/01/25","","","10.3109/07853890.2010.541490"
"21249653","Laxatives or methylnaltrexone for the management of constipation in palliative care patients","Candy B, Jones L, Goodman ML, Drake R, Tookman A.","Cochrane Database Syst Rev. 2011 Jan 19;(1):CD003448. doi: 10.1002/14651858.CD003448.pub3.","Candy B","Cochrane Database Syst Rev","2011","2011/01/21","","","10.1002/14651858.CD003448.pub3"
"21246556","Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery","Abdelkader H, Ismail S, Kamal A, Alany RG.","J Pharm Sci. 2011 May;100(5):1833-46. doi: 10.1002/jps.22422. Epub 2011 Jan 18.","Abdelkader H","J Pharm Sci","2011","2011/01/20","","","10.1002/jps.22422"
"21238560","Controlled release of linear-dendritic hybrids of carbosiloxane dendrimer: the effect of hybrid's amphiphilicity on drug-incorporation; hybrid-drug interactions and hydrolytic behavior of nanocarriers","Namazi H, Jafarirad S.","Int J Pharm. 2011 Apr 4;407(1-2):167-73. doi: 10.1016/j.ijpharm.2011.01.007. Epub 2011 Jan 14.","Namazi H","Int J Pharm","2011","2011/01/18","","","10.1016/j.ijpharm.2011.01.007"
"21222554","Methylnaltrexone bromide: research update of pharmacokinetics following parenteral administration","Rotshteyn Y, Boyd TA, Yuan CS.","Expert Opin Drug Metab Toxicol. 2011 Feb;7(2):227-35. doi: 10.1517/17425255.2011.549824. Epub 2011 Jan 11.","Rotshteyn Y","Expert Opin Drug Metab Toxicol","2011","2011/01/13","","","10.1517/17425255.2011.549824"
"21211500","Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms","Iyer SS, Randazzo BP, Tzanis EL, Schulman SL, Zhang H, Wang W, Manley AL.","Value Health. 2011 Jan;14(1):177-83. doi: 10.1016/j.jval.2010.11.003.","Iyer SS","Value Health","2011","2011/01/08","","","10.1016/j.jval.2010.11.003"
"21209242","Pharmacokinetics, safety, and tolerability of ascending doses of sublingual fentanyl, with and without naltrexone, in Japanese subjects","Lister N, Warrington S, Boyce M, Eriksson C, Tamaoka M, Kilborn J.","J Clin Pharmacol. 2011 Aug;51(8):1195-204. doi: 10.1177/0091270010379410. Epub 2011 Jan 5.","Lister N","J Clin Pharmacol","2011","2011/01/07","","","10.1177/0091270010379410"
"21209213","Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons","Pennock RL, Hentges ST.","Version 2. J Neurosci. 2011 Jan 5;31(1):281-8. doi: 10.1523/JNEUROSCI.4654-10.2011.","Pennock RL","J Neurosci","2011","2011/01/07","PMC3061472","NIHMS261997","10.1523/JNEUROSCI.4654-10.2011"
"21209211","μ-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice","Wiskerke J, Schetters D, van Es IE, van Mourik Y, den Hollander BR, Schoffelmeer AN, Pattij T.","J Neurosci. 2011 Jan 5;31(1):262-72. doi: 10.1523/JNEUROSCI.4794-10.2011.","Wiskerke J","J Neurosci","2011","2011/01/07","PMC6622756","","10.1523/JNEUROSCI.4794-10.2011"
"21198709","Endogenously released opioids mediate meal-induced gastric relaxation via peripheral mu-opioid receptors","Janssen P, Pottel H, Vos R, Tack J.","Aliment Pharmacol Ther. 2011 Mar;33(5):607-14. doi: 10.1111/j.1365-2036.2010.04557.x. Epub 2010 Dec 29.","Janssen P","Aliment Pharmacol Ther","2011","2011/01/05","","","10.1111/j.1365-2036.2010.04557.x"
"21192125","The association between naltrexone treatment and symptoms of depression in opioid-dependent patients","Mysels DJ, Cheng WY, Nunes EV, Sullivan MA.","Am J Drug Alcohol Abuse. 2011 Jan;37(1):22-6. doi: 10.3109/00952990.2010.540281. Epub 2010 Dec 30.","Mysels DJ","Am J Drug Alcohol Abuse","2011","2010/12/31","PMC3111044","NIHMS295336","10.3109/00952990.2010.540281"
"21186972","The importance of taking a history of over-the-counter medication use: a brief review and case illustration of ""PRN"" antihistamine dependence in a hospitalized adolescent","Gracious B, Abe N, Sundberg J.","J Child Adolesc Psychopharmacol. 2010 Dec;20(6):521-4. doi: 10.1089/cap.2010.0031.","Gracious B","J Child Adolesc Psychopharmacol","2010","2010/12/29","PMC3025184","","10.1089/cap.2010.0031"
"21186583","[Delayed electrical uncoupling is involved in kappa-opioid receptor activation -induced cardioprotective effect in the isolated rat heart]","Chen BP, Fan FY, Mao HJ, Xia Q.","Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2006 Feb;22(1):64-70.","Chen BP","Zhongguo Ying Yong Sheng Li Xue Za Zhi","2006","2010/12/29","","",""
"21175019","The effect of morphine on orthodontic tooth movement in rats","Akhoundi MS, Dehpour AR, Rashidpour M, Alaeddini M, Kharazifard MJ, Noroozi H.","Aust Orthod J. 2010 Nov;26(2):113-8.","Akhoundi MS","Aust Orthod J","2010","2010/12/24","","",""
"21174518","ALSUntangled No. 8: Low dose naltrexone for ALS","ALSUntangled Group.","Amyotroph Lateral Scler. 2011 Jan;12(1):76-8. doi: 10.3109/17482968.2010.544386. Epub 2010 Dec 21.","ALSUntangled Group","Amyotroph Lateral Scler","2011","2010/12/23","","","10.3109/17482968.2010.544386"
"21168038","New obesity pill: new hopes, old fears","","Lancet. 2010 Dec 18;376(9758):2042. doi: 10.1016/S0140-6736(10)62281-7.","","Lancet","2010","2010/12/21","","","10.1016/S0140-6736(10)62281-7"
"21166833","Use of an algorithm applied to urine drug screening to assess adherence to a hydrocodone regimen","Couto JE, Webster L, Romney MC, Leider HL, Linden A.","J Clin Pharm Ther. 2011 Apr;36(2):200-7. doi: 10.1111/j.1365-2710.2010.01236.x. Epub 2010 Dec 19.","Couto JE","J Clin Pharm Ther","2011","2010/12/21","","","10.1111/j.1365-2710.2010.01236.x"
"21165394","Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of δ₂-opioid receptors, protein kinase C, and K(ATP) channels","Maslov LN, Barzakh EI, Krylatov AV, Chernysheva GA, Krieg T, Solenkova NV, Lishmanov AY, Cybulnikov SY, Zhang Y.","Bull Exp Biol Med. 2010 Oct;149(5):591-3. doi: 10.1007/s10517-010-1000-6.","Maslov LN","Bull Exp Biol Med","2010","2010/12/18","","","10.1007/s10517-010-1000-6"
"21160425","Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys","Jimenez-Gomez C, Winger G, Dean RL, Deaver DR, Woods JH.","Behav Pharmacol. 2011 Feb;22(1):87-90. doi: 10.1097/FBP.0b013e3283423d55.","Jimenez-Gomez C","Behav Pharmacol","2011","2010/12/17","PMC4429516","NIHMS259977","10.1097/FBP.0b013e3283423d55"
"21155387","Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization","Abdelkader H, Ismail S, Kamal A, Alany RG.","Pharmazie. 2010 Nov;65(11):811-7.","Abdelkader H","Pharmazie","2010","2010/12/16","","",""
"21154349","Opioid antagonists for alcohol dependence","Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M.","Cochrane Database Syst Rev. 2010 Dec 8;(12):CD001867. doi: 10.1002/14651858.CD001867.pub2.","Rösner S","Cochrane Database Syst Rev","2010","2010/12/15","","","10.1002/14651858.CD001867.pub2"
"21152846","Recent developments in naltrexone implants and depot injections for opiate abuse: the new kid on the block is approaching adulthood","Brewer C, Streel E.","Adicciones. 2010;22(4):285-91.","Brewer C","Adicciones","2010","2010/12/15","","",""
"21146937","A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients","Guardia J, Roncero C, Galan J, Gonzalvo B, Burguete T, Casas M.","Addict Behav. 2011 Mar;36(3):265-9. doi: 10.1016/j.addbeh.2010.11.006. Epub 2010 Nov 10.","Guardia J","Addict Behav","2011","2010/12/15","","","10.1016/j.addbeh.2010.11.006"
"21145938","The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice","Yang QZ, Lu SS, Tian XZ, Yang AM, Ge WW, Chen Q.","Neurosci Lett. 2011 Feb 4;489(2):131-5. doi: 10.1016/j.neulet.2010.12.002. Epub 2010 Dec 9.","Yang QZ","Neurosci Lett","2011","2010/12/15","","","10.1016/j.neulet.2010.12.002"
"21143249","Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study","Gueorguieva R, Wu R, Donovan D, Rounsaville BJ, Couper D, Krystal JH, O'Malley SS.","Alcohol Clin Exp Res. 2011 Mar;35(3):523-31. doi: 10.1111/j.1530-0277.2010.01369.x. Epub 2010 Dec 8.","Gueorguieva R","Alcohol Clin Exp Res","2011","2010/12/15","PMC3062945","NIHMS246557","10.1111/j.1530-0277.2010.01369.x"
"21138720","Does family history of alcoholism moderate naltrexone's effects on alcohol use?","Capone C, Kahler CW, Swift RM, O'Malley SS.","J Stud Alcohol Drugs. 2011 Jan;72(1):135-40. doi: 10.15288/jsad.2011.72.135.","Capone C","J Stud Alcohol Drugs","2011","2010/12/09","","","10.15288/jsad.2011.72.135"
"21137665","Shortening anesthesia duration does not affect severity of withdrawal syndrome in patients undergoing ultra rapid opioid detoxification","Nasseri K, Ahsan B, Farhadifar F, Shami S.","Acta Med Iran. 2010 Jan-Feb;48(1):27-32.","Nasseri K","Acta Med Iran","2010","2010/12/09","","",""
"21132313","The role of opioid system and its interaction with sympathetic nervous system in the processing of polycystic ovary syndrome modeling in rat","Zangeneh FZ, Mohammadi A, Ejtemaeimehr Sh, Naghizadeh MM, Fatemeh A.","Arch Gynecol Obstet. 2011 Apr;283(4):885-92. doi: 10.1007/s00404-010-1776-7. Epub 2010 Dec 4.","Zangeneh FZ","Arch Gynecol Obstet","2011","2010/12/07","","","10.1007/s00404-010-1776-7"
"21126550","Investigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice","Inan S, Dun NJ, Cowan A.","Peptides. 2011 Feb;32(2):286-92. doi: 10.1016/j.peptides.2010.11.022. Epub 2010 Nov 30.","Inan S","Peptides","2011","2010/12/04","PMC3995915","NIHMS261001","10.1016/j.peptides.2010.11.022"
"21118901","Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment","Fonsi Elbreder M, de Souza e Silva R, Pillon SC, Laranjeira R.","Alcohol Alcohol. 2011 Jan-Feb;46(1):74-6. doi: 10.1093/alcalc/agq078. Epub 2010 Nov 30.","Fonsi Elbreder M","Alcohol Alcohol","2011","2010/12/02","","","10.1093/alcalc/agq078"
"21117244","Opioid mediation of amniotic fluid effects on chemosensory responsiveness in the neonatal rat","Méndez-Gallardo V, Robinson SR.","Dev Psychobiol. 2010 Dec;52(8):740-54. doi: 10.1002/dev.20469.","Méndez-Gallardo V","Dev Psychobiol","2010","2010/12/01","PMC3060046","NIHMS206828","10.1002/dev.20469"
"21111029","Changes in the expression of transthyretin and protein kinase Cγ genes in the prefrontal cortex in response to naltrexone","Yu J, Halder D, Baek MN, Das ND, Choi MR, Oh DY, Choi IG, Jung KH, Chai YG.","Neurosci Lett. 2011 Jan 25;488(3):288-93. doi: 10.1016/j.neulet.2010.11.049. Epub 2010 Nov 24.","Yu J","Neurosci Lett","2011","2010/11/30","","","10.1016/j.neulet.2010.11.049"
"21098692","A randomized study of the effects of food on the pharmacokinetics of once-daily extended-release hydromorphone in healthy volunteers","Moore KT, St-Fleur D, Marricco NC, Ariyawansa J, Pagé V, Natarajan J, Morelli G, Richarz U.","J Clin Pharmacol. 2011 Nov;51(11):1571-9. doi: 10.1177/0091270010383858. Epub 2010 Nov 23.","Moore KT","J Clin Pharmacol","2011","2010/11/25","","","10.1177/0091270010383858"
"21085073","Naltrexone in the treatment of opioid dependence","George S, Ekhtiari H.","Br J Hosp Med (Lond). 2010 Oct;71(10):568-70. doi: 10.12968/hmed.2010.71.10.78943.","George S","Br J Hosp Med (Lond)","2010","2010/11/19","","","10.12968/hmed.2010.71.10.78943"
"21083993","[Serum NT-proBNP levels in neonates with severe asphyxia and the effects of nalmefene on the NT-proBNP levels]","Zhang Q, Cheng XR, Sheng GY.","Zhongguo Dang Dai Er Ke Za Zhi. 2010 Nov;12(11):922-3.","Zhang Q","Zhongguo Dang Dai Er Ke Za Zhi","2010","2010/11/19","","",""
"21075578","Does adding low doses of oral naltrexone to morphine alter the subsequent opioid requirements and side effects in trauma patients?","Farahmand S, Ahmadi O, Dehpour A, Khashayar P.","Am J Emerg Med. 2012 Jan;30(1):75-8. doi: 10.1016/j.ajem.2010.09.031. Epub 2010 Nov 13.","Farahmand S","Am J Emerg Med","2012","2010/11/16","","","10.1016/j.ajem.2010.09.031"
"21075272","Long-term safety and efficacy of morphine sulfate and naltrexone hydrochloride extended release capsules, a novel formulation containing morphine and sequestered naltrexone, in patients with chronic, moderate to severe pain","Webster LR, Brewer R, Wang C, Sekora D, Johnson FK, Morris D, Stauffer J.","J Pain Symptom Manage. 2010 Nov;40(5):734-46. doi: 10.1016/j.jpainsymman.2010.05.004.","Webster LR","J Pain Symptom Manage","2010","2010/11/16","","","10.1016/j.jpainsymman.2010.05.004"
"21057739","Differential itch- and pain-related behavioral responses and µ-opoid modulation in mice","Akiyama T, Carstens MI, Carstens E.","Acta Derm Venereol. 2010 Nov;90(6):575-81. doi: 10.2340/00015555-0962.","Akiyama T","Acta Derm Venereol","2010","2010/11/09","","","10.2340/00015555-0962"
"21051498","Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal","Paronis CA, Bergman J.","J Pharmacol Exp Ther. 2011 Feb;336(2):488-95. doi: 10.1124/jpet.110.173823. Epub 2010 Nov 4.","Paronis CA","J Pharmacol Exp Ther","2011","2010/11/06","PMC3033719","","10.1124/jpet.110.173823"
"21045597","Drug treatment as HIV prevention: a research update","Metzger DS, Woody GE, O'Brien CP.","J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(Suppl 1):S32-6. doi: 10.1097/QAI.0b013e3181f9c10b.","Metzger DS","J Acquir Immune Defic Syndr","2010","2010/11/04","PMC3155766","NIHMS312263","10.1097/QAI.0b013e3181f9c10b"
"21038665","[The study of effects and mechanism of U50, 488H on electrical coupling during ischemia in the perfused isolated rat heart]","Mao HJ, Chen BP, Wang HP, Gao YF, Xia Q.","Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2010 Aug;26(3):261-5.","Mao HJ","Zhongguo Ying Yong Sheng Li Xue Za Zhi","2010","2010/11/03","","",""
"21034750","U50,488H postconditioning reduces apoptosis after myocardial ischemia and reperfusion","Tong G, Sun Z, Wei X, Gu C, Kaye AD, Wang Y, Li J, Zhang Q, Guo H, Yu S, Yi D, Pei J.","Life Sci. 2011 Jan 3;88(1-2):31-8. doi: 10.1016/j.lfs.2010.10.018. Epub 2010 Oct 27.","Tong G","Life Sci","2011","2010/11/02","","","10.1016/j.lfs.2010.10.018"
"21030009","Exposure to cocaine alters dynorphin-mediated regulation of excitatory synaptic transmission in nucleus accumbens neurons","Mu P, Neumann PA, Panksepp J, Schlüter OM, Dong Y.","Biol Psychiatry. 2011 Feb 1;69(3):228-35. doi: 10.1016/j.biopsych.2010.09.014. Epub 2010 Oct 27.","Mu P","Biol Psychiatry","2011","2010/10/30","PMC3790254","NIHMS517031","10.1016/j.biopsych.2010.09.014"
"21029249","Dorsal hippocampal opioidergic system modulates anxiety-like behaviors in adult male Wistar rats","Solati J, Zarrindast MR, Salari AA.","Psychiatry Clin Neurosci. 2010 Dec;64(6):634-41. doi: 10.1111/j.1440-1819.2010.02143.x. Epub 2010 Oct 28.","Solati J","Psychiatry Clin Neurosci","2010","2010/10/30","","","10.1111/j.1440-1819.2010.02143.x"
"20981002","Breaking barriers in the genomics and pharmacogenetics of drug addiction","Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, Munafò MR, Tyndale RF.","Clin Pharmacol Ther. 2010 Dec;88(6):779-91. doi: 10.1038/clpt.2010.175. Epub 2010 Oct 27.","Ho MK","Clin Pharmacol Ther","2010","2010/10/29","PMC3738009","NIHMS496670","10.1038/clpt.2010.175"
"20975274","Topiramate for the treatment of alcohol dependence: comparison with naltrexone","Flórez G, Saiz PA, García-Portilla P, Alvarez S, Nogueiras L, Bobes J.","Eur Addict Res. 2011;17(1):29-36. doi: 10.1159/000320471. Epub 2010 Oct 26.","Flórez G","Eur Addict Res","2011","2010/10/27","","","10.1159/000320471"
"20975079","Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors","McLaughlin PJ, Rogosnitzky M, Zagon IS.","Exp Biol Med (Maywood). 2010 Nov;235(11):1292-9. doi: 10.1258/ebm.2010.010203.","McLaughlin PJ","Exp Biol Med (Maywood)","2010","2010/10/27","","","10.1258/ebm.2010.010203"
"20973888","New therapeutic approaches in the treatment of diabetic keratopathy: a review","Abdelkader H, Patel DV, McGhee CNj, Alany RG.","Clin Exp Ophthalmol. 2011 Apr;39(3):259-70. doi: 10.1111/j.1442-9071.2010.02435.x. Epub 2011 Apr 4.","Abdelkader H","Clin Exp Ophthalmol","2011","2010/10/27","","","10.1111/j.1442-9071.2010.02435.x"
"20969849","Differential effects of chronic naltrexone treatment on food intake patterns and body weight in rats depend on their food deprivation status","De Tomasi EB, Juárez J.","Eur J Pharmacol. 2011 Jan 10;650(1):261-7. doi: 10.1016/j.ejphar.2010.10.029. Epub 2010 Oct 20.","De Tomasi EB","Eur J Pharmacol","2011","2010/10/26","","","10.1016/j.ejphar.2010.10.029"
"20965606","T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases","Zagon IS, Donahue RN, Bonneau RH, McLaughlin PJ.","Immunobiology. 2011 May;216(5):579-90. doi: 10.1016/j.imbio.2010.09.014. Epub 2010 Sep 29.","Zagon IS","Immunobiology","2011","2010/10/23","","","10.1016/j.imbio.2010.09.014"
"20957216","Thermosensitive Pluronic hydrogel: prolonged injectable formulation for drug abuse","Derakhshandeh K, Fashi M, Seifoleslami S.","Drug Des Devel Ther. 2010 Sep 24;4:255-62. doi: 10.2147/dddt.s13289.","Derakhshandeh K","Drug Des Devel Ther","2010","2010/10/20","PMC2948935","","10.2147/dddt.s13289"
"20955107","Heroin anticraving medications: a systematic review","Fareed A, Vayalapalli S, Casarella J, Amar R, Drexler K.","Am J Drug Alcohol Abuse. 2010 Nov;36(6):332-41. doi: 10.3109/00952990.2010.505991. Epub 2010 Oct 19.","Fareed A","Am J Drug Alcohol Abuse","2010","2010/10/20","","","10.3109/00952990.2010.505991"
"20952764","Clinical predictors of outcome from an Australian pharmacological relapse prevention trial","Morley KC, Teesson M, Sannibale C, Baillie A, Haber PS.","Alcohol Alcohol. 2010 Nov-Dec;45(6):520-6. doi: 10.1093/alcalc/agq068. Epub 2010 Oct 16.","Morley KC","Alcohol Alcohol","2010","2010/10/19","","","10.1093/alcalc/agq068"
"20949341","Food effects on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules","Johnson F, Ciric S, Boudriau S, Swearingen D, Stauffer J.","Adv Ther. 2010 Nov;27(11):846-58. doi: 10.1007/s12325-010-0074-x. Epub 2010 Oct 14.","Johnson F","Adv Ther","2010","2010/10/16","","","10.1007/s12325-010-0074-x"
"20948447","Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children","Zellos A, Roy A, Schwarz KB.","J Pediatr Gastroenterol Nutr. 2010 Dec;51(6):787-9. doi: 10.1097/MPG.0b013e3181eb5ac0.","Zellos A","J Pediatr Gastroenterol Nutr","2010","2010/10/16","","","10.1097/MPG.0b013e3181eb5ac0"
"20946740","Network support as a prognostic indicator of drinking outcomes: the COMBINE Study","Longabaugh R, Wirtz PW, Zywiak WH, O'Malley SS.","J Stud Alcohol Drugs. 2010 Nov;71(6):837-46. doi: 10.15288/jsad.2010.71.837.","Longabaugh R","J Stud Alcohol Drugs","2010","2010/10/16","PMC2965482","","10.15288/jsad.2010.71.837"
"20926192","Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia","Lawson KP, Nag S, Thompson AD, Mokha SS.","Pain. 2010 Dec;151(3):806-15. doi: 10.1016/j.pain.2010.09.018.","Lawson KP","Pain","2010","2010/10/08","PMC2972410","NIHMS237978","10.1016/j.pain.2010.09.018"
"20924880","Effect of ultra-rapid opiate detoxification on withdrawal syndrome","Safari F, Mottaghi K, Malek S, Salimi A.","J Addict Dis. 2010 Oct;29(4):449-54. doi: 10.1080/10550887.2010.509278.","Safari F","J Addict Dis","2010","2010/10/07","","","10.1080/10550887.2010.509278"
"20889669","Naltrexone effects in patients with dementia","Read SL.","Am J Psychiatry. 2010 Oct;167(10):1278-9. doi: 10.1176/appi.ajp.2010.09111630.","Read SL","Am J Psychiatry","2010","2010/10/05","","","10.1176/appi.ajp.2010.09111630"
"20888988","Addiction treatment in Russia","Krupitsky E, Woody GE, Zvartau E, O'Brien CP.","Lancet. 2010 Oct 2;376(9747):1145. doi: 10.1016/S0140-6736(10)61537-1.","Krupitsky E","Lancet","2010","2010/10/05","","","10.1016/S0140-6736(10)61537-1"
"20884959","Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study","Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW.","Br J Psychiatry. 2010 Oct;197(4):330-1. doi: 10.1192/bjp.bp.110.078105.","Grant JE","Br J Psychiatry","2010","2010/10/02","","","10.1192/bjp.bp.110.078105"
"20868291","Nalmefene for treatment of alcohol dependence","Soyka M, Rösner S.","Expert Opin Investig Drugs. 2010 Nov;19(11):1451-9. doi: 10.1517/13543784.2010.522990. Epub 2010 Sep 25.","Soyka M","Expert Opin Investig Drugs","2010","2010/09/28","","","10.1517/13543784.2010.522990"
"20864883","The relative bioavailability of morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®) and an extended release morphine sulfate capsule formulation (KADIAN®) in healthy adults under fasting conditions","Johnson FK, Ciric S, Boudriau S, Kisicki JC, Stauffer J.","Am J Ther. 2011 Jan;18(1):2-8. doi: 10.1097/MJT.0b013e3181f05957.","Johnson FK","Am J Ther","2011","2010/09/25","","","10.1097/MJT.0b013e3181f05957"
"20862910","Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature","Ruan X, Chen T, Gudin J, Couch JP, Chiravuri S.","J Opioid Manag. 2010 Jul-Aug;6(4):300-3. doi: 10.5055/jom.2010.0028.","Ruan X","J Opioid Manag","2010","2010/09/25","","","10.5055/jom.2010.0028"
"20860620","Acupuncture inhibits GABA neuron activity in the ventral tegmental area and reduces ethanol self-administration","Yang CH, Yoon SS, Hansen DM, Wilcox JD, Blumell BR, Park JJ, Steffensen SC.","Alcohol Clin Exp Res. 2010 Dec;34(12):2137-46. doi: 10.1111/j.1530-0277.2010.01310.x. Epub 2010 Sep 22.","Yang CH","Alcohol Clin Exp Res","2010","2010/09/24","PMC2988973","NIHMS225662","10.1111/j.1530-0277.2010.01310.x"
"20846190","Miracle pills for weight loss: what is the number needed to treat, number needed to harm and likelihood to be helped or harmed for naltrexone-bupropion combination?","Citrome L.","Int J Clin Pract. 2010 Oct;64(11):1462-1465. doi: 10.1111/j.1742-1241.2010.02501.x.","Citrome L","Int J Clin Pract","2010","2010/09/18","","","10.1111/j.1742-1241.2010.02501.x"
"20843635","Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking","Tanchuck MA, Yoneyama N, Ford MM, Fretwell AM, Finn DA.","Alcohol. 2011 Feb;45(1):33-44. doi: 10.1016/j.alcohol.2010.07.009. Epub 2010 Sep 16.","Tanchuck MA","Alcohol","2011","2010/09/17","PMC3003942","NIHMS229622","10.1016/j.alcohol.2010.07.009"
"20839388","The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health","Wong BS, Rao AS, Camilleri M, Manabe N, McKinzie S, Busciglio I, Burton DD, Ryks M, Zinsmeister AR.","Aliment Pharmacol Ther. 2010 Oct;32(7):884-93. doi: 10.1111/j.1365-2036.2010.04422.x.","Wong BS","Aliment Pharmacol Ther","2010","2010/09/15","","","10.1111/j.1365-2036.2010.04422.x"
"20833967","Dark chocolate receptors: epicatechin-induced cardiac protection is dependent on delta-opioid receptor stimulation","Panneerselvam M, Tsutsumi YM, Bonds JA, Horikawa YT, Saldana M, Dalton ND, Head BP, Patel PM, Roth DM, Patel HH.","Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1604-9. doi: 10.1152/ajpheart.00073.2010. Epub 2010 Sep 10.","Panneerselvam M","Am J Physiol Heart Circ Physiol","2010","2010/09/14","PMC2993198","","10.1152/ajpheart.00073.2010"
"20832981","Methylnaltrexone in the treatment of opioid-induced constipation in cancer patients receiving palliative care: willingness-to-pay and cost-benefit analysis","Iskedjian M, Iyer S, Librach SL, Wang M, Farah B, Berbari J.","J Pain Symptom Manage. 2011 Jan;41(1):104-15. doi: 10.1016/j.jpainsymman.2010.04.012. Epub 2010 Sep 15.","Iskedjian M","J Pain Symptom Manage","2011","2010/09/14","","","10.1016/j.jpainsymman.2010.04.012"
"20826199","Activation of phosphatidylinositol 3-kinase/Akt-mammalian target of Rapamycin signaling pathway in the hippocampus is essential for the acquisition of morphine-induced place preference in rats","Cui Y, Zhang XQ, Cui Y, Xin WJ, Jing J, Liu XG.","Neuroscience. 2010 Nov 24;171(1):134-43. doi: 10.1016/j.neuroscience.2010.08.064. Epub 2010 Sep 6.","Cui Y","Neuroscience","2010","2010/09/10","","","10.1016/j.neuroscience.2010.08.064"
"20812413","Treating depression along with alcohol dependence","","Harv Ment Health Lett. 2010 Jul;27(1):7.","","Harv Ment Health Lett","2010","2010/09/04","","",""
"20807519","Attenuation of cannabinoid-induced inhibition of medullary dorsal horn neurons by a kappa-opioid receptor antagonist","Okada-Ogawa A, Kurose M, Meng ID.","Brain Res. 2010 Nov 4;1359:81-9. doi: 10.1016/j.brainres.2010.08.073. Epub 2010 Aug 31.","Okada-Ogawa A","Brain Res","2010","2010/09/03","PMC3166581","NIHMS240472","10.1016/j.brainres.2010.08.073"
"20803321","Drug treatment as HIV prevention: expanding treatment options","Metzger DS, Zhang Y.","Curr HIV/AIDS Rep. 2010 Nov;7(4):220-5. doi: 10.1007/s11904-010-0059-z.","Metzger DS","Curr HIV/AIDS Rep","2010","2010/08/31","PMC3155767","NIHMS312447","10.1007/s11904-010-0059-z"
"20801917","Methylnaltrexone: treatment for opioid-induced constipation","Licup N, Baumrucker SJ.","Am J Hosp Palliat Care. 2011 Feb;28(1):59-61. doi: 10.1177/1049909110373507. Epub 2010 Aug 27.","Licup N","Am J Hosp Palliat Care","2011","2010/08/31","","","10.1177/1049909110373507"
"20801150","Basolateral amygdala opioids contribute to increased high-fat intake following intra-accumbens opioid administration, but not following 24-h food deprivation","Parker KE, McCall JG, Will MJ.","Pharmacol Biochem Behav. 2010 Dec;97(2):262-6. doi: 10.1016/j.pbb.2010.08.008. Epub 2010 Aug 27.","Parker KE","Pharmacol Biochem Behav","2010","2010/08/31","PMC2988487","NIHMS238490","10.1016/j.pbb.2010.08.008"
"20799006","The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review","Leppert W.","Adv Ther. 2010 Oct;27(10):714-30. doi: 10.1007/s12325-010-0063-0. Epub 2010 Aug 26.","Leppert W","Adv Ther","2010","2010/08/28","","","10.1007/s12325-010-0063-0"
"20739455","Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons","Fyfe LW, Cleary DR, Macey TA, Morgan MM, Ingram SL.","J Pharmacol Exp Ther. 2010 Dec;335(3):674-80. doi: 10.1124/jpet.110.172643. Epub 2010 Aug 25.","Fyfe LW","J Pharmacol Exp Ther","2010","2010/08/27","PMC2993552","","10.1124/jpet.110.172643"
"20731474","Opioid formulations designed to resist/deter abuse","Raffa RB, Pergolizzi JV Jr.","Drugs. 2010 Sep 10;70(13):1657-75. doi: 10.2165/11537940-000000000-00000.","Raffa RB","Drugs","2010","2010/08/25","","","10.2165/11537940-000000000-00000"
"20730419","A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors","Randall-Thompson JF, Pescatore KA, Unterwald EM.","Psychopharmacology (Berl). 2010 Dec;212(4):585-95. doi: 10.1007/s00213-010-1980-y. Epub 2010 Aug 21.","Randall-Thompson JF","Psychopharmacology (Berl)","2010","2010/08/24","PMC3990196","NIHMS568103","10.1007/s00213-010-1980-y"
"20729716","Influence of new deltorphin analogues on reinstatement of cocaine-induced conditioned place preference in rats","Kotlinska JH, Gibula-Bruzda E, Pachuta A, Kunce D, Witkowska E, Chung NN, Schiller PW, Izdebski J.","Behav Pharmacol. 2010 Oct;21(7):638-48. doi: 10.1097/FBP.0b013e32833e7e97.","Kotlinska JH","Behav Pharmacol","2010","2010/08/24","","","10.1097/FBP.0b013e32833e7e97"
"20728384","Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects","Hay JL, La Vincente SF, Somogyi AA, Chapleo CB, White JM.","Eur J Pain. 2011 Mar;15(3):293-8. doi: 10.1016/j.ejpain.2010.07.009. Epub 2010 Aug 21.","Hay JL","Eur J Pain","2011","2010/08/24","","","10.1016/j.ejpain.2010.07.009"
"20722263","Immobilization and intravenous anesthesia in a Sumatran rhinoceros (Dicerorhinus sumatrensis)","Walzer C, Goritz F, Hermes R, Nathan S, Kretzschmar P, Hildebrandt T.","J Zoo Wildl Med. 2010 Mar;41(1):115-20. doi: 10.1638/2009-0150.1.","Walzer C","J Zoo Wildl Med","2010","2010/08/21","","","10.1638/2009-0150.1"
"20716305","A randomized trial of oral naltrexone for treating opioid-dependent offenders","Coviello DM, Cornish JW, Lynch KG, Alterman AI, O'Brien CP.","Am J Addict. 2010 Sep-Oct;19(5):422-32. doi: 10.1111/j.1521-0391.2010.00070.x.","Coviello DM","Am J Addict","2010","2010/08/19","PMC3040635","NIHMS215291","10.1111/j.1521-0391.2010.00070.x"
"20713109","Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model","Bedini A, Baiula M, Gentilucci L, Tolomelli A, De Marco R, Spampinato S.","Peptides. 2010 Nov;31(11):2135-40. doi: 10.1016/j.peptides.2010.08.005. Epub 2010 Aug 14.","Bedini A","Peptides","2010","2010/08/18","","","10.1016/j.peptides.2010.08.005"
"20709155","Spontaneous itch in the absence of hyperalgesia in a mouse hindpaw dry skin model","Akiyama T, Carstens MI, Carstens E.","Neurosci Lett. 2010 Oct 22;484(1):62-5. doi: 10.1016/j.neulet.2010.08.020. Epub 2010 Aug 13.","Akiyama T","Neurosci Lett","2010","2010/08/17","PMC2943416","NIHMS233839","10.1016/j.neulet.2010.08.020"
"20707781","Challenges to antagonist blockade during sustained-release naltrexone treatment","Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Gossop M, Hegstad S, Kristensen Ø, Waal H.","Addiction. 2010 Sep;105(9):1633-9. doi: 10.1111/j.1360-0443.2010.03031.x.","Kunøe N","Addiction","2010","2010/08/17","","","10.1111/j.1360-0443.2010.03031.x"
"20702761","The μ-opioid receptor variant N190K is unresponsive to peptide agonists yet can be rescued by small-molecule drugs","Fortin JP, Ci L, Schroeder J, Goldstein C, Montefusco MC, Peter I, Reis SE, Huggins GS, Beinborn M, Kopin AS.","Mol Pharmacol. 2010 Nov;78(5):837-45. doi: 10.1124/mol.110.064188. Epub 2010 Aug 11.","Fortin JP","Mol Pharmacol","2010","2010/08/13","PMC2981363","","10.1124/mol.110.064188"
"20695650","Opioid regulation of Pavlovian overshadowing in fear conditioning","Zelikowsky M, Fanselow MS.","Behav Neurosci. 2010 Aug;124(4):510-9. doi: 10.1037/a0020083.","Zelikowsky M","Behav Neurosci","2010","2010/08/11","PMC2921234","NIHMS216194","10.1037/a0020083"
"20695007","Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis","Cree BA, Kornyeyeva E, Goodin DS.","Ann Neurol. 2010 Aug;68(2):145-50. doi: 10.1002/ana.22006.","Cree BA","Ann Neurol","2010","2010/08/10","","","10.1002/ana.22006"
"20678989","In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin","Milewski M, Yerramreddy TR, Ghosh P, Crooks PA, Stinchcomb AL.","J Control Release. 2010 Aug 17;146(1):37-44. doi: 10.1016/j.jconrel.2010.05.034. Epub 2010 Jun 4.","Milewski M","J Control Release","2010","2010/08/04","PMC2916235","NIHMS216279","10.1016/j.jconrel.2010.05.034"
"20676292","Intranasal naltrexone and atipamezole for reversal of white-tailed deer immobilized with carfentanil and medetomidine","Shury TK, Caulkett NA, Woodbury MR.","Can Vet J. 2010 May;51(5):501-5.","Shury TK","Can Vet J","2010","2010/08/03","PMC2857429","",""
"20675975","Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain","Katz N, Hale M, Morris D, Stauffer J.","Postgrad Med. 2010 Jul;122(4):112-28. doi: 10.3810/pgm.2010.07.2179.","Katz N","Postgrad Med","2010","2010/08/03","","","10.3810/pgm.2010.07.2179"
"20673996","Is cardiometabolic risk improved by weight-loss drugs?","Astrup A.","Lancet. 2010 Aug 21;376(9741):567-8. doi: 10.1016/S0140-6736(10)60999-3. Epub 2010 Jul 29.","Astrup A","Lancet","2010","2010/08/03","","","10.1016/S0140-6736(10)60999-3"
"20673995","Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E; COR-I Study Group.","Lancet. 2010 Aug 21;376(9741):595-605. doi: 10.1016/S0140-6736(10)60888-4. Epub 2010 Jul 29.","Greenway FL","Lancet","2010","2010/08/03","","","10.1016/S0140-6736(10)60888-4"
"20673549","Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment","Brooks AC, Comer SD, Sullivan MA, Bisaga A, Carpenter KM, Raby WM, Yu E, O'Brien CP, Nunes EV.","J Clin Psychiatry. 2010 Oct;71(10):1371-8. doi: 10.4088/JCP.09m05080ecr. Epub 2010 Jul 13.","Brooks AC","J Clin Psychiatry","2010","2010/08/03","PMC2974056","NIHMS142242","10.4088/JCP.09m05080ecr"
"20659066","Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials","Falk D, Wang XQ, Liu L, Fertig J, Mattson M, Ryan M, Johnson B, Stout R, Litten RZ.","Alcohol Clin Exp Res. 2010 Dec;34(12):2022-34. doi: 10.1111/j.1530-0277.2010.01290.x.","Falk D","Alcohol Clin Exp Res","2010","2010/07/28","","","10.1111/j.1530-0277.2010.01290.x"
"20655942","Opioid mediation of starch and sugar preference in the rat","Bonacchi KB, Ackroff K, Touzani K, Bodnar RJ, Sclafani A.","Pharmacol Biochem Behav. 2010 Oct;96(4):507-14. doi: 10.1016/j.pbb.2010.07.013. Epub 2010 Jul 23.","Bonacchi KB","Pharmacol Biochem Behav","2010","2010/07/27","PMC2930144","NIHMS224793","10.1016/j.pbb.2010.07.013"
"20655182","A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence","Grant JE, Odlaug BL, Kim SW.","Eur Neuropsychopharmacol. 2010 Nov;20(11):823-8. doi: 10.1016/j.euroneuro.2010.06.018. Epub 2010 Jul 22.","Grant JE","Eur Neuropsychopharmacol","2010","2010/07/27","","","10.1016/j.euroneuro.2010.06.018"
"20654704","Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens","Shin AC, Pistell PJ, Phifer CB, Berthoud HR.","Neuroscience. 2010 Oct 13;170(2):580-8. doi: 10.1016/j.neuroscience.2010.07.017. Epub 2010 Jul 27.","Shin AC","Neuroscience","2010","2010/07/27","PMC2933316","NIHMS225011","10.1016/j.neuroscience.2010.07.017"
"20645934","Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study","Greenfield SF, Pettinati HM, O'Malley S, Randall PK, Randall CL.","Alcohol Clin Exp Res. 2010 Oct;34(10):1803-12. doi: 10.1111/j.1530-0277.2010.01267.x. Epub 2010 Jul 20.","Greenfield SF","Alcohol Clin Exp Res","2010","2010/07/22","PMC3048309","NIHMS242979","10.1111/j.1530-0277.2010.01267.x"
"20640538","Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available","Krupitsky E, Zvartau E, Woody G.","Curr Psychiatry Rep. 2010 Oct;12(5):448-53. doi: 10.1007/s11920-010-0135-5.","Krupitsky E","Curr Psychiatry Rep","2010","2010/07/20","PMC3160743","NIHMS315485","10.1007/s11920-010-0135-5"
"20637968","Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers","Johnson FK, Stark JG, Bieberdorf FA, Stauffer J.","Clin Ther. 2010 Jun;32(6):1149-64. doi: 10.1016/j.clinthera.2010.05.011.","Johnson FK","Clin Ther","2010","2010/07/20","","","10.1016/j.clinthera.2010.05.011"
"20631574","Reduced cannabis use after low-dose naltrexone addition to opioid detoxification","Mannelli P, Peindl K, Patkar AA, Wu LT, Pae CU, Gorelick DA.","J Clin Psychopharmacol. 2010 Aug;30(4):476-8. doi: 10.1097/JCP.0b013e3181e5c168.","Mannelli P","J Clin Psychopharmacol","2010","2010/07/16","PMC3091262","NIHMS267293","10.1097/JCP.0b013e3181e5c168"
"20626732","Region-specific induction of FosB/ΔFosB by voluntary alcohol intake: effects of naltrexone","Li J, Cheng Y, Bian W, Liu X, Zhang C, Ye JH.","Alcohol Clin Exp Res. 2010 Oct;34(10):1742-50. doi: 10.1111/j.1530-0277.2010.01261.x. Epub 2010 Jul 9.","Li J","Alcohol Clin Exp Res","2010","2010/07/15","PMC2950882","NIHMS210207","10.1111/j.1530-0277.2010.01261.x"
"20626723","Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility","Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G.","Addiction. 2010 Sep;105(9):1669-76. doi: 10.1111/j.1360-0443.2010.03015.x. Epub 2010 Jul 9.","Fishman MJ","Addiction","2010","2010/07/15","","","10.1111/j.1360-0443.2010.03015.x"
"20626460","Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse","Billa SK, Xia Y, Morón JA.","Eur J Neurosci. 2010 Aug;32(4):625-31. doi: 10.1111/j.1460-9568.2010.07314.x. Epub 2010 Jul 9.","Billa SK","Eur J Neurosci","2010","2010/07/15","PMC3596814","NIHMS246290","10.1111/j.1460-9568.2010.07314.x"
"20626081","Russian injected drug use soars in face of political inertia","Holt E.","Lancet. 2010 Jul 3;376(9734):13-4. doi: 10.1016/s0140-6736(10)61041-0.","Holt E","Lancet","2010","2010/07/14","","","10.1016/s0140-6736(10)61041-0"
"20623586","A patient-supported clinical trial","O'Brien C.","Ann Neurol. 2010 Aug;68(2):124-5. doi: 10.1002/ana.22080.","O'Brien C","Ann Neurol","2010","2010/07/13","","","10.1002/ana.22080"
"20619194","Methylnaltrexone and gastrointestinal perforation","Mackey AC, Green L, Greene P, Avigan M.","J Pain Symptom Manage. 2010 Jul;40(1):e1-3. doi: 10.1016/j.jpainsymman.2010.01.011.","Mackey AC","J Pain Symptom Manage","2010","2010/07/13","","","10.1016/j.jpainsymman.2010.01.011"
"20605909","Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety","van Rijn RM, Brissett DI, Whistler JL.","J Pharmacol Exp Ther. 2010 Oct;335(1):133-9. doi: 10.1124/jpet.110.170969. Epub 2010 Jul 6.","van Rijn RM","J Pharmacol Exp Ther","2010","2010/07/08","PMC2957775","","10.1124/jpet.110.170969"
"20605007","[Impact of functional social support for abstinence after inpatient detoxification]","Mutschler J, Kobiella A, Grosshans M, Kiefer F.","Neuropsychiatr. 2010;24(2):118-24.","Mutschler J","Neuropsychiatr","2010","2010/07/08","","",""
"20600917","Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity?","Gassani BC, Rezende RM, Paiva-Lima P, Ferreira-Alves DL, dos Reis WG, Bakhle YS, de Francischi JN.","Pharmacol Res. 2010 Nov;62(5):439-43. doi: 10.1016/j.phrs.2010.06.007. Epub 2010 Jun 19.","Gassani BC","Pharmacol Res","2010","2010/07/06","","","10.1016/j.phrs.2010.06.007"
"20598772","B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases","Zagon IS, Donahue RN, Bonneau RH, McLaughlin PJ.","Immunobiology. 2011 Jan-Feb;216(1-2):173-83. doi: 10.1016/j.imbio.2010.06.001. Epub 2010 Jun 11.","Zagon IS","Immunobiology","2011","2010/07/06","","","10.1016/j.imbio.2010.06.001"
"20597217","Evaluation of medetomidine-ketamine-butorphanol anesthesia with atipamezole-naltrexone antagonism in captive male guanacos (Lama guanicoe)","Georoff TA, James SB, Kalk P, Calle PP, Martin-Flores M.","J Zoo Wildl Med. 2010 Jun;41(2):255-62. doi: 10.1638/2009-0203R.1.","Georoff TA","J Zoo Wildl Med","2010","2010/07/06","","","10.1638/2009-0203R.1"
"20594468","[Clinical observation of the effect of nalmefene in treatment of septic shock]","Wang HL, Yu KJ, Liu HT.","Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 Jun;22(6):351-3.","Wang HL","Zhongguo Wei Zhong Bing Ji Jiu Yi Xue","2010","2010/07/03","","",""
"20579355","Delta opioid receptor on equine sperm cells: subcellular localization and involvement in sperm motility analyzed by computer assisted sperm analyzer (CASA)","Albrizio M, Lacalandra GM, Micera E, Guaricci AC, Nicassio M, Zarrilli A.","Reprod Biol Endocrinol. 2010 Jun 25;8:78. doi: 10.1186/1477-7827-8-78.","Albrizio M","Reprod Biol Endocrinol","2010","2010/06/29","PMC2901311","","10.1186/1477-7827-8-78"
"20579007","Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats","Walker BM, Zorrilla EP, Koob GF.","Addict Biol. 2011 Jan;16(1):116-9. doi: 10.1111/j.1369-1600.2010.00226.x.","Walker BM","Addict Biol","2011","2010/06/29","PMC2988980","NIHMS213108","10.1111/j.1369-1600.2010.00226.x"
"20579004","Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system","Jerlhag E, Egecioglu E, Dickson SL, Engel JA.","Addict Biol. 2011 Jan;16(1):82-91. doi: 10.1111/j.1369-1600.2010.00231.x.","Jerlhag E","Addict Biol","2011","2010/06/29","PMC3015055","","10.1111/j.1369-1600.2010.00231.x"
"20577787","Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride","Milewski M, Stinchcomb AL.","Pharm Res. 2011 Jan;28(1):124-34. doi: 10.1007/s11095-010-0191-x. Epub 2010 Jun 25.","Milewski M","Pharm Res","2011","2010/06/26","","","10.1007/s11095-010-0191-x"
"20570059","Retention in naltrexone implant treatment for opioid dependence","Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen O, Waal H.","Drug Alcohol Depend. 2010 Sep 1;111(1-2):166-9. doi: 10.1016/j.drugalcdep.2010.03.021. Epub 2010 May 31.","Kunøe N","Drug Alcohol Depend","2010","2010/06/24","","","10.1016/j.drugalcdep.2010.03.021"
"20561758","Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch","Epperson CN, Toll B, Wu R, Amin Z, Czarkowski KA, Jatlow P, Mazure CM, O'Malley SS.","Drug Alcohol Depend. 2010 Nov 1;112(1-2):1-8. doi: 10.1016/j.drugalcdep.2010.04.021. Epub 2010 Jun 19.","Epperson CN","Drug Alcohol Depend","2010","2010/06/22","PMC2946976","NIHMS207588","10.1016/j.drugalcdep.2010.04.021"
"20559296","Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial","Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O'Neil PM, Perri MG, Pi-Sunyer FX, Rock CL, Erickson JS, Maier HN, Kim DD, Dunayevich E.","Obesity (Silver Spring). 2011 Jan;19(1):110-20. doi: 10.1038/oby.2010.147. Epub 2010 Jun 17.","Wadden TA","Obesity (Silver Spring)","2011","2010/06/19","PMC4459776","NIHMS695181","10.1038/oby.2010.147"
"20546721","Effect of acute topical application of +-pentazocine on the mechanical allodynia in diabetic mice","Ohsawa M, Hayashi SS, Kamei J.","Eur J Pharmacol. 2010 Sep 1;641(1):49-53. doi: 10.1016/j.ejphar.2010.05.005. Epub 2010 May 21.","Ohsawa M","Eur J Pharmacol","2010","2010/06/16","","","10.1016/j.ejphar.2010.05.005"
"20542391","Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial","Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O'Malley SS.","Drug Alcohol Depend. 2010 Oct 1;111(3):200-6. doi: 10.1016/j.drugalcdep.2010.04.015. Epub 2010 Jun 12.","Toll BA","Drug Alcohol Depend","2010","2010/06/15","PMC3771701","NIHMS215248","10.1016/j.drugalcdep.2010.04.015"
"20537615","Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone","Hulse GK, Ngo HT, Tait RJ.","Biol Psychiatry. 2010 Aug 1;68(3):296-302. doi: 10.1016/j.biopsych.2010.04.003. Epub 2010 May 26.","Hulse GK","Biol Psychiatry","2010","2010/06/12","","","10.1016/j.biopsych.2010.04.003"
"20535453","Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats","Rezvani AH, Slade S, Wells C, Petro A, Lumeng L, Li TK, Xiao Y, Brown ML, Paige MA, McDowell BE, Rose JE, Kellar KJ, Levin ED.","Psychopharmacology (Berl). 2010 Aug;211(2):161-74. doi: 10.1007/s00213-010-1878-8. Epub 2010 Jun 10.","Rezvani AH","Psychopharmacology (Berl)","2010","2010/06/11","PMC3695635","NIHMS474664","10.1007/s00213-010-1878-8"
"20534644","The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial","Sharafaddinzadeh N, Moghtaderi A, Kashipazha D, Majdinasab N, Shalbafan B.","Mult Scler. 2010 Aug;16(8):964-9. doi: 10.1177/1352458510366857. Epub 2010 Jun 9.","Sharafaddinzadeh N","Mult Scler","2010","2010/06/11","","","10.1177/1352458510366857"
"20528823","Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation","Ray LA, Hutchison KE, Ashenhurst JR, Morrow AL.","Alcohol Clin Exp Res. 2010 Aug;34(8):1479-87. doi: 10.1111/j.1530-0277.2010.01233.x. Epub 2010 Jun 7.","Ray LA","Alcohol Clin Exp Res","2010","2010/06/10","","","10.1111/j.1530-0277.2010.01233.x"
"20525037","Opioid detoxification: from controlled clinical trial to clinical practice","Dijkstra BA, De Jong CA, Wensing M, Krabbe PF, van der Staak CP.","Am J Addict. 2010 May-Jun;19(3):283-90. doi: 10.1111/j.1521-0391.2010.00033.x.","Dijkstra BA","Am J Addict","2010","2010/06/08","","","10.1111/j.1521-0391.2010.00033.x"
"20516163","Medication treatment of different types of alcoholism","Johnson BA.","Am J Psychiatry. 2010 Jun;167(6):630-9. doi: 10.1176/appi.ajp.2010.08101500.","Johnson BA","Am J Psychiatry","2010","2010/06/03","PMC2939449","NIHMS233056","10.1176/appi.ajp.2010.08101500"
"20516159","Treatments for alcohol dependence: rethinking the role of comorbidity and clinical subtypes","Patkar AA, Li TK.","Am J Psychiatry. 2010 Jun;167(6):620-2. doi: 10.1176/appi.ajp.2010.10030309.","Patkar AA","Am J Psychiatry","2010","2010/06/03","","","10.1176/appi.ajp.2010.10030309"
"20509712","Naltrexone/bupropion: Contrave(R); naltrexone SR/bupropion SR","","Version 2. Drugs R D. 2010;10(1):25-32. doi: 10.2165/11537710-000000000-00000.","","Drugs R D","2010","2010/06/01","PMC3586099","","10.2165/11537710-000000000-00000"
"20491739","Pharmacologic dissociation between impulsivity and alcohol drinking in high alcohol preferring mice","Oberlin BG, Bristow RE, Heighton ME, Grahame NJ.","Alcohol Clin Exp Res. 2010 Aug;34(8):1363-75. doi: 10.1111/j.1530-0277.2010.01220.x. Epub 2010 May 17.","Oberlin BG","Alcohol Clin Exp Res","2010","2010/05/25","PMC3967789","NIHMS558436","10.1111/j.1530-0277.2010.01220.x"
"20490465","Opioid antagonism enhances marijuana's effects in heavy marijuana smokers","Cooper ZD, Haney M.","Psychopharmacology (Berl). 2010 Aug;211(2):141-8. doi: 10.1007/s00213-010-1875-y. Epub 2010 May 19.","Cooper ZD","Psychopharmacology (Berl)","2010","2010/05/22","PMC2923559","NIHMS201310","10.1007/s00213-010-1875-y"
"20489046","micro-Opioid receptor stimulation in the medial subnucleus of the tractus solitarius inhibits gastric tone and motility by reducing local GABA activity","Herman MA, Alayan A, Sahibzada N, Bayer B, Verbalis J, Dretchen KL, Gillis RA.","Am J Physiol Gastrointest Liver Physiol. 2010 Aug;299(2):G494-506. doi: 10.1152/ajpgi.00038.2010. Epub 2010 May 20.","Herman MA","Am J Physiol Gastrointest Liver Physiol","2010","2010/05/22","PMC2928531","","10.1152/ajpgi.00038.2010"
"20483601","Investigation of Beckett-Casy model 2: synthesis of novel 15-16 nornaltrexone derivatives and their pharmacology","Nagase H, Imaide S, Tomatsu M, Nemoto T, Nakajima M, Nakao K, Mochizuki H, Fujii H.","Bioorg Med Chem Lett. 2010 Jun 15;20(12):3726-9. doi: 10.1016/j.bmcl.2010.04.080. Epub 2010 Apr 22.","Nagase H","Bioorg Med Chem Lett","2010","2010/05/21","","","10.1016/j.bmcl.2010.04.080"
"20482515","Efficacy and tolerability of naltrexone in the management of alcohol dependence","Garbutt JC.","Curr Pharm Des. 2010;16(19):2091-7. doi: 10.2174/138161210791516459.","Garbutt JC","Curr Pharm Des","2010","2010/05/21","","","10.2174/138161210791516459"
"20479618","New drug formulation treats chronic pain","Belavic JM.","Nurse Pract. 2010 Jun;35(6):10-1. doi: 10.1097/01.NPR.0000375802.97911.35.","Belavic JM","Nurse Pract","2010","2010/05/19","","","10.1097/01.NPR.0000375802.97911.35"
"20478707","Investigation of Beckett-Casy model 3: synthesis of novel naltrexone derivatives with contracted and expanded D-rings and their pharmacology","Nagase H, Imaide S, Tomatsu M, Hirayama S, Nemoto T, Sato N, Nakajima M, Nakao K, Mochizuki H, Gouda H, Hirono S, Fujii H.","Bioorg Med Chem Lett. 2010 Jun 15;20(12):3801-4. doi: 10.1016/j.bmcl.2010.04.044. Epub 2010 Apr 14.","Nagase H","Bioorg Med Chem Lett","2010","2010/05/19","","","10.1016/j.bmcl.2010.04.044"
"20466249","Carfentanil--an ultra potent opioid","George AV, Lu JJ, Pisano MV, Metz J, Erickson TB.","Am J Emerg Med. 2010 May;28(4):530-2. doi: 10.1016/j.ajem.2010.03.003.","George AV","Am J Emerg Med","2010","2010/05/15","","","10.1016/j.ajem.2010.03.003"
"20462660","Antipruritic treatment with systemic μ-opioid receptor antagonists: a review","Phan NQ, Bernhard JD, Luger TA, Ständer S.","J Am Acad Dermatol. 2010 Oct;63(4):680-8. doi: 10.1016/j.jaad.2009.08.052. Epub 2010 May 11.","Phan NQ","J Am Acad Dermatol","2010","2010/05/14","","","10.1016/j.jaad.2009.08.052"
"20460140","Naltrexone in adults with intellectual disability improves compulsive and dissocial disorders: a case report","Orihuela-Flores M, Deriaz N, Carminati GG.","Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1137-8. doi: 10.1016/j.pnpbp.2010.05.003. Epub 2010 May 9.","Orihuela-Flores M","Prog Neuropsychopharmacol Biol Psychiatry","2010","2010/05/13","","","10.1016/j.pnpbp.2010.05.003"
"20456289","Ethanol-induced activation of AKT and DARPP-32 in the mouse striatum mediated by opioid receptors","Björk K, Terasmaa A, Sun H, Thorsell A, Sommer WH, Heilig M.","Addict Biol. 2010 Jul;15(3):299-303. doi: 10.1111/j.1369-1600.2010.00212.x. Epub 2010 Apr 29.","Björk K","Addict Biol","2010","2010/05/12","PMC2903651","NIHMS186408","10.1111/j.1369-1600.2010.00212.x"
"20451376","Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery","Yerramreddy TR, Milewski M, Penthala NR, Stinchcomb AL, Crooks PA.","Bioorg Med Chem Lett. 2010 Jun 1;20(11):3280-3. doi: 10.1016/j.bmcl.2010.04.049. Epub 2010 Apr 18.","Yerramreddy TR","Bioorg Med Chem Lett","2010","2010/05/11","PMC3726000","NIHMS204782","10.1016/j.bmcl.2010.04.049"
"20445500","Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms","Schindler AG, Li S, Chavkin C.","Version 2. Neuropsychopharmacology. 2010 Aug;35(9):1932-42. doi: 10.1038/npp.2010.67. Epub 2010 May 5.","Schindler AG","Neuropsychopharmacology","2010","2010/05/07","PMC2904851","NIHMS194499","10.1038/npp.2010.67"
"20443648","Morphine/naltrexone","Duggan ST, Scott LJ.","CNS Drugs. 2010 Jun;24(6):527-38. doi: 10.2165/11204620-000000000-00000.","Duggan ST","CNS Drugs","2010","2010/05/07","","","10.2165/11204620-000000000-00000"
"20441245","Dose proportionality of fentanyl buccal tablet in doses ranging from 600 to 1300 microg in healthy adult subjects: a randomized, open-label, four-period, crossover, single-centre study","Darwish M, Kirby M, Robertson P Jr, Tracewell W, Xie F.","Clin Drug Investig. 2010;30(6):365-73. doi: 10.1007/BF03256906.","Darwish M","Clin Drug Investig","2010","2010/05/06","","","10.1007/BF03256906"
"20438777","Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: a trial on pigs","Campisi G, Giannola LI, Florena AM, De Caro V, Schumacher A, Göttsche T, Paderni C, Wolff A.","J Control Release. 2010 Aug 3;145(3):214-20. doi: 10.1016/j.jconrel.2010.04.027. Epub 2010 May 11.","Campisi G","J Control Release","2010","2010/05/05","","","10.1016/j.jconrel.2010.04.027"
"20438745","Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose range","Codd EE, Ma J, Zhang SP, Stone DJ Jr, Colburn RW, Brandt MR, Chevalier KM, Zhu Y, Peng S, Cai C, Acton PD, Flores CM.","Pharmacol Biochem Behav. 2010 Aug;96(2):130-5. doi: 10.1016/j.pbb.2010.04.020. Epub 2010 May 12.","Codd EE","Pharmacol Biochem Behav","2010","2010/05/05","","","10.1016/j.pbb.2010.04.020"
"20438317","Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study","Salamina G, Diecidue R, Vigna-Taglianti F, Jarre P, Schifano P, Bargagli AM, Davoli M, Amato L, Perucci CA, Faggiano F; VEdeTTE Study Group.","Subst Use Misuse. 2010 Oct;45(12):2076-92. doi: 10.3109/10826081003791932.","Salamina G","Subst Use Misuse","2010","2010/05/05","","","10.3109/10826081003791932"
"20432720","[Mechanisms of corticotropin-releasing factor-induced analgesic effect in conscious rats]","Iarushkina NI, Bagaeva TR.","Ross Fiziol Zh Im I M Sechenova. 2010 Feb;96(2):128-37.","Iarushkina NI","Ross Fiziol Zh Im I M Sechenova","2010","2010/05/04","","",""
"20426500","Methylnaltrexone","Garnock-Jones KP, McKeage K.","Drugs. 2010 May 7;70(7):919-28. doi: 10.2165/11204520-000000000-00000.","Garnock-Jones KP","Drugs","2010","2010/04/30","","","10.2165/11204520-000000000-00000"
"20424458","Naltrexone implants compared to methadone: outcomes six months after prison release","Lobmaier PP, Kunøe N, Gossop M, Katevoll T, Waal H.","Eur Addict Res. 2010;16(3):139-45. doi: 10.1159/000313336. Epub 2010 Apr 26.","Lobmaier PP","Eur Addict Res","2010","2010/04/29","","","10.1159/000313336"
"20418186","Hyperbaric oxygen treatment induces a 2-phase antinociceptive response of unusually long duration in mice","Chung E, Zelinski LM, Ohgami Y, Shirachi DY, Quock RM.","J Pain. 2010 Sep;11(9):847-53. doi: 10.1016/j.jpain.2009.12.004. Epub 2010 Apr 24.","Chung E","J Pain","2010","2010/04/27","PMC2910818","NIHMS166362","10.1016/j.jpain.2009.12.004"
"20415289","The diverse clinical uses of opioid receptor drugs","Howland RH.","J Psychosoc Nurs Ment Health Serv. 2010 May;48(5):11-4. doi: 10.3928/02793695-20100408-01.","Howland RH","J Psychosoc Nurs Ment Health Serv","2010","2010/04/27","","","10.3928/02793695-20100408-01"
"20409441","Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector","Abraham AJ, Roman PM.","J Stud Alcohol Drugs. 2010 May;71(3):460-6. doi: 10.15288/jsad.2010.71.460.","Abraham AJ","J Stud Alcohol Drugs","2010","2010/04/23","PMC2859794","","10.15288/jsad.2010.71.460"
"20401980","Targeting opioid receptors: A new treatment for brain disorders","Rahman S.","CNS Neurol Disord Drug Targets. 2010 Apr;9(2):128. doi: 10.2174/187152710791012116.","Rahman S","CNS Neurol Disord Drug Targets","2010","2010/04/20","","","10.2174/187152710791012116"
"20401606","Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration","Sperling RE, Gomes SM, Sypek EI, Carey AN, McLaughlin JP.","Psychopharmacology (Berl). 2010 Jun;210(2):199-209. doi: 10.1007/s00213-010-1844-5. Epub 2010 Apr 17.","Sperling RE","Psychopharmacology (Berl)","2010","2010/04/20","","","10.1007/s00213-010-1844-5"
"20401605","Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats","Ismayilova N, Shoaib M.","Psychopharmacology (Berl). 2010 Jun;210(2):211-20. doi: 10.1007/s00213-010-1845-4. Epub 2010 Apr 17.","Ismayilova N","Psychopharmacology (Berl)","2010","2010/04/20","","","10.1007/s00213-010-1845-4"
"20400686","Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts","Gross GJ, Baker JE, Hsu A, Wu HE, Falck JR, Nithipatikom K.","Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H2201-7. doi: 10.1152/ajpheart.00815.2009. Epub 2010 Apr 16.","Gross GJ","Am J Physiol Heart Circ Physiol","2010","2010/04/20","PMC2886625","","10.1152/ajpheart.00815.2009"
"20398374","Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats","Mattioli TA, Milne B, Cahill CM.","Mol Pain. 2010 Apr 16;6:22. doi: 10.1186/1744-8069-6-22.","Mattioli TA","Mol Pain","2010","2010/04/20","PMC2862024","","10.1186/1744-8069-6-22"
"20394808","Opioid receptor internalization contributes to dermorphin-mediated antinociception","Macey TA, Ingram SL, Bobeck EN, Hegarty DM, Aicher SA, Arttamangkul S, Morgan MM.","Neuroscience. 2010 Jun 30;168(2):543-50. doi: 10.1016/j.neuroscience.2010.04.003. Epub 2010 Apr 13.","Macey TA","Neuroscience","2010","2010/04/17","PMC3312465","NIHMS197203","10.1016/j.neuroscience.2010.04.003"
"20393362","The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study","Zarkin GA, Bray JW, Aldridge A, Mills M, Cisler RA, Couper D, McKay JR, O'Malley S.","Med Care. 2010 May;48(5):396-401. doi: 10.1097/MLR.0b013e3181d68859.","Zarkin GA","Med Care","2010","2010/04/16","PMC3130073","NIHMS288195","10.1097/MLR.0b013e3181d68859"
"20392197","The effects of acute restraint stress on nociceptive responses evoked by the injection of formalin into the temporomandibular joint of female rats","Botelho AP, Gameiro GH, Tuma CE, Marcondes FK, de Arruda Veiga MC.","Stress. 2010 May;13(3):269-75. doi: 10.3109/10253890903362645.","Botelho AP","Stress","2010","2010/04/16","","","10.3109/10253890903362645"
"20390697","Favorable mortality profile of naltrexone implants for opiate addiction","Reece AS.","J Addict Dis. 2010 Jan;29(1):30-50. doi: 10.1080/10550880903435988.","Reece AS","J Addict Dis","2010","2010/04/15","","","10.1080/10550880903435988"
"20386884","Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone","Tompkins DA, Lanier RK, Harrison JA, Strain EC, Bigelow GE.","Psychopharmacology (Berl). 2010 Jul;210(4):471-80. doi: 10.1007/s00213-010-1838-3. Epub 2010 Apr 13.","Tompkins DA","Psychopharmacology (Berl)","2010","2010/04/14","PMC2878387","NIHMS197721","10.1007/s00213-010-1838-3"
"20374204","Effects of naltrexone treatment for alcohol-related disorders on healthcare costs in an insured population","Kranzler HR, Montejano LB, Stephenson JJ, Wang S, Gastfriend DR.","Alcohol Clin Exp Res. 2010 Jun;34(6):1090-7. doi: 10.1111/j.1530-0277.2010.01185.x. Epub 2010 Apr 5.","Kranzler HR","Alcohol Clin Exp Res","2010","2010/04/09","PMC3159684","NIHMS317257","10.1111/j.1530-0277.2010.01185.x"
"20372878","Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats","Beardsley PM, Pollard GT, Howard JL, Carroll FI.","Psychopharmacology (Berl). 2010 Jun;210(2):189-98. doi: 10.1007/s00213-010-1846-3. Epub 2010 Apr 7.","Beardsley PM","Psychopharmacology (Berl)","2010","2010/04/08","PMC2872796","NIHMS197723","10.1007/s00213-010-1846-3"
"20363090","Extended-release naltrexone for treatment of alcohol dependence in primary care","Lee JD, Grossman E, DiRocco D, Truncali A, Hanley K, Stevens D, Rotrosen J, Gourevitch MN.","J Subst Abuse Treat. 2010 Jul;39(1):14-21. doi: 10.1016/j.jsat.2010.03.005. Epub 2010 Apr 2.","Lee JD","J Subst Abuse Treat","2010","2010/04/06","","","10.1016/j.jsat.2010.03.005"
"20360279","Pharmacotherapy of alcohol use disorders in the Veterans Health Administration","Harris AH, Kivlahan DR, Bowe T, Humphreys KN.","Psychiatr Serv. 2010 Apr;61(4):392-8. doi: 10.1176/ps.2010.61.4.392.","Harris AH","Psychiatr Serv","2010","2010/04/03","","","10.1176/ps.2010.61.4.392"
"20360157","Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance","Ngo HT, Tait RJ, Hulse GK.","J Psychopharmacol. 2011 Jun;25(6):774-82. doi: 10.1177/0269881110364266. Epub 2010 Apr 1.","Ngo HT","J Psychopharmacol","2011","2010/04/03","","","10.1177/0269881110364266"
"20357165","Pretreatment time with norbinaltorphimine","Theisen MM, Ploner F, Van Aken HK, Weber TP.","Anesth Analg. 2010 Apr 1;110(4):1243-4; author reply 1244. doi: 10.1213/ANE.0b013e3181ced654.","Theisen MM","Anesth Analg","2010","2010/04/02","","","10.1213/ANE.0b013e3181ced654"
"20356587","Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome","Hadžiomerović-Pekić D, Wildt L, Weiss JM, Moeller K, Mattle V, Seeber BE.","Fertil Steril. 2010 Nov;94(6):2385-8. doi: 10.1016/j.fertnstert.2010.02.041. Epub 2010 Mar 31.","Hadžiomerović-Pekić D","Fertil Steril","2010","2010/04/02","","","10.1016/j.fertnstert.2010.02.041"
"20355261","Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective","Dunlap LJ, Zarkin GA, Bray JW, Mills M, Kivlahan DR, McKay JR, Latham P, Tonigan JS.","Med Care. 2010 Apr;48(4):306-13. doi: 10.1097/mlr.0b013e3181ca3d40.","Dunlap LJ","Med Care","2010","2010/04/01","PMC3140763","NIHMS304096","10.1097/mlr.0b013e3181ca3d40"
"20347940","Artificial microRNA-based neurokinin-1 receptor gene silencing reduces alcohol consumption in mice","Baek MN, Jung KH, Halder D, Choi MR, Lee BH, Lee BC, Jung MH, Choi IG, Chung MK, Oh DY, Chai YG.","Neurosci Lett. 2010 May 21;475(3):124-8. doi: 10.1016/j.neulet.2010.03.051. Epub 2010 Mar 25.","Baek MN","Neurosci Lett","2010","2010/03/30","","","10.1016/j.neulet.2010.03.051"
"20347820","Evidence of central and peripheral sensitization in a rat model of narcotic bowel-like syndrome","Agostini S, Eutamene H, Cartier C, Broccardo M, Improta G, Houdeau E, Petrella C, Ferrier L, Theodorou V, Bueno L.","Gastroenterology. 2010 Aug;139(2):553-63, 563.e1-5. doi: 10.1053/j.gastro.2010.03.046. Epub 2010 Mar 25.","Agostini S","Gastroenterology","2010","2010/03/30","","","10.1053/j.gastro.2010.03.046"
"20345211","Emerging new therapeutic options for the management of opioid induced constipation","Kapoor S.","J Pain Palliat Care Pharmacother. 2010 Mar;24(1):98-9. doi: 10.3109/15360280903475593.","Kapoor S","J Pain Palliat Care Pharmacother","2010","2010/03/30","","","10.3109/15360280903475593"
"20336033","A morphine/naltrexone combination (Embeda) for pain","","Med Lett Drugs Ther. 2010 Mar 22;52(1334):22-3.","","Med Lett Drugs Ther","2010","2010/03/26","","",""
"20333506","Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands","Ansonoff MA, Portoghese PS, Pintar JE.","Psychopharmacology (Berl). 2010 Jun;210(2):161-8. doi: 10.1007/s00213-010-1826-7. Epub 2010 Mar 24.","Ansonoff MA","Psychopharmacology (Berl)","2010","2010/03/25","","","10.1007/s00213-010-1826-7"
"20235445","A review of the community reinforcement approach in the treatment of opioid dependence","Abbott PJ.","J Psychoactive Drugs. 2009 Dec;41(4):379-85. doi: 10.1080/02791072.2009.10399776.","Abbott PJ","J Psychoactive Drugs","2009","2010/03/19","","","10.1080/02791072.2009.10399776"
"20232494","Pharmacotherapies for alcoholism: the old and the new","Olive MF.","CNS Neurol Disord Drug Targets. 2010 Mar;9(1):2-4. doi: 10.2174/187152710790966722.","Olive MF","CNS Neurol Disord Drug Targets","2010","2010/03/17","","","10.2174/187152710790966722"
"20232058","The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat","Tejeda HA, Chefer VI, Zapata A, Shippenberg TS.","Psychopharmacology (Berl). 2010 Jun;210(2):231-40. doi: 10.1007/s00213-010-1799-6. Epub 2010 Mar 16.","Tejeda HA","Psychopharmacology (Berl)","2010","2010/03/17","PMC2946822","NIHMS236623","10.1007/s00213-010-1799-6"
"20231324","A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence","Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, Dackis CA, O'Brien CP.","Am J Psychiatry. 2010 Jun;167(6):668-75. doi: 10.1176/appi.ajp.2009.08060852. Epub 2010 Mar 15.","Pettinati HM","Am J Psychiatry","2010","2010/03/17","PMC3121313","NIHMS301367","10.1176/appi.ajp.2009.08060852"
"20224403","Long-acting depot formulations of naltrexone for heroin dependence: a review","Krupitsky EM, Blokhina EA.","Curr Opin Psychiatry. 2010 May;23(3):210-4. doi: 10.1097/YCO.0b013e3283386578.","Krupitsky EM","Curr Opin Psychiatry","2010","2010/03/13","","","10.1097/YCO.0b013e3283386578"
"20223408","First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction","Lemesle F, Lemesle F, Nicola W, Pierre Jonville-Béra A.","Am J Emerg Med. 2010 Mar;28(3):387.e5-6. doi: 10.1016/j.ajem.2009.07.007.","Lemesle F","Am J Emerg Med","2010","2010/03/13","","","10.1016/j.ajem.2009.07.007"
"20202580","Pharmacologic therapies for obesity","Kaplan LM.","Gastroenterol Clin North Am. 2010 Mar;39(1):69-79. doi: 10.1016/j.gtc.2010.01.001.","Kaplan LM","Gastroenterol Clin North Am","2010","2010/03/06","","","10.1016/j.gtc.2010.01.001"
"20201811","Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics","Ray LA, Chin PF, Miotto K.","CNS Neurol Disord Drug Targets. 2010 Mar;9(1):13-22. doi: 10.2174/187152710790966704.","Ray LA","CNS Neurol Disord Drug Targets","2010","2010/03/06","","","10.2174/187152710790966704"
"20196983","Augmentation with naltrexone to treat compulsive sexual behavior: a case series","Raymond NC, Grant JE, Coleman E.","Ann Clin Psychiatry. 2010 Feb;22(1):56-62.","Raymond NC","Ann Clin Psychiatry","2010","2010/03/04","","",""
"20195661","Study of a structurally similar kappa opioid receptor agonist and antagonist pair by molecular dynamics simulations","Kolinski M, Filipek S.","J Mol Model. 2010 Oct;16(10):1567-76. doi: 10.1007/s00894-010-0678-8. Epub 2010 Feb 27.","Kolinski M","J Mol Model","2010","2010/03/03","","","10.1007/s00894-010-0678-8"
"20192948","Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat","Häggkvist J, Björkholm C, Steensland P, Lindholm S, Franck J, Schilström B.","Addict Biol. 2011 Jan;16(1):20-9. doi: 10.1111/j.1369-1600.2009.00199.x.","Häggkvist J","Addict Biol","2011","2010/03/03","","","10.1111/j.1369-1600.2009.00199.x"
"20190923","Modification of perseverative responding that increased earnings but impeded skill acquisition in a job-skills training program","DeFulio A, Iati C, Needham M, Silverman K.","J Appl Behav Anal. 2009 Fall;42(3):627-40. doi: 10.1901/jaba.2009.42-627.","DeFulio A","J Appl Behav Anal","2009","2010/03/02","PMC2741061","","10.1901/jaba.2009.42-627"
"20185926","The involvement of micro-opioid receptors in the central nervous system in the worsening of allergic airway inflammation by psychological stress in mice","Okuyama K, Wada K, Sakurada S, Mizoguchi H, Komatsu H, Sora I, Tamura G, Ohkawara Y, Takayanagi M, Ohno I.","Int Arch Allergy Immunol. 2010;152(4):342-52. doi: 10.1159/000288287. Epub 2010 Feb 26.","Okuyama K","Int Arch Allergy Immunol","2010","2010/02/27","","","10.1159/000288287"
"20173089","In vitro metabolism and identification of human enzymes involved in the metabolism of methylnaltrexone","Tong Z, Chandrasekaran A, Li H, Rotshteyn Y, Erve JC, Demaio W, Talaat R, Hultin T, Scatina J.","Drug Metab Dispos. 2010 May;38(5):801-7. doi: 10.1124/dmd.110.032169. Epub 2010 Feb 19.","Tong Z","Drug Metab Dispos","2010","2010/02/23","","","10.1124/dmd.110.032169"
"20171465","Severe opioid withdrawal due to misuse of new combined morphine and naltrexone product (Embeda)","Jang DH, Rohe JC, Hoffman RS, Nelson LS.","Ann Emerg Med. 2010 Mar;55(3):303-4. doi: 10.1016/j.annemergmed.2009.10.013.","Jang DH","Ann Emerg Med","2010","2010/02/23","","","10.1016/j.annemergmed.2009.10.013"
"20170672","Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system","Berrendero F, Robledo P, Trigo JM, Martín-García E, Maldonado R.","Neurosci Biobehav Rev. 2010 Nov;35(2):220-31. doi: 10.1016/j.neubiorev.2010.02.006. Epub 2010 Feb 16.","Berrendero F","Neurosci Biobehav Rev","2010","2010/02/23","PMC2908214","NIHMS189197","10.1016/j.neubiorev.2010.02.006"
"20169438","The pharmacological treatment of opioid addiction--a clinical perspective","Lobmaier P, Gossop M, Waal H, Bramness J.","Eur J Clin Pharmacol. 2010 Jun;66(6):537-45. doi: 10.1007/s00228-010-0793-6. Epub 2010 Feb 19.","Lobmaier P","Eur J Clin Pharmacol","2010","2010/02/20","","","10.1007/s00228-010-0793-6"
"20167252","Effects of intracerebroventricular application of the delta opioid receptor agonist [D-Ala2, D-Leu5] enkephalin on neurological recovery following asphyxial cardiac arrest in rats","Gao CJ, Li JP, Wang W, Lü BC, Niu L, Zhu C, Wei YY, Zhang T, Wu SX, Chai W, Li YQ.","Neuroscience. 2010 Jun 30;168(2):531-42. doi: 10.1016/j.neuroscience.2010.02.025. Epub 2010 Feb 16.","Gao CJ","Neuroscience","2010","2010/02/20","","","10.1016/j.neuroscience.2010.02.025"
"20166200","Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs","Banks SL, Pinninti RR, Gill HS, Paudel KS, Crooks PA, Brogden NK, Prausnitz MR, Stinchcomb AL.","J Pharm Sci. 2010 Jul;99(7):3072-80. doi: 10.1002/jps.22083.","Banks SL","J Pharm Sci","2010","2010/02/19","PMC2862091","NIHMS176516","10.1002/jps.22083"
"20159022","In vivo characterization of the opioid antagonist nalmefene in mice","Osborn MD, Lowery JJ, Skorput AG, Giuvelis D, Bilsky EJ.","Life Sci. 2010 Apr 10;86(15-16):624-30. doi: 10.1016/j.lfs.2010.02.013. Epub 2010 Feb 14.","Osborn MD","Life Sci","2010","2010/02/18","PMC2848904","NIHMS179398","10.1016/j.lfs.2010.02.013"
"20157832","Involvement of the kappa-opioid receptor in nitrous oxide-induced analgesia in mice","Koyama T, Fukuda K.","J Anesth. 2010 Apr;24(2):297-9. doi: 10.1007/s00540-010-0886-5. Epub 2010 Feb 17.","Koyama T","J Anesth","2010","2010/02/17","","","10.1007/s00540-010-0886-5"
"20153935","A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys","Vallender EJ, Rüedi-Bettschen D, Miller GM, Platt DM.","Drug Alcohol Depend. 2010 Jun 1;109(1-3):252-6. doi: 10.1016/j.drugalcdep.2010.01.005. Epub 2010 Feb 13.","Vallender EJ","Drug Alcohol Depend","2010","2010/02/16","PMC2875311","NIHMS176624","10.1016/j.drugalcdep.2010.01.005"
"20153756","Cholestasis induced nephrotoxicity: the role of endogenous opioids","Deroee AF, Nezami BG, Mehr SE, Hosseini R, Salmasi AH, Talab SS, Jahanzad I, Dehpour AR.","Life Sci. 2010 Mar 27;86(13-14):488-92. doi: 10.1016/j.lfs.2010.02.005. Epub 2010 Feb 12.","Deroee AF","Life Sci","2010","2010/02/16","","","10.1016/j.lfs.2010.02.005"
"20153438","Opioid and non-opioid receptor-mediated immunoregulatory role of leucine-enkephalin in teleost Channa punctatus","Singh R, Rai U.","Fish Shellfish Immunol. 2010 May-Jun;28(5-6):872-8. doi: 10.1016/j.fsi.2010.02.007. Epub 2010 Feb 11.","Singh R","Fish Shellfish Immunol","2010","2010/02/16","","","10.1016/j.fsi.2010.02.007"
"20153142","Working memory fMRI activation in cocaine-dependent subjects: association with treatment response","Moeller FG, Steinberg JL, Schmitz JM, Ma L, Liu S, Kjome KL, Rathnayaka N, Kramer LA, Narayana PA.","Psychiatry Res. 2010 Mar 30;181(3):174-82. doi: 10.1016/j.pscychresns.2009.11.003. Epub 2010 Feb 12.","Moeller FG","Psychiatry Res","2010","2010/02/16","PMC2832606","NIHMS180243","10.1016/j.pscychresns.2009.11.003"
"20141248","Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment","Ray LA, Miranda R Jr, Tidey JW, McGeary JE, MacKillop J, Gwaltney CJ, Rohsenow DJ, Swift RM, Monti PM.","J Abnorm Psychol. 2010 Feb;119(1):115-25. doi: 10.1037/a0017550.","Ray LA","J Abnorm Psychol","2010","2010/02/10","PMC3703617","NIHMS480772","10.1037/a0017550"
"20138067","Oral sensory and cephalic hormonal responses to fat and non-fat liquids in bulimia nervosa","Bello NT, Coughlin JW, Redgrave GW, Moran TH, Guarda AS.","Physiol Behav. 2010 Apr 19;99(5):611-7. doi: 10.1016/j.physbeh.2010.01.033. Epub 2010 Feb 4.","Bello NT","Physiol Behav","2010","2010/02/09","PMC2840197","NIHMS176271","10.1016/j.physbeh.2010.01.033"
"20134275","Subcutaneous methylnaltrexone to restore postoperative bowel function in a long-term opiate user","Ladanyi A, Temkin SM, Moss J.","Int J Gynecol Cancer. 2010 Feb;20(2):308-10. doi: 10.1111/IGC.0b013e3181cd1828.","Ladanyi A","Int J Gynecol Cancer","2010","2010/02/06","","","10.1111/IGC.0b013e3181cd1828"
"20132853","Kappa-opioid receptor-mediated modulation of innate immune response by dynorphin in teleost Channa punctatus","Singh R, Rai U.","Peptides. 2010 May;31(5):973-8. doi: 10.1016/j.peptides.2010.01.009. Epub 2010 Feb 2.","Singh R","Peptides","2010","2010/02/06","","","10.1016/j.peptides.2010.01.009"
"20117908","The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation","Abraham AJ, Knudsen HK, Rothrauff TC, Roman PM.","J Subst Abuse Treat. 2010 Apr;38(3):275-83. doi: 10.1016/j.jsat.2010.01.003. Epub 2010 Feb 1.","Abraham AJ","J Subst Abuse Treat","2010","2010/02/02","PMC2835814","NIHMS168802","10.1016/j.jsat.2010.01.003"
"20116338","Nucleus accumbens mu opioid receptors mediate immediate postictal decrease in locomotion after an amygdaloid kindled seizure in rats","Ma J, Boyce R, Leung LS.","Epilepsy Behav. 2010 Feb;17(2):165-71. doi: 10.1016/j.yebeh.2009.12.024. Epub 2010 Jan 29.","Ma J","Epilepsy Behav","2010","2010/02/02","","","10.1016/j.yebeh.2009.12.024"
"20101570","Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran","Naderi-Heiden A, Naderi A, Naderi MM, Rahmani-Didar F, Salimi AR, Gleiss A, Kasper S, Frey R.","Pharmacopsychiatry. 2010 Jun;43(4):130-7. doi: 10.1055/s-0029-1242820. Epub 2010 Jan 25.","Naderi-Heiden A","Pharmacopsychiatry","2010","2010/01/27","","","10.1055/s-0029-1242820"
"20101391","Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats","Negus SS, Morrissey EM, Rosenberg M, Cheng K, Rice KC.","Psychopharmacology (Berl). 2010 Jun;210(2):149-59. doi: 10.1007/s00213-009-1770-6. Epub 2010 Jan 26.","Negus SS","Psychopharmacology (Berl)","2010","2010/01/27","PMC3156454","NIHMS249559","10.1007/s00213-009-1770-6"
"20096717","Operant responding for sucrose by rats bred for high or low saccharin consumption","Gosnell BA, Mitra A, Avant RA, Anker JJ, Carroll ME, Levine AS.","Physiol Behav. 2010 Mar 30;99(4):529-33. doi: 10.1016/j.physbeh.2010.01.010. Epub 2010 Jan 22.","Gosnell BA","Physiol Behav","2010","2010/01/26","PMC2847856","NIHMS185594","10.1016/j.physbeh.2010.01.010"
"20096019","Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis","Earnshaw SR, Klok RM, Iyer S, McDade C.","Aliment Pharmacol Ther. 2010 Apr;31(8):911-21. doi: 10.1111/j.1365-2036.2010.04244.x. Epub 2010 Jan 20.","Earnshaw SR","Aliment Pharmacol Ther","2010","2010/01/26","","","10.1111/j.1365-2036.2010.04244.x"
"20091613","Disulfiram for the treatment of cocaine dependence","Pani PP, Trogu E, Vacca R, Amato L, Vecchi S, Davoli M.","Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007024. doi: 10.1002/14651858.CD007024.pub2.","Pani PP","Cochrane Database Syst Rev","2010","2010/01/22","","","10.1002/14651858.CD007024.pub2"
"20091529","Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal","Gowing L, Ali R, White JM.","Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD002022. doi: 10.1002/14651858.CD002022.pub3.","Gowing L","Cochrane Database Syst Rev","2010","2010/01/22","PMC7065589","","10.1002/14651858.CD002022.pub3"
"20084370","Locomotor stimulant effects of acute and repeated intrategmental injections of salsolinol in rats: role of mu-opioid receptors","Hipólito L, Sánchez-Catalán MJ, Zornoza T, Polache A, Granero L.","Psychopharmacology (Berl). 2010 Mar;209(1):1-11. doi: 10.1007/s00213-009-1751-9.","Hipólito L","Psychopharmacology (Berl)","2010","2010/01/20","","","10.1007/s00213-009-1751-9"
"20081727","Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients","Kyle G.","Int J Palliat Nurs. 2009 Nov;15(11):533-40. doi: 10.12968/ijpn.2009.15.11.45492.","Kyle G","Int J Palliat Nurs","2009","2010/01/19","","","10.12968/ijpn.2009.15.11.45492"
"20077761","Gender differences in the genetic risk for alcohol dependence--the results of a pharmacogenetic study in Korean alcoholics","Kim SG.","Nihon Arukoru Yakubutsu Igakkai Zasshi. 2009 Dec;44(6):680-5.","Kim SG","Nihon Arukoru Yakubutsu Igakkai Zasshi","2009","2010/01/19","","",""
"20073411","Methylnaltrexone potentiates body weight and fat reduction with leptin","Yuan CS, Sun S, Attele A, Wang CZ, Tong R, Israel RJ.","J Opioid Manag. 2009 Nov-Dec;5(6):373-8. doi: 10.5055/jom.2009.0037.","Yuan CS","J Opioid Manag","2009","2010/01/16","","","10.5055/jom.2009.0037"
"20073409","Use of an algorithm applied to urine drug screening to assess adherence to an oxycontin regimen","Couto JE, Webster L, Romney MC, Leider HL, Linden A.","J Opioid Manag. 2009 Nov-Dec;5(6):359-64. doi: 10.5055/jom.2009.0035.","Couto JE","J Opioid Manag","2009","2010/01/16","","","10.5055/jom.2009.0035"
"20066010","A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis","Teng L, Zhao J, Wang F, Ma L, Pei G.","Cell Res. 2010 Feb;20(2):138-53. doi: 10.1038/cr.2010.3. Epub 2010 Jan 12.","Teng L","Cell Res","2010","2010/01/13","","","10.1038/cr.2010.3"
"20065959","Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats","Lenard NR, Zheng H, Berthoud HR.","Int J Obes (Lond). 2010 Jun;34(6):1001-10. doi: 10.1038/ijo.2009.297. Epub 2010 Jan 12.","Lenard NR","Int J Obes (Lond)","2010","2010/01/13","PMC2885588","NIHMS165738","10.1038/ijo.2009.297"
"20058821","[Changes in the thyroid activity and influence of dehydroepiandrosterone-sulfate under the cold and not cold influence]","Obut TA, Saryg SK, Erdynieva TA, Dement'eva TIu.","Ross Fiziol Zh Im I M Sechenova. 2009 Nov;95(11):1234-41.","Obut TA","Ross Fiziol Zh Im I M Sechenova","2009","2010/01/12","","",""
"20056557","Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia","Bohren Y, Karavelic D, Tessier LH, Yalcin I, Gavériaux-Ruff C, Kieffer BL, Freund-Mercier MJ, Barrot M.","Eur J Pain. 2010 Aug;14(7):700-704. doi: 10.1016/j.ejpain.2009.11.014. Epub 2009 Dec 28.","Bohren Y","Eur J Pain","2010","2010/01/09","PMC4469366","NIHMS381969","10.1016/j.ejpain.2009.11.014"
"20056539","Investigation of Beckett-Casy model 1: synthesis of novel 16,17-seco-naltrexone derivatives and their pharmacology","Imaide S, Fujii H, Watanabe A, Nemoto T, Nakajima M, Nakao K, Mochizuki H, Nagase H.","Bioorg Med Chem Lett. 2010 Feb 1;20(3):1055-8. doi: 10.1016/j.bmcl.2009.12.039. Epub 2009 Dec 26.","Imaide S","Bioorg Med Chem Lett","2010","2010/01/09","","","10.1016/j.bmcl.2009.12.039"
"20053817","Metabolism of intravenous methylnaltrexone in mice, rats, dogs, and humans","Chandrasekaran A, Tong Z, Li H, Erve JC, DeMaio W, Goljer I, McConnell O, Rotshteyn Y, Hultin T, Talaat R, Scatina J.","Drug Metab Dispos. 2010 Apr;38(4):606-16. doi: 10.1124/dmd.109.031179. Epub 2010 Jan 6.","Chandrasekaran A","Drug Metab Dispos","2010","2010/01/08","","","10.1124/dmd.109.031179"
"20051236","Antinociceptive effects of galanin in the central nucleus of amygdala of rats, an involvement of opioid receptors","Jin WY, Liu Z, Liu D, Yu LC.","Brain Res. 2010 Mar 12;1320:16-21. doi: 10.1016/j.brainres.2009.12.060. Epub 2010 Jan 4.","Jin WY","Brain Res","2010","2010/01/07","","","10.1016/j.brainres.2009.12.060"
"20045447","Mu and kappa opioid receptor expression in the mediobasal hypothalamus and effectiveness of selective antagonists on prolactin release during lactation","Tavakoli-Nezhad M, Arbogast LA.","Neuroscience. 2010 Mar 17;166(2):359-67. doi: 10.1016/j.neuroscience.2009.12.066. Epub 2010 Jan 4.","Tavakoli-Nezhad M","Neuroscience","2010","2010/01/05","PMC2824054","NIHMS168539","10.1016/j.neuroscience.2009.12.066"
"20044669","Naltrexone implants","Kelly KI, McBride A.","Br J Psychiatry. 2010 Jan;196(1):77; author reply 77. doi: 10.1192/bjp.196.1.77.","Kelly KI","Br J Psychiatry","2010","2010/01/02","","","10.1192/bjp.196.1.77"
"20042414","Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases","Berkson BM, Rubin DM, Berkson AJ.","Integr Cancer Ther. 2009 Dec;8(4):416-22. doi: 10.1177/1534735409352082.","Berkson BM","Integr Cancer Ther","2009","2010/01/01","","","10.1177/1534735409352082"
"20039197","Hypoalgesia associated with elevated resting blood pressure: evidence for endogenous opioid involvement","Bruehl S, Burns JW, Chung OY, Magid E, Chont M, Gilliam W, Matsuura J, Somar K, Goodlad JK, Stone K, Cairl H.","J Behav Med. 2010 Apr;33(2):168-76. doi: 10.1007/s10865-009-9241-4. Epub 2009 Dec 29.","Bruehl S","J Behav Med","2010","2009/12/30","PMC2844461","NIHMS172381","10.1007/s10865-009-9241-4"
"20026311","Genetic variance contributes to dopamine and opioid receptor antagonist-induced inhibition of intralipid (fat) intake in inbred and outbred mouse strains","Dym CT, Bae VS, Kraft T, Yakubov Y, Winn A, Sclafani A, Bodnar RJ.","Brain Res. 2010 Feb 26;1316:51-61. doi: 10.1016/j.brainres.2009.12.021. Epub 2009 Dec 22.","Dym CT","Brain Res","2010","2009/12/23","PMC2822056","NIHMS166457","10.1016/j.brainres.2009.12.021"
"20025367","A stress-coping profile of opioid dependent individuals entering naltrexone treatment: a comparison with healthy controls","Hyman SM, Hong KI, Chaplin TM, Dabre Z, Comegys AD, Kimmerling A, Sinha R.","Psychol Addict Behav. 2009 Dec;23(4):613-9. doi: 10.1037/a0017324.","Hyman SM","Psychol Addict Behav","2009","2009/12/23","PMC2802459","NIHMS154212","10.1037/a0017324"
"20014281","Enhanced skin permeation of naltrexone by pulsed electromagnetic fields in human skin in vitro","Krishnan G, Edwards J, Chen Y, Benson HA.","J Pharm Sci. 2010 Jun;99(6):2724-31. doi: 10.1002/jps.22024.","Krishnan G","J Pharm Sci","2010","2009/12/17","","","10.1002/jps.22024"
"20014017","Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient","Shannon A, Alkhouri N, Mayacy S, Kaplan B, Mahajan L.","Inflamm Bowel Dis. 2010 Sep;16(9):1457. doi: 10.1002/ibd.21185.","Shannon A","Inflamm Bowel Dis","2010","2009/12/17","","","10.1002/ibd.21185"
"20005975","Effect of opioid compounds on feeding and activity of the cockroach, Periplaneta americana","Cooper PD, Dennis SR, Woodman JD, Cowlings A, Donnelly C.","Comp Biochem Physiol C Toxicol Pharmacol. 2010 Apr;151(3):298-302. doi: 10.1016/j.cbpc.2009.12.002. Epub 2009 Dec 22.","Cooper PD","Comp Biochem Physiol C Toxicol Pharmacol","2010","2009/12/17","","","10.1016/j.cbpc.2009.12.002"
"19999169","PRODUCT: Embeda 20mg/0.8mg","Physician Assistant's Prescribing Reference.","JAAPA. 2009 Nov;22(11):12.","Physician Assistant's Prescribing Reference","JAAPA","2009","2009/12/17","","",""
"19997907","Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity","Gieryk A, Ziolkowska B, Solecki W, Kubik J, Przewlocki R.","Psychopharmacology (Berl). 2010 Feb;208(2):291-300. doi: 10.1007/s00213-009-1730-1. Epub 2009 Dec 9.","Gieryk A","Psychopharmacology (Berl)","2010","2009/12/10","","","10.1007/s00213-009-1730-1"
"19996949","Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor","Juni A, Cai M, Stankova M, Waxman AR, Arout C, Klein G, Dahan A, Hruby VJ, Mogil JS, Kest B.","Anesthesiology. 2010 Jan;112(1):181-8. doi: 10.1097/ALN.0b013e3181c53849.","Juni A","Anesthesiology","2010","2009/12/10","PMC4642894","NIHMS726374","10.1097/ALN.0b013e3181c53849"
"19995587","Synthesis and biological evaluation of cyclic endomorphin-2 analogs","Perlikowska R, do-Rego JC, Cravezic A, Fichna J, Wyrebska A, Toth G, Janecka A.","Peptides. 2010 Feb;31(2):339-45. doi: 10.1016/j.peptides.2009.12.002. Epub 2009 Dec 6.","Perlikowska R","Peptides","2010","2009/12/10","","","10.1016/j.peptides.2009.12.002"
"19969427","Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study","Gueorguieva R, Wu R, Donovan D, Rounsaville BJ, Couper D, Krystal JH, O'Malley SS.","Drug Alcohol Depend. 2010 Mar 1;107(2-3):221-9. doi: 10.1016/j.drugalcdep.2009.10.017. Epub 2009 Dec 6.","Gueorguieva R","Drug Alcohol Depend","2010","2009/12/09","PMC2821955","NIHMS158247","10.1016/j.drugalcdep.2009.10.017"
"19969014","Blunted opiate modulation of prolactin response in smoking men and women","Shaw D, al'Absi M.","Pharmacol Biochem Behav. 2010 Mar;95(1):1-5. doi: 10.1016/j.pbb.2009.11.016. Epub 2009 Dec 5.","Shaw D","Pharmacol Biochem Behav","2010","2009/12/09","PMC2834276","NIHMS168485","10.1016/j.pbb.2009.11.016"
"19953654","Delta opioid peptide DADLE and naltrexone cause cell cycle arrest and differentiation in a CNS neural progenitor cell line","Tsai SY, Lee CT, Hayashi T, Freed WJ, Su TP.","Synapse. 2010 Apr;64(4):267-73. doi: 10.1002/syn.20727.","Tsai SY","Synapse","2010","2009/12/03","PMC3155725","NIHMS314914","10.1002/syn.20727"
"19951296","Chronic naltrexone treatment and ethanol responsivity in outbred rats","Hill KG, Sable HJ, Ferraro Iii FM, Kiefer SW.","Alcohol Clin Exp Res. 2010 Feb;34(2):272-9. doi: 10.1111/j.1530-0277.2009.01090.x. Epub 2009 Nov 24.","Hill KG","Alcohol Clin Exp Res","2010","2009/12/03","","","10.1111/j.1530-0277.2009.01090.x"
"19946676","Determination of naltrexone and 6beta-naltrexol in human blood: comparison of high-performance liquid chromatography with spectrophotometric and tandem-mass-spectrometric detection","Brünen S, Krüger R, Finger S, Korf F, Kiefer F, Wiedemann K, Lackner KJ, Hiemke C.","Anal Bioanal Chem. 2010 Feb;396(3):1249-57. doi: 10.1007/s00216-009-3301-z. Epub 2009 Nov 28.","Brünen S","Anal Bioanal Chem","2010","2009/12/01","","","10.1007/s00216-009-3301-z"
"19945794","Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112","Hu E, Calò G, Guerrini R, Ko MC.","Pain. 2010 Jan;148(1):107-13. doi: 10.1016/j.pain.2009.10.026. Epub 2009 Nov 28.","Hu E","Pain","2010","2009/12/01","PMC2861283","NIHMS196261","10.1016/j.pain.2009.10.026"
"19945352","A prolonged protein kinase C-mediated, opioid-related antinociceptive effect of st John's Wort in mice","Galeotti N, Vivoli E, Bilia AR, Bergonzi MC, Bartolini A, Ghelardini C.","J Pain. 2010 Feb;11(2):149-59. doi: 10.1016/j.jpain.2009.06.013. Epub 2009 Nov 27.","Galeotti N","J Pain","2010","2009/12/01","","","10.1016/j.jpain.2009.06.013"
"19944650","ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety","Katz N, Sun S, Johnson F, Stauffer J.","J Pain. 2010 Apr;11(4):303-11. doi: 10.1016/j.jpain.2009.07.017. Epub 2009 Nov 27.","Katz N","J Pain","2010","2009/12/01","","","10.1016/j.jpain.2009.07.017"
"19934782","Combining functional magnetic resonance imaging with mouse genomics: new options in pain research","Heindl-Erdmann C, Axmann R, Kreitz S, Zwerina J, Penninger J, Schett G, Brune K, Hess A.","Neuroreport. 2010 Jan 6;21(1):29-33. doi: 10.1097/WNR.0b013e3283324faf.","Heindl-Erdmann C","Neuroreport","2010","2009/11/26","","","10.1097/WNR.0b013e3283324faf"
"19930235","Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation","Greenfield SF, Shields A, Connery HS, Livchits V, Yanov SA, Lastimoso CS, Strelis AK, Mishustin SP, Fitzmaurice G, Mathew TA, Shin S.","Alcohol Clin Exp Res. 2010 Feb;34(2):317-30. doi: 10.1111/j.1530-0277.2009.01094.x. Epub 2009 Nov 20.","Greenfield SF","Alcohol Clin Exp Res","2010","2009/11/26","PMC2898509","NIHMS205049","10.1111/j.1530-0277.2009.01094.x"
"19929573","Opioid-like activity of naltrexone on natural killer cell cytolytic activity and cytokine production in splenocytes: effects of alcohol","Boyadjieva NI, Sarkar DK.","J Interferon Cytokine Res. 2010 Jan;30(1):15-22. doi: 10.1089/jir.2009.0008.","Boyadjieva NI","J Interferon Cytokine Res","2010","2009/11/26","PMC3096475","","10.1089/jir.2009.0008"
"19926400","An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects","Wilcox CS, Oskooilar N, Erickson JS, Billes SK, Katz BB, Tollefson G, Dunayevich E.","Addict Behav. 2010 Mar;35(3):229-34. doi: 10.1016/j.addbeh.2009.10.017. Epub 2009 Oct 31.","Wilcox CS","Addict Behav","2010","2009/11/21","","","10.1016/j.addbeh.2009.10.017"
"19917212","Novel and emerging treatments for autism spectrum disorders: a systematic review","Rossignol DA.","Ann Clin Psychiatry. 2009 Oct-Dec;21(4):213-36.","Rossignol DA","Ann Clin Psychiatry","2009","2009/11/18","","",""
"19913193","Young Investigator Award symposium","Witkiewitz K, Holmes A, Ray LA, Murphy JG, Richardson HN, Chen YC, McDevitt-Murphy ME, Cruz MT, Roberto M.","Alcohol. 2009 Nov;43(7):499-508. doi: 10.1016/j.alcohol.2009.06.004.","Witkiewitz K","Alcohol","2009","2009/11/17","","","10.1016/j.alcohol.2009.06.004"
"19901212","Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus","Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ.","Arch Ophthalmol. 2009 Nov;127(11):1468-73. doi: 10.1001/archophthalmol.2009.270.","Zagon IS","Arch Ophthalmol","2009","2009/11/11","PMC2840396","NIHMS179032","10.1001/archophthalmol.2009.270"
"19898269","Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction","Baker DE.","Rev Gastroenterol Disord. 2009 Summer;9(3):E84-93.","Baker DE","Rev Gastroenterol Disord","2009","2009/11/10","","",""
"19895666","Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases","Hahn JW, Jagwani S, Kim E, Rendell VR, He J, Ezerskiy LA, Wesselschmidt R, Coscia CJ, Belcheva MM.","J Neurochem. 2010 Mar;112(6):1431-41. doi: 10.1111/j.1471-4159.2009.06479.x. Epub 2009 Nov 6.","Hahn JW","J Neurochem","2010","2009/11/10","PMC2856797","NIHMS159247","10.1111/j.1471-4159.2009.06479.x"
"19892550","A bivalent ligand (KMN-21) antagonist for mu/kappa heterodimeric opioid receptors","Zhang S, Yekkirala A, Tang Y, Portoghese PS.","Bioorg Med Chem Lett. 2009 Dec 15;19(24):6978-80. doi: 10.1016/j.bmcl.2009.10.045. Epub 2009 Nov 4.","Zhang S","Bioorg Med Chem Lett","2009","2009/11/07","PMC5060004","NIHMS157601","10.1016/j.bmcl.2009.10.045"
"19888784","Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-controlled, crossover study","Stauffer J, Setnik B, Sokolowska M, Romach M, Johnson F, Sellers E.","Clin Drug Investig. 2009;29(12):777-90. doi: 10.2165/11530800-000000000-00000.","Stauffer J","Clin Drug Investig","2009","2009/11/06","","","10.2165/11530800-000000000-00000"
"19882797","Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support","","Prescrire Int. 2009 Oct;18(103):222-3.","","Prescrire Int","2009","2009/11/04","","",""
"19878098","Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation","Wong GT, Li R, Jiang LL, Irwin MG.","Acta Anaesthesiol Scand. 2010 Apr;54(4):510-8. doi: 10.1111/j.1399-6576.2009.02145.x. Epub 2009 Oct 29.","Wong GT","Acta Anaesthesiol Scand","2010","2009/11/03","","","10.1111/j.1399-6576.2009.02145.x"
"19874153","High-dose naltrexone therapy for cocaine-alcohol dependence","Schmitz JM, Lindsay JA, Green CE, Herin DV, Stotts AL, Moeller FG.","Am J Addict. 2009 Sep-Oct;18(5):356-62. doi: 10.3109/10550490903077929.","Schmitz JM","Am J Addict","2009","2009/10/31","PMC2907651","NIHMS196684","10.3109/10550490903077929"
"19864633","Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking","Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D, Hnasko TS, Palmiter RD, Chavkin C.","Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19168-73. doi: 10.1073/pnas.0910705106. Epub 2009 Oct 28.","Land BB","Proc Natl Acad Sci U S A","2009","2009/10/30","PMC2776420","","10.1073/pnas.0910705106"
"19859697","Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms","Rüedi-Bettschen D, Rowlett JK, Spealman RD, Platt DM.","Psychopharmacology (Berl). 2010 Jun;210(2):169-77. doi: 10.1007/s00213-009-1705-2. Epub 2009 Oct 27.","Rüedi-Bettschen D","Psychopharmacology (Berl)","2010","2009/10/28","PMC2866039","NIHMS151436","10.1007/s00213-009-1705-2"
"19855354","Two patients with eating disorders treated by naltrexone","Kmoch V, Papezova H, Yamamotova A.","Neuro Endocrinol Lett. 2009;30(3):327-30.","Kmoch V","Neuro Endocrinol Lett","2009","2009/10/27","","",""
"19855075","Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis","Zagon IS, Rahn KA, Turel AP, McLaughlin PJ.","Exp Biol Med (Maywood). 2009 Nov;234(11):1383-92. doi: 10.3181/0906-RM-189.","Zagon IS","Exp Biol Med (Maywood)","2009","2009/10/27","","","10.3181/0906-RM-189"
"19853024","Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits","Zagon IS, Sassani JW, Carroll MA, McLaughlin PJ.","Brain Res Bull. 2010 Feb 15;81(2-3):248-55. doi: 10.1016/j.brainresbull.2009.10.009. Epub 2009 Oct 21.","Zagon IS","Brain Res Bull","2010","2009/10/27","PMC2815253","NIHMS153984","10.1016/j.brainresbull.2009.10.009"
"19846734","Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo","Greenway FL, Dunayevich E, Tollefson G, Erickson J, Guttadauria M, Fujioka K, Cowley MA; NB-201 Study Group.","J Clin Endocrinol Metab. 2009 Dec;94(12):4898-906. doi: 10.1210/jc.2009-1350. Epub 2009 Oct 21.","Greenway FL","J Clin Endocrinol Metab","2009","2009/10/23","","","10.1210/jc.2009-1350"
"19843777","Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion","Gross ER, Hsu AK, Gross GJ.","Anesth Analg. 2009 Nov;109(5):1395-402. doi: 10.1213/ANE.0b013e3181b92201.","Gross ER","Anesth Analg","2009","2009/10/22","PMC2877584","NIHMS202493","10.1213/ANE.0b013e3181b92201"
"19840789","Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain","Yalcin I, Tessier LH, Petit-Demoulière N, Waltisperger E, Hein L, Freund-Mercier MJ, Barrot M.","Exp Neurol. 2010 Jan;221(1):115-21. doi: 10.1016/j.expneurol.2009.10.008. Epub 2009 Oct 17.","Yalcin I","Exp Neurol","2010","2009/10/21","","","10.1016/j.expneurol.2009.10.008"
"19837518","Acute HPA axis response to naltrexone differs in female vs. male smokers","Roche DJ, Childs E, Epstein AM, King AC.","Psychoneuroendocrinology. 2010 May;35(4):596-606. doi: 10.1016/j.psyneuen.2009.09.016. Epub 2009 Oct 17.","Roche DJ","Psychoneuroendocrinology","2010","2009/10/20","PMC2843791","NIHMS149273","10.1016/j.psyneuen.2009.09.016"
"19834993","Pharmacotherapy of addictive disorders","Ross S, Peselow E.","Clin Neuropharmacol. 2009 Sep-Oct;32(5):277-89. doi: 10.1097/wnf.0b013e3181a91655.","Ross S","Clin Neuropharmacol","2009","2009/10/17","","","10.1097/wnf.0b013e3181a91655"
"19831162","Long-term use of methylnaltrexone for the management of constipation in advanced cancer","Dutka J, Lowe SS, Michaud M, Watanabe S.","J Support Oncol. 2009 Sep-Oct;7(5):177-9.","Dutka J","J Support Oncol","2009","2009/10/17","","",""
"19822541","Dehydration-induced modulation of kappa-opioid inhibition of vasopressin neurone activity","Scott V, Bishop VR, Leng G, Brown CH.","J Physiol. 2009 Dec 1;587(Pt 23):5679-89. doi: 10.1113/jphysiol.2009.180232. Epub 2009 Oct 12.","Scott V","J Physiol","2009","2009/10/14","PMC2805378","","10.1113/jphysiol.2009.180232"
"19822132","The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake","Pritchett CE, Pardee AL, McGuirk SR, Will MJ.","Brain Res. 2010 Jan 8;1306:85-92. doi: 10.1016/j.brainres.2009.09.115. Epub 2009 Oct 12.","Pritchett CE","Brain Res","2010","2009/10/14","PMC4443807","NIHMS692539","10.1016/j.brainres.2009.09.115"
"19821290","Opioid antagonists with minimal sedation for opioid withdrawal","Gowing L, Ali R, White JM.","Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002021. doi: 10.1002/14651858.CD002021.pub3.","Gowing L","Cochrane Database Syst Rev","2009","2009/10/13","","","10.1002/14651858.CD002021.pub3"
"19819313","Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats","Chevillard L, Mégarbane B, Risède P, Baud FJ.","Toxicol Lett. 2009 Dec 15;191(2-3):327-40. doi: 10.1016/j.toxlet.2009.09.017. Epub 2009 Oct 9.","Chevillard L","Toxicol Lett","2009","2009/10/13","","","10.1016/j.toxlet.2009.09.017"
"19817669","Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness","Diego L, Atayee R, Helmons P, von Gunten CF.","Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):473-85. doi: 10.1586/egh.09.42.","Diego L","Expert Rev Gastroenterol Hepatol","2009","2009/10/13","","","10.1586/egh.09.42"
"19809318","Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance","Palomba S, Falbo A, Zullo F.","Curr Opin Obstet Gynecol. 2009 Dec;21(6):465-73. doi: 10.1097/GCO.0b013e328332d188.","Palomba S","Curr Opin Obstet Gynecol","2009","2009/10/08","","","10.1097/GCO.0b013e328332d188"
"19806909","[Pharmacokinetics of 6beta-naltrexol after single and multiple intramuscular injections in Beagle dogs]","Yan LD, Liu J, Dong HJ, Cui MX, Yao XJ, Liu YS, Gong ZH, Gong ZH.","Yao Xue Xue Bao. 2009 Jul;44(7):722-5.","Yan LD","Yao Xue Xue Bao","2009","2009/10/08","","",""
"19806051","Chronic upregulation of the endogenous opioid system impairs the skin flap survival in rats","Nezami BG, Talab SS, Emami H, Assa S, Rasouli MR, Asadi S, Tavangar SM, Dehpour AR.","Ann Plast Surg. 2009 Nov;63(5):558-63. doi: 10.1097/SAP.0b013e31818d458e.","Nezami BG","Ann Plast Surg","2009","2009/10/07","","","10.1097/SAP.0b013e31818d458e"
"19805701","Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone","Hulse GK, Morris N, Arnold-Reed D, Tait RJ.","Arch Gen Psychiatry. 2009 Oct;66(10):1108-15. doi: 10.1001/archgenpsychiatry.2009.130.","Hulse GK","Arch Gen Psychiatry","2009","2009/10/07","","","10.1001/archgenpsychiatry.2009.130"
"19800397","Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value","Riba P, Friedmann T, Király KP, Al-Khrasani M, Sobor M, Asim MF, Spetea M, Schmidhammer H, Furst S.","Brain Res Bull. 2010 Jan 15;81(1):178-84. doi: 10.1016/j.brainresbull.2009.09.011.","Riba P","Brain Res Bull","2010","2009/10/06","","","10.1016/j.brainresbull.2009.09.011"
"19785977","The genetics of alcoholism","Stacey D, Clarke TK, Schumann G.","Curr Psychiatry Rep. 2009 Oct;11(5):364-9. doi: 10.1007/s11920-009-0055-4.","Stacey D","Curr Psychiatry Rep","2009","2009/09/30","","","10.1007/s11920-009-0055-4"
"19783223","A single nitrous oxide (N2O) exposure leads to persistent alleviation of neuropathic pain in rats","Bessière B, Laboureyras E, Chateauraynaud J, Laulin JP, Simonnet G.","J Pain. 2010 Jan;11(1):13-23. doi: 10.1016/j.jpain.2009.05.003. Epub 2009 Sep 26.","Bessière B","J Pain","2010","2009/09/29","","","10.1016/j.jpain.2009.05.003"
"19783106","Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence","Plebani JG, Tirado CF, Pettinati HM, Kampman KM, Volpicelli JR, Oslin DW.","Addict Behav. 2010 Feb;35(2):123-8. doi: 10.1016/j.addbeh.2009.09.012. Epub 2009 Sep 10.","Plebani JG","Addict Behav","2010","2009/09/29","PMC2784285","NIHMS144967","10.1016/j.addbeh.2009.09.012"
"19777400","Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity","Padwal R.","Curr Opin Investig Drugs. 2009 Oct;10(10):1117-25.","Padwal R","Curr Opin Investig Drugs","2009","2009/09/25","","",""
"19773693","Effectiveness of two opioid antagonists in treating opioid-induced constipation","Healy R.","Br J Nurs. 2009 Sep 10-23;18(16):998-1002. doi: 10.12968/bjon.2009.18.16.43969.","Healy R","Br J Nurs","2009","2009/09/24","","","10.12968/bjon.2009.18.16.43969"
"19764344","Association of increased pain threshold by noise with central opioid neurons","Chen YF, Chiang HM, Tsai YT, Tsai HY.","Chin J Physiol. 2009 Apr 30;52(2):93-8.","Chen YF","Chin J Physiol","2009","2009/09/22","","",""
"19762760","The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model","Mecs L, Tuboly G, Nagy E, Benedek G, Horvath G.","Anesth Analg. 2009 Oct;109(4):1297-304. doi: 10.1213/ane.0b013e3181b21c5e.","Mecs L","Anesth Analg","2009","2009/09/19","","","10.1213/ane.0b013e3181b21c5e"
"19748538","Feeding association between the nucleus of the solitary tract and the ventral tegmental area","Kim EM, Quinn JG, Spanswick D, O'Hare E.","Appetite. 2009 Dec;53(3):457-60. doi: 10.1016/j.appet.2009.09.003. Epub 2009 Sep 11.","Kim EM","Appetite","2009","2009/09/15","","","10.1016/j.appet.2009.09.003"
"19748082","Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus","Barr CS, Chen SA, Schwandt ML, Lindell SG, Sun H, Suomi SJ, Heilig M.","Biol Psychiatry. 2010 Jan 1;67(1):78-80. doi: 10.1016/j.biopsych.2009.07.026.","Barr CS","Biol Psychiatry","2010","2009/09/15","PMC2794913","NIHMS146095","10.1016/j.biopsych.2009.07.026"
"19744765","Evaluation of the tocolytic effect of morphine in a mouse model of lipopolysaccharide-induced preterm delivery: the role of nitric oxide","Javadi-Paydar M, Lesani A, Vakilipour R, Ghazi P, Tavangar SM, Hantoushzadeh S, Norouzi A, Dehpour AR.","Eur J Obstet Gynecol Reprod Biol. 2009 Dec;147(2):166-72. doi: 10.1016/j.ejogrb.2009.08.014. Epub 2009 Sep 9.","Javadi-Paydar M","Eur J Obstet Gynecol Reprod Biol","2009","2009/09/12","","","10.1016/j.ejogrb.2009.08.014"
"19743572","Methylnaltrexone: new drug. Opiate-induced constipation: barely more effective than placebo","","Prescrire Int. 2009 Aug;18(102):158.","","Prescrire Int","2009","2009/09/12","","",""
"19736901","Methylnaltrexone reduced body weight gain in ob/ob mice","Yuan CS, Wang CZ, Attele A, Zhang L.","J Opioid Manag. 2009 Jul-Aug;5(4):213-8. doi: 10.5055/jom.2009.0023.","Yuan CS","J Opioid Manag","2009","2009/09/10","","","10.5055/jom.2009.0023"
"19729051","The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway","Mabrouk OS, Marti M, Salvadori S, Morari M.","Neuroscience. 2009 Dec 1;164(2):360-9. doi: 10.1016/j.neuroscience.2009.08.058. Epub 2009 Sep 1.","Mabrouk OS","Neuroscience","2009","2009/09/05","","","10.1016/j.neuroscience.2009.08.058"
"19728455","[Preventing weight gain in smoking cessation: there is no miracle solution]","Nanchen D, Willi C, Peytremann-Bridevaux I, Burnand B, Walther MR.","Rev Med Suisse. 2009 Aug 5;5(212):1577.","Nanchen D","Rev Med Suisse","2009","2009/09/05","","",""
"19724193","Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions","Corwin RL, Wojnicki FH.","Behav Pharmacol. 2009 Sep;20(5-6):537-48. doi: 10.1097/FBP.0b013e3283313168.","Corwin RL","Behav Pharmacol","2009","2009/09/03","","","10.1097/FBP.0b013e3283313168"
"19723567","Possible involvement of the hypothalamic pro-opiomelanocortin gene and beta-endorphin expression on acute morphine withdrawal development","Seo YJ, Kwon MS, Choi SM, Lee JK, Park SH, Jung JS, Sim YB, Suh HW.","Brain Res Bull. 2009 Dec 16;80(6):359-70. doi: 10.1016/j.brainresbull.2009.08.020. Epub 2009 Aug 31.","Seo YJ","Brain Res Bull","2009","2009/09/03","","","10.1016/j.brainresbull.2009.08.020"
"19717248","Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study","Ray LA, Oslin DW.","Drug Alcohol Depend. 2009 Dec 1;105(3):256-8. doi: 10.1016/j.drugalcdep.2009.07.006. Epub 2009 Aug 29.","Ray LA","Drug Alcohol Depend","2009","2009/09/01","PMC3409877","NIHMS138088","10.1016/j.drugalcdep.2009.07.006"
"19713070","Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness","Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ.","J Pain Symptom Manage. 2009 Nov;38(5):683-90. doi: 10.1016/j.jpainsymman.2009.02.234. Epub 2009 Aug 26.","Chamberlain BH","J Pain Symptom Manage","2009","2009/08/29","","","10.1016/j.jpainsymman.2009.02.234"
"19708041","Regional Fos expression induced by morphine withdrawal in the 7-day-old rat","McPhie AA, Barr GA.","Dev Psychobiol. 2009 Nov;51(7):544-52. doi: 10.1002/dev.20392.","McPhie AA","Dev Psychobiol","2009","2009/08/27","PMC6040917","NIHMS977051","10.1002/dev.20392"
"19692854","Trichotillomania across the life span","Bloch MH.","J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):879-883. doi: 10.1097/CHI.0b013e3181ae09f3.","Bloch MH","J Am Acad Child Adolesc Psychiatry","2009","2009/08/21","","","10.1097/CHI.0b013e3181ae09f3"
"19690895","[Methylnaltrexone. A new approach for therapy of opioid-induced obstipation]","Chappell D, Conzen P.","Schmerz. 2009 Oct;23(5):471-8. doi: 10.1007/s00482-009-0824-3.","Chappell D","Schmerz","2009","2009/08/20","","","10.1007/s00482-009-0824-3"
"19686472","Roles of opioid receptor subtypes in mediating alcohol-seeking induced by discrete cues and context","Marinelli PW, Funk D, Harding S, Li Z, Juzytsch W, Lê AD.","Eur J Neurosci. 2009 Aug;30(4):671-8. doi: 10.1111/j.1460-9568.2009.06851.x. Epub 2009 Aug 3.","Marinelli PW","Eur J Neurosci","2009","2009/08/19","PMC2772149","NIHMS147730","10.1111/j.1460-9568.2009.06851.x"
"19683562","Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review","McLaughlin PJ, Sassani JW, Klocek MS, Zagon IS.","Brain Res Bull. 2010 Feb 15;81(2-3):236-47. doi: 10.1016/j.brainresbull.2009.08.008. Epub 2009 Aug 14.","McLaughlin PJ","Brain Res Bull","2010","2009/08/18","PMC2852609","NIHMS180230","10.1016/j.brainresbull.2009.08.008"
"19683449","Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation","Ghirmai S, Azar MR, Cashman JR.","Bioorg Med Chem. 2009 Sep 15;17(18):6671-81. doi: 10.1016/j.bmc.2009.07.069. Epub 2009 Aug 6.","Ghirmai S","Bioorg Med Chem","2009","2009/08/18","PMC2915928","NIHMS222674","10.1016/j.bmc.2009.07.069"
"19682793","Endogenous opioids may buffer effects of anger arousal on sensitivity to subsequent pain","Burns JW, Bruehl S, Chung OY, Magid E, Chont M, Goodlad JK, Gilliam W, Matsuura J, Somar K.","Pain. 2009 Dec;146(3):276-82. doi: 10.1016/j.pain.2009.07.024. Epub 2009 Aug 13.","Burns JW","Pain","2009","2009/08/18","PMC4180294","NIHMS160968","10.1016/j.pain.2009.07.024"
"19675283","Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers","Zagon IS, Donahue RN, McLaughlin PJ.","Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1154-61. doi: 10.1152/ajpregu.00414.2009. Epub 2009 Aug 12.","Zagon IS","Am J Physiol Regul Integr Comp Physiol","2009","2009/08/14","","","10.1152/ajpregu.00414.2009"
"19673746","A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence","Brown ES, Carmody TJ, Schmitz JM, Caetano R, Adinoff B, Swann AC, John Rush A.","Alcohol Clin Exp Res. 2009 Nov;33(11):1863-9. doi: 10.1111/j.1530-0277.2009.01024.x. Epub 2009 Aug 10.","Brown ES","Alcohol Clin Exp Res","2009","2009/08/14","PMC3040070","NIHMS267605","10.1111/j.1530-0277.2009.01024.x"
"19671461","Opioid antagonists block the acquisition of ethanol-mediated conditioned tactile preference in infant rats","Nizhnikov ME, Pautassi RM, Truxell E, Spear NE.","Alcohol. 2009 Aug;43(5):347-58. doi: 10.1016/j.alcohol.2009.06.001.","Nizhnikov ME","Alcohol","2009","2009/08/13","PMC2726826","NIHMS128064","10.1016/j.alcohol.2009.06.001"
"19670554","Treatment of alcohol dependence","Hanwella R, de Silva V.","Ceylon Med J. 2009 Jun;54(2):63-5. doi: 10.4038/cmj.v54i2.877.","Hanwella R","Ceylon Med J","2009","2009/08/13","","","10.4038/cmj.v54i2.877"
"19661297","Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells","Wang CZ, Li XL, Sun S, Xie JT, Aung HH, Tong R, McEntee E, Yuan CS.","Anticancer Res. 2009 Aug;29(8):2927-32.","Wang CZ","Anticancer Res","2009","2009/08/08","","",""
"19657356","Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin","Andoh T, Saito A, Kuraishi Y.","J Invest Dermatol. 2009 Dec;129(12):2854-60. doi: 10.1038/jid.2009.155. Epub 2009 Aug 6.","Andoh T","J Invest Dermatol","2009","2009/08/07","","","10.1038/jid.2009.155"
"19656202","P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone","Kanaan M, Daali Y, Dayer P, Desmeules J.","Fundam Clin Pharmacol. 2009 Oct;23(5):543-8. doi: 10.1111/j.1472-8206.2009.00724.x. Epub 2009 Jul 28.","Kanaan M","Fundam Clin Pharmacol","2009","2009/08/07","","","10.1111/j.1472-8206.2009.00724.x"
"19650155","Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy","Messinis L, Lyros E, Andrian V, Katsakiori P, Panagis G, Georgiou V, Papathanasopoulos P.","Hum Psychopharmacol. 2009 Oct;24(7):524-31. doi: 10.1002/hup.1050.","Messinis L","Hum Psychopharmacol","2009","2009/08/04","","","10.1002/hup.1050"
"19647365","The importance of emotional processes in the modulation of pain","Rhudy JL.","Pain. 2009 Dec;146(3):233-4. doi: 10.1016/j.pain.2009.07.003. Epub 2009 Jul 31.","Rhudy JL","Pain","2009","2009/08/04","","","10.1016/j.pain.2009.07.003"
"19639303","Extended naltrexone and broad spectrum treatment or motivational enhancement therapy","Longabaugh R, Wirtz PW, Gulliver SB, Davidson D.","Psychopharmacology (Berl). 2009 Oct;206(3):367-76. doi: 10.1007/s00213-009-1615-3. Epub 2009 Jul 29.","Longabaugh R","Psychopharmacology (Berl)","2009","2009/07/30","","","10.1007/s00213-009-1615-3"
"19636536","The peripheral administration of a nitric oxide donor potentiates the local antinociceptive effects of a DOR agonist during chronic inflammatory pain in mice","Hervera A, Leánez S, Negrete R, Pol O.","Naunyn Schmiedebergs Arch Pharmacol. 2009 Oct;380(4):345-52. doi: 10.1007/s00210-009-0436-6. Epub 2009 Jul 28.","Hervera A","Naunyn Schmiedebergs Arch Pharmacol","2009","2009/07/29","","","10.1007/s00210-009-0436-6"
"19634953","Appetitive motivational experience during adolescence results in enhanced alcohol consumption during adulthood","Walker BM, Ehlers CL.","Behav Neurosci. 2009 Aug;123(4):926-35. doi: 10.1037/a0016002.","Walker BM","Behav Neurosci","2009","2009/07/29","PMC2787447","NIHMS154083","10.1037/a0016002"
"19630726","Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review","Soyka M, Rösner S.","Curr Drug Abuse Rev. 2008 Nov;1(3):280-91. doi: 10.2174/1874473710801030280.","Soyka M","Curr Drug Abuse Rev","2008","2009/07/28","","","10.2174/1874473710801030280"
"19624329","Topiramate: 'small is beautiful'?","Shah R, Basu D.","Addiction. 2009 Aug;104(8):1428. doi: 10.1111/j.1360-0443.2009.02618.x.","Shah R","Addiction","2009","2009/07/24","","","10.1111/j.1360-0443.2009.02618.x"
"19621272","Effects of dehydroepiandrosterone sulfate on the conversion of corticosterone into 11-dehydrocorticosterone in stress: a regulatory scheme","Obut TA, Ovsyukova MV, Dement'eva TY, Cherkasova OP, Saryg SK, Grigor'eva TA.","Neurosci Behav Physiol. 2009 Sep;39(7):695-9. doi: 10.1007/s11055-009-9179-6. Epub 2009 Jul 21.","Obut TA","Neurosci Behav Physiol","2009","2009/07/22","","","10.1007/s11055-009-9179-6"
"19619521","Role of large-conductance Ca(2+) -activated potassium channels in adenosine A(1) receptor-mediated pharmacological preconditioning in H9c2 cells","Fretwell L, Dickenson JM.","Eur J Pharmacol. 2009 Sep 15;618(1-3):37-44. doi: 10.1016/j.ejphar.2009.07.008. Epub 2009 Jul 18.","Fretwell L","Eur J Pharmacol","2009","2009/07/22","","","10.1016/j.ejphar.2009.07.008"
"19619518","Delta opioid agonist [D-Ala2, D-Leu5] enkephalin (DADLE) reduced oxygen-glucose deprivation caused neuronal injury through the MAPK pathway","Ke S, Dian-san S, Xiang-rui W.","Brain Res. 2009 Oct 6;1292:100-6. doi: 10.1016/j.brainres.2009.06.104. Epub 2009 Jul 18.","Ke S","Brain Res","2009","2009/07/22","","","10.1016/j.brainres.2009.06.104"
"19617648","Lack of effect of naltrindole on the spinal synergism of morphine and non-steroidal anti-inflammatory drugs (NSAIDS)","Miranda HF, Pinardi G.","J Physiol Pharmacol. 2009 Jun;60(2):71-6.","Miranda HF","J Physiol Pharmacol","2009","2009/07/21","","",""
"19608010","Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist","Rong F, Peng Z, Ye MX, Zhang QY, Zhao Y, Zhang SM, Guo HT, Hui B, Wang YM, Liang C, Gu CH, Tao C, Cui Q, Yu SQ, Yi DH, Pei JM.","Arch Med Res. 2009 May;40(4):227-34. doi: 10.1016/j.arcmed.2009.04.009.","Rong F","Arch Med Res","2009","2009/07/18","","","10.1016/j.arcmed.2009.04.009"
"19605844","Methylnaltrexone","Hendrikx JJ, Beijnen JH, Schellens JH.","Oncologist. 2009 Jul;14(7):679-82. doi: 10.1634/theoncologist.2009-0049. Epub 2009 Jul 15.","Hendrikx JJ","Oncologist","2009","2009/07/17","","","10.1634/theoncologist.2009-0049"
"19605761","Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation","Cheng F, McLaughlin PJ, Banks WA, Zagon IS.","Am J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R844-52. doi: 10.1152/ajpregu.00311.2009. Epub 2009 Jul 15.","Cheng F","Am J Physiol Regul Integr Comp Physiol","2009","2009/07/17","","","10.1152/ajpregu.00311.2009"
"19595518","Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients","Baltieri DA, Daró FR, Ribeiro PL, Andrade AG.","Drug Alcohol Depend. 2009 Nov 1;105(1-2):33-41. doi: 10.1016/j.drugalcdep.2009.05.025.","Baltieri DA","Drug Alcohol Depend","2009","2009/07/15","","","10.1016/j.drugalcdep.2009.05.025"
"19593174","Targeted naltrexone for problem drinkers","Kranzler HR, Tennen H, Armeli S, Chan G, Covault J, Arias A, Oncken C.","J Clin Psychopharmacol. 2009 Aug;29(4):350-7. doi: 10.1097/JCP.0b013e3181ac5213.","Kranzler HR","J Clin Psychopharmacol","2009","2009/07/14","PMC3184851","NIHMS319318","10.1097/JCP.0b013e3181ac5213"
"19592350","College student receptiveness to various alcohol treatment options","Epler AJ, Sher KJ, Loomis TB, O'Malley SS.","J Am Coll Health. 2009 Jul-Aug;58(1):26-32. doi: 10.3200/JACH.58.1.26-32.","Epler AJ","J Am Coll Health","2009","2009/07/14","PMC2818496","NIHMS159663","10.3200/JACH.58.1.26-32"
"19591067","Patient and provider attitudes towards monitored naltrexone treatment of alcohol dependence in schizophrenia","Leontieva L, Dimmock J, Cavallerano M, DeRycke S, Meszaros Z, Carey K, Ploutz-Snyder R, Batki SL.","Am J Drug Alcohol Abuse. 2009;35(5):273-8. doi: 10.1080/00952990902939727.","Leontieva L","Am J Drug Alcohol Abuse","2009","2009/07/11","PMC4651625","NIHMS708672","10.1080/00952990902939727"
"19585396","Atypical anorexia in a male patient accompanied by strong obsessive-compulsive symptoms successfully treated with naltrexone","Gade K, Häussinger C, Bandelow B.","Pharmacopsychiatry. 2009 Jul;42(4):164-5. doi: 10.1055/s-0028-1128114. Epub 2009 Jul 7.","Gade K","Pharmacopsychiatry","2009","2009/07/09","","","10.1055/s-0028-1128114"
"19585156","[Successful treatment of treatment-resistant opioid-induced constipation in a patient with incomplete paraplegia with methylnaltrexone]","Lux EA.","Schmerz. 2009 Oct;23(5):523-4. doi: 10.1007/s00482-009-0820-7.","Lux EA","Schmerz","2009","2009/07/09","","","10.1007/s00482-009-0820-7"
"19583969","6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice","Yancey-Wrona JE, Raymond TJ, Mercer HK, Sadée W, Bilsky EJ.","Life Sci. 2009 Sep 9;85(11-12):413-20. doi: 10.1016/j.lfs.2009.06.016. Epub 2009 Jul 5.","Yancey-Wrona JE","Life Sci","2009","2009/07/09","","","10.1016/j.lfs.2009.06.016"
"19583062","Preventing paralytic ileus: can the anesthesiologist help","Frost EA.","Middle East J Anaesthesiol. 2009 Jun;20(2):159-65.","Frost EA","Middle East J Anaesthesiol","2009","2009/07/09","","",""
"19581571","Questionable efficacy for naltrexone in patients with Asp40","Mattes JA.","Arch Gen Psychiatry. 2009 Jul;66(7):796; author reply 796-7. doi: 10.1001/archgenpsychiatry.2009.68.","Mattes JA","Arch Gen Psychiatry","2009","2009/07/08","","","10.1001/archgenpsychiatry.2009.68"
"19577903","The antinociceptive properties of reboxetine in acute pain","Schreiber S, Frishtick R, Volis I, Rubovitch V, Pick CG, Weizman R.","Eur Neuropsychopharmacol. 2009 Oct;19(10):735-9. doi: 10.1016/j.euroneuro.2009.06.004. Epub 2009 Jul 5.","Schreiber S","Eur Neuropsychopharmacol","2009","2009/07/07","","","10.1016/j.euroneuro.2009.06.004"
"19576910","Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides","Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T.","Neuropharmacology. 2010 Jan;58(1):286-96. doi: 10.1016/j.neuropharm.2009.06.030. Epub 2009 Jul 2.","Tamim MK","Neuropharmacology","2010","2009/07/07","","","10.1016/j.neuropharm.2009.06.030"
"19576213","Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats","Klocek MS, Sassani JW, McLaughlin PJ, Zagon IS.","Exp Eye Res. 2009 Nov;89(5):686-92. doi: 10.1016/j.exer.2009.06.010. Epub 2009 Jul 1.","Klocek MS","Exp Eye Res","2009","2009/07/07","PMC2757498","NIHMS129338","10.1016/j.exer.2009.06.010"
"19559544","Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice","Shin EJ, Jang CG, Bing G, Park DH, Oh CH, Koo KH, Oh KW, Yamada K, Nabeshima T, Kim HC.","Drug Alcohol Depend. 2009 Sep 1;104(1-2):175-84. doi: 10.1016/j.drugalcdep.2009.05.015. Epub 2009 Jun 25.","Shin EJ","Drug Alcohol Depend","2009","2009/06/30","","","10.1016/j.drugalcdep.2009.05.015"
"19559072","Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice","Waxman AR, Arout C, Caldwell M, Dahan A, Kest B.","Neurosci Lett. 2009 Oct 2;462(1):68-72. doi: 10.1016/j.neulet.2009.06.061. Epub 2009 Jun 24.","Waxman AR","Neurosci Lett","2009","2009/06/30","","","10.1016/j.neulet.2009.06.061"
"19555139","New drug update: 2008","Hussar DA.","Consult Pharm. 2009 Apr;24(4):268-70, 273-80. doi: 10.4140/tcp.n.2009.268.","Hussar DA","Consult Pharm","2009","2009/06/27","","","10.4140/tcp.n.2009.268"
"19555136","Methylnaltrexone methobromide: the first peripherally active, centrally inactive opioid receptor-antagonist","Guay DR.","Consult Pharm. 2009 Mar;24(3):210-26. doi: 10.4140/tcp.n.2009.210.","Guay DR","Consult Pharm","2009","2009/06/27","","","10.4140/tcp.n.2009.210"
"19551457","Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study","Kasture S, Vinci S, Ibba F, Puddu A, Marongiu M, Murali B, Pisanu A, Lecca D, Zernig G, Acquas E.","Neurotox Res. 2009 Nov;16(4):343-55. doi: 10.1007/s12640-009-9069-2. Epub 2009 Jun 24.","Kasture S","Neurotox Res","2009","2009/06/25","","","10.1007/s12640-009-9069-2"
"19549515","Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5'-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence","Inan S, Dun NJ, Cowan A.","Eur J Pharmacol. 2009 Aug 15;616(1-3):141-6. doi: 10.1016/j.ejphar.2009.06.026. Epub 2009 Jun 21.","Inan S","Eur J Pharmacol","2009","2009/06/25","PMC2735214","NIHMS126627","10.1016/j.ejphar.2009.06.026"
"19537999","Naltrexone for the treatment of obesity: review and update","Lee MW, Fujioka K.","Expert Opin Pharmacother. 2009 Aug;10(11):1841-5. doi: 10.1517/14656560903048959.","Lee MW","Expert Opin Pharmacother","2009","2009/06/23","","","10.1517/14656560903048959"
"19531698","An overview of constipation and newer therapies","Enck RE.","Am J Hosp Palliat Care. 2009 Jun-Jul;26(3):157-8. doi: 10.1177/1049909109337298.","Enck RE","Am J Hosp Palliat Care","2009","2009/06/18","","","10.1177/1049909109337298"
"19531382","Role of the opioid system in incentive downshift situations","Daniel AM, Ortega LA, Papini MR.","Neurobiol Learn Mem. 2009 Oct;92(3):439-50. doi: 10.1016/j.nlm.2009.06.003. Epub 2009 Jun 14.","Daniel AM","Neurobiol Learn Mem","2009","2009/06/18","","","10.1016/j.nlm.2009.06.003"
"19524022","Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice","Inan S, Dun NJ, Cowan A.","Neuroscience. 2009 Sep 29;163(1):23-33. doi: 10.1016/j.neuroscience.2009.06.016. Epub 2009 Jun 10.","Inan S","Neuroscience","2009","2009/06/16","PMC2735087","NIHMS130049","10.1016/j.neuroscience.2009.06.016"
"19523380","Central administration of somatostatin stimulates feeding behavior in chicks","Tachibana T, Cline MA, Sugahara K, Ueda H, Hiramatsu K.","Gen Comp Endocrinol. 2009 May;161(3):354-9. doi: 10.1016/j.ygcen.2009.01.022. Epub 2009 Feb 1.","Tachibana T","Gen Comp Endocrinol","2009","2009/06/16","","","10.1016/j.ygcen.2009.01.022"
"19523167","Central adiponectin functions to inhibit arginine vasopressin release in conscious rats","Iwama S, Sugimura Y, Murase T, Hiroi M, Goto M, Hayashi M, Arima H, Oiso Y.","J Neuroendocrinol. 2009 Sep;21(9):753-9. doi: 10.1111/j.1365-2826.2009.01894.x. Epub 2009 Jun 12.","Iwama S","J Neuroendocrinol","2009","2009/06/16","","","10.1111/j.1365-2826.2009.01894.x"
"19523047","Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators","Ooteman W, Naassila M, Koeter MW, Verheul R, Schippers GM, Houchi H, Daoust M, van den Brink W.","Addict Biol. 2009 Jul;14(3):328-37. doi: 10.1111/j.1369-1600.2009.00159.x.","Ooteman W","Addict Biol","2009","2009/06/16","","","10.1111/j.1369-1600.2009.00159.x"
"19523041","Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice","Belkaï E, Scherrmann JM, Noble F, Marie-Claire C.","Addict Biol. 2009 Jul;14(3):245-52. doi: 10.1111/j.1369-1600.2009.00156.x.","Belkaï E","Addict Biol","2009","2009/06/16","PMC2922624","HALMS416565","10.1111/j.1369-1600.2009.00156.x"
"19520121","The unconditioned fear produced by morphine withdrawal is regulated by mu- and kappa-opioid receptors in the midbrain tectum","De Ross J, Avila MA, Ruggiero RN, Nobre MJ, Brandão ML, Castilho VM.","Behav Brain Res. 2009 Dec 1;204(1):140-6. doi: 10.1016/j.bbr.2009.05.033. Epub 2009 Jun 9.","De Ross J","Behav Brain Res","2009","2009/06/13","","","10.1016/j.bbr.2009.05.033"
"19515305","Counselor attitudes toward pharmacotherapies for alcohol dependence","Abraham AJ, Ducharme LJ, Roman PM.","J Stud Alcohol Drugs. 2009 Jul;70(4):628-35. doi: 10.15288/jsad.2009.70.628.","Abraham AJ","J Stud Alcohol Drugs","2009","2009/06/12","PMC2696303","","10.15288/jsad.2009.70.628"
"19506836","Selective mu- and kappa-opioid receptor antagonists administered into the nucleus accumbens interfere with rapid tolerance to ethanol in rats","Varaschin RK, Morato GS.","Psychopharmacology (Berl). 2009 Sep;206(1):85-96. doi: 10.1007/s00213-009-1582-8. Epub 2009 Jun 9.","Varaschin RK","Psychopharmacology (Berl)","2009","2009/06/10","","","10.1007/s00213-009-1582-8"
"19505486","Naltrexone fails to increase pain affect in response to inflammatory pain in a novel escape/avoidance paradigm","Uhelski ML, Fuchs PN.","Physiol Behav. 2009 Sep 7;98(3):263-7. doi: 10.1016/j.physbeh.2009.05.019. Epub 2009 Jun 6.","Uhelski ML","Physiol Behav","2009","2009/06/10","","","10.1016/j.physbeh.2009.05.019"
"19494155","Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization","Virk MS, Arttamangkul S, Birdsong WT, Williams JT.","Version 2. J Neurosci. 2009 Jun 3;29(22):7341-8. doi: 10.1523/JNEUROSCI.3723-08.2009.","Virk MS","J Neurosci","2009","2009/06/05","PMC2752300","NIHMS122764","10.1523/JNEUROSCI.3723-08.2009"
"19492707","[Pharmacological therapy of dependency on alcohol]","Alho H, Hyytiä P.","Duodecim. 2009;125(8):912-8.","Alho H","Duodecim","2009","2009/06/05","","",""
"19489752","Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats","Todtenkopf MS, O'Neill KS, Kriksciukaite K, Turncliff RZ, Dean RL, Ostrovsky-Day I, Deaver DR.","Addict Biol. 2009 Sep;14(4):408-18. doi: 10.1111/j.1369-1600.2009.00161.x. Epub 2009 Jun 1.","Todtenkopf MS","Addict Biol","2009","2009/06/04","","","10.1111/j.1369-1600.2009.00161.x"
"19486259","Opioid receptor antagonist promotes angiogenesis in bile duct ligated rats","Faramarzi N, Abbasi A, Tavangar SM, Mazouchi M, Dehpour AR.","J Gastroenterol Hepatol. 2009 Jul;24(7):1226-9. doi: 10.1111/j.1440-1746.2009.05794.x. Epub 2009 May 26.","Faramarzi N","J Gastroenterol Hepatol","2009","2009/06/03","","","10.1111/j.1440-1746.2009.05794.x"
"19485973","Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study","Leggio L, Ray LA, Kenna GA, Swift RM.","Alcohol Clin Exp Res. 2009 Sep;33(9):1539-44. doi: 10.1111/j.1530-0277.2009.00982.x. Epub 2009 May 26.","Leggio L","Alcohol Clin Exp Res","2009","2009/06/03","PMC2955866","NIHMS235408","10.1111/j.1530-0277.2009.00982.x"
"19484223","Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine","Wee S, Orio L, Ghirmai S, Cashman JR, Koob GF.","Psychopharmacology (Berl). 2009 Sep;205(4):565-75. doi: 10.1007/s00213-009-1563-y. Epub 2009 May 30.","Wee S","Psychopharmacology (Berl)","2009","2009/06/02","PMC2739447","NIHMS140638","10.1007/s00213-009-1563-y"
"19478295","Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial","Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen Ø, Waal H.","Br J Psychiatry. 2009 Jun;194(6):541-6. doi: 10.1192/bjp.bp.108.055319.","Kunøe N","Br J Psychiatry","2009","2009/05/30","","","10.1192/bjp.bp.108.055319"
"19469728","The use of depot naltrexone under legal coercion: the case for caution","Hall W, Capps B, Carter A.","Addiction. 2008 Dec;103(12):1922-4. doi: 10.1111/j.1360-0443.2008.02370.x.","Hall W","Addiction","2008","2009/05/28","","","10.1111/j.1360-0443.2008.02370.x"
"19463750","Delta opioid receptor-mediated immunoregulatory role of methionine-enkephalin in freshwater teleost Channa punctatus (Bloch.)","Singh R, Rai U.","Peptides. 2009 Jun;30(6):1158-64. doi: 10.1016/j.peptides.2009.02.016. Epub 2009 Mar 13.","Singh R","Peptides","2009","2009/05/26","","","10.1016/j.peptides.2009.02.016"
"19463266","Opioid, cannabinoid CB1 and NOP receptors do not mediate APAP-induced hypothermia in rats","Corley G, Rawls SM.","Pharmacol Biochem Behav. 2009 May;92(3):503-7. doi: 10.1016/j.pbb.2009.01.020. Epub 2009 Jan 31.","Corley G","Pharmacol Biochem Behav","2009","2009/05/26","","","10.1016/j.pbb.2009.01.020"
"19463265","Receptor reserve reflects differential intrinsic efficacy associated with opioid diastereomers","Carliss RD, Keefer JF, Perschke S, Welch S, Rich TC, Weissman AD.","Pharmacol Biochem Behav. 2009 May;92(3):495-502. doi: 10.1016/j.pbb.2009.01.019. Epub 2009 Jan 31.","Carliss RD","Pharmacol Biochem Behav","2009","2009/05/26","","","10.1016/j.pbb.2009.01.019"
"19461298","Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans","van Dorp EL, Kest B, Kowalczyk WJ, Morariu AM, Waxman AR, Arout CA, Dahan A, Sarton EY.","Anesthesiology. 2009 Jun;110(6):1356-63. doi: 10.1097/ALN.0b013e3181a105de.","van Dorp EL","Anesthesiology","2009","2009/05/23","","","10.1097/ALN.0b013e3181a105de"
"19453963","Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study","Younger J, Mackey S.","Pain Med. 2009 May-Jun;10(4):663-72. doi: 10.1111/j.1526-4637.2009.00613.x. Epub 2009 Apr 22.","Younger J","Pain Med","2009","2009/05/21","PMC2891387","NIHMS209741","10.1111/j.1526-4637.2009.00613.x"
"19453814","Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study","Malekzad F, Arbabi M, Mohtasham N, Toosi P, Jaberian M, Mohajer M, Mohammadi MR, Roodsari MR, Nasiri S.","J Eur Acad Dermatol Venereol. 2009 Aug;23(8):948-50. doi: 10.1111/j.1468-3083.2009.03129.x. Epub 2009 May 6.","Malekzad F","J Eur Acad Dermatol Venereol","2009","2009/05/21","","","10.1111/j.1468-3083.2009.03129.x"
"19448232","The individual and combined effects of U50,488, and flurbiprofen axetil on visceral pain in conscious rats","Kitamura T, Ogawa M, Yamada Y.","Anesth Analg. 2009 Jun;108(6):1964-6. doi: 10.1213/ane.0b013e3181a2b5e8.","Kitamura T","Anesth Analg","2009","2009/05/19","","","10.1213/ane.0b013e3181a2b5e8"
"19446408","Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry","van Nieuwenhuijzen PS, McGregor IS.","Drug Alcohol Depend. 2009 Aug 1;103(3):137-47. doi: 10.1016/j.drugalcdep.2009.03.004. Epub 2009 May 14.","van Nieuwenhuijzen PS","Drug Alcohol Depend","2009","2009/05/19","","","10.1016/j.drugalcdep.2009.03.004"
"19445924","Alteration in male reproductive system in experimental cholestasis: roles for opioids and nitric oxide overproduction","Kiani S, Valizadeh B, Hormazdi B, Samadi H, Najafi T, Samini M, Dehpour AR.","Eur J Pharmacol. 2009 Aug 1;615(1-3):246-51. doi: 10.1016/j.ejphar.2009.04.049. Epub 2009 May 13.","Kiani S","Eur J Pharmacol","2009","2009/05/19","","","10.1016/j.ejphar.2009.04.049"
"19444734","Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence","Raby WN, Carpenter KM, Rothenberg J, Brooks AC, Jiang H, Sullivan M, Bisaga A, Comer S, Nunes EV.","Am J Addict. 2009 Jul-Aug;18(4):301-8. doi: 10.1080/10550490902927785.","Raby WN","Am J Addict","2009","2009/05/16","PMC2753886","NIHMS141953","10.1080/10550490902927785"
"19443938","Lack of effect of naltrexone on the spinal synergism between morphine and non steroidal anti-inflammatory drugs","Miranda HF, Pinardi G.","Pharmacol Rep. 2009 Mar-Apr;61(2):268-74. doi: 10.1016/s1734-1140(09)70031-3.","Miranda HF","Pharmacol Rep","2009","2009/05/16","","","10.1016/s1734-1140(09)70031-3"
"19443130","Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle","Vann RE, Wise LE, Varvel SA, Philibin SD, Walentiny DM, Porter JH.","Drug Alcohol Depend. 2009 Aug 1;103(3):124-30. doi: 10.1016/j.drugalcdep.2009.02.015. Epub 2009 May 14.","Vann RE","Drug Alcohol Depend","2009","2009/05/16","PMC3386854","NIHMS376355","10.1016/j.drugalcdep.2009.02.015"
"19422370","Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents","Braida D, Capurro V, Zani A, Rubino T, Viganò D, Parolaro D, Sala M.","Br J Pharmacol. 2009 Jul;157(5):844-53. doi: 10.1111/j.1476-5381.2009.00230.x. Epub 2009 May 5.","Braida D","Br J Pharmacol","2009","2009/05/09","PMC2721268","","10.1111/j.1476-5381.2009.00230.x"
"19399212","Pharmacological management of postoperative ileus","Zeinali F, Stulberg JJ, Delaney CP.","Can J Surg. 2009 Apr;52(2):153-7.","Zeinali F","Can J Surg","2009","2009/04/29","PMC2663489","",""
"19394789","Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine","Reece AS.","J Subst Abuse Treat. 2009 Oct;37(3):256-65. doi: 10.1016/j.jsat.2009.03.008. Epub 2009 Apr 25.","Reece AS","J Subst Abuse Treat","2009","2009/04/28","","","10.1016/j.jsat.2009.03.008"
"19393386","[Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form]","Desjardins S, Doyen C, Contejean Y, Kaye K, Paubel P.","Encephale. 2009 Apr;35(2):168-72. doi: 10.1016/j.encep.2008.01.004. Epub 2008 Jul 7.","Desjardins S","Encephale","2009","2009/04/28","","","10.1016/j.encep.2008.01.004"
"19383946","Findings on alcohol dependence point to promising avenues for targeted therapies","Kuehn BM.","JAMA. 2009 Apr 22;301(16):1643-5. doi: 10.1001/jama.2009.535.","Kuehn BM","JAMA","2009","2009/04/23","","","10.1001/jama.2009.535"
"19382412","The role of peripheral opiate antagonists in pain medicine and perioperative care","Tanaka PP, Moss J.","Rev Bras Anestesiol. 2008 Sep-Oct;58(5):540-7, 533-9. doi: 10.1590/s0034-70942008000500011.","Tanaka PP","Rev Bras Anestesiol","2008","2009/04/23","","","10.1590/s0034-70942008000500011"
"19380658","Chronic ulcers caused by injection of substances: healing aided by naltrexone","Reece AS.","Arch Dermatol. 2009 Apr;145(4):375-7. doi: 10.1001/archdermatol.2009.4.","Reece AS","Arch Dermatol","2009","2009/04/22","","","10.1001/archdermatol.2009.4"
"19377433","Naltrexone in drug addiction: significance in the prevention of relapse","Hoque MM, Hossain KJ, Kamal MM, Akhtaruzzaman M.","Mymensingh Med J. 2009 Jan;18(1 Suppl):S56-65.","Hoque MM","Mymensingh Med J","2009","2009/04/21","","",""
"19374836","Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models","Yoshikawa S, Hareyama N, Ikeda K, Kurokawa T, Nakajima M, Nakao K, Mochizuki H, Ichinose H.","Eur J Pharmacol. 2009 Mar 15;606(1-3):102-8. doi: 10.1016/j.ejphar.2009.01.043. Epub 2009 Feb 5.","Yoshikawa S","Eur J Pharmacol","2009","2009/04/21","","","10.1016/j.ejphar.2009.01.043"
"19370651","Detoxification treatments for opiate dependent adolescents","Minozzi S, Amato L, Davoli M.","Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006749. doi: 10.1002/14651858.CD006749.pub2.","Minozzi S","Cochrane Database Syst Rev","2009","2009/04/17","","","10.1002/14651858.CD006749.pub2"
"19368530","Shadows across mu-Star? Constitutively active mu-opioid receptors revisited","Connor M.","Br J Pharmacol. 2009 Apr;156(7):1041-3. doi: 10.1111/j.1476-5381.2009.00067.x.","Connor M","Br J Pharmacol","2009","2009/04/17","PMC2697690","","10.1111/j.1476-5381.2009.00067.x"
"19365548","Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology","Younger JW, Zautra AJ, Cummins ET.","PLoS One. 2009;4(4):e5180. doi: 10.1371/journal.pone.0005180. Epub 2009 Apr 13.","Younger JW","PLoS One","2009","2009/04/15","PMC2664472","","10.1371/journal.pone.0005180"
"19364645","Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypes","Pelotte AL, Smith RM, Ayestas M, Dersch CM, Bilsky EJ, Rothman RB, Deveau AM.","Bioorg Med Chem Lett. 2009 May 15;19(10):2811-4. doi: 10.1016/j.bmcl.2009.03.095. Epub 2009 Mar 26.","Pelotte AL","Bioorg Med Chem Lett","2009","2009/04/15","","","10.1016/j.bmcl.2009.03.095"
"19364254","Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity","Plodkowski RA, Nguyen Q, Sundaram U, Nguyen L, Chau DL, St Jeor S.","Expert Opin Pharmacother. 2009 Apr;10(6):1069-81. doi: 10.1517/14656560902775750.","Plodkowski RA","Expert Opin Pharmacother","2009","2009/04/15","","","10.1517/14656560902775750"
"19364251","Methylnaltrexone: the answer to opioid-induced constipation?","Cannom RR, Mason RJ.","Expert Opin Pharmacother. 2009 Apr;10(6):1039-45. doi: 10.1517/14656560902833914.","Cannom RR","Expert Opin Pharmacother","2009","2009/04/15","","","10.1517/14656560902833914"
"19362480","Design and synthesis of novel delta opioid receptor agonists and their pharmacologies","Nagase H, Osa Y, Nemoto T, Fujii H, Imai M, Nakamura T, Kanemasa T, Kato A, Gouda H, Hirono S.","Bioorg Med Chem Lett. 2009 May 15;19(10):2792-5. doi: 10.1016/j.bmcl.2009.03.099. Epub 2009 Mar 26.","Nagase H","Bioorg Med Chem Lett","2009","2009/04/14","","","10.1016/j.bmcl.2009.03.099"
"19346279","Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial","Martinotti G, Di Nicola M, Tedeschi D, Andreoli S, Reina D, Pomponi M, Mazza M, Romanelli R, Moroni N, De Filippis R, Di Giannantonio M, Pozzi G, Bria P, Janiri L.","J Psychopharmacol. 2010 Sep;24(9):1367-74. doi: 10.1177/0269881109102623. Epub 2009 Apr 3.","Martinotti G","J Psychopharmacol","2010","2009/04/07","","","10.1177/0269881109102623"
"19345246","Opioid receptors in the gastrointestinal tract","Holzer P.","Regul Pept. 2009 Jun 5;155(1-3):11-7. doi: 10.1016/j.regpep.2009.03.012. Epub 2009 Apr 2.","Holzer P","Regul Pept","2009","2009/04/07","PMC3163293","UKMS32582","10.1016/j.regpep.2009.03.012"
"19344707","Ethanol aggravates itch-related scratching in hairless mice developing atopic dermatitis","Fujii M, Nakamura T, Fukuno S, Mizutani N, Nabe T, Kohno S.","Eur J Pharmacol. 2009 Jun 2;611(1-3):92-9. doi: 10.1016/j.ejphar.2009.03.051. Epub 2009 Apr 1.","Fujii M","Eur J Pharmacol","2009","2009/04/07","","","10.1016/j.ejphar.2009.03.051"
"19340676","The cost effectiveness of naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence","Walters D, Connor JP, Feeney GF, Young RM.","J Addict Dis. 2009;28(2):137-44. doi: 10.1080/10550880902772456.","Walters D","J Addict Dis","2009","2009/04/03","","","10.1080/10550880902772456"
"19340640","A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling","Toneatto T, Brands B, Selby P.","Am J Addict. 2009 May-Jun;18(3):219-25. doi: 10.1080/10550490902787007.","Toneatto T","Am J Addict","2009","2009/04/03","","","10.1080/10550490902787007"
"19339623","Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory","Carey AN, Lyons AM, Shay CF, Dunton O, McLaughlin JP.","J Neurosci. 2009 Apr 1;29(13):4293-300. doi: 10.1523/JNEUROSCI.6146-08.2009.","Carey AN","J Neurosci","2009","2009/04/03","PMC6665365","","10.1523/JNEUROSCI.6146-08.2009"
"19322519","Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma","Kast RE.","J Neurooncol. 2009 Sep;94(2):163-7. doi: 10.1007/s11060-009-9863-y. Epub 2009 Mar 26.","Kast RE","J Neurooncol","2009","2009/03/27","","","10.1007/s11060-009-9863-y"
"19302083","Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study","King A, Cao D, Vanier C, Wilcox T.","Alcohol Clin Exp Res. 2009 Jun;33(6):1044-50. doi: 10.1111/j.1530-0277.2009.00925.x. Epub 2009 Mar 19.","King A","Alcohol Clin Exp Res","2009","2009/03/24","PMC4625790","NIHMS733364","10.1111/j.1530-0277.2009.00925.x"
"19298318","The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat","Häggkvist J, Lindholm S, Franck J.","Addict Biol. 2009 Jul;14(3):260-9. doi: 10.1111/j.1369-1600.2009.00150.x. Epub 2009 Mar 5.","Häggkvist J","Addict Biol","2009","2009/03/21","","","10.1111/j.1369-1600.2009.00150.x"
"19297547","Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis","Donahue RN, McLaughlin PJ, Zagon IS.","Am J Physiol Regul Integr Comp Physiol. 2009 Jun;296(6):R1716-25. doi: 10.1152/ajpregu.00075.2009. Epub 2009 Mar 18.","Donahue RN","Am J Physiol Regul Integr Comp Physiol","2009","2009/03/20","","","10.1152/ajpregu.00075.2009"
"19293390","Scratching behavior and Fos expression in superficial dorsal horn elicited by protease-activated receptor agonists and other itch mediators in mice","Akiyama T, Merrill AW, Zanotto K, Carstens MI, Carstens E.","J Pharmacol Exp Ther. 2009 Jun;329(3):945-51. doi: 10.1124/jpet.109.152256. Epub 2009 Mar 17.","Akiyama T","J Pharmacol Exp Ther","2009","2009/03/19","PMC2683773","","10.1124/jpet.109.152256"
"19290689","Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence","Carpenter KM, Jiang H, Sullivan MA, Bisaga A, Comer SD, Raby WN, Brooks AC, Nunes EV.","Psychol Addict Behav. 2009 Mar;23(1):47-55. doi: 10.1037/a0013049.","Carpenter KM","Psychol Addict Behav","2009","2009/03/18","PMC2832469","NIHMS59340","10.1037/a0013049"
"19283561","Early outcomes following low dose naltrexone enhancement of opioid detoxification","Mannelli P, Patkar AA, Peindl K, Gottheil E, Wu LT, Gorelick DA.","Am J Addict. 2009 Mar-Apr;18(2):109-16. doi: 10.1080/10550490902772785.","Mannelli P","Am J Addict","2009","2009/03/14","PMC3190236","NIHMS326570","10.1080/10550490902772785"
"19282177","Syntheses of novel high affinity ligands for opioid receptors","Wentland MP, Lou R, Lu Q, Bu Y, Denhardt C, Jin J, Ganorkar R, VanAlstine MA, Guo C, Cohen DJ, Bidlack JM.","Bioorg Med Chem Lett. 2009 Apr 15;19(8):2289-94. doi: 10.1016/j.bmcl.2009.02.078. Epub 2009 Feb 25.","Wentland MP","Bioorg Med Chem Lett","2009","2009/03/14","PMC2791460","NIHMS98143","10.1016/j.bmcl.2009.02.078"
"19279568","Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys","Ko MC, Woods JH, Fantegrossi WE, Galuska CM, Wichmann J, Prinssen EP.","Neuropsychopharmacology. 2009 Aug;34(9):2088-96. doi: 10.1038/npp.2009.33. Epub 2009 Mar 11.","Ko MC","Neuropsychopharmacology","2009","2009/03/13","PMC2804925","NIHMS162725","10.1038/npp.2009.33"
"19278178","Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients","Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R.","J Support Oncol. 2009 Jan-Feb;7(1):39-46.","Slatkin N","J Support Oncol","2009","2009/03/13","","",""
"19273844","Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions","Pan YX, Xu J, Xu M, Rossi GC, Matulonis JE, Pasternak GW.","Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4917-22. doi: 10.1073/pnas.0811586106. Epub 2009 Mar 9.","Pan YX","Proc Natl Acad Sci U S A","2009","2009/03/11","PMC2660730","","10.1073/pnas.0811586106"
"19270623","Unintentional rapid opioid detoxification: case report","Singh SM, Sharma B.","Psychiatr Danub. 2009 Mar;21(1):65-7.","Singh SM","Psychiatr Danub","2009","2009/03/10","","",""
"19270472","Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence","Colagiuri B, Morley K, Boakes R, Haber P.","Psychother Psychosom. 2009;78(3):167-71. doi: 10.1159/000206871. Epub 2009 Mar 9.","Colagiuri B","Psychother Psychosom","2009","2009/03/10","","","10.1159/000206871"
"19269773","The role of alcoholic beverage preference in the severity of alcohol dependence and adherence to the treatment","Baltieri DA, Daró FR, Ribeiro PL, De Andrade AG.","Alcohol. 2009 May;43(3):185-95. doi: 10.1016/j.alcohol.2009.01.001. Epub 2009 Mar 9.","Baltieri DA","Alcohol","2009","2009/03/10","","","10.1016/j.alcohol.2009.01.001"
"19263773","Treating opioid-induced constipation with methylnaltrexone bromide","Kyle G.","Nurs Times. 2009 Feb 3-9;105(4):25.","Kyle G","Nurs Times","2009","2009/03/07","","",""
"19261235","Course of late-life depression with alcoholism following combination therapy","Gopalakrishnan R, Ross J, O'Brien C, Oslin D.","J Stud Alcohol Drugs. 2009 Mar;70(2):237-41. doi: 10.15288/jsad.2009.70.237.","Gopalakrishnan R","J Stud Alcohol Drugs","2009","2009/03/06","PMC2653609","","10.15288/jsad.2009.70.237"
"19258022","Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network","Boettiger CA, Kelley EA, Mitchell JM, D'Esposito M, Fields HL.","Pharmacol Biochem Behav. 2009 Sep;93(3):291-9. doi: 10.1016/j.pbb.2009.02.008. Epub 2009 Feb 28.","Boettiger CA","Pharmacol Biochem Behav","2009","2009/03/05","PMC2729462","NIHMS99086","10.1016/j.pbb.2009.02.008"
"19255384","Insufficient information in drug-related hospital morbidity study","Newman RG.","Arch Gen Psychiatry. 2009 Mar;66(3):331; author reply 331-2. doi: 10.1001/archgenpsychiatry.2008.549.","Newman RG","Arch Gen Psychiatry","2009","2009/03/04","","","10.1001/archgenpsychiatry.2008.549"
"19253983","14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity","Moynihan H, Jales AR, Greedy BM, Rennison D, Broadbear JH, Purington L, Traynor JR, Woods JH, Lewis JW, Husbands SM.","J Med Chem. 2009 Mar 26;52(6):1553-7. doi: 10.1021/jm8012272.","Moynihan H","J Med Chem","2009","2009/03/04","PMC3063885","NIHMS280373","10.1021/jm8012272"
"19253970","Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines","Cami-Kobeci G, Neal AP, Bradbury FA, Purington LC, Aceto MD, Harris LS, Lewis JW, Traynor JR, Husbands SM.","J Med Chem. 2009 Mar 26;52(6):1546-52. doi: 10.1021/jm8015552.","Cami-Kobeci G","J Med Chem","2009","2009/03/04","PMC3070388","NIHMS280367","10.1021/jm8015552"
"19251113","Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection","Williams KL, Broadbridge CL.","Alcohol. 2009 Mar;43(2):119-26. doi: 10.1016/j.alcohol.2008.11.003.","Williams KL","Alcohol","2009","2009/03/03","PMC2692629","NIHMS112523","10.1016/j.alcohol.2008.11.003"
"19248160","Mu-opioid receptor redistribution in the locus coeruleus upon precipitation of withdrawal in opiate-dependent rats","Scavone JL, Van Bockstaele EJ.","Anat Rec (Hoboken). 2009 Mar;292(3):401-11. doi: 10.1002/ar.20860.","Scavone JL","Anat Rec (Hoboken)","2009","2009/02/28","PMC2863286","NIHMS195404","10.1002/ar.20860"
"19240629","Methylnaltrexone for opioid-induced constipation","Belavic JM.","Nurse Pract. 2009 Mar;34(3):6-7. doi: 10.1097/01.NPR.0000346585.18786.65.","Belavic JM","Nurse Pract","2009","2009/02/26","","","10.1097/01.NPR.0000346585.18786.65"
"19238363","Motor stimulant effects of ethanol and acetaldehyde injected into the posterior ventral tegmental area of rats: role of opioid receptors","Sánchez-Catalán MJ, Hipólito L, Zornoza T, Polache A, Granero L.","Psychopharmacology (Berl). 2009 Jul;204(4):641-53. doi: 10.1007/s00213-009-1495-6. Epub 2009 Feb 24.","Sánchez-Catalán MJ","Psychopharmacology (Berl)","2009","2009/02/25","","","10.1007/s00213-009-1495-6"
"19234831","Inhibitory effect of low-dose pentazocine on the development of antinociceptive tolerance to morphine","Chiba S, Hayashida M, Yoshikawa M, Shu H, Nishiyama T, Yamada Y.","J Anesth. 2009;23(1):99-107. doi: 10.1007/s00540-008-0697-0. Epub 2009 Feb 22.","Chiba S","J Anesth","2009","2009/02/24","","","10.1007/s00540-008-0697-0"
"19232396","Central administration of metastin increases food intake through opioid neurons in chicks","Khan MS, Ohkubo T, Masuda N, Tachibana T, Ueda H.","Comp Biochem Physiol A Mol Integr Physiol. 2009 Jun;153(2):209-12. doi: 10.1016/j.cbpa.2009.02.013. Epub 2009 Feb 14.","Khan MS","Comp Biochem Physiol A Mol Integr Physiol","2009","2009/02/24","","","10.1016/j.cbpa.2009.02.013"
"19225763","Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine","Achat-Mendes C, Valdez GR, Platt DM, Rowlett JK, Spealman RD.","Psychopharmacology (Berl). 2009 Jun;204(3):489-98. doi: 10.1007/s00213-009-1480-0. Epub 2009 Feb 19.","Achat-Mendes C","Psychopharmacology (Berl)","2009","2009/02/20","PMC2682624","NIHMS90292","10.1007/s00213-009-1480-0"
"19220294","Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor","Divin MF, Bradbury FA, Carroll FI, Traynor JR.","Br J Pharmacol. 2009 Apr;156(7):1044-53. doi: 10.1111/j.1476-5381.2008.00035.x. Epub 2009 Feb 13.","Divin MF","Br J Pharmacol","2009","2009/02/18","PMC2697693","","10.1111/j.1476-5381.2008.00035.x"
"19219669","Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment","Ahmadi J, Kampman KM, Oslin DM, Pettinati HM, Dackis C, Sparkman T.","Am J Addict. 2009 Jan-Feb;18(1):81-6. doi: 10.1080/10550490802545174.","Ahmadi J","Am J Addict","2009","2009/02/17","PMC3777818","NIHMS514107","10.1080/10550490802545174"
"19217918","Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions","Wong KJ, Wojnicki FH, Corwin RL.","Pharmacol Biochem Behav. 2009 May;92(3):528-36. doi: 10.1016/j.pbb.2009.02.002. Epub 2009 Feb 13.","Wong KJ","Pharmacol Biochem Behav","2009","2009/02/17","PMC2841009","NIHMS95895","10.1016/j.pbb.2009.02.002"
"19217656","Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus","Becker G, Blum HE.","Lancet. 2009 Apr 4;373(9670):1198-206. doi: 10.1016/S0140-6736(09)60139-2. Epub 2009 Feb 13.","Becker G","Lancet","2009","2009/02/17","","","10.1016/S0140-6736(09)60139-2"
"19217280","14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies","Li G, Aschenbach LC, He H, Selley DE, Zhang Y.","Bioorg Med Chem Lett. 2009 Mar 15;19(6):1825-9. doi: 10.1016/j.bmcl.2008.12.093. Epub 2008 Dec 29.","Li G","Bioorg Med Chem Lett","2009","2009/02/17","PMC2802822","NIHMS163497","10.1016/j.bmcl.2008.12.093"
"19217077","A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania","Grant JE, Kim SW, Odlaug BL.","Biol Psychiatry. 2009 Apr 1;65(7):600-6. doi: 10.1016/j.biopsych.2008.11.022. Epub 2009 Feb 12.","Grant JE","Biol Psychiatry","2009","2009/02/17","","","10.1016/j.biopsych.2008.11.022"
"19212878","Evaluation of biomarkers for pharmacological activity","Alonso A, Molenberghs G, Renard D, Darstein C.","J Biopharm Stat. 2009;19(2):256-72. doi: 10.1080/10543400802622386.","Alonso A","J Biopharm Stat","2009","2009/02/13","","","10.1080/10543400802622386"
"19200607","The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study","Kim SW, Grant JE, Potenza MN, Blanco C, Hollander E.","Psychiatry Res. 2009 Mar 31;166(1):76-84. doi: 10.1016/j.psychres.2007.11.008. Epub 2009 Feb 5.","Kim SW","Psychiatry Res","2009","2009/02/10","PMC3641525","NIHMS102281","10.1016/j.psychres.2007.11.008"
"19199782","Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists","Li G, Aschenbach LC, Chen J, Cassidy MP, Stevens DL, Gabra BH, Selley DE, Dewey WL, Westkaemper RB, Zhang Y.","J Med Chem. 2009 Mar 12;52(5):1416-27. doi: 10.1021/jm801272c.","Li G","J Med Chem","2009","2009/02/10","PMC2880636","NIHMS163495","10.1021/jm801272c"
"19198188","[The denydroepiandrosterone sulfate thyroid activation through the mu-opioid receptors under cold influences]","Obut TA, Saryg SK, Grigor'eva TA, Dement'eva TIu.","Ross Fiziol Zh Im I M Sechenova. 2008 Dec;94(12):1420-5.","Obut TA","Ross Fiziol Zh Im I M Sechenova","2008","2009/02/10","","",""
"19189996","Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence","Garbutt JC, Osborne M, Gallop R, Barkenbus J, Grace K, Cody M, Flannery B, Kampov-Polevoy AB.","Alcohol Alcohol. 2009 May-Jun;44(3):293-300. doi: 10.1093/alcalc/agn122. Epub 2009 Feb 3.","Garbutt JC","Alcohol Alcohol","2009","2009/02/05","PMC2720729","","10.1093/alcalc/agn122"
"19186002","The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids","Rezende RM, Dos Reis WG, Duarte ID, Lima PP, Bakhle YS, de Francischi JN.","Pain. 2009 Mar;142(1-2):94-100. doi: 10.1016/j.pain.2008.12.005. Epub 2009 Jan 30.","Rezende RM","Pain","2009","2009/02/03","","","10.1016/j.pain.2008.12.005"
"19182485","A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?","Larney S, Dolan K.","Eur Addict Res. 2009;15(2):107-12. doi: 10.1159/000199046. Epub 2009 Feb 2.","Larney S","Eur Addict Res","2009","2009/02/03","","","10.1159/000199046"
"19172864","Electrically enhanced and controlled drug delivery through buccal mucosa","Mościcka-Studzińska A, Czarnecka K, Ciach T.","Acta Pol Pharm. 2008 Nov-Dec;65(6):767-9.","Mościcka-Studzińska A","Acta Pol Pharm","2008","2009/01/29","","",""
"19170666","Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study","Mann K, Kiefer F, Smolka M, Gann H, Wellek S, Heinz A; PREDICT Study Research Team.","Alcohol Clin Exp Res. 2009 Apr;33(4):674-83. doi: 10.1111/j.1530-0277.2008.00884.x. Epub 2009 Jan 20.","Mann K","Alcohol Clin Exp Res","2009","2009/01/28","","","10.1111/j.1530-0277.2008.00884.x"
"19167814","Opposite effects of opioid blockade on the blood pressure-pain relationship in depressed and non-depressed participants","Frew AK, Drummond PD.","Pain. 2009 Mar;142(1-2):68-74. doi: 10.1016/j.pain.2008.11.014. Epub 2009 Jan 23.","Frew AK","Pain","2009","2009/01/27","","","10.1016/j.pain.2008.11.014"
"19165115","Efficacy of naltrexone in the treatment of chronic refractory itching in burn patients: preliminary report of an open trial","Jung SI, Seo CH, Jang K, Ham BJ, Choi IG, Kim JH, Lee BC.","J Burn Care Res. 2009 Mar-Apr;30(2):257-60; discussion 261. doi: 10.1097/BCR.0b013e318198a282.","Jung SI","J Burn Care Res","2009","2009/01/24","","","10.1097/BCR.0b013e318198a282"
"19162083","Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test","Brocardo PS, Budni J, Lobato KR, Santos AR, Rodrigues AL.","Behav Brain Res. 2009 Jun 8;200(1):122-7. doi: 10.1016/j.bbr.2009.01.004. Epub 2009 Jan 8.","Brocardo PS","Behav Brain Res","2009","2009/01/24","","","10.1016/j.bbr.2009.01.004"
"19155882","Drug approvals: '08 in review. Methylnaltrexone (Relistor)","Laustsen G, Carrillo F, Johnson J, Smith C.","Nurse Pract. 2009 Feb;34(2):31. doi: 10.1097/01.NPR.0000345271.43913.9f.","Laustsen G","Nurse Pract","2009","2009/01/22","","","10.1097/01.NPR.0000345271.43913.9f"
"19153715","Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats","Czachowski CL, Delory MJ.","Psychopharmacology (Berl). 2009 Jun;204(2):335-48. doi: 10.1007/s00213-009-1465-z. Epub 2009 Jan 20.","Czachowski CL","Psychopharmacology (Berl)","2009","2009/01/21","PMC2864152","NIHMS197903","10.1007/s00213-009-1465-z"
"19146834","Protection conferred by Corticotropin-releasing hormone in rat primary cortical neurons against chemical ischemia involves opioid receptor activation","Charron C, Schock SC, Proulx G, Thompson CS, Hakim AM, Plamondon H.","Brain Res. 2009 Feb 27;1257:117-27. doi: 10.1016/j.brainres.2008.12.053. Epub 2008 Dec 30.","Charron C","Brain Res","2009","2009/01/17","","","10.1016/j.brainres.2008.12.053"
"19136019","Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia","Beckman TR, Shi Q, Levine AS, Billington CJ.","Physiol Behav. 2009 Mar 23;96(4-5):568-73. doi: 10.1016/j.physbeh.2008.12.007. Epub 2008 Dec 24.","Beckman TR","Physiol Behav","2009","2009/01/13","PMC4284077","NIHMS650825","10.1016/j.physbeh.2008.12.007"
"19135092","Validation of a novel social investigation task that may dissociate social motivation from exploratory activity","Deak T, Arakawa H, Bekkedal MY, Panksepp J.","Behav Brain Res. 2009 May 16;199(2):326-33. doi: 10.1016/j.bbr.2008.12.011. Epub 2008 Dec 14.","Deak T","Behav Brain Res","2009","2009/01/13","PMC2678686","NIHMS83053","10.1016/j.bbr.2008.12.011"
"19118134","Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception","Naidu PS, Booker L, Cravatt BF, Lichtman AH.","J Pharmacol Exp Ther. 2009 Apr;329(1):48-56. doi: 10.1124/jpet.108.143487. Epub 2008 Dec 31.","Naidu PS","J Pharmacol Exp Ther","2009","2009/01/02","PMC2670588","","10.1124/jpet.108.143487"
"19115979","Novel synthesis of a 1,3,5-trioxazatriquinane skeleton using a nitrogen clamp","Nagase H, Watanabe A, Harada M, Nakajima M, Hasebe K, Mochizuki H, Yoza K, Fujii H.","Org Lett. 2009 Feb 5;11(3):539-42. doi: 10.1021/ol8024988.","Nagase H","Org Lett","2009","2009/01/01","","","10.1021/ol8024988"
"19110556","Role of opioid system in modulation of pain sensitivity under conditons of low and high environmental temperature","Kolotilova AB, Guzevatikh LS, Valujskikh DV, Emel'yanova TG.","Bull Exp Biol Med. 2008 Jun;145(6):707-9. doi: 10.1007/s10517-008-0171-x.","Kolotilova AB","Bull Exp Biol Med","2008","2008/12/27","","","10.1007/s10517-008-0171-x"
"19110553","Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists","Lishmanov YB, Stakheev DL, Krylatov AV, Naryzhnaya NV, Maslov LN, Ovchinnikov MV, Kolar F.","Bull Exp Biol Med. 2008 Jun;145(6):696-9. doi: 10.1007/s10517-008-0172-9.","Lishmanov YB","Bull Exp Biol Med","2008","2008/12/27","","","10.1007/s10517-008-0172-9"
"19106336","FDA panel debates merits of next-generation opioid formulations","Lavine G.","Am J Health Syst Pharm. 2009 Jan 1;66(1):8-11. doi: 10.2146/news090002.","Lavine G","Am J Health Syst Pharm","2009","2008/12/25","","","10.2146/news090002"
"19104662","Ethanol/naltrexone interactions at the mu-opioid receptor. CLSM/FCS study in live cells","Vukojević V, Ming Y, D'Addario C, Rigler R, Johansson B, Terenius L.","PLoS One. 2008;3(12):e4008. doi: 10.1371/journal.pone.0004008. Epub 2008 Dec 23.","Vukojević V","PLoS One","2008","2008/12/24","PMC2602977","","10.1371/journal.pone.0004008"
"19097147","Minor pathological changes are induced by naltrexone-poly(DL-lactide) implants in pregnant rats","Farid WO, McCallum D, Tait RJ, Dunlop SA, Hulse GK.","J Biomed Mater Res A. 2009 Dec 15;91(4):964-74. doi: 10.1002/jbm.a.32283.","Farid WO","J Biomed Mater Res A","2009","2008/12/20","","","10.1002/jbm.a.32283"
"19081679","Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study","Sigmon SC, Dunn KE, Badger GJ, Heil SH, Higgins ST.","Addict Behav. 2009 Mar;34(3):304-11. doi: 10.1016/j.addbeh.2008.11.017. Epub 2008 Nov 24.","Sigmon SC","Addict Behav","2009","2008/12/17","PMC2643343","NIHMS91618","10.1016/j.addbeh.2008.11.017"
"19080995","[Recent results in relaps prevention of alcoholism with Disulfiram]","Mutschler J, Diehl A, Vollmert C, Herre H, Mann K, Kiefer F.","Neuropsychiatr. 2008;22(4):243-51.","Mutschler J","Neuropsychiatr","2008","2008/12/17","","",""
"19070270","Hospital morbidity associated with the natural history of heroin use","Tait RJ, Hulse GK.","J Opioid Manag. 2008 Sep-Oct;4(5):321-7. doi: 10.5055/jom.2008.0036.","Tait RJ","J Opioid Manag","2008","2008/12/17","","","10.5055/jom.2008.0036"
"19068776","[Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence]","Kato H.","Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008 Oct;43(5):697-704.","Kato H","Nihon Arukoru Yakubutsu Igakkai Zasshi","2008","2008/12/17","","",""
"19062347","The state of pharmacotherapy for the treatment of alcohol dependence","Garbutt JC.","J Subst Abuse Treat. 2009 Jan;36(1):S15-23; quiz S24-5.","Garbutt JC","J Subst Abuse Treat","2009","2008/12/09","","",""
"19059761","Tolerance to the anticonvulsant effect of morphine in mice: blockage by ultra-low dose naltrexone","Roshanpour M, Ghasemi M, Riazi K, Rafiei-Tabatabaei N, Ghahremani MH, Dehpour AR.","Epilepsy Res. 2009 Feb;83(2-3):261-4. doi: 10.1016/j.eplepsyres.2008.10.011. Epub 2008 Dec 6.","Roshanpour M","Epilepsy Res","2009","2008/12/09","","","10.1016/j.eplepsyres.2008.10.011"
"19059275","Open elevated plus maze-induced antinociception in rats: a non-opioid type of pain inhibition?","Cornélio AM, Nunes-de-Souza RL.","Physiol Behav. 2009 Mar 2;96(3):440-7. doi: 10.1016/j.physbeh.2008.11.007. Epub 2008 Nov 24.","Cornélio AM","Physiol Behav","2009","2008/12/09","","","10.1016/j.physbeh.2008.11.007"
"19059045","Opiate agonist treatment for addiction","Newman RG.","Lancet. 2008 Dec 6;372(9654):1951-2; author reply 1952. doi: 10.1016/S0140-6736(08)61838-3.","Newman RG","Lancet","2008","2008/12/09","","","10.1016/S0140-6736(08)61838-3"
"19058542","Strain-specific differences in modulatory effects of morphine on peritoneal inflammation in mice","Natorska J, Plytycz B.","Folia Biol (Krakow). 2005;53(3-4):189-95. doi: 10.3409/173491605775142701.","Natorska J","Folia Biol (Krakow)","2005","2008/12/09","","","10.3409/173491605775142701"
"19056363","Neuroprotective role of delta-opioid receptors against mitochondrial respiratory chain injury","Zhu M, Li MW, Tian XS, Ou XM, Zhu CQ, Guo JC.","Brain Res. 2009 Feb 3;1252:183-91. doi: 10.1016/j.brainres.2008.11.030. Epub 2008 Nov 19.","Zhu M","Brain Res","2009","2008/12/06","","","10.1016/j.brainres.2008.11.030"
"19054276","Novel role for the delta-opioid receptor in hypoxic preconditioning in rat retinas","Peng PH, Huang HS, Lee YJ, Chen YS, Ma MC.","J Neurochem. 2009 Feb;108(3):741-54. doi: 10.1111/j.1471-4159.2008.05807.x. Epub 2008 Nov 28.","Peng PH","J Neurochem","2009","2008/12/05","","","10.1111/j.1471-4159.2008.05807.x"
"19053979","Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients","Pettinati HM, Gastfriend DR, Dong Q, Kranzler HR, O'Malley SS.","Alcohol Clin Exp Res. 2009 Feb;33(2):350-6. doi: 10.1111/j.1530-0277.2008.00843.x. Epub 2008 Nov 25.","Pettinati HM","Alcohol Clin Exp Res","2009","2008/12/05","PMC2976586","NIHMS238602","10.1111/j.1530-0277.2008.00843.x"
"19053977","OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach","Oroszi G, Anton RF, O'Malley S, Swift R, Pettinati H, Couper D, Yuan Q, Goldman D.","Alcohol Clin Exp Res. 2009 Mar;33(3):383-93. doi: 10.1111/j.1530-0277.2008.00846.x. Epub 2008 Nov 25.","Oroszi G","Alcohol Clin Exp Res","2009","2008/12/05","PMC2679376","NIHMS84373","10.1111/j.1530-0277.2008.00846.x"
"19043694","Effects of training and withdrawal periods on heroin seeking induced by conditioned cue in an animal of model of relapse","Zhou W, Zhang F, Liu H, Tang S, Lai M, Zhu H, Kalivas PW.","Psychopharmacology (Berl). 2009 May;203(4):677-84. doi: 10.1007/s00213-008-1414-2. Epub 2008 Nov 29.","Zhou W","Psychopharmacology (Berl)","2009","2008/12/02","","","10.1007/s00213-008-1414-2"
"19042127","Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonists","Fujii H, Watanabe A, Nemoto T, Narita M, Miyoshi K, Nakamura A, Suzuki T, Nagase H.","Bioorg Med Chem Lett. 2009 Jan 15;19(2):438-41. doi: 10.1016/j.bmcl.2008.11.050. Epub 2008 Nov 18.","Fujii H","Bioorg Med Chem Lett","2009","2008/12/02","","","10.1016/j.bmcl.2008.11.050"
"19041189","Low-dose naltrexone for disease prevention and quality of life","Brown N, Panksepp J.","Med Hypotheses. 2009 Mar;72(3):333-7. doi: 10.1016/j.mehy.2008.06.048. Epub 2008 Nov 28.","Brown N","Med Hypotheses","2009","2008/12/02","","","10.1016/j.mehy.2008.06.048"
"19038694","Holidays, triggers, and willpower--is there a role for medications? A commentary on ""The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients""","Rosenbloom DL.","J Subst Abuse Treat. 2009 Jan;36(1):7. doi: 10.1016/j.jsat.2008.10.008.","Rosenbloom DL","J Subst Abuse Treat","2009","2008/11/29","","","10.1016/j.jsat.2008.10.008"
"19034737","Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence","Suh JJ, Pettinati HM, Kampman KM, O'Brien CP.","Am J Addict. 2008 Nov-Dec;17(6):463-8. doi: 10.1080/10550490802409074.","Suh JJ","Am J Addict","2008","2008/11/27","PMC2657877","NIHMS82901","10.1080/10550490802409074"
"19032573","Behavioral consequences of repeated nicotine during adolescence in alcohol-preferring AA and alcohol-avoiding ANA rats","Kemppainen H, Hyytiä P, Kiianmaa K.","Alcohol Clin Exp Res. 2009 Feb;33(2):340-9. doi: 10.1111/j.1530-0277.2008.00838.x. Epub 2008 Nov 19.","Kemppainen H","Alcohol Clin Exp Res","2009","2008/11/27","","","10.1111/j.1530-0277.2008.00838.x"
"19032530","Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization","Kranzler HR, Stephenson JJ, Montejano L, Wang S, Gastfriend DR.","Addiction. 2008 Nov;103(11):1801-8. doi: 10.1111/j.1360-0443.2008.02345.x.","Kranzler HR","Addiction","2008","2008/11/27","PMC2652482","NIHMS68051","10.1111/j.1360-0443.2008.02345.x"
"19031547","Unplanned admissions to two Sydney public hospitals after naltrexone implants","Kozminsky MP.","Med J Aust. 2008 Oct 20;189(8):469-70; author reply 470-1.","Kozminsky MP","Med J Aust","2008","2008/11/26","","",""
"19027764","Naltrexone effects on male sexual behavior, corticosterone, and testosterone in stressed male rats","Retana-Márquez S, Bonilla-Jaime H, Vázquez-Palacios G, Martínez-García R.","Physiol Behav. 2009 Feb 16;96(2):333-42. doi: 10.1016/j.physbeh.2008.10.022. Epub 2008 Nov 7.","Retana-Márquez S","Physiol Behav","2009","2008/11/26","","","10.1016/j.physbeh.2008.10.022"
"19027735","Role of delta opioid efficacy as a determinant of mu/delta opioid interactions in rhesus monkeys","Negus SS, Bear AE, Folk JE, Rice KC.","Eur J Pharmacol. 2009 Jan 5;602(1):92-100. doi: 10.1016/j.ejphar.2008.11.004. Epub 2008 Nov 11.","Negus SS","Eur J Pharmacol","2009","2008/11/26","PMC2671208","NIHMS96712","10.1016/j.ejphar.2008.11.004"
"19024886","Unplanned admissions to two Sydney public hospitals after naltrexone implants","Brewer CL.","Med J Aust. 2008 Oct 20;189(8):470; author reply 470-1.","Brewer CL","Med J Aust","2008","2008/11/26","","",""
"19024885","Unplanned admissions to two Sydney public hospitals after naltrexone implants","Little M, Murray LM.","Med J Aust. 2008 Oct 20;189(8):469; author reply 470-1.","Little M","Med J Aust","2008","2008/11/26","","",""
"19023176","Naltrexone protects against lipopolysaccharide/D-galactosamine-induced hepatitis in mice","Wang CC, Cheng PY, Peng YJ, Wu ES, Wei HP, Yen MH.","J Pharmacol Sci. 2008 Nov;108(3):239-47. doi: 10.1254/jphs.08096fp.","Wang CC","J Pharmacol Sci","2008","2008/11/22","","","10.1254/jphs.08096fp"
"19020145","Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone","Woo M, O'Connor M, Yuan CS, Moss J.","Anesth Analg. 2008 Dec;107(6):1965-7. doi: 10.1213/ane.0b013e31818556d3.","Woo M","Anesth Analg","2008","2008/11/21","","","10.1213/ane.0b013e31818556d3"
"19011456","Alleviation of both binge eating and sexual dysfunction with naltrexone","Meyer F.","J Clin Psychopharmacol. 2008 Dec;28(6):722-3. doi: 10.1097/JCP.0b013e31818d6d26.","Meyer F","J Clin Psychopharmacol","2008","2008/11/18","","","10.1097/JCP.0b013e31818d6d26"
"18997675","Rational design of a combination medication for the treatment of obesity","Greenway FL, Whitehouse MJ, Guttadauria M, Anderson JW, Atkinson RL, Fujioka K, Gadde KM, Gupta AK, O'Neil P, Schumacher D, Smith D, Dunayevich E, Tollefson GD, Weber E, Cowley MA.","Obesity (Silver Spring). 2009 Jan;17(1):30-9. doi: 10.1038/oby.2008.461. Epub 2008 Nov 6.","Greenway FL","Obesity (Silver Spring)","2009","2008/11/11","","","10.1038/oby.2008.461"
"18997098","Repeated arterial occlusion, delta-opioid receptor (DOR) plasticity and vagal transmission within the sinoatrial node of the anesthetized dog","Deo SH, Barlow MA, Gonzalez L, Yoshishige D, Caffrey JL.","Exp Biol Med (Maywood). 2009 Jan;234(1):84-94. doi: 10.3181/0808-RM-242. Epub 2008 Nov 7.","Deo SH","Exp Biol Med (Maywood)","2009","2008/11/11","","","10.3181/0808-RM-242"
"18976963","A prolonged nitric oxide-dependent, opioid-mediated antinociceptive effect of hyperbaric oxygen in mice","Zelinski LM, Ohgami Y, Chung E, Shirachi DY, Quock RM.","J Pain. 2009 Feb;10(2):167-72. doi: 10.1016/j.jpain.2008.08.003. Epub 2008 Oct 31.","Zelinski LM","J Pain","2009","2008/11/04","PMC2650380","NIHMS95788","10.1016/j.jpain.2008.08.003"
"18972573","Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone","Vaddi HK, Banks SL, Chen J, Hammell DC, Crooks PA, Stinchcomb AL.","J Pharm Sci. 2009 Aug;98(8):2611-25. doi: 10.1002/jps.21594.","Vaddi HK","J Pharm Sci","2009","2008/10/31","PMC2764244","NIHMS150671","10.1002/jps.21594"
"18971181","[Pharmacokinetics of nalmefene after a single or multiple intravenous doses in Chinese healthy volunteers]","Liao RF, Zeng ZP, Wen YG.","Nan Fang Yi Ke Da Xue Xue Bao. 2008 Oct;28(10):1816-9.","Liao RF","Nan Fang Yi Ke Da Xue Xue Bao","2008","2008/10/31","","",""
"18956615","[Analysis of central mechanisms involved in gastric mucosal integrity]","Gyires K, Zádori Z.","Neuropsychopharmacol Hung. 2008 Jun;10(3):121-5.","Gyires K","Neuropsychopharmacol Hung","2008","2008/10/30","","",""
"18955144","Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol","Mitchell JM, Bergren LJ, Chen KS, Rowbotham MC, Fields HL.","Neurobiol Dis. 2009 Jan;33(1):72-80. doi: 10.1016/j.nbd.2008.09.018. Epub 2008 Oct 1.","Mitchell JM","Neurobiol Dis","2009","2008/10/29","","","10.1016/j.nbd.2008.09.018"
"18950747","Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine","Shippenberg TS, Chefer VI, Thompson AC.","Biol Psychiatry. 2009 Jan 15;65(2):169-74. doi: 10.1016/j.biopsych.2008.09.009. Epub 2008 Oct 31.","Shippenberg TS","Biol Psychiatry","2009","2008/10/28","PMC3832215","NIHMS85564","10.1016/j.biopsych.2008.09.009"
"18942470","[Impact of rotational stress on development of local immune response in mice. The role of k-opiate receptors]","Geĭn SV, Siatchikhin AA.","Patol Fiziol Eksp Ter. 2008 Jul-Sep;(3):13-5.","Geĭn SV","Patol Fiziol Eksp Ter","2008","2008/10/24","","",""
"18942066","Dynorphin inhibits NEP activity in R1.1 mouse thymoma cells","Martin-Kleiner I, Balog T, Marotti T.","Cell Biochem Funct. 2008 Dec;26(8):916-9. doi: 10.1002/cbf.1524.","Martin-Kleiner I","Cell Biochem Funct","2008","2008/10/23","","","10.1002/cbf.1524"
"18931323","delta-Opioid receptor antagonism induces NMDA receptor-dependent excitotoxicity in anoxic turtle cortex","Pamenter ME, Buck LT.","J Exp Biol. 2008 Nov;211(Pt 21):3512-7. doi: 10.1242/jeb.021949.","Pamenter ME","J Exp Biol","2008","2008/10/22","","","10.1242/jeb.021949"
"18928445","Unplanned admissions to two Sydney public hospitals after naltrexone implants","Lloyd-Jones DM.","Med J Aust. 2008 Oct 20;189(8):468-9; author reply 470-1.","Lloyd-Jones DM","Med J Aust","2008","2008/10/22","","",""
"18926274","Substitution treatment in Malaysia","Noordin NM, Merican MI, Rahman HA, Lee SS, Ramly R.","Lancet. 2008 Sep 27;372(9644):1149-50. doi: 10.1016/S0140-6736(08)61479-8.","Noordin NM","Lancet","2008","2008/10/18","","","10.1016/S0140-6736(08)61479-8"
"18925346","Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study","Weiss RD, O'malley SS, Hosking JD, Locastro JS, Swift R; COMBINE Study Research Group.","Version 2. J Stud Alcohol Drugs. 2008 Nov;69(6):878-84. doi: 10.15288/jsad.2008.69.878.","Weiss RD","J Stud Alcohol Drugs","2008","2008/10/18","PMC2575123","NIHMS54991","10.15288/jsad.2008.69.878"
"18923399","Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate","Wiley MD, Poveromo LB, Antapasis J, Herrera CM, Bolaños Guzmán CA.","Neuropsychopharmacology. 2009 Apr;34(5):1339-50. doi: 10.1038/npp.2008.188. Epub 2008 Oct 15.","Wiley MD","Neuropsychopharmacology","2009","2008/10/17","PMC2656574","NIHMS69982","10.1038/npp.2008.188"
"18855831","Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone","Fishman M.","Addiction. 2008 Aug;103(8):1399-401. doi: 10.1111/j.1360-0443.2008.02252.x.","Fishman M","Addiction","2008","2008/10/16","","","10.1111/j.1360-0443.2008.02252.x"
"18855810","Comparing topiramate with naltrexone in the treatment of alcohol dependence","Baltieri DA, Daró FR, Ribeiro PL, de Andrade AG.","Addiction. 2008 Dec;103(12):2035-44. doi: 10.1111/j.1360-0443.2008.02355.x. Epub 2008 Oct 8.","Baltieri DA","Addiction","2008","2008/10/16","","","10.1111/j.1360-0443.2008.02355.x"
"18855800","Developing human laboratory models of smoking lapse behavior for medication screening","McKee SA.","Addict Biol. 2009 Jan;14(1):99-107. doi: 10.1111/j.1369-1600.2008.00135.x. Epub 2008 Oct 9.","McKee SA","Addict Biol","2009","2008/10/16","PMC2732001","NIHMS123809","10.1111/j.1369-1600.2008.00135.x"
"18849356","M5 muscarinic receptor knockout mice show reduced morphine-induced locomotion but increased locomotion after cholinergic antagonism in the ventral tegmental area","Steidl S, Yeomans JS.","J Pharmacol Exp Ther. 2009 Jan;328(1):263-75. doi: 10.1124/jpet.108.144824. Epub 2008 Oct 10.","Steidl S","J Pharmacol Exp Ther","2009","2008/10/14","","","10.1124/jpet.108.144824"
"18848839","Antinociceptive action of 4-methyl-5-trifluoromethyl-5-hydroxy-4, 5-dihydro-1H-pyrazole methyl ester in models of inflammatory pain in mice","Milano J, Rossato MF, Oliveira SM, Drewes C, Machado P, Beck P, Zanatta N, Martins MA, Mello CF, Rubin MA, Ferreira J, Bonacorso HG.","Life Sci. 2008 Nov 21;83(21-22):739-46. doi: 10.1016/j.lfs.2008.09.010. Epub 2008 Sep 24.","Milano J","Life Sci","2008","2008/10/14","","","10.1016/j.lfs.2008.09.010"
"18841469","The effects of endomorphins on striatal [3H]GABA release induced by electrical stimulation: an in vitro superfusion study in rats","Bagosi Z, Jászberényi M, Telegdy G.","Neurochem Res. 2009 May;34(5):905-8. doi: 10.1007/s11064-008-9853-z. Epub 2008 Oct 8.","Bagosi Z","Neurochem Res","2009","2008/10/09","","","10.1007/s11064-008-9853-z"
"18838638","Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients","Zarkin GA, Bray JW, Aldridge A, Mitra D, Mills MJ, Couper DJ, Cisler RA; COMBINE Cost-Effectiveness Research Group.","Arch Gen Psychiatry. 2008 Oct;65(10):1214-21. doi: 10.1001/archpsyc.65.10.1214.","Zarkin GA","Arch Gen Psychiatry","2008","2008/10/08","PMC3095105","NIHMS284939","10.1001/archpsyc.65.10.1214"
"18832863","Disposition of naltrexone after intravenous bolus administration in Wistar rats, low-alcohol-drinking rats and high-alcohol-drinking rats","Akala EO, Wang H, Adedoyin A.","Neuropsychobiology. 2008;58(2):81-90. doi: 10.1159/000159776. Epub 2008 Oct 3.","Akala EO","Neuropsychobiology","2008","2008/10/04","PMC2910369","NIHMS219909","10.1159/000159776"
"18828797","Effects of alcoholism typology on response to naltrexone in the COMBINE study","Bogenschutz MP, Scott Tonigan J, Pettinati HM.","Alcohol Clin Exp Res. 2009 Jan;33(1):10-8. doi: 10.1111/j.1530-0277.2008.00804.x. Epub 2008 Sep 30.","Bogenschutz MP","Alcohol Clin Exp Res","2009","2008/10/03","PMC2626136","NIHMS67980","10.1111/j.1530-0277.2008.00804.x"
"18826910","New drugs: methylnaltrexone bromide, alvimopan, and rilonacept","Hussar DA.","J Am Pharm Assoc (2003). 2008 Sep-Oct;48(5):688-91. doi: 10.1331/JAPhA.2008.08537.","Hussar DA","J Am Pharm Assoc (2003)","2008","2008/10/02","","","10.1331/JAPhA.2008.08537"
"18825935","[Dehydroepiandrosterone sulfate effect at the conversion of corticosterone to 11-dehydrocorticosterone in stress conditions: the scheme of regulation]","Obut TA, Ovsiukova MV, Dement'eva TIu, Cherkasova OP, Saryg SK, Grigor'eva TA.","Ross Fiziol Zh Im I M Sechenova. 2008 Aug;94(8):945-51.","Obut TA","Ross Fiziol Zh Im I M Sechenova","2008","2008/10/02","","",""
"18824022","Effects of naltrexone on cortisol levels in heavy drinkers","Ray LA, Mackillop J, Leggio L, Morgan M, Hutchison KE.","Pharmacol Biochem Behav. 2009 Feb;91(4):489-94. doi: 10.1016/j.pbb.2008.09.004. Epub 2008 Sep 13.","Ray LA","Pharmacol Biochem Behav","2009","2008/10/01","PMC3660224","NIHMS98174","10.1016/j.pbb.2008.09.004"
"18823989","Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands","Cline MA, Mathews DS.","Gen Comp Endocrinol. 2008 Nov-Dec;159(2-3):125-9. doi: 10.1016/j.ygcen.2008.09.001. Epub 2008 Sep 14.","Cline MA","Gen Comp Endocrinol","2008","2008/10/01","","","10.1016/j.ygcen.2008.09.001"
"18819759","Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty","Mark TL, Kassed CA, Vandivort-Warren R, Levit KR, Kranzler HR.","Drug Alcohol Depend. 2009 Jan 1;99(1-3):345-9. doi: 10.1016/j.drugalcdep.2008.07.018. Epub 2008 Sep 25.","Mark TL","Drug Alcohol Depend","2009","2008/09/30","PMC3166770","NIHMS320798","10.1016/j.drugalcdep.2008.07.018"
"18813049","Differential effect of morphine and morphine-6-glucuronide on the control of breathing in the anesthetized cat","Teppema LJ, van Dorp E, Mousavi Gourabi B, van Kleef JW, Dahan A.","Anesthesiology. 2008 Oct;109(4):689-97. doi: 10.1097/ALN.0b013e31818631bd.","Teppema LJ","Anesthesiology","2008","2008/09/25","","","10.1097/ALN.0b013e31818631bd"
"18810678","[News from the cochrane library: mu opioid antagonists for opioid-induced bowel dysfunction]","Meerpohl JJ, Timmer A.","Z Gastroenterol. 2008 Sep;46(9):917-21. doi: 10.1055/s-2008-1027720. Epub 2008 Sep 22.","Meerpohl JJ","Z Gastroenterol","2008","2008/09/24","","","10.1055/s-2008-1027720"
"18807246","Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats","Liu X, Palmatier MI, Caggiula AR, Sved AF, Donny EC, Gharib M, Booth S.","Psychopharmacology (Berl). 2009 Mar;202(4):589-98. doi: 10.1007/s00213-008-1335-0. Epub 2008 Sep 21.","Liu X","Psychopharmacology (Berl)","2009","2008/09/23","PMC2811405","NIHMS170059","10.1007/s00213-008-1335-0"
"18805072","An automated, highly sensitive LC-MS/MS assay for the quantification of the opiate antagonist naltrexone and its major metabolite 6beta-naltrexol in dog and human plasma","Clavijo C, Bendrick-Peart J, Zhang YL, Johnson G, Gasparic A, Christians U.","J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Oct 15;874(1-2):33-41. doi: 10.1016/j.jchromb.2008.08.021. Epub 2008 Sep 5.","Clavijo C","J Chromatogr B Analyt Technol Biomed Life Sci","2008","2008/09/23","","","10.1016/j.jchromb.2008.08.021"
"18804151","Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not","Abrahao KP, Quadros IM, Souza-Formigoni ML.","Neuroscience. 2008 Oct 28;156(4):857-64. doi: 10.1016/j.neuroscience.2008.08.012. Epub 2008 Aug 19.","Abrahao KP","Neuroscience","2008","2008/09/23","","","10.1016/j.neuroscience.2008.08.012"
"18804120","Nociceptin produces antinociception after spinal administration in amphibians","Stevens CW, Martin KK, Stahlheber BW.","Pharmacol Biochem Behav. 2009 Jan;91(3):436-40. doi: 10.1016/j.pbb.2008.08.022. Epub 2008 Sep 5.","Stevens CW","Pharmacol Biochem Behav","2009","2008/09/23","PMC2662521","NIHMS89813","10.1016/j.pbb.2008.08.022"
"18803909","Preserved DNA from past clinical trials yields new information about a subtype of alcoholism","O'Brien CP.","Curr Psychiatry Rep. 2008 Oct;10(5):375-6. doi: 10.1007/s11920-008-0060-z.","O'Brien CP","Curr Psychiatry Rep","2008","2008/09/23","","","10.1007/s11920-008-0060-z"
"18803106","""Narcotics helped, I thought."" Recurrent traumatization and recovery from drug dependence","Kueppenbender K, Herman J, Khantzian E, Albanese M.","Harv Rev Psychiatry. 2008;16(5):308-17. doi: 10.1080/10673220802432418.","Kueppenbender K","Harv Rev Psychiatry","2008","2008/09/23","","","10.1080/10673220802432418"
"18800067","Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone","Wittmann W, Schunk E, Rosskothen I, Gaburro S, Singewald N, Herzog H, Schwarzer C.","Neuropsychopharmacology. 2009 Feb;34(3):775-85. doi: 10.1038/npp.2008.142. Epub 2008 Sep 17.","Wittmann W","Neuropsychopharmacology","2009","2008/09/19","PMC2873573","UKMS29510","10.1038/npp.2008.142"
"18799434","Alcohol dependence drug prompts warning","Mitka M.","JAMA. 2008 Sep 17;300(11):1289. doi: 10.1001/jama.300.11.1289.","Mitka M","JAMA","2008","2008/09/19","","","10.1001/jama.300.11.1289"
"18799426","Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke","al'Absi M, Wittmers LE, Hatsukami D, Westra R.","Psychosom Med. 2008 Oct;70(8):928-35. doi: 10.1097/PSY.0b013e31818434ab. Epub 2008 Sep 16.","al'Absi M","Psychosom Med","2008","2008/09/19","PMC4915218","NIHMS792341","10.1097/PSY.0b013e31818434ab"
"18797246","Ethanol injected into the hypothalamic arcuate nucleus induces behavioral stimulation in rats: an effect prevented by catalase inhibition and naltrexone","Pastor R, Aragon CM.","Behav Pharmacol. 2008 Oct;19(7):698-705. doi: 10.1097/FBP.0b013e328315ecd7.","Pastor R","Behav Pharmacol","2008","2008/09/18","","","10.1097/FBP.0b013e328315ecd7"
"18796184","Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation","O'Malley SS, Krishnan-Sarin S, McKee SA, Leeman RF, Cooney NL, Meandzija B, Wu R, Makuch RW.","Int J Neuropsychopharmacol. 2009 Jun;12(5):589-97. doi: 10.1017/S146114570800936X. Epub 2008 Sep 17.","O'Malley SS","Int J Neuropsychopharmacol","2009","2008/09/18","PMC3094855","NIHMS133352","10.1017/S146114570800936X"
"18795264","A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients","Kim SG, Kim CM, Choi SW, Jae YM, Lee HG, Son BK, Kim JG, Choi YS, Kim HO, Kim SY, Oslin DW.","Psychopharmacology (Berl). 2009 Jan;201(4):611-8. doi: 10.1007/s00213-008-1330-5. Epub 2008 Sep 16.","Kim SG","Psychopharmacology (Berl)","2009","2008/09/17","","","10.1007/s00213-008-1330-5"
"18793682","The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat","Häggkvist J, Lindholm S, Franck J.","Behav Brain Res. 2009 Jan 30;197(1):219-24. doi: 10.1016/j.bbr.2008.08.021. Epub 2008 Aug 28.","Häggkvist J","Behav Brain Res","2009","2008/09/17","","","10.1016/j.bbr.2008.08.021"
"18779548","An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care","Ernst DB, Pettinati HM, Weiss RD, Donovan DM, Longabaugh R.","Ann Fam Med. 2008 Sep-Oct;6(5):435-40. doi: 10.1370/afm.884.","Ernst DB","Ann Fam Med","2008","2008/09/10","PMC2532776","","10.1370/afm.884"
"18777614","Methylnaltrexone for opioid-induced constipation in advanced illness","Chappell D, Rehm M, Conzen P.","N Engl J Med. 2008 Sep 4;359(10):1071; author reply 1071.","Chappell D","N Engl J Med","2008","2008/09/09","","",""
"18775624","The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients","Lapham S, Forman R, Alexander M, Illeperuma A, Bohn MJ.","J Subst Abuse Treat. 2009 Jan;36(1):1-6. doi: 10.1016/j.jsat.2008.07.001. Epub 2008 Sep 4.","Lapham S","J Subst Abuse Treat","2009","2008/09/09","","","10.1016/j.jsat.2008.07.001"
"18774673","Effect of naltrexone during extinction of alcohol-reinforced responding and during repeated cue-conditioned reinstatement sessions in a cue exposure style treatment","Williams KL, Schimmel JS.","Alcohol. 2008 Nov;42(7):553-63. doi: 10.1016/j.alcohol.2008.06.003. Epub 2008 Sep 6.","Williams KL","Alcohol","2008","2008/09/09","PMC2628460","NIHMS74489","10.1016/j.alcohol.2008.06.003"
"18768955","Methylnaltrexone for opioid-induced constipation in advanced illness","Sanz Rubiales A, del Valle Rivero ML.","N Engl J Med. 2008 Sep 4;359(10):1070-1; author reply 1071. doi: 10.1056/NEJMc081373.","Sanz Rubiales A","N Engl J Med","2008","2008/09/05","","","10.1056/NEJMc081373"
"18768770","Food deprivation increases the mRNA expression of micro-opioid receptors in the ventral medial hypothalamus and arcuate nucleus","Barnes MJ, Primeaux SD, Bray GA.","Am J Physiol Regul Integr Comp Physiol. 2008 Nov;295(5):R1385-90. doi: 10.1152/ajpregu.00030.2008. Epub 2008 Sep 3.","Barnes MJ","Am J Physiol Regul Integr Comp Physiol","2008","2008/09/05","PMC2584848","","10.1152/ajpregu.00030.2008"
"18766023","Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2","Bruchas MR, Xu M, Chavkin C.","Neuroreport. 2008 Sep 17;19(14):1417-22. doi: 10.1097/WNR.0b013e32830dd655.","Bruchas MR","Neuroreport","2008","2008/09/04","PMC2641011","NIHMS89971","10.1097/WNR.0b013e32830dd655"
"18765480","Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial","Jayaram-Lindström N, Hammarberg A, Beck O, Franck J.","Am J Psychiatry. 2008 Nov;165(11):1442-8. doi: 10.1176/appi.ajp.2008.08020304. Epub 2008 Sep 2.","Jayaram-Lindström N","Am J Psychiatry","2008","2008/09/04","","","10.1176/appi.ajp.2008.08020304"
"18755589","Synthesis of N-isobutylnoroxymorphone from naltrexone by a selective cyclopropane ring opening reaction","Fujii H, Osa Y, Ishihara M, Hanamura S, Nemoto T, Nakajima M, Hasebe K, Mochizuki H, Nagase H.","Bioorg Med Chem Lett. 2008 Sep 15;18(18):4978-81. doi: 10.1016/j.bmcl.2008.08.019. Epub 2008 Aug 12.","Fujii H","Bioorg Med Chem Lett","2008","2008/08/30","","","10.1016/j.bmcl.2008.08.019"
"18753268","C2 spinal cord stimulation induces dynorphin release from rat T4 spinal cord: potential modulation of myocardial ischemia-sensitive neurons","Ding X, Hua F, Sutherly K, Ardell JL, Williams CA.","Am J Physiol Regul Integr Comp Physiol. 2008 Nov;295(5):R1519-28. doi: 10.1152/ajpregu.00899.2007. Epub 2008 Aug 27.","Ding X","Am J Physiol Regul Integr Comp Physiol","2008","2008/08/30","PMC2584856","","10.1152/ajpregu.00899.2007"
"18729628","Narp regulates long-term aversive effects of morphine withdrawal","Reti IM, Crombag HS, Takamiya K, Sutton JM, Guo N, Dinenna ML, Huganir RL, Holland PC, Baraban JM.","Behav Neurosci. 2008 Aug;122(4):760-8. doi: 10.1037/a0012514.","Reti IM","Behav Neurosci","2008","2008/08/30","PMC2562546","NIHMS59344","10.1037/a0012514"
"18728058","A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis","Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G.","Mult Scler. 2008 Sep;14(8):1076-83. doi: 10.1177/1352458508095828.","Gironi M","Mult Scler","2008","2008/08/30","","","10.1177/1352458508095828"
"18726088","Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys","Becker GL, Gerak LR, Koek W, France CP.","Psychopharmacology (Berl). 2008 Dec;201(3):373-82. doi: 10.1007/s00213-008-1293-6. Epub 2008 Aug 23.","Becker GL","Psychopharmacology (Berl)","2008","2008/08/30","PMC3449323","NIHMS406526","10.1007/s00213-008-1293-6"
"18725311","Central administration of galanin stimulates feeding behavior in chicks","Tachibana T, Mori M, Khan MS, Ueda H, Sugahara K, Hiramatsu K.","Comp Biochem Physiol A Mol Integr Physiol. 2008 Dec;151(4):637-40. doi: 10.1016/j.cbpa.2008.08.001. Epub 2008 Aug 6.","Tachibana T","Comp Biochem Physiol A Mol Integr Physiol","2008","2008/08/30","","","10.1016/j.cbpa.2008.08.001"
"18721804","kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B)","Wu G, Wang H, Yang J, Yang Y, Liu C, Jing L, Wong TM.","Eur J Pharmacol. 2008 Oct 24;595(1-3):52-7. doi: 10.1016/j.ejphar.2008.07.059. Epub 2008 Aug 5.","Wu G","Eur J Pharmacol","2008","2008/08/30","","","10.1016/j.ejphar.2008.07.059"
"18717537","Hyaluronan-tethered opioid depots: synthetic strategies and release kinetics in vitro and in vivo","Gianolio DA, Philbrook M, Avila LZ, Young LE, Plate L, Santos MR, Bernasconi R, Liu H, Ahn S, Sun W, Jarrett PK, Miller RJ.","Bioconjug Chem. 2008 Sep;19(9):1767-74. doi: 10.1021/bc8000479. Epub 2008 Aug 22.","Gianolio DA","Bioconjug Chem","2008","2008/08/23","","","10.1021/bc8000479"
"18715283","Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial","Mannelli P, Patkar AA, Peindl K, Gorelick DA, Wu LT, Gottheil E.","Addict Biol. 2009 Apr;14(2):204-13. doi: 10.1111/j.1369-1600.2008.00119.x. Epub 2008 Aug 19.","Mannelli P","Addict Biol","2009","2008/08/22","PMC2657183","NIHMS71369","10.1111/j.1369-1600.2008.00119.x"
"18712053","Immobilization stress inhibits intimal fibromuscular proliferation in the process of arterial remodeling in rats","Iwai K, Takahashi T, Nakahashi T, Nomura K, Atsumi M, Zeng L, Ishigami K, Kanda T, Yamaguchi N, Morimoto S.","Hypertens Res. 2008 May;31(5):977-86. doi: 10.1291/hypres.31.977.","Iwai K","Hypertens Res","2008","2008/08/21","","","10.1291/hypres.31.977"
"18705652","Crucial role of peripheral kappa-opioid receptors in a model of periodontal disease in rats","Pacheco CM, Queiroz-Junior CM, Maltos KL, Caliari MV, Pacheco DF, Duarte ID, Francischi JN.","J Periodontal Res. 2008 Dec;43(6):730-6. doi: 10.1111/j.1600-0765.2008.01102.x. Epub 2008 Aug 14.","Pacheco CM","J Periodontal Res","2008","2008/08/19","","","10.1111/j.1600-0765.2008.01102.x"
"18704097","Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice","Chefer VI, Shippenberg TS.","Neuropsychopharmacology. 2009 Mar;34(4):887-98. doi: 10.1038/npp.2008.128. Epub 2008 Aug 13.","Chefer VI","Neuropsychopharmacology","2009","2008/08/16","PMC2639630","NIHMS78398","10.1038/npp.2008.128"
"18703474","Naltrexone for the management of alcohol dependence","Anton RF.","N Engl J Med. 2008 Aug 14;359(7):715-21. doi: 10.1056/NEJMct0801733.","Anton RF","N Engl J Med","2008","2008/08/16","PMC2565602","NIHMS67847","10.1056/NEJMct0801733"
"18701308","Design and synthesis of a metabolically stable and potent antitussive agent, a novel delta opioid receptor antagonist, TRK-851","Sakami S, Kawai K, Maeda M, Aoki T, Fujii H, Ohno H, Ito T, Saitoh A, Nakao K, Izumimoto N, Matsuura H, Endo T, Ueno S, Natsume K, Nagase H.","Bioorg Med Chem. 2008 Sep 1;16(17):7956-67. doi: 10.1016/j.bmc.2008.07.065. Epub 2008 Jul 29.","Sakami S","Bioorg Med Chem","2008","2008/08/15","","","10.1016/j.bmc.2008.07.065"
"18701256","Negative symptoms are associated with less alcohol use, craving, and ""high"" in alcohol dependent patients with schizophrenia","Batki SL, Leontieva L, Dimmock JA, Ploutz-Snyder R.","Schizophr Res. 2008 Oct;105(1-3):201-7. doi: 10.1016/j.schres.2008.06.020. Epub 2008 Aug 13.","Batki SL","Schizophr Res","2008","2008/08/15","PMC2582942","NIHMS74867","10.1016/j.schres.2008.06.020"
"18694369","Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus","Kraft MD.","Expert Opin Investig Drugs. 2008 Sep;17(9):1365-77. doi: 10.1517/13543784.17.9.1365.","Kraft MD","Expert Opin Investig Drugs","2008","2008/08/13","","","10.1517/13543784.17.9.1365"
"18690389","[Effects of intracerebroventricular injection of delta-opioid receptor agonist TAN-67 or antagonist naltrindole on acute cerebral ischemia in rat]","Tian XS, Zhou F, Yang R, Xia Y, Wu GC, Guo JC.","Sheng Li Xue Bao. 2008 Aug 25;60(4):475-84.","Tian XS","Sheng Li Xue Bao","2008","2008/08/12","","",""
"18688808","The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior","Sandman CA, Touchette PE, Marion SD, Chicz-DeMet A.","Dev Psychobiol. 2008 Nov;50(7):680-9. doi: 10.1002/dev.20323.","Sandman CA","Dev Psychobiol","2008","2008/08/09","PMC2577125","NIHMS64982","10.1002/dev.20323"
"18688204","Methylnaltrexone (Relistor) for opioid induced constipation","","Med Lett Drugs Ther. 2008 Aug 11;50(1292):63-4.","","Med Lett Drugs Ther","2008","2008/08/09","","",""
"18681987","Naltrexone treatment produces dose-related effects on food and water intake but daily alcohol consumption is not affected","Juárez J, Barrios De Tomasi E.","Nutr Neurosci. 2008 Aug;11(4):183-92. doi: 10.1179/147683008X301577.","Juárez J","Nutr Neurosci","2008","2008/08/07","","","10.1179/147683008X301577"
"18680838","[Pharmacotherapy of alcohol dependence]","Soyka M.","MMW Fortschr Med. 2008 May 19;150 Suppl 2:22-4.","Soyka M","MMW Fortschr Med","2008","2008/08/06","","",""
"18671992","Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice","Amirshahrokhi K, Dehpour AR, Hadjati J, Sotoudeh M, Ghazi-Khansari M.","Toxicol Appl Pharmacol. 2008 Oct 1;232(1):119-24. doi: 10.1016/j.taap.2008.06.020. Epub 2008 Jul 11.","Amirshahrokhi K","Toxicol Appl Pharmacol","2008","2008/08/02","","","10.1016/j.taap.2008.06.020"
"18671810","Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats","Simms JA, Steensland P, Medina B, Abernathy KE, Chandler LJ, Wise R, Bartlett SE.","Alcohol Clin Exp Res. 2008 Oct;32(10):1816-23. doi: 10.1111/j.1530-0277.2008.00753.x. Epub 2008 Jul 30.","Simms JA","Alcohol Clin Exp Res","2008","2008/08/02","PMC3151464","NIHMS314108","10.1111/j.1530-0277.2008.00753.x"
"18662331","Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)","Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, Sholar PW, Patel SJ, Crysdale NY, Harrison JA, Maier SF, Rice KC, Watkins LR.","Eur J Neurosci. 2008 Jul;28(1):20-9. doi: 10.1111/j.1460-9568.2008.06321.x.","Hutchinson MR","Eur J Neurosci","2008","2008/07/30","PMC2588470","NIHMS79045","10.1111/j.1460-9568.2008.06321.x"
"18656501","Differential responses to morphine-induced analgesia in the tail-flick test","Cecchi M, Capriles N, Watson SJ, Akil H.","Behav Brain Res. 2008 Dec 12;194(2):146-51. doi: 10.1016/j.bbr.2008.06.034. Epub 2008 Jul 6.","Cecchi M","Behav Brain Res","2008","2008/07/29","PMC2566943","NIHMS70913","10.1016/j.bbr.2008.06.034"
"18656459","Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone","Crain SM, Shen KF.","Brain Res. 2008 Sep 22;1231:16-24. doi: 10.1016/j.brainres.2008.07.015. Epub 2008 Jul 12.","Crain SM","Brain Res","2008","2008/07/29","","","10.1016/j.brainres.2008.07.015"
"18644685","A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence","Farren CK, Scimeca M, Wu R, Malley SO.","Drug Alcohol Depend. 2009 Jan 1;99(1-3):317-21. doi: 10.1016/j.drugalcdep.2008.06.006. Epub 2008 Jul 21.","Farren CK","Drug Alcohol Depend","2009","2008/07/23","PMC3668640","NIHMS90440","10.1016/j.drugalcdep.2008.06.006"
"18641399","Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome","Ahmed MI, Duleba AJ, El Shahat O, Ibrahim ME, Salem A.","Hum Reprod. 2008 Nov;23(11):2564-9. doi: 10.1093/humrep/den273. Epub 2008 Jul 18.","Ahmed MI","Hum Reprod","2008","2008/07/22","","","10.1093/humrep/den273"
"18639579","Genetic and early environmental contributions to alcohol's aversive and physiological effects","Roma PG, Rinker JA, Serafine KM, Chen SA, Barr CS, Cheng K, Rice KC, Riley AL.","Pharmacol Biochem Behav. 2008 Nov;91(1):134-9. doi: 10.1016/j.pbb.2008.06.022. Epub 2008 Jun 29.","Roma PG","Pharmacol Biochem Behav","2008","2008/07/22","PMC2565690","NIHMS70157","10.1016/j.pbb.2008.06.022"
"18639530","In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat","Antonilli L, Brusadin V, Milella MS, Sobrero F, Badiani A, Nencini P.","Biochem Pharmacol. 2008 Sep 1;76(5):672-9. doi: 10.1016/j.bcp.2008.06.011. Epub 2008 Jul 1.","Antonilli L","Biochem Pharmacol","2008","2008/07/22","","","10.1016/j.bcp.2008.06.011"
"18637671","Structure-antitussive activity relationships of naltrindole derivatives. Identification of novel and potent antitussive agents","Sakami S, Maeda M, Kawai K, Aoki T, Kawamura K, Fujii H, Hasebe K, Nakajima M, Endo T, Ueno S, Ito T, Kamei J, Nagase H.","J Med Chem. 2008 Aug 14;51(15):4404-11. doi: 10.1021/jm701440h. Epub 2008 Jul 19.","Sakami S","J Med Chem","2008","2008/07/22","","","10.1021/jm701440h"
"18636243","Some effects of dopamine transporter and receptor ligands on discriminative stimulus, physiologic, and directly observable indices of opioid withdrawal in rhesus monkeys","McMahon LR, Li JX, Carroll FI, France CP.","Psychopharmacology (Berl). 2009 Apr;203(2):411-20. doi: 10.1007/s00213-008-1242-4. Epub 2008 Jul 18.","McMahon LR","Psychopharmacology (Berl)","2009","2008/07/19","PMC3489006","NIHMS414696","10.1007/s00213-008-1242-4"
"18635711","The effects of opioid receptor blockade on experimental panic provocation with CO2","Esquivel G, Fernández-Torre O, Schruers KR, Wijnhoven LL, Griez EJ.","J Psychopharmacol. 2009 Nov;23(8):975-8. doi: 10.1177/0269881108093844. Epub 2008 Jul 17.","Esquivel G","J Psychopharmacol","2009","2008/07/19","","","10.1177/0269881108093844"
"18633703","Electroacupuncture reduces voluntary alcohol intake in alcohol-preferring rats via an opiate-sensitive mechanism","Overstreet DH, Cui CL, Ma YY, Guo CY, Han JS, Lukas SE, Lee DY.","Neurochem Res. 2008 Oct;33(10):2166-70. doi: 10.1007/s11064-008-9791-9. Epub 2008 Jul 17.","Overstreet DH","Neurochem Res","2008","2008/07/18","","","10.1007/s11064-008-9791-9"
"18631323","Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats","Gilpin NW, Richardson HN, Koob GF.","Alcohol Clin Exp Res. 2008 Sep;32(9):1535-42. doi: 10.1111/j.1530-0277.2008.00745.x. Epub 2008 Jul 10.","Gilpin NW","Alcohol Clin Exp Res","2008","2008/07/18","PMC2583093","NIHMS76718","10.1111/j.1530-0277.2008.00745.x"
"18616687","Relationship between medication adherence and treatment outcomes: the COMBINE study","Zweben A, Pettinati HM, Weiss RD, Youngblood M, Cox CE, Mattson ME, Gorroochurn P, Ciraulo D.","Alcohol Clin Exp Res. 2008 Sep;32(9):1661-9. doi: 10.1111/j.1530-0277.2008.00743.x. Epub 2008 Jul 9.","Zweben A","Alcohol Clin Exp Res","2008","2008/07/12","PMC2574640","NIHMS64366","10.1111/j.1530-0277.2008.00743.x"
"18612890","Substance abuse and domestic violence interventions: the need for theoretical based research","Easton CJ, Lee B, Wupperman P, Zonana H.","Am J Addict. 2008 Jul-Aug;17(4):341-2. doi: 10.1080/10550490802139101.","Easton CJ","Am J Addict","2008","2008/07/10","","","10.1080/10550490802139101"
"18612879","Effects of naltrexone during the descending limb of the blood alcohol curve","Ray LA, Hutchison KE, MacKillop J, Miranda R Jr, Audette A, Swift R, Monti PM.","Am J Addict. 2008 Jul-Aug;17(4):257-64. doi: 10.1080/10550490802138400.","Ray LA","Am J Addict","2008","2008/07/10","","","10.1080/10550490802138400"
"18602932","The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum","Bosse KE, Jutkiewicz EM, Gnegy ME, Traynor JR.","Neuropharmacology. 2008 Oct;55(5):755-62. doi: 10.1016/j.neuropharm.2008.06.017. Epub 2008 Jun 18.","Bosse KE","Neuropharmacology","2008","2008/07/08","PMC2659683","NIHMS72820","10.1016/j.neuropharm.2008.06.017"
"18598850","Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption","White DA, Ballard ME, Harmon AC, Holtzman SG.","Brain Res Bull. 2008 Aug 15;76(6):597-604. doi: 10.1016/j.brainresbull.2008.04.002. Epub 2008 May 9.","White DA","Brain Res Bull","2008","2008/07/05","PMC2504860","NIHMS59434","10.1016/j.brainresbull.2008.04.002"
"18597954","Non-opioid induction of morphine-6-glucuronide synthesis is elicited by prolonged exposure of rat hepatocytes to heroin","Graziani M, Antonilli L, Togna AR, Brusadin V, Viola S, Togna G, Badiani A, Nencini P.","Drug Alcohol Depend. 2008 Dec 1;98(3):179-84. doi: 10.1016/j.drugalcdep.2008.05.008. Epub 2008 Jul 1.","Graziani M","Drug Alcohol Depend","2008","2008/07/04","","","10.1016/j.drugalcdep.2008.05.008"
"18594026","A 50-year-old woman addicted to heroin: review of treatment of heroin addiction","O'Brien CP.","JAMA. 2008 Jul 16;300(3):314-21. doi: 10.1001/jama.300.1.jrr80005. Epub 2008 Jul 1.","O'Brien CP","JAMA","2008","2008/07/03","PMC3812920","NIHMS314996","10.1001/jama.300.1.jrr80005"
"18593955","The effects of herkinorin, the first mu-selective ligand from a salvinorin A-derived scaffold, in a neuroendocrine biomarker assay in nonhuman primates","Butelman ER, Rus S, Simpson DS, Wolf A, Prisinzano TE, Kreek MJ.","J Pharmacol Exp Ther. 2008 Oct;327(1):154-60. doi: 10.1124/jpet.108.140079. Epub 2008 Jul 1.","Butelman ER","J Pharmacol Exp Ther","2008","2008/07/03","PMC2614932","NIHMS57326","10.1124/jpet.108.140079"
"18593582","Pyritinol reduces nociception and oxidative stress in diabetic rats","Jiménez-Andrade GY, Reyes-García G, Sereno G, Ceballos-Reyes G, Vidal-Cantú GC, Granados-Soto V.","Eur J Pharmacol. 2008 Aug 20;590(1-3):170-6. doi: 10.1016/j.ejphar.2008.06.050. Epub 2008 Jun 18.","Jiménez-Andrade GY","Eur J Pharmacol","2008","2008/07/03","","","10.1016/j.ejphar.2008.06.050"
"18586174","Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial","Schottenfeld RS, Chawarski MC, Mazlan M.","Lancet. 2008 Jun 28;371(9631):2192-200. doi: 10.1016/S0140-6736(08)60954-X.","Schottenfeld RS","Lancet","2008","2008/07/01","PMC4041792","NIHMS57282","10.1016/S0140-6736(08)60954-X"
"18585861","Roles of opioid receptor subtypes on the antinociceptive effect of intrathecal sildenafil in the formalin test of rats","Yoon MH, Kim WM, Lee HG, Kim YO, Huang LJ, An TH.","Neurosci Lett. 2008 Aug 15;441(1):125-8. doi: 10.1016/j.neulet.2008.06.011. Epub 2008 Jun 7.","Yoon MH","Neurosci Lett","2008","2008/07/01","","","10.1016/j.neulet.2008.06.011"
"18584575","The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials","Snyder JL, Bowers TG.","Am J Drug Alcohol Abuse. 2008;34(4):449-61. doi: 10.1080/00952990802082198.","Snyder JL","Am J Drug Alcohol Abuse","2008","2008/06/28","","","10.1080/00952990802082198"
"18584566","Pharmacogenetic treatments for drug addiction: alcohol and opiates","Haile CN, Kosten TA, Kosten TR.","Am J Drug Alcohol Abuse. 2008;34(4):355-81. doi: 10.1080/00952990802122564.","Haile CN","Am J Drug Alcohol Abuse","2008","2008/06/28","","","10.1080/00952990802122564"
"18584469","Correspondence of Interactive Voice Response (IVR) reports of nicotine withdrawal, craving, and negative mood with questionnaire ratings","Toll BA, Cooney JL, McKee SA, O'Malley SS, Cooney NL.","Nicotine Tob Res. 2008 Jun;10(6):1057-64. doi: 10.1080/14622200802097498.","Toll BA","Nicotine Tob Res","2008","2008/06/28","PMC2791461","NIHMS150553","10.1080/14622200802097498"
"18584398","Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'","Brewer C.","Drug Alcohol Rev. 2008 Jul;27(4):447-8; author reply 448-9. doi: 10.1080/09595230802090782.","Brewer C","Drug Alcohol Rev","2008","2008/06/28","","","10.1080/09595230802090782"
"18581096","Predicting response to opiate antagonists and placebo in the treatment of pathological gambling","Grant JE, Kim SW, Hollander E, Potenza MN.","Psychopharmacology (Berl). 2008 Nov;200(4):521-7. doi: 10.1007/s00213-008-1235-3. Epub 2008 Jun 26.","Grant JE","Psychopharmacology (Berl)","2008","2008/06/27","PMC3683409","NIHMS199198","10.1007/s00213-008-1235-3"
"18580669","Managing opioid-induced constipation","","Nursing. 2008 Jul;38(7):55. doi: 10.1097/01.NURSE.0000325349.32104.aa.","","Nursing","2008","2008/06/27","","","10.1097/01.NURSE.0000325349.32104.aa"
"18579164","Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception","Chen SR, Pan HL.","Neuropharmacology. 2008 Aug;55(2):215-22. doi: 10.1016/j.neuropharm.2008.05.011. Epub 2008 May 22.","Chen SR","Neuropharmacology","2008","2008/06/27","PMC2578815","NIHMS64990","10.1016/j.neuropharm.2008.05.011"
"18577062","The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case","Chang Y, Golkar L.","Pediatr Dermatol. 2008 May-Jun;25(3):403-4. doi: 10.1111/j.1525-1470.2008.00699.x.","Chang Y","Pediatr Dermatol","2008","2008/06/26","","","10.1111/j.1525-1470.2008.00699.x"
"18571771","Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2","Sakurada S, Sawai T, Mizoguchi H, Watanabe H, Watanabe C, Yonezawa A, Morimoto M, Sato T, Komatsu T, Sakurada T.","Peptides. 2008 Sep;29(9):1554-60. doi: 10.1016/j.peptides.2008.04.012. Epub 2008 Apr 30.","Sakurada S","Peptides","2008","2008/06/24","","","10.1016/j.peptides.2008.04.012"
"18571706","Inhibition of the development of morphine tolerance by a potent dual mu-delta-opioid antagonist, H-Dmt-Tic-Lys-NH-CH2-Ph","Jinsmaa Y, Marczak ED, Balboni G, Salvadori S, Lazarus LH.","Pharmacol Biochem Behav. 2008 Oct;90(4):651-7. doi: 10.1016/j.pbb.2008.05.008.","Jinsmaa Y","Pharmacol Biochem Behav","2008","2008/06/24","PMC2597683","NIHMS64770","10.1016/j.pbb.2008.05.008"
"18569389","The opioid antagonist naltrexone improves murine inflammatory bowel disease","Matters GL, Harms JF, McGovern C, Fitzpatrick L, Parikh A, Nilo N, Smith JP.","J Immunotoxicol. 2008 Apr;5(2):179-87. doi: 10.1080/15476910802131469.","Matters GL","J Immunotoxicol","2008","2008/06/24","","","10.1080/15476910802131469"
"18566238","Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis","Singleton PA, Garcia JG, Moss J.","Mol Cancer Ther. 2008 Jun;7(6):1669-79. doi: 10.1158/1535-7163.MCT-07-2217.","Singleton PA","Mol Cancer Ther","2008","2008/06/21","","","10.1158/1535-7163.MCT-07-2217"
"18562104","Stress-evoked opioid release inhibits pain in major depressive disorder","Frew AK, Drummond PD.","Pain. 2008 Oct 15;139(2):284-92. doi: 10.1016/j.pain.2008.04.022. Epub 2008 Jun 17.","Frew AK","Pain","2008","2008/06/20","","","10.1016/j.pain.2008.04.022"
"18562017","Morphine suppresses intracellular interferon-alpha expression in neuronal cells","Wan Q, Wang X, Wang YJ, Song L, Wang SH, Ho WZ.","J Neuroimmunol. 2008 Aug 13;199(1-2):1-9. doi: 10.1016/j.jneuroim.2008.04.026. Epub 2008 Jun 17.","Wan Q","J Neuroimmunol","2008","2008/06/20","PMC2535790","NIHMS64372","10.1016/j.jneuroim.2008.04.026"
"18552729","Community treatment programs take up buprenorphine","Casadonte PP, Kolodner GF, Horton T, McMurphy SM.","Sci Pract Perspect. 2004 Aug;2(2):24-9. doi: 10.1151/spp042224.","Casadonte PP","Sci Pract Perspect","2004","2008/06/17","PMC2851018","","10.1151/spp042224"
"18552399","Association between the Stin2 VNTR polymorphism of the serotonin transporter gene and treatment outcome in alcohol-dependent patients","Florez G, Saiz P, Garcia-Portilla P, Alvarez S, Nogueíras L, Morales B, Alvarez V, Coto E, Bobes J.","Alcohol Alcohol. 2008 Sep-Oct;43(5):516-22. doi: 10.1093/alcalc/agn048. Epub 2008 Jun 14.","Florez G","Alcohol Alcohol","2008","2008/06/17","","","10.1093/alcalc/agn048"
"18551889","The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation","Walsh Z, Epstein A, Munisamy G, King A.","J Addict Dis. 2008;27(1):65-72. doi: 10.1300/J069v27n01_07.","Walsh Z","J Addict Dis","2008","2008/06/17","","","10.1300/J069v27n01_07"
"18549816","The Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipation","Lang L.","Gastroenterology. 2008 Jul;135(1):6. doi: 10.1053/j.gastro.2008.06.003. Epub 2008 Jun 10.","Lang L","Gastroenterology","2008","2008/06/14","","","10.1053/j.gastro.2008.06.003"
"18540910","A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention","Oslin DW, Lynch KG, Pettinati HM, Kampman KM, Gariti P, Gelfand L, Ten Have T, Wortman S, Dundon W, Dackis C, Volpicelli JR, O'Brien CP.","Alcohol Clin Exp Res. 2008 Jul;32(7):1299-308. doi: 10.1111/j.1530-0277.2008.00698.x.","Oslin DW","Alcohol Clin Exp Res","2008","2008/06/11","PMC3812909","NIHMS315003","10.1111/j.1530-0277.2008.00698.x"
"18537939","Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers","Arias AJ, Armeli S, Gelernter J, Covault J, Kallio A, Karhuvaara S, Koivisto T, Mäkelä R, Kranzler HR.","Alcohol Clin Exp Res. 2008 Jul;32(7):1159-66. doi: 10.1111/j.1530-0277.2008.00735.x.","Arias AJ","Alcohol Clin Exp Res","2008","2008/06/10","PMC2950972","NIHMS238559","10.1111/j.1530-0277.2008.00735.x"
"18536755","Involvement of the BLT2 receptor in the itch-associated scratching induced by 12-(S)-lipoxygenase products in ICR mice","Kim HJ, Kim DK, Kim H, Koh JY, Kim KM, Noh MS, Lee S, Kim S, Park SH, Kim JJ, Kim SY, Lee CH.","Br J Pharmacol. 2008 Jul;154(5):1073-8. doi: 10.1038/bjp.2008.220. Epub 2008 Jun 9.","Kim HJ","Br J Pharmacol","2008","2008/06/10","PMC2451041","","10.1038/bjp.2008.220"
"18528756","In vivo characterization of (-)(-)MCL-144 and (+)(-)MCL-193: isomeric, bivalent ligands with mu/kappa agonist properties","Mathews JL, Fulton BS, Negus SS, Neumeyer JL, Bidlack JM.","Neurochem Res. 2008 Oct;33(10):2142-50. doi: 10.1007/s11064-008-9752-3. Epub 2008 Jun 5.","Mathews JL","Neurochem Res","2008","2008/06/06","PMC2574661","NIHMS51035","10.1007/s11064-008-9752-3"
"18518841","Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence","Anton RF.","Pharmacogenomics. 2008 Jun;9(6):655-8. doi: 10.2217/14622416.9.6.655.","Anton RF","Pharmacogenomics","2008","2008/06/04","","","10.2217/14622416.9.6.655"
"18515460","Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone","Martinotti G, Di Nicola M, Di Giannantonio M, Janiri L.","J Psychopharmacol. 2009 Mar;23(2):123-9. doi: 10.1177/0269881108089596. Epub 2008 May 30.","Martinotti G","J Psychopharmacol","2009","2008/06/03","","","10.1177/0269881108089596"
"18509126","Opioid side effects--mechanism-based therapy","Berde C, Nurko S.","N Engl J Med. 2008 May 29;358(22):2400-2. doi: 10.1056/NEJMe0801783.","Berde C","N Engl J Med","2008","2008/05/30","","","10.1056/NEJMe0801783"
"18509120","Methylnaltrexone for opioid-induced constipation in advanced illness","Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ.","N Engl J Med. 2008 May 29;358(22):2332-43. doi: 10.1056/NEJMoa0707377.","Thomas J","N Engl J Med","2008","2008/05/30","","","10.1056/NEJMoa0707377"
"18502613","The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice","Bahremand A, Shafaroodi H, Ghasemi M, Nasrabady SE, Gholizadeh S, Dehpour AR.","Epilepsy Res. 2008 Sep;81(1):44-51. doi: 10.1016/j.eplepsyres.2008.04.010. Epub 2008 May 27.","Bahremand A","Epilepsy Res","2008","2008/05/27","","","10.1016/j.eplepsyres.2008.04.010"
"18502591","A pilot study of naltrexone and BASICS for heavy drinking young adults","Leeman RF, Palmer RS, Corbin WR, Romano DM, Meandzija B, O'Malley SS.","Addict Behav. 2008 Aug;33(8):1048-54. doi: 10.1016/j.addbeh.2008.04.007. Epub 2008 Apr 13.","Leeman RF","Addict Behav","2008","2008/05/27","PMC2568078","NIHMS56357","10.1016/j.addbeh.2008.04.007"
"18499867","Relistor approved for opioid-related constipation","Traynor K.","Am J Health Syst Pharm. 2008 Jun 1;65(11):996. doi: 10.2146/news080043.","Traynor K","Am J Health Syst Pharm","2008","2008/05/24","","","10.2146/news080043"
"18499626","The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies","Xie H, Woods JH, Traynor JR, Ko MC.","Anesth Analg. 2008 Jun;106(6):1873-81. doi: 10.1213/ane.0b013e31817300be.","Xie H","Anesth Analg","2008","2008/05/24","PMC2443862","NIHMS56125","10.1213/ane.0b013e31817300be"
"18482418","Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?","Richardson K, Baillie A, Reid S, Morley K, Teesson M, Sannibale C, Weltman M, Haber P.","Addiction. 2008 Jun;103(6):953-9. doi: 10.1111/j.1360-0443.2008.02215.x.","Richardson K","Addiction","2008","2008/05/17","","","10.1111/j.1360-0443.2008.02215.x"
"18482157","Using topiramate or naltrexone for the treatment of alcohol-dependent patients","Flórez G, García-Portilla P, Alvarez S, Saiz PA, Nogueiras L, Bobes J.","Alcohol Clin Exp Res. 2008 Jul;32(7):1251-9. doi: 10.1111/j.1530-0277.2008.00680.x.","Flórez G","Alcohol Clin Exp Res","2008","2008/05/17","","","10.1111/j.1530-0277.2008.00680.x"
"18482155","Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial","O'Malley SS, Robin RW, Levenson AL, GreyWolf I, Chance LE, Hodgkinson CA, Romano D, Robinson J, Meandzija B, Stillner V, Wu R, Goldman D.","Alcohol Clin Exp Res. 2008 Jul;32(7):1271-83. doi: 10.1111/j.1530-0277.2008.00682.x.","O'Malley SS","Alcohol Clin Exp Res","2008","2008/05/17","PMC2746027","NIHMS106873","10.1111/j.1530-0277.2008.00682.x"
"18473169","Mu-opioid receptor in the nucleus submedius: involvement in opioid-induced inhibition of mirror-image allodynia in a rat model of neuropathic pain","Wang JY, Zhao M, Huang FS, Tang JS, Yuan YK.","Neurochem Res. 2008 Oct;33(10):2134-41. doi: 10.1007/s11064-008-9733-6. Epub 2008 May 13.","Wang JY","Neurochem Res","2008","2008/05/14","","","10.1007/s11064-008-9733-6"
"18470505","Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception","Li JX, McMahon LR, Gerak LR, Becker GL, France CP.","Psychopharmacology (Berl). 2008 Aug;199(2):199-208. doi: 10.1007/s00213-008-1157-0. Epub 2008 May 10.","Li JX","Psychopharmacology (Berl)","2008","2008/05/13","PMC3480084","NIHMS257867","10.1007/s00213-008-1157-0"
"18468954","Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling","Largent-Milnes TM, Guo W, Wang HY, Burns LH, Vanderah TW.","J Pain. 2008 Aug;9(8):700-13. doi: 10.1016/j.jpain.2008.03.005. Epub 2008 May 12.","Largent-Milnes TM","J Pain","2008","2008/05/13","PMC5469510","NIHMS860555","10.1016/j.jpain.2008.03.005"
"18466896","Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure","Vihavainen T, Piltonen M, Tuominen RK, Korpi ER, Ahtee L.","Eur J Pharmacol. 2008 Jun 10;587(1-3):169-74. doi: 10.1016/j.ejphar.2008.03.028. Epub 2008 Apr 1.","Vihavainen T","Eur J Pharmacol","2008","2008/05/10","","","10.1016/j.ejphar.2008.03.028"
"18465827","Synthesis and characterization of thermosensitive and pH-sensitive poly (N-isopropylacrylamide-acrylamide-vinylpyrrolidone) for use in controlled release of naltrexone","Salehi R, Arsalani N, Davaran S, Entezami AA.","J Biomed Mater Res A. 2009 Jun 15;89(4):919-28. doi: 10.1002/jbm.a.32047.","Salehi R","J Biomed Mater Res A","2009","2008/05/10","","","10.1002/jbm.a.32047"
"18465246","Opioid receptor blockade improves mesenteric responsiveness in biliary cirrhosis","Ebrahimkhani MR, Moezi L, Kiani S, Merat S, Dehpour AR.","Dig Dis Sci. 2008 Nov;53(11):3007-11. doi: 10.1007/s10620-008-0261-7. Epub 2008 May 9.","Ebrahimkhani MR","Dig Dis Sci","2008","2008/05/10","","","10.1007/s10620-008-0261-7"
"18461494","[Gender differences in the treatment of the opiate dependence with naltrexone]","Ochoa E, Madoz-Gúrpide A, Salvador E.","Actas Esp Psiquiatr. 2008 Jul-Aug;36(4):197-204.","Ochoa E","Actas Esp Psiquiatr","2008","2008/05/08","","",""
"18457849","Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment","Juni A, Klein G, Kowalczyk B, Ragnauth A, Kest B.","Neuropharmacology. 2008 Jun;54(8):1264-70. doi: 10.1016/j.neuropharm.2008.04.004. Epub 2008 Apr 11.","Juni A","Neuropharmacology","2008","2008/05/07","","","10.1016/j.neuropharm.2008.04.004"
"18454775","Role of state policies in the adoption of naltrexone for substance abuse treatment","Heinrich CJ, Hill CJ.","Health Serv Res. 2008 Jun;43(3):951-70. doi: 10.1111/j.1475-6773.2007.00812.x.","Heinrich CJ","Health Serv Res","2008","2008/05/06","PMC2442246","","10.1111/j.1475-6773.2007.00812.x"
"18449628","Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro","Banks SL, Pinninti RR, Gill HS, Crooks PA, Prausnitz MR, Stinchcomb AL.","Pharm Res. 2008 Jul;25(7):1677-85. doi: 10.1007/s11095-008-9578-3. Epub 2008 May 1.","Banks SL","Pharm Res","2008","2008/05/02","PMC2757057","NIHMS141780","10.1007/s11095-008-9578-3"
"18443666","[Drug therapy of opioid withdrawal]","Cortese S, Risso M.","Vertex. 2008 Jan-Feb;19(77):522-6.","Cortese S","Vertex","2008","2008/04/30","","",""
"18443665","[Pharmacological review of alcoholic dependence treatment]","Oural L, Paris MV, Sullivan O, Polach M, Pavlovsky F, Capece J.","Vertex. 2008 Jan-Feb;19(77):512-21.","Oural L","Vertex","2008","2008/04/30","","",""
"18441391","High voluntary alcohol consumption, in experimental liver cirrhosis is hardly responsive to opioid antagonist treatment","Stasiak A, Fogel WA.","J Physiol Pharmacol. 2008 Mar;59(1):101-14.","Stasiak A","J Physiol Pharmacol","2008","2008/04/29","","",""
"18440447","Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study","Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, Von Gunten CF, Israel RJ.","J Pain Symptom Manage. 2008 May;35(5):458-68. doi: 10.1016/j.jpainsymman.2007.12.005.","Portenoy RK","J Pain Symptom Manage","2008","2008/04/29","","","10.1016/j.jpainsymman.2007.12.005"
"18439862","Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse","Huge V, Rammes G, Beyer A, Zieglgänsberger W, Azad SC.","Eur J Pain. 2009 Feb;13(2):124-9. doi: 10.1016/j.ejpain.2008.03.010. Epub 2008 Apr 24.","Huge V","Eur J Pain","2009","2008/04/29","","","10.1016/j.ejpain.2008.03.010"
"18436318","Effects of opioid blockade on nociceptive flexion reflex thresholds and nociceptive responding in hypertensive and normotensive individuals","Edwards L, Ring C, France CR, McIntyre D, Martin U.","Int J Psychophysiol. 2008 Aug;69(2):96-100. doi: 10.1016/j.ijpsycho.2008.03.005. Epub 2008 Mar 15.","Edwards L","Int J Psychophysiol","2008","2008/04/26","PMC2527540","NIHMS60431","10.1016/j.ijpsycho.2008.03.005"
"18434189","An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients","Stella L, Addolorato G, Rinaldi B, Capuano A, Berrino L, Rossi F, Maione S.","Pharmacol Res. 2008 Apr;57(4):312-7. doi: 10.1016/j.phrs.2008.03.001. Epub 2008 Mar 14.","Stella L","Pharmacol Res","2008","2008/04/25","","","10.1016/j.phrs.2008.03.001"
"18434033","Distinct inhibition of voltage-activated Ca2+ channels by delta-opioid agonists in dorsal root ganglion neurons devoid of functional T-type Ca2+ currents","Wu ZZ, Chen SR, Pan HL.","Neuroscience. 2008 Jun 2;153(4):1256-67. doi: 10.1016/j.neuroscience.2008.03.031. Epub 2008 Mar 22.","Wu ZZ","Neuroscience","2008","2008/04/25","","","10.1016/j.neuroscience.2008.03.031"
"18429708","Unplanned admissions to two Sydney public hospitals after naltrexone implants","Lintzeris N, Lee S, Scopelliti L, Mabbutt J, Haber PS.","Med J Aust. 2008 Apr 21;188(8):441-4.","Lintzeris N","Med J Aust","2008","2008/04/24","","",""
"18429707","Ensuring the safety of new medications and devices: are naltrexone implants safe?","Wodak AD, Ali R, Henry D, Sansom L.","Med J Aust. 2008 Apr 21;188(8):438-9.","Wodak AD","Med J Aust","2008","2008/04/24","","",""
"18428571","Preclinical models to evaluate potential pharmacotherapeutic agents in treating alcoholism and studying the neuropharmacological bases of ethanol-seeking behaviors in rats","June HL.","Curr Protoc Neurosci. 2002 Aug;Chapter 9:Unit 9.12. doi: 10.1002/0471142301.ns0912s19.","June HL","Curr Protoc Neurosci","2002","2008/04/23","","","10.1002/0471142301.ns0912s19"
"18427989","Effects of naltrexone and acamprosate on alcohol-induced NGFI-A expression in mouse brain","Lindholm J, Guitart-Masip M, Hassankhali H, Landgren S, Nicoleau C, Giménez-Llort L, Terenius L, Ogren SO, Johansson B.","Neurochem Res. 2008 Oct;33(10):2062-9. doi: 10.1007/s11064-008-9687-8. Epub 2008 Apr 22.","Lindholm J","Neurochem Res","2008","2008/04/23","","","10.1007/s11064-008-9687-8"
"18425947","Mu-opioid antagonists for opioid-induced bowel dysfunction","McNicol ED, Boyce D, Schumann R, Carr DB.","Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006332. doi: 10.1002/14651858.CD006332.pub2.","McNicol ED","Cochrane Database Syst Rev","2008","2008/04/22","","","10.1002/14651858.CD006332.pub2"
"18425938","Sustained-release naltrexone for opioid dependence","Lobmaier P, Kornør H, Kunøe N, Bjørndal A.","Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006140. doi: 10.1002/14651858.CD006140.pub2.","Lobmaier P","Cochrane Database Syst Rev","2008","2008/04/22","","","10.1002/14651858.CD006140.pub2"
"18413519","Prevention of exuberant granulation tissue and neovascularization in the rat cornea by naltrexone","Zagon IS, Klocek MS, Griffith JW, Sassani JW, Komáromy AM, McLaughlin PJ.","Arch Ophthalmol. 2008 Apr;126(4):501-6. doi: 10.1001/archopht.126.4.501.","Zagon IS","Arch Ophthalmol","2008","2008/04/17","PMC2431172","NIHMS51181","10.1001/archopht.126.4.501"
"18391135","Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people","Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K.","Arch Gen Psychiatry. 2008 Apr;65(4):466-75. doi: 10.1001/archpsyc.65.4.466.","Myrick H","Arch Gen Psychiatry","2008","2008/04/09","PMC2504413","NIHMS55593","10.1001/archpsyc.65.4.466"
"18391134","Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation","Ngo HT, Tait RJ, Hulse GK.","Arch Gen Psychiatry. 2008 Apr;65(4):457-65. doi: 10.1001/archpsyc.65.4.457.","Ngo HT","Arch Gen Psychiatry","2008","2008/04/09","","","10.1001/archpsyc.65.4.457"
"18387856","The analgesic effect of paeoniflorin on neonatal maternal separation-induced visceral hyperalgesia in rats","Zhang XJ, Li Z, Leung WM, Liu L, Xu HX, Bian ZX.","J Pain. 2008 Jun;9(6):497-505. doi: 10.1016/j.jpain.2007.12.009. Epub 2008 Apr 3.","Zhang XJ","J Pain","2008","2008/04/05","","","10.1016/j.jpain.2007.12.009"
"18384246","A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges","Grant JE, Kim SW, Hartman BK.","J Clin Psychiatry. 2008 May;69(5):783-9. doi: 10.4088/jcp.v69n0511.","Grant JE","J Clin Psychiatry","2008","2008/04/04","","","10.4088/jcp.v69n0511"
"18367303","Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain","Van Bockstaele EJ, Qian Y, Sterling RC, Page ME.","Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):1048-56. doi: 10.1016/j.pnpbp.2008.02.004. Epub 2008 Mar 25.","Van Bockstaele EJ","Prog Neuropsychopharmacol Biol Psychiatry","2008","2008/03/28","PMC2701363","NIHMS52099","10.1016/j.pnpbp.2008.02.004"
"18364621","From the neurobiologic basis of alcohol dependency to pharmacologic treatment strategies: bridging the knowledge gap","Shea CW.","South Med J. 2008 Feb;101(2):179-85. doi: 10.1097/SMJ.0b013e3181617307.","Shea CW","South Med J","2008","2008/03/28","","","10.1097/SMJ.0b013e3181617307"
"18353618","Naltrexone augmentation in OCD: a double-blind placebo-controlled cross-over study","Amiaz R, Fostick L, Gershon A, Zohar J.","Eur Neuropsychopharmacol. 2008 Jun;18(6):455-61. doi: 10.1016/j.euroneuro.2008.01.006. Epub 2008 Mar 18.","Amiaz R","Eur Neuropsychopharmacol","2008","2008/03/21","","","10.1016/j.euroneuro.2008.01.006"
"18353432","Baclofen, raclopride, and naltrexone differentially reduce solid fat emulsion intake under limited access conditions","Rao RE, Wojnicki FH, Coupland J, Ghosh S, Corwin RL.","Pharmacol Biochem Behav. 2008 Jun;89(4):581-90. doi: 10.1016/j.pbb.2008.02.013. Epub 2008 Feb 15.","Rao RE","Pharmacol Biochem Behav","2008","2008/03/21","PMC2669792","NIHMS49062","10.1016/j.pbb.2008.02.013"
"18349865","Drug addiction: a critical problem calling for novel solutions","Tyndale R.","Clin Pharmacol Ther. 2008 Apr;83(4):503-6. doi: 10.1038/clpt.2008.11.","Tyndale R","Clin Pharmacol Ther","2008","2008/03/20","","","10.1038/clpt.2008.11"
"18349186","The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes","Bonnet MP, Beloeil H, Benhamou D, Mazoit JX, Asehnoune K.","Anesth Analg. 2008 Apr;106(4):1142-9, table of contents. doi: 10.1213/ane.0b013e318165de89.","Bonnet MP","Anesth Analg","2008","2008/03/20","","","10.1213/ane.0b013e318165de89"
"18348601","Early treatment response in alcohol dependence with extended-release naltrexone","Ciraulo DA, Dong Q, Silverman BL, Gastfriend DR, Pettinati HM.","J Clin Psychiatry. 2008 Feb;69(2):190-5. doi: 10.4088/jcp.v69n0204.","Ciraulo DA","J Clin Psychiatry","2008","2008/03/20","","","10.4088/jcp.v69n0204"
"18343595","Presynaptic actions of opioid receptor agonists in ventromedial hypothalamic neurons in estrogen- and oil-treated female mice","Devidze N, Zhang Q, Zhou J, Lee AW, Pataky S, Kow LM, Pfaff DW.","Neuroscience. 2008 Apr 9;152(4):942-9. doi: 10.1016/j.neuroscience.2008.01.033. Epub 2008 Feb 5.","Devidze N","Neuroscience","2008","2008/03/18","","","10.1016/j.neuroscience.2008.01.033"
"18343363","Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors","Klein G, Juni A, Arout CA, Waxman AR, Inturrisi CE, Kest B.","Eur J Pharmacol. 2008 May 31;586(1-3):179-88. doi: 10.1016/j.ejphar.2008.02.035. Epub 2008 Feb 19.","Klein G","Eur J Pharmacol","2008","2008/03/18","PMC3627364","NIHMS242594","10.1016/j.ejphar.2008.02.035"
"18342360","Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone","Dean RL, Todtenkopf MS, Deaver DR, Arastu MF, Dong N, Reitano K, O'Driscoll K, Kriksciukaite K, Gastfriend DR.","Pharmacol Biochem Behav. 2008 Jun;89(4):515-22. doi: 10.1016/j.pbb.2008.02.006. Epub 2008 Feb 11.","Dean RL","Pharmacol Biochem Behav","2008","2008/03/18","","","10.1016/j.pbb.2008.02.006"
"18339813","Neurobiology and treatment in alcoholism--recent findings regarding Lesch's typology of alcohol dependence","Hillemacher T, Bleich S.","Alcohol Alcohol. 2008 May-Jun;43(3):341-6. doi: 10.1093/alcalc/agn016. Epub 2008 Mar 13.","Hillemacher T","Alcohol Alcohol","2008","2008/03/15","","","10.1093/alcalc/agn016"
"18339371","Memantine enhances the inhibitory effects of naltrexone on ethanol consumption","Kuzmin A, Stenback T, Liljequist S.","Eur J Pharmacol. 2008 Apr 28;584(2-3):352-6. doi: 10.1016/j.ejphar.2008.02.015. Epub 2008 Feb 14.","Kuzmin A","Eur J Pharmacol","2008","2008/03/15","","","10.1016/j.ejphar.2008.02.015"
"18336635","Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist?","Baros AM, Latham PK, Anton RF.","Alcohol Clin Exp Res. 2008 May;32(5):771-6. doi: 10.1111/j.1530-0277.2008.00633.x. Epub 2008 Mar 11.","Baros AM","Alcohol Clin Exp Res","2008","2008/03/14","PMC2553698","NIHMS65293","10.1111/j.1530-0277.2008.00633.x"
"18332675","Dopamine-independent psychostimulant activity of a delta-agonist","Ito S, Mori T, Sawaguchi T.","Behav Pharmacol. 2008 Mar;19(2):113-9. doi: 10.1097/FBP.0b013e3282f62c1b.","Ito S","Behav Pharmacol","2008","2008/03/12","","","10.1097/FBP.0b013e3282f62c1b"
"18329827","The therapeutic alliance in medical-based interventions impacts outcome in treating alcohol dependence","Dundon WD, Pettinati HM, Lynch KG, Xie H, Varillo KM, Makadon C, Oslin DW.","Drug Alcohol Depend. 2008 Jun 1;95(3):230-6. doi: 10.1016/j.drugalcdep.2008.01.010. Epub 2008 Mar 10.","Dundon WD","Drug Alcohol Depend","2008","2008/03/11","PMC2600892","NIHMS51466","10.1016/j.drugalcdep.2008.01.010"
"18329227","Improving acceptance of naltrexone in community addiction treatment centers: a pilot study","Thomas SE, Miller PM, Randall PK, Book SW.","J Subst Abuse Treat. 2008 Oct;35(3):260-8. doi: 10.1016/j.jsat.2007.11.001. Epub 2008 Mar 7.","Thomas SE","J Subst Abuse Treat","2008","2008/03/11","PMC2612537","NIHMS71151","10.1016/j.jsat.2007.11.001"
"18328652","The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine","Shu H, Hayashida M, Huang W, An K, Chiba S, Hanaoka K, Arita H.","J Ethnopharmacol. 2008 Apr 17;117(1):158-65. doi: 10.1016/j.jep.2008.01.029. Epub 2008 Feb 6.","Shu H","J Ethnopharmacol","2008","2008/03/11","","","10.1016/j.jep.2008.01.029"
"18325676","Naltrexone for the management of post-burn pruritus: A preliminary report","LaSalle L, Rachelska G, Nedelec B.","Burns. 2008 Sep;34(6):797-802. doi: 10.1016/j.burns.2007.10.009. Epub 2008 Mar 5.","LaSalle L","Burns","2008","2008/03/08","","","10.1016/j.burns.2007.10.009"
"18321686","In vivo evaluation of a transdermal codrug of 6-beta-naltrexol linked to hydroxybupropion in hairless guinea pigs","Kiptoo PK, Paudel KS, Hammell DC, Hamad MO, Crooks PA, Stinchcomb AL.","Eur J Pharm Sci. 2008 Apr 23;33(4-5):371-9. doi: 10.1016/j.ejps.2008.01.006. Epub 2008 Jan 31.","Kiptoo PK","Eur J Pharm Sci","2008","2008/03/07","PMC2390923","NIHMS47240","10.1016/j.ejps.2008.01.006"
"18308913","Voucher-based incentives for naltrexone treatment attendance in schizophrenia and alcohol use disorders","Leontieva L, Dimmock JA, Gately PW, Gallinger L, Ploutz-Snyder R, Batki SL.","Psychiatr Serv. 2008 Mar;59(3):310-4. doi: 10.1176/ps.2008.59.3.310.","Leontieva L","Psychiatr Serv","2008","2008/03/01","","","10.1176/ps.2008.59.3.310"
"18305456","Contingency management: utility in the treatment of drug abuse disorders","Stitzer ML, Vandrey R.","Clin Pharmacol Ther. 2008 Apr;83(4):644-7. doi: 10.1038/sj.clpt.6100508. Epub 2008 Feb 27.","Stitzer ML","Clin Pharmacol Ther","2008","2008/02/29","","","10.1038/sj.clpt.6100508"
"18305023","Alcohol preference in mice lacking the Avpr1a vasopressin receptor","Sanbe A, Takagi N, Fujiwara Y, Yamauchi J, Endo T, Mizutani R, Takeo S, Tsujimoto G, Tanoue A.","Am J Physiol Regul Integr Comp Physiol. 2008 May;294(5):R1482-90. doi: 10.1152/ajpregu.00708.2007. Epub 2008 Feb 27.","Sanbe A","Am J Physiol Regul Integr Comp Physiol","2008","2008/02/29","","","10.1152/ajpregu.00708.2007"
"18298266","Peripheral inflammation undermines the plasticity of the isolated spinal cord","Hook MA, Huie JR, Grau JW.","Behav Neurosci. 2008 Feb;122(1):233-49. doi: 10.1037/0735-7044.122.1.233.","Hook MA","Behav Neurosci","2008","2008/02/27","PMC2665167","NIHMS92913","10.1037/0735-7044.122.1.233"
"18298057","Synthesis and biological evaluation of alpha- and beta-6-amido derivatives of 17-cyclopropylmethyl-3, 14beta-dihydroxy-4, 5alpha-epoxymorphinan: potential alcohol-cessation agents","Ghirmai S, Azar MR, Polgar WE, Berzetei-Gurske I, Cashman JR.","J Med Chem. 2008 Mar 27;51(6):1913-24. doi: 10.1021/jm701060e. Epub 2008 Feb 26.","Ghirmai S","J Med Chem","2008","2008/02/27","","","10.1021/jm701060e"
"18294086","An open-label pilot study of naltrexone in childhood-onset trichotillomania","De Sousa A.","J Child Adolesc Psychopharmacol. 2008 Feb;18(1):30-3. doi: 10.1089/cap.2006.0111.","De Sousa A","J Child Adolesc Psychopharmacol","2008","2008/02/26","","","10.1089/cap.2006.0111"
"18289521","Characterizations of sphingosylphosphorylcholine-induced scratching responses in ICR mice using naltrexon, capsaicin, ketotifen and Y-27632","Kim HJ, Kim H, Han ES, Park SM, Koh JY, Kim KM, Noh MS, Kim JJ, Lee CH.","Eur J Pharmacol. 2008 Mar 31;583(1):92-6. doi: 10.1016/j.ejphar.2008.01.005. Epub 2008 Jan 26.","Kim HJ","Eur J Pharmacol","2008","2008/02/22","","","10.1016/j.ejphar.2008.01.005"
"18288356","Activation of δ-opioid receptors inhibits L-type Ca(2+) current and transient outward K(+) current in rat ventricular myocytes","Lin YY, Wu DM, Liu L, Liu QH, Yan ZY, Wu BW.","Sheng Li Xue Bao. 2008 Feb 25;60(1):38-42.","Lin YY","Sheng Li Xue Bao","2008","2008/02/22","","",""
"18281128","[Alcohol dependence: diagnosis and treatment]","Perney P, Rigole H, Blanc F.","Rev Med Interne. 2008 Apr;29(4):297-304. doi: 10.1016/j.revmed.2007.09.026. Epub 2007 Oct 22.","Perney P","Rev Med Interne","2008","2008/02/19","","","10.1016/j.revmed.2007.09.026"
"18278557","Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells","Davis RL, Buck DJ, Saffarian N, Mohan S, DeSilva U, Fernando SC, Stevens CW.","J Neuroimmune Pharmacol. 2008 Sep;3(3):150-3. doi: 10.1007/s11481-008-9102-x. Epub 2008 Feb 16.","Davis RL","J Neuroimmune Pharmacol","2008","2008/02/19","PMC3062940","NIHMS280411","10.1007/s11481-008-9102-x"
"18275956","Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice","Divin MF, Holden Ko MC, Traynor JR.","Eur J Pharmacol. 2008 Mar 31;583(1):48-55. doi: 10.1016/j.ejphar.2008.01.004. Epub 2008 Jan 24.","Divin MF","Eur J Pharmacol","2008","2008/02/16","PMC3010382","NIHMS243087","10.1016/j.ejphar.2008.01.004"
"18273737","World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism","Soyka M, Kranzler HR, Berglund M, Gorelick D, Hesselbrock V, Johnson BA, Möller HJ; WFSBP Task Force on Treatment Guidelines for Substance Use Disorders.","World J Biol Psychiatry. 2008;9(1):6-23. doi: 10.1080/15622970801896390.","Soyka M","World J Biol Psychiatry","2008","2008/02/15","","","10.1080/15622970801896390"
"18269381","A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration","Burattini C, McGeehan AJ, Griffin WC 3rd, Gass JT, Kinder JR, Janak PH, Olive MF.","Addict Biol. 2008 Mar;13(1):70-9. doi: 10.1111/j.1369-1600.2008.00097.x.","Burattini C","Addict Biol","2008","2008/02/14","","","10.1111/j.1369-1600.2008.00097.x"
"18262387","In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice","Fu CY, Zhao YL, Dong L, Chen Q, Ni JM, Wang R.","Brain Behav Immun. 2008 Aug;22(6):850-60. doi: 10.1016/j.bbi.2007.12.010. Epub 2008 Feb 8.","Fu CY","Brain Behav Immun","2008","2008/02/12","","","10.1016/j.bbi.2007.12.010"
"18262210","Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone","Zalewska-Kaszubska J, Gorska D, Dyr W, Czarnecka E.","Physiol Behav. 2008 Mar 18;93(4-5):1005-10. doi: 10.1016/j.physbeh.2008.01.007. Epub 2008 Jan 16.","Zalewska-Kaszubska J","Physiol Behav","2008","2008/02/12","","","10.1016/j.physbeh.2008.01.007"
"18250251","An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study","Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D.","Arch Gen Psychiatry. 2008 Feb;65(2):135-44. doi: 10.1001/archpsyc.65.2.135.","Anton RF","Arch Gen Psychiatry","2008","2008/02/06","PMC2666924","NIHMS63620","10.1001/archpsyc.65.2.135"
"18250250","Prospects for a genomic approach to the treatment of alcoholism","O'Brien CP.","Arch Gen Psychiatry. 2008 Feb;65(2):132-3. doi: 10.1001/archgenpsychiatry.2007.32.","O'Brien CP","Arch Gen Psychiatry","2008","2008/02/06","","","10.1001/archgenpsychiatry.2007.32"
"18241634","Internet sex addiction treated with naltrexone","Bostwick JM, Bucci JA.","Mayo Clin Proc. 2008 Feb;83(2):226-30. doi: 10.4065/83.2.226.","Bostwick JM","Mayo Clin Proc","2008","2008/02/05","","","10.4065/83.2.226"
"18241321","Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics","Lucey MR, Silverman BL, Illeperuma A, O'Brien CP.","Alcohol Clin Exp Res. 2008 Mar;32(3):498-504. doi: 10.1111/j.1530-0277.2007.00593.x. Epub 2008 Jan 30.","Lucey MR","Alcohol Clin Exp Res","2008","2008/02/05","","","10.1111/j.1530-0277.2007.00593.x"
"18237778","Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors","Stanojević S, Vujić V, Mitić K, Kustrimović N, Kovacević-Jovanović V, Miletić T, Dimitrijević M.","Neuropeptides. 2008 Apr;42(2):147-58. doi: 10.1016/j.npep.2007.12.004. Epub 2008 Jan 30.","Stanojević S","Neuropeptides","2008","2008/02/02","","","10.1016/j.npep.2007.12.004"
"18225476","Prooxidative/antioxidative homeostasis in heroin addiction and detoxification","Pereska Z, Dejanova B, Bozinovska C, Petkovska L.","Bratisl Lek Listy. 2007;108(9):393-8.","Pereska Z","Bratisl Lek Listy","2007","2008/01/30","","",""
"18223355","New therapies in the treatment of postoperative ileus after gastrointestinal surgery","Maron DJ, Fry RD.","Am J Ther. 2008 Jan-Feb;15(1):59-65. doi: 10.1097/MJT.0b013e31804c6f37.","Maron DJ","Am J Ther","2008","2008/01/29","","","10.1097/MJT.0b013e31804c6f37"
"18222040","Blockade of micro-opioid receptors in the medial thalamus inhibits acquisition, but not expression, of morphine-induced conditioned place preference","Guo N, Garcia MM, Taylor BK, Zadina JE, Harlan RE.","Neuroscience. 2008 Feb 19;151(4):948-54. doi: 10.1016/j.neuroscience.2007.10.058. Epub 2007 Dec 14.","Guo N","Neuroscience","2008","2008/01/29","","","10.1016/j.neuroscience.2007.10.058"
"18221622","Toward a rational selection of treatment for addiction","O'Brien CP.","Curr Psychiatry Rep. 2007 Dec;9(6):441-2. doi: 10.1007/s11920-007-0058-y.","O'Brien CP","Curr Psychiatry Rep","2007","2008/01/29","","","10.1007/s11920-007-0058-y"
"18212797","Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders","McCann DJ.","Clin Pharmacol Ther. 2008 Apr;83(4):627-30. doi: 10.1038/sj.clpt.6100503. Epub 2008 Jan 23.","McCann DJ","Clin Pharmacol Ther","2008","2008/01/24","","","10.1038/sj.clpt.6100503"
"18203844","Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation","Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Caffrey JL, Vinten-Johansen J.","Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1444-51. doi: 10.1152/ajpheart.01279.2006. Epub 2008 Jan 18.","Zatta AJ","Am J Physiol Heart Circ Physiol","2008","2008/01/22","","","10.1152/ajpheart.01279.2006"
"18198283","Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization","Virk MS, Williams JT.","Mol Pharmacol. 2008 Apr;73(4):1301-8. doi: 10.1124/mol.107.042952. Epub 2008 Jan 15.","Virk MS","Mol Pharmacol","2008","2008/01/17","PMC3640555","NIHMS456680","10.1124/mol.107.042952"
"18195589","Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats","Ji D, Gilpin NW, Richardson HN, Rivier CL, Koob GF.","Behav Pharmacol. 2008 Feb;19(1):1-12. doi: 10.1097/FBP.0b013e3282f3cf70.","Ji D","Behav Pharmacol","2008","2008/01/16","PMC2586833","NIHMS76722","10.1097/FBP.0b013e3282f3cf70"
"18190670","On treatment mechanisms--what can we learn from the COMBINE study?","Bergmark A.","Addiction. 2008 May;103(5):703-5. doi: 10.1111/j.1360-0443.2007.02073.x. Epub 2008 Jan 8.","Bergmark A","Addiction","2008","2008/01/15","","","10.1111/j.1360-0443.2007.02073.x"
"18187529","Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes","Rösner S, Leucht S, Lehert P, Soyka M.","J Psychopharmacol. 2008 Jan;22(1):11-23. doi: 10.1177/0269881107078308.","Rösner S","J Psychopharmacol","2008","2008/01/12","","","10.1177/0269881107078308"
"18184783","The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C.","Version 2. J Neurosci. 2008 Jan 9;28(2):407-14. doi: 10.1523/JNEUROSCI.4458-07.2008.","Land BB","J Neurosci","2008","2008/01/11","PMC2612708","NIHMS47019","10.1523/JNEUROSCI.4458-07.2008"
"18183621","YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment","Vats ID, Dolt KS, Kumar K, Karar J, Nath M, Mohan A, Pasha MA, Pasha S.","J Neurosci Res. 2008 May 15;86(7):1599-607. doi: 10.1002/jnr.21605.","Vats ID","J Neurosci Res","2008","2008/01/10","","","10.1002/jnr.21605"
"18183536","Methylnaltrexone, a new peripheral mu-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side effects","Reichle FM, Conzen PF.","Curr Opin Investig Drugs. 2008 Jan;9(1):90-100.","Reichle FM","Curr Opin Investig Drugs","2008","2008/01/10","","",""
"18178175","The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'","Raffa RB, Stagliano GW, Ross G, Powell JA, Phillips AG, Ding Z, Rawls SM.","Brain Res. 2008 Feb 8;1193:51-6. doi: 10.1016/j.brainres.2007.12.001. Epub 2007 Dec 8.","Raffa RB","Brain Res","2008","2008/01/08","PMC2695878","NIHMS41884","10.1016/j.brainres.2007.12.001"
"18171605","Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates","Butelman ER, Reed B, Chait BT, Mandau M, Yuferov V, Kreek MJ.","Psychoneuroendocrinology. 2008 Apr;33(3):292-304. doi: 10.1016/j.psyneuen.2007.11.011. Epub 2008 Jan 2.","Butelman ER","Psychoneuroendocrinology","2008","2008/01/04","PMC2275163","NIHMS42536","10.1016/j.psyneuen.2007.11.011"
"18164287","Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide","Gholipour T, Riazi K, Noorian AR, Jannati A, Honar H, Doratotaj B, Nik HH, Shariftabrizi A, Dehpour AR.","Eur J Pharmacol. 2008 Feb 12;580(3):322-8. doi: 10.1016/j.ejphar.2007.11.018. Epub 2007 Nov 23.","Gholipour T","Eur J Pharmacol","2008","2008/01/01","","","10.1016/j.ejphar.2007.11.018"
"18157167","Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain","Rezende RM, França DS, Menezes GB, dos Reis WG, Bakhle YS, Francischi JN.","Br J Pharmacol. 2008 Feb;153(4):760-8. doi: 10.1038/sj.bjp.0707630. Epub 2007 Dec 24.","Rezende RM","Br J Pharmacol","2008","2007/12/25","PMC2259218","","10.1038/sj.bjp.0707630"
"18155248","Morphine postconditioning protects against reperfusion injury in the isolated rat hearts","Chen Z, Li T, Zhang B.","J Surg Res. 2008 Apr;145(2):287-94. doi: 10.1016/j.jss.2007.07.020. Epub 2007 Aug 23.","Chen Z","J Surg Res","2008","2007/12/25","","","10.1016/j.jss.2007.07.020"
"18079068","A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence","Pettinati HM, Kampman KM, Lynch KG, Xie H, Dackis C, Rabinowitz AR, O'Brien CP.","Addict Behav. 2008 May;33(5):651-67. doi: 10.1016/j.addbeh.2007.11.011. Epub 2007 Nov 17.","Pettinati HM","Addict Behav","2008","2007/12/15","PMC2374760","NIHMS44586","10.1016/j.addbeh.2007.11.011"
"18078579","A LC-electrospray tandem MS method for the analysis of naltrexone in canine plasma employing a molecular model to demonstrate the absence of internal standard deuterium isotope effects","Iyer SS, Kellogg GE, Karnes HT.","J Chromatogr Sci. 2007 Nov-Dec;45(10):694-700. doi: 10.1093/chromsci/45.10.694.","Iyer SS","J Chromatogr Sci","2007","2007/12/15","","","10.1093/chromsci/45.10.694"
"18070245","Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, ""Naltrexone in the treatment of alcoholism""","Krystal JH, Gueorguieva R, Cramer J, Collins J, Rosenheck R; VA CSP No. 425 Study Team.","Alcohol Clin Exp Res. 2008 Jan;32(1):85-91. doi: 10.1111/j.1530-0277.2007.00555.x. Epub 2007 Dec 7.","Krystal JH","Alcohol Clin Exp Res","2008","2007/12/12","","","10.1111/j.1530-0277.2007.00555.x"
"18068383","Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin","Kosson D, Klinowiecka A, Kosson P, Bonney I, Carr DB, Mayzner-Zawadzka E, Lipkowski AW.","Eur J Pain. 2008 Jul;12(5):611-6. doi: 10.1016/j.ejpain.2007.10.005. Epub 2008 Feb 20.","Kosson D","Eur J Pain","2008","2007/12/11","","","10.1016/j.ejpain.2007.10.005"
"18058408","The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders","Ralevski E, Ball S, Nich C, Limoncelli D, Petrakis I.","Am J Addict. 2007 Nov-Dec;16(6):443-9. doi: 10.1080/10550490701643336.","Ralevski E","Am J Addict","2007","2007/12/07","","","10.1080/10550490701643336"
"18056897","New therapies for alcohol dependence open options for office-based treatment","Kuehn BM.","JAMA. 2007 Dec 5;298(21):2467-8. doi: 10.1001/jama.298.21.2467.","Kuehn BM","JAMA","2007","2007/12/07","","","10.1001/jama.298.21.2467"
"18053632","Naltrexone effect on physiological and subjective response to a cold pressor task","Kotlyar M, al'Absi M, Brauer LH, Grant JE, Fong E, Kim SW.","Biol Psychol. 2008 Feb;77(2):233-6. doi: 10.1016/j.biopsycho.2007.10.005. Epub 2007 Oct 13.","Kotlyar M","Biol Psychol","2008","2007/12/07","PMC2758556","NIHMS40482","10.1016/j.biopsycho.2007.10.005"
"18048026","Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines","Loscalzo LM, Wasowski C, Paladini AC, Marder M.","Eur J Pharmacol. 2008 Feb 12;580(3):306-13. doi: 10.1016/j.ejphar.2007.11.011. Epub 2007 Nov 13.","Loscalzo LM","Eur J Pharmacol","2008","2007/12/01","","","10.1016/j.ejphar.2007.11.011"
"18047635","delta-Opioid receptor stimulation enhances the growth of neonatal rat ventricular myocytes via the extracellular signal-regulated kinase pathway","Zhao M, Wang HX, Yang J, Su YH, Su RJ, Wong TM.","Clin Exp Pharmacol Physiol. 2008 Jan;35(1):97-102. doi: 10.1111/j.1440-1681.2007.04831.x.","Zhao M","Clin Exp Pharmacol Physiol","2008","2007/12/01","","","10.1111/j.1440-1681.2007.04831.x"
"18046309","Tolerance to repeated morphine administration is associated with increased potency of opioid agonists","Ingram SL, Macey TA, Fossum EN, Morgan MM.","Neuropsychopharmacology. 2008 Sep;33(10):2494-504. doi: 10.1038/sj.npp.1301634. Epub 2007 Nov 28.","Ingram SL","Neuropsychopharmacology","2008","2007/11/30","PMC5688517","NIHMS888371","10.1038/sj.npp.1301634"
"18036213","Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program","Reece AS.","Subst Abuse Treat Prev Policy. 2007 Nov 23;2:35. doi: 10.1186/1747-597X-2-35.","Reece AS","Subst Abuse Treat Prev Policy","2007","2007/11/27","PMC2211472","","10.1186/1747-597X-2-35"
"18034375","Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy","Degenhardt L, Gibson A, Mattick RP, Hall W.","Drug Alcohol Rev. 2008 Jan;27(1):1-3. doi: 10.1080/09595230701711157.","Degenhardt L","Drug Alcohol Rev","2008","2007/11/24","","","10.1080/09595230701711157"
"18031920","Effects of naltrexone on electrocutaneous pain in patients with hypertension compared to normotensive individuals","Ring C, France CR, al'Absi M, Edwards L, McIntyre D, Carroll D, Martin U.","Biol Psychol. 2008 Feb;77(2):191-6. doi: 10.1016/j.biopsycho.2007.10.006. Epub 2007 Oct 13.","Ring C","Biol Psychol","2008","2007/11/23","PMC2271049","NIHMS40785","10.1016/j.biopsycho.2007.10.006"
"18028530","Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment","Tidey JW, Monti PM, Rohsenow DJ, Gwaltney CJ, Miranda R Jr, McGeary JE, MacKillop J, Swift RM, Abrams DB, Shiffman S, Paty JA.","Alcohol Clin Exp Res. 2008 Jan;32(1):58-66. doi: 10.1111/j.1530-0277.2007.00545.x. Epub 2007 Nov 20.","Tidey JW","Alcohol Clin Exp Res","2008","2007/11/22","PMC2743136","NIHMS118266","10.1111/j.1530-0277.2007.00545.x"
"18027539","Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study","Hamann S, Sloan P.","J Opioid Manag. 2007 May-Jun;3(3):137-44. doi: 10.5055/jom.2007.0051.","Hamann S","J Opioid Manag","2007","2007/11/22","","","10.5055/jom.2007.0051"
"18023854","Isobolographic analysis of multimodal analgesia in an animal model of visceral acute pain","Miranda HF, Prieto JC, Puig MM, Pinardi G.","Pharmacol Biochem Behav. 2008 Feb;88(4):481-6. doi: 10.1016/j.pbb.2007.10.005. Epub 2007 Oct 22.","Miranda HF","Pharmacol Biochem Behav","2008","2007/11/21","","","10.1016/j.pbb.2007.10.005"
"18022696","The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor","DeHaven-Hudkins DL, DeHaven RN, Little PJ, Techner LM.","Pharmacol Ther. 2008 Jan;117(1):162-87. doi: 10.1016/j.pharmthera.2007.09.007. Epub 2007 Oct 16.","DeHaven-Hudkins DL","Pharmacol Ther","2008","2007/11/21","","","10.1016/j.pharmthera.2007.09.007"
"18004130","12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study","Dannon PN, Lowengrub K, Musin E, Gonopolsky Y, Kotler M.","J Clin Psychopharmacol. 2007 Dec;27(6):620-4. doi: 10.1097/jcp.0b013e31815a4400.","Dannon PN","J Clin Psychopharmacol","2007","2007/11/16","","","10.1097/jcp.0b013e31815a4400"
"18001278","Effects of opioid receptor blockade on the renewal of alcohol seeking induced by context: relationship to c-fos mRNA expression","Marinelli PW, Funk D, Juzytsch W, Li Z, Lê AD.","Eur J Neurosci. 2007 Nov;26(10):2815-23. doi: 10.1111/j.1460-9568.2007.05898.x.","Marinelli PW","Eur J Neurosci","2007","2007/11/16","","","10.1111/j.1460-9568.2007.05898.x"
"17997266","A categorical typology of naltrexone-adopting private substance abuse treatment centers","Oser CB, Roman PM.","J Subst Abuse Treat. 2008 Jun;34(4):433-42. doi: 10.1016/j.jsat.2007.08.003. Epub 2007 Nov 7.","Oser CB","J Subst Abuse Treat","2008","2007/11/13","PMC2682460","NIHMS51101","10.1016/j.jsat.2007.08.003"
"17997230","Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia","Gendron L, Pintar JE, Chavkin C.","Neuroscience. 2007 Dec 19;150(4):807-17. doi: 10.1016/j.neuroscience.2007.09.060. Epub 2007 Oct 5.","Gendron L","Neuroscience","2007","2007/11/13","PMC2194644","NIHMS36587","10.1016/j.neuroscience.2007.09.060"
"17988459","Quantitative analysis of naltrexone and 6beta-naltrexol in human, rat, and rabbit plasma by liquid chromatography-electrospray ionization tandem mass spectrometry with application to the pharmacokinetics of Depotrex in rabbits","Slawson MH, Chen M, Moody D, Comer SD, Nuwayser ES, Fang WB, Foltz RL.","J Anal Toxicol. 2007 Oct;31(8):453-61. doi: 10.1093/jat/31.8.453.","Slawson MH","J Anal Toxicol","2007","2007/11/09","","","10.1093/jat/31.8.453"
"17970197","Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and K(ATP) channels","Lishmanov AY, Maslov LN, Lasukova TV, Crawford D, Wong TM.","Bull Exp Biol Med. 2007 Feb;143(2):187-90. doi: 10.1007/s10517-007-0046-6.","Lishmanov AY","Bull Exp Biol Med","2007","2007/11/01","","","10.1007/s10517-007-0046-6"
"17969089","Treatment of alcohol and other drug dependence","Saitz R.","Liver Transpl. 2007 Nov;13(11 Suppl 2):S59-64. doi: 10.1002/lt.21339.","Saitz R","Liver Transpl","2007","2007/10/31","","","10.1002/lt.21339"
"17965444","A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence","Laaksonen E, Koski-Jännes A, Salaspuro M, Ahtinen H, Alho H.","Alcohol Alcohol. 2008 Jan-Feb;43(1):53-61. doi: 10.1093/alcalc/agm136. Epub 2007 Oct 27.","Laaksonen E","Alcohol Alcohol","2008","2007/10/30","","","10.1093/alcalc/agm136"
"17965283","Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy","McCloskey DT, Turcato S, Wang GY, Turnbull L, Zhu BQ, Bambino T, Nguyen AP, Lovett DH, Nissenson RA, Karliner JS, Baker AJ.","Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H205-12. doi: 10.1152/ajpheart.00829.2007. Epub 2007 Oct 26.","McCloskey DT","Am J Physiol Heart Circ Physiol","2008","2007/10/30","PMC3372085","NIHMS380617","10.1152/ajpheart.00829.2007"
"17960304","Population pharmacokinetics of extended-release injectable naltrexone (XR-NTX) in patients with alcohol dependence","Dunbar JL, Turncliff RZ, Hayes SC, Farrell CB.","J Stud Alcohol Drugs. 2007 Nov;68(6):862-70. doi: 10.15288/jsad.2007.68.862.","Dunbar JL","J Stud Alcohol Drugs","2007","2007/10/26","","","10.15288/jsad.2007.68.862"
"17960303","Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers","Oser CB, Roman PM.","J Stud Alcohol Drugs. 2007 Nov;68(6):852-61. doi: 10.15288/jsad.2007.68.852.","Oser CB","J Stud Alcohol Drugs","2007","2007/10/26","PMC4267569","NIHMS647260","10.15288/jsad.2007.68.852"
"17959202","Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats","Shannon HE, Eberle EL, Mitch CH, McKinzie DL, Statnick MA.","Neuropharmacology. 2007 Dec;53(8):930-41. doi: 10.1016/j.neuropharm.2007.09.002. Epub 2007 Sep 20.","Shannon HE","Neuropharmacology","2007","2007/10/26","","","10.1016/j.neuropharm.2007.09.002"
"17957221","Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence","Jayaram-Lindström N, Konstenius M, Eksborg S, Beck O, Hammarberg A, Franck J.","Neuropsychopharmacology. 2008 Jul;33(8):1856-63. doi: 10.1038/sj.npp.1301572. Epub 2007 Oct 24.","Jayaram-Lindström N","Neuropsychopharmacology","2008","2007/10/25","","","10.1038/sj.npp.1301572"
"17951371","Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism","Dickson EW, Hogrefe CP, Ludwig PS, Ackermann LW, Stoll LL, Denning GM.","Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H402-8. doi: 10.1152/ajpheart.00280.2007. Epub 2007 Oct 19.","Dickson EW","Am J Physiol Heart Circ Physiol","2008","2007/10/24","","","10.1152/ajpheart.00280.2007"
"17949924","Behavioral economic analysis of drug preference using multiple choice procedure data","Greenwald MK.","Drug Alcohol Depend. 2008 Jan 11;93(1-2):103-10. doi: 10.1016/j.drugalcdep.2007.09.002. Epub 2007 Oct 18.","Greenwald MK","Drug Alcohol Depend","2008","2007/10/24","PMC2248460","NIHMS38503","10.1016/j.drugalcdep.2007.09.002"
"17949718","Heligmosomoides polygyrus: opioid peptides are involved in immune regulation of the histotropic phase of infection","Donskow-Schmelter K, Laskowska M, Doligalska M.","Exp Parasitol. 2008 Mar;118(3):338-44. doi: 10.1016/j.exppara.2007.09.003. Epub 2007 Sep 14.","Donskow-Schmelter K","Exp Parasitol","2008","2007/10/24","","","10.1016/j.exppara.2007.09.003"
"17939765","Long-acting injectable naltrexone for the treatment of alcohol dependence","Mannelli P, Peindl K, Masand PS, Patkar AA.","Expert Rev Neurother. 2007 Oct;7(10):1265-77. doi: 10.1586/14737175.7.10.1265.","Mannelli P","Expert Rev Neurother","2007","2007/10/18","","","10.1586/14737175.7.10.1265"
"17936964","[Trends in therapy for alcoholism]","Saito T.","Seishin Shinkeigaku Zasshi. 2007;109(6):536-40.","Saito T","Seishin Shinkeigaku Zasshi","2007","2007/10/17","","",""
"17931824","Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment","Tait RJ, Ngo HT, Hulse GK.","J Subst Abuse Treat. 2008 Sep;35(2):116-24. doi: 10.1016/j.jsat.2007.08.014. Epub 2007 Oct 10.","Tait RJ","J Subst Abuse Treat","2008","2007/10/13","","","10.1016/j.jsat.2007.08.014"
"17920585","Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats","Arreola-Espino R, Urquiza-Marín H, Ambriz-Tututi M, Araiza-Saldaña CI, Caram-Salas NL, Rocha-González HI, Mixcoatl-Zecuatl T, Granados-Soto V.","Eur J Pharmacol. 2007 Dec 22;577(1-3):203-10. doi: 10.1016/j.ejphar.2007.09.006. Epub 2007 Sep 24.","Arreola-Espino R","Eur J Pharmacol","2007","2007/10/09","","","10.1016/j.ejphar.2007.09.006"
"17920565","Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward","Braida D, Limonta V, Capurro V, Fadda P, Rubino T, Mascia P, Zani A, Gori E, Fratta W, Parolaro D, Sala M.","Biol Psychiatry. 2008 Feb 1;63(3):286-92. doi: 10.1016/j.biopsych.2007.07.020. Epub 2007 Oct 24.","Braida D","Biol Psychiatry","2008","2007/10/09","","","10.1016/j.biopsych.2007.07.020"
"17917294","Catalytic aerobic oxidation of nor-binaltorphimine (nor-BNI) analogs without 4,5-epoxy bridge affords a more selective ligand for kappa opioid receptor than the representative kappa antagonist nor-BNI","Osa Y, Ida Y, Fujii H, Nemoto T, Hasebe K, Momen S, Mochizuki H, Nagase H.","Chem Pharm Bull (Tokyo). 2007 Oct;55(10):1489-93. doi: 10.1248/cpb.55.1489.","Osa Y","Chem Pharm Bull (Tokyo)","2007","2007/10/06","","","10.1248/cpb.55.1489"
"17910895","Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells","Zagon IS, Rahn KA, McLaughlin PJ.","Neuropeptides. 2007 Dec;41(6):441-52. doi: 10.1016/j.npep.2007.08.002. Epub 2007 Oct 1.","Zagon IS","Neuropeptides","2007","2007/10/04","","","10.1016/j.npep.2007.08.002"
"17909753","Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade","Walsh SL, Chausmer AE, Strain EC, Bigelow GE.","Psychopharmacology (Berl). 2008 Jan;196(1):143-55. doi: 10.1007/s00213-007-0948-z. Epub 2007 Oct 2.","Walsh SL","Psychopharmacology (Berl)","2008","2007/10/03","PMC2766188","NIHMS145585","10.1007/s00213-007-0948-z"
"17906961","Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours","Noble F, Benturquia N, Bilkei-Gorzo A, Zimmer A, Roques BP.","Psychopharmacology (Berl). 2008 Feb;196(2):327-35. doi: 10.1007/s00213-007-0964-z. Epub 2007 Oct 1.","Noble F","Psychopharmacology (Berl)","2008","2007/10/02","","","10.1007/s00213-007-0964-z"
"17893463","Opiate receptor revisited","Snyder SH.","Anesthesiology. 2007 Oct;107(4):659-61. doi: 10.1097/01.anes.0000282101.03811.b7.","Snyder SH","Anesthesiology","2007","2007/09/26","","","10.1097/01.anes.0000282101.03811.b7"
"17891658","A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance","Arnold-Reed DE, O'Neil P, Holman CD, Bulsara MK, Rodiguez C, Gawthorne G, Tait RJ, Hulse GK.","Am J Drug Alcohol Abuse. 2007;33(5):655-64. doi: 10.1080/00952990701522666.","Arnold-Reed DE","Am J Drug Alcohol Abuse","2007","2007/09/25","","","10.1080/00952990701522666"
"17891655","Pharmacotherapeutic environments for substance use disorders","Gardner TJ, Kosten TR.","Am J Drug Alcohol Abuse. 2007;33(5):627-9. doi: 10.1080/00952990701578676.","Gardner TJ","Am J Drug Alcohol Abuse","2007","2007/09/25","","","10.1080/00952990701578676"
"17882404","Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats","Steinmiller CL, Young AM.","Psychopharmacology (Berl). 2008 Jan;195(4):497-507. doi: 10.1007/s00213-007-0898-5. Epub 2007 Sep 19.","Steinmiller CL","Psychopharmacology (Berl)","2008","2007/09/21","PMC2565866","NIHMS68569","10.1007/s00213-007-0898-5"
"17880925","Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings","Johnson BA.","Biochem Pharmacol. 2008 Jan 1;75(1):34-56. doi: 10.1016/j.bcp.2007.08.005. Epub 2007 Aug 9.","Johnson BA","Biochem Pharmacol","2008","2007/09/21","PMC2359153","NIHMS37095","10.1016/j.bcp.2007.08.005"
"17874317","Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys","Li JX, McMahon LR, France CP.","Psychopharmacology (Berl). 2008 Jan;195(4):479-86. doi: 10.1007/s00213-007-0914-9. Epub 2007 Sep 16.","Li JX","Psychopharmacology (Berl)","2008","2007/09/18","","","10.1007/s00213-007-0914-9"
"17873704","GABAergic medications for treating alcohol dependence","Caputo F, Vignoli T, Francini S, Stoppo M, Bernardi M.","J Clin Psychopharmacol. 2007 Oct;27(5):539-40; author reply 540-2. doi: 10.1097/JCP.0b013e31814fb51a.","Caputo F","J Clin Psychopharmacol","2007","2007/09/18","","","10.1097/JCP.0b013e31814fb51a"
"17873686","Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment","O'Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR.","J Clin Psychopharmacol. 2007 Oct;27(5):507-12. doi: 10.1097/jcp.0b013e31814ce50d.","O'Malley SS","J Clin Psychopharmacol","2007","2007/09/18","","","10.1097/jcp.0b013e31814ce50d"
"17873678","Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence","Mannelli P, Patkar AA, Peindl K, Murray HW, Wu LT, Hubbard R.","J Clin Psychopharmacol. 2007 Oct;27(5):468-74. doi: 10.1097/jcp.0b013e31814e5e9d.","Mannelli P","J Clin Psychopharmacol","2007","2007/09/18","","","10.1097/jcp.0b013e31814e5e9d"
"17850768","Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence","Kakko J, von Wachenfeldt J, Svanborg KD, Lidström J, Barr CS, Heilig M.","Biol Psychiatry. 2008 Jan 15;63(2):172-7. doi: 10.1016/j.biopsych.2007.05.001. Epub 2007 Sep 11.","Kakko J","Biol Psychiatry","2008","2007/09/14","","","10.1016/j.biopsych.2007.05.001"
"17850414","Biodegradability of naltrexone-poly(DL) lactide implants in vivo assessed under ultrasound in humans","Hulse GK, Low VH, Stalenberg V, Morris N, Thompson RI, Tait RJ, Phan CT, Ngo HT, Arnold-Reed DE.","Addict Biol. 2008 Sep;13(3-4):364-72. doi: 10.1111/j.1369-1600.2007.00081.x. Epub 2007 Sep 11.","Hulse GK","Addict Biol","2008","2007/09/14","","","10.1111/j.1369-1600.2007.00081.x"
"17844725","Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus","Neyens R, Jackson KC 2nd.","J Pain Palliat Care Pharmacother. 2007;21(2):27-33.","Neyens R","J Pain Palliat Care Pharmacother","2007","2007/09/12","","",""
"17768272","Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study","Ray LA, Hutchison KE.","Arch Gen Psychiatry. 2007 Sep;64(9):1069-77. doi: 10.1001/archpsyc.64.9.1069.","Ray LA","Arch Gen Psychiatry","2007","2007/09/05","","","10.1001/archpsyc.64.9.1069"
"17768078","Intramuscular administration of morphine reduces mustard-oil-induced craniofacial-muscle pain behavior in lightly anesthetized rats","Han SR, Lee MK, Lim KH, Yang GY, Jeon HJ, Ju JS, Yoon YW, Kim SK, Ahn DK.","Eur J Pain. 2008 Apr;12(3):361-70. doi: 10.1016/j.ejpain.2007.07.002. Epub 2007 Sep 4.","Han SR","Eur J Pain","2008","2007/09/05","","","10.1016/j.ejpain.2007.07.002"
"17764531","Elevation of pentylenetetrazole-induced seizure threshold in cholestatic mice: interaction between opioid and cannabinoid systems","Shafaroodi H, Ghasemi M, Dehpour AR.","J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e251-7. doi: 10.1111/j.1440-1746.2007.05101.x. Epub 2007 Aug 30.","Shafaroodi H","J Gastroenterol Hepatol","2008","2007/09/04","","","10.1111/j.1440-1746.2007.05101.x"
"17761642","Reversal of signs and symptoms of a B-cell lymphoma in a patient using only low-dose naltrexone","Berkson BM, Rubin DM, Berkson AJ.","Integr Cancer Ther. 2007 Sep;6(3):293-6. doi: 10.1177/1534735407306358.","Berkson BM","Integr Cancer Ther","2007","2007/09/01","","","10.1177/1534735407306358"
"17725853","Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice","Tokuyama S, Nagae R, Mashida E, Hamabe W.","J Pharm Pharmacol. 2007 Aug;59(8):1109-15. doi: 10.1211/jpp.59.8.0008.","Tokuyama S","J Pharm Pharmacol","2007","2007/08/30","","","10.1211/jpp.59.8.0008"
"17720886","A select set of opioid ligands induce up-regulation by promoting the maturation and stability of the rat kappa-opioid receptor in human embryonic kidney 293 cells","Wannemacher KM, Yadav PN, Howells RD.","J Pharmacol Exp Ther. 2007 Nov;323(2):614-25. doi: 10.1124/jpet.107.125500. Epub 2007 Aug 24.","Wannemacher KM","J Pharmacol Exp Ther","2007","2007/08/28","","","10.1124/jpet.107.125500"
"17716077","Contingency management for treatment of substance abuse","Stitzer M, Petry N.","Annu Rev Clin Psychol. 2006;2:411-34. doi: 10.1146/annurev.clinpsy.2.022305.095219.","Stitzer M","Annu Rev Clin Psychol","2006","2007/08/25","","","10.1146/annurev.clinpsy.2.022305.095219"
"17705265","Hepatitis C treatment, subcutaneous naltrexone implants, and methadone maintenance treatment","Novick DM, Kreek MJ.","Hepatology. 2007 Sep;46(3):951-2. doi: 10.1002/hep.21718.","Novick DM","Hepatology","2007","2007/08/21","","","10.1002/hep.21718"
"17704092","Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia","Iwata M, Inoue S, Kawaguchi M, Nakamura M, Konishi N, Furuya H.","Br J Anaesth. 2007 Oct;99(4):538-46. doi: 10.1093/bja/aem220. Epub 2007 Aug 17.","Iwata M","Br J Anaesth","2007","2007/08/21","","","10.1093/bja/aem220"
"17702903","Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms","Valdez GR, Platt DM, Rowlett JK, Rüedi-Bettschen D, Spealman RD.","J Pharmacol Exp Ther. 2007 Nov;323(2):525-33. doi: 10.1124/jpet.107.125484. Epub 2007 Aug 16.","Valdez GR","J Pharmacol Exp Ther","2007","2007/08/19","","","10.1124/jpet.107.125484"
"17698975","Mu-opioid receptor up-regulation and functional supersensitivity are independent of antagonist efficacy","Sirohi S, Kumar P, Yoburn BC.","J Pharmacol Exp Ther. 2007 Nov;323(2):701-7. doi: 10.1124/jpet.107.127019. Epub 2007 Aug 14.","Sirohi S","J Pharmacol Exp Ther","2007","2007/08/19","","","10.1124/jpet.107.127019"
"17696684","Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers","Knott VJ, Fisher DJ.","Exp Clin Psychopharmacol. 2007 Aug;15(4):368-81. doi: 10.1037/1064-1297.15.4.368.","Knott VJ","Exp Clin Psychopharmacol","2007","2007/08/21","","","10.1037/1064-1297.15.4.368"
"17692296","Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice","Crain SM, Shen KF.","Brain Res. 2007 Sep 5;1167:31-41. doi: 10.1016/j.brainres.2007.06.058. Epub 2007 Jul 14.","Crain SM","Brain Res","2007","2007/08/19","","","10.1016/j.brainres.2007.06.058"
"17689189","Dose-dependent neuroprotection of delta opioid peptide [D-Ala2, D-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats","Su DS, Wang ZH, Zheng YJ, Zhao YH, Wang XR.","Neurosci Lett. 2007 Aug 16;423(2):113-7. doi: 10.1016/j.neulet.2007.06.044. Epub 2007 Aug 6.","Su DS","Neurosci Lett","2007","2007/08/11","","","10.1016/j.neulet.2007.06.044"
"17685876","Sustained-release naltrexone: novel treatment for opioid dependence","Comer SD, Sullivan MA, Hulse GK.","Expert Opin Investig Drugs. 2007 Aug;16(8):1285-94. doi: 10.1517/13543784.16.8.1285.","Comer SD","Expert Opin Investig Drugs","2007","2007/08/10","","","10.1517/13543784.16.8.1285"
"17685875","Oxytrex: an oxycodone and ultra-low-dose naltrexone formulation","Webster LR.","Expert Opin Investig Drugs. 2007 Aug;16(8):1277-83. doi: 10.1517/13543784.16.8.1277.","Webster LR","Expert Opin Investig Drugs","2007","2007/08/10","","","10.1517/13543784.16.8.1277"
"17684846","Plasma met-enkephalin, beta-endorphin and leu-enkephalin levels in human hepatic encephalopathy","Kamel L, Saleh A, Morsy A, Ghali A, El Khayat H.","East Mediterr Health J. 2007 Mar-Apr;13(2):257-65.","Kamel L","East Mediterr Health J","2007","2007/08/10","","",""
"17683915","Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrain","Emmanouil DE, Dickens AS, Heckert RW, Ohgami Y, Chung E, Han S, Quock RM.","Eur Neuropsychopharmacol. 2008 Mar;18(3):194-9. doi: 10.1016/j.euroneuro.2007.06.008. Epub 2007 Aug 1.","Emmanouil DE","Eur Neuropsychopharmacol","2008","2007/08/09","PMC2279102","NIHMS40089","10.1016/j.euroneuro.2007.06.008"
"17683166","Two-photon excitation fluorescence cross-correlation assay for ligand-receptor binding: cell membrane nanopatches containing the human micro-opioid receptor","Swift JL, Burger MC, Massotte D, Dahms TE, Cramb DT.","Anal Chem. 2007 Sep 1;79(17):6783-91. doi: 10.1021/ac0709495. Epub 2007 Aug 8.","Swift JL","Anal Chem","2007","2007/08/09","","","10.1021/ac0709495"
"17681716","Management of relapse in naltrexone maintenance for heroin dependence","Sullivan MA, Garawi F, Bisaga A, Comer SD, Carpenter K, Raby WN, Anen SJ, Brooks AC, Jiang H, Akerele E, Nunes EV.","Drug Alcohol Depend. 2007 Dec 1;91(2-3):289-92. doi: 10.1016/j.drugalcdep.2007.06.013. Epub 2007 Aug 2.","Sullivan MA","Drug Alcohol Depend","2007","2007/08/08","PMC4153601","NIHMS33193","10.1016/j.drugalcdep.2007.06.013"
"17674315","Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication","Li Y, Ye L, Peng JS, Wang CQ, Luo GX, Zhang T, Wan Q, Ho WZ.","J Infect Dis. 2007 Sep 1;196(5):719-30. doi: 10.1086/520093. Epub 2007 Jul 18.","Li Y","J Infect Dis","2007","2007/08/04","","","10.1086/520093"
"17664051","Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence","Pettinati HM, Kampman KM, Lynch KG, Suh JJ, Dackis CA, Oslin DW, O'Brien CP.","J Subst Abuse Treat. 2008 Jun;34(4):378-90. doi: 10.1016/j.jsat.2007.05.011. Epub 2007 Jul 30.","Pettinati HM","J Subst Abuse Treat","2008","2007/08/01","PMC2600888","NIHMS51079","10.1016/j.jsat.2007.05.011"
"17661192","Monitored naltrexone without counseling for alcohol abuse/dependence in schizophrenia-spectrum disorders","Batki SL, Dimmock JA, Wade M, Gately PW, Cornell M, Maisto SA, Carey KB, Ploutz-Snyder R.","Am J Addict. 2007 Jul-Aug;16(4):253-9. doi: 10.1080/10550490701389732.","Batki SL","Am J Addict","2007","2007/07/31","","","10.1080/10550490701389732"
"17651881","Blood naltrexone levels over time following naltrexone implant","Ngo HT, Arnold-Reed DE, Hansson RC, Tait RJ, Hulse GK.","Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):23-8. doi: 10.1016/j.pnpbp.2007.06.007. Epub 2007 Jun 19.","Ngo HT","Prog Neuropsychopharmacol Biol Psychiatry","2008","2007/07/27","","","10.1016/j.pnpbp.2007.06.007"
"17651799","beta-Endorphin regulates diverse functions of splenic phagocytes through different opioid receptors in freshwater fish Channa punctatus (Bloch): an in vitro study","Singh R, Rai U.","Dev Comp Immunol. 2008;32(4):330-8. doi: 10.1016/j.dci.2007.06.005. Epub 2007 Jul 9.","Singh R","Dev Comp Immunol","2008","2007/07/27","","","10.1016/j.dci.2007.06.005"
"17638297","Increase in diazepam binding inhibitor expression by sustained morphine exposure is mediated via mu-opioid receptors in primary cultures of mouse cerebral cortical neurons","Shibasaki M, Katsura M, Torigoe F, Honda T, Sumimoto A, Tsujimura A, Ohkuma S.","J Neurosci Res. 2007 Oct;85(13):2971-80. doi: 10.1002/jnr.21415.","Shibasaki M","J Neurosci Res","2007","2007/07/20","","","10.1002/jnr.21415"
"17632507","A tarantula peptide against pain via ASIC1a channels and opioid mechanisms","Mazzuca M, Heurteaux C, Alloui A, Diochot S, Baron A, Voilley N, Blondeau N, Escoubas P, Gélot A, Cupo A, Zimmer A, Zimmer AM, Eschalier A, Lazdunski M.","Nat Neurosci. 2007 Aug;10(8):943-5. doi: 10.1038/nn1940. Epub 2007 Jul 15.","Mazzuca M","Nat Neurosci","2007","2007/07/17","","","10.1038/nn1940"
"17632219","Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis","Pallesen S, Molde H, Arnestad HM, Laberg JC, Skutle A, Iversen E, Støylen IJ, Kvale G, Holsten F.","J Clin Psychopharmacol. 2007 Aug;27(4):357-64. doi: 10.1097/jcp.013e3180dcc304d.","Pallesen S","J Clin Psychopharmacol","2007","2007/07/17","","","10.1097/jcp.013e3180dcc304d"
"17626178","Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking","Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE.","Version 2. Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12518-23. doi: 10.1073/pnas.0705368104. Epub 2007 Jul 11.","Steensland P","Proc Natl Acad Sci U S A","2007","2007/07/13","PMC1914040","","10.1073/pnas.0705368104"
"17623758","Low-dose naltrexone for treatment of multiple sclerosis: clinical trials are needed","Patel PN.","Ann Pharmacother. 2007 Sep;41(9):1549-50. doi: 10.1345/aph.1H083. Epub 2007 Jul 10.","Patel PN","Ann Pharmacother","2007","2007/07/12","","","10.1345/aph.1H083"
"17619840","[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review]","Wobrock T, D'Amelio R, Falkai P.","Nervenarzt. 2008 Jan;79(1):17-8, 20-2, 24-6 passim. doi: 10.1007/s00115-007-2310-4.","Wobrock T","Nervenarzt","2008","2007/07/11","","","10.1007/s00115-007-2310-4"
"17617474","Opioid receptor blockade increases the number of lymphocytes without altering T cell response in draining lymph nodes in vivo","Jaume M, Laffont S, Chapey E, Blanpied C, Dietrich G.","J Neuroimmunol. 2007 Aug;188(1-2):95-102. doi: 10.1016/j.jneuroim.2007.06.013. Epub 2007 Jul 6.","Jaume M","J Neuroimmunol","2007","2007/07/10","","","10.1016/j.jneuroim.2007.06.013"
"17611081","Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study","Caputo F, Addolorato G, Stoppo M, Francini S, Vignoli T, Lorenzini F, Del Re A, Comaschi C, Andreone P, Trevisani F, Bernardi M; Alcohol Treatment Study Group.","Eur Neuropsychopharmacol. 2007 Dec;17(12):781-9. doi: 10.1016/j.euroneuro.2007.04.008. Epub 2007 Jul 3.","Caputo F","Eur Neuropsychopharmacol","2007","2007/07/06","","","10.1016/j.euroneuro.2007.04.008"
"17610914","Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens","Lindholm S, Rosin A, Dahlin I, Georgieva J, Franck J.","Physiol Behav. 2007 Sep 10;92(1-2):167-71. doi: 10.1016/j.physbeh.2007.05.039. Epub 2007 May 21.","Lindholm S","Physiol Behav","2007","2007/07/06","","","10.1016/j.physbeh.2007.05.039"
"17606820","Lack of information in naltrexone study","Rastegar DA.","Arch Gen Psychiatry. 2007 Jul;64(7):865; author reply 865. doi: 10.1001/archpsyc.64.7.865-a.","Rastegar DA","Arch Gen Psychiatry","2007","2007/07/04","","","10.1001/archpsyc.64.7.865-a"
"17605713","Opioid overdose deaths can occur in patients with naltrexone implants","Kunøe N, Waal H.","Med J Aust. 2007 Jul 2;187(1):56; author reply 56-7.","Kunøe N","Med J Aust","2007","2007/07/04","","",""
"17605712","Opioid overdose deaths can occur in patients with naltrexone implants","Khong E, Choy W.","Med J Aust. 2007 Jul 2;187(1):56; author reply 56-7.","Khong E","Med J Aust","2007","2007/07/04","","",""
"17605710","Opioid overdose deaths can occur in patients with naltrexone implants","Brewer CL.","Med J Aust. 2007 Jul 2;187(1):55; author reply 56-7.","Brewer CL","Med J Aust","2007","2007/07/04","","",""
"17605709","Opioid overdose deaths can occur in patients with naltrexone implants","Batey RG.","Med J Aust. 2007 Jul 2;187(1):55; author reply 56-7.","Batey RG","Med J Aust","2007","2007/07/04","","",""
"17605708","Opioid overdose deaths can occur in patients with naltrexone implants","Hulse GK, Tait RJ.","Med J Aust. 2007 Jul 2;187(1):54; author reply 56-7.","Hulse GK","Med J Aust","2007","2007/07/04","","",""
"17605707","Opioid overdose deaths can occur in patients with naltrexone implants","Sim MG.","Med J Aust. 2007 Jul 2;187(1):54; author reply 56-7.","Sim MG","Med J Aust","2007","2007/07/04","","",""
"17601558","Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies","Zhang H, Shi YG, Woods JH, Watson SJ, Ko MC.","Eur J Pharmacol. 2007 Sep 10;570(1-3):89-96. doi: 10.1016/j.ejphar.2007.05.045. Epub 2007 Jun 9.","Zhang H","Eur J Pharmacol","2007","2007/07/03","PMC2031926","NIHMS29730","10.1016/j.ejphar.2007.05.045"
"17600376","The neural pathway of galanin in the hypothalamic arcuate nucleus of rats: activation of beta-endorphinergic neurons projecting to periaqueductal gray matter","Sun YG, Gu XL, Yu LC.","J Neurosci Res. 2007 Aug 15;85(11):2400-6. doi: 10.1002/jnr.21396.","Sun YG","J Neurosci Res","2007","2007/06/30","","","10.1002/jnr.21396"
"17599812","Relative contribution of peripheral versus central opioid receptors to antinociception","Labuz D, Mousa SA, Schäfer M, Stein C, Machelska H.","Brain Res. 2007 Jul 30;1160:30-8. doi: 10.1016/j.brainres.2007.05.049. Epub 2007 Jun 2.","Labuz D","Brain Res","2007","2007/06/30","","","10.1016/j.brainres.2007.05.049"
"17598951","Effects of loperamide on mechanical allodynia induced by herpes simplex virus type-1 in mice","Sasaki A, Nakashima Y, Takasaki I, Andoh T, Shiraki K, Kuraishi Y.","J Pharmacol Sci. 2007 Jul;104(3):218-24. doi: 10.1254/jphs.fp0070294. Epub 2007 Jun 29.","Sasaki A","J Pharmacol Sci","2007","2007/06/30","","","10.1254/jphs.fp0070294"
"17592483","CREB1 haplotypes and the relative reinforcing value of nicotine","Ray R, Jepson C, Wileyto P, Patterson F, Strasser AA, Rukstalis M, Perkins K, Blendy J, Lerman C.","Mol Psychiatry. 2007 Jul;12(7):615-7. doi: 10.1038/sj.mp.4002002.","Ray R","Mol Psychiatry","2007","2007/06/27","","","10.1038/sj.mp.4002002"
"17588352","Cancer-related constipation","Thomas J.","Curr Oncol Rep. 2007 Jul;9(4):278-84. doi: 10.1007/s11912-007-0034-z.","Thomas J","Curr Oncol Rep","2007","2007/06/26","","","10.1007/s11912-007-0034-z"
"17587504","A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain","Toll BA, Leary V, Wu R, Salovey P, Meandzija B, O'Malley SS.","Addict Behav. 2008 Jan;33(1):173-9. doi: 10.1016/j.addbeh.2007.05.012. Epub 2007 Jun 2.","Toll BA","Addict Behav","2008","2007/06/26","PMC2488403","NIHMS34630","10.1016/j.addbeh.2007.05.012"
"17582810","Structural characterization of anhydrous naloxone- and naltrexone hydrochloride by high resolution laboratory X-ray powder diffraction and thermal analysis","Sugimoto K, Dinnebier RE, Zakrzewski M.","J Pharm Sci. 2007 Dec;96(12):3316-23. doi: 10.1002/jps.20972.","Sugimoto K","J Pharm Sci","2007","2007/06/22","","","10.1002/jps.20972"
"17581528","Micro-opioid receptor alkylation in the ventral pallidum and ventral tegmental area, but not in the nucleus accumbens, attenuates the effects of heroin on cocaine self-administration in rats","Martin TJ, Coller M, Co C, Smith JE.","Neuropsychopharmacology. 2008 Apr;33(5):1171-8. doi: 10.1038/sj.npp.1301490. Epub 2007 Jun 20.","Martin TJ","Neuropsychopharmacology","2008","2007/06/22","","","10.1038/sj.npp.1301490"
"17578067","A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation","Shaiova L, Rim F, Friedman D, Jahdi M.","Palliat Support Care. 2007 Jun;5(2):161-6. doi: 10.1017/s147895150707023x.","Shaiova L","Palliat Support Care","2007","2007/06/21","","","10.1017/s147895150707023x"
"17574793","Substance abuse and schizophrenia: pharmacotherapeutic intervention","Green AI, Noordsy DL, Brunette MF, O'Keefe C.","J Subst Abuse Treat. 2008 Jan;34(1):61-71. doi: 10.1016/j.jsat.2007.01.008. Epub 2007 Jun 15.","Green AI","J Subst Abuse Treat","2008","2007/06/19","PMC2930488","NIHMS211253","10.1016/j.jsat.2007.01.008"
"17574300","Validation of a scale for the assessment of food cravings among smokers","Toll BA, Katulak NA, Williams-Piehota P, O'Malley S.","Appetite. 2008 Jan;50(1):25-32. doi: 10.1016/j.appet.2007.05.001. Epub 2007 May 18.","Toll BA","Appetite","2008","2007/06/19","PMC2386855","NIHMS35062","10.1016/j.appet.2007.05.001"
"17573782","Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone","Kiefer F, Jiménez-Arriero MA, Klein O, Diehl A, Rubio G.","Addict Biol. 2008 Mar;13(1):124-9. doi: 10.1111/j.1369-1600.2007.00073.x. Epub 2007 Jun 16.","Kiefer F","Addict Biol","2008","2007/06/19","","","10.1111/j.1369-1600.2007.00073.x"
"17572514","Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement","Ward SJ, Roberts DC.","Behav Brain Res. 2007 Aug 22;182(1):140-4. doi: 10.1016/j.bbr.2007.05.003. Epub 2007 May 18.","Ward SJ","Behav Brain Res","2007","2007/06/19","PMC2076745","NIHMS27667","10.1016/j.bbr.2007.05.003"
"17564876","Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records","Gibson AE, Degenhardt LJ.","Drug Alcohol Rev. 2007 Jul;26(4):405-10. doi: 10.1080/09595230701373834.","Gibson AE","Drug Alcohol Rev","2007","2007/06/15","","","10.1080/09595230701373834"
"17563214","Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics","Rohsenow DJ, Miranda R Jr, McGeary JE, Monti PM.","Exp Clin Psychopharmacol. 2007 Jun;15(3):272-81. doi: 10.1037/1064-1297.15.3.272.","Rohsenow DJ","Exp Clin Psychopharmacol","2007","2007/06/15","","","10.1037/1064-1297.15.3.272"
"17562397","Maternal separation alters ICSS responding in adult male and female rats, but morphine and naltrexone have little affect on that behavior","Michaels CC, Easterling KW, Holtzman SG.","Brain Res Bull. 2007 Jul 12;73(4-6):310-8. doi: 10.1016/j.brainresbull.2007.04.008. Epub 2007 May 22.","Michaels CC","Brain Res Bull","2007","2007/06/15","","","10.1016/j.brainresbull.2007.04.008"
"17560720","Effects of opioid blockade on the modulation of pain and mood by sweet taste and blood pressure in young adults","Lewkowski MD, Young SN, Ghosh S, Ditto B.","Pain. 2008 Mar;135(1-2):75-81. doi: 10.1016/j.pain.2007.05.003. Epub 2007 Jun 8.","Lewkowski MD","Pain","2008","2007/06/15","","","10.1016/j.pain.2007.05.003"
"17555306","o-Naphthalenedicarboxaldehyde derivative of 7'-aminonaltrindole as a selective delta-opioid receptor affinity label","Haris SP, Zhang Y, Le Bourdonnec B, McCurdy CR, Portoghese PS.","J Med Chem. 2007 Jul 12;50(14):3392-6. doi: 10.1021/jm061194h. Epub 2007 Jun 8.","Haris SP","J Med Chem","2007","2007/06/09","","","10.1021/jm061194h"
"17550406","Central inhibition of opioid receptor subtypes and its effect on haemorrhagic hypotension in conscious sheep","Frithiof R, Eriksson S, Rundgren M.","Acta Physiol (Oxf). 2007 Sep;191(1):25-34. doi: 10.1111/j.1748-1716.2007.01720.x. Epub 2007 Jun 5.","Frithiof R","Acta Physiol (Oxf)","2007","2007/06/07","","","10.1111/j.1748-1716.2007.01720.x"
"17550364","Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception","Campbell VC, Taylor RE, Tizabi Y.","Alcohol Clin Exp Res. 2007 Aug;31(8):1435-40. doi: 10.1111/j.1530-0277.2007.00432.x. Epub 2007 Jun 5.","Campbell VC","Alcohol Clin Exp Res","2007","2007/06/07","","","10.1111/j.1530-0277.2007.00432.x"
"17539894","Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial","Foxx-Orenstein AE, Camilleri M, Szarka LA, McKinzie S, Burton D, Thomforde G, Baxter K, Zinsmeister AR.","Neurogastroenterol Motil. 2007 Oct;19(10):821-30. doi: 10.1111/j.1365-2982.2007.00944.x. Epub 2007 May 21.","Foxx-Orenstein AE","Neurogastroenterol Motil","2007","2007/06/02","","","10.1111/j.1365-2982.2007.00944.x"
"17530745","Electron density analyses of opioids: a comparative study","Scheins S, Messerschmidt M, Morgenroth W, Paulmann C, Luger P.","J Phys Chem A. 2007 Jun 28;111(25):5499-508. doi: 10.1021/jp0709252. Epub 2007 May 26.","Scheins S","J Phys Chem A","2007","2007/05/29","","","10.1021/jp0709252"
"17526634","Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokers","Schmidt LG, Smolka MN.","Alcohol Alcohol. 2007 May-Jun;42(3):241-6. doi: 10.1093/alcalc/agm027.","Schmidt LG","Alcohol Alcohol","2007","2007/05/29","","","10.1093/alcalc/agm027"
"17523463","[Role of kappa-opioid receptors in the regulation of cardiac resistance to arrhythmogenic effects of ischemia and reperfusion]","Lishmanov AIu, Lasukova TV, Maslov LN, Platonov AA.","Ross Fiziol Zh Im I M Sechenova. 2006 Dec;92(12):1419-28.","Lishmanov AIu","Ross Fiziol Zh Im I M Sechenova","2006","2007/05/26","","",""
"17517820","Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland","Buri C, Moggi F, Giovanoli A, Strik W.","Alcohol Alcohol. 2007 Jul-Aug;42(4):333-9. doi: 10.1093/alcalc/agm038. Epub 2007 May 21.","Buri C","Alcohol Alcohol","2007","2007/05/23","","","10.1093/alcalc/agm038"
"17514344","Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment","Davidson D, Wirtz PW, Gulliver SB, Longabaugh R.","Psychopharmacology (Berl). 2007 Sep;194(1):1-10. doi: 10.1007/s00213-007-0807-y. Epub 2007 May 19.","Davidson D","Psychopharmacology (Berl)","2007","2007/05/22","","","10.1007/s00213-007-0807-y"
"17512663","Negative affect, pain and sex: the role of endogenous opioids","Frew AK, Drummond PD.","Pain. 2007 Nov;132 Suppl 1:S77-85. doi: 10.1016/j.pain.2007.04.010. Epub 2007 May 18.","Frew AK","Pain","2007","2007/05/22","","","10.1016/j.pain.2007.04.010"
"17508990","Does naltrexone affect craving in abstinent opioid-dependent patients?","Dijkstra BA, De Jong CA, Bluschke SM, Krabbe PF, van der Staak CP.","Addict Biol. 2007 Jun;12(2):176-82. doi: 10.1111/j.1369-1600.2007.00067.x.","Dijkstra BA","Addict Biol","2007","2007/05/19","","","10.1111/j.1369-1600.2007.00067.x"
"17504835","Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects","Yuan CS.","Ann Pharmacother. 2007 Jun;41(6):984-93. doi: 10.1345/aph.1K009. Epub 2007 May 15.","Yuan CS","Ann Pharmacother","2007","2007/05/17","","","10.1345/aph.1K009"
"17502848","Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists","Abul-Husn NS, Sutak M, Milne B, Jhamandas K.","Br J Pharmacol. 2007 Jul;151(6):877-87. doi: 10.1038/sj.bjp.0707277. Epub 2007 May 14.","Abul-Husn NS","Br J Pharmacol","2007","2007/05/16","PMC2014123","","10.1038/sj.bjp.0707277"
"17499959","Availability of addiction medications in private health plans","Horgan CM, Reif S, Hodgkin D, Garnick DW, Merrick EL.","J Subst Abuse Treat. 2008 Mar;34(2):147-56. doi: 10.1016/j.jsat.2007.02.004. Epub 2007 May 17.","Horgan CM","J Subst Abuse Treat","2008","2007/05/15","PMC2347353","NIHMS40530","10.1016/j.jsat.2007.02.004"
"17499930","Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux","Tao R, Ma Z, Thakkar MM, McCarley RW, Auerbach SB.","Neuroscience. 2007 Jun 15;147(1):106-16. doi: 10.1016/j.neuroscience.2007.02.011. Epub 2007 May 14.","Tao R","Neuroscience","2007","2007/05/15","","","10.1016/j.neuroscience.2007.02.011"
"17498182","Overcoming opioid blockade from depot naltrexone (Prodetoxon)","Kruptisky EM, Burakov AM, Tsoy MV, Egorova VY, Slavina TY, Grinenko AY, Zvartau EE, Woody GE.","Addiction. 2007 Jul;102(7):1164-5. doi: 10.1111/j.1360-0443.2007.01817.x.","Kruptisky EM","Addiction","2007","2007/05/15","","","10.1111/j.1360-0443.2007.01817.x"
"17488879","Sexually dimorphic recruitment of spinal opioid analgesic pathways by the spinal application of morphine","Liu NJ, von Gizycki H, Gintzler AR.","J Pharmacol Exp Ther. 2007 Aug;322(2):654-60. doi: 10.1124/jpet.107.123620. Epub 2007 May 8.","Liu NJ","J Pharmacol Exp Ther","2007","2007/05/10","","","10.1124/jpet.107.123620"
"17487577","Implications of cannabis use and heavy alcohol use on HIV drug risk behaviors in Russian heroin users","Walley AY, Krupitsky EM, Cheng DM, Raj A, Edwards EM, Bridden C, Egorova VY, Zvartau EE, Woody GE, Samet JH.","AIDS Behav. 2008 Jul;12(4):662-9. doi: 10.1007/s10461-007-9243-6. Epub 2007 May 9.","Walley AY","AIDS Behav","2008","2007/05/10","PMC2480514","","10.1007/s10461-007-9243-6"
"17487229","Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects","Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ, McCaul ME.","Neuropsychopharmacology. 2008 Feb;33(3):653-65. doi: 10.1038/sj.npp.1301440. Epub 2007 May 9.","Weerts EM","Neuropsychopharmacology","2008","2007/05/10","","","10.1038/sj.npp.1301440"
"17484067","Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study","Ray LA, Miranda R Jr, Kahler CW, Leventhal AM, Monti PM, Swift R, Hutchison KE.","Psychopharmacology (Berl). 2007 Sep;193(4):449-56. doi: 10.1007/s00213-007-0794-z. Epub 2007 May 6.","Ray LA","Psychopharmacology (Berl)","2007","2007/05/08","","","10.1007/s00213-007-0794-z"
"17482777","A 'biorelevant' approach to accelerated in vitro drug release testing of a biodegradable, naltrexone implant","Iyer SS, Barr WH, Karnes HT.","Int J Pharm. 2007 Aug 1;340(1-2):119-25. doi: 10.1016/j.ijpharm.2007.03.033. Epub 2007 Mar 30.","Iyer SS","Int J Pharm","2007","2007/05/08","","","10.1016/j.ijpharm.2007.03.033"
"17482393","A 'biorelevant' system to investigate in vitro drug released from a naltrexone implant","Iyer SS, Barr WH, Dance ME, Coleman PR, Karnes HT.","Int J Pharm. 2007 Aug 1;340(1-2):104-18. doi: 10.1016/j.ijpharm.2007.03.032. Epub 2007 Mar 30.","Iyer SS","Int J Pharm","2007","2007/05/08","","","10.1016/j.ijpharm.2007.03.032"
"17475725","Medical treatment of opiate dependence: expanding treatment options","Brady KT.","Am J Psychiatry. 2007 May;164(5):702-4. doi: 10.1176/ajp.2007.164.5.702.","Brady KT","Am J Psychiatry","2007","2007/05/04","","","10.1176/ajp.2007.164.5.702"
"17475345","AM 251 and beta-Funaltrexamine reduce fat intake in a fat-preferring strain of mouse","South T, Deng C, Huang XF.","Behav Brain Res. 2007 Jul 19;181(1):153-7. doi: 10.1016/j.bbr.2007.03.028. Epub 2007 Mar 31.","South T","Behav Brain Res","2007","2007/05/04","","","10.1016/j.bbr.2007.03.028"
"17475341","The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells","Davis RL, Buck DJ, Saffarian N, Stevens CW.","J Neuroimmunol. 2007 May;186(1-2):141-9. doi: 10.1016/j.jneuroim.2007.03.021. Epub 2007 May 1.","Davis RL","J Neuroimmunol","2007","2007/05/04","PMC1948894","NIHMS25308","10.1016/j.jneuroim.2007.03.021"
"17473837","Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence","Walker BM, Koob GF.","Neuropsychopharmacology. 2008 Feb;33(3):643-52. doi: 10.1038/sj.npp.1301438. Epub 2007 May 2.","Walker BM","Neuropsychopharmacology","2008","2007/05/03","PMC2739278","NIHMS140624","10.1038/sj.npp.1301438"
"17470643","Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958","Hawkinson JE, Szoke BG, Garofalo AW, Hom DS, Zhang H, Dreyer M, Fukuda JY, Chen L, Samant B, Simmonds S, Zeitz KP, Wadsworth A, Liao A, Chavez RA, Zmolek W, Ruslim L, Bova MP, Holcomb R, Butelman ER, Ko MC, Malmberg AB.","J Pharmacol Exp Ther. 2007 Aug;322(2):619-30. doi: 10.1124/jpet.107.120352. Epub 2007 Apr 30.","Hawkinson JE","J Pharmacol Exp Ther","2007","2007/05/02","","","10.1124/jpet.107.120352"
"17469937","Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment","Hyman SM, Fox H, Hong KI, Doebrick C, Sinha R.","Exp Clin Psychopharmacol. 2007 Apr;15(2):134-43. doi: 10.1037/1064-1297.15.2.134.","Hyman SM","Exp Clin Psychopharmacol","2007","2007/05/02","PMC2392893","NIHMS47855","10.1037/1064-1297.15.2.134"
"17459462","Enhanced sensitivity to naltrexone-induced drinking suppression of fluid intake and sucrose consumption in maternally separated rats","Michaels CC, Holtzman SG.","Pharmacol Biochem Behav. 2007 Apr;86(4):784-96. doi: 10.1016/j.pbb.2007.03.007. Epub 2007 Mar 28.","Michaels CC","Pharmacol Biochem Behav","2007","2007/04/27","PMC2075100","NIHMS25900","10.1016/j.pbb.2007.03.007"
"17459369","NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action","Naidu PS, Lichtman AH, Archer CC, May EL, Harris LS, Aceto MD.","Eur J Pharmacol. 2007 Jul 2;566(1-3):132-6. doi: 10.1016/j.ejphar.2007.03.031. Epub 2007 Mar 30.","Naidu PS","Eur J Pharmacol","2007","2007/04/27","PMC1939727","NIHMS25223","10.1016/j.ejphar.2007.03.031"
"17457147","Oxycodone's mechanism of action and potency differences after spinal and systemic routes of administration","Smith MT, Edwards SR, Nielsen CK.","Anesthesiology. 2007 May;106(5):1063-4; author reply 1064-5. doi: 10.1097/01.anes.0000265176.75372.ed.","Smith MT","Anesthesiology","2007","2007/04/26","","","10.1097/01.anes.0000265176.75372.ed"
"17456590","The effect of kappa opioid receptor antagonism on energy expenditure in the obese Zucker rat","Jarosz PA.","Biol Res Nurs. 2007 Apr;8(4):294-9. doi: 10.1177/1099800406298774.","Jarosz PA","Biol Res Nurs","2007","2007/04/26","","","10.1177/1099800406298774"
"17454716","Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit","Toll BA, McKee SA, Martin DJ, Jatlow P, O'Malley SS.","Nicotine Tob Res. 2007 May;9(5):597-605. doi: 10.1080/14622200701239662.","Toll BA","Nicotine Tob Res","2007","2007/04/25","PMC2527736","NIHMS52644","10.1080/14622200701239662"
"17454177","Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome","Grant JE, Odlaug BL, Potenza MN.","Harv Rev Psychiatry. 2007 Mar-Apr;15(2):80-5. doi: 10.1080/10673220701298407.","Grant JE","Harv Rev Psychiatry","2007","2007/04/25","","","10.1080/10673220701298407"
"17451927","Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design","Giannola LI, De Caro V, Giandalia G, Siragusa MG, Tripodo C, Florena AM, Campisi G.","Eur J Pharm Biopharm. 2007 Sep;67(2):425-33. doi: 10.1016/j.ejpb.2007.02.020. Epub 2007 Mar 3.","Giannola LI","Eur J Pharm Biopharm","2007","2007/04/25","","","10.1016/j.ejpb.2007.02.020"
"17451401","Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study","Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.","Alcohol Clin Exp Res. 2007 Jul;31(7):1179-87. doi: 10.1111/j.1530-0277.2007.00401.x. Epub 2007 Apr 19.","Karhuvaara S","Alcohol Clin Exp Res","2007","2007/04/25","","","10.1111/j.1530-0277.2007.00401.x"
"17447051","Time-dependent decreases in apparent pA2 values for naltrexone studied in combination with morphine in rhesus monkeys","Gerak LR, France CP.","Psychopharmacology (Berl). 2007 Aug;193(3):315-21. doi: 10.1007/s00213-007-0787-y. Epub 2007 Apr 20.","Gerak LR","Psychopharmacology (Berl)","2007","2007/04/21","","","10.1007/s00213-007-0787-y"
"17444796","Topically applied naltrexone restores corneal reepithelialization in diabetic rats","Klocek MS, Sassani JW, McLaughlin PJ, Zagon IS.","J Ocul Pharmacol Ther. 2007 Apr;23(2):89-102. doi: 10.1089/jop.2006.0111.","Klocek MS","J Ocul Pharmacol Ther","2007","2007/04/21","","","10.1089/jop.2006.0111"
"17443124","Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food","Cottone P, Sabino V, Steardo L, Zorrilla EP.","Neuropsychopharmacology. 2008 Feb;33(3):524-35. doi: 10.1038/sj.npp.1301430. Epub 2007 Apr 18.","Cottone P","Neuropsychopharmacology","2008","2007/04/20","","","10.1038/sj.npp.1301430"
"17436366","Antinociception of heterotopic electro-acupuncture mediated by the dorsolateral funiculus","Lee SJ, Lyu YS, Kang HW, Sohn IC, Koo S, Kim MS, Park BR, Song JH, Kim JH.","Am J Chin Med. 2007;35(2):251-64. doi: 10.1142/S0192415X07004795.","Lee SJ","Am J Chin Med","2007","2007/04/17","","","10.1142/S0192415X07004795"
"17434480","Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082)","Aceto MD, May EL, Harris LS, Bowman ER, Cook CD.","Eur J Pharmacol. 2007 Jul 2;566(1-3):88-93. doi: 10.1016/j.ejphar.2007.03.008. Epub 2007 Mar 19.","Aceto MD","Eur J Pharmacol","2007","2007/04/17","PMC2994320","NIHMS242590","10.1016/j.ejphar.2007.03.008"
"17428895","Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding","Naleid AM, Grace MK, Chimukangara M, Billington CJ, Levine AS.","Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R99-105. doi: 10.1152/ajpregu.00675.2006. Epub 2007 Apr 11.","Naleid AM","Am J Physiol Regul Integr Comp Physiol","2007","2007/04/13","","","10.1152/ajpregu.00675.2006"
"17428615","Smoke and mirrors: magnified beliefs that cigarette smoking suppresses weight","White MA, McKee SA, O'malley SS.","Addict Behav. 2007 Oct;32(10):2200-10. doi: 10.1016/j.addbeh.2007.02.011. Epub 2007 Mar 7.","White MA","Addict Behav","2007","2007/04/13","PMC1993360","NIHMS29474","10.1016/j.addbeh.2007.02.011"
"17418693","Delta receptor antagonism, ethanol taste reactivity, and ethanol consumption in outbred male rats","Higley AE, Kiefer SW.","Alcohol. 2006 Nov;40(3):143-50. doi: 10.1016/j.alcohol.2007.01.003.","Higley AE","Alcohol","2006","2007/04/10","","","10.1016/j.alcohol.2007.01.003"
"17414239","Naltrexone and disulfiram in patients with alcohol dependence and current depression","Petrakis I, Ralevski E, Nich C, Levinson C, Carroll K, Poling J, Rounsaville B; VA VISN I MIRECC Study Group.","J Clin Psychopharmacol. 2007 Apr;27(2):160-5. doi: 10.1097/jcp.0b13e3180337fcb.","Petrakis I","J Clin Psychopharmacol","2007","2007/04/07","","","10.1097/jcp.0b13e3180337fcb"
"17410417","Anger management style and endogenous opioid function: is gender a moderator?","Bruehl S, al'Absi M, France CR, France J, Harju A, Burns JW, Chung OY.","J Behav Med. 2007 Jun;30(3):209-19. doi: 10.1007/s10865-007-9099-2. Epub 2007 Apr 5.","Bruehl S","J Behav Med","2007","2007/04/06","","","10.1007/s10865-007-9099-2"
"17409260","Renal responses to the kappa-opioid-receptor agonist U-50488H in conscious lambs","Qi W, Ebenezar KK, Samhan MA, Smith FG.","Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R162-8. doi: 10.1152/ajpregu.00863.2006. Epub 2007 Apr 4.","Qi W","Am J Physiol Regul Integr Comp Physiol","2007","2007/04/06","","","10.1152/ajpregu.00863.2006"
"17407496","Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice","Heidbreder CA, Andreoli M, Marcon C, Hutcheson DM, Gardner EL, Ashby CR Jr.","Addict Biol. 2007 Mar;12(1):35-50. doi: 10.1111/j.1369-1600.2007.00051.x.","Heidbreder CA","Addict Biol","2007","2007/04/05","","","10.1111/j.1369-1600.2007.00051.x"
"17407276","Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors","Peng X, Knapp BI, Bidlack JM, Neumeyer JL.","J Med Chem. 2007 May 3;50(9):2254-8. doi: 10.1021/jm061327z. Epub 2007 Apr 4.","Peng X","J Med Chem","2007","2007/04/05","PMC3357624","NIHMS62101","10.1021/jm061327z"
"17405958","Brain scans, genes provide addiction clues","Kuehn BM.","JAMA. 2007 Apr 4;297(13):1419-21. doi: 10.1001/jama.297.13.1419.","Kuehn BM","JAMA","2007","2007/04/05","","","10.1001/jama.297.13.1419"
"17403194","Endogenous opioids modulate hepatocyte apoptosis in a rat model of chronic cholestasis: the role of oxidative stress","Payabvash S, Kiumehr S, Nezami BG, Zandieh A, Anvari P, Tavangar SM, Dehpour AR.","Liver Int. 2007 May;27(4):538-47. doi: 10.1111/j.1478-3231.2007.01457.x.","Payabvash S","Liver Int","2007","2007/04/04","","","10.1111/j.1478-3231.2007.01457.x"
"17402725","Indium-labeled macrocyclic conjugates of naltrindole: high-affinity radioligands for in vivo studies of peripheral delta opioid receptors","Duval RA, Allmon RL, Lever JR.","J Med Chem. 2007 May 3;50(9):2144-56. doi: 10.1021/jm0700013. Epub 2007 Apr 3.","Duval RA","J Med Chem","2007","2007/04/04","","","10.1021/jm0700013"
"17400888","Selectivity of delta- and kappa-opioid ligands depends on the route of central administration in mice","Lunzer MM, Portoghese PS.","J Pharmacol Exp Ther. 2007 Jul;322(1):166-71. doi: 10.1124/jpet.107.120279. Epub 2007 Mar 30.","Lunzer MM","J Pharmacol Exp Ther","2007","2007/04/03","","","10.1124/jpet.107.120279"
"17397097","High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients","Martinotti G, Di Nicola M, Romanelli R, Andreoli S, Pozzi G, Moroni N, Janiri L.","Hum Psychopharmacol. 2007 Apr;22(3):149-56. doi: 10.1002/hup.833.","Martinotti G","Hum Psychopharmacol","2007","2007/04/03","","","10.1002/hup.833"
"17395891","Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation","Singleton PA, Moreno-Vinasco L, Sammani S, Wanderling SL, Moss J, Garcia JG.","Am J Respir Cell Mol Biol. 2007 Aug;37(2):222-31. doi: 10.1165/rcmb.2006-0327OC. Epub 2007 Mar 29.","Singleton PA","Am J Respir Cell Mol Biol","2007","2007/03/31","","","10.1165/rcmb.2006-0327OC"
"17392726","Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone","Rosow CE, Gomery P, Chen TY, Stefanovich P, Stambler N, Israel R.","Clin Pharmacol Ther. 2007 Jul;82(1):48-53. doi: 10.1038/sj.clpt.6100164. Epub 2007 Mar 28.","Rosow CE","Clin Pharmacol Ther","2007","2007/03/30","","","10.1038/sj.clpt.6100164"
"17391743","Conditioned place preferences (CPPs) to high-caloric ""snack foods"" in rat strains genetically prone vs. resistant to diet-induced obesity: resistance to naltrexone blockade","Jarosz PA, Kessler JT, Sekhon P, Coscina DV.","Pharmacol Biochem Behav. 2007 Apr;86(4):699-704. doi: 10.1016/j.pbb.2007.02.017. Epub 2007 Feb 23.","Jarosz PA","Pharmacol Biochem Behav","2007","2007/03/30","","","10.1016/j.pbb.2007.02.017"
"17391655","Anisomycin protects cortical neurons from prolonged hypoxia with differential regulation of p38 and ERK","Hong SS, Qian H, Zhao P, Bazzy-Asaad A, Xia Y.","Brain Res. 2007 May 29;1149:76-86. doi: 10.1016/j.brainres.2007.02.062. Epub 2007 Mar 1.","Hong SS","Brain Res","2007","2007/03/30","PMC1937507","NIHMS23339","10.1016/j.brainres.2007.02.062"
"17383633","Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores","Lenard NR, Daniels DJ, Portoghese PS, Roerig SC.","Eur J Pharmacol. 2007 Jul 2;566(1-3):75-82. doi: 10.1016/j.ejphar.2007.02.040. Epub 2007 Mar 3.","Lenard NR","Eur J Pharmacol","2007","2007/03/27","","","10.1016/j.ejphar.2007.02.040"
"17379484","The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics","Ooteman W, Koeter MW, Verheul R, Schippers GM, van den Brink W.","Eur Neuropsychopharmacol. 2007 Jul;17(8):558-66. doi: 10.1016/j.euroneuro.2007.02.012. Epub 2007 Mar 26.","Ooteman W","Eur Neuropsychopharmacol","2007","2007/03/24","","","10.1016/j.euroneuro.2007.02.012"
"17379253","Antagonism of phosphoramidon-induced antinociception in mice by mu- but not kappa-opioid receptor blockers","Pruhs RJ, Peña RT, Quock RM.","Life Sci. 2007 Apr 17;80(19):1816-20. doi: 10.1016/j.lfs.2007.02.019. Epub 2007 Feb 22.","Pruhs RJ","Life Sci","2007","2007/03/24","","","10.1016/j.lfs.2007.02.019"
"17376310","Involvement of delta-and mu-opioid receptors in the delayed cerebral ischemic tolerance induced by repeated electroacupuncture preconditioning in rats","Xiong LZ, Yang J, Wang Q, Lu ZH.","Chin Med J (Engl). 2007 Mar 5;120(5):394-9.","Xiong LZ","Chin Med J (Engl)","2007","2007/03/23","","",""
"17374494","Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice","Daumas S, Betourne A, Halley H, Wolfer DP, Lipp HP, Lassalle JM, Francés B.","Neurobiol Learn Mem. 2007 Jul;88(1):94-103. doi: 10.1016/j.nlm.2007.02.001. Epub 2007 Mar 19.","Daumas S","Neurobiol Learn Mem","2007","2007/03/22","","","10.1016/j.nlm.2007.02.001"
"17374042","Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial","O'Malley SS, Sinha R, Grilo CM, Capone C, Farren CK, McKee SA, Rounsaville BJ, Wu R.","Alcohol Clin Exp Res. 2007 Apr;31(4):625-34. doi: 10.1111/j.1530-0277.2007.00347.x.","O'Malley SS","Alcohol Clin Exp Res","2007","2007/03/22","","","10.1111/j.1530-0277.2007.00347.x"
"17374038","What role does measuring medication compliance play in evaluating the efficacy of naltrexone?","Baros AM, Latham PK, Moak DH, Voronin K, Anton RF.","Alcohol Clin Exp Res. 2007 Apr;31(4):596-603. doi: 10.1111/j.1530-0277.2007.00343.x.","Baros AM","Alcohol Clin Exp Res","2007","2007/03/22","","","10.1111/j.1530-0277.2007.00343.x"
"17374034","Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study","Gelernter J, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R, Krystal JH; VA Cooperative Study #425 Study Group.","Alcohol Clin Exp Res. 2007 Apr;31(4):555-63. doi: 10.1111/j.1530-0277.2007.00339.x.","Gelernter J","Alcohol Clin Exp Res","2007","2007/03/22","","","10.1111/j.1530-0277.2007.00339.x"
"17369946","Effect of beta-endorphin on production of antibodies and IL-4 under conditions of opioid receptor blockade","Gein SV, Baeva TA, Kichanova OA.","Bull Exp Biol Med. 2006 Aug;142(2):226-9. doi: 10.1007/s10517-006-0334-6.","Gein SV","Bull Exp Biol Med","2006","2007/03/21","","","10.1007/s10517-006-0334-6"
"17368966","Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists","Miller DK, Lever JR, Rodvelt KR, Baskett JA, Will MJ, Kracke GR.","Drug Alcohol Depend. 2007 Jul 10;89(2-3):282-91. doi: 10.1016/j.drugalcdep.2007.02.003. Epub 2007 Mar 21.","Miller DK","Drug Alcohol Depend","2007","2007/03/21","","","10.1016/j.drugalcdep.2007.02.003"
"17351423","Resistance to change of alcohol self-administration: effects of alcohol-delivery rate on disruption by extinction and naltrexone","Jimenez-Gomez C, Shahan TA.","Behav Pharmacol. 2007 Mar;18(2):161-9. doi: 10.1097/FBP.0b013e3280f2756f.","Jimenez-Gomez C","Behav Pharmacol","2007","2007/03/14","","","10.1097/FBP.0b013e3280f2756f"
"17347252","Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors","Loacker S, Sayyah M, Wittmann W, Herzog H, Schwarzer C.","Brain. 2007 Apr;130(Pt 4):1017-28. doi: 10.1093/brain/awl384. Epub 2007 Mar 8.","Loacker S","Brain","2007","2007/03/10","","","10.1093/brain/awl384"
"17345066","14-Methoxymetopon, a highly potent mu opioid agonist, biphasically affects ethanol intake in Sardinian alcohol-preferring rats","Sabino V, Cottone P, Steardo L, Schmidhammer H, Zorrilla EP.","Psychopharmacology (Berl). 2007 Jul;192(4):537-46. doi: 10.1007/s00213-007-0746-7. Epub 2007 Mar 8.","Sabino V","Psychopharmacology (Berl)","2007","2007/03/09","","","10.1007/s00213-007-0746-7"
"17344394","Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase","Xu M, Bruchas MR, Ippolito DL, Gendron L, Chavkin C.","Version 2. J Neurosci. 2007 Mar 7;27(10):2570-81. doi: 10.1523/JNEUROSCI.3728-06.2007.","Xu M","J Neurosci","2007","2007/03/09","PMC2104780","NIHMS34352","10.1523/JNEUROSCI.3728-06.2007"
"17340127","The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone","Beattie DT, Cheruvu M, Mai N, O'Keefe M, Johnson-Rabidoux S, Peterson C, Kaufman E, Vickery R.","Naunyn Schmiedebergs Arch Pharmacol. 2007 May;375(3):205-20. doi: 10.1007/s00210-007-0146-x. Epub 2007 Mar 6.","Beattie DT","Naunyn Schmiedebergs Arch Pharmacol","2007","2007/03/07","","","10.1007/s00210-007-0146-x"
"17336941","Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking","Krishnan-Sarin S, Krystal JH, Shi J, Pittman B, O'Malley SS.","Biol Psychiatry. 2007 Sep 15;62(6):694-7. doi: 10.1016/j.biopsych.2006.11.018. Epub 2007 Mar 6.","Krishnan-Sarin S","Biol Psychiatry","2007","2007/03/06","","","10.1016/j.biopsych.2006.11.018"
"17336286","History of cocaine self-administration alters morphine reinforcement in the rat","Mierzejewski P, Stefanski R, Bienkowski P, Kostowski W.","Eur J Pharmacol. 2007 May 7;562(1-2):77-81. doi: 10.1016/j.ejphar.2007.01.064. Epub 2007 Feb 8.","Mierzejewski P","Eur J Pharmacol","2007","2007/03/06","","","10.1016/j.ejphar.2007.01.064"
"17335644","Effects of naltrexone on cocaine- and sucrose-seeking behaviour in response to associated stimuli in rats","Burattini C, Burbassi S, Aicardi G, Cervo L.","Int J Neuropsychopharmacol. 2008 Feb;11(1):103-9. doi: 10.1017/S1461145707007705. Epub 2007 Mar 5.","Burattini C","Int J Neuropsychopharmacol","2008","2007/03/06","","","10.1017/S1461145707007705"
"17332915","Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells","Zagon IS, Verderame MF, Hankins J, McLaughlin PJ.","Int J Oncol. 2007 Apr;30(4):775-83.","Zagon IS","Int J Oncol","2007","2007/03/03","","",""
"17329463","Schizophrenia and co-occurring substance use disorder","Green AI, Drake RE, Brunette MF, Noordsy DL.","Am J Psychiatry. 2007 Mar;164(3):402-8. doi: 10.1176/ajp.2007.164.3.402.","Green AI","Am J Psychiatry","2007","2007/03/03","","","10.1176/ajp.2007.164.3.402"
"17329173","Application of a sensitive liquid chromatographic/tandem mass spectrometric method to pharmacokinetic study of nalmefene in humans","Li P, Chen X, Dai X, Wen A, Zhang Y, Zhong D.","J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):479-84. doi: 10.1016/j.jchromb.2007.02.013. Epub 2007 Feb 15.","Li P","J Chromatogr B Analyt Technol Biomed Life Sci","2007","2007/03/03","","","10.1016/j.jchromb.2007.02.013"
"17322180","Alcohol dependence and pharmacologic treatment. Introduction","McDonough KP.","Am J Health Syst Pharm. 2007 Mar 1;64(5 Suppl 3):S3-4. doi: 10.2145/ajhp060646.","McDonough KP","Am J Health Syst Pharm","2007","2007/02/27","","","10.2145/ajhp060646"
"17322179","Improving adherence in patients with alcohol dependence: a new role for pharmacists","Peterson AM.","Am J Health Syst Pharm. 2007 Mar 1;64(5 Suppl 3):S23-9. doi: 10.2146/ajhp060648.","Peterson AM","Am J Health Syst Pharm","2007","2007/02/27","","","10.2146/ajhp060648"
"17322178","Emerging approaches to managing alcohol dependence","Swift R.","Am J Health Syst Pharm. 2007 Mar 1;64(5 Suppl 3):S12-22. doi: 10.2146/ajhp060644.","Swift R","Am J Health Syst Pharm","2007","2007/02/27","","","10.2146/ajhp060644"
"17320293","Nucleus accumbens opioid signaling conditions short-term flavor preferences","Woolley JD, Lee BS, Taha SA, Fields HL.","Neuroscience. 2007 Apr 25;146(1):19-30. doi: 10.1016/j.neuroscience.2007.01.005. Epub 2007 Feb 21.","Woolley JD","Neuroscience","2007","2007/02/27","","","10.1016/j.neuroscience.2007.01.005"
"17320241","Treatment of pruritus with topically applied opiate receptor antagonist","Bigliardi PL, Stammer H, Jost G, Rufli T, Büchner S, Bigliardi-Qi M.","J Am Acad Dermatol. 2007 Jun;56(6):979-88. doi: 10.1016/j.jaad.2007.01.007. Epub 2007 Feb 22.","Bigliardi PL","J Am Acad Dermatol","2007","2007/02/27","","","10.1016/j.jaad.2007.01.007"
"17319558","A comparison of oral and implant naltrexone outcomes at 12 months","Colquhoun R, Tan DY, Hull S.","J Opioid Manag. 2005 Nov-Dec;1(5):249-56. doi: 10.5055/jom.2005.0054.","Colquhoun R","J Opioid Manag","2005","2007/02/27","","","10.5055/jom.2005.0054"
"17319131","Pharmacokinetics and pharmacodynamics of carfentanil and naltrexone in female common eland (Taurotragus oryx)","Cole A, Mutlow A, Isaza R, Carpenter JW, Koch DE, Hunter RP, Dresser BL.","J Zoo Wildl Med. 2006 Sep;37(3):318-26. doi: 10.1638/05-070.1.","Cole A","J Zoo Wildl Med","2006","2007/02/27","","","10.1638/05-070.1"
"17315407","A comparison of rapid (opioid) detoxification with clonidine-assisted detoxification for heroin-dependent persons","Arnold-Reed DE, Hulse GK.","J Opioid Manag. 2005 Mar-Apr;1(1):17-23. doi: 10.5055/jom.2005.0007.","Arnold-Reed DE","J Opioid Manag","2005","2007/02/24","","","10.5055/jom.2005.0007"
"17309406","Opioid overdose deaths can occur in patients with naltrexone implants","Gibson AE, Degenhardt LJ, Hall WD.","Med J Aust. 2007 Feb 5;186(3):152-3.","Gibson AE","Med J Aust","2007","2007/02/21","","",""
"17307158","Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists","McNaull B, Trang T, Sutak M, Jhamandas K.","Eur J Pharmacol. 2007 Apr 10;560(2-3):132-41. doi: 10.1016/j.ejphar.2006.12.013. Epub 2007 Jan 17.","McNaull B","Eur J Pharmacol","2007","2007/02/20","","","10.1016/j.ejphar.2006.12.013"
"17306730","Regarding naltrexone for probationers and parolees","Stancliff S.","J Subst Abuse Treat. 2007 Mar;32(2):217-8; author reply 218-9. doi: 10.1016/j.jsat.2006.11.011. Epub 2007 Feb 1.","Stancliff S","J Subst Abuse Treat","2007","2007/02/20","","","10.1016/j.jsat.2006.11.011"
"17305578","Kappa receptor bivalent ligands","Peng X, Neumeyer JL.","Curr Top Med Chem. 2007;7(4):363-73. doi: 10.2174/156802607779941251.","Peng X","Curr Top Med Chem","2007","2007/02/20","","","10.2174/156802607779941251"
"17303503","Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium","Zagon IS, Sassani JW, Myers RL, McLaughlin PJ.","Brain Res Bull. 2007 Apr 2;72(1):18-24. doi: 10.1016/j.brainresbull.2006.12.007. Epub 2007 Jan 8.","Zagon IS","Brain Res Bull","2007","2007/02/17","","","10.1016/j.brainresbull.2006.12.007"
"17295587","High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking","Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB.","Exp Clin Psychopharmacol. 2007 Feb;15(1):81-92. doi: 10.1037/1064-1297.15.1.81.","Rohsenow DJ","Exp Clin Psychopharmacol","2007","2007/02/14","","","10.1037/1064-1297.15.1.81"
"17292346","Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice","Nozaki C, Kamei J.","Eur J Pharmacol. 2007 Apr 10;560(2-3):160-2. doi: 10.1016/j.ejphar.2007.01.021. Epub 2007 Jan 19.","Nozaki C","Eur J Pharmacol","2007","2007/02/13","","","10.1016/j.ejphar.2007.01.021"
"17286343","Measuring economic outcomes of alcohol treatment using the Economic Form 90","Bray JW, Zarkin GA, Miller WR, Mitra D, Kivlahan DR, Martin DJ, Couper DJ, Cisler RA.","J Stud Alcohol Drugs. 2007 Mar;68(2):248-55. doi: 10.15288/jsad.2007.68.248.","Bray JW","J Stud Alcohol Drugs","2007","2007/02/09","","","10.15288/jsad.2007.68.248"
"17286342","Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational-enhancement therapy for alcohol-dependent patients treated with naltrexone?","Davidson D, Gulliver SB, Longabaugh R, Wirtz PW, Swift R.","J Stud Alcohol Drugs. 2007 Mar;68(2):238-47. doi: 10.15288/jsad.2007.68.238.","Davidson D","J Stud Alcohol Drugs","2007","2007/02/09","","","10.15288/jsad.2007.68.238"
"17286293","Nano-level detection of naltrexone hydrochloride in its pharmaceutical preparation at Au microelectrode in flowing solutions by fast fourier transforms continuous cyclic voltammetry as a novel detector","Norouzi P, Ganjali MR, Zare M, Mohammadi A.","J Pharm Sci. 2007 Aug;96(8):2009-17. doi: 10.1002/jps.20851.","Norouzi P","J Pharm Sci","2007","2007/02/09","","","10.1002/jps.20851"
"17284238","Treatment of hyperactivity in children with pervasive developmental disorders","Scahill L, Pachler M.","J Child Adolesc Psychiatr Nurs. 2007 Feb;20(1):59-62. doi: 10.1111/j.1744-6171.2007.00080.x.","Scahill L","J Child Adolesc Psychiatr Nurs","2007","2007/02/08","","","10.1111/j.1744-6171.2007.00080.x"
"17280624","Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation","Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.","Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. doi: 10.3310/hta11060.","Adi Y","Health Technol Assess","2007","2007/02/07","","","10.3310/hta11060"
"17273875","Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice","Kamdar NK, Miller SA, Syed YM, Bhayana R, Gupta T, Rhodes JS.","Psychopharmacology (Berl). 2007 Jun;192(2):207-17. doi: 10.1007/s00213-007-0711-5. Epub 2007 Feb 2.","Kamdar NK","Psychopharmacology (Berl)","2007","2007/02/03","","","10.1007/s00213-007-0711-5"
"17270142","Local opioids in a model of periodontal disease in rats","Pacheco CM, Queiroz CM Jr, Maltos KL, Caliari MV, Rocha OA, Francischi JN.","Arch Oral Biol. 2007 Jul;52(7):677-83. doi: 10.1016/j.archoralbio.2006.12.012. Epub 2007 Jan 31.","Pacheco CM","Arch Oral Biol","2007","2007/02/03","","","10.1016/j.archoralbio.2006.12.012"
"17270055","Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food","Sathyan G, Xu E, Thipphawong J, Gupta SK.","BMC Clin Pharmacol. 2007 Feb 2;7:2. doi: 10.1186/1472-6904-7-2.","Sathyan G","BMC Clin Pharmacol","2007","2007/02/03","PMC1810515","","10.1186/1472-6904-7-2"
"17267782","Alcohol use and anxiety: diagnostic and management issues","Brady KT, Tolliver BK, Verduin ML.","Am J Psychiatry. 2007 Feb;164(2):217-21; quiz 372. doi: 10.1176/ajp.2007.164.2.217.","Brady KT","Am J Psychiatry","2007","2007/02/03","","","10.1176/ajp.2007.164.2.217"
"17267582","Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment","Wang D, Sun X, Sadee W.","J Pharmacol Exp Ther. 2007 May;321(2):544-52. doi: 10.1124/jpet.106.118810. Epub 2007 Jan 31.","Wang D","J Pharmacol Exp Ther","2007","2007/02/03","","","10.1124/jpet.106.118810"
"17264794","Drug approvals","Laustsen G, Gilbert M, Wimett L.","Nurse Pract. 2007 Feb;32(2):43-51; quiz 51-2. doi: 10.1097/00006205-200702000-00009.","Laustsen G","Nurse Pract","2007","2007/02/01","","","10.1097/00006205-200702000-00009"
"17250617","Alcohol consumption is enhanced after naltrexone treatment","Juárez J, Eliana Bde T.","Alcohol Clin Exp Res. 2007 Feb;31(2):260-4. doi: 10.1111/j.1530-0277.2006.00313.x.","Juárez J","Alcohol Clin Exp Res","2007","2007/01/26","","","10.1111/j.1530-0277.2006.00313.x"
"17244518","Nociceptive flexion reflex and pain rating responses during endogenous opiate blockade with naltrexone in healthy young adults","France CR, al'Absi M, Ring C, France JL, Harju A, Wittmers LE.","Biol Psychol. 2007 Apr;75(1):95-100. doi: 10.1016/j.biopsycho.2006.12.005. Epub 2006 Dec 27.","France CR","Biol Psychol","2007","2007/01/25","PMC1892310","NIHMS21202","10.1016/j.biopsycho.2006.12.005"
"17229510","Mental health outcomes following naltrexone implant treatment for heroin-dependence","Ngo HT, Tait RJ, Arnold-Reed DE, Hulse GK.","Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):605-12. doi: 10.1016/j.pnpbp.2006.12.005. Epub 2007 Jan 16.","Ngo HT","Prog Neuropsychopharmacol Biol Psychiatry","2007","2007/01/19","","","10.1016/j.pnpbp.2006.12.005"
"17227441","Preclinical and clinical pharmacology of alcohol dependence","Tambour S, Quertemont E.","Fundam Clin Pharmacol. 2007 Feb;21(1):9-28. doi: 10.1111/j.1472-8206.2006.00459.x.","Tambour S","Fundam Clin Pharmacol","2007","2007/01/18","","","10.1111/j.1472-8206.2006.00459.x"
"17224736","The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers","Mitchell JM, Fields HL, White RL, Meadoff TM, Joslyn G, Rowbotham MC.","J Clin Psychopharmacol. 2007 Feb;27(1):112-5. doi: 10.1097/JCP.0b013e31802e68b0.","Mitchell JM","J Clin Psychopharmacol","2007","2007/01/17","","","10.1097/JCP.0b013e31802e68b0"
"17224132","New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trials","Gueorguieva R, Wu R, Pittman B, Cramer J, Rosenheck RA, O'malley SS, Krystal JH.","Biol Psychiatry. 2007 Jun 1;61(11):1290-5. doi: 10.1016/j.biopsych.2006.09.038. Epub 2007 Jan 16.","Gueorguieva R","Biol Psychiatry","2007","2007/01/17","PMC1952242","NIHMS24022","10.1016/j.biopsych.2006.09.038"
"17222320","Low-dose naltrexone therapy improves active Crohn's disease","Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS.","Am J Gastroenterol. 2007 Apr;102(4):820-8. doi: 10.1111/j.1572-0241.2007.01045.x. Epub 2007 Jan 11.","Smith JP","Am J Gastroenterol","2007","2007/01/16","","","10.1111/j.1572-0241.2007.01045.x"
"17220940","Effect of prolonged progesterone treatment on the proenkephalin mRNA gene expression and enkephalins concentration in the sheep brain","Pierzchała-Koziec K, Zubel J, Rzasa J.","Reprod Biol. 2006;6 Suppl 2:37-46.","Pierzchała-Koziec K","Reprod Biol","2006","2007/01/16","","",""
"17220427","Thienorphine: receptor binding and behavioral effects in rhesus monkeys","Li JX, Becker GL, Traynor JR, Gong ZH, France CP.","J Pharmacol Exp Ther. 2007 Apr;321(1):227-36. doi: 10.1124/jpet.106.113290. Epub 2007 Jan 12.","Li JX","J Pharmacol Exp Ther","2007","2007/01/16","","","10.1124/jpet.106.113290"
"17219220","Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement","Braida D, Limonta V, Pegorini S, Zani A, Guerini-Rocco C, Gori E, Sala M.","Psychopharmacology (Berl). 2007 Mar;190(4):441-8. doi: 10.1007/s00213-006-0639-1. Epub 2007 Jan 12.","Braida D","Psychopharmacology (Berl)","2007","2007/01/16","","","10.1007/s00213-006-0639-1"
"17213681","Daily increase of fat ingestion mediated via mu-opioid receptor signaling pathway","Mizushige T, Matsumura S, Yoneda T, Tsuzuki S, Inoue K, Fushiki T.","Biomed Res. 2006 Dec;27(6):259-63. doi: 10.2220/biomedres.27.259.","Mizushige T","Biomed Res","2006","2007/01/11","","","10.2220/biomedres.27.259"
"17207102","Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats","Rezvani AH, Overstreet DH, Levin ED, Rosenthal DI, Kordik CP, Reitz AB, Vaidya AH.","Alcohol Clin Exp Res. 2007 Jan;31(1):57-63. doi: 10.1111/j.1530-0277.2006.00264.x.","Rezvani AH","Alcohol Clin Exp Res","2007","2007/01/09","","","10.1111/j.1530-0277.2006.00264.x"
"17207100","Development of naltrexone supersensitivity during food-maintained responding enhances naltrexone's ability to reduce ethanol-maintained responding","Williams KL.","Alcohol Clin Exp Res. 2007 Jan;31(1):39-47. doi: 10.1111/j.1530-0277.2006.00272.x.","Williams KL","Alcohol Clin Exp Res","2007","2007/01/09","","","10.1111/j.1530-0277.2006.00272.x"
"17205392","Effects of opioid blockade with naltrexone and distraction on cold and ischemic pain in hypertension","Ring C, France CR, al'Absi M, Beesley L, Edwards L, McIntyre D, Carroll D, Martin U.","J Behav Med. 2007 Feb;30(1):59-68. doi: 10.1007/s10865-006-9084-1. Epub 2007 Jan 5.","Ring C","J Behav Med","2007","2007/01/06","","","10.1007/s10865-006-9084-1"
"17204254","Genetic variance contributes to naltrexone-induced inhibition of sucrose intake in inbred and outbred mouse strains","Dym CT, Pinhas A, Ginzberg M, Kest B, Bodnar RJ.","Brain Res. 2007 Mar 2;1135(1):136-45. doi: 10.1016/j.brainres.2006.12.012. Epub 2007 Jan 3.","Dym CT","Brain Res","2007","2007/01/06","","","10.1016/j.brainres.2006.12.012"
"17192502","Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers","Darwish M, Kirby M, Robertson P Jr, Hellriegel E, Jiang JG.","J Clin Pharmacol. 2007 Jan;47(1):56-63. doi: 10.1177/0091270006294129.","Darwish M","J Clin Pharmacol","2007","2006/12/29","","","10.1177/0091270006294129"
"17190531","Extended-release intramuscular naltrexone in alcohol dependence in adults: profile report","Swainston Harrison T, Plosker GL, Keam SJ.","CNS Drugs. 2007;21(1):83-7. doi: 10.2165/00023210-200721010-00007.","Swainston Harrison T","CNS Drugs","2007","2006/12/28","","","10.2165/00023210-200721010-00007"
"17187435","Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants","Jeffrey GP, MacQuillan G, Chua F, Galhenage S, Bull J, Young E, Hulse G, O'Neil G.","Hepatology. 2007 Jan;45(1):111-7. doi: 10.1002/hep.21470.","Jeffrey GP","Hepatology","2007","2006/12/26","","","10.1002/hep.21470"
"17187427","Enhancing hepatitis C treatment uptake and outcomes for injection drug users","Dore GJ.","Hepatology. 2007 Jan;45(1):3-5. doi: 10.1002/hep.21478.","Dore GJ","Hepatology","2007","2006/12/26","","","10.1002/hep.21478"
"17182194","Psychometrics of the Drinker Inventory of Consequences (DrInC)","Forcehimes AA, Tonigan JS, Miller WR, Kenna GA, Baer JS.","Addict Behav. 2007 Aug;32(8):1699-704. doi: 10.1016/j.addbeh.2006.11.009. Epub 2006 Dec 19.","Forcehimes AA","Addict Behav","2007","2006/12/22","","","10.1016/j.addbeh.2006.11.009"
"17177100","[Paraphilia, sexual preference disorders. Diagnosis, etiology, epidemiology, treatment and prevention]","Berner W, Briken P.","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Jan;50(1):33-43. doi: 10.1007/s00103-007-0108-y.","Berner W","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","2007","2006/12/21","","","10.1007/s00103-007-0108-y"
"17176635","Chronic sucrose intake reduces the antagonist effect of beta-funaltrexamine on morphine-induced antinociception in female but not in male rats","Coy RT, Kanarek RB.","Nutr Neurosci. 2006 Jun-Aug;9(3-4):131-9. doi: 10.1080/10284150600895881.","Coy RT","Nutr Neurosci","2006","2006/12/21","","","10.1080/10284150600895881"
"17174102","Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: a pilot study","Grassi MC, Cioce AM, Giudici FD, Antonilli L, Nencini P.","Pharmacol Res. 2007 Feb;55(2):117-21. doi: 10.1016/j.phrs.2006.11.005. Epub 2006 Nov 21.","Grassi MC","Pharmacol Res","2007","2006/12/19","","","10.1016/j.phrs.2006.11.005"
"17172775","Naltrexone-assisted rapid methadone discontinuation: a pilot study","Camarasa X, Khazaal Y, Besson J, Zullino DF.","Eur Addict Res. 2007;13(1):20-4. doi: 10.1159/000095811.","Camarasa X","Eur Addict Res","2007","2006/12/19","","","10.1159/000095811"
"17172258","Knowledge and attitudes about pharmacotherapy for alcoholism: a survey of counselors and administrators in community-based addiction treatment centres","Thomas SE, Miller PM.","Alcohol Alcohol. 2007 Mar-Apr;42(2):113-8. doi: 10.1093/alcalc/agl100. Epub 2006 Dec 15.","Thomas SE","Alcohol Alcohol","2007","2006/12/19","","","10.1093/alcalc/agl100"
"17170774","[Drugs against alcohol abuse]","Mørland J.","Tidsskr Nor Laegeforen. 2006 Dec 14;126(24):3268-9.","Mørland J","Tidsskr Nor Laegeforen","2006","2006/12/16","","",""
"17165363","Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst","Nava F, Premi S, Manzato E, Lucchini A.","J Psychoactive Drugs. 2006 Sep;38(3):211-7. doi: 10.1080/02791072.2006.10399846.","Nava F","J Psychoactive Drugs","2006","2006/12/15","","","10.1080/02791072.2006.10399846"
"17157780","Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain","Webster LR, Butera PG, Moran LV, Wu N, Burns LH, Friedmann N.","J Pain. 2006 Dec;7(12):937-46. doi: 10.1016/j.jpain.2006.05.005.","Webster LR","J Pain","2006","2006/12/13","","","10.1016/j.jpain.2006.05.005"
"17152360","Negative inotropic and chronotropic effects of delta-opioid receptor antagonists are mediated via non-opioid receptors","Maslov LN, Lishmanov YB, Barzakh EI, Lasukova TV, Rice KK, Oeltgen PR.","Bull Exp Biol Med. 2006 Apr;141(4):420-3. doi: 10.1007/s10517-006-0188-y.","Maslov LN","Bull Exp Biol Med","2006","2006/12/13","","","10.1007/s10517-006-0188-y"
"17146025","Youth: a health plan-based lifestyle intervention increases bone mineral density in adolescent girls","DeBar LL, Ritenbaugh C, Aickin M, Orwoll E, Elliot D, Dickerson J, Vuckovic N, Stevens VJ, Moe E, Irving LM.","Arch Pediatr Adolesc Med. 2006 Dec;160(12):1269-76. doi: 10.1001/archpedi.160.12.1269.","DeBar LL","Arch Pediatr Adolesc Med","2006","2006/12/06","","","10.1001/archpedi.160.12.1269"
"17139110","The permeation of nalmefene hydrochloride across different regions of ovine nasal mucosa","Du G, Gao Y, Nie S, Pan W.","Chem Pharm Bull (Tokyo). 2006 Dec;54(12):1722-4. doi: 10.1248/cpb.54.1722.","Du G","Chem Pharm Bull (Tokyo)","2006","2006/12/02","","","10.1248/cpb.54.1722"
"17136399","Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings","Sinha R, Kimmerling A, Doebrick C, Kosten TR.","Psychopharmacology (Berl). 2007 Mar;190(4):569-74. doi: 10.1007/s00213-006-0640-8. Epub 2006 Nov 29.","Sinha R","Psychopharmacology (Berl)","2007","2006/12/01","","","10.1007/s00213-006-0640-8"
"17136216","Differential effects of naltrexone on cardiac, subjective and behavioural reactions to acute ethanol intoxication","Peterson JB, Conrod P, Vassileva J, Gianoulakis C, Pihl RO.","J Psychiatry Neurosci. 2006 Nov;31(6):386-93.","Peterson JB","J Psychiatry Neurosci","2006","2006/12/01","PMC1635799","",""
"17127538","Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?","Nunes EV, Rothenberg JL, Sullivan MA, Carpenter KM, Kleber HD.","Am J Drug Alcohol Abuse. 2006;32(4):503-17. doi: 10.1080/00952990600918973.","Nunes EV","Am J Drug Alcohol Abuse","2006","2006/11/28","","","10.1080/00952990600918973"
"17126860","Pharmacological and genetic manipulation of kappa opioid receptors: effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling","Kaminski RM, Witkin JM, Shippenberg TS.","Neuropharmacology. 2007 Mar;52(3):895-903. doi: 10.1016/j.neuropharm.2006.10.007. Epub 2006 Nov 28.","Kaminski RM","Neuropharmacology","2007","2006/11/28","","","10.1016/j.neuropharm.2006.10.007"
"17126318","Activators of potassium M currents have anticonvulsant actions in two rat models of encephalitis","Solbrig MV, Adrian R, Wechsler SL, Koob GF.","Eur J Pharmacol. 2007 Jan 19;555(1):23-9. doi: 10.1016/j.ejphar.2006.10.025. Epub 2006 Oct 20.","Solbrig MV","Eur J Pharmacol","2007","2006/11/28","PMC2981072","NIHMS16758","10.1016/j.ejphar.2006.10.025"
"17122900","[Pharmacological relapse prevention in alcohol and tobacco dependence]","Diehl A, Mann K.","Internist (Berl). 2007 Jan;48(1):79-84, 86-8. doi: 10.1007/s00108-006-1755-z.","Diehl A","Internist (Berl)","2007","2006/11/24","","","10.1007/s00108-006-1755-z"
"17114950","Trends in the adoption of medications for alcohol dependence","Ducharme LJ, Knudsen HK, Roman PM.","J Clin Psychopharmacol. 2006 Dec;26 Suppl 1:S13-9. doi: 10.1097/01.jcp.0000246209.18777.14.","Ducharme LJ","J Clin Psychopharmacol","2006","2006/11/23","","","10.1097/01.jcp.0000246209.18777.14"
"17112507","12(S)-HPETE induces itch-associated scratchings in mice","Kim DK, Kim HJ, Sung KS, Kim H, Cho SA, Kim KM, Lee CH, Kim JJ.","Eur J Pharmacol. 2007 Jan 5;554(1):30-3. doi: 10.1016/j.ejphar.2006.09.057. Epub 2006 Oct 10.","Kim DK","Eur J Pharmacol","2007","2006/11/23","","","10.1016/j.ejphar.2006.09.057"
"17112504","Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat","Terashvili M, Wu HE, Schwasinger E, Tseng LF.","Eur J Pharmacol. 2007 Jan 12;554(2-3):137-44. doi: 10.1016/j.ejphar.2006.10.014. Epub 2006 Oct 17.","Terashvili M","Eur J Pharmacol","2007","2006/11/23","PMC3732481","NIHMS16903","10.1016/j.ejphar.2006.10.014"
"17110818","The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking","Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.","J Clin Psychopharmacol. 2006 Dec;26(6):610-25. doi: 10.1097/01.jcp.0000245566.52401.20.","Pettinati HM","J Clin Psychopharmacol","2006","2006/11/18","","","10.1097/01.jcp.0000245566.52401.20"
"17109943","The role of delta opioid receptors in the anxiolytic actions of benzodiazepines","Primeaux SD, Wilson SP, McDonald AJ, Mascagni F, Wilson MA.","Pharmacol Biochem Behav. 2006 Nov;85(3):545-54. doi: 10.1016/j.pbb.2006.09.025. Epub 2006 Nov 15.","Primeaux SD","Pharmacol Biochem Behav","2006","2006/11/18","PMC1892843","NIHMS17232","10.1016/j.pbb.2006.09.025"
"17109610","New pharmacological approaches for the treatment of alcoholism","Soyka M, Roesner S.","Expert Opin Pharmacother. 2006 Dec;7(17):2341-53. doi: 10.1517/14656566.7.17.2341.","Soyka M","Expert Opin Pharmacother","2006","2006/11/18","","","10.1517/14656566.7.17.2341"
"17105998","Pain management research goes beyond the obvious","Thompson CA.","Am J Health Syst Pharm. 2006 Dec 1;63(23):2298, 2302, 2304. doi: 10.2146/news060027.","Thompson CA","Am J Health Syst Pharm","2006","2006/11/16","","","10.2146/news060027"
"17098330","Naltrexone reverses age-induced cognitive deficits in rats","Rodefer JS, Nguyen TN.","Neurobiol Aging. 2008 Feb;29(2):309-13. doi: 10.1016/j.neurobiolaging.2006.10.005. Epub 2006 Nov 13.","Rodefer JS","Neurobiol Aging","2008","2006/11/14","","","10.1016/j.neurobiolaging.2006.10.005"
"17098214","Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone","Dayas CV, Liu X, Simms JA, Weiss F.","Biol Psychiatry. 2007 Apr 15;61(8):979-89. doi: 10.1016/j.biopsych.2006.07.034. Epub 2006 Nov 13.","Dayas CV","Biol Psychiatry","2007","2006/11/14","PMC2831298","NIHMS170082","10.1016/j.biopsych.2006.07.034"
"17097925","Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats","Gu XL, Yu LC.","J Pain. 2007 Jan;8(1):85-90. doi: 10.1016/j.jpain.2006.07.001. Epub 2006 Nov 9.","Gu XL","J Pain","2007","2006/11/14","","","10.1016/j.jpain.2006.07.001"
"17091128","Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers","Haney M.","Neuropsychopharmacology. 2007 Jun;32(6):1391-403. doi: 10.1038/sj.npp.1301243. Epub 2006 Nov 8.","Haney M","Neuropsychopharmacology","2007","2006/11/09","","","10.1038/sj.npp.1301243"
"17089424","Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia","Hallett PJ, Brotchie JM.","Mov Disord. 2007 Jan;22(1):28-40. doi: 10.1002/mds.21163.","Hallett PJ","Mov Disord","2007","2006/11/08","","","10.1002/mds.21163"
"17088223","Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification","Davison JW, Sweeney ML, Bush KR, Davis Correale TM, Calsyn DA, Reoux JP, Sloan KL, Kivlahan DR.","J Addict Dis. 2006;25(4):27-35. doi: 10.1300/J069v25n04_03.","Davison JW","J Addict Dis","2006","2006/11/08","","","10.1300/J069v25n04_03"
"17084785","Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia","Krupitsky EM, Zvartau EE, Masalov DV, Tsoy MV, Burakov AM, Egorova VY, Didenko TY, Romanova TN, Ivanova EB, Bespalov AY, Verbitskaya EV, Neznanov NG, Grinenko AY, O'Brien CP, Woody GE.","J Subst Abuse Treat. 2006 Dec;31(4):319-28. doi: 10.1016/j.jsat.2006.05.005. Epub 2006 Jul 24.","Krupitsky EM","J Subst Abuse Treat","2006","2006/11/07","","","10.1016/j.jsat.2006.05.005"
"17080248","Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study","Kariv R, Tiomny E, Grenshpon R, Dekel R, Waisman G, Ringel Y, Halpern Z.","Dig Dis Sci. 2006 Dec;51(12):2128-33. doi: 10.1007/s10620-006-9289-8. Epub 2006 Nov 1.","Kariv R","Dig Dis Sci","2006","2006/11/03","","","10.1007/s10620-006-9289-8"
"17076633","Corneal safety of topically applied naltrexone","Zagon IS, Klocek MS, Sassani JW, Mauger DT, McLaughlin PJ.","J Ocul Pharmacol Ther. 2006 Oct;22(5):377-87. doi: 10.1089/jop.2006.22.377.","Zagon IS","J Ocul Pharmacol Ther","2006","2006/11/02","","","10.1089/jop.2006.22.377"
"17075571","In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay","Walker EA.","Br J Pharmacol. 2006 Dec;149(8):1071-82. doi: 10.1038/sj.bjp.0706946. Epub 2006 Oct 30.","Walker EA","Br J Pharmacol","2006","2006/11/01","PMC2014630","","10.1038/sj.bjp.0706946"
"17073520","Methylnaltrexone: MNTX","","Drugs R D. 2006;7(6):374-8. doi: 10.2165/00126839-200607060-00006.","","Drugs R D","2006","2006/11/01","","","10.2165/00126839-200607060-00006"
"17068460","Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone","Zagon IS, Sassani JW, McLaughlin PJ.","Cornea. 2006 Aug;25(7):821-9. doi: 10.1097/01.ico.0000224646.66472.aa.","Zagon IS","Cornea","2006","2006/10/28","","","10.1097/01.ico.0000224646.66472.aa"
"17063152","Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats","Oliva JM, Manzanares J.","Neuropsychopharmacology. 2007 Jun;32(6):1358-69. doi: 10.1038/sj.npp.1301237. Epub 2006 Oct 25.","Oliva JM","Neuropsychopharmacology","2007","2006/10/26","","","10.1038/sj.npp.1301237"
"17060493","Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans","Butelman ER, Mandau M, Tidgewell K, Prisinzano TE, Yuferov V, Kreek MJ.","J Pharmacol Exp Ther. 2007 Jan;320(1):300-6. doi: 10.1124/jpet.106.112417. Epub 2006 Oct 23.","Butelman ER","J Pharmacol Exp Ther","2007","2006/10/25","","","10.1124/jpet.106.112417"
"17058899","[Alcohol dependence. Behavior therapy is effective with naltrexone]","Schmitt-Hönl B.","Med Monatsschr Pharm. 2006 Oct;29(10):380-1.","Schmitt-Hönl B","Med Monatsschr Pharm","2006","2006/10/25","","",""
"17054160","Opioid antagonists for smoking cessation","David S, Lancaster T, Stead LF, Evins AE.","Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003086. doi: 10.1002/14651858.CD003086.pub2.","David S","Cochrane Database Syst Rev","2006","2006/10/21","","","10.1002/14651858.CD003086.pub2"
"17049180","Nucleus accumbens opioids regulate flavor-based preferences in food consumption","Woolley JD, Lee BS, Fields HL.","Neuroscience. 2006 Nov 17;143(1):309-17. doi: 10.1016/j.neuroscience.2006.06.067.","Woolley JD","Neuroscience","2006","2006/10/20","","","10.1016/j.neuroscience.2006.06.067"
"17047935","Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats","Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC, Zorrilla EP.","Psychopharmacology (Berl). 2006 Dec;189(2):175-86. doi: 10.1007/s00213-006-0546-5. Epub 2006 Oct 18.","Sabino V","Psychopharmacology (Berl)","2006","2006/10/19","","","10.1007/s00213-006-0546-5"
"17047667","Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls","Mitchell JM, Tavares VC, Fields HL, D'Esposito M, Boettiger CA.","Neuropsychopharmacology. 2007 Feb;32(2):439-49. doi: 10.1038/sj.npp.1301226. Epub 2006 Oct 18.","Mitchell JM","Neuropsychopharmacology","2007","2006/10/19","","","10.1038/sj.npp.1301226"
"17045445","Characterization of a potential medium for 'biorelevant' in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method","Iyer SS, Barr WH, Karnes HT.","J Pharm Biomed Anal. 2007 Feb 19;43(3):845-53. doi: 10.1016/j.jpba.2006.08.023. Epub 2006 Oct 11.","Iyer SS","J Pharm Biomed Anal","2007","2006/10/19","","","10.1016/j.jpba.2006.08.023"
"17045311","Blocking effects of intra-hippocampal naltrexone microinjections on glucocorticoid-induced impairment of spatial memory retrieval in rats","Sajadi AA, Samaei SA, Rashidy-Pour A.","Neuropharmacology. 2007 Feb;52(2):347-54. doi: 10.1016/j.neuropharm.2006.08.021. Epub 2006 Oct 10.","Sajadi AA","Neuropharmacology","2007","2006/10/19","","","10.1016/j.neuropharm.2006.08.021"
"17031777","[Neurobiological mechanisms and pharmacological treatment options for alcohol craving]","Hillemacher T, Kornhuber J, Bleich S.","Fortschr Neurol Psychiatr. 2007 Jan;75(1):26-32. doi: 10.1055/s-2006-944309. Epub 2006 Oct 10.","Hillemacher T","Fortschr Neurol Psychiatr","2007","2006/10/13","","","10.1055/s-2006-944309"
"17020440","Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?","Doggrell SA.","Expert Opin Pharmacother. 2006 Oct;7(15):2169-73. doi: 10.1517/14656566.7.15.2169.","Doggrell SA","Expert Opin Pharmacother","2006","2006/10/06","","","10.1517/14656566.7.15.2169"
"17012527","Effects of naltrexone on repressive coping and disclosure of emotional material: a test of the opioid-peptide hypothesis of repression and hypertension","Younger JW, Lawler-Row KA, Moe KA, Kratz AL, Keenum AJ.","Psychosom Med. 2006 Sep-Oct;68(5):734-41. doi: 10.1097/01.psy.0000234029.38245.c9.","Younger JW","Psychosom Med","2006","2006/10/03","","","10.1097/01.psy.0000234029.38245.c9"
"17010143","Role of beta-endorphin, corticotropin-releasing hormone, and autonomic nervous system in mediation of the effect of chronic ethanol on natural killer cell cytolytic activity","Boyadjieva N, Advis JP, Sarkar DK.","Alcohol Clin Exp Res. 2006 Oct;30(10):1761-7. doi: 10.1111/j.1530-0277.2006.00209.x.","Boyadjieva N","Alcohol Clin Exp Res","2006","2006/10/03","","","10.1111/j.1530-0277.2006.00209.x"
"17008194","Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences","King A, de Wit H, Riley RC, Cao D, Niaura R, Hatsukami D.","Nicotine Tob Res. 2006 Oct;8(5):671-82. doi: 10.1080/14622200600789767.","King A","Nicotine Tob Res","2006","2006/09/30","","","10.1080/14622200600789767"
"17008146","Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder","Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Ralevski E, Rounsaville B.","Biol Psychiatry. 2006 Oct 1;60(7):777-83. doi: 10.1016/j.biopsych.2006.03.074.","Petrakis IL","Biol Psychiatry","2006","2006/09/30","","","10.1016/j.biopsych.2006.03.074"
"17000788","Kappa-opioid receptor antagonism improves recovery from myocardial stunning in chronically instrumented dogs","Grosse Hartlage MA, Theisen MM, Monteiro de Oliveira NP, Van Aken H, Fobker M, Weber TP.","Anesth Analg. 2006 Oct;103(4):822-32. doi: 10.1213/01.ane.0000237246.40665.34.","Grosse Hartlage MA","Anesth Analg","2006","2006/09/27","","","10.1213/01.ane.0000237246.40665.34"
"16984994","Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility","Agirregoitia E, Valdivia A, Carracedo A, Casis L, Gil J, Subiran N, Ochoa C, Irazusta J.","J Clin Endocrinol Metab. 2006 Dec;91(12):4969-75. doi: 10.1210/jc.2006-0599. Epub 2006 Sep 19.","Agirregoitia E","J Clin Endocrinol Metab","2006","2006/09/21","","","10.1210/jc.2006-0599"
"16983662","Morphine upregulates functional expression of neurokinin-1 receptor in neurons","Wan Q, Douglas SD, Wang X, Kolson DL, O'Donnell LA, Ho WZ.","J Neurosci Res. 2006 Nov 15;84(7):1588-96. doi: 10.1002/jnr.21053.","Wan Q","J Neurosci Res","2006","2006/09/20","","","10.1002/jnr.21053"
"16979347","Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study","Linari G, Agostini S, Broccardo M, Petrella C, Improta G.","Pharmacol Res. 2006 Nov;54(5):356-60. doi: 10.1016/j.phrs.2006.07.007. Epub 2006 Aug 15.","Linari G","Pharmacol Res","2006","2006/09/19","","","10.1016/j.phrs.2006.07.007"
"16978601","Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa","Matsumoto K, Hatori Y, Murayama T, Tashima K, Wongseripipatana S, Misawa K, Kitajima M, Takayama H, Horie S.","Eur J Pharmacol. 2006 Nov 7;549(1-3):63-70. doi: 10.1016/j.ejphar.2006.08.013. Epub 2006 Aug 16.","Matsumoto K","Eur J Pharmacol","2006","2006/09/19","","","10.1016/j.ejphar.2006.08.013"
"16978600","Beta-endorphin differentially affects inflammation in two inbred rat strains","Stanojević S, Mitić K, Vujić V, Kovacević-Jovanović V, Dimitrijević M.","Eur J Pharmacol. 2006 Nov 7;549(1-3):157-65. doi: 10.1016/j.ejphar.2006.08.012. Epub 2006 Aug 16.","Stanojević S","Eur J Pharmacol","2006","2006/09/19","","","10.1016/j.ejphar.2006.08.012"
"16978040","Extended-release intramuscular naltrexone: a viewpoint by Steven Siegel","Siegel S.","Drugs. 2006;66(13):1752. doi: 10.2165/00003495-200666130-00007.","Siegel S","Drugs","2006","2006/09/19","","","10.2165/00003495-200666130-00007"
"16978039","Extended-release intramuscular naltrexone: a viewpoint by Falk Kiefer","Kiefer F.","Drugs. 2006;66(13):1752-3. doi: 10.2165/00003495-200666130-00008.","Kiefer F","Drugs","2006","2006/09/19","","","10.2165/00003495-200666130-00008"
"16978038","Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler","Kranzler HR.","Drugs. 2006;66(13):1753-4. doi: 10.2165/00003495-200666130-00009.","Kranzler HR","Drugs","2006","2006/09/19","","","10.2165/00003495-200666130-00009"
"16978037","Extended-release intramuscular naltrexone","Swainston Harrison T, Plosker GL, Keam SJ.","Drugs. 2006;66(13):1741-51. doi: 10.2165/00003495-200666130-00006.","Swainston Harrison T","Drugs","2006","2006/09/19","","","10.2165/00003495-200666130-00006"
"16972105","Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin","Sullivan MA, Vosburg SK, Comer SD.","Psychopharmacology (Berl). 2006 Nov;189(1):37-46. doi: 10.1007/s00213-006-0509-x. Epub 2006 Sep 14.","Sullivan MA","Psychopharmacology (Berl)","2006","2006/09/15","","","10.1007/s00213-006-0509-x"
"16971059","The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters","Knudsen HK, Ducharme LJ, Roman PM.","Drug Alcohol Depend. 2007 Mar 16;87(2-3):164-74. doi: 10.1016/j.drugalcdep.2006.08.013. Epub 2006 Sep 12.","Knudsen HK","Drug Alcohol Depend","2007","2006/09/15","PMC1868517","NIHMS20576","10.1016/j.drugalcdep.2006.08.013"
"16969243","Analgesia and sedation in the presence of a naltrexone implant: a novel pharmacological challenge","O'Brien B, Cody C.","Eur J Emerg Med. 2006 Oct;13(5):315-6. doi: 10.1097/00063110-200610000-00017.","O'Brien B","Eur J Emerg Med","2006","2006/09/14","","","10.1097/00063110-200610000-00017"
"16968619","Choosing the right medication for the treatment of alcoholism","Pettinati HM, Rabinowitz AR.","Curr Psychiatry Rep. 2006 Oct;8(5):383-8. doi: 10.1007/s11920-006-0040-0.","Pettinati HM","Curr Psychiatry Rep","2006","2006/09/14","","","10.1007/s11920-006-0040-0"
"16968615","Continuing care in the treatment of addictive disorders","McKay JR.","Curr Psychiatry Rep. 2006 Oct;8(5):355-62. doi: 10.1007/s11920-006-0036-9.","McKay JR","Curr Psychiatry Rep","2006","2006/09/14","","","10.1007/s11920-006-0036-9"
"16968416","Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats","Ebrahimi F, Tavakoli S, Hajrasouliha AR, Sadeghipour H, Dehghani M, Ahmadi SH, Dehpour AR.","Fundam Clin Pharmacol. 2006 Oct;20(5):461-71. doi: 10.1111/j.1472-8206.2006.00431.x.","Ebrahimi F","Fundam Clin Pharmacol","2006","2006/09/14","","","10.1111/j.1472-8206.2006.00431.x"
"16968347","Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial","Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N, Weltman M, Bell JR, Richardson K, Haber PS.","Addiction. 2006 Oct;101(10):1451-62. doi: 10.1111/j.1360-0443.2006.01555.x.","Morley KC","Addiction","2006","2006/09/14","","","10.1111/j.1360-0443.2006.01555.x"
"16963172","Influence of naltrexone administration on dehydroepiandrosterone sulfate levels in male and female participants","Ceballos NA, France CR, al'Absi M.","Biol Psychol. 2007 Mar;74(3):414-6. doi: 10.1016/j.biopsycho.2006.08.001. Epub 2006 Sep 11.","Ceballos NA","Biol Psychol","2007","2006/09/12","","","10.1016/j.biopsycho.2006.08.001"
"16962298","Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features","Giannola LI, De Caro V, Giandalia G, Siragusa MG, Campisi G, Florena AM, Ciach T.","Eur J Pharm Biopharm. 2007 Feb;65(2):238-46. doi: 10.1016/j.ejpb.2006.07.004. Epub 2006 Jul 26.","Giannola LI","Eur J Pharm Biopharm","2007","2006/09/12","","","10.1016/j.ejpb.2006.07.004"
"16961767","Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone","Oslin DW, Berrettini WH, O'Brien CP.","Addict Biol. 2006 Sep;11(3-4):397-403. doi: 10.1111/j.1369-1600.2006.00036.x.","Oslin DW","Addict Biol","2006","2006/09/12","","","10.1111/j.1369-1600.2006.00036.x"
"16961764","Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment","Overstreet DH, Rezvani AH, Cowen M, Chen F, Lawrence AJ.","Addict Biol. 2006 Sep;11(3-4):356-73. doi: 10.1111/j.1369-1600.2006.00033.x.","Overstreet DH","Addict Biol","2006","2006/09/12","","","10.1111/j.1369-1600.2006.00033.x"
"16961422","Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches","Green AI.","J Clin Psychiatry. 2006;67 Suppl 7:31-5; quiz 36-7.","Green AI","J Clin Psychiatry","2006","2006/09/12","","",""
"16960700","Association of OPRM1 A118G variant with the relative reinforcing value of nicotine","Ray R, Jepson C, Patterson F, Strasser A, Rukstalis M, Perkins K, Lynch KG, O'Malley S, Berrettini WH, Lerman C.","Psychopharmacology (Berl). 2006 Oct;188(3):355-63. doi: 10.1007/s00213-006-0504-2. Epub 2006 Sep 8.","Ray R","Psychopharmacology (Berl)","2006","2006/09/09","","","10.1007/s00213-006-0504-2"
"16939945","New challenges and opportunities in managing substance abuse in Malaysia","Mazlan M, Schottenfeld RS, Chawarski MC.","Drug Alcohol Rev. 2006 Sep;25(5):473-8. doi: 10.1080/09595230600883354.","Mazlan M","Drug Alcohol Rev","2006","2006/08/31","","","10.1080/09595230600883354"
"16934320","Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone","Zalewska-Kaszubska J, Gorska D, Dyr W, Czarnecka E.","Pharmacol Biochem Behav. 2006 Sep;85(1):155-9. doi: 10.1016/j.pbb.2006.07.028. Epub 2006 Aug 24.","Zalewska-Kaszubska J","Pharmacol Biochem Behav","2006","2006/08/29","","","10.1016/j.pbb.2006.07.028"
"16930351","Possible importance of antibiotics and naltrexone in neurodegenerative disease","Agrawal YP.","Eur J Neurol. 2006 Sep;13(9):e7. doi: 10.1111/j.1468-1331.2006.01370.x.","Agrawal YP","Eur J Neurol","2006","2006/08/26","","","10.1111/j.1468-1331.2006.01370.x"
"16925586","Endogenous opioids encode relative taste preference","Taha SA, Norsted E, Lee LS, Lang PD, Lee BS, Woolley JD, Fields HL.","Eur J Neurosci. 2006 Aug;24(4):1220-6. doi: 10.1111/j.1460-9568.2006.04987.x. Epub 2006 Aug 21.","Taha SA","Eur J Neurosci","2006","2006/08/24","","","10.1111/j.1460-9568.2006.04987.x"
"16923153","Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal","Beadles-Bohling AS, Wiren KM.","Genes Brain Behav. 2006 Aug;5(6):483-96. doi: 10.1111/j.1601-183X.2005.00200.x.","Beadles-Bohling AS","Genes Brain Behav","2006","2006/08/23","","","10.1111/j.1601-183X.2005.00200.x"
"16921657","Treatment of alcoholism: new results","","Harv Ment Health Lett. 2006 Aug;23(2):6-7.","","Harv Ment Health Lett","2006","2006/08/23","","",""
"16919740","Naltrexone as negative reinforcement comments on ""A behavioral analysis of coerced treatment for addicted offenders""","Farabee D.","J Subst Abuse Treat. 2006 Sep;31(2):141-2. doi: 10.1016/j.jsat.2006.06.006.","Farabee D","J Subst Abuse Treat","2006","2006/08/22","","","10.1016/j.jsat.2006.06.006"
"16919739","Depot naltrexone in lieu of incarceration: a behavioral analysis of coerced treatment for addicted offenders","Marlowe DB.","J Subst Abuse Treat. 2006 Sep;31(2):131-9. doi: 10.1016/j.jsat.2006.06.005. Epub 2006 Aug 2.","Marlowe DB","J Subst Abuse Treat","2006","2006/08/22","","","10.1016/j.jsat.2006.06.005"
"16919738","Naltrexone as a ""mandate"" or as a choice comments on ""Judicially mandated naltrexone use by criminal offenders: a legal analysis""","Presenza LJ.","J Subst Abuse Treat. 2006 Sep;31(2):129-30. doi: 10.1016/j.jsat.2006.06.004. Epub 2006 Aug 2.","Presenza LJ","J Subst Abuse Treat","2006","2006/08/22","","","10.1016/j.jsat.2006.06.004"
"16919737","Judicially mandated naltrexone use by criminal offenders: a legal analysis","Bonnie RJ.","J Subst Abuse Treat. 2006 Sep;31(2):121-7. doi: 10.1016/j.jsat.2006.06.003. Epub 2006 Aug 2.","Bonnie RJ","J Subst Abuse Treat","2006","2006/08/22","","","10.1016/j.jsat.2006.06.003"
"16919735","Research on naltrexone in the criminal justice system","Patapis NS, Nordstrom BR.","J Subst Abuse Treat. 2006 Sep;31(2):113-5. doi: 10.1016/j.jsat.2006.06.021. Epub 2006 Aug 2.","Patapis NS","J Subst Abuse Treat","2006","2006/08/22","","","10.1016/j.jsat.2006.06.021"
"16919734","Naltrexone for probationers and parolees","O'Brien C, Cornish JW.","J Subst Abuse Treat. 2006 Sep;31(2):107-11. doi: 10.1016/j.jsat.2006.06.002. Epub 2006 Aug 2.","O'Brien C","J Subst Abuse Treat","2006","2006/08/22","","","10.1016/j.jsat.2006.06.002"
"16910369","Understanding and treating kleptomania: new models and new treatments","Grant JE.","Isr J Psychiatry Relat Sci. 2006;43(2):81-7.","Grant JE","Isr J Psychiatry Relat Sci","2006","2006/08/17","","",""
"16905132","The antinociceptive effect of salvinorin A in mice","John TF, French LG, Erlichman JS.","Eur J Pharmacol. 2006 Sep 18;545(2-3):129-33. doi: 10.1016/j.ejphar.2006.06.077. Epub 2006 Jul 4.","John TF","Eur J Pharmacol","2006","2006/08/15","","","10.1016/j.ejphar.2006.06.077"
"16902718","Medicalising the treatment of opioid dependence","Peh LH, Ng BY.","Ann Acad Med Singapore. 2006 Jul;35(7):447-9.","Peh LH","Ann Acad Med Singapore","2006","2006/08/12","","",""
"16901484","Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women","Hadziomerović D, Rabenbauer B, Wildt L.","Fertil Steril. 2006 Sep;86(3):651-7. doi: 10.1016/j.fertnstert.2006.01.039. Epub 2006 Aug 8.","Hadziomerović D","Fertil Steril","2006","2006/08/12","","","10.1016/j.fertnstert.2006.01.039"
"16899413","Noradrenaline is necessary for the hedonic properties of addictive drugs","Jasmin L, Narasaiah M, Tien D.","Vascul Pharmacol. 2006 Oct;45(4):243-50. doi: 10.1016/j.vph.2005.08.030. Epub 2006 Jul 7.","Jasmin L","Vascul Pharmacol","2006","2006/08/11","","","10.1016/j.vph.2005.08.030"
"16899031","Genetic moderators of naltrexone's effects on alcohol cue reactivity","McGeary JE, Monti PM, Rohsenow DJ, Tidey J, Swift R, Miranda R Jr.","Alcohol Clin Exp Res. 2006 Aug;30(8):1288-96. doi: 10.1111/j.1530-0277.2006.00156.x.","McGeary JE","Alcohol Clin Exp Res","2006","2006/08/11","","","10.1111/j.1530-0277.2006.00156.x"
"16880770","The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking","Kuzmin A, Kreek MJ, Bakalkin G, Liljequist S.","Neuropsychopharmacology. 2007 Apr;32(4):902-10. doi: 10.1038/sj.npp.1301169. Epub 2006 Jul 26.","Kuzmin A","Neuropsychopharmacology","2007","2006/08/02","","","10.1038/sj.npp.1301169"
"16874283","Naltrexone (vivitrol)--a once-monthly injection for alcoholism","","Med Lett Drugs Ther. 2006 Jul 31;48(1240):63-4.","","Med Lett Drugs Ther","2006","2006/07/29","","",""
"16865045","Pharmacological management of a teen with significant alcohol use and depression","Kratochvil CJ, Kazura A, Deas D, Martin CA, Dosh T, Wilens TE.","J Am Acad Child Adolesc Psychiatry. 2006 Aug;45(8):1011-1015. doi: 10.1097/01.chi.0000224332.93442.d5.","Kratochvil CJ","J Am Acad Child Adolesc Psychiatry","2006","2006/07/26","","","10.1097/01.chi.0000224332.93442.d5"
"16847946","Alkylation of opioid receptors by 5'-naltrindole-isothiocyanate injected into the nucleus accumbens of rats: receptor selectivity and anatomical diffusion","Martin TJ, McIntosh S, Smith JE.","Synapse. 2006 Oct;60(5):384-91. doi: 10.1002/syn.20310.","Martin TJ","Synapse","2006","2006/07/19","","","10.1002/syn.20310"
"16847679","Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food","Ward HG, Simansky KJ.","Psychopharmacology (Berl). 2006 Sep;187(4):435-46. doi: 10.1007/s00213-006-0463-7. Epub 2006 Jul 18.","Ward HG","Psychopharmacology (Berl)","2006","2006/07/19","","","10.1007/s00213-006-0463-7"
"16847538","The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response","Brady KT, Waldrop AE, McRae AL, Back SE, Saladin ME, Upadhyaya HP, Anton RF, Randall PK.","J Stud Alcohol. 2006 Sep;67(5):700-6. doi: 10.15288/jsa.2006.67.700.","Brady KT","J Stud Alcohol","2006","2006/07/19","","","10.15288/jsa.2006.67.700"
"16841344","Naltrexone in patients with bipolar disorder and alcohol dependence","Brown ES, Beard L, Dobbs L, Rush AJ.","Depress Anxiety. 2006;23(8):492-5. doi: 10.1002/da.20213.","Brown ES","Depress Anxiety","2006","2006/07/15","","","10.1002/da.20213"
"16839858","Study of hepatotoxicity of naltrexone in the treatment of alcoholism","Yen MH, Ko HC, Tang FI, Lu RB, Hong JS.","Alcohol. 2006 Feb;38(2):117-20. doi: 10.1016/j.alcohol.2006.05.003.","Yen MH","Alcohol","2006","2006/07/15","","","10.1016/j.alcohol.2006.05.003"
"16836206","[Maintaining abstinence after alcohol detoxification]","Batel P, Balester-Mouret S.","Rev Prat. 2006 May 31;56(10):1100-6.","Batel P","Rev Prat","2006","2006/07/14","","",""
"16824510","Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide","Tavakoli S, Hajrasouliha AR, Jabehdar-Maralani P, Ebrahimi F, Sadeghipour H, Dehghani M, Shafaroodi H, Dehpour AR.","Eur J Pharmacol. 2006 Aug 7;542(1-3):148-53. doi: 10.1016/j.ejphar.2006.04.052. Epub 2006 May 7.","Tavakoli S","Eur J Pharmacol","2006","2006/07/11","","","10.1016/j.ejphar.2006.04.052"
"16822973","Food-induced behavioral sensitization, its cross-sensitization to cocaine and morphine, pharmacological blockade, and effect on food intake","Le Merrer J, Stephens DN.","J Neurosci. 2006 Jul 5;26(27):7163-71. doi: 10.1523/JNEUROSCI.5345-05.2006.","Le Merrer J","J Neurosci","2006","2006/07/11","PMC6673946","","10.1523/JNEUROSCI.5345-05.2006"
"16820176","Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation","Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J.","Microvasc Res. 2006 Jul-Sep;72(1-2):3-11. doi: 10.1016/j.mvr.2006.04.004. Epub 2006 Jul 3.","Singleton PA","Microvasc Res","2006","2006/07/06","","","10.1016/j.mvr.2006.04.004"
"16819215","Optimization of the preparation of nalmefene-loaded sustained-release microspheres using central composite design","Wu XG, Li G, Gao YL.","Chem Pharm Bull (Tokyo). 2006 Jul;54(7):977-81. doi: 10.1248/cpb.54.977.","Wu XG","Chem Pharm Bull (Tokyo)","2006","2006/07/05","","","10.1248/cpb.54.977"
"16815987","The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of delta2-opioid receptor stimulation","Davis S, Deo SH, Barlow M, Yoshishige D, Farias M, Caffrey JL.","Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2318-26. doi: 10.1152/ajpheart.00455.2006. Epub 2006 Jun 30.","Davis S","Am J Physiol Heart Circ Physiol","2006","2006/07/04","","","10.1152/ajpheart.00455.2006"
"16815593","The effects of endomorphins and diprotin A on striatal dopamine release induced by electrical stimulation-an in vitro superfusion study in rats","Bagosi Z, Jászberényi M, Bujdosó E, Szabó G, Telegdy G.","Neurochem Int. 2006 Dec;49(7):665-8. doi: 10.1016/j.neuint.2006.05.006. Epub 2006 Jul 3.","Bagosi Z","Neurochem Int","2006","2006/07/04","","","10.1016/j.neuint.2006.05.006"
"16802164","Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes","Rodgers RJ, Augar R, Berryman N, Hansom CJ, O'Mahony ML, Palmer RM, Stevens A, Tallett AJ.","Psychopharmacology (Berl). 2006 Aug;187(3):345-55. doi: 10.1007/s00213-006-0435-y. Epub 2006 Jun 27.","Rodgers RJ","Psychopharmacology (Berl)","2006","2006/06/28","","","10.1007/s00213-006-0435-y"
"16798000","Synthesis and hydrolytic behavior of two novel tripartate codrugs of naltrexone and 6beta-naltrexol with hydroxybupropion as potential alcohol abuse and smoking cessation agents","Hamad MO, Kiptoo PK, Stinchcomb AL, Crooks PA.","Bioorg Med Chem. 2006 Oct 15;14(20):7051-61. doi: 10.1016/j.bmc.2006.06.018. Epub 2006 Jun 23.","Hamad MO","Bioorg Med Chem","2006","2006/06/27","","","10.1016/j.bmc.2006.06.018"
"16797494","The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats","Fukuda H, Suenaga K, Tsuchida D, Mantyh CR, Pappas TN, Hicks GA, Dehaven-Hudkins DL, Takahashi T.","Brain Res. 2006 Aug 2;1102(1):63-70. doi: 10.1016/j.brainres.2006.02.092. Epub 2006 Jun 22.","Fukuda H","Brain Res","2006","2006/06/27","","","10.1016/j.brainres.2006.02.092"
"16785213","Antagonist treatment of opioid withdrawal translational low dose approach","Mannelli P, Gottheil E, Van Bockstaele EJ.","J Addict Dis. 2006;25(2):1-8. doi: 10.1300/J069v25n02_01.","Mannelli P","J Addict Dis","2006","2006/06/21","","","10.1300/J069v25n02_01"
"16784760","Pharmacological manipulations of dopamine and opioids have differential effects on sexually motivated song in male European starlings","Schroeder MB, Riters LV.","Physiol Behav. 2006 Jul 30;88(4-5):575-84. doi: 10.1016/j.physbeh.2006.05.011. Epub 2006 Jun 19.","Schroeder MB","Physiol Behav","2006","2006/06/21","","","10.1016/j.physbeh.2006.05.011"
"16782849","Repeated delta1-opioid receptor stimulation reduces delta2-opioid receptor responses in the SA node","Deo SH, Johnson-Davis S, Barlow MA, Yoshishige D, Caffrey JL.","Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2246-54. doi: 10.1152/ajpheart.00122.2006. Epub 2006 Jun 16.","Deo SH","Am J Physiol Heart Circ Physiol","2006","2006/06/20","","","10.1152/ajpheart.00122.2006"
"16782179","Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1","Jinsmaa Y, Marczak E, Fujita Y, Shiotani K, Miyazaki A, Li T, Tsuda Y, Ambo A, Sasaki Y, Bryant SD, Okada Y, Lazarus LH.","Pharmacol Biochem Behav. 2006 Jun;84(2):252-8. doi: 10.1016/j.pbb.2006.05.005. Epub 2006 Jun 19.","Jinsmaa Y","Pharmacol Biochem Behav","2006","2006/06/20","","","10.1016/j.pbb.2006.05.005"
"16781738","Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration","Doyon WM, Howard EC, Shippenberg TS, Gonzales RA.","Neuropharmacology. 2006 Sep;51(3):487-96. doi: 10.1016/j.neuropharm.2006.04.005. Epub 2006 Jun 15.","Doyon WM","Neuropharmacology","2006","2006/06/20","PMC1973091","NIHMS23162","10.1016/j.neuropharm.2006.04.005"
"16778434","Naltrexone implants -- duration, tolerability and clinical usefulness. A pilot study","Waal H, Frogopsahl G, Olsen L, Christophersen AS, Mørland J.","Eur Addict Res. 2006;12(3):138-44. doi: 10.1159/000092115.","Waal H","Eur Addict Res","2006","2006/06/17","","","10.1159/000092115"
"16773140","Cortical delta-opioid receptors potentiate K+ homeostasis during anoxia and oxygen-glucose deprivation","Chao D, Donnelly DF, Feng Y, Bazzy-Asaad A, Xia Y.","J Cereb Blood Flow Metab. 2007 Feb;27(2):356-68. doi: 10.1038/sj.jcbfm.9600352. Epub 2006 Jun 14.","Chao D","J Cereb Blood Flow Metab","2007","2006/06/15","","","10.1038/sj.jcbfm.9600352"
"16769444","Heroin dependence and HIV infection in Malaysia","Chawarski MC, Mazlan M, Schottenfeld RS.","Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S39-42. doi: 10.1016/s0376-8716(06)80007-4.","Chawarski MC","Drug Alcohol Depend","2006","2006/06/14","","","10.1016/s0376-8716(06)80007-4"
"16766718","Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies","Ko MC, Wei H, Woods JH, Kennedy RT.","J Pharmacol Exp Ther. 2006 Sep;318(3):1257-64. doi: 10.1124/jpet.106.106120. Epub 2006 Jun 9.","Ko MC","J Pharmacol Exp Ther","2006","2006/06/13","","","10.1124/jpet.106.106120"
"16759815","Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?","Good P.","Med Hypotheses. 2006;67(3):671-2. doi: 10.1016/j.mehy.2006.04.015. Epub 2006 Jun 8.","Good P","Med Hypotheses","2006","2006/06/09","","","10.1016/j.mehy.2006.04.015"
"16759337","Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone","Escher T, Mittleman G.","Addict Biol. 2006 Mar;11(1):55-63. doi: 10.1111/j.1369-1600.2006.00004.x.","Escher T","Addict Biol","2006","2006/06/09","","","10.1111/j.1369-1600.2006.00004.x"
"16756424","The effects of naltrexone on alcohol consumption and affect reactivity to daily interpersonal events among heavy drinkers","Armeli S, Feinn R, Tennen H, Kranzler HR.","Exp Clin Psychopharmacol. 2006 May;14(2):199-208. doi: 10.1037/1064-1297.14.2.199.","Armeli S","Exp Clin Psychopharmacol","2006","2006/06/08","","","10.1037/1064-1297.14.2.199"
"16750868","Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion","Kiptoo PK, Hamad MO, Crooks PA, Stinchcomb AL.","J Control Release. 2006 Jun 28;113(2):137-45. doi: 10.1016/j.jconrel.2006.04.003. Epub 2006 Apr 25.","Kiptoo PK","J Control Release","2006","2006/06/06","","","10.1016/j.jconrel.2006.04.003"
"16750225","Chronic morphine treatment induces oxidant and apoptotic damage in the mice liver","Payabvash S, Beheshtian A, Salmasi AH, Kiumehr S, Ghahremani MH, Tavangar SM, Sabzevari O, Dehpour AR.","Life Sci. 2006 Aug 1;79(10):972-80. doi: 10.1016/j.lfs.2006.05.008. Epub 2006 May 17.","Payabvash S","Life Sci","2006","2006/06/06","","","10.1016/j.lfs.2006.05.008"
"16740093","Pharmacokinetics of the opioid antagonist N-methylnaltrexone and evaluation of its effects on gastrointestinal tract function in horses treated or not treated with morphine","Boscan P, Van Hoogmoed LM, Pypendop BH, Farver TB, Snyder JR.","Am J Vet Res. 2006 Jun;67(6):998-1004. doi: 10.2460/ajvr.67.6.998.","Boscan P","Am J Vet Res","2006","2006/06/03","","","10.2460/ajvr.67.6.998"
"16739470","Role of delta-opioid receptors in the regulation of humoral and cell-mediated immune response in rotational stress","Gein SV, Sharav'eva IL, Tendryakova SP.","Dokl Biol Sci. 2006 Mar-Apr;407:119-20. doi: 10.1134/s0012496606020013.","Gein SV","Dokl Biol Sci","2006","2006/06/03","","","10.1134/s0012496606020013"
"16737694","Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria","Raffa RB, Baron DA, Tallarida RJ.","Eur J Pharmacol. 2006 Jul 1;540(1-3):200-1. doi: 10.1016/j.ejphar.2006.04.027. Epub 2006 May 3.","Raffa RB","Eur J Pharmacol","2006","2006/06/02","","","10.1016/j.ejphar.2006.04.027"
"16735648","Efficacy and safety of naltrexone use in pediatric patients with autistic disorder","Elchaar GM, Maisch NM, Augusto LM, Wehring HJ.","Ann Pharmacother. 2006 Jun;40(6):1086-95. doi: 10.1345/aph.1G499. Epub 2006 May 30.","Elchaar GM","Ann Pharmacother","2006","2006/06/01","","","10.1345/aph.1G499"
"16728904","The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders","Starosta AN, Leeman RF, Volpicelli JR.","J Psychiatr Pract. 2006 Mar;12(2):80-9. doi: 10.1097/00131746-200603000-00003.","Starosta AN","J Psychiatr Pract","2006","2006/05/27","PMC2764009","NIHMS134734","10.1097/00131746-200603000-00003"
"16728455","Modulation of systemic and renal haemodynamics by kappa-opioids in conscious lambs","Qi W, Smith FG.","Exp Physiol. 2006 Sep;91(5):877-85. doi: 10.1113/expphysiol.2006.033456. Epub 2006 May 25.","Qi W","Exp Physiol","2006","2006/05/27","","","10.1113/expphysiol.2006.033456"
"16722816","A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependence","Johnson BA.","Expert Opin Pharmacother. 2006 Jun;7(8):1065-73. doi: 10.1517/14656566.7.8.1065.","Johnson BA","Expert Opin Pharmacother","2006","2006/05/26","","","10.1517/14656566.7.8.1065"
"16719691","Reinforcing properties of ethanol in neonatal rats: involvement of the opioid system","Nizhnikov ME, Varlinskaya EI, Petrov ES, Spear NE.","Behav Neurosci. 2006 Apr;120(2):267-80. doi: 10.1037/0735-7044.120.2.267.","Nizhnikov ME","Behav Neurosci","2006","2006/05/25","","","10.1037/0735-7044.120.2.267"
"16716514","Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice","San-Emeterio EP, Hurlé MA.","Neurosci Lett. 2006 Aug 7;403(3):276-9. doi: 10.1016/j.neulet.2006.04.053. Epub 2006 May 22.","San-Emeterio EP","Neurosci Lett","2006","2006/05/24","","","10.1016/j.neulet.2006.04.053"
"16713505","Ethanol familiarity and naltrexone treatment affect ethanol responses in rats","Kiefer SW, Hill KG, Coonfield DL, Ferraro FM 3rd.","Alcohol. 2005 Nov;37(3):167-72. doi: 10.1016/j.alcohol.2006.03.004.","Kiefer SW","Alcohol","2005","2006/05/23","","","10.1016/j.alcohol.2006.03.004"
"16712978","Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice","Reeta Kh, Mediratta PK, Rathi N, Jain H, Chugh C, Sharma KK.","Regul Pept. 2006 Jul 15;135(1-2):85-90. doi: 10.1016/j.regpep.2006.04.004. Epub 2006 May 19.","Reeta Kh","Regul Pept","2006","2006/05/23","","","10.1016/j.regpep.2006.04.004"
"16712910","The involvement of endogenous opioid mechanisms in the antinociceptive effects induced by antidepressant drugs, desipramine and trimipramine","Oztürk Y, Aydin S, Beis R, Herekman-Demir T.","Pharmacol Biochem Behav. 2006 Apr;83(4):592-7. doi: 10.1016/j.pbb.2006.03.022. Epub 2006 May 19.","Oztürk Y","Pharmacol Biochem Behav","2006","2006/05/23","","","10.1016/j.pbb.2006.03.022"
"16696849","Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction","Narita M, Kuzumaki N, Narita M, Kaneko C, Hareyama N, Miyatake M, Shindo K, Miyoshi K, Nakajima M, Nagumo Y, Sato F, Wachi H, Seyama Y, Suzuki T.","J Neurochem. 2006 Jun;97(5):1369-78. doi: 10.1111/j.1471-4159.2006.03824.x.","Narita M","J Neurochem","2006","2006/05/16","","","10.1111/j.1471-4159.2006.03824.x"
"16682504","Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling","Breit A, Gagnidze K, Devi LA, Lagacé M, Bouvier M.","Mol Pharmacol. 2006 Aug;70(2):686-96. doi: 10.1124/mol.106.022897. Epub 2006 May 8.","Breit A","Mol Pharmacol","2006","2006/05/10","","","10.1124/mol.106.022897"
"16681181","Obviation of opioid withdrawal syndrome by concomitant administration of naltrexone in microgram doses: two psychonautic bioassays","Ott J.","J Psychoactive Drugs. 2006 Mar;38(1):101-5. doi: 10.1080/02791072.2006.10399833.","Ott J","J Psychoactive Drugs","2006","2006/05/10","","","10.1080/02791072.2006.10399833"
"16670409","Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group.","JAMA. 2006 May 3;295(17):2003-17. doi: 10.1001/jama.295.17.2003.","Anton RF","JAMA","2006","2006/05/04","","","10.1001/jama.295.17.2003"
"16669899","Opiate addiction in China: current situation and treatments","Tang YL, Zhao D, Zhao C, Cubells JF.","Addiction. 2006 May;101(5):657-65. doi: 10.1111/j.1360-0443.2006.01367.x.","Tang YL","Addiction","2006","2006/05/04","","","10.1111/j.1360-0443.2006.01367.x"
"16648139","Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes","Bruchas MR, Macey TA, Lowe JD, Chavkin C.","J Biol Chem. 2006 Jun 30;281(26):18081-9. doi: 10.1074/jbc.M513640200. Epub 2006 Apr 28.","Bruchas MR","J Biol Chem","2006","2006/05/02","PMC2096730","NIHMS34350","10.1074/jbc.M513640200"
"16647240","Naltrexone renders one-session exposure therapy less effective: a controlled pilot study","Kozak AT, Spates CR, McChargue DE, Bailey KC, Schneider KL, Liepman MR.","J Anxiety Disord. 2007;21(1):142-52. doi: 10.1016/j.janxdis.2006.03.011. Epub 2006 May 2.","Kozak AT","J Anxiety Disord","2007","2006/05/02","","","10.1016/j.janxdis.2006.03.011"
"16644488","Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line","Parkhill AL, Bidlack JM.","Int Immunopharmacol. 2006 Jun;6(6):1013-9. doi: 10.1016/j.intimp.2006.01.012. Epub 2006 Feb 17.","Parkhill AL","Int Immunopharmacol","2006","2006/04/29","","","10.1016/j.intimp.2006.01.012"
"16644121","Involvement of mu- and delta-opioid receptors in the antinociceptive effects induced by AMPA receptor antagonist in the spinal cord of rats","Kong LL, Yu LC.","Neurosci Lett. 2006 Jul 10;402(1-2):180-3. doi: 10.1016/j.neulet.2006.03.071. Epub 2006 Apr 27.","Kong LL","Neurosci Lett","2006","2006/04/29","","","10.1016/j.neulet.2006.03.071"
"16642544","Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention","Jung YC, Namkoong K.","Yonsei Med J. 2006 Apr 30;47(2):167-78. doi: 10.3349/ymj.2006.47.2.167.","Jung YC","Yonsei Med J","2006","2006/04/28","PMC2687624","","10.3349/ymj.2006.47.2.167"
"16639868","Effects of naltrexone on the acquisition of alcohol intake in male and female periadolescent and adult alcohol-preferring (P) rats","Sable HJ, Bell RL, Rodd ZA, McBride WJ.","Int J Adolesc Med Health. 2006 Jan-Mar;18(1):139-49. doi: 10.1515/ijamh.2006.18.1.139.","Sable HJ","Int J Adolesc Med Health","2006","2006/04/28","","","10.1515/ijamh.2006.18.1.139"
"16634855","Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking","Hernandez-Avila CA, Song C, Kuo L, Tennen H, Armeli S, Kranzler HR.","Alcohol Clin Exp Res. 2006 May;30(5):860-5. doi: 10.1111/j.1530-0277.2006.00101.x.","Hernandez-Avila CA","Alcohol Clin Exp Res","2006","2006/04/26","","","10.1111/j.1530-0277.2006.00101.x"
"16634692","Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects","Yuan CS, Israel RJ.","Expert Opin Investig Drugs. 2006 May;15(5):541-52. doi: 10.1517/13543784.15.5.541.","Yuan CS","Expert Opin Investig Drugs","2006","2006/04/26","","","10.1517/13543784.15.5.541"
"16632823","S(+)-ketamine attenuates increase in electroencephalograph activity and amplitude height of sensory-evoked potentials during rapid opioid detoxification","Freye E, Latasch L, Levy JV.","Anesth Analg. 2006 May;102(5):1439-44. doi: 10.1213/01.ane.0000202382.82847.64.","Freye E","Anesth Analg","2006","2006/04/25","","","10.1213/01.ane.0000202382.82847.64"
"16621893","Downstream regulatory element antagonistic modulator regulates islet prodynorphin expression","Jacobson DA, Cho J, Landa LR Jr, Tamarina NA, Roe MW, Buxbaum JD, Philipson LH.","Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E587-95. doi: 10.1152/ajpendo.00612.2005. Epub 2006 Apr 18.","Jacobson DA","Am J Physiol Endocrinol Metab","2006","2006/04/20","","","10.1152/ajpendo.00612.2005"
"16620880","Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan","França DS, Ferreira-Alves DL, Duarte ID, Ribeiro MC, Rezende RM, Bakhle YS, Francischi JN.","Neuropharmacology. 2006 Jul;51(1):37-43. doi: 10.1016/j.neuropharm.2006.02.012. Epub 2006 Apr 18.","França DS","Neuropharmacology","2006","2006/04/20","","","10.1016/j.neuropharm.2006.02.012"
"16614539","Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients","Kim SW, Grant JE, Yoon G, Williams KA, Remmel RP.","Clin Neuropharmacol. 2006 Mar-Apr;29(2):77-9. doi: 10.1097/00002826-200603000-00004.","Kim SW","Clin Neuropharmacol","2006","2006/04/15","","","10.1097/00002826-200603000-00004"
"16611820","Opioid receptors in the nucleus accumbens regulate attentional learning in the blocking paradigm","Iordanova MD, McNally GP, Westbrook RF.","J Neurosci. 2006 Apr 12;26(15):4036-45. doi: 10.1523/JNEUROSCI.4679-05.2006.","Iordanova MD","J Neurosci","2006","2006/04/14","PMC6673876","","10.1523/JNEUROSCI.4679-05.2006"
"16597534","Current choices--good or bad--for the proactive management of postoperative ileus: A surgeon's view","Saclarides TJ.","J Perianesth Nurs. 2006 Apr;21(2A Suppl):S7-15. doi: 10.1016/j.jopan.2006.01.008.","Saclarides TJ","J Perianesth Nurs","2006","2006/04/07","","","10.1016/j.jopan.2006.01.008"
"16597532","The surgical team and outcomes management: focus on postoperative ileus","Carter S.","J Perianesth Nurs. 2006 Apr;21(2A Suppl):S2-6. doi: 10.1016/j.jopan.2006.01.012.","Carter S","J Perianesth Nurs","2006","2006/04/07","","","10.1016/j.jopan.2006.01.012"
"16597531","Peripherally acting mu-opioid-receptor antagonists and the connection between postoperative ileus and pain management: The anesthesiologist's view and beyond","Sinatra RS.","J Perianesth Nurs. 2006 Apr;21(2A Suppl):S16-23. doi: 10.1016/j.jopan.2006.01.016.","Sinatra RS","J Perianesth Nurs","2006","2006/04/07","","","10.1016/j.jopan.2006.01.016"
"16595353","Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial","Sullivan MA, Rothenberg JL, Vosburg SK, Church SH, Feldman SJ, Epstein EM, Kleber HD, Nunes EV.","Am J Addict. 2006 Mar-Apr;15(2):150-9. doi: 10.1080/10550490500528464.","Sullivan MA","Am J Addict","2006","2006/04/06","","","10.1080/10550490500528464"
"16574767","Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes","Wang X, Douglas SD, Peng JS, Metzger DS, O'Brien CP, Zhang T, Ho WZ.","J Leukoc Biol. 2006 Jun;79(6):1166-72. doi: 10.1189/jlb.1105642. Epub 2006 Mar 30.","Wang X","J Leukoc Biol","2006","2006/04/01","","","10.1189/jlb.1105642"
"16573576","Endogenous kappa opioid receptor systems modulate the responsiveness of mesoaccumbal dopamine neurons to ethanol","Zapata A, Shippenberg TS.","Alcohol Clin Exp Res. 2006 Apr;30(4):592-7. doi: 10.1111/j.1530-0277.2006.00069.x.","Zapata A","Alcohol Clin Exp Res","2006","2006/04/01","","","10.1111/j.1530-0277.2006.00069.x"
"16567607","A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation","O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P.","Arch Intern Med. 2006 Mar 27;166(6):667-74. doi: 10.1001/archinte.166.6.667.","O'Malley SS","Arch Intern Med","2006","2006/03/29","","","10.1001/archinte.166.6.667"
"16565434","Vagotonic effects of enkephalin are not mediated by sympatholytic mechanisms","Barlow MA, Deo S, Johnson S, Caffrey JL.","Exp Biol Med (Maywood). 2006 Apr;231(4):387-95. doi: 10.1177/153537020623100404.","Barlow MA","Exp Biol Med (Maywood)","2006","2006/03/28","","","10.1177/153537020623100404"
"16554396","Adrenocortical and nociceptive responses to opioid blockade in hypertension-prone men and women","al'Absi M, France C, Harju A, France J, Wittmers L.","Psychosom Med. 2006 Mar-Apr;68(2):292-8. doi: 10.1097/01.psy.0000203240.64965.bd.","al'Absi M","Psychosom Med","2006","2006/03/24","","","10.1097/01.psy.0000203240.64965.bd"
"16553624","Mu-opioid receptor cellular function in the nucleus accumbens is essential for hedonically driven eating","Ward HG, Nicklous DM, Aloyo VJ, Simansky KJ.","Eur J Neurosci. 2006 Mar;23(6):1605-13. doi: 10.1111/j.1460-9568.2006.04674.x.","Ward HG","Eur J Neurosci","2006","2006/03/24","","","10.1111/j.1460-9568.2006.04674.x"
"16548929","Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review","Johansson BA, Berglund M, Lindgren A.","Addiction. 2006 Apr;101(4):491-503. doi: 10.1111/j.1360-0443.2006.01369.x.","Johansson BA","Addiction","2006","2006/03/22","","","10.1111/j.1360-0443.2006.01369.x"
"16548923","Do antagonists have a role in the treatment of opioid dependence?","Jaffe JH.","Addiction. 2006 Apr;101(4):468-9. doi: 10.1111/j.1360-0443.2006.01402.x.","Jaffe JH","Addiction","2006","2006/03/22","","","10.1111/j.1360-0443.2006.01402.x"
"16546596","Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners","Kaur M, Liguori A, Lang W, Rapp SR, Fleischer AB Jr, Feldman SR.","J Am Acad Dermatol. 2006 Apr;54(4):709-11. doi: 10.1016/j.jaad.2005.11.1059.","Kaur M","J Am Acad Dermatol","2006","2006/03/21","","","10.1016/j.jaad.2005.11.1059"
"16545872","Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms","Heilig M, Egli M.","Pharmacol Ther. 2006 Sep;111(3):855-76. doi: 10.1016/j.pharmthera.2006.02.001. Epub 2006 Mar 20.","Heilig M","Pharmacol Ther","2006","2006/03/21","","","10.1016/j.pharmthera.2006.02.001"
"16543289","Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats","Ebrahimkhani MR, Kiani S, Oakley F, Kendall T, Shariftabrizi A, Tavangar SM, Moezi L, Payabvash S, Karoon A, Hoseininik H, Mann DA, Moore KP, Mani AR, Dehpour AR.","Gut. 2006 Nov;55(11):1606-16. doi: 10.1136/gut.2005.076778. Epub 2006 Mar 16.","Ebrahimkhani MR","Gut","2006","2006/03/18","PMC1860108","","10.1136/gut.2005.076778"
"16540156","Effect of opioid antagonism on conditioned place preferences to snack foods","Jarosz PA, Sekhon P, Coscina DV.","Pharmacol Biochem Behav. 2006 Feb;83(2):257-64. doi: 10.1016/j.pbb.2006.02.004. Epub 2006 Mar 15.","Jarosz PA","Pharmacol Biochem Behav","2006","2006/03/17","","","10.1016/j.pbb.2006.02.004"
"16534857","Effect of oral naltrexone on pruritus in cholestatic patients","Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z.","World J Gastroenterol. 2006 Feb 21;12(7):1125-8. doi: 10.3748/wjg.v12.i7.1125.","Mansour-Ghanaei F","World J Gastroenterol","2006","2006/03/15","PMC4087908","","10.3748/wjg.v12.i7.1125"
"16533506","Characterization of the antinociceptive effects of oxycodone in diabetic mice","Nozaki C, Saitoh A, Kamei J.","Eur J Pharmacol. 2006 Mar 27;535(1-3):145-51. doi: 10.1016/j.ejphar.2006.02.002. Epub 2006 Mar 14.","Nozaki C","Eur J Pharmacol","2006","2006/03/15","","","10.1016/j.ejphar.2006.02.002"
"16533497","Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system","Ciccocioppo R, Economidou D, Rimondini R, Sommer W, Massi M, Heilig M.","Biol Psychiatry. 2007 Jan 1;61(1):4-12. doi: 10.1016/j.biopsych.2006.01.006. Epub 2006 Mar 14.","Ciccocioppo R","Biol Psychiatry","2007","2006/03/15","PMC3035814","NIHMS266996","10.1016/j.biopsych.2006.01.006"
"16533167","Role of opioid antagonists in the treatment of women with glucoregulation abnormalities","Guido M, Romualdi D, Lanzone A.","Curr Pharm Des. 2006;12(8):1001-12. doi: 10.2174/138161206776055895.","Guido M","Curr Pharm Des","2006","2006/03/15","","","10.2174/138161206776055895"
"16527399","Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains","Terner JM, Barrett AC, Lomas LM, Negus SS, Picker MJ.","Pain. 2006 May;122(1-2):90-101. doi: 10.1016/j.pain.2006.01.019. Epub 2006 Mar 9.","Terner JM","Pain","2006","2006/03/11","","","10.1016/j.pain.2006.01.019"
"16520558","Naltrexone influences protein kinase Ce and integrin alpha7 activity in SH-SY5Y neuroblastoma cells","Oh DY, Jung KH, Yang BH, Lee JS, Choi IG, Chai YG.","Exp Mol Med. 2006 Feb 28;38(1):100-6. doi: 10.1038/emm.2006.12.","Oh DY","Exp Mol Med","2006","2006/03/08","","","10.1038/emm.2006.12"
"16519663","Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects","Zhang H, Torregrossa MM, Jutkiewicz EM, Shi YG, Rice KC, Woods JH, Watson SJ, Ko MC.","Eur J Neurosci. 2006 Feb;23(4):984-94. doi: 10.1111/j.1460-9568.2006.04621.x.","Zhang H","Eur J Neurosci","2006","2006/03/08","PMC1462954","NIHMS9647","10.1111/j.1460-9568.2006.04621.x"
"16516392","The ethanol self-administration context as a reinstatement cue: acute effects of naltrexone","Burattini C, Gill TM, Aicardi G, Janak PH.","Neuroscience. 2006;139(3):877-87. doi: 10.1016/j.neuroscience.2006.01.009. Epub 2006 Mar 3.","Burattini C","Neuroscience","2006","2006/03/07","","","10.1016/j.neuroscience.2006.01.009"
"16514101","Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor","Zhang J, Qian H, Zhao P, Hong SS, Xia Y.","Stroke. 2006 Apr;37(4):1094-9. doi: 10.1161/01.STR.0000206444.29930.18. Epub 2006 Mar 2.","Zhang J","Stroke","2006","2006/03/04","","","10.1161/01.STR.0000206444.29930.18"
"16503093","Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice","Doran CM, Duszynski KM, Beilby JJ, Mattick RP.","Addict Behav. 2006 Nov;31(11):1947-58. doi: 10.1016/j.addbeh.2006.01.008. Epub 2006 Feb 24.","Doran CM","Addict Behav","2006","2006/03/01","","","10.1016/j.addbeh.2006.01.008"
"16502200","Successful treatment of refractory aquagenic pruritus with naltrexone","Ingber S, Cohen PD.","J Cutan Med Surg. 2005 Oct;9(5):215-6. doi: 10.1007/s10227-005-0144-x.","Ingber S","J Cutan Med Surg","2005","2006/02/28","","","10.1007/s10227-005-0144-x"
"16499489","Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone","Dunbar JL, Turncliff RZ, Dong Q, Silverman BL, Ehrich EW, Lasseter KC.","Alcohol Clin Exp Res. 2006 Mar;30(3):480-90. doi: 10.1111/j.1530-0277.2006.00052.x.","Dunbar JL","Alcohol Clin Exp Res","2006","2006/02/28","","","10.1111/j.1530-0277.2006.00052.x"
"16496034","Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence","Dean AJ, Saunders JB, Jones RT, Young RM, Connor JP, Lawford BR.","J Psychiatry Neurosci. 2006 Jan;31(1):38-45.","Dean AJ","J Psychiatry Neurosci","2006","2006/02/24","PMC1325065","",""
"16495366","Endogenous activation of supraoptic nucleus kappa-opioid receptors terminates spontaneous phasic bursts in rat magnocellular neurosecretory cells","Brown CH, Leng G, Ludwig M, Bourque CW.","J Neurophysiol. 2006 May;95(5):3235-44. doi: 10.1152/jn.00062.2006. Epub 2006 Feb 22.","Brown CH","J Neurophysiol","2006","2006/02/24","","","10.1152/jn.00062.2006"
"16493098","Detoxification and treating opioid dependence","de Jong CJ.","JAMA. 2006 Feb 22;295(8):887; author reply 887-8. doi: 10.1001/jama.295.8.887-a.","de Jong CJ","JAMA","2006","2006/02/24","","","10.1001/jama.295.8.887-a"
"16493097","Detoxification and treating opioid dependence","Contreras JA.","JAMA. 2006 Feb 22;295(8):886-7; author reply 887-8. doi: 10.1001/jama.295.8.886-b.","Contreras JA","JAMA","2006","2006/02/24","","","10.1001/jama.295.8.886-b"
"16493096","Heroin detoxification","Favrat B, Besson J.","JAMA. 2006 Feb 22;295(8):885; author reply 886. doi: 10.1001/jama.295.8.885-a.","Favrat B","JAMA","2006","2006/02/24","","","10.1001/jama.295.8.885-a"
"16493095","Heroin detoxification","Miller MM.","JAMA. 2006 Feb 22;295(8):885-6; author reply 886. doi: 10.1001/jama.295.8.885-b.","Miller MM","JAMA","2006","2006/02/24","","","10.1001/jama.295.8.885-b"
"16492121","Motivational control of heroin seeking by conditioned stimuli associated with withdrawal and heroin taking by rats","Hellemans KG, Dickinson A, Everitt BJ.","Behav Neurosci. 2006 Feb;120(1):103-14. doi: 10.1037/0735-7044.120.1.103.","Hellemans KG","Behav Neurosci","2006","2006/02/24","","","10.1037/0735-7044.120.1.103"
"16491101","Delta opioid receptor ligands modulate anxiety-like behaviors in the rat","Perrine SA, Hoshaw BA, Unterwald EM.","Br J Pharmacol. 2006 Apr;147(8):864-72. doi: 10.1038/sj.bjp.0706686.","Perrine SA","Br J Pharmacol","2006","2006/02/24","PMC1760715","","10.1038/sj.bjp.0706686"
"16490317","Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats","Xiong W, Yu LC.","Neurosci Lett. 2006 May 15;399(1-2):167-70. doi: 10.1016/j.neulet.2006.01.052. Epub 2006 Feb 21.","Xiong W","Neurosci Lett","2006","2006/02/24","","","10.1016/j.neulet.2006.01.052"
"16489449","Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors","Kathmann M, Flau K, Redmer A, Tränkle C, Schlicker E.","Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):354-61. doi: 10.1007/s00210-006-0033-x. Epub 2006 Feb 18.","Kathmann M","Naunyn Schmiedebergs Arch Pharmacol","2006","2006/02/21","","","10.1007/s00210-006-0033-x"
"16487509","Systemic and spinal administration of the mu opioid, remifentanil, produces antinociception in amphibians","Mohan S, Stevens CW.","Eur J Pharmacol. 2006 Mar 18;534(1-3):89-94. doi: 10.1016/j.ejphar.2006.01.011. Epub 2006 Feb 17.","Mohan S","Eur J Pharmacol","2006","2006/02/21","PMC3070367","NIHMS280416","10.1016/j.ejphar.2006.01.011"
"16484716","The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol","Berkson BM, Rubin DM, Berkson AJ.","Integr Cancer Ther. 2006 Mar;5(1):83-9. doi: 10.1177/1534735405285901.","Berkson BM","Integr Cancer Ther","2006","2006/02/18","","","10.1177/1534735405285901"
"16483549","Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?","Kiefer F, Jahn H, Otte C, Naber D, Wiedemann K.","Biol Psychiatry. 2006 Jul 1;60(1):74-6. doi: 10.1016/j.biopsych.2005.11.023. Epub 2006 Feb 14.","Kiefer F","Biol Psychiatry","2006","2006/02/18","","","10.1016/j.biopsych.2005.11.023"
"16472918","Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray","De Luca-Vinhas MC, Macedo CE, Brandão ML.","Pain. 2006 Mar;121(1-2):94-104. doi: 10.1016/j.pain.2005.12.008. Epub 2006 Feb 10.","De Luca-Vinhas MC","Pain","2006","2006/02/14","","","10.1016/j.pain.2005.12.008"
"16467406","Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy","Feeney GF, Connor JP, Young RM, Tucker J, McPherson A.","Alcohol Alcohol. 2006 May-Jun;41(3):321-7. doi: 10.1093/alcalc/agl007. Epub 2006 Feb 8.","Feeney GF","Alcohol Alcohol","2006","2006/02/10","","","10.1093/alcalc/agl007"
"16466808","Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens","Chefer VI, Zapata A, Shippenberg TS, Bungay PM.","J Neurosci Methods. 2006 Sep 15;155(2):187-93. doi: 10.1016/j.jneumeth.2005.12.018. Epub 2006 Feb 8.","Chefer VI","J Neurosci Methods","2006","2006/02/10","","","10.1016/j.jneumeth.2005.12.018"
"16465467","Development of a mouse model of ethanol addiction: naltrexone efficacy in reducing consumption but not craving","Fachin-Scheit DJ, Frozino Ribeiro A, Pigatto G, Oliveira Goeldner F, Boerngen de Lacerda R.","J Neural Transm (Vienna). 2006 Sep;113(9):1305-21. doi: 10.1007/s00702-005-0416-z. Epub 2006 Feb 9.","Fachin-Scheit DJ","J Neural Transm (Vienna)","2006","2006/02/09","","","10.1007/s00702-005-0416-z"
"16461865","Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial","Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O'Brien CP.","Arch Gen Psychiatry. 2006 Feb;63(2):210-8. doi: 10.1001/archpsyc.63.2.210.","Comer SD","Arch Gen Psychiatry","2006","2006/02/08","PMC4200530","NIHMS516233","10.1001/archpsyc.63.2.210"
"16455607","In vitro and in vivo release of naltrexone from biodegradable depot systems","Liu Y, Sunderland VB, O'Neil AG.","Drug Dev Ind Pharm. 2006 Jan;32(1):85-94. doi: 10.1080/03639040500388466.","Liu Y","Drug Dev Ind Pharm","2006","2006/02/04","","","10.1080/03639040500388466"
"16449486","Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling","Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A.","Am J Psychiatry. 2006 Feb;163(2):303-12. doi: 10.1176/appi.ajp.163.2.303.","Grant JE","Am J Psychiatry","2006","2006/02/02","","","10.1176/appi.ajp.163.2.303"
"16449466","Pathological gambling: focusing on the addiction, not the activity","Tamminga CA, Nestler EJ.","Am J Psychiatry. 2006 Feb;163(2):180-1. doi: 10.1176/appi.ajp.163.2.180.","Tamminga CA","Am J Psychiatry","2006","2006/02/02","","","10.1176/appi.ajp.163.2.180"
"16449421","Opioid analgesia in persons at risk for hypertension","McCubbin JA, Helfer SG, Switzer FS 3rd, Galloway C, Griffith WV.","Psychosom Med. 2006 Jan-Feb;68(1):116-20. doi: 10.1097/01.psy.0000195742.24850.79.","McCubbin JA","Psychosom Med","2006","2006/02/02","","","10.1097/01.psy.0000195742.24850.79"
"16446067","Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappa-opioid receptors","Shu H, Arita H, Hayashida M, Chiba S, Sekiyama H, Hanaoka K.","J Ethnopharmacol. 2006 Jun 30;106(2):263-71. doi: 10.1016/j.jep.2006.01.004. Epub 2006 Jan 30.","Shu H","J Ethnopharmacol","2006","2006/02/01","","","10.1016/j.jep.2006.01.004"
"16442521","Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects","Jutkiewicz EM, Torregrossa MM, Sobczyk-Kojiro K, Mosberg HI, Folk JE, Rice KC, Watson SJ, Woods JH.","Eur J Pharmacol. 2006 Feb 15;531(1-3):151-9. doi: 10.1016/j.ejphar.2005.12.002. Epub 2006 Jan 25.","Jutkiewicz EM","Eur J Pharmacol","2006","2006/01/31","PMC1828120","NIHMS15858","10.1016/j.ejphar.2005.12.002"
"16437438","Opioid antagonists with minimal sedation for opioid withdrawal","Gowing L, Ali R, White J.","Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002021. doi: 10.1002/14651858.CD002021.pub2.","Gowing L","Cochrane Database Syst Rev","2006","2006/01/27","","","10.1002/14651858.CD002021.pub2"
"16437431","Oral naltrexone maintenance treatment for opioid dependence","Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.","Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001333. doi: 10.1002/14651858.CD001333.pub2.","Minozzi S","Cochrane Database Syst Rev","2006","2006/01/27","","","10.1002/14651858.CD001333.pub2"
"16434091","Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist","McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ.","Pharmacol Biochem Behav. 2006 Jan;83(1):109-13. doi: 10.1016/j.pbb.2005.12.011. Epub 2006 Jan 23.","McCurdy CR","Pharmacol Biochem Behav","2006","2006/01/26","","","10.1016/j.pbb.2005.12.011"
"16427098","Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors","Pisanu A, Acquas E, Fenu S, Di Chiara G.","Neuropharmacology. 2006 May;50(6):661-70. doi: 10.1016/j.neuropharm.2005.11.023. Epub 2006 Jan 19.","Pisanu A","Neuropharmacology","2006","2006/01/24","","","10.1016/j.neuropharm.2005.11.023"
"16425675","Vivitrex (Alkermes/Cephalon)","Heading CE.","Curr Opin Investig Drugs. 2006 Jan;7(1):81-8.","Heading CE","Curr Opin Investig Drugs","2006","2006/01/24","","",""
"16424470","Naltrexone and problems in pain management","Vickers AP, Jolly A.","BMJ. 2006 Jan 21;332(7534):132-3. doi: 10.1136/bmj.332.7534.132.","Vickers AP","BMJ","2006","2006/01/21","PMC1336752","","10.1136/bmj.332.7534.132"
"16422967","Pharmacotherapy for erectile dysfunction","Padma-Nathan H, Christ G, Adaikan G, Becher E, Brock G, Carrier S, Carson C, Corbin J, Francis S, DeBusk R, Eardley I, Hedlund H, Hutter A, Jackson G, Kloner R, Lin CS, McVary K, McCullough A, Nehra A, Porst H, Schulman C, Seftel A, Sharlip I, Stief C, Teloken C.","J Sex Med. 2004 Sep;1(2):128-40. doi: 10.1111/j.1743-6109.2004.04021.x.","Padma-Nathan H","J Sex Med","2004","2006/01/21","","","10.1111/j.1743-6109.2004.04021.x"
"16420432","Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens","Chefer VI, Shippenberg TS.","Eur J Neurosci. 2006 Jan;23(1):229-38. doi: 10.1111/j.1460-9568.2005.04525.x.","Chefer VI","Eur J Neurosci","2006","2006/01/20","","","10.1111/j.1460-9568.2005.04525.x"
"16416546","New alcohol abuse drugs emerging. Anti-craving meds are finally here to treat alcohol dependence, recognized as a disease of the brain","","Health News. 2005 Dec;11(12):6-7.","","Health News","2005","2006/01/19","","",""
"16413146","Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability","Koch AL, Arfken CL, Schuster CR.","Drug Alcohol Depend. 2006 Jul 27;83(3):274-8. doi: 10.1016/j.drugalcdep.2005.12.005. Epub 2006 Jan 18.","Koch AL","Drug Alcohol Depend","2006","2006/01/18","","","10.1016/j.drugalcdep.2005.12.005"
"16409995","Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems","Juni A, Klein G, Kest B.","Brain Res. 2006 Jan 27;1070(1):35-44. doi: 10.1016/j.brainres.2005.11.054. Epub 2006 Jan 10.","Juni A","Brain Res","2006","2006/01/18","","","10.1016/j.brainres.2005.11.054"
"16406668","mu- but not delta- and kappa-opioid receptor mediates the nucleus submedius interferon-alpha-evoked antinociception in the rat","Wang JY, Zeng XY, Fan GX, Yuan YK, Tang JS.","Neurosci Lett. 2006 Apr 24;397(3):254-8. doi: 10.1016/j.neulet.2005.12.046. Epub 2006 Jan 9.","Wang JY","Neurosci Lett","2006","2006/01/13","","","10.1016/j.neulet.2005.12.046"
"16401957","[Safety and effectiveness of opiate antagonist detoxification under general anesthesia]","Ivaskevicius J, Jovaisa T, Laurinenas G, Vosylius S, Sipylaite J, Badaras R.","Medicina (Kaunas). 2005;41(12):1011-8.","Ivaskevicius J","Medicina (Kaunas)","2005","2006/01/13","","",""
"16401652","Naltrexone and buprenorphine combination in the treatment of opioid dependence","Gerra G, Fantoma A, Zaimovic A.","J Psychopharmacol. 2006 Nov;20(6):806-14. doi: 10.1177/0269881106060835. Epub 2006 Jan 9.","Gerra G","J Psychopharmacol","2006","2006/01/13","","","10.1177/0269881106060835"
"16398390","Severe uncontrolled pain in buttock in a patient on naltrexone: a diagnostic challenge","Graham JM, Evans B.","Anaesth Intensive Care. 2005 Dec;33(6):808-11. doi: 10.1177/0310057X0503300618.","Graham JM","Anaesth Intensive Care","2005","2006/01/10","","","10.1177/0310057X0503300618"
"16395307","Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism","Krystal JH, Madonick S, Perry E, Gueorguieva R, Brush L, Wray Y, Belger A, D'Souza DC.","Neuropsychopharmacology. 2006 Aug;31(8):1793-800. doi: 10.1038/sj.npp.1300994. Epub 2006 Jan 4.","Krystal JH","Neuropsychopharmacology","2006","2006/01/06","","","10.1038/sj.npp.1300994"
"16393735","Effects on smoking cessation: naltrexone combined with a cognitive behavioral treatment based on the community reinforcement approach","Roozen HG, Van Beers SE, Weevers HJ, Breteler MH, Willemsen MC, Postmus PE, Kerkhof AJ.","Subst Use Misuse. 2006;41(1):45-60. doi: 10.1080/10826080500318665.","Roozen HG","Subst Use Misuse","2006","2006/01/06","","","10.1080/10826080500318665"
"16390364","Alcoholism and suicidal behavior: a clinical overview","Sher L.","Acta Psychiatr Scand. 2006 Jan;113(1):13-22. doi: 10.1111/j.1600-0447.2005.00643.x.","Sher L","Acta Psychiatr Scand","2006","2006/01/05","","","10.1111/j.1600-0447.2005.00643.x"
"16385558","Elevated mu-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats","Van Bockstaele EJ, Rudoy C, Mannelli P, Oropeza V, Qian Y.","J Neurosci Res. 2006 Feb 15;83(3):508-14. doi: 10.1002/jnr.20738.","Van Bockstaele EJ","J Neurosci Res","2006","2005/12/31","","","10.1002/jnr.20738"
"16382192","Role of opioidergic mechanisms and GABA uptake inhibition in the heroin-induced discriminative stimulus effects in rats","Solecki W, Krówka T, Filip M, Przewłocki R.","Pharmacol Rep. 2005 Nov-Dec;57(6):744-54.","Solecki W","Pharmacol Rep","2005","2005/12/31","","",""
"16379031","Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene","Geer EB, Landman RE, Wardlaw SL, Conwell IM, Freda PU.","Pituitary. 2005;8(2):115-22. doi: 10.1007/s11102-005-5227-6.","Geer EB","Pituitary","2005","2005/12/28","","","10.1007/s11102-005-5227-6"
"16375164","Health for life. Addiction: how to break the chain","Miller MC.","Newsweek. 2005 Dec 12;146(24):58.","Miller MC","Newsweek","2005","2005/12/27","","",""
"16367990","De Jong, Krabbe, Laheij & Van Cauter refuted: evidence-based non-effectiveness can hardly be patient-friendly","de Jong CJ, Laheij RJ, Krabbe PF, van Cauter Victory RM.","Addiction. 2005 Dec;100(12):1884-5. doi: 10.1111/j.1360-0443.2005.01332.x.","de Jong CJ","Addiction","2005","2005/12/22","","","10.1111/j.1360-0443.2005.01332.x"
"16365317","Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series","Daniels DJ, Lenard NR, Etienne CL, Law PY, Roerig SC, Portoghese PS.","Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19208-13. doi: 10.1073/pnas.0506627102. Epub 2005 Dec 19.","Daniels DJ","Proc Natl Acad Sci U S A","2005","2005/12/21","PMC1323165","","10.1073/pnas.0506627102"
"16361086","A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence","Roozen HG, de Waart R, van der Windt DA, van den Brink W, de Jong CA, Kerkhof AJ.","Eur Neuropsychopharmacol. 2006 Jul;16(5):311-23. doi: 10.1016/j.euroneuro.2005.11.001. Epub 2005 Dec 19.","Roozen HG","Eur Neuropsychopharmacol","2006","2005/12/20","","","10.1016/j.euroneuro.2005.11.001"
"16360145","Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice","Sakaguchi M, Koseki M, Wakamatsu M, Matsumura E.","Eur J Pharmacol. 2006 Jan 13;530(1-2):81-7. doi: 10.1016/j.ejphar.2005.11.014. Epub 2005 Dec 15.","Sakaguchi M","Eur J Pharmacol","2006","2005/12/20","","","10.1016/j.ejphar.2005.11.014"
"16353425","Influence of opioids in hypothalamic nuclei on cold thermogenesis of lean and obese LA/N-cp rats","Rodd DW, Loomis JL, Farrell PA.","Obes Res. 1994 May;2(3):246-54. doi: 10.1002/j.1550-8528.1994.tb00054.x.","Rodd DW","Obes Res","1994","1994/05/01","","","10.1002/j.1550-8528.1994.tb00054.x"
"16325734","Evidence-based treatment of geriatric substance abuse","Oslin DW.","Psychiatr Clin North Am. 2005 Dec;28(4):897-911, ix. doi: 10.1016/j.psc.2005.09.005.","Oslin DW","Psychiatr Clin North Am","2005","2005/12/06","","","10.1016/j.psc.2005.09.005"
"16320411","[Antipuritic therapy with naltrexone]","","Hautarzt. 2005 Apr;56(4):312.","","Hautarzt","2005","2005/12/02","","",""
"16318951","Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?","Egli M.","Addict Biol. 2005 Dec;10(4):309-19. doi: 10.1080/13556210500314550.","Egli M","Addict Biol","2005","2005/12/02","","","10.1080/13556210500314550"
"16317112","Involvement of cAMP/cAMP-dependent protein kinase signaling pathway in regulation of Na+,K+-ATPase upon activation of opioid receptors by morphine","Wu ZQ, Li M, Chen J, Chi ZQ, Liu JG.","Mol Pharmacol. 2006 Mar;69(3):866-76. doi: 10.1124/mol.105.016501. Epub 2005 Nov 29.","Wu ZQ","Mol Pharmacol","2006","2005/12/01","","","10.1124/mol.105.016501"
"16316650","A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833","Whiteside GT, Gottshall SL, Boulet JM, Chaffer SM, Harrison JE, Pearson MS, Turchin PI, Mark L, Garrison AE, Valenzano KJ.","Eur J Pharmacol. 2005 Dec 28;528(1-3):65-72. doi: 10.1016/j.ejphar.2005.10.043. Epub 2005 Nov 28.","Whiteside GT","Eur J Pharmacol","2005","2005/12/01","","","10.1016/j.ejphar.2005.10.043"
"16314688","Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice","Omiya Y, Suzuki Y, Yuzurihara M, Murata M, Aburada M, Kase Y, Takeda S.","J Pharmacol Sci. 2005 Dec;99(4):373-80. doi: 10.1254/jphs.fp0050536. Epub 2005 Nov 26.","Omiya Y","J Pharmacol Sci","2005","2005/11/30","","","10.1254/jphs.fp0050536"
"16313958","Dynorphin A (2-13) improves mecamylamine-induced learning impairment accompanied by reversal of reductions in acetylcholine release in rats","Hiramatsu M, Watanabe E.","Neuropeptides. 2006 Feb;40(1):47-56. doi: 10.1016/j.npep.2005.10.003. Epub 2005 Nov 28.","Hiramatsu M","Neuropeptides","2006","2005/11/30","","","10.1016/j.npep.2005.10.003"
"16313098","Involvement of delta1-opioid receptors in the spatial learning impairment in streptozotocin-induced diabetic mice","Kamei J, Miyata S, Takahashi M, Saitoh A.","Nihon Shinkei Seishin Yakurigaku Zasshi. 2005 Oct;25(5):221-5.","Kamei J","Nihon Shinkei Seishin Yakurigaku Zasshi","2005","2005/11/30","","",""
"16305998","In vitro release studies on matrix type transdermal drug delivery systems of naltrexone and its acetyl prodrug","Nalluri BN, Milligan C, Chen J, Crooks PA, Stinchcomb AL.","Drug Dev Ind Pharm. 2005 Oct;31(9):871-7. doi: 10.1080/03639040500271944.","Nalluri BN","Drug Dev Ind Pharm","2005","2005/11/25","","","10.1080/03639040500271944"
"16303583","Stereotypy II: a review of neurobiological interpretations and suggestions for an integration with behavioral methods","Rapp JT, Vollmer TR.","Res Dev Disabil. 2005 Nov-Dec;26(6):548-64. doi: 10.1016/j.ridd.2004.11.006. Epub 2005 Jan 25.","Rapp JT","Res Dev Disabil","2005","2005/11/24","","","10.1016/j.ridd.2004.11.006"
"16300039","Medications for treating alcohol dependence","Williams SH.","Am Fam Physician. 2005 Nov 1;72(9):1775-80.","Williams SH","Am Fam Physician","2005","2005/11/23","","",""
"16292318","Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice","Mendizábal V, Zimmer A, Maldonado R.","Neuropsychopharmacology. 2006 Sep;31(9):1957-66. doi: 10.1038/sj.npp.1300957. Epub 2005 Nov 16.","Mendizábal V","Neuropsychopharmacology","2006","2005/11/18","","","10.1038/sj.npp.1300957"
"16292317","Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice","Kuzmin A, Madjid N, Terenius L, Ogren SO, Bakalkin G.","Neuropsychopharmacology. 2006 Sep;31(9):1928-37. doi: 10.1038/sj.npp.1300959. Epub 2005 Nov 16.","Kuzmin A","Neuropsychopharmacology","2006","2005/11/18","","","10.1038/sj.npp.1300959"
"16289278","Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites","Gackenheimer SL, Suter TM, Pintar JE, Quimby SJ, Wheeler WJ, Mitch CH, Gehlert DR, Statnick MA.","Neuropeptides. 2005 Dec;39(6):559-67. doi: 10.1016/j.npep.2005.09.006. Epub 2005 Nov 9.","Gackenheimer SL","Neuropeptides","2005","2005/11/18","","","10.1016/j.npep.2005.09.006"
"16289028","Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine","Panchal V, Taraschenko OD, Maisonneuve IM, Glick SD.","Eur J Pharmacol. 2005 Nov 21;525(1-3):98-104. doi: 10.1016/j.ejphar.2005.09.060. Epub 2005 Nov 10.","Panchal V","Eur J Pharmacol","2005","2005/11/18","","","10.1016/j.ejphar.2005.09.060"
"16286818","Reduction of Submissive Behavior Model for antidepressant drug activity testing: study using a video-tracking system","Pinhasov A, Crooke J, Rosenthal D, Brenneman D, Malatynska E.","Behav Pharmacol. 2005 Dec;16(8):657-64. doi: 10.1097/00008877-200512000-00009.","Pinhasov A","Behav Pharmacol","2005","2005/11/16","","","10.1097/00008877-200512000-00009"
"16286814","Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse","Fantegrossi WE, Kugle KM, Valdes LJ 3rd, Koreeda M, Woods JH.","Behav Pharmacol. 2005 Dec;16(8):627-33. doi: 10.1097/00008877-200512000-00005.","Fantegrossi WE","Behav Pharmacol","2005","2005/11/16","","","10.1097/00008877-200512000-00005"
"16286810","Ultra-low dose naltrexone enhances cannabinoid-induced antinociception","Paquette J, Olmstead MC.","Behav Pharmacol. 2005 Dec;16(8):597-603. doi: 10.1097/00008877-200512000-00001.","Paquette J","Behav Pharmacol","2005","2005/11/16","","","10.1097/00008877-200512000-00001"
"16283255","Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia","Baamonde A, Lastra A, Juárez L, García V, Hidalgo A, Menéndez L.","Naunyn Schmiedebergs Arch Pharmacol. 2005 Nov;372(3):213-9. doi: 10.1007/s00210-005-0013-6. Epub 2005 Nov 8.","Baamonde A","Naunyn Schmiedebergs Arch Pharmacol","2005","2005/11/12","","","10.1007/s00210-005-0013-6"
"16282845","Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study","Dannon PN, Lowengrub K, Musin E, Gonopolski Y, Kotler M.","J Clin Psychopharmacol. 2005 Dec;25(6):593-6. doi: 10.1097/01.jcp.0000186867.90289.ed.","Dannon PN","J Clin Psychopharmacol","2005","2005/11/12","","","10.1097/01.jcp.0000186867.90289.ed"
"16282090","Pharmacotherapy of alcohol use disorders","Buonopane A, Petrakis IL.","Subst Use Misuse. 2005;40(13-14):2001-20, 2043-8. doi: 10.1080/10826080500294890.","Buonopane A","Subst Use Misuse","2005","2005/11/12","","","10.1080/10826080500294890"
"16282089","Pharmacotherapy treatment in substance-dependent correctional populations: a review","Cropsey KL, Villalobos GC, St Clair CL.","Subst Use Misuse. 2005;40(13-14):1983-99, 2043-8. doi: 10.1080/10826080500294866.","Cropsey KL","Subst Use Misuse","2005","2005/11/12","","","10.1080/10826080500294866"
"16277635","General anaesthesia is patient-friendly in opioid antagonist detoxification treatment","De Jong CJ.","Addiction. 2005 Nov;100(11):1742-4. doi: 10.1111/j.1360-0443.2005.01267.x.","De Jong CJ","Addiction","2005","2005/11/10","","","10.1111/j.1360-0443.2005.01267.x"
"16268664","Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders","Malone RP, Gratz SS, Delaney MA, Hyman SB.","CNS Drugs. 2005;19(11):923-34. doi: 10.2165/00023210-200519110-00003.","Malone RP","CNS Drugs","2005","2005/11/05","","","10.2165/00023210-200519110-00003"
"16262589","Naltrexone treatment of adolescent alcoholics: an open-label pilot study","Deas D, May MP, Randall C, Johnson N, Anton R.","J Child Adolesc Psychopharmacol. 2005 Oct;15(5):723-8. doi: 10.1089/cap.2005.15.723.","Deas D","J Child Adolesc Psychopharmacol","2005","2005/11/03","","","10.1089/cap.2005.15.723"
"16258020","Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey","Ko MC, Divin MF, Lee H, Woods JH, Traynor JR.","J Pharmacol Exp Ther. 2006 Feb;316(2):772-9. doi: 10.1124/jpet.105.094409. Epub 2005 Oct 28.","Ko MC","J Pharmacol Exp Ther","2006","2005/11/01","","","10.1124/jpet.105.094409"
"16257886","New-onset mania and psychosis following heroin detoxification and naltrexone maintenance","Sullivan MA, Nunes EV.","Am J Addict. 2005 Oct-Dec;14(5):486-7. doi: 10.1080/10550490500247230.","Sullivan MA","Am J Addict","2005","2005/11/01","","","10.1080/10550490500247230"
"16257420","The dynamic relationship between mu and kappa opioid receptors in body temperature regulation","Chen X, McClatchy DB, Geller EB, Tallarida RJ, Adler MW.","Life Sci. 2005 Dec 12;78(4):329-33. doi: 10.1016/j.lfs.2005.04.084. Epub 2005 Oct 28.","Chen X","Life Sci","2005","2005/11/01","","","10.1016/j.lfs.2005.04.084"
"16256106","Antinociceptive effect of oxycodone in diabetic mice","Nozaki C, Saitoh A, Tamura N, Kamei J.","Eur J Pharmacol. 2005 Nov 7;524(1-3):75-9. doi: 10.1016/j.ejphar.2005.09.051. Epub 2005 Oct 25.","Nozaki C","Eur J Pharmacol","2005","2005/11/01","","","10.1016/j.ejphar.2005.09.051"
"16254488","Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats","Sgambato-Faure V, Buggia V, Gilbert F, Lévesque D, Benabid AL, Berger F.","J Neuropathol Exp Neurol. 2005 Nov;64(11):936-47. doi: 10.1097/01.jnen.0000186922.42592.b7.","Sgambato-Faure V","J Neuropathol Exp Neurol","2005","2005/10/29","","","10.1097/01.jnen.0000186922.42592.b7"
"16251241","Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies","Wikström B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y.","J Am Soc Nephrol. 2005 Dec;16(12):3742-7. doi: 10.1681/ASN.2005020152. Epub 2005 Oct 26.","Wikström B","J Am Soc Nephrol","2005","2005/10/28","","","10.1681/ASN.2005020152"
"16247334","Subclass opioid receptors associated with the cardiovascular depression after traumatic shock and the antishock effects of its specific receptor antagonists","Liu LM, Hu DY, Pan XK, Lu RQ, Dan FJ.","Shock. 2005 Nov;24(5):470-5. doi: 10.1097/01.shk.0000183432.17092.34.","Liu LM","Shock","2005","2005/10/26","","","10.1097/01.shk.0000183432.17092.34"
"16239359","Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment","Turncliff RZ, Dunbar JL, Dong Q, Silverman BL, Ehrich EW, Dilzer SC, Lasseter KC.","J Clin Pharmacol. 2005 Nov;45(11):1259-67. doi: 10.1177/0091270005280199.","Turncliff RZ","J Clin Pharmacol","2005","2005/10/22","","","10.1177/0091270005280199"
"16237389","The role of opioid receptor subtypes in the development of behavioral sensitization to ethanol","Pastor R, Aragon CM.","Neuropsychopharmacology. 2006 Jul;31(7):1489-99. doi: 10.1038/sj.npp.1300928. Epub 2005 Oct 12.","Pastor R","Neuropsychopharmacology","2006","2005/10/21","","","10.1038/sj.npp.1300928"
"16236028","High-frequency, but not low-frequency, transcutaneous electrical nerve stimulation reduces aspartate and glutamate release in the spinal cord dorsal horn","Sluka KA, Vance CG, Lisi TL.","J Neurochem. 2005 Dec;95(6):1794-801. doi: 10.1111/j.1471-4159.2005.03511.x. Epub 2005 Oct 17.","Sluka KA","J Neurochem","2005","2005/10/21","","","10.1111/j.1471-4159.2005.03511.x"
"16226248","Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats","Ebrahimi F, Tavakoli S, Hajrasouliha AR, Shafaroodi H, Sadeghipour H, Riazi K, Borhani AA, Houshmand G, Ahmadi SH, Dehpour AR.","Eur J Pharmacol. 2005 Oct 31;523(1-3):93-100. doi: 10.1016/j.ejphar.2005.08.057. Epub 2005 Oct 13.","Ebrahimi F","Eur J Pharmacol","2005","2005/10/18","","","10.1016/j.ejphar.2005.08.057"
"16223067","The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field","Johnson BA, Ait-Daoud N, Roache JD.","J Stud Alcohol Suppl. 2005 Jul;(15):157-67; discussion 140. doi: 10.15288/jsas.2005.s15.157.","Johnson BA","J Stud Alcohol Suppl","2005","2005/10/15","","","10.15288/jsas.2005.s15.157"
"16223066","Rationale for combining acamprosate and naltrexone for treating alcohol dependence","Mason BJ.","J Stud Alcohol Suppl. 2005 Jul;(15):148-56; discussion 140. doi: 10.15288/jsas.2005.s15.148.","Mason BJ","J Stud Alcohol Suppl","2005","2005/10/15","","","10.15288/jsas.2005.s15.148"
"16223065","Choosing pharmacotherapies for the COMBINE Study--process and procedures: an investigational approach to combination pharmacotherapy for the treatment of alcohol dependence","Swift R, Pettinati HM.","J Stud Alcohol Suppl. 2005 Jul;(15):141-7; discussion 140. doi: 10.15288/jsas.2005.s15.141.","Swift R","J Stud Alcohol Suppl","2005","2005/10/15","","","10.15288/jsas.2005.s15.141"
"16223058","How pilot studies improve large-scale clinical trials: lessons learned from the COMBINE Study","O'Malley SS, Martin DJ, Hosking JD, Mason BJ.","J Stud Alcohol Suppl. 2005 Jul;(15):66-71; discussion 65. doi: 10.15288/jsas.2005.s15.66.","O'Malley SS","J Stud Alcohol Suppl","2005","2005/10/15","","","10.15288/jsas.2005.s15.66"
"16223057","COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms","Goldman D, Oroszi G, O'Malley S, Anton R.","J Stud Alcohol Suppl. 2005 Jul;(15):56-64; discussion 33. doi: 10.15288/jsas.2005.s15.56.","Goldman D","J Stud Alcohol Suppl","2005","2005/10/15","","","10.15288/jsas.2005.s15.56"
"16223051","Combining treatments for alcoholism: why and how?","Mattson ME, Litten RZ.","J Stud Alcohol Suppl. 2005 Jul;(15):8-16; discussion 6-7. doi: 10.15288/jsas.2005.s15.8.","Mattson ME","J Stud Alcohol Suppl","2005","2005/10/15","","","10.15288/jsas.2005.s15.8"
"16216499","Affinity identification of delta-opioid receptors using latex nanoparticles","Hasegawa M, Ohno H, Tanaka H, Hatakeyama M, Kawaguchi H, Takahashi T, Handa H.","Bioorg Med Chem Lett. 2006 Jan 1;16(1):158-61. doi: 10.1016/j.bmcl.2005.09.028. Epub 2005 Oct 10.","Hasegawa M","Bioorg Med Chem Lett","2006","2005/10/12","","","10.1016/j.bmcl.2005.09.028"
"16216149","Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence","O'Brien CP.","Curr Psychiatry Rep. 2005 Oct;7(5):327-8. doi: 10.1007/s11920-005-0031-6.","O'Brien CP","Curr Psychiatry Rep","2005","2005/10/12","","","10.1007/s11920-005-0031-6"
"16210602","Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism","Greeneltch KM, Kelly-Welch AE, Shi Y, Keegan AD.","J Immunol. 2005 Oct 15;175(8):4999-5005. doi: 10.4049/jimmunol.175.8.4999.","Greeneltch KM","J Immunol","2005","2005/10/08","","","10.4049/jimmunol.175.8.4999"
"16204962","Pharmacological study on the novel antinociceptive agent, a novel monoterpene alkaloid from Incarvillea sinensis","Chi YM, Nakamura M, Yoshizawa T, Zhao XY, Yan WM, Hashimoto F, Kinjo J, Nohara T, Sakurada S.","Biol Pharm Bull. 2005 Oct;28(10):1989-91. doi: 10.1248/bpb.28.1989.","Chi YM","Biol Pharm Bull","2005","2005/10/06","","","10.1248/bpb.28.1989"
"16203962","Adolescent opioid abuse","O'Brien CP.","Arch Gen Psychiatry. 2005 Oct;62(10):1165. doi: 10.1001/archpsyc.62.10.1165.","O'Brien CP","Arch Gen Psychiatry","2005","2005/10/06","","","10.1001/archpsyc.62.10.1165"
"16202615","Molecular modeling and 3D-QSAR studies of indolomorphinan derivatives as kappa opioid antagonists","Li W, Tang Y, Zheng YL, Qiu ZB.","Bioorg Med Chem. 2006 Feb 1;14(3):601-10. doi: 10.1016/j.bmc.2005.08.052. Epub 2005 Oct 3.","Li W","Bioorg Med Chem","2006","2005/10/06","","","10.1016/j.bmc.2005.08.052"
"16201030","Naltrexone implants as treatment for heroin dependence: part II","Wodak A, Graham R.","Addict Biol. 2005 Jun;10(2):202; author reply 202-4. doi: 10.1111/j.1369-1600.2005.tb00270.x.","Wodak A","Addict Biol","2005","2005/10/05","","","10.1111/j.1369-1600.2005.tb00270.x"
"16200660","Structural determination of the novel fragmentation routes of morphine opiate receptor antagonists using electrospray ionization quadrupole time-of-flight tandem mass spectrometry","Joly N, El Aneed A, Martin P, Cecchelli R, Banoub J.","Rapid Commun Mass Spectrom. 2005;19(21):3119-30. doi: 10.1002/rcm.2179.","Joly N","Rapid Commun Mass Spectrom","2005","2005/10/04","","","10.1002/rcm.2179"
"16198154","Differential effects of morphine and naltrexone on the in vitro LH secretion from male and female carp pituitary gland","Sokolowska-Mikolajczyk M, Socha M, Mikolajczyk T, Chyb J, Szymacha J, Epler P.","Comp Biochem Physiol C Toxicol Pharmacol. 2005 Aug;141(4):325-31. doi: 10.1016/j.cbpc.2005.09.001. Epub 2005 Sep 28.","Sokolowska-Mikolajczyk M","Comp Biochem Physiol C Toxicol Pharmacol","2005","2005/10/04","","","10.1016/j.cbpc.2005.09.001"
"16195116","An open clinical trial of naltrexone for amphetamine dependence: compliance and tolerability","Jayaram-Lindström N, Wennberg P, Beck O, Franck J.","Nord J Psychiatry. 2005;59(3):167-71. doi: 10.1080/08039480510023052.","Jayaram-Lindström N","Nord J Psychiatry","2005","2005/10/01","","","10.1080/08039480510023052"
"16193562","Drug treatment for alcoholism today","","Harv Ment Health Lett. 2005 Jul;22(1):3-5.","","Harv Ment Health Lett","2005","2005/10/01","","",""
"16191674","Naltrexone implants as treatment for heroin dependence: part I","Byrne A, Graham G, Hallinan R, Murnion B.","Addict Biol. 2005 Jun;10(2):201; author reply 201-2. doi: 10.1080/13556210500155789.","Byrne A","Addict Biol","2005","2005/09/30","","","10.1080/13556210500155789"
"16191664","Constitutive opioid receptor activation: a prerequisite mechanism involved in acute opioid withdrawal","Freye E, Levy J.","Addict Biol. 2005 Jun;10(2):131-7. doi: 10.1080/13556210500123019.","Freye E","Addict Biol","2005","2005/09/30","","","10.1080/13556210500123019"
"16191203","An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons","Luo MC, Zhang DQ, Ma SW, Huang YY, Shuster SJ, Porreca F, Lai J.","Mol Pain. 2005 Sep 28;1:29. doi: 10.1186/1744-8069-1-29.","Luo MC","Mol Pain","2005","2005/09/30","PMC1253531","","10.1186/1744-8069-1-29"
"16188952","ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects","Watson MJ, Holt JD, O'Neill SJ, Wei K, Pendergast W, Gross GJ, Gengo PJ, Chang KJ.","J Pharmacol Exp Ther. 2006 Jan;316(1):423-30. doi: 10.1124/jpet.105.092742. Epub 2005 Sep 27.","Watson MJ","J Pharmacol Exp Ther","2006","2005/09/29","","","10.1124/jpet.105.092742"
"16188718","Clinical characterization of use of acamprosate and naltrexone: data from an addiction center in India","Basu D, Jhirwal OP, Mattoo SK.","Am J Addict. 2005 Jul-Sep;14(4):381-95. doi: 10.1080/10550490591006933.","Basu D","Am J Addict","2005","2005/09/29","","","10.1080/10550490591006933"
"16187808","Do daily interactive voice response reports of smoking behavior correspond with retrospective reports?","Toll BA, Cooney NL, McKee SA, O'Malley SS.","Psychol Addict Behav. 2005 Sep;19(3):291-5. doi: 10.1037/0893-164X.19.3.291.","Toll BA","Psychol Addict Behav","2005","2005/09/29","PMC2527779","NIHMS52636","10.1037/0893-164X.19.3.291"
"16183224","Pain-relieving effects of processed Aconiti tuber in CCI-neuropathic rats","Xu H, Arita H, Hayashida M, Zhang L, Sekiyama H, Hanaoka K.","J Ethnopharmacol. 2006 Feb 20;103(3):392-7. doi: 10.1016/j.jep.2005.08.050. Epub 2005 Sep 23.","Xu H","J Ethnopharmacol","2006","2005/09/27","","","10.1016/j.jep.2005.08.050"
"16182352","Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats","Leri F, Burns LH.","Pharmacol Biochem Behav. 2005 Oct;82(2):252-62. doi: 10.1016/j.pbb.2005.08.008. Epub 2005 Sep 21.","Leri F","Pharmacol Biochem Behav","2005","2005/09/27","","","10.1016/j.pbb.2005.08.008"
"16169076","Opioids and differentiation in human cancer cells","Zagon IS, McLaughlin PJ.","Neuropeptides. 2005 Oct;39(5):495-505. doi: 10.1016/j.npep.2005.07.001. Epub 2005 Sep 15.","Zagon IS","Neuropeptides","2005","2005/09/20","","","10.1016/j.npep.2005.07.001"
"16169018","Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa","Matsumoto K, Horie S, Takayama H, Ishikawa H, Aimi N, Ponglux D, Murayama T, Watanabe K.","Life Sci. 2005 Nov 19;78(1):2-7. doi: 10.1016/j.lfs.2004.10.086. Epub 2005 Sep 15.","Matsumoto K","Life Sci","2005","2005/09/20","","","10.1016/j.lfs.2004.10.086"
"16168488","Delta opioid agonists attenuate TAT(1-72)-induced oxidative stress in SK-N-SH cells","Wallace DR, Dodson SL, Nath A, Booze RM.","Neurotoxicology. 2006 Jan;27(1):101-7. doi: 10.1016/j.neuro.2005.07.008. Epub 2005 Sep 15.","Wallace DR","Neurotoxicology","2006","2005/09/20","","","10.1016/j.neuro.2005.07.008"
"16166181","Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats","Perfumi M, Mattioli L, Cucculelli M, Massi M.","J Psychopharmacol. 2005 Sep;19(5):448-54. doi: 10.1177/0269881105056519.","Perfumi M","J Psychopharmacol","2005","2005/09/17","","","10.1177/0269881105056519"
"16163520","Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats","Jutkiewicz EM, Rice KC, Traynor JR, Woods JH.","Psychopharmacology (Berl). 2005 Nov;182(4):588-96. doi: 10.1007/s00213-005-0138-9. Epub 2005 Oct 19.","Jutkiewicz EM","Psychopharmacology (Berl)","2005","2005/09/16","PMC1307499","NIHMS5901","10.1007/s00213-005-0138-9"
"16156050","Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry","Johnson BA, Mann K, Willenbring ML, Litten RZ, Swift RM, Lesch OM, Berglund M.","Alcohol Clin Exp Res. 2005 Aug;29(8):1528-40. doi: 10.1097/01.alc.0000174690.63787.fc.","Johnson BA","Alcohol Clin Exp Res","2005","2005/09/13","","","10.1097/01.alc.0000174690.63787.fc"
"16154223","Histological changes over time around the site of sustained release naltrexone-poly(DL-lactide) implants in humans","Hulse GK, Stalenberg V, McCallum D, Smit W, O'neil G, Morris N, Tait RJ.","J Control Release. 2005 Nov 2;108(1):43-55. doi: 10.1016/j.jconrel.2005.08.001. Epub 2005 Sep 9.","Hulse GK","J Control Release","2005","2005/09/13","","","10.1016/j.jconrel.2005.08.001"
"16142766","Letter to the editor concerning Lai's letter on ""Radial arm maze performance of rats following repeated low level microwave radiation exposure"" [Bioelectromagnetics 25:49-57 (2004)]","R Jauchem J.","Bioelectromagnetics. 2005 Oct;26(7):525; author reply 528. doi: 10.1002/bem.20163.","R Jauchem J","Bioelectromagnetics","2005","2005/09/06","","","10.1002/bem.20163"
"16142764","Letter to the editor concerning ""Radial arm maze performance of rats following repeated low-level microwave radiation exposure"" by Cobb et al. [BEMS, 2004, 25:49-57] and ""letter to the editor"" by Lai [BEMS, 2005, 26:81]","Cassel JC.","Bioelectromagnetics. 2005 Oct;26(7):526-7; author reply 528. doi: 10.1002/bem.20162.","Cassel JC","Bioelectromagnetics","2005","2005/09/06","","","10.1002/bem.20162"
"16140168","Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone","Chiu CT, Ma T, Ho IK.","Brain Res Bull. 2005 Sep 30;67(1-2):100-9. doi: 10.1016/j.brainresbull.2005.05.028.","Chiu CT","Brain Res Bull","2005","2005/09/06","PMC3138078","NIHMS304632","10.1016/j.brainresbull.2005.05.028"
"16135386","Opioid receptors modulate recovery from consummatory successive negative contrast","Pellegrini S, Wood M, Daniel AM, Papini MR.","Behav Brain Res. 2005 Nov 7;164(2):239-49. doi: 10.1016/j.bbr.2005.06.035.","Pellegrini S","Behav Brain Res","2005","2005/09/02","","","10.1016/j.bbr.2005.06.035"
"16135369","delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway","Pacheco DF, Reis GM, Francischi JN, Castro MS, Perez AC, Duarte ID.","Life Sci. 2005 Nov 19;78(1):54-60. doi: 10.1016/j.lfs.2005.04.032. Epub 2005 Aug 29.","Pacheco DF","Life Sci","2005","2005/09/02","","","10.1016/j.lfs.2005.04.032"
"16133139","Habituation to test procedure modulates the involvement of dopamine D2- but not D1-receptors in ethanol-induced locomotor stimulation in mice","Pastor R, Miquel M, Aragon CM.","Psychopharmacology (Berl). 2005 Nov;182(3):436-46. doi: 10.1007/s00213-005-0115-3. Epub 2005 Oct 19.","Pastor R","Psychopharmacology (Berl)","2005","2005/09/01","","","10.1007/s00213-005-0115-3"
"16132108","Attenuation of post-ischemia reperfusion injury by thaliporphine and morphine in rat hearts","Chang WL, Lee SS, Su MJ.","J Biomed Sci. 2005;12(4):611-9. doi: 10.1007/s11373-005-7401-2. Epub 2005 Nov 10.","Chang WL","J Biomed Sci","2005","2005/09/01","","","10.1007/s11373-005-7401-2"
"16125682","Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors","Hiramatsu M, Hoshino T.","Brain Res. 2005 Sep 28;1057(1-2):72-80. doi: 10.1016/j.brainres.2005.07.028.","Hiramatsu M","Brain Res","2005","2005/08/30","","","10.1016/j.brainres.2005.07.028"
"16123756","Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala","Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T.","Neuropsychopharmacology. 2006 Apr;31(4):739-50. doi: 10.1038/sj.npp.1300858.","Narita M","Neuropsychopharmacology","2006","2005/08/27","","","10.1038/sj.npp.1300858"
"16123750","Microinjection of naltrexone into the central, but not the basolateral, amygdala blocks the anxiolytic effects of diazepam in the plus maze","Burghardt PR, Wilson MA.","Neuropsychopharmacology. 2006 Jun;31(6):1227-40. doi: 10.1038/sj.npp.1300864.","Burghardt PR","Neuropsychopharmacology","2006","2005/08/27","PMC2678962","NIHMS107289","10.1038/sj.npp.1300864"
"16123746","Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system","McLaughlin JP, Li S, Valdez J, Chavkin TA, Chavkin C.","Neuropsychopharmacology. 2006 Jun;31(6):1241-8. doi: 10.1038/sj.npp.1300872.","McLaughlin JP","Neuropsychopharmacology","2006","2005/08/27","PMC2096774","NIHMS34349","10.1038/sj.npp.1300872"
"16122731","Barium potentiates the conditioned aversion to, but not the somatic signs of, morphine withdrawal in mice","Sato M, Wada K, Funada M.","Eur J Pharmacol. 2005 Sep 20;519(3):215-22. doi: 10.1016/j.ejphar.2005.06.033.","Sato M","Eur J Pharmacol","2005","2005/08/27","","","10.1016/j.ejphar.2005.06.033"
"16118388","Methods of detoxification and their role in treating patients with opioid dependence","O'Connor PG.","JAMA. 2005 Aug 24;294(8):961-3. doi: 10.1001/jama.294.8.961.","O'Connor PG","JAMA","2005","2005/08/25","","","10.1001/jama.294.8.961"
"16118380","Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial","Collins ED, Kleber HD, Whittington RA, Heitler NE.","JAMA. 2005 Aug 24;294(8):903-13. doi: 10.1001/jama.294.8.903.","Collins ED","JAMA","2005","2005/08/25","","","10.1001/jama.294.8.903"
"16118379","Naltrexone treatment for alcohol dependency","Ameisen O.","JAMA. 2005 Aug 24;294(8):899-900; author reply 900. doi: 10.1001/jama.294.8.899-b.","Ameisen O","JAMA","2005","2005/08/25","","","10.1001/jama.294.8.899-b"
"16112476","Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors","Nieto MM, Guen SL, Kieffer BL, Roques BP, Noble F.","Neuroscience. 2005;135(2):305-13. doi: 10.1016/j.neuroscience.2005.06.025.","Nieto MM","Neuroscience","2005","2005/08/23","","","10.1016/j.neuroscience.2005.06.025"
"16111831","Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens","Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.","Neuroscience. 2005;135(1):213-25. doi: 10.1016/j.neuroscience.2005.03.065.","Hirose N","Neuroscience","2005","2005/08/23","","","10.1016/j.neuroscience.2005.03.065"
"16109592","A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan","Huang MC, Chen CH, Yu JM, Chen CC.","Addict Biol. 2005 Sep;10(3):289-92. doi: 10.1080/13556210500223504.","Huang MC","Addict Biol","2005","2005/08/20","","","10.1080/13556210500223504"
"16098996","Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model","Ammon-Treiber S, Stolze D, Schröder H, Loh H, Höllt V.","Neuropharmacology. 2005 Dec;49(8):1160-9. doi: 10.1016/j.neuropharm.2005.06.016. Epub 2005 Aug 11.","Ammon-Treiber S","Neuropharmacology","2005","2005/08/16","","","10.1016/j.neuropharm.2005.06.016"
"16095820","Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke","Simons CT, Cuellar JM, Moore JA, Pinkerton KE, Uyeminami D, Carstens MI, Carstens E.","Neurosci Lett. 2005 Dec 2;389(2):71-6. doi: 10.1016/j.neulet.2005.07.025.","Simons CT","Neurosci Lett","2005","2005/08/13","","","10.1016/j.neulet.2005.07.025"
"16088999","Suppression of the HPA axis stress-response: implications for relapse","Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S.","Alcohol Clin Exp Res. 2005 Jul;29(7):1351-5. doi: 10.1097/01.alc.0000176356.97620.84.","Adinoff B","Alcohol Clin Exp Res","2005","2005/08/10","PMC2584966","NIHMS77882","10.1097/01.alc.0000176356.97620.84"
"16084660","Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats","Lane DA, Patel PA, Morgan MM.","Neuroscience. 2005;135(1):227-34. doi: 10.1016/j.neuroscience.2005.06.014.","Lane DA","Neuroscience","2005","2005/08/09","","","10.1016/j.neuroscience.2005.06.014"
"16075288","Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats","Saitoh A, Yoshikawa Y, Onodera K, Kamei J.","Psychopharmacology (Berl). 2005 Nov;182(3):327-34. doi: 10.1007/s00213-005-0112-6. Epub 2005 Oct 19.","Saitoh A","Psychopharmacology (Berl)","2005","2005/08/03","","","10.1007/s00213-005-0112-6"
"16055763","Anticraving medications for relapse prevention: a possible new class of psychoactive medications","O'Brien CP.","Am J Psychiatry. 2005 Aug;162(8):1423-31. doi: 10.1176/appi.ajp.162.8.1423.","O'Brien CP","Am J Psychiatry","2005","2005/08/02","","","10.1176/appi.ajp.162.8.1423"
"16055114","Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride","Umeuchi H, Kawashima Y, Aoki CA, Kurokawa T, Nakao K, Itoh M, Kikuchi K, Kato T, Okano K, Gershwin ME, Miyakawa H.","Eur J Pharmacol. 2005 Aug 22;518(2-3):133-9. doi: 10.1016/j.ejphar.2005.06.019.","Umeuchi H","Eur J Pharmacol","2005","2005/08/02","","","10.1016/j.ejphar.2005.06.019"
"16053424","Riluzole: a glimmer of hope in the treatment of motor neurone disease","Henderson RD, McCombe PA.","Med J Aust. 2005 Aug 1;183(3):164; author reply 164-5.","Henderson RD","Med J Aust","2005","2005/08/02","","",""
"16052561","Transdermal delivery of naltrexone and its active metabolite 6-beta-naltrexol in human skin in vitro and guinea pigs in vivo","Paudel KS, Nalluri BN, Hammell DC, Valiveti S, Kiptoo P, Hamad MO, Crooks PA, Stinchcomb AL.","J Pharm Sci. 2005 Sep;94(9):1965-75. doi: 10.1002/jps.20398.","Paudel KS","J Pharm Sci","2005","2005/07/30","","","10.1002/jps.20398"
"16052110","In vitro electrophysiologic effects of morphine in rabbit ventricular myocytes","Xiao GS, Zhou JJ, Wang GY, Cao CM, Li GR, Wong TM.","Anesthesiology. 2005 Aug;103(2):280-6. doi: 10.1097/00000542-200508000-00011.","Xiao GS","Anesthesiology","2005","2005/07/30","","","10.1097/00000542-200508000-00011"
"16046046","A new approach to preventing relapse in opiate addicts: a psychometric evaluation","Grüsser SM, Thalemann CN, Platz W, Gölz J, Partecke G.","Biol Psychol. 2006 Mar;71(3):231-5. doi: 10.1016/j.biopsycho.2005.06.005. Epub 2005 Jul 19.","Grüsser SM","Biol Psychol","2006","2005/07/28","","","10.1016/j.biopsycho.2005.06.005"
"16028621","In vitro evaluation of the effect of the opioid antagonist N-methylnaltrexone on motility of the equine jejunum and pelvic flexure","van Hoogmoed LM, Boscan PL.","Equine Vet J. 2005 Jul;37(4):325-8. doi: 10.2746/0425164054529346.","van Hoogmoed LM","Equine Vet J","2005","2005/07/21","","","10.2746/0425164054529346"
"16026468","Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation","Jabourian M, Venance L, Bourgoin S, Ozon S, Pérez S, Godeheu G, Glowinski J, Kemel ML.","Eur J Neurosci. 2005 Jun;21(12):3301-9. doi: 10.1111/j.1460-9568.2005.04154.x.","Jabourian M","Eur J Neurosci","2005","2005/07/20","","","10.1111/j.1460-9568.2005.04154.x"
"16025425","A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment","Kiefer F, Jahn H, Wiedemann K.","Pharmacopsychiatry. 2005 Jul;38(4):184-6. doi: 10.1055/s-2005-871244.","Kiefer F","Pharmacopsychiatry","2005","2005/07/19","","","10.1055/s-2005-871244"
"16025314","Systemic and intra-accumbens microinjections of naltrexone interfere with tolerance to ethanol in rats","Varaschin RK, Wazlawik E, Morato GS.","Psychopharmacology (Berl). 2005 Nov;182(3):366-74. doi: 10.1007/s00213-005-0095-3. Epub 2005 Oct 19.","Varaschin RK","Psychopharmacology (Berl)","2005","2005/07/19","","","10.1007/s00213-005-0095-3"
"16024184","Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: a randomised clinical trial","Favrat B, Zimmermann G, Zullino D, Krenz S, Dorogy F, Muller J, Zwahlen A, Broers B, Besson J.","Drug Alcohol Depend. 2006 Feb 1;81(2):109-16. doi: 10.1016/j.drugalcdep.2005.06.003. Epub 2005 Jul 15.","Favrat B","Drug Alcohol Depend","2006","2005/07/19","","","10.1016/j.drugalcdep.2005.06.003"
"16023251","Cholestatic liver disease modulates susceptibility to ischemia/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: the role of endogenous opioid peptides","Hajrasouliha AR, Tavakoli S, Jabehdar-Maralani P, Ebrahimi F, Shafaroodi H, Mirkhani SH, Amanpour S, Dehpour AR.","J Hepatol. 2005 Sep;43(3):491-8. doi: 10.1016/j.jhep.2005.02.043.","Hajrasouliha AR","J Hepatol","2005","2005/07/19","","","10.1016/j.jhep.2005.02.043"
"16020629","DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats","Holt JD, Watson MJ, Chang JP, O'Neill SJ, Wei K, Pendergast W, Gengo PJ, Chang KJ.","J Pharmacol Exp Ther. 2005 Nov;315(2):601-8. doi: 10.1124/jpet.105.090498. Epub 2005 Jul 14.","Holt JD","J Pharmacol Exp Ther","2005","2005/07/16","","","10.1124/jpet.105.090498"
"16019900","Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique","Dinarvand R, Moghadam SH, Sheikhi A, Atyabi F.","J Microencapsul. 2005 Mar;22(2):139-51. doi: 10.1080/02652040400026392.","Dinarvand R","J Microencapsul","2005","2005/07/16","","","10.1080/02652040400026392"
"16012278","Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence","Anton RF, Moak DH, Latham P, Waid LR, Myrick H, Voronin K, Thevos A, Wang W, Woolson R.","J Clin Psychopharmacol. 2005 Aug;25(4):349-57. doi: 10.1097/01.jcp.0000172071.81258.04.","Anton RF","J Clin Psychopharmacol","2005","2005/07/14","","","10.1097/01.jcp.0000172071.81258.04"
"16010543","Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats","Olmstead MC, Burns LH.","Psychopharmacology (Berl). 2005 Sep;181(3):576-81. doi: 10.1007/s00213-005-0022-7. Epub 2005 Oct 12.","Olmstead MC","Psychopharmacology (Berl)","2005","2005/07/13","","","10.1007/s00213-005-0022-7"
"16006595","Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells","Xie Z, Bhushan RG, Daniels DJ, Portoghese PS.","Mol Pharmacol. 2005 Oct;68(4):1079-86. doi: 10.1124/mol.105.012070. Epub 2005 Jul 8.","Xie Z","Mol Pharmacol","2005","2005/07/12","","","10.1124/mol.105.012070"
"16001119","A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats","Mitchell JM, Liang MT, Fields HL.","Psychopharmacology (Berl). 2005 Nov;182(3):384-92. doi: 10.1007/s00213-005-0067-7. Epub 2005 Oct 19.","Mitchell JM","Psychopharmacology (Berl)","2005","2005/07/08","","","10.1007/s00213-005-0067-7"
"16001107","Unexpected placebo response in premenstrual dysphoric disorder: implication of endogenous opioids","Van Ree JM, Schagen Van Leeuwen JH, Koppeschaar HP, Te Velde ER.","Psychopharmacology (Berl). 2005 Oct;182(2):318-9. doi: 10.1007/s00213-005-0090-8. Epub 2005 Oct 19.","Van Ree JM","Psychopharmacology (Berl)","2005","2005/07/08","","","10.1007/s00213-005-0090-8"
"16000393","Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells","Wang X, Tan N, Douglas SD, Zhang T, Wang YJ, Ho WZ.","J Leukoc Biol. 2005 Sep;78(3):772-6. doi: 10.1189/jlb.0305167. Epub 2005 Jul 6.","Wang X","J Leukoc Biol","2005","2005/07/08","","","10.1189/jlb.0305167"
"15996565","Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys","Samadi P, Grégoire L, Hadj Tahar A, Di Paolo T, Rouillard C, Bédard PJ.","Neuropharmacology. 2005 Aug;49(2):165-73. doi: 10.1016/j.neuropharm.2005.02.009. Epub 2005 Mar 29.","Samadi P","Neuropharmacology","2005","2005/07/06","","","10.1016/j.neuropharm.2005.02.009"
"15992564","Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism","Kiefer F, Jahn H, Otte C, Demiralay C, Wolf K, Wiedemann K.","J Psychiatr Res. 2005 Sep;39(5):545-51. doi: 10.1016/j.jpsychires.2004.11.005. Epub 2005 Jan 21.","Kiefer F","J Psychiatr Res","2005","2005/07/05","","","10.1016/j.jpsychires.2004.11.005"
"15988468","Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?","Bart G, Schluger JH, Borg L, Ho A, Bidlack JM, Kreek MJ.","Neuropsychopharmacology. 2005 Dec;30(12):2254-62. doi: 10.1038/sj.npp.1300811.","Bart G","Neuropsychopharmacology","2005","2005/07/01","","","10.1038/sj.npp.1300811"
"15986196","Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat","Antonilli L, Petecchia E, Caprioli D, Badiani A, Nencini P.","Psychopharmacology (Berl). 2005 Oct;182(1):58-64. doi: 10.1007/s00213-005-0030-7. Epub 2005 Sep 29.","Antonilli L","Psychopharmacology (Berl)","2005","2005/06/30","","","10.1007/s00213-005-0030-7"
"15979652","Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients","Stella L, D'Ambra C, Mazzeo F, Capuano A, Del Franco F, Avolio A, Ambrosino F.","Life Sci. 2005 Oct 7;77(21):2717-22. doi: 10.1016/j.lfs.2005.05.036.","Stella L","Life Sci","2005","2005/06/28","","","10.1016/j.lfs.2005.05.036"
"15979169","The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety","Marco EM, Llorente R, Pérez-Alvarez L, Moreno E, Guaza C, Viveros MP.","Behav Brain Res. 2005 Sep 8;163(2):212-8. doi: 10.1016/j.bbr.2005.05.005.","Marco EM","Behav Brain Res","2005","2005/06/28","","","10.1016/j.bbr.2005.05.005"
"15976524","Does effect size in naltrexone trials for alcohol dependence differ for single-site vs. multi-center studies?","Feinn R, Kranzler HR.","Alcohol Clin Exp Res. 2005 Jun;29(6):983-8. doi: 10.1097/01.alc.0000171061.03686.bc.","Feinn R","Alcohol Clin Exp Res","2005","2005/06/25","","","10.1097/01.alc.0000171061.03686.bc"
"15976307","Endogenous central kappa-opioid systems augment renal sympathetic nerve activity to maximally retain urinary sodium during hypotonic saline volume expansion","Gottlieb HB, Kapusta DR.","Am J Physiol Regul Integr Comp Physiol. 2005 Nov;289(5):R1289-96. doi: 10.1152/ajpregu.00302.2005. Epub 2005 Jun 23.","Gottlieb HB","Am J Physiol Regul Integr Comp Physiol","2005","2005/06/25","","","10.1152/ajpregu.00302.2005"
"15972245","A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)","Shanahan MD, Doran CM, Digiusto E, Bell J, Lintzeris N, White J, Ali R, Saunders JB, Mattick RP, Gilmour S.","Addict Behav. 2006 Mar;31(3):371-87. doi: 10.1016/j.addbeh.2005.05.016. Epub 2005 Jun 21.","Shanahan MD","Addict Behav","2006","2005/06/24","","","10.1016/j.addbeh.2005.05.016"
"15961147","Endogenous opioids are necessary for benzodiazepine palatability enhancement: naltrexone blocks diazepam-induced increase of sucrose-'liking'","Richardson DK, Reynolds SM, Cooper SJ, Berridge KC.","Pharmacol Biochem Behav. 2005 Jul;81(3):657-63. doi: 10.1016/j.pbb.2005.05.006.","Richardson DK","Pharmacol Biochem Behav","2005","2005/06/18","","","10.1016/j.pbb.2005.05.006"
"15956985","Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing","Ingman K, Hagelberg N, Aalto S, Någren K, Juhakoski A, Karhuvaara S, Kallio A, Oikonen V, Hietala J, Scheinin H.","Neuropsychopharmacology. 2005 Dec;30(12):2245-53. doi: 10.1038/sj.npp.1300790.","Ingman K","Neuropsychopharmacology","2005","2005/06/16","","","10.1038/sj.npp.1300790"
"15956269","Treatment of late-life depression complicated by alcohol dependence","Oslin DW.","Am J Geriatr Psychiatry. 2005 Jun;13(6):491-500. doi: 10.1176/appi.ajgp.13.6.491.","Oslin DW","Am J Geriatr Psychiatry","2005","2005/06/16","PMC3172720","NIHMS322062","10.1176/appi.ajgp.13.6.491"
"15955020","Blame the counselling, not the implant. A response to Oliver, Horspool & Keen (2005)","Kunøe N, Lobmaier P.","Addiction. 2005 Jul;100(7):1027-8; author reply 1028-9. doi: 10.1111/j.1360-0443.2005.01209.x.","Kunøe N","Addiction","2005","2005/06/16","","","10.1111/j.1360-0443.2005.01209.x"
"15953492","Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats","Bortolato M, Aru GN, Frau R, Orrù M, Fà M, Manunta M, Puddu M, Mereu G, Gessa GL.","Biol Psychiatry. 2005 Jun 15;57(12):1550-8. doi: 10.1016/j.biopsych.2005.02.030.","Bortolato M","Biol Psychiatry","2005","2005/06/15","","","10.1016/j.biopsych.2005.02.030"
"15948042","In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs","Valiveti S, Paudel KS, Hammell DC, Hamad MO, Chen J, Crooks PA, Stinchcomb AL.","Pharm Res. 2005 Jun;22(6):981-9. doi: 10.1007/s11095-005-4593-0. Epub 2005 Jun 8.","Valiveti S","Pharm Res","2005","2005/06/11","","","10.1007/s11095-005-4593-0"
"15943961","Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex","Chindalore VL, Craven RA, Yu KP, Butera PG, Burns LH, Friedmann N.","J Pain. 2005 Jun;6(6):392-9. doi: 10.1016/j.jpain.2005.01.356.","Chindalore VL","J Pain","2005","2005/06/10","","","10.1016/j.jpain.2005.01.356"
"15940094","Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice","Carai MA, Colombo G, Gessa GL.","Ann Emerg Med. 2005 Jun;45(6):614-9. doi: 10.1016/j.annemergmed.2004.12.013.","Carai MA","Ann Emerg Med","2005","2005/06/09","","","10.1016/j.annemergmed.2004.12.013"
"15939519","Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioids levels in nicotine dependence after naltrexone treatment","Lee YS, Joe KH, Sohn IK, Na C, Kee BS, Chae SL.","Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):639-47. doi: 10.1016/j.pnpbp.2005.04.008.","Lee YS","Prog Neuropsychopharmacol Biol Psychiatry","2005","2005/06/09","","","10.1016/j.pnpbp.2005.04.008"
"15937151","The role of central and peripheral mu opioid receptors in inflammatory pain and edema: a study using morphine and DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid)","Whiteside GT, Boulet JM, Walker K.","J Pharmacol Exp Ther. 2005 Sep;314(3):1234-40. doi: 10.1124/jpet.105.088351. Epub 2005 Jun 3.","Whiteside GT","J Pharmacol Exp Ther","2005","2005/06/07","","","10.1124/jpet.105.088351"
"15936866","Assessment of opiate modulation of pain and nociceptive responding in young adults with a parental history of hypertension","France CR, al'absi M, Ring C, France JL, Brose J, Spaeth D, Harju A, Nordehn G, Wittmers LE.","Biol Psychol. 2005 Dec;70(3):168-74. doi: 10.1016/j.biopsycho.2005.01.012. Epub 2005 Jun 3.","France CR","Biol Psychol","2005","2005/06/07","","","10.1016/j.biopsycho.2005.01.012"
"15932946","A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers","Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, Kostenis E, Portoghese PS, Whistler JL.","Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):9050-5. doi: 10.1073/pnas.0501112102. Epub 2005 Jun 2.","Waldhoer M","Proc Natl Acad Sci U S A","2005","2005/06/04","PMC1157030","","10.1073/pnas.0501112102"
"15917999","Effects of naltrexone on lipopolysaccharide-induced sepsis in rats","Lin SL, Lee YM, Chang HY, Cheng YW, Yen MH.","J Biomed Sci. 2005;12(2):431-40. doi: 10.1007/s11373-005-0647-x.","Lin SL","J Biomed Sci","2005","2005/05/27","","","10.1007/s11373-005-0647-x"
"15914331","Potentiation of rat lymphocyte proliferation by novel non-peptidic synthetic opioids","Caballero-Hernández D, Weber RJ, Hicks ME, Tamez-Guerra R, Rodríguez-Padilla C, Tamez-Guerra P, Rice KC, Ananthan S, Gomez-Flores R.","Int Immunopharmacol. 2005 Jul;5(7-8):1271-8. doi: 10.1016/j.intimp.2005.03.009. Epub 2005 Apr 12.","Caballero-Hernández D","Int Immunopharmacol","2005","2005/05/26","","","10.1016/j.intimp.2005.03.009"
"15912719","Measurement of symptom withdrawal severity in a 24-hour period after the anesthesia-assisted rapid opiate detoxification procedure","Teplin D, Raz B, Daiter J, Varenbut M, Zachos CT, Whang P, Herman S, Chaudry S, Yung M.","Am J Drug Alcohol Abuse. 2005;31(2):327-35.","Teplin D","Am J Drug Alcohol Abuse","2005","2005/05/26","","",""
"15912139","Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence","Walker EA, Sterious SN.","Br J Pharmacol. 2005 Aug;145(7):975-83. doi: 10.1038/sj.bjp.0706247.","Walker EA","Br J Pharmacol","2005","2005/05/25","PMC1576205","","10.1038/sj.bjp.0706247"
"15910805","alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids","Borhani AA, Houshmand G, Samini M, Namiranian K, Hajrasouliha AR, Tavakoli S, Ebrahimi F, Dehpour AR.","Eur J Pharmacol. 2005 May 9;514(2-3):183-9. doi: 10.1016/j.ejphar.2005.03.015.","Borhani AA","Eur J Pharmacol","2005","2005/05/25","","","10.1016/j.ejphar.2005.03.015"
"15908043","Kinin and opioid receptors in the paratrigeminal nucleus modulate the somatosensory reflex to rat sciatic nerve stimulation","Koepp J, Caous CA, Rae GA, Balan AC, Lindsey CJ.","Peptides. 2005 Aug;26(8):1339-45. doi: 10.1016/j.peptides.2005.03.033.","Koepp J","Peptides","2005","2005/05/24","","","10.1016/j.peptides.2005.03.033"
"15907990","Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat","White DA, Hwang ML, Holtzman SG.","Pharmacol Biochem Behav. 2005 Jul;81(3):451-8. doi: 10.1016/j.pbb.2005.04.002.","White DA","Pharmacol Biochem Behav","2005","2005/05/24","","","10.1016/j.pbb.2005.04.002"
"15907989","Involvement of 5-HT2 receptors in the antinociceptive effect of Uncaria tomentosa","Jürgensen S, Dalbó S, Angers P, Santos AR, Ribeiro-do-Valle RM.","Pharmacol Biochem Behav. 2005 Jul;81(3):466-77. doi: 10.1016/j.pbb.2005.04.004.","Jürgensen S","Pharmacol Biochem Behav","2005","2005/05/24","","","10.1016/j.pbb.2005.04.004"
"15906171","Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone","Vaddi HK, Hamad MO, Chen J, Banks SL, Crooks PA, Stinchcomb AL.","Pharm Res. 2005 May;22(5):758-65. doi: 10.1007/s11095-005-2592-9. Epub 2005 May 17.","Vaddi HK","Pharm Res","2005","2005/05/21","","","10.1007/s11095-005-2592-9"
"15899557","Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants","Hulse GK, Tait RJ, Comer SD, Sullivan MA, Jacobs IG, Arnold-Reed D.","Drug Alcohol Depend. 2005 Sep 1;79(3):351-7. doi: 10.1016/j.drugalcdep.2005.02.009.","Hulse GK","Drug Alcohol Depend","2005","2005/05/19","PMC1646626","NIHMS8158","10.1016/j.drugalcdep.2005.02.009"
"15897221","Effects of naltrexone on the ethanol-induced changes in the rat central dopaminergic system","Lee YK, Park SW, Kim YK, Kim DJ, Jeong J, Myrick H, Kim YH.","Alcohol Alcohol. 2005 Jul-Aug;40(4):297-301. doi: 10.1093/alcalc/agh163. Epub 2005 May 16.","Lee YK","Alcohol Alcohol","2005","2005/05/18","","","10.1093/alcalc/agh163"
"15894374","Inhibitory control of the acute mu-withdrawal response by indirectly activated adenosine A1 and kappa-opioid systems in the Guinea-pig ileum; reversal by cholecystokinin","Romanelli L, Morrone LA, Amico MC, Palmery M, Tucci P, Valeri P.","Neurotoxicology. 2005 Oct;26(5):829-39. doi: 10.1016/j.neuro.2005.02.001.","Romanelli L","Neurotoxicology","2005","2005/05/17","","","10.1016/j.neuro.2005.02.001"
"15886360","Injection of neuropeptide W into paraventricular nucleus of hypothalamus increases food intake","Levine AS, Winsky-Sommerer R, Huitron-Resendiz S, Grace MK, de Lecea L.","Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1727-32. doi: 10.1152/ajpregu.00638.2003.","Levine AS","Am J Physiol Regul Integr Comp Physiol","2005","2005/05/12","","","10.1152/ajpregu.00638.2003"
"15880304","[Pharmacotherapy in personality disorders]","Wedekind D, Bandelow B, Rüther E.","Fortschr Neurol Psychiatr. 2005 May;73(5):259-67. doi: 10.1055/s-2004-830107.","Wedekind D","Fortschr Neurol Psychiatr","2005","2005/05/10","","","10.1055/s-2004-830107"
"15876908","An open trial of naltrexone in the treatment of depersonalization disorder","Simeon D, Knutelska M.","J Clin Psychopharmacol. 2005 Jun;25(3):267-70. doi: 10.1097/01.jcp.0000162803.61700.4f.","Simeon D","J Clin Psychopharmacol","2005","2005/05/07","","","10.1097/01.jcp.0000162803.61700.4f"
"15866552","Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Rounsaville B; VA New England VISN I MIRECC Study Group.","Biol Psychiatry. 2005 May 15;57(10):1128-37. doi: 10.1016/j.biopsych.2005.02.016.","Petrakis IL","Biol Psychiatry","2005","2005/05/04","","","10.1016/j.biopsych.2005.02.016"
"15861022","Effective opiate-receptor antagonist therapy of cholestatic pruritus induced by an oral contraceptive","Kunzmann S, Kullak-Ublick GA, Greiner A, Jeschke R, Hebestreit H.","J Pediatr Gastroenterol Nutr. 2005 May;40(5):596-9. doi: 10.1097/01.mpg.0000148775.64966.96.","Kunzmann S","J Pediatr Gastroenterol Nutr","2005","2005/04/30","","","10.1097/01.mpg.0000148775.64966.96"
"15858493","Side effects of naltrexone observed in frequent tanners: could frequent tanners have ultraviolet-induced high opioid levels?","Kaur M, Liguori A, Fleischer AB Jr, Feldman SR.","J Am Acad Dermatol. 2005 May;52(5):916. doi: 10.1016/j.jaad.2005.02.026.","Kaur M","J Am Acad Dermatol","2005","2005/04/29","","","10.1016/j.jaad.2005.02.026"
"15857728","Adoption of naltrexone to treat alcohol dependence","Fuller BE, Rieckmann T, McCarty D, Smith KW, Levine H.","J Subst Abuse Treat. 2005 Apr;28(3):273-80. doi: 10.1016/j.jsat.2005.02.003.","Fuller BE","J Subst Abuse Treat","2005","2005/04/29","","","10.1016/j.jsat.2005.02.003"
"15850502","Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials","Srisurapanont M, Jarusuraisin N.","Int J Neuropsychopharmacol. 2005 Jun;8(2):267-80. doi: 10.1017/S1461145704004997.","Srisurapanont M","Int J Neuropsychopharmacol","2005","2005/04/27","","","10.1017/S1461145704004997"
"15843500","Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization","White DA, Holtzman SG.","J Pharmacol Exp Ther. 2005 Jul;314(1):374-82. doi: 10.1124/jpet.104.078584. Epub 2005 Apr 20.","White DA","J Pharmacol Exp Ther","2005","2005/04/22","","","10.1124/jpet.104.078584"
"15842759","Determination of nalmefene by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry","Fang WB, Andrenyak DM, Moody DE, Nuwayser ES.","J Anal Toxicol. 2005 Apr;29(3):169-74. doi: 10.1093/jat/29.3.169.","Fang WB","J Anal Toxicol","2005","2005/04/22","","","10.1093/jat/29.3.169"
"15837582","Dyskinesias occur in response to saline and naltrexone alone after priming with combination of dopaminergic agents and naltrexone in the MPTP parkinsonian monkeys","Samadi P, Grégoire L, Rouillard C, Bédard PJ.","Neurobiol Dis. 2005 Jun-Jul;19(1-2):266-72. doi: 10.1016/j.nbd.2005.01.006.","Samadi P","Neurobiol Dis","2005","2005/04/20","","","10.1016/j.nbd.2005.01.006"
"15831777","Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans","Yuan CS, Doshan H, Charney MR, O'connor M, Karrison T, Maleckar SA, Israel RJ, Moss J.","J Clin Pharmacol. 2005 May;45(5):538-46. doi: 10.1177/0091270004273491.","Yuan CS","J Clin Pharmacol","2005","2005/04/16","","","10.1177/0091270004273491"
"15829417","Detection of opioid receptors on murine lymphocytes by indirect immunofluorescence: mature normal and tumor bearing mice lymphocytes","Karaji AG, Khansari N, Ansary B, Dehpour Ar.","Int Immunopharmacol. 2005 Jun;5(6):1019-27. doi: 10.1016/j.intimp.2005.01.012.","Karaji AG","Int Immunopharmacol","2005","2005/04/15","","","10.1016/j.intimp.2005.01.012"
"15821952","Effect of the blockade of mu1-opioid and 5HT2A-serotonergic/alpha1-noradrenergic receptors on sweet-substance-induced analgesia","Rebouças EC, Segato EN, Kishi R, Freitas RL, Savoldi M, Morato S, Coimbra NC.","Psychopharmacology (Berl). 2005 May;179(2):349-55. doi: 10.1007/s00213-004-2045-x. Epub 2004 Dec 10.","Rebouças EC","Psychopharmacology (Berl)","2005","2005/04/12","","","10.1007/s00213-004-2045-x"
"15821338","Naltrexone protects against hypotension, hyperthermia, and beta-endorphin overproduction during heatstroke in the rat","Huang YP, Lin MT, Chen JS, Wu PY.","J Pharmacol Sci. 2005 Apr;97(4):519-24. doi: 10.1254/jphs.fp0040844. Epub 2005 Apr 9.","Huang YP","J Pharmacol Sci","2005","2005/04/12","","","10.1254/jphs.fp0040844"
"15820419","Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone","Gerrits MA, Kuzmin AV, van Ree JM.","Eur Neuropsychopharmacol. 2005 May;15(3):297-303. doi: 10.1016/j.euroneuro.2004.11.004. Epub 2005 Jan 25.","Gerrits MA","Eur Neuropsychopharmacol","2005","2005/04/12","","","10.1016/j.euroneuro.2004.11.004"
"15811981","Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group.","JAMA. 2005 Apr 6;293(13):1617-25. doi: 10.1001/jama.293.13.1617.","Garbutt JC","JAMA","2005","2005/04/07","","","10.1001/jama.293.13.1617"
"15808478","Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone","Wentland MP, Lu Q, Lou R, Bu Y, Knapp BI, Bidlack JM.","Bioorg Med Chem Lett. 2005 Apr 15;15(8):2107-10. doi: 10.1016/j.bmcl.2005.02.032.","Wentland MP","Bioorg Med Chem Lett","2005","2005/04/06","","","10.1016/j.bmcl.2005.02.032"
"15806307","Effects of met-enkephalin on cell proliferation in different models of adrenocortical-cell growth","Malendowicz LK, Rebuffat P, Tortorella C, Nussdorfer GG, Ziolkowska A, Hochol A.","Int J Mol Med. 2005 May;15(5):841-5.","Malendowicz LK","Int J Mol Med","2005","2005/04/05","","",""
"15804355","Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial","Galloway GP, Koch M, Cello R, Smith DE.","BMC Psychiatry. 2005 Apr 1;5:18. doi: 10.1186/1471-244X-5-18.","Galloway GP","BMC Psychiatry","2005","2005/04/05","PMC1087493","","10.1186/1471-244X-5-18"
"15799109","Treating opiate addiction, Part II: alternatives to maintenance","","Harv Ment Health Lett. 2005 Jan;21(7):4-6.","","Harv Ment Health Lett","2005","2005/04/01","","",""
"15797885","Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?","Rubio G, Ponce G, Rodriguez-Jiménez R, Jiménez-Arriero MA, Hoenicka J, Palomo T.","Alcohol Alcohol. 2005 May-Jun;40(3):227-33. doi: 10.1093/alcalc/agh151. Epub 2005 Mar 29.","Rubio G","Alcohol Alcohol","2005","2005/03/31","","","10.1093/alcalc/agh151"
"15795552","Suppression of craving for gamma-hydroxybutyric acid by naltrexone administration: three case reports","Caputo F, Vignoli T, Lorenzini F, Ciuffoli E, Del Re A, Stefanini GF, Addolorato G, Trevisani F, Bernardi M; Alcoholism Treatment Study Group.","Clin Neuropharmacol. 2005 Mar-Apr;28(2):87-9. doi: 10.1097/01.wnf.0000159954.49393.76.","Caputo F","Clin Neuropharmacol","2005","2005/03/30","","","10.1097/01.wnf.0000159954.49393.76"
"15789195","Pharmacological treatments of pathological gambling","Hollander E, Sood E, Pallanti S, Baldini-Rossi N, Baker B.","J Gambl Stud. 2005 Spring;21(1):99-110. doi: 10.1007/s10899-004-1932-8.","Hollander E","J Gambl Stud","2005","2005/03/25","","","10.1007/s10899-004-1932-8"
"15788780","In vivo activation of a mutant mu-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: role of mu-receptor activation and delta-receptor blockade in morphine tolerance","Roy S, Guo X, Kelschenbach J, Liu Y, Loh HH.","Version 2. J Neurosci. 2005 Mar 23;25(12):3229-33. doi: 10.1523/JNEUROSCI.0332-05.2005.","Roy S","J Neurosci","2005","2005/03/25","PMC5764089","NIHMS698663","10.1523/JNEUROSCI.0332-05.2005"
"15786960","[The antiarrhythmic effect of (-)-U-50,488 in rats with acute ischemia and reperfusion of heart is mediated by kappa1-opioid receptor activation]","Maslov LN, Lishmanov AIu, Solenkova NV, Budankova EV, Wong TM, Chang WC, Bray LX.","Eksp Klin Farmakol. 2005 Jan-Feb;68(1):25-9.","Maslov LN","Eksp Klin Farmakol","2005","2005/03/25","","",""
"15785069","Pharmacological relapse prevention of alcoholism: clinical predictors of outcome","Kiefer F, Helwig H, Tarnaske T, Otte C, Jahn H, Wiedemann K.","Eur Addict Res. 2005;11(2):83-91. doi: 10.1159/000083037.","Kiefer F","Eur Addict Res","2005","2005/03/24","","","10.1159/000083037"
"15784523","Naltrexone augments the effects of nicotine replacement therapy in female smokers","Byars JA, Frost-Pineda K, Jacobs WS, Gold MS.","J Addict Dis. 2005;24(2):49-60. doi: 10.1300/J069v24n02_05.","Byars JA","J Addict Dis","2005","2005/03/24","","","10.1300/J069v24n02_05"
"15784071","Fatal opiate overdose following regimen changes in naltrexone treatment","Oliver P, Horspool M, Keen J.","Addiction. 2005 Apr;100(4):560-1. doi: 10.1111/j.1360-0443.2005.01020.x.","Oliver P","Addiction","2005","2005/03/24","","","10.1111/j.1360-0443.2005.01020.x"
"15778877","Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice","Balerio GN, Aso E, Maldonado R.","Psychopharmacology (Berl). 2005 Sep;181(2):260-9. doi: 10.1007/s00213-005-2238-y. Epub 2005 Oct 14.","Balerio GN","Psychopharmacology (Berl)","2005","2005/03/22","","","10.1007/s00213-005-2238-y"
"15776407","Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system","Zhang Y, Sham YY, Rajamani R, Gao J, Portoghese PS.","Chembiochem. 2005 May;6(5):853-9. doi: 10.1002/cbic.200400207.","Zhang Y","Chembiochem","2005","2005/03/19","","","10.1002/cbic.200400207"
"15771416","A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes","Daniels DJ, Kulkarni A, Xie Z, Bhushan RG, Portoghese PS.","J Med Chem. 2005 Mar 24;48(6):1713-6. doi: 10.1021/jm034234f.","Daniels DJ","J Med Chem","2005","2005/03/18","","","10.1021/jm034234f"
"15764427","A case report of naltrexone for alcoholism in a liver transplant recipient: side effects and safety","Weinrieb RM, O'Brien CP.","Am J Addict. 2004 Oct-Dec;13(5):495-7. doi: 10.1080/10550490490512870.","Weinrieb RM","Am J Addict","2004","2005/03/15","","","10.1080/10550490490512870"
"15744636","Naltrexone treatment of combined alcohol and opioid dependence: deterioration of co-morbid major depression","Schürks M, Overlack M, Bonnet U.","Pharmacopsychiatry. 2005 Mar;38(2):100-2. doi: 10.1055/s-2005-837812.","Schürks M","Pharmacopsychiatry","2005","2005/03/04","","","10.1055/s-2005-837812"
"15743210","Major effect of pyrrolic N-benzylation in norbinaltorphimine, the selective kappa-opioid receptor antagonist","Chauvignac C, Miller CN, Srivastava SK, Lewis JW, Husbands SM, Traynor JR.","J Med Chem. 2005 Mar 10;48(5):1676-9. doi: 10.1021/jm049172n.","Chauvignac C","J Med Chem","2005","2005/03/04","","","10.1021/jm049172n"
"15743203","3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies","Peng Y, Keenan SM, Zhang Q, Kholodovych V, Welsh WJ.","J Med Chem. 2005 Mar 10;48(5):1620-9. doi: 10.1021/jm049117e.","Peng Y","J Med Chem","2005","2005/03/04","","","10.1021/jm049117e"
"15736197","Bioconversion of naltrexone and its 3-O-alkyl-ester prodrugs in a human skin equivalent","Hammell DC, Stolarczyk EI, Klausner M, Hamad MO, Crooks PA, Stinchcomb AL.","J Pharm Sci. 2005 Apr;94(4):828-36. doi: 10.1002/jps.20238.","Hammell DC","J Pharm Sci","2005","2005/03/01","","","10.1002/jps.20238"
"15733548","Sensitization to morphine withdrawal in guinea-pigs","Mizutani A, Arvidsson J, Chahl LA.","Eur J Pharmacol. 2005 Feb 21;509(2-3):135-43. doi: 10.1016/j.ejphar.2004.12.043.","Mizutani A","Eur J Pharmacol","2005","2005/03/01","","","10.1016/j.ejphar.2004.12.043"
"15732589","Pharmacokinetics of carfentanil and naltrexone in domestic goats (Capra hircus)","Mutlow A, Isaza R, Carpenter JW, Koch DE, Hunter RP.","J Zoo Wildl Med. 2004 Dec;35(4):489-96. doi: 10.1638/03-074.","Mutlow A","J Zoo Wildl Med","2004","2005/03/01","","","10.1638/03-074"
"15732235","Naltrexone for alcohol-dependent patients","Ahmadi J, Babaeebeigi M, Maany I, Porter J, Mohagheghzadeh M, Ahmadi N, Dehbozorgi G.","Ir J Med Sci. 2004 Jan-Mar;173(1):34-7. doi: 10.1007/BF02914522.","Ahmadi J","Ir J Med Sci","2004","2005/03/01","","","10.1007/BF02914522"
"15729444","[The pharmacologic treatment of the alcohol dependence]","Castro LA, Baltieri DA.","Braz J Psychiatry. 2004 May;26 Suppl 1:S43-6. doi: 10.1590/s1516-44462004000500011. Epub 2005 Jan 4.","Castro LA","Braz J Psychiatry","2004","2005/02/25","","","10.1590/s1516-44462004000500011"
"15726882","Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysis","Kambia NK, Dine T, Odou P, Bah S, Azar R, Gressier B, Dupin-Spriet T, Luyckx M, Brunet C.","Eur J Drug Metab Pharmacokinet. 2004 Oct-Dec;29(4):225-30. doi: 10.1007/BF03190603.","Kambia NK","Eur J Drug Metab Pharmacokinet","2004","2005/02/25","","","10.1007/BF03190603"
"15726017","Opioids are responsible for neurochemical feminization of the brain in prenatally stressed male rats","Reznikov AG, Nosenko ND, Tarasenko LV.","Neuro Endocrinol Lett. 2005 Feb;26(1):35-8.","Reznikov AG","Neuro Endocrinol Lett","2005","2005/02/24","","",""
"15718062","Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project","Digiusto E, Lintzeris N, Breen C, Kimber J, Mattick RP, Bell J, Ali R, Saunders JB; NEPOD Research Group.","Addict Behav. 2005 Mar;30(3):443-56. doi: 10.1016/j.addbeh.2004.06.002.","Digiusto E","Addict Behav","2005","2005/02/19","","","10.1016/j.addbeh.2004.06.002"
"15716384","In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice","Raehal KM, Lowery JJ, Bhamidipati CM, Paolino RM, Blair JR, Wang D, Sadée W, Bilsky EJ.","J Pharmacol Exp Ther. 2005 Jun;313(3):1150-62. doi: 10.1124/jpet.104.082966. Epub 2005 Feb 16.","Raehal KM","J Pharmacol Exp Ther","2005","2005/02/18","","","10.1124/jpet.104.082966"
"15713427","Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse","Jinsmaa Y, Fujita Y, Shiotani K, Miyazaki A, Li T, Tsuda Y, Okada Y, Ambo A, Sasaki Y, Bryant SD, Lazarus LH.","Eur J Pharmacol. 2005 Feb 10;509(1):37-42. doi: 10.1016/j.ejphar.2004.12.015. Epub 2005 Jan 22.","Jinsmaa Y","Eur J Pharmacol","2005","2005/02/17","","","10.1016/j.ejphar.2004.12.015"
"15711433","Outcome study of kleptomania patients treated with naltrexone: a chart review","Grant JE.","Clin Neuropharmacol. 2005 Jan-Feb;28(1):11-4. doi: 10.1097/01.wnf.0000150868.06512.0b.","Grant JE","Clin Neuropharmacol","2005","2005/02/16","","","10.1097/01.wnf.0000150868.06512.0b"
"15707874","Anti-inflammatory and opioid-mediated effects of melatonin on experimental peritonitis in chickens","Majewski P, Dziwinski T, Pawlak J, Waloch M, Skwarlo-Sonta K.","Life Sci. 2005 Mar 11;76(17):1907-20. doi: 10.1016/j.lfs.2004.04.062.","Majewski P","Life Sci","2005","2005/02/15","","","10.1016/j.lfs.2004.04.062"
"15706786","Pharmacotherapy of adolescent alcohol and other drug use disorders","Solhkhah R, Wilens TE.","Alcohol Health Res World. 1998;22(2):122-5.","Solhkhah R","Alcohol Health Res World","1998","2005/02/15","PMC6761805","",""
"15706138","Monoaminergic drugs and directly observable signs of LAAM withdrawal in rhesus monkeys","Sell SL, McMahon LR, Koek W, France CP.","Behav Pharmacol. 2005 Feb;16(1):53-8. doi: 10.1097/00008877-200502000-00006.","Sell SL","Behav Pharmacol","2005","2005/02/12","","","10.1097/00008877-200502000-00006"
"15704026","[Efficacy of naltrexone in the treatment of alcohol dependence disorder in women]","Ponce G, Sánchez-García J, Rubio G, Rodríguez-Jiménez R, Jiménez-Arriero MA, Palomo T.","Actas Esp Psiquiatr. 2005 Jan-Feb;33(1):13-8.","Ponce G","Actas Esp Psiquiatr","2005","2005/02/11","","",""
"15703368","Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways","Adams M, Pieniaszek HJ Jr, Gammaitoni AR, Ahdieh H.","J Clin Pharmacol. 2005 Mar;45(3):337-45. doi: 10.1177/0091270004271969.","Adams M","J Clin Pharmacol","2005","2005/02/11","","","10.1177/0091270004271969"
"15694688","Low dose naltrexone therapy in multiple sclerosis","Agrawal YP.","Med Hypotheses. 2005;64(4):721-4. doi: 10.1016/j.mehy.2004.09.024.","Agrawal YP","Med Hypotheses","2005","2005/02/08","","","10.1016/j.mehy.2004.09.024"
"15682300","Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm","Rukstalis M, Jepson C, Strasser A, Lynch KG, Perkins K, Patterson F, Lerman C.","Psychopharmacology (Berl). 2005 Jun;180(1):41-8. doi: 10.1007/s00213-004-2136-8. Epub 2005 Jan 29.","Rukstalis M","Psychopharmacology (Berl)","2005","2005/02/01","","","10.1007/s00213-004-2136-8"
"15680308","Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities","Sadée W, Wang D, Bilsky EJ.","Life Sci. 2005 Feb 11;76(13):1427-37. doi: 10.1016/j.lfs.2004.10.024. Epub 2004 Dec 8.","Sadée W","Life Sci","2005","2005/02/01","","","10.1016/j.lfs.2004.10.024"
"15678085","Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum","Gray AC, White PJ, Coupar IM.","Br J Pharmacol. 2005 Mar;144(5):687-94. doi: 10.1038/sj.bjp.0706107.","Gray AC","Br J Pharmacol","2005","2005/01/29","PMC1576049","","10.1038/sj.bjp.0706107"
"15674887","Opioid antagonists for alcohol dependence","Srisurapanont M, Jarusuraisin N.","Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001867. doi: 10.1002/14651858.CD001867.pub2.","Srisurapanont M","Cochrane Database Syst Rev","2005","2005/01/28","","","10.1002/14651858.CD001867.pub2"
"15672375","Comment on ""Radial arm maze performance of rats following repeated low level microwave radiation exposure""","Lai H.","Bioelectromagnetics. 2005 Feb;26(2):81. doi: 10.1002/bem.20093.","Lai H","Bioelectromagnetics","2005","2005/01/27","","","10.1002/bem.20093"
"15665949","Delta-opioid receptor antagonists exhibit properties of partial delta-receptor agonists in isolated perfused heart","Maslov LN, Lasukova TV, Bespalova ZhD, Oldgen P, Rice KK, Nagase H.","Bull Exp Biol Med. 2004 Oct;138(4):376-9. doi: 10.1007/s10517-005-0046-3.","Maslov LN","Bull Exp Biol Med","2004","2005/01/25","","","10.1007/s10517-005-0046-3"
"15664788","Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids","Tseng RJ, Padgett DA, Dhabhar FS, Engler H, Sheridan JF.","Brain Behav Immun. 2005 Mar;19(2):153-64. doi: 10.1016/j.bbi.2004.07.001.","Tseng RJ","Brain Behav Immun","2005","2005/01/25","","","10.1016/j.bbi.2004.07.001"
"15662454","Ratio between the contents of 11-dehydrocorticosterone and corticosterone after acute and repeated stress: effect of dehydroepiandrosterone sulfate","Obut TA, Ovsyukova MV, Cherkasova OP.","Bull Exp Biol Med. 2004 Aug;138(2):137-9. doi: 10.1023/b:bebm.0000048370.47097.b0.","Obut TA","Bull Exp Biol Med","2004","2005/01/22","","","10.1023/b:bebm.0000048370.47097.b0"
"15661634","Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving","Heidbreder CA, Hagan JJ.","Curr Opin Pharmacol. 2005 Feb;5(1):107-18. doi: 10.1016/j.coph.2004.08.013.","Heidbreder CA","Curr Opin Pharmacol","2005","2005/01/22","","","10.1016/j.coph.2004.08.013"
"15658877","Extension of the Nenitzescu reaction to simple ketones provides an efficient route to 1'-alkyl-5'-hydroxynaltrindole analogues, potent and selective delta-opioid receptor antagonists","Shefali S, Srivastava SK, Husbands SM, Lewis JW.","J Med Chem. 2005 Jan 27;48(2):635-8. doi: 10.1021/jm040853s.","Shefali S","J Med Chem","2005","2005/01/22","","","10.1021/jm040853s"
"15653167","In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs","Valiveti S, Hammell DC, Paudel KS, Hamad MO, Crooks PA, Stinchcomb AL.","J Control Release. 2005 Feb 2;102(2):509-20. doi: 10.1016/j.jconrel.2004.10.005.","Valiveti S","J Control Release","2005","2005/01/18","","","10.1016/j.jconrel.2004.10.005"
"15639162","Lack of evidence for mu-opioid regulation of a socially mediated separation response","Shair HN, Brunelli SA, Hofer MA.","Physiol Behav. 2005 Jan 17;83(5):767-77. doi: 10.1016/j.physbeh.2004.09.019. Epub 2004 Nov 11.","Shair HN","Physiol Behav","2005","2005/01/11","","","10.1016/j.physbeh.2004.09.019"
"15630073","Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil","Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, Dohmen BM, Braus DF, Schumann G, Machulla HJ, Bares R, Mann K.","Arch Gen Psychiatry. 2005 Jan;62(1):57-64. doi: 10.1001/archpsyc.62.1.57.","Heinz A","Arch Gen Psychiatry","2005","2005/01/05","","","10.1001/archpsyc.62.1.57"
"15620581","Peripheral effect of a kappa opioid receptor antagonist on nociception evoked by formalin injected in TMJ of pregnant rats","Arthuri MT, Gameiro GH, Tambeli CH, de Arruda Veiga MC.","Life Sci. 2005 Jan 21;76(10):1177-88. doi: 10.1016/j.lfs.2004.10.019.","Arthuri MT","Life Sci","2005","2004/12/29","","","10.1016/j.lfs.2004.10.019"
"15619107","Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats","Solinas M, Goldberg SR.","Psychopharmacology (Berl). 2005 Jun;179(4):804-12. doi: 10.1007/s00213-004-2118-x. Epub 2004 Dec 24.","Solinas M","Psychopharmacology (Berl)","2005","2004/12/25","","","10.1007/s00213-004-2118-x"
"15615836","Modulation of synaptic transmission in the rat nucleus of the solitary tract by endomorphin-1","Glatzer NR, Smith BN.","J Neurophysiol. 2005 May;93(5):2530-40. doi: 10.1152/jn.00429.2004. Epub 2004 Dec 22.","Glatzer NR","J Neurophysiol","2005","2004/12/24","","","10.1152/jn.00429.2004"
"15611982","Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis","Symons FJ, Thompson A, Rodriguez MC.","Ment Retard Dev Disabil Res Rev. 2004;10(3):193-200. doi: 10.1002/mrdd.20031.","Symons FJ","Ment Retard Dev Disabil Res Rev","2004","2004/12/22","","","10.1002/mrdd.20031"
"15610829","A randomized control trial of group counseling in a naltrexone treatment program","Tucker T, Ritter A, Maher C, Jackson H.","J Subst Abuse Treat. 2004 Dec;27(4):277-88. doi: 10.1016/j.jsat.2004.08.003.","Tucker T","J Subst Abuse Treat","2004","2004/12/22","","","10.1016/j.jsat.2004.08.003"
"15608607","Brain catalase activity inhibition as well as opioid receptor antagonism increases ethanol-induced HPA axis activation","Pastor R, Sanchis-Segura C, Aragon CM.","Alcohol Clin Exp Res. 2004 Dec;28(12):1898-906. doi: 10.1097/01.alc.0000148107.64739.76.","Pastor R","Alcohol Clin Exp Res","2004","2004/12/21","","","10.1097/01.alc.0000148107.64739.76"
"15607845","Effect of the combination of naltrexone and baclofen, on acquisition of alcohol drinking behavior in alcohol-preferring rats","Colombo G, Serra S, Vacca G, Carai MA, Gessa GL.","Drug Alcohol Depend. 2005 Jan 7;77(1):87-91. doi: 10.1016/j.drugalcdep.2004.07.003.","Colombo G","Drug Alcohol Depend","2005","2004/12/21","","","10.1016/j.drugalcdep.2004.07.003"
"15607829","The development of tolerance to locomotor effects of morphine and the effect of various opioid receptor antagonists in rats chronically treated with morphine","Timár J, Gyarmati Z, Fürst Z.","Brain Res Bull. 2005 Jan 15;64(5):417-24. doi: 10.1016/j.brainresbull.2004.09.005.","Timár J","Brain Res Bull","2005","2004/12/21","","","10.1016/j.brainresbull.2004.09.005"
"15602100","Kleptomania after head trauma: two case reports and combination treatment strategies","Aizer A, Lowengrub K, Dannon PN.","Clin Neuropharmacol. 2004 Sep-Oct;27(5):211-5. doi: 10.1097/01.wnf.0000144042.66342.d3.","Aizer A","Clin Neuropharmacol","2004","2004/12/17","","","10.1097/01.wnf.0000144042.66342.d3"
"15599336","Acamprosate campral for alcoholism","","Med Lett Drugs Ther. 2005 Jan 3;47(1199):1-3.","","Med Lett Drugs Ther","2005","2004/12/16","","",""
"15598150","Pain in a balance: noxious events engage opposing processes that concurrently modulate nociceptive reactivity","Crown ED, Grau JW, Meagher MW.","Behav Neurosci. 2004 Dec;118(6):1418-26. doi: 10.1037/0735-7044.118.6.1418.","Crown ED","Behav Neurosci","2004","2004/12/16","","","10.1037/0735-7044.118.6.1418"
"15591768","Role of opioid receptors in cardioprotection of cold-restraint stress and morphine","Wu S, Wong MC, Chen M, Cho CH, Wong TM.","J Biomed Sci. 2004 Nov-Dec;11(6):726-31. doi: 10.1007/BF02254356.","Wu S","J Biomed Sci","2004","2004/12/14","","","10.1007/BF02254356"
"15590769","Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors","Tryoen-Tóth P, Décaillot FM, Filliol D, Befort K, Lazarus LH, Schiller PW, Schmidhammer H, Kieffer BL.","J Pharmacol Exp Ther. 2005 Apr;313(1):410-21. doi: 10.1124/jpet.104.077321. Epub 2004 Dec 8.","Tryoen-Tóth P","J Pharmacol Exp Ther","2005","2004/12/14","","","10.1124/jpet.104.077321"
"15588100","Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan","Srivastava SK, Shefali S, Miller CN, Aceto MD, Traynor JR, Lewis JW, Husbands SM.","J Med Chem. 2004 Dec 16;47(26):6645-8. doi: 10.1021/jm040817t.","Srivastava SK","J Med Chem","2004","2004/12/14","","","10.1021/jm040817t"
"15584033","Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium","Zagon IS, Ruth TB, McLaughlin PJ.","Anat Rec A Discov Mol Cell Evol Biol. 2005 Jan;282(1):24-37. doi: 10.1002/ar.a.20161.","Zagon IS","Anat Rec A Discov Mol Cell Evol Biol","2005","2004/12/08","","","10.1002/ar.a.20161"
"15581674","Opioid-mediated pain sensitivity in mice bred for high voluntary wheel running","Li G, Rhodes JS, Girard I, Gammie SC, Garland T Jr.","Physiol Behav. 2004 Dec 15;83(3):515-24. doi: 10.1016/j.physbeh.2004.09.003.","Li G","Physiol Behav","2004","2004/12/08","","","10.1016/j.physbeh.2004.09.003"
"15581261","Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2","Kenna GA, McGeary JE, Swift RM.","Am J Health Syst Pharm. 2004 Nov 15;61(22):2380-8. doi: 10.1093/ajhp/61.22.2380.","Kenna GA","Am J Health Syst Pharm","2004","2004/12/08","","","10.1093/ajhp/61.22.2380"
"15579496","Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor","Claude-Geppert PA, Liu J, Solberg J, Erickson-Herbrandson LJ, Loh HH, Law PY.","J Pharmacol Exp Ther. 2005 Apr;313(1):216-26. doi: 10.1124/jpet.104.076505. Epub 2004 Dec 3.","Claude-Geppert PA","J Pharmacol Exp Ther","2005","2004/12/08","","","10.1124/jpet.104.076505"
"15574783","Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells","Chen YL, Law PY, Loh HH.","Cancer Res. 2004 Dec 1;64(23):8723-30. doi: 10.1158/0008-5472.CAN-03-3091.","Chen YL","Cancer Res","2004","2004/12/03","","","10.1158/0008-5472.CAN-03-3091"
"15569605","The preclinical development of Medisorb Naltrexone, a once a month long acting injection, for the treatment of alcohol dependence","Dean RL.","Front Biosci. 2005 Jan 1;10:643-55. doi: 10.2741/1559.","Dean RL","Front Biosci","2005","2004/12/01","","","10.2741/1559"
"15569037","Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching","Ajayi AA, Kolawole BA, Udoh SJ.","Int J Dermatol. 2004 Dec;43(12):972-7. doi: 10.1111/j.1365-4632.2004.02347.x.","Ajayi AA","Int J Dermatol","2004","2004/12/01","","","10.1111/j.1365-4632.2004.02347.x"
"15563768","Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol","Breyer-Pfaff U, Nill K.","J Pharm Pharmacol. 2004 Dec;56(12):1601-6. doi: 10.1211/0022357045020.","Breyer-Pfaff U","J Pharm Pharmacol","2004","2004/11/27","","","10.1211/0022357045020"
"15561796","A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse","Watanabe H, Nakayama D, Ito K, Watanabe C, Mizoguchi H, Fujimura T, Murayama K, Kawamura S, Sato T, Sakurada C, Sakurada T, Sakurada S.","J Pharmacol Exp Ther. 2005 Mar;312(3):1075-81. doi: 10.1124/jpet.104.075697. Epub 2004 Nov 23.","Watanabe H","J Pharmacol Exp Ther","2005","2004/11/25","","","10.1124/jpet.104.075697"
"15552634","Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1","Kenna GA, McGeary JE, Swift RM.","Am J Health Syst Pharm. 2004 Nov 1;61(21):2272-9. doi: 10.1093/ajhp/61.21.2272.","Kenna GA","Am J Health Syst Pharm","2004","2004/11/24","","","10.1093/ajhp/61.21.2272"
"15550451","Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects","Manzanares J, Ortiz S, Oliva JM, Pérez-Rial S, Palomo T.","Alcohol Alcohol. 2005 Jan-Feb;40(1):25-34. doi: 10.1093/alcalc/agh112. Epub 2004 Nov 18.","Manzanares J","Alcohol Alcohol","2005","2004/11/20","","","10.1093/alcalc/agh112"
"15550284","Pharmacologic management of relapse prevention in addictive disorders","Sofuoglu M, Kosten TR.","Psychiatr Clin North Am. 2004 Dec;27(4):627-48. doi: 10.1016/j.psc.2004.06.002.","Sofuoglu M","Psychiatr Clin North Am","2004","2004/11/20","","","10.1016/j.psc.2004.06.002"
"15547458","Effectiveness of naltrexone in a community treatment program","Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF.","Alcohol Clin Exp Res. 2004 Nov;28(11):1710-7. doi: 10.1097/01.alc.0000145688.30448.2c.","Killeen TK","Alcohol Clin Exp Res","2004","2004/11/18","","","10.1097/01.alc.0000145688.30448.2c"
"15544839","Interactions of galanin and opioids in nociceptive modulation in the arcuate nucleus of hypothalamus in rats","Sun YG, Yu LC.","Regul Pept. 2005 Jan 15;124(1-3):37-43. doi: 10.1016/j.regpep.2004.06.023.","Sun YG","Regul Pept","2005","2004/11/17","","","10.1016/j.regpep.2004.06.023"
"15542768","Convergent effects on cell signaling mechanisms mediate the actions of different neurobehavioral teratogens: alterations in cholinergic regulation of protein kinase C in chick and avian models","Yanai J, Beer A, Huleihel R, Izrael M, Katz S, Levi Y, Rozenboim I, Yaniv SP, Slotkin TA.","Ann N Y Acad Sci. 2004 Oct;1025:595-601. doi: 10.1196/annals.1316.074.","Yanai J","Ann N Y Acad Sci","2004","2004/11/16","","","10.1196/annals.1316.074"
"15542250","Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint","Clemente JT, Parada CA, Veiga MC, Gear RW, Tambeli CH.","Neurosci Lett. 2004 Dec 6;372(3):250-5. doi: 10.1016/j.neulet.2004.09.048.","Clemente JT","Neurosci Lett","2004","2004/11/16","","","10.1016/j.neulet.2004.09.048"
"15541894","Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures","Honar H, Riazi K, Homayoun H, Sadeghipour H, Rashidi N, Ebrahimkhani MR, Mirazi N, Dehpour AR.","Neuroscience. 2004;129(3):733-42. doi: 10.1016/j.neuroscience.2004.08.029.","Honar H","Neuroscience","2004","2004/11/16","","","10.1016/j.neuroscience.2004.08.029"
"15541425","Local transcutaneous electrical stimulation (TENS) effects in experimental inflammatory edema and pain","Resende MA, Sabino GG, Cândido CR, Pereira LS, Francischi JN.","Eur J Pharmacol. 2004 Nov 19;504(3):217-22. doi: 10.1016/j.ejphar.2004.09.055.","Resende MA","Eur J Pharmacol","2004","2004/11/16","","","10.1016/j.ejphar.2004.09.055"
"15538132","Effects of naltrexone on the subjective response to amphetamine in healthy volunteers","Jayaram-Lindström N, Wennberg P, Hurd YL, Franck J.","J Clin Psychopharmacol. 2004 Dec;24(6):665-9. doi: 10.1097/01.jcp.0000144893.29987.e5.","Jayaram-Lindström N","J Clin Psychopharmacol","2004","2004/11/13","","","10.1097/01.jcp.0000144893.29987.e5"
"15533326","A bi-directional mu-opioid-opioid connection between the nucleus of the accumbens shell and the central nucleus of the amygdala in the rat","Kim EM, Quinn JG, Levine AS, O'Hare E.","Brain Res. 2004 Dec 10;1029(1):135-9. doi: 10.1016/j.brainres.2004.10.001.","Kim EM","Brain Res","2004","2004/11/10","","","10.1016/j.brainres.2004.10.001"
"15530502","Obstructive cholestasis alters intestinal transit in mice: role of opioid system","Ghaffari K, Savadkuhi ST, Honar H, Riazi K, Shafaroodi H, Moezi L, Ebrahimkhani MR, Tahmasebi MS, Dehpour AR.","Life Sci. 2004 Dec 10;76(4):397-406. doi: 10.1016/j.lfs.2004.09.002.","Ghaffari K","Life Sci","2004","2004/11/09","","","10.1016/j.lfs.2004.09.002"
"15525790","A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence","De Sousa A, De Sousa A.","Alcohol Alcohol. 2004 Nov-Dec;39(6):528-31. doi: 10.1093/alcalc/agh104.","De Sousa A","Alcohol Alcohol","2004","2004/11/05","","","10.1093/alcalc/agh104"
"15517116","[Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients]","Brune A, Metze D, Luger TA, Ständer S.","Hautarzt. 2004 Dec;55(12):1130-6. doi: 10.1007/s00105-004-0802-8.","Brune A","Hautarzt","2004","2004/11/02","","","10.1007/s00105-004-0802-8"
"15506891","Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone","Coonfield DL, Kiefer SW, Ferraro FM 3rd, Sinclair JD.","Behav Neurosci. 2004 Oct;118(5):1089-96. doi: 10.1037/0735-7044.118.5.1089.","Coonfield DL","Behav Neurosci","2004","2004/10/28","","","10.1037/0735-7044.118.5.1089"
"15496370","Ask the doctor. I need to quit drinking, but don't think I can do it on my own. Can I use a drug like Antabuse even though I have heart disease?","Lee TH.","Harv Heart Lett. 2004 Oct;15(2):8.","Lee TH","Harv Heart Lett","2004","2004/10/22","","",""
"15496316","Opioid receptors and acetaminophen (paracetamol)","Raffa RB, Walker EA, Sterious SN.","Eur J Pharmacol. 2004 Oct 25;503(1-3):209-10. doi: 10.1016/j.ejphar.2004.08.055.","Raffa RB","Eur J Pharmacol","2004","2004/10/22","","","10.1016/j.ejphar.2004.08.055"
"15468820","Preparation of naltrexone hydrochloride loaded poly (DL-lactide-co-glycolide) microspheres and the effect of polyvinyl alcohol (PVA) as surfactant on the characteristics of the microspheres","Suhaida MG, Yahya IB, Darmawati MY.","Med J Malaysia. 2004 May;59 Suppl B:63-4.","Suhaida MG","Med J Malaysia","2004","2004/10/08","","",""
"15465965","The mosaic of addiction","O'Brien CP.","Am J Psychiatry. 2004 Oct;161(10):1741-2. doi: 10.1176/ajp.161.10.1741.","O'Brien CP","Am J Psychiatry","2004","2004/10/07","","","10.1176/ajp.161.10.1741"
"15457969","[Cholestatic liver diseases]","Thimme R, Opitz OG, Blum HE, Kreisel W.","Ther Umsch. 2004 Aug;61(8):521-7. doi: 10.1024/0040-5930.61.8.521.","Thimme R","Ther Umsch","2004","2004/10/02","","","10.1024/0040-5930.61.8.521"
"15456690","Combined therapy: what does acamprosate and naltrexone combination tell us?","Kiefer F, Wiedemann K.","Alcohol Alcohol. 2004 Nov-Dec;39(6):542-7. doi: 10.1093/alcalc/agh093. Epub 2004 Sep 29.","Kiefer F","Alcohol Alcohol","2004","2004/10/01","","","10.1093/alcalc/agh093"
"15381053","Resistance of cholestatic rats against epinephrine-induced arrhythmia: the role of nitric oxide and endogenous opioids","Hajrasouliha AR, Tavakoli S, Jabehdar-Maralani P, Shafaroodi H, Borhani AA, Houshmand G, Sadeghipour H, Dehghani M, Dehpour AR.","Eur J Pharmacol. 2004 Sep 24;499(3):307-13. doi: 10.1016/j.ejphar.2004.07.099.","Hajrasouliha AR","Eur J Pharmacol","2004","2004/09/24","","","10.1016/j.ejphar.2004.07.099"
"15380837","The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats","Zhu H, Barr GA.","Int J Dev Neurosci. 2004 Aug-Oct;22(5-6):379-95. doi: 10.1016/j.ijdevneu.2004.06.005.","Zhu H","Int J Dev Neurosci","2004","2004/09/24","","","10.1016/j.ijdevneu.2004.06.005"
"15380723","Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma","Valiveti S, Nalluri BN, Hammell DC, Paudel KS, Stinchcomb AL.","J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Oct 25;810(2):259-67. doi: 10.1016/j.jchromb.2004.08.016.","Valiveti S","J Chromatogr B Analyt Technol Biomed Life Sci","2004","2004/09/24","","","10.1016/j.jchromb.2004.08.016"
"15370932","Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy","Schmitz JM, Stotts AL, Sayre SL, DeLaune KA, Grabowski J.","Am J Addict. 2004 Jul-Sep;13(4):333-41. doi: 10.1080/10550490490480982.","Schmitz JM","Am J Addict","2004","2004/09/17","","","10.1080/10550490490480982"
"15370010","Naltrexone maintenance for heroin dependence: uptake, attrition and retention","Tucker T, Ritter A, Maher C, Jackson H.","Drug Alcohol Rev. 2004 Sep;23(3):299-309. doi: 10.1080/09595230412331289464.","Tucker T","Drug Alcohol Rev","2004","2004/09/17","","","10.1080/09595230412331289464"
"15369544","Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status","Feeney GF, Connor JP, Young RM, Tucker J, McPherson A.","Aust N Z J Psychiatry. 2004 Oct;38(10):842-8. doi: 10.1080/j.1440-1614.2004.01469.x.","Feeney GF","Aust N Z J Psychiatry","2004","2004/09/17","","","10.1080/j.1440-1614.2004.01469.x"
"15368903","The role of adrenocorticotropic hormone in the inhibition of pain reactions in conscious rats","Bogdanov AI, Yarushkina NI.","Neurosci Behav Physiol. 2004 Jul;34(6):575-8. doi: 10.1023/b:neab.0000028287.61380.05.","Bogdanov AI","Neurosci Behav Physiol","2004","2004/09/17","","","10.1023/b:neab.0000028287.61380.05"
"15365307","Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers","Drobes DJ, Anton RF, Thomas SE, Voronin K.","Alcohol Clin Exp Res. 2004 Sep;28(9):1362-70. doi: 10.1097/01.alc.0000139704.88862.01.","Drobes DJ","Alcohol Clin Exp Res","2004","2004/09/15","","","10.1097/01.alc.0000139704.88862.01"
"15365306","A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence","Johnson BA, Ait-Daoud N, Aubin HJ, Van Den Brink W, Guzzetta R, Loewy J, Silverman B, Ehrich E.","Alcohol Clin Exp Res. 2004 Sep;28(9):1356-61. doi: 10.1097/01.alc.0000139823.30096.52.","Johnson BA","Alcohol Clin Exp Res","2004","2004/09/15","","","10.1097/01.alc.0000139823.30096.52"
"15363499","Implantable technology for long-term delivery of nalmefene for treatment of alcoholism","Costantini LC, Kleppner SR, McDonough J, Azar MR, Patel R.","Int J Pharm. 2004 Sep 28;283(1-2):35-44. doi: 10.1016/j.ijpharm.2004.05.034.","Costantini LC","Int J Pharm","2004","2004/09/15","","","10.1016/j.ijpharm.2004.05.034"
"15362828","Immobilization of mule deer with thiafentanil (A-3080) or thiafentanil plus xylazine","Wolfe LL, Lance WR, Miller MW.","J Wildl Dis. 2004 Apr;40(2):282-7. doi: 10.7589/0090-3558-40.2.282.","Wolfe LL","J Wildl Dis","2004","2004/09/15","","","10.7589/0090-3558-40.2.282"
"15355755","Recent advances in the pharmacotherapy of alcoholism","Myrick H, Anton R.","Curr Psychiatry Rep. 2004 Oct;6(5):332-8. doi: 10.1007/s11920-004-0019-7.","Myrick H","Curr Psychiatry Rep","2004","2004/09/10","","","10.1007/s11920-004-0019-7"
"15354595","Pharmacological treatments for substance use disorders","Bailey KP.","J Psychosoc Nurs Ment Health Serv. 2004 Aug;42(8):14-20.","Bailey KP","J Psychosoc Nurs Ment Health Serv","2004","2004/09/10","","",""
"15353173","Effects of chronic naltrexone treatment in rats on place preference and locomotor activation after acute administration of cocaethylene or ethanol plus cocaine","Sable HJ, White SL, Steinpreis RE.","Alcohol. 2004 May;33(1):51-61. doi: 10.1016/j.alcohol.2004.04.004.","Sable HJ","Alcohol","2004","2004/09/09","","","10.1016/j.alcohol.2004.04.004"
"15351451","Posttraining administration of pentylenetetrazol dissociates gabapentin effects on memory consolidation from that on memory retrieval process in mice","Blake MG, Boccia MM, Acosta GB, Baratti CM.","Neurosci Lett. 2004 Sep 23;368(2):211-5. doi: 10.1016/j.neulet.2004.07.019.","Blake MG","Neurosci Lett","2004","2004/09/08","","","10.1016/j.neulet.2004.07.019"
"15345269","Rats on the grog: novel pharmacotherapies for alcohol craving","McGregor IS, Gallate JE.","Addict Behav. 2004 Sep;29(7):1341-57. doi: 10.1016/j.addbeh.2004.06.011.","McGregor IS","Addict Behav","2004","2004/09/04","","","10.1016/j.addbeh.2004.06.011"
"15342276","Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward","Anggadiredja K, Sakimura K, Hiranita T, Yamamoto T.","Brain Res. 2004 Sep 24;1021(2):272-6. doi: 10.1016/j.brainres.2004.06.051.","Anggadiredja K","Brain Res","2004","2004/09/03","","","10.1016/j.brainres.2004.06.051"
"15339711","Naltrexone and pharmacy benefit management","Harris KM, Thomas C.","J Addict Dis. 2004;23(4):11-29. doi: 10.1300/J069v23n04_02.","Harris KM","J Addict Dis","2004","2004/09/02","","","10.1300/J069v23n04_02"
"15330732","An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence","Johnson BA.","Expert Opin Pharmacother. 2004 Sep;5(9):1943-55. doi: 10.1517/14656566.5.9.1943.","Johnson BA","Expert Opin Pharmacother","2004","2004/08/28","","","10.1517/14656566.5.9.1943"
"15329066","Sex and estrus cycle differences in the modulatory effects of morphine on seizure susceptibility in mice","Riazi K, Honar H, Homayoun H, Rashidi N, Dehghani M, Sadeghipour H, Gaskari SA, Dehpour AR.","Epilepsia. 2004 Sep;45(9):1035-42. doi: 10.1111/j.0013-9580.2004.69903.x.","Riazi K","Epilepsia","2004","2004/08/27","","","10.1111/j.0013-9580.2004.69903.x"
"15328815","Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects","Yuan CS.","J Support Oncol. 2004 Mar-Apr;2(2):111-7; discussion 119-22.","Yuan CS","J Support Oncol","2004","2004/08/27","","",""
"15327822","Estrogen and mu-opioid receptor antagonists counteract the 17 beta-estradiol-induced licking increase and interferon-gamma reduction occurring during the formalin test in male rats","Ceccarelli I, Fiorenzani P, Grasso G, Lariviere WR, Massafra C, Massai L, Muscettola M, Aloisi AM.","Pain. 2004 Sep;111(1-2):181-90. doi: 10.1016/j.pain.2004.06.005.","Ceccarelli I","Pain","2004","2004/08/26","","","10.1016/j.pain.2004.06.005"
"15318122","Patterns of dispensed disulfiram and naltrexone for alcoholism treatment in a veteran patient population","Hermos JA, Young MM, Gagnon DR, Fiore LD.","Alcohol Clin Exp Res. 2004 Aug;28(8):1229-35. doi: 10.1097/01.alc.0000134234.39303.17.","Hermos JA","Alcohol Clin Exp Res","2004","2004/08/20","","","10.1097/01.alc.0000134234.39303.17"
"15317713","Orthoptic status before and immediately after heroin detoxification","Firth AY, Pulling S, Carr MP, Beaini AY.","Br J Ophthalmol. 2004 Sep;88(9):1186-90. doi: 10.1136/bjo.2003.032334.","Firth AY","Br J Ophthalmol","2004","2004/08/20","PMC1772312","","10.1136/bjo.2003.032334"
"15312814","Chronic very low dose naltrexone administration attenuates opioid withdrawal expression","Mannelli P, Gottheil E, Peoples JF, Oropeza VC, Van Bockstaele EJ.","Biol Psychiatry. 2004 Aug 15;56(4):261-8. doi: 10.1016/j.biopsych.2004.05.013.","Mannelli P","Biol Psychiatry","2004","2004/08/18","","","10.1016/j.biopsych.2004.05.013"
"15312181","Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, Duman RS.","J Neurochem. 2004 Sep;90(5):1258-68. doi: 10.1111/j.1471-4159.2004.02589.x.","Shirayama Y","J Neurochem","2004","2004/08/18","","","10.1111/j.1471-4159.2004.02589.x"
"15312180","Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat","Stragier B, Sarre S, Vanderheyden P, Vauquelin G, Fournié-Zaluski MC, Ebinger G, Michotte Y.","J Neurochem. 2004 Sep;90(5):1251-7. doi: 10.1111/j.1471-4159.2004.02600.x.","Stragier B","J Neurochem","2004","2004/08/18","","","10.1111/j.1471-4159.2004.02600.x"
"15301930","The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat","Stromberg MF.","Pharmacol Biochem Behav. 2004 Aug;78(4):743-50. doi: 10.1016/j.pbb.2004.05.006.","Stromberg MF","Pharmacol Biochem Behav","2004","2004/08/11","","","10.1016/j.pbb.2004.05.006"
"15301655","Millon Clinical Multiaxial Inventory-III subtypes of opioid dependence: validity and matching to behavioral therapies","Ball SA, Nich C, Rounsaville BJ, Eagan D, Carroll KM.","J Consult Clin Psychol. 2004 Aug;72(4):698-711. doi: 10.1037/0022-006X.72.4.698.","Ball SA","J Consult Clin Psychol","2004","2004/08/11","PMC3709250","NIHMS466089","10.1037/0022-006X.72.4.698"
"15296587","Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk","Chan CF, Page-Sharp M, Kristensen JH, O'Neil G, Ilett KF.","J Hum Lact. 2004 Aug;20(3):322-6. doi: 10.1177/0890334404266881.","Chan CF","J Hum Lact","2004","2004/08/07","","","10.1177/0890334404266881"
"15291688","Naltrexone in the treatment of adolescent sexual offenders","Ryback RS.","J Clin Psychiatry. 2004 Jul;65(7):982-6. doi: 10.4088/jcp.v65n0715.","Ryback RS","J Clin Psychiatry","2004","2004/08/05","","","10.4088/jcp.v65n0715"
"15290853","Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone","Pillai O, Hamad MO, Crooks PA, Stinchcomb AL.","Pharm Res. 2004 Jul;21(7):1146-52. doi: 10.1023/b:pham.0000033000.03652.73.","Pillai O","Pharm Res","2004","2004/08/05","","","10.1023/b:pham.0000033000.03652.73"
"15288384","Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy","Chen TJ, Blum K, Payte JT, Schoolfield J, Hopper D, Stanford M, Braverman ER.","Med Hypotheses. 2004;63(3):538-48. doi: 10.1016/j.mehy.2004.02.051.","Chen TJ","Med Hypotheses","2004","2004/08/04","","","10.1016/j.mehy.2004.02.051"
"15282074","[Validation study of the Multidimensional Alcohol Craving Scale (MACS)]","Guardia Serecigni J, Segura García L, Gonzalvo Cirac B, Trujols Albet J, Tejero Pociello A, Suárez González A, Martí Gil A.","Med Clin (Barc). 2004 Jul 10;123(6):211-6. doi: 10.1016/s0025-7753(04)74463-2.","Guardia Serecigni J","Med Clin (Barc)","2004","2004/07/30","","","10.1016/s0025-7753(04)74463-2"
"15275828","The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice","Shafaroodi H, Samini M, Moezi L, Homayoun H, Sadeghipour H, Tavakoli S, Hajrasouliha AR, Dehpour AR.","Neuropharmacology. 2004 Sep;47(3):390-400. doi: 10.1016/j.neuropharm.2004.04.011.","Shafaroodi H","Neuropharmacology","2004","2004/07/28","","","10.1016/j.neuropharm.2004.04.011"
"15273760","Possible role of the phosphoinositide pathway for signal transduction in changes in the sensitivity of delta-opiate receptors during diabetes mellitus","Agadjanov MI, Vartanian GS, Tadevosyan YV, Batikyan TB, Agadjanova EM.","Bull Exp Biol Med. 2004 Feb;137(2):147-9. doi: 10.1023/b:bebm.0000028125.22568.aa.","Agadjanov MI","Bull Exp Biol Med","2004","2004/07/27","","","10.1023/b:bebm.0000028125.22568.aa"
"15265836","Genes harbor clues to addiction, recovery","Hampton T.","JAMA. 2004 Jul 21;292(3):321-2. doi: 10.1001/jama.292.3.321.","Hampton T","JAMA","2004","2004/07/22","","","10.1001/jama.292.3.321"
"15265541","The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production","Greeneltch KM, Haudenschild CC, Keegan AD, Shi Y.","Brain Behav Immun. 2004 Sep;18(5):476-84. doi: 10.1016/j.bbi.2003.12.001.","Greeneltch KM","Brain Behav Immun","2004","2004/07/22","","","10.1016/j.bbi.2003.12.001"
"15257307","Mu-opioid receptors are not involved in acute cocaine-induced locomotor activity nor in development of cocaine-induced behavioral sensitization in mice","Lesscher HM, Hordijk M, Bondar NP, Alekseyenko OV, Burbach JP, van Ree JM, Gerrits MA.","Neuropsychopharmacology. 2005 Feb;30(2):278-85. doi: 10.1038/sj.npp.1300529.","Lesscher HM","Neuropsychopharmacology","2005","2004/07/17","","","10.1038/sj.npp.1300529"
"15257306","Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state","Narita M, Kishimoto Y, Ise Y, Yajima Y, Misawa K, Suzuki T.","Neuropsychopharmacology. 2005 Jan;30(1):111-8. doi: 10.1038/sj.npp.1300527.","Narita M","Neuropsychopharmacology","2005","2004/07/17","","","10.1038/sj.npp.1300527"
"15255997","The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors","Robledo P, Mendizabal V, Ortuño J, de la Torre R, Kieffer BL, Maldonado R.","Eur J Neurosci. 2004 Aug;20(3):853-8. doi: 10.1111/j.1460-9568.2004.03532.x.","Robledo P","Eur J Neurosci","2004","2004/07/17","","","10.1111/j.1460-9568.2004.03532.x"
"15255807","Plasma concentrations during naltrexone implant treatment of opiate-dependent patients","Olsen L, Christophersen AS, Frogopsahl G, Waal H, Mørland J.","Br J Clin Pharmacol. 2004 Aug;58(2):219-22. doi: 10.1111/j.1365-2125.2004.02122.x.","Olsen L","Br J Clin Pharmacol","2004","2004/07/17","PMC1884587","","10.1111/j.1365-2125.2004.02122.x"
"15252292","Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study","Kranzler HR, Abu-Hasaballah K, Tennen H, Feinn R, Young K.","Alcohol Clin Exp Res. 2004 Jul;28(7):1060-4. doi: 10.1097/01.alc.0000130806.12066.9c.","Kranzler HR","Alcohol Clin Exp Res","2004","2004/07/15","","","10.1097/01.alc.0000130806.12066.9c"
"15252291","Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial","Kranzler HR, Wesson DR, Billot L; DrugAbuse Sciences Naltrexone Depot Study Group.","Alcohol Clin Exp Res. 2004 Jul;28(7):1051-9. doi: 10.1097/01.alc.0000130804.08397.29.","Kranzler HR","Alcohol Clin Exp Res","2004","2004/07/15","","","10.1097/01.alc.0000130804.08397.29"
"15252277","The NMDA receptor channel blocker memantine and opioid receptor antagonist naltrexone inhibit the saccharin deprivation effect in rats","Zakharova E, Malyshkin A, Kashkin V, Neznanova O, Sukhotina I, Danysz W, Bespalov A.","Behav Pharmacol. 2004 Jul;15(4):273-8. doi: 10.1097/01.fbp.0000137213.85321.8e.","Zakharova E","Behav Pharmacol","2004","2004/07/15","","","10.1097/01.fbp.0000137213.85321.8e"
"15246539","Opposite conditioned place preference responses to endomorphin-1 and endomorphin-2 in the mouse","Wu HE, MacDougall RS, Clithero AD, Leitermann RJ, Terashvili M, Tseng LF.","Neurosci Lett. 2004 Jul 29;365(3):157-61. doi: 10.1016/j.neulet.2004.03.093.","Wu HE","Neurosci Lett","2004","2004/07/13","","","10.1016/j.neulet.2004.03.093"
"15236831","Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers","Davidson D, Saha C, Scifres S, Fyffe J, O'Connor S, Selzer C.","Addict Behav. 2004 Aug;29(6):1253-8. doi: 10.1016/j.addbeh.2004.03.027.","Davidson D","Addict Behav","2004","2004/07/09","","","10.1016/j.addbeh.2004.03.027"
"15232748","[Addiction characteristics as prognostic factors in opiate dependence treated with naltrexone]","Madoz-Gúrpide A, Barbudo del Cura E, Leira Sanmartín M, Navio Acosta M, Villoria Borrego L, Ochoa Mangado E.","Actas Esp Psiquiatr. 2004 Jul-Aug;32(4):199-210.","Madoz-Gúrpide A","Actas Esp Psiquiatr","2004","2004/07/03","","",""
"15232337","Naltrexone treatment of tardive dyskinesia in patients with schizophrenia","Wonodi I, Adami H, Sherr J, Avila M, Hong LE, Thaker GK.","J Clin Psychopharmacol. 2004 Aug;24(4):441-5. doi: 10.1097/01.jcp.0000132440.27854.44.","Wonodi I","J Clin Psychopharmacol","2004","2004/07/03","","","10.1097/01.jcp.0000132440.27854.44"
"15232334","A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence","Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S.","J Clin Psychopharmacol. 2004 Aug;24(4):421-8. doi: 10.1097/01.jcp.0000130555.63254.73.","Anton RF","J Clin Psychopharmacol","2004","2004/07/03","","","10.1097/01.jcp.0000130555.63254.73"
"15225891","A randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence","Rea F, Bell JR, Young MR, Mattick RP.","Drug Alcohol Depend. 2004 Jul 15;75(1):79-88. doi: 10.1016/j.drugalcdep.2004.02.003.","Rea F","Drug Alcohol Depend","2004","2004/07/01","","","10.1016/j.drugalcdep.2004.02.003"
"15222772","What place does naltrexone have in the treatment of alcoholism?","Rohsenow DJ.","CNS Drugs. 2004;18(9):547-60. doi: 10.2165/00023210-200418090-00001.","Rohsenow DJ","CNS Drugs","2004","2004/06/30","","","10.2165/00023210-200418090-00001"
"15219821","Chronic administration of nalmefene leads to increased food intake and body weight gain in mice","Chen RZ, Huang RR, Shen CP, MacNeil DJ, Fong TM.","Eur J Pharmacol. 2004 Jul 8;495(1):63-6. doi: 10.1016/j.ejphar.2004.05.025.","Chen RZ","Eur J Pharmacol","2004","2004/06/29","","","10.1016/j.ejphar.2004.05.025"
"15219763","Naltrexone does not prevent acquisition or expression of flavor preferences conditioned by fructose in rats","Baker RW, Li Y, Lee MG, Sclafani A, Bodnar RJ.","Pharmacol Biochem Behav. 2004 Jun;78(2):239-46. doi: 10.1016/j.pbb.2004.03.013.","Baker RW","Pharmacol Biochem Behav","2004","2004/06/29","","","10.1016/j.pbb.2004.03.013"
"15219707","Opposite effects of acute versus chronic naltrexone administration on ethanol-induced locomotion","Sanchis-Segura C, Pastor R, Aragon CM.","Behav Brain Res. 2004 Aug 12;153(1):61-7. doi: 10.1016/j.bbr.2003.11.003.","Sanchis-Segura C","Behav Brain Res","2004","2004/06/29","","","10.1016/j.bbr.2003.11.003"
"15212969","Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine","Amarante LH, Alves DP, Duarte ID.","Eur J Pharmacol. 2004 Jun 28;494(2-3):155-60. doi: 10.1016/j.ejphar.2004.05.009.","Amarante LH","Eur J Pharmacol","2004","2004/06/24","","","10.1016/j.ejphar.2004.05.009"
"15212965","Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists","Emmerson PJ, McKinzie JH, Surface PL, Suter TM, Mitch CH, Statnick MA.","Eur J Pharmacol. 2004 Jun 28;494(2-3):121-30. doi: 10.1016/j.ejphar.2004.04.050.","Emmerson PJ","Eur J Pharmacol","2004","2004/06/24","","","10.1016/j.ejphar.2004.04.050"
"15210757","Opioid antagonist naltrexone disrupts feedback interaction between mu and delta opioid receptors in splenocytes to prevent alcohol inhibition of NK cell function","Boyadjieva NI, Chaturvedi K, Poplawski MM, Sarkar DK.","J Immunol. 2004 Jul 1;173(1):42-9. doi: 10.4049/jimmunol.173.1.42.","Boyadjieva NI","J Immunol","2004","2004/06/24","","","10.4049/jimmunol.173.1.42"
"15204037","Interactions of ""ultra-low"" doses of naltrexone and morphine in mature and young male and female rats","Hamann SR, Malik H, Sloan JW, Wala EP.","Receptors Channels. 2004;10(2):73-81. doi: 10.1080/10606820490464334.","Hamann SR","Receptors Channels","2004","2004/06/19","","","10.1080/10606820490464334"
"15203443","Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature","Brewer C, Wong VS.","Addict Biol. 2004 Mar;9(1):81-7. doi: 10.1080/13556210410001674130.","Brewer C","Addict Biol","2004","2004/06/19","","","10.1080/13556210410001674130"
"15203441","Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants","Hulse GK, Arnold-Reed DE, O'Neil G, Chan CT, Hansson RC.","Addict Biol. 2004 Mar;9(1):67-72. doi: 10.1080/13556210410001674112.","Hulse GK","Addict Biol","2004","2004/06/19","","","10.1080/13556210410001674112"
"15203440","Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants","Hulse GK, Arnold-Reed DE, O'Neil G, Chan CT, Hansson R, O'Neil P.","Addict Biol. 2004 Mar;9(1):59-65. doi: 10.1080/13556210410001674103.","Hulse GK","Addict Biol","2004","2004/06/19","","","10.1080/13556210410001674103"
"15200577","Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review","Bouza C, Angeles M, Muñoz A, Amate JM.","Addiction. 2004 Jul;99(7):811-28. doi: 10.1111/j.1360-0443.2004.00763.x.","Bouza C","Addiction","2004","2004/06/18","","","10.1111/j.1360-0443.2004.00763.x"
"15196755","A duplex ""Gemini"" prodrug of naltrexone for transdermal delivery","Hammell DC, Hamad M, Vaddi HK, Crooks PA, Stinchcomb AL.","J Control Release. 2004 Jun 18;97(2):283-90. doi: 10.1016/j.jconrel.2004.03.020.","Hammell DC","J Control Release","2004","2004/06/16","","","10.1016/j.jconrel.2004.03.020"
"15193076","Reversible anesthesia of captive California sea lions (Zalophus californianus) with medetomidine, midazolam, butorphanol, and isoflurane","Spelman LH.","J Zoo Wildl Med. 2004 Mar;35(1):65-9. doi: 10.1638/01-102.","Spelman LH","J Zoo Wildl Med","2004","2004/06/15","","","10.1638/01-102"
"15189765","The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat","Cox ML, Welch SP.","Eur J Pharmacol. 2004 Jun 16;493(1-3):65-74. doi: 10.1016/j.ejphar.2004.04.022.","Cox ML","Eur J Pharmacol","2004","2004/06/11","","","10.1016/j.ejphar.2004.04.022"
"15183169","Instrumental learning within the spinal cord: III. Prior exposure to noncontingent shock induces a behavioral deficit that is blocked by an opioid antagonist","Joynes RL, Grau JW.","Neurobiol Learn Mem. 2004 Jul;82(1):35-51. doi: 10.1016/j.nlm.2004.04.001.","Joynes RL","Neurobiol Learn Mem","2004","2004/06/09","","","10.1016/j.nlm.2004.04.001"
"15182893","Naltrexone for heroin dependence treatment in St. Petersburg, Russia","Krupitsky EM, Zvartau EE, Masalov DV, Tsoi MV, Burakov AM, Egorova VY, Didenko TY, Romanova TN, Ivanova EB, Bespalov AY, Verbitskaya EV, Neznanov NG, Grinenko AY, O'Brien CP, Woody GE.","J Subst Abuse Treat. 2004 Jun;26(4):285-94. doi: 10.1016/j.jsat.2004.02.002.","Krupitsky EM","J Subst Abuse Treat","2004","2004/06/09","","","10.1016/j.jsat.2004.02.002"
"15178915","A comparative study on the effects of naltrexone and loratadine on uremic pruritus","Legroux-Crespel E, Clèdes J, Misery L.","Dermatology. 2004;208(4):326-30. doi: 10.1159/000077841.","Legroux-Crespel E","Dermatology","2004","2004/06/05","","","10.1159/000077841"
"15177920","Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats","Gao L, Yu LC.","Regul Pept. 2004 Aug 15;120(1-3):53-8. doi: 10.1016/j.regpep.2004.02.011.","Gao L","Regul Pept","2004","2004/06/05","","","10.1016/j.regpep.2004.02.011"
"15165712","Supraspinal anti-allodynic and rewarding effects of endomorphins in rats","Huang EY, Chen CM, Tao PL.","Peptides. 2004 Apr;25(4):577-83. doi: 10.1016/j.peptides.2004.02.009.","Huang EY","Peptides","2004","2004/05/29","","","10.1016/j.peptides.2004.02.009"
"15164157","Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures","Harris AC, Hanes SL, Gewirtz JC.","Psychopharmacology (Berl). 2004 Nov;176(3-4):266-73. doi: 10.1007/s00213-004-1889-4. Epub 2004 May 26.","Harris AC","Psychopharmacology (Berl)","2004","2004/05/28","","","10.1007/s00213-004-1889-4"
"15163177","A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers","Bhushan RG, Sharma SK, Xie Z, Daniels DJ, Portoghese PS.","J Med Chem. 2004 Jun 3;47(12):2969-72. doi: 10.1021/jm0342358.","Bhushan RG","J Med Chem","2004","2004/05/28","","","10.1021/jm0342358"
"15153753","Mu opioid modulation of oxytocin secretion in late pregnant and parturient rats. Involvement of noradrenergic neurotransmission","Kutlu S, Yilmaz B, Canpolat S, Sandal S, Ozcan M, Kumru S, Kelestimur H.","Neuroendocrinology. 2004;79(4):197-203. doi: 10.1159/000078101. Epub 2004 May 18.","Kutlu S","Neuroendocrinology","2004","2004/05/22","","","10.1159/000078101"
"15150936","The treatment of alcohol dependence--new horizons","Pienaar W.","S Afr Med J. 2004 Apr;94(4):264-6.","Pienaar W","S Afr Med J","2004","2004/05/21","","",""
"15140631","5-HT3 antagonist ICS 205-930 enhances naltrexone's effects on ethanol intake","Mhatre M, Pruthi R, Hensley K, Holloway F.","Eur J Pharmacol. 2004 May 3;491(2-3):149-56. doi: 10.1016/j.ejphar.2004.03.011.","Mhatre M","Eur J Pharmacol","2004","2004/05/14","","","10.1016/j.ejphar.2004.03.011"
"15138586","Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells","Zagon IS, McLaughlin PJ.","Int J Oncol. 2004 Jun;24(6):1443-8.","Zagon IS","Int J Oncol","2004","2004/05/13","","",""
"15135926","Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans","Holzer P.","Neurosci Lett. 2004 May 6;361(1-3):192-5. doi: 10.1016/j.neulet.2003.12.004.","Holzer P","Neurosci Lett","2004","2004/05/12","","","10.1016/j.neulet.2003.12.004"
"15130554","Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD)--correlation with neurophysiological parameters--","Freye E, Levy JV, Partecke L.","Neurophysiol Clin. 2004 Apr;34(2):81-9. doi: 10.1016/j.neucli.2004.02.002.","Freye E","Neurophysiol Clin","2004","2004/05/08","","","10.1016/j.neucli.2004.02.002"
"15120597","Effect of protein kinases on lactate dehydrogenase activity in cortical neurons during hypoxia","Hong SS, Gibney GT, Esquilin M, Yu J, Xia Y.","Brain Res. 2004 May 29;1009(1-2):195-202. doi: 10.1016/j.brainres.2004.03.004.","Hong SS","Brain Res","2004","2004/05/04","","","10.1016/j.brainres.2004.03.004"
"15112935","Building bridges: the transdisciplinary study of craving from the animal laboratory to the lamppost","Monti PM, Tidey J, Czachowski CL, Grant KA, Rohsenow DJ, Sayette M, Maners N, Pierre P.","Alcohol Clin Exp Res. 2004 Feb;28(2):279-87. doi: 10.1097/01.alc.0000113422.04849.fa.","Monti PM","Alcohol Clin Exp Res","2004","2004/04/29","","","10.1097/01.alc.0000113422.04849.fa"
"15112031","Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys","Negus SS.","Psychopharmacology (Berl). 2004 Nov;176(2):204-13. doi: 10.1007/s00213-004-1878-7. Epub 2004 Apr 27.","Negus SS","Psychopharmacology (Berl)","2004","2004/04/28","","","10.1007/s00213-004-1878-7"
"15102530","Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms","Murakawa K, Hirose N, Takada K, Suzuki T, Nagase H, Cools AR, Koshikawa N.","Eur J Pharmacol. 2004 Apr 26;491(1):31-6. doi: 10.1016/j.ejphar.2004.03.028.","Murakawa K","Eur J Pharmacol","2004","2004/04/23","","","10.1016/j.ejphar.2004.03.028"
"15102522","Effect of novel non-peptidic delta opioid receptor antagonists on human T and B cell activation","D'Ambrosio A, Noviello L, Negri L, Schmidhammer H, Quintieri F.","Life Sci. 2004 May 21;75(1):63-75. doi: 10.1016/j.lfs.2003.12.003.","D'Ambrosio A","Life Sci","2004","2004/04/23","","","10.1016/j.lfs.2003.12.003"
"15100607","Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic-pituitary-adrenal activity in rhesus monkeys","Williams KL, Broadbear JH, Woods JH.","Alcohol Clin Exp Res. 2004 Apr;28(4):566-71. doi: 10.1097/01.alc.0000121655.48922.c4.","Williams KL","Alcohol Clin Exp Res","2004","2004/04/22","","","10.1097/01.alc.0000121655.48922.c4"
"15099783","Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user","Hulse GK, O'Neil G, Arnold-Reed DE.","Int J Gynaecol Obstet. 2004 May;85(2):170-1. doi: 10.1016/j.ijgo.2003.10.001.","Hulse GK","Int J Gynaecol Obstet","2004","2004/04/22","","","10.1016/j.ijgo.2003.10.001"
"15093968","Add-on gabapentin in the treatment of opiate withdrawal","Martínez-Raga J, Sabater A, Perez-Galvez B, Castellano M, Cervera G.","Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):599-601. doi: 10.1016/j.pnpbp.2003.11.020.","Martínez-Raga J","Prog Neuropsychopharmacol Biol Psychiatry","2004","2004/04/20","","","10.1016/j.pnpbp.2003.11.020"
"15093714","Relative contribution of endogenous opioids to myocardial ischemic tolerance","Romano MA, Seymour EM, Berry JA, McNish RA, Bolling SF.","J Surg Res. 2004 May 1;118(1):32-7. doi: 10.1016/j.jss.2003.12.006.","Romano MA","J Surg Res","2004","2004/04/20","","","10.1016/j.jss.2003.12.006"
"15085560","Naltrexone antagonism of morphine antinociception in sucrose- and chow-fed rats","D'Anci KE, Kanarek RB.","Nutr Neurosci. 2004 Feb;7(1):57-61. doi: 10.1080/1028415042000198807.","D'Anci KE","Nutr Neurosci","2004","2004/04/17","","","10.1080/1028415042000198807"
"15078558","Differential regulation of hippocampal progenitor proliferation by opioid receptor antagonists in running and non-running spontaneously hypertensive rats","Persson AI, Naylor AS, Jonsdottir IH, Nyberg F, Eriksson PS, Thorlin T.","Eur J Neurosci. 2004 Apr;19(7):1847-55. doi: 10.1111/j.1460-9568.2004.03268.x.","Persson AI","Eur J Neurosci","2004","2004/04/14","","","10.1111/j.1460-9568.2004.03268.x"
"15077841","Unexpected delirium during Rapid Opioid Detoxification (ROD)","Golden SA, Sakhrani DL.","J Addict Dis. 2004;23(1):65-75. doi: 10.1300/J069v23n01_06.","Golden SA","J Addict Dis","2004","2004/04/14","","","10.1300/J069v23n01_06"
"15066462","Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study","Cucinelli F, Soranna L, Perri C, Barini A, Cento RM, Mancuso S, Lanzone A.","Fertil Steril. 2004 Apr;81(4):1047-54. doi: 10.1016/j.fertnstert.2003.05.036.","Cucinelli F","Fertil Steril","2004","2004/04/07","","","10.1016/j.fertnstert.2003.05.036"
"15065964","Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers","Kranzler HR, Armeli S, Feinn R, Tennen H.","J Consult Clin Psychol. 2004 Apr;72(2):317-27. doi: 10.1037/0022-006X.72.2.317.","Kranzler HR","J Consult Clin Psychol","2004","2004/04/07","","","10.1037/0022-006X.72.2.317"
"15063013","Functional opioid pathways are necessary for hypocretin-1 (orexin-A)-induced feeding","Sweet DC, Levine AS, Kotz CM.","Peptides. 2004 Feb;25(2):307-14. doi: 10.1016/j.peptides.2003.12.014.","Sweet DC","Peptides","2004","2004/04/06","","","10.1016/j.peptides.2003.12.014"
"15055889","Supraspinal and spinal cord opioid receptors are responsible for antinociception following intrathecal morphine injections","Goodchild CS, Nadeson R, Cohen E.","Eur J Anaesthesiol. 2004 Mar;21(3):179-85. doi: 10.1017/s0265021504003035.","Goodchild CS","Eur J Anaesthesiol","2004","2004/04/02","","","10.1017/s0265021504003035"
"15051522","delta-Opioid receptor antagonists inhibit GIRK channel currents in acutely dissociated brainstem neurons of rat","Shirasaki T, Abe K, Soeda F, Takahama K.","Brain Res. 2004 May 1;1006(2):190-7. doi: 10.1016/j.brainres.2004.02.004.","Shirasaki T","Brain Res","2004","2004/03/31","","","10.1016/j.brainres.2004.02.004"
"15051160","Genetic and pharmacological manipulation of mu opioid receptors in mice reveals a differential effect on behavioral sensitization to cocaine","Hummel M, Ansonoff MA, Pintar JE, Unterwald EM.","Neuroscience. 2004;125(1):211-20. doi: 10.1016/j.neuroscience.2004.01.025.","Hummel M","Neuroscience","2004","2004/03/31","","","10.1016/j.neuroscience.2004.01.025"
"15050620","Sensitivity of neuronal nicotinic acetylcholine receptors to the opiate antagonists naltrexone and naloxone: receptor blockade and up-regulation","Almeida LE, Pereira EF, Camara AL, Maelicke A, Albuquerque EX.","Bioorg Med Chem Lett. 2004 Apr 19;14(8):1879-87. doi: 10.1016/j.bmcl.2004.01.004.","Almeida LE","Bioorg Med Chem Lett","2004","2004/03/31","","","10.1016/j.bmcl.2004.01.004"
"15049745","Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)","Digiusto E, Shakeshaft A, Ritter A, O'Brien S, Mattick RP; NEPOD Research Group.","Addiction. 2004 Apr;99(4):450-60. doi: 10.1111/j.1360-0443.2004.00654.x.","Digiusto E","Addiction","2004","2004/03/31","","","10.1111/j.1360-0443.2004.00654.x"
"15044534","Role of hippocampal CA3 mu-opioid receptors in spatial learning and memory","Meilandt WJ, Barea-Rodriguez E, Harvey SA, Martinez JL Jr.","J Neurosci. 2004 Mar 24;24(12):2953-62. doi: 10.1523/JNEUROSCI.5569-03.2004.","Meilandt WJ","J Neurosci","2004","2004/03/27","PMC6729851","","10.1523/JNEUROSCI.5569-03.2004"
"15043984","Methylnaltrexone prevents morphine-induced kaolin intake in the rat","Aung HH, Mehendale SR, Xie JT, Moss J, Yuan CS.","Life Sci. 2004 Apr 16;74(22):2685-91. doi: 10.1016/j.lfs.2003.08.047.","Aung HH","Life Sci","2004","2004/03/27","","","10.1016/j.lfs.2003.08.047"
"15039504","Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade","al'Absi M, Wittmers LE, Ellestad D, Nordehn G, Kim SW, Kirschbaum C, Grant JE.","Psychosom Med. 2004 Mar-Apr;66(2):198-206. doi: 10.1097/01.psy.0000116250.81254.5d.","al'Absi M","Psychosom Med","2004","2004/03/25","","","10.1097/01.psy.0000116250.81254.5d"
"15037219","Buprenorphine produces naltrexone reversible alterations of immune status","Carrigan KA, Saurer TB, Ijames SG, Lysle DT.","Int Immunopharmacol. 2004 Mar;4(3):419-28. doi: 10.1016/j.intimp.2004.01.011.","Carrigan KA","Int Immunopharmacol","2004","2004/03/24","","","10.1016/j.intimp.2004.01.011"
"15034918","Kinetics of beta-funaltrexamine binding to wild-type and mutant mu-opioid receptors expressed in Chinese hamster ovary cells","Spivak CE, Beglan CL.","Synapse. 2004 May;52(2):123-35. doi: 10.1002/syn.20014.","Spivak CE","Synapse","2004","2004/03/23","","","10.1002/syn.20014"
"15030891","Determination of naltrexone and 6-beta-naltrexol in human plasma following implantation of naltrexone pellets using gas chromatography-mass spectrometry","Toennes SW, Kauert GF, Grüsser SM, Jäkel W, Partecke G.","J Pharm Biomed Anal. 2004 Apr 1;35(1):169-76. doi: 10.1016/j.jpba.2004.01.013.","Toennes SW","J Pharm Biomed Anal","2004","2004/03/20","","","10.1016/j.jpba.2004.01.013"
"15029983","Controlled trial of maintenance treatment of intravenous buprenorphine dependence","Ahmadi J, Ahmadi K.","Ir J Med Sci. 2003 Oct-Dec;172(4):171-3. doi: 10.1007/BF02915283.","Ahmadi J","Ir J Med Sci","2003","2004/03/20","","","10.1007/BF02915283"
"15024546","Application of a simple and sensitive GC-MS method for determination of morphine in the hair of opium abusers","Sabzevari O, Abdi Kh, Amini M, Shafiee A.","Anal Bioanal Chem. 2004 May;379(1):120-4. doi: 10.1007/s00216-004-2563-8. Epub 2004 Mar 13.","Sabzevari O","Anal Bioanal Chem","2004","2004/03/17","","","10.1007/s00216-004-2563-8"
"15018691","Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation","Grant JE, Grosz R.","J Geriatr Psychiatry Neurol. 2004 Mar;17(1):9-12. doi: 10.1177/0891988703262000.","Grant JE","J Geriatr Psychiatry Neurol","2004","2004/03/17","","","10.1177/0891988703262000"
"15001719","Datapoints: Trends in naltrexone use among members of a large private health plan","Harris KM, DeVries A, Dimidjian K.","Psychiatr Serv. 2004 Mar;55(3):221. doi: 10.1176/appi.ps.55.3.221.","Harris KM","Psychiatr Serv","2004","2004/03/06","","","10.1176/appi.ps.55.3.221"
"15000897","Opioid receptor antagonists increase [Ca2+]i in rat arterial smooth muscle cells in hemorrhagic shock","Kai L, Wang ZF, Shi YL, Liu LM, Hu DY.","Acta Pharmacol Sin. 2004 Mar;25(3):395-400.","Kai L","Acta Pharmacol Sin","2004","2004/03/06","","",""
"14999057","Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord","Wu HE, Thompson J, Sun HS, Leitermann RJ, Fujimoto JM, Tseng LF.","J Pharmacol Exp Ther. 2004 Jul;310(1):240-6. doi: 10.1124/jpet.104.065334. Epub 2004 Mar 3.","Wu HE","J Pharmacol Exp Ther","2004","2004/03/05","","","10.1124/jpet.104.065334"
"14994264","Social learning about ethanol in preweanling rats: role of endogenous opioids","Hallmark RA, Hunt PS.","Dev Psychobiol. 2004 Mar;44(2):132-9. doi: 10.1002/dev.10163.","Hallmark RA","Dev Psychobiol","2004","2004/03/03","","","10.1002/dev.10163"
"14993372","The near-death experience of delta opioid receptors leads to new drug targets","Bartlett SE, Whistler JL.","Mol Interv. 2002 Jun;2(3):134-6. doi: 10.1124/mi.2.3.134.","Bartlett SE","Mol Interv","2002","2004/03/03","","","10.1124/mi.2.3.134"
"14988322","Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders","Raingeard I, Courtet P, Renard E, Bringer J.","Diabetes Care. 2004 Mar;27(3):847-8. doi: 10.2337/diacare.27.3.847.","Raingeard I","Diabetes Care","2004","2004/02/28","","","10.2337/diacare.27.3.847"
"14985838","Effects of chronic administration of PL017 and beta-funaltrexamine hydrochloride on susceptibility of kainic acid-induced seizures in rats","Liu H, Gao HM, Zhang WQ, Tang YY, Song HS.","Sheng Li Xue Bao. 2004 Feb 25;56(1):101-6.","Liu H","Sheng Li Xue Bao","2004","2004/02/27","","",""
"14981261","Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system","Fernández-Solari J, Scorticati C, Mohn C, De Laurentiis A, Billi S, Franchi A, McCann SM, Rettori V.","Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3264-8. doi: 10.1073/pnas.0307346101. Epub 2004 Feb 23.","Fernández-Solari J","Proc Natl Acad Sci U S A","2004","2004/02/26","PMC365778","","10.1073/pnas.0307346101"
"14972781","Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective","Soyka M, Chick J.","Am J Addict. 2003;12(s1):s69-s80. doi: 10.1111/j.1521-0391.2003.tb00497.x.","Soyka M","Am J Addict","2003","2004/02/20","","","10.1111/j.1521-0391.2003.tb00497.x"
"14972780","Current pharmacotherapies of alcoholism: a U.S. perspective","Anton RF, Swift RM.","Am J Addict. 2003;12(s1):s53-s68. doi: 10.1111/j.1521-0391.2003.tb00496.x.","Anton RF","Am J Addict","2003","2004/02/20","","","10.1111/j.1521-0391.2003.tb00496.x"
"14972776","Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence","Littleton J, Zieglgänsberger W.","Am J Addict. 2003;12(s1):s3-s11. doi: 10.1111/j.1521-0391.2003.tb00492.x.","Littleton J","Am J Addict","2003","2004/02/20","","","10.1111/j.1521-0391.2003.tb00492.x"
"14962489","Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart","Weinbrenner C, Schulze F, Sárváry L, Strasser RH.","Cardiovasc Res. 2004 Feb 15;61(3):591-9. doi: 10.1016/j.cardiores.2003.10.008.","Weinbrenner C","Cardiovasc Res","2004","2004/02/14","","","10.1016/j.cardiores.2003.10.008"
"14960343","Temporal dissociation of the feedback effects of dendritically co-released peptides on rhythmogenesis in vasopressin cells","Brown CH, Ludwig M, Leng G.","Neuroscience. 2004;124(1):105-11. doi: 10.1016/j.neuroscience.2003.11.038.","Brown CH","Neuroscience","2004","2004/02/13","","","10.1016/j.neuroscience.2003.11.038"
"14870516","[Drug therapy of alcohol dependence--a critical review]","Salaspuro M.","Duodecim. 2003;119(24):2503-7.","Salaspuro M","Duodecim","2003","2004/02/12","","",""
"14761209","Importance of phenolic address groups in opioid kappa receptor selective antagonists","Thomas JB, Fix SE, Rothman RB, Mascarella SW, Dersch CM, Cantrell BE, Zimmerman DM, Carroll FI.","J Med Chem. 2004 Feb 12;47(4):1070-3. doi: 10.1021/jm030467v.","Thomas JB","J Med Chem","2004","2004/02/06","","","10.1021/jm030467v"
"14759503","Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice","Chen RZ, Huang RR, Shen CP, MacNeil DJ, Fong TM.","Brain Res. 2004 Mar 5;999(2):227-30. doi: 10.1016/j.brainres.2003.12.004.","Chen RZ","Brain Res","2004","2004/02/05","","","10.1016/j.brainres.2003.12.004"
"14755004","Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat","Terashvili M, Wu HE, Leitermann RJ, Hung KC, Clithero AD, Schwasinger ET, Tseng LF.","J Pharmacol Exp Ther. 2004 May;309(2):816-24. doi: 10.1124/jpet.103.059287. Epub 2004 Jan 30.","Terashvili M","J Pharmacol Exp Ther","2004","2004/02/03","","","10.1124/jpet.103.059287"
"14752586","Effects of morphine and naltrexone on impulsive decision making in rats","Kieres AK, Hausknecht KA, Farrar AM, Acheson A, de Wit H, Richards JB.","Psychopharmacology (Berl). 2004 Apr;173(1-2):167-74. doi: 10.1007/s00213-003-1697-2. Epub 2004 Jan 30.","Kieres AK","Psychopharmacology (Berl)","2004","2004/01/31","","","10.1007/s00213-003-1697-2"
"14750508","Naltrexone and nicotine patch smoking cessation: a preliminary study","Krishnan-Sarin S, Meandzija B, O'Malley S.","Nicotine Tob Res. 2003 Dec;5(6):851-7. doi: 10.1080/14622200310001614601.","Krishnan-Sarin S","Nicotine Tob Res","2003","2004/01/31","","","10.1080/14622200310001614601"
"14748873","Intestinal inflammation alters the susceptibility to pentylenetetrazole-induced seizure in mice","Riazi K, Honar H, Homayoun H, Demehri S, Bahadori M, Dehpour AR.","J Gastroenterol Hepatol. 2004 Mar;19(3):270-7. doi: 10.1111/j.1440-1746.2003.03284.x.","Riazi K","J Gastroenterol Hepatol","2004","2004/01/30","","","10.1111/j.1440-1746.2003.03284.x"
"14746884","Region-dependent G-protein activation by kappa-opioid receptor agonists in the mouse brain","Mizoguchi H, Leitermann RJ, Narita M, Nagase H, Suzuki T, Tseng LF.","Neurosci Lett. 2004 Feb 12;356(2):145-7. doi: 10.1016/j.neulet.2003.09.034.","Mizoguchi H","Neurosci Lett","2004","2004/01/30","","","10.1016/j.neulet.2003.09.034"
"14742380","Differential opioid inhibition of C- and A delta- fiber mediated thermonociception after stimulation of the nucleus raphe magnus","Lu Y, Sweitzer SM, Laurito CE, Yeomans DC.","Anesth Analg. 2004 Feb;98(2):414-9, table of contents. doi: 10.1213/01.ane.0000094334.12027.06.","Lu Y","Anesth Analg","2004","2004/01/27","","","10.1213/01.ane.0000094334.12027.06"
"14741774","Reversal of ongoing thermal hyperalgesia in mice by a recombinant herpesvirus that encodes human preproenkephalin","Yeomans DC, Jones T, Laurito CE, Lu Y, Wilson SP.","Mol Ther. 2004 Jan;9(1):24-9. doi: 10.1016/j.ymthe.2003.10.008.","Yeomans DC","Mol Ther","2004","2004/01/27","","","10.1016/j.ymthe.2003.10.008"
"14741441","Antibody response and allogeneic mixed lymphocyte reaction in mu-, delta-, and kappa-opioid receptor knockout mice","Gaveriaux-Ruff C, Simonin F, Filliol D, Kieffer B.","J Neuroimmunol. 2004 Feb;147(1-2):121-2. doi: 10.1016/j.jneuroim.2003.10.025.","Gaveriaux-Ruff C","J Neuroimmunol","2004","2004/01/27","","","10.1016/j.jneuroim.2003.10.025"
"14733280","A comparison of carfentanil/xylazine and Telazol/xylazine for immobilization of white-tailed deer","Miller BF, Muller LI, Storms TN, Ramsay EC, Osborn DA, Warren RJ, Miller KV, Adams KA.","J Wildl Dis. 2003 Oct;39(4):851-8. doi: 10.7589/0090-3558-39.4.851.","Miller BF","J Wildl Dis","2003","2004/01/22","","","10.7589/0090-3558-39.4.851"
"14728803","Lymphocyte reduction induced by hindlimb unloading: distinct mechanisms in the spleen and thymus","Wei LX, Zhou JN, Roberts AI, Shi YF.","Cell Res. 2003 Dec;13(6):465-71. doi: 10.1038/sj.cr.7290189.","Wei LX","Cell Res","2003","2004/01/20","","","10.1038/sj.cr.7290189"
"14727002","Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats","Todtenkopf MS, Marcus JF, Portoghese PS, Carlezon WA Jr.","Psychopharmacology (Berl). 2004 Apr;172(4):463-70. doi: 10.1007/s00213-003-1680-y. Epub 2004 Jan 16.","Todtenkopf MS","Psychopharmacology (Berl)","2004","2004/01/17","","","10.1007/s00213-003-1680-y"
"14724039","Naltrexone attenuates acute cigarette smoking behavior","Epstein AM, King AC.","Pharmacol Biochem Behav. 2004 Jan;77(1):29-37. doi: 10.1016/j.pbb.2003.09.017.","Epstein AM","Pharmacol Biochem Behav","2004","2004/01/16","","","10.1016/j.pbb.2003.09.017"
"14723960","Syntheses and receptor-binding studies of derivatives of the opioid antagonist naltrexone","Uwai K, Uchiyama H, Sakurada S, Kabuto C, Takeshita M.","Bioorg Med Chem. 2004 Jan 15;12(2):417-21. doi: 10.1016/j.bmc.2003.10.039.","Uwai K","Bioorg Med Chem","2004","2004/01/16","","","10.1016/j.bmc.2003.10.039"
"14722705","Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking","Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D.","Psychopharmacology (Berl). 2004 Apr;173(1-2):32-40. doi: 10.1007/s00213-003-1720-7. Epub 2004 Jan 14.","Anton RF","Psychopharmacology (Berl)","2004","2004/01/15","","","10.1007/s00213-003-1720-7"
"14717319","Naltrexone implant and blood naltrexone levels over pregnancy","Hulse GK, Arnold-Reed DE, O'Neil G, Hansson RC.","Aust N Z J Obstet Gynaecol. 2003 Oct;43(5):386-8. doi: 10.1046/j.0004-8666.2003.00121.x.","Hulse GK","Aust N Z J Obstet Gynaecol","2003","2004/01/14","","","10.1046/j.0004-8666.2003.00121.x"
"14712342","Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice","Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ.","Psychopharmacology (Berl). 2004 Apr;173(1-2):146-52. doi: 10.1007/s00213-003-1716-3. Epub 2004 Jan 8.","Zhang Y","Psychopharmacology (Berl)","2004","2004/01/09","","","10.1007/s00213-003-1716-3"
"14708606","Sex differences in opioid-induced enhancement of contact hypersensitivity","Elliott JC, Picker MJ, Nelson CJ, Carrigan KA, Lysle DT.","J Invest Dermatol. 2003 Nov;121(5):1053-9. doi: 10.1046/j.1523-1747.2003.12569.x.","Elliott JC","J Invest Dermatol","2003","2004/01/08","","","10.1046/j.1523-1747.2003.12569.x"
"14706785","Mu opioid control of the N-methyl-D-aspartate-evoked release of [3H]-acetylcholine in the limbic territory of the rat striatum in vitro: diurnal variations and implication of a dopamine link","Jabourian M, Bourgoin S, Pérez S, Godeheu G, Glowinski J, Kemel ML.","Neuroscience. 2004;123(3):733-42. doi: 10.1016/j.neuroscience.2003.10.017.","Jabourian M","Neuroscience","2004","2004/01/07","","","10.1016/j.neuroscience.2003.10.017"
"14699892","Differential antinociceptive effects of L-arginine and 3-morpholinosydoimine","Chung E, Day E, Bieber A, Ohgami Y, Quock RM.","Proc West Pharmacol Soc. 2003;46:78-9.","Chung E","Proc West Pharmacol Soc","2003","2004/01/01","","",""
"14696053","Radial arm maze performance of rats following repeated low level microwave radiation exposure","Cobb BL, Jauchem JR, Adair ER.","Bioelectromagnetics. 2004 Jan;25(1):49-57. doi: 10.1002/bem.10148.","Cobb BL","Bioelectromagnetics","2004","2003/12/30","","","10.1002/bem.10148"
"14691376","Chronic ethanol consumption by C57BL/6 mice promotes tolerance to its interoceptive cues and increases extracellular dopamine, an effect blocked by naltrexone","Middaugh LD, Szumlinski KK, Van Patten Y, Marlowe AL, Kalivas PW.","Alcohol Clin Exp Res. 2003 Dec;27(12):1892-900. doi: 10.1097/01.ALC.0000099264.36220.48.","Middaugh LD","Alcohol Clin Exp Res","2003","2003/12/24","","","10.1097/01.ALC.0000099264.36220.48"
"14691068","Effect of naltrexone administration on short-term memory in chronically ethanol-treated outbred rats","Okulicz-Kozaryn I, Mikolajczak P, Kaminska E, Kaminska I, Szulc M, Bobkiewicz-Kozlowska T.","Alcohol Alcohol. 2004 Jan-Feb;39(1):14-9. doi: 10.1093/alcalc/agh010.","Okulicz-Kozaryn I","Alcohol Alcohol","2004","2003/12/24","","","10.1093/alcalc/agh010"
"14690879","Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence","Carreño JE, Alvarez CE, Narciso GI, Bascarán MT, Díaz M, Bobes J.","Addict Biol. 2003 Dec;8(4):429-38. doi: 10.1080/13556210310001646402.","Carreño JE","Addict Biol","2003","2003/12/24","","","10.1080/13556210310001646402"
"14681963","[Detoxification in withdrawal state in methadone maintenance patients]","Sivolap I, Savchenkov VA, Aksel'rod BA, Kubarev DA, Chichenkov TO.","Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(11):33-7.","Sivolap I","Zh Nevrol Psikhiatr Im S S Korsakova","2003","2003/12/20","","",""
"14678454","Effect of the combination of naltrexone and acamprosate on alcohol intake in mice","Kim SG, Han BD, Park JM, Kim MJ, Stromberg MF.","Psychiatry Clin Neurosci. 2004 Feb;58(1):30-6. doi: 10.1111/j.1440-1819.2004.01189.x.","Kim SG","Psychiatry Clin Neurosci","2004","2003/12/18","","","10.1111/j.1440-1819.2004.01189.x"
"14668977","The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys","Justinova Z, Tanda G, Munzar P, Goldberg SR.","Psychopharmacology (Berl). 2004 Apr;173(1-2):186-94. doi: 10.1007/s00213-003-1693-6. Epub 2003 Dec 11.","Justinova Z","Psychopharmacology (Berl)","2004","2003/12/12","","","10.1007/s00213-003-1693-6"
"14666517","Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response","Spadoni F, Martella G, Martorana A, Lavaroni F, D'Angelo V, Bernardi G, Stefani A.","Synapse. 2004 Mar 1;51(3):194-205. doi: 10.1002/syn.10294.","Spadoni F","Synapse","2004","2003/12/11","","","10.1002/syn.10294"
"14666116","GABA(A) and opioid receptors of the central nucleus of the amygdala selectively regulate ethanol-maintained behaviors","Foster KL, McKay PF, Seyoum R, Milbourne D, Yin W, Sarma PV, Cook JM, June HL.","Neuropsychopharmacology. 2004 Feb;29(2):269-84. doi: 10.1038/sj.npp.1300306.","Foster KL","Neuropsychopharmacology","2004","2003/12/11","","","10.1038/sj.npp.1300306"
"14665981","Enhanced sensitivity to the antinociceptive effects of kappa opioids in naltrexone-treated rats: dose- and time-dependent effects","Smith MA, McClean JM, Greene JL.","Behav Pharmacol. 2003 Dec;14(8):641-7. doi: 10.1097/00008877-200312000-00008.","Smith MA","Behav Pharmacol","2003","2003/12/11","","","10.1097/00008877-200312000-00008"
"14663553","Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats","Gallate JE, Mallet PE, McGregor IS.","Psychopharmacology (Berl). 2004 Apr;173(1-2):210-6. doi: 10.1007/s00213-003-1694-5. Epub 2003 Dec 9.","Gallate JE","Psychopharmacology (Berl)","2004","2003/12/10","","","10.1007/s00213-003-1694-5"
"14660133","Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users","Lubman D, Koutsogiannis Z, Kronborg I.","Drug Alcohol Rev. 2003 Dec;22(4):433-6. doi: 10.1080/09595230310001613958.","Lubman D","Drug Alcohol Rev","2003","2003/12/09","","","10.1080/09595230310001613958"
"14660132","Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity","Ali R, Thomas P, White J, McGregor C, Danz C, Gowing L, Stegink A, Athanasos P.","Drug Alcohol Rev. 2003 Dec;22(4):425-31. doi: 10.1080/09595230310001613949.","Ali R","Drug Alcohol Rev","2003","2003/12/09","","","10.1080/09595230310001613949"
"14647966","Stress-induced REM sleep increase is antagonized by naltrexone in rats","Vázquez-Palacios G, Retana-Márquez S, Bonilla-Jaime H, Velázquez-Moctezuma J.","Psychopharmacology (Berl). 2004 Jan;171(2):186-90. doi: 10.1007/s00213-003-1570-3. Epub 2003 Nov 25.","Vázquez-Palacios G","Psychopharmacology (Berl)","2004","2003/12/03","","","10.1007/s00213-003-1570-3"
"14647482","The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats","Torregrossa MM, Isgor C, Folk JE, Rice KC, Watson SJ, Woods JH.","Neuropsychopharmacology. 2004 Apr;29(4):649-59. doi: 10.1038/sj.npp.1300345.","Torregrossa MM","Neuropsychopharmacology","2004","2003/12/03","","","10.1038/sj.npp.1300345"
"14646221","Effects of beta-casomorphin-5 on passive avoidance response in mice","Sakaguchi M, Koseki M, Wakamatsu M, Matsumura E.","Biosci Biotechnol Biochem. 2003 Nov;67(11):2501-4. doi: 10.1271/bbb.67.2501.","Sakaguchi M","Biosci Biotechnol Biochem","2003","2003/12/04","","","10.1271/bbb.67.2501"
"14645470","Opioid modulation of scratching and spinal c-fos expression evoked by intradermal serotonin","Nojima H, Simons CT, Cuellar JM, Carstens MI, Moore JA, Carstens E.","J Neurosci. 2003 Nov 26;23(34):10784-90. doi: 10.1523/JNEUROSCI.23-34-10784.2003.","Nojima H","J Neurosci","2003","2003/12/04","PMC6740982","","10.1523/JNEUROSCI.23-34-10784.2003"
"14644063","Peripheral selectivity and apparent efficacy of dynorphins: comparison to non-peptidic kappa-opioid agonists in rhesus monkeys","Butelman ER, Ball JW, Kreek MJ.","Psychoneuroendocrinology. 2004 Apr;29(3):307-26. doi: 10.1016/s0306-4530(03)00030-1.","Butelman ER","Psychoneuroendocrinology","2004","2003/12/04","","","10.1016/s0306-4530(03)00030-1"
"14640824","Treatment of pathological gambling: a critical review of the literature","Toneatto T, Ladoceur R.","Psychol Addict Behav. 2003 Dec;17(4):284-92. doi: 10.1037/0893-164X.17.4.284.","Toneatto T","Psychol Addict Behav","2003","2003/12/04","","","10.1037/0893-164X.17.4.284"
"14636963","Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment","Mason BJ.","Eur Neuropsychopharmacol. 2003 Dec;13(6):469-75. doi: 10.1016/j.euroneuro.2003.08.009.","Mason BJ","Eur Neuropsychopharmacol","2003","2003/11/26","","","10.1016/j.euroneuro.2003.08.009"
"14635995","Mechanisms of the effects of adrenocorticotropic hormone on pain sensitivity in rats","Bogdanov AI, Yarushkina NI.","Neurosci Behav Physiol. 2003 Oct;33(8):795-8. doi: 10.1023/a:1025149432058.","Bogdanov AI","Neurosci Behav Physiol","2003","2003/11/26","","","10.1023/a:1025149432058"
"14634716","Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia","Petrakis IL, O'Malley S, Rounsaville B, Poling J, McHugh-Strong C, Krystal JH; VA Naltrexone Study Collaboration Group.","Psychopharmacology (Berl). 2004 Mar;172(3):291-7. doi: 10.1007/s00213-003-1658-9. Epub 2003 Nov 21.","Petrakis IL","Psychopharmacology (Berl)","2004","2003/11/25","","","10.1007/s00213-003-1658-9"
"14634494","Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs","Petrakis IL, Leslie D, Rosenheck R.","Alcohol Clin Exp Res. 2003 Nov;27(11):1780-4. doi: 10.1097/01.ALC.0000095861.43232.19.","Petrakis IL","Alcohol Clin Exp Res","2003","2003/11/25","","","10.1097/01.ALC.0000095861.43232.19"
"14634035","Opioid partial agonist effects of 3-O-methylnaltrexone in rhesus monkeys","Platt DM, Rowlett JK, Izenwasser S, Spealman RD.","J Pharmacol Exp Ther. 2004 Mar;308(3):1030-9. doi: 10.1124/jpet.103.060962. Epub 2003 Nov 21.","Platt DM","J Pharmacol Exp Ther","2004","2003/11/25","","","10.1124/jpet.103.060962"
"14633559","Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats","Zhang Z, Chen TY, Kirsch JR, Toung TJ, Traystman RJ, Koehler RC, Hurn PD, Bhardwaj A.","Anesth Analg. 2003 Dec;97(6):1776-83. doi: 10.1213/01.ane.0000087800.56290.2e.","Zhang Z","Anesth Analg","2003","2003/11/25","","","10.1213/01.ane.0000087800.56290.2e"
"14628446","[Comparison of the antagonistic effects of 6 beta-naltrexol and naltrexone against morphine analgesia]","Yan LD, Gong ZH, Yao XJ, Qin BY.","Yao Xue Xue Bao. 2003 Aug;38(8):578-81.","Yan LD","Yao Xue Xue Bao","2003","2003/11/25","","",""
"14627063","Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes","Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J; VA Naltrexone Study Group 425.","Value Health. 2003 Sep-Oct;6(5):566-73. doi: 10.1046/j.1524-4733.2003.65269.x.","Cramer J","Value Health","2003","2003/11/25","","","10.1046/j.1524-4733.2003.65269.x"
"14625057","Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus","Osaki MY, Castellan-Baldan L, Calvo F, Carvalho AD, Felippotti TT, de Oliveira R, Ubiali WA, Paschoalin-Maurin T, Elias-Filho DH, Motta V, da Silva LA, Coimbra NC.","Brain Res. 2003 Dec 5;992(2):179-92. doi: 10.1016/j.brainres.2003.08.040.","Osaki MY","Brain Res","2003","2003/11/20","","","10.1016/j.brainres.2003.08.040"
"14621966","Preparation of biodegradable microspheres and matrix devices containing naltrexone","Dinarvand R, Moghadam SH, Mohammadyari-Fard L, Atyabi F.","AAPS PharmSciTech. 2003;4(3):E34. doi: 10.1208/pt040334.","Dinarvand R","AAPS PharmSciTech","2003","2003/11/19","PMC2750627","","10.1208/pt040334"
"14615874","Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations","Tzschentke TM.","Psychopharmacology (Berl). 2004 Feb;172(1):58-67. doi: 10.1007/s00213-003-1626-4. Epub 2003 Nov 13.","Tzschentke TM","Psychopharmacology (Berl)","2004","2003/11/15","","","10.1007/s00213-003-1626-4"
"14613087","Characterization and opioid modulation of inflammatory temporomandibular joint pain in the rat","Hartwig AC, Mathias SI, Law AS, Gebhart GF.","J Oral Maxillofac Surg. 2003 Nov;61(11):1302-9. doi: 10.1016/s0278-2391(03)00732-8.","Hartwig AC","J Oral Maxillofac Surg","2003","2003/11/13","","","10.1016/s0278-2391(03)00732-8"
"14609552","Delta-opioid agonist-stimulated inositol phosphate formation in isolated, rabbit iris-ciliary bodies: role of G(i/o) proteins and Gbetagamma-subunits","Dortch-Carnes J, Potter DE.","Exp Eye Res. 2003 Dec;77(6):647-52. doi: 10.1016/j.exer.2003.09.006.","Dortch-Carnes J","Exp Eye Res","2003","2003/11/12","","","10.1016/j.exer.2003.09.006"
"14607106","The expression and function of the OGF-OGFr axis - a tonically active negative regulator of growth - in COS cells","Zagon IS, Verderame MF, McLaughlin PJ.","Neuropeptides. 2003 Oct;37(5):290-7. doi: 10.1016/j.npep.2003.07.001.","Zagon IS","Neuropeptides","2003","2003/11/11","","","10.1016/j.npep.2003.07.001"
"14607103","Delta opioid receptors are involved in morphine-induced inhibition of luteinizing hormone releasing hormone in SK-N-SH cells","Bennett L, Ratka A.","Neuropeptides. 2003 Oct;37(5):264-70. doi: 10.1016/s0143-4179(03)00066-0.","Bennett L","Neuropeptides","2003","2003/11/11","","","10.1016/s0143-4179(03)00066-0"
"14603266","Central opioid receptors differentially regulate the nalmefene-induced suppression of ethanol- and saccharin-reinforced behaviors in alcohol-preferring (P) rats","June HL, Cummings R, Eiler WJ 2nd, Foster KL, McKay PF, Seyoum R, Garcia M, McCane S, Grey C, Hawkins SE, Mason D.","Neuropsychopharmacology. 2004 Feb;29(2):285-99. doi: 10.1038/sj.npp.1300338.","June HL","Neuropsychopharmacology","2004","2003/11/07","","","10.1038/sj.npp.1300338"
"14602811","Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons","Margolis EB, Hjelmstad GO, Bonci A, Fields HL.","J Neurosci. 2003 Nov 5;23(31):9981-6. doi: 10.1523/JNEUROSCI.23-31-09981.2003.","Margolis EB","J Neurosci","2003","2003/11/07","PMC6740851","","10.1523/JNEUROSCI.23-31-09981.2003"
"14601290","Naltrexone implants","Warhaft N.","Anaesth Intensive Care. 2003 Oct;31(5):592-3.","Warhaft N","Anaesth Intensive Care","2003","2003/11/07","","",""
"14600246","Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence","Wang D, Raehal KM, Lin ET, Lowery JJ, Kieffer BL, Bilsky EJ, Sadée W.","J Pharmacol Exp Ther. 2004 Feb;308(2):512-20. doi: 10.1124/jpet.103.054049. Epub 2003 Nov 4.","Wang D","J Pharmacol Exp Ther","2004","2003/11/06","","","10.1124/jpet.103.054049"
"14598513","[Pharmacotherapy in heroin addiction: pharmacological approaches to remission stabilization and recurrence prevention]","Grinenko AIa, Krupitskiĭ EM, Zvartau EE.","Vestn Ross Akad Med Nauk. 2003;(10):54-6.","Grinenko AIa","Vestn Ross Akad Med Nauk","2003","2003/11/06","","",""
"14598304","Nonopioid receptor-mediated effects of U-50,488H on [Ca(2+)]i and extracellular dopamine in PC12 cells","Chudapongse N, Kim SY, Sasaki K, Kramer RE, Ho IK.","J Neurosci Res. 2003 Nov 15;74(4):598-604. doi: 10.1002/jnr.10801.","Chudapongse N","J Neurosci Res","2003","2003/11/05","","","10.1002/jnr.10801"
"14597630","Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance","McLaughlin JP, Myers LC, Zarek PE, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE, Chavkin C.","J Biol Chem. 2004 Jan 16;279(3):1810-8. doi: 10.1074/jbc.M305796200. Epub 2003 Nov 3.","McLaughlin JP","J Biol Chem","2004","2003/11/05","PMC2131729","NIHMS34357","10.1074/jbc.M305796200"
"14575897","Interrelationships between mu opioid and melanocortin receptors in mediating food intake in rats","Grossman HC, Hadjimarkou MM, Silva RM, Giraudo SQ, Bodnar RJ.","Brain Res. 2003 Nov 21;991(1-2):240-4. doi: 10.1016/s0006-8993(03)03442-5.","Grossman HC","Brain Res","2003","2003/10/25","","","10.1016/s0006-8993(03)03442-5"
"14575893","Evidence for a mu-opioid-opioid connection between the paraventricular nucleus and ventral tegmental area in the rat","Quinn JG, O'Hare E, Levine AS, Kim EM.","Brain Res. 2003 Nov 21;991(1-2):206-11. doi: 10.1016/j.brainres.2003.08.020.","Quinn JG","Brain Res","2003","2003/10/25","","","10.1016/j.brainres.2003.08.020"
"14575806","Effect of opioid receptor ligands on the mu-S196A knock-in and mu knockout mouse vas deferens","Portoghese PS, Law PY, Loh HH.","Eur J Pharmacol. 2003 Oct 8;478(2-3):207-10. doi: 10.1016/j.ejphar.2003.08.041.","Portoghese PS","Eur J Pharmacol","2003","2003/10/25","","","10.1016/j.ejphar.2003.08.041"
"14575714","Expression of functional mu-opioid receptors in human osteoarthritic cartilage and chondrocytes","Elvenes J, Andjelkov N, Figenschau Y, Seternes T, Bjørkøy G, Johansen O.","Biochem Biophys Res Commun. 2003 Nov 7;311(1):202-7. doi: 10.1016/j.bbrc.2003.09.191.","Elvenes J","Biochem Biophys Res Commun","2003","2003/10/25","","","10.1016/j.bbrc.2003.09.191"
"14573388","Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems","Samadi P, Grégoire L, Bédard PJ.","Neuropharmacology. 2003 Dec;45(7):954-63. doi: 10.1016/s0028-3908(03)00249-1.","Samadi P","Neuropharmacology","2003","2003/10/24","","","10.1016/s0028-3908(03)00249-1"
"14569055","Cocaine and other indirect-acting monoamine agonists differentially attenuate a naltrexone discriminative stimulus in morphine-treated rhesus monkeys","McMahon LR, Sell SL, France CP.","J Pharmacol Exp Ther. 2004 Jan;308(1):111-9. doi: 10.1124/jpet.103.058917. Epub 2003 Oct 20.","McMahon LR","J Pharmacol Exp Ther","2004","2003/10/22","","","10.1124/jpet.103.058917"
"14568185","Modulation of Chelidonii herba on glycine-activated and glutamate-activated ion currents in rat periaqueductal gray neurons","Shin MC, Jang MH, Chang HK, Lim S, Han SM, Park HJ, Shim I, Lee JS, Kim KA, Kim CJ.","Clin Chim Acta. 2003 Nov;337(1-2):93-101. doi: 10.1016/j.cccn.2003.07.002.","Shin MC","Clin Chim Acta","2003","2003/10/22","","","10.1016/j.cccn.2003.07.002"
"14563545","Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naïve healthy male volunteers under a naltrexone block","McAleer SD, Mills RJ, Polack T, Hussain T, Rolan PE, Gibbs AD, Mullins FG, Hussein Z.","Drug Alcohol Depend. 2003 Oct 24;72(1):75-83. doi: 10.1016/s0376-8716(03)00188-1.","McAleer SD","Drug Alcohol Depend","2003","2003/10/18","","","10.1016/s0376-8716(03)00188-1"
"14563249","[Use of naltrexone in the treatment of alcoholism in Spain]","Conde Martel A, Gómez Arnáiz A.","Rev Clin Esp. 2003 Oct;203(10):509. doi: 10.1016/s0014-2565(03)71341-1.","Conde Martel A","Rev Clin Esp","2003","2003/10/18","","","10.1016/s0014-2565(03)71341-1"
"14560041","Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes","Ho WZ, Guo CJ, Yuan CS, Douglas SD, Moss J.","J Pharmacol Exp Ther. 2003 Dec;307(3):1158-62. doi: 10.1124/jpet.103.056697. Epub 2003 Oct 14.","Ho WZ","J Pharmacol Exp Ther","2003","2003/10/16","PMC4016816","NIHMS575103","10.1124/jpet.103.056697"
"14559445","HL-1 myocytes exhibit PKC and K(ATP) channel-dependent delta opioid preconditioning","Seymour EM, Wu SY, Kovach MA, Romano MA, Traynor JR, Claycomb WC, Bolling SF.","J Surg Res. 2003 Oct;114(2):187-94. doi: 10.1016/s0022-4804(03)00248-8.","Seymour EM","J Surg Res","2003","2003/10/16","","","10.1016/s0022-4804(03)00248-8"
"14557717","Characterization of scratching responses in rats following centrally administered morphine or bombesin","Lee H, Naughton NN, Woods JH, Ko MC.","Behav Pharmacol. 2003 Nov;14(7):501-8. doi: 10.1097/01.fbp.0000095082.80017.0f.","Lee H","Behav Pharmacol","2003","2003/10/15","PMC1810379","NIHMS18489","10.1097/01.fbp.0000095082.80017.0f"
"14557380","Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception","Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, Negus SS.","J Pharmacol Exp Ther. 2003 Dec;307(3):1054-64. doi: 10.1124/jpet.103.056515. Epub 2003 Oct 13.","Stevenson GW","J Pharmacol Exp Ther","2003","2003/10/15","","","10.1124/jpet.103.056515"
"14557378","Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord","Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.","J Pharmacol Exp Ther. 2003 Dec;307(3):1135-41. doi: 10.1124/jpet.103.056242. Epub 2003 Oct 13.","Wu HE","J Pharmacol Exp Ther","2003","2003/10/15","","","10.1124/jpet.103.056242"
"14556956","Antinociceptive role of oxytocin in the nucleus raphe magnus of rats, an involvement of mu-opioid receptor","Wang JW, Lundeberg T, Yu LC.","Regul Pept. 2003 Oct 15;115(3):153-9. doi: 10.1016/s0167-0115(03)00152-6.","Wang JW","Regul Pept","2003","2003/10/15","","","10.1016/s0167-0115(03)00152-6"
"14534156","Roles of KATP channels in delayed cardioprotection and intracellular Ca(2+) in the rat heart as revealed by kappa-opioid receptor stimulation with U50488H","Chen M, Zhou JJ, Kam KW, Qi JS, Yan WY, Wu S, Wong TM.","Br J Pharmacol. 2003 Oct;140(4):750-8. doi: 10.1038/sj.bjp.0705475.","Chen M","Br J Pharmacol","2003","2003/10/10","PMC1574065","","10.1038/sj.bjp.0705475"
"14534152","Pharmacological characterization of a 7-benzylidenenaltrexone-preferring opioid receptor in porcine ileal submucosa","Townsend DW 4th, Brown DR.","Br J Pharmacol. 2003 Oct;140(4):691-700. doi: 10.1038/sj.bjp.0705485.","Townsend DW 4th","Br J Pharmacol","2003","2003/10/10","PMC1574073","","10.1038/sj.bjp.0705485"
"14530213","Effects of endomorphin on substantia gelatinosa neurons in rat spinal cord slices","Wu SY, Ohtubo Y, Brailoiu GC, Dun NJ.","Br J Pharmacol. 2003 Nov;140(6):1088-96. doi: 10.1038/sj.bjp.0705534. Epub 2003 Oct 6.","Wu SY","Br J Pharmacol","2003","2003/10/08","PMC1574121","","10.1038/sj.bjp.0705534"
"14519525","Herpes virus-mediated preproenkephalin gene transfer in the ventral striatum mimics behavioral changes produced by olfactory bulbectomy in rats","Primeaux SD, Wilson MA, Wilson SP, Guth AN, Lelutiu NB, Holmes PV.","Brain Res. 2003 Oct 24;988(1-2):43-55. doi: 10.1016/s0006-8993(03)03337-7.","Primeaux SD","Brain Res","2003","2003/10/02","","","10.1016/s0006-8993(03)03337-7"
"14512095","Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system","Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, Nagase H.","Eur J Pharmacol. 2003 Sep 5;477(1):29-35. doi: 10.1016/j.ejphar.2003.08.007.","Umeuchi H","Eur J Pharmacol","2003","2003/09/27","","","10.1016/j.ejphar.2003.08.007"
"14506404","Psychometric properties of the short index of problems as a measure of recent alcohol-related problems","Feinn R, Tennen H, Kranzler HR.","Alcohol Clin Exp Res. 2003 Sep;27(9):1436-41. doi: 10.1097/01.ALC.0000087582.44674.AF.","Feinn R","Alcohol Clin Exp Res","2003","2003/09/25","","","10.1097/01.ALC.0000087582.44674.AF"
"14504025","Patient attitudes toward treatment predict attendance in clinical pharmacotherapy trials of alcohol and drug treatment","Pettinati HM, Monterosso J, Lipkin C, Volpicelli JR.","Am J Addict. 2003 Jul-Sep;12(4):324-35.","Pettinati HM","Am J Addict","2003","2003/09/25","","",""
"14504021","Barriers to the use of medications to treat alcoholism","Mark TL, Kranzler HR, Poole VH, Hagen CA, McLeod C, Crosse S.","Am J Addict. 2003 Jul-Sep;12(4):281-94.","Mark TL","Am J Addict","2003","2003/09/25","","",""
"14502980","[Anxiolytic effect of the dehydroepiandrosterone sulfate: mu-opioid mechanism]","Ovsiukova MV, Kudriavtseva NN, Obut TA, Amikishieva AV.","Ross Fiziol Zh Im I M Sechenova. 2003 May;89(5):598-604.","Ovsiukova MV","Ross Fiziol Zh Im I M Sechenova","2003","2003/09/25","","",""
"14502469","Using absolute and relative reasoning in the prediction of the potential metabolism of xenobiotics","Button WG, Judson PN, Long A, Vessey JD.","J Chem Inf Comput Sci. 2003 Sep-Oct;43(5):1371-7. doi: 10.1021/ci0202739.","Button WG","J Chem Inf Comput Sci","2003","2003/09/23","","","10.1021/ci0202739"
"13129837","Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdoses","Arnold-Reed DE, Hulse GK, Hansson RC, Murray SD, O'Neil G, Basso MR, Holman CD.","Addict Biol. 2003 Sep;8(3):343-50. doi: 10.1080/13556210310001602266.","Arnold-Reed DE","Addict Biol","2003","2003/09/18","","","10.1080/13556210310001602266"
"13129836","A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users","Hulse GK, Tait RJ.","Addict Biol. 2003 Sep;8(3):337-42. doi: 10.1080/13556210310001602257.","Hulse GK","Addict Biol","2003","2003/09/18","","","10.1080/13556210310001602257"
"13129827","Naltrexone-mediated opiate detoxification: a matter of terminology!","Johnson TS, Carr M.","Addict Biol. 2003 Sep;8(3):267-9. doi: 10.1080/13556210310001613471.","Johnson TS","Addict Biol","2003","2003/09/18","","","10.1080/13556210310001613471"
"12968061","Leucine-enkephalin interrupts sympathetically mediated tachycardia prejunctionally in the canine sinoatrial node","Stanfill AA, Jackson K, Farias M, Barlow M, Deo S, Johnson S, Caffrey JL.","Exp Biol Med (Maywood). 2003 Sep;228(8):898-906. doi: 10.1177/153537020322800805.","Stanfill AA","Exp Biol Med (Maywood)","2003","2003/09/12","","","10.1177/153537020322800805"
"12967683","An opioid basis for early-phase isoflurane-induced hypotension in rats","Ellenberger EA, Lucas HL, Russo JM, Mueller JL, Barrington PL, Tseng LF, Quock RM.","Life Sci. 2003 Oct 3;73(20):2591-602. doi: 10.1016/s0024-3205(03)00667-2.","Ellenberger EA","Life Sci","2003","2003/09/12","","","10.1016/s0024-3205(03)00667-2"
"12966323","Measurement and prediction of medication compliance in problem drinkers","Feinn R, Tennen H, Cramer J, Kranzler HR.","Alcohol Clin Exp Res. 2003 Aug;27(8):1286-92. doi: 10.1097/01.ALC.0000080670.59386.6E.","Feinn R","Alcohol Clin Exp Res","2003","2003/09/11","","","10.1097/01.ALC.0000080670.59386.6E"
"12963349","Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: a potential expression system for large-scale production of G-protein coupled receptors","Perret BG, Wagner R, Lecat S, Brillet K, Rabut G, Bucher B, Pattus F.","Protein Expr Purif. 2003 Sep;31(1):123-32. doi: 10.1016/s1046-5928(03)00140-2.","Perret BG","Protein Expr Purif","2003","2003/09/10","","","10.1016/s1046-5928(03)00140-2"
"12957340","Understanding US addiction physicians' low rate of naltrexone prescription","Mark TL, Kranzler HR, Song X.","Drug Alcohol Depend. 2003 Sep 10;71(3):219-28. doi: 10.1016/s0376-8716(03)00134-0.","Mark TL","Drug Alcohol Depend","2003","2003/09/06","","","10.1016/s0376-8716(03)00134-0"
"12957222","Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans","Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A.","Pharmacol Biochem Behav. 2003 Jul;75(4):801-8. doi: 10.1016/s0091-3057(03)00157-6.","Sofuoglu M","Pharmacol Biochem Behav","2003","2003/09/06","","","10.1016/s0091-3057(03)00157-6"
"12951188","kappa-Opioid withdrawal in Planaria","Raffa RB, Stagliano GW, Umeda S.","Neurosci Lett. 2003 Oct 9;349(3):139-42. doi: 10.1016/s0304-3940(03)00814-0.","Raffa RB","Neurosci Lett","2003","2003/09/03","","","10.1016/s0304-3940(03)00814-0"
"12944440","Ultrarapid opiate detoxification: a review","Kaye AD, Gevirtz C, Bosscher HA, Duke JB, Frost EA, Richards TA, Fields AM.","Can J Anaesth. 2003 Aug-Sep;50(7):663-71. doi: 10.1007/BF03018708.","Kaye AD","Can J Anaesth","2003","2003/08/29","","","10.1007/BF03018708"
"12937158","Morphine enhances hepatitis C virus (HCV) replicon expression","Li Y, Zhang T, Douglas SD, Lai JP, Xiao WD, Pleasure DE, Ho WZ.","Am J Pathol. 2003 Sep;163(3):1167-75. doi: 10.1016/S0002-9440(10)63476-1.","Li Y","Am J Pathol","2003","2003/08/26","PMC1868275","","10.1016/S0002-9440(10)63476-1"
"12931140","Vivitrex, an injectable, extended-release formulation of naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for 1 month in rats","Bartus RT, Emerich DF, Hotz J, Blaustein M, Dean RL, Perdomo B, Basile AS.","Neuropsychopharmacology. 2003 Nov;28(11):1973-82. doi: 10.1038/sj.npp.1300274.","Bartus RT","Neuropsychopharmacology","2003","2003/08/22","","","10.1038/sj.npp.1300274"
"12925043","Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study","Ahmadi J, Ahmadi K, Ohaeri J.","Eur J Clin Invest. 2003 Sep;33(9):824-9. doi: 10.1046/j.1365-2362.2003.01218.x.","Ahmadi J","Eur J Clin Invest","2003","2003/08/20","","","10.1046/j.1365-2362.2003.01218.x"
"12922933","In vitro and ex vivo effects of a selective nociceptin/orphanin FQ (N/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N/OFQ and [35S]GTPgammaS in rat brain and spinal cord","Yamada S, Kusaka T, Urayama A, Kimura R, Watanabe Y.","Br J Pharmacol. 2003 Aug;139(8):1462-8. doi: 10.1038/sj.bjp.0705371.","Yamada S","Br J Pharmacol","2003","2003/08/19","PMC1573970","","10.1038/sj.bjp.0705371"
"12920386","Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traits","Gerra G, Ceresini S, Esposito A, Zaimovic A, Moi G, Bussandri M, Raggi MA, Molina E.","Int Clin Psychopharmacol. 2003 Sep;18(5):261-9. doi: 10.1097/00004850-200309000-00002.","Gerra G","Int Clin Psychopharmacol","2003","2003/08/16","","","10.1097/00004850-200309000-00002"
"12915238","Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys","Ko MC, Willmont KJ, Lee H, Flory GS, Woods JH.","Brain Res. 2003 Aug 22;982(1):38-44. doi: 10.1016/s0006-8993(03)02938-x.","Ko MC","Brain Res","2003","2003/08/14","PMC2863110","NIHMS196258","10.1016/s0006-8993(03)02938-x"
"12914962","Involvement of oxytocin in spinal antinociception in rats with inflammation","Yu SQ, Lundeberg T, Yu LC.","Brain Res. 2003 Sep 5;983(1-2):13-22. doi: 10.1016/s0006-8993(03)03019-1.","Yu SQ","Brain Res","2003","2003/08/14","","","10.1016/s0006-8993(03)03019-1"
"12914502","New pharmacotherapies for alcohol dependence: are they being used and what do they cost?","Doran CM, Fawcett JE, Shakeshaft AP, Shanahan MD, Mattick RP.","Med J Aust. 2003 Aug 18;179(4):218.","Doran CM","Med J Aust","2003","2003/08/14","","",""
"12913365","Learning the language of abstinence in addiction treatment: some similarities between relapse-prevention with disulfiram, naltrexone, and other pharmacological antagonists and intensive ""immersion"" methods of foreign language teaching","Brewer C, Streel E.","Subst Abus. 2003 Sep;24(3):157-73. doi: 10.1080/08897070309511545.","Brewer C","Subst Abus","2003","2003/08/13","","","10.1080/08897070309511545"
"12910275","Participation of endogenous opioids in pathogenesis of early neuroendocrine manifestations of prenatal stress syndrome","Reznikov AG, Nosenko ND, Tarasenko LV.","Bull Exp Biol Med. 2003 May;135(5):421-3. doi: 10.1023/a:1024994704644.","Reznikov AG","Bull Exp Biol Med","2003","2003/08/12","","","10.1023/a:1024994704644"
"12907414","Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat","MacDonald AF, Billington CJ, Levine AS.","Am J Physiol Regul Integr Comp Physiol. 2003 Nov;285(5):R999-R1004. doi: 10.1152/ajpregu.00271.2003. Epub 2003 Aug 7.","MacDonald AF","Am J Physiol Regul Integr Comp Physiol","2003","2003/08/09","","","10.1152/ajpregu.00271.2003"
"12906910","Extraction and quantitation of carfentanil and naltrexone in goat plasma with liquid chromatography-mass spectrometry","Hunter RP, Koch DE, Mutlow A, Isaza R.","J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Aug 15;793(2):351-5. doi: 10.1016/s1570-0232(03)00351-9.","Hunter RP","J Chromatogr B Analyt Technol Biomed Life Sci","2003","2003/08/09","","","10.1016/s1570-0232(03)00351-9"
"12905712","[Dual regulation by delta opioid receptor agonists on the delayed rectified potassium channels in NG108-15 cells]","Ye CY, Li QX, Yu XL, Qi JJ, Li J, Zhang DC.","Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Apr;25(2):164-7.","Ye CY","Zhongguo Yi Xue Ke Xue Yuan Xue Bao","2003","2003/08/09","","",""
"12896887","Emergency department presentations of naltrexone-accelerated detoxification","Armstrong J, Little M, Murray L.","Acad Emerg Med. 2003 Aug;10(8):860-6. doi: 10.1111/j.1553-2712.2003.tb00629.x.","Armstrong J","Acad Emerg Med","2003","2003/08/05","","","10.1111/j.1553-2712.2003.tb00629.x"
"12895661","Endomorphin-1, an endogenous mu-opioid receptor agonist, improves apomorphine-induced impairment of prepulse inhibition in mice","Ukai M, Okuda A.","Peptides. 2003 May;24(5):741-4. doi: 10.1016/s0196-9781(03)00123-2.","Ukai M","Peptides","2003","2003/08/05","","","10.1016/s0196-9781(03)00123-2"
"12892831","Antinociceptive properties of oxymorphazole in the mouse","Wu HE, Sun HS, Darpolar M, Dunn W 3rd, Tseng LF.","Eur J Pharmacol. 2003 Jul 25;473(2-3):143-8. doi: 10.1016/s0014-2999(03)01912-5.","Wu HE","Eur J Pharmacol","2003","2003/08/02","","","10.1016/s0014-2999(03)01912-5"
"12892826","Effects of U50,488H on transient outward and ultra-rapid delayed rectifier K+ currents in young human atrial myocytes","Xiao GS, Zhou JJ, Cheung YF, Li GR, Wong TM.","Eur J Pharmacol. 2003 Jul 25;473(2-3):97-103. doi: 10.1016/s0014-2999(03)01974-5.","Xiao GS","Eur J Pharmacol","2003","2003/08/02","","","10.1016/s0014-2999(03)01974-5"
"12885685","Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials","O'Malley SS, Rounsaville BJ, Farren C, Namkoong K, Wu R, Robinson J, O'Connor PG.","Arch Intern Med. 2003 Jul 28;163(14):1695-704. doi: 10.1001/archinte.163.14.1695.","O'Malley SS","Arch Intern Med","2003","2003/07/30","","","10.1001/archinte.163.14.1695"
"12878920","A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence","Balldin J, Berglund M, Borg S, Månsson M, Bendtsen P, Franck J, Gustafsson L, Halldin J, Nilsson LH, Stolt G, Willander A.","Alcohol Clin Exp Res. 2003 Jul;27(7):1142-9. doi: 10.1097/01.ALC.0000075548.83053.A9.","Balldin J","Alcohol Clin Exp Res","2003","2003/07/25","","","10.1097/01.ALC.0000075548.83053.A9"
"12878918","Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study","COMBINE Study Research Group.","Alcohol Clin Exp Res. 2003 Jul;27(7):1123-31. doi: 10.1097/01.ALC.0000078020.92938.0B.","COMBINE Study Research Group","Alcohol Clin Exp Res","2003","2003/07/25","","","10.1097/01.ALC.0000078020.92938.0B"
"12878917","Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods","COMBINE Study Research Group.","Alcohol Clin Exp Res. 2003 Jul;27(7):1107-22. doi: 10.1097/00000374-200307000-00011.","COMBINE Study Research Group","Alcohol Clin Exp Res","2003","2003/07/25","","","10.1097/00000374-200307000-00011"
"12875273","Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002","Colker AC.","Issue Brief Health Policy Track Serv. 2002 Dec 31:1-6.","Colker AC","Issue Brief Health Policy Track Serv","2002","2003/07/24","","",""
"12873638","Antinociception induced by stimulation of ventrolateral periaqueductal gray at the freezing threshold is regulated by opioid and 5-HT2A receptors as assessed by the tail-flick and formalin tests","de Luca MC, Brandão ML, Motta VA, Landeira-Fernandez J.","Pharmacol Biochem Behav. 2003 May;75(2):459-66. doi: 10.1016/s0091-3057(03)00145-x.","de Luca MC","Pharmacol Biochem Behav","2003","2003/07/23","","","10.1016/s0091-3057(03)00145-x"
"12873637","Possible antinociceptive mechanisms of opioid receptor antagonists in the mouse formalin test","Choi SS, Han KJ, Lee HK, Han EJ, Suh HW.","Pharmacol Biochem Behav. 2003 May;75(2):447-57. doi: 10.1016/s0091-3057(03)00144-8.","Choi SS","Pharmacol Biochem Behav","2003","2003/07/23","","","10.1016/s0091-3057(03)00144-8"
"12873620","Beta-funaltrexamine affects cocaine self-administration in rats responding on a progressive ratio schedule of reinforcement","Ward SJ, Martin TJ, Roberts DC.","Pharmacol Biochem Behav. 2003 May;75(2):301-7. doi: 10.1016/s0091-3057(03)00087-x.","Ward SJ","Pharmacol Biochem Behav","2003","2003/07/23","","","10.1016/s0091-3057(03)00087-x"
"12872295","Chronic opioid antagonist treatment selectively regulates trafficking and signaling proteins in mouse spinal cord","Patel CN, Rajashekara V, Patel K, Purohit V, Yoburn BC.","Synapse. 2003 Oct;50(1):67-76. doi: 10.1002/syn.10246.","Patel CN","Synapse","2003","2003/07/23","","","10.1002/syn.10246"
"12871838","Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated mice","Bailey A, Hawkins RM, Hourani SM, Kitchen I.","Br J Pharmacol. 2003 Jul;139(6):1187-95. doi: 10.1038/sj.bjp.0705340.","Bailey A","Br J Pharmacol","2003","2003/07/23","PMC1573935","","10.1038/sj.bjp.0705340"
"12865168","Presence of kappa-opioid tone at the onset of the ovulatory luteinizing hormone surge in the proestrous rat","Zhang Q, Gallo RV.","Brain Res. 2003 Aug 1;980(1):135-9. doi: 10.1016/s0006-8993(03)02965-2.","Zhang Q","Brain Res","2003","2003/07/17","","","10.1016/s0006-8993(03)02965-2"
"12859589","Using stated preference modeling to forecast the effect of medication attributes on prescriptions of alcoholism medications","Mark TL, Swait J.","Value Health. 2003 Jul-Aug;6(4):474-82. doi: 10.1046/j.1524-4733.2003.64247.x.","Mark TL","Value Health","2003","2003/07/16","","","10.1046/j.1524-4733.2003.64247.x"
"12857662","Research advances in the understanding and treatment of addiction","O'Brien CP.","Am J Addict. 2003;12(s2):S36-S47.","O'Brien CP","Am J Addict","2003","2003/07/15","","",""
"12857659","Pharmacologic treatments for heroin and cocaine dependence","Kleber HD.","Am J Addict. 2003;12(s2):S5-S18.","Kleber HD","Am J Addict","2003","2003/07/15","","",""
"12852217","[Effect of dehydroepiandrosterone sulfate on stress reactivity: mu-opioid mechanism]","Obut TA, Ovsiukova MV, Cherkasova OP.","Ross Fiziol Zh Im I M Sechenova. 2002 Dec;88(12):1578-84.","Obut TA","Ross Fiziol Zh Im I M Sechenova","2002","2003/07/11","","",""
"12851023","Naltrexone-bupropion combination therapy for protracted abstinence dysphoria","Williams J, Ziedonis DM.","Am J Addict. 2003 May-Jun;12(3):270-2.","Williams J","Am J Addict","2003","2003/07/10","","",""
"12850780","Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels","Foster J, Brewer C, Steele T.","Addict Biol. 2003 Jun;8(2):211-7. doi: 10.1080/1355621031000117446.","Foster J","Addict Biol","2003","2003/07/10","","","10.1080/1355621031000117446"
"12850776","Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats","Ingman K, Salvadori S, Lazarus L, Korpi ER, Honkanen A.","Addict Biol. 2003 Jun;8(2):173-9. doi: 10.1080/1355621031000117400.","Ingman K","Addict Biol","2003","2003/07/10","","","10.1080/1355621031000117400"
"12845226","Involvement of mesolimbic structures in short-term sodium depletion: in situ hybridization and ligand-binding analyses","Lucas LR, Grillo CA, McEwen BS.","Neuroendocrinology. 2003 Jun;77(6):406-15. doi: 10.1159/000071312.","Lucas LR","Neuroendocrinology","2003","2003/07/08","","","10.1159/000071312"
"12843270","Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","McLaughlin JP, Marton-Popovici M, Chavkin C.","Version 2. J Neurosci. 2003 Jul 2;23(13):5674-83. doi: 10.1523/JNEUROSCI.23-13-05674.2003.","McLaughlin JP","J Neurosci","2003","2003/07/05","PMC2104777","NIHMS34356","10.1523/JNEUROSCI.23-13-05674.2003"
"12842283","Neuroprotection of naloxone against ischemic injury in rats: role of mu receptor antagonism","Liao SL, Chen WY, Raung SL, Chen CJ.","Neurosci Lett. 2003 Jul 24;345(3):169-72. doi: 10.1016/s0304-3940(03)00540-8.","Liao SL","Neurosci Lett","2003","2003/07/05","","","10.1016/s0304-3940(03)00540-8"
"12838444","[Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine]","Haro G, Cervera G, Martínez-Raga J, Pérez-Gálvez B, Fernández-Garcés M, Sanjuan J.","Actas Esp Psiquiatr. 2003 Jul-Aug;31(4):205-19.","Haro G","Actas Esp Psiquiatr","2003","2003/07/03","","",""
"12835417","Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity","Rougeot C, Messaoudi M, Hermitte V, Rigault AG, Blisnick T, Dugave C, Desor D, Rougeon F.","Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8549-54. doi: 10.1073/pnas.1431850100. Epub 2003 Jun 30.","Rougeot C","Proc Natl Acad Sci U S A","2003","2003/07/02","PMC166266","","10.1073/pnas.1431850100"
"12835366","Effect of innappropriate naltrexone use in a heroin misuser","Boyce SH, Armstrong PA, Stevenson J.","Emerg Med J. 2003 Jul;20(4):381-2. doi: 10.1136/emj.20.4.381.","Boyce SH","Emerg Med J","2003","2003/07/02","PMC1726126","","10.1136/emj.20.4.381"
"12829987","Alcohol potentiates hepatitis C virus replicon expression","Zhang T, Li Y, Lai JP, Douglas SD, Metzger DS, O'Brien CP, Ho WZ.","Hepatology. 2003 Jul;38(1):57-65. doi: 10.1053/jhep.2003.50295.","Zhang T","Hepatology","2003","2003/06/28","","","10.1053/jhep.2003.50295"
"12828963","Therapy and supportive care of alcoholics: guidelines for practitioners","Heinz A, Wilwer M, Mann K.","Best Pract Res Clin Gastroenterol. 2003 Aug;17(4):695-708. doi: 10.1016/s1521-6918(03)00030-1.","Heinz A","Best Pract Res Clin Gastroenterol","2003","2003/06/28","","","10.1016/s1521-6918(03)00030-1"
"12826991","Targeted naltrexone for early problem drinkers","Kranzler HR, Armeli S, Tennen H, Blomqvist O, Oncken C, Petry N, Feinn R.","J Clin Psychopharmacol. 2003 Jun;23(3):294-304. doi: 10.1097/01.jcp.0000084030.22282.6d.","Kranzler HR","J Clin Psychopharmacol","2003","2003/06/27","","","10.1097/01.jcp.0000084030.22282.6d"
"12826990","Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects","Johnson BA, O'Malley SS, Ciraulo DA, Roache JD, Chambers RA, Sarid-Segal O, Couper D.","J Clin Psychopharmacol. 2003 Jun;23(3):281-93. doi: 10.1097/01.jcp.0000084029.22282.bb.","Johnson BA","J Clin Psychopharmacol","2003","2003/06/27","","","10.1097/01.jcp.0000084029.22282.bb"
"12821984","[Naltrexone in the treatment of addiction]","Bachs L, Waal H.","Tidsskr Nor Laegeforen. 2003 Jun 12;123(12):1665-7.","Bachs L","Tidsskr Nor Laegeforen","2003","2003/06/25","","",""
"12821983","[Use of naltrexone in the treatment of young drug addicts]","Waal H, Aamodt Ø, Olsen H.","Tidsskr Nor Laegeforen. 2003 Jun 12;123(12):1662-4.","Waal H","Tidsskr Nor Laegeforen","2003","2003/06/25","","",""
"12821982","[Naltrexone implants--a pilot project]","Waal H, Christophersen AS, Frogopsahl G, Olsen LH, Mørland J.","Tidsskr Nor Laegeforen. 2003 Jun 12;123(12):1660-1.","Waal H","Tidsskr Nor Laegeforen","2003","2003/06/25","","",""
"12814838","Quantitative assessment of directed hind limb scratching behavior as a rodent itch model","Nojima H, Carstens E.","J Neurosci Methods. 2003 Jun 30;126(2):137-43. doi: 10.1016/s0165-0270(03)00074-8.","Nojima H","J Neurosci Methods","2003","2003/06/20","","","10.1016/s0165-0270(03)00074-8"
"12814374","Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system","Le Guen S, Gestreau C, Besson JM.","Eur J Neurosci. 2003 Jun;17(11):2425-37. doi: 10.1046/j.1460-9568.2003.02678.x.","Le Guen S","Eur J Neurosci","2003","2003/06/20","","","10.1046/j.1460-9568.2003.02678.x"
"12813472","A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP.","Neuropsychopharmacology. 2003 Aug;28(8):1546-52. doi: 10.1038/sj.npp.1300219. Epub 2003 Jun 18.","Oslin DW","Neuropsychopharmacology","2003","2003/06/19","","","10.1038/sj.npp.1300219"
"12810146","Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone","Ahmadi J, Ashkani H, Ahmadi M, Ahmadi N.","J Subst Abuse Treat. 2003 Apr;24(3):251-5. doi: 10.1016/s0740-5472(03)00027-8.","Ahmadi J","J Subst Abuse Treat","2003","2003/06/18","","","10.1016/s0740-5472(03)00027-8"
"12804405","Naltrexone maintenance treatment for opioid dependence","Kirchmayer U, Davoli M, Verster A.","Cochrane Database Syst Rev. 2003;(2):CD001333. doi: 10.1002/14651858.CD001367.","Kirchmayer U","Cochrane Database Syst Rev","2003","2003/06/14","","","10.1002/14651858.CD001367"
"12802873","Establishment of a preference by the newborn lamb for its mother: the role of opioids","Shayit M, Nowak R, Keller M, Weller A.","Behav Neurosci. 2003 Jun;117(3):446-54. doi: 10.1037/0735-7044.117.3.446.","Shayit M","Behav Neurosci","2003","2003/06/14","","","10.1037/0735-7044.117.3.446"
"12802388","Stress-limiting effect of dehydroepiandrosterone sulfate and its mechanism","Obut TA, Ovsyukova MV, Cherkasova OP.","Bull Exp Biol Med. 2003 Mar;135(3):231-3. doi: 10.1023/a:1024168510925.","Obut TA","Bull Exp Biol Med","2003","2003/06/13","","","10.1023/a:1024168510925"
"12795568","Behavioral family counseling and naltrexone for male opioid-dependent patients","Fals-Stewart W, O'Farrell TJ.","J Consult Clin Psychol. 2003 Jun;71(3):432-42. doi: 10.1037/0022-006x.71.3.432.","Fals-Stewart W","J Consult Clin Psychol","2003","2003/06/11","","","10.1037/0022-006x.71.3.432"
"12794053","Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages","Sacerdote P.","Ann N Y Acad Sci. 2003 May;992:129-40. doi: 10.1111/j.1749-6632.2003.tb03144.x.","Sacerdote P","Ann N Y Acad Sci","2003","2003/06/10","","","10.1111/j.1749-6632.2003.tb03144.x"
"12790418","Chemical anesthesia of northern sea otters (Enhydra lutris): results of past field studies","Monson DH, McCormick C, Ballachey BE.","J Zoo Wildl Med. 2001 Jun;32(2):181-9. doi: 10.1638/1042-7260(2001)032[0181:CAONSO]2.0.CO;2.","Monson DH","J Zoo Wildl Med","2001","2003/06/07","","","10.1638/1042-7260(2001)032[0181:CAONSO]2.0.CO;2"
"12784103","Opiate withdrawal induces Narp in the extended amygdala","Reti IM, Baraban JM.","Neuropsychopharmacology. 2003 Sep;28(9):1606-13. doi: 10.1038/sj.npp.1300205. Epub 2003 May 14.","Reti IM","Neuropsychopharmacology","2003","2003/06/05","","","10.1038/sj.npp.1300205"
"12782427","Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone","Cruciani RA, Lussier D, Miller-Saultz D, Arbuck DM.","J Pain Symptom Manage. 2003 Jun;25(6):491-4. doi: 10.1016/s0885-3924(03)00139-8.","Cruciani RA","J Pain Symptom Manage","2003","2003/06/05","","","10.1016/s0885-3924(03)00139-8"
"12774318","Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol","Fan LW, Tien LT, Tanaka S, Sasaki K, Park Y, Ma T, Rockhold RW, Ho IK.","J Neurosci Res. 2003 Jun 15;72(6):781-9. doi: 10.1002/jnr.10578.","Fan LW","J Neurosci Res","2003","2003/05/30","","","10.1002/jnr.10578"
"12768528","[Pharmacological treatment of kleptomania--review]","Kozian R, Otto FG.","Psychiatr Prax. 2003 May;30(4):216-20. doi: 10.1055/s-2003-39487.","Kozian R","Psychiatr Prax","2003","2003/05/28","","","10.1055/s-2003-39487"
"12766254","Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone","Sell SL, McMahon LR, France CP.","J Pharmacol Exp Ther. 2003 Sep;306(3):1167-73. doi: 10.1124/jpet.103.051425. Epub 2003 May 23.","Sell SL","J Pharmacol Exp Ther","2003","2003/05/27","","","10.1124/jpet.103.051425"
"12759132","Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats","Craft RM, McNiel DM.","Pharmacol Biochem Behav. 2003 Apr;75(1):235-45. doi: 10.1016/s0091-3057(03)00076-5.","Craft RM","Pharmacol Biochem Behav","2003","2003/05/22","","","10.1016/s0091-3057(03)00076-5"
"12755943","Acute opioid withdrawal on accidental injection of naltrexone","Yeo M, Campbell V, Bonomo Y, Sawyer SM.","J Paediatr Child Health. 2003 May-Jun;39(4):315-7. doi: 10.1046/j.1440-1754.2003.00143.x.","Yeo M","J Paediatr Child Health","2003","2003/05/21","","","10.1046/j.1440-1754.2003.00143.x"
"12751979","Physicians' opinions about medications to treat alcoholism","Mark TL, Kranzler HR, Song X, Bransberger P, Poole VH, Crosse S.","Addiction. 2003 May;98(5):617-26. doi: 10.1046/j.1360-0443.2003.00377.x.","Mark TL","Addiction","2003","2003/05/20","","","10.1046/j.1360-0443.2003.00377.x"
"12751155","Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer","Shekelle P, Coulter I, Hardy ML, Morton SC, Favreau JT, Gagne J, Coulter SA, Udani J, Roth EA, Jungvig LK, Newberry S, Rohr L, Ramirez LR.","Evid Rep Technol Assess (Summ). 2003 Apr;(78):2p..","Shekelle P","Evid Rep Technol Assess (Summ)","2003","2003/05/20","PMC4781214","",""
"12747953","Phosphorylation of activating transcription factor in murine splenocytes through delta opioid receptors","Shahabi NA, McAllen K, Sharp BM.","Cell Immunol. 2003 Feb;221(2):122-7. doi: 10.1016/s0008-8749(03)00068-6.","Shahabi NA","Cell Immunol","2003","2003/05/16","","","10.1016/s0008-8749(03)00068-6"
"12747945","Blockade of dorsal hippocampal kappa-opioid receptors increases blood pressure in normotensive and isolation-induced hypertensive rats","Wright RC, Ingenito AJ.","Neuropeptides. 2003 Apr;37(2):127-32. doi: 10.1016/s0143-4179(03)00024-6.","Wright RC","Neuropeptides","2003","2003/05/16","","","10.1016/s0143-4179(03)00024-6"
"12747939","Opioids and the apoptotic pathway in human cancer cells","Zagon IS, McLaughlin PJ.","Neuropeptides. 2003 Apr;37(2):79-88. doi: 10.1016/s0143-4179(03)00007-6.","Zagon IS","Neuropeptides","2003","2003/05/16","","","10.1016/s0143-4179(03)00007-6"
"12745496","Naltrexone treatment for alcoholics: effect on cigarette smoking rates","Rohsenow DJ, Monti PM, Colby SM, Gulliver SB, Swift RM, Abrams DB.","Nicotine Tob Res. 2003 Apr;5(2):231-6. doi: 10.1080/1462220031000073298.","Rohsenow DJ","Nicotine Tob Res","2003","2003/05/15","","","10.1080/1462220031000073298"
"12738035","Alpha-2-adrenoceptor hyporesponsiveness in isolated tissues of cholestatic animals: involvement of opioid and nitric oxide systems","Demehri S, Namiranian K, Mehr SE, Rastegar H, Shariftabrizi A, Gaskari SA, Roushanzamir F, Dehpour AR.","Life Sci. 2003 May 30;73(2):209-20. doi: 10.1016/s0024-3205(03)00258-3.","Demehri S","Life Sci","2003","2003/05/10","","","10.1016/s0024-3205(03)00258-3"
"12730349","Interleukin-2 increases activity of sarcoplasmic reticulum Ca2+-ATPase, but decreases its sensitivity to calcium in rat cardiomyocytes","Cao CM, Xia Q, Bruce IC, Zhang X, Fu C, Chen JZ.","J Pharmacol Exp Ther. 2003 Aug;306(2):572-80. doi: 10.1124/jpet.102.048264. Epub 2003 May 2.","Cao CM","J Pharmacol Exp Ther","2003","2003/05/06","","","10.1124/jpet.102.048264"
"12730057","Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels","Cao Z, Liu L, Van Winkle DM.","Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1032-9. doi: 10.1152/ajpheart.01004.2002. Epub 2003 May 1.","Cao Z","Am J Physiol Heart Circ Physiol","2003","2003/05/06","","","10.1152/ajpheart.01004.2002"
"12721333","Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse","Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF.","J Pharmacol Exp Ther. 2003 Jul;306(1):394-400. doi: 10.1124/jpet.103.048835. Epub 2003 Apr 29.","Mizoguchi H","J Pharmacol Exp Ther","2003","2003/05/02","","","10.1124/jpet.103.048835"
"12714007","Melatonin enhances cellular and humoral immune responses in the Japanese quail (Coturnix coturnix japonica) via an opiatergic mechanism","Moore CB, Siopes TD.","Gen Comp Endocrinol. 2003 May;131(3):258-63. doi: 10.1016/s0016-6480(03)00011-x.","Moore CB","Gen Comp Endocrinol","2003","2003/04/26","","","10.1016/s0016-6480(03)00011-x"
"12712786","Use of oral and implantable naltrexone in the management of the opioid impaired physician","Hulse GK, O'Neil G, Hatton M, Paech MJ.","Anaesth Intensive Care. 2003 Apr;31(2):196-201. doi: 10.1177/0310057X0303100211.","Hulse GK","Anaesth Intensive Care","2003","2003/04/26","","","10.1177/0310057X0303100211"
"12710015","beta-Funaltrexamine, a gauge for the recognition site of wildtype and mutant H297Q mu-opioid receptors","Spivak CE, Beglan CL, Zöllner C, Surratt CK.","Synapse. 2003 Jul;49(1):55-60. doi: 10.1002/syn.10205.","Spivak CE","Synapse","2003","2003/04/24","","","10.1002/syn.10205"
"12707143","The effect of clonidine on gastrointestinal side effects associated with ultra-rapid opioid detoxification","Ma H, Tang J, White PF, Wender RH, Leverone T, Quon R, Pearce S, Chiao F, Erice S.","Anesth Analg. 2003 May;96(5):1409-12, table of contents. doi: 10.1213/01.ane.0000060451.82578.3a.","Ma H","Anesth Analg","2003","2003/04/23","","","10.1213/01.ane.0000060451.82578.3a"
"12706480","Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord","Portoghese PS, Lunzer MM.","Eur J Pharmacol. 2003 Apr 25;467(1-3):233-4. doi: 10.1016/s0014-2999(03)01599-1.","Portoghese PS","Eur J Pharmacol","2003","2003/04/23","","","10.1016/s0014-2999(03)01599-1"
"12706478","The antitussive effects of endomorphin-1 and endomorphin-2 in mice","Kamei J, Morita K, Saitoh A, Nagase H.","Eur J Pharmacol. 2003 Apr 25;467(1-3):219-22. doi: 10.1016/s0014-2999(03)01634-0.","Kamei J","Eur J Pharmacol","2003","2003/04/23","","","10.1016/s0014-2999(03)01634-0"
"12706459","Activation of the kappa-opioid receptor in Caco-2 cells decreases interleukin-8 secretion","Neudeck BL, Loeb J, Buck J.","Eur J Pharmacol. 2003 Apr 25;467(1-3):81-4. doi: 10.1016/s0014-2999(03)01633-9.","Neudeck BL","Eur J Pharmacol","2003","2003/04/23","","","10.1016/s0014-2999(03)01633-9"
"12703669","Use of very low-dose naltrexone during opiate detoxification","Mannelli P, Gottheil E, Buonanno A, De Risio S.","J Addict Dis. 2003;22(2):63-70. doi: 10.1300/J069v22n02_05.","Mannelli P","J Addict Dis","2003","2003/04/22","","","10.1300/J069v22n02_05"
"12703332","Clinical treatment of opioid addiction and dependence","Ling W, Rawson RA, Compton M.","Methods Mol Med. 2003;84:285-95. doi: 10.1385/1-59259-379-8:285.","Ling W","Methods Mol Med","2003","2003/04/22","","","10.1385/1-59259-379-8:285"
"12700689","Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats","Heyser CJ, Moc K, Koob GF.","Neuropsychopharmacology. 2003 Aug;28(8):1463-71. doi: 10.1038/sj.npp.1300175. Epub 2003 Apr 9.","Heyser CJ","Neuropsychopharmacology","2003","2003/04/18","","","10.1038/sj.npp.1300175"
"12694640","Behavioral and neuroendocrine actions of the Met-enkephalin-related peptide MERF","Bujdosó E, Jászberényi M, Farkas J, Tóth G, Wollemann M, Telegdy G.","Horm Behav. 2003 Feb;43(2):302-11. doi: 10.1016/s0018-506x(03)00004-7.","Bujdosó E","Horm Behav","2003","2003/04/16","","","10.1016/s0018-506x(03)00004-7"
"12689609","Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys","Williams KL, Ko MC, Rice KC, Woods JH.","Psychoneuroendocrinology. 2003 May;28(4):513-28. doi: 10.1016/s0306-4530(02)00037-9.","Williams KL","Psychoneuroendocrinology","2003","2003/04/12","","","10.1016/s0306-4530(02)00037-9"
"12688708","Solid-phase synthesis of naltrindole derivatives using Fischer indole synthesis based on one-pot release and cyclization methodology","Tanaka H, Ohno H, Kawamura K, Ohtake A, Nagase H, Takahashi T.","Org Lett. 2003 Apr 17;5(8):1159-62. doi: 10.1021/ol020230d.","Tanaka H","Org Lett","2003","2003/04/12","","","10.1021/ol020230d"
"12684740","Cue-induced behavioural activation: a novel model of alcohol craving?","Pickering C, Liljequist S.","Psychopharmacology (Berl). 2003 Jul;168(3):307-13. doi: 10.1007/s00213-003-1454-6. Epub 2003 Apr 9.","Pickering C","Psychopharmacology (Berl)","2003","2003/04/10","","","10.1007/s00213-003-1454-6"
"12683918","Interaction among beta-endorphin, nitric oxide and prostaglandins during ovulation in rats","Faletti AG, Mohn C, Farina M, Lomniczi A, Rettori V.","Reproduction. 2003 Apr;125(4):469-77. doi: 10.1530/rep.0.1250469.","Faletti AG","Reproduction","2003","2003/04/10","","","10.1530/rep.0.1250469"
"12683088","[Molecular aspects of pharmacological activity of naltrexone and naloxone]","Golovko AI, Golovko SI, Leont'eva LV, Romanenko OI, Konoplin DA.","Eksp Klin Farmakol. 2003 Jan-Feb;66(1):71-8.","Golovko AI","Eksp Klin Farmakol","2003","2003/04/10","","",""
"12681528","Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study","Caputo F, Addolorato G, Lorenzini F, Domenicali M, Greco G, del RE A, Gasbarrini G, Stefanini GF, Bernardi M.","Drug Alcohol Depend. 2003 May 1;70(1):85-91. doi: 10.1016/s0376-8716(02)00340-x.","Caputo F","Drug Alcohol Depend","2003","2003/04/12","","","10.1016/s0376-8716(02)00340-x"
"12681522","Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamine","Negus SS, Brandt MR, Gatch MB, Mello NK.","Drug Alcohol Depend. 2003 May 1;70(1):17-27. doi: 10.1016/s0376-8716(02)00331-9.","Negus SS","Drug Alcohol Depend","2003","2003/04/12","","","10.1016/s0376-8716(02)00331-9"
"12676268","Effect of cold acclimation and repeated swimming on opioid and nonopioid swim stress-induced analgesia in selectively bred mice","Lapo IB, Konarzewski M, Sadowski B.","Physiol Behav. 2003 Mar;78(3):345-50. doi: 10.1016/s0031-9384(02)01004-1.","Lapo IB","Physiol Behav","2003","2003/04/05","","","10.1016/s0031-9384(02)01004-1"
"12669594","[The role of adrenocorticotropic hormone in inhibition of pain reaction in awake rats]","Bogdanov AI, Iarushkina NI.","Ross Fiziol Zh Im I M Sechenova. 2003 Jan;89(1):60-5.","Bogdanov AI","Ross Fiziol Zh Im I M Sechenova","2003","2003/04/03","","",""
"12668220","Effect of rubiscolin, a delta opioid peptide derived from Rubisco, on memory consolidation","Yang S, Kawamura Y, Yoshikawa M.","Peptides. 2003 Feb;24(2):325-8. doi: 10.1016/s0196-9781(03)00044-5.","Yang S","Peptides","2003","2003/04/02","","","10.1016/s0196-9781(03)00044-5"
"12664190","Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone","Ciccocioppo R, Lin D, Martin-Fardon R, Weiss F.","Psychopharmacology (Berl). 2003 Jul;168(1-2):208-215. doi: 10.1007/s00213-002-1380-z. Epub 2003 Mar 27.","Ciccocioppo R","Psychopharmacology (Berl)","2003","2003/03/29","","","10.1007/s00213-002-1380-z"
"12658121","Preclinical and clinical studies on naltrexone: what have they taught each other?","Froehlich J, O'Malley S, Hyytiä P, Davidson D, Farren C.","Alcohol Clin Exp Res. 2003 Mar;27(3):533-9. doi: 10.1097/01.ALC.0000057943.57330.AB.","Froehlich J","Alcohol Clin Exp Res","2003","2003/03/27","","","10.1097/01.ALC.0000057943.57330.AB"
"12656645","Opioid-induced bowel dysfunction: pathophysiology and potential new therapies","Kurz A, Sessler DI.","Drugs. 2003;63(7):649-71. doi: 10.2165/00003495-200363070-00003.","Kurz A","Drugs","2003","2003/03/27","","","10.2165/00003495-200363070-00003"
"12655322","A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene","Drobes DJ, Anton RF, Thomas SE, Voronin K.","Neuropsychopharmacology. 2003 Apr;28(4):755-64. doi: 10.1038/sj.npp.1300101. Epub 2002 Oct 30.","Drobes DJ","Neuropsychopharmacology","2003","2003/03/26","","","10.1038/sj.npp.1300101"
"12653976","Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice","Lesscher HM, Bailey A, Burbach JP, Van Ree JM, Kitchen I, Gerrits MA.","Eur J Neurosci. 2003 Mar;17(5):1006-12. doi: 10.1046/j.1460-9568.2003.02502.x.","Lesscher HM","Eur J Neurosci","2003","2003/03/26","","","10.1046/j.1460-9568.2003.02502.x"
"12653973","Regulation of RGS proteins by chronic morphine in rat locus coeruleus","Gold SJ, Han MH, Herman AE, Ni YG, Pudiak CM, Aghajanian GK, Liu RJ, Potts BW, Mumby SM, Nestler EJ.","Eur J Neurosci. 2003 Mar;17(5):971-80. doi: 10.1046/j.1460-9568.2003.02529.x.","Gold SJ","Eur J Neurosci","2003","2003/03/26","","","10.1046/j.1460-9568.2003.02529.x"
"12653834","Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice","Holán V, Zajícová A, Krulova M, Blahoutová V, Wilczek H.","Clin Exp Immunol. 2003 Apr;132(1):40-5. doi: 10.1046/j.1365-2249.2003.02103.x.","Holán V","Clin Exp Immunol","2003","2003/03/26","PMC1808676","","10.1046/j.1365-2249.2003.02103.x"
"12652938","[The opiatergic link between the antiarrhythmic effect of adaptation and hypoxia in the model of ischemia and reperfusion in vivo]","Lishmanov IuB, Naryzhnaia NV, Maslov LN, Gross GJ.","Patol Fiziol Eksp Ter. 2003 Jan-Mar;(1):19-21.","Lishmanov IuB","Patol Fiziol Eksp Ter","2003","2003/03/26","","",""
"12651662","Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats","Hao S, Mamiya K, Takahata O, Iwasaki H, Mata M, Fink DJ.","Anesth Analg. 2003 Apr;96(4):1065-71, table of contents. doi: 10.1213/01.ane.0000050559.44049.67.","Hao S","Anesth Analg","2003","2003/03/26","","","10.1213/01.ane.0000050559.44049.67"
"12649366","Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys","Ko MC, Lee H, Song MS, Sobczyk-Kojiro K, Mosberg HI, Kishioka S, Woods JH, Naughton NN.","J Pharmacol Exp Ther. 2003 Apr;305(1):173-9. doi: 10.1124/jpet.102.044909.","Ko MC","J Pharmacol Exp Ther","2003","2003/03/22","","","10.1124/jpet.102.044909"
"12649297","Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox","Barrett AC, Smith ES, Picker MJ.","J Pharmacol Exp Ther. 2003 Jun;305(3):1061-70. doi: 10.1124/jpet.102.047068. Epub 2003 Mar 20.","Barrett AC","J Pharmacol Exp Ther","2003","2003/03/22","","","10.1124/jpet.102.047068"
"12646325","Research to practice: adoption of naltrexone in alcoholism treatment","Thomas CP, Wallack SS, Lee S, McCarty D, Swift R.","J Subst Abuse Treat. 2003 Jan;24(1):1-11.","Thomas CP","J Subst Abuse Treat","2003","2003/03/21","","",""
"12644889","Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey","White DA, Holtzman SG.","Psychopharmacology (Berl). 2003 May;167(2):203-10. doi: 10.1007/s00213-002-1367-9. Epub 2003 Mar 18.","White DA","Psychopharmacology (Berl)","2003","2003/03/20","","","10.1007/s00213-002-1367-9"
"12644730","Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity","Roozen HG, Kerkhof AJ, van den Brink W.","Eur Addict Res. 2003 Apr;9(2):53-8. doi: 10.1159/000068808.","Roozen HG","Eur Addict Res","2003","2003/03/20","","","10.1159/000068808"
"12642578","Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors","Borgland SL, Connor M, Osborne PB, Furness JB, Christie MJ.","J Biol Chem. 2003 May 23;278(21):18776-84. doi: 10.1074/jbc.M300525200. Epub 2003 Mar 17.","Borgland SL","J Biol Chem","2003","2003/03/19","","","10.1074/jbc.M300525200"
"12638640","Advances in the use of naltrexone: an integration of preclinical and clinical findings","O'Malley SS, Froehlich JC.","Recent Dev Alcohol. 2003;16:217-45.","O'Malley SS","Recent Dev Alcohol","2003","2003/03/18","","",""
"12638639","Acamprosate","Mason BJ.","Recent Dev Alcohol. 2003;16:203-15.","Mason BJ","Recent Dev Alcohol","2003","2003/03/18","","",""
"12637353","Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors","Peart JN, Gross GJ.","Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H81-9. doi: 10.1152/ajpheart.00985.2002. Epub 2003 Mar 13.","Peart JN","Am J Physiol Heart Circ Physiol","2003","2003/03/15","","","10.1152/ajpheart.00985.2002"
"12633914","Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results","Bochud Tornay C, Favrat B, Monnat M, Daeppen JB, Schnyder C, Bertschy G, Besson J.","Drug Alcohol Depend. 2003 Apr 1;69(3):283-8. doi: 10.1016/s0376-8716(02)00326-5.","Bochud Tornay C","Drug Alcohol Depend","2003","2003/03/14","","","10.1016/s0376-8716(02)00326-5"
"12620465","Long-term response to naltrexone in polycystic ovary syndrome?","Cagnacci A, Paoletti AM.","Fertil Steril. 2003 Mar;79(3):659; author reply 659-60. doi: 10.1016/s0015-0282(02)04747-7.","Cagnacci A","Fertil Steril","2003","2003/03/07","","","10.1016/s0015-0282(02)04747-7"
"12618704","Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery","Zagon IS, Essis FM Jr, Verderame MF, Healy DA, Atnip RG, McLaughlin PJ.","J Vasc Surg. 2003 Mar;37(3):636-43. doi: 10.1067/mva.2003.165.","Zagon IS","J Vasc Surg","2003","2003/03/06","","","10.1067/mva.2003.165"
"12606628","Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA","Szeto HH, Soong Y, Wu D, Qian X, Zhao GM.","J Pharmacol Exp Ther. 2003 May;305(2):696-702. doi: 10.1124/jpet.102.048561. Epub 2003 Jan 24.","Szeto HH","J Pharmacol Exp Ther","2003","2003/02/28","","","10.1124/jpet.102.048561"
"12604679","Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence","Holtzman SG.","J Pharmacol Exp Ther. 2003 Mar;304(3):1033-41. doi: 10.1124/jpet.102.044875.","Holtzman SG","J Pharmacol Exp Ther","2003","2003/02/27","","","10.1124/jpet.102.044875"
"12601499","Discriminative stimulus and antinociceptive effects of dihydroetorphine in rhesus monkeys","Gerak LR, Gauthier CR, France CR.","Psychopharmacology (Berl). 2003 Apr;166(4):351-9. doi: 10.1007/s00213-002-1268-y. Epub 2003 Feb 25.","Gerak LR","Psychopharmacology (Berl)","2003","2003/02/26","","","10.1007/s00213-002-1268-y"
"12598254","Modulation of myofilament Ca2+ densitivity by delta- and kappa-opioid agonists in intact guinea pig hearts","Nakae Y, Fujita S, Namiki A.","Anesth Analg. 2003 Mar;96(3):733-9, table of contents. doi: 10.1213/01.ane.0000050281.16556.33.","Nakae Y","Anesth Analg","2003","2003/02/25","","","10.1213/01.ane.0000050281.16556.33"
"12591116","Opioid modulation of taste responses in the nucleus of the solitary tract","Li CS, Davis BJ, Smith DV.","Brain Res. 2003 Mar 7;965(1-2):21-34. doi: 10.1016/s0006-8993(02)03973-2.","Li CS","Brain Res","2003","2003/02/20","","","10.1016/s0006-8993(02)03973-2"
"12588510","Opioid receptor subtypes involved in the regulation of prolactin secretion during pregnancy and lactation","Andrews ZB, Grattan DR.","J Neuroendocrinol. 2003 Mar;15(3):227-36. doi: 10.1046/j.1365-2826.2003.00975.x.","Andrews ZB","J Neuroendocrinol","2003","2003/02/18","","","10.1046/j.1365-2826.2003.00975.x"
"12572526","Sufentanil-related respiratory depression and antinociception in the dog. Mediation by different receptor types","Latasch L, Freye E.","Arzneimittelforschung. 2002;52(12):870-6. doi: 10.1055/s-0031-1299983.","Latasch L","Arzneimittelforschung","2002","2003/02/08","","","10.1055/s-0031-1299983"
"12570015","Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis?","Gaskari SA, Mani AR, Ejtemaei-Mehr S, Namiranian K, Homayoun H, Ahmadi H, Dehpour AR.","Fundam Clin Pharmacol. 2002 Aug;16(4):273-9. doi: 10.1046/j.1472-8206.2002.00089.x.","Gaskari SA","Fundam Clin Pharmacol","2002","2003/02/07","","","10.1046/j.1472-8206.2002.00089.x"
"12568913","Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice","Mizoguchi H, Hung KC, Leitermann R, Narita M, Nagase H, Suzuki T, Tseng LF.","Eur J Pharmacol. 2003 Feb 7;461(1):35-9. doi: 10.1016/s0014-2999(03)01299-8.","Mizoguchi H","Eur J Pharmacol","2003","2003/02/06","","","10.1016/s0014-2999(03)01299-8"
"12565965","Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinans","Ananthan S, Kezar HS 3rd, Saini SK, Khare NK, Davis P, Dersch CM, Porreca F, Rothman RB.","Bioorg Med Chem Lett. 2003 Feb 10;13(3):529-32. doi: 10.1016/s0960-894x(02)00934-4.","Ananthan S","Bioorg Med Chem Lett","2003","2003/02/05","","","10.1016/s0960-894x(02)00934-4"
"12558150","Opioid receptor antagonists modulate Ca2+-activated K+ channels in mesenteric arterial smooth muscle cells of rats in hemorrhagic shock","Kai L, Wang ZF, Hu DY, Shi YL, Liu LM.","Shock. 2003 Jan;19(1):85-90. doi: 10.1097/00024382-200301000-00016.","Kai L","Shock","2003","2003/02/01","","","10.1097/00024382-200301000-00016"
"12551758","Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat","Stromberg MF, Sengpiel T, Mackler SA, Volpicelli JR, O'Brien CP, Vogel WH.","Alcohol. 2002 Nov;28(3):169-79. doi: 10.1016/s0741-8329(02)00280-x.","Stromberg MF","Alcohol","2002","2003/01/29","","","10.1016/s0741-8329(02)00280-x"
"12543635","Role of kappa-opioid receptor activation in pharmacological preconditioning of swine","Coles JA Jr, Sigg DC, Iaizzo PA.","Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2091-9. doi: 10.1152/ajpheart.00843.2002. Epub 2003 Jan 23.","Coles JA Jr","Am J Physiol Heart Circ Physiol","2003","2003/01/25","","","10.1152/ajpheart.00843.2002"
"12543227","Effects of beta-funaltrexamine and naloxonazine on single-trial morphine-conditioned place preference and locomotor activity","Bardo MT, Gehrke BJ, Shortridge BE, Rauhut AS.","Pharmacol Biochem Behav. 2003 Feb;74(3):617-22. doi: 10.1016/s0091-3057(02)01049-3.","Bardo MT","Pharmacol Biochem Behav","2003","2003/01/25","","","10.1016/s0091-3057(02)01049-3"
"12542894","Inhibition of urinary bladder motility by a spinal action of U-50488H in rats","Gotoh A, Goto K, Sengoku A, Shirakawa T, Akao Y, Fujisawa M, Okada H, Arakawa S, Sasaki H, Kamidono S.","J Pharm Pharmacol. 2002 Dec;54(12):1645-50. doi: 10.1211/002235702397.","Gotoh A","J Pharm Pharmacol","2002","2003/01/25","","","10.1211/002235702397"
"12538812","Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence","Kalinichev M, Holtzman SG.","J Pharmacol Exp Ther. 2003 Feb;304(2):603-9. doi: 10.1124/jpet.102.044206.","Kalinichev M","J Pharmacol Exp Ther","2003","2003/01/23","","","10.1124/jpet.102.044206"
"12537702","Characteristics, retention and readmissions of opioid-dependent clients treated with oral naltrexone","Bartu A, Freeman NC, Gawthorne GS, Allsop SJ, Quigley AJ.","Drug Alcohol Rev. 2002 Dec;21(4):335-40. doi: 10.1080/0959523021000023180.","Bartu A","Drug Alcohol Rev","2002","2003/01/23","","","10.1080/0959523021000023180"
"12536020","Consolidation and expression of a shock-induced odor preference in rat pups is facilitated by opioids","Roth TL, Sullivan RM.","Physiol Behav. 2003 Jan;78(1):135-42. doi: 10.1016/s0031-9384(02)00961-7.","Roth TL","Physiol Behav","2003","2003/01/22","","","10.1016/s0031-9384(02)00961-7"
"12536012","Effect of naltrexone on food intake and body weight in Syrian hamsters depends on metabolic status","Jones JE, Corp ES.","Physiol Behav. 2003 Jan;78(1):67-72. doi: 10.1016/s0031-9384(02)00894-6.","Jones JE","Physiol Behav","2003","2003/01/22","","","10.1016/s0031-9384(02)00894-6"
"12535697","Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats","Sipols AJ, Bayer J, Bennett R, Figlewicz DP.","Peptides. 2002 Dec;23(12):2181-7. doi: 10.1016/s0196-9781(02)00246-2.","Sipols AJ","Peptides","2002","2003/01/22","","","10.1016/s0196-9781(02)00246-2"
"12532846","[Repeated 100 Hz TENS for the treatment of chronic inflammatory pain in rats: optimal parameters and possible neuro-chemical mechanisms]","Liu HX.","Sheng Li Ke Xue Jin Zhan. 1999 Jan;30(1):35-7.","Liu HX","Sheng Li Ke Xue Jin Zhan","1999","2003/01/21","","",""
"12521939","Cardiac enkephalins interrupt vagal bradycardia via delta 2-opioid receptors in sinoatrial node","Farias M 3rd, Jackson KE, Yoshishige D, Caffrey JL.","Am J Physiol Heart Circ Physiol. 2003 May;284(5):H1693-701. doi: 10.1152/ajpheart.00730.2002. Epub 2003 Jan 9.","Farias M 3rd","Am J Physiol Heart Circ Physiol","2003","2003/01/11","","","10.1152/ajpheart.00730.2002"
"12519069","The role of the side chain in determining relative delta- and kappa-affinity in C5'-substituted analogues of naltrindole","Black SL, Jales AR, Brandt W, Lewis JW, Husbands SM.","J Med Chem. 2003 Jan 16;46(2):314-7. doi: 10.1021/jm020997b.","Black SL","J Med Chem","2003","2003/01/10","","","10.1021/jm020997b"
"12513698","Activity of opioid ligands in cells expressing cloned mu opioid receptors","Gharagozlou P, Demirci H, David Clark J, Lameh J.","BMC Pharmacol. 2003 Jan 4;3:1. doi: 10.1186/1471-2210-3-1. Epub 2003 Jan 4.","Gharagozlou P","BMC Pharmacol","2003","2003/01/07","PMC140036","","10.1186/1471-2210-3-1"
"12511176","Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study","Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kämpf P, Stracke R, Baehr M, Naber D, Wiedemann K.","Arch Gen Psychiatry. 2003 Jan;60(1):92-9. doi: 10.1001/archpsyc.60.1.92.","Kiefer F","Arch Gen Psychiatry","2003","2003/01/07","","","10.1001/archpsyc.60.1.92"
"12505529","Agonist-specific down-regulation of the human delta-opioid receptor","Okura T, Varga EV, Hosohata Y, Navratilova E, Cowell SM, Rice K, Nagase H, Hruby VJ, Roeske WR, Yamamura HI.","Eur J Pharmacol. 2003 Jan 10;459(1):9-16. doi: 10.1016/s0014-2999(02)02823-6.","Okura T","Eur J Pharmacol","2003","2002/12/31","","","10.1016/s0014-2999(02)02823-6"
"12503615","Specific stimulation of migration of human keratinocytes by mu-opiate receptor agonists","Bigliardi PL, Büchner S, Rufli T, Bigliardi-Qi M.","J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):191-9. doi: 10.1081/rrs-120014595.","Bigliardi PL","J Recept Signal Transduct Res","2002","2002/12/31","","","10.1081/rrs-120014595"
"12500129","Role of naltrexone in initial smoking cessation: preliminary findings","King AC.","Alcohol Clin Exp Res. 2002 Dec;26(12):1942-4. doi: 10.1097/01.ALC.0000041003.44118.9B.","King AC","Alcohol Clin Exp Res","2002","2002/12/25","","","10.1097/01.ALC.0000041003.44118.9B"
"12498912","Functional interactions between delta- and mu-opioid receptors in rat thermoregulation","Salmi P, Kela J, Arvidsson U, Wahlestedt C.","Eur J Pharmacol. 2003 Jan 1;458(1-2):101-6. doi: 10.1016/s0014-2999(02)02736-x.","Salmi P","Eur J Pharmacol","2003","2002/12/25","","","10.1016/s0014-2999(02)02736-x"
"12495798","Naltrexone improves outcome of a controlled drinking program","Rubio G, Manzanares J, Lopez-Muñoz F, Alamo C, Ponce G, Jimenez-Arriero MA, Palomo T.","J Subst Abuse Treat. 2002 Dec;23(4):361-6. doi: 10.1016/s0740-5472(02)00296-9.","Rubio G","J Subst Abuse Treat","2002","2002/12/24","","","10.1016/s0740-5472(02)00296-9"
"12495797","Behavioral naltrexone therapy: an integrated treatment for opiate dependence","Rothenberg JL, Sullivan MA, Church SH, Seracini A, Collins E, Kleber HD, Nunes EV.","J Subst Abuse Treat. 2002 Dec;23(4):351-60. doi: 10.1016/s0740-5472(02)00301-x.","Rothenberg JL","J Subst Abuse Treat","2002","2002/12/24","","","10.1016/s0740-5472(02)00301-x"
"12495120","Using naltrexone implants in the management of the pregnant heroin user","Hulse G, O'Neil G.","Aust N Z J Obstet Gynaecol. 2002 Nov;42(5):569-73. doi: 10.1111/j.0004-8666.2002.548_14.x.","Hulse G","Aust N Z J Obstet Gynaecol","2002","2002/12/24","","","10.1111/j.0004-8666.2002.548_14.x"
"12491025","Interaction between naltrexone and oral THC in heavy marijuana smokers","Haney M, Bisaga A, Foltin RW.","Psychopharmacology (Berl). 2003 Feb;166(1):77-85. doi: 10.1007/s00213-002-1279-8. Epub 2002 Dec 19.","Haney M","Psychopharmacology (Berl)","2003","2002/12/20","","","10.1007/s00213-002-1279-8"
"12490605","Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay","Sterious SN, Walker EA.","J Pharmacol Exp Ther. 2003 Jan;304(1):301-9. doi: 10.1124/jpet.102.042093.","Sterious SN","J Pharmacol Exp Ther","2003","2002/12/20","","","10.1124/jpet.102.042093"
"12486182","Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect","Newton SS, Thome J, Wallace TL, Shirayama Y, Schlesinger L, Sakai N, Chen J, Neve R, Nestler EJ, Duman RS.","J Neurosci. 2002 Dec 15;22(24):10883-90. doi: 10.1523/JNEUROSCI.22-24-10883.2002.","Newton SS","J Neurosci","2002","2002/12/18","PMC6758459","","10.1523/JNEUROSCI.22-24-10883.2002"
"12479844","Opioid peptides and the control of human ingestive behaviour","Yeomans MR, Gray RW.","Neurosci Biobehav Rev. 2002 Oct;26(6):713-28. doi: 10.1016/s0149-7634(02)00041-6.","Yeomans MR","Neurosci Biobehav Rev","2002","2002/12/14","","","10.1016/s0149-7634(02)00041-6"
"12474121","Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats","Castilho VM, Macedo CE, Brandão ML.","Psychopharmacology (Berl). 2002 Dec;165(1):77-85. doi: 10.1007/s00213-002-1246-4. Epub 2002 Oct 24.","Castilho VM","Psychopharmacology (Berl)","2002","2002/12/11","","","10.1007/s00213-002-1246-4"
"12473373","U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes","Sheng WS, Hu S, Lokensgard JR, Peterson PK.","Biochem Pharmacol. 2003 Jan 1;65(1):9-14. doi: 10.1016/s0006-2952(02)01480-6.","Sheng WS","Biochem Pharmacol","2003","2002/12/11","","","10.1016/s0006-2952(02)01480-6"
"12467995","Dynorphin-independent spinal cannabinoid antinociception","Gardell LR, Ossipov MH, Vanderah TW, Lai J, Porreca F.","Pain. 2002 Dec;100(3):243-8. doi: 10.1016/s0304-3959(02)00173-2.","Gardell LR","Pain","2002","2002/12/07","","","10.1016/s0304-3959(02)00173-2"
"12467912","Naltrexone potentiates both amnestic and anxiolytic effects of chlordiazepoxide in mice","Silva RH, Frussa-Filho R.","Life Sci. 2002 Dec 27;72(6):721-30. doi: 10.1016/s0024-3205(02)02298-1.","Silva RH","Life Sci","2002","2002/12/07","","","10.1016/s0024-3205(02)02298-1"
"12454559","Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study","Gastpar M, Bonnet U, Böning J, Mann K, Schmidt LG, Soyka M, Wetterling T, Kielstein V, Labriola D, Croop R.","J Clin Psychopharmacol. 2002 Dec;22(6):592-8. doi: 10.1097/00004714-200212000-00009.","Gastpar M","J Clin Psychopharmacol","2002","2002/11/28","","","10.1097/00004714-200212000-00009"
"12445704","Formalin-induced pain and mu-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice","Borghi V, Przewlocka B, Labuz D, Maj M, Ilona O, Pavone F.","Brain Res. 2002 Nov 29;956(2):339-48. doi: 10.1016/s0006-8993(02)03568-0.","Borghi V","Brain Res","2002","2002/11/26","","","10.1016/s0006-8993(02)03568-0"
"12445410","Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study","Terg R, Coronel E, Sordá J, Muñoz AE, Findor J.","J Hepatol. 2002 Dec;37(6):717-22. doi: 10.1016/s0168-8278(02)00318-5.","Terg R","J Hepatol","2002","2002/11/26","","","10.1016/s0168-8278(02)00318-5"
"12435410","Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse","Mizoguchi H, Wu HE, Narita M, Hall FS, Sora I, Uhl GR, Nagase H, Tseng LF.","Neuroscience. 2002;115(3):715-21. doi: 10.1016/s0306-4522(02)00486-4.","Mizoguchi H","Neuroscience","2002","2002/11/19","","","10.1016/s0306-4522(02)00486-4"
"12434400","Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin","Stinchcomb AL, Swaan PW, Ekabo O, Harris KK, Browe J, Hammell DC, Cooperman TA, Pearsall M.","J Pharm Sci. 2002 Dec;91(12):2571-8. doi: 10.1002/jps.10239.","Stinchcomb AL","J Pharm Sci","2002","2002/11/16","","","10.1002/jps.10239"
"12427583","Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes","Oslin DW, Pettinati H, Volpicelli JR.","Am J Geriatr Psychiatry. 2002 Nov-Dec;10(6):740-7.","Oslin DW","Am J Geriatr Psychiatry","2002","2002/11/13","","",""
"12425430","Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor","Guo CJ, Li Y, Tian S, Wang X, Douglas SD, Ho WZ.","J Investig Med. 2002 Nov;50(6):435-42. doi: 10.1136/jim-50-06-03.","Guo CJ","J Investig Med","2002","2002/11/12","PMC4037869","NIHMS575122","10.1136/jim-50-06-03"
"12424303","Activation of delta-opioid receptors excites spinally projecting locus coeruleus neurons through inhibition of GABAergic inputs","Pan YZ, Li DP, Chen SR, Pan HL.","J Neurophysiol. 2002 Nov;88(5):2675-83. doi: 10.1152/jn.00298.2002.","Pan YZ","J Neurophysiol","2002","2002/11/09","","","10.1152/jn.00298.2002"
"12422250","Naltrexone in the treatment of alcohol dependence: a Canadian trial","Romach MK, Sellers EM, Somer GR, Landry M, Cunningham GM, Jovey RD, McKay C, Boislard J, Mercier C, Pépin JM, Perreault J, Lemire E, Baker RP, Campbell W, Ryan D.","Can J Clin Pharmacol. 2002 Fall;9(3):130-6.","Romach MK","Can J Clin Pharmacol","2002","2002/11/08","","",""
"12419891","Effects of naltrexone on spontaneous itch-associated responses in NC mice with chronic dermatitis","Maekawa T, Yamaguchi-Miyamoto T, Nojima H, Kuraishi Y.","Jpn J Pharmacol. 2002 Oct;90(2):193-6. doi: 10.1254/jjp.90.193.","Maekawa T","Jpn J Pharmacol","2002","2002/11/07","","","10.1254/jjp.90.193"
"12404685","Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study","Lubin G, Weizman A, Shmushkevitz M, Valevski A.","Hum Psychopharmacol. 2002 Jun;17(4):181-5. doi: 10.1002/hup.395.","Lubin G","Hum Psychopharmacol","2002","2002/10/31","","","10.1002/hup.395"
"12401350","Determination of methylnaltrexone in clinical samples by solid-phase extraction and high-performance liquid chromatography for a pharmacokinetics study","Osinski J, Wang A, Wu JA, Foss JF, Yuan CS.","J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 25;780(2):251-9. doi: 10.1016/s1570-0232(02)00527-5.","Osinski J","J Chromatogr B Analyt Technol Biomed Life Sci","2002","2002/10/29","","","10.1016/s1570-0232(02)00527-5"
"12401058","The role of opioid systems on orthodontic tooth movement in cholestatic rats","Nilforoushan D, Shirazi M, Dehpour AR.","Angle Orthod. 2002 Oct;72(5):476-80. doi: 10.1043/0003-3219(2002)072<0476:TROOSO>2.0.CO;2.","Nilforoushan D","Angle Orthod","2002","2002/10/29","","","10.1043/0003-3219(2002)072<0476:TROOSO>2.0.CO;2"
"12399421","Combined blockade of both micro - and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein","Brugman S, Clegg DJ, Woods SC, Seeley RJ.","Endocrinology. 2002 Nov;143(11):4265-70. doi: 10.1210/en.2002-220230.","Brugman S","Endocrinology","2002","2002/10/26","","","10.1210/en.2002-220230"
"12398307","Repeated chemical immobilization of a captive greater one-horned rhinoceros (Rhinoceros unicornis), using combinations of etorphine, detomidine, and ketamine","Atkinson MW, Hull B, Gandolf AR, Blumer ES.","J Zoo Wildl Med. 2002 Jun;33(2):157-62. doi: 10.1638/1042-7260(2002)033[0157:RCIOAC]2.0.CO;2.","Atkinson MW","J Zoo Wildl Med","2002","2002/10/26","","","10.1638/1042-7260(2002)033[0157:RCIOAC]2.0.CO;2"
"12393329","Combining naltrexone and behavior therapy","","Harv Ment Health Lett. 2002 Oct;19(4):7-8.","","Harv Ment Health Lett","2002","2002/10/24","","",""
"12393157","A new technique for long term, stress free, cannulation of the lateral ventricle in postpubertal, freely moving, pigs","van Eerdenburg FJ, Dierx JA.","J Neurosci Methods. 2002 Nov 15;121(1):13-20. doi: 10.1016/s0165-0270(02)00226-1.","van Eerdenburg FJ","J Neurosci Methods","2002","2002/10/24","","","10.1016/s0165-0270(02)00226-1"
"12388657","Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice","Broom DC, Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR.","J Pharmacol Exp Ther. 2002 Nov;303(2):723-9. doi: 10.1124/jpet.102.036525.","Broom DC","J Pharmacol Exp Ther","2002","2002/10/22","","","10.1124/jpet.102.036525"
"12388654","GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system","Tao R, Auerbach SB.","J Pharmacol Exp Ther. 2002 Nov;303(2):704-10. doi: 10.1124/jpet.102.038133.","Tao R","J Pharmacol Exp Ther","2002","2002/10/22","","","10.1124/jpet.102.038133"
"12388635","Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system","Tao R, Auerbach SB.","J Pharmacol Exp Ther. 2002 Nov;303(2):549-56. doi: 10.1124/jpet.102.037861.","Tao R","J Pharmacol Exp Ther","2002","2002/10/22","","","10.1124/jpet.102.037861"
"12385794","The role of delta-opioid receptors in estrogen facilitation of lordosis behavior","Acosta-Martinez M, Etgen AM.","Behav Brain Res. 2002 Oct 17;136(1):93-102. doi: 10.1016/s0166-4328(02)00103-1.","Acosta-Martinez M","Behav Brain Res","2002","2002/10/19","","","10.1016/s0166-4328(02)00103-1"
"12384473","Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits","Kodani E, Xuan YT, Shinmura K, Takano H, Tang XL, Bolli R.","Am J Physiol Heart Circ Physiol. 2002 Nov;283(5):H1943-57. doi: 10.1152/ajpheart.00150.2002.","Kodani E","Am J Physiol Heart Circ Physiol","2002","2002/10/18","","","10.1152/ajpheart.00150.2002"
"12377396","A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone","Mason BJ, Goodman AM, Dixon RM, Hameed MH, Hulot T, Wesnes K, Hunter JA, Boyeson MG.","Neuropsychopharmacology. 2002 Oct;27(4):596-606. doi: 10.1016/S0893-133X(02)00368-8.","Mason BJ","Neuropsychopharmacology","2002","2002/10/16","","","10.1016/S0893-133X(02)00368-8"
"12376408","Naltrexone infusion inhibits the development of preference for a high-sucrose diet","Levine AS, Grace MK, Cleary JP, Billington CJ.","Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1149-54. doi: 10.1152/ajpregu.00040.2002.","Levine AS","Am J Physiol Regul Integr Comp Physiol","2002","2002/10/12","","","10.1152/ajpregu.00040.2002"
"12376173","Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis","Sinchaisuk S, Ho IK, Rockhold RW.","Pharmacol Biochem Behav. 2002 Dec;74(1):241-52. doi: 10.1016/s0091-3057(02)00993-0.","Sinchaisuk S","Pharmacol Biochem Behav","2002","2002/10/12","","","10.1016/s0091-3057(02)00993-0"
"12376164","Naltrexone suppresses the late but not early licking response to a palatable sweet solution: opioid hedonic hypothesis reconsidered","Frisina PG, Sclafani A.","Pharmacol Biochem Behav. 2002 Dec;74(1):163-72. doi: 10.1016/s0091-3057(02)00995-4.","Frisina PG","Pharmacol Biochem Behav","2002","2002/10/12","","","10.1016/s0091-3057(02)00995-4"
"12376160","Tolerance to the disruptive effects of Delta(9)-THC on learning in rats","Delatte MS, Winsauer PJ, Moerschbaecher JM.","Pharmacol Biochem Behav. 2002 Dec;74(1):129-40. doi: 10.1016/s0091-3057(02)00966-8.","Delatte MS","Pharmacol Biochem Behav","2002","2002/10/12","","","10.1016/s0091-3057(02)00966-8"
"12373442","Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys","Negus SS, Mello NK, Linsenmayer DC, Jones RM, Portoghese PS.","Psychopharmacology (Berl). 2002 Oct;163(3-4):412-9. doi: 10.1007/s00213-002-1038-x. Epub 2002 Mar 13.","Negus SS","Psychopharmacology (Berl)","2002","2002/10/10","","","10.1007/s00213-002-1038-x"
"12373072","Exposure to the opioid antagonist naltrexone throughout gestation alters postnatal heart development","McLaughlin PJ.","Biol Neonate. 2002;82(3):207-16. doi: 10.1159/000063611.","McLaughlin PJ","Biol Neonate","2002","2002/10/10","","","10.1159/000063611"
"12369474","Voucher-based incentives. A substance abuse treatment innovation","Higgins ST, Alessi SM, Dantona RL.","Addict Behav. 2002 Nov-Dec;27(6):887-910. doi: 10.1016/s0306-4603(02)00297-6.","Higgins ST","Addict Behav","2002","2002/10/09","","","10.1016/s0306-4603(02)00297-6"
"12366698","Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema","Heyer G, Groene D, Martus P.","Exp Dermatol. 2002 Oct;11(5):448-55. doi: 10.1034/j.1600-0625.2002.110508.x.","Heyer G","Exp Dermatol","2002","2002/10/09","","","10.1034/j.1600-0625.2002.110508.x"
"12362827","[Opioid detoxication under general anesthesia]","Zemtsovski MJ, Trosko O, Schmidt H.","Ugeskr Laeger. 2002 Sep 2;164(36):4165-9.","Zemtsovski MJ","Ugeskr Laeger","2002","2002/10/05","","",""
"12359026","A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence","Kirchmayer U, Davoli M, Verster AD, Amato L, Ferri A, Perucci CA.","Addiction. 2002 Oct;97(10):1241-9. doi: 10.1046/j.1360-0443.2002.00217.x.","Kirchmayer U","Addiction","2002","2002/10/03","","","10.1046/j.1360-0443.2002.00217.x"
"12357166","Pharmacology of opioid inhibition to noxious uterine cervical distension","Sandner-Kiesling A, Eisenach JC.","Anesthesiology. 2002 Oct;97(4):966-71. doi: 10.1097/00000542-200210000-00032.","Sandner-Kiesling A","Anesthesiology","2002","2002/10/03","","","10.1097/00000542-200210000-00032"
"12356367","[A review of naltrexone maintenance programs: effectiveness, predictors and profile]","Madoz-Gúrpide A, Ochoa E, Baca-García E.","Med Clin (Barc). 2002 Sep 21;119(9):351-5. doi: 10.1016/s0025-7753(02)73411-8.","Madoz-Gúrpide A","Med Clin (Barc)","2002","2002/10/03","","","10.1016/s0025-7753(02)73411-8"
"12351933","A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial","Guardia J, Caso C, Arias F, Gual A, Sanahuja J, Ramírez M, Mengual I, Gonzalvo B, Segura L, Trujols J, Casas M.","Alcohol Clin Exp Res. 2002 Sep;26(9):1381-7. doi: 10.1097/01.ALC.0000030561.15921.A9.","Guardia J","Alcohol Clin Exp Res","2002","2002/09/28","","","10.1097/01.ALC.0000030561.15921.A9"
"12351447","Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat","Zagon IS, Jenkins JB, Sassani JW, Wylie JD, Ruth TB, Fry JL, Lang CM, McLaughlin PJ.","Diabetes. 2002 Oct;51(10):3055-62. doi: 10.2337/diabetes.51.10.3055.","Zagon IS","Diabetes","2002","2002/09/28","","","10.2337/diabetes.51.10.3055"
"12323382","Quantitative stoichiometry of G-proteins activated by mu-opioid receptors in postmortem human brain","González-Maeso J, Rodríguez-Puertas R, Meana JJ.","Eur J Pharmacol. 2002 Sep 27;452(1):21-33. doi: 10.1016/s0014-2999(02)02242-2.","González-Maeso J","Eur J Pharmacol","2002","2002/09/27","","","10.1016/s0014-2999(02)02242-2"
"12244149","Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor","Mahajan SD, Schwartz SA, Shanahan TC, Chawda RP, Nair MP.","J Immunol. 2002 Oct 1;169(7):3589-99. doi: 10.4049/jimmunol.169.7.3589.","Mahajan SD","J Immunol","2002","2002/09/24","","","10.4049/jimmunol.169.7.3589"
"12233982","Clinical uses of naltrexone: a review of the evidence","Modesto-Lowe V, Van Kirk J.","Exp Clin Psychopharmacol. 2002 Aug;10(3):213-27. doi: 10.1037//1064-1297.10.3.213.","Modesto-Lowe V","Exp Clin Psychopharmacol","2002","2002/09/18","","","10.1037//1064-1297.10.3.213"
"12225696","Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats","Ciccocioppo R, Martin-Fardon R, Weiss F.","Neuropsychopharmacology. 2002 Sep;27(3):391-9. doi: 10.1016/S0893-133X(02)00302-0.","Ciccocioppo R","Neuropsychopharmacology","2002","2002/09/13","","","10.1016/S0893-133X(02)00302-0"
"12225656","Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury","Kulkarni M, Armstead WM.","J Neurotrauma. 2002 Aug;19(8):965-73. doi: 10.1089/089771502320317113.","Kulkarni M","J Neurotrauma","2002","2002/09/13","","","10.1089/089771502320317113"
"12223538","Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms","Liu X, Weiss F.","J Neurosci. 2002 Sep 15;22(18):7856-61. doi: 10.1523/JNEUROSCI.22-18-07856.2002.","Liu X","J Neurosci","2002","2002/09/12","PMC6758095","","10.1523/JNEUROSCI.22-18-07856.2002"
"12217420","Different effects of methionine-enkephalin on paw edema in two inbred rat strains","Stanojević S, Radulović J, Kovacević-Jovanović V, Vujić V, Dimitrijević M.","Peptides. 2002 Sep;23(9):1597-605. doi: 10.1016/s0196-9781(02)00105-5.","Stanojević S","Peptides","2002","2002/09/10","","","10.1016/s0196-9781(02)00105-5"
"12217419","Lack of the nociceptin receptor does not affect acute or chronic nociception in mice","Bertorelli R, Bastia E, Citterio F, Corradini L, Forlani A, Ongini E.","Peptides. 2002 Sep;23(9):1589-96. doi: 10.1016/s0196-9781(02)00102-x.","Bertorelli R","Peptides","2002","2002/09/10","","","10.1016/s0196-9781(02)00102-x"
"12209151","Pharmacotherapy of addictions","Kreek MJ, LaForge KS, Butelman E.","Nat Rev Drug Discov. 2002 Sep;1(9):710-26. doi: 10.1038/nrd897.","Kreek MJ","Nat Rev Drug Discov","2002","2002/09/05","","","10.1038/nrd897"
"12208688","Rapid opioid detoxification in Australia","O'Neil G, Hulse G, Armstrong J, Little M, Murray L.","Acad Emerg Med. 2002 Sep;9(9):960. doi: 10.1111/j.1553-2712.2002.tb02199.x.","O'Neil G","Acad Emerg Med","2002","2002/09/05","","","10.1111/j.1553-2712.2002.tb02199.x"
"12208687","Rapid opioid detoxification in Australia","Reece S.","Acad Emerg Med. 2002 Sep;9(9):960-2. doi: 10.1197/aemj.9.9.960-a.","Reece S","Acad Emerg Med","2002","2002/09/05","","","10.1197/aemj.9.9.960-a"
"12206854","Naltrexone attenuates plasma nitric oxide release following acute heat stress","Sachidhanandam SB, Low KS, Moochhala SM.","Eur J Pharmacol. 2002 Aug 23;450(2):163-7. doi: 10.1016/s0014-2999(02)02123-4.","Sachidhanandam SB","Eur J Pharmacol","2002","2002/09/11","","","10.1016/s0014-2999(02)02123-4"
"12204561","Design of naltrexone-loaded hydrolyzable crosslinked nanoparticles","Yin W, Akala EO, Taylor RE.","Int J Pharm. 2002 Sep 5;244(1-2):9-19. doi: 10.1016/s0378-5173(02)00297-1.","Yin W","Int J Pharm","2002","2002/09/03","PMC2925203","NIHMS219912","10.1016/s0378-5173(02)00297-1"
"12202015","A pilot double blind placebo controlled trial of sertraline with naltrexone in the treatment of opiate dependence","Farren CK, O'Malley S.","Am J Addict. 2002 Summer;11(3):228-34. doi: 10.1080/10550490290088009.","Farren CK","Am J Addict","2002","2002/08/31","","","10.1080/10550490290088009"
"12199993","[Naltrexone use in the treatment of alcoholism in Spain]","Rubio Valladolid G, Espí Martínez F, Sanchís Fortea M, Bravo García De Laguna JL.","Rev Clin Esp. 2002 Aug;202(8):435-9.","Rubio Valladolid G","Rev Clin Esp","2002","2002/08/30","","",""
"12198205","Uraemic pruritus--new perspectives and insights from recent trials","Mettang T, Pauli-Magnus C, Alscher DM.","Nephrol Dial Transplant. 2002 Sep;17(9):1558-63. doi: 10.1093/ndt/17.9.1558.","Mettang T","Nephrol Dial Transplant","2002","2002/08/29","","","10.1093/ndt/17.9.1558"
"12195238","Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system","Lissoni P, Malugani F, Malysheva O, Kozlov V, Laudon M, Conti A, Maestroni G.","Neuro Endocrinol Lett. 2002 Aug;23(4):341-4.","Lissoni P","Neuro Endocrinol Lett","2002","2002/08/27","","",""
"12191809","Influence of acute or repeated restraint stress on morphine-induced locomotion: involvement of dopamine, opioid and glutamate receptors","del Rosario CN, Pacchioni AM, Cancela LM.","Behav Brain Res. 2002 Aug 21;134(1-2):229-38. doi: 10.1016/s0166-4328(02)00038-4.","del Rosario CN","Behav Brain Res","2002","2002/08/23","","","10.1016/s0166-4328(02)00038-4"
"12189623","[Neurochemical basis of ultra rapid opioid detoxication]","Golovko AI, Leont'eva LV, Golovko SI, Zefirov SIu, Konoplin DA, Romanenko OP.","Vopr Med Khim. 2002 Mar-Apr;48(2):154-73.","Golovko AI","Vopr Med Khim","2002","2002/08/23","","",""
"12188097","Alcohol urge and plasma beta-endorphin change after alcohol challenge with naltrexone pretreatment in social drinkers","Na C, Lee YS.","Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):663-70. doi: 10.1016/s0278-5846(01)00315-3.","Na C","Prog Neuropsychopharmacol Biol Psychiatry","2002","2002/08/22","","","10.1016/s0278-5846(01)00315-3"
"12185408","Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol","Berrendero F, Maldonado R.","Psychopharmacology (Berl). 2002 Aug;163(1):111-7. doi: 10.1007/s00213-002-1144-9. Epub 2002 Jun 27.","Berrendero F","Psychopharmacology (Berl)","2002","2002/08/20","","","10.1007/s00213-002-1144-9"
"12184663","The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating","Jarosz PA, Metzger BL.","Biol Res Nurs. 2002 Apr;3(4):198-209. doi: 10.1177/10900402003004005.","Jarosz PA","Biol Res Nurs","2002","2002/08/20","","","10.1177/10900402003004005"
"12183665","Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors","Liu JG, Prather PL.","J Pharmacol Exp Ther. 2002 Sep;302(3):1070-9. doi: 10.1124/jpet.102.035964.","Liu JG","J Pharmacol Exp Ther","2002","2002/08/17","","","10.1124/jpet.102.035964"
"12175594","Alterations in food intake elicited by GABA and opioid agonists and antagonists administered into the ventral tegmental area region of rats","Echo JA, Lamonte N, Ackerman TF, Bodnar RJ.","Physiol Behav. 2002 May 1;76(1):107-16. doi: 10.1016/s0031-9384(02)00690-x.","Echo JA","Physiol Behav","2002","2002/08/15","","","10.1016/s0031-9384(02)00690-x"
"12167548","A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months","McGregor C, Ali R, White JM, Thomas P, Gowing L.","Drug Alcohol Depend. 2002 Sep 1;68(1):5-14. doi: 10.1016/s0376-8716(02)00077-7.","McGregor C","Drug Alcohol Depend","2002","2002/08/09","","","10.1016/s0376-8716(02)00077-7"
"12166621","Effect of prodynorphin-derived opioid peptides on the ovulatory luteinizing hormone surge in the proestrous rat","Zhang Q, Gallo RV.","Endocrine. 2002 Jun;18(1):27-32. doi: 10.1385/ENDO:18:1:27.","Zhang Q","Endocrine","2002","2002/08/09","","","10.1385/ENDO:18:1:27"
"12161282","Expression of functional kappa-opioid receptors on murine dendritic cells","Kirst A, Wack C, Lutz WK, Eggert A, Kämpgen E, Fischer WH.","Immunol Lett. 2002 Oct 21;84(1):41-8. doi: 10.1016/s0165-2478(02)00128-1.","Kirst A","Immunol Lett","2002","2002/08/06","","","10.1016/s0165-2478(02)00128-1"
"12152529","Pathological gambling. Current status and new treatments","Kim SW, Grant JE, Grosz RL.","Minn Med. 2002 Jul;85(7):48-50, 52.","Kim SW","Minn Med","2002","2002/08/03","","",""
"12151036","Effects of opioid antagonists on unconditioned and conditioned hyperactivity to morphine","Rauhut AS, Gehrke BJ, Phillips SB, Bardo MT.","Pharmacol Biochem Behav. 2002 Oct;73(3):611-22. doi: 10.1016/s0091-3057(02)00855-9.","Rauhut AS","Pharmacol Biochem Behav","2002","2002/08/02","","","10.1016/s0091-3057(02)00855-9"
"12150199","Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites","Narita M, Imai S, Itou Y, Yajima Y, Suzuki T.","Life Sci. 2002 Apr 5;70(20):2341-54. doi: 10.1016/s0024-3205(01)01550-8.","Narita M","Life Sci","2002","2002/08/02","","","10.1016/s0024-3205(01)01550-8"
"12144610","Dangers involved in rapid opioid detoxification while using opioid antagonists: dehydration and renal failure","Roozen HG, de Kan R, van den Brink W, Kerkhof BJ, Geerlings PJ.","Addiction. 2002 Aug;97(8):1071-3. doi: 10.1046/j.1360-0443.2002.00122.x.","Roozen HG","Addiction","2002","2002/07/30","","","10.1046/j.1360-0443.2002.00122.x"
"12136727","[Mechanisms of effect of adrenocorticotropic hormone on the rat pain sensitivity]","Bogdanov AI, Iarushkina NI.","Ross Fiziol Zh Im I M Sechenova. 2002 May;88(5):596-601.","Bogdanov AI","Ross Fiziol Zh Im I M Sechenova","2002","2002/07/26","","",""
"12131605","Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies","Raymond NC, Grant JE, Kim SW, Coleman E.","Int Clin Psychopharmacol. 2002 Jul;17(4):201-5. doi: 10.1097/00004850-200207000-00008.","Raymond NC","Int Clin Psychopharmacol","2002","2002/07/20","","","10.1097/00004850-200207000-00008"
"12126492","Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases","Brewer C.","Addict Biol. 2002 Jul;7(3):321-3. doi: 10.1080/13556210220139541.","Brewer C","Addict Biol","2002","2002/07/20","","","10.1080/13556210220139541"
"12113955","Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats","Yu LC, Lu JT, Huang YH, Meuser T, Pietruck C, Gabriel A, Grond S, Pierce Palmer P.","Brain Res. 2002 Jul 26;945(1):88-96. doi: 10.1016/s0006-8993(02)02743-9.","Yu LC","Brain Res","2002","2002/07/13","","","10.1016/s0006-8993(02)02743-9"
"12106830","Naltrexone modifies the palatability of basic tastes and alcohol in outbred male rats","Ferraro FM 3rd, Hill KG, Kaczmarek HJ, Coonfield DL, Kiefer SW.","Alcohol. 2002 Jun;27(2):107-14. doi: 10.1016/s0741-8329(02)00220-3.","Ferraro FM 3rd","Alcohol","2002","2002/07/11","","","10.1016/s0741-8329(02)00220-3"
"12101261","Differential morphine tolerance development in the modulation of macrophage cytokine production in mice","Limiroli E, Gaspani L, Panerai AE, Sacerdote P.","J Leukoc Biol. 2002 Jul;72(1):43-8.","Limiroli E","J Leukoc Biol","2002","2002/07/09","","",""
"12100788","Clinical inquiries. How effective are pharmacologic agents for alcoholism?","Hunt RR.","J Fam Pract. 2002 Jun;51(6):577.","Hunt RR","J Fam Pract","2002","2002/07/09","","",""
"12098583","Antagonist-induced micro-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord","Patel M, Gomes B, Patel C, Yoburn BC.","Eur J Pharmacol. 2002 Jun 20;446(1-3):37-42. doi: 10.1016/s0014-2999(02)01823-x.","Patel M","Eur J Pharmacol","2002","2002/07/06","","","10.1016/s0014-2999(02)01823-x"
"12098353","New pharmacotherapies for alcohol dependence","Graham R, Wodak AD, Whelan G.","Med J Aust. 2002 Jul 15;177(2):103-7.","Graham R","Med J Aust","2002","2002/07/06","","",""
"12094129","Exercise under hot conditions: a major threat to the immune response?","Shephard RJ.","J Sports Med Phys Fitness. 2002 Sep;42(3):368-78.","Shephard RJ","J Sports Med Phys Fitness","2002","2002/07/03","","",""
"12090733","Methylnaltrexone Progenics","De Ponti F.","Curr Opin Investig Drugs. 2002 Apr;3(4):614-20.","De Ponti F","Curr Opin Investig Drugs","2002","2002/07/02","","",""
"12088744","Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia","McCormick SE, Stoessl AJ.","Neuroscience. 2002;112(4):851-9. doi: 10.1016/s0306-4522(02)00127-6.","McCormick SE","Neuroscience","2002","2002/06/29","","","10.1016/s0306-4522(02)00127-6"
"12084520","Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone","Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Sato T, Zadina JE, Kastin AJ, Sakurada T.","Peptides. 2002 May;23(5):895-901. doi: 10.1016/s0196-9781(02)00016-5.","Sakurada S","Peptides","2002","2002/06/27","","","10.1016/s0196-9781(02)00016-5"
"12080288","A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone","Lissoni P, Malugani F, Bordin V, Conti A, Maestroni G, Tancini G.","Neuro Endocrinol Lett. 2002 Jun;23(3):255-8.","Lissoni P","Neuro Endocrinol Lett","2002","2002/06/25","","",""
"12076425","Opioid antagonists for alcohol dependence","Srisurapanont M, Jarusuraisin N.","Cochrane Database Syst Rev. 2002;(2):CD001867. doi: 10.1002/14651858.CD001867.","Srisurapanont M","Cochrane Database Syst Rev","2002","2002/06/22","","","10.1002/14651858.CD001867"
"12076406","Naltrexone maintenance treatment for opioid dependence","Kirchmayer U, Davoli M, Verster A.","Cochrane Database Syst Rev. 2002;(2):CD001333. doi: 10.1002/14651858.CD001333.","Kirchmayer U","Cochrane Database Syst Rev","2002","2002/06/22","","","10.1002/14651858.CD001333"
"12072165","Adoption and implementation of new technologies in substance abuse treatment","Roman PM, Johnson JA.","J Subst Abuse Treat. 2002 Jun;22(4):211-8. doi: 10.1016/s0740-5472(02)00241-6.","Roman PM","J Subst Abuse Treat","2002","2002/06/20","","","10.1016/s0740-5472(02)00241-6"
"12069941","Opioid receptor blockade in rat nucleus tractus solitarius alters amygdala dynorphin gene expression","Glass MJ, Briggs JE, Billington CJ, Kotz CM, Levine AS.","Am J Physiol Regul Integr Comp Physiol. 2002 Jul;283(1):R161-7. doi: 10.1152/ajpregu.00480.2001.","Glass MJ","Am J Physiol Regul Integr Comp Physiol","2002","2002/06/19","","","10.1152/ajpregu.00480.2001"
"12068285","[Long-term treatment of alcohol dependance]","Fideli LP, Lejoyeux M.","Gastroenterol Clin Biol. 2002 May;26(5 Suppl):B169-73.","Fideli LP","Gastroenterol Clin Biol","2002","2002/06/18","","",""
"12067677","Methylnaltrexone reverses opioid-induced constipation","Stephenson J.","Lancet Oncol. 2002 Apr;3(4):202. doi: 10.1016/s1470-2045(02)00706-4.","Stephenson J","Lancet Oncol","2002","2002/06/18","","","10.1016/s1470-2045(02)00706-4"
"12065726","Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys","Bowen CA, Fischer BD, Mello NK, Negus SS.","J Pharmacol Exp Ther. 2002 Jul;302(1):264-73. doi: 10.1124/jpet.302.1.264.","Bowen CA","J Pharmacol Exp Ther","2002","2002/06/18","","","10.1124/jpet.302.1.264"
"12065675","The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord","Ballet S, Braz J, Mauborgne A, Bourgoin S, Zajac JM, Hamon M, Cesselin F.","J Neurochem. 2002 May;81(3):659-62. doi: 10.1046/j.1471-4159.2002.00914.x.","Ballet S","J Neurochem","2002","2002/06/18","","","10.1046/j.1471-4159.2002.00914.x"
"12064984","Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting","Latt NC, Jurd S, Houseman J, Wutzke SE.","Med J Aust. 2002 Jun 3;176(11):530-4.","Latt NC","Med J Aust","2002","2002/06/18","","",""
"12062477","Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO","Kow LM, Commons KG, Ogawa S, Pfaff DW.","Brain Res. 2002 May 10;935(1-2):87-102. doi: 10.1016/s0006-8993(02)02532-5.","Kow LM","Brain Res","2002","2002/06/14","","","10.1016/s0006-8993(02)02532-5"
"12057779","Acute ethanol treatment increases level of progesterone in ovariectomized rats","Budec M, Koko V, Milovanović T, Balint-Perić L, Petković A.","Alcohol. 2002 Apr;26(3):173-8. doi: 10.1016/s0741-8329(02)00197-0.","Budec M","Alcohol","2002","2002/06/12","","","10.1016/s0741-8329(02)00197-0"
"12052441","Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems","Hao S, Takahata O, Mamiya K, Iwasaki H.","Life Sci. 2002 Jun 21;71(5):571-80. doi: 10.1016/s0024-3205(02)01704-6.","Hao S","Life Sci","2002","2002/06/08","","","10.1016/s0024-3205(02)01704-6"
"12049976","Simultaneous development of six LC-MS-MS methods for the determination of multiple analytes in human plasma","Naidong W, Bu H, Chen YL, Shou WZ, Jiang X, Halls TD.","J Pharm Biomed Anal. 2002 Jun 15;28(6):1115-26. doi: 10.1016/s0731-7085(02)00002-x.","Naidong W","J Pharm Biomed Anal","2002","2002/06/07","","","10.1016/s0731-7085(02)00002-x"
"12044452","Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism","Díaz A, Pazos A, Flórez J, Ayesta FJ, Santana V, Hurlé MA.","Neuroscience. 2002;112(2):345-53. doi: 10.1016/s0306-4522(02)00073-8.","Díaz A","Neuroscience","2002","2002/06/05","","","10.1016/s0306-4522(02)00073-8"
"12043046","[The level of 8-iso-prostaglandin F2 alpha, 4-hydroxynonenal and malondialdehyde in alcohol dependent men during combined therapy]","Kopczyńska E, Lampka M, Torliński L, Ziółkowski M.","Psychiatr Pol. 2002;36(2):293-302.","Kopczyńska E","Psychiatr Pol","2002","2002/06/05","","",""
"12038658","Neuroprotective agents in acute ischemic stroke","Sareen D.","J Assoc Physicians India. 2002 Feb;50:250-8.","Sareen D","J Assoc Physicians India","2002","2002/06/01","","",""
"12038149","Anesthesia of boma-captured Lichtenstein's hartebeest (Sigmoceros lichtensteinii) with a combination of thiafentanil, medetomidine, and ketamine","Citino SB, Bush M, Grobler D, Lance W.","J Wildl Dis. 2002 Apr;38(2):457-62. doi: 10.7589/0090-3558-38.2.457.","Citino SB","J Wildl Dis","2002","2002/06/01","","","10.7589/0090-3558-38.2.457"
"12033750","Adolescent kleptomania treated with naltrexone--a case report","Grant JE, Kim SW.","Eur Child Adolesc Psychiatry. 2002 Apr;11(2):92-5. doi: 10.1007/s007870200016.","Grant JE","Eur Child Adolesc Psychiatry","2002","2002/05/30","","","10.1007/s007870200016"
"12031880","N1'-fluoroethyl-naltrindole (BU97001) and N1'-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligands","Tyacke RJ, Robinson ES, Schnabel R, Lewis JW, Husbands SM, Nutt DJ, Hudson AL.","Nucl Med Biol. 2002 May;29(4):455-62. doi: 10.1016/s0969-8051(02)00300-1.","Tyacke RJ","Nucl Med Biol","2002","2002/05/29","","","10.1016/s0969-8051(02)00300-1"
"12031840","Rapid and sensitive determination of nalmefene in human plasma by gas chromatography-mass spectrometry","Xie S, Suckow RF, Mason BJ, Allen D, Cooper TB.","J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 25;773(2):143-9. doi: 10.1016/s1570-0232(02)00138-1.","Xie S","J Chromatogr B Analyt Technol Biomed Life Sci","2002","2002/05/29","","","10.1016/s1570-0232(02)00138-1"
"12030807","Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists","Russell KR, Moore TT, Potter DE.","Neuropeptides. 2001 Oct-Dec;35(5-6):232-7. doi: 10.1054/npep.2001.0883.","Russell KR","Neuropeptides","2001","2002/05/29","","","10.1054/npep.2001.0883"
"12028745","Naltrexone and dysphoria: fact or myth?","Miotto K, McCann M, Basch J, Rawson R, Ling W.","Am J Addict. 2002 Spring;11(2):151-60. doi: 10.1080/10550490290087929.","Miotto K","Am J Addict","2002","2002/05/25","","","10.1080/10550490290087929"
"12023543","Cocaine and amphetamine attenuate the discriminative stimulus effects of naltrexone in opioid-dependent rhesus monkeys","Sell SL, France CP.","J Pharmacol Exp Ther. 2002 Jun;301(3):1103-10. doi: 10.1124/jpet.301.3.1103.","Sell SL","J Pharmacol Exp Ther","2002","2002/05/23","","","10.1124/jpet.301.3.1103"
"12020877","Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect","Li Y, Li JJ, Yu LC.","Brain Res. 2002 Jun 14;940(1-2):69-78. doi: 10.1016/s0006-8993(02)02594-5.","Li Y","Brain Res","2002","2002/05/22","","","10.1016/s0006-8993(02)02594-5"
"12020864","Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms","Tierno A, Fiore P, Gannon RL.","Brain Res. 2002 May 24;937(1-2):66-73. doi: 10.1016/s0006-8993(02)02468-x.","Tierno A","Brain Res","2002","2002/05/22","","","10.1016/s0006-8993(02)02468-x"
"12009347","Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome","Fruzzetti F, Bersi C, Parrini D, Ricci C, Genazzani AR.","Fertil Steril. 2002 May;77(5):936-44. doi: 10.1016/s0015-0282(02)02955-2.","Fruzzetti F","Fertil Steril","2002","2002/05/16","","","10.1016/s0015-0282(02)02955-2"
"12007748","Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism","King AC, Schluger J, Gunduz M, Borg L, Perret G, Ho A, Kreek MJ.","Neuropsychopharmacology. 2002 Jun;26(6):778-88. doi: 10.1016/S0893-133X(01)00416-X.","King AC","Neuropsychopharmacology","2002","2002/05/15","","","10.1016/S0893-133X(01)00416-X"
"12006220","24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures","Carreño JE, Bobes J, Brewer C, Alvarez CE, San Narciso GI, Bascarán MT, Sánchez del Río J.","Addict Biol. 2002 Apr;7(2):243-50. doi: 10.1080/135562102200120479.","Carreño JE","Addict Biol","2002","2002/05/15","","","10.1080/135562102200120479"
"12006217","In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone","Porter SJ, Somogyi AA, White JM.","Addict Biol. 2002 Apr;7(2):219-25. doi: 10.1080/135562102200120442.","Porter SJ","Addict Biol","2002","2002/05/15","","","10.1080/135562102200120442"
"12000210","An open-label study of naltrexone in the treatment of kleptomania","Grant JE, Kim SW.","J Clin Psychiatry. 2002 Apr;63(4):349-56. doi: 10.4088/jcp.v63n0413.","Grant JE","J Clin Psychiatry","2002","2002/05/10","","","10.4088/jcp.v63n0413"
"11997236","Neuroprotective role of delta-opioid receptors in cortical neurons","Zhang J, Gibney GT, Zhao P, Xia Y.","Am J Physiol Cell Physiol. 2002 Jun;282(6):C1225-34. doi: 10.1152/ajpcell.00226.2001.","Zhang J","Am J Physiol Cell Physiol","2002","2002/05/09","","","10.1152/ajpcell.00226.2001"
"11997146","Motivational effects mu- and kappa-opioid agonists following acute and chronic restraint stress: involvement of dopamine D(1) and D(2) receptors","del Rosario Capriles N, Cancela LM.","Behav Brain Res. 2002 May 14;132(2):159-69. doi: 10.1016/s0166-4328(01)00414-4.","del Rosario Capriles N","Behav Brain Res","2002","2002/05/09","","","10.1016/s0166-4328(01)00414-4"
"11985706","Crystal structure of biphalin sulfate: a multireceptor opioid peptide","Flippen-Anderson JL, Deschamps JR, George C, Hruby VJ, Misicka A, Lipkowski AW.","J Pept Res. 2002 Mar;59(3):123-33. doi: 10.1034/j.1399-3011.2002.01967.x.","Flippen-Anderson JL","J Pept Res","2002","2002/05/03","","","10.1034/j.1399-3011.2002.01967.x"
"11982544","Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose","Ritter AJ.","Aust N Z J Psychiatry. 2002 Apr;36(2):224-8. doi: 10.1046/j.1440-1614.2002.01012.x.","Ritter AJ","Aust N Z J Psychiatry","2002","2002/05/02","","","10.1046/j.1440-1614.2002.01012.x"
"11981595","Differential involvement of mu-opioid receptors in the rostral versus caudal nucleus accumbens in the reinforcing effects of heroin in rats: evidence from focal injections of beta-funaltrexamine","Martin TJ, Kim SA, Lyupina Y, Smith JE.","Psychopharmacology (Berl). 2002 May;161(2):152-9. doi: 10.1007/s00213-002-1008-3. Epub 2002 Mar 14.","Martin TJ","Psychopharmacology (Berl)","2002","2002/05/01","","","10.1007/s00213-002-1008-3"
"11978842","Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal","Shaw-Lutchman TZ, Barrot M, Wallace T, Gilden L, Zachariou V, Impey S, Duman RS, Storm D, Nestler EJ.","J Neurosci. 2002 May 1;22(9):3663-72. doi: 10.1523/JNEUROSCI.22-09-03663.2002.","Shaw-Lutchman TZ","J Neurosci","2002","2002/04/30","PMC6758390","","10.1523/JNEUROSCI.22-09-03663.2002"
"11976056","The effects of naltrexone, an opioid receptor antagonist, on plasma LH levels in common carp (Cyprinus carpio L.)","Sokolowska-Mikolajczyk M, Socha M, Mikolajczyk T, Chyb J, Epler P.","Comp Biochem Physiol C Toxicol Pharmacol. 2002 Apr;131(4):417-24. doi: 10.1016/s1532-0456(02)00024-8.","Sokolowska-Mikolajczyk M","Comp Biochem Physiol C Toxicol Pharmacol","2002","2002/04/27","","","10.1016/s1532-0456(02)00024-8"
"11973854","Naltrexone for alcohol dependence","Sinclair JD, Alho H, Shinderman M.","N Engl J Med. 2002 Apr 25;346(17):1329-31; author reply 1329-31.","Sinclair JD","N Engl J Med","2002","2002/04/27","","",""
"11973371","Naltrexone for alcohol dependence","Rubio G, Ponce G, Manzanares J.","N Engl J Med. 2002 Apr 25;346(17):1329-31; author reply 1329-31. doi: 10.1056/NEJM200204253461716.","Rubio G","N Engl J Med","2002","2002/04/26","","","10.1056/NEJM200204253461716"
"11961062","Inhibition of cAMP accumulation by kappa-receptor activation in isolated iris-ciliary bodies: role of phosphodiesterase and protein kinase C","Dortch-Carnes J, Potter DE.","J Pharmacol Exp Ther. 2002 May;301(2):599-604. doi: 10.1124/jpet.301.2.599.","Dortch-Carnes J","J Pharmacol Exp Ther","2002","2002/04/19","","","10.1124/jpet.301.2.599"
"11961051","Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats","Silva RM, Grossman HC, Hadjimarkou MM, Rossi GC, Pasternak GW, Bodnar RJ.","J Pharmacol Exp Ther. 2002 May;301(2):513-8. doi: 10.1124/jpet.301.2.513.","Silva RM","J Pharmacol Exp Ther","2002","2002/04/19","","","10.1124/jpet.301.2.513"
"11959527","Drug treatments for alcoholism","","Harv Ment Health Lett. 2002 Apr;18(10):4-7.","","Harv Ment Health Lett","2002","2002/04/18","","",""
"11958946","Low doses of naltrexone reduce palatability and consumption of ethanol in outbred rats","Coonfield DL, Hill KG, Kaczmarek HJ, Ferraro FM 3rd, Kiefer SW.","Alcohol. 2002 Jan;26(1):43-7. doi: 10.1016/s0741-8329(01)00180-x.","Coonfield DL","Alcohol","2002","2002/04/18","","","10.1016/s0741-8329(01)00180-x"
"11958852","Blockade of the antinociceptive effect of spinally administered kyotorphin by naltrindole in mice","Ochi T, Ohkubo Y, Mutoh S.","Neurosci Lett. 2002 Apr 5;322(2):95-8. doi: 10.1016/s0304-3940(02)00109-x.","Ochi T","Neurosci Lett","2002","2002/04/18","","","10.1016/s0304-3940(02)00109-x"
"11958364","A case of kleptomania and compulsive sexual behavior treated with naltrexone","Grant JE, Kim SW.","Ann Clin Psychiatry. 2001 Dec;13(4):229-31. doi: 10.1023/a:1014626102110.","Grant JE","Ann Clin Psychiatry","2001","2002/04/18","","","10.1023/a:1014626102110"
"11949883","Itch-associated response induced by experimental dry skin in mice","Miyamoto T, Nojima H, Shinkado T, Nakahashi T, Kuraishi Y.","Jpn J Pharmacol. 2002 Mar;88(3):285-92. doi: 10.1254/jjp.88.285.","Miyamoto T","Jpn J Pharmacol","2002","2002/04/13","","","10.1254/jjp.88.285"
"11948251","Effect of precipitated morphine withdrawal on post-translational processing of prothyrotropin releasing hormone (proTRH) in the ventrolateral column of the midbrain periaqueductal gray","Nillni EA, Lee A, Legradi G, Lechan RM.","J Neurochem. 2002 Mar;80(5):874-84. doi: 10.1046/j.0022-3042.2002.00763.x.","Nillni EA","J Neurochem","2002","2002/04/12","","","10.1046/j.0022-3042.2002.00763.x"
"11927547","Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation","Petäjä-Repo UE, Hogue M, Bhalla S, Laperrière A, Morello JP, Bouvier M.","EMBO J. 2002 Apr 2;21(7):1628-37. doi: 10.1093/emboj/21.7.1628.","Petäjä-Repo UE","EMBO J","2002","2002/04/03","PMC125943","","10.1093/emboj/21.7.1628"
"11926651","A possible role for implantable naltrexone in the management of the high-risk pregnant heroin user","Hulse GK, O'Neill G.","Aust N Z J Obstet Gynaecol. 2002 Feb;42(1):93-4. doi: 10.1111/j.0004-8666.2002.00104.x.","Hulse GK","Aust N Z J Obstet Gynaecol","2002","2002/04/03","","","10.1111/j.0004-8666.2002.00104.x"
"11914975","Opioid receptor blockade eliminates mood effects of aerobic gymnastics","Järvekülg A, Viru A.","Int J Sports Med. 2002 Apr;23(3):155-7. doi: 10.1055/s-2002-23168.","Järvekülg A","Int J Sports Med","2002","2002/03/27","","","10.1055/s-2002-23168"
"11912062","Seasonal short-term effects of naltrexone on LH secretion in male carp (Cyprinus carpio L.)","Sokolowska-Mikolajczyk M, Socha M, Mikolajczyk T, Chyb J, Epler P.","Comp Biochem Physiol C Toxicol Pharmacol. 2002 Mar;131(3):379-85. doi: 10.1016/s1532-0456(02)00027-3.","Sokolowska-Mikolajczyk M","Comp Biochem Physiol C Toxicol Pharmacol","2002","2002/03/26","","","10.1016/s1532-0456(02)00027-3"
"11910276","Conservative management with naltrexone of an iatrogenic methadone overdose in an opiate-naive patient","Dhopesh V, Yu E, Fudala PJ.","J Clin Psychopharmacol. 2002 Apr;22(2):231-2. doi: 10.1097/00004714-200204000-00024.","Dhopesh V","J Clin Psychopharmacol","2002","2002/03/23","","","10.1097/00004714-200204000-00024"
"11900823","A comparison of the effects of 6-beta naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats","Stromberg MF, Rukstalis MR, Mackler SA, Volpicelli JR, O'Brien CP.","Pharmacol Biochem Behav. 2002 May;72(1-2):483-90. doi: 10.1016/s0091-3057(02)00721-9.","Stromberg MF","Pharmacol Biochem Behav","2002","2002/03/20","","","10.1016/s0091-3057(02)00721-9"
"11898802","Defensive behavior and hippocampal cell proliferation: differential modulation by naltrexone during stress","Holmes MM, Galea LA.","Behav Neurosci. 2002 Feb;116(1):160-8.","Holmes MM","Behav Neurosci","2002","2002/03/20","","",""
"11895560","The additive effect of opioids and nitric oxide in increasing pentylenetetrazole-induced seizure threshold in cholestatic mice","Homayoun H, Sayyah M, Dehpour AR.","J Gastroenterol Hepatol. 2002 Jan;17(1):96-101. doi: 10.1046/j.1440-1746.2002.02658.x.","Homayoun H","J Gastroenterol Hepatol","2002","2002/03/16","","","10.1046/j.1440-1746.2002.02658.x"
"11887546","The use of nalmefene for intrathecal opioid-associated nausea in postpartum patients","Ward RC, Lawrence RL, Hawkins RJ, DiChiara SE, Biegner AR, Vacchiano CA.","AANA J. 2002 Feb;70(1):57-60.","Ward RC","AANA J","2002","2002/03/13","","",""
"11881233","[Methadone and naltrexone in heroin addiction--an explanation from the SBU]","Asplund K, Jonsson E.","Lakartidningen. 2002 Feb 7;99(6):552-3.","Asplund K","Lakartidningen","2002","2002/03/08","","",""
"11881232","[Documented effect of methadone, but not naltrexone]","Heilig M.","Lakartidningen. 2002 Feb 7;99(6):551-2.","Heilig M","Lakartidningen","2002","2002/03/08","","",""
"11877704","Differential effects of vascular growth factors on arterial and venous angiogenesis","Blebea J, Vu JH, Assadnia S, McLaughlin PJ, Atnip RG, Zagon IS.","J Vasc Surg. 2002 Mar;35(3):532-8. doi: 10.1067/mva.2002.120042.","Blebea J","J Vasc Surg","2002","2002/03/06","","","10.1067/mva.2002.120042"
"11876583","Outcomes of naltrexone maintenance following ultra rapid opiate detoxification versus intensive inpatient detoxification","Rabinowitz J, Cohen H, Atias S.","Am J Addict. 2002 Winter;11(1):52-6. doi: 10.1080/10550490252801639.","Rabinowitz J","Am J Addict","2002","2002/03/06","","","10.1080/10550490252801639"
"11875630","Characterization of the discriminative stimulus effects of buprenorphine in pigeons","Galici R, Brandt MR, France CP.","Psychopharmacology (Berl). 2002 Mar;160(2):132-9. doi: 10.1007/s00213-001-0943-8. Epub 2002 Jan 22.","Galici R","Psychopharmacology (Berl)","2002","2002/03/05","","","10.1007/s00213-001-0943-8"
"11866252","Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude","Carroll KM, Sinha R, Nich C, Babuscio T, Rounsaville BJ.","Exp Clin Psychopharmacol. 2002 Feb;10(1):54-63. doi: 10.1037//1064-1297.10.1.54.","Carroll KM","Exp Clin Psychopharmacol","2002","2002/02/28","","","10.1037//1064-1297.10.1.54"
"11862809","New kinds of treatment","","AIDS Treat News. 2001 Jan 25;(377):4-5.","","AIDS Treat News","2001","2002/02/28","","",""
"11862370","Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis","O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ.","Psychopharmacology (Berl). 2002 Feb;160(1):19-29. doi: 10.1007/s002130100919. Epub 2002 Jan 22.","O'Malley SS","Psychopharmacology (Berl)","2002","2002/02/28","","","10.1007/s002130100919"
"11861796","Predominance of delta-opioid-binding sites in the porcine enteric nervous system","Townsend D 4th, Brown DR.","J Pharmacol Exp Ther. 2002 Mar;300(3):900-9. doi: 10.1124/jpet.300.3.900.","Townsend D 4th","J Pharmacol Exp Ther","2002","2002/02/28","","","10.1124/jpet.300.3.900"
"11852035","Analysis of opioid receptor subtype antagonist effects upon mu opioid agonist-induced feeding elicited from the ventral tegmental area of rats","Lamonte N, Echo JA, Ackerman TF, Christian G, Bodnar RJ.","Brain Res. 2002 Mar 1;929(1):96-100. doi: 10.1016/s0006-8993(01)03382-0.","Lamonte N","Brain Res","2002","2002/02/20","","","10.1016/s0006-8993(01)03382-0"
"11845802","[Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis]","Naryzhnaia NV, Krylatov AV, Maslov LN, Lishmanov IuB, Gross GJ, Stephano JB.","Ross Fiziol Zh Im I M Sechenova. 2001 Dec;87(12):1617-25.","Naryzhnaia NV","Ross Fiziol Zh Im I M Sechenova","2001","2002/02/16","","",""
"11840882","Naltrexone for opioid dependence. An additional tool for general practitioners","Tedeschi M.","Aust Fam Physician. 2002 Jan;31(1):18-20.","Tedeschi M","Aust Fam Physician","2002","2002/02/14","","",""
"11838078","[Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence]","Heilig M.","Lakartidningen. 2002 Jan 17;99(3):200-4.","Heilig M","Lakartidningen","2002","2002/02/13","","",""
"11832541","Selective postoperative inhibition of gastrointestinal opioid receptors","Moss J, Yuan CS.","N Engl J Med. 2002 Feb 7;346(6):455. doi: 10.1056/NEJM200202073460617.","Moss J","N Engl J Med","2002","2002/02/08","","","10.1056/NEJM200202073460617"
"11826036","Long-term potentiation in direct perforant path projections to the hippocampal CA3 region in vivo","Do VH, Martinez CO, Martinez JL Jr, Derrick BE.","J Neurophysiol. 2002 Feb;87(2):669-78. doi: 10.1152/jn.00938.2000.","Do VH","J Neurophysiol","2002","2002/02/05","","","10.1152/jn.00938.2000"
"11823887","Depot naltrexone: long-lasting antagonism of the effects of heroin in humans","Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW.","Psychopharmacology (Berl). 2002 Feb;159(4):351-60. doi: 10.1007/s002130100909. Epub 2001 Nov 1.","Comer SD","Psychopharmacology (Berl)","2002","2002/02/02","PMC4079470","NIHMS516231","10.1007/s002130100909"
"11821035","Antipruritic activity of the kappa-opioid receptor agonist, TRK-820","Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T, Kawamura K, Endoh T, Utsumi J, Kamei J, Tanaka T, Nagase H.","Eur J Pharmacol. 2002 Jan 25;435(2-3):259-64. doi: 10.1016/s0014-2999(01)01588-6.","Togashi Y","Eur J Pharmacol","2002","2002/02/01","","","10.1016/s0014-2999(01)01588-6"
"11805228","Roles of endogenous opioid peptides in modulation of nocifensive response to formalin","Wu HE, Hung KC, Mizoguchi H, Nagase H, Tseng LF.","J Pharmacol Exp Ther. 2002 Feb;300(2):647-54. doi: 10.1124/jpet.300.2.647.","Wu HE","J Pharmacol Exp Ther","2002","2002/01/24","","","10.1124/jpet.300.2.647"
"11804622","Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats","Shannon HE, Lutz EA.","Neuropharmacology. 2002 Feb;42(2):253-61. doi: 10.1016/s0028-3908(01)00173-3.","Shannon HE","Neuropharmacology","2002","2002/01/24","","","10.1016/s0028-3908(01)00173-3"
"11791533","Getting beyond the research clinic studies: comments on Morris et al. (2001)","O'Malley SS.","Addiction. 2001 Dec;96(12):1859-60.","O'Malley SS","Addiction","2001","2002/01/17","","",""
"11791532","Naltrexone for alcohol dependence: compliance is a key issue","O'Brien CP.","Addiction. 2001 Dec;96(12):1857.","O'Brien CP","Addiction","2001","2002/01/17","","",""
"11791531","Naltrexone for drinking problems: useful further evidence on efficacy","Chick J.","Addiction. 2001 Dec;96(12):1856.","Chick J","Addiction","2001","2002/01/17","","",""
"11791527","Naltrexone in the treatment of alcohol dependence: what clinicians need to know","Drummond C.","Addiction. 2001 Dec;96(12):1857-9.","Drummond C","Addiction","2001","2002/01/17","","",""
"11787918","Obstetric and neonatal outcomes associated with maternal naltrexone exposure","Hulse GK, O'Neill G, Pereira C, Brewer C.","Aust N Z J Obstet Gynaecol. 2001 Nov;41(4):424-8. doi: 10.1111/j.1479-828x.2001.tb01322.x.","Hulse GK","Aust N Z J Obstet Gynaecol","2001","2002/01/15","","","10.1111/j.1479-828x.2001.tb01322.x"
"11786275","[(11)C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers","Ravert HT, Scheffel U, Mathews WB, Musachio JL, Dannals RF.","Nucl Med Biol. 2002 Jan;29(1):47-53. doi: 10.1016/s0969-8051(01)00285-2.","Ravert HT","Nucl Med Biol","2002","2002/01/12","","","10.1016/s0969-8051(01)00285-2"
"11786240","Central discriminative effects of morphine in rats: training via intracerebroventricular administration","Easterling KW, Holtzman SG.","Brain Res Bull. 2001 Dec;56(6):545-51. doi: 10.1016/s0361-9230(01)00661-x.","Easterling KW","Brain Res Bull","2001","2002/01/12","","","10.1016/s0361-9230(01)00661-x"
"11784478","Naltrexone for alcohol dependence: comments on Morris et al. (2001)","Anton RF.","Addiction. 2001 Dec;96(12):1855. doi: 10.1046/j.1360-0443.2001.9612185515.x.","Anton RF","Addiction","2001","2002/01/11","","","10.1046/j.1360-0443.2001.9612185515.x"
"11784454","Naltrexone for alcohol dependence: a randomized controlled trial","Morris PL, Hopwood M, Whelan G, Gardiner J, Drummond E.","Addiction. 2001 Nov;96(11):1565-73. doi: 10.1046/j.1360-0443.2001.961115654.x.","Morris PL","Addiction","2001","2002/01/11","","","10.1046/j.1360-0443.2001.961115654.x"
"11783744","Effect of opioid dependence pharmacotherapies on zidovudine disposition","McCance-Katz EF, Rainey PM, Friedland G, Kosten TR, Jatlow P.","Am J Addict. 2001 Fall;10(4):296-307.","McCance-Katz EF","Am J Addict","2001","2002/01/11","","",""
"11780876","Demographic and clinical features of 131 adult pathological gamblers","Grant JE, Kim SW.","J Clin Psychiatry. 2001 Dec;62(12):957-62. doi: 10.4088/jcp.v62n1207.","Grant JE","J Clin Psychiatry","2001","2002/01/10","","","10.4088/jcp.v62n1207"
"11772672","Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets","Hamilton RJ, Olmedo RE, Shah S, Hung OL, Howland MA, Perrone J, Nelson LS, Lewin NL, Hoffman RS.","Acad Emerg Med. 2002 Jan;9(1):63-8. doi: 10.1111/j.1553-2712.2002.tb01169.x.","Hamilton RJ","Acad Emerg Med","2002","2002/01/05","","","10.1111/j.1553-2712.2002.tb01169.x"
"11765304","Effect of nonnicotine pharmacotherapy on smoking behavior","Kotlyar M, Golding M, Hatsukami DK, Jamerson BD.","Pharmacotherapy. 2001 Dec;21(12):1530-48. doi: 10.1592/phco.21.20.1530.34477.","Kotlyar M","Pharmacotherapy","2001","2002/01/05","","","10.1592/phco.21.20.1530.34477"
"11763022","A preliminary report on possible naltrexone and nonsteroidal analgesic interactions","Kim SW, Grant JE, Adson DE, Remmel RP.","J Clin Psychopharmacol. 2001 Dec;21(6):632-4. doi: 10.1097/00004714-200112000-00024.","Kim SW","J Clin Psychopharmacol","2001","2002/01/05","","","10.1097/00004714-200112000-00024"
"11760922","Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon","Stimmel B.","J Addict Dis. 2001;20(4):1-5. doi: 10.1300/J069v20n04_01.","Stimmel B","J Addict Dis","2001","2002/01/05","","","10.1300/J069v20n04_01"
"11759562","The impact of nalmefene on side effects due to intrathecal morphine at cesarean section","Pellegrini JE, Bailey SL, Graves J, Paice JA, Shott S, Faut-Callahan M.","AANA J. 2001 Jun;69(3):199-205.","Pellegrini JE","AANA J","2001","2002/01/05","","",""
"11759147","Conflict for the court","Blumenreich GA.","AANA J. 2001 Apr;69(2):91-4.","Blumenreich GA","AANA J","2001","2002/01/05","","",""
"11756991","Methadone enhances human immunodeficiency virus infection of human immune cells","Li Y, Wang X, Tian S, Guo CJ, Douglas SD, Ho WZ.","J Infect Dis. 2002 Jan 1;185(1):118-22. doi: 10.1086/338011. Epub 2001 Dec 14.","Li Y","J Infect Dis","2002","2002/01/05","PMC4009627","NIHMS575077","10.1086/338011"
"11755893","A review of the potential role of methylnaltrexone in opioid bowel dysfunction","Foss JF.","Am J Surg. 2001 Nov;182(5A Suppl):19S-26S. doi: 10.1016/s0002-9610(01)00783-8.","Foss JF","Am J Surg","2001","2002/01/05","","","10.1016/s0002-9610(01)00783-8"
"11755892","Incidence, prevalence, and management of opioid bowel dysfunction","Pappagallo M.","Am J Surg. 2001 Nov;182(5A Suppl):11S-18S. doi: 10.1016/s0002-9610(01)00782-6.","Pappagallo M","Am J Surg","2001","2002/01/05","","","10.1016/s0002-9610(01)00782-6"
"11752886","Immunomodulation by opioid peptidomimetic compound","Narayan P, Singh VK, Agarwal SS, Tandon R, Haq W, Raghubir R, Dhar MM.","Neuroimmunomodulation. 2001;9(3):134-40. doi: 10.1159/000049017.","Narayan P","Neuroimmunomodulation","2001","2001/12/26","","","10.1159/000049017"
"11752119","Rapid elevation of plasma interleukin-6 by morphine is dependent on autonomic stimulation of adrenal gland","Houghtling RA, Bayer BM.","J Pharmacol Exp Ther. 2002 Jan;300(1):213-9. doi: 10.1124/jpet.300.1.213.","Houghtling RA","J Pharmacol Exp Ther","2002","2001/12/26","","","10.1124/jpet.300.1.213"
"11752106","Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial","Yuan CS, Wei G, Foss JF, O'Connor M, Karrison T, Osinski J.","J Pharmacol Exp Ther. 2002 Jan;300(1):118-23. doi: 10.1124/jpet.300.1.118.","Yuan CS","J Pharmacol Exp Ther","2002","2001/12/26","","","10.1124/jpet.300.1.118"
"11750915","Neuroanatomical and psychopharmacological evidence for interaction between opioid and GABAergic neural pathways in the modulation of fear and defense elicited by electrical and chemical stimulation of the deep layers of the superior colliculus and dorsal periaqueductal gray matter","Eichenberger GC, Ribeiro SJ, Osaki MY, Maruoka RY, Resende GC, Castellan-Baldan L, Corrêa SA, Da Silva LA, Coimbra NC.","Neuropharmacology. 2002 Jan;42(1):48-59. doi: 10.1016/s0028-3908(01)00155-1.","Eichenberger GC","Neuropharmacology","2002","2001/12/26","","","10.1016/s0028-3908(01)00155-1"
"11747760","Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice","He GA, Hou HM, Liu XJ.","Acta Pharmacol Sin. 2001 Jun;22(6):530-3.","He GA","Acta Pharmacol Sin","2001","2001/12/19","","",""
"11742054","Naltrexone treatment for alcohol dependence","Fuller RK, Gordis E.","N Engl J Med. 2001 Dec 13;345(24):1770-1. doi: 10.1056/NEJM200112133452411.","Fuller RK","N Engl J Med","2001","2001/12/14","","","10.1056/NEJM200112133452411"
"11742047","Naltrexone in the treatment of alcohol dependence","Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA; Veterans Affairs Naltrexone Cooperative Study 425 Group.","N Engl J Med. 2001 Dec 13;345(24):1734-9. doi: 10.1056/NEJMoa011127.","Krystal JH","N Engl J Med","2001","2001/12/14","","","10.1056/NEJMoa011127"
"11739879","Opioid and cholecystokinin antagonists alleviate gastric inhibition of food intake by premeal loads of casein in meal-fed rats","Froetschel MA, Azain MJ, Edwards GL, Barb CR, Amos HE.","J Nutr. 2001 Dec;131(12):3270-6. doi: 10.1093/jn/131.12.3270.","Froetschel MA","J Nutr","2001","2001/12/12","","","10.1093/jn/131.12.3270"
"11736840","Gangrenous ischaemic colitis following non-steroidal anti-inflammatory drug overdose","Appu S, Thompson G.","ANZ J Surg. 2001 Nov;71(11):694-5. doi: 10.1046/j.1445-1433.2001.02240.x.","Appu S","ANZ J Surg","2001","2001/12/12","","","10.1046/j.1445-1433.2001.02240.x"
"11731107","Selective depression of nociceptive responses of dorsal horn neurones by SNC 80 in a perfused hindquarter preparation of adult mouse","Cao CQ, Hong YG, Dray A, Perkins MN.","Neuroscience. 2001;107(2):329-38. doi: 10.1016/s0306-4522(01)00349-9.","Cao CQ","Neuroscience","2001","2001/12/04","","","10.1016/s0306-4522(01)00349-9"
"11729596","Addiction medicine for the primary care physician","Yarborough WH.","J Okla State Med Assoc. 2001 Nov;94(11):499-506.","Yarborough WH","J Okla State Med Assoc","2001","2001/12/04","","",""
"11728419","Desensitization of endogenously expressed delta-opioid receptors: no evidence for involvement of G protein-coupled receptor kinase 2","Willets J, Kelly E.","Eur J Pharmacol. 2001 Nov 16;431(2):133-41. doi: 10.1016/s0014-2999(01)01360-7.","Willets J","Eur J Pharmacol","2001","2001/12/01","","","10.1016/s0014-2999(01)01360-7"
"11727785","Morphine upregulates kappa-opioid receptors of human lymphocytes","Suzuki S, Chuang TK, Chuang LF, Doi RH, Chuang RY.","Adv Exp Med Biol. 2001;493:81-7. doi: 10.1007/0-306-47611-8_10.","Suzuki S","Adv Exp Med Biol","2001","2001/12/01","","","10.1007/0-306-47611-8_10"
"11727763","Effect of opioids on oral Salmonella infection and immune function","Eisenstein LK, MacFarland AS, Peng X, Hilburger ME, Rahim RT, Meissler LJ Jr, Rogers TJ, Wan AC, Adler MW.","Adv Exp Med Biol. 2001;493:169-76. doi: 10.1007/0-306-47611-8_20.","Eisenstein LK","Adv Exp Med Biol","2001","2001/12/01","","","10.1007/0-306-47611-8_20"
"11726782","Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice","Ukai M, Katoh T, Mamiya T.","Neuroreport. 2001 Dec 4;12(17):3723-7. doi: 10.1097/00001756-200112040-00024.","Ukai M","Neuroreport","2001","2001/12/01","","","10.1097/00001756-200112040-00024"
"11725975","Activation of mu-opioid pathway is associated with the canceling effect of footshock stimulus on the restraint stress-induced inhibition of small intestinal motility in rats","Tsukada F, Ohuchi Y, Terunuma T, Sugawara M, Kohno H, Ohkubo Y.","Biol Pharm Bull. 2001 Nov;24(11):1332-4. doi: 10.1248/bpb.24.1332.","Tsukada F","Biol Pharm Bull","2001","2001/12/01","","","10.1248/bpb.24.1332"
"11720714","Excitatory amino acid receptor subtype agonists induce feeding in the nucleus accumbens shell in rats: opioid antagonist actions and interactions with mu-opioid agonists","Echo JA, Lamonte N, Christian G, Znamensky V, Ackerman TF, Bodnar RJ.","Brain Res. 2001 Dec 7;921(1-2):86-97. doi: 10.1016/s0006-8993(01)03094-3.","Echo JA","Brain Res","2001","2001/11/27","","","10.1016/s0006-8993(01)03094-3"
"11715458","[The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts]","Yang G, Zhou W, Xu K.","Zhonghua Yi Xue Za Zhi. 1999 Sep;79(9):679-82.","Yang G","Zhonghua Yi Xue Za Zhi","1999","2001/11/22","","",""
"11711042","The neuropeptide FF analogue, 1DMe, acts as a functional opioid autoreceptor antagonist in the rat spinal cord","Mauborgne A, Bourgoin S, Poliénor H, Roumy M, Simonnet G, Zajac JM, Cesselin F.","Eur J Pharmacol. 2001 Nov 2;430(2-3):273-6. doi: 10.1016/s0014-2999(01)01384-x.","Mauborgne A","Eur J Pharmacol","2001","2001/11/17","","","10.1016/s0014-2999(01)01384-x"
"11710747","Interaction of morphine and naltrexone on oral ethanol self-administration in rhesus monkeys","Williams KL, Kane EC, Woods JH.","Behav Pharmacol. 2001 Sep;12(5):325-33. doi: 10.1097/00008877-200109000-00003.","Williams KL","Behav Pharmacol","2001","2001/11/17","","","10.1097/00008877-200109000-00003"
"11707638","Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes","Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, Brown RA, Gordon A, Abrams DB, Niaura RS, Asher MK.","Alcohol Clin Exp Res. 2001 Nov;25(11):1634-47.","Monti PM","Alcohol Clin Exp Res","2001","2001/11/15","","",""
"11707635","Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats","Koistinen M, Tuomainen P, Hyytiä P, Kiianmaa K.","Alcohol Clin Exp Res. 2001 Nov;25(11):1605-12.","Koistinen M","Alcohol Clin Exp Res","2001","2001/11/15","","",""
"11707632","Effects of naltrexone and Ro 15-4513 on a multiple schedule of ethanol and Tang self-administration","Shelton KL, Grant KA.","Alcohol Clin Exp Res. 2001 Nov;25(11):1576-85.","Shelton KL","Alcohol Clin Exp Res","2001","2001/11/15","","",""
"11707162","Opioid antagonists in the treatment of alcohol dependence","O'Leary G, Borrow J, Weiss RD.","Curr Psychiatry Rep. 2001 Dec;3(6):484-8. doi: 10.1007/s11920-001-0042-x.","O'Leary G","Curr Psychiatry Rep","2001","2001/11/15","","","10.1007/s11920-001-0042-x"
"11704620","Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials","Streeton C, Whelan G.","Alcohol Alcohol. 2001 Nov-Dec;36(6):544-52. doi: 10.1093/alcalc/36.6.544.","Streeton C","Alcohol Alcohol","2001","2001/11/13","","","10.1093/alcalc/36.6.544"
"11701384","The effect of the leucopyrokinin analogue: [2-8]-leucopyrokinin on central opioid receptors in rats","Rykaczewska-Czerwińska M, Konopińska D, Plech A.","Comp Biochem Physiol C Toxicol Pharmacol. 2001 Nov;130(3):271-9. doi: 10.1016/s1532-0456(01)00230-7.","Rykaczewska-Czerwińska M","Comp Biochem Physiol C Toxicol Pharmacol","2001","2001/11/10","","","10.1016/s1532-0456(01)00230-7"
"11698998","Nalmefene for elective reversal of procedural sedation in children","Chumpa A, Kaplan RL, Burns MM, Shannon MW.","Am J Emerg Med. 2001 Nov;19(7):545-8. doi: 10.1053/ajem.2001.27141.","Chumpa A","Am J Emerg Med","2001","2001/11/08","","","10.1053/ajem.2001.27141"
"11698436","Chronic ethanol inhibits NK cell cytolytic activity: role of opioid peptide beta-endorphin","Boyadjieva N, Dokur M, Advis JP, Meadows GG, Sarkar DK.","J Immunol. 2001 Nov 15;167(10):5645-52. doi: 10.4049/jimmunol.167.10.5645.","Boyadjieva N","J Immunol","2001","2001/11/08","","","10.4049/jimmunol.167.10.5645"
"11696513","Unintentional rapid opioid detoxification","Quigley MA, Boyce SH.","Emerg Med J. 2001 Nov;18(6):494-5. doi: 10.1136/emj.18.6.494.","Quigley MA","Emerg Med J","2001","2001/11/07","PMC1725733","","10.1136/emj.18.6.494"
"11694173","The role of endogenous opioids in moderate exercise training-induced enhancement of the secondary antibody response in mice","Kapasi ZF, Catlin PA, Beck J, Roehling T, Smith K.","Phys Ther. 2001 Nov;81(11):1801-9.","Kapasi ZF","Phys Ther","2001","2001/11/06","","",""
"11692070","Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy","Neuberger J, Jones EA.","Eur J Gastroenterol Hepatol. 2001 Nov;13(11):1393-4. doi: 10.1097/00042737-200111000-00022.","Neuberger J","Eur J Gastroenterol Hepatol","2001","2001/11/03","","","10.1097/00042737-200111000-00022"
"11689159","Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence","Shen KF, Crain SM.","Brain Res. 2001 Nov 16;919(1):20-30. doi: 10.1016/s0006-8993(01)02990-0.","Shen KF","Brain Res","2001","2001/11/02","","","10.1016/s0006-8993(01)02990-0"
"11687108","Naltrexone maintenance treatment for opioid dependence","Kirchmayer U, Davoli M, Verster A.","Cochrane Database Syst Rev. 2001;(4):CD001333. doi: 10.1002/14651858.CD001333.","Kirchmayer U","Cochrane Database Syst Rev","2001","2001/11/01","","","10.1002/14651858.CD001333"
"11687036","Opioid antagonists for smoking cessation","David S, Lancaster T, Stead LF.","Cochrane Database Syst Rev. 2001;(3):CD003086. doi: 10.1002/14651858.CD003086.","David S","Cochrane Database Syst Rev","2001","2001/11/01","","","10.1002/14651858.CD003086"
"11682161","Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice","Skoubis PD, Matthes HW, Walwyn WM, Kieffer BL, Maidment NT.","Neuroscience. 2001;106(4):757-63. doi: 10.1016/s0306-4522(01)00333-5.","Skoubis PD","Neuroscience","2001","2001/10/30","","","10.1016/s0306-4522(01)00333-5"
"11672940","Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4+ lymphocyte cultures","Gekker G, Lokensgard JR, Peterson PK.","Drug Alcohol Depend. 2001 Nov 1;64(3):257-63. doi: 10.1016/s0376-8716(01)00140-5.","Gekker G","Drug Alcohol Depend","2001","2001/10/24","","","10.1016/s0376-8716(01)00140-5"
"11668014","Effects of ethanol on flash-evoked potentials of rats: lack of antagonism by naltrexone","Hetzler BE, Bednarek EM.","Alcohol. 2001 Aug;25(1):21-30. doi: 10.1016/s0741-8329(01)00160-4.","Hetzler BE","Alcohol","2001","2001/10/23","","","10.1016/s0741-8329(01)00160-4"
"11668013","Effects of naltrexone on the intake of ethanol and flavored solutions in rats","Goodwin FL, Campisi M, Babinska I, Amit Z.","Alcohol. 2001 Aug;25(1):9-19. doi: 10.1016/s0741-8329(01)00163-x.","Goodwin FL","Alcohol","2001","2001/10/23","","","10.1016/s0741-8329(01)00163-x"
"11665839","Binding, pharmacological and immunological profiles of the delta-selective opioid receptor antagonist HS 378","Spetea M, Harris HE, Berzetei-Gurske IP, Klareskog L, Schmidhammer H.","Life Sci. 2001 Aug 31;69(15):1775-82. doi: 10.1016/s0024-3205(01)01271-1.","Spetea M","Life Sci","2001","2001/10/23","","","10.1016/s0024-3205(01)01271-1"
"11606031","Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses","Rahim RT, Meissler JJ Jr, Cowan A, Rogers TJ, Geller EB, Gaughan J, Adler MW, Eisenstein TK.","Int Immunopharmacol. 2001 Oct;1(11):2001-9. doi: 10.1016/s1567-5769(01)00128-x.","Rahim RT","Int Immunopharmacol","2001","2001/10/19","","","10.1016/s1567-5769(01)00128-x"
"11602692","Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms","Platt DM, Rowlett JK, Spealman RD.","J Pharmacol Exp Ther. 2001 Nov;299(2):760-7.","Platt DM","J Pharmacol Exp Ther","2001","2001/10/17","","",""
"11585135","Quantification of naltrexone and 6,beta-naltrexol in plasma and milk using gas chromatography-mass spectrometry. Application to studies in the lactating sheep","Chan CF, Chiswell GM, Bencini R, Hackett LP, Dusci LJ, Ilett KF.","J Chromatogr B Biomed Sci Appl. 2001 Sep 15;761(1):85-92. doi: 10.1016/s0378-4347(01)00309-7.","Chan CF","J Chromatogr B Biomed Sci Appl","2001","2001/10/05","","","10.1016/s0378-4347(01)00309-7"
"11584874","Alcohol abuse and alcoholism: an overview","Volpicelli JR.","J Clin Psychiatry. 2001;62 Suppl 20:4-10.","Volpicelli JR","J Clin Psychiatry","2001","2001/10/05","","",""
"11584873","Comorbid alcoholism and depression: treatment issues","Thase ME, Salloum IM, Cornelius JD.","J Clin Psychiatry. 2001;62 Suppl 20:32-41.","Thase ME","J Clin Psychiatry","2001","2001/10/05","","",""
"11584870","Pharmacologic approaches to the management of alcoholism","Anton RF.","J Clin Psychiatry. 2001;62 Suppl 20:11-7.","Anton RF","J Clin Psychiatry","2001","2001/10/05","","",""
"11584154","Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis","Kranzler HR, Van Kirk J.","Alcohol Clin Exp Res. 2001 Sep;25(9):1335-41.","Kranzler HR","Alcohol Clin Exp Res","2001","2001/10/05","","",""
"11580103","Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase","Lysle DT, Carrigan KA.","Inflammation. 2001 Aug;25(4):267-75. doi: 10.1023/a:1010924320902.","Lysle DT","Inflammation","2001","2001/10/03","","","10.1023/a:1010924320902"
"11579624","Predicting treatment response to naltrexone: the influence of craving and family history","Monterosso JR, Flannery BA, Pettinati HM, Oslin DW, Rukstalis M, O'Brien CP, Volpicelli JR.","Am J Addict. 2001 Summer;10(3):258-68. doi: 10.1080/105504901750532148.","Monterosso JR","Am J Addict","2001","2001/10/03","","","10.1080/105504901750532148"
"11578102","Effectiveness of repeated administration of a new oral naltrexone controlled-release system on morphine analgesia","Alvarez-Fuentes J, Rojas -Corrales MO, Holgado MA, Sánchez-Lafuente C, Micó JA, Fernández -Arévalo M.","J Pharm Pharmacol. 2001 Sep;53(9):1201-5. doi: 10.1211/0022357011776649.","Alvarez-Fuentes J","J Pharm Pharmacol","2001","2001/10/02","","","10.1211/0022357011776649"
"11575386","Pharmacokinetic profile of epidurally administered methylnaltrexone, a novel peripheral opioid antagonist in a rabbit model","Murph DB, El Behiery H, Chan VW, Foss JF.","Br J Anaesth. 2001 Jan;86(1):120-2. doi: 10.1093/bja/86.1.120.","Murph DB","Br J Anaesth","2001","2001/09/29","","","10.1093/bja/86.1.120"
"11571786","Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo","Stiene-Martin A, Knapp PE, Martin K, Gurwell JA, Ryan S, Thornton SR, Smith FL, Hauser KF.","Glia. 2001 Oct;36(1):78-88.","Stiene-Martin A","Glia","2001","2001/09/26","PMC4303466","NIHMS655623",""
"11567650","Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse","Sakurada S, Hayashi T, Yuhki M, Orito T, Zadina JE, Kastin AJ, Fujimura T, Murayama K, Sakurada C, Sakurada T, Narita M, Suzuki T, Tan-no K, Tseng LF.","Eur J Pharmacol. 2001 Sep 21;427(3):203-10. doi: 10.1016/s0014-2999(01)01238-9.","Sakurada S","Eur J Pharmacol","2001","2001/09/25","","","10.1016/s0014-2999(01)01238-9"
"11566144","Opioid blockade improves human recognition memory following physiological arousal","Katzen-Perez KR, Jacobs DW, Lincoln A, Ellis RJ.","Pharmacol Biochem Behav. 2001 Sep;70(1):77-84. doi: 10.1016/s0091-3057(01)00589-5.","Katzen-Perez KR","Pharmacol Biochem Behav","2001","2001/09/22","","","10.1016/s0091-3057(01)00589-5"
"11562065","Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence","Suzuki S, Chuang LF, Doi RH, Bidlack JM, Chuang RY.","Int Immunopharmacol. 2001 Sep;1(9-10):1733-42. doi: 10.1016/s1567-5769(01)00083-2.","Suzuki S","Int Immunopharmacol","2001","2001/09/20","","","10.1016/s1567-5769(01)00083-2"
"11557349","Parallel synthesis and biological activity of a new class of high affinity and selective delta-opioid ligand","Barn DR, Caulfield WL, Cottney J, McGurk K, Morphy JR, Rankovic Z, Roberts B.","Bioorg Med Chem. 2001 Oct;9(10):2609-24. doi: 10.1016/s0968-0896(01)00017-7.","Barn DR","Bioorg Med Chem","2001","2001/09/15","","","10.1016/s0968-0896(01)00017-7"
"11557302","Research with rats germane to medication for alcoholism: consequences of noncompliance","Reid ML, Hubbell CL, Douglass AV, Boedeker KL, Reid LD.","Alcohol. 2001 Jul;24(3):169-77. doi: 10.1016/s0741-8329(01)00153-7.","Reid ML","Alcohol","2001","2001/09/15","","","10.1016/s0741-8329(01)00153-7"
"11557167","Naltrexone dampens ethanol-induced cardiovascular and hypothalamic- pituitary-adrenal axis activation","McCaul ME, Wand GS, Stauffer R, Lee SM, Rohde CA.","Neuropsychopharmacology. 2001 Oct;25(4):537-47. doi: 10.1016/S0893-133X(01)00241-X.","McCaul ME","Neuropsychopharmacology","2001","2001/09/15","","","10.1016/S0893-133X(01)00241-X"
"11556522","Critical role of mast cells in morphine-mediated impairment of zymosan-induced peritonitis in mice","Kolaczkowska E, Seljelid R, Plytycz B.","Inflamm Res. 2001 Aug;50(8):415-21. doi: 10.1007/PL00000264.","Kolaczkowska E","Inflamm Res","2001","2001/09/15","","","10.1007/PL00000264"
"11554869","Acute opioid withdrawal in the emergency department: inadvertent naltrexone abuse?","Bristow K, Meek R, Clark N.","Emerg Med (Fremantle). 2001 Sep;13(3):359-63. doi: 10.1046/j.1035-6851.2001.00240.x.","Bristow K","Emerg Med (Fremantle)","2001","2001/09/14","","","10.1046/j.1035-6851.2001.00240.x"
"11553360","Enkephalin release and opioid receptor activation does not mediate the antinociceptive or sedative/hypnotic effects of nitrous oxide","Kingery WS, Sawamura S, Agashe GS, Davies MF, Clark JD, Zimmer A.","Eur J Pharmacol. 2001 Sep 7;427(1):27-35. doi: 10.1016/s0014-2999(01)01193-1.","Kingery WS","Eur J Pharmacol","2001","2001/09/13","","","10.1016/s0014-2999(01)01193-1"
"11552772","An open naltrexone treatment study in pathological gambling disorder","Kim SW, Grant JE.","Int Clin Psychopharmacol. 2001 Sep;16(5):285-9. doi: 10.1097/00004850-200109000-00006.","Kim SW","Int Clin Psychopharmacol","2001","2001/09/13","","","10.1097/00004850-200109000-00006"
"11548109","Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity","Collins SL, Gerdes RM, D'Addario C, Izenwasser S.","Behav Pharmacol. 2001 Jul;12(4):237-45. doi: 10.1097/00008877-200107000-00002.","Collins SL","Behav Pharmacol","2001","2001/09/08","","","10.1097/00008877-200107000-00002"
"11547297","Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists","Bolling SF, Badhwar V, Schwartz CF, Oeltgen PR, Kilgore K, Su TP.","J Thorac Cardiovasc Surg. 2001 Sep;122(3):476-81. doi: 10.1067/mtc.2001.116203.","Bolling SF","J Thorac Cardiovasc Surg","2001","2001/09/08","","","10.1067/mtc.2001.116203"
"11543951","SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors","Xu H, Lu YF, Rice KC, Ananthan S, Rothman RB.","Brain Res Bull. 2001 Jul 1;55(4):507-11. doi: 10.1016/s0361-9230(01)00550-0.","Xu H","Brain Res Bull","2001","2001/09/07","","","10.1016/s0361-9230(01)00550-0"
"11534537","Sequential analysis of the effects of naltrexone on the environmental mediation of self-injurious behavior","Symons FJ, Tapp J, Wulfsberg A, Sutton KA, Heeth WL, Bodfish JW.","Exp Clin Psychopharmacol. 2001 Aug;9(3):269-76. doi: 10.1037//1064-1297.9.3.269.","Symons FJ","Exp Clin Psychopharmacol","2001","2001/09/06","","","10.1037//1064-1297.9.3.269"
"11531723","Outpatient cognitive behavioural therapy programme for alcohol dependence: impact of naltrexone use on outcome","Feeney GF, Young RM, Connor JP, Tucker J, McPherson A.","Aust N Z J Psychiatry. 2001 Aug;35(4):443-8. doi: 10.1046/j.1440-1614.2001.00935.x.","Feeney GF","Aust N Z J Psychiatry","2001","2001/09/05","","","10.1046/j.1440-1614.2001.00935.x"
"11527069","Modulation of Chelidonii herba on GABA activated chloride current in rat PAG neurons","Kim Y, Shin M, Chung J, Kim E, Koo G, Lee C, Kim C.","Am J Chin Med. 2001;29(2):265-79. doi: 10.1142/S0192415X01000290.","Kim Y","Am J Chin Med","2001","2001/08/31","","","10.1142/S0192415X01000290"
"11526977","Characterization of the analgesic properties of nomifensine in rats","Gilbert AK, Franklin KB.","Pharmacol Biochem Behav. 2001 Apr;68(4):783-7. doi: 10.1016/s0091-3057(01)00479-8.","Gilbert AK","Pharmacol Biochem Behav","2001","2001/08/31","","","10.1016/s0091-3057(01)00479-8"
"11525800","Intracerebroventricular interleukin-1beta impairs clearance of tumor cells from the lungs: role of brain prostaglandins","Hodgson DM, Yirmiya R, Taylor AN.","J Neuroimmunol. 2001 Sep 3;119(1):57-63. doi: 10.1016/s0165-5728(01)00369-1.","Hodgson DM","J Neuroimmunol","2001","2001/08/30","","","10.1016/s0165-5728(01)00369-1"
"11524777","[Alcohol--mechanism of action, interactions and treatment of alcohol abuse]","Korpi E, Seppälä T.","Duodecim. 1998;114(10):1029-36.","Korpi E","Duodecim","1998","2001/08/30","","",""
"11524308","Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment","Rubio G, Jiménez-Arriero MA, Ponce G, Palomo T.","Alcohol Alcohol. 2001 Sep-Oct;36(5):419-25. doi: 10.1093/alcalc/36.5.419.","Rubio G","Alcohol Alcohol","2001","2001/08/29","","","10.1093/alcalc/36.5.419"
"11522323","Control of the efficiency of agonist-induced information transfer and stability of the ternary complex containing the delta opioid receptor and the alpha subunit of G(i1) by mutation of a receptor/G protein contact interface","Moon HE, Bahia DS, Cavalli A, Hoffmann M, Milligan G.","Neuropharmacology. 2001 Sep;41(3):321-30. doi: 10.1016/s0028-3908(01)00076-4.","Moon HE","Neuropharmacology","2001","2001/08/28","","","10.1016/s0028-3908(01)00076-4"
"11522322","Opioid and GABA receptors involved in mediation and modulation of tonic and stimulus-evoked inhibition of a spinal reflex in the decerebrated and spinalized rabbit","Clarke RW, Bhandari RN, Leggett J.","Neuropharmacology. 2001 Sep;41(3):311-20. doi: 10.1016/s0028-3908(01)00068-5.","Clarke RW","Neuropharmacology","2001","2001/08/28","","","10.1016/s0028-3908(01)00068-5"
"11520128","Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","Henry B, Fox SH, Crossman AR, Brotchie JM.","Exp Neurol. 2001 Sep;171(1):139-46. doi: 10.1006/exnr.2001.7727.","Henry B","Exp Neurol","2001","2001/08/25","","","10.1006/exnr.2001.7727"
"11510952","Effects of endomorphin-2 on arterial blood pressure and pain threshold in spontaneously hypertensive rats and modification of these effects by beta-funaltrexamine and nor-binaltorphimine","Makulska-Nowak HE, Gumułka SW, Lipkowski AW, Rawa MA.","Life Sci. 2001 Jun 22;69(5):581-9. doi: 10.1016/s0024-3205(01)01147-x.","Makulska-Nowak HE","Life Sci","2001","2001/08/21","","","10.1016/s0024-3205(01)01147-x"
"11508781","Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study","Fulghesu AM, Ciampelli M, Belosi C, Apa R, Guido M, Caruso A, Mancuso S, Lanzone A.","J Endocrinol Invest. 2001 Jul-Aug;24(7):483-90. doi: 10.1007/BF03343880.","Fulghesu AM","J Endocrinol Invest","2001","2001/08/18","","","10.1007/BF03343880"
"11506261","Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence","Church SH, Rothenberg JL, Sullivan MA, Bornstein G, Nunes EV.","Am J Drug Alcohol Abuse. 2001 Aug;27(3):441-52. doi: 10.1081/ada-100104511.","Church SH","Am J Drug Alcohol Abuse","2001","2001/08/17","","","10.1081/ada-100104511"
"11506187","Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists","Raghavendra V, Singh V, Kulkarni SK, Agrewala JN.","Mol Cell Biochem. 2001 May;221(1-2):57-62. doi: 10.1023/a:1010968611716.","Raghavendra V","Mol Cell Biochem","2001","2001/08/17","","","10.1023/a:1010968611716"
"11505043","Alterations in central preproenkephalin mRNA expression after chronic free-choice ethanol consumption by fawn-hooded rats","Cowen MS, Lawrence AJ.","Alcohol Clin Exp Res. 2001 Aug;25(8):1126-33.","Cowen MS","Alcohol Clin Exp Res","2001","2001/08/16","","",""
"11504820","Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity","Gavériaux-Ruff C, Filliol D, Simonin F, Matthes HW, Kieffer BL.","J Pharmacol Exp Ther. 2001 Sep;298(3):1193-8.","Gavériaux-Ruff C","J Pharmacol Exp Ther","2001","2001/08/16","","",""
"11504802","GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys","Butelman ER, Ko MC, Traynor JR, Vivian JA, Kreek MJ, Woods JH.","J Pharmacol Exp Ther. 2001 Sep;298(3):1049-59.","Butelman ER","J Pharmacol Exp Ther","2001","2001/08/16","","",""
"11504788","Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine","Russell KR, Potter DE.","J Pharmacol Exp Ther. 2001 Sep;298(3):941-6.","Russell KR","J Pharmacol Exp Ther","2001","2001/08/16","","",""
"11503313","[Limited role of naltrexone in the treatment of opiate addiction]","van Brussel GH.","Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1452-6.","van Brussel GH","Ned Tijdschr Geneeskd","2001","2001/08/16","","",""
"11500514","Constitutively active mu-opioid receptors inhibit adenylyl cyclase activity in intact cells and activate G-proteins differently than the agonist [D-Ala2,N-MePhe4,Gly-ol5]enkephalin","Liu JG, Ruckle MB, Prather PL.","J Biol Chem. 2001 Oct 12;276(41):37779-86. doi: 10.1074/jbc.M106104200. Epub 2001 Aug 10.","Liu JG","J Biol Chem","2001","2001/08/14","","","10.1074/jbc.M106104200"
"11496583","Does the alcoholic's remedy come in a pill?","Gordon SM.","Behav Healthc Tomorrow. 2001 Aug;10(4):SR29-30, SR34.","Gordon SM","Behav Healthc Tomorrow","2001","2001/08/11","","",""
"11495955","Preserving and restoring behavioral potential within the spinal cord using an instrumental training paradigm","Crown ED, Grau JW.","J Neurophysiol. 2001 Aug;86(2):845-55. doi: 10.1152/jn.2001.86.2.845.","Crown ED","J Neurophysiol","2001","2001/08/10","","","10.1152/jn.2001.86.2.845"
"11495498","Probing the shape of a hydrophobic pocket in the active site of delta-opioid antagonists","Santagada V, Caliendo G, Severino B, Perissutti E, Ceccarelli F, Giusti L, Mazzoni MR, Salvadori S, Temussi PA.","J Pept Sci. 2001 Jul;7(7):374-85. doi: 10.1002/psc.331.","Santagada V","J Pept Sci","2001","2001/08/10","","","10.1002/psc.331"
"11487800","Pharmacotherapy for alcohol dependence","West SL, Garbutt JC, Carey TS, Lux LJ, Jackman AM, Tolleson-Rinehart S, Lohr KN, Crews FT.","Evid Rep Technol Assess (Summ). 1999 Jan;(3):1-5.","West SL","Evid Rep Technol Assess (Summ)","1999","2001/08/08","PMC4781062","",""
"11483141","Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement","Carroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ.","Arch Gen Psychiatry. 2001 Aug;58(8):755-61. doi: 10.1001/archpsyc.58.8.755.","Carroll KM","Arch Gen Psychiatry","2001","2001/09/06","PMC3651594","NIHMS466095","10.1001/archpsyc.58.8.755"
"11480392","Combined behavioral and pharmacologic treatments of alcoholism","Bean P, Mattson M.","Am Clin Lab. 2001 Jul;20(6):8, 10-1.","Bean P","Am Clin Lab","2001","2001/08/02","","",""
"11479827","[Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders]","Bolm T, Piegler T.","Psychiatr Prax. 2001 Jul;28(5):214-8. doi: 10.1055/s-2001-15573.","Bolm T","Psychiatr Prax","2001","2001/08/02","","","10.1055/s-2001-15573"
"11478923","The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats","Jewett DC, Grace MK, Jones RM, Billington CJ, Portoghese PS, Levine AS.","Brain Res. 2001 Aug 3;909(1-2):75-80. doi: 10.1016/s0006-8993(01)02624-5.","Jewett DC","Brain Res","2001","2001/08/02","","","10.1016/s0006-8993(01)02624-5"
"11474645","Rostral ventrolateral medullary opioid receptor subtypes in the inhibitory effect of electroacupuncture on reflex autonomic response in cats","Li P, Tjen-A-Looi S, Longhurst JC.","Auton Neurosci. 2001 Jun 20;89(1-2):38-47. doi: 10.1016/S1566-0702(01)00247-8.","Li P","Auton Neurosci","2001","2001/07/28","","","10.1016/S1566-0702(01)00247-8"
"11468029","The role of the interaction between endogenous opioids and nitric oxide in the pathophysiology of ethanol-induced gastric damage in cholestatic rats","Nahavandi A, Mani AR, Homayounfar H, Akbari MR, Dehpour AR.","Fundam Clin Pharmacol. 2001 Jun;15(3):181-7. doi: 10.1046/j.1472-8206.2001.00028.x.","Nahavandi A","Fundam Clin Pharmacol","2001","2001/07/27","","","10.1046/j.1472-8206.2001.00028.x"
"11466444","Progesterone blockade of estrogen activation of mu-opioid receptors regulates reproductive behavior","Sinchak K, Micevych PE.","J Neurosci. 2001 Aug 1;21(15):5723-9. doi: 10.1523/JNEUROSCI.21-15-05723.2001.","Sinchak K","J Neurosci","2001","2001/07/24","PMC6762652","","10.1523/JNEUROSCI.21-15-05723.2001"
"11465601","Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion","McPherson BC, Yao Z.","Anesthesiology. 2001 Jun;94(6):1082-8. doi: 10.1097/00000542-200106000-00024.","McPherson BC","Anesthesiology","2001","2001/07/24","","","10.1097/00000542-200106000-00024"
"11465595","Analgesic and antiinflammatory effects of two novel kappa-opioid peptides","Binder W, Machelska H, Mousa S, Schmitt T, Rivière PJ, Junien JL, Stein C, Schäfer M.","Anesthesiology. 2001 Jun;94(6):1034-44. doi: 10.1097/00000542-200106000-00018.","Binder W","Anesthesiology","2001","2001/07/24","","","10.1097/00000542-200106000-00018"
"11457836","Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding","Wang D, Quillan JM, Winans K, Lucas JL, Sadée W.","J Biol Chem. 2001 Sep 14;276(37):34624-30. doi: 10.1074/jbc.M104083200. Epub 2001 Jul 16.","Wang D","J Biol Chem","2001","2001/07/18","","","10.1074/jbc.M104083200"
"11455175","Prevention of suicide by naltrexone in a recently detoxified heroin addict","Krupitsky EM, Masalov DV, Didenko TY, Burakov AM, Romanova TN, Zvartau EE, Woody G.","Eur Addict Res. 2001 Jul;7(2):87-8. doi: 10.1159/000050722.","Krupitsky EM","Eur Addict Res","2001","2001/07/17","","","10.1159/000050722"
"11448484","Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems","Namiranian K, Samini M, Mehr SE, Gaskari SA, Rastegar H, Homayoun H, Dehpour AR.","Eur J Pharmacol. 2001 Jul 6;423(2-3):185-93. doi: 10.1016/s0014-2999(01)01091-3.","Namiranian K","Eur J Pharmacol","2001","2001/07/13","","","10.1016/s0014-2999(01)01091-3"
"11448134","BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation","Patel HH, Hsu A, Moore J, Gross GJ.","J Mol Cell Cardiol. 2001 Aug;33(8):1455-65. doi: 10.1006/jmcc.2001.1408.","Patel HH","J Mol Cell Cardiol","2001","2001/07/13","","","10.1006/jmcc.2001.1408"
"11448128","Essential role of oxygen radicals in delayed pharmacological preconditioning","Kukreja RC.","J Mol Cell Cardiol. 2001 Aug;33(8):1395-8. doi: 10.1006/jmcc.2001.1422.","Kukreja RC","J Mol Cell Cardiol","2001","2001/07/13","","","10.1006/jmcc.2001.1422"
"11446767","Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation","Moore TT, Potter DE.","Exp Eye Res. 2001 Aug;73(2):167-78. doi: 10.1006/exer.2001.1022.","Moore TT","Exp Eye Res","2001","2001/07/12","","","10.1006/exer.2001.1022"
"11445275","Lack of the involvement of mu1-opioid receptor subtype on motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse","Narita M, Ozaki S, Ioka M, Mizoguchi H, Nagase H, Tseng LF, Suzuki T.","Neurosci Lett. 2001 Jul 27;308(1):17-20. doi: 10.1016/s0304-3940(01)01975-9.","Narita M","Neurosci Lett","2001","2001/07/11","","","10.1016/s0304-3940(01)01975-9"
"11445231","Antidepressant-type effect of the NK3 tachykinin receptor agonist aminosenktide in mouse lines differing in endogenous opioid system activity","Panocka I, Massi M, Lapo I, Swiderski T, Kowalczyk M, Sadowski B.","Peptides. 2001 Jul;22(7):1037-42. doi: 10.1016/s0196-9781(01)00438-7.","Panocka I","Peptides","2001","2001/07/11","","","10.1016/s0196-9781(01)00438-7"
"11439748","Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management","Williams PG, Allard A, Sears L, Dalrymple N, Bloom AS.","J Autism Dev Disord. 2001 Feb;31(1):103-8. doi: 10.1023/a:1005674016014.","Williams PG","J Autism Dev Disord","2001","2001/07/07","","","10.1023/a:1005674016014"
"11438603","Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor","Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan TP Jr, Ossipov MH, Lappi DA, Lai J.","J Neurosci. 2001 Jul 15;21(14):5281-8. doi: 10.1523/JNEUROSCI.21-14-05281.2001.","Porreca F","J Neurosci","2001","2001/07/05","PMC6762871","","10.1523/JNEUROSCI.21-14-05281.2001"
"11432017","Naltrexone and acamprosate. Using new drugs for alcohol dependence","Tedeschi M.","Aust Fam Physician. 2001 May;30(5):447-50.","Tedeschi M","Aust Fam Physician","2001","2001/07/04","","",""
"11430864","gamma-Aminobutyric acid receptor subtype antagonists differentially alter opioid-induced feeding in the shell region of the nucleus accumbens in rats","Znamensky V, Echo JA, Lamonte N, Christian G, Ragnauth A, Bodnar RJ.","Brain Res. 2001 Jul 6;906(1-2):84-91. doi: 10.1016/s0006-8993(01)02558-6.","Znamensky V","Brain Res","2001","2001/06/30","","","10.1016/s0006-8993(01)02558-6"
"11428919","From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes","Portoghese PS.","J Med Chem. 2001 Jul 5;44(14):2259-69. doi: 10.1021/jm010158+.","Portoghese PS","J Med Chem","2001","2001/06/29","","","10.1021/jm010158+"
"11425545","3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties","Wentland MP, Lou R, Dehnhardt CM, Duan W, Cohen DJ, Bidlack JM.","Bioorg Med Chem Lett. 2001 Jul 9;11(13):1717-21. doi: 10.1016/s0960-894x(01)00278-5.","Wentland MP","Bioorg Med Chem Lett","2001","2001/06/27","","","10.1016/s0960-894x(01)00278-5"
"11414874","Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities","Symons FJ, Sutton KA, Bodfish JW.","Am J Ment Retard. 2001 Jul;106(4):336-43. doi: 10.1352/0895-8017(2001)106<0336:PSOAST>2.0.CO;2.","Symons FJ","Am J Ment Retard","2001","2001/06/21","","","10.1352/0895-8017(2001)106<0336:PSOAST>2.0.CO;2"
"11413242","Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence","Wang D, Raehal KM, Bilsky EJ, Sadée W.","J Neurochem. 2001 Jun;77(6):1590-600. doi: 10.1046/j.1471-4159.2001.00362.x.","Wang D","J Neurochem","2001","2001/06/20","","","10.1046/j.1471-4159.2001.00362.x"
"11412618","[Naltrexone in the treatment of alcoholism. Clinical evolution, safety and efficacy in a sample of 198 patients]","Gual Solé A.","Med Clin (Barc). 2001 Apr 21;116(14):526-32.","Gual Solé A","Med Clin (Barc)","2001","2001/06/20","","",""
"11410729","Effects of ethanol and naltrexone in a model of traumatic brain injury with hemorrhagic shock","Zink BJ, Schultz CH, Stern SA, Mertz M, Wang X, Johnston P, Keep RF.","Alcohol Clin Exp Res. 2001 Jun;25(6):916-23.","Zink BJ","Alcohol Clin Exp Res","2001","2001/06/19","","",""
"11410720","Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker","Ait-Daoud N, Johnson BA, Javors M, Roache JD, Zanca NA.","Alcohol Clin Exp Res. 2001 Jun;25(6):847-9.","Ait-Daoud N","Alcohol Clin Exp Res","2001","2001/06/19","","",""
"11409748","Evidence of interactions between melanocortin and opioid systems in regulation of feeding","Olszewski PK, Wirth MM, Grace MK, Levine AS, Giraudo SQ.","Neuroreport. 2001 Jun 13;12(8):1727-30. doi: 10.1097/00001756-200106130-00042.","Olszewski PK","Neuroreport","2001","2001/06/21","","","10.1097/00001756-200106130-00042"
"11408600","Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment","Liu JG, Prather PL.","Mol Pharmacol. 2001 Jul;60(1):53-62. doi: 10.1124/mol.60.1.53.","Liu JG","Mol Pharmacol","2001","2001/06/16","","","10.1124/mol.60.1.53"
"11408550","Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS)","Kalra A, Urban MO, Sluka KA.","J Pharmacol Exp Ther. 2001 Jul;298(1):257-63.","Kalra A","J Pharmacol Exp Ther","2001","2001/06/16","","",""
"11408537","Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats","White DA, Holtzman SG.","J Pharmacol Exp Ther. 2001 Jul;298(1):156-64.","White DA","J Pharmacol Exp Ther","2001","2001/06/16","","",""
"11408532","Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein","Alt A, McFadyen IJ, Fan CD, Woods JH, Traynor JR.","J Pharmacol Exp Ther. 2001 Jul;298(1):116-21.","Alt A","J Pharmacol Exp Ther","2001","2001/06/16","","",""
"11407272","[Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol]","Fontaine E, Godfroid IO, Guillaume R.","Encephale. 2001 Mar-Apr;27(2):187-93.","Fontaine E","Encephale","2001","2001/06/16","","",""
"11406466","Inducible HSP70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes","Zhou JJ, Pei JM, Wang GY, Wu S, Wang WP, Cho CH, Wong TM.","Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H40-7. doi: 10.1152/ajpheart.2001.281.1.H40.","Zhou JJ","Am J Physiol Heart Circ Physiol","2001","2001/06/19","","","10.1152/ajpheart.2001.281.1.H40"
"11405645","Transformation of a kappa-opioid receptor antagonist to a kappa-agonist by transfer of a guanidinium group from the 5'- to 6'-position of naltrindole","Sharma SK, Jones RM, Metzger TG, Ferguson DM, Portoghese PS.","J Med Chem. 2001 Jun 21;44(13):2073-9. doi: 10.1021/jm010095v.","Sharma SK","J Med Chem","2001","2001/06/19","","","10.1021/jm010095v"
"11399267","Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in mice","Ukai M, Watanabe Y, Kameyama T.","Eur J Pharmacol. 2001 Jun 8;421(2):115-9. doi: 10.1016/s0014-2999(01)01009-3.","Ukai M","Eur J Pharmacol","2001","2001/06/12","","","10.1016/s0014-2999(01)01009-3"
"11395188","Naltrexone-induced augmentation of sexual response in men","Sathe RS, Komisaruk BR, Ladas AK, Godbole SV.","Arch Med Res. 2001 May-Jun;32(3):221-6. doi: 10.1016/s0188-4409(01)00279-x.","Sathe RS","Arch Med Res","2001","2001/06/08","","","10.1016/s0188-4409(01)00279-x"
"11391061","Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials","Boening JA, Lesch OM, Spanagel R, Wolffgramm J, Narita M, Sinclair D, Mason BJ, Wiesbeck GA.","Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):127S-131S. doi: 10.1097/00000374-200105051-00022.","Boening JA","Alcohol Clin Exp Res","2001","2001/06/08","","","10.1097/00000374-200105051-00022"
"11386621","Opiate modulation of hemodynamic, hormonal, and cytokine responses to hemorrhage","Molina PE.","Shock. 2001 Jun;15(6):471-8. doi: 10.1097/00024382-200115060-00011.","Molina PE","Shock","2001","2001/06/02","","","10.1097/00024382-200115060-00011"
"11386491","Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial","Heinälä P, Alho H, Kiianmaa K, Lönnqvist J, Kuoppasalmi K, Sinclair JD.","J Clin Psychopharmacol. 2001 Jun;21(3):287-92. doi: 10.1097/00004714-200106000-00006.","Heinälä P","J Clin Psychopharmacol","2001","2001/06/02","","","10.1097/00004714-200106000-00006"
"11386008","Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists","Makó E, Rónai AZ.","Med Sci Monit. 2001 May-Jun;7(3):350-6.","Makó E","Med Sci Monit","2001","2001/06/02","","",""
"11382405","Opioid neurotransmission in the post-ictal analgesia: involvement of mu(1)-opioid receptor","Coimbra NC, Freitas RL, Savoldi M, Castro-Souza C, Segato EN, Kishi R, Weltson A, Resende GC.","Brain Res. 2001 Jun 8;903(1-2):216-21. doi: 10.1016/s0006-8993(01)02366-6.","Coimbra NC","Brain Res","2001","2001/05/31","","","10.1016/s0006-8993(01)02366-6"
"11377409","Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling","Kim SW, Grant JE, Adson DE, Shin YC.","Biol Psychiatry. 2001 Jun 1;49(11):914-21. doi: 10.1016/s0006-3223(01)01079-4.","Kim SW","Biol Psychiatry","2001","2001/05/30","","","10.1016/s0006-3223(01)01079-4"
"11367890","Thyroid function of former opioid addicts on naltrexone treatment","Ilias I, Kakoulas I, Christakopoulou I, Katsadoros K.","Acta Medica (Hradec Kralove). 2001;44(1):33-5.","Ilias I","Acta Medica (Hradec Kralove)","2001","2001/05/23","","",""
"11366548","New treatments for hepatitis B and C [antigen-specific transfer for A, B & C (chisolm biologicals) and thymate]","Konlee M.","Posit Health News. 1998 Fall;(No 17):19-21.","Konlee M","Posit Health News","1998","2001/05/22","","",""
"11366547","L-methionine and naltrexone for insomnia","","Posit Health News. 1998 Fall;(No 17):19.","","Posit Health News","1998","2001/05/22","","",""
"11365012","Interviews and anecdotal reports","","Posit Health News. 1998 Spring;(No 16):13-5.","","Posit Health News","1998","2001/05/22","","",""
"11361353","Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV/AIDS","Bihari B.","AIDS Patient Care. 1995 Feb;9(1):3.","Bihari B","AIDS Patient Care","1995","1995/02/01","","",""
"11359522","Respiratory function in adult mice lacking the mu-opioid receptor: role of delta-receptors","Morin-Surun MP, Boudinot E, Dubois C, Matthes HW, Kieffer BL, Denavit-Saubié M, Champagnat J, Foutz AS.","Eur J Neurosci. 2001 May;13(9):1703-10. doi: 10.1046/j.0953-816x.2001.01547.x.","Morin-Surun MP","Eur J Neurosci","2001","2001/05/22","","","10.1046/j.0953-816x.2001.01547.x"
"11358332","Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activation","Hosohata Y, Varga EV, Stropova D, Li X, Knapp RJ, Hruby VJ, Rice KC, Nagase H, Roeske WR, Yamamura HI.","Life Sci. 2001 Apr 6;68(19-20):2233-42. doi: 10.1016/s0024-3205(01)01011-6.","Hosohata Y","Life Sci","2001","2001/05/19","","","10.1016/s0024-3205(01)01011-6"
"11353600","Naltrexone as a treatment of self-injurious behavior: a case report","Griengl H, Dantendorfer K.","Eur Psychiatry. 2001 Apr;16(3):193-4. doi: 10.1016/s0924-9338(01)00564-8.","Griengl H","Eur Psychiatry","2001","2001/05/17","","","10.1016/s0924-9338(01)00564-8"
"11349393","Adverse effects of oral naltrexone: analysis of data from two clinical trials","Oncken C, Van Kirk J, Kranzler HR.","Psychopharmacology (Berl). 2001 Apr;154(4):397-402. doi: 10.1007/s002130000666.","Oncken C","Psychopharmacology (Berl)","2001","2001/05/15","","","10.1007/s002130000666"
"11348625","Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide","Neilan CL, Nguyen TM, Schiller PW, Pasternak GW.","Eur J Pharmacol. 2001 May 4;419(1):15-23. doi: 10.1016/s0014-2999(01)00946-3.","Neilan CL","Eur J Pharmacol","2001","2001/05/12","","","10.1016/s0014-2999(01)00946-3"
"11336609","Pharmacotherapeutic management of autism","Posey DJ, McDougle CJ.","Expert Opin Pharmacother. 2001 Apr;2(4):587-600. doi: 10.1517/14656566.2.4.587.","Posey DJ","Expert Opin Pharmacother","2001","2001/05/05","","","10.1517/14656566.2.4.587"
"11334876","Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice","Kamei J, Nagase H.","Eur J Pharmacol. 2001 Apr 20;418(1-2):141-5. doi: 10.1016/s0014-2999(01)00941-4.","Kamei J","Eur J Pharmacol","2001","2001/05/04","","","10.1016/s0014-2999(01)00941-4"
"11334233","An opioid receptor antagonist, naltrexone, does not alter taste and smell responses in humans","Scińska A, Koroś E, Polanowska E, Kukwa A, Bogucka-Bonikowska A, Kostowski W, Habrat B, Bieńkowski P.","Pol J Pharmacol. 2000 Sep-Oct;52(5):397-402.","Scińska A","Pol J Pharmacol","2000","2001/05/04","","",""
"11331108","Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption","Stromberg MF, Mackler SA, Volpicelli JR, O'Brien CP.","Alcohol. 2001 Feb;23(2):109-16. doi: 10.1016/s0741-8329(00)00137-3.","Stromberg MF","Alcohol","2001","2001/05/02","","","10.1016/s0741-8329(00)00137-3"
"11325808","Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats","Coudoré-Civiale MA, Méen M, Fournié-Zaluski MC, Boucher M, Roques BP, Eschalier A.","Br J Pharmacol. 2001 May;133(1):179-85. doi: 10.1038/sj.bjp.0704059.","Coudoré-Civiale MA","Br J Pharmacol","2001","2001/04/28","PMC1572770","","10.1038/sj.bjp.0704059"
"11325790","Endogenous opioids suppress activation of nociceptors by sub-nanomolar nicotine","Miao FJ, Benowitz NL, Levine JD.","Br J Pharmacol. 2001 May;133(1):23-8. doi: 10.1038/sj.bjp.0704031.","Miao FJ","Br J Pharmacol","2001","2001/04/28","PMC1572752","","10.1038/sj.bjp.0704031"
"11325021","TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys","Endoh T, Tajima A, Izumimoto N, Suzuki T, Saitoh A, Suzuki T, Narita M, Kamei J, Tseng LF, Mizoguchi H, Nagase H.","Jpn J Pharmacol. 2001 Mar;85(3):282-90. doi: 10.1254/jjp.85.282.","Endoh T","Jpn J Pharmacol","2001","2001/04/28","","","10.1254/jjp.85.282"
"11319622","Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion","Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ.","Gene Ther. 2001 Apr;8(7):551-6. doi: 10.1038/sj.gt.3301430.","Goss JR","Gene Ther","2001","2001/04/25","","","10.1038/sj.gt.3301430"
"11318394","Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates","Weinrieb RM, Van Horn DH, McLellan AT, Volpicelli JR, Calarco JS, Lucey MR.","J Addict Dis. 2001;20(2):105-19. doi: 10.1300/J069v20n02_09.","Weinrieb RM","J Addict Dis","2001","2001/04/25","","","10.1300/J069v20n02_09"
"11316769","Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments","Dermitzaki E, Gravanis A, Venihaki M, Stournaras C, Margioris AN.","Endocrinology. 2001 May;142(5):2022-31. doi: 10.1210/endo.142.5.8133.","Dermitzaki E","Endocrinology","2001","2001/04/24","","","10.1210/endo.142.5.8133"
"11316375","Naltrexone and relapse prevention treatment for cocaine-dependent patients","Schmitz JM, Stotts AL, Rhoades HM, Grabowski J.","Addict Behav. 2001 Mar-Apr;26(2):167-80. doi: 10.1016/s0306-4603(00)00098-8.","Schmitz JM","Addict Behav","2001","2001/04/24","","","10.1016/s0306-4603(00)00098-8"
"11311730","Effects of naltrexone and CCK on estrous behavior and food intake in Syrian hamsters","Jones JE, Corp ES, Wade GN.","Peptides. 2001 Apr;22(4):601-6. doi: 10.1016/s0196-9781(01)00370-9.","Jones JE","Peptides","2001","2001/04/20","","","10.1016/s0196-9781(01)00370-9"
"11309844","Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent","Zhu H, Barr GA.","Synapse. 2001 Jun 15;40(4):282-93. doi: 10.1002/syn.1051.","Zhu H","Synapse","2001","2001/04/20","","","10.1002/syn.1051"
"11303057","Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa","Poonyachoti S, Portoghese PS, Brown DR.","J Pharmacol Exp Ther. 2001 May;297(2):672-9.","Poonyachoti S","J Pharmacol Exp Ther","2001","2001/04/17","","",""
"11303050","Blockade of delta opioid receptors in the ventrolateral periaqueductal gray region inhibits the fall in arterial pressure evoked by hemorrhage","Cavun S, Resch GE, Evec AD, Rapacon-Baker MM, Millington WR.","J Pharmacol Exp Ther. 2001 May;297(2):612-9.","Cavun S","J Pharmacol Exp Ther","2001","2001/04/17","","",""
"11303047","Beta-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats","Silva RM, Hadjimarkou MM, Rossi GC, Pasternak GW, Bodnar RJ.","J Pharmacol Exp Ther. 2001 May;297(2):590-6.","Silva RM","J Pharmacol Exp Ther","2001","2001/04/17","","",""
"11303046","Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia","Rady JJ, Holmes BB, Tseng LF, Fujimoto JM.","J Pharmacol Exp Ther. 2001 May;297(2):582-9.","Rady JJ","J Pharmacol Exp Ther","2001","2001/04/17","","",""
"11301063","The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids","Campbell VC, Welch SP.","Eur J Pharmacol. 2001 Apr 6;417(1-2):91-8. doi: 10.1016/s0014-2999(01)00885-8.","Campbell VC","Eur J Pharmacol","2001","2001/04/13","","","10.1016/s0014-2999(01)00885-8"
"11300867","Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the ""address"" recognition locus","Metzger TG, Paterlini MG, Ferguson DM, Portoghese PS.","J Med Chem. 2001 Mar 15;44(6):857-62. doi: 10.1021/jm000381r.","Metzger TG","J Med Chem","2001","2001/04/13","","","10.1021/jm000381r"
"11297446","Covalently induced activation of the delta opioid receptor by a fluorogenic affinity label, 7'-(phthalaldehydecarboxamido)naltrindole (PNTI)","Le Bourdonnec B, El Kouhen R, Poda G, Law PY, Loh HH, Ferguson DM, Portoghese PS.","J Med Chem. 2001 Mar 29;44(7):1017-20. doi: 10.1021/jm010004u.","Le Bourdonnec B","J Med Chem","2001","2001/04/12","","","10.1021/jm010004u"
"11296707","[Modifying effect of the repeated experience of agonistic confrontations on effect of naltrexone in male mice]","Kudriavtseva NN, Dolgov VV, Avgustinovich DF, Alekseenko OV, Lipina TV, Koriakina LA.","Ross Fiziol Zh Im I M Sechenova. 2001 Feb;87(2):227-38.","Kudriavtseva NN","Ross Fiziol Zh Im I M Sechenova","2001","2001/04/12","","",""
"11294484","Effect of acute lipopolysaccharide administration on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane-induced wet dog shake behavior in rats: comparison with body weight change and locomotor activity","Kouhata S, Kagaya A, Nakae S, Nakata Y, Yamawaki S.","Prog Neuropsychopharmacol Biol Psychiatry. 2001 Feb;25(2):395-407. doi: 10.1016/s0278-5846(00)00172-x.","Kouhata S","Prog Neuropsychopharmacol Biol Psychiatry","2001","2001/04/11","","","10.1016/s0278-5846(00)00172-x"
"11294396","Selective delta-opioid receptor ligands: potential PET ligands based on naltrindole","Clayson J, Jales A, Tyacke RJ, Hudson AL, Nutt DJ, Lewis JW, Husbands SM.","Bioorg Med Chem Lett. 2001 Apr 9;11(7):939-43. doi: 10.1016/s0960-894x(01)00112-3.","Clayson J","Bioorg Med Chem Lett","2001","2001/04/11","","","10.1016/s0960-894x(01)00112-3"
"11292002","Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence","Ait-Daoud N, Johnson BA, Prihoda TJ, Hargita ID.","Psychopharmacology (Berl). 2001 Feb;154(1):23-7. doi: 10.1007/s002130000607.","Ait-Daoud N","Psychopharmacology (Berl)","2001","2001/04/09","","","10.1007/s002130000607"
"11286610","Adherence with naltrexone prescription advice in hospital outpatient alcohol rehabilitation programme","Feeney GF, Connor JP, Young RM, Tucker J, Czajkowski F.","J Clin Pharm Ther. 2001 Feb;26(1):73-9. doi: 10.1046/j.1365-2710.2001.00326.x.","Feeney GF","J Clin Pharm Ther","2001","2001/04/05","","","10.1046/j.1365-2710.2001.00326.x"
"11282159","Involvement of substance P and central opioid receptors in morphine modulation of the CHS response","Nelson CJ, Lysle DT.","J Neuroimmunol. 2001 Apr 2;115(1-2):101-10. doi: 10.1016/s0165-5728(01)00258-2.","Nelson CJ","J Neuroimmunol","2001","2001/04/03","","","10.1016/s0165-5728(01)00258-2"
"11274995","Ultrasonic vocalizations of preweanling rats: involvement of both alpha(2)-adrenoceptor and kappa-opioid receptor systems","Nazarian A, Krall CM, Osburn JR, McDougall SA.","Eur J Pharmacol. 2001 Mar;415(2-3):165-71. doi: 10.1016/s0014-2999(01)00849-4.","Nazarian A","Eur J Pharmacol","2001","2001/03/29","","","10.1016/s0014-2999(01)00849-4"
"11272410","Stereological study of rat spleen following acute ethanol treatment","Budec M, Milićević Z, Koko V.","Indian J Exp Biol. 2000 May;38(5):462-6.","Budec M","Indian J Exp Biol","2000","2001/03/29","","",""
"11271014","The physical and psychosocial consequences of opioid addiction: an overview of changes in opioid treatment","Brown R, Lo R.","Aust N Z J Ment Health Nurs. 2000 Jun;9(2):65-74. doi: 10.1046/j.1440-0979.2000.00160.x.","Brown R","Aust N Z J Ment Health Nurs","2000","2001/03/29","","","10.1046/j.1440-0979.2000.00160.x"
"11270618","The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice","Tsuji M, Takeda H, Matsumiya T, Nagase H, Narita M, Suzuki T.","Life Sci. 2001 Mar 2;68(15):1717-25. doi: 10.1016/s0024-3205(01)00957-2.","Tsuji M","Life Sci","2001","2001/03/29","","","10.1016/s0024-3205(01)00957-2"
"11268820","New developments in the pharmacotherapy of alcohol dependence","Myrick H, Brady KT, Malcolm R.","Am J Addict. 2001;10(s1):s3-s15. doi: 10.1080/10550490150504092.","Myrick H","Am J Addict","2001","2001/03/28","","","10.1080/10550490150504092"
"11264327","Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury","Hurley RW, Hammond DL.","J Neurosci. 2001 Apr 1;21(7):2536-45. doi: 10.1523/JNEUROSCI.21-07-02536.2001.","Hurley RW","J Neurosci","2001","2001/03/27","PMC6762402","","10.1523/JNEUROSCI.21-07-02536.2001"
"11264242","Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene","Maldonado R, Severini C, Matthes HW, Kieffer BL, Melchiorri P, Negri L.","Br J Pharmacol. 2001 Apr;132(7):1485-92. doi: 10.1038/sj.bjp.0703966.","Maldonado R","Br J Pharmacol","2001","2001/03/27","PMC1572701","","10.1038/sj.bjp.0703966"
"11262303","[Naltrexone in the treatment of alcohol addiction]","Ochoa E.","Actas Esp Psiquiatr. 2000 Dec;28(8):37-43.","Ochoa E","Actas Esp Psiquiatr","2000","2001/03/23","","",""
"11259547","Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists","Carey GJ, Bergman J.","J Pharmacol Exp Ther. 2001 Apr;297(1):215-23.","Carey GJ","J Pharmacol Exp Ther","2001","2001/03/22","","",""
"11259529","Characterization of opioid receptors modulating neurogenic contractions of circular muscle from porcine ileum and evidence that delta- and kappa-opioid receptors are coexpressed in myenteric neurons","Poonyachoti S, Portoghese PS, Brown DR.","J Pharmacol Exp Ther. 2001 Apr;297(1):69-77.","Poonyachoti S","J Pharmacol Exp Ther","2001","2001/03/22","","",""
"11259498","The human delta opioid receptor activates G(i1)alpha more efficiently than G(o1)alpha","Moon HE, Cavalli A, Bahia DS, Hoffmann M, Massotte D, Milligan G.","J Neurochem. 2001 Mar;76(6):1805-13. doi: 10.1046/j.1471-4159.2001.00196.x.","Moon HE","J Neurochem","2001","2001/03/22","","","10.1046/j.1471-4159.2001.00196.x"
"11256100","[In search of the Golden Fleece]","Solís Rojas LR.","Rev Invest Clin. 2000 Nov-Dec;52(6):598-9.","Solís Rojas LR","Rev Invest Clin","2000","2001/03/21","","",""
"11255932","Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats","Hölter SM, Henniger MS, Lipkowski AW, Spanagel R.","Psychopharmacology (Berl). 2000 Dec;153(1):93-102. doi: 10.1007/s002130000601.","Hölter SM","Psychopharmacology (Berl)","2000","2001/03/21","","","10.1007/s002130000601"
"11254789","High dose naltrexone for dyskinesias induced by levodopa","Manson AJ, Katzenschlager R, Hobart J, Lees AJ.","J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):554-6. doi: 10.1136/jnnp.70.4.554.","Manson AJ","J Neurol Neurosurg Psychiatry","2001","2001/03/20","PMC1737317","","10.1136/jnnp.70.4.554"
"11246723","Can this pill stop you from hitting the bottle?","Kalb C.","Newsweek. 2001 Feb 12;137(7):48-51.","Kalb C","Newsweek","2001","2001/03/15","","",""
"11245849","The role of delta-opioid receptor subtypes in neuropathic pain","Mika J, Przewłocki R, Przewłocka B.","Eur J Pharmacol. 2001 Mar 9;415(1):31-7. doi: 10.1016/s0014-2999(01)00814-7.","Mika J","Eur J Pharmacol","2001","2001/03/14","","","10.1016/s0014-2999(01)00814-7"
"11240582","Naltrexone as a treatment of self-injurious behavior--a case report","Griengl H, Sendera A, Dantendorfer K.","Acta Psychiatr Scand. 2001 Mar;103(3):234-6. doi: 10.1034/j.1600-0447.2001.00087.x.","Griengl H","Acta Psychiatr Scand","2001","2001/03/10","","","10.1034/j.1600-0447.2001.00087.x"
"11239123","Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed","Weinrieb RM, Van Horn DH, McLellan AT, Alterman AI, Calarco JS, O'Brien CP, Lucey MR.","Psychosomatics. 2001 Mar-Apr;42(2):110-6. doi: 10.1176/appi.psy.42.2.110.","Weinrieb RM","Psychosomatics","2001","2001/03/10","","","10.1176/appi.psy.42.2.110"
"11233997","Pharmacological effects of naltriben as a ligand for opioid mu and kappa receptors in rat cerebral cortex","Kim KW, Son Y, Shin BS, Cho KP.","Life Sci. 2001 Feb 2;68(11):1305-15. doi: 10.1016/s0024-3205(00)01037-7.","Kim KW","Life Sci","2001","2001/03/10","","","10.1016/s0024-3205(00)01037-7"
"11226714","Role of PAG in the antinociception evoked from the medial or central amygdala in rats","Oliveira MA, Prado WA.","Brain Res Bull. 2001 Jan 1;54(1):55-63. doi: 10.1016/s0361-9230(00)00420-2.","Oliveira MA","Brain Res Bull","2001","2001/02/28","","","10.1016/s0361-9230(00)00420-2"
"11215403","[Evolution and update of detoxification techniques for opiate addicts]","Yui K.","Nihon Shinkei Seishin Yakurigaku Zasshi. 2000 Oct;20(4):175-7.","Yui K","Nihon Shinkei Seishin Yakurigaku Zasshi","2000","2001/02/24","","",""
"11210198","Addiction pharmacotherapy 2000: new options, new challenges","Rawson RA, McCann MJ, Hasson AJ, Ling W.","J Psychoactive Drugs. 2000 Oct-Dec;32(4):371-8. doi: 10.1080/02791072.2000.10400238.","Rawson RA","J Psychoactive Drugs","2000","2001/02/24","","","10.1080/02791072.2000.10400238"
"11199951","Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism","Anton RF, Moak DH, Latham PK, Waid LR, Malcolm RJ, Dias JK, Roberts JS.","J Clin Psychopharmacol. 2001 Feb;21(1):72-7. doi: 10.1097/00004714-200102000-00013.","Anton RF","J Clin Psychopharmacol","2001","2001/02/24","","","10.1097/00004714-200102000-00013"
"11199877","Contemporary methods in pharmacotherapy in the opiate dependent treatment","Radomska M, Bisaga A, Popik P.","Przegl Lek. 2000;57(10):509-18.","Radomska M","Przegl Lek","2000","2001/02/24","","",""
"11198711","Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats","Hyytiä P, Kiianmaa K.","Alcohol Clin Exp Res. 2001 Jan;25(1):25-33. doi: 10.1111/j.1530-0277.2001.tb02123.x.","Hyytiä P","Alcohol Clin Exp Res","2001","2001/02/24","","","10.1111/j.1530-0277.2001.tb02123.x"
"11198129","Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter","Sante AB, Nobre MJ, Brandão ML.","Behav Pharmacol. 2000 Nov;11(7-8):583-9. doi: 10.1097/00008877-200011000-00005.","Sante AB","Behav Pharmacol","2000","2001/02/24","","","10.1097/00008877-200011000-00005"
"11197589","Opioid antagonists in the treatment of opioid-induced constipation and pruritus","Friedman JD, Dello Buono FA.","Ann Pharmacother. 2001 Jan;35(1):85-91. doi: 10.1345/aph.10121.","Friedman JD","Ann Pharmacother","2001","2001/02/24","","","10.1345/aph.10121"
"11195999","Naltrexone's effects on reactivity to alcohol cues among alcoholic men","Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB.","J Abnorm Psychol. 2000 Nov;109(4):738-42.","Rohsenow DJ","J Abnorm Psychol","2000","2001/02/24","","",""
"11188492","Does affect mediate the association between daily events and alcohol use?","Armeli S, Tennen H, Affleck G, Kranzler HR.","J Stud Alcohol. 2000 Nov;61(6):862-71. doi: 10.15288/jsa.2000.61.862.","Armeli S","J Stud Alcohol","2000","2001/02/24","","","10.15288/jsa.2000.61.862"
"11182162","The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat","Lindholm S, Werme M, Brené S, Franck J.","Behav Brain Res. 2001 May;120(2):137-46. doi: 10.1016/s0166-4328(00)00368-5.","Lindholm S","Behav Brain Res","2001","2001/02/22","","","10.1016/s0166-4328(00)00368-5"
"11181901","Influence of maternal milk on functional activation of delta-opioid receptors in postnatal rats","Goody RJ, Kitchen I.","J Pharmacol Exp Ther. 2001 Mar;296(3):744-8.","Goody RJ","J Pharmacol Exp Ther","2001","2001/02/22","","",""
"11180501","Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat","Jones KL, Barr GA.","Synapse. 2001 Feb;39(2):139-51. doi: 10.1002/1098-2396(200102)39:2<139::AID-SYN5>3.0.CO;2-#.","Jones KL","Synapse","2001","2001/02/17","","","10.1002/1098-2396(200102)39:2<139::AID-SYN5>3.0.CO;2-#"
"11179083","Essential activation of PKC-delta in opioid-initiated cardioprotection","Fryer RM, Wang Y, Hsu AK, Gross GJ.","Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1346-53. doi: 10.1152/ajpheart.2001.280.3.H1346.","Fryer RM","Am J Physiol Heart Circ Physiol","2001","2001/02/17","","","10.1152/ajpheart.2001.280.3.H1346"
"11173171","Parametric evaluation of the development of sensitization to the effects of morphine on locomotor activity","Powell KR, Holtzman SG.","Drug Alcohol Depend. 2001 Mar 1;62(1):83-90. doi: 10.1016/s0376-8716(00)00167-8.","Powell KR","Drug Alcohol Depend","2001","2001/02/15","","","10.1016/s0376-8716(00)00167-8"
"11166066","Naltrexone and alcohol drinking in mice lacking beta-endorphin by site-directed mutagenesis","Grahame NJ, Mosemiller AK, Low MJ, Froehlich JC.","Pharmacol Biochem Behav. 2000 Dec;67(4):759-66. doi: 10.1016/s0091-3057(00)00411-1.","Grahame NJ","Pharmacol Biochem Behav","2000","2001/02/13","","","10.1016/s0091-3057(00)00411-1"
"11164832","Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test","Tan-No K, Ohshima K, Taira A, Inoue M, Niijima F, Nakagawasai O, Tadano T, Nylander I, Silberring J, Terenius L, Kisara K.","Brain Res. 2001 Feb 9;891(1-2):274-80. doi: 10.1016/s0006-8993(00)03225-x.","Tan-No K","Brain Res","2001","2001/02/13","","","10.1016/s0006-8993(00)03225-x"
"11164085","Naltrexone fails to block the acquisition or expression of a flavor preference conditioned by intragastric carbohydrate infusions","Azzara AV, Bodnar RJ, Delamater AR, Sclafani A.","Pharmacol Biochem Behav. 2000 Nov;67(3):545-57. doi: 10.1016/s0091-3057(00)00395-6.","Azzara AV","Pharmacol Biochem Behav","2000","2001/02/13","","","10.1016/s0091-3057(00)00395-6"
"11160621","Intestinal inflammation enhances the inhibitory effects of opioids on intestinal permeability in mice","Valle L, Pol O, Puig MM.","J Pharmacol Exp Ther. 2001 Feb;296(2):378-87.","Valle L","J Pharmacol Exp Ther","2001","2001/02/13","","",""
"11160607","Gabapentin antinociception in mice with acute herpetic pain induced by herpes simplex virus infection","Takasaki I, Andoh T, Nojima H, Shiraki K, Kuraishi Y.","J Pharmacol Exp Ther. 2001 Feb;296(2):270-5.","Takasaki I","J Pharmacol Exp Ther","2001","2001/02/13","","",""
"11154860","Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis","Yamaguchi T, Maekawa T, Nishikawa Y, Nojima H, Kaneko M, Kawakita T, Miyamoto T, Kuraishi Y.","J Dermatol Sci. 2001 Jan;25(1):20-8. doi: 10.1016/s0923-1811(00)00099-2.","Yamaguchi T","J Dermatol Sci","2001","2001/01/13","","","10.1016/s0923-1811(00)00099-2"
"11153302","Intraoperative high-dose remifentanil in a patient on naltrexone therapy","Schwab CA, Wright DA.","Anaesth Intensive Care. 2000 Dec;28(6):701-3. doi: 10.1177/0310057X0002800618.","Schwab CA","Anaesth Intensive Care","2000","2001/01/12","","","10.1177/0310057X0002800618"
"11146395","Inhibition of passive cutaneous anaphylaxis-associated scratching behavior by mu-opioid receptor antagonists in ICR mice","Inagaki N, Nakamura N, Nagao M, Kawasaki H, Nagai H.","Int Arch Allergy Immunol. 2000 Dec;123(4):365-8. doi: 10.1159/000053650.","Inagaki N","Int Arch Allergy Immunol","2000","2001/01/09","","","10.1159/000053650"
"11146054","Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia","Crain SM, Shen KF.","Brain Res. 2001 Jan 5;888(1):75-82. doi: 10.1016/s0006-8993(00)03010-9.","Crain SM","Brain Res","2001","2001/01/09","","","10.1016/s0006-8993(00)03010-9"
"11140779","Opiate antagonists in children and adolescents","Chabane N, Leboyer M, Mouren-Simeoni MC.","Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I44-50. doi: 10.1007/s007870070018.","Chabane N","Eur Child Adolesc Psychiatry","2000","2001/01/05","","","10.1007/s007870070018"
"11139447","Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test","Lutfy K, Maidment NT.","Br J Pharmacol. 2000 Dec;131(8):1684-8. doi: 10.1038/sj.bjp.0703746.","Lutfy K","Br J Pharmacol","2000","2001/01/05","PMC1572505","","10.1038/sj.bjp.0703746"
"11139409","Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism","Sinclair JD.","Alcohol Alcohol. 2001 Jan-Feb;36(1):2-10. doi: 10.1093/alcalc/36.1.2.","Sinclair JD","Alcohol Alcohol","2001","2001/01/05","","","10.1093/alcalc/36.1.2"
"11137281","Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes","Elman I, D'Ambra MN, Krause S, Breiter H, Kane M, Morris R, Tuffy L, Gastfriend DR.","Drug Alcohol Depend. 2001 Jan 1;61(2):163-72. doi: 10.1016/s0376-8716(00)00139-3.","Elman I","Drug Alcohol Depend","2001","2001/01/04","","","10.1016/s0376-8716(00)00139-3"
"11125673","Naltrexone treatment of dementia with severe self-injurious behaviors: a single case study","Vance HB, Kauffmann C, Pumariega AJ, Del Mundo A.","Psychiatry. 2000 Fall;63(3):288-99. doi: 10.1080/00332747.2000.11024920.","Vance HB","Psychiatry","2000","2000/12/28","","","10.1080/00332747.2000.11024920"
"11125013","Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine","Thompson AC, Zapata A, Justice JB Jr, Vaughan RA, Sharpe LG, Shippenberg TS.","J Neurosci. 2000 Dec 15;20(24):9333-40. doi: 10.1523/JNEUROSCI.20-24-09333.2000.","Thompson AC","J Neurosci","2000","2000/12/23","PMC6773021","","10.1523/JNEUROSCI.20-24-09333.2000"
"11123254","Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels","Huh J, Gross GJ, Nagase H, Liang BT.","Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H377-83. doi: 10.1152/ajpheart.2001.280.1.H377.","Huh J","Am J Physiol Heart Circ Physiol","2001","2000/12/21","","","10.1152/ajpheart.2001.280.1.H377"
"11122358","Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved","Georges F, Stinus L, Le Moine C.","Eur J Neurosci. 2000 Dec;12(12):4475-86. doi: 10.1046/j.0953-816x.2000.01334.x.","Georges F","Eur J Neurosci","2000","2000/12/21","","","10.1046/j.0953-816x.2000.01334.x"
"11116795","[Alcohol consumption in opioid-dependence patients in treatment with naltrexone]","Ochoa Mangado E, Arias Horcajadas F.","Actas Esp Psiquiatr. 2000 Jul-Aug;28(4):239-49.","Ochoa Mangado E","Actas Esp Psiquiatr","2000","2000/12/16","","",""
"11113622","The effect of antagonists selective for mu- and delta-opioid receptor subtypes on alcohol consumption in C57BL/6 mice","Kim SG, Stromberg MF, Kim MJ, Volpicelli JR, Park JM.","Alcohol. 2000 Oct;22(2):85-90. doi: 10.1016/s0741-8329(00)00109-9.","Kim SG","Alcohol","2000","2000/12/13","","","10.1016/s0741-8329(00)00109-9"
"11113514","The role of opioid receptors in morphine withdrawal in the infant rat","McPhie AA, Barr GA.","Brain Res Dev Brain Res. 2000 Nov 30;124(1-2):73-80. doi: 10.1016/s0165-3806(00)00102-4.","McPhie AA","Brain Res Dev Brain Res","2000","2000/12/13","","","10.1016/s0165-3806(00)00102-4"
"11113500","Testosterone is required for corticosteroid-binding globulin upregulation by morphine to be fully manifested","Nock B, Wich M, Cicero TJ, O'Connor LH.","Pharmacol Biochem Behav. 2000 Sep;67(1):193-8. doi: 10.1016/s0091-3057(00)00322-1.","Nock B","Pharmacol Biochem Behav","2000","2000/12/13","","","10.1016/s0091-3057(00)00322-1"
"11112994","An immortalized myocyte cell line, HL-1, expresses a functional delta -opioid receptor","Neilan CL, Kenyon E, Kovach MA, Bowden K, Claycomb WC, Traynor JR, Bolling SF.","J Mol Cell Cardiol. 2000 Dec;32(12):2187-93. doi: 10.1006/jmcc.2000.1241.","Neilan CL","J Mol Cell Cardiol","2000","2000/12/13","","","10.1006/jmcc.2000.1241"
"11111000","Acoustic startle and open-field behavior in mice bred for magnitude of swim analgesia","Błaszczyk JW, Tajchert K, Lapo I, Sadowski B.","Physiol Behav. 2000 Sep 15;70(5):471-6. doi: 10.1016/s0031-9384(00)00289-4.","Błaszczyk JW","Physiol Behav","2000","2000/12/09","","","10.1016/s0031-9384(00)00289-4"
"11110065","Plasma naltrexone during opioid detoxification","McDonald T, Berkowitz R, Hoffman WE.","J Addict Dis. 2000;19(4):59-64. doi: 10.1300/J069v19n04_06.","McDonald T","J Addict Dis","2000","2000/12/08","","","10.1300/J069v19n04_06"
"11106302","Morphine inhibits human microglial cell production of, and migration towards, RANTES","Hu S, Chao CC, Hegg CC, Thayer S, Peterson PK.","J Psychopharmacol. 2000;14(3):238-43. doi: 10.1177/026988110001400307.","Hu S","J Psychopharmacol","2000","2000/12/06","","","10.1177/026988110001400307"
"11105989","Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors","Mizoguchi H, Narita M, Nagase H, Tseng LF.","Life Sci. 2000 Oct 20;67(22):2733-43. doi: 10.1016/s0024-3205(00)00852-3.","Mizoguchi H","Life Sci","2000","2000/12/06","","","10.1016/s0024-3205(00)00852-3"
"11104658","Naltrexone administration attenuates surgery-induced immune alterations in rats","Nelson CJ, Carrigan KA, Lysle DT.","J Surg Res. 2000 Dec;94(2):172-7. doi: 10.1006/jsre.2000.6003.","Nelson CJ","J Surg Res","2000","2000/12/06","","","10.1006/jsre.2000.6003"
"11102568","delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury","Zhang J, Haddad GG, Xia Y.","Brain Res. 2000 Dec 8;885(2):143-53. doi: 10.1016/s0006-8993(00)02906-1.","Zhang J","Brain Res","2000","2000/12/05","","","10.1016/s0006-8993(00)02906-1"
"11099770","Early exposure to chronic variable stress facilitates the occurrence of anhedonia and enhanced emotional reactions to novel stressors: reversal by naltrexone pretreatment","Zurita A, Martijena I, Cuadra G, Brandão ML, Molina V.","Behav Brain Res. 2000 Dec 20;117(1-2):163-71. doi: 10.1016/s0166-4328(00)00302-8.","Zurita A","Behav Brain Res","2000","2000/12/02","","","10.1016/s0166-4328(00)00302-8"
"11097674","Antagonism of gastrointestinal opioid effects","Yuan CS, Foss JF.","Reg Anesth Pain Med. 2000 Nov-Dec;25(6):639-42. doi: 10.1053/rapm.2000.8658.","Yuan CS","Reg Anesth Pain Med","2000","2000/11/30","","","10.1053/rapm.2000.8658"
"11093966","A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse","Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B.","Alcohol Alcohol. 2000 Nov-Dec;35(6):587-93. doi: 10.1093/alcalc/35.6.587.","Chick J","Alcohol Alcohol","2000","2000/11/30","","","10.1093/alcalc/35.6.587"
"11093959","Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research","Kranzler HR.","Alcohol Alcohol. 2000 Nov-Dec;35(6):537-47. doi: 10.1093/alcalc/35.6.537.","Kranzler HR","Alcohol Alcohol","2000","2000/11/30","","","10.1093/alcalc/35.6.537"
"11091301","Borderline personality, opioids, and naltrexone","Saper JR.","Headache. 2000 Oct;40(9):765. doi: 10.1046/j.1526-4610.2000.00137-1.x.","Saper JR","Headache","2000","2000/11/25","","","10.1046/j.1526-4610.2000.00137-1.x"
"11091028","Effect of naltrexone on acute tolerance to ethanol in UChB rats","Quintanilla ME, Tampier L.","Alcohol. 2000 Jul;21(3):245-9. doi: 10.1016/s0741-8329(00)00092-6.","Quintanilla ME","Alcohol","2000","2000/11/25","","","10.1016/s0741-8329(00)00092-6"
"11091024","Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats","Parkes H, Sinclair JD.","Alcohol. 2000 Jul;21(3):215-21. doi: 10.1016/s0741-8329(00)00091-4.","Parkes H","Alcohol","2000","2000/11/25","","","10.1016/s0741-8329(00)00091-4"
"11090116","Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus","Osborne PB, Chieng B, Christie MJ.","Br J Pharmacol. 2000 Dec;131(7):1422-8. doi: 10.1038/sj.bjp.0703697.","Osborne PB","Br J Pharmacol","2000","2000/11/23","PMC1572456","","10.1038/sj.bjp.0703697"
"11085330","Plasma catecholamines during an ultrarapid heroin detoxification","Macedo TR, Relvas J, Fontes Ribeiro CA, Pacheco F, Morgadinho MT, Pinto CM, Gomes PC, Ventura M, Henriques V, Nunes SV, Ruis GR, Ramalheira C, Boto I, Vale LL.","Ann N Y Acad Sci. 2000 Sep;914:303-10. doi: 10.1111/j.1749-6632.2000.tb05205.x.","Macedo TR","Ann N Y Acad Sci","2000","2000/11/21","","","10.1111/j.1749-6632.2000.tb05205.x"
"11082451","Inhibition of morphine tolerance development by a substance P-opioid peptide chimera","Foran SE, Carr DB, Lipkowski AW, Maszczynska I, Marchand JE, Misicka A, Beinborn M, Kopin AS, Kream RM.","J Pharmacol Exp Ther. 2000 Dec;295(3):1142-8.","Foran SE","J Pharmacol Exp Ther","2000","2000/11/18","","",""
"11082442","Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts","Kling MA, Carson RE, Borg L, Zametkin A, Matochik JA, Schluger J, Herscovitch P, Rice KC, Ho A, Eckelman WC, Kreek MJ.","J Pharmacol Exp Ther. 2000 Dec;295(3):1070-6.","Kling MA","J Pharmacol Exp Ther","2000","2000/11/18","","",""
"11082438","Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice","Kuzmin A, Sandin J, Terenius L, Ogren SO.","J Pharmacol Exp Ther. 2000 Dec;295(3):1031-42.","Kuzmin A","J Pharmacol Exp Ther","2000","2000/11/18","","",""
"11078933","Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat","Cui CL, Wu LZ, Han JS.","Neurosci Lett. 2000 Dec 1;295(1-2):45-8. doi: 10.1016/s0304-3940(00)01593-7.","Cui CL","Neurosci Lett","2000","2000/11/18","","","10.1016/s0304-3940(00)01593-7"
"11078827","Expression of functional delta opioid receptors in vascular smooth muscle","Saeed RW, Stefano GB, Murga JD, Short TW, Qi F, Bilfinger TV, Magazine HI.","Int J Mol Med. 2000 Dec;6(6):673-7. doi: 10.3892/ijmm.6.6.673.","Saeed RW","Int J Mol Med","2000","2000/11/18","","","10.3892/ijmm.6.6.673"
"11078198","N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole","Coop A, Jacobson AE, Aceto MD, Harris LS, Traynor JR, Woods JH, Rice KC.","Bioorg Med Chem Lett. 2000 Nov 6;10(21):2449-51. doi: 10.1016/s0960-894x(00)00479-0.","Coop A","Bioorg Med Chem Lett","2000","2000/11/15","","","10.1016/s0960-894x(00)00479-0"
"11076138","Naltrexone: effects on motor function, speech, and activities of daily living in a patient with traumatic brain injury","Calvanio R, Burke DT, Kim HJ, Cheng J, Lepak P, Leonard J, Dwyer MA, Gavande V.","Brain Inj. 2000 Oct;14(10):933-42. doi: 10.1080/026990500445745.","Calvanio R","Brain Inj","2000","2000/11/15","","","10.1080/026990500445745"
"11076120","Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness","Maxwell S, Shinderman MS.","J Addict Dis. 2000;19(3):61-9. doi: 10.1300/J069v19n03_05.","Maxwell S","J Addict Dis","2000","2000/11/15","","","10.1300/J069v19n03_05"
"11073113","Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages","Peng X, Mosser DM, Adler MW, Rogers TJ, Meissler JJ Jr, Eisenstein TK.","J Leukoc Biol. 2000 Nov;68(5):723-8.","Peng X","J Leukoc Biol","2000","2000/11/10","","",""
"11069441","Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosol","Porter SJ, Somogyi AA, White JM.","Br J Clin Pharmacol. 2000 Nov;50(5):465-71. doi: 10.1046/j.1365-2125.2000.00281.x.","Porter SJ","Br J Clin Pharmacol","2000","2000/11/09","PMC2014407","","10.1046/j.1365-2125.2000.00281.x"
"11055575","Influence of opioid receptor antagonists on motor-impairing effects of benzodiazepines","Fidecka S, Langwiński R.","Pol J Pharmacol. 2000 May-Jun;52(3):187-93.","Fidecka S","Pol J Pharmacol","2000","2000/10/31","","",""
"11055333","Selective kappa-opioid antagonists related to naltrindole. Effect of side-chain spacer in the 5'-amidinoalkyl series","Jales AR, Husbands SM, Lewis JW.","Bioorg Med Chem Lett. 2000 Oct 16;10(20):2259-61. doi: 10.1016/s0960-894x(00)00433-9.","Jales AR","Bioorg Med Chem Lett","2000","2000/10/31","","","10.1016/s0960-894x(00)00433-9"
"11053123","Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions","Salamon Z, Cowell S, Varga E, Yamamura HI, Hruby VJ, Tollin G.","Biophys J. 2000 Nov;79(5):2463-74. doi: 10.1016/S0006-3495(00)76489-7.","Salamon Z","Biophys J","2000","2000/10/29","PMC1301131","","10.1016/S0006-3495(00)76489-7"
"11049837","Muscle pain perception and sympathetic nerve activity to exercise during opioid modulation","Cook DB, O'Connor PJ, Ray CA.","Am J Physiol Regul Integr Comp Physiol. 2000 Nov;279(5):R1565-73. doi: 10.1152/ajpregu.2000.279.5.R1565.","Cook DB","Am J Physiol Regul Integr Comp Physiol","2000","2000/10/26","","","10.1152/ajpregu.2000.279.5.R1565"
"11046088","delta-Opioid receptors are more efficiently coupled to adenylyl cyclase than to L-type Ca(2+) channels in transfected rat pituitary cells","Prather PL, Song L, Piros ET, Law PY, Hales TG.","J Pharmacol Exp Ther. 2000 Nov;295(2):552-62.","Prather PL","J Pharmacol Exp Ther","2000","2000/10/25","","",""
"11045869","6-beta-naltrexol reduces alcohol consumption in rats","Rukstalis MR, Stromberg MF, O'Brien CP, Volpicelli JR.","Alcohol Clin Exp Res. 2000 Oct;24(10):1593-6.","Rukstalis MR","Alcohol Clin Exp Res","2000","2000/10/25","","",""
"11045863","Predictors of compliance with naltrexone among alcoholics","Rohsenow DJ, Colby SM, Monti PM, Swift RM, Martin RA, Mueller TI, Gordon A, Eaton CA.","Alcohol Clin Exp Res. 2000 Oct;24(10):1542-9.","Rohsenow DJ","Alcohol Clin Exp Res","2000","2000/10/25","","",""
"11044861","The first suckling episode in the rat: the role of endogenous activity at mu and kappa opioid receptors","Petrov ES, Varlinskaya EI, Smotherman WP.","Dev Psychobiol. 2000 Nov;37(3):129-43. doi: 10.1002/1098-2302(200011)37:3<129::aid-dev2>3.0.co;2-p.","Petrov ES","Dev Psychobiol","2000","2000/10/25","","","10.1002/1098-2302(200011)37:3<129::aid-dev2>3.0.co;2-p"
"11044755","Kappa-opioid receptor modulation of nicotine-induced behaviour","Hahn B, Stolerman IP, Shoaib M.","Neuropharmacology. 2000 Oct;39(13):2848-55. doi: 10.1016/s0028-3908(00)00119-2.","Hahn B","Neuropharmacology","2000","2000/10/25","","","10.1016/s0028-3908(00)00119-2"
"11044744","The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs","Almeida LE, Pereira EF, Alkondon M, Fawcett WP, Randall WR, Albuquerque EX.","Neuropharmacology. 2000 Oct;39(13):2740-55. doi: 10.1016/s0028-3908(00)00157-x.","Almeida LE","Neuropharmacology","2000","2000/10/25","","","10.1016/s0028-3908(00)00157-x"
"11040344","Effects of naltrexone on the accumulation of L-3, 4-dihydroxyphenylalanine and 5-hydroxy-L-tryptophan and on the firing rate induced by acute ethanol administration","Inoue H.","Eur J Pharmacol. 2000 Oct 20;406(3):375-80. doi: 10.1016/s0014-2999(00)00703-2.","Inoue H","Eur J Pharmacol","2000","2000/10/21","","","10.1016/s0014-2999(00)00703-2"
"11034715","Naltrexone maintenance treatment for opioid dependence","Kirchmayer U, Davoli M, Verster A.","Cochrane Database Syst Rev. 2000;(4):CD001333. doi: 10.1002/14651858.CD001333.","Kirchmayer U","Cochrane Database Syst Rev","2000","2000/10/18","","","10.1002/14651858.CD001333"
"11033087","Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone","Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Zadina JE, Kastin AJ, Sakurada T.","Brain Res. 2000 Oct 20;881(1):1-8. doi: 10.1016/s0006-8993(00)02770-0.","Sakurada S","Brain Res","2000","2000/10/18","","","10.1016/s0006-8993(00)02770-0"
"11029512","Opioid growth factor regulates the cell cycle of human neoplasias","Zagon IS, Roesener CD, Verderame MF, Ohlsson-Wilhelm BM, Levin RJ, McLaughlin PJ.","Int J Oncol. 2000 Nov;17(5):1053-61. doi: 10.3892/ijo.17.5.1053.","Zagon IS","Int J Oncol","2000","2000/10/13","","","10.3892/ijo.17.5.1053"
"11026738","Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice","Middaugh LD, Bandy AL.","Psychopharmacology (Berl). 2000 Sep;151(4):321-7. doi: 10.1007/s002130000479.","Middaugh LD","Psychopharmacology (Berl)","2000","2000/10/12","","","10.1007/s002130000479"
"11026735","Endomorphin-1 induces antinociception without immunomodulatory effects in the rat","Carrigan KA, Nelson CJ, Lysle DT.","Psychopharmacology (Berl). 2000 Sep;151(4):299-305. doi: 10.1007/s002130000487.","Carrigan KA","Psychopharmacology (Berl)","2000","2000/10/12","","","10.1007/s002130000487"
"11021352","Is there a basis for novel pharmacotherapy of autism?","Hunsinger DM, Nguyen T, Zebraski SE, Raffa RB.","Life Sci. 2000 Aug 25;67(14):1667-82. doi: 10.1016/s0024-3205(00)00763-3.","Hunsinger DM","Life Sci","2000","2000/10/06","","","10.1016/s0024-3205(00)00763-3"
"11020761","Activation of mu- and delta-opioid receptors causes presynaptic inhibition of glutamatergic excitation in neocortical neurons","Ostermeier AM, Schlösser B, Schwender D, Sutor B.","Anesthesiology. 2000 Oct;93(4):1053-63. doi: 10.1097/00000542-200010000-00029.","Ostermeier AM","Anesthesiology","2000","2000/10/06","","","10.1097/00000542-200010000-00029"
"11018796","Opiate receptor avidity in the thalamus is sexually dimorphic in the elderly","Cohen RM, Carson RE, Sunderland T.","Synapse. 2000 Nov;38(2):226-9. doi: 10.1002/1098-2396(200011)38:2<226::AID-SYN13>3.0.CO;2-#.","Cohen RM","Synapse","2000","2000/10/06","","","10.1002/1098-2396(200011)38:2<226::AID-SYN13>3.0.CO;2-#"
"11016587","Inhibitory effects of morphine on some inflammation-related parameters in the goldfish Carassius auratus L","Chadzinska M, Scislowska-Czarnecka A, Plytycz B.","Fish Shellfish Immunol. 2000 Aug;10(6):531-42. doi: 10.1006/fsim.2000.0270.","Chadzinska M","Fish Shellfish Immunol","2000","2000/10/04","","","10.1006/fsim.2000.0270"
"11011049","Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue","Labarre M, Butterworth J, St-Onge S, Payza K, Schmidhammer H, Salvadori S, Balboni G, Guerrini R, Bryant SD, Lazarus LH.","Eur J Pharmacol. 2000 Oct 6;406(1):R1-3. doi: 10.1016/s0014-2999(00)00636-1.","Labarre M","Eur J Pharmacol","2000","2000/09/30","","","10.1016/s0014-2999(00)00636-1"
"11010998","Opiate receptor avidity is increased in rhesus monkeys following unilateral optic tract lesion combined with transections of corpus callosum and hippocampal and anterior commissures","Cohen RM, Carson RE, Saunders RC, Doudet DJ.","Brain Res. 2000 Oct 6;879(1-2):1-6. doi: 10.1016/s0006-8993(00)02528-2.","Cohen RM","Brain Res","2000","2000/09/30","","","10.1016/s0006-8993(00)02528-2"
"11007709","Naltrexone treatment for a 3-year-old boy with self-injurious behavior","White T, Schultz SK.","Am J Psychiatry. 2000 Oct;157(10):1574-82. doi: 10.1176/appi.ajp.157.10.1574.","White T","Am J Psychiatry","2000","2000/09/29","","","10.1176/appi.ajp.157.10.1574"
"11003204","Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers","McCaul ME, Wand GS, Rohde C, Lee SM.","Alcohol Clin Exp Res. 2000 Sep;24(9):1385-91.","McCaul ME","Alcohol Clin Exp Res","2000","2000/09/26","","",""
"11003196","Pharmacogenetics of alcohol: treatment implications","Busto UE.","Alcohol Clin Exp Res. 2000 Sep;24(9):1323-6.","Busto UE","Alcohol Clin Exp Res","2000","2000/09/26","","",""
"11003137","Synthesis and antinociceptive activity of pyrrolidinylnaphthalenes","Collina S, Azzolina O, Vercesi D, Sbacchi M, Scheideler MA, Barbieri A, Lanza E, Ghislandi V.","Bioorg Med Chem. 2000 Aug;8(8):1925-30. doi: 10.1016/s0968-0896(00)00117-6.","Collina S","Bioorg Med Chem","2000","2000/09/26","","","10.1016/s0968-0896(00)00117-6"
"11002917","Toward bridging the gap between biological, psychobiological and psychosocial models of alcohol craving","Monti PM, Rohsenow DJ, Hutchison KE.","Addiction. 2000 Aug;95 Suppl 2:S229-36. doi: 10.1080/09652140050111799.","Monti PM","Addiction","2000","2000/09/26","","","10.1080/09652140050111799"
"11002911","Laboratory-based assessment of alcohol craving in social drinkers","de Wit H.","Addiction. 2000 Aug;95 Suppl 2:S165-9. doi: 10.1080/09652140050111735.","de Wit H","Addiction","2000","2000/09/26","","","10.1080/09652140050111735"
"11002904","Animal models of craving for ethanol","Koob GF.","Addiction. 2000 Aug;95 Suppl 2:S73-81. doi: 10.1080/09652140050111663.","Koob GF","Addiction","2000","2000/09/26","","","10.1080/09652140050111663"
"11000698","[Alcohol dependence treatment with naltrexone: safety assessment. Observation study group of alcoholic dependence]","Ochoa Mangado E, Arias Horcajadas F, Torres Hernández MA.","Actas Esp Psiquiatr. 2000 May-Jun;28(3):161-8.","Ochoa Mangado E","Actas Esp Psiquiatr","2000","2000/09/23","","",""
"10996023","Modulation of humoral immune responses in the rat by centrally applied Met-Enk and opioid receptor antagonists: functional interactions of brain OP1, OP2 and OP3 receptors","Dimitrijević M, Stanojević S, Kovacević-Jovanović V, Miletić T, Vujić-Redzić V, Radulović J.","Immunopharmacology. 2000 Sep;49(3):255-62. doi: 10.1016/s0162-3109(00)00213-7.","Dimitrijević M","Immunopharmacology","2000","2000/09/21","","","10.1016/s0162-3109(00)00213-7"
"10990349","Effect of a long-lasting opioid receptor antagonist (naltrexone) on pulsatile LH release in early postpartum Holstein dairy cows","Kadokawa H, Yamada Y.","Theriogenology. 2000 Jul 1;54(1):75-81. doi: 10.1016/S0093-691X(00)00326-5.","Kadokawa H","Theriogenology","2000","2000/09/16","","","10.1016/S0093-691X(00)00326-5"
"10989777","Ultra rapid opiate detoxification as compared to 30-day inpatient detoxification program--a retrospective follow-up study","Lawental E.","J Subst Abuse. 2000;11(2):173-81. doi: 10.1016/s0899-3289(00)00019-5.","Lawental E","J Subst Abuse","2000","2000/09/16","","","10.1016/s0899-3289(00)00019-5"
"10989399","Oral methylnaltrexone for opioid-induced constipation","Yuan CS, Foss JF.","JAMA. 2000 Sep 20;284(11):1383-4. doi: 10.1001/jama.284.11.1383.","Yuan CS","JAMA","2000","2000/09/16","","","10.1001/jama.284.11.1383"
"10989273","A pharmacological analysis of the substrates underlying conditioned feeding induced by repeated opioid stimulation of the nucleus accumbens","Kelley AE, Bakshi VP, Fleming S, Holahan MR.","Neuropsychopharmacology. 2000 Oct;23(4):455-67. doi: 10.1016/S0893-133X(00)00117-2.","Kelley AE","Neuropsychopharmacology","2000","2000/09/16","","","10.1016/S0893-133X(00)00117-2"
"10986803","Naltrexone treatment of self-injurious behavior","Godart NT, Agman G, Perdereau F, Jeammet P.","J Am Acad Child Adolesc Psychiatry. 2000 Sep;39(9):1076-8. doi: 10.1097/00004583-200009000-00005.","Godart NT","J Am Acad Child Adolesc Psychiatry","2000","2000/09/15","","","10.1097/00004583-200009000-00005"
"10986732","Pathological gambling","Hollander E, Buchalter AJ, DeCaria CM.","Psychiatr Clin North Am. 2000 Sep;23(3):629-42. doi: 10.1016/s0193-953x(05)70185-4.","Hollander E","Psychiatr Clin North Am","2000","2000/09/15","","","10.1016/s0193-953x(05)70185-4"
"10983373","[The development of coma after the use of naltrexone in a patient with opioid addiction]","Sivolap IuP, Savchenkov VA, Mishnaevskiĭ AL, Iakovchuk AM, Rasulov MM, Kaludzherovich LV, Parfenov DA, Mustafin KhKh.","Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(8):55-7.","Sivolap IuP","Zh Nevrol Psikhiatr Im S S Korsakova","2000","2000/09/13","","",""
"10982140","Diagnosis and treatment of obstructive urolithiasis in a captive Rocky Mountain wapiti (Cervus elaphus nelsoni)","Larsen RS, Cebra CK, Wild MA.","J Zoo Wildl Med. 2000 Jun;31(2):236-9. doi: 10.1638/1042-7260(2000)031[0236:DATOOU]2.0.CO;2.","Larsen RS","J Zoo Wildl Med","2000","2000/09/12","","","10.1638/1042-7260(2000)031[0236:DATOOU]2.0.CO;2"
"10982133","Standing laparoscopic-guided uterine biopsy in a southern white rhinoceros (Ceratotherium simum simum)","Radcliffe RM, Hendrickson DA, Richardson GL, Zuba JR, Radcliffe RW.","J Zoo Wildl Med. 2000 Jun;31(2):201-7. doi: 10.1638/1042-7260(2000)031[0201:SLGUBI]2.0.CO;2.","Radcliffe RM","J Zoo Wildl Med","2000","2000/09/12","","","10.1638/1042-7260(2000)031[0201:SLGUBI]2.0.CO;2"
"10982132","Butorphanol and azaperone as a safe alternative for repeated chemical restraint in captive white rhinoceros (Ceratotherium simum)","Radcliffe RW, Ferrell ST, Childs SE.","J Zoo Wildl Med. 2000 Jun;31(2):196-200. doi: 10.1638/1042-7260(2000)031[0196:BAAAAS]2.0.CO;2.","Radcliffe RW","J Zoo Wildl Med","2000","2000/09/12","","","10.1638/1042-7260(2000)031[0196:BAAAAS]2.0.CO;2"
"10982130","Oral induction of anesthesia with droperidol and transmucosal carfentanil citrate in chimpanzees (Pan troglodytes)","Kearns KS, Swenson B, Ramsay EC.","J Zoo Wildl Med. 2000 Jun;31(2):185-9. doi: 10.1638/1042-7260(2000)031[0185:OIOAWD]2.0.CO;2.","Kearns KS","J Zoo Wildl Med","2000","2000/09/12","","","10.1638/1042-7260(2000)031[0185:OIOAWD]2.0.CO;2"
"10973525","Morphine discriminative control is mediated by the mu opioid receptor: assessment of delta opioid substitution and antagonism","Stevenson GW, Cañadas F, Zhang X, Rice KC, Riley AL.","Pharmacol Biochem Behav. 2000 Aug;66(4):851-6. doi: 10.1016/s0091-3057(00)00280-x.","Stevenson GW","Pharmacol Biochem Behav","2000","2000/09/06","","","10.1016/s0091-3057(00)00280-x"
"10973516","Assessment of SNC 80 and naltrindole within a conditioned taste aversion design","Hutchinson AC, Simpson GR, Randall JF, Zhang X, Calderon SN, Rice KC, Riley AL.","Pharmacol Biochem Behav. 2000 Aug;66(4):779-87. doi: 10.1016/s0091-3057(00)00278-1.","Hutchinson AC","Pharmacol Biochem Behav","2000","2000/09/06","","","10.1016/s0091-3057(00)00278-1"
"10973506","Opiate delta-2-receptor antagonist naltriben does not alter discriminative stimulus effects of ethanol","Mhatre MC, Carl K, Garrett KM, Holloway FA.","Pharmacol Biochem Behav. 2000 Aug;66(4):701-6. doi: 10.1016/s0091-3057(00)00272-0.","Mhatre MC","Pharmacol Biochem Behav","2000","2000/09/06","","","10.1016/s0091-3057(00)00272-0"
"10970678","Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation","Nelson CJ, Schneider GM, Lysle DT.","Brain Behav Immun. 2000 Sep;14(3):170-84. doi: 10.1006/brbi.1999.0575.","Nelson CJ","Brain Behav Immun","2000","2000/09/06","","","10.1006/brbi.1999.0575"
"10969141","Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop","Bonner G, Meng F, Akil H.","Eur J Pharmacol. 2000 Sep 1;403(1-2):37-44. doi: 10.1016/s0014-2999(00)00578-1.","Bonner G","Eur J Pharmacol","2000","2000/09/02","","","10.1016/s0014-2999(00)00578-1"
"10968654","Ethanol reinforcement in nondeprived mice: effects of abstinence and naltrexone","Middaugh LD, Lee AM, Bandy AL.","Alcohol Clin Exp Res. 2000 Aug;24(8):1172-9.","Middaugh LD","Alcohol Clin Exp Res","2000","2000/09/01","","",""
"10962832","Safe approaches to treating drug addiction","Keaney F, Farrell M.","Practitioner. 2000 May;244(1610):410, 414-6, 418-20 passim.","Keaney F","Practitioner","2000","2000/08/30","","",""
"10958998","Uncoupling of proopiomelanocortin (POMC) fragments is related to self-injury","Sandman CA, Hetrick W, Talyor D, Marion S, Chicz-DeMet A.","Peptides. 2000 Jun;21(6):785-91. doi: 10.1016/s0196-9781(00)00209-6.","Sandman CA","Peptides","2000","2000/08/26","","","10.1016/s0196-9781(00)00209-6"
"10956449","Alcohol in pregnancy and neonatal outcome","Hannigan JH, Armant DR.","Semin Neonatol. 2000 Aug;5(3):243-54. doi: 10.1053/siny.2000.0027.","Hannigan JH","Semin Neonatol","2000","2000/08/24","","","10.1053/siny.2000.0027"
"10955836","Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following beta-funaltrexamine-induced mu-opioid receptor ""knockdown"" in vivo","Garrido M, Gubbens-Stibbe J, Tukker E, Cox E, von Frijtag J, Künzel D, IJzerman A, Danhof M, van der Graaf PH.","Pharm Res. 2000 Jun;17(6):653-9. doi: 10.1023/a:1007513812018.","Garrido M","Pharm Res","2000","2000/08/24","","","10.1023/a:1007513812018"
"10953721","Use of orally administered carfentanil prior to isoflurane-induced anesthesia in a Kodiak brown bear","Mama KR, Steffey EP, Withrow SJ.","J Am Vet Med Assoc. 2000 Aug 15;217(4):546-9, 503. doi: 10.2460/javma.2000.217.546.","Mama KR","J Am Vet Med Assoc","2000","2000/08/23","","","10.2460/javma.2000.217.546"
"10946851","The effects of delta agonists on locomotor activity in habituated and non-habituated rats","Fraser GL, Parenteau H, Tu TM, Ducharme J, Perkins MN, Clarke PB.","Life Sci. 2000 Jul 14;67(8):913-22. doi: 10.1016/s0024-3205(00)00690-1.","Fraser GL","Life Sci","2000","2000/08/18","","","10.1016/s0024-3205(00)00690-1"
"10945877","BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice","Broom DC, Guo L, Coop A, Husbands SM, Lewis JW, Woods JH, Traynor JR.","J Pharmacol Exp Ther. 2000 Sep;294(3):1195-200.","Broom DC","J Pharmacol Exp Ther","2000","2000/08/17","","",""
"10945849","Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats","Martin TJ, Kim SA, Cannon DG, Sizemore GM, Bian D, Porreca F, Smith JE.","J Pharmacol Exp Ther. 2000 Sep;294(3):975-82.","Martin TJ","J Pharmacol Exp Ther","2000","2000/08/17","","",""
"10945843","Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine","Broadbear JH, Sumpter TL, Burke TF, Husbands SM, Lewis JW, Woods JH, Traynor JR.","J Pharmacol Exp Ther. 2000 Sep;294(3):933-40.","Broadbear JH","J Pharmacol Exp Ther","2000","2000/08/17","","",""
"10943907","Pharmacological validation of a new animal model of alcoholism","Spanagel R, Hölter SM.","J Neural Transm (Vienna). 2000;107(6):669-80. doi: 10.1007/s007020070068.","Spanagel R","J Neural Transm (Vienna)","2000","2000/08/16","","","10.1007/s007020070068"
"10942854","Expression of fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist","Walters CL, Aston-Jones G, Druhan JP.","Neuropsychopharmacology. 2000 Sep;23(3):307-15. doi: 10.1016/S0893-133X(00)00113-5.","Walters CL","Neuropsychopharmacology","2000","2000/08/16","","","10.1016/S0893-133X(00)00113-5"
"10940783","Differential involvement of opioid receptors in stress-induced antinociception caused by repeated exposure to forced walking stress in mice","Onodera K, Sakurada S, Furuta S, Yonezawa A, Arai K, Hayashi T, Katsuyama S, Sato T, Miyazaki S, Kisara K.","Pharmacology. 2000 Aug;61(2):96-100. doi: 10.1159/000028387.","Onodera K","Pharmacology","2000","2000/08/15","","","10.1159/000028387"
"10940375","beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells","Mandyam CD, Altememi GF, Standifer KM.","Eur J Pharmacol. 2000 Aug 18;402(1-2):R1-37. doi: 10.1016/s0014-2999(00)00497-0.","Mandyam CD","Eur J Pharmacol","2000","2000/08/15","","","10.1016/s0014-2999(00)00497-0"
"10937841","Chronic blockade of hippocampal kappa receptors increases arterial pressure in conscious spontaneously hypertensive rats but not in normotensive Wistar Kyoto rats","Shen S, Ingenito AJ.","Clin Exp Hypertens. 2000 Jul;22(5):507-19. doi: 10.1081/ceh-100100087.","Shen S","Clin Exp Hypertens","2000","2000/08/11","","","10.1081/ceh-100100087"
"10928315","Reductions in ethanol, phencyclidine, and food-maintained behavior by naltrexone pretreatment in monkeys is enhanced by open economic conditions","Carroll ME, Cosgrove KP, Campbell UC, Morgan AD, Mickelberg JL.","Psychopharmacology (Berl). 2000 Mar;148(4):412-22. doi: 10.1007/s002130050071.","Carroll ME","Psychopharmacology (Berl)","2000","2000/08/06","","","10.1007/s002130050071"
"10923761","Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists","Zhu H, Barr GA.","Psychopharmacology (Berl). 2000 Jun;150(3):325-36. doi: 10.1007/s002130000442.","Zhu H","Psychopharmacology (Berl)","2000","2000/08/03","","","10.1007/s002130000442"
"10921509","Morphine stimulates mesangial cell TNF-alpha and nitrite production","Kapasi AA, Gibbons N, Mattana J, Singhal PC.","Inflammation. 2000 Oct;24(5):463-76. doi: 10.1023/a:1007016329300.","Kapasi AA","Inflammation","2000","2000/08/02","","","10.1023/a:1007016329300"
"10921076","[Regulation of the central opioidergic nervous system on the emotional state of anxiety and its possible mechanisms]","Zhang HT.","Sheng Li Ke Xue Jin Zhan. 1997 Jan;28(1):41-4.","Zhang HT","Sheng Li Ke Xue Jin Zhan","1997","1997/01/01","","",""
"10913589","Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice","Abdel-Fattah AM, Matsumoto K, Watanabe H.","Eur J Pharmacol. 2000 Jul 14;400(1):89-97. doi: 10.1016/s0014-2999(00)00340-x.","Abdel-Fattah AM","Eur J Pharmacol","2000","2000/07/29","","","10.1016/s0014-2999(00)00340-x"
"10911926","Interactions between kappa opioid agonists and cocaine. Preclinical studies","Mello NK, Negus SS.","Ann N Y Acad Sci. 2000;909:104-32. doi: 10.1111/j.1749-6632.2000.tb06678.x.","Mello NK","Ann N Y Acad Sci","2000","2000/07/27","","","10.1111/j.1749-6632.2000.tb06678.x"
"10908513","Opioid antagonists for alcohol dependence","Srisurapanont M, Jarusuraisin N.","Cochrane Database Syst Rev. 2000;(3):CD001867. doi: 10.1002/14651858.CD001867.","Srisurapanont M","Cochrane Database Syst Rev","2000","2000/07/25","","","10.1002/14651858.CD001867"
"10907964","Nalmefene to prevent epidural narcotic side effects in pediatric patients: a pharmacokinetic and safety study","Rosen DA, Morris JL, Rosen KR, Nelson ER, Steelman RJ, Gustafson RA, Wilhelm JA, Chang CT, Thackara JW, Frye RF.","Pharmacotherapy. 2000 Jul;20(7):745-9. doi: 10.1592/phco.20.9.745.35207.","Rosen DA","Pharmacotherapy","2000","2000/07/25","","","10.1592/phco.20.9.745.35207"
"10907672","Cocaine-like discriminative stimulus effects of heroin in squirrel monkeys: role of active metabolites and opioid receptor mechanisms","Rowlett JK, Spealman RD, Platt DM.","Psychopharmacology (Berl). 2000 Jun;150(2):191-9. doi: 10.1007/s002130000427.","Rowlett JK","Psychopharmacology (Berl)","2000","2000/07/25","","","10.1007/s002130000427"
"10903965","Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test","Makino M, Kitano Y, Komiyama C, Hirohashi M, Takasuna K.","Br J Pharmacol. 2000 Jul;130(6):1269-74. doi: 10.1038/sj.bjp.0703432.","Makino M","Br J Pharmacol","2000","2000/07/25","PMC1572192","","10.1038/sj.bjp.0703432"
"10900694","[Multiple visceral lesions of internal organs in opioid dependency]","Sivolap IuP, Savchenkov VA, Mishnaevakiĭ AL, Iakovchuk Am.","Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(6):64-5.","Sivolap IuP","Zh Nevrol Psikhiatr Im S S Korsakova","2000","2000/07/20","","",""
"10900229","Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal","Druhan JP, Walters CL, Aston-Jones G.","J Pharmacol Exp Ther. 2000 Aug;294(2):531-8.","Druhan JP","J Pharmacol Exp Ther","2000","2000/07/20","","",""
"10899953","Calmodulin regulation of basal and agonist-stimulated G protein coupling by the mu-opioid receptor (OP(3)) in morphine-pretreated cell","Wang D, Surratt CK, Sadée W.","J Neurochem. 2000 Aug;75(2):763-71. doi: 10.1046/j.1471-4159.2000.0750763.x.","Wang D","J Neurochem","2000","2000/07/19","","","10.1046/j.1471-4159.2000.0750763.x"
"10899371","Naltrexone alteration of acute smoking response in nicotine-dependent subjects","King AC, Meyer PJ.","Pharmacol Biochem Behav. 2000 Jul;66(3):563-72. doi: 10.1016/s0091-3057(00)00258-6.","King AC","Pharmacol Biochem Behav","2000","2000/07/19","","","10.1016/s0091-3057(00)00258-6"
"10899364","Further characterization of the discriminative stimulus effects of spiradoline","Holtzman SG.","Pharmacol Biochem Behav. 2000 Jul;66(3):517-22. doi: 10.1016/s0091-3057(00)00172-6.","Holtzman SG","Pharmacol Biochem Behav","2000","2000/07/19","","","10.1016/s0091-3057(00)00172-6"
"10897756","Managing constipation that's opioid-induced","Scholz M.","RN. 2000 Jun;63(6):103.","Scholz M","RN","2000","2000/07/18","","",""
"10896868","Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy","Glass MJ, Billington CJ, Levine AS.","Am J Physiol Regul Integr Comp Physiol. 2000 Jul;279(1):R86-92. doi: 10.1152/ajpregu.2000.279.1.R86.","Glass MJ","Am J Physiol Regul Integr Comp Physiol","2000","2000/07/18","","","10.1152/ajpregu.2000.279.1.R86"
"10896771","Heroin-induced alterations in leukocyte numbers and apoptosis in the rat spleen","Fecho K, Lysle DT.","Cell Immunol. 2000 Jun 15;202(2):113-23. doi: 10.1006/cimm.2000.1653.","Fecho K","Cell Immunol","2000","2000/07/18","","","10.1006/cimm.2000.1653"
"10896030","Receptor selectivity of Met-enkephalin-Arg6-Phe7, an endogenous opioid peptide, in cerebral cortex of human and rat","Kim KW, Woo RS, Kim CJ, Cheong YP, Kim JK, Kwun J, Cho KP.","Life Sci. 2000 May 26;67(1):61-71. doi: 10.1016/s0024-3205(00)00606-8.","Kim KW","Life Sci","2000","2000/07/15","","","10.1016/s0024-3205(00)00606-8"
"10893314","Potent and selective indolomorphinan antagonists of the kappa-opioid receptor","Stevens WC Jr, Jones RM, Subramanian G, Metzger TG, Ferguson DM, Portoghese PS.","J Med Chem. 2000 Jul 13;43(14):2759-69. doi: 10.1021/jm0000665.","Stevens WC Jr","J Med Chem","2000","2000/07/14","","","10.1021/jm0000665"
"10891863","Altered opioid-mediated control of the spinal release of dynorphin and met-enkephalin in polyarthritic rats","Ballet S, Mauborgne A, Hamon M, Cesselin F, Collin E.","Synapse. 2000 Sep 15;37(4):262-72. doi: 10.1002/1098-2396(20000915)37:4<262::AID-SYN3>3.0.CO;2-6.","Ballet S","Synapse","2000","2000/07/13","","","10.1002/1098-2396(20000915)37:4<262::AID-SYN3>3.0.CO;2-6"
"10891632","Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification","Buntwal N, Bearn J, Gossop M, Strang J.","Drug Alcohol Depend. 2000 May 1;59(2):183-8. doi: 10.1016/s0376-8716(99)00116-7.","Buntwal N","Drug Alcohol Depend","2000","2000/07/13","","","10.1016/s0376-8716(99)00116-7"
"10891107","Reporter affinity labels: an o-phthalaldehyde derivative of beta-naltrexamine as a fluorogenic ligand for opioid receptors","Le Bourdonnec B, El Kouhen R, Lunzer MM, Law PY, Loh HH, Portoghese PS.","J Med Chem. 2000 Jun 29;43(13):2489-92. doi: 10.1021/jm000138s.","Le Bourdonnec B","J Med Chem","2000","2000/07/13","","","10.1021/jm000138s"
"10890799","Alcoholism treatment in the United States. An overview","Fuller RK, Hiller-Sturmhöfel S.","Alcohol Res Health. 1999;23(2):69-77.","Fuller RK","Alcohol Res Health","1999","2000/07/13","PMC6760419","",""
"10882839","Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal","Zachariou V, Thome J, Parikh K, Picciotto MR.","Neuropsychopharmacology. 2000 Aug;23(2):127-37. doi: 10.1016/S0893-133X(00)00094-4.","Zachariou V","Neuropsychopharmacology","2000","2000/07/07","","","10.1016/S0893-133X(00)00094-4"
"10880699","Opiate withdrawal in the fetal rat: a behavioral profile","Jones KL, Barr GA.","Pharmacol Biochem Behav. 2000 Jun;66(2):419-24. doi: 10.1016/s0091-3057(00)00209-4.","Jones KL","Pharmacol Biochem Behav","2000","2000/07/06","","","10.1016/s0091-3057(00)00209-4"
"10880689","The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity","Lee SC, Yoburn BC.","Pharmacol Biochem Behav. 2000 Jun;66(2):347-51. doi: 10.1016/s0091-3057(00)00170-2.","Lee SC","Pharmacol Biochem Behav","2000","2000/07/06","","","10.1016/s0091-3057(00)00170-2"
"10880679","Acute effects of nalmefene on LH, prolactin, and testosterone in male rhesus monkeys","Mello NK, Mendelson JH, Kelly M.","Pharmacol Biochem Behav. 2000 Jun;66(2):275-83. doi: 10.1016/s0091-3057(00)00190-8.","Mello NK","Pharmacol Biochem Behav","2000","2000/07/06","","","10.1016/s0091-3057(00)00190-8"
"10877739","Pharmacologic treatment of heroin-dependent patients","O'Connor PG, Fiellin DA.","Ann Intern Med. 2000 Jul 4;133(1):40-54. doi: 10.7326/0003-4819-133-1-200007040-00008.","O'Connor PG","Ann Intern Med","2000","2000/07/06","","","10.7326/0003-4819-133-1-200007040-00008"
"10875542","Preclinical study of an oral controlled release naltrexone complex in mice","Alvarez-Fuentes J, Rojas-Corrales MO, Holgado MA, Caraballo I, Micó JA, Fernández-Arévalo M.","J Pharm Pharmacol. 2000 Jun;52(6):659-63. doi: 10.1211/0022357001774499.","Alvarez-Fuentes J","J Pharm Pharmacol","2000","2000/06/30","","","10.1211/0022357001774499"
"10871309","Chronic l-alpha-acetylmethadol (LAAM) in rhesus monkeys: tolerance and cross-tolerance to the antinociceptive, ventilatory, and rate-decreasing effects of opioids","Brandt MR, France CP.","J Pharmacol Exp Ther. 2000 Jul;294(1):168-78.","Brandt MR","J Pharmacol Exp Ther","2000","2000/06/28","","",""
"10867960","Neuropharmacological treatments for alcoholism: scientific basis and clinical findings","Johnson BA, Ait-Daoud N.","Psychopharmacology (Berl). 2000 May;149(4):327-44. doi: 10.1007/s002130000371.","Johnson BA","Psychopharmacology (Berl)","2000","2000/06/27","","","10.1007/s002130000371"
"10865052","Stress-induced analgesia in mu-opioid receptor knockout mice reveals normal function of the delta-opioid receptor system","LaBuda CJ, Sora I, Uhl GR, Fuchs PN.","Brain Res. 2000 Jun 30;869(1-2):1-5. doi: 10.1016/s0006-8993(00)02196-x.","LaBuda CJ","Brain Res","2000","2000/06/24","","","10.1016/s0006-8993(00)02196-x"
"10856456","Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys","Kishioka S, Paronis CA, Woods JH.","Eur J Pharmacol. 2000 Jun 9;398(1):121-30. doi: 10.1016/s0014-2999(00)00279-x.","Kishioka S","Eur J Pharmacol","2000","2000/06/17","","","10.1016/s0014-2999(00)00279-x"
"10854754","Role of agonist-dependent receptor internalization in the regulation of mu opioid receptors","Sternini C, Brecha NC, Minnis J, D'Agostino G, Balestra B, Fiori E, Tonini M.","Neuroscience. 2000;98(2):233-41. doi: 10.1016/s0306-4522(00)00118-4.","Sternini C","Neuroscience","2000","2000/06/16","","","10.1016/s0306-4522(00)00118-4"
"10850617","High-performance liquid chromatographic determination of naltrexone in plasma of hemodialysis patients","Kambia K, Bah S, Dine T, Azar R, Odou P, Gressier B, Luyckx M, Brunet C, Ballester L, Cazin M, Cazin JC.","Biomed Chromatogr. 2000 May;14(3):151-5. doi: 10.1002/1099-0801(200005)14:3<151::AID-BMC941>3.0.CO;2-E.","Kambia K","Biomed Chromatogr","2000","2000/06/13","","","10.1002/1099-0801(200005)14:3<151::AID-BMC941>3.0.CO;2-E"
"10846724","[Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments]","Schmahl C, Bohus M.","Nervenarzt. 2000 May;71(5):427. doi: 10.1007/s001150050582.","Schmahl C","Nervenarzt","2000","2000/06/10","","","10.1007/s001150050582"
"10845251","The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin","Wilson RP, McLaughlin PJ, Lang CM, Zagon IS.","Cell Prolif. 2000 Apr;33(2):63-73. doi: 10.1046/j.1365-2184.2000.00161.x.","Wilson RP","Cell Prolif","2000","2000/06/09","PMC6496561","","10.1046/j.1365-2184.2000.00161.x"
"10844122","Selective opioid receptor agonist and antagonist displacement of [3H]naloxone binding in amphibian brain","Newman LC, Wallace DR, Stevens CW.","Eur J Pharmacol. 2000 Jun 2;397(2-3):255-62. doi: 10.1016/s0014-2999(00)00265-x.","Newman LC","Eur J Pharmacol","2000","2000/06/14","","","10.1016/s0014-2999(00)00265-x"
"10843787","The effects of highly selective opioid receptor antagonists on the release of arginine vasotocin induced by hyperosmotic stimulation and angiotensin II injection","Sasaki T, Arakawa K, Shimada K, Saito N.","Gen Comp Endocrinol. 2000 Jun;118(3):365-72. doi: 10.1006/gcen.2000.7470.","Sasaki T","Gen Comp Endocrinol","2000","2000/06/14","","","10.1006/gcen.2000.7470"
"10841978","Electroacupuncture potentiates the antinociceptive effect of intrathecal endomorphin-1 in the rat formalin test","Hao S, Takahata O, Iwasaki H.","Neurosci Lett. 2000 Jun 16;287(1):9-12. doi: 10.1016/s0304-3940(00)01155-1.","Hao S","Neurosci Lett","2000","2000/06/08","","","10.1016/s0304-3940(00)01155-1"
"10835636","Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gavériaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL.","Nat Genet. 2000 Jun;25(2):195-200. doi: 10.1038/76061.","Filliol D","Nat Genet","2000","2000/06/03","","","10.1038/76061"
"10835438","Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators","Clark WM, Raps EC, Tong DC, Kelly RE.","Stroke. 2000 Jun;31(6):1234-9. doi: 10.1161/01.str.31.6.1234.","Clark WM","Stroke","2000","2000/06/03","","","10.1161/01.str.31.6.1234"
"10833818","Naltrexone for lipodystrophy","","AIDS Patient Care STDS. 2000 May;14(5):283.","","AIDS Patient Care STDS","2000","2000/06/02","","",""
"10832917","Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence","Johnson BA, Ait-Daoud N, Prihoda TJ.","Alcohol Clin Exp Res. 2000 May;24(5):737-42.","Johnson BA","Alcohol Clin Exp Res","2000","2000/06/01","","",""
"10825321","14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog","Freye E, Schmidhammer H, Latasch L.","Anesth Analg. 2000 Jun;90(6):1359-64. doi: 10.1097/00000539-200006000-00018.","Freye E","Anesth Analg","2000","2000/05/29","","","10.1097/00000539-200006000-00018"
"10822066","Functional evidence that gastroprotection can be induced by activation of central alpha(2B)-adrenoceptor subtypes in the rat","Gyires K, Müllner K, Rónai AZ.","Eur J Pharmacol. 2000 May 19;396(2-3):131-5. doi: 10.1016/s0014-2999(00)00231-4.","Gyires K","Eur J Pharmacol","2000","2000/05/24","","","10.1016/s0014-2999(00)00231-4"
"10822054","5'-Guanidinonaltrindole, a highly selective and potent kappa-opioid receptor antagonist","Jones RM, Portoghese PS.","Eur J Pharmacol. 2000 May 12;396(1):49-52. doi: 10.1016/s0014-2999(00)00208-9.","Jones RM","Eur J Pharmacol","2000","2000/05/24","","","10.1016/s0014-2999(00)00208-9"
"10821987","Nalmefene: blockade of intravenous morphine challenge effects in opioid abusing humans","Jones HE, Johnson RE, Fudala PJ, Henningfield JE, Heishman SJ.","Drug Alcohol Depend. 2000 Jul 1;60(1):29-37. doi: 10.1016/s0376-8716(99)00138-6.","Jones HE","Drug Alcohol Depend","2000","2000/05/24","","","10.1016/s0376-8716(99)00138-6"
"10821435","Naloxone antagonizes GABA(A)/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes","Svensson AI, Berntsson A, Eirefelt M, Söderpalm B.","J Neural Transm (Vienna). 2000;107(3):261-70. doi: 10.1007/s007020050021.","Svensson AI","J Neural Transm (Vienna)","2000","2000/05/23","","","10.1007/s007020050021"
"10817009","[Treatment of alcoholic liver diseases. Abstinence, nutritional support, drug therapy, liver transplantation]","Pár A.","Orv Hetil. 2000 Apr 16;141(16):827-33.","Pár A","Orv Hetil","2000","2000/05/19","","",""
"10816681","Effective treatment of pruritus with naltrexone, an orally active opiate antagonist","Metze D, Reimann S, Luger TA.","Ann N Y Acad Sci. 1999 Oct 20;885:430-2. doi: 10.1111/j.1749-6632.1999.tb08705.x.","Metze D","Ann N Y Acad Sci","1999","2000/05/19","","","10.1111/j.1749-6632.1999.tb08705.x"
"10814729","Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray","Tershner SA, Helmstetter FJ.","Brain Res. 2000 May 19;865(1):17-26. doi: 10.1016/s0006-8993(00)02179-x.","Tershner SA","Brain Res","2000","2000/05/18","","","10.1016/s0006-8993(00)02179-x"
"10813616","Butorphanol/xylazine/ketamine immobilization of free-ranging Baird's tapirs in Costa Rica","Foerster SH, Bailey JE, Aguilar R, Loria DL, Foerster CR.","J Wildl Dis. 2000 Apr;36(2):335-41. doi: 10.7589/0090-3558-36.2.335.","Foerster SH","J Wildl Dis","2000","2000/05/17","","","10.7589/0090-3558-36.2.335"
"10812288","Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study","Pozzi G, Conte G, De Risio S.","Drug Alcohol Depend. 2000 Jun 1;59(3):287-94. doi: 10.1016/s0376-8716(99)00125-8.","Pozzi G","Drug Alcohol Depend","2000","2000/05/17","","","10.1016/s0376-8716(99)00125-8"
"10812286","Antinociceptive, subjective and behavioral effects of smoked marijuana in humans","Greenwald MK, Stitzer ML.","Drug Alcohol Depend. 2000 Jun 1;59(3):261-75. doi: 10.1016/s0376-8716(99)00128-3.","Greenwald MK","Drug Alcohol Depend","2000","2000/05/17","","","10.1016/s0376-8716(99)00128-3"
"10812285","Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans","Wachtel SR, de Wit H.","Drug Alcohol Depend. 2000 Jun 1;59(3):251-60. doi: 10.1016/s0376-8716(99)00127-1.","Wachtel SR","Drug Alcohol Depend","2000","2000/05/17","","","10.1016/s0376-8716(99)00127-1"
"10812051","Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice","Ukai M, Watanabe Y, Kameyama T.","Eur J Pharmacol. 2000 May 3;395(3):211-5. doi: 10.1016/s0014-2999(00)00179-5.","Ukai M","Eur J Pharmacol","2000","2000/05/17","","","10.1016/s0014-2999(00)00179-5"
"10810247","The nucleus paragigantocellularis and opioid withdrawal-like behavior","Rockhold RW, Liu N, Coleman D, Commiskey S, Shook J, Ho IK.","J Biomed Sci. 2000 May-Jun;7(3):270-6. doi: 10.1007/BF02255476.","Rockhold RW","J Biomed Sci","2000","2000/05/16","","","10.1007/BF02255476"
"10810246","Acute cross-tolerance to opioids in heroin delta-opioid-responding Swiss Webster mice","Rady JJ, Fujimoto JM.","J Biomed Sci. 2000 May-Jun;7(3):258-69. doi: 10.1007/BF02255475.","Rady JJ","J Biomed Sci","2000","2000/05/16","","","10.1007/BF02255475"
"10810240","G protein activation by endomorphins in the mouse periaqueductal gray matter","Narita M, Mizoguchi H, Narita M, Dun NJ, Hwang BH, Endoh T, Suzuki T, Nagase H, Suzuki T, Tseng LF.","J Biomed Sci. 2000 May-Jun;7(3):221-5. doi: 10.1007/BF02255469.","Narita M","J Biomed Sci","2000","2000/05/16","","","10.1007/BF02255469"
"10809517","Outcome and six month follow up of patients after Ultra Rapid Opiate Detoxification (UROD)","Albanese AP, Gevirtz C, Oppenheim B, Field JM, Abels I, Eustace JC.","J Addict Dis. 2000;19(2):11-28. doi: 10.1300/J069v19n02_02.","Albanese AP","J Addict Dis","2000","2000/05/16","","","10.1300/J069v19n02_02"
"10806416","Morphine tolerance in mice changes response of heroin from mu to delta opioid receptors","Rady JJ, Holmes BB, Portoghese PS, Fujimoto JM.","Proc Soc Exp Biol Med. 2000 Jun;224(2):93-101. doi: 10.1046/j.1525-1373.2000.22406.x.","Rady JJ","Proc Soc Exp Biol Med","2000","2000/05/12","","","10.1046/j.1525-1373.2000.22406.x"
"10802031","Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats","Stein JA, Znamensky V, Baumer F, Rossi GC, Pasternak GW, Bodnar RJ.","Brain Res. 2000 May 12;864(2):240-51. doi: 10.1016/s0006-8993(00)02162-4.","Stein JA","Brain Res","2000","2000/05/10","","","10.1016/s0006-8993(00)02162-4"
"10802030","Identification of the opioid receptors involved in passive-avoidance learning in the day-old chick during the second wave of neuronal activity","Freeman FM, Young IG.","Brain Res. 2000 May 12;864(2):230-9. doi: 10.1016/s0006-8993(00)02181-8.","Freeman FM","Brain Res","2000","2000/05/10","","","10.1016/s0006-8993(00)02181-8"
"10801249","Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time","Yuan CS, Foss JF, O'Connor M, Karrison T, Osinski J, Roizen MF, Moss J.","Clin Pharmacol Ther. 2000 Apr;67(4):398-404. doi: 10.1067/mcp.2000.105037.","Yuan CS","Clin Pharmacol Ther","2000","2000/05/09","","","10.1067/mcp.2000.105037"
"10799676","Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse","Yajima Y, Narita M, Takahashi-Nakano Y, Misawa M, Nagase H, Mizoguchi H, Tseng LF, Suzuki T.","Brain Res. 2000 Apr 17;862(1-2):120-6. doi: 10.1016/s0006-8993(00)02096-5.","Yajima Y","Brain Res","2000","2000/05/09","","","10.1016/s0006-8993(00)02096-5"
"10796779","Naltrexone maintenance treatment for opioid dependence","Kirchmayer U, Davoli M, Verster A.","Cochrane Database Syst Rev. 2000;(2):CD001333. doi: 10.1002/14651858.CD001333.","Kirchmayer U","Cochrane Database Syst Rev","2000","2000/05/05","","","10.1002/14651858.CD001333"
"10794821","Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory","Hiramatsu M, Inoue K.","Eur J Pharmacol. 2000 Apr 28;395(2):149-56. doi: 10.1016/s0014-2999(00)00162-x.","Hiramatsu M","Eur J Pharmacol","2000","2000/05/05","","","10.1016/s0014-2999(00)00162-x"
"10794815","Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors","Sakurada S, Takeda S, Sato T, Hayashi T, Yuki M, Kutsuwa M, Tan-No K, Sakurada C, Kisara K, Sakurada T.","Eur J Pharmacol. 2000 Apr 28;395(2):107-12. doi: 10.1016/s0014-2999(00)00166-7.","Sakurada S","Eur J Pharmacol","2000","2000/05/05","","","10.1016/s0014-2999(00)00166-7"
"10789883","Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors","McNally GP, Westbrook RF.","Psychopharmacology (Berl). 2000 Mar;149(1):56-62. doi: 10.1007/s002139900337.","McNally GP","Psychopharmacology (Berl)","2000","2000/05/02","","","10.1007/s002139900337"
"10781668","Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice","Raghavendra V, Agrewala JN, Kulkarni SK.","Eur J Pharmacol. 2000 Apr 21;395(1):15-21. doi: 10.1016/s0014-2999(00)00196-5.","Raghavendra V","Eur J Pharmacol","2000","2000/04/27","","","10.1016/s0014-2999(00)00196-5"
"10780914","Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists","Larson DL, Jones RM, Hjorth SA, Schwartz TW, Portoghese PS.","J Med Chem. 2000 Apr 20;43(8):1573-6. doi: 10.1021/jm000059g.","Larson DL","J Med Chem","2000","2000/04/26","","","10.1021/jm000059g"
"10780808","Naltrexone does not attenuate the acute behavioral effects of ethanol or pentobarbital in humans","Rush CR, Ali JA.","Behav Pharmacol. 1999 Jul;10(4):401-13. doi: 10.1097/00008877-199907000-00007.","Rush CR","Behav Pharmacol","1999","2000/04/26","","","10.1097/00008877-199907000-00007"
"10780298","Naltrexone and morphine alter the discrimination and plasma levels of ethanol","Kosten TA, Haile CN, Jatlow P.","Behav Pharmacol. 1999 Feb;10(1):1-13. doi: 10.1097/00008877-199902000-00001.","Kosten TA","Behav Pharmacol","1999","2000/04/26","","","10.1097/00008877-199902000-00001"
"10780260","Daily mirfentanil induces (cross-) tolerance to the rate-decreasing effects of morphine and not mirfentanil","Gauthier CA, Bagley JR, Brockunier LL, France CP.","Behav Pharmacol. 1999 Sep;10(5):543-7. doi: 10.1097/00008877-199909000-00012.","Gauthier CA","Behav Pharmacol","1999","2000/04/26","","","10.1097/00008877-199909000-00012"
"10780251","Strain-dependent effects of anandamide on memory consolidation in mice are antagonized by naltrexone","Castellano C, Ventura R, Cabib S, Puglisi-Allegra S.","Behav Pharmacol. 1999 Sep;10(5):453-7. doi: 10.1097/00008877-199909000-00003.","Castellano C","Behav Pharmacol","1999","2000/04/26","","","10.1097/00008877-199909000-00003"
"10773040","Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in rats","Valle M, Garrido MJ, Pavón JM, Calvo R, Trocóniz IF.","J Pharmacol Exp Ther. 2000 May;293(2):646-53.","Valle M","J Pharmacol Exp Ther","2000","2000/04/25","","",""
"10772604","Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients","Pettinati HM, Volpicelli JR, Pierce JD Jr, O'Brien CP.","J Addict Dis. 2000;19(1):71-83. doi: 10.1300/J069v19n01_06.","Pettinati HM","J Addict Dis","2000","2000/04/20","","","10.1300/J069v19n01_06"
"10771495","Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat","Bonaz B, Rivière PJ, Sinniger V, Pascaud X, Junien JL, Fournet J, Feuerstein C.","Neurogastroenterol Motil. 2000 Apr;12(2):135-47. doi: 10.1046/j.1365-2982.2000.00188.x.","Bonaz B","Neurogastroenterol Motil","2000","2000/04/20","","","10.1046/j.1365-2982.2000.00188.x"
"10764959","Inhibitory effect of intracerebroventricularly-administered [D-Arg(2), beta-Ala(4)]-dermorphin (1-4) on gastrointestinal transit","Niijima F, Tan-No K, Esashi A, Nakagawasai O, Tadano T, Takahashi N, Yonezawa A, Sakurada S, Kisara K.","Peptides. 2000 Feb;21(2):295-9. doi: 10.1016/s0196-9781(99)00195-3.","Niijima F","Peptides","2000","2000/04/15","","","10.1016/s0196-9781(99)00195-3"
"10764925","Pharmacology of sucrose-reinforced place-preference conditioning: effects of naltrexone","Delamater AR, Sclafani A, Bodnar RJ.","Pharmacol Biochem Behav. 2000 Apr;65(4):697-704. doi: 10.1016/s0091-3057(99)00251-8.","Delamater AR","Pharmacol Biochem Behav","2000","2000/04/15","","","10.1016/s0091-3057(99)00251-8"
"10764213","Characterization of delta-opioid receptors and effect of enkephalins on IRD 98 rat epithelial intestinal cell line","Nano JL, Fournel S, Rampal P.","Pflugers Arch. 2000 Mar;439(5):547-54. doi: 10.1007/s004249900160.","Nano JL","Pflugers Arch","2000","2000/04/14","","","10.1007/s004249900160"
"10762693","Concurrent modulation of anxiety and memory","Wall PM, Messier C.","Behav Brain Res. 2000 May;109(2):229-41. doi: 10.1016/s0166-4328(99)00177-1.","Wall PM","Behav Brain Res","2000","2000/04/14","","","10.1016/s0166-4328(99)00177-1"
"10762566","Morphine increases susceptibility to oral Salmonella typhimurium infection","MacFarlane AS, Peng X, Meissler JJ Jr, Rogers TJ, Geller EB, Adler MW, Eisenstein TK.","J Infect Dis. 2000 Apr;181(4):1350-8. doi: 10.1086/315403. Epub 2000 Apr 13.","MacFarlane AS","J Infect Dis","2000","2000/04/14","","","10.1086/315403"
"10760491","Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study","Rawls SM, McGinty JF.","Brain Res. 2000 Apr 10;861(2):296-304. doi: 10.1016/s0006-8993(00)02030-8.","Rawls SM","Brain Res","2000","2000/04/13","","","10.1016/s0006-8993(00)02030-8"
"10757131","Drinking in alcoholics following an alcohol challenge research protocol","Drobes DJ, Anton RF.","J Stud Alcohol. 2000 Mar;61(2):220-4. doi: 10.15288/jsa.2000.61.220.","Drobes DJ","J Stud Alcohol","2000","2000/04/11","","","10.15288/jsa.2000.61.220"
"10755739","Acute opioid but not benzodiazepine dependence in rats responding for intracranial self-stimulation","Easterling KW, Plovnick RM, Holtzman SG.","Psychopharmacology (Berl). 2000 Feb;148(3):263-71. doi: 10.1007/s002130050050.","Easterling KW","Psychopharmacology (Berl)","2000","2001/02/07","","","10.1007/s002130050050"
"10755174","Long-term effects of naltrexone on self-injurious behavior","Sandman CA, Hetrick W, Taylor DV, Marion SD, Touchette P, Barron JL, Martinezzi V, Steinberg RM, Crinella FM.","Am J Ment Retard. 2000 Mar;105(2):103-17. doi: 10.1352/0895-8017(2000)105<0103:LEONOS>2.0.CO;2.","Sandman CA","Am J Ment Retard","2000","2001/02/07","","","10.1352/0895-8017(2000)105<0103:LEONOS>2.0.CO;2"
"10754685","Investigation of phenolic bioisosterism in opiates: 3-sulfonamido analogues of naltrexone and oxymorphone","McCurdy CR, Jones RM, Portoghese PS.","Org Lett. 2000 Mar 23;2(6):819-21. doi: 10.1021/ol005561+.","McCurdy CR","Org Lett","2000","2001/02/07","","","10.1021/ol005561+"
"10754620","Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesia","Dougherty TB, Porche VH, Thall PF.","Anesthesiology. 2000 Apr;92(4):1010-6. doi: 10.1097/00000542-200004000-00018.","Dougherty TB","Anesthesiology","2000","2001/02/07","","","10.1097/00000542-200004000-00018"
"10746640","Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus","Laorden ML, Castells MT, Martínez MD, Martínez PJ, Milanés MV.","Endocrinology. 2000 Apr;141(4):1366-76. doi: 10.1210/endo.141.4.7407.","Laorden ML","Endocrinology","2000","2000/04/04","","","10.1210/endo.141.4.7407"
"10744894","Naltrexone does not prevent the weight gain and hyperphagia induced by the antipsychotic drug sulpiride in rats","Baptista T, Lacruz A, Acosta A, Colasante C, de Quijada M, de Mendoza S, Mendoza JM, Hernández L.","Appetite. 2000 Feb;34(1):77-86. doi: 10.1006/appe.1999.0284.","Baptista T","Appetite","2000","2000/04/04","","","10.1006/appe.1999.0284"
"10743904","A clinical laboratory model for direct assessment of medication-induced antihyperalgesia and subjective effects: initial validation study","Eissenberg T, Riggins EC 3rd, Harkins SW, Weaver MF.","Exp Clin Psychopharmacol. 2000 Feb;8(1):47-60. doi: 10.1037//1064-1297.8.1.47.","Eissenberg T","Exp Clin Psychopharmacol","2000","2000/04/01","","","10.1037//1064-1297.8.1.47"
"10743458","EEG controlled rapid opioid withdrawal under general anaesthesia","Hensel M, Wolter S, Kox WJ.","Br J Anaesth. 2000 Feb;84(2):236-8. doi: 10.1093/oxfordjournals.bja.a013408.","Hensel M","Br J Anaesth","2000","2000/04/01","","","10.1093/oxfordjournals.bja.a013408"
"10742642","An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence","Rothman RB, Gorelick DA, Heishman SJ, Eichmiller PR, Hill BH, Norbeck J, Liberto JG.","J Subst Abuse Treat. 2000 Apr;18(3):277-81. doi: 10.1016/s0740-5472(99)00074-4.","Rothman RB","J Subst Abuse Treat","2000","2000/04/01","","","10.1016/s0740-5472(99)00074-4"
"10741900","Phenotypic and functional assessments of immune status in the rat spleen following acute heroin treatment","Fecho K, Nelson CJ, Lysle DT.","Immunopharmacology. 2000 Mar;46(3):193-207. doi: 10.1016/s0162-3109(99)00175-7.","Fecho K","Immunopharmacology","2000","2000/03/31","","","10.1016/s0162-3109(99)00175-7"
"10741899","Heroin modulates the expression of inducible nitric oxide synthase","Lysle DT, How T.","Immunopharmacology. 2000 Mar;46(3):181-92. doi: 10.1016/s0162-3109(99)00172-1.","Lysle DT","Immunopharmacology","2000","2000/03/31","","","10.1016/s0162-3109(99)00172-1"
"10737418","Enhancement of natural immunity seen after voluntary exercise in rats. Role of central opioid receptors","Jonsdottir IH, Hellstrand K, Thorén P, Hoffmann P.","Life Sci. 2000 Feb 18;66(13):1231-9. doi: 10.1016/s0024-3205(00)00428-8.","Jonsdottir IH","Life Sci","2000","2000/03/29","","","10.1016/s0024-3205(00)00428-8"
"10731624","Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial","Kranzler HR, Modesto-Lowe V, Van Kirk J.","Neuropsychopharmacology. 2000 May;22(5):493-503. doi: 10.1016/S0893-133X(99)00135-9.","Kranzler HR","Neuropsychopharmacology","2000","2000/03/25","","","10.1016/S0893-133X(99)00135-9"
"10731623","Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects","McCaul ME, Wand GS, Eissenberg T, Rohde CA, Cheskin LJ.","Neuropsychopharmacology. 2000 May;22(5):480-92. doi: 10.1016/S0893-133X(99)00147-5.","McCaul ME","Neuropsychopharmacology","2000","2000/03/25","","","10.1016/S0893-133X(99)00147-5"
"10731040","Short-acting NMDA receptor antagonist MRZ 2/576 produces prolonged suppression of morphine withdrawal in mice","Belozertseva IV, Danysz W, Bespalov AY.","Naunyn Schmiedebergs Arch Pharmacol. 2000 Mar;361(3):279-82. doi: 10.1007/s002109900179.","Belozertseva IV","Naunyn Schmiedebergs Arch Pharmacol","2000","2000/03/24","","","10.1007/s002109900179"
"10730843","Development of rhabdomyolysis after rapid opioid detoxification with subcutaneous naltrexone maintenance therapy","Chanmugam AS, Hengeller M, Ezenkwele U.","Acad Emerg Med. 2000 Mar;7(3):303-5. doi: 10.1111/j.1553-2712.2000.tb01084.x.","Chanmugam AS","Acad Emerg Med","2000","2000/03/24","","","10.1111/j.1553-2712.2000.tb01084.x"
"10729741","Gypsies and drug addictions. Study of the adherence to treatment","Iraurgi I, Jiménez-Lerma JM, Landabaso MA, Arrazola X, Gutiérrez-Fraile M.","Eur Addict Res. 2000 Mar;6(1):34-41. doi: 10.1159/000019007.","Iraurgi I","Eur Addict Res","2000","2000/03/24","","","10.1159/000019007"
"10729637","Postnatal naltrindole treatments induce behavioural modifications in preweanling rats","Fernández B, Romero EM, Kitchen I, Paz Viveros M.","Neurosci Lett. 2000 Mar 31;283(1):73-6. doi: 10.1016/s0304-3940(00)00918-6.","Fernández B","Neurosci Lett","2000","2000/03/24","","","10.1016/s0304-3940(00)00918-6"
"10727705","Lack of expression of long-term potentiation in the dentate gyrus but not in the CA1 region of the hippocampus of mu-opioid receptor-deficient mice","Matthies H, Schroeder H, Becker A, Loh H, Höllt V, Krug M.","Neuropharmacology. 2000 Apr 3;39(6):952-60. doi: 10.1016/s0028-3908(99)00203-8.","Matthies H","Neuropharmacology","2000","2000/03/23","","","10.1016/s0028-3908(99)00203-8"
"10723977","New therapies for alcohol problems: application to primary care","Fiellin DA, Reid MC, O'Connor PG.","Am J Med. 2000 Feb 15;108(3):227-37. doi: 10.1016/s0002-9343(99)00448-9.","Fiellin DA","Am J Med","2000","2000/03/21","","","10.1016/s0002-9343(99)00448-9"
"10720639","The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice","Kamei J, Zushida K, Ohsawa M, Nagase H.","Eur J Pharmacol. 2000 Mar 10;391(1-2):91-6. doi: 10.1016/s0014-2999(00)00049-2.","Kamei J","Eur J Pharmacol","2000","2000/03/18","","","10.1016/s0014-2999(00)00049-2"
"10719958","An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception","Ko MC, Naughton NN.","Anesthesiology. 2000 Mar;92(3):795-805. doi: 10.1097/00000542-200003000-00023.","Ko MC","Anesthesiology","2000","2000/03/17","PMC1937505","NIHMS26641","10.1097/00000542-200003000-00023"
"10718289","Dynorphin A-(1-13) and (2-13) improve beta-amyloid peptide-induced amnesia in mice","Hiramatsu M, Inoue K, Kameyama T.","Neuroreport. 2000 Feb 28;11(3):431-5. doi: 10.1097/00001756-200002280-00001.","Hiramatsu M","Neuroreport","2000","2000/03/16","","","10.1097/00001756-200002280-00001"
"10716102","Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance","Gerra G, Zaimovic A, Rustichelli P, Fontanesi B, Zambelli U, Timpano M, Bocchi C, Delsignore R.","J Subst Abuse Treat. 2000 Mar;18(2):185-91. doi: 10.1016/s0740-5472(99)00050-1.","Gerra G","J Subst Abuse Treat","2000","2000/03/15","","","10.1016/s0740-5472(99)00050-1"
"10714849","Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts","Hensel M, Kox WJ.","Acta Anaesthesiol Scand. 2000 Mar;44(3):326-33. doi: 10.1034/j.1399-6576.2000.440319.x.","Hensel M","Acta Anaesthesiol Scand","2000","2000/03/14","","","10.1034/j.1399-6576.2000.440319.x"
"10708700","Acute delta-opioid receptor activation induces CREB phosphorylation in NG108-15 cells","Bilecki W, Höllt V, Przewłocki R.","Eur J Pharmacol. 2000 Feb 25;390(1-2):1-6. doi: 10.1016/s0014-2999(00)00018-2.","Bilecki W","Eur J Pharmacol","2000","2000/03/10","","","10.1016/s0014-2999(00)00018-2"
"10707430","Mechanisms of fatal opioid overdose","White JM, Irvine RJ.","Addiction. 1999 Jul;94(7):961-72.","White JM","Addiction","1999","2000/03/09","","",""
"10703775","Rapid heroin detoxification under general anesthesia","Laheij RJ, Krabbe PF, de Jong CA.","JAMA. 2000 Mar 1;283(9):1143. doi: 10.1001/jama.283.9.1143.","Laheij RJ","JAMA","2000","2000/03/07","","","10.1001/jama.283.9.1143"
"10703675","Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study","Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, Risler T, Berger ED, Kuhlmann U, Mettang T.","J Am Soc Nephrol. 2000 Mar;11(3):514-9.","Pauli-Magnus C","J Am Soc Nephrol","2000","2000/03/07","","",""
"10698357","In vivo effects of chronic treatment with [MET5]-enkephalin on hematological values and natural killer cell activity in athymic mice","Zalys R, Zagon IS, Bonneau RH, Lang CM, McLaughlin PJ.","Life Sci. 2000 Jan 21;66(9):829-34. doi: 10.1016/s0024-3205(99)00655-4.","Zalys R","Life Sci","2000","2000/03/04","","","10.1016/s0024-3205(99)00655-4"
"10692626","Delta opioid receptor mediated actions in the rostral ventromedial medulla on tail flick latency and nociceptive modulatory neurons","Harasawa I, Fields HL, Meng ID.","Pain. 2000 Mar;85(1-2):255-62. doi: 10.1016/s0304-3959(99)00280-8.","Harasawa I","Pain","2000","2000/02/29","","","10.1016/s0304-3959(99)00280-8"
"10688971","Modulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileum","Allescher HD, Storr M, Brechmann C, Hahn A, Schusdziarra V.","Neuropeptides. 2000 Feb;34(1):62-8. doi: 10.1054/npep.1999.0789.","Allescher HD","Neuropeptides","2000","2000/02/26","","","10.1054/npep.1999.0789"
"10684784","Naltrexone exerts a favourable effect on plasma lipids in abstinent patients with alcohol dependence","Budzyński J, Rybakowski J, Swiatkowski M, Torliński L, Kłopocka M, Kosmowski W, Ziółkowski M.","Alcohol Alcohol. 2000 Jan;35(1):91-7. doi: 10.1093/alcalc/35.1.91.","Budzyński J","Alcohol Alcohol","2000","2000/02/24","","","10.1093/alcalc/35.1.91"
"10684782","Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats","Rezvani AH, Overstreet DH, Mason GA, Janowsky DS, Hamedi M, Clark E Jr, Yang Y.","Alcohol Alcohol. 2000 Jan;35(1):76-83. doi: 10.1093/alcalc/35.1.76.","Rezvani AH","Alcohol Alcohol","2000","2000/02/24","","","10.1093/alcalc/35.1.76"
"10681104","Using naltrexone in inpatient alcoholism treatment","Knox PC, Donovan DM.","J Psychoactive Drugs. 1999 Oct-Dec;31(4):373-88. doi: 10.1080/02791072.1999.10471767.","Knox PC","J Psychoactive Drugs","1999","2000/02/19","","","10.1080/02791072.1999.10471767"
"10677630","Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions","Crain SM, Shen K.","Brain Res. 2000 Feb 21;856(1-2):227-35. doi: 10.1016/s0006-8993(99)02446-4.","Crain SM","Brain Res","2000","2000/03/10","","","10.1016/s0006-8993(99)02446-4"
"10677616","Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by kappa-opioids","Gschossmann JM, Chaban VV, McRoberts JA, Raybould HE, Young SH, Ennes HS, Lembo T, Mayer EA.","Brain Res. 2000 Feb 21;856(1-2):101-10. doi: 10.1016/s0006-8993(99)02353-7.","Gschossmann JM","Brain Res","2000","2000/03/10","","","10.1016/s0006-8993(99)02353-7"
"10677202","Nalmefene for alcohol dependence","","Harv Ment Health Lett. 2000 Mar;16(9):7.","","Harv Ment Health Lett","2000","2000/02/17","","",""
"10676852","Analgesic effect of interferon-alpha via mu opioid receptor in the rat","Jiang CL, Son LX, Lu CL, You ZD, Wang YX, Sun LY, Cui RY, Liu XY.","Neurochem Int. 2000 Mar;36(3):193-6. doi: 10.1016/s0197-0186(99)00124-2.","Jiang CL","Neurochem Int","2000","2000/02/17","","","10.1016/s0197-0186(99)00124-2"
"10673107","8-Aminocyclazocine analogues: synthesis and structure-activity relationships","Wentland MP, Xu G, Cioffi CL, Ye Y, Duan W, Cohen DJ, Colasurdo AM, Bidlack JM.","Bioorg Med Chem Lett. 2000 Jan 17;10(2):183-7. doi: 10.1016/s0960-894x(99)00670-8.","Wentland MP","Bioorg Med Chem Lett","2000","2000/02/15","","","10.1016/s0960-894x(99)00670-8"
"10672987","Mechanisms of chloroquine-induced body-scratching behavior in rats: evidence of involvement of endogenous opioid peptides","Onigbogi O, Ajayi AA, Ukponmwan OE.","Pharmacol Biochem Behav. 2000 Feb;65(2):333-7. doi: 10.1016/s0091-3057(99)00221-x.","Onigbogi O","Pharmacol Biochem Behav","2000","2000/02/15","","","10.1016/s0091-3057(99)00221-x"
"10672978","Changes in analgesia-producing mechanism of repeated cold stress loading in mice","Omiya Y, Goto K, Ishige A, Komatsu Y.","Pharmacol Biochem Behav. 2000 Feb;65(2):261-6. doi: 10.1016/s0091-3057(99)00215-4.","Omiya Y","Pharmacol Biochem Behav","2000","2000/02/15","","","10.1016/s0091-3057(99)00215-4"
"10672907","An interaction of opioids and galanin in dorsal horn of the spinal cord in mononeuropathic rats","Zhang YP, Yu LC, Lundeberg T.","Regul Pept. 2000 Jan 29;86(1-3):89-94. doi: 10.1016/s0167-0115(99)00091-9.","Zhang YP","Regul Pept","2000","2000/02/15","","","10.1016/s0167-0115(99)00091-9"
"10672634","Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze","Cole JC, Littleton JM, Little HJ.","Psychopharmacology (Berl). 2000 Jan;147(4):403-11. doi: 10.1007/s002130050009.","Cole JC","Psychopharmacology (Berl)","2000","2000/02/15","","","10.1007/s002130050009"
"10669903","Involvement of spinal delta 1-opioid receptors in forced walking stress-induced antinociception in the tail-flick test in mice","Kamei J, Taki K, Ohsawa M, Nagase H, Onodera K.","Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):595-8.","Kamei J","Methods Find Exp Clin Pharmacol","1999","2000/02/12","","",""
"10669052","Gender differences in hostility of opioid-dependent outpatients: role in early treatment termination","Petry NM, Bickel WK.","Drug Alcohol Depend. 2000 Feb 1;58(1-2):27-33. doi: 10.1016/s0376-8716(99)00058-7.","Petry NM","Drug Alcohol Depend","2000","2000/02/11","","","10.1016/s0376-8716(99)00058-7"
"10666153","Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding","Kotz CM, Glass MJ, Levine AS, Billington CJ.","Am J Physiol Regul Integr Comp Physiol. 2000 Feb;278(2):R499-503. doi: 10.1152/ajpregu.2000.278.2.R499.","Kotz CM","Am J Physiol Regul Integr Comp Physiol","2000","2000/02/09","","","10.1152/ajpregu.2000.278.2.R499"
"10665987","Kappa-opioid receptor stimulation increases the expression of Na+-H+ exchange gene in the heart","Gan T, Pei J, Chan I, Wong T.","Life Sci. 2000;66(4):355-61. doi: 10.1016/s0024-3205(99)00597-4.","Gan T","Life Sci","2000","2000/02/09","","","10.1016/s0024-3205(99)00597-4"
"10665828","U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression","Chao CC, Hu S, Gekker G, Lokensgard JR, Heyes MP, Peterson PK.","Neuropharmacology. 2000;39(1):150-60. doi: 10.1016/s0028-3908(99)00063-5.","Chao CC","Neuropharmacology","2000","2000/02/09","","","10.1016/s0028-3908(99)00063-5"
"10663428","Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids","Zhang L, Walker EA, Sutherland J 2nd, Young AM.","Psychopharmacology (Berl). 2000 Feb;148(2):136-45. doi: 10.1007/s002130050035.","Zhang L","Psychopharmacology (Berl)","2000","2000/02/09","","","10.1007/s002130050035"
"10663423","Selective mu and delta, but not kappa, opiate receptor antagonists inhibit the habituation of novelty-induced hypoalgesia in the rat","Spreekmeester E, Rochford J.","Psychopharmacology (Berl). 2000 Jan;148(1):99-105. doi: 10.1007/s002130050030.","Spreekmeester E","Psychopharmacology (Berl)","2000","2000/02/09","","","10.1007/s002130050030"
"10658923","Tritiated kappa receptor antagonist norbinal torphimine: synthesis and in vitro binding in three different tissues","Márki A, Otvös F, Tóth G, Hosztafi S, Borsodi A.","Life Sci. 2000;66(1):43-9. doi: 10.1016/s0024-3205(99)00560-3.","Márki A","Life Sci","2000","2000/02/05","","","10.1016/s0024-3205(99)00560-3"
"10657483","Dynorphin A enhances mitogen-induced proliferative response and interleukin-2 production of rat splenocytes","Ni X, Lin BC, Song CY, Wang CH.","Neuropeptides. 1999 Apr;33(2):137-43. doi: 10.1054/npep.1999.0008.","Ni X","Neuropeptides","1999","2000/02/05","","","10.1054/npep.1999.0008"
"10653225","Naltrexone for individuals with comorbid bipolar disorder and alcohol dependence","Sonne SC, Brady KT.","J Clin Psychopharmacol. 2000 Feb;20(1):114-5. doi: 10.1097/00004714-200002000-00026.","Sonne SC","J Clin Psychopharmacol","2000","2000/02/01","","","10.1097/00004714-200002000-00026"
"10653211","Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects","O'Malley SS, Krishnan-Sarin S, Farren C, O'Connor PG.","J Clin Psychopharmacol. 2000 Feb;20(1):69-76. doi: 10.1097/00004714-200002000-00012.","O'Malley SS","J Clin Psychopharmacol","2000","2000/02/01","","","10.1097/00004714-200002000-00012"
"10650167","Differential down-regulation of the human delta-opioid receptor by SNC80 and [D-Pen(2),D-Pen(5)]enkephalin","Okura T, Cowell SM, Varga E, Burkey TH, Roeske WR, Hruby VJ, Yamamura HI.","Eur J Pharmacol. 2000 Jan 10;387(2):R11-3. doi: 10.1016/s0014-2999(99)00761-x.","Okura T","Eur J Pharmacol","2000","2000/01/29","","","10.1016/s0014-2999(99)00761-x"
"10650156","Enhanced delta-opioid receptor-mediated antinociception in mu-opioid receptor-deficient mice","Qiu C, Sora I, Ren K, Uhl G, Dubner R.","Eur J Pharmacol. 2000 Jan 10;387(2):163-9. doi: 10.1016/s0014-2999(99)00813-4.","Qiu C","Eur J Pharmacol","2000","2000/01/29","","","10.1016/s0014-2999(99)00813-4"
"10648876","kappa-Opioid receptors in the substantia nigra pars reticulata mediate the U-50,488-induced locomotor activity of preweanling rats","Collins RL, Zavala AR, Nazarian A, McDougall SA.","Brain Res Dev Brain Res. 2000 Jan 3;119(1):97-103. doi: 10.1016/s0165-3806(99)00153-4.","Collins RL","Brain Res Dev Brain Res","2000","2000/01/29","","","10.1016/s0165-3806(99)00153-4"
"10648471","Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis","Jones EA, Dekker LR.","Gastroenterology. 2000 Feb;118(2):431-2. doi: 10.1016/s0016-5085(00)70225-3.","Jones EA","Gastroenterology","2000","2000/01/29","","","10.1016/s0016-5085(00)70225-3"
"10647800","Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial","Yuan CS, Foss JF, O'Connor M, Osinski J, Karrison T, Moss J, Roizen MF.","JAMA. 2000 Jan 19;283(3):367-72. doi: 10.1001/jama.283.3.367.","Yuan CS","JAMA","2000","2000/01/27","","","10.1001/jama.283.3.367"
"10638648","Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice","Middaugh LD, Kelley BM, Groseclose CH, Cuison ER Jr.","Pharmacol Biochem Behav. 2000 Jan 1;65(1):145-54. doi: 10.1016/s0091-3057(99)00184-7.","Middaugh LD","Pharmacol Biochem Behav","2000","2000/01/19","","","10.1016/s0091-3057(99)00184-7"
"10636483","Immune deviation following stress odor exposure: role of endogenous opioids","Moynihan JA, Karp JD, Cohen N, Ader R.","J Neuroimmunol. 2000 Jan 24;102(2):145-53. doi: 10.1016/s0165-5728(99)00173-3.","Moynihan JA","J Neuroimmunol","2000","2000/01/15","","","10.1016/s0165-5728(99)00173-3"
"10636363","Is there a pharmacological basis for therapy with rapid opioid detoxification?","Spanagel R.","Lancet. 1999 Dec 11;354(9195):2017-8. doi: 10.1016/S0140-6736(99)90248-9.","Spanagel R","Lancet","1999","2000/01/15","","","10.1016/S0140-6736(99)90248-9"
"10634604","Reepithelialization of the human cornea is regulated by endogenous opioids","Zagon IS, Sassani JW, McLaughlin PJ.","Invest Ophthalmol Vis Sci. 2000 Jan;41(1):73-81.","Zagon IS","Invest Ophthalmol Vis Sci","2000","2000/01/14","","",""
"10633587","Itching for relief","","Health News. 1999 Dec 15;5(15):6.","","Health News","1999","2000/01/14","","",""
"10627107","Alcoholics Anonymous and the use of medications to prevent relapse: an anonymous survey of member attitudes","Rychtarik RG, Connors GJ, Dermen KH, Stasiewicz PR.","J Stud Alcohol. 2000 Jan;61(1):134-8. doi: 10.15288/jsa.2000.61.134.","Rychtarik RG","J Stud Alcohol","2000","2000/01/08","","","10.15288/jsa.2000.61.134"
"10619553","Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons","Hauser KF, Foldes JK, Turbek CS.","Exp Neurol. 1999 Dec;160(2):361-75. doi: 10.1006/exnr.1999.7235.","Hauser KF","Exp Neurol","1999","2000/01/05","PMC4868554","NIHMS785543","10.1006/exnr.1999.7235"
"10617121","Role of corticotropin-releasing factor receptor-1 in opiate withdrawal","Iredale PA, Alvaro JD, Lee Y, Terwilliger R, Chen YL, Duman RS.","J Neurochem. 2000 Jan;74(1):199-208. doi: 10.1046/j.1471-4159.2000.0740199.x.","Iredale PA","J Neurochem","2000","2000/01/05","","","10.1046/j.1471-4159.2000.0740199.x"
"10617086","Delta opioid binding selectivity of 3-ether analogs of naltrindole","Coop A, Pinto J, Wang L, McCullough K, Rothman RB, Dersch C, Jacobson AE, Rice KC.","Bioorg Med Chem Lett. 1999 Dec 20;9(24):3435-8. doi: 10.1016/s0960-894x(99)00622-8.","Coop A","Bioorg Med Chem Lett","1999","2000/01/05","","","10.1016/s0960-894x(99)00622-8"
"10615738","A randomized trial of naltrexone for smoking cessation","Wong GY, Wolter TD, Croghan GA, Croghan IT, Offord KP, Hurt RD.","Addiction. 1999 Aug;94(8):1227-37. doi: 10.1046/j.1360-0443.1999.948122713.x.","Wong GY","Addiction","1999","2000/01/01","","","10.1046/j.1360-0443.1999.948122713.x"
"10615349","Clinical experience with naltrexone maintenance in a hospital drug and alcohol outpatient setting","Zador DA, Adams M, Curry KH.","Med J Aust. 1999 Nov 1;171(9):501.","Zador DA","Med J Aust","1999","2000/01/01","","",""
"10615348","Risks associated with the inappropriate use of naltrexone in the treatment of opioid dependence","Latt NC.","Med J Aust. 1999 Nov 1;171(9):500-1.","Latt NC","Med J Aust","1999","2000/01/01","","",""
"10615347","Active surveillance of adverse events associated with naltrexone in New South Wales","Thackway SV, Ward PL, Taylor LK.","Med J Aust. 1999 Nov 1;171(9):499-500.","Thackway SV","Med J Aust","1999","2000/01/01","","",""
"10615346","First, do no harm: naltrexone-accelerated detoxification","Gaughwin MD.","Med J Aust. 1999 Nov 1;171(9):499.","Gaughwin MD","Med J Aust","1999","2000/01/01","","",""
"10612447","Characterization of [125I]AR-M100613, a high-affinity radioligand for delta opioid receptors","Fraser GL, Labarre M, Godbout C, Butterworth J, Clarke PB, Payza K, Schmidt R.","Peptides. 1999 Nov;20(11):1327-35. doi: 10.1016/s0196-9781(99)00138-2.","Fraser GL","Peptides","1999","1999/12/28","","","10.1016/s0196-9781(99)00138-2"
"10607867","ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides","Lohmann AB, Welch SP.","Eur J Pharmacol. 1999 Dec 3;385(2-3):119-27. doi: 10.1016/s0014-2999(99)00618-4.","Lohmann AB","Eur J Pharmacol","1999","1999/12/23","","","10.1016/s0014-2999(99)00618-4"
"10605854","Serendipitous rapid detoxification from opiates: the importance of time-dependent processes","Mannelli P, De Risio S, Pozzi G, Janiri L, De Giacomo M.","Addiction. 1999 Apr;94(4):589-91. doi: 10.1046/j.1360-0443.1999.94458913.x.","Mannelli P","Addiction","1999","1999/12/22","","","10.1046/j.1360-0443.1999.94458913.x"
"10602339","The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat","Hill MP, Brotchie JM.","Br J Pharmacol. 1999 Dec;128(7):1577-85. doi: 10.1038/sj.bjp.0702943.","Hill MP","Br J Pharmacol","1999","1999/12/22","PMC1571785","","10.1038/sj.bjp.0702943"
"10598605","Rapid opioid detoxification during general anesthesia: a review of 20 patients","Gold CG, Cullen DJ, Gonzales S, Houtmeyers D, Dwyer MJ.","Anesthesiology. 1999 Dec;91(6):1639-47. doi: 10.1097/00000542-199912000-00015.","Gold CG","Anesthesiology","1999","1999/12/22","","","10.1097/00000542-199912000-00015"
"10593209","Neonatal naltrindole and handling differently affect morphine antinociception in male and female rats","Fernández B, Alberti I, Kitchen I, Viveros MP.","Pharmacol Biochem Behav. 1999 Dec;64(4):851-5. doi: 10.1016/s0091-3057(99)00142-2.","Fernández B","Pharmacol Biochem Behav","1999","1999/12/11","","","10.1016/s0091-3057(99)00142-2"
"10591900","A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test","Anseloni VC, Coimbra NC, Morato S, Brandão ML.","Exp Brain Res. 1999 Nov;129(2):260-8. doi: 10.1007/s002210050896.","Anseloni VC","Exp Brain Res","1999","1999/12/11","","","10.1007/s002210050896"
"10591884","Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments","Frussa-Filho R, Barbosa-Júnior H, Silva RH, Da Cunha C, Mello CF.","Psychopharmacology (Berl). 1999 Nov;147(2):168-73. doi: 10.1007/s002130051157.","Frussa-Filho R","Psychopharmacology (Berl)","1999","1999/12/11","","","10.1007/s002130051157"
"10591872","The delta 2-opioid receptor antagonist naltriben reduces motivated responding for ethanol","June HL, McCane SR, Zink RW, Portoghese PS, Li TK, Froehlich JC.","Psychopharmacology (Berl). 1999 Nov;147(1):81-9. doi: 10.1007/s002130051145.","June HL","Psychopharmacology (Berl)","1999","1999/12/11","","","10.1007/s002130051145"
"10591871","Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serum prolactin levels in rhesus monkeys","Butelman ER, Harris TJ, Kreek MJ.","Psychopharmacology (Berl). 1999 Nov;147(1):73-80. doi: 10.1007/s002130051144.","Butelman ER","Psychopharmacology (Berl)","1999","1999/12/11","","","10.1007/s002130051144"
"10585524","Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone","Walker JR, King M, Izzo E, Koob GF, Pasternak GW.","Eur J Pharmacol. 1999 Oct 27;383(2):115-9. doi: 10.1016/s0014-2999(99)00633-0.","Walker JR","Eur J Pharmacol","1999","1999/12/11","","","10.1016/s0014-2999(99)00633-0"
"10585498","3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors","Filizola M, Laakkonen L, Loew GH.","Protein Eng. 1999 Nov;12(11):927-42. doi: 10.1093/protein/12.11.927.","Filizola M","Protein Eng","1999","1999/12/10","","","10.1093/protein/12.11.927"
"10578145","Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry","Narita M, Mizoguchi H, Oji DE, Dun NJ, Hwang BH, Nagase H, Tseng LF.","Br J Pharmacol. 1999 Nov;128(6):1300-6. doi: 10.1038/sj.bjp.0702907.","Narita M","Br J Pharmacol","1999","1999/12/01","PMC1571752","","10.1038/sj.bjp.0702907"
"10574547","Highly delta selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO","Hirakawa N, Tershner SA, Fields HL.","Neuroreport. 1999 Oct 19;10(15):3125-9. doi: 10.1097/00001756-199910190-00001.","Hirakawa N","Neuroreport","1999","1999/11/26","","","10.1097/00001756-199910190-00001"
"10568873","Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study","Yuan CS, Foss JF, O'Connor M, Osinski J, Roizen MF, Moss J.","Pain. 1999 Dec;83(3):631-5. doi: 10.1016/s0304-3959(99)00162-1.","Yuan CS","Pain","1999","1999/11/24","","","10.1016/s0304-3959(99)00162-1"
"10568850","Hypoalgesia elicited by a conditioned stimulus is blocked by a mu, but not a delta or a kappa, opioid antagonist injected into the rostral ventromedial medulla","Foo H, Helmstetter FJ.","Pain. 1999 Dec;83(3):427-31. doi: 10.1016/s0304-3959(99)00125-6.","Foo H","Pain","1999","1999/11/24","","","10.1016/s0304-3959(99)00125-6"
"10565979","Nalmefene. JF 1, nalmetrene, NIH 10365, ORF 11676, Arthrene, Cervene, Incystene, Revex","","Drugs R D. 1999 Jan;1(1):32-3. doi: 10.2165/00126839-199901010-00012.","","Drugs R D","1999","1999/11/24","","","10.2165/00126839-199901010-00012"
"10565831","Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys","Ko MC, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, Woods JH.","J Pharmacol Exp Ther. 1999 Dec;291(3):1113-20.","Ko MC","J Pharmacol Exp Ther","1999","1999/11/24","PMC2939326","NIHMS196257",""
"10557566","Naltrexone: new preparation. Transient preventive efficacy on alcoholic relapse","","Prescrire Int. 1999 Feb;8(39):9-11.","","Prescrire Int","1999","1999/11/11","","",""
"10556931","Preweanling naltrindole administration differentially affects clonidine induced antinociception and plasma adrenaline levels in male and female neonatal rats","Alberti I, Fernández B, Alguacil LF, Aguilar A, Caamaño M, Romero EM, Viveros MP.","Br J Pharmacol. 1999 Nov;128(5):953-60. doi: 10.1038/sj.bjp.0702852.","Alberti I","Br J Pharmacol","1999","1999/11/11","PMC1571715","","10.1038/sj.bjp.0702852"
"10556678","Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception","Hutcheson DM, Sánchez-Blazquez P, Rodriguez-Diaz M, Garzon J, Schmidhammer H, Borsodi A, Roques BP, Maldonado R.","Eur J Pharmacol. 1999 Oct 21;383(1):29-37. doi: 10.1016/s0014-2999(99)00611-1.","Hutcheson DM","Eur J Pharmacol","1999","1999/11/11","","","10.1016/s0014-2999(99)00611-1"
"10556633","Hyperalgesic response to noxious stimulation in genetically polydipsic mice","Kamikawa H, Katafuchi T, Hosoi M, Yamamoto T, Hori T.","Brain Res. 1999 Nov 6;846(2):171-6. doi: 10.1016/s0006-8993(99)02006-5.","Kamikawa H","Brain Res","1999","1999/11/11","","","10.1016/s0006-8993(99)02006-5"
"10553740","Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial","Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK.","Am J Psychiatry. 1999 Nov;156(11):1758-64. doi: 10.1176/ajp.156.11.1758.","Anton RF","Am J Psychiatry","1999","1999/11/30","","","10.1176/ajp.156.11.1758"
"10551592","The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord","Zhang C, Davies MF, Guo TZ, Maze M.","Anesthesiology. 1999 Nov;91(5):1401-7. doi: 10.1097/00000542-199911000-00033.","Zhang C","Anesthesiology","1999","1999/11/07","","","10.1097/00000542-199911000-00033"
"10548274","Pharmacology of flavor preference conditioning in sham-feeding rats: effects of naltrexone","Yu WZ, Sclafani A, Delamater AR, Bodnar RJ.","Pharmacol Biochem Behav. 1999 Nov;64(3):573-84. doi: 10.1016/s0091-3057(99)00124-0.","Yu WZ","Pharmacol Biochem Behav","1999","1999/11/05","","","10.1016/s0091-3057(99)00124-0"
"10536099","MK-801-induced disruptions of one-trial inhibitory avoidance are potentiated by stress and reversed by naltrexone","Castellano C, Cestari V, Ciamei A, Pavone F.","Neurobiol Learn Mem. 1999 Nov;72(3):215-29. doi: 10.1006/nlme.1999.3908.","Castellano C","Neurobiol Learn Mem","1999","1999/10/28","","","10.1006/nlme.1999.3908"
"10535763","Hematopoietic effect of melatonin involvement of type 1 kappa-opioid receptor on bone marrow macrophages and interleukin-1","Maestroni GJ, Zammaretti F, Pedrinis E.","J Pineal Res. 1999 Oct;27(3):145-53. doi: 10.1111/j.1600-079x.1999.tb00609.x.","Maestroni GJ","J Pineal Res","1999","1999/10/27","","","10.1111/j.1600-079x.1999.tb00609.x"
"10529720","Opioid peptide receptor studies. 10. Nor-BNI differentially inhibits kappa receptor agonist-induced G-protein activation in the guinea pig caudate: further evidence of kappa receptor heterogeneity","Heyliger SO, Jackson C, Rice KC, Rothman RB.","Synapse. 1999 Dec 15;34(4):256-65. doi: 10.1002/(SICI)1098-2396(19991215)34:4<256::AID-SYN2>3.0.CO;2-6.","Heyliger SO","Synapse","1999","1999/10/26","","","10.1002/(SICI)1098-2396(19991215)34:4<256::AID-SYN2>3.0.CO;2-6"
"10529020","Naltrexone shortened opioid detoxification with buprenorphine","Umbricht A, Montoya ID, Hoover DR, Demuth KL, Chiang CT, Preston KL.","Drug Alcohol Depend. 1999 Oct 1;56(3):181-90. doi: 10.1016/s0376-8716(99)00033-2.","Umbricht A","Drug Alcohol Depend","1999","1999/10/21","","","10.1016/s0376-8716(99)00033-2"
"10527694","Enhancement of the contact hypersensitivity reaction by acute morphine administration at the elicitation phase","Nelson CJ, How T, Lysle DT.","Clin Immunol. 1999 Nov;93(2):176-83. doi: 10.1006/clim.1999.4783.","Nelson CJ","Clin Immunol","1999","1999/10/21","","","10.1006/clim.1999.4783"
"10526114","Role of the dorsal raphe nucleus in morphine-induced immediate early gene expression in the rat striatum","Frankel PS, Harlan RE, Garcia MM.","Brain Res. 1999 Sep 18;842(1):220-3. doi: 10.1016/s0006-8993(99)01826-0.","Frankel PS","Brain Res","1999","1999/10/20","","","10.1016/s0006-8993(99)01826-0"
"10525749","Strain-dependent effects of MK-801 on passive avoidance behaviour in mice: interactions with morphine and immobilization stress","Cestari V, Ciamei A, Castellano C.","Psychopharmacology (Berl). 1999 Sep;146(2):144-52. doi: 10.1007/s002130051100.","Cestari V","Psychopharmacology (Berl)","1999","1999/10/20","","","10.1007/s002130051100"
"10525419","Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway","Yu XC, Wang HX, Pei JM, Wong TM.","J Mol Cell Cardiol. 1999 Oct;31(10):1809-19. doi: 10.1006/jmcc.1999.1014.","Yu XC","J Mol Cell Cardiol","1999","1999/10/20","","","10.1006/jmcc.1999.1014"
"10520978","Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial","Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Böhme R, Schmahl CG.","J Clin Psychiatry. 1999 Sep;60(9):598-603. doi: 10.4088/jcp.v60n0906.","Bohus MJ","J Clin Psychiatry","1999","1999/10/16","","","10.4088/jcp.v60n0906"
"10519055","Opioid growth factor and organ development in rat and human embryos","Zagon IS, Wu Y, McLaughlin PJ.","Brain Res. 1999 Aug 28;839(2):313-22. doi: 10.1016/s0006-8993(99)01753-9.","Zagon IS","Brain Res","1999","1999/10/16","","","10.1016/s0006-8993(99)01753-9"
"10515328","Discriminative stimulus effects of nalbuphine in nontreated and morphine-treated pigeons","Walker EA, Hawkins ER, Tiano MJ, Picker MJ, Dykstra LA.","Pharmacol Biochem Behav. 1999 Oct;64(2):445-8. doi: 10.1016/s0091-3057(99)00086-6.","Walker EA","Pharmacol Biochem Behav","1999","1999/10/09","","","10.1016/s0091-3057(99)00086-6"
"10515315","Effects of a novel fentanyl derivative on drug discrimination and learning in rhesus monkeys","Gerak LR, Moerschbaecher JM, Bagley JR, Brockunier LL, France CP.","Pharmacol Biochem Behav. 1999 Oct;64(2):367-71. doi: 10.1016/s0091-3057(99)00058-1.","Gerak LR","Pharmacol Biochem Behav","1999","1999/10/09","","","10.1016/s0091-3057(99)00058-1"
"10513565","Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors","Ochi T, Fujii T, Motoyama Y, Goto T.","Eur J Pharmacol. 1999 Sep 10;380(2-3):73-9. doi: 10.1016/s0014-2999(99)00522-1.","Ochi T","Eur J Pharmacol","1999","1999/10/08","","","10.1016/s0014-2999(99)00522-1"
"10512582","Opioid-dependent effects of inescapable shock on escape behavior and conditioned fear responding are mediated by the dorsal raphe nucleus","Grahn RE, Maswood S, McQueen MB, Watkins LR, Maier SF.","Behav Brain Res. 1999 Mar;99(2):153-67. doi: 10.1016/s0166-4328(98)00101-6.","Grahn RE","Behav Brain Res","1999","1999/10/08","","","10.1016/s0166-4328(98)00101-6"
"10512314","Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale","Roberts JS, Anton RF, Latham PK, Moak DH.","Alcohol Clin Exp Res. 1999 Sep;23(9):1484-91.","Roberts JS","Alcohol Clin Exp Res","1999","1999/10/08","","",""
"10512311","Naltrexone reduces ethanol- and/or water-reinforced responding in rhesus monkeys: effect depends upon ethanol concentration","Williams KL, Woods JH.","Alcohol Clin Exp Res. 1999 Sep;23(9):1462-7.","Williams KL","Alcohol Clin Exp Res","1999","1999/10/08","","",""
"10507757","Characterization of [3H]-diprenorphine binding in Rana pipiens: observations of filter binding enhanced by naltrexone","Newman LC, Wallace DR, Stevens CW.","J Pharmacol Toxicol Methods. 1999 Feb;41(1):43-8. doi: 10.1016/s1056-8719(99)00020-9.","Newman LC","J Pharmacol Toxicol Methods","1999","1999/10/03","","","10.1016/s1056-8719(99)00020-9"
"10506865","[Acute delirium psychosis induced by naltrexone chlorhydrate]","Amraoui A, Burgos V, Baron P, Alexandre JY.","Presse Med. 1999 Sep 4;28(25):1361-2.","Amraoui A","Presse Med","1999","1999/10/03","","",""
"10497682","Under-diagnosed psychiatric syndrome. I: Trichotillomania","Ko SM.","Ann Acad Med Singapore. 1999 Mar;28(2):279-81.","Ko SM","Ann Acad Med Singapore","1999","1999/09/25","","",""
"10495371","Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","Metze D, Reimann S, Beissert S, Luger T.","J Am Acad Dermatol. 1999 Oct;41(4):533-9.","Metze D","J Am Acad Dermatol","1999","1999/09/25","","",""
"10494884","Involvement of delta-opioid receptors in pentylenetetrazol kindling development and kindling-related processes in rats","Grecksch G, Becker A, Schroeder H, Höllt V.","Naunyn Schmiedebergs Arch Pharmacol. 1999 Aug;360(2):151-6. doi: 10.1007/s002109900066.","Grecksch G","Naunyn Schmiedebergs Arch Pharmacol","1999","1999/09/24","","","10.1007/s002109900066"
"10493099","Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception","Mason DJ Jr, Lowe J, Welch SP.","Eur J Pharmacol. 1999 Aug 13;378(3):237-48. doi: 10.1016/s0014-2999(99)00479-3.","Mason DJ Jr","Eur J Pharmacol","1999","1999/09/24","","","10.1016/s0014-2999(99)00479-3"
"10485962","Non-specific effect of naltrexone on ethanol consumption in social drinkers","de Wit H, Svenson J, York A.","Psychopharmacology (Berl). 1999 Sep 1;146(1):33-41. doi: 10.1007/s002130051085.","de Wit H","Psychopharmacology (Berl)","1999","1999/09/15","","","10.1007/s002130051085"
"10483613","A rapid sample preparation method for the HPLC determination of the opioid antagonist naltrexone in serum","Hurst WJ, Zagon IS, Aboul-Enein HY.","Pharmazie. 1999 Aug;54(8):595-6.","Hurst WJ","Pharmazie","1999","1999/09/14","","",""
"10479286","Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans","Ananthan S, Kezar HS 3rd, Carter RL, Saini SK, Rice KC, Wells JL, Davis P, Xu H, Dersch CM, Bilsky EJ, Porreca F, Rothman RB.","J Med Chem. 1999 Sep 9;42(18):3527-38. doi: 10.1021/jm990039i.","Ananthan S","J Med Chem","1999","1999/09/10","","","10.1021/jm990039i"
"10478647","Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography","Smith JS, Zubieta JK, Price JC, Flesher JE, Madar I, Lever JR, Kinter CM, Dannals RF, Frost JJ.","J Cereb Blood Flow Metab. 1999 Sep;19(9):956-66. doi: 10.1097/00004647-199909000-00003.","Smith JS","J Cereb Blood Flow Metab","1999","1999/09/09","","","10.1097/00004647-199909000-00003"
"10474054","Delta-opioid receptor antagonist inhibits immunomodulation by Met-enkephalin analogs","Singh VK, Bajpai K, Narayan P, Yadav VS, Dhawan VC, Haq W, Mathur KB, Agarwal SS.","Neuroimmunomodulation. 1999 Sep-Oct;6(5):355-60. doi: 10.1159/000026395.","Singh VK","Neuroimmunomodulation","1999","1999/09/04","","","10.1159/000026395"
"10472515","Influence of naltrexone on cue-elicited craving among hazardous drinkers: the moderational role of positive outcome expectancies","Palfai T, Davidson D, Swift R.","Exp Clin Psychopharmacol. 1999 Aug;7(3):266-73. doi: 10.1037//1064-1297.7.3.266.","Palfai T","Exp Clin Psychopharmacol","1999","1999/09/03","","","10.1037//1064-1297.7.3.266"
"10470982","Naltrexone's effect on cue-elicited craving among alcoholics in treatment","Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, Brown RA, Gulliver SB, Gordon A, Abrams DB.","Alcohol Clin Exp Res. 1999 Aug;23(8):1386-94.","Monti PM","Alcohol Clin Exp Res","1999","1999/09/02","","",""
"10470970","Psychometric properties of the Penn Alcohol Craving Scale","Flannery BA, Volpicelli JR, Pettinati HM.","Alcohol Clin Exp Res. 1999 Aug;23(8):1289-95.","Flannery BA","Alcohol Clin Exp Res","1999","1999/09/02","","",""
"10466747","Modulation of enteric cholinergic neurons by hetero- and autoreceptors: cooperation among inhibitory inputs","Giaroni C, Somaini L, Marino F, Cosentino M, Senaldi A, De Ponti F, Lecchini S, Frigo G.","Life Sci. 1999;65(8):813-21. doi: 10.1016/s0024-3205(99)00308-2.","Giaroni C","Life Sci","1999","1999/08/31","","","10.1016/s0024-3205(99)00308-2"
"10465452","Endomorphin-1 and endomorphin-2, endogenous ligands for the mu-opioid receptor, inhibit electrical activity of rat rostral ventrolateral medulla neurons in vitro","Chu XP, Xu NS, Li P, Wang JQ.","Neuroscience. 1999;93(2):681-6. doi: 10.1016/s0306-4522(99)00171-2.","Chu XP","Neuroscience","1999","1999/08/28","","","10.1016/s0306-4522(99)00171-2"
"10463317","Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans","Schuh KJ, Walsh SL, Stitzer ML.","Psychopharmacology (Berl). 1999 Jul;145(2):162-74. doi: 10.1007/s002130051045.","Schuh KJ","Psychopharmacology (Berl)","1999","1999/08/27","","","10.1007/s002130051045"
"10461896","The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum","Gray AM, Rawls SM, Shippenberg TS, McGinty JF.","J Neurochem. 1999 Sep;73(3):1066-74. doi: 10.1046/j.1471-4159.1999.0731066.x.","Gray AM","J Neurochem","1999","1999/08/26","","","10.1046/j.1471-4159.1999.0731066.x"
"10461895","Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes","Rawls SM, McGinty JF, Terrian DM.","J Neurochem. 1999 Sep;73(3):1058-65. doi: 10.1046/j.1471-4159.1999.0731058.x.","Rawls SM","J Neurochem","1999","1999/08/26","","","10.1046/j.1471-4159.1999.0731058.x"
"10461561","Emergency therapeutical approach simulating ultrarapid opioid detoxification in methadone withdrawal precipitated by erroneous administration of naltrexone","De Giacomo M, Gaspari R, Stefanelli A, Barelli A, Mannelli P.","Eur J Emerg Med. 1999 Jun;6(2):153-5. doi: 10.1097/00063110-199906000-00013.","De Giacomo M","Eur J Emerg Med","1999","1999/08/26","","","10.1097/00063110-199906000-00013"
"10460312","Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats","Hölter SM, Spanagel R.","Psychopharmacology (Berl). 1999 Aug;145(4):360-9. doi: 10.1007/s002130051069.","Hölter SM","Psychopharmacology (Berl)","1999","1999/08/25","","","10.1007/s002130051069"
"10459171","Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat","Becker C, Hamon M, Cesselin F, Benoliel JJ.","Synapse. 1999 Oct;34(1):47-54. doi: 10.1002/(SICI)1098-2396(199910)34:1<47::AID-SYN6>3.0.CO;2-9.","Becker C","Synapse","1999","1999/08/25","","","10.1002/(SICI)1098-2396(199910)34:1<47::AID-SYN6>3.0.CO;2-9"
"10459118","Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study","Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA.","J Am Acad Dermatol. 1999 Sep;41(3 Pt 1):431-4. doi: 10.1016/s0190-9622(99)70117-9.","Bergasa NV","J Am Acad Dermatol","1999","1999/08/25","","","10.1016/s0190-9622(99)70117-9"
"10457541","Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress","Lê AD, Poulos CX, Harding S, Watchus J, Juzytsch W, Shaham Y.","Neuropsychopharmacology. 1999 Sep;21(3):435-44. doi: 10.1016/S0893-133X(99)00024-X.","Lê AD","Neuropsychopharmacology","1999","1999/08/24","","","10.1016/S0893-133X(99)00024-X"
"10456559","Peripheral opioid receptors may mediate a portion of the aversive and depressant effect of EtOH: CPP and locomotor activity","Bedingfield JB, King DA, Holloway FA.","Alcohol. 1999 Jun-Jul;18(2-3):93-101. doi: 10.1016/s0741-8329(98)00054-8.","Bedingfield JB","Alcohol","1999","1999/08/24","","","10.1016/s0741-8329(98)00054-8"
"10456231","Effects of diethylstilbestrol on mouse hippocampal evoked potentials in vitro","SanMartín S, Gutiérrez M, Menéndez L, Hidalgo A, Baamonde A.","Cell Mol Neurobiol. 1999 Dec;19(6):691-703. doi: 10.1023/a:1006996805017.","SanMartín S","Cell Mol Neurobiol","1999","1999/08/24","","","10.1023/a:1006996805017"
"10455296","Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats","Courteix C, Coudoré-Civiale MA, Privat AM, Zajac JM, Eschalier A, Fialip J.","Br J Pharmacol. 1999 Jul;127(6):1454-62. doi: 10.1038/sj.bjp.0702682.","Courteix C","Br J Pharmacol","1999","1999/08/24","PMC1760663","","10.1038/sj.bjp.0702682"
"10454508","Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides","You ZB, Herrera-Marschitz M, Terenius L.","J Pharmacol Exp Ther. 1999 Sep;290(3):1307-15.","You ZB","J Pharmacol Exp Ther","1999","1999/08/24","","",""
"10454490","Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys","Brandt MR, Negus SS, Mello NK, Furness MS, Zhang X, Rice KC.","J Pharmacol Exp Ther. 1999 Sep;290(3):1157-64.","Brandt MR","J Pharmacol Exp Ther","1999","1999/08/24","","",""
"10454482","Discriminative stimulus effects of morphine in squirrel monkeys: stimulants, opioids, and stimulant-opioid combinations","Platt DM, Grech DM, Rowlett JK, Spealman RD.","J Pharmacol Exp Ther. 1999 Sep;290(3):1092-100.","Platt DM","J Pharmacol Exp Ther","1999","1999/08/24","","",""
"10453799","Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications","Namkoong K, Farren CK, O'Connor PG, O'Malley SS.","J Clin Psychiatry. 1999 Jul;60(7):449-53. doi: 10.4088/jcp.v60n0706.","Namkoong K","J Clin Psychiatry","1999","1999/08/24","","","10.4088/jcp.v60n0706"
"10451668","A pilot study of naltrexone-accelerated detoxification in opioid dependence","Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G.","Med J Aust. 1999 Jul 5;171(1):26-30.","Bell JR","Med J Aust","1999","1999/08/19","","",""
"10451663","Is naltrexone a cure for heroin dependence?","Hall WD, Wodak A.","Med J Aust. 1999 Jul 5;171(1):9-10.","Hall WD","Med J Aust","1999","1999/08/19","","",""
"10450269","Occurrence and management of depression in the context of naltrexone treatment of alcoholism","Farren CK, O'Malley SS.","Am J Psychiatry. 1999 Aug;156(8):1258-62. doi: 10.1176/ajp.156.8.1258.","Farren CK","Am J Psychiatry","1999","1999/08/18","","","10.1176/ajp.156.8.1258"
"10448921","Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine","Powell KR, Holtzman SG.","Eur J Pharmacol. 1999 Jul 14;377(1):21-8. doi: 10.1016/s0014-2999(99)00394-5.","Powell KR","Eur J Pharmacol","1999","1999/08/17","","","10.1016/s0014-2999(99)00394-5"
"10446338","Infusion of beta-FNA into the thalamus attenuates morphine-induced c-Fos induction in the rat caudate putamen","Frankel PS, Garcia MM, Harlan RE.","Brain Res. 1999 Aug 14;838(1-2):222-6. doi: 10.1016/s0006-8993(99)01709-6.","Frankel PS","Brain Res","1999","1999/08/14","","","10.1016/s0006-8993(99)01709-6"
"10441888","An addict who wants to detoxify","Smith P, Gerada C, Kemp K.","Practitioner. 1998 Nov;242(1592):735-6, 739-40.","Smith P","Practitioner","1998","1999/08/12","","",""
"10435781","Effects of mu and kappa opioid receptor antagonists on glucoprivic induction of Fos immunoreactivity in the rat preoptic area and hypothalamus","Briski KP, Teodecki L.","Brain Res Bull. 1999 Jun;49(3):181-7. doi: 10.1016/s0361-9230(99)00054-4.","Briski KP","Brain Res Bull","1999","1999/08/06","","","10.1016/s0361-9230(99)00054-4"
"10435606","A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence","Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB.","Arch Gen Psychiatry. 1999 Aug;56(8):719-24. doi: 10.1001/archpsyc.56.8.719.","Mason BJ","Arch Gen Psychiatry","1999","1999/08/06","","","10.1001/archpsyc.56.8.719"
"10435403","Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone's effects","Williams KL, Pakarinen ED, Woods JH.","Psychopharmacology (Berl). 1999 Jun;144(4):316-22. doi: 10.1007/s002130051013.","Williams KL","Psychopharmacology (Berl)","1999","1999/08/06","","","10.1007/s002130051013"
"10433874","Neutrophil function and opioid receptor expression on leucocytes during chronic naltrexone treatment in humans","Caldiroli E, Leoni O, Cattaneo S, Rasini E, Marino V, Tosetto C, Mazzone A, Fietta AM, Lecchini S, Frigo GM.","Pharmacol Res. 1999 Aug;40(2):153-8. doi: 10.1006/phrs.1999.0488.","Caldiroli E","Pharmacol Res","1999","1999/08/06","","","10.1006/phrs.1999.0488"
"10433498","Interactions between cholecystokinin and opioids in the isolated guinea-pig ileum","Romanelli L, Amico MC, Mattioli F, Morrone LA, Valeri P.","Br J Pharmacol. 1999 Jun;127(4):909-18. doi: 10.1038/sj.bjp.0702621.","Romanelli L","Br J Pharmacol","1999","1999/08/05","PMC1566095","","10.1038/sj.bjp.0702621"
"10428418","Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the delta opioid system in the nucleus accumbens of rat","Daugé V, Samir A, Cupo A, Roques BP.","Neuropharmacology. 1999 Jul;38(7):999-1007. doi: 10.1016/s0028-3908(99)00028-3.","Daugé V","Neuropharmacology","1999","1999/07/31","","","10.1016/s0028-3908(99)00028-3"
"10422898","Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children","Cazzullo AG, Musetti MC, Musetti L, Bajo S, Sacerdote P, Panerai A.","Eur Neuropsychopharmacol. 1999 Jun;9(4):361-6. doi: 10.1016/s0924-977x(99)00010-3.","Cazzullo AG","Eur Neuropsychopharmacol","1999","1999/07/28","","","10.1016/s0924-977x(99)00010-3"
"10422776","Ethanol-reinforced behaviour in the rat: effects of naltrexone","Bienkowski P, Kostowski W, Koros E.","Eur J Pharmacol. 1999 Jun 25;374(3):321-7. doi: 10.1016/s0014-2999(99)00245-9.","Bienkowski P","Eur J Pharmacol","1999","1999/07/28","","","10.1016/s0014-2999(99)00245-9"
"10422643","Modulation of emesis by fentanyl and opioid receptor antagonists in Suncus murinus (house musk shrew)","Rudd JA, Cheng CH, Naylor RJ, Ngan MP, Wai MK.","Eur J Pharmacol. 1999 Jun 11;374(1):77-84. doi: 10.1016/s0014-2999(99)00285-x.","Rudd JA","Eur J Pharmacol","1999","1999/07/28","","","10.1016/s0014-2999(99)00285-x"
"10421709","Opiate receptor avidity is reduced bilaterally in rhesus monkeys unilaterally lesioned with MPTP","Cohen RM, Carson RE, Wyatt RJ, Doudet DJ.","Synapse. 1999 Sep 15;33(4):282-8. doi: 10.1002/(SICI)1098-2396(19990915)33:4<282::AID-SYN5>3.0.CO;2-5.","Cohen RM","Synapse","1999","1999/07/27","","","10.1002/(SICI)1098-2396(19990915)33:4<282::AID-SYN5>3.0.CO;2-5"
"10421425","Paradoxical effects of intracerebroventricular low-dose opioid antagonists in SHR with chronic pain","Kolaric S, Makulska-Nowak HE, Gumułka SW, Mizerska K.","Life Sci. 1999;65(4):395-402. doi: 10.1016/s0024-3205(99)00260-x.","Kolaric S","Life Sci","1999","1999/07/27","","","10.1016/s0024-3205(99)00260-x"
"10419920","Kappa opioid receptor agonists differentially inhibit two classes of rat spinal neurons excited by colorectal distention","Ness TJ.","Gastroenterology. 1999 Aug;117(2):388-94. doi: 10.1053/gast.1999.0029900388.","Ness TJ","Gastroenterology","1999","1999/07/27","","","10.1053/gast.1999.0029900388"
"10418795","Opioid receptor blockade promotes weight loss and improves the display of sexual behaviors in obese Zucker female rats","Marín-Bivens CL, Olster DH.","Pharmacol Biochem Behav. 1999 Jul;63(3):515-20. doi: 10.1016/s0091-3057(99)00042-8.","Marín-Bivens CL","Pharmacol Biochem Behav","1999","1999/07/27","","","10.1016/s0091-3057(99)00042-8"
"10418775","Paradoxical effects of serotonin and opioids in pemoline-induced self-injurious behavior","Turner C, Panksepp J, Bekkedal M, Borkowski C, Burgdorf J.","Pharmacol Biochem Behav. 1999 Jul;63(3):361-6. doi: 10.1016/s0091-3057(99)00018-0.","Turner C","Pharmacol Biochem Behav","1999","1999/07/27","","","10.1016/s0091-3057(99)00018-0"
"10416823","ASP147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone","Li JG, Chen C, Yin J, Rice K, Zhang Y, Matecka D, de Riel JK, DesJarlais RL, Liu-Chen LY.","Life Sci. 1999;65(2):175-85. doi: 10.1016/s0024-3205(99)00234-9.","Li JG","Life Sci","1999","1999/07/23","","","10.1016/s0024-3205(99)00234-9"
"10416817","Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice","Duttaroy A, Shen J, Shah S, Chen B, Sehba F, Carroll J, Yoburn BC.","Life Sci. 1999;65(2):113-23. doi: 10.1016/s0024-3205(99)00228-3.","Duttaroy A","Life Sci","1999","1999/07/23","","","10.1016/s0024-3205(99)00228-3"
"10415942","The renal actions of moxonidine are mediated by atrial natriuretic peptide and involve the opioid receptors","Mukaddam-Daher S, Gutkowska J.","Ann N Y Acad Sci. 1999 Jun 21;881:385-7. doi: 10.1111/j.1749-6632.1999.tb09386.x.","Mukaddam-Daher S","Ann N Y Acad Sci","1999","1999/07/23","","","10.1111/j.1749-6632.1999.tb09386.x"
"10415666","The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal","Aston-Jones G, Delfs JM, Druhan J, Zhu Y.","Ann N Y Acad Sci. 1999 Jun 29;877:486-98. doi: 10.1111/j.1749-6632.1999.tb09284.x.","Aston-Jones G","Ann N Y Acad Sci","1999","1999/07/23","","","10.1111/j.1749-6632.1999.tb09284.x"
"10414675","Heart rate variability and plasma catecholamines in patients during opioid detoxification","McDonald T, Hoffman WE, Berkowitz R, Cunningham F, Cooke B.","J Neurosurg Anesthesiol. 1999 Jul;11(3):195-9. doi: 10.1097/00008506-199907000-00007.","McDonald T","J Neurosurg Anesthesiol","1999","1999/07/22","","","10.1097/00008506-199907000-00007"
"10414445","Irreversible labelling of the opioid receptors by a melphalan-substituted [Met5]enkephalin-Arg-Phe derivative","Sartania N, Szatmári I, Orosz G, Rónai AZ, Medzihradszky K, Borsodi A, Benyhe S.","Eur J Pharmacol. 1999 Jun 4;373(2-3):241-9. doi: 10.1016/s0014-2999(99)00248-4.","Sartania N","Eur J Pharmacol","1999","1999/07/22","","","10.1016/s0014-2999(99)00248-4"
"10407116","The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist","Le Guen S, Honoré P, Catheline G, Fournié-Zaluski MC, Roques BP, Besson JM.","Brain Res. 1999 Jul 10;834(1-2):200-6. doi: 10.1016/s0006-8993(99)01569-3.","Le Guen S","Brain Res","1999","1999/07/17","","","10.1016/s0006-8993(99)01569-3"
"10407016","kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons","Dalman FC, O'Malley KL.","J Neurosci. 1999 Jul 15;19(14):5750-7. doi: 10.1523/JNEUROSCI.19-14-05750.1999.","Dalman FC","J Neurosci","1999","1999/07/17","PMC6783098","","10.1523/JNEUROSCI.19-14-05750.1999"
"10403501","Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress","Lishmanov YuB, Maslov LN, Naryzhnaya NV, Tam SW.","Life Sci. 1999;65(1):PL13-7. doi: 10.1016/s0024-3205(99)00226-x.","Lishmanov YuB","Life Sci","1999","1999/07/14","","","10.1016/s0024-3205(99)00226-x"
"10401549","Naloxone blocks endomorphin-1 but not endomorphin-2 induced inhibition of tachykinergic contractions of guinea-pig isolated bronchus","Fischer A, Undem BJ.","Br J Pharmacol. 1999 Jun;127(3):605-8. doi: 10.1038/sj.bjp.0702630.","Fischer A","Br J Pharmacol","1999","1999/07/13","PMC1566076","","10.1038/sj.bjp.0702630"
"10400226","Supersensitization of the adenylyl cyclase system in Chinese hamster ovary cells co-expressing cloned opioid receptors and Gz, a PTX-insensitive G protein","Ozawa T, Nakagawa T, Minami M, Satoh M.","Neurosci Lett. 1999 May 28;267(2):117-20. doi: 10.1016/s0304-3940(99)00347-x.","Ozawa T","Neurosci Lett","1999","1999/07/10","","","10.1016/s0304-3940(99)00347-x"
"10397284","Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density","Cowen MS, Rezvani AH, Jarrott B, Lawrence AJ.","Alcohol Clin Exp Res. 1999 Jun;23(6):1008-14.","Cowen MS","Alcohol Clin Exp Res","1999","1999/07/09","","",""
"10397028","Medical allies against alcoholism","Mason B.","Health News. 1999 Jun 25;5(8):3-4.","Mason B","Health News","1999","1999/07/09","","",""
"10394993","The discriminative stimulus effects of naloxone and naltrexone in morphine-treated rhesus monkeys: comparison of oral and subcutaneous administration","Gauthier CA, France CP.","Psychopharmacology (Berl). 1999 May;144(2):131-6. doi: 10.1007/s002130050985.","Gauthier CA","Psychopharmacology (Berl)","1999","1999/07/08","","","10.1007/s002130050985"
"10386982","Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy","Emmerson PJ, Clark MJ, Medzihradsky F, Remmers AE.","J Neurochem. 1999 Jul;73(1):289-300. doi: 10.1046/j.1471-4159.1999.0730289.x.","Emmerson PJ","J Neurochem","1999","1999/07/01","","","10.1046/j.1471-4159.1999.0730289.x"
"10382138","Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design","Willemsen-Swinkels SH, Buitelaar JK, van Berckelaer-Onnes IA, van Engeland H.","J Autism Dev Disord. 1999 Apr;29(2):167-9. doi: 10.1023/a:1023000929040.","Willemsen-Swinkels SH","J Autism Dev Disord","1999","1999/06/26","","","10.1023/a:1023000929040"
"10381993","Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose","Kaplan JL, Marx JA, Calabro JJ, Gin-Shaw SL, Spiller JD, Spivey WL, Gaddis GM, Zhao N, Harchelroad FP Jr.","Ann Emerg Med. 1999 Jul;34(1):42-50. doi: 10.1016/s0196-0644(99)70270-2.","Kaplan JL","Ann Emerg Med","1999","1999/06/26","","","10.1016/s0196-0644(99)70270-2"
"10381891","Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels","Liang BT, Gross GJ.","Circ Res. 1999 Jun 25;84(12):1396-400. doi: 10.1161/01.res.84.12.1396.","Liang BT","Circ Res","1999","1999/06/26","","","10.1161/01.res.84.12.1396"
"10381890","Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor","Wu S, Li HY, Wong TM.","Circ Res. 1999 Jun 25;84(12):1388-95. doi: 10.1161/01.res.84.12.1388.","Wu S","Circ Res","1999","1999/06/26","","","10.1161/01.res.84.12.1388"
"10379623","Naltrexone and beta-funaltrexamine antagonism of the antinociceptive and response rate-decreasing effects of morphine, dezocine, and d-propoxyphene","Walker EA, Tiano MJ, Benyas SI, Dykstra LA, Picker MJ.","Psychopharmacology (Berl). 1999 May;144(1):45-53. doi: 10.1007/s002130050975.","Walker EA","Psychopharmacology (Berl)","1999","1999/06/24","","","10.1007/s002130050975"
"10376126","The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers","Rosen MI, Kosten TR, Kreek MJ.","Biol Psychiatry. 1999 Jun 15;45(12):1636-45. doi: 10.1016/s0006-3223(98)00259-5.","Rosen MI","Biol Psychiatry","1999","1999/06/22","","","10.1016/s0006-3223(98)00259-5"
"10374711","Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception","Sakurada S, Zadina JE, Kastin AJ, Katsuyama S, Fujimura T, Murayama K, Yuki M, Ueda H, Sakurada T.","Eur J Pharmacol. 1999 May 7;372(1):25-30. doi: 10.1016/s0014-2999(99)00181-8.","Sakurada S","Eur J Pharmacol","1999","1999/06/22","","","10.1016/s0014-2999(99)00181-8"
"10373467","Constitutive activation of the delta opioid receptor by mutations in transmembrane domains III and VII","Befort K, Zilliox C, Filliol D, Yue S, Kieffer BL.","J Biol Chem. 1999 Jun 25;274(26):18574-81. doi: 10.1074/jbc.274.26.18574.","Befort K","J Biol Chem","1999","1999/06/22","","","10.1074/jbc.274.26.18574"
"10370199","Design of controlled release inert matrices of naltrexone hydrochloride based on percolation concepts","Caraballo I, Melgoza LM, Alvarez-Fuentes J, Soriano MC, Rabasco AM.","Int J Pharm. 1999 Apr 20;181(1):23-30. doi: 10.1016/s0378-5173(98)00415-3.","Caraballo I","Int J Pharm","1999","1999/06/17","","","10.1016/s0378-5173(98)00415-3"
"10369483","Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatum","Hill MP, Brotchie JM.","Br J Pharmacol. 1999 May;127(1):275-83. doi: 10.1038/sj.bjp.0702523.","Hill MP","Br J Pharmacol","1999","1999/06/16","PMC1565998","","10.1038/sj.bjp.0702523"
"10367562","Resolution of treatment-refractory depression with naltrexone augmentation of paroxetine--a case report","Amiaz R, Stein O, Dannon PN, Grunhaus L, Schreiber S.","Psychopharmacology (Berl). 1999 Apr;143(4):433-4. doi: 10.1007/s002130050969.","Amiaz R","Psychopharmacology (Berl)","1999","1999/06/15","","","10.1007/s002130050969"
"10367550","Naltrexone blockade of nicotine effects in cigarette smokers","Brauer LH, Behm FM, Westman EC, Patel P, Rose JE.","Psychopharmacology (Berl). 1999 Apr;143(4):339-46. doi: 10.1007/s002130050957.","Brauer LH","Psychopharmacology (Berl)","1999","1999/06/15","","","10.1007/s002130050957"
"10357456","Isolation reduces contextual but not auditory-cue fear conditioning: a role for endogenous opioids","Rudy JW, Kuwagama K, Pugh CR.","Behav Neurosci. 1999 Apr;113(2):316-23. doi: 10.1037//0735-7044.113.2.316.","Rudy JW","Behav Neurosci","1999","1999/06/05","","","10.1037//0735-7044.113.2.316"
"10353595","Roles of 5-HT3 and opioid receptors in the ethanol-induced place preference in rats exposed to conditioned fear stress","Matsuzawa S, Suzuki T, Misawa M, Nagase H.","Life Sci. 1999;64(21):PL241-9. doi: 10.1016/s0024-3205(99)00144-7.","Matsuzawa S","Life Sci","1999","1999/06/03","","","10.1016/s0024-3205(99)00144-7"
"10352398","Effects of dexamethasone and dexamethasone plus naltrexone on pituitary response to GnRH and TRH in normal women","la Marca A, Torricelli M, Morgante G, Lanzetta D, De Leo V.","Horm Res. 1999;51(2):85-90. doi: 10.1159/000023320.","la Marca A","Horm Res","1999","1999/06/03","","","10.1159/000023320"
"10344782","Craving for alcohol: findings from the clinic and the laboratory","Sinha R, O'Malley SS.","Alcohol Alcohol. 1999 Mar-Apr;34(2):223-30. doi: 10.1093/alcalc/34.2.223.","Sinha R","Alcohol Alcohol","1999","1999/05/27","","","10.1093/alcalc/34.2.223"
"10340539","The effects of intravenous naltrindole and naltrindole 5'-isothiocyanate on sufentanil-induced respiratory depression and antinociception in rats","Verborgh C, Meert TF.","Pharmacol Biochem Behav. 1999 May;63(1):175-83. doi: 10.1016/s0091-3057(98)00238-x.","Verborgh C","Pharmacol Biochem Behav","1999","1999/05/26","","","10.1016/s0091-3057(98)00238-x"
"10340522","Evaluation of hypothermia-induced analgesia and influence of opioid antagonists in leopard frogs (Rana pipiens)","Suckow MA, Terril LA, Grigdesby CF, March PA.","Pharmacol Biochem Behav. 1999 May;63(1):39-43. doi: 10.1016/s0091-3057(98)00237-8.","Suckow MA","Pharmacol Biochem Behav","1999","1999/05/26","","","10.1016/s0091-3057(98)00237-8"
"10334505","Effects of U-69,593, a kappa-opioid receptor agonist, on carrageenin-induced peripheral oedema and Fos expression in the rat spinal cord","Catheline G, Le Guen S, Besson JM.","Eur J Pharmacol. 1999 Apr 16;370(3):287-96. doi: 10.1016/s0014-2999(99)00153-3.","Catheline G","Eur J Pharmacol","1999","1999/05/20","","","10.1016/s0014-2999(99)00153-3"
"10328565","Possible neural mechanisms involved in footshock stress-induced enhancement of exploratory behavior in mice","Kohno H, Katayama S, Ohuchi Y, Ohkubo Y.","Biol Pharm Bull. 1999 Apr;22(4):418-21. doi: 10.1248/bpb.22.418.","Kohno H","Biol Pharm Bull","1999","1999/05/18","","","10.1248/bpb.22.418"
"10327921","Addition of naltrexone to fluoxetine in the treatment of binge eating disorder","Neumeister A, Winkler A, Wöber-Bingöl C.","Am J Psychiatry. 1999 May;156(5):797. doi: 10.1176/ajp.156.5.797.","Neumeister A","Am J Psychiatry","1999","1999/05/18","","","10.1176/ajp.156.5.797"
"10319691","[Evaluation of drug treatment of primary alcoholism]","Rueff B.","Rev Prat. 1999 Feb 15;49(4):400-2.","Rueff B","Rev Prat","1999","1999/05/13","","",""
"10235307","Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys","Williams KL, Woods JH.","Alcohol Clin Exp Res. 1999 Apr;23(4):708-15.","Williams KL","Alcohol Clin Exp Res","1999","1999/05/11","","",""
"10234561","Naltrexone effects on short-term and long-term smoking cessation","Covey LS, Glassman AH, Stetner F.","J Addict Dis. 1999;18(1):31-40. doi: 10.1300/J069v18n01_04.","Covey LS","J Addict Dis","1999","1999/05/11","","","10.1300/J069v18n01_04"
"10231814","[Treatment of dissociative symptoms in borderline patients with naltrexone]","Schmahl C, Stiglmayr C, Böhme R, Bohus M.","Nervenarzt. 1999 Mar;70(3):262-4. doi: 10.1007/s001150050431.","Schmahl C","Nervenarzt","1999","1999/05/08","","","10.1007/s001150050431"
"10230857","Analgesia-producing mechanism of processed Aconiti tuber: role of dynorphin, an endogenous kappa-opioid ligand, in the rodent spinal cord","Omiya Y, Goto K, Suzuki Y, Ishige A, Komatsu Y.","Jpn J Pharmacol. 1999 Mar;79(3):295-301. doi: 10.1254/jjp.79.295.","Omiya Y","Jpn J Pharmacol","1999","1999/05/07","","","10.1254/jjp.79.295"
"10230191","Naltrexone and communication skills in young children with autism","Feldman HM, Kolmen BK, Gonzaga AM.","J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):587-93. doi: 10.1097/00004583-199905000-00021.","Feldman HM","J Am Acad Child Adolesc Psychiatry","1999","1999/05/07","","","10.1097/00004583-199905000-00021"
"10230186","Anxiolytics, adrenergic agents, and naltrexone","Riddle MA, Bernstein GA, Cook EH, Leonard HL, March JS, Swanson JM.","J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):546-56. doi: 10.1097/00004583-199905000-00016.","Riddle MA","J Am Acad Child Adolesc Psychiatry","1999","1999/05/07","","","10.1097/00004583-199905000-00016"
"10229636","delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole","Coop A, Rothman RB, Dersch C, Partilla J, Porreca F, Davis P, Jacobson AE, Rice KC.","J Med Chem. 1999 May 6;42(9):1673-9. doi: 10.1021/jm9807003.","Coop A","J Med Chem","1999","1999/05/07","","","10.1021/jm9807003"
"10225369","Algogenic mediator-induced nociceptive response in diabetic mice","Kamei J, Kashiwazaki T, Taki K, Hitosugi H, Nagase H.","Eur J Pharmacol. 1999 Mar 26;369(3):319-23. doi: 10.1016/s0014-2999(99)00076-x.","Kamei J","Eur J Pharmacol","1999","1999/05/04","","","10.1016/s0014-2999(99)00076-x"
"10222487","Analgesia in selectively bred mice exposed to cold in helium/oxygen atmosphere","Sadowski B, Konarzewski M.","Physiol Behav. 1999 Mar;66(1):145-51. doi: 10.1016/s0031-9384(98)00282-0.","Sadowski B","Physiol Behav","1999","1999/05/01","","","10.1016/s0031-9384(98)00282-0"
"10220088","Nalmefene hydrochloride","Chumpa A.","Pediatr Emerg Care. 1999 Apr;15(2):141-3. doi: 10.1097/00006565-199904000-00016.","Chumpa A","Pediatr Emerg Care","1999","1999/04/29","","","10.1097/00006565-199904000-00016"
"10219980","Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses","Yuan CS, Foss JF.","Neuropharmacology. 1999 Mar;38(3):425-32. doi: 10.1016/s0028-3908(98)00192-0.","Yuan CS","Neuropharmacology","1999","1999/04/29","","","10.1016/s0028-3908(98)00192-0"
"10218862","The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal","Vandergriff J, Rasmussen K.","Neuropharmacology. 1999 Feb;38(2):217-22. doi: 10.1016/s0028-3908(98)00196-8.","Vandergriff J","Neuropharmacology","1999","1999/04/28","","","10.1016/s0028-3908(98)00196-8"
"10217552","Improvement in naltrexone treatment compliance with contingency management","Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR.","Drug Alcohol Depend. 1999 Apr 1;54(2):127-35. doi: 10.1016/s0376-8716(98)00152-5.","Preston KL","Drug Alcohol Depend","1999","1999/04/27","","","10.1016/s0376-8716(98)00152-5"
"10215661","Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats","Sluka KA, Deacon M, Stibal A, Strissel S, Terpstra A.","J Pharmacol Exp Ther. 1999 May;289(2):840-6.","Sluka KA","J Pharmacol Exp Ther","1999","1999/04/24","","",""
"10212062","The involvement of an opiate mechanism in the sensitized behavioral deficit induced by early chronic variable stress: influence of desipramine","Zurita A, Cuadra G, Molina VA.","Behav Brain Res. 1999 Apr;100(1-2):153-9. doi: 10.1016/s0166-4328(98)00124-7.","Zurita A","Behav Brain Res","1999","1999/04/22","","","10.1016/s0166-4328(98)00124-7"
"10209244","Growth inhibitory effects of a mu opioid on cultured cholinergic neurons from fetal rat ventral forebrain, brainstem, and spinal cord","Miller JH, Azmitia EC.","Brain Res Dev Brain Res. 1999 Apr 12;114(1):69-77. doi: 10.1016/s0165-3806(99)00021-8.","Miller JH","Brain Res Dev Brain Res","1999","1999/04/21","","","10.1016/s0165-3806(99)00021-8"
"10208762","The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine","Koyuncuoglu H, Nurten A, Yamantürk P, Nurten R.","Pharmacol Res. 1999 Apr;39(4):311-9. doi: 10.1006/phrs.1998.0443.","Koyuncuoglu H","Pharmacol Res","1999","1999/04/20","","","10.1006/phrs.1998.0443"
"10208698","Prevention of relapse in alcohol dependence","Malerich JA Jr.","Am Fam Physician. 1999 Apr 1;59(7):1753-4.","Malerich JA Jr","Am Fam Physician","1999","1999/04/20","","",""
"10208324","Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference","Nestby P, Schoffelmeer AN, Homberg JR, Wardeh G, De Vries TJ, Mulder AH, Vanderschuren LJ.","Psychopharmacology (Berl). 1999 Mar;142(3):309-17. doi: 10.1007/s002130050894.","Nestby P","Psychopharmacology (Berl)","1999","1999/04/20","","","10.1007/s002130050894"
"10208148","Pharmacological treatment of alcohol dependence: a review of the evidence","Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT.","JAMA. 1999 Apr 14;281(14):1318-25. doi: 10.1001/jama.281.14.1318.","Garbutt JC","JAMA","1999","1999/04/20","","","10.1001/jama.281.14.1318"
"10207596","[Interactions between naltrexone, an opioid antagonist, and opioids administered during general anesthesia]","Tesson B, Bigot-Viale A, Vigue JP, Pierrot M, Granry JC.","Ann Fr Anesth Reanim. 1999 Feb;18(2):230-2.","Tesson B","Ann Fr Anesth Reanim","1999","1999/04/20","","",""
"10205153","Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels","Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ.","Circ Res. 1999 Apr 16;84(7):846-51. doi: 10.1161/01.res.84.7.846.","Fryer RM","Circ Res","1999","1999/04/16","","","10.1161/01.res.84.7.846"
"10202629","Sudden infant death syndrome, child sexual abuse, and child development","Blatt SD, Meguid V, Church CC, Botash AS, Jean-Louis F, Siripornsawan MP, Weinberger HL.","Curr Opin Pediatr. 1999 Apr;11(2):175-86. doi: 10.1097/00008480-199904000-00013.","Blatt SD","Curr Opin Pediatr","1999","1999/04/15","","","10.1097/00008480-199904000-00013"
"10201671","Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia","Joshi GP, Duffy L, Chehade J, Wesevich J, Gajraj N, Johnson ER.","Anesthesiology. 1999 Apr;90(4):1007-11. doi: 10.1097/00000542-199904000-00013.","Joshi GP","Anesthesiology","1999","1999/04/14","","","10.1097/00000542-199904000-00013"
"10200856","Rhabdomyolysis associated with naltrexone","Zaim S, Wiley DB, Albano SA.","Ann Pharmacother. 1999 Mar;33(3):312-3. doi: 10.1345/aph.18214.","Zaim S","Ann Pharmacother","1999","1999/04/14","","","10.1345/aph.18214"
"10200198","Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat","Müller W, Hallermann S, Swandulla D.","J Neurophysiol. 1999 Apr;81(4):1617-25. doi: 10.1152/jn.1999.81.4.1617.","Müller W","J Neurophysiol","1999","1999/04/14","","","10.1152/jn.1999.81.4.1617"
"10198826","delta 1-Opioid receptor-mediated control of acetylcholine (ACh) release in human neocortex slices","Feuerstein TJ, Albrecht C, Wessler I, Zentner J, Jackisch R.","Int J Dev Neurosci. 1998 Nov-Dec;16(7-8):795-802. doi: 10.1016/s0736-5748(98)00086-0.","Feuerstein TJ","Int J Dev Neurosci","1998","1999/04/13","","","10.1016/s0736-5748(98)00086-0"
"10195825","Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study","Farren CK, O'Malley S, Grebski G, Maniar S, Porter M, Kreek MJ.","Alcohol Clin Exp Res. 1999 Mar;23(3):502-8.","Farren CK","Alcohol Clin Exp Res","1999","1999/04/09","","",""
"10195818","Naltrexone effects on ethanol reward and discrimination in C57BL/6 mice","Middaugh LD, Kelley BM, Cuison ER Jr, Groseclose CH.","Alcohol Clin Exp Res. 1999 Mar;23(3):456-64.","Middaugh LD","Alcohol Clin Exp Res","1999","1999/04/09","","",""
"10195332","Effect of acute and chronic administration of dehydroepiandrosterone on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced wet dog shaking behavior in rats","Inagaki M, Kagaya A, Takebayashi M, Horiguchi J, Yamawaki S.","J Neural Transm (Vienna). 1999;106(1):23-33. doi: 10.1007/s007020050138.","Inagaki M","J Neural Transm (Vienna)","1999","1999/04/09","","","10.1007/s007020050138"
"10192827","Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat","Katner SN, Magalong JG, Weiss F.","Neuropsychopharmacology. 1999 May;20(5):471-9. doi: 10.1016/S0893-133X(98)00084-0.","Katner SN","Neuropsychopharmacology","1999","1999/04/08","","","10.1016/S0893-133X(98)00084-0"
"10190139","[A molecular mechanism for supersensitization of adenylyl cyclase system in cloned opioid receptor-transfected cells following sustained opioid treatment]","Nakagawa T, Ozawa T, Watanabe T, Minami M, Satoh M.","Nihon Yakurigaku Zasshi. 1998 Oct;112 Suppl 1:78P-82P. doi: 10.1254/fpj.112.supplement_78.","Nakagawa T","Nihon Yakurigaku Zasshi","1998","1999/04/06","","","10.1254/fpj.112.supplement_78"
"10190097","Interaction between Ukrain and Naltrexone in the writhing syndrome test in mice","Jagiello-Wójtowicz E, Kleinrok Z, Gustaw K.","Drugs Exp Clin Res. 1998;24(5-6):327-30.","Jagiello-Wójtowicz E","Drugs Exp Clin Res","1998","1999/04/06","","",""
"10146246","A morphine-triggered delivery system useful in the treatment of heroin addiction","Roskos KV, Tefft JA, Heller J.","Clin Mater. 1993;13(1-4):109-19. doi: 10.1016/0267-6605(93)90097-q.","Roskos KV","Clin Mater","1993","1992/12/09","","","10.1016/0267-6605(93)90097-q"
"10102765","Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results","Hutchison KE, Monti PM, Rohsenow DJ, Swift RM, Colby SM, Gnys M, Niaura RS, Sirota AD.","Psychopharmacology (Berl). 1999 Feb;142(2):139-43. doi: 10.1007/s002130050872.","Hutchison KE","Psychopharmacology (Berl)","1999","1999/04/02","","","10.1007/s002130050872"
"10102674","Immunomodulatory action of class mu-, delta- and kappa-opioid receptor agonists in mice","Kowalski J.","Neuropeptides. 1998 Aug;32(4):301-6. doi: 10.1016/s0143-4179(98)90052-x.","Kowalski J","Neuropeptides","1998","1999/04/02","","","10.1016/s0143-4179(98)90052-x"
"10097028","The effect of naltrexone on taste detection and recognition threshold","Arbisi PA, Billington CJ, Levine AS.","Appetite. 1999 Apr;32(2):241-9. doi: 10.1006/appe.1998.0217.","Arbisi PA","Appetite","1999","1999/03/31","","","10.1006/appe.1998.0217"
"10096764","Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress","Matsuzawa S, Suzuki T, Misawa M, Nagase H.","Eur J Pharmacol. 1999 Feb 26;368(1):9-16. doi: 10.1016/s0014-2999(99)00008-4.","Matsuzawa S","Eur J Pharmacol","1999","1999/03/30","","","10.1016/s0014-2999(99)00008-4"
"10096661","CSAT consensus panel supports expanded use of naltrexone for treatment of alcohol dependence. Center for Substance Abuse Treatment","","Psychiatr Serv. 1999 Mar;50(3):437.","","Psychiatr Serv","1999","1999/03/30","","",""
"10096442","Spinal administration of selective opioid antagonists in amphibians: evidence for an opioid unireceptor","Stevens CW, Newman LC.","Life Sci. 1999;64(10):PL125-30. doi: 10.1016/s0024-3205(99)00013-2.","Stevens CW","Life Sci","1999","1999/03/30","","","10.1016/s0024-3205(99)00013-2"
"10095946","[Opiatergic mechanisms of cardioprotective and anti-arrhythmic effects of adaptation]","Lishmanov IuB, Maĭmeskulova LA, Uskina EV, Maslov LN.","Biull Eksp Biol Med. 1999 Feb;127(2):167-70.","Lishmanov IuB","Biull Eksp Biol Med","1999","1999/03/30","","",""
"10095048","Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord","Catheline G, Le Guen S, Besson JM.","Brain Res. 1999 Apr 3;824(1):105-11. doi: 10.1016/s0006-8993(99)01207-x.","Catheline G","Brain Res","1999","1999/03/30","","","10.1016/s0006-8993(99)01207-x"
"10093048","Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart","Zhang WM, Wu S, Yu XC, Wang HX, Bian JS, Wong TM.","J Mol Cell Cardiol. 1999 Feb;31(2):355-62. doi: 10.1006/jmcc.1998.9998.","Zhang WM","J Mol Cell Cardiol","1999","1999/03/27","","","10.1006/jmcc.1998.9998"
"10091477","Recent studies of cutaneous nociception in atopic and non-atopic subjects","Heyer GR, Hornstein OP.","J Dermatol. 1999 Feb;26(2):77-86. doi: 10.1111/j.1346-8138.1999.tb03516.x.","Heyer GR","J Dermatol","1999","1999/03/26","","","10.1111/j.1346-8138.1999.tb03516.x"
"10090652","Naltrexone pretreatment decreases the reinforcing effectiveness of ethanol and saccharin but not PCP or food under concurrent progressive-ratio schedules in rhesus monkeys","Rodefer JS, Campbell UC, Cosgrove KP, Carroll ME.","Psychopharmacology (Berl). 1999 Feb;141(4):436-46. doi: 10.1007/s002130050854.","Rodefer JS","Psychopharmacology (Berl)","1999","1999/03/25","","","10.1007/s002130050854"
"10087027","Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys","Ko MC, Butelman ER, Woods JH.","J Pharmacol Exp Ther. 1999 Apr;289(1):378-85.","Ko MC","J Pharmacol Exp Ther","1999","1999/03/23","PMC2865196","NIHMS196250",""
"10082891","Transcranial electrical stimulation (Limoge's currents) potentiates the inhibition of righting reflex induced by droperidol in rats","Robert C, Limoge A, Stinus L.","Brain Res. 1999 Mar 20;822(1-2):132-41. doi: 10.1016/s0006-8993(99)01140-3.","Robert C","Brain Res","1999","1999/03/20","","","10.1016/s0006-8993(99)01140-3"
"10082881","Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala","Carr KD, Kutchukhidze N, Park TH.","Brain Res. 1999 Mar 20;822(1-2):34-42. doi: 10.1016/s0006-8993(99)01088-4.","Carr KD","Brain Res","1999","1999/03/20","","","10.1016/s0006-8993(99)01088-4"
"10082725","Maintenance programmes are denied to addicted prisoners in Victoria","Simpson S.","BMJ. 1999 Mar 20;318(7186):811. doi: 10.1136/bmj.318.7186.811.","Simpson S","BMJ","1999","1999/03/20","PMC1115236","","10.1136/bmj.318.7186.811"
"10082233","Naltrexone affects cocaine self-administration in naïve rats through the ventral tegmental area rather than dopaminergic target regions","Ramsey NF, Gerrits MA, Van Ree JM.","Eur Neuropsychopharmacol. 1999 Jan;9(1-2):93-9. doi: 10.1016/s0924-977x(98)00009-1.","Ramsey NF","Eur Neuropsychopharmacol","1999","1999/03/19","","","10.1016/s0924-977x(98)00009-1"
"10080233","Antinociception elicited by aversive stimulation of the inferior colliculus","Castilho VM, Avanzi V, Brandão ML.","Pharmacol Biochem Behav. 1999 Mar;62(3):425-31. doi: 10.1016/s0091-3057(98)00197-x.","Castilho VM","Pharmacol Biochem Behav","1999","1999/03/18","","","10.1016/s0091-3057(98)00197-x"
"10080036","Effect of gonadectomy on discriminative stimulus effects of morphine in female versus male rats","Craft RM, Heideman LM, Bartok RE.","Drug Alcohol Depend. 1999 Jan 7;53(2):95-109. doi: 10.1016/s0376-8716(98)00112-4.","Craft RM","Drug Alcohol Depend","1999","1999/03/18","","","10.1016/s0376-8716(98)00112-4"
"10078159","Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure","Pfab R, Hirtl C, Zilker T.","J Toxicol Clin Toxicol. 1999;37(1):43-50. doi: 10.1081/clt-100102407.","Pfab R","J Toxicol Clin Toxicol","1999","1999/03/17","","","10.1081/clt-100102407"
"10077314","Endomorphin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons in vitro","Wu SY, Dun SL, Wright MT, Chang JK, Dun NJ.","Neuroscience. 1999 Mar;89(2):317-21. doi: 10.1016/s0306-4522(98)00570-3.","Wu SY","Neuroscience","1999","1999/03/17","","","10.1016/s0306-4522(98)00570-3"
"10071829","Comparative bioavailability study of a generic naltrexone tablet preparation","Yuen KH, Peh KK, Billa N.","Drug Dev Ind Pharm. 1999 Mar;25(3):353-6. doi: 10.1081/ddc-100102181.","Yuen KH","Drug Dev Ind Pharm","1999","1999/03/11","","","10.1081/ddc-100102181"
"10069545","Effects of naltrexone on alcohol self-administration in heavy drinkers","Davidson D, Palfai T, Bird C, Swift R.","Alcohol Clin Exp Res. 1999 Feb;23(2):195-203.","Davidson D","Alcohol Clin Exp Res","1999","1999/03/09","","",""
"10064148","Dynorphin A increases substance P release from trigeminal primary afferent C-fibers","Arcaya JL, Cano G, Gómez G, Maixner W, Suárez-Roca H.","Eur J Pharmacol. 1999 Jan 29;366(1):27-34. doi: 10.1016/s0014-2999(98)00897-8.","Arcaya JL","Eur J Pharmacol","1999","1999/03/04","","","10.1016/s0014-2999(98)00897-8"
"10051226","Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus","Mazarati A, Liu H, Wasterlain C.","Neuroscience. 1999 Mar;89(1):167-73. doi: 10.1016/s0306-4522(98)00320-0.","Mazarati A","Neuroscience","1999","1999/03/02","","","10.1016/s0306-4522(98)00320-0"
"10048886","Consensus Conference on the Neuropharmacology of Alcohol Dependence and the Role of Pharmacotherapy in its Treatment. Amsterdam, The Netherlands, September 16-17, 1994","","Alcohol Alcohol Suppl. 1996 Mar;31(1):1-87.","","Alcohol Alcohol Suppl","1996","1996/03/01","","",""
"10048082","Drug reduces alcohol craving","","Nurse Pract. 1999 Feb;24(2):104.","","Nurse Pract","1999","1999/02/27","","",""
"10029211","Contribution of carbohydrate deficient transferrin to gamma glutamyl transpeptidase in evaluating progress of patients in treatment for alcoholism","Allen JP, Sillamaukee P, Anton R.","Alcohol Clin Exp Res. 1999 Jan;23(1):115-20.","Allen JP","Alcohol Clin Exp Res","1999","1999/02/24","","",""
"10029204","Reversal of chronic ethanol-induced testosterone suppression in peripubertal male rats by opiate blockade","Emanuele NV, LaPaglia N, Steiner J, Kirsteins L, Emanuele MA.","Alcohol Clin Exp Res. 1999 Jan;23(1):60-6.","Emanuele NV","Alcohol Clin Exp Res","1999","1999/02/24","","",""
"10028207","The validity of self-reported cocaine use in two groups of cocaine abusers","Hersh D, Mulgrew CL, Van Kirk J, Kranzler HR.","J Consult Clin Psychol. 1999 Feb;67(1):37-42. doi: 10.1037//0022-006x.67.1.37.","Hersh D","J Consult Clin Psychol","1999","1999/02/24","","","10.1037//0022-006x.67.1.37"
"10027868","Discriminative stimulus effects of naltrexone after a single dose of morphine in the rat","Easterling KW, Holtzman SG.","J Pharmacol Exp Ther. 1999 Mar;288(3):1269-77.","Easterling KW","J Pharmacol Exp Ther","1999","1999/02/23","","",""
"10027746","Role of the kappa-opioid system in the attenuation of the morphine-induced place preference under chronic pain","Suzuki T, Kishimoto Y, Misawa M, Nagase H, Takeda F.","Life Sci. 1999;64(1):PL1-7. doi: 10.1016/s0024-3205(98)00537-2.","Suzuki T","Life Sci","1999","1999/02/23","","","10.1016/s0024-3205(98)00537-2"
"10025704","Chronic naltrindole administration does not modify the inhibitory effect of morphine on vocalization responses in the tail electric stimulation test in rats","Fernández B, Alberti I, Kitchen I, Paz Viveros M.","Neurosci Lett. 1999 Jan 29;260(2):81-4. doi: 10.1016/s0304-3940(98)00954-9.","Fernández B","Neurosci Lett","1999","1999/02/20","","","10.1016/s0304-3940(98)00954-9"
"10023615","The effects of naltrexone on alcohol and cocaine use in dually addicted patients","Oslin DW, Pettinati HM, Volpicelli JR, Wolf AL, Kampman KM, O'Brien CP.","J Subst Abuse Treat. 1999 Mar;16(2):163-7. doi: 10.1016/s0740-5472(98)00039-7.","Oslin DW","J Subst Abuse Treat","1999","1999/02/19","","","10.1016/s0740-5472(98)00039-7"
"10023607","Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings","Litten RZ, Allen JP.","J Subst Abuse Treat. 1999 Mar;16(2):105-12. doi: 10.1016/s0740-5472(98)00028-2.","Litten RZ","J Subst Abuse Treat","1999","1999/02/19","","","10.1016/s0740-5472(98)00028-2"
"9990091","beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release","Faletti AG, Mastronardi CA, Lomniczi A, Seilicovich A, Gimeno M, McCann SM, Rettori V.","Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1722-6. doi: 10.1073/pnas.96.4.1722.","Faletti AG","Proc Natl Acad Sci U S A","1999","1999/02/17","PMC15573","","10.1073/pnas.96.4.1722"
"9988097","The involvement of opioidergic and noradrenergic mechanisms in nefopam antinociception","Gray AM, Nevinson MJ, Sewell RD.","Eur J Pharmacol. 1999 Jan 22;365(2-3):149-57. doi: 10.1016/s0014-2999(98)00837-1.","Gray AM","Eur J Pharmacol","1999","1999/02/13","","","10.1016/s0014-2999(98)00837-1"
"9988096","Stereoselective mu- and delta-opioid receptor-related antinociception and binding with (+)-thebaine","Aceto MD, Harris LS, Abood ME, Rice KC.","Eur J Pharmacol. 1999 Jan 22;365(2-3):143-7. doi: 10.1016/s0014-2999(98)00862-0.","Aceto MD","Eur J Pharmacol","1999","1999/02/13","","","10.1016/s0014-2999(98)00862-0"
"9987807","Using analog baselines to assess the effects of naltrexone on self-injurious behavior","Garcia D, Smith RG.","Res Dev Disabil. 1999 Jan-Feb;20(1):1-21. doi: 10.1016/s0891-4222(98)00028-6.","Garcia D","Res Dev Disabil","1999","1999/02/13","","","10.1016/s0891-4222(98)00028-6"
"9974167","Naltrindole administration during the preweanling period and manipulation affect adrenocortical reactivity in young rats","Fernández B, Antelo MT, Guaza C, Alberti I, Pinillos ML, Viveros MP.","Brain Res Dev Brain Res. 1999 Jan 11;112(1):135-7. doi: 10.1016/s0165-3806(98)00154-0.","Fernández B","Brain Res Dev Brain Res","1999","1999/02/12","","","10.1016/s0165-3806(98)00154-0"
"9972857","Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to mu and kappa agonists in rats","Fernández B, Antelo MT, Kitchen I, Viveros MP.","Pharmacol Biochem Behav. 1999 Jan;62(1):145-9. doi: 10.1016/s0091-3057(98)00138-5.","Fernández B","Pharmacol Biochem Behav","1999","1999/02/11","","","10.1016/s0091-3057(98)00138-5"
"9972851","The effects of the naltrexone implant on rodent social interactions and cocaine-induced conditioned place preference","Mitchem LD, Kruschel CK, Dallman E, Anders KA, Czapiga M, Panos JJ, Steinpreis RE.","Pharmacol Biochem Behav. 1999 Jan;62(1):97-102. doi: 10.1016/s0091-3057(98)00150-6.","Mitchem LD","Pharmacol Biochem Behav","1999","1999/02/11","","","10.1016/s0091-3057(98)00150-6"
"9952035","Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice","Bespalov AY, Tokarz ME, Bowen SE, Balster RL, Beardsley PM.","Psychopharmacology (Berl). 1999 Jan;141(2):118-22. doi: 10.1007/s002130050815.","Bespalov AY","Psychopharmacology (Berl)","1999","1999/02/10","","","10.1007/s002130050815"
"9935127","Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism","Villa P, Valle D, Mancini A, De Marinis L, Pavone V, Fulghesu AM, Mancuso S, Lanzone A.","Fertil Steril. 1999 Jan;71(1):115-21. doi: 10.1016/s0015-0282(98)00405-1.","Villa P","Fertil Steril","1999","1999/02/06","","","10.1016/s0015-0282(98)00405-1"
"9935051","Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexone challenge during detoxification","Catafau AM, Etcheberrigaray A, Perez de los Cobos J, Estorch M, Guardia J, Flotats A, Bernà L, Marí C, Casas M, Carrió I.","J Nucl Med. 1999 Jan;40(1):19-24.","Catafau AM","J Nucl Med","1999","1999/02/06","","",""
"9932732","Phosphorylation of adenylyl cyclase VI upon chronic delta-opioid receptor stimulation","Varga EV, Stropova D, Rubenzik M, Waite S, Roeske WR, Yamamura HI.","Eur J Pharmacol. 1999 Jan 8;364(2-3):R1-3. doi: 10.1016/s0014-2999(98)00847-4.","Varga EV","Eur J Pharmacol","1999","1999/02/05","","","10.1016/s0014-2999(98)00847-4"
"9928069","The stimulatory effect of VIP on progesterone release in rats after adrenalectomy, ovariectomy, and hysterectomy: influence of VIP and PACAP38 on progesterone release in rats after ovariectomy and hysterectomy","Wasilewska-Dziubínska E, Radzikowska M, Baranowska B.","Ann N Y Acad Sci. 1998 Dec 11;865:556-60. doi: 10.1111/j.1749-6632.1998.tb11236.x.","Wasilewska-Dziubínska E","Ann N Y Acad Sci","1998","1999/02/03","","","10.1111/j.1749-6632.1998.tb11236.x"
"9928055","The stimulatory effect of VIP and PACAP on adrenal aldosterone release","Radzikowska M, Wasilewska-Dziubińska E, Baranowska B.","Ann N Y Acad Sci. 1998 Dec 11;865:482-5. doi: 10.1111/j.1749-6632.1998.tb11221.x.","Radzikowska M","Ann N Y Acad Sci","1998","1999/02/03","","","10.1111/j.1749-6632.1998.tb11221.x"
"9923893","Role of maintenance treatment in opioid dependence","Ward J, Hall W, Mattick RP.","Lancet. 1999 Jan 16;353(9148):221-6. doi: 10.1016/S0140-6736(98)05356-2.","Ward J","Lancet","1999","1999/01/29","","","10.1016/S0140-6736(98)05356-2"
"9923889","New treatments for alcohol dependency better than old","Bonn D.","Lancet. 1999 Jan 16;353(9148):213. doi: 10.1016/S0140-6736(99)00012-4.","Bonn D","Lancet","1999","1999/01/29","","","10.1016/S0140-6736(99)00012-4"
"9922560","No interactive effects of naltrexone and benzodiazepines on pain during phobic fear","Janssen SA, Arntz A.","Behav Res Ther. 1999 Jan;37(1):77-86. doi: 10.1016/s0005-7967(98)00100-4.","Janssen SA","Behav Res Ther","1999","1999/01/29","","","10.1016/s0005-7967(98)00100-4"
"9920206","Effects of peptidase inhibitors on the enkephalin-induced anti-nociception in rats","Taniguchi T, Fan XT, Kitamura K, Oka T.","Jpn J Pharmacol. 1998 Dec;78(4):487-92. doi: 10.1254/jjp.78.487.","Taniguchi T","Jpn J Pharmacol","1998","1999/01/27","","","10.1254/jjp.78.487"
"9920201","Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice","Rady JJ, Gorny JM, Fujimoto JM.","Jpn J Pharmacol. 1998 Dec;78(4):443-54. doi: 10.1254/jjp.78.443.","Rady JJ","Jpn J Pharmacol","1998","1999/01/27","","","10.1254/jjp.78.443"
"9918595","Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor","Remmers AE, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F.","J Pharmacol Exp Ther. 1999 Feb;288(2):827-33.","Remmers AE","J Pharmacol Exp Ther","1999","1999/01/26","","",""
"9918569","The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses","Mellon RD, Bayer BM.","J Pharmacol Exp Ther. 1999 Feb;288(2):635-42.","Mellon RD","J Pharmacol Exp Ther","1999","1999/01/26","","",""
"9918551","Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes","Lysle DT, How T.","J Pharmacol Exp Ther. 1999 Feb;288(2):502-8.","Lysle DT","J Pharmacol Exp Ther","1999","1999/01/26","","",""
"9917888","Effect of mu-selective opioid antagonists on MIP-1 beta and IL-1 beta-induced fever","Handler CM, Price RW, Geller EB, Adler MW.","Ann N Y Acad Sci. 1998 Sep 29;856:270-3. doi: 10.1111/j.1749-6632.1998.tb08336.x.","Handler CM","Ann N Y Acad Sci","1998","1999/01/26","","","10.1111/j.1749-6632.1998.tb08336.x"
"9890406","Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism","Murphy DB, Murphy MB.","J Cardiovasc Pharmacol. 1999 Jan;33(1):122-5. doi: 10.1097/00005344-199901000-00018.","Murphy DB","J Cardiovasc Pharmacol","1999","1999/01/16","","","10.1097/00005344-199901000-00018"
"9884167","Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat","Stromberg MF, Volpicelli JR, O'Brien CP.","Alcohol Clin Exp Res. 1998 Dec;22(9):2186-91.","Stromberg MF","Alcohol Clin Exp Res","1998","1999/01/12","","",""
"9884166","The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats","June HL, Grey C, Warren-Reese C, Durr LF, Ricks-Cord A, Johnson A, McCane S, Williams LS, Mason D, Cummings R, Lawrence A.","Alcohol Clin Exp Res. 1998 Dec;22(9):2174-85.","June HL","Alcohol Clin Exp Res","1998","1999/01/12","","",""
"9879730","Endomorphin-1 and endomorphin-2 activate mu-opioid receptors in myenteric neurons of the guinea-pig small intestine","Tonini M, Fiori E, Balestra B, Spelta V, D'Agostino G, Di Nucci A, Brecha NC, Sternini C.","Naunyn Schmiedebergs Arch Pharmacol. 1998 Dec;358(6):686-9. doi: 10.1007/pl00005313.","Tonini M","Naunyn Schmiedebergs Arch Pharmacol","1998","1999/01/08","","","10.1007/pl00005313"
"9878785","Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV","Shane R, Wilk S, Bodnar RJ.","Brain Res. 1999 Jan 9;815(2):278-86. doi: 10.1016/s0006-8993(98)01121-4.","Shane R","Brain Res","1999","1999/01/08","","","10.1016/s0006-8993(98)01121-4"
"9871544","Synthesis and biological activity of 3-substituted 3-desoxynaltrindole derivatives","Kubota H, Rothman RB, Dersch C, McCullough K, Pinto J, Rice KC.","Bioorg Med Chem Lett. 1998 Apr 7;8(7):799-804. doi: 10.1016/s0960-894x(98)00105-x.","Kubota H","Bioorg Med Chem Lett","1998","1999/01/01","","","10.1016/s0960-894x(98)00105-x"
"9870938","Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence","Ignatova EG, Belcheva MM, Bohn LM, Neuman MC, Coscia CJ.","Version 2. J Neurosci. 1999 Jan 1;19(1):56-63. doi: 10.1523/JNEUROSCI.19-01-00056.1999.","Ignatova EG","J Neurosci","1999","1998/12/31","PMC2504521","NIHMS57748","10.1523/JNEUROSCI.19-01-00056.1999"
"9864294","Peripheral effects of opioids in a model of chronic intestinal inflammation in mice","Puig MM, Pol O.","J Pharmacol Exp Ther. 1998 Dec;287(3):1068-75.","Puig MM","J Pharmacol Exp Ther","1998","1998/12/24","","",""
"9864259","Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception","Su YF, McNutt RW, Chang KJ.","J Pharmacol Exp Ther. 1998 Dec;287(3):815-23.","Su YF","J Pharmacol Exp Ther","1998","1998/12/24","","",""
"9863971","Validation study of the conductometrical analysis. Application to the drug release studies from controlled release systems","Caraballo I, Alvarez-Fuentes J, Melgoza LM, Millán M, Holgado MA, Rabasco AM, Fernández-Arévalo M.","J Pharm Biomed Anal. 1998 Oct;18(1-2):281-5. doi: 10.1016/s0731-7085(98)00180-0.","Caraballo I","J Pharm Biomed Anal","1998","1998/12/24","","","10.1016/s0731-7085(98)00180-0"
"9862779","Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions","Kreek MJ, Schluger J, Borg L, Gunduz M, Ho A.","J Pharmacol Exp Ther. 1999 Jan;288(1):260-9.","Kreek MJ","J Pharmacol Exp Ther","1999","1998/12/23","","",""
"9862407","Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat","Easterling KW, Holtzman SG.","Psychopharmacology (Berl). 1998 Nov;140(1):91-7. doi: 10.1007/s002130050743.","Easterling KW","Psychopharmacology (Berl)","1998","1998/12/23","","","10.1007/s002130050743"
"9862398","The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor","Morgan D, Picker MJ.","Psychopharmacology (Berl). 1998 Nov;140(1):20-8. doi: 10.1007/s002130050734.","Morgan D","Psychopharmacology (Berl)","1998","1998/12/23","","","10.1007/s002130050734"
"9861326","Effects of chronic opioid antagonism on gonadotrophin and ovarian sex steroid secretion during the luteal phase","Rossmanith WG, Monn M, Benz R.","Clin Endocrinol (Oxf). 1998 Sep;49(3):343-51. doi: 10.1046/j.1365-2265.1998.00474.x.","Rossmanith WG","Clin Endocrinol (Oxf)","1998","1998/12/23","","","10.1046/j.1365-2265.1998.00474.x"
"9860109","Naltrexone administration affects ad libitum smoking behavior","Wewers ME, Dhatt R, Tejwani GA.","Psychopharmacology (Berl). 1998 Nov;140(2):185-90. doi: 10.1007/s002130050756.","Wewers ME","Psychopharmacology (Berl)","1998","1998/12/22","","","10.1007/s002130050756"
"9856954","Regulation of cocaine reward by CREB","Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ.","Science. 1998 Dec 18;282(5397):2272-5. doi: 10.1126/science.282.5397.2272.","Carlezon WA Jr","Science","1998","1998/12/18","","","10.1126/science.282.5397.2272"
"9852601","Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens","Gonzales RA, Weiss F.","J Neurosci. 1998 Dec 15;18(24):10663-71. doi: 10.1523/JNEUROSCI.18-24-10663.1998.","Gonzales RA","J Neurosci","1998","1998/12/16","PMC6793337","","10.1523/JNEUROSCI.18-24-10663.1998"
"9846635","Weaning-induced development of delta-opioid receptors in rat brain: differential effects of guanine nucleotides and sodium upon ligand-receptor recognition","Kelly MD, Hill RG, Borsodi A, Toth G, Kitchen I.","Br J Pharmacol. 1998 Nov;125(5):979-86. doi: 10.1038/sj.bjp.0702142.","Kelly MD","Br J Pharmacol","1998","1998/12/10","PMC1565665","","10.1038/sj.bjp.0702142"
"9845936","[Preventive therapy of opiate addiction with naltrexone]","Sivolap IuP, Savchenkov VA.","Zh Nevrol Psikhiatr Im S S Korsakova. 1998;98(11):22-5.","Sivolap IuP","Zh Nevrol Psikhiatr Im S S Korsakova","1998","1998/12/10","","",""
"9845042","Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse","O'Malley SS.","Alcohol Alcohol Suppl. 1996 Mar;31(1):77-81.","O'Malley SS","Alcohol Alcohol Suppl","1996","1996/03/01","","",""
"9845037","Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions","Anton RF.","Alcohol Alcohol Suppl. 1996 Mar;31(1):43-53.","Anton RF","Alcohol Alcohol Suppl","1996","1996/03/01","","",""
"9845000","Intrathecal administration of p-hydroxymercuribenzoate or phosphoramidon/bestatin-combined induces antinociceptive effects through different opioid mechanisms","Tan-No K, Taira A, Inoue M, Ohshima K, Sakurada T, Sakurada C, Nylander I, Demuth HU, Silberring J, Terenius L, Tadano T, Kisara K.","Neuropeptides. 1998 Oct;32(5):411-5. doi: 10.1016/s0143-4179(98)90064-6.","Tan-No K","Neuropeptides","1998","1998/12/09","","","10.1016/s0143-4179(98)90064-6"
"9843861","beta-Endorphin and natural killer cell cytolytic activity during prolonged exercise. is there a connection?","Gannon GA, Rhind SG, Suzui M, Zamecnik J, Sabiston BH, Shek PN, Shephard RJ.","Am J Physiol. 1998 Dec;275(6):R1725-34. doi: 10.1152/ajpregu.1998.275.6.R1725.","Gannon GA","Am J Physiol","1998","1998/12/09","","","10.1152/ajpregu.1998.275.6.R1725"
"9839150","Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results","Cucchia AT, Monnat M, Spagnoli J, Ferrero F, Bertschy G.","Drug Alcohol Depend. 1998 Nov 1;52(3):243-50. doi: 10.1016/s0376-8716(98)00100-8.","Cucchia AT","Drug Alcohol Depend","1998","1998/12/05","","","10.1016/s0376-8716(98)00100-8"
"9839147","Serum time course of naltrexone and 6 beta-naltrexol levels during long-term treatment in drug addicts","Ferrari A, Bertolotti M, Dell'Utri A, Avico U, Sternieri E.","Drug Alcohol Depend. 1998 Nov 1;52(3):211-20. doi: 10.1016/s0376-8716(98)00098-2.","Ferrari A","Drug Alcohol Depend","1998","1998/12/05","","","10.1016/s0376-8716(98)00098-2"
"9836606","Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors","Jones RM, Hjorth SA, Schwartz TW, Portoghese PS.","J Med Chem. 1998 Dec 3;41(25):4911-4. doi: 10.1021/jm9805182.","Jones RM","J Med Chem","1998","1998/12/04","","","10.1021/jm9805182"
"9835275","Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor","Williams KL, Woods JH.","Alcohol Clin Exp Res. 1998 Nov;22(8):1634-9. doi: 10.1111/j.1530-0277.1998.tb03960.x.","Williams KL","Alcohol Clin Exp Res","1998","1998/12/03","","","10.1111/j.1530-0277.1998.tb03960.x"
"9833574","How is naltrexone used in the treatment of alcoholism?","Osser DN.","Harv Ment Health Lett. 1998 Dec;15(6):8.","Osser DN","Harv Ment Health Lett","1998","1998/12/02","","",""
"9832980","Behavioural effects induced by nitrous oxide in rats performing a vigilance task","Courtière A, Hardouin J.","Behav Pharmacol. 1997 Oct;8(5):408-15.","Courtière A","Behav Pharmacol","1997","1998/12/02","","",""
"9832959","Effect of naltrexone and its derivatives, nalmefene and naltrindole, on conditioned anticipatory behaviour and saccharin intake in rats","Chow BL, Sellers EM, Tomkins DM.","Behav Pharmacol. 1997 Dec;8(8):725-35. doi: 10.1097/00008877-199712000-00008.","Chow BL","Behav Pharmacol","1997","1998/12/02","","","10.1097/00008877-199712000-00008"
"9832943","Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats","Longoni R, Cadoni C, Mulas A, Di Chiara G, Spina L.","Behav Pharmacol. 1998 Feb;9(1):9-14.","Longoni R","Behav Pharmacol","1998","1998/12/02","","",""
"9831304","Naltrexone effects on insulin sensitivity and insulin secretion in hyperandrogenic women","Sir-Petermann T, López G, Castillo T, Calvillán M, Rabenbauer B, Wildt L.","Exp Clin Endocrinol Diabetes. 1998;106(5):389-94. doi: 10.1055/s-0029-1212004.","Sir-Petermann T","Exp Clin Endocrinol Diabetes","1998","1998/11/27","","","10.1055/s-0029-1212004"
"9830862","Reentry using naltrexone: one anesthesia department's experience","Hudson S.","AANA J. 1998 Aug;66(4):360-4.","Hudson S","AANA J","1998","1998/11/27","","",""
"9825182","Time window for the contribution of the delta-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart","Tsuchida A, Miura T, Tanno M, Nozawa Y, Kita H, Shimamoto K.","Cardiovasc Drugs Ther. 1998 Sep;12(4):365-73. doi: 10.1023/a:1007720801004.","Tsuchida A","Cardiovasc Drugs Ther","1998","1998/11/24","","","10.1023/a:1007720801004"
"9822884","Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats","Kuzmin AV, Gerrits MA, Van Ree JM.","Eur J Pharmacol. 1998 Oct 9;358(3):197-202. doi: 10.1016/s0014-2999(98)00637-2.","Kuzmin AV","Eur J Pharmacol","1998","1998/11/21","","","10.1016/s0014-2999(98)00637-2"
"9819798","Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice","Kameyama T, Ukai M, Shinkai N.","Methods Find Exp Clin Pharmacol. 1998 Sep;20(7):555-60. doi: 10.1358/mf.1998.20.7.485718.","Kameyama T","Methods Find Exp Clin Pharmacol","1998","1998/11/20","","","10.1358/mf.1998.20.7.485718"
"9815027","5-HT4 receptor agonists and delta-opioid receptor antagonists act synergistically to stimulate colonic propulsion","Foxx-Orenstein AE, Jin JG, Grider JR.","Am J Physiol. 1998 Nov;275(5):G979-83. doi: 10.1152/ajpgi.1998.275.5.G979.","Foxx-Orenstein AE","Am J Physiol","1998","1998/11/14","","","10.1152/ajpgi.1998.275.5.G979"
"9812711","Anxiogenic effect of naltrexone in social interaction test in rats","Zhang HT, Xu ZM, Luo ZP, Qin BY.","Zhongguo Yao Li Xue Bao. 1996 Jul;17(4):314-7.","Zhang HT","Zhongguo Yao Li Xue Bao","1996","1996/07/01","","",""
"9810190","[Medical treatment of alcohol dependence]","Gache P, Siegrist G.","Rev Med Suisse Romande. 1998 Sep;118(9):767-9.","Gache P","Rev Med Suisse Romande","1998","1998/11/12","","",""
"9809509","Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands","Endres CJ, Carson RE.","J Cereb Blood Flow Metab. 1998 Nov;18(11):1196-210. doi: 10.1097/00004647-199811000-00006.","Endres CJ","J Cereb Blood Flow Metab","1998","1998/11/11","","","10.1097/00004647-199811000-00006"
"9806215","Opioid involvement in behavior modifications of mice infected with the parasitic nematode, Nippostrongylus brasiliensis","Pryor SC, Carter C, Mendes M, Cherian E.","Life Sci. 1998;63(18):1619-28. doi: 10.1016/s0024-3205(98)00431-7.","Pryor SC","Life Sci","1998","1998/11/07","","","10.1016/s0024-3205(98)00431-7"
"9804884","The effect of pentylenetetrazol kindling on synaptic mechanisms of interacting glutamatergic and opioid system in the hippocampus of rats","Schroeder H, Becker A, Grecksch G, Schroeder U, Hoellt V.","Brain Res. 1998 Nov 16;811(1-2):40-6. doi: 10.1016/s0006-8993(98)00929-9.","Schroeder H","Brain Res","1998","1998/11/07","","","10.1016/s0006-8993(98)00929-9"
"9802524","Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism","Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, Perret G, King A, Kreek MJ.","Alcohol Clin Exp Res. 1998 Oct;22(7):1430-6. doi: 10.1111/j.1530-0277.1998.tb03931.x.","Schluger JH","Alcohol Clin Exp Res","1998","1998/11/05","","","10.1111/j.1530-0277.1998.tb03931.x"
"9801385","kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo","Brown CH, Ludwig M, Leng G.","J Neurosci. 1998 Nov 15;18(22):9480-8. doi: 10.1523/JNEUROSCI.18-22-09480.1998.","Brown CH","J Neurosci","1998","1998/11/05","PMC6792869","","10.1523/JNEUROSCI.18-22-09480.1998"
"9800146","Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage","D'Ippoliti D, Davoli M, Perucci CA, Pasqualini F, Bargagli AM.","Drug Alcohol Depend. 1998 Oct 1;52(2):167-71. doi: 10.1016/s0376-8716(98)00091-x.","D'Ippoliti D","Drug Alcohol Depend","1998","1998/11/04","","","10.1016/s0376-8716(98)00091-x"
"9800145","Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine","Yuan CS, Foss JF, O'Connor M, Osinski J, Roizen MF, Moss J.","Drug Alcohol Depend. 1998 Oct 1;52(2):161-5. doi: 10.1016/s0376-8716(98)00087-8.","Yuan CS","Drug Alcohol Depend","1998","1998/11/04","","","10.1016/s0376-8716(98)00087-8"
"9800143","Effects of beta-funaltrexamine on dose-effect curves for heroin self-administration in rats: comparison with alteration of [3H]DAMGO binding to rat brain sections","Martin TJ, DeMontis MG, Kim SA, Sizemore GM, Dworkin SI, Smith JE.","Drug Alcohol Depend. 1998 Oct 1;52(2):135-47. doi: 10.1016/s0376-8716(98)00082-9.","Martin TJ","Drug Alcohol Depend","1998","1998/11/04","","","10.1016/s0376-8716(98)00082-9"
"9799662","Phospholipase C inhibitors attenuate arrhythmias induced by kappa-receptor stimulation in the isolated rat heart","Bian JS, Zhang WM, Xia Q, Wong TM.","J Mol Cell Cardiol. 1998 Oct;30(10):2103-10. doi: 10.1006/jmcc.1998.0774.","Bian JS","J Mol Cell Cardiol","1998","1998/11/04","","","10.1006/jmcc.1998.0774"
"9799403","Inhibition of the neuronal nicotinic receptor-mediated current by kappa opioid receptor agonists in PC12 cells","Oka K, Andoh T, Watanabe I, Kamiya Y, Ito H.","Pflugers Arch. 1998 Nov;436(6):887-93. doi: 10.1007/s004240050719.","Oka K","Pflugers Arch","1998","1998/11/03","","","10.1007/s004240050719"
"9797933","Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions","Mills IH, Park GR, Manara AR, Merriman RJ.","QJM. 1998 Jul;91(7):493-503. doi: 10.1093/qjmed/91.7.493.","Mills IH","QJM","1998","1998/11/03","","","10.1093/qjmed/91.7.493"
"9797033","Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats","Catheline G, Guilbaud G, Kayser V.","Eur J Pharmacol. 1998 Sep 18;357(2-3):171-8. doi: 10.1016/s0014-2999(98)00597-4.","Catheline G","Eur J Pharmacol","1998","1998/10/31","","","10.1016/s0014-2999(98)00597-4"
"9796603","Simultaneous increases in respiration and sympathetic function during opiate detoxification","Hoffman WE, McDonald T, Berkowitz R.","J Neurosurg Anesthesiol. 1998 Oct;10(4):205-10. doi: 10.1097/00008506-199810000-00001.","Hoffman WE","J Neurosurg Anesthesiol","1998","1998/10/31","","","10.1097/00008506-199810000-00001"
"9795212","MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions","Roy S, Barke RA, Loh HH.","Brain Res Mol Brain Res. 1998 Oct 30;61(1-2):190-4. doi: 10.1016/s0169-328x(98)00212-5.","Roy S","Brain Res Mol Brain Res","1998","1998/10/31","","","10.1016/s0169-328x(98)00212-5"
"9789158","Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism","Swift RM, Duncan D, Nirenberg T, Femino J.","J Addict Dis. 1998;17(3):35-47. doi: 10.1300/J069v17n03_04.","Swift RM","J Addict Dis","1998","1998/10/28","","","10.1300/J069v17n03_04"
"9783840","New treatment options for substance abuse from a public health viewpoint","Sinclair JD.","Ann Med. 1998 Aug;30(4):406-11. doi: 10.3109/07853899809029941.","Sinclair JD","Ann Med","1998","1998/10/23","","","10.3109/07853899809029941"
"9771587","Intracerebroventricular injection of mu- and delta-opiate receptor antagonists block 60 Hz magnetic field-induced decreases in cholinergic activity in the frontal cortex and hippocampus of the rat","Lai H, Carino M.","Bioelectromagnetics. 1998;19(7):432-7.","Lai H","Bioelectromagnetics","1998","1998/10/15","","",""
"9770647","Identification of L-type calcium channels associated with kappa opioid receptors in human placenta","Cemerikic B, Zamah R, Ahmed MS.","J Mol Neurosci. 1998 Jun;10(3):261-72. doi: 10.1007/BF02761779.","Cemerikic B","J Mol Neurosci","1998","1998/10/15","","","10.1007/BF02761779"
"9768542","Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys","Williams KL, Winger G, Pakarinen ED, Woods JH.","Psychopharmacology (Berl). 1998 Sep;139(1-2):53-61. doi: 10.1007/s002130050689.","Williams KL","Psychopharmacology (Berl)","1998","1998/10/13","","","10.1007/s002130050689"
"9768541","Naltrexone treatment of comorbid alcohol and cocaine use disorders","Hersh D, Van Kirk JR, Kranzler HR.","Psychopharmacology (Berl). 1998 Sep;139(1-2):44-52. doi: 10.1007/s002130050688.","Hersh D","Psychopharmacology (Berl)","1998","1998/10/13","","","10.1007/s002130050688"
"9768539","Advances in development of medications for alcoholism treatment","Litten RZ, Allen JP.","Psychopharmacology (Berl). 1998 Sep;139(1-2):20-33. doi: 10.1007/s002130050686.","Litten RZ","Psychopharmacology (Berl)","1998","1998/10/13","","","10.1007/s002130050686"
"9767654","7-Arylidenenaltrexones as selective delta1 opioid receptor antagonists","Ohkawa S, Portoghese PS.","J Med Chem. 1998 Oct 8;41(21):4177-80. doi: 10.1021/jm980384s.","Ohkawa S","J Med Chem","1998","1998/10/10","","","10.1021/jm980384s"
"9766834","Sex differences in opioid and N-methyl-D-aspartate mediated non-opioid biting fly exposure induced analgesia in deer mice","Kavaliers M, Colwell DD, Choleris E.","Pain. 1998 Aug;77(2):163-71. doi: 10.1016/s0304-3959(98)00092-x.","Kavaliers M","Pain","1998","1998/10/10","","","10.1016/s0304-3959(98)00092-x"
"9765353","Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species","Tsao LI, Ladenheim B, Andrews AM, Chiueh CC, Cadet JL, Su TP.","J Pharmacol Exp Ther. 1998 Oct;287(1):322-31.","Tsao LI","J Pharmacol Exp Ther","1998","1998/10/09","","",""
"9765348","Contribution of the opioid system to alcohol aversion and alcohol drinking behavior","Froehlich JC, Badia-Elder NE, Zink RW, McCullough DE, Portoghese PS.","J Pharmacol Exp Ther. 1998 Oct;287(1):284-92.","Froehlich JC","J Pharmacol Exp Ther","1998","1998/10/09","","",""
"9765343","Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats","Sezen SF, Kenigs VA, Kapusta DR.","J Pharmacol Exp Ther. 1998 Oct;287(1):238-45.","Sezen SF","J Pharmacol Exp Ther","1998","1998/10/09","","",""
"9762206","[Opiod antagonists and treatment of cholestatic pruritus]","Sapey T.","Gastroenterol Clin Biol. 1998 Feb;22(2):255-6.","Sapey T","Gastroenterol Clin Biol","1998","1998/10/08","","",""
"9756153","Adult head-banging and stereotypic movement disorders","Mendez MF, Mirea A.","Mov Disord. 1998 Sep;13(5):825-8. doi: 10.1002/mds.870130512.","Mendez MF","Mov Disord","1998","1998/10/02","","","10.1002/mds.870130512"
"9756033","Reversal of ethanol-induced testosterone suppression in peripubertal male rats by opiate blockade","Emanuele MA, LaPaglia N, Steiner J, Jabamoni K, Hansen M, Kirsteins L, Emanuele NV.","Alcohol Clin Exp Res. 1998 Sep;22(6):1199-204.","Emanuele MA","Alcohol Clin Exp Res","1998","1998/10/02","","",""
"9754924","Apparent thermodynamic parameters of ligand binding to the cloned rat mu-opioid receptor","Li JG, Raffa RB, Cheung P, Tzeng TB, Liu-Chen LY.","Eur J Pharmacol. 1998 Aug 7;354(2-3):227-37. doi: 10.1016/s0014-2999(98)00444-0.","Li JG","Eur J Pharmacol","1998","1998/10/01","","","10.1016/s0014-2999(98)00444-0"
"9749928","Relationship between inhibitory effect of endogenous opioid via mu-receptors and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum","Nishiwaki H, Saitoh N, Nishio H, Takeuchi T, Hata F.","Jpn J Pharmacol. 1998 Aug;77(4):279-86. doi: 10.1254/jjp.77.279.","Nishiwaki H","Jpn J Pharmacol","1998","1998/09/28","","","10.1254/jjp.77.279"
"9748566","Association between the amygdala and nucleus of the solitary tract in mu-opioid induced feeding in the rat","Giraudo SQ, Kotz CM, Billington CJ, Levine AS.","Brain Res. 1998 Aug 17;802(1-2):184-8. doi: 10.1016/s0006-8993(98)00602-7.","Giraudo SQ","Brain Res","1998","1998/09/28","","","10.1016/s0006-8993(98)00602-7"
"9747902","Naltrexone, but not atropine or yohimbine, antagonizes suppression of formalin-induced spinal sensitization by intrathecal nociceptin","Hao S, Ogawa H.","Life Sci. 1998;63(11):PL 167-73. doi: 10.1016/s0024-3205(98)00359-2.","Hao S","Life Sci","1998","1998/09/25","","","10.1016/s0024-3205(98)00359-2"
"9746454","Treatment of obsessive-compulsive cutting behavior with naltrexone","Bystritsky A, Strausser BP.","J Clin Psychiatry. 1996 Sep;57(9):423-4.","Bystritsky A","J Clin Psychiatry","1996","1996/09/01","","",""
"9744938","Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms","Yu TP, Xie CW.","J Neurophysiol. 1998 Sep;80(3):1277-84. doi: 10.1152/jn.1998.80.3.1277.","Yu TP","J Neurophysiol","1998","1998/09/24","","","10.1152/jn.1998.80.3.1277"
"9744773","Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine","Foss JF, Yuan CS, Roizen MF, Goldberg LI.","Cancer Chemother Pharmacol. 1998;42(4):287-91. doi: 10.1007/s002800050819.","Foss JF","Cancer Chemother Pharmacol","1998","1998/09/23","","","10.1007/s002800050819"
"9744578","Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures","Chao CC, Gekker G, Hu S, Kravitz F, Peterson PK.","Biochem Pharmacol. 1998 Aug 1;56(3):397-404. doi: 10.1016/s0006-2952(98)00161-0.","Chao CC","Biochem Pharmacol","1998","1998/09/23","","","10.1016/s0006-2952(98)00161-0"
"9744564","Delta-opioid suppression of human immunodeficiency virus-1 expression in T cells (Jurkat)","Sharp BM, Gekker G, Li MD, Chao CC, Peterson PK.","Biochem Pharmacol. 1998 Aug 1;56(3):289-92. doi: 10.1016/s0006-2952(98)00155-5.","Sharp BM","Biochem Pharmacol","1998","1998/09/23","","","10.1016/s0006-2952(98)00155-5"
"9739155","Opiate receptor avidity is reduced in non-motor impaired MPTP-lesioned rhesus monkeys","Cohen RM, Carson RE, Aigner TG, Doudet DJ.","Brain Res. 1998 Sep 28;806(2):292-6. doi: 10.1016/s0006-8993(98)00777-x.","Cohen RM","Brain Res","1998","1998/09/18","","","10.1016/s0006-8993(98)00777-x"
"9738534","Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone","Pabello NG, Hubbell CL, Cavallaro CA, Barringer TM, Mendez JJ, Reid LD.","Pharmacol Biochem Behav. 1998 Oct;61(2):181-92. doi: 10.1016/s0091-3057(98)00084-7.","Pabello NG","Pharmacol Biochem Behav","1998","1998/09/17","","","10.1016/s0091-3057(98)00084-7"
"9737222","Developments in the treatment of alcoholism","Tinsley JA, Finlayson RE, Morse RM.","Mayo Clin Proc. 1998 Sep;73(9):857-63. doi: 10.4065/73.9.857.","Tinsley JA","Mayo Clin Proc","1998","1998/09/16","","","10.4065/73.9.857"
"9733960","Neuroanatomical patterns of fos-like immunoreactivity induced by a palatable meal and meal-paired environment in saline- and naltrexone-treated rats","Park TH, Carr KD.","Brain Res. 1998 Sep 14;805(1-2):169-80. doi: 10.1016/s0006-8993(98)00719-7.","Park TH","Brain Res","1998","1998/09/12","","","10.1016/s0006-8993(98)00719-7"
"9733946","Effects of preweanling chronic naltrindole administration on stress-induced antinociceptive responses in rats","Antelo MT, Fernández B, Kitchen I, Viveros MP.","Brain Res Dev Brain Res. 1998 Sep 10;110(1):127-30. doi: 10.1016/s0165-3806(98)00095-9.","Antelo MT","Brain Res Dev Brain Res","1998","1998/09/12","","","10.1016/s0165-3806(98)00095-9"
"9732026","Health evaluation of free-ranging guanaco (Lama guanicoe)","Karesh WB, Uhart MM, Dierenfeld ES, Braselton WE, Torres A, House C, Puche H, Cook RA.","J Zoo Wildl Med. 1998 Jun;29(2):134-41.","Karesh WB","J Zoo Wildl Med","1998","1998/09/10","","",""
"9729364","Involvement of mu- and delta-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress","Matsuzawa S, Suzuki T, Misawa M, Nagase H.","Brain Res. 1998 Aug 24;803(1-2):169-77. doi: 10.1016/s0006-8993(98)00679-9.","Matsuzawa S","Brain Res","1998","1998/09/05","","","10.1016/s0006-8993(98)00679-9"
"9729280","Re-epithelialization of the rabbit cornea is regulated by opioid growth factor","Zagon IS, Sassani JW, McLaughlin PJ.","Brain Res. 1998 Aug 24;803(1-2):61-8. doi: 10.1016/s0006-8993(98)00610-6.","Zagon IS","Brain Res","1998","1998/09/05","","","10.1016/s0006-8993(98)00610-6"
"9726837","Role of central mu-opioid receptors in the modulation of nitric oxide production by splenocytes","Schneider GM, Lysle DT.","J Neuroimmunol. 1998 Aug 14;89(1-2):150-9. doi: 10.1016/s0165-5728(98)00128-3.","Schneider GM","J Neuroimmunol","1998","1998/09/03","","","10.1016/s0165-5728(98)00128-3"
"9726640","The delta1-opioid receptor antagonist, 7-(benzospiroindanyl)naltrexone [correction of 7-benzylspiroindanylnaltrexone], prolongs renal allograft survival in a rat model","Linner KM, Stickney BJ, Quist HE, Sharp BM, Portoghese PS.","Eur J Pharmacol. 1998 Jul 31;354(1):R3-5. doi: 10.1016/s0014-2999(98)00477-4.","Linner KM","Eur J Pharmacol","1998","1998/09/03","","","10.1016/s0014-2999(98)00477-4"
"9726624","Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model","Tejedor-Real P, Micó JA, Smadja C, Maldonado R, Roques BP, Gilbert-Rahola J.","Eur J Pharmacol. 1998 Jul 31;354(1):1-7. doi: 10.1016/s0014-2999(98)00423-3.","Tejedor-Real P","Eur J Pharmacol","1998","1998/09/03","","","10.1016/s0014-2999(98)00423-3"
"9726277","Sustained-release naltrexone for alcoholism treatment: a preliminary study","Kranzler HR, Modesto-Lowe V, Nuwayser ES.","Alcohol Clin Exp Res. 1998 Aug;22(5):1074-9.","Kranzler HR","Alcohol Clin Exp Res","1998","1998/09/03","","",""
"9724290","Role of opioids in hypoxic pial artery dilation is stimulus duration dependent","Armstead WM.","Am J Physiol. 1998 Sep;275(3):H861-7. doi: 10.1152/ajpheart.1998.275.3.H861.","Armstead WM","Am J Physiol","1998","1998/09/02","","","10.1152/ajpheart.1998.275.3.H861"
"9722357","Rapid opioid detoxification under anaesthesia","Cook TM, Collins PD.","Hosp Med. 1998 Mar;59(3):245-7.","Cook TM","Hosp Med","1998","1998/08/29","","",""
"9712411","The effect of acute stress and opioid antagonist on the activity of NADPH-P450 reductase in rat Leydig cells","Kostić T, Andrić S, Marić D, Kovacević R.","J Steroid Biochem Mol Biol. 1998 Jul;66(1-2):51-4. doi: 10.1016/s0960-0760(98)00003-x.","Kostić T","J Steroid Biochem Mol Biol","1998","1998/08/26","","","10.1016/s0960-0760(98)00003-x"
"9712193","Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids","Spetea M, Nevin ST, Hosztafi S, Rónai AZ, Tóth G, Borsodi A.","Neurochem Res. 1998 Sep;23(9):1211-6. doi: 10.1023/a:1020738304036.","Spetea M","Neurochem Res","1998","1998/08/26","","","10.1023/a:1020738304036"
"9709489","Chemiluminescence determination of naltrexone based on potassium permanganate oxidation","Campiglio A.","Analyst. 1998 May;123(5):1053-6. doi: 10.1039/a706647c.","Campiglio A","Analyst","1998","1998/08/26","","","10.1039/a706647c"
"9707654","Pain tolerance in opioid addicts on and off naltrexone pharmacotherapy: a pilot study","Compton P.","J Pain Symptom Manage. 1998 Jul;16(1):21-8. doi: 10.1016/s0885-3924(98)00035-9.","Compton P","J Pain Symptom Manage","1998","1998/08/26","","","10.1016/s0885-3924(98)00035-9"
"9705580","Acetyl salmon endorphin-like and interrenal stress response in male gilthead sea bream, Sparus aurata","Mosconi G, Gallinelli A, Polzonetti-Magni AM, Facchinetti F.","Neuroendocrinology. 1998 Aug;68(2):129-34. doi: 10.1159/000054359.","Mosconi G","Neuroendocrinology","1998","1998/08/15","","","10.1159/000054359"
"9702615","Ultra-rapid opioid detoxification increases spontaneous ventilation","Hoffman WE, Berkowitz R, McDonald T, Hass F.","J Clin Anesth. 1998 Aug;10(5):372-6. doi: 10.1016/s0952-8180(98)00047-6.","Hoffman WE","J Clin Anesth","1998","1998/08/14","","","10.1016/s0952-8180(98)00047-6"
"9700968","A combination of isradipine and naltrexone blocks cocaine's enhancement of a cocaine place preference","Cramer CM, Hubbell CL, Reid LD.","Pharmacol Biochem Behav. 1998 Aug;60(4):847-53. doi: 10.1016/s0091-3057(98)00063-x.","Cramer CM","Pharmacol Biochem Behav","1998","1998/08/13","","","10.1016/s0091-3057(98)00063-x"
"9696425","Selective in vivo binding of [3H]naltriben to delta-opioid receptors in mouse brain","Lever JR, Scheffel U.","Eur J Pharmacol. 1998 Jun 5;350(2-3):335-44. doi: 10.1016/s0014-2999(98)00268-4.","Lever JR","Eur J Pharmacol","1998","1998/08/08","","","10.1016/s0014-2999(98)00268-4"
"9695440","Naltrexone in children with autism","Buitelaar JK, Willemsen-Swinkels S, Van Engeland H.","J Am Acad Child Adolesc Psychiatry. 1998 Aug;37(8):800-2. doi: 10.1097/00004583-199808000-00006.","Buitelaar JK","J Am Acad Child Adolesc Psychiatry","1998","1998/08/08","","","10.1097/00004583-199808000-00006"
"9692272","A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts","Landabaso MA, Iraurgi I, Jiménez-Lerma JM, Sanz J, Fernádez de Corres B, Araluce K, Calle R, Gutiérrez-Fraile M.","Addiction. 1998 May;93(5):739-44. doi: 10.1046/j.1360-0443.1998.9357399.x.","Landabaso MA","Addiction","1998","1998/08/06","","","10.1046/j.1360-0443.1998.9357399.x"
"9690858","The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds","Gray AM, Spencer PS, Sewell RD.","Br J Pharmacol. 1998 Jun;124(4):669-74. doi: 10.1038/sj.bjp.0701882.","Gray AM","Br J Pharmacol","1998","1998/08/05","PMC1565439","","10.1038/sj.bjp.0701882"
"9690068","[Differences in the effects of naltrexone on the communicative and aggressive behaviors of subjects with different experiences of social conquests]","Lipina TV, Avgustinovich DF, Koriakina LA, Aleksaeenko OV, Kudriavtseva NN.","Eksp Klin Farmakol. 1998 May-Jun;61(3):13-8.","Lipina TV","Eksp Klin Farmakol","1998","1998/08/05","","",""
"9688682","Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat","Kotz CM, Briggs JE, Grace MK, Levine AS, Billington CJ.","Am J Physiol. 1998 Aug;275(2):R471-7. doi: 10.1152/ajpregu.1998.275.2.R471.","Kotz CM","Am J Physiol","1998","1998/08/04","","","10.1152/ajpregu.1998.275.2.R471"
"9688462","Beta-funaltrexamine discriminates between two subtypes of mu2-opioid receptors in electrically stimulated longitudinal muscle of guinea pig ileum","Takayanagi I, Okayasu A, Koike K, Suzuki T, Kizawa Y.","Gen Pharmacol. 1998 Aug;31(2):215-20. doi: 10.1016/s0306-3623(97)00460-6.","Takayanagi I","Gen Pharmacol","1998","1998/08/04","","","10.1016/s0306-3623(97)00460-6"
"9687292","Imidazoles suppress rat testosterone secretion and testicular interstitial fluid formation In vivo","Adams ML, Meyer ER, Cicero TJ.","Biol Reprod. 1998 Aug;59(2):248-54. doi: 10.1095/biolreprod59.2.248.","Adams ML","Biol Reprod","1998","1998/08/01","","","10.1095/biolreprod59.2.248"
"9687089","Naltrexone suppresses the rejection of cardiac tissue transplantation","Li YF, Wang JX, Shao L, Ding GF, Ottaviani E, Stefano GB, Bilfinger TV, Fan SG.","Int J Cardiol. 1998 Apr 30;64 Suppl 1:S23-7. doi: 10.1016/s0167-5273(98)00032-1.","Li YF","Int J Cardiol","1998","1998/08/01","","","10.1016/s0167-5273(98)00032-1"
"9685249","Synthesis of 7-arylmorphinans. Probing the ""address"" requirements for selectivity at opioid delta receptors","Gao P, Larson DL, Portoghese PS.","J Med Chem. 1998 Jul 30;41(16):3091-8. doi: 10.1021/jm9802214.","Gao P","J Med Chem","1998","1998/07/31","","","10.1021/jm9802214"
"9682822","NTI4F: a non-peptide fluorescent probe selective for functional delta opioid receptors","Kshirsagar T, Nakano AH, Law PY, Elde R, Portoghese PS.","Neurosci Lett. 1998 Jun 19;249(2-3):83-6. doi: 10.1016/s0304-3940(98)00379-6.","Kshirsagar T","Neurosci Lett","1998","1998/07/31","","","10.1016/s0304-3940(98)00379-6"
"9680247","The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide","Agmo A, Belzung C.","Neuropharmacology. 1998;37(2):223-32. doi: 10.1016/s0028-3908(98)00003-3.","Agmo A","Neuropharmacology","1998","1998/07/29","","","10.1016/s0028-3908(98)00003-3"
"9678655","Genetic relationship between central beta-endorphin and novelty-induced locomotor activity","Radcliffe RA, Erwin VG.","Pharmacol Biochem Behav. 1998 Jul;60(3):709-18. doi: 10.1016/s0091-3057(98)00045-8.","Radcliffe RA","Pharmacol Biochem Behav","1998","1998/07/25","","","10.1016/s0091-3057(98)00045-8"
"9678650","Pharmacological profile of a deuterium-substituted mirfentanil derivative, OHM10579, in rhesus monkeys","Lelas S, Gerak LR, Landers LK, Brandt MR, Bagley JR, Brockunier LL, France CP.","Pharmacol Biochem Behav. 1998 Jul;60(3):665-75. doi: 10.1016/s0091-3057(98)00046-x.","Lelas S","Pharmacol Biochem Behav","1998","1998/07/25","","","10.1016/s0091-3057(98)00046-x"
"9673794","Pharmacological studies on the ""orphan"" opioid receptor in central and peripheral sites","Nicholson JR, Paterson SJ, Menzies JR, Corbett AD, McKnight AT.","Can J Physiol Pharmacol. 1998 Mar;76(3):304-13.","Nicholson JR","Can J Physiol Pharmacol","1998","1998/07/23","","",""
"9669488","Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia","Leventhal L, Mathis JP, Rossi GC, Pasternak GW, Bodnar RJ.","Eur J Pharmacol. 1998 May 15;349(1):R1-3. doi: 10.1016/s0014-2999(98)00272-6.","Leventhal L","Eur J Pharmacol","1998","1998/07/21","","","10.1016/s0014-2999(98)00272-6"
"9667975","Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety","Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB.","J Med Chem. 1998 Jul 16;41(15):2872-81. doi: 10.1021/jm980083i.","Ananthan S","J Med Chem","1998","1998/07/21","","","10.1021/jm980083i"
"9666270","Novel non-peptidic opioid compounds with immunopotentiating effects","Riley ME, Ananthan S, Weber RJ.","Adv Exp Med Biol. 1998;437:183-7. doi: 10.1007/978-1-4615-5347-2_20.","Riley ME","Adv Exp Med Biol","1998","1998/07/17","","","10.1007/978-1-4615-5347-2_20"
"9666256","The expression of interleukin-1-beta converting enzyme (ICE) in rat is decreased following chronic exposure to morphine","Wu GD, Graf JA, Zadina JE, Chang SL.","Adv Exp Med Biol. 1998;437:51-8. doi: 10.1007/978-1-4615-5347-2_6.","Wu GD","Adv Exp Med Biol","1998","1998/07/17","","","10.1007/978-1-4615-5347-2_6"
"9666142","Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors","Zagon IS, Sassani JW, McLaughlin PJ.","Brain Res. 1998 Jul 6;798(1-2):254-60. doi: 10.1016/s0006-8993(98)00427-2.","Zagon IS","Brain Res","1998","1998/07/17","","","10.1016/s0006-8993(98)00427-2"
"9655893","Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine","Tao R, Ma Z, Auerbach SB.","J Pharmacol Exp Ther. 1998 Jul;286(1):481-8.","Tao R","J Pharmacol Exp Ther","1998","1998/07/10","","",""
"9655854","The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys","Ko MC, Butelman ER, Woods JH.","J Pharmacol Exp Ther. 1998 Jul;286(1):150-6.","Ko MC","J Pharmacol Exp Ther","1998","1998/07/10","PMC2866037","NIHMS196249",""
"9655842","Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone","Rowlett JK, Wilcox KM, Woolverton WL.","J Pharmacol Exp Ther. 1998 Jul;286(1):61-9.","Rowlett JK","J Pharmacol Exp Ther","1998","1998/07/10","","",""
"9655606","Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons","Lai SL, Gu Y, Huang LY.","Neurosci Lett. 1998 May 15;247(2-3):115-8. doi: 10.1016/s0304-3940(98)00293-6.","Lai SL","Neurosci Lett","1998","1998/07/09","","","10.1016/s0304-3940(98)00293-6"
"9651172","14-Desoxy analogues of naltrindole and 7-spiroindanyloxymorphone: the role of the 14-hydroxy group at delta opioid receptors","Kshirsagar TA, Fang X, Portoghese PS.","J Med Chem. 1998 Jul 2;41(14):2657-60. doi: 10.1021/jm980209b.","Kshirsagar TA","J Med Chem","1998","1998/07/03","","","10.1021/jm980209b"
"9641956","Opiate detoxification under anaesthesia","Brewer C.","BMJ. 1998 Jun 27;316(7149):1983-4.","Brewer C","BMJ","1998","1998/06/26","PMC1113425","",""
"9641463","Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats","Zhai QZ, Ingenito AJ.","J Cardiovasc Pharmacol. 1998 Jun;31(6):806-12. doi: 10.1097/00005344-199806000-00002.","Zhai QZ","J Cardiovasc Pharmacol","1998","1998/06/26","","","10.1097/00005344-199806000-00002"
"9639282","Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone","Unterwald EM, Anton B, To T, Lam H, Evans CJ.","Neuroscience. 1998 Aug;85(3):897-905. doi: 10.1016/s0306-4522(97)00659-3.","Unterwald EM","Neuroscience","1998","1998/06/25","","","10.1016/s0306-4522(97)00659-3"
"9639257","Opioids modulate the calcitonin gene-related peptide8-37-mediated hindpaw withdrawal latency increase in thermally injured rats","Löfgren O, Yu LC, Theodorsson E, Hansson P, Lundeberg T.","Neuropeptides. 1998 Apr;32(2):173-7. doi: 10.1016/s0143-4179(98)90034-8.","Löfgren O","Neuropeptides","1998","1998/06/25","","","10.1016/s0143-4179(98)90034-8"
"9634251","Rapid opioid detoxification","Brewer C, Gastfriend DR.","JAMA. 1998 Jun 17;279(23):1872.","Brewer C","JAMA","1998","1998/06/20","","",""
"9634250","Rapid opioid detoxification","Gooberman LL.","JAMA. 1998 Jun 17;279(23):1871; author reply 1872.","Gooberman LL","JAMA","1998","1998/06/20","","",""
"9634168","Outcomes of ultrarapid opiate detoxification combined with naltrexone maintenance and counseling","Rabinowitz J, Cohen H, Kotler M.","Psychiatr Serv. 1998 Jun;49(6):831-3. doi: 10.1176/ps.49.6.831.","Rabinowitz J","Psychiatr Serv","1998","1998/06/20","","","10.1176/ps.49.6.831"
"9632234","Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats","Bespalov AY, Beardsley PM, Balster RL.","Pharmacol Biochem Behav. 1998 Jun;60(2):507-17. doi: 10.1016/s0091-3057(98)00006-9.","Bespalov AY","Pharmacol Biochem Behav","1998","1998/06/19","","","10.1016/s0091-3057(98)00006-9"
"9632224","Training dose and session time as contextual determinants of heroin self-administration in rats","Martin TJ, Smith JE, Dworkin SI.","Pharmacol Biochem Behav. 1998 Jun;60(2):415-21. doi: 10.1016/s0091-3057(97)00599-6.","Martin TJ","Pharmacol Biochem Behav","1998","1998/06/19","","","10.1016/s0091-3057(97)00599-6"
"9632223","Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats","Biggs TA, Myers RD.","Pharmacol Biochem Behav. 1998 Jun;60(2):407-13. doi: 10.1016/s0091-3057(97)00598-4.","Biggs TA","Pharmacol Biochem Behav","1998","1998/06/19","","","10.1016/s0091-3057(97)00598-4"
"9632216","Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol","Cramer CM, Gardell LR, Boedeker KL, Harris JR, Hubbell CL, Reid LD.","Pharmacol Biochem Behav. 1998 Jun;60(2):345-56. doi: 10.1016/s0091-3057(97)00593-5.","Cramer CM","Pharmacol Biochem Behav","1998","1998/06/19","","","10.1016/s0091-3057(97)00593-5"
"9631958","The rate-decreasing effects of fentanyl derivatives in pigeons before, during and after chronic morphine treatment","Gauthier CA, Gerak LR, Bagley JR, Brockunier LL, France CP.","Psychopharmacology (Berl). 1998 May;137(1):67-73. doi: 10.1007/s002130050594.","Gauthier CA","Psychopharmacology (Berl)","1998","1998/06/19","","","10.1007/s002130050594"
"9630517","Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems","Dawson-Basoa M, Gintzler AR.","Brain Res. 1998 May 25;794(1):61-7. doi: 10.1016/s0006-8993(98)00192-9.","Dawson-Basoa M","Brain Res","1998","1998/06/19","","","10.1016/s0006-8993(98)00192-9"
"9630003","Studies on benzodiazepines and opioids administered alone and in combination in rhesus monkeys: ventilation and drug discrimination","Gerak LR, Brandt MR, France CP.","Psychopharmacology (Berl). 1998 May;137(2):164-74. doi: 10.1007/s002130050606.","Gerak LR","Psychopharmacology (Berl)","1998","1998/06/18","","","10.1007/s002130050606"
"9624727","Clinical experience with antagonist-induced opiate withdrawal under anaesthesia","Tretter F, Burkhardt D, Bussello-Spieth B, Reiss J, Walcher S, Büchele W.","Addiction. 1998 Feb;93(2):269-75. doi: 10.1046/j.1360-0443.1998.93226910.x.","Tretter F","Addiction","1998","1998/06/13","","","10.1046/j.1360-0443.1998.93226910.x"
"9622237","Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect","Sandin J, Nylander I, Georgieva J, Schött PA, Ogren SO, Terenius L.","Neuroscience. 1998 Jul;85(2):375-82. doi: 10.1016/s0306-4522(97)00605-2.","Sandin J","Neuroscience","1998","1998/06/11","","","10.1016/s0306-4522(97)00605-2"
"9617985","Naltrexone augmentation of neuroleptics in schizophrenia","Sernyak MJ, Glazer WM, Heninger GR, Charney DS, Woods SW, Petrakis IL, Krystal JH, Price LH.","J Clin Psychopharmacol. 1998 Jun;18(3):248-51. doi: 10.1097/00004714-199806000-00011.","Sernyak MJ","J Clin Psychopharmacol","1998","1998/06/09","","","10.1097/00004714-199806000-00011"
"9617748","Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice","Decker MW, Bannon AW, Buckley MJ, Kim DJ, Holladay MW, Ryther KB, Lin NH, Wasicak JT, Williams M, Arneric SP.","Eur J Pharmacol. 1998 Apr 3;346(1):23-33. doi: 10.1016/s0014-2999(98)00042-9.","Decker MW","Eur J Pharmacol","1998","1998/06/09","","","10.1016/s0014-2999(98)00042-9"
"9612997","Heroin addiction and naltrexone","Byrne A.","Aust Fam Physician. 1998 May;27(5):344.","Byrne A","Aust Fam Physician","1998","1998/06/05","","",""
"9610980","Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine","Wang DS, Sternbach G, Varon J.","J Emerg Med. 1998 May-Jun;16(3):471-5. doi: 10.1016/s0736-4679(98)00019-5.","Wang DS","J Emerg Med","1998","1998/06/04","","","10.1016/s0736-4679(98)00019-5"
"9610949","Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17)","Rady JJ, Holmes BB, Fujimoto JM.","Pharmacol Biochem Behav. 1998 May;60(1):245-54. doi: 10.1016/s0091-3057(97)00578-9.","Rady JJ","Pharmacol Biochem Behav","1998","1998/06/04","","","10.1016/s0091-3057(97)00578-9"
"9610930","Neonatal withdrawal following pre- and postnatal exposure to methadone in the rat","Barr GA, Zmitrovich A, Hamowy AS, Liu PY, Wang S, Hutchings DE.","Pharmacol Biochem Behav. 1998 May;60(1):97-104. doi: 10.1016/s0091-3057(97)00596-0.","Barr GA","Pharmacol Biochem Behav","1998","1998/06/04","","","10.1016/s0091-3057(97)00596-0"
"9602057","Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity","Mellon RD, Bayer BM.","Brain Res. 1998 Apr 6;789(1):56-67. doi: 10.1016/s0006-8993(97)01529-1.","Mellon RD","Brain Res","1998","1998/05/29","","","10.1016/s0006-8993(97)01529-1"
"9595829","[The solubility and in vivo-in vitro correlation of naltrexone]","Navarro Guerrero J, Ruiz Ramirez JC, Lorduy Oses L.","Boll Chim Farm. 1998 Jan;137(1):16-20.","Navarro Guerrero J","Boll Chim Farm","1998","1998/05/22","","",""
"9593954","The effects of aging on mu and delta opioid receptors in the spinal cord of Fischer-344 rats","Hoskins DL, Gordon TL, Crisp T.","Brain Res. 1998 Apr 27;791(1-2):299-302. doi: 10.1016/s0006-8993(98)00034-1.","Hoskins DL","Brain Res","1998","1998/06/19","","","10.1016/s0006-8993(98)00034-1"
"9593835","The role of mu and kappa opioid receptors within the periaqueductal gray in the expression of conditional hypoalgesia","Bellgowan PS, Helmstetter FJ.","Brain Res. 1998 Apr 27;791(1-2):83-9. doi: 10.1016/s0006-8993(98)00057-2.","Bellgowan PS","Brain Res","1998","1998/06/19","","","10.1016/s0006-8993(98)00057-2"
"9593593","Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception","Kest B, Lee CE, Jenab S, Kao B, Inturrisi CE.","Eur J Pharmacol. 1998 Mar 12;345(1):47-53. doi: 10.1016/s0014-2999(97)01584-7.","Kest B","Eur J Pharmacol","1998","1998/05/21","","","10.1016/s0014-2999(97)01584-7"
"9592116","Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat","Rohde DS, Basbaum AI.","J Neurosci. 1998 Jun 1;18(11):4393-402. doi: 10.1523/JNEUROSCI.18-11-04393.1998.","Rohde DS","J Neurosci","1998","1998/06/06","PMC6792821","","10.1523/JNEUROSCI.18-11-04393.1998"
"9590665","Opioid antagonists in the treatment of impulse-control disorders","Kim SW.","J Clin Psychiatry. 1998 Apr;59(4):159-64.","Kim SW","J Clin Psychiatry","1998","1998/05/20","","",""
"9590512","A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat","Stromberg MF, Casale M, Volpicelli L, Volpicelli JR, O'Brien CP.","Alcohol. 1998 May;15(4):281-9. doi: 10.1016/s0741-8329(97)00131-6.","Stromberg MF","Alcohol","1998","1998/05/20","","","10.1016/s0741-8329(97)00131-6"
"9589685","Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome","Guido M, Pavone V, Ciampelli M, Murgia F, Fulghesu AM, Apa R, Caruso A, Mancuso S, Lanzone A.","J Clin Endocrinol Metab. 1998 May;83(5):1742-5. doi: 10.1210/jcem.83.5.4775.","Guido M","J Clin Endocrinol Metab","1998","1998/05/20","","","10.1210/jcem.83.5.4775"
"9587897","Influence of oral buprenorphine, oral naltrexone or morphine on the effects of laparotomy in the rat","Liles JH, Flecknell PA, Roughan J, Cruz-Madorran I.","Lab Anim. 1998 Apr;32(2):149-61. doi: 10.1258/002367798780600025.","Liles JH","Lab Anim","1998","1998/05/20","","","10.1258/002367798780600025"
"9585164","Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice","Thongpradichote S, Matsumoto K, Tohda M, Takayama H, Aimi N, Sakai S, Watanabe H.","Life Sci. 1998;62(16):1371-8. doi: 10.1016/s0024-3205(98)00075-7.","Thongpradichote S","Life Sci","1998","1998/05/19","","","10.1016/s0024-3205(98)00075-7"
"9583170","[The endogenous opioid system tonically activates the locomotor neurons in the mollusk Lymnaea stagnalis]","D'iakonova VE.","Zh Vyssh Nerv Deiat Im I P Pavlova. 1998 Jan-Feb;48(1):113-20.","D'iakonova VE","Zh Vyssh Nerv Deiat Im I P Pavlova","1998","1998/05/16","","",""
"9581652","Involvement of kappa-opioids in the mouse cerebellar adenosinergic modulation of ethanol-induced motor incoordination","Dar MS.","Alcohol Clin Exp Res. 1998 Apr;22(2):444-54.","Dar MS","Alcohol Clin Exp Res","1998","1998/05/15","","",""
"9581641","Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys","Boyle AE, Stewart RB, Macenski MJ, Spiga R, Johnson BA, Meisch RA.","Alcohol Clin Exp Res. 1998 Apr;22(2):359-66.","Boyle AE","Alcohol Clin Exp Res","1998","1998/05/15","","",""
"9580643","Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens","Zhang M, Gosnell BA, Kelley AE.","J Pharmacol Exp Ther. 1998 May;285(2):908-14.","Zhang M","J Pharmacol Exp Ther","1998","1998/05/15","","",""
"9580603","kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception","Butelman ER, Ko MC, Sobczyk-Kojiro K, Mosberg HI, Van Bemmel B, Zernig G, Woods JH.","J Pharmacol Exp Ther. 1998 May;285(2):595-601.","Butelman ER","J Pharmacol Exp Ther","1998","1998/05/15","","",""
"9580592","Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys","Ko MC, Butelman ER, Traynor JR, Woods JH.","J Pharmacol Exp Ther. 1998 May;285(2):518-26.","Ko MC","J Pharmacol Exp Ther","1998","1998/05/15","PMC2882849","NIHMS196247",""
"9577049","The use of naltrexone to treat ambulatory patients with alcohol dependence","Galarza NJ, Díaz Ramírez D, Guzmán F, Caballero JA, Martínez AJ.","Bol Asoc Med P R. 1997 Oct-Dec;89(10-12):157-60.","Galarza NJ","Bol Asoc Med P R","1997","1998/05/13","","",""
"9574828","Differential modulation of mu- and delta-opioid antinociception by neuropeptide FF receptors in young mice","Desprat C, Zajac JM.","Neuropeptides. 1997 Feb;31(1):1-7. doi: 10.1016/s0143-4179(97)90010-x.","Desprat C","Neuropeptides","1997","1997/02/01","","","10.1016/s0143-4179(97)90010-x"
"9570823","Estrogen-induced alteration of mu-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala","Eckersell CB, Popper P, Micevych PE.","J Neurosci. 1998 May 15;18(10):3967-76. doi: 10.1523/JNEUROSCI.18-10-03967.1998.","Eckersell CB","J Neurosci","1998","1998/06/06","PMC6793150","","10.1523/JNEUROSCI.18-10-03967.1998"
"9570799","Structural features determining differential receptor regulation of neuronal Ca channels","Simen AA, Miller RJ.","J Neurosci. 1998 May 15;18(10):3689-98. doi: 10.1523/JNEUROSCI.18-10-03689.1998.","Simen AA","J Neurosci","1998","1998/06/06","PMC6793165","","10.1523/JNEUROSCI.18-10-03689.1998"
"9570716","Receptor-mediated activation of G-proteins by kappa opioid agonists in frog (Rana esculenta) brain membranes","Rottmann M, Fábián G, Spicher K, Offermanns S, Szücs M.","Brain Res Bull. 1998 Mar 15;45(5):467-74. doi: 10.1016/s0361-9230(97)00407-3.","Rottmann M","Brain Res Bull","1998","1998/05/07","","","10.1016/s0361-9230(97)00407-3"
"9570343","[125I-Tyr1]biphalin binding to opioid receptors of rat brain and NG108-15 cell membranes","Slaninova J, Appleyard SM, Misicka A, Lipkowski AW, Knapp RJ, Weber SJ, Davis TP, Yamamura HI, Hruby VJ.","Life Sci. 1998;62(14):PL199-204. doi: 10.1016/s0024-3205(98)00058-7.","Slaninova J","Life Sci","1998","1998/05/07","","","10.1016/s0024-3205(98)00058-7"
"9570199","Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors","Schultz JE, Hsu AK, Gross GJ.","Circulation. 1998 Apr 7;97(13):1282-9. doi: 10.1161/01.cir.97.13.1282.","Schultz JE","Circulation","1998","1998/05/07","","","10.1161/01.cir.97.13.1282"
"9564207","Naltrexone utility in depressed alcoholics","Salloum IM, Cornelius JR, Thase ME, Daley DC, Kirisci L, Spotts C.","Psychopharmacol Bull. 1998;34(1):111-5.","Salloum IM","Psychopharmacol Bull","1998","1998/05/02","","",""
"9560874","Endogenous opioids inhibit ambulatory blood pressure during naturally occurring stress","McCubbin JA, Bruehl S, Wilson JF, Sherman JJ, Norton JA, Colclough G.","Psychosom Med. 1998 Mar-Apr;60(2):227-31. doi: 10.1097/00006842-199803000-00020.","McCubbin JA","Psychosom Med","1998","1998/04/30","","","10.1097/00006842-199803000-00020"
"9554156","[Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy]","Roozen HG, Deden AL, Kerkhof AJ, Vorsteveld JP, van den Brink W.","Ned Tijdschr Geneeskd. 1997 Dec 6;141(49):2377-80.","Roozen HG","Ned Tijdschr Geneeskd","1997","1998/04/29","","",""
"9549136","[Naltrexone in the treatment of alcohol dependence]","Ochoa Mangado E.","Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1998 Jan-Feb;26(1):51-7.","Ochoa Mangado E","Actas Luso Esp Neurol Psiquiatr Cienc Afines","1998","1998/04/29","","",""
"9547096","Evidence that spinal endogenous opioidergic systems control the expression of chronic pain-related behaviors in spinally injured rats","Hao JX, Yu W, Xu XJ.","Exp Brain Res. 1998 Jan;118(2):259-68. doi: 10.1007/s002210050280.","Hao JX","Exp Brain Res","1998","1998/04/18","","","10.1007/s002210050280"
"9539380","Brain opioid receptor binding of [3H]CTOP and [3H]naltrindole in alcohol-preferring AA and alcohol-avoiding ANA rats","Soini SL, Ovaska T, Honkanen A, Hyytiä P, Korpi ER.","Alcohol. 1998 Apr;15(3):227-32. doi: 10.1016/s0741-8329(97)00125-0.","Soini SL","Alcohol","1998","1998/04/16","","","10.1016/s0741-8329(97)00125-0"
"9527644","Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors","Grung M, Skurtveit S, Aasmundstad TA, Handal M, Alkana RL, Mørland J.","Pharmacol Toxicol. 1998 Jan;82(1):3-10. doi: 10.1111/j.1600-0773.1998.tb01390.x.","Grung M","Pharmacol Toxicol","1998","1998/04/04","","","10.1111/j.1600-0773.1998.tb01390.x"
"9526141","Establishing morphine and U-50,488H as discriminative stimuli in a three-choice assay with pigeons","Makhay MM, Young AM, Poling A.","Exp Clin Psychopharmacol. 1998 Feb;6(1):3-9. doi: 10.1037//1064-1297.6.1.3.","Makhay MM","Exp Clin Psychopharmacol","1998","1998/04/04","","","10.1037//1064-1297.6.1.3"
"9526037","Opioid receptor modulation of feeding-evoked dopamine release in the rat nucleus accumbens","Taber MT, Zernig G, Fibiger HC.","Brain Res. 1998 Feb 23;785(1):24-30. doi: 10.1016/s0006-8993(97)01124-4.","Taber MT","Brain Res","1998","1998/06/06","","","10.1016/s0006-8993(97)01124-4"
"9522002","Use of the Internet for addiction education. Combining network therapy with pharmacotherapy","Galanter M, Keller DS, Dermatis H, Biderman D.","Am J Addict. 1998 Winter;7(1):7-13.","Galanter M","Am J Addict","1998","1998/04/02","","",""
"9519245","Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat","Giraudo SQ, Billington CJ, Levine AS.","Brain Res. 1998 Jan 26;782(1-2):18-23. doi: 10.1016/s0006-8993(97)01140-2.","Giraudo SQ","Brain Res","1998","1998/03/31","","","10.1016/s0006-8993(97)01140-2"
"9515017","U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors","Yu XC, Li HY, Wang HX, Wong TM.","J Mol Cell Cardiol. 1998 Feb;30(2):405-13. doi: 10.1006/jmcc.1997.0604.","Yu XC","J Mol Cell Cardiol","1998","1998/05/30","","","10.1006/jmcc.1997.0604"
"9512078","Differential involvement of opioid receptors in intrathecal butorphanol-induced analgesia: compared to morphine","Wongchanapai W, Tsang BK, He Z, Ho IK.","Pharmacol Biochem Behav. 1998 Mar;59(3):723-7. doi: 10.1016/s0091-3057(97)00558-3.","Wongchanapai W","Pharmacol Biochem Behav","1998","1998/03/25","","","10.1016/s0091-3057(97)00558-3"
"9512064","Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking","Krishnan-Sarin S, Wand GS, Li XW, Portoghese PS, Froehlich JC.","Pharmacol Biochem Behav. 1998 Mar;59(3):627-35. doi: 10.1016/s0091-3057(97)00474-7.","Krishnan-Sarin S","Pharmacol Biochem Behav","1998","1998/03/25","","","10.1016/s0091-3057(97)00474-7"
"9501763","Naltrexone-induced panic attacks","Maremmani I, Marini G, Fornai F.","Am J Psychiatry. 1998 Mar;155(3):447. doi: 10.1176/ajp.155.3.447.","Maremmani I","Am J Psychiatry","1998","1998/03/21","","","10.1176/ajp.155.3.447"
"9500694","Open-label trial of oral nalmefene therapy for the pruritus of cholestasis","Bergasa NV, Schmitt JM, Talbot TL, Alling DW, Swain MG, Turner ML, Jenkins JB, Jones EA.","Hepatology. 1998 Mar;27(3):679-84. doi: 10.1002/hep.510270307.","Bergasa NV","Hepatology","1998","1998/03/21","","","10.1002/hep.510270307"
"9498728","Naltrexone effects on diazepam intoxication and pharmacokinetics in humans","Swift R, Davidson D, Rosen S, Fitz E, Camara P.","Psychopharmacology (Berl). 1998 Feb;135(3):256-62. doi: 10.1007/s002130050507.","Swift R","Psychopharmacology (Berl)","1998","1998/03/14","","","10.1007/s002130050507"
"9494755","Naltrexone in the treatment of pathological gambling and alcohol dependence","Crockford DN, el-Guebaly N.","Can J Psychiatry. 1998 Feb;43(1):86.","Crockford DN","Can J Psychiatry","1998","1998/03/12","","",""
"9493566","Opioid inhibition of adenylyl cyclase in membranes from pertussis toxin-treated NG108-15 cells","Selley DE, Breivogel CS, Childers SR.","J Recept Signal Transduct Res. 1998 Jan;18(1):25-49. doi: 10.3109/10799899809039163.","Selley DE","J Recept Signal Transduct Res","1998","1998/03/11","","","10.3109/10799899809039163"
"9491065","Naltrexone-induced reduction of tobacco intake","Lerner AG, Oyffe I, Sigal M.","J Clin Psychiatry. 1998 Jan;59(1):30-1. doi: 10.4088/jcp.v59n0107c.","Lerner AG","J Clin Psychiatry","1998","1998/03/10","","","10.4088/jcp.v59n0107c"
"9488100","Naltrexone is not detected in preweaning rats following transplacental exposure: implications for growth modulation","Zagon IS, Hurst WJ, McLaughlin PJ.","Life Sci. 1998;62(3):221-8. doi: 10.1016/s0024-3205(97)01090-4.","Zagon IS","Life Sci","1998","1998/03/06","","","10.1016/s0024-3205(97)01090-4"
"9476956","Effects of naltrexone and ethanol on auditory event-related brain potentials","Jääskeläinen IP, Hirvonen J, Kujala T, Alho K, Eriksson CJ, Lehtokoski A, Pekkonen E, Sinclair JD, Yabe H, Näätänen R, Sillanaukee P.","Alcohol. 1998 Feb;15(2):105-11. doi: 10.1016/s0741-8329(97)00104-3.","Jääskeläinen IP","Alcohol","1998","1998/02/26","","","10.1016/s0741-8329(97)00104-3"
"9476694","Effects of naltrexone on cue-elicited craving for alcohol and cocaine","Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR.","Drug Alcohol Depend. 1997 Dec;49(1):9-16. doi: 10.1016/s0376-8716(97)00134-8.","Modesto-Lowe V","Drug Alcohol Depend","1997","1998/02/26","","","10.1016/s0376-8716(97)00134-8"
"9475374","Effects of nalmefene, CG3703, tirilazad, or dopamine on cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and hemorrhage","Dewitt DS, Prough DS, Uchida T, Deal DD, Vines SM.","J Neurotrauma. 1997 Dec;14(12):931-41. doi: 10.1089/neu.1997.14.931.","Dewitt DS","J Neurotrauma","1997","1998/02/25","","","10.1089/neu.1997.14.931"
"9474037","Nalmefene and the urine opiate screen","Storrow AB, Hernandez AV, Norton JA.","Clin Chem. 1998 Feb;44(2):346-8.","Storrow AB","Clin Chem","1998","1998/02/25","","",""
"9473572","Neuroanatomical patterns of Fos-like immunoreactivity induced by naltrexone in food-restricted and ad libitum fed rats","Carr KD, Park TH, Zhang Y, Stone EA.","Brain Res. 1998 Jan 1;779(1-2):26-32. doi: 10.1016/s0006-8993(97)01074-3.","Carr KD","Brain Res","1998","1998/02/25","","","10.1016/s0006-8993(97)01074-3"
"9472963","Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease","Fulghesu AM, Ciampelli M, Guido M, Murgia F, Caruso A, Mancuso S, Lanzone A.","Metabolism. 1998 Feb;47(2):158-62. doi: 10.1016/s0026-0495(98)90213-x.","Fulghesu AM","Metabolism","1998","1998/02/24","","","10.1016/s0026-0495(98)90213-x"
"9468674","Addict died after rapid opiate detoxification","Dyer C.","BMJ. 1998 Jan 17;316(7126):170. doi: 10.1136/bmj.316.7126.167e.","Dyer C","BMJ","1998","1998/02/20","PMC2665460","","10.1136/bmj.316.7126.167e"
"9463438","Opioid receptor-mediated inhibition of omega-conotoxin GVIA-sensitive calcium channel currents in rat intracardiac neurons","Adams DJ, Trequattrini C.","J Neurophysiol. 1998 Feb;79(2):753-62. doi: 10.1152/jn.1998.79.2.753.","Adams DJ","J Neurophysiol","1998","1998/04/18","","","10.1152/jn.1998.79.2.753"
"9458715","Suppression of cAMP by phosphoinositol/Ca2+ pathway in the cardiac kappa-opioid receptor","Zhang WM, Wong TM.","Am J Physiol. 1998 Jan;274(1):C82-7. doi: 10.1152/ajpcell.1998.274.1.C82.","Zhang WM","Am J Physiol","1998","1998/02/12","","","10.1152/ajpcell.1998.274.1.C82"
"9453556","Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum","Rawls SM, McGinty JF.","J Neurochem. 1998 Feb;70(2):626-34. doi: 10.1046/j.1471-4159.1998.70020626.x.","Rawls SM","J Neurochem","1998","1998/02/07","","","10.1046/j.1471-4159.1998.70020626.x"
"9453554","Proenkephalin gene regulation in the paraventricular nucleus by GABA: interactions with opioid systems in a transgenic model","Borsook D, Falkowski O, Smirnova O.","J Neurochem. 1998 Feb;70(2):604-16. doi: 10.1046/j.1471-4159.1998.70020604.x.","Borsook D","J Neurochem","1998","1998/02/07","","","10.1046/j.1471-4159.1998.70020604.x"
"9450624","Enkephalins modulate differentiation of normal human keratinocytes in vitro","Nissen JB, Kragballe K.","Exp Dermatol. 1997 Oct;6(5):222-9. doi: 10.1111/j.1600-0625.1997.tb00166.x.","Nissen JB","Exp Dermatol","1997","1998/02/05","","","10.1111/j.1600-0625.1997.tb00166.x"
"9449900","Unethical promotion of rapid opiate detoxification under anaesthesia (RODA)","Brewer C, Williams J, Carreño Rendueles E, Garcia JB.","Lancet. 1998 Jan 17;351(9097):218. doi: 10.1016/s0140-6736(05)78171-x.","Brewer C","Lancet","1998","1998/02/05","","","10.1016/s0140-6736(05)78171-x"
"9447547","Flow injection analysis with amperometric detection of naltrexone in pharmaceuticals","Fernández-Abedul MT, Costa-García A.","J Pharm Biomed Anal. 1997 Sep;16(1):15-9. doi: 10.1016/s0731-7085(96)01962-0.","Fernández-Abedul MT","J Pharm Biomed Anal","1997","1998/02/03","","","10.1016/s0731-7085(96)01962-0"
"9446217","Drug abuse and therapy","McMillen BA.","Science. 1998 Jan 9;279(5348):159-61. doi: 10.1126/science.279.5348.155g.","McMillen BA","Science","1998","1998/01/31","","","10.1126/science.279.5348.155g"
"9443556","Opioid receptor blockade throughout prenatal life confers long-term insensitivity to morphine and alters mu opioid receptors","Zagon IS, Tobias SW, Hytrek SD, McLaughlin PJ.","Pharmacol Biochem Behav. 1998 Jan;59(1):201-7. doi: 10.1016/s0091-3057(97)00419-x.","Zagon IS","Pharmacol Biochem Behav","1998","1998/01/27","","","10.1016/s0091-3057(97)00419-x"
"9439841","Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain","Unterwald EM, Tsukada H, Kakiuchi T, Kosugi T, Nishiyama S, Kreek MJ.","Brain Res. 1997 Nov 14;775(1-2):183-8. doi: 10.1016/s0006-8993(97)00931-1.","Unterwald EM","Brain Res","1997","1998/01/24","","","10.1016/s0006-8993(97)00931-1"
"9439792","Hippocampal theta activity after systemic administration of a non-peptide delta-opioid agonist in freely-moving rats: relationship to D1 dopamine receptors","Marrosu F, Cozzolino A, Puligheddu M, Giagheddu M, Di Chiara G.","Brain Res. 1997 Nov 21;776(1-2):24-9. doi: 10.1016/s0006-8993(97)00969-4.","Marrosu F","Brain Res","1997","1998/01/24","","","10.1016/s0006-8993(97)00969-4"
"9438745","Rapid and ultrarapid opioid detoxification techniques","O'Connor PG, Kosten TR.","JAMA. 1998 Jan 21;279(3):229-34. doi: 10.1001/jama.279.3.229.","O'Connor PG","JAMA","1998","1998/01/23","","","10.1001/jama.279.3.229"
"9438517","Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage","Gardell LR, Reid LD, Boedeker KL, Liakos TM, Hubbell CL.","Alcohol Clin Exp Res. 1997 Dec;21(9):1592-8.","Gardell LR","Alcohol Clin Exp Res","1997","1998/01/23","","",""
"9437766","Characterization of opiate binding sites on the goldfish (Carassius auratus L.) pronephric leukocytes","Józefowski S, Płytycz B.","Pol J Pharmacol. 1997 Aug;49(4):229-37.","Józefowski S","Pol J Pharmacol","1997","1997/08/01","","",""
"9437746","Differential response to kappa-opioidergic agents in dietary fat selection between Osborne-Mendel and S5B/P1 rats","Ookuma K, Barton C, York DA, Bray GA.","Peptides. 1998;19(1):141-7. doi: 10.1016/s0196-9781(97)00255-6.","Ookuma K","Peptides","1998","1998/01/23","","","10.1016/s0196-9781(97)00255-6"
"9437624","Naltrexone pharmacotherapy for opioid dependent federal probationers","Cornish JW, Metzger D, Woody GE, Wilson D, McLellan AT, Vandergrift B, O'Brien CP.","J Subst Abuse Treat. 1997 Nov-Dec;14(6):529-34. doi: 10.1016/s0740-5472(97)00020-2.","Cornish JW","J Subst Abuse Treat","1997","1998/01/23","","","10.1016/s0740-5472(97)00020-2"
"9437228","Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects","Villa P, Valle D, De Marinis L, Mancini A, Bianchi A, Fulghesu AM, Caruso A, Mancuso S, Lanzone A.","Eur J Endocrinol. 1997 Dec;137(6):631-4. doi: 10.1530/eje.0.1370631.","Villa P","Eur J Endocrinol","1997","1998/01/23","","","10.1530/eje.0.1370631"
"9435189","Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist","Bot G, Blake AD, Li S, Reisine T.","J Pharmacol Exp Ther. 1998 Jan;284(1):283-90.","Bot G","J Pharmacol Exp Ther","1998","1998/01/22","","",""
"9431714","Naltrexone: a case report of pruritus from an antipruritic","Sullivan JR, Watson A.","Australas J Dermatol. 1997 Nov;38(4):196-8. doi: 10.1111/j.1440-0960.1997.tb01696.x.","Sullivan JR","Australas J Dermatol","1997","1998/02/12","","","10.1111/j.1440-0960.1997.tb01696.x"
"9430443","Kappa-opioid restraint of oxytocin secretion: plasticity through pregnancy","Leng G, Dye S, Bicknell RJ.","Neuroendocrinology. 1997 Dec;66(6):378-83. doi: 10.1159/000127263.","Leng G","Neuroendocrinology","1997","1998/01/16","","","10.1159/000127263"
"9430418","Antinociceptive effects of (+)-matrine in mice","Kamei J, Xiao P, Ohsawa M, Kubo H, Higashiyama K, Takahashi H, Li J, Nagase H, Ohmiya S.","Eur J Pharmacol. 1997 Oct 22;337(2-3):223-6. doi: 10.1016/s0014-2999(97)01273-9.","Kamei J","Eur J Pharmacol","1997","1998/01/16","","","10.1016/s0014-2999(97)01273-9"
"9428830","A preliminary investigation of the management of alcohol dependence with naltrexone by primary care providers","O'Connor PG, Farren CK, Rounsaville BJ, O'Malley SS.","Am J Med. 1997 Dec;103(6):477-82. doi: 10.1016/s0002-9343(97)00271-4.","O'Connor PG","Am J Med","1997","1998/01/16","","","10.1016/s0002-9343(97)00271-4"
"9426837","Methylnaltrexone attenuates taste aversion conditioned by low-dose ethanol","Bedingfield JB, Holloway FA.","Alcohol. 1998 Jan;15(1):51-4. doi: 10.1016/s0741-8329(97)00097-9.","Bedingfield JB","Alcohol","1998","1998/01/14","","","10.1016/s0741-8329(97)00097-9"
"9415511","Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis","Heyer G, Dotzer M, Diepgen TL, Handwerker HO.","Pain. 1997 Nov;73(2):239-43. doi: 10.1016/s0304-3959(97)00098-5.","Heyer G","Pain","1997","1998/02/07","","","10.1016/s0304-3959(97)00098-5"
"9413582","Endogenous opioids and prenatal determinants of neuroplasticity","Zagon IS, Tobias SW, McLaughlin PJ.","Adv Exp Med Biol. 1997;429:289-303. doi: 10.1007/978-1-4757-9551-6_21.","Zagon IS","Adv Exp Med Biol","1997","1997/01/01","","","10.1007/978-1-4757-9551-6_21"
"9411543","[Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection]","Lozano Polo JL, Gutiérrez Mora E, Martínez Pérez V, Santamaría Gutiérrez J, Vada Sánchez J, Vallejo Correas JA.","Rev Clin Esp. 1997 Jul;197(7):479-83.","Lozano Polo JL","Rev Clin Esp","1997","1997/07/01","","",""
"9408216","Opioid receptor blockade during prenatal life modifies postnatal behavioral development","McLaughlin PJ, Tobias SW, Lang CM, Zagon IS.","Pharmacol Biochem Behav. 1997 Dec;58(4):1075-82. doi: 10.1016/s0091-3057(97)00307-9.","McLaughlin PJ","Pharmacol Biochem Behav","1997","1998/01/04","","","10.1016/s0091-3057(97)00307-9"
"9401674","Effect of ethanol drinking and naltrexone on subsequent drinking in rats","Davidson D, Amit Z.","Alcohol. 1997 Nov-Dec;14(6):581-4. doi: 10.1016/s0741-8329(97)00052-9.","Davidson D","Alcohol","1997","1997/12/24","","","10.1016/s0741-8329(97)00052-9"
"9400350","The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group","Croop RS, Faulkner EB, Labriola DF.","Arch Gen Psychiatry. 1997 Dec;54(12):1130-5. doi: 10.1001/archpsyc.1997.01830240090013.","Croop RS","Arch Gen Psychiatry","1997","1997/12/24","","","10.1001/archpsyc.1997.01830240090013"
"9400003","Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects","Szekeres PG, Traynor JR.","J Pharmacol Exp Ther. 1997 Dec;283(3):1276-84.","Szekeres PG","J Pharmacol Exp Ther","1997","1998/02/12","","",""
"9399992","Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat","Thorat SN, Hammond DL.","J Pharmacol Exp Ther. 1997 Dec;283(3):1185-92.","Thorat SN","J Pharmacol Exp Ther","1997","1998/02/12","","",""
"9399970","Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists","Picker MJ.","J Pharmacol Exp Ther. 1997 Dec;283(3):1009-17.","Picker MJ","J Pharmacol Exp Ther","1997","1998/02/12","","",""
"9396060","Naltrexone, naltrindole, and CTOP block cocaine-induced sensitization to seizures and death","Braida D, Paladini E, Gori E, Sala M.","Peptides. 1997;18(8):1189-95. doi: 10.1016/s0196-9781(97)00182-4.","Braida D","Peptides","1997","1997/01/01","","","10.1016/s0196-9781(97)00182-4"
"9394942","Naltrexone in young autistic children: replication study and learning measures","Kolmen BK, Feldman HM, Handen BL, Janosky JE.","J Am Acad Child Adolesc Psychiatry. 1997 Nov;36(11):1570-8. doi: 10.1016/S0890-8567(09)66567-9.","Kolmen BK","J Am Acad Child Adolesc Psychiatry","1997","1997/12/12","","","10.1016/S0890-8567(09)66567-9"
"9394782","Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes","Perez L, Lysle DT.","J Neuroimmunol. 1997 Nov;79(2):101-12. doi: 10.1016/s0165-5728(97)00106-9.","Perez L","J Neuroimmunol","1997","1997/12/12","","","10.1016/s0165-5728(97)00106-9"
"9394115","Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage","Gardell LR, Whalen CA, Chattophadyay S, Cavallaro CA, Hubbell CL, Reid LD.","Alcohol Clin Exp Res. 1997 Nov;21(8):1435-9.","Gardell LR","Alcohol Clin Exp Res","1997","1997/12/12","","",""
"9393936","Spinal mu, delta and kappa opioids alter chemical, mechanical and thermal sensitivities in amphibians","Willenbring S, Stevens CW.","Life Sci. 1997;61(22):2167-76. doi: 10.1016/s0024-3205(97)00919-3.","Willenbring S","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(97)00919-3"
"9392785","Effects of neonatal naltrexone on neurological and somatic development in rats of both genders","de Cabo C, Paz Viveros M.","Neurotoxicol Teratol. 1997 Nov-Dec;19(6):499-509. doi: 10.1016/s0892-0362(97)00043-3.","de Cabo C","Neurotoxicol Teratol","1997","1997/12/11","","","10.1016/s0892-0362(97)00043-3"
"9391680","Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone","Fawcett JP, Morgan NC, Woods DJ.","Ann Pharmacother. 1997 Nov;31(11):1291-5. doi: 10.1177/106002809703101102.","Fawcett JP","Ann Pharmacother","1997","1997/12/10","","","10.1177/106002809703101102"
"9389815","Suppression of luteal phase, but not midcycle, prolactin levels by chronic follicular phase opiate antagonism","Brzyski RG, Viniegra A, Archer DF.","Fertil Steril. 1997 Nov;68(5):855-9. doi: 10.1016/s0015-0282(97)00357-9.","Brzyski RG","Fertil Steril","1997","1997/12/09","","","10.1016/s0015-0282(97)00357-9"
"9389350","Simple liquid chromatographic method for the determination of naltrexone in human plasma using amperometric detection","Peh KK, Billa N, Yuen KH.","J Chromatogr B Biomed Sci Appl. 1997 Nov 7;701(1):140-5. doi: 10.1016/s0378-4347(97)00352-6.","Peh KK","J Chromatogr B Biomed Sci Appl","1997","1997/12/06","","","10.1016/s0378-4347(97)00352-6"
"9379982","Ultrarapid opiate detoxification","Hall W, Mattick RP.","Med J Aust. 1997 Oct 6;167(7):393, 396.","Hall W","Med J Aust","1997","1997/11/05","","",""
"9379981","Ultrarapid opiate detoxification. What's all the fuss about?","Caplehorn JR.","Med J Aust. 1997 Oct 6;167(7):393.","Caplehorn JR","Med J Aust","1997","1997/11/05","","",""
"9379837","Opioid regulation of AP-1 DNA-binding activity in NG108-15 cells under conditions of opioid-receptor adaptation","Tencheva ZS, Belcheva MM, Velichkova AA, Lissichkova EG, Coscia CJ.","Brain Res Mol Brain Res. 1997 Aug;48(1):156-8. doi: 10.1016/s0169-328x(97)00128-9.","Tencheva ZS","Brain Res Mol Brain Res","1997","1997/08/01","","","10.1016/s0169-328x(97)00128-9"
"9379438","Discovery of a novel class of substituted pyrrolooctahydroisoquinolines as potent and selective delta opioid agonists, based on an extension of the message-address concept","Dondio G, Ronzoni S, Eggleston DS, Artico M, Petrillo P, Petrone G, Visentin L, Farina C, Vecchietti V, Clarke GD.","J Med Chem. 1997 Sep 26;40(20):3192-8. doi: 10.1021/jm9608218.","Dondio G","J Med Chem","1997","1997/11/05","","","10.1021/jm9608218"
"9378852","Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain","Sim LJ, Childers SR.","J Comp Neurol. 1997 Oct 6;386(4):562-72. doi: 10.1002/(sici)1096-9861(19971006)386:4<562::aid-cne4>3.0.co;2-0.","Sim LJ","J Comp Neurol","1997","1997/10/23","","","10.1002/(sici)1096-9861(19971006)386:4<562::aid-cne4>3.0.co;2-0"
"9378255","Effects of Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, on elevated plus-maze learning and spontaneous alternation performance in mice","Ukai M, Monma J, Shinkai N, Sasaki Y, Kameyama T.","Gen Pharmacol. 1997 Sep;29(3):453-6. doi: 10.1016/s0306-3623(96)00483-1.","Ukai M","Gen Pharmacol","1997","1997/09/01","","","10.1016/s0306-3623(96)00483-1"
"9376777","New drug treatments for alcohol problems: a critical appraisal","Moncrieff J, Drummond DC.","Addiction. 1997 Aug;92(8):939-47; discussion 949-64.","Moncrieff J","Addiction","1997","1997/08/01","","",""
"9374341","Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system","Kim S, Wagner HN Jr, Villemagne VL, Kao PF, Dannals RF, Ravert HT, Joh T, Dixon RB, Civelek AC.","J Nucl Med. 1997 Nov;38(11):1726-31.","Kim S","J Nucl Med","1997","1997/11/28","","",""
"9374199","Lactation decreases mRNA levels of opioid peptides in the arcuate nucleus of the rat","Kim EM, Kotz CM, Welch CC, Grace MK, Billington CJ, Levine AS.","Brain Res. 1997 Sep 26;769(2):303-8. doi: 10.1016/s0006-8993(97)00722-1.","Kim EM","Brain Res","1997","1997/11/28","","","10.1016/s0006-8993(97)00722-1"
"9373881","Naltrexone enhances ovulation and prostaglandin synthesis in the rat ovary","Faletti A, Jawerbaum A, Viggiano J, Gimeno MA.","Prostaglandins. 1997 Sep;54(3):665-75. doi: 10.1016/s0090-6980(97)00132-9.","Faletti A","Prostaglandins","1997","1997/11/28","","","10.1016/s0090-6980(97)00132-9"
"9373773","Regulation of stress-induced reduced myelopoiesis in rats","Malacrida SA, Teixeira NA, Queiroz ML.","Int J Immunopharmacol. 1997 Apr;19(4):227-33. doi: 10.1016/s0192-0561(97)00029-5.","Malacrida SA","Int J Immunopharmacol","1997","1997/04/01","","","10.1016/s0192-0561(97)00029-5"
"9373422","Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success","Seoane A, Carrasco G, Cabré L, Puiggrós A, Hernández E, Alvarez M, Costa J, Molina R, Sobrepere G.","Br J Psychiatry. 1997 Oct;171:340-5. doi: 10.1192/bjp.171.4.340.","Seoane A","Br J Psychiatry","1997","1997/11/28","","","10.1192/bjp.171.4.340"
"9372533","Use of antisense oligodeoxynucleotide to delta-opioid receptor mRNA in the study of turnover of delta-opioid receptors in the spinal cord of the mouse","Narita M, Mizoguchi H, Nagase H, Tseng LF.","Psychopharmacology (Berl). 1997 Oct;133(4):347-50. doi: 10.1007/s002130050412.","Narita M","Psychopharmacology (Berl)","1997","1998/01/24","","","10.1007/s002130050412"
"9369307","The effect of blockade of kappa-opioid receptors in the medial preoptic area on the luteinizing hormone surge in the proestrous rat","Smith MJ, Gallo RV.","Brain Res. 1997 Sep 12;768(1-2):111-9. doi: 10.1016/s0006-8993(97)00622-7.","Smith MJ","Brain Res","1997","1997/11/22","","","10.1016/s0006-8993(97)00622-7"
"9368834","Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects","De Marinis L, Mancini A, Valle D, Bianchi A, De Luca AM, Fulghesu AM, Villa P, Mancuso S, Lanzone A.","Int J Obes Relat Metab Disord. 1997 Nov;21(11):1076-81. doi: 10.1038/sj.ijo.0800519.","De Marinis L","Int J Obes Relat Metab Disord","1997","1997/11/22","","","10.1038/sj.ijo.0800519"
"9366009","The effect of opioid antagonists in local regulation of testicular response to acute stress in adult rats","Kostić T, Andrić S, Kovacević R, Marić D.","Steroids. 1997 Nov;62(11):703-8. doi: 10.1016/s0039-128x(97)00071-8.","Kostić T","Steroids","1997","1997/11/20","","","10.1016/s0039-128x(97)00071-8"
"9365010","Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions","Ragnauth A, Ruegg H, Bodnar RJ.","Brain Res. 1997 Aug 29;767(1):8-16. doi: 10.1016/s0006-8993(97)00539-8.","Ragnauth A","Brain Res","1997","1997/08/29","","","10.1016/s0006-8993(97)00539-8"
"9363289","Naltrexone as an adjunctive treatment for older patients with alcohol dependence","Oslin D, Liberto JG, O'Brien J, Krois S, Norbeck J.","Am J Geriatr Psychiatry. 1997 Fall;5(4):324-32. doi: 10.1097/00019442-199700540-00007.","Oslin D","Am J Geriatr Psychiatry","1997","1997/11/18","","","10.1097/00019442-199700540-00007"
"9359985","Persistent analgesia in former opiate addicts is resistant to blockade of endogenous opioids","Liebmann PM, Lehofer M, Moser M, Hoehn-Saric R, Legl T, Pernhaupt G, Schauenstein K.","Biol Psychiatry. 1997 Nov 15;42(10):962-4. doi: 10.1016/S0006-3223(97)00337-5.","Liebmann PM","Biol Psychiatry","1997","1997/11/14","","","10.1016/S0006-3223(97)00337-5"
"9357876","Opioid-induced delay in gastric emptying: a peripheral mechanism in humans","Murphy DB, Sutton JA, Prescott LF, Murphy MB.","Anesthesiology. 1997 Oct;87(4):765-70. doi: 10.1097/00000542-199710000-00008.","Murphy DB","Anesthesiology","1997","1997/11/14","","","10.1097/00000542-199710000-00008"
"9357871","Methylnaltrexone: reversing the gastrointestinal effects of opioids","Rosow CE.","Anesthesiology. 1997 Oct;87(4):736-7. doi: 10.1097/00000542-199710000-00003.","Rosow CE","Anesthesiology","1997","1997/11/14","","","10.1097/00000542-199710000-00003"
"9353416","Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats","Feng Y, Rockhold RW, Ho IK.","J Pharmacol Exp Ther. 1997 Nov;283(2):932-8.","Feng Y","J Pharmacol Exp Ther","1997","1997/11/14","","",""
"9353165","Antinociceptive effects of morphine and U-50,488H on vaginal distension in the anesthetized rat","Friese N, Diop L, Lambert C, Rivière PJ, Dahl SG.","Life Sci. 1997;61(16):1559-70. doi: 10.1016/s0024-3205(97)00735-2.","Friese N","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(97)00735-2"
"9346759","Current research in the treatment of alcoholism in liver transplant recipients","Weinrieb RM, O'Brien CP.","Liver Transpl Surg. 1997 May;3(3):328-36. doi: 10.1002/lt.500030321.","Weinrieb RM","Liver Transpl Surg","1997","1997/05/01","","","10.1002/lt.500030321"
"9346757","Treatment of alcohol dependence","Kranzler HR.","Liver Transpl Surg. 1997 May;3(3):311-21. doi: 10.1002/lt.500030319.","Kranzler HR","Liver Transpl Surg","1997","1997/05/01","","","10.1002/lt.500030319"
"9343457","Opiate detoxification under anesthesia","Brewer C, Maksoud NA.","JAMA. 1997 Oct 22-29;278(16):1318. doi: 10.1001/jama.278.16.1318a.","Brewer C","JAMA","1997","1997/10/29","","","10.1001/jama.278.16.1318a"
"9329153","Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections","Martin TJ, Sim LJ, Selley DE, deMontis MG, Childers SR.","Synapse. 1997 Nov;27(3):177-82. doi: 10.1002/(SICI)1098-2396(199711)27:3<177::AID-SYN3>3.0.CO;2-A.","Martin TJ","Synapse","1997","1997/11/05","","","10.1002/(SICI)1098-2396(199711)27:3<177::AID-SYN3>3.0.CO;2-A"
"9328809","The integration of pharmacotherapy and nonpharmacotherapy","Miller NS, Smith DE.","J Addict Dis. 1997;16(4):51-64. doi: 10.1080/10550889709511143.","Miller NS","J Addict Dis","1997","1997/01/01","","","10.1080/10550889709511143"
"9327093","Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers","Sandman CA, Hetrick W, Taylor DV, Chicz-DeMet A.","Am J Ment Retard. 1997 Sep;102(2):182-99. doi: 10.1352/0895-8017(1997)102<0182:DOPPAS>2.0.CO;2.","Sandman CA","Am J Ment Retard","1997","1997/11/05","","","10.1352/0895-8017(1997)102<0182:DOPPAS>2.0.CO;2"
"9324068","Transplacental transfer of naltrexone in rats","Zagon IS, Hurst WJ, McLaughlin PJ.","Life Sci. 1997;61(13):1261-7. doi: 10.1016/s0024-3205(97)00671-1.","Zagon IS","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(97)00671-1"
"9323442","The possible role of protein phosphatase 2A in the sodium sensitivity of the receptor binding of opiate antagonists naloxone and naltrindole","Murányi A, Gergely P, Nagy GM, Fekete MI.","Brain Res Bull. 1997;44(3):273-9. doi: 10.1016/s0361-9230(97)00136-6.","Murányi A","Brain Res Bull","1997","1997/01/01","","","10.1016/s0361-9230(97)00136-6"
"9322521","Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study","Wolfhagen FH, Sternieri E, Hop WC, Vitale G, Bertolotti M, Van Buuren HR.","Gastroenterology. 1997 Oct;113(4):1264-9. doi: 10.1053/gast.1997.v113.pm9322521.","Wolfhagen FH","Gastroenterology","1997","1997/10/10","","","10.1053/gast.1997.v113.pm9322521"
"9321873","Interleukin-6 is differently modulated by central opioid receptor subtypes","Bertolucci M, Perego C, De Simoni MG.","Am J Physiol. 1997 Sep;273(3 Pt 2):R956-9. doi: 10.1152/ajpregu.1997.273.3.R956.","Bertolucci M","Am J Physiol","1997","1997/10/10","","","10.1152/ajpregu.1997.273.3.R956"
"9316853","Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO","Leventhal L, Stevens LB, Rossi GC, Pasternak GW, Bodnar RJ.","J Pharmacol Exp Ther. 1997 Sep;282(3):1402-7.","Leventhal L","J Pharmacol Exp Ther","1997","1997/10/08","","",""
"9316833","Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement","Garner HR, Burke TF, Lawhorn CD, Stoner JM, Wessinger WD.","J Pharmacol Exp Ther. 1997 Sep;282(3):1253-61.","Garner HR","J Pharmacol Exp Ther","1997","1997/10/08","","",""
"9314128","Effect of liver cirrhosis on the systemic availability of naltrexone in humans","Bertolotti M, Ferrari A, Vitale G, Stefani M, Trenti T, Loria P, Carubbi F, Carulli N, Sternieri E.","J Hepatol. 1997 Sep;27(3):505-11. doi: 10.1016/s0168-8278(97)80355-8.","Bertolotti M","J Hepatol","1997","1997/10/06","","","10.1016/s0168-8278(97)80355-8"
"9313020","Three methods of opioid detoxification in a primary care setting. A randomized trial","O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ.","Ann Intern Med. 1997 Oct 1;127(7):526-30. doi: 10.7326/0003-4819-127-7-199710010-00004.","O'Connor PG","Ann Intern Med","1997","1997/10/06","","","10.7326/0003-4819-127-7-199710010-00004"
"9311660","Naltrindole, a selective delta-opioid receptor antagonist, potentiates the lethal effects of cocaine by a central mechanism of action","Patterson AB, Gordon FJ, Holtzman SG.","Eur J Pharmacol. 1997 Aug 20;333(1):47-54. doi: 10.1016/s0014-2999(97)01090-x.","Patterson AB","Eur J Pharmacol","1997","1997/08/20","","","10.1016/s0014-2999(97)01090-x"
"9310588","Rapid opiate detoxification. Assessment is needed to exclude certain patients before detoxification","Rumball D, Williams J.","BMJ. 1997 Sep 13;315(7109):682.","Rumball D","BMJ","1997","1997/10/06","PMC2127444","",""
"9310411","Role of spinal delta1 and delta2 opioid receptors in the antinociception produced by microinjection of L-glutamate in the ventromedial medulla of the rat","Hammond DL, Donahue BB, Stewart PE.","Brain Res. 1997 Aug 8;765(1):177-81. doi: 10.1016/s0006-8993(97)00658-6.","Hammond DL","Brain Res","1997","1997/08/08","","","10.1016/s0006-8993(97)00658-6"
"9309533","The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration","Fulghesu AM, Lanzone A, Apa R, Guido M, Ciampelli M, Cucinelli F, Caruso A, Mancuso S.","J Endocrinol Invest. 1997 Jul-Aug;20(7):368-73. doi: 10.1007/BF03347986.","Fulghesu AM","J Endocrinol Invest","1997","1997/07/01","","","10.1007/BF03347986"
"9308800","Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment","Roozenburg BJ, van Dessel HJ, Evers JL, Bots RS.","Hum Reprod. 1997 Aug;12(8):1720-2. doi: 10.1093/humrep/12.8.1720.","Roozenburg BJ","Hum Reprod","1997","1997/08/01","","","10.1093/humrep/12.8.1720"
"9301669","7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands","Fang X, Larson DL, Portoghese PS.","J Med Chem. 1997 Sep 12;40(19):3064-70. doi: 10.1021/jm970283e.","Fang X","J Med Chem","1997","1997/09/25","","","10.1021/jm970283e"
"9301573","Naltrexone for the treatment of alcoholism","Ciraulo AM, Alpert N, Franko KJ.","Am Fam Physician. 1997 Sep 1;56(3):803-6.","Ciraulo AM","Am Fam Physician","1997","1997/09/25","","",""
"9300254","Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in guinea-pig left atrium","Giuliani S, Maggi CA.","Eur J Pharmacol. 1997 Aug 13;332(3):231-6. doi: 10.1016/s0014-2999(97)01076-5.","Giuliani S","Eur J Pharmacol","1997","1997/08/13","","","10.1016/s0014-2999(97)01076-5"
"9298332","Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment","Doty P, Kirk JM, Cramblett MJ, de Wit H.","Drug Alcohol Depend. 1997 Aug 25;47(2):109-16. doi: 10.1016/s0376-8716(97)00094-x.","Doty P","Drug Alcohol Depend","1997","1997/08/25","","","10.1016/s0376-8716(97)00094-x"
"9298329","Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study","Rabinowitz J, Cohen H, Tarrasch R, Kotler M.","Drug Alcohol Depend. 1997 Aug 25;47(2):77-86. doi: 10.1016/s0376-8716(97)00073-2.","Rabinowitz J","Drug Alcohol Depend","1997","1997/08/25","","","10.1016/s0376-8716(97)00073-2"
"9295191","Food intake and food choice: the role of the endogenous opioid peptides in the marsupial Sminthopsis crassicaudata","Hope PJ, Chapman I, Morley JE, Horowitz M, Wittert GA.","Brain Res. 1997 Aug 1;764(1-2):39-45. doi: 10.1016/s0006-8993(97)00390-9.","Hope PJ","Brain Res","1997","1997/08/01","","","10.1016/s0006-8993(97)00390-9"
"9292116","Effects of naltrexone and cross-tolerance to morphine in a learned helplessness paradigm","Teixeira NA, Pereira DG, Hermini AH.","Braz J Med Biol Res. 1997 Jun;30(6):775-82. doi: 10.1590/s0100-879x1997000600012.","Teixeira NA","Braz J Med Biol Res","1997","1997/06/01","","","10.1590/s0100-879x1997000600012"
"9288436","A possible new treatment approach to obsessive-compulsive disorder","Warneke L.","Can J Psychiatry. 1997 Aug;42(6):667-8. doi: 10.1177/070674379704200624.","Warneke L","Can J Psychiatry","1997","1997/08/01","","","10.1177/070674379704200624"
"9286627","Immunomodulatory responses to delta-opioid receptor ligands in human lymphocytes","Noviello L, Papadia S, Capobianchi MR, Negri L.","Eur J Pharmacol. 1997 Aug 6;332(2):R1-2. doi: 10.1016/s0014-2999(97)01123-0.","Noviello L","Eur J Pharmacol","1997","1997/08/06","","","10.1016/s0014-2999(97)01123-0"
"9285925","Effect of enterostatin and kappa-opioids on macronutrient selection and consumption","Ookuma K, Barton C, York DA, Bray GA.","Peptides. 1997;18(6):785-91. doi: 10.1016/s0196-9781(97)00029-6.","Ookuma K","Peptides","1997","1997/01/01","","","10.1016/s0196-9781(97)00029-6"
"9283509","Naltrexone and alcohol dependence. Role of subject compliance","Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP.","Arch Gen Psychiatry. 1997 Aug;54(8):737-42. doi: 10.1001/archpsyc.1997.01830200071010.","Volpicelli JR","Arch Gen Psychiatry","1997","1997/08/01","","","10.1001/archpsyc.1997.01830200071010"
"9282948","Brain and spinal cord distribution of biphalin: correlation with opioid receptor density and mechanism of CNS entry","Abbruscato TJ, Thomas SA, Hruby VJ, Davis TP.","J Neurochem. 1997 Sep;69(3):1236-45. doi: 10.1046/j.1471-4159.1997.69031236.x.","Abbruscato TJ","J Neurochem","1997","1997/09/01","","","10.1046/j.1471-4159.1997.69031236.x"
"9281450","Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart","Schultz JJ, Hsu AK, Gross GJ.","J Mol Cell Cardiol. 1997 Aug;29(8):2187-95. doi: 10.1006/jmcc.1997.0454.","Schultz JJ","J Mol Cell Cardiol","1997","1997/08/01","","","10.1006/jmcc.1997.0454"
"9280519","[Central K1-opiate receptors and mechanisms of arrhythmogenesis]","Ugdyzhekova DS, Maslov LN, Lishmanov IB.","Biull Eksp Biol Med. 1997 Jun;123(6):656-8.","Ugdyzhekova DS","Biull Eksp Biol Med","1997","1997/06/01","","",""
"9279405","Cardiopulmonary effects of carfentanil in dama gazelles (Gazella dama)","Schumacher J, Heard DJ, Young L, Citino SB.","J Zoo Wildl Med. 1997 Jun;28(2):166-70.","Schumacher J","J Zoo Wildl Med","1997","1997/06/01","","",""
"9279404","Immobilization of domestic goats (Capra hircus) using orally administered carfentanil citrate and detomidine hydrochloride","Sleeman JM, Carter W, Tobin T, Ramsay EC.","J Zoo Wildl Med. 1997 Jun;28(2):158-65.","Sleeman JM","J Zoo Wildl Med","1997","1997/06/01","","",""
"9274924","Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians","Stevens CW, Rothe KS.","Eur J Pharmacol. 1997 Jul 16;331(1):15-21. doi: 10.1016/s0014-2999(97)01026-1.","Stevens CW","Eur J Pharmacol","1997","1997/07/16","PMC3100726","NIHMS280423","10.1016/s0014-2999(97)01026-1"
"9274922","The role of delta-opioid receptors in the discriminative stimulus properties of a low dose of methamphetamine","Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H.","Eur J Pharmacol. 1997 Jul 16;331(1):1-8. doi: 10.1016/s0014-2999(97)01020-0.","Suzuki T","Eur J Pharmacol","1997","1997/07/16","","","10.1016/s0014-2999(97)01020-0"
"9272656","Chronic exposure to the opioid antagonist naltrexone during pregnancy: maternal and offspring effects","McLaughlin PJ, Tobias SW, Lang CM, Zagon IS.","Physiol Behav. 1997 Sep;62(3):501-8. doi: 10.1016/s0031-9384(97)00007-3.","McLaughlin PJ","Physiol Behav","1997","1997/09/01","","","10.1016/s0031-9384(97)00007-3"
"9269372","What you need to know: addiction--prescribing naltrexone","Yeo BK.","Singapore Med J. 1997 Feb;38(2):92-3.","Yeo BK","Singapore Med J","1997","1997/02/01","","",""
"9267542","Naltrexone biotransformation and incidence of subjective side effects: a preliminary study","King AC, Volpicelli JR, Gunduz M, O'Brien CP, Kreek MJ.","Alcohol Clin Exp Res. 1997 Aug;21(5):906-9.","King AC","Alcohol Clin Exp Res","1997","1997/08/01","","",""
"9264103","Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats","Piepponen TP, Kivastik T, Katajamäki J, Zharkovsky A, Ahtee L.","Pharmacol Biochem Behav. 1997 Sep;58(1):275-9. doi: 10.1016/s0091-3057(96)00567-9.","Piepponen TP","Pharmacol Biochem Behav","1997","1997/09/01","","","10.1016/s0091-3057(96)00567-9"
"9264083","The analgesia-enhancing component of ingested amniotic fluid does not affect nicotine-induced antinociception in naltrexone-treated rats","Robinson-Vanderwerf TM, Di Pirro JM, Caggiula AR, Kristal MB.","Pharmacol Biochem Behav. 1997 Sep;58(1):147-51. doi: 10.1016/s0091-3057(97)00006-3.","Robinson-Vanderwerf TM","Pharmacol Biochem Behav","1997","1997/09/01","","","10.1016/s0091-3057(97)00006-3"
"9264074","Effects of opioids on the absorption of alcohol","Linseman MA, Lê AD.","Pharmacol Biochem Behav. 1997 Sep;58(1):79-84. doi: 10.1016/s0091-3057(97)00002-6.","Linseman MA","Pharmacol Biochem Behav","1997","1997/09/01","","","10.1016/s0091-3057(97)00002-6"
"9264063","D1 and D2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine","Díaz-Otañez CS, Capriles NR, Cancela LM.","Pharmacol Biochem Behav. 1997 Sep;58(1):9-14. doi: 10.1016/s0091-3057(96)00344-9.","Díaz-Otañez CS","Pharmacol Biochem Behav","1997","1997/09/01","","","10.1016/s0091-3057(96)00344-9"
"9262337","Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat","Kimmel HL, Holtzman SG.","J Pharmacol Exp Ther. 1997 Aug;282(2):734-46.","Kimmel HL","J Pharmacol Exp Ther","1997","1997/08/01","","",""
"9262317","Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys","Brandt MR, Cabansag SR, France CP.","J Pharmacol Exp Ther. 1997 Aug;282(2):574-84.","Brandt MR","J Pharmacol Exp Ther","1997","1997/08/01","","",""
"9259006","Precipitated morphine withdrawal induces a conditioned aversion in the preweaning rat","Barr GA, Goodwin GA.","Pharmacol Biochem Behav. 1997 Aug;57(4):779-83. doi: 10.1016/s0091-3057(96)00382-6.","Barr GA","Pharmacol Biochem Behav","1997","1997/08/01","","","10.1016/s0091-3057(96)00382-6"
"9259005","Antagonism of morphine-like discriminative effects by beta-funaltrexamine","Holtzman SG.","Pharmacol Biochem Behav. 1997 Aug;57(4):771-7. doi: 10.1016/s0091-3057(96)00395-4.","Holtzman SG","Pharmacol Biochem Behav","1997","1997/08/01","","","10.1016/s0091-3057(96)00395-4"
"9257684","3-Methoxynaltrexone, a selective heroin/morphine-6beta-glucuronide antagonist","Brown GP, Yang K, King MA, Rossi GC, Leventhal L, Chang A, Pasternak GW.","FEBS Lett. 1997 Jul 21;412(1):35-8. doi: 10.1016/s0014-5793(97)00710-2.","Brown GP","FEBS Lett","1997","1997/07/21","","","10.1016/s0014-5793(97)00710-2"
"9256993","Tolerability of naltrexone in treating older, alcohol-dependent patients","Oslin D, Liberto JG, O'Brien J, Krois S.","Am J Addict. 1997 Summer;6(3):266-70.","Oslin D","Am J Addict","1997","1997/07/01","","",""
"9256987","Outpatient non-opioid detoxification for opioid withdrawal. Who is likely to benefit?","McCann MJ, Miotto K, Rawson RA, Huber A, Shoptaw S, Ling W.","Am J Addict. 1997 Summer;6(3):218-23.","McCann MJ","Am J Addict","1997","1997/07/01","","",""
"9251903","Time course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse: reversal by naltrexone","Kumar S, Bhargava HN.","Gen Pharmacol. 1997 Aug;29(2):223-7. doi: 10.1016/s0306-3623(96)00416-8.","Kumar S","Gen Pharmacol","1997","1997/08/01","","","10.1016/s0306-3623(96)00416-8"
"9248940","Determination of naltrexone and 6-beta-naltrexol in plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry","Huang W, Moody DE, Foltz RL, Walsh SL.","J Anal Toxicol. 1997 Jul-Aug;21(4):252-7. doi: 10.1093/jat/21.4.252.","Huang W","J Anal Toxicol","1997","1997/07/01","","","10.1093/jat/21.4.252"
"9243420","Naltrexone: a controversial therapy for alcohol dependence","Freed PE, York LN.","J Psychosoc Nurs Ment Health Serv. 1997 Jul;35(7):24-8.","Freed PE","J Psychosoc Nurs Ment Health Serv","1997","1997/07/01","","",""
"9234287","In vivo binding of [125I]NH2-carfentanil to mu opioid receptors in mouse brain","Tafani JA, Francés B, Coulais Y, Méjean-Galzi A, Goeldner M, Hirth C, Guiraud R, Zajac JM.","Nucl Med Biol. 1994 Feb;21(2):231-8. doi: 10.1016/0969-8051(94)90013-2.","Tafani JA","Nucl Med Biol","1994","1994/02/01","","","10.1016/0969-8051(94)90013-2"
"9231866","Reversal of spinal cord non-opiate analgesia by conditioned anti-analgesia in the rat","Watkins LR, McGorry M, Schwartz B, Sisk D, Wiertelak EP, Maier SF.","Pain. 1997 Jul;71(3):237-47. doi: 10.1016/s0304-3959(97)03375-7.","Watkins LR","Pain","1997","1997/07/01","","","10.1016/s0304-3959(97)03375-7"
"9226337","Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect","Yeomans MR, Gray RW.","Physiol Behav. 1997 Jul;62(1):15-21. doi: 10.1016/s0031-9384(97)00101-7.","Yeomans MR","Physiol Behav","1997","1997/07/01","","","10.1016/s0031-9384(97)00101-7"
"9223573","Ventilation in morphine-maintained rhesus monkeys. I: Effects of naltrexone and abstinence-associated withdrawal","Paronis CA, Woods JH.","J Pharmacol Exp Ther. 1997 Jul;282(1):348-54.","Paronis CA","J Pharmacol Exp Ther","1997","1997/07/01","","",""
"9223538","Effects of kappa opioids on cocaine self-administration by rhesus monkeys","Negus SS, Mello NK, Portoghese PS, Lin CE.","J Pharmacol Exp Ther. 1997 Jul;282(1):44-55.","Negus SS","J Pharmacol Exp Ther","1997","1997/07/01","","",""
"9219867","Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor","Zagon IS, Sassani JW, Kane ER, McLaughlin PJ.","Brain Res. 1997 Jun 6;759(1):92-102. doi: 10.1016/s0006-8993(97)00238-2.","Zagon IS","Brain Res","1997","1997/06/06","","","10.1016/s0006-8993(97)00238-2"
"9218232","Naltrexone plus group therapy for the treatment of opiate-abusing health-care professionals","Roth A, Hogan I, Farren C.","J Subst Abuse Treat. 1997 Jan-Feb;14(1):19-22. doi: 10.1016/s0740-5472(96)00164-x.","Roth A","J Subst Abuse Treat","1997","1997/01/01","","","10.1016/s0740-5472(96)00164-x"
"9217295","Participation of central kappa-opioid receptor in arrhythmogenesis","Lishmanov YB, Maslov LN, Ugdyzhekova DS, Smagin GN.","Life Sci. 1997;61(3):PL33-8. doi: 10.1016/s0024-3205(97)00391-3.","Lishmanov YB","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(97)00391-3"
"9217271","Extraordinary potency of a novel delta opioid receptor agonist is due in part to increased efficacy","Kramer TH, Bartosz-Bechowski H, Davis P, Hruby VJ, Porreca F.","Life Sci. 1997;61(2):129-35. doi: 10.1016/s0024-3205(97)00367-6.","Kramer TH","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(97)00367-6"
"9213363","Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors","Bhargava HN, Zhao GM, Bian JT, Nan Y, Upadhyaya SP, Xu W, Dunn WJ 3rd, Bauer L.","Peptides. 1997;18(5):695-701. doi: 10.1016/s0196-9781(97)00121-6.","Bhargava HN","Peptides","1997","1997/01/01","","","10.1016/s0196-9781(97)00121-6"
"9208648","[Pharmacokinetics of naltrexone hydrochloride and naltrexone glucuronide in the dog]","Li H, Zhao SF, Wang N, Ge ZH.","Yao Xue Xue Bao. 1996;31(4):254-7.","Li H","Yao Xue Xue Bao","1996","1996/01/01","","",""
"9208156","Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study","Sacerdote P, Manfredi B, Mantegazza P, Panerai AE.","Br J Pharmacol. 1997 Jun;121(4):834-40. doi: 10.1038/sj.bjp.0701138.","Sacerdote P","Br J Pharmacol","1997","1997/06/01","PMC1564723","","10.1038/sj.bjp.0701138"
"9207365","Morphine induces sepsis in mice","Hilburger ME, Adler MW, Truant AL, Meissler JJ Jr, Satishchandran V, Rogers TJ, Eisenstein TK.","J Infect Dis. 1997 Jul;176(1):183-8. doi: 10.1086/514021.","Hilburger ME","J Infect Dis","1997","1997/07/01","","","10.1086/514021"
"9203233","Effects of naltrexone on amphetamine-induced locomotion and rearing: acute and repeated injections","Balcells-Olivero M, Vezina P.","Psychopharmacology (Berl). 1997 Jun;131(3):230-8. doi: 10.1007/s002130050288.","Balcells-Olivero M","Psychopharmacology (Berl)","1997","1997/06/01","","","10.1007/s002130050288"
"9201801","Opioid modulation of attention-related responses: delta-receptors modulate habituation and conditioned bradycardia","Hernández LL, Watson KL.","Psychopharmacology (Berl). 1997 May;131(2):140-7. doi: 10.1007/s002130050276.","Hernández LL","Psychopharmacology (Berl)","1997","1997/05/01","","","10.1007/s002130050276"
"9200746","Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice","Shen KF, Crain SM.","Brain Res. 1997 May 23;757(2):176-90. doi: 10.1016/s0006-8993(97)00197-2.","Shen KF","Brain Res","1997","1997/05/23","","","10.1016/s0006-8993(97)00197-2"
"9200497","Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation","Dawson-Basoa M, Gintzler AR.","Brain Res. 1997 May 16;757(1):37-42. doi: 10.1016/s0006-8993(97)00092-9.","Dawson-Basoa M","Brain Res","1997","1997/05/16","","","10.1016/s0006-8993(97)00092-9"
"9194926","Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice","Phillips TJ, Wenger CD, Dorow JD.","Alcohol Clin Exp Res. 1997 Jun;21(4):691-702.","Phillips TJ","Alcohol Clin Exp Res","1997","1997/06/01","","",""
"9194925","Interactions between alcohol- and opioid-induced suppression of rat testicular steroidogenesis in vivo","Adams ML, Meyer ER, Cicero TJ.","Alcohol Clin Exp Res. 1997 Jun;21(4):684-90.","Adams ML","Alcohol Clin Exp Res","1997","1997/06/01","","",""
"9194924","Naltrexone blocks acquisition of voluntary ethanol intake in rats","Davidson D, Amit Z.","Alcohol Clin Exp Res. 1997 Jun;21(4):677-83.","Davidson D","Alcohol Clin Exp Res","1997","1997/06/01","","",""
"9194917","Naltrexone treatment increases the aversiveness of alcohol for outbred rats","Hill KG, Kiefer SW.","Alcohol Clin Exp Res. 1997 Jun;21(4):637-41.","Hill KG","Alcohol Clin Exp Res","1997","1997/06/01","","",""
"9194685","Effect of prior nicotine treatment on drug induced changes in serum LH concentrations in rats","Hodson CA, Davis MC, Burden HW.","Life Sci. 1997;60(25):2303-8. doi: 10.1016/s0024-3205(97)00285-3.","Hodson CA","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(97)00285-3"
"9190871","Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats","Hepburn MJ, Little PJ, Gingras J, Kuhn CM.","J Pharmacol Exp Ther. 1997 Jun;281(3):1350-6.","Hepburn MJ","J Pharmacol Exp Ther","1997","1997/06/01","","",""
"9185790","Addiction medicine","O'Brien CP, McLellan AT.","JAMA. 1997 Jun 18;277(23):1840-1.","O'Brien CP","JAMA","1997","1997/06/18","","",""
"9183513","Targeted naltrexone treatment of early problem drinkers","Kranzler HR, Tennen H, Penta C, Bohn MJ.","Addict Behav. 1997 May-Jun;22(3):431-6. doi: 10.1016/s0306-4603(96)00064-0.","Kranzler HR","Addict Behav","1997","1997/05/01","","","10.1016/s0306-4603(96)00064-0"
"9180346","Antinociceptive effect of buprenorphine in mu1-opioid receptor deficient CXBK mice","Kamei J, Sodeyama M, Tsuda M, Suzuki T, Nagase H.","Life Sci. 1997;60(22):PL 333-7. doi: 10.1016/s0024-3205(97)00170-7.","Kamei J","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(97)00170-7"
"9179521","Antagonism of the response rate-decreasing effects of meperidine and morphine by beta-funaltrexamine and naltrexone in squirrel monkeys","Hughes CE, Dykstra LA.","Drug Alcohol Depend. 1997 May 2;45(3):197-206. doi: 10.1016/s0376-8716(97)01316-1.","Hughes CE","Drug Alcohol Depend","1997","1997/05/02","","","10.1016/s0376-8716(97)01316-1"
"9179515","Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts","Miotto K, McCann MJ, Rawson RA, Frosch D, Ling W.","Drug Alcohol Depend. 1997 Apr 14;45(1-2):131-4. doi: 10.1016/s0376-8716(97)01348-3.","Miotto K","Drug Alcohol Depend","1997","1997/04/14","","","10.1016/s0376-8716(97)01348-3"
"9179505","Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems","Welch SP.","Drug Alcohol Depend. 1997 Apr 14;45(1-2):39-45. doi: 10.1016/s0376-8716(97)01342-2.","Welch SP","Drug Alcohol Depend","1997","1997/04/14","","","10.1016/s0376-8716(97)01342-2"
"9178661","Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor","Quock RM, Hosohata Y, Knapp RJ, Burkey TH, Hosohata K, Zhang X, Rice KC, Nagase H, Hruby VJ, Porreca F, Roeske WR, Yamamura HI.","Eur J Pharmacol. 1997 May 12;326(1):101-4. doi: 10.1016/s0014-2999(97)83488-7.","Quock RM","Eur J Pharmacol","1997","1997/05/12","","","10.1016/s0014-2999(97)83488-7"
"9178652","The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice","Kamei J, Kashiwazaki T, Hitosugi H, Nagase H.","Eur J Pharmacol. 1997 May 12;326(1):31-6. doi: 10.1016/s0014-2999(97)00157-x.","Kamei J","Eur J Pharmacol","1997","1997/05/12","","","10.1016/s0014-2999(97)00157-x"
"9178351","Are mu-opioid receptors involved in the control of endothelin-1 release from the pituitary gland in normal and dehydrated rats?","Płonowski A, Szymańska-Debińska T, Radzikowska M, Baranowska B, Woźniewicz B.","Regul Pept. 1997 Mar 26;69(2):89-94. doi: 10.1016/s0167-0115(97)02134-4.","Płonowski A","Regul Pept","1997","1997/03/26","","","10.1016/s0167-0115(97)02134-4"
"9175973","5-HT spinal antinociception involves mu opioid receptors: cross tolerance and antagonist studies","Goodchild CS, Guo Z, Freeman J, Gent JP.","Br J Anaesth. 1997 May;78(5):563-9. doi: 10.1093/bja/78.5.563.","Goodchild CS","Br J Anaesth","1997","1997/05/01","","","10.1093/bja/78.5.563"
"9171881","7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors","Ohkawa S, DiGiacomo B, Larson DL, Takemori AE, Portoghese PS.","J Med Chem. 1997 May 23;40(11):1720-5. doi: 10.1021/jm9700880.","Ohkawa S","J Med Chem","1997","1997/05/23","","","10.1021/jm9700880"
"9168225","Nalmefene, an intravenous alternative to naltrexone for extradural morphine prophylaxis","Stuart AL, McDavid AJ.","Reg Anesth. 1997 May-Jun;22(3):291. doi: 10.1016/s1098-7339(06)80018-0.","Stuart AL","Reg Anesth","1997","1997/05/01","","","10.1016/s1098-7339(06)80018-0"
"9164597","Prior exposure to palatable solutions enhances the effects of naltrexone on food intake in rats","Kanarek RB, Mathes WF, Heisler LK, Lima RP, Monfared LS.","Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):377-81. doi: 10.1016/s0091-3057(96)00337-1.","Kanarek RB","Pharmacol Biochem Behav","1997","1997/05/01","","","10.1016/s0091-3057(96)00337-1"
"9164585","Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice","Suzuki T, Tsuji M, Mori T, Misawa M, Nagase H.","Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):293-9. doi: 10.1016/s0091-3057(96)00319-x.","Suzuki T","Pharmacol Biochem Behav","1997","1997/05/01","","","10.1016/s0091-3057(96)00319-x"
"9164554","Effects of mu- and delta-opioid-receptor antagonists on the stimulus properties of cholecystokinin","Riley AL, Melton PM.","Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):57-62. doi: 10.1016/s0091-3057(96)00119-0.","Riley AL","Pharmacol Biochem Behav","1997","1997/05/01","","","10.1016/s0091-3057(96)00119-0"
"9162233","[Cardioprotective effects of stimulation of peripheral mu-opiate receptors, and the role of opiatergic mechanisms in the pathogenesis of stress-induced heart damage]","Lishmanov IuB, Maslov LN, Naryzhnaia NV.","Biull Eksp Biol Med. 1997 Mar;123(3):276-8.","Lishmanov IuB","Biull Eksp Biol Med","1997","1997/03/01","","",""
"9160821","Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients","Villa P, Fulghesu AM, De Marinis L, Valle D, Mancini A, Pavone V, Caruso A, Lanzone A.","Metabolism. 1997 May;46(5):538-43. doi: 10.1016/s0026-0495(97)90191-8.","Villa P","Metabolism","1997","1997/05/01","","","10.1016/s0026-0495(97)90191-8"
"9152396","M1 receptor agonist activity is not a requirement for muscarinic antinociception","Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P.","J Pharmacol Exp Ther. 1997 May;281(2):868-75.","Sheardown MJ","J Pharmacol Exp Ther","1997","1997/05/01","","",""
"9152388","Changes in sensitivity to the rate-decreasing effects of opioids in pigeons treated acutely or chronically with l-alpha-acetylmethadol","Gerak LR, France CP.","J Pharmacol Exp Ther. 1997 May;281(2):799-809.","Gerak LR","J Pharmacol Exp Ther","1997","1997/05/01","","",""
"9149302","Neuropeptide FF in the rat spinal cord during carrageenan inflammation","Kontinen VK, Aarnisalo AA, Idänpään-Heikkilä JJ, Panula P, Kalso E.","Peptides. 1997;18(2):287-92. doi: 10.1016/s0196-9781(96)00287-2.","Kontinen VK","Peptides","1997","1997/01/01","","","10.1016/s0196-9781(96)00287-2"
"9144662","Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats","Bristow LJ, Hogg JE, Hutson PH.","Neuropharmacology. 1997 Feb;36(2):241-50. doi: 10.1016/s0028-3908(97)00006-3.","Bristow LJ","Neuropharmacology","1997","1997/02/01","","","10.1016/s0028-3908(97)00006-3"
"9142997","Effect of naltrexone on feeding, neuropeptide Y and uncoupling protein gene expression during lactation","Kotz CM, Levine AS, Billington CJ.","Neuroendocrinology. 1997 Apr;65(4):259-64. doi: 10.1159/000127183.","Kotz CM","Neuroendocrinology","1997","1997/04/01","","","10.1159/000127183"
"9142869","Central opioid receptors mediate glucoprivic inhibition of pituitary LH secretion","Briski KP.","Am J Physiol. 1997 Apr;272(4 Pt 1):E517-22. doi: 10.1152/ajpendo.1997.272.4.E517.","Briski KP","Am J Physiol","1997","1997/04/01","","","10.1152/ajpendo.1997.272.4.E517"
"9140828","Distinct components of morphine effects on cardiac myocytes are mediated by the kappa and delta opioid receptors","Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y.","J Mol Cell Cardiol. 1997 Feb;29(2):711-20. doi: 10.1006/jmcc.1996.0313.","Ela C","J Mol Cell Cardiol","1997","1997/02/01","","","10.1006/jmcc.1996.0313"
"9140007","Opioid growth factor is present in human and mouse gastrointestinal tract and inhibits DNA synthesis","Zagon IS, Wu Y, McLaughlin PJ.","Am J Physiol. 1997 Apr;272(4 Pt 2):R1094-104. doi: 10.1152/ajpregu.1997.272.4.R1094.","Zagon IS","Am J Physiol","1997","1997/04/01","","","10.1152/ajpregu.1997.272.4.R1094"
"9139997","Opioids in the nucleus of the solitary tract are involved in feeding in the rat","Kotz CM, Billington CJ, Levine AS.","Am J Physiol. 1997 Apr;272(4 Pt 2):R1028-32. doi: 10.1152/ajpregu.1997.272.4.R1028.","Kotz CM","Am J Physiol","1997","1997/04/01","","","10.1152/ajpregu.1997.272.4.R1028"
"9138735","Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine","Glick SD, Maisonneuve IM, Pearl SM.","Brain Res. 1997 Feb 28;749(2):340-3. doi: 10.1016/S0006-8993(96)01414-X.","Glick SD","Brain Res","1997","1997/02/28","","","10.1016/S0006-8993(96)01414-X"
"9137139","Sequential use of naltrexone in the treatment of relapsing alcoholism","Farren CK, O'Malley S.","Am J Psychiatry. 1997 May;154(5):714. doi: 10.1176/ajp.154.5.714a.","Farren CK","Am J Psychiatry","1997","1997/05/01","","","10.1176/ajp.154.5.714a"
"9132506","Psychological coping with acute pain: an examination of the role of endogenous opioid mechanisms","Bruehl S, Carlson CR, Wilson JF, Norton JA, Colclough G, Brady MJ, Sherman JJ, McCubbin JA.","J Behav Med. 1996 Apr;19(2):129-42. doi: 10.1007/BF01857603.","Bruehl S","J Behav Med","1996","1996/04/01","","","10.1007/BF01857603"
"9129564","The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time","Yuan CS, Foss JF, Osinski J, Toledano A, Roizen MF, Moss J.","Clin Pharmacol Ther. 1997 Apr;61(4):467-75. doi: 10.1016/S0009-9236(97)90197-1.","Yuan CS","Clin Pharmacol Ther","1997","1997/04/01","","","10.1016/S0009-9236(97)90197-1"
"9129113","Opiate receptor avidity and cerebral blood flow in Alzheimer's disease","Cohen RM, Andreason PJ, Doudet DJ, Carson RE, Sunderland T.","J Neurol Sci. 1997 May 29;148(2):171-80. doi: 10.1016/s0022-510x(96)05315-4.","Cohen RM","J Neurol Sci","1997","1997/05/29","","","10.1016/s0022-510x(96)05315-4"
"9128834","Dynorphin-(1-8) inhibits the release of substance P-like immunoreactivity in the spinal cord of rats following a noxious mechanical stimulus","Zachariou V, Goldstein BD.","Eur J Pharmacol. 1997 Apr 4;323(2-3):159-65. doi: 10.1016/s0014-2999(97)00038-1.","Zachariou V","Eur J Pharmacol","1997","1997/04/04","","","10.1016/s0014-2999(97)00038-1"
"9125432","Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine","Hoshi K, Ma T, Oh S, Ho IK.","Brain Res. 1997 Apr 4;753(1):63-8. doi: 10.1016/s0006-8993(96)01492-8.","Hoshi K","Brain Res","1997","1997/04/04","","","10.1016/s0006-8993(96)01492-8"
"9122358","Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence","King AC, Volpicelli JR, Frazer A, O'Brien CP.","Psychopharmacology (Berl). 1997 Jan;129(1):15-22. doi: 10.1007/s002130050156.","King AC","Psychopharmacology (Berl)","1997","1997/01/01","","","10.1007/s002130050156"
"9117944","The pharmacological treatment of alcohol dependence","Swift RM.","Med Health R I. 1997 Mar;80(3):91-3.","Swift RM","Med Health R I","1997","1997/03/01","","",""
"9114457","Actions of beta-endorphin peptides on the contractions of mouse diaphragm muscle","Khan S, Smith ME.","Peptides. 1997;18(1):87-92. doi: 10.1016/s0196-9781(96)00250-1.","Khan S","Peptides","1997","1997/01/01","","","10.1016/s0196-9781(96)00250-1"
"9113217","Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes","Carroll KM.","Addict Behav. 1997 Mar-Apr;22(2):233-45. doi: 10.1016/s0306-4603(96)00038-x.","Carroll KM","Addict Behav","1997","1997/03/01","","","10.1016/s0306-4603(96)00038-x"
"9113103","Inhibition of swine microglial cell phagocytosis of Cryptococcus neoformans by femtomolar concentrations of morphine","Sowa G, Gekker G, Lipovsky MM, Hu S, Chao CC, Molitor TW, Peterson PK.","Biochem Pharmacol. 1997 Mar 21;53(6):823-8. doi: 10.1016/s0006-2952(97)00006-3.","Sowa G","Biochem Pharmacol","1997","1997/03/21","","","10.1016/s0006-2952(97)00006-3"
"9112681","Effects of opioid antagonists on anticonvulsant and hypnotic activity of benzodiazepines","Fidecka S, Langwiński R.","Pol J Pharmacol. 1996 Jul-Aug;48(4):409-14.","Fidecka S","Pol J Pharmacol","1996","1996/07/01","","",""
"9111732","Modulation of neurotransmitter release by opioid mu- and kappa-receptors from adrenergic terminals in the myenteric plexus of the guinea-pig colon: effect of alpha 2-autoreceptor blockade","Cosentino M, Marino F, Bombelli R, Ferrari M, Rasini E, Giaroni C, Lecchini S, Frigo G.","Neurosci Lett. 1997 Jan 31;222(2):75-8. doi: 10.1016/s0304-3940(97)13344-4.","Cosentino M","Neurosci Lett","1997","1997/01/31","","","10.1016/s0304-3940(97)13344-4"
"9106744","A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease","Newman DD, Rajakumar N, Flumerfelt BA, Stoessl AJ.","Neuroreport. 1997 Feb 10;8(3):669-72. doi: 10.1097/00001756-199702100-00018.","Newman DD","Neuroreport","1997","1997/02/10","","","10.1097/00001756-199702100-00018"
"9105683","Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain","Castelli MP, Melis M, Mameli M, Fadda P, Diaz G, Gessa GL.","Brain Res Mol Brain Res. 1997 Apr;45(1):149-53. doi: 10.1016/s0169-328x(96)00305-1.","Castelli MP","Brain Res Mol Brain Res","1997","1997/04/01","","","10.1016/s0169-328x(96)00305-1"
"9105212","Naltrexone in alcohol dependence","Hartmann PM.","Am Fam Physician. 1997 Apr;55(5):1877-9, 1883-4.","Hartmann PM","Am Fam Physician","1997","1997/04/01","","",""
"9103917","Managing pain in addicted patients","Pasero CL, Compton P.","Am J Nurs. 1997 Apr;97(4):17-8.","Pasero CL","Am J Nurs","1997","1997/04/01","","",""
"9103497","Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists","Easterling KW, Holtzman SG.","J Pharmacol Exp Ther. 1997 Apr;281(1):188-99.","Easterling KW","J Pharmacol Exp Ther","1997","1997/04/01","","",""
"9103479","Alpha-2a/d adrenoceptor subtype stimulation by guanfacine increases osmolar clearance","Intengan HD, Smyth DD.","J Pharmacol Exp Ther. 1997 Apr;281(1):48-53.","Intengan HD","J Pharmacol Exp Ther","1997","1997/04/01","","",""
"9100935","Opioid receptor antagonists attenuate heat stress-induced reduction in cerebral blood flow, increased blood-brain barrier permeability, vasogenic edema and cell changes in the rat","Sharma HS, Westman J, Cervós-Navarro J, Dey PK, Nyberg F.","Ann N Y Acad Sci. 1997 Mar 15;813:559-71. doi: 10.1111/j.1749-6632.1997.tb51747.x.","Sharma HS","Ann N Y Acad Sci","1997","1997/03/15","","","10.1111/j.1749-6632.1997.tb51747.x"
"9100933","Naltrexone modifies thermoregulatory symptoms and lessens the severity of heat stroke in guinea pigs","Romanovsky AA, Blatteis CM.","Ann N Y Acad Sci. 1997 Mar 15;813:548-52. doi: 10.1111/j.1749-6632.1997.tb51745.x.","Romanovsky AA","Ann N Y Acad Sci","1997","1997/03/15","","","10.1111/j.1749-6632.1997.tb51745.x"
"9098801","Opioid-mediated responses of dietary protein on reticular motility and plasma insulin","Froetschel MA, Courchaine JK, Nichols SW, Amos HE, Murry AC Jr.","J Dairy Sci. 1997 Mar;80(3):511-8. doi: 10.3168/jds.S0022-0302(97)75964-2.","Froetschel MA","J Dairy Sci","1997","1997/03/01","","","10.3168/jds.S0022-0302(97)75964-2"
"9097868","High-dose naltrexone and liver function safety","Marrazzi MA, Wroblewski JM, Kinzie J, Luby ED.","Am J Addict. 1997 Winter;6(1):21-9. doi: 10.3109/10550499708993159.","Marrazzi MA","Am J Addict","1997","1997/01/01","","","10.3109/10550499708993159"
"9090311","Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes","Spanagel R, Zieglgänsberger W.","Trends Pharmacol Sci. 1997 Feb;18(2):54-9.","Spanagel R","Trends Pharmacol Sci","1997","1997/02/01","","",""
"9088539","Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore","Bryant SD, Balboni G, Guerrini R, Salvadori S, Tomatis R, Lazarus LH.","Biol Chem. 1997 Feb;378(2):107-14. doi: 10.1515/bchm.1997.378.2.107.","Bryant SD","Biol Chem","1997","1997/02/01","","","10.1515/bchm.1997.378.2.107"
"9085963","Nalbuphine coadministered with morphine prevents tolerance and dependence","Lee SC, Wang JJ, Ho ST, Tao PL.","Anesth Analg. 1997 Apr;84(4):810-5. doi: 10.1097/00000539-199704000-00021.","Lee SC","Anesth Analg","1997","1997/04/01","","","10.1097/00000539-199704000-00021"
"9084601","Dynorphin A-mediated reduction in multiple calcium currents involves a G(o) alpha-subtype G protein in rat primary afferent neurons","Wiley JW, Moises HC, Gross RA, MacDonald RL.","J Neurophysiol. 1997 Mar;77(3):1338-48. doi: 10.1152/jn.1997.77.3.1338.","Wiley JW","J Neurophysiol","1997","1997/03/01","","","10.1152/jn.1997.77.3.1338"
"9084416","Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes","Breivogel CS, Selley DE, Childers SR.","J Neurochem. 1997 Apr;68(4):1462-72. doi: 10.1046/j.1471-4159.1997.68041462.x.","Breivogel CS","J Neurochem","1997","1997/04/01","","","10.1046/j.1471-4159.1997.68041462.x"
"9084406","Overexpression of delta-opioid receptors in recombinant baculovirus-infected Trichoplusia ni ""High 5"" insect cells","Wehmeyer A, Schulz R.","J Neurochem. 1997 Apr;68(4):1361-71.","Wehmeyer A","J Neurochem","1997","1997/04/01","","",""
"9078589","Influence of chronic prenatal and postnatal administration of naltrexone in locomotor activity induced by morphine in mice","Medina Jiménez M, Luján Estrada M, Rodríguez R.","Arch Med Res. 1997 Spring;28(1):61-5.","Medina Jiménez M","Arch Med Res","1997","1997/04/01","","",""
"9068975","Effects of mu-, delta- and kappa-opioid antagonists in atrial preparations from nonfailing and failing human hearts","Llobel F, Laorden ML.","Gen Pharmacol. 1997 Mar;28(3):371-4. doi: 10.1016/s0306-3623(96)00221-2.","Llobel F","Gen Pharmacol","1997","1997/03/01","","","10.1016/s0306-3623(96)00221-2"
"9067458","Effects of naltrexone and histamine antagonists on the antinociceptive activity of the cimetidine analog SKF92374 in rats","Li BY, Nalwalk JW, Hough LB.","Brain Res. 1997 Feb 14;748(1-2):168-74. doi: 10.1016/s0006-8993(96)01288-7.","Li BY","Brain Res","1997","1997/02/14","","","10.1016/s0006-8993(96)01288-7"
"9067000","Effect of naltrexone on weight gain and food craving induced by tricyclic antidepressants and lithium: an open study","Zimmermann U, Rechlin T, Plaskacewicz GJ, Barocka A, Wildt L, Kaschka WP.","Biol Psychiatry. 1997 Mar 15;41(6):747-9. doi: 10.1016/S0006-3223(96)00523-9.","Zimmermann U","Biol Psychiatry","1997","1997/03/15","","","10.1016/S0006-3223(96)00523-9"
"9064496","Prognostic significance of depression occurrence in infantile autism","Scifo R, Calandra C, Parrinello MA, Marchetti B.","Minerva Pediatr. 1996 Nov;48(11):495-8.","Scifo R","Minerva Pediatr","1996","1996/11/01","","",""
"9064478","Inhibition of the LH surge in cyclic rats by stress is not mediated by opioids","Roozendaal MM, Swarts JJ, van Maanen JC, Wiegant VM, Mattheij JA.","Life Sci. 1997;60(10):735-42. doi: 10.1016/s0024-3205(96)00652-2.","Roozendaal MM","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(96)00652-2"
"9062678","Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice","Ukai M, Itoh J, Kobayashi T, Shinkai N, Kameyama T.","Behav Brain Res. 1997 Feb;83(1-2):169-72. doi: 10.1016/s0166-4328(97)86063-9.","Ukai M","Behav Brain Res","1997","1997/02/01","","","10.1016/s0166-4328(97)86063-9"
"9057861","(E)- and (Z)-7-arylidenenaltrexones: synthesis and opioid receptor radioligand displacement assays","Palmer RB, Upthagrove AL, Nelson WL.","J Med Chem. 1997 Feb 28;40(5):749-53. doi: 10.1021/jm960573f.","Palmer RB","J Med Chem","1997","1997/02/28","","","10.1021/jm960573f"
"9055839","Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone","McGee MD.","J Clin Psychiatry. 1997 Jan;58(1):32-3. doi: 10.4088/jcp.v58n0106e.","McGee MD","J Clin Psychiatry","1997","1997/01/01","","","10.4088/jcp.v58n0106e"
"9054806","Naltrexone for alcoholic adolescents","Lifrak PD, Alterman AI, O'Brien CP, Volpicelli JR.","Am J Psychiatry. 1997 Mar;154(3):439-41. doi: 10.1176/ajp.154.3.439b.","Lifrak PD","Am J Psychiatry","1997","1997/03/01","","","10.1176/ajp.154.3.439b"
"9054801","Naltrexone treatment of hallucinogen persisting perception disorder","Lerner AG, Oyefe I, Isaacs G, Sigal M.","Am J Psychiatry. 1997 Mar;154(3):437. doi: 10.1176/ajp.154.3.437a.","Lerner AG","Am J Psychiatry","1997","1997/03/01","","","10.1176/ajp.154.3.437a"
"9053071","[The role of endogenous opioid peptides in the mechanisms of the antiarrhythmic effect of adaptation]","Lishmanov IuB, Maslov LN, Krylamov AV, Uskina EV.","Fiziol Zh Im I M Sechenova. 1996 May-Jun;82(5-6):48-52.","Lishmanov IuB","Fiziol Zh Im I M Sechenova","1996","1996/05/01","","",""
"9050939","Fluorescent staining of kappa opioid receptors using naltrexamine derivatives and phycoerythrin","Lawrence DM, Hutchinson I, Seyed-Mozaffari A, Archer S, Bidlack JM.","J Immunol Methods. 1997 Feb 28;201(2):173-81. doi: 10.1016/s0022-1759(96)00223-2.","Lawrence DM","J Immunol Methods","1997","1997/02/28","","","10.1016/s0022-1759(96)00223-2"
"9050081","Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss Webster mice","Rady JJ, Baemmert D, Takemori AE, Portoghese PS, Fujimoto JM.","Pharmacol Biochem Behav. 1997 Feb;56(2):243-9. doi: 10.1016/s0091-3057(96)00219-5.","Rady JJ","Pharmacol Biochem Behav","1997","1997/02/01","","","10.1016/s0091-3057(96)00219-5"
"9048971","Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1)","Kest B, Lee CE, Mogil JS, Inturrisi CE.","Life Sci. 1997;60(9):PL155-9. doi: 10.1016/s0024-3205(96)00704-7.","Kest B","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(96)00704-7"
"9048965","Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats","Friese N, Chevalier E, Angel F, Pascaud X, Junien JL, Dahl SG, Riviere PJ.","Life Sci. 1997;60(9):625-34. doi: 10.1016/s0024-3205(96)00647-9.","Friese N","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(96)00647-9"
"9048750","Regulation of mu-opioid receptor in neural cells by extracellular sodium","Yabaluri N, Medzihradsky F.","J Neurochem. 1997 Mar;68(3):1053-61. doi: 10.1046/j.1471-4159.1997.68031053.x.","Yabaluri N","J Neurochem","1997","1997/03/01","","","10.1046/j.1471-4159.1997.68031053.x"
"9048269","Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic study","Foss JF, O'Connor MF, Yuan CS, Murphy M, Moss J, Roizen MF.","J Clin Pharmacol. 1997 Jan;37(1):25-30. doi: 10.1177/009127009703700105.","Foss JF","J Clin Pharmacol","1997","1997/01/01","","","10.1177/009127009703700105"
"9046978","Naltrexone in the treatment of alcoholism","Weinrieb RM, O'Brien CP.","Annu Rev Med. 1997;48:477-87. doi: 10.1146/annurev.med.48.1.477.","Weinrieb RM","Annu Rev Med","1997","1997/01/01","","","10.1146/annurev.med.48.1.477"
"9046073","Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET","Madar I, Lever JR, Kinter CM, Scheffel U, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ.","Synapse. 1996 Sep;24(1):19-28. doi: 10.1002/(SICI)1098-2396(199609)24:1<19::AID-SYN3>3.0.CO;2-J.","Madar I","Synapse","1996","1996/09/01","","","10.1002/(SICI)1098-2396(199609)24:1<19::AID-SYN3>3.0.CO;2-J"
"9042392","Isradipine in combination with naltrexone as a medicine for treating cocaine abuse","Reid LD, Pabello NG, Cramer CM, Hubbell CL.","Life Sci. 1997;60(8):PL119-26. doi: 10.1016/s0024-3205(96)00693-5.","Reid LD","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(96)00693-5"
"9040159","Methadone vs naltrexone","Blansfield HN.","Conn Med. 1997 Jan;61(1):53-4.","Blansfield HN","Conn Med","1997","1997/01/01","","",""
"9040115","Endogenous opioid systems and alcohol addiction","Herz A.","Psychopharmacology (Berl). 1997 Jan;129(2):99-111. doi: 10.1007/s002130050169.","Herz A","Psychopharmacology (Berl)","1997","1997/01/01","","","10.1007/s002130050169"
"9038970","Chronic opiate-receptor inhibition in experimental congestive heart failure in dogs","Yatani A, Imai N, Himura Y, Suematsu M, Liang CS.","Am J Physiol. 1997 Jan;272(1 Pt 2):H478-84. doi: 10.1152/ajpheart.1997.272.1.H478.","Yatani A","Am J Physiol","1997","1997/01/01","","","10.1152/ajpheart.1997.272.1.H478"
"9038367","Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma x glioma NG108-15 hybrid cells","Ma L, Cheng ZJ, Fan GH, Cai YC, Jiang LZ, Pei G.","FEBS Lett. 1997 Feb 10;403(1):91-4. doi: 10.1016/s0014-5793(97)00031-8.","Ma L","FEBS Lett","1997","1997/02/10","","","10.1016/s0014-5793(97)00031-8"
"9037404","Interaction of cholecystokinin and somatostatin with a selective mu-opioid agonist and mu- and kappa-antagonists in thermoregulation","Ghosh S, Geller EB, Adler MW.","Brain Res. 1997 Jan 16;745(1-2):152-7. doi: 10.1016/s0006-8993(96)01144-4.","Ghosh S","Brain Res","1997","1997/01/16","","","10.1016/s0006-8993(96)01144-4"
"9030905","Determination of delta-opioid in NG108-15 cells","Ho BY, Holmes BB, Zhao J, Fujimoto J.","Eur J Pharmacol. 1997 Jan 14;319(1):109-14. doi: 10.1016/s0014-2999(96)00827-8.","Ho BY","Eur J Pharmacol","1997","1997/01/14","","","10.1016/s0014-2999(96)00827-8"
"9028057","Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone","Scifo R, Cioni M, Nicolosi A, Batticane N, Tirolo C, Testa N, Quattropani MC, Morale MC, Gallo F, Marchetti B.","Ann Ist Super Sanita. 1996;32(3):351-9.","Scifo R","Ann Ist Super Sanita","1996","1996/01/01","","",""
"9024170","Effects of liver disease on the disposition of the opioid antagonist nalmefene","Frye RF, Matzke GR, Schade R, Dixon R, Rabinovitz M.","Clin Pharmacol Ther. 1997 Jan;61(1):15-23. doi: 10.1016/S0009-9236(97)90178-8.","Frye RF","Clin Pharmacol Ther","1997","1997/01/01","","","10.1016/S0009-9236(97)90178-8"
"9023069","Characterization of the decline in alcohol consumption by aminopeptidase inhibition","Szczepanska R, Harding S, Grupp LA.","Drug Alcohol Depend. 1996 Dec 11;43(3):133-41. doi: 10.1016/s0376-8716(96)01293-8.","Szczepanska R","Drug Alcohol Depend","1996","1996/12/11","","","10.1016/s0376-8716(96)01293-8"
"9019453","[Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism]","Poser W, Ehrenreich H.","Internist (Berl). 1996 Oct;37(10):1061-7; discussion 1067.","Poser W","Internist (Berl)","1996","1996/10/01","","",""
"9018507","Heat stroke: opioid-mediated mechanisms","Romanovsky AA, Blatteis CM.","J Appl Physiol (1985). 1996 Dec;81(6):2565-70. doi: 10.1152/jappl.1996.81.6.2565.","Romanovsky AA","J Appl Physiol (1985)","1996","1996/12/01","","","10.1152/jappl.1996.81.6.2565"
"9018394","Consideration of the relevance of ethological animal models for human repetitive behavioral spectrum disorders","Nurnberg HG, Keith SJ, Paxton DM.","Biol Psychiatry. 1997 Jan 15;41(2):226-9. doi: 10.1016/s0006-3223(96)00100-x.","Nurnberg HG","Biol Psychiatry","1997","1997/01/15","","","10.1016/s0006-3223(96)00100-x"
"9017246","Opioid stimulation in the ventral tegmental area facilitates the onset of maternal behavior in rats","Thompson AC, Kristal MB.","Brain Res. 1996 Dec 16;743(1-2):184-201. doi: 10.1016/s0006-8993(96)01041-4.","Thompson AC","Brain Res","1996","1996/12/16","","","10.1016/s0006-8993(96)01041-4"
"9016909","Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system","Hernando F, Fuentes JA, Fournié-Zaluski MC, Roques BP, Ruiz-Gayo M.","Eur J Pharmacol. 1996 Dec 30;318(2-3):221-9. doi: 10.1016/s0014-2999(96)00773-x.","Hernando F","Eur J Pharmacol","1996","1996/12/30","","","10.1016/s0014-2999(96)00773-x"
"9014630","Antinociception by intrathecal midazolam involves endogenous neurotransmitters acting at spinal cord delta opioid receptors","Goodchild CS, Guo Z, Musgreave A, Gent JP.","Br J Anaesth. 1996 Dec;77(6):758-63. doi: 10.1093/bja/77.6.758.","Goodchild CS","Br J Anaesth","1996","1996/12/01","","","10.1093/bja/77.6.758"
"9013390","Neuropharmacological characterization of local ibogaine effects on dopamine release","Reid MS, Hsu K Jr, Souza KH, Broderick PA, Berger SP.","J Neural Transm (Vienna). 1996;103(8-9):967-85. doi: 10.1007/BF01291787.","Reid MS","J Neural Transm (Vienna)","1996","1996/01/01","","","10.1007/BF01291787"
"9013388","Effect of interferon-alpha on DOI-induced wet-dog shakes in rats","Kugaya A, Kagaya A, Uchitomi Y, Yokota N, Yamawaki S.","J Neural Transm (Vienna). 1996;103(8-9):947-55. doi: 10.1007/BF01291785.","Kugaya A","J Neural Transm (Vienna)","1996","1996/01/01","","","10.1007/BF01291785"
"9010155","Experts debate merits of 1-day opiate detoxification under anesthesia","Stephenson J.","JAMA. 1997 Feb 5;277(5):363-4.","Stephenson J","JAMA","1997","1997/02/05","","",""
"9007506","Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors","Reche I, Fuentes JA, Ruiz-Gayo M.","Eur J Pharmacol. 1996 Dec 27;318(1):11-6. doi: 10.1016/s0014-2999(96)00752-2.","Reche I","Eur J Pharmacol","1996","1996/12/27","","","10.1016/s0014-2999(96)00752-2"
"9003244","Differential localization of three distinct binding sites for sigma receptor ligands in rat spleen","Wolfe SA Jr, Ha BK, Whitlock BB, Saini P.","J Neuroimmunol. 1997 Jan;72(1):45-58. doi: 10.1016/s0165-5728(96)00140-3.","Wolfe SA Jr","J Neuroimmunol","1997","1997/01/01","","","10.1016/s0165-5728(96)00140-3"
"9003056","Monoamine metabolism in the locus coeruleus measured concurrently with behavior during opiate withdrawal: an in vivo microdialysis study in freely moving rats","Javelle N, Renaud B, Lambás-Señas L.","J Neurochem. 1997 Feb;68(2):683-90. doi: 10.1046/j.1471-4159.1997.68020683.x.","Javelle N","J Neurochem","1997","1997/02/01","","","10.1046/j.1471-4159.1997.68020683.x"
"9001736","Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats","Leventhal L, Bodnar RJ.","Brain Res. 1996 Nov 25;741(1-2):300-8. doi: 10.1016/s0006-8993(96)00951-1.","Leventhal L","Brain Res","1996","1996/11/25","","","10.1016/s0006-8993(96)00951-1"
"9000774","Naltrexone for alcohol abuse","Wold M, Kaminer Y.","J Am Acad Child Adolesc Psychiatry. 1997 Jan;36(1):6-7. doi: 10.1097/00004583-199701000-00010.","Wold M","J Am Acad Child Adolesc Psychiatry","1997","1997/01/01","","","10.1097/00004583-199701000-00010"
"8998112","Potential danger of nalmefene use in the emergency department","Gaeta TJ, Capodano RJ, Spevack TA.","Ann Emerg Med. 1997 Jan;29(1):193-4. doi: 10.1016/s0196-0644(97)70334-2.","Gaeta TJ","Ann Emerg Med","1997","1997/01/01","","","10.1016/s0196-0644(97)70334-2"
"8996532","Opiate effects on 5-fluorouracil disposition in mice","Li Y, Looney GA, Kimler BF, Hurwitz A.","Cancer Chemother Pharmacol. 1997;39(3):273-7. doi: 10.1007/s002800050572.","Li Y","Cancer Chemother Pharmacol","1997","1997/01/01","","","10.1007/s002800050572"
"8996182","Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures","Kong LY, McMillian MK, Hudson PM, Jin L, Hong JS.","J Pharmacol Exp Ther. 1997 Jan;280(1):61-6.","Kong LY","J Pharmacol Exp Ther","1997","1997/01/01","","",""
"8993452","Effects of PACAP and VIP on adrenal progesterone release","Baranowska B, Wasilewska-Dziubińska E, Radzikowska M, Płlonowski A, Roguski K, Krawczyk E, Kawalec M.","Ann N Y Acad Sci. 1996 Dec 26;805:628-33. doi: 10.1111/j.1749-6632.1996.tb17532.x.","Baranowska B","Ann N Y Acad Sci","1996","1996/12/26","","","10.1111/j.1749-6632.1996.tb17532.x"
"8991797","Attenuation of memory with Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog with high affinity for mu-opioid receptors","Ukai M, Kobayashi T, Mori K, Shinkai N, Sasaki Y, Kameyama T.","Eur J Pharmacol. 1995 Dec 20;287(3):245-9. doi: 10.1016/0014-2999(95)00492-0.","Ukai M","Eur J Pharmacol","1995","1995/12/20","","","10.1016/0014-2999(95)00492-0"
"8989838","The importance of delta and kappa opioid receptors in the property of thyrotropin-releasing hormone against hemorrhagic shock","Liu LM, Hu DY, Chen HS, Lu RQ, Yan W.","Shock. 1997 Jan;7(1):60-4. doi: 10.1097/00024382-199701000-00008.","Liu LM","Shock","1997","1997/01/01","","","10.1097/00024382-199701000-00008"
"8989528","Stress decreases lymphocyte cytolytic activity in the young monkey even after blockade of steroid and opiate hormone receptors","Coe CL, Erickson CM.","Dev Psychobiol. 1997 Jan;30(1):1-10.","Coe CL","Dev Psychobiol","1997","1997/01/01","","",""
"8989029","Acute pulmonary edema in a young male after intravenous nalmefene","Henderson CA, Reynolds JE.","Anesth Analg. 1997 Jan;84(1):218-9. doi: 10.1097/00000539-199701000-00040.","Henderson CA","Anesth Analg","1997","1997/01/01","","","10.1097/00000539-199701000-00040"
"8987434","Naltrexone hydrochloride use in the treatment of alcoholism","Ey SR.","West J Med. 1996 Oct;165(4):227.","Ey SR","West J Med","1996","1996/10/01","PMC1303756","",""
"8985972","Cancer pain remedy wins orphan drug status","","Oncology (Williston Park). 1996 Dec;10(12):1880.","","Oncology (Williston Park)","1996","1996/12/01","","",""
"8981612","Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice","Hiramatsu M, Sasaki M, Nabeshima T, Kameyama T.","Pharmacol Biochem Behav. 1997 Jan;56(1):73-9. doi: 10.1016/S0091-3057(96)00159-1.","Hiramatsu M","Pharmacol Biochem Behav","1997","1997/01/01","","","10.1016/S0091-3057(96)00159-1"
"8981257","Melatonin-induced T-helper cell hematopoietic cytokines resembling both interleukin-4 and dynorphin","Maestroni GJ, Hertens E, Galli P, Conti A, Pedrinis E.","J Pineal Res. 1996 Oct;21(3):131-9. doi: 10.1111/j.1600-079x.1996.tb00280.x.","Maestroni GJ","J Pineal Res","1996","1996/10/01","","","10.1111/j.1600-079x.1996.tb00280.x"
"8979434","The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction","Simon DL.","Conn Med. 1996 Nov;60(11):683-5.","Simon DL","Conn Med","1996","1996/11/01","","",""
"8974478","[Opiatergic mechanisms of antiarrhythmic effect of adaptation]","Lishmanov IuB, Uskina EV, Maslov LN, Krylatov AV.","Biull Eksp Biol Med. 1996 Sep;122(9):276-8.","Lishmanov IuB","Biull Eksp Biol Med","1996","1996/09/01","","",""
"8974381","Interaction between opiate and 5-HT3 receptor antagonists in the regulation of alcohol intake","Le AD, Sellers EM.","Alcohol Alcohol Suppl. 1994;2:545-9.","Le AD","Alcohol Alcohol Suppl","1994","1994/01/01","","",""
"8964897","Modulation of humoral immune response by central administration of leucine-enkephalin: effects of mu, delta and kappa opioid receptor antagonists","Radulović J, Mancev Z, Stanojević S, Vasiljević T, Kovacević-Jovanović V, Pesić G.","J Neuroimmunol. 1996 Apr;65(2):155-61. doi: 10.1016/0165-5728(96)00017-3.","Radulović J","J Neuroimmunol","1996","1996/04/01","","","10.1016/0165-5728(96)00017-3"
"8960876","Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors","Catheline G, Kayser V, Guilbaud G.","Eur J Pharmacol. 1996 Nov 14;315(2):135-43. doi: 10.1016/s0014-2999(96)00629-2.","Catheline G","Eur J Pharmacol","1996","1996/11/14","","","10.1016/s0014-2999(96)00629-2"
"8960874","U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice","Hiramatsu M, Hyodo T, Kameyama T.","Eur J Pharmacol. 1996 Nov 14;315(2):119-25. doi: 10.1016/s0014-2999(96)00622-x.","Hiramatsu M","Eur J Pharmacol","1996","1996/11/14","","","10.1016/s0014-2999(96)00622-x"
"8957215","Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat","Yuan CS.","Eur J Pharmacol. 1996 Oct 24;314(1-2):27-32. doi: 10.1016/s0014-2999(96)00531-6.","Yuan CS","Eur J Pharmacol","1996","1996/10/24","","","10.1016/s0014-2999(96)00531-6"
"8955943","Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat","Wang XM, Yan JQ, Zhang KM, Mokha SS.","Brain Res. 1996 Nov 11;739(1-2):235-43. doi: 10.1016/s0006-8993(96)00828-1.","Wang XM","Brain Res","1996","1996/11/11","","","10.1016/s0006-8993(96)00828-1"
"8951719","Opioid receptors on guinea-pig intestinal crypt epithelial cells","Lang ME, Davison JS, Bates SL, Meddings JB.","J Physiol. 1996 Nov 15;497 ( Pt 1)(Pt 1):161-74. doi: 10.1113/jphysiol.1996.sp021757.","Lang ME","J Physiol","1996","1996/11/15","PMC1160920","","10.1113/jphysiol.1996.sp021757"
"8950882","Randomised crossover trial of naltrexone in uraemic pruritus","Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, laina A.","Lancet. 1996 Dec 7;348(9041):1552-4. doi: 10.1016/s0140-6736(96)04176-1.","Peer G","Lancet","1996","1996/12/07","","","10.1016/s0140-6736(96)04176-1"
"8949946","Naltrexone prevents ethanol-induced changes in rat thymus","Budec M, Leposavić G, Karapetrović B, Kosec D.","Alcohol. 1996 Nov-Dec;13(6):533-7. doi: 10.1016/s0741-8329(96)00035-3.","Budec M","Alcohol","1996","1996/11/01","","","10.1016/s0741-8329(96)00035-3"
"8947926","Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo","Chen XH, Liu-Chen LY, Tallarida RJ, Geller EB, de Riel JK, Adler MW.","Neurochem Res. 1996 Nov;21(11):1363-8. doi: 10.1007/BF02532377.","Chen XH","Neurochem Res","1996","1996/11/01","","","10.1007/BF02532377"
"8947918","Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor models","Metzger TG, Paterlini MG, Portoghese PS, Ferguson DM.","Neurochem Res. 1996 Nov;21(11):1287-94. doi: 10.1007/BF02532369.","Metzger TG","Neurochem Res","1996","1996/11/01","","","10.1007/BF02532369"
"8947306","Periodic naltrexone and propensity to take alcoholic beverage","Reid LD, Gardell LR, Chattopadhyay S, Hubbell CL.","Alcohol Clin Exp Res. 1996 Nov;20(8):1329-34. doi: 10.1111/j.1530-0277.1996.tb01130.x.","Reid LD","Alcohol Clin Exp Res","1996","1996/11/01","","","10.1111/j.1530-0277.1996.tb01130.x"
"8947271","Alternatives to naltrexone in animal models","Overstreet DH.","Alcohol Clin Exp Res. 1996 Nov;20(8 Suppl):231A-235A. doi: 10.1111/j.1530-0277.1996.tb01782.x.","Overstreet DH","Alcohol Clin Exp Res","1996","1996/11/01","","","10.1111/j.1530-0277.1996.tb01782.x"
"8947268","International update: new findings on promising medications","Litten RZ.","Alcohol Clin Exp Res. 1996 Nov;20(8 Suppl):216A-218A. doi: 10.1111/j.1530-0277.1996.tb01779.x.","Litten RZ","Alcohol Clin Exp Res","1996","1996/11/01","","","10.1111/j.1530-0277.1996.tb01779.x"
"8947259","Pharmacotherapy of alcoholism--10 years of progress","Anton RF.","Alcohol Clin Exp Res. 1996 Nov;20(8 Suppl):172A-175A. doi: 10.1111/j.1530-0277.1996.tb01770.x.","Anton RF","Alcohol Clin Exp Res","1996","1996/11/01","","","10.1111/j.1530-0277.1996.tb01770.x"
"8943250","Moving from the orphanin FQ receptor to an opioid receptor using four point mutations","Meng F, Taylor LP, Hoversten MT, Ueda Y, Ardati A, Reinscheid RK, Monsma FJ, Watson SJ, Civelli O, Akil H.","J Biol Chem. 1996 Dec 13;271(50):32016-20. doi: 10.1074/jbc.271.50.32016.","Meng F","J Biol Chem","1996","1996/12/13","","","10.1074/jbc.271.50.32016"
"8939309","Reducing naltrexone-resistant hyperphagia using laser acupuncture to increase endogenous opiates","Read A, Beaty P, Corner J, Sommerville Ville C.","Brain Inj. 1996 Dec;10(12):911-9. doi: 10.1080/026990596123882.","Read A","Brain Inj","1996","1996/12/01","","","10.1080/026990596123882"
"8938664","Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma","Niroomand F, Mura RA, Piacentini L, Kübler W.","Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):643-9. doi: 10.1007/BF00170840.","Niroomand F","Naunyn Schmiedebergs Arch Pharmacol","1996","1996/11/01","","","10.1007/BF00170840"
"8938656","Opioid receptor-mediated control of acetylcholine release in human neocortex tissue","Feuerstein TJ, Gleichauf O, Peckys D, Landwehrmeyer GB, Scheremet R, Jackisch R.","Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):586-92. doi: 10.1007/BF00170832.","Feuerstein TJ","Naunyn Schmiedebergs Arch Pharmacol","1996","1996/11/01","","","10.1007/BF00170832"
"8937625","Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95)","Hosoki R, Niizawa S, Koike K, Sagara T, Kanematsu K, Takayanagi I.","Arch Int Pharmacodyn Ther. 1996 Mar-Apr;331(2):136-52.","Hosoki R","Arch Int Pharmacodyn Ther","1996","1996/03/01","","",""
"8935170","Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of beta-naltrexamine","Derrick I, Lewis JW, Moynihan HA, Broadbear J, Woods JH.","J Pharm Pharmacol. 1996 Feb;48(2):192-6. doi: 10.1111/j.2042-7158.1996.tb07121.x.","Derrick I","J Pharm Pharmacol","1996","1996/02/01","","","10.1111/j.2042-7158.1996.tb07121.x"
"8933423","Stability of revex, nalmefene hydrochloride injection, in injectable solutions","Murthy SS, Brittain HG.","J Pharm Biomed Anal. 1996 Nov;15(2):221-6. doi: 10.1016/0731-7085(96)01847-x.","Murthy SS","J Pharm Biomed Anal","1996","1996/11/01","","","10.1016/0731-7085(96)01847-x"
"8931460","Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens","Schad CA, Justice JB Jr, Holtzman SG.","J Neurochem. 1996 Dec;67(6):2292-9. doi: 10.1046/j.1471-4159.1996.67062292.x.","Schad CA","J Neurochem","1996","1996/12/01","","","10.1046/j.1471-4159.1996.67062292.x"
"8930374","Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity","Hsueh CM, Chen SF, Huang HJ, Ghanta VK, Hiramoto RN.","Brain Res. 1996 Oct 21;737(1-2):263-8. doi: 10.1016/0006-8993(96)00740-8.","Hsueh CM","Brain Res","1996","1996/10/21","","","10.1016/0006-8993(96)00740-8"
"8930364","kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids","Gurwell JA, Duncan MJ, Maderspach K, Stiene-Martin A, Elde RP, Hauser KF.","Brain Res. 1996 Oct 21;737(1-2):175-87. doi: 10.1016/0006-8993(96)00728-7.","Gurwell JA","Brain Res","1996","1996/10/21","PMC4859821","NIHMS781346","10.1016/0006-8993(96)00728-7"
"8930342","Effects of the blockade of opioid receptor on defensive reactions elicited by electrical stimulation within the deep layers of the superior colliculus and DPAG","Coimbra NC, Eichenberger GC, Gorchinski RT, Maisonnette S.","Brain Res. 1996 Oct 14;736(1-2):348-52. doi: 10.1016/0006-8993(96)00928-6.","Coimbra NC","Brain Res","1996","1996/10/14","","","10.1016/0006-8993(96)00928-6"
"8930337","Delta-Opioid receptor modulation of the release of substance P-like immunoreactivity in the dorsal horn of the rat following mechanical or thermal noxious stimulation","Zachariou V, Goldstein BD.","Brain Res. 1996 Oct 14;736(1-2):305-14. doi: 10.1016/0006-8993(96)00718-4.","Zachariou V","Brain Res","1996","1996/10/14","","","10.1016/0006-8993(96)00718-4"
"8930154","Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans","Walsh SL, Sullivan JT, Preston KL, Garner JE, Bigelow GE.","J Pharmacol Exp Ther. 1996 Nov;279(2):524-38.","Walsh SL","J Pharmacol Exp Ther","1996","1996/11/01","","",""
"8916634","Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching","Jaffe AJ, Rounsaville B, Chang G, Schottenfeld RS, Meyer RE, O'Malley SS.","J Consult Clin Psychol. 1996 Oct;64(5):1044-53. doi: 10.1037//0022-006x.64.5.1044.","Jaffe AJ","J Consult Clin Psychol","1996","1996/10/01","","","10.1037//0022-006x.64.5.1044"
"8915966","Water transport in cultured cells from the rat inner medullary collecting duct","Hubbard JI.","J Am Soc Nephrol. 1996 Oct;7(10):2062-71.","Hubbard JI","J Am Soc Nephrol","1996","1996/10/01","","",""
"8914859","Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats","Kolta MG, Ngong JM, Rutledge LP, Pierzchala K, Van Loon GR.","Neuropeptides. 1996 Aug;30(4):335-44. doi: 10.1016/s0143-4179(96)90022-0.","Kolta MG","Neuropeptides","1996","1996/08/01","","","10.1016/s0143-4179(96)90022-0"
"8914123","A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal","Rasmussen K, Kendrick WT, Kogan JH, Aghajanian GK.","Neuropsychopharmacology. 1996 Nov;15(5):497-505. doi: 10.1016/S0893-133X(96)00094-2.","Rasmussen K","Neuropsychopharmacology","1996","1996/11/01","","","10.1016/S0893-133X(96)00094-2"
"8913353","Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein","Pak Y, Kouvelas A, Scheideler MA, Rasmussen J, O'Dowd BF, George SR.","Mol Pharmacol. 1996 Nov;50(5):1214-22.","Pak Y","Mol Pharmacol","1996","1996/11/01","","",""
"8911587","Rapid opiate detoxification","Bartter T, Gooberman LL.","Am J Drug Alcohol Abuse. 1996 Nov;22(4):489-95. doi: 10.3109/00952999609001675.","Bartter T","Am J Drug Alcohol Abuse","1996","1996/11/01","","","10.3109/00952999609001675"
"8910807","Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of mu and kappa opiate receptor subtypes","Callahan P, Baumann MH, Rabii J.","J Neuroendocrinol. 1996 Oct;8(10):771-6. doi: 10.1046/j.1365-2826.1996.05207.x.","Callahan P","J Neuroendocrinol","1996","1996/10/01","","","10.1046/j.1365-2826.1996.05207.x"
"8909339","Misuse of naltrexone","Measom MO.","J Clin Psychiatry. 1996 Oct;57(10):488-9.","Measom MO","J Clin Psychiatry","1996","1996/10/01","","",""
"8908412","Effects of chronic treatment with methadone and naltrexone on sleep in addicts","Staedt J, Wassmuth F, Stoppe G, Hajak G, Rodenbeck A, Poser W, Rüther E.","Eur Arch Psychiatry Clin Neurosci. 1996;246(6):305-9. doi: 10.1007/BF02189023.","Staedt J","Eur Arch Psychiatry Clin Neurosci","1996","1996/01/01","","","10.1007/BF02189023"
"8905323","Systemic administration of dynorphin A-(1-13) markedly improves cycloheximide-induced amnesia in mice","Ukai M, Shan-Wu X, Kobayashi T, Kameyama T.","Eur J Pharmacol. 1996 Oct 10;313(1-2):11-5. doi: 10.1016/0014-2999(96)00484-0.","Ukai M","Eur J Pharmacol","1996","1996/10/10","","","10.1016/0014-2999(96)00484-0"
"8905252","A risk-benefit assessment of naltrexone in the treatment of alcohol dependence","Berg BJ, Pettinati HM, Volpicelli JR.","Drug Saf. 1996 Oct;15(4):274-82. doi: 10.2165/00002018-199615040-00005.","Berg BJ","Drug Saf","1996","1996/10/01","","","10.2165/00002018-199615040-00005"
"8904989","Dosing issues in the pharmacotherapy of alcoholism","Mason BJ.","Alcohol Clin Exp Res. 1996 Oct;20(7 Suppl):10A-16A. doi: 10.1111/j.1530-0277.1996.tb01184.x.","Mason BJ","Alcohol Clin Exp Res","1996","1996/10/01","","","10.1111/j.1530-0277.1996.tb01184.x"
"8904639","Clonidine-induced increase in osmolar clearance and free water clearance via activation of two distinct alpha 2-adrenoceptor sites","Intengan HD, Smyth DD.","Br J Pharmacol. 1996 Oct;119(4):663-70. doi: 10.1111/j.1476-5381.1996.tb15724.x.","Intengan HD","Br J Pharmacol","1996","1996/10/01","PMC1915753","","10.1111/j.1476-5381.1996.tb15724.x"
"8899738","Antiallodynic effects of a CCKB antagonist in rats with nerve ligation injury: role of endogenous enkephalins","Nichols ML, Bian D, Ossipov MH, Malan TP Jr, Porreca F.","Neurosci Lett. 1996 Sep 13;215(3):161-4. doi: 10.1016/0304-3940(96)12964-5.","Nichols ML","Neurosci Lett","1996","1996/09/13","","","10.1016/0304-3940(96)12964-5"
"8896712","Effects of dopaminergic agents on visceral pain measured by the mouse writhing test","Frussa-Filho R, Rocha JB, Conceição IM, Mello CF, Pereira ME.","Arch Int Pharmacodyn Ther. 1996 Jan-Feb;331(1):74-93.","Frussa-Filho R","Arch Int Pharmacodyn Ther","1996","1996/01/01","","",""
"8895244","Sensitization of the tail-flick reflex following exposure to either a single prolonged test trial or behavioral testing under the analgesic influence of morphine","Baldwin AE, Cannon JT.","Pain. 1996 Sep;67(1):163-72. doi: 10.1016/0304-3959(96)03084-9.","Baldwin AE","Pain","1996","1996/09/01","","","10.1016/0304-3959(96)03084-9"
"8894177","alpha-Adrenoceptor and opioid receptor modulation of clonidine-induced antinociception","Sierralta F, Naquira D, Pinardi G, Miranda HF.","Br J Pharmacol. 1996 Oct;119(3):551-4. doi: 10.1111/j.1476-5381.1996.tb15707.x.","Sierralta F","Br J Pharmacol","1996","1996/10/01","PMC1915699","","10.1111/j.1476-5381.1996.tb15707.x"
"8891592","Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of delta 1- and delta 2-opioid receptor agonists","Bhargava HN, Zhao GM, House RV, Thomas PT.","Eur J Pharmacol. 1996 Sep 12;311(2-3):127-32. doi: 10.1016/0014-2999(96)00411-6.","Bhargava HN","Eur J Pharmacol","1996","1996/09/12","","","10.1016/0014-2999(96)00411-6"
"8891291","The effects of morphine on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist","Honoré P, Buritova J, Besson JM.","Brain Res. 1996 Sep 2;732(1-2):242-6. doi: 10.1016/0006-8993(96)00749-4.","Honoré P","Brain Res","1996","1996/09/02","","","10.1016/0006-8993(96)00749-4"
"8891275","Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons","Durham RA, Johnson JD, Moore KE, Lookingland KJ.","Brain Res. 1996 Sep 2;732(1-2):113-20. doi: 10.1016/0006-8993(96)00501-x.","Durham RA","Brain Res","1996","1996/09/02","","","10.1016/0006-8993(96)00501-x"
"8889912","Naltrexone and self-injurious behavior: a retrospective population study","Casner JA, Weinheimer B, Gualtieri CT.","J Clin Psychopharmacol. 1996 Oct;16(5):389-94. doi: 10.1097/00004714-199610000-00008.","Casner JA","J Clin Psychopharmacol","1996","1996/10/01","","","10.1097/00004714-199610000-00008"
"8888582","Spatial learning in deer mice: sex differences and the effects of endogenous opioids and 60 Hz magnetic fields","Kavaliers M, Ossenkopp KP, Prato FS, Innes DG, Galea LA, Kinsella DM, Perrot-Sinal TS.","J Comp Physiol A. 1996 Nov;179(5):715-24. doi: 10.1007/BF00216135.","Kavaliers M","J Comp Physiol A","1996","1996/11/01","","","10.1007/BF00216135"
"8887719","Determination of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma using liquid chromatography with electrochemical detection","Davidson AF, Emm TA, Pieniaszek HJ Jr.","J Pharm Biomed Anal. 1996 Sep;14(12):1717-25. doi: 10.1016/0731-7085(96)01794-3.","Davidson AF","J Pharm Biomed Anal","1996","1996/09/01","","","10.1016/0731-7085(96)01794-3"
"8885579","Hyperactivity and ADHD","Adesman AR.","J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1262. doi: 10.1097/00004583-199610000-00009.","Adesman AR","J Am Acad Child Adolesc Psychiatry","1996","1996/10/01","","","10.1097/00004583-199610000-00009"
"8884884","Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism","Piepponen TP, Ahtee L.","Pharmacol Toxicol. 1995 Sep;77(3):204-8. doi: 10.1111/j.1600-0773.1995.tb01013.x.","Piepponen TP","Pharmacol Toxicol","1995","1995/09/01","","","10.1111/j.1600-0773.1995.tb01013.x"
"8884782","Endogenous opioids acting at a medullary mu-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray","Roychowdhury SM, Fields HL.","Neuroscience. 1996 Oct;74(3):863-72. doi: 10.1016/0306-4522(96)00180-7.","Roychowdhury SM","Neuroscience","1996","1996/10/01","","","10.1016/0306-4522(96)00180-7"
"8883853","Induction of Fos-like immunoreactivity by opioids in guinea-pig brain","Bot G, Chahl LA.","Brain Res. 1996 Aug 26;731(1-2):45-56. doi: 10.1016/0006-8993(96)00457-x.","Bot G","Brain Res","1996","1996/08/26","","","10.1016/0006-8993(96)00457-x"
"8880858","The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro","Feng J, Kendig JJ.","Pain. 1996 Aug;66(2-3):343-9. doi: 10.1016/0304-3959(96)03024-2.","Feng J","Pain","1996","1996/08/01","","","10.1016/0304-3959(96)03024-2"
"8880835","Anxiety and pain: attentional and endorphinergic influences","Janssen SA, Arntz A.","Pain. 1996 Aug;66(2-3):145-50. doi: 10.1016/0304-3959(96)03031-x.","Janssen SA","Pain","1996","1996/08/01","","","10.1016/0304-3959(96)03031-x"
"8877704","Comparison of cyclic delta-opioid peptides with non-peptide delta-agonist spiroindanyloxymorphone (SIOM) using the message-address concept: a molecular modeling study","Gao P.","J Comput Aided Mol Des. 1996 Aug;10(4):327-36. doi: 10.1007/BF00124502.","Gao P","J Comput Aided Mol Des","1996","1996/08/01","","","10.1007/BF00124502"
"8877019","The effect of age on the pharmacokinetics of the opioid antagonist nalmefene","Frye RF, Matzke GR, Jallad NS, Wilhelm JA, Bikhazi GB.","Br J Clin Pharmacol. 1996 Sep;42(3):301-6. doi: 10.1046/j.1365-2125.1996.04133.x.","Frye RF","Br J Clin Pharmacol","1996","1996/09/01","PMC2042672","","10.1046/j.1365-2125.1996.04133.x"
"8876019","Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure","Negus SS, Morgan D, Cook CD, Picker MJ.","Psychopharmacology (Berl). 1996 Aug;126(3):199-205. doi: 10.1007/BF02246449.","Negus SS","Psychopharmacology (Berl)","1996","1996/08/01","","","10.1007/BF02246449"
"8875651","Closing the gap between alcoholism research and practice: the case for pharmacotherapy","Meza E, Kranzler HR.","Psychiatr Serv. 1996 Sep;47(9):917-20. doi: 10.1176/ps.47.9.917.","Meza E","Psychiatr Serv","1996","1996/09/01","","","10.1176/ps.47.9.917"
"8874872","Opiate withdrawal increases ProTRH gene expression in the ventrolateral column of the midbrain periaqueductal gray","Légrádi G, Rand WM, Hitz S, Nillni EA, Jackson IM, Lechan RM.","Brain Res. 1996 Aug 5;729(1):10-19. doi: 10.1016/s0006-8993(96)00210-7.","Légrádi G","Brain Res","1996","1996/08/05","","","10.1016/s0006-8993(96)00210-7"
"8873259","Reductions in locomotor activity following central opioid receptor subtype antagonists in rats","Leventhal L, Cole JL, Bodnar RJ.","Physiol Behav. 1996 Sep;60(3):833-6. doi: 10.1016/0031-9384(96)00103-5.","Leventhal L","Physiol Behav","1996","1996/09/01","","","10.1016/0031-9384(96)00103-5"
"8868206","The therapeutic role of naltrexone in negative symptom schizophrenia","Marchesi GF, Santone G, Cotani P, Giordano A, Chelli F.","Prog Neuropsychopharmacol Biol Psychiatry. 1995 Dec;19(8):1239-49. doi: 10.1016/0278-5846(95)00263-4.","Marchesi GF","Prog Neuropsychopharmacol Biol Psychiatry","1995","1995/12/01","","","10.1016/0278-5846(95)00263-4"
"8868205","Hostility in heroin abusers subtypes: fluoxetine and naltrexone treatment","Gerra G, Fertonani G, Zaimovic A, Rota-Graziosi I, Avanzini P, Caccavari R, Delsignore R, Lucchini A.","Prog Neuropsychopharmacol Biol Psychiatry. 1995 Dec;19(8):1225-37. doi: 10.1016/0278-5846(95)00262-6.","Gerra G","Prog Neuropsychopharmacol Biol Psychiatry","1995","1995/12/01","","","10.1016/0278-5846(95)00262-6"
"8867260","Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms","Dawson-Basoa ME, Gintzler AR.","Pain. 1996 Jan;64(1):169-77. doi: 10.1016/0304-3959(95)00092-5.","Dawson-Basoa ME","Pain","1996","1996/01/01","","","10.1016/0304-3959(95)00092-5"
"8866962","Intraseptal microinjection of beta-funaltrexamine blocked a microwave-induced decrease of hippocampal cholinergic activity in the rat","Lai H, Carino MA, Horita A, Guy AW.","Pharmacol Biochem Behav. 1996 Mar;53(3):613-6. doi: 10.1016/0091-3057(95)02058-6.","Lai H","Pharmacol Biochem Behav","1996","1996/03/01","","","10.1016/0091-3057(95)02058-6"
"8862129","Stereoselective inhibition of natural killer activity by the sigma ligand (+)-pentazocine","Maity R, Mukherjee R, Skolnick P.","J Neuroimmunol. 1996 Oct;70(1):7-13. doi: 10.1016/s0165-5728(96)00046-x.","Maity R","J Neuroimmunol","1996","1996/10/01","","","10.1016/s0165-5728(96)00046-x"
"8858991","Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice","Suzuki T, Tsuji M, Mori T, Misawa M, Endoh T, Nagase H.","J Pharmacol Exp Ther. 1996 Oct;279(1):177-85.","Suzuki T","J Pharmacol Exp Ther","1996","1996/10/01","","",""
"8853703","Naltrindole sensitive delta 2 opioid receptor mediates invertebrate immunocyte activation","Stefano GB, Casares F, Liu U.","Acta Biol Hung. 1995;46(2-4):321-7.","Stefano GB","Acta Biol Hung","1995","1995/01/01","","",""
"8853184","The influence of opioid antagonists on the discriminative stimulus effects of ethanol","Spanagel R.","Pharmacol Biochem Behav. 1996 Aug;54(4):645-9. doi: 10.1016/0091-3057(95)02288-0.","Spanagel R","Pharmacol Biochem Behav","1996","1996/08/01","","","10.1016/0091-3057(95)02288-0"
"8852390","The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene","Matzke GR, Frye RF, Alexander AC, Reynolds R, Dixon R, Johnston J, Rault RM.","J Clin Pharmacol. 1996 Feb;36(2):144-51. doi: 10.1002/j.1552-4604.1996.tb04179.x.","Matzke GR","J Clin Pharmacol","1996","1996/02/01","","","10.1002/j.1552-4604.1996.tb04179.x"
"8851629","Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome","Bhargava HN, Thorat SN.","Pharmacology. 1996 Feb;52(2):86-91. doi: 10.1159/000139371.","Bhargava HN","Pharmacology","1996","1996/02/01","","","10.1159/000139371"
"8851160","The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter","Izenwasser S, Newman AH, Cox BM, Katz JL.","Eur J Pharmacol. 1996 Feb 15;297(1-2):9-17. doi: 10.1016/0014-2999(95)00696-6.","Izenwasser S","Eur J Pharmacol","1996","1996/02/15","","","10.1016/0014-2999(95)00696-6"
"8849681","Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids","Mollereau C, Moisand C, Butour JL, Parmentier M, Meunier JC.","FEBS Lett. 1996 Oct 14;395(1):17-21. doi: 10.1016/0014-5793(96)00993-3.","Mollereau C","FEBS Lett","1996","1996/10/14","","","10.1016/0014-5793(96)00993-3"
"8848528","Opioid antagonists and the sexual satiation phenomenon","Rodríguez-Manzo G, Fernández-Guasti A.","Psychopharmacology (Berl). 1995 Nov;122(2):131-6. doi: 10.1007/BF02246087.","Rodríguez-Manzo G","Psychopharmacology (Berl)","1995","1995/11/01","","","10.1007/BF02246087"
"8848519","Opiate systems in mother and infant primates coordinate intimate contact during reunion","Kalin NH, Shelton SE, Lynn DE.","Psychoneuroendocrinology. 1995;20(7):735-42. doi: 10.1016/0306-4530(95)00023-2.","Kalin NH","Psychoneuroendocrinology","1995","1995/01/01","","","10.1016/0306-4530(95)00023-2"
"8848471","Opioid and nonopioid swim stress-induced analgesia: a parametric analysis in mice","Mogil JS, Sternberg WF, Balian H, Liebeskind JC, Sadowski B.","Physiol Behav. 1996 Jan;59(1):123-32. doi: 10.1016/0031-9384(95)02073-x.","Mogil JS","Physiol Behav","1996","1996/01/01","","","10.1016/0031-9384(95)02073-x"
"8846821","Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors","Gergen KA, Zadina JE, Kastin AJ, Paul D.","Eur J Pharmacol. 1996 Mar 18;298(3):235-9. doi: 10.1016/0014-2999(95)00823-3.","Gergen KA","Eur J Pharmacol","1996","1996/03/18","","","10.1016/0014-2999(95)00823-3"
"8846818","Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine","Heidbreder C, Shoaib M, Shippenberg TS.","Eur J Pharmacol. 1996 Mar 18;298(3):207-16. doi: 10.1016/0014-2999(95)00815-2.","Heidbreder C","Eur J Pharmacol","1996","1996/03/18","","","10.1016/0014-2999(95)00815-2"
"8846056","Stability of Revex, nalmefene hydrochloride injection","Brittain HG, Lafferty L, Bousserski P, Diegnan G, Lessor R, Small C, Pejaver S.","PDA J Pharm Sci Technol. 1996 Jan-Feb;50(1):35-9.","Brittain HG","PDA J Pharm Sci Technol","1996","1996/01/01","","",""
"8845013","Effects of methylnaltrexone on morphine-induced cough suppression in guinea pigs","Foss JF, Orelind E, Goldberg LI.","Life Sci. 1996;59(15):PL235-8. doi: 10.1016/0024-3205(96)00451-1.","Foss JF","Life Sci","1996","1996/01/01","","","10.1016/0024-3205(96)00451-1"
"8844764","Pronociceptive effects of the neuropeptide, nociceptin, in the land snail, Cepaea nemoralis","Kavaliers M, Perrot-Sinal TS.","Peptides. 1996;17(5):763-8. doi: 10.1016/0196-9781(96)00105-2.","Kavaliers M","Peptides","1996","1996/01/01","","","10.1016/0196-9781(96)00105-2"
"8841087","Chronic blockade of opioid receptors alters the binding of [3H]GBR 12935 to dopamine transporter in rat brain regions and spinal cord","Bhargava HN, Gudehithlu KP.","Pharmacology. 1996 Apr;52(4):243-51. doi: 10.1159/000139389.","Bhargava HN","Pharmacology","1996","1996/04/01","","","10.1159/000139389"
"8840904","Selective effects of naltrexone on food pleasantness and intake","Yeomans MR, Gray RW.","Physiol Behav. 1996 Aug;60(2):439-46. doi: 10.1016/s0031-9384(96)80017-5.","Yeomans MR","Physiol Behav","1996","1996/08/01","","","10.1016/s0031-9384(96)80017-5"
"8837935","Opiate and 5-HT2A receptors in alcohol drinking: preference in HAD rats is inhibited by combination treatment with naltrexone and amperozide","Lankford MF, Myers RD.","Alcohol. 1996 Jan-Feb;13(1):53-7. doi: 10.1016/0741-8329(95)02011-x.","Lankford MF","Alcohol","1996","1996/01/01","","","10.1016/0741-8329(95)02011-x"
"8837932","Naltrexone in the treatment of alcoholism: a clinical review","O'Brien CP, Volpicelli LA, Volpicelli JR.","Alcohol. 1996 Jan-Feb;13(1):35-9. doi: 10.1016/0741-8329(95)02038-1.","O'Brien CP","Alcohol","1996","1996/01/01","","","10.1016/0741-8329(95)02038-1"
"8837931","Alcohol addiction (alcoholism) and the opioid system","Terenius L.","Alcohol. 1996 Jan-Feb;13(1):31-4. doi: 10.1016/0741-8329(95)02037-3.","Terenius L","Alcohol","1996","1996/01/01","","","10.1016/0741-8329(95)02037-3"
"8837930","Endorphins and experimental addiction","Van Ree JM.","Alcohol. 1996 Jan-Feb;13(1):25-30. doi: 10.1016/0741-8329(95)02036-5.","Van Ree JM","Alcohol","1996","1996/01/01","","","10.1016/0741-8329(95)02036-5"
"8837214","Involvement of beta-endorphin in the modulation of paw inflammatory edema in the rat","Sacerdote P, Bianchi M, Panerai AE.","Regul Pept. 1996 Jul 5;63(2-3):79-83. doi: 10.1016/0167-0115(96)00014-6.","Sacerdote P","Regul Pept","1996","1996/07/05","","","10.1016/0167-0115(96)00014-6"
"8833225","Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence","Feng YZ, Zhang T, Tokuyama S, Zhu H, Rockhold RW, Ho IK.","Neurochem Res. 1996 Jan;21(1):63-71. doi: 10.1007/BF02527673.","Feng YZ","Neurochem Res","1996","1996/01/01","","","10.1007/BF02527673"
"8831097","Involvement of the opioid system in the anxiolytic effect of diazepam in mice","Tsuda M, Suzuki T, Misawa M, Nagase H.","Eur J Pharmacol. 1996 Jun 20;307(1):7-14. doi: 10.1016/0014-2999(96)00219-1.","Tsuda M","Eur J Pharmacol","1996","1996/06/20","","","10.1016/0014-2999(96)00219-1"
"8826544","Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats","Shaham Y, Stewart J.","Psychopharmacology (Berl). 1996 Jun;125(4):385-91. doi: 10.1007/BF02246022.","Shaham Y","Psychopharmacology (Berl)","1996","1996/06/01","","","10.1007/BF02246022"
"8822536","Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone","Myers RD, Lankford MF.","Neuropsychopharmacology. 1996 Feb;14(2):139-49. doi: 10.1016/0893-133X(95)00081-N.","Myers RD","Neuropsychopharmacology","1996","1996/02/01","","","10.1016/0893-133X(95)00081-N"
"8821539","Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues","Gouardères C, Jhamandas K, Sutak M, Zajac JM.","Br J Pharmacol. 1996 Feb;117(3):493-501. doi: 10.1111/j.1476-5381.1996.tb15217.x.","Gouardères C","Br J Pharmacol","1996","1996/02/01","PMC1909318","","10.1111/j.1476-5381.1996.tb15217.x"
"8819538","Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats","Kelley AE, Bless EP, Swanson CJ.","J Pharmacol Exp Ther. 1996 Sep;278(3):1499-507.","Kelley AE","J Pharmacol Exp Ther","1996","1996/09/01","","",""
"8819520","Suppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system","Wu WJ, Pruett SB.","J Pharmacol Exp Ther. 1996 Sep;278(3):1331-9.","Wu WJ","J Pharmacol Exp Ther","1996","1996/09/01","","",""
"8819489","Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80","Malatynska E, Wang Y, Knapp RJ, Waite S, Calderon S, Rice K, Hruby VJ, Yamamura HI, Roeske WR.","J Pharmacol Exp Ther. 1996 Sep;278(3):1083-9.","Malatynska E","J Pharmacol Exp Ther","1996","1996/09/01","","",""
"8819305","Disposition of the opioid antagonist, nalmefene, in rat and dog","Murthy SS, Mathur C, Kvalo LT, Lessor RA, Wilhelm JA.","Xenobiotica. 1996 Jul;26(7):779-92. doi: 10.3109/00498259609046748.","Murthy SS","Xenobiotica","1996","1996/07/01","","","10.3109/00498259609046748"
"8819143","Preprothyrotropin-releasing hormone mRNA in the rat central gray is strongly and persistently induced during morphine withdrawal","Gahn LG, Sevarino KA.","Neuropeptides. 1996 Jun;30(3):207-12. doi: 10.1016/s0143-4179(96)90065-7.","Gahn LG","Neuropeptides","1996","1996/06/01","","","10.1016/s0143-4179(96)90065-7"
"8813578","Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats","Honkanen A, Vilamo L, Wegelius K, Sarviharju M, Hyytiä P, Korpi ER.","Eur J Pharmacol. 1996 May 23;304(1-3):7-13. doi: 10.1016/0014-2999(96)00118-5.","Honkanen A","Eur J Pharmacol","1996","1996/05/23","","","10.1016/0014-2999(96)00118-5"
"8809497","Within-session determination of dose-response curves for heroin self-administration in rats: Comparison with between-session determination and effects of naltrexone","Martin TJ, Walker LE, Sizemore GM, Smith JE, Dworkin SI.","Drug Alcohol Depend. 1996 Jun;41(2):93-100. doi: 10.1016/0376-8716(96)01245-8.","Martin TJ","Drug Alcohol Depend","1996","1996/06/01","","","10.1016/0376-8716(96)01245-8"
"8808161","Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation","Reid LD, Hubbell CL, Tsai J, Fishkin MD, Amendola CA.","Pharmacol Biochem Behav. 1996 Feb;53(2):477-80. doi: 10.1016/0091-3057(95)02020-9.","Reid LD","Pharmacol Biochem Behav","1996","1996/02/01","","","10.1016/0091-3057(95)02020-9"
"8808151","Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay","Wettstein JG, Grouhel A.","Pharmacol Biochem Behav. 1996 Feb;53(2):411-6. doi: 10.1016/0091-3057(95)02043-8.","Wettstein JG","Pharmacol Biochem Behav","1996","1996/02/01","","","10.1016/0091-3057(95)02043-8"
"8806713","The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1","King CD, Green MD, Rios GR, Coffman BL, Owens IS, Bishop WP, Tephly TR.","Arch Biochem Biophys. 1996 Aug 1;332(1):92-100. doi: 10.1006/abbi.1996.0320.","King CD","Arch Biochem Biophys","1996","1996/08/01","","","10.1006/abbi.1996.0320"
"8803356","Recent developments in the pharmacotherapy of alcohol dependence","Schuckit MA.","J Consult Clin Psychol. 1996 Aug;64(4):669-76. doi: 10.1037//0022-006x.64.4.669.","Schuckit MA","J Consult Clin Psychol","1996","1996/08/01","","","10.1037//0022-006x.64.4.669"
"8801607","Inhibitory effects of naltrexone on the induction of parental behavior in juvenile rats","Zaias J, Okimoto L, Trivedi A, Mann PE, Bridges RS.","Pharmacol Biochem Behav. 1996 Apr;53(4):987-93. doi: 10.1016/0091-3057(95)02138-8.","Zaias J","Pharmacol Biochem Behav","1996","1996/04/01","","","10.1016/0091-3057(95)02138-8"
"8801599","Effects of beta-FNA on sympathoadrenal, cardiovascular, and analgesic responses to DAMPGO at rest and during stress","Houdi AA, Marson L, Davenport KE, Van Loon GR.","Pharmacol Biochem Behav. 1996 Apr;53(4):927-33. doi: 10.1016/0091-3057(95)02139-6.","Houdi AA","Pharmacol Biochem Behav","1996","1996/04/01","","","10.1016/0091-3057(95)02139-6"
"8801527","Opioid receptor subtype control of galanin-induced feeding","Barton C, York DA, Bray GA.","Peptides. 1996;17(2):237-40. doi: 10.1016/0196-9781(95)02103-5.","Barton C","Peptides","1996","1996/01/01","","","10.1016/0196-9781(95)02103-5"
"8800392","Naltrexone increases the latency to drink alcohol in social drinkers","Davidson D, Swift R, Fitz E.","Alcohol Clin Exp Res. 1996 Jun;20(4):732-9. doi: 10.1111/j.1530-0277.1996.tb01679.x.","Davidson D","Alcohol Clin Exp Res","1996","1996/06/01","","","10.1111/j.1530-0277.1996.tb01679.x"
"8790989","Opioid receptor selectivity alteration by single residue replacement: synthesis and activity profile of [Dmt1]deltorphin B","Guerrini R, Capasso A, Sorrentino L, Anacardio R, Bryant SD, Lazarus LH, Attila M, Salvadori S.","Eur J Pharmacol. 1996 Apr 29;302(1-3):37-42. doi: 10.1016/0014-2999(96)00067-2.","Guerrini R","Eur J Pharmacol","1996","1996/04/29","","","10.1016/0014-2999(96)00067-2"
"8786838","Naltrexone administration during the preweanling period affects striatal and hypothalamic serotonergic systems, but not midbrain serotonergic or striatal dopaminergic systems in the adult rat","Viveros MP, de Cabo C, Colado MI, Martín MI.","Neurosci Lett. 1995 Dec 15;201(3):195-8. doi: 10.1016/0304-3940(95)12171-4.","Viveros MP","Neurosci Lett","1995","1995/12/15","","","10.1016/0304-3940(95)12171-4"
"8783328","Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms","Dawson-Basoa ME, Gintzler AR.","Pain. 1996 Mar;64(3):608-15. doi: 10.1016/0304-3959(96)87175-2.","Dawson-Basoa ME","Pain","1996","1996/03/01","","","10.1016/0304-3959(96)87175-2"
"8780837","The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study","Willemsen-Swinkels SH, Buitelaar JK, van Engeland H.","Biol Psychiatry. 1996 Jun 15;39(12):1023-31. doi: 10.1016/0006-3223(95)00297-9.","Willemsen-Swinkels SH","Biol Psychiatry","1996","1996/06/15","","","10.1016/0006-3223(95)00297-9"
"8779961","kappa-Opioid agonist inhibition of osmotically induced AVP release: preferential action at hypothalamic sites","Rossi NF, Brooks DP.","Am J Physiol. 1996 Feb;270(2 Pt 1):E367-72. doi: 10.1152/ajpendo.1996.270.2.E367.","Rossi NF","Am J Physiol","1996","1996/02/01","","","10.1152/ajpendo.1996.270.2.E367"
"8778878","Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats","Krystal JH, Compere S, Nestler EJ, Rasmussen K.","Physiol Behav. 1996 Apr-May;59(4-5):863-6. doi: 10.1016/0031-9384(95)02206-6.","Krystal JH","Physiol Behav","1996","1996/04/01","","","10.1016/0031-9384(95)02206-6"
"8778169","Effects of melatonin in vivo upon luteinizing hormone and prolactin releases induced by opiate receptor antagonists in adult male rats","Shacoori V, Saïag B, Lemay V, Girre A, Rault B.","J Endocrinol Invest. 1996 Feb;19(2):76-82. doi: 10.1007/BF03349840.","Shacoori V","J Endocrinol Invest","1996","1996/02/01","","","10.1007/BF03349840"
"8774952","Gene-peptide relationships in the developing rat brain: the response of preproenkephalin mRNA and [Met5]-enkephalin to acute opioid antagonist (naltrexone) exposure","Zagon IS, McLaughlin PJ.","Brain Res Mol Brain Res. 1995 Oct;33(1):111-20. doi: 10.1016/0169-328x(95)00119-d.","Zagon IS","Brain Res Mol Brain Res","1995","1995/10/01","","","10.1016/0169-328x(95)00119-d"
"8773929","Ocular action of an opioid peptide, DPDPE","Wang D, Potter DE.","J Ocul Pharmacol Ther. 1996 Summer;12(2):131-9. doi: 10.1089/jop.1996.12.131.","Wang D","J Ocul Pharmacol Ther","1996","1996/01/01","","","10.1089/jop.1996.12.131"
"8773788","Opioid receptors in the ventral tegmental area contribute to stress-induced analgesia in the formalin test for tonic pain","Altier N, Stewart J.","Brain Res. 1996 Apr 29;718(1-2):203-6. doi: 10.1016/0006-8993(96)00121-7.","Altier N","Brain Res","1996","1996/04/29","","","10.1016/0006-8993(96)00121-7"
"8773469","Repeated naltrexone administration accelerates resolution of morphine somatic withdrawal signs in morphine-dependent rats","Muntoni AL, Diana M, Gessa GL.","Eur J Pharmacol. 1996 Apr 22;301(1-3):R9-10. doi: 10.1016/0014-2999(96)00126-4.","Muntoni AL","Eur J Pharmacol","1996","1996/04/22","","","10.1016/0014-2999(96)00126-4"
"8773449","A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice","Reche I, Fuentes JA, Ruiz-Gayo M.","Eur J Pharmacol. 1996 Apr 22;301(1-3):75-81. doi: 10.1016/0014-2999(96)00045-3.","Reche I","Eur J Pharmacol","1996","1996/04/22","","","10.1016/0014-2999(96)00045-3"
"8769781","Opioid growth factor-dependent DNA synthesis in the neonatal rat aorta","Zagon IS, Wu Y, McLaughlin PJ.","Am J Physiol. 1996 Jan;270(1 Pt 2):R22-32. doi: 10.1152/ajpregu.1996.270.1.R22.","Zagon IS","Am J Physiol","1996","1996/01/01","","","10.1152/ajpregu.1996.270.1.R22"
"8768756","Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner","Scott M, Carr DJ.","J Pharmacol Exp Ther. 1996 Aug;278(2):980-8.","Scott M","J Pharmacol Exp Ther","1996","1996/08/01","","",""
"8767048","[Psychopharmacology of autism]","Chabrol H, Bonnet D, Roge B.","Encephale. 1996 May-Jun;22(3):197-203.","Chabrol H","Encephale","1996","1996/05/01","","",""
"8765330","Initial characterization and autoradiographic localization of a novel sigma/opioid binding site in immune tissues","Whitlock BB, Liu Y, Chang S, Saini P, Ha BK, Barrett TW, Wolfe SA Jr.","J Neuroimmunol. 1996 Jul;67(2):83-96. doi: 10.1016/0165-5728(96)00041-0.","Whitlock BB","J Neuroimmunol","1996","1996/07/01","","","10.1016/0165-5728(96)00041-0"
"8761010","Use of antisense oligodeoxynucleotide to determine delta-opioid receptor involvement in [D-Ala2]deltorphin II-induced locomotor hyperactivity","Mizoguchi H, Narita M, Nagase H, Suzuki T, Quock RM, Tseng LF.","Life Sci. 1996;59(4):PL69-73. doi: 10.1016/0024-3205(96)00307-4.","Mizoguchi H","Life Sci","1996","1996/01/01","","","10.1016/0024-3205(96)00307-4"
"8760232","Naltrexone induces arcuate nucleus neuropeptide Y gene expression in the rat","Kotz CM, Grace MK, Briggs JE, Billington CJ, Levine AS.","Am J Physiol. 1996 Jul;271(1 Pt 2):R289-94. doi: 10.1152/ajpregu.1996.271.1.R289.","Kotz CM","Am J Physiol","1996","1996/07/01","","","10.1152/ajpregu.1996.271.1.R289"
"8758278","[Receptor mechanism of dynorphin A in rat secondary spinal cord injuries]","Li M, Yang Y, Hong X.","Zhonghua Yi Xue Za Zhi. 1996 Apr;76(4):290-3.","Li M","Zhonghua Yi Xue Za Zhi","1996","1996/04/01","","",""
"8754765","Beta-endorphin enhances Concanavalin-A-stimulated calcium mobilization by murine splenic T cells","Shahabi NA, Heagy W, Sharp BM.","Endocrinology. 1996 Aug;137(8):3386-93. doi: 10.1210/endo.137.8.8754765.","Shahabi NA","Endocrinology","1996","1996/08/01","","","10.1210/endo.137.8.8754765"
"8750897","Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels","Unterwald EM, Rubenfeld JM, Imai Y, Wang JB, Uhl GR, Kreek MJ.","Brain Res Mol Brain Res. 1995 Nov;33(2):351-5. doi: 10.1016/0169-328x(95)00143-g.","Unterwald EM","Brain Res Mol Brain Res","1995","1995/11/01","","","10.1016/0169-328x(95)00143-g"
"8750728","Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice","Toyoshi T, Ukai M, Kameyama T.","Eur J Pharmacol. 1995 Dec 29;294(2-3):637-43. doi: 10.1016/0014-2999(95)00601-x.","Toyoshi T","Eur J Pharmacol","1995","1995/12/29","","","10.1016/0014-2999(95)00601-x"
"8748967","Ontogeny of morphine withdrawal in the rat","Jones KL, Barr GA.","Behav Neurosci. 1995 Dec;109(6):1189-98. doi: 10.1037//0735-7044.109.6.1189.","Jones KL","Behav Neurosci","1995","1995/12/01","","","10.1037//0735-7044.109.6.1189"
"8748437","Naltrexone for the treatment of trichotillomania: a case report","Carrion VG.","J Clin Psychopharmacol. 1995 Dec;15(6):444-5. doi: 10.1097/00004714-199512000-00012.","Carrion VG","J Clin Psychopharmacol","1995","1995/12/01","","","10.1097/00004714-199512000-00012"
"8748073","Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor","Peterson PK, Gekker G, Hu S, Sheng WS, Molitor TW, Chao CC.","Adv Neuroimmunol. 1995;5(3):299-309. doi: 10.1016/0960-5428(95)00020-3.","Peterson PK","Adv Neuroimmunol","1995","1995/01/01","","","10.1016/0960-5428(95)00020-3"
"8747034","Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea","Genazzani AD, Gastaldi M, Petraglia F, Battaglia C, Surico N, Volpe A, Genazzani AR.","Hum Reprod. 1995 Nov;10(11):2868-71. doi: 10.1093/oxfordjournals.humrep.a135809.","Genazzani AD","Hum Reprod","1995","1995/11/01","","","10.1093/oxfordjournals.humrep.a135809"
"8743590","Effects of cold acclimation and central opioid processes on thermoregulation in rats","Wilson JR, Howard BA.","Pharmacol Biochem Behav. 1996 Jun;54(2):317-25. doi: 10.1016/0091-3057(95)02124-8.","Wilson JR","Pharmacol Biochem Behav","1996","1996/06/01","","","10.1016/0091-3057(95)02124-8"
"8742772","Strategies to maximize the efficacy of naltrexone for alcohol dependence","O'Malley SS.","NIDA Res Monogr. 1995;150:53-64.","O'Malley SS","NIDA Res Monogr","1995","1995/01/01","","",""
"8742771","Can psychotherapy rescue naltrexone treatment of opioid addiction?","Rounsaville BJ.","NIDA Res Monogr. 1995;150:37-52.","Rounsaville BJ","NIDA Res Monogr","1995","1995/01/01","","",""
"8741185","delta-Opioid receptor: the third extracellular loop determines naltrindole selectivity","Li X, Varga EV, Stropova D, Zalewska T, Malatynska E, Knapp RJ, Roeske WR, Yamamura HI.","Eur J Pharmacol. 1996 Apr 4;300(1-2):R1-2. doi: 10.1016/0014-2999(96)00098-2.","Li X","Eur J Pharmacol","1996","1996/04/04","","","10.1016/0014-2999(96)00098-2"
"8741168","Antinociceptive and antitussive effects of morphine in the DA-bg/bg (beige) rat","Kamei J, Morita K, Saitoh A, Suzuki T, Nagase H.","Eur J Pharmacol. 1996 Apr 4;300(1-2):75-8. doi: 10.1016/0014-2999(96)00032-5.","Kamei J","Eur J Pharmacol","1996","1996/04/04","","","10.1016/0014-2999(96)00032-5"
"8741160","Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat","Funada M, Schutz CG, Shippenberg TS.","Eur J Pharmacol. 1996 Apr 4;300(1-2):17-24. doi: 10.1016/0014-2999(95)00860-8.","Funada M","Eur J Pharmacol","1996","1996/04/04","","","10.1016/0014-2999(95)00860-8"
"8738262","Distribution of c-Fos in guinea-pig brain following morphine withdrawal","Chahl LA, Leah J, Herdegen T, Trueman L, Lynch-Frame AM.","Brain Res. 1996 Apr 22;717(1-2):127-34. doi: 10.1016/0006-8993(96)00041-8.","Chahl LA","Brain Res","1996","1996/04/22","","","10.1016/0006-8993(96)00041-8"
"8737968","Differential effects of morphine-6-glucuronide, an active metabolite of morphine, and morphine on locomotor activity in mice: involvement of the opioid receptor","Uchihashi Y, Kuribara H, Morita T, Kitani Y, Karasawa F, Sato T.","Pharmacol Toxicol. 1996 May;78(5):322-6. doi: 10.1111/j.1600-0773.1996.tb01383.x.","Uchihashi Y","Pharmacol Toxicol","1996","1996/05/01","","","10.1111/j.1600-0773.1996.tb01383.x"
"8737005","Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse","O'Malley SS.","Alcohol Alcohol. 1996 Mar;31 Suppl 1:77-81.","O'Malley SS","Alcohol Alcohol","1996","1996/03/01","","",""
"8731059","The isolation and companion comfort responses of 7- and 3-day-old rat pups are modulated by drugs active at the opioid receptor","Carden SE, Hernandez N, Hofer MA.","Behav Neurosci. 1996 Apr;110(2):324-30. doi: 10.1037//0735-7044.110.2.324.","Carden SE","Behav Neurosci","1996","1996/04/01","","","10.1037//0735-7044.110.2.324"
"8730720","Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal [corrected]","Rohde DS, Detweiler DJ, Basbaum AI.","Neuroscience. 1996 May;72(1):233-42. doi: 10.1016/0306-4522(95)00529-3.","Rohde DS","Neuroscience","1996","1996/05/01","","","10.1016/0306-4522(95)00529-3"
"8728556","Prenatal naltrexone facilitates male sexual behavior in the rat","Cohen E, Keshet G, Shavit Y, Weinstock M.","Pharmacol Biochem Behav. 1996 May;54(1):183-8. doi: 10.1016/0091-3057(95)02160-4.","Cohen E","Pharmacol Biochem Behav","1996","1996/05/01","","","10.1016/0091-3057(95)02160-4"
"8727259","Naltrexone persistently reduces rats' intake of a palatable alcoholic beverage","Gardell LR, Hubbell CL, Reid LD.","Alcohol Clin Exp Res. 1996 May;20(3):584-8. doi: 10.1111/j.1530-0277.1996.tb01097.x.","Gardell LR","Alcohol Clin Exp Res","1996","1996/05/01","","","10.1111/j.1530-0277.1996.tb01097.x"
"8722635","Effects of nitric oxide-related agents on opioid regulation of rat testicular steroidogenesis","Adams ML, Meyer ER, Cicero TJ.","Biol Reprod. 1996 May;54(5):1128-34. doi: 10.1095/biolreprod54.5.1128.","Adams ML","Biol Reprod","1996","1996/05/01","","","10.1095/biolreprod54.5.1128"
"8722260","Efficacy and safety of naltrexone hydrochloride for antagonizing carfentanil citrate immobilization in captive Rocky Mountain elk (Cervus elaphus nelsoni)","Miller MW, Wild MA, Lance WR.","J Wildl Dis. 1996 Apr;32(2):234-9. doi: 10.7589/0090-3558-32.2.234.","Miller MW","J Wildl Dis","1996","1996/04/01","","","10.7589/0090-3558-32.2.234"
"8720635","Resolved: autistic children should have a trial of naltrexone","Campbell M, Harris JC.","J Am Acad Child Adolesc Psychiatry. 1996 Feb;35(2):246-9; discussion 249-51.","Campbell M","J Am Acad Child Adolesc Psychiatry","1996","1996/02/01","","",""
"8720622","Treatment of autistic disorder","Campbell M, Schopler E, Cueva JE, Hallin A.","J Am Acad Child Adolesc Psychiatry. 1996 Feb;35(2):134-43. doi: 10.1097/00004583-199602000-00005.","Campbell M","J Am Acad Child Adolesc Psychiatry","1996","1996/02/01","","","10.1097/00004583-199602000-00005"
"8720473","Central antinociceptive effect of L-ornithine, a metabolite of L-arginine, in rats and mice","Kawabata A, Iwatsubo K, Takaya S, Takagi H.","Eur J Pharmacol. 1996 Jan 18;296(1):23-31. doi: 10.1016/0014-2999(95)00683-4.","Kawabata A","Eur J Pharmacol","1996","1996/01/18","","","10.1016/0014-2999(95)00683-4"
"8720471","Antinociceptive and behavioral effects of synthetic deltorphin analogs","Negri L, Noviello L, Noviello V.","Eur J Pharmacol. 1996 Jan 18;296(1):9-16. doi: 10.1016/0014-2999(95)00644-3.","Negri L","Eur J Pharmacol","1996","1996/01/18","","","10.1016/0014-2999(95)00644-3"
"8712718","Relative efficacy of the opioid antagonist, naltrexone, on the initiation and promotion phases of rat mammary carcinogenesis","Koo KL, Tejwani GA, Abou-Issa H.","Anticancer Res. 1996 Jul-Aug;16(4A):1893-8.","Koo KL","Anticancer Res","1996","1996/07/01","","",""
"8702924","Determination of the amino acid residue involved in [3H]beta-funaltrexamine covalent binding in the cloned rat mu-opioid receptor","Chen C, Yin J, Riel JK, DesJarlais RL, Raveglia LF, Zhu J, Liu-Chen LY.","J Biol Chem. 1996 Aug 30;271(35):21422-9. doi: 10.1074/jbc.271.35.21422.","Chen C","J Biol Chem","1996","1996/08/30","","","10.1074/jbc.271.35.21422"
"8698954","Relaxation training and opioid inhibition of blood pressure response to stress","McCubbin JA, Wilson JF, Bruehl S, Ibarra P, Carlson CR, Norton JA, Colclough GW.","J Consult Clin Psychol. 1996 Jun;64(3):593-601. doi: 10.1037//0022-006x.64.3.593.","McCubbin JA","J Consult Clin Psychol","1996","1996/06/01","","","10.1037//0022-006x.64.3.593"
"8698228","Tonic endogenous opioid inhibition of visceral noxious information in rabbits","Borgbjerg FM, Frigast C, Madsen JB.","Gastroenterology. 1996 Jul;111(1):78-84. doi: 10.1053/gast.1996.v111.pm8698228.","Borgbjerg FM","Gastroenterology","1996","1996/07/01","","","10.1053/gast.1996.v111.pm8698228"
"8693836","Endogenous opioids may modulate the activity of the hypothalamus-pituitary-adrenocortical axis in domestic fowl","Pierzchała-Koziec K, Niezgoda J, Bobek S, Przewłocki R.","Zentralbl Veterinarmed A. 1996 May;43(3):139-46. doi: 10.1111/j.1439-0442.1996.tb00438.x.","Pierzchała-Koziec K","Zentralbl Veterinarmed A","1996","1996/05/01","","","10.1111/j.1439-0442.1996.tb00438.x"
"8685173","[Effects of naltrexone on automutilation behavior in autistic psychosis]","Decocq G, Kandelaft N, Compagnon M.","Presse Med. 1996 Feb 24;25(7):305.","Decocq G","Presse Med","1996","1996/02/24","","",""
"8679801","[Evaluation of the efficacy of naltrexone in alcoholism by the determination of serum carbohydrate-deficient transferrin]","Martinez Ruiz M, Llobell Segui G, Peralba Vaño JL, Toral Revuelta JR.","An Med Interna. 1995 Dec;12(12):589-92.","Martinez Ruiz M","An Med Interna","1995","1995/12/01","","",""
"8679021","Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment","Volpicelli JR, Volpicelli LA, O'Brien CP.","Alcohol Alcohol. 1995 Nov;30(6):789-98.","Volpicelli JR","Alcohol Alcohol","1995","1995/11/01","","",""
"8675970","A detailed longitudinal analysis on the use of naltrexone in the treatment of bulimia","Marrazzi MA, Kinzie J, Luby ED.","Int Clin Psychopharmacol. 1995 Sep;10(3):173-6. doi: 10.1097/00004850-199510030-00006.","Marrazzi MA","Int Clin Psychopharmacol","1995","1995/09/01","","","10.1097/00004850-199510030-00006"
"8675969","Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa","Marrazzi MA, Bacon JP, Kinzie J, Luby ED.","Int Clin Psychopharmacol. 1995 Sep;10(3):163-72. doi: 10.1097/00004850-199510030-00005.","Marrazzi MA","Int Clin Psychopharmacol","1995","1995/09/01","","","10.1097/00004850-199510030-00005"
"8669218","Evaluation of methylnaltrexone for the reduction of postoperative vomiting and nausea incidences","Moerman I, Franck P, Camu F.","Acta Anaesthesiol Belg. 1995;46(3-4):127-32.","Moerman I","Acta Anaesthesiol Belg","1995","1995/01/01","","",""
"8667185","The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats","Hemby SE, Smith JE, Dworkin SI.","J Pharmacol Exp Ther. 1996 Jun;277(3):1247-58.","Hemby SE","J Pharmacol Exp Ther","1996","1996/06/01","","",""
"8666558","Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial","Roth AS, Ostroff RB, Hoffman RE.","J Clin Psychiatry. 1996 Jun;57(6):233-7.","Roth AS","J Clin Psychiatry","1996","1996/06/01","","",""
"8664207","Effects of naltrexone on mannerisms and water imbalance in polydipsic schizophrenics: a pilot study","Becker JA, Goldman MB, Alam MY, Luchins DJ.","Schizophr Res. 1995 Nov;17(3):279-82. doi: 10.1016/0920-9964(95)00011-9.","Becker JA","Schizophr Res","1995","1995/11/01","","","10.1016/0920-9964(95)00011-9"
"8657836","Interaction of opioids with antidepressant-induced antinociception","Sierralta F, Pinardi G, Mendez M, Miranda HF.","Psychopharmacology (Berl). 1995 Dec;122(4):374-8. doi: 10.1007/BF02246269.","Sierralta F","Psychopharmacology (Berl)","1995","1995/12/01","","","10.1007/BF02246269"
"8649341","A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter","Fremeau RT Jr, Velaz-Faircloth M, Miller JW, Henzi VA, Cohen SM, Nadler JV, Shafqat S, Blakely RD, Domin B.","Mol Pharmacol. 1996 Jun;49(6):1033-41.","Fremeau RT Jr","Mol Pharmacol","1996","1996/06/01","","",""
"8648182","The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis","Zagon IS, Wu Y, McLaughlin PJ.","J Invest Dermatol. 1996 Mar;106(3):490-7. doi: 10.1111/1523-1747.ep12343712.","Zagon IS","J Invest Dermatol","1996","1996/03/01","","","10.1111/1523-1747.ep12343712"
"8638797","Alkaloid delta agonist BW373U86 increases hypoxic tolerance","Bofetiado DM, Mayfield KP, D'Alecy LG.","Anesth Analg. 1996 Jun;82(6):1237-41. doi: 10.1097/00000539-199606000-00023.","Bofetiado DM","Anesth Analg","1996","1996/06/01","","","10.1097/00000539-199606000-00023"
"8637403","In vivo labeling of delta opioid receptors in mouse brain by [3H]benzylidenenaltrexone, a ligand selective for the delta 1 subtype","Lever JR, Stathis M, Kinter CM, Scheffel U.","Life Sci. 1996;58(21):PL331-6. doi: 10.1016/0024-3205(96)00175-0.","Lever JR","Life Sci","1996","1996/01/01","","","10.1016/0024-3205(96)00175-0"
"8633543","Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease","Carson KL, Tran TT, Cotton P, Sharara AI, Hunt CM.","Am J Gastroenterol. 1996 May;91(5):1022-3.","Carson KL","Am J Gastroenterol","1996","1996/05/01","","",""
"8632330","Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats","Fecho K, Maslonek KA, Dykstra LA, Lysle DT.","J Pharmacol Exp Ther. 1996 Feb;276(2):626-36.","Fecho K","J Pharmacol Exp Ther","1996","1996/02/01","","",""
"8632320","kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine","Shippenberg TS, LeFevour A, Heidbreder C.","J Pharmacol Exp Ther. 1996 Feb;276(2):545-54.","Shippenberg TS","J Pharmacol Exp Ther","1996","1996/02/01","","",""
"8632318","Discriminative stimulus effects of nalbuphine in rhesus monkeys","Gerak LR, France CP.","J Pharmacol Exp Ther. 1996 Feb;276(2):523-31.","Gerak LR","J Pharmacol Exp Ther","1996","1996/02/01","","",""
"8632309","Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans","Eissenberg T, Greenwald MK, Johnson RE, Liebson IA, Bigelow GE, Stitzer ML.","J Pharmacol Exp Ther. 1996 Feb;276(2):449-59.","Eissenberg T","J Pharmacol Exp Ther","1996","1996/02/01","","",""
"8632308","Relative analgesic potency of mu, delta and kappa opioids after spinal administration in amphibians","Stevens CW.","J Pharmacol Exp Ther. 1996 Feb;276(2):440-8.","Stevens CW","J Pharmacol Exp Ther","1996","1996/02/01","","",""
"8627605","Opioid antagonist activity of naltrexone-derived bivalent ligands: importance of a properly oriented molecular scaffold to guide ""address"" recognition at kappa opioid receptors","Bolognesi ML, Ojala WH, Gleason WB, Griffin JF, Farouz-Grant F, Larson DL, Takemori AE, Portoghese PS.","J Med Chem. 1996 Apr 26;39(9):1816-22. doi: 10.1021/jm950807f.","Bolognesi ML","J Med Chem","1996","1996/04/26","","","10.1021/jm950807f"
"8627579","Discriminative stimulus effects on enadoline in pigeons","Brandt MR, France CP.","J Pharmacol Exp Ther. 1996 May;277(2):960-7.","Brandt MR","J Pharmacol Exp Ther","1996","1996/05/01","","",""
"8627559","Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone","Ossipov MH, Kovelowski CJ, Wheeler-Aceto H, Cowan A, Hunter JC, Lai J, Malan TP Jr, Porreca F.","J Pharmacol Exp Ther. 1996 May;277(2):784-8.","Ossipov MH","J Pharmacol Exp Ther","1996","1996/05/01","","",""
"8627542","Electrical stimulation at traditional acupuncture sites in periphery produces brain opioid-receptor-mediated antinociception in rats","Chen XH, Geller EB, Adler MW.","J Pharmacol Exp Ther. 1996 May;277(2):654-60.","Chen XH","J Pharmacol Exp Ther","1996","1996/05/01","","",""
"8624711","General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions","Bodnar RJ, Glass MJ, Ragnauth A, Cooper ML.","Brain Res. 1995 Nov 27;700(1-2):205-12. doi: 10.1016/0006-8993(95)00957-r.","Bodnar RJ","Brain Res","1995","1995/11/27","","","10.1016/0006-8993(95)00957-r"
"8620464","Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone","Hytrek SD, McLaughlin PJ, Lang CM, Zagon IS.","Cancer Lett. 1996 Mar 29;101(2):159-64. doi: 10.1016/0304-3835(96)04119-5.","Hytrek SD","Cancer Lett","1996","1996/03/29","","","10.1016/0304-3835(96)04119-5"
"8612393","Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial","Yuan CS, Foss JF, O'Connor M, Toledano A, Roizen MF, Moss J.","Clin Pharmacol Ther. 1996 Apr;59(4):469-75. doi: 10.1016/S0009-9236(96)90117-4.","Yuan CS","Clin Pharmacol Ther","1996","1996/04/01","","","10.1016/S0009-9236(96)90117-4"
"8611059","The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies","Anton RF, Moak DH, Latham PK.","Arch Gen Psychiatry. 1996 Mar;53(3):225-31. doi: 10.1001/archpsyc.1996.01830030047008.","Anton RF","Arch Gen Psychiatry","1996","1996/03/01","","","10.1001/archpsyc.1996.01830030047008"
"8611058","Six-month follow-up of naltrexone and psychotherapy for alcohol dependence","O'Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE, Rounsaville B.","Arch Gen Psychiatry. 1996 Mar;53(3):217-24. doi: 10.1001/archpsyc.1996.01830030039007.","O'Malley SS","Arch Gen Psychiatry","1996","1996/03/01","","","10.1001/archpsyc.1996.01830030039007"
"8609891","Induction of chronic Fos-related antigens in rat brain by chronic morphine administration","Nye HE, Nestler EJ.","Mol Pharmacol. 1996 Apr;49(4):636-45.","Nye HE","Mol Pharmacol","1996","1996/04/01","","",""
"8600226","Naltrexone treatment of self-injurious thoughts and behaviors","Sonne S, Rubey R, Brady K, Malcolm R, Morris T.","J Nerv Ment Dis. 1996 Mar;184(3):192-5. doi: 10.1097/00005053-199603000-00011.","Sonne S","J Nerv Ment Dis","1996","1996/03/01","","","10.1097/00005053-199603000-00011"
"8598706","What is important in drug misuse treatment?","Seivewright NA, Greenwood J.","Lancet. 1996 Feb 10;347(8998):373-6. doi: 10.1016/s0140-6736(96)90542-5.","Seivewright NA","Lancet","1996","1996/02/10","","","10.1016/s0140-6736(96)90542-5"
"8592635","Suppression of immune function by non-peptidic delta opioid receptor antagonists","House RV, Thomas PT, Kozak JT, Bhargava HN.","Neurosci Lett. 1995 Sep 29;198(2):119-22. doi: 10.1016/0304-3940(95)11983-4.","House RV","Neurosci Lett","1995","1995/09/29","","","10.1016/0304-3940(95)11983-4"
"8592362","Immobilization of black bears (Ursus americanus) with orally administered carfentanil citrate","Ramsay EC, Sleeman JM, Clyde VL.","J Wildl Dis. 1995 Jul;31(3):391-3. doi: 10.7589/0090-3558-31.3.391.","Ramsay EC","J Wildl Dis","1995","1995/07/01","","","10.7589/0090-3558-31.3.391"
"8590066","Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatment","Jenab S, Kest B, Inturrisi CE.","Brain Res. 1995 Sep 11;691(1-2):69-75. doi: 10.1016/0006-8993(95)00615-w.","Jenab S","Brain Res","1995","1995/09/11","","","10.1016/0006-8993(95)00615-w"
"8589193","Biocompatibility and in vivo morphine diffusion into a placebo morphine-triggered naltrexone delivery device in rabbits","Roskos KV, Fritzinger BK, Tefft JA, Nakayama GR, Heller J.","Biomaterials. 1995 Nov;16(16):1235-9. doi: 10.1016/0142-9612(95)98130-7.","Roskos KV","Biomaterials","1995","1995/11/01","","","10.1016/0142-9612(95)98130-7"
"8587914","Naltrexone delays the onset of maternal behavior in primiparous parturient ewes","Caba M, Poindron P, Krehbiel D, Lévy F, Romeyer A, Vénier G.","Pharmacol Biochem Behav. 1995 Dec;52(4):743-8. doi: 10.1016/0091-3057(95)00168-v.","Caba M","Pharmacol Biochem Behav","1995","1995/12/01","","","10.1016/0091-3057(95)00168-v"
"8587906","Differential effects of intrahypothalamic administration of opioids on food intake in naive and tolerant rats","Gulati K.","Pharmacol Biochem Behav. 1995 Dec;52(4):689-94. doi: 10.1016/0091-3057(95)00127-i.","Gulati K","Pharmacol Biochem Behav","1995","1995/12/01","","","10.1016/0091-3057(95)00127-i"
"8582907","A study of reversibly inactivated lipases for use in a morphine-triggered naltrexone delivery system","Nakayama GR, Roskos KV, Fritzinger BK, Heller J.","J Biomed Mater Res. 1995 Nov;29(11):1389-96. doi: 10.1002/jbm.820291110.","Nakayama GR","J Biomed Mater Res","1995","1995/11/01","","","10.1002/jbm.820291110"
"8582789","Morphine affects cytostatic activity of macrophages by the modulation of nitric oxide release","Pacifici R, Minetti M, Zuccaro P, Pietraforte D.","Int J Immunopharmacol. 1995 Sep;17(9):771-7. doi: 10.1016/0192-0561(95)00046-5.","Pacifici R","Int J Immunopharmacol","1995","1995/09/01","","","10.1016/0192-0561(95)00046-5"
"8582228","[Effects of intrasubarachnoid space injection of anti dynorphin A1-13 serum or nor-BNI on the recovery of spinal cord injury in rats]","Hong X, Li B, Li M.","Zhonghua Wai Ke Za Zhi. 1995 Jun;33(6):378-81.","Hong X","Zhonghua Wai Ke Za Zhi","1995","1995/06/01","","",""
"8581505","Effects of chronic opiate and opioid antagonist treatment on striatal opioid peptides","Trujillo KA, Bronstein DM, Sanchez IO, Akil H.","Brain Res. 1995 Nov 6;698(1-2):69-78. doi: 10.1016/0006-8993(95)00809-5.","Trujillo KA","Brain Res","1995","1995/11/06","","","10.1016/0006-8993(95)00809-5"
"8581488","Opioid antagonists naloxone, beta-funaltrexamine and naltrindole, but not nor-binaltorphimine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37","Yu LC, Hansson P, Lundeberg T.","Brain Res. 1995 Nov 6;698(1-2):23-9. doi: 10.1016/0006-8993(95)00752-c.","Yu LC","Brain Res","1995","1995/11/06","","","10.1016/0006-8993(95)00752-c"
"8581470","The role of norepinephrine in mediating luteinizing hormone release in response to blockade of kappa-opioid receptors in the medial preoptic area","Zhen S, Gallo RV.","Brain Res. 1995 Nov 6;698(1-2):121-9. doi: 10.1016/0006-8993(95)00874-p.","Zhen S","Brain Res","1995","1995/11/06","","","10.1016/0006-8993(95)00874-p"
"8574503","Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimation","Wilhelm JA, Veng-Pedersen P, Zakszewski TB, Osifchin E, Waters SJ.","Int J Clin Pharmacol Ther. 1995 Oct;33(10):540-5.","Wilhelm JA","Int J Clin Pharmacol Ther","1995","1995/10/01","","",""
"8570918","Cardiorespiratory and sleep-wake behavior in developing swine: kappa-opioid influence","Moss IR, Faltus RE, Inman JD, Laferrière A.","Respir Physiol. 1995 Aug;101(2):161-9. doi: 10.1016/0034-5687(95)00024-8.","Moss IR","Respir Physiol","1995","1995/08/01","","","10.1016/0034-5687(95)00024-8"
"8570776","Placebo-controlled acute dosage naltrexone study in young autistic children","Willemsen-Swinkels SH, Buitelaar JK, Weijnen FG, van Engeland H.","Psychiatry Res. 1995 Oct 16;58(3):203-15. doi: 10.1016/0165-1781(95)02749-m.","Willemsen-Swinkels SH","Psychiatry Res","1995","1995/10/16","","","10.1016/0165-1781(95)02749-m"
"8570775","Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study","Bouvard MP, Leboyer M, Launay JM, Recasens C, Plumet MH, Waller-Perotte D, Tabuteau F, Bondoux D, Dugas M, Lensing P, et al.","Psychiatry Res. 1995 Oct 16;58(3):191-201. doi: 10.1016/0165-1781(95)02601-r.","Bouvard MP","Psychiatry Res","1995","1995/10/16","","","10.1016/0165-1781(95)02601-r"
"8566146","Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi]","Fundytus ME, Schiller PW, Shapiro M, Weltrowska G, Coderre TJ.","Eur J Pharmacol. 1995 Nov 3;286(1):105-8. doi: 10.1016/0014-2999(95)00554-x.","Fundytus ME","Eur J Pharmacol","1995","1995/11/03","","","10.1016/0014-2999(95)00554-x"
"8565795","Current strategies for the treatment of alcohol dependence in the United States","O'Malley SS.","Drug Alcohol Depend. 1995 Sep;39 Suppl 1:S3-7. doi: 10.1016/0376-8716(95)01167-w.","O'Malley SS","Drug Alcohol Depend","1995","1995/09/01","","","10.1016/0376-8716(95)01167-w"
"8561215","Experience of a ""slip"" among alcoholics treated with naltrexone or placebo","O'Malley SS, Jaffe AJ, Rode S, Rounsaville BJ.","Am J Psychiatry. 1996 Feb;153(2):281-3. doi: 10.1176/ajp.153.2.281.","O'Malley SS","Am J Psychiatry","1996","1996/02/01","","","10.1176/ajp.153.2.281"
"8559793","Opioid modulation of sucrose intake in CD-1 mice: effects of gender and housing conditions","Moles A, Cooper SJ.","Physiol Behav. 1995 Oct;58(4):791-6. doi: 10.1016/0031-9384(95)00134-5.","Moles A","Physiol Behav","1995","1995/10/01","","","10.1016/0031-9384(95)00134-5"
"8558458","Biochemical and pharmacological characterization of multiple beta-endorphinergic antinociceptive systems in the rat periaqueductal gray","Monroe PJ, Hawranko AA, Smith DL, Smith DJ.","J Pharmacol Exp Ther. 1996 Jan;276(1):65-73.","Monroe PJ","J Pharmacol Exp Ther","1996","1996/01/01","","",""
"8555746","The use of opiate antagonists for recurrent self-injurious behavior","Buzan RD, Thomas M, Dubovsky SL, Treadway J.","J Neuropsychiatry Clin Neurosci. 1995 Fall;7(4):437-44. doi: 10.1176/jnp.7.4.437.","Buzan RD","J Neuropsychiatry Clin Neurosci","1995","1995/01/01","","","10.1176/jnp.7.4.437"
"8549626","Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors","Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H.","Eur J Pharmacol. 1995 Sep 15;284(1-2):195-8. doi: 10.1016/0014-2999(95)00440-v.","Suzuki T","Eur J Pharmacol","1995","1995/09/15","","","10.1016/0014-2999(95)00440-v"
"8549624","8-OH-DPAT stimulates gastric acid secretion through a vagal-independent, adrenal-mediated mechanism","Gidener S, LePard KJ, Stephens RL Jr.","Eur J Pharmacol. 1995 Sep 15;284(1-2):19-24. doi: 10.1016/0014-2999(95)00331-e.","Gidener S","Eur J Pharmacol","1995","1995/09/15","","","10.1016/0014-2999(95)00331-e"
"8544993","Kappa opioid receptors participate in nerve growth factor-induced hyperalgesia","Apfel SC, Newel M, Dormia C, Kessler JA.","Neuroscience. 1995 Oct;68(4):1199-206. doi: 10.1016/0306-4522(95)00209-2.","Apfel SC","Neuroscience","1995","1995/10/01","","","10.1016/0306-4522(95)00209-2"
"8539325","Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine","de Vries TJ, Babovic-Vuksanovic D, Elmer G, Shippenberg TS.","Psychopharmacology (Berl). 1995 Aug;120(4):442-8. doi: 10.1007/BF02245816.","de Vries TJ","Psychopharmacology (Berl)","1995","1995/08/01","","","10.1007/BF02245816"
"8539322","Naltrexone, smoking behaviour and cigarette withdrawal","Sutherland G, Stapleton JA, Russell MA, Feyerabend C.","Psychopharmacology (Berl). 1995 Aug;120(4):418-25. doi: 10.1007/BF02245813.","Sutherland G","Psychopharmacology (Berl)","1995","1995/08/01","","","10.1007/BF02245813"
"8537889","Duration of opioid antagonism by nalmefene and naloxone in the dog: an integrated pharmacokinetic/pharmacodynamic comparison","Veng-Pedersen P, Wilhelm JA, Zakszewski TB, Osifchin E, Waters SJ.","J Pharm Sci. 1995 Sep;84(9):1101-6. doi: 10.1002/jps.2600840913.","Veng-Pedersen P","J Pharm Sci","1995","1995/09/01","","","10.1002/jps.2600840913"
"8536780","Opiate antagonists in erectile dysfunction: a possible new treatment option? Results of a pilot study with naltrexone","van Ahlen H, Piechota HJ, Kias HJ, Brennemann W, Klingmüller D.","Eur Urol. 1995;28(3):246-50. doi: 10.1159/000475059.","van Ahlen H","Eur Urol","1995","1995/01/01","","","10.1159/000475059"
"8531129","Participation of delta opioid receptor subtypes in the stimulation of adenylyl cyclase activity in rat olfactory bulb","Olianas MC, Onali P.","J Pharmacol Exp Ther. 1995 Dec;275(3):1560-7.","Olianas MC","J Pharmacol Exp Ther","1995","1995/12/01","","",""
"8530646","Effect of opioid blockade on insulin metabolism in polycystic ovarian disease","Fulghesu AM, Ciampelli M, Fortini A, Cucinelli F, Guido M, Caruso A, Lanzone A, Mancuso S.","Hum Reprod. 1995 Sep;10(9):2253-7. doi: 10.1093/oxfordjournals.humrep.a136279.","Fulghesu AM","Hum Reprod","1995","1995/09/01","","","10.1093/oxfordjournals.humrep.a136279"
"8530590","Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion","Lanzone A, Fulghesu AM, Cucinelli F, Ciampelli M, Caruso A, Mancuso S.","J Clin Endocrinol Metab. 1995 Dec;80(12):3501-6. doi: 10.1210/jcem.80.12.8530590.","Lanzone A","J Clin Endocrinol Metab","1995","1995/12/01","","","10.1210/jcem.80.12.8530590"
"8529534","Assessment of nalmefene glucuronide as a selective gut opioid antagonist","Cheskin LJ, Chami TN, Johnson RE, Jaffe JH.","Drug Alcohol Depend. 1995 Aug;39(2):151-4. doi: 10.1016/0376-8716(95)01153-p.","Cheskin LJ","Drug Alcohol Depend","1995","1995/08/01","","","10.1016/0376-8716(95)01153-p"
"8520812","Relative bioavailability of controlled-release oral morphine sulfate during naltrexone blockade","Bashaw ED, Kaiko RF, Grandy RP, Reder RF, Goldenheim PD.","Int J Clin Pharmacol Ther. 1995 Sep;33(9):524-9.","Bashaw ED","Int J Clin Pharmacol Ther","1995","1995/09/01","","",""
"8516354","Opioid and nonopioid interactions in two forms of stress-induced analgesia","Grisel JE, Fleshner M, Watkins LR, Maier SF.","Pharmacol Biochem Behav. 1993 May;45(1):161-72. doi: 10.1016/0091-3057(93)90100-8.","Grisel JE","Pharmacol Biochem Behav","1993","1993/05/01","","","10.1016/0091-3057(93)90100-8"
"8511404","Hypoxia, sleep and respiration in relation to opioids in developing swine","Moss IR, Scott SC, Inman JD.","Respir Physiol. 1993 Apr;92(1):115-25. doi: 10.1016/0034-5687(93)90124-s.","Moss IR","Respir Physiol","1993","1993/04/01","","","10.1016/0034-5687(93)90124-s"
"8499351","Role of endogenous opioids in progesterone antagonism on oestradiol-induced DNA synthesis in the rat uterus","Ordög T, Vértes Z, Vértes M.","J Steroid Biochem Mol Biol. 1993 May;45(5):455-7. doi: 10.1016/0960-0760(93)90014-n.","Ordög T","J Steroid Biochem Mol Biol","1993","1993/05/01","","","10.1016/0960-0760(93)90014-n"
"8498150","Nalmefene enhances LH secretion in a proportion of oligo-amenorrheic athletes","McArthur JW, Turnbull BA, Pehrson J, Bauman M, Henley K, Turner A, Evans WJ, Bullen BA, Skrinar GS.","Acta Endocrinol (Copenh). 1993 Apr;128(4):325-33. doi: 10.1530/acta.0.1280325.","McArthur JW","Acta Endocrinol (Copenh)","1993","1993/04/01","","","10.1530/acta.0.1280325"
"8496271","Measurement of naloxone in plasma using high-performance liquid chromatography with electrochemical detection","Reid RW, Deakin A, Leehey DJ.","J Chromatogr. 1993 Apr 21;614(1):117-22. doi: 10.1016/0378-4347(93)80230-2.","Reid RW","J Chromatogr","1993","1993/04/21","","","10.1016/0378-4347(93)80230-2"
"8492675","[Naltrexone therapy. Experience with ""Telephone Assistance"" in Rome]","Coccoli M, Rugolo AP, Rocchi R, Giannini P, Ciervo U.","Minerva Psichiatr. 1993 Mar;34(1):39-43.","Coccoli M","Minerva Psichiatr","1993","1993/03/01","","",""
"8492076","Opioids and testicular activity in the frog, Rana esculenta","Facchinetti F, Genazzani AR, Vallarino M, Pestarino M, Polzonetti-Magni A, Carnevali O, Ciarcia G, Fasano S, D'Antonio M, Pierantoni R.","J Endocrinol. 1993 Apr;137(1):49-57. doi: 10.1677/joe.0.1370049.","Facchinetti F","J Endocrinol","1993","1993/04/01","","","10.1677/joe.0.1370049"
"8491826","Determination of nalmefene in plasma by high-performance liquid chromatography with electrochemical detection and its application in pharmacokinetic studies","Chou JZ, Albeck H, Kreek MJ.","J Chromatogr. 1993 Apr 2;613(2):359-64. doi: 10.1016/0378-4347(93)80155-w.","Chou JZ","J Chromatogr","1993","1993/04/02","","","10.1016/0378-4347(93)80155-w"
"8481792","Chronic food restriction and weight loss produce opioid facilitation of perifornical hypothalamic self-stimulation","Carr KD, Wolinsky TD.","Brain Res. 1993 Apr 2;607(1-2):141-8. doi: 10.1016/0006-8993(93)91499-i.","Carr KD","Brain Res","1993","1993/04/02","","","10.1016/0006-8993(93)91499-i"
"8481789","Naltrexone-induced alterations of the distribution of morphine in brain regions and spinal cord of the rat","Bhargava HN, Larsen AK, Rahmani NH, Villar VM.","Brain Res. 1993 Apr 2;607(1-2):1-8. doi: 10.1016/0006-8993(93)91482-8.","Bhargava HN","Brain Res","1993","1993/04/02","","","10.1016/0006-8993(93)91482-8"
"8480840","Ultrashort noninvasive opiate detoxification","Loimer N, Hofmann P, Chaudhry H.","Am J Psychiatry. 1993 May;150(5):839. doi: 10.1176/ajp.150.5.839a.","Loimer N","Am J Psychiatry","1993","1993/05/01","","","10.1176/ajp.150.5.839a"
"8474146","Perinatal morphine treatment inhibits pruning effect and regeneration of serotoninergic pathways following neonatal 5,7-HT lesions","Gorio A, Di Giulio AM, Germani E, Bendotti C, Bertelli A, Mantegazza P.","J Neurosci Res. 1993 Mar 1;34(4):462-71. doi: 10.1002/jnr.490340411.","Gorio A","J Neurosci Res","1993","1993/03/01","","","10.1002/jnr.490340411"
"8474033","Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice","Freier DO, Fuchs BA.","J Pharmacol Exp Ther. 1993 Apr;265(1):81-8.","Freier DO","J Pharmacol Exp Ther","1993","1993/04/01","","",""
"8473447","Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy","Wildt L, Leyendecker G, Sir-Petermann T, Waibel-Treber S.","Hum Reprod. 1993 Mar;8(3):350-8. doi: 10.1093/oxfordjournals.humrep.a138050.","Wildt L","Hum Reprod","1993","1993/03/01","","","10.1093/oxfordjournals.humrep.a138050"
"8472282","Influence of hyperkalaemia and ischaemia on non-receptor-mediated cardiac electrophysiological effects of naloxone","Oldroyd KG, Hicks MN, Cobbe SM.","Cardiovasc Res. 1993 Feb;27(2):296-303. doi: 10.1093/cvr/27.2.296.","Oldroyd KG","Cardiovasc Res","1993","1993/02/01","","","10.1093/cvr/27.2.296"
"8469378","Nerve growth factor and its receptor are differentially modified by chronic naltrexone treatment during rat brain development","Pérez-Navarro E, Alberch J, Arenas E, Marsal J.","Neurosci Lett. 1993 Jan 4;149(1):47-50. doi: 10.1016/0304-3940(93)90344-k.","Pérez-Navarro E","Neurosci Lett","1993","1993/01/04","","","10.1016/0304-3940(93)90344-k"
"8464327","Effects of the opioid antagonist naltrexone-estrone azine on the luteinizing hormone-releasing hormone induced release of luteinizing hormone from the pituitary glands of ovariectomized rats","Armeanu MC, van Dieten JA, Kolb VM, Schoemaker J, de Koning J.","Life Sci. 1993;52(15):1311-8.","Armeanu MC","Life Sci","1993","1993/01/01","","",""
"8458488","Long-term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome","Lanzone A, Apa R, Fulghesu AM, Cutillo G, Caruso A, Mancuso S.","Fertil Steril. 1993 Apr;59(4):734-7. doi: 10.1016/s0015-0282(16)55851-8.","Lanzone A","Fertil Steril","1993","1993/04/01","","","10.1016/s0015-0282(16)55851-8"
"8456048","Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine","Gold MS.","Psychiatr Clin North Am. 1993 Mar;16(1):61-73.","Gold MS","Psychiatr Clin North Am","1993","1993/03/01","","",""
"8452203","Amethystic agents and adjunct behavioral therapy and psychotherapy","Gallant D.","Alcohol Clin Exp Res. 1993 Feb;17(1):197-8. doi: 10.1111/j.1530-0277.1993.tb00748.x.","Gallant D","Alcohol Clin Exp Res","1993","1993/02/01","","","10.1111/j.1530-0277.1993.tb00748.x"
"8451312","Evidence for a direct central anorectic effect of tumor-necrosis-factor-alpha in the rat","Fantino M, Wieteska L.","Physiol Behav. 1993 Mar;53(3):477-83. doi: 10.1016/0031-9384(93)90141-2.","Fantino M","Physiol Behav","1993","1993/03/01","","","10.1016/0031-9384(93)90141-2"
"8450619","[Prevention of undesirable effects during the use of opiate antagonists]","Rust M.","Klin Anasthesiol Intensivther. 1993;42:108-16.","Rust M","Klin Anasthesiol Intensivther","1993","1993/01/01","","",""
"8446667","Discriminative stimulus effects of the PCP/sigma-ligand (+)-N-allylnormetazocine in monkeys","Holtzman SG.","Pharmacol Biochem Behav. 1993 Feb;44(2):349-55. doi: 10.1016/0091-3057(93)90473-7.","Holtzman SG","Pharmacol Biochem Behav","1993","1993/02/01","","","10.1016/0091-3057(93)90473-7"
"8446660","Conditioning of the allogeneic cytotoxic lymphocyte response","Hiramoto RN, Hsueh CM, Rogers CF, Demissie S, Hiramoto NS, Soong SJ, Ghanta VK.","Pharmacol Biochem Behav. 1993 Feb;44(2):275-80. doi: 10.1016/0091-3057(93)90462-3.","Hiramoto RN","Pharmacol Biochem Behav","1993","1993/02/01","","","10.1016/0091-3057(93)90462-3"
"8445984","(D-Ala, D-Leu) enkephalin reduces the binding of GTP in hippocampal membranes","Aramaki T, Saito K, Shinno E, Ohnishi T, Ooi Y, Maeda S, Inoki R.","Life Sci. 1993;52(11):901-6. doi: 10.1016/0024-3205(93)90524-7.","Aramaki T","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90524-7"
"8442782","Effects of a 60 Hz magnetic field on central cholinergic systems of the rat","Lai H, Carino MA, Horita A, Guy AW.","Bioelectromagnetics. 1993;14(1):5-15. doi: 10.1002/bem.2250140104.","Lai H","Bioelectromagnetics","1993","1993/01/01","","","10.1002/bem.2250140104"
"8441758","Effects of naltrexone on pharmacodynamics and pharmacokinetics of intravenously administered morphine in the rat","Bhargava HN, Rahmani NH, Villar VM, Larsen AK.","Pharmacology. 1993;46(2):66-74. doi: 10.1159/000139030.","Bhargava HN","Pharmacology","1993","1993/01/01","","","10.1159/000139030"
"8437122","Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat","Negus SS, Pasternak GW, Koob GF, Weinger MB.","J Pharmacol Exp Ther. 1993 Feb;264(2):739-45.","Negus SS","J Pharmacol Exp Ther","1993","1993/02/01","","",""
"8432363","A comparison of YM-14673, U-50488H, and nalmefene after spinal cord injury in the rat","Behrmann DL, Bresnahan JC, Beattie MS.","Exp Neurol. 1993 Feb;119(2):258-67. doi: 10.1006/exnr.1993.1028.","Behrmann DL","Exp Neurol","1993","1993/02/01","","","10.1006/exnr.1993.1028"
"8428834","Naltrexone-induced pruritus in a dog with tail-chasing behavior","Schwartz S.","J Am Vet Med Assoc. 1993 Jan 15;202(2):278-80.","Schwartz S","J Am Vet Med Assoc","1993","1993/01/15","","",""
"8427429","Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: a pilot study","Kaplan JL, Marx JA.","Ann Emerg Med. 1993 Feb;22(2):187-90. doi: 10.1016/s0196-0644(05)80200-8.","Kaplan JL","Ann Emerg Med","1993","1993/02/01","","","10.1016/s0196-0644(05)80200-8"
"8422093","Heroin withdrawal precipitated by nonmedical use of naltrexone","Galloway G.","Am J Psychiatry. 1993 Feb;150(2):347-8. doi: 10.1176/ajp.150.2.347b.","Galloway G","Am J Psychiatry","1993","1993/02/01","","","10.1176/ajp.150.2.347b"
"8421432","Effects of in vivo morphine treatment on antibody responses in C57BL/6 bgJ/bgJ (beige) mice","Bussiere JL, Adler MW, Rogers TJ, Eisenstein TK.","Life Sci. 1993;52(4):PL43-8. doi: 10.1016/0024-3205(93)90157-x.","Bussiere JL","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90157-x"
"8417165","Pre- and posttranslational regulation of beta-endorphin biosynthesis in the CNS: effects of chronic naltrexone treatment","Bronstein DM, Day NC, Gutstein HB, Trujillo KA, Akil H.","J Neurochem. 1993 Jan;60(1):40-9. doi: 10.1111/j.1471-4159.1993.tb05820.x.","Bronstein DM","J Neurochem","1993","1993/01/01","","","10.1111/j.1471-4159.1993.tb05820.x"
"8417149","Morphine inhibits calcium influx and the response to acetylcholine in Xenopus oocytes","Lipinsky D, Oron Y, Sarne Y.","J Neurochem. 1993 Jan;60(1):299-304. doi: 10.1111/j.1471-4159.1993.tb05851.x.","Lipinsky D","J Neurochem","1993","1993/01/01","","","10.1111/j.1471-4159.1993.tb05851.x"
"8416050","Effects of beta-funaltrexamine treatment and sexual isolation in the perinatal period on the development of mu-opioid receptors and nociception","de Cabo C, Kitchen I, Kelly M, Viveros MP.","Psychoneuroendocrinology. 1993;18(5-6):415-24. doi: 10.1016/0306-4530(93)90016-e.","de Cabo C","Psychoneuroendocrinology","1993","1993/01/01","","","10.1016/0306-4530(93)90016-e"
"8413857","Kinetic parameters of antagonism by the delta opioid receptor selective peptide antagonist Boc-Tyr-Pro-Gly-Phe-Leu-Thr against selective and non-selective agonists in the mouse vas deferens","Rónai AZ, Magyar A, Medzihradszky K.","Neuropeptides. 1993 Aug;25(2):127-9. doi: 10.1016/0143-4179(93)90092-o.","Rónai AZ","Neuropeptides","1993","1993/08/01","","","10.1016/0143-4179(93)90092-o"
"8413824","Opiate receptor subtype involvement in the stimulation of prolactin release by beta-endorphin in female rats","Kehoe L, Parman R, Janik J, Callahan P.","Neuroendocrinology. 1993 May;57(5):875-83. doi: 10.1159/000126448.","Kehoe L","Neuroendocrinology","1993","1993/05/01","","","10.1159/000126448"
"8413082","Naltrexone does not increase brain and body development in rats","Petrie BF.","Neurotoxicol Teratol. 1993 Jul-Aug;15(4):275-7. doi: 10.1016/0892-0362(93)90009-d.","Petrie BF","Neurotoxicol Teratol","1993","1993/07/01","","","10.1016/0892-0362(93)90009-d"
"8411221","Comparison of single and combination drug treatment strategies in experimental brain trauma","Faden AI.","J Neurotrauma. 1993 Summer;10(2):91-100. doi: 10.1089/neu.1993.10.91.","Faden AI","J Neurotrauma","1993","1993/01/01","","","10.1089/neu.1993.10.91"
"8408737","Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs","Foss JF, Bass AS, Goldberg LI.","J Clin Pharmacol. 1993 Aug;33(8):747-51. doi: 10.1002/j.1552-4604.1993.tb05618.x.","Foss JF","J Clin Pharmacol","1993","1993/08/01","","","10.1002/j.1552-4604.1993.tb05618.x"
"8405123","Involvement of delta-opioid receptors in physical dependence on butorphanol","Jaw SP, Hoskins B, Ho IK.","Eur J Pharmacol. 1993 Aug 10;240(1):67-72. doi: 10.1016/0014-2999(93)90546-t.","Jaw SP","Eur J Pharmacol","1993","1993/08/10","","","10.1016/0014-2999(93)90546-t"
"8397420","Evidence for the up-regulation of kappa opiate mechanisms in mice selectively bred for high analgesia","Kest B, Mogil JS, Sternberg WF, Liebeskind JC, Sadowski B.","Proc West Pharmacol Soc. 1993;36:249-53.","Kest B","Proc West Pharmacol Soc","1993","1993/01/01","","",""
"8397052","U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice","Itoh J, Ukai M, Kameyama T.","Brain Res. 1993 Aug 13;619(1-2):223-8. doi: 10.1016/0006-8993(93)91615-y.","Itoh J","Brain Res","1993","1993/08/13","","","10.1016/0006-8993(93)91615-y"
"8397050","Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats","Beczkowska IW, Koch JE, Bostock ME, Leibowitz SF, Bodnar RJ.","Brain Res. 1993 Aug 6;618(2):261-70. doi: 10.1016/0006-8993(93)91274-v.","Beczkowska IW","Brain Res","1993","1993/08/06","","","10.1016/0006-8993(93)91274-v"
"8396634","Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level","Alcaraz C, Milanés MV, Vargas ML.","J Pharmacol Exp Ther. 1993 Sep;266(3):1385-9.","Alcaraz C","J Pharmacol Exp Ther","1993","1993/09/01","","",""
"8396630","Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used","Adams JU, Tallarida RJ, Geller EB, Adler MW.","J Pharmacol Exp Ther. 1993 Sep;266(3):1261-7.","Adams JU","J Pharmacol Exp Ther","1993","1993/09/01","","",""
"8396355","Role of mu 1- and delta-opioid receptors in modulation of fetal EEG and respiratory activity","Cheng PY, Wu D, Soong Y, McCabe S, Decena JA, Szeto HH.","Am J Physiol. 1993 Aug;265(2 Pt 2):R433-8. doi: 10.1152/ajpregu.1993.265.2.R433.","Cheng PY","Am J Physiol","1993","1993/08/01","","","10.1152/ajpregu.1993.265.2.R433"
"8396188","The mixed antinociceptive agonist-antagonist activity of beta-endorphin(1-27) in mice","Takemori AE, Portoghese PS.","Life Sci. 1993;53(13):1049-52. doi: 10.1016/0024-3205(93)90257-4.","Takemori AE","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90257-4"
"8395669","Antitussive effects of mu- and kappa-agonists in diabetic rats","Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y.","Neurosci Lett. 1993 May 14;154(1-2):65-8. doi: 10.1016/0304-3940(93)90172-h.","Kamei J","Neurosci Lett","1993","1993/05/14","","","10.1016/0304-3940(93)90172-h"
"8395559","Altered transition between agonist- and antagonist-favoring states of mu-opioid receptor in brain membranes with modified microviscosity","Lazar DF, Medzihradsky F.","J Neurochem. 1993 Sep;61(3):1135-40. doi: 10.1111/j.1471-4159.1993.tb03630.x.","Lazar DF","J Neurochem","1993","1993/09/01","","","10.1111/j.1471-4159.1993.tb03630.x"
"8395294","Effect of delayed weaning on opioid receptor control of swim stress-induced antinociception in the developing rat","Muhammad BY, Kitchen I.","Br J Pharmacol. 1993 Jul;109(3):651-4. doi: 10.1111/j.1476-5381.1993.tb13622.x.","Muhammad BY","Br J Pharmacol","1993","1993/07/01","PMC2175657","","10.1111/j.1476-5381.1993.tb13622.x"
"8394999","Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells","Baumhaker Y, Gafni M, Keren O, Sarne Y.","Mol Pharmacol. 1993 Aug;44(2):461-7.","Baumhaker Y","Mol Pharmacol","1993","1993/08/01","","",""
"8394964","Kappa opioid receptor-mediated regulation of prolactin and alpha-melanocyte-stimulating hormone secretion in male and female rats","Manzanares J, Wagner EJ, Moore KE, Lookingland KJ.","Life Sci. 1993;53(10):795-801. doi: 10.1016/0024-3205(93)90501-s.","Manzanares J","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90501-s"
"8394926","DAMGO stimulates the hypothalamo-pituitary-adrenal axis through a mu-2 opioid receptor","Eisenberg RM.","J Pharmacol Exp Ther. 1993 Aug;266(2):985-91.","Eisenberg RM","J Pharmacol Exp Ther","1993","1993/08/01","","",""
"8394918","Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin","Stewart PE, Hammond DL.","J Pharmacol Exp Ther. 1993 Aug;266(2):820-8.","Stewart PE","J Pharmacol Exp Ther","1993","1993/08/01","","",""
"8394563","Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain","Desmeules JA, Kayser V, Guilbaud G.","Pain. 1993 Jun;53(3):277-85. doi: 10.1016/0304-3959(93)90224-d.","Desmeules JA","Pain","1993","1993/06/01","","","10.1016/0304-3959(93)90224-d"
"8394180","Opioid receptor regulation of 5-hydroxytryptamine release from the rat hippocampus measured by in vivo microdialysis","Yoshioka M, Matsumoto M, Togashi H, Smith CB, Saito H.","Brain Res. 1993 Jun 4;613(1):74-9. doi: 10.1016/0006-8993(93)90456-w.","Yoshioka M","Brain Res","1993","1993/06/04","","","10.1016/0006-8993(93)90456-w"
"8394176","Opiate detoxification protocols. A clinical manual","Fishbain DA, Rosomoff HL, Cutler R.","Ann Clin Psychiatry. 1993 Mar;5(1):53-65. doi: 10.3109/10401239309148924.","Fishbain DA","Ann Clin Psychiatry","1993","1993/03/01","","","10.3109/10401239309148924"
"8393497","Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice","Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M, Nagase H.","Jpn J Pharmacol. 1993 May;62(1):15-24. doi: 10.1254/jjp.62.15.","Narita M","Jpn J Pharmacol","1993","1993/05/01","","","10.1254/jjp.62.15"
"8392894","Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice","Menendez L, Andres-Trelles F, Hidalgo A, Baamonde A.","Brain Res. 1993 May 21;611(2):264-71. doi: 10.1016/0006-8993(93)90512-l.","Menendez L","Brain Res","1993","1993/05/21","","","10.1016/0006-8993(93)90512-l"
"8392893","The highly selective delta agonist BUBU induces an analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphine","Desmeules JA, Kayser V, Gacel G, Guilbaud G, Roques BP.","Brain Res. 1993 May 21;611(2):243-8. doi: 10.1016/0006-8993(93)90509-l.","Desmeules JA","Brain Res","1993","1993/05/21","","","10.1016/0006-8993(93)90509-l"
"8392730","Factors that modulate inescapable shock-induced reductions in daily activity in the rat","Woodmansee WW, Silbert LH, Maier SF.","Pharmacol Biochem Behav. 1993 Jul;45(3):553-9. doi: 10.1016/0091-3057(93)90505-n.","Woodmansee WW","Pharmacol Biochem Behav","1993","1993/07/01","","","10.1016/0091-3057(93)90505-n"
"8392719","Mu-delta opioid interactions. III: Differential antagonism of DPDPE-induced increases in morphine EEG and EEG power spectra by DALCE and naltrindole","Stamidis H, Young GA.","Peptides. 1993 May-Jun;14(3):511-7. doi: 10.1016/0196-9781(93)90140-c.","Stamidis H","Peptides","1993","1993/05/01","","","10.1016/0196-9781(93)90140-c"
"8392556","Opioid-induced suppression of rat testicular function","Adams ML, Sewing B, Forman JB, Meyer ER, Cicero TJ.","J Pharmacol Exp Ther. 1993 Jul;266(1):323-8.","Adams ML","J Pharmacol Exp Ther","1993","1993/07/01","","",""
"8392427","Mode of action of interleukin-1 in suppression of pituitary LH release in castrated male rats","Bonavera JJ, Kalra SP, Kalra PS.","Brain Res. 1993 May 28;612(1-2):1-8. doi: 10.1016/0006-8993(93)91637-8.","Bonavera JJ","Brain Res","1993","1993/05/28","","","10.1016/0006-8993(93)91637-8"
"8392157","Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat","Spanagel R, Shippenberg TS.","Neurosci Lett. 1993 Apr 30;153(2):232-6. doi: 10.1016/0304-3940(93)90329-j.","Spanagel R","Neurosci Lett","1993","1993/04/30","","","10.1016/0304-3940(93)90329-j"
"8391456","Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat","Saphier D, Welch JE, Chuluyan HE.","Eur J Pharmacol. 1993 May 19;236(2):183-91. doi: 10.1016/0014-2999(93)90588-9.","Saphier D","Eur J Pharmacol","1993","1993/05/19","","","10.1016/0014-2999(93)90588-9"
"8391455","Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat","Tiseo PJ, Yaksh TL.","Eur J Pharmacol. 1993 May 12;236(1):89-96. doi: 10.1016/0014-2999(93)90230-f.","Tiseo PJ","Eur J Pharmacol","1993","1993/05/12","","","10.1016/0014-2999(93)90230-f"
"8390240","Endorphins stimulate approach behaviour, but do not reduce subjective fear. A pilot study","Arntz A.","Behav Res Ther. 1993 May;31(4):403-5. doi: 10.1016/0005-7967(93)90097-e.","Arntz A","Behav Res Ther","1993","1993/05/01","","","10.1016/0005-7967(93)90097-e"
"8389996","CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors","Rivest S, Plotsky PM, Rivier C.","Neuroendocrinology. 1993;57(2):236-46. doi: 10.1159/000126365.","Rivest S","Neuroendocrinology","1993","1993/01/01","","","10.1159/000126365"
"8389861","Involvement of delta 2 opioid receptors in acute dependence on morphine in mice","Miyamoto Y, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1993 Jun;265(3):1325-7.","Miyamoto Y","J Pharmacol Exp Ther","1993","1993/06/01","","",""
"8389859","Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats","Negus SS, Henriksen SJ, Mattox A, Pasternak GW, Portoghese PS, Takemori AE, Weinger MB, Koob GF.","J Pharmacol Exp Ther. 1993 Jun;265(3):1245-52.","Negus SS","J Pharmacol Exp Ther","1993","1993/06/01","","",""
"8389648","Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo","Collin E, Frechilla D, Pohl M, Bourgoin S, Le Bars D, Hamon M, Cesselin F.","Brain Res. 1993 Apr 23;609(1-2):211-22. doi: 10.1016/0006-8993(93)90875-n.","Collin E","Brain Res","1993","1993/04/23","","","10.1016/0006-8993(93)90875-n"
"8388977","Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering mu-opioid receptor sensitivity","De Vries TJ, Tjon Tien Ril GH, Van der Laan JW, Mulder AH, Schoffelmeer AN.","Life Sci. 1993;52(21):1685-93. doi: 10.1016/0024-3205(93)90476-j.","De Vries TJ","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90476-j"
"8388852","Role of kappa opioid receptors during stress responsiveness in rats","Ray A, Gulati K, Puri S, Sen P.","Indian J Exp Biol. 1993 Feb;31(2):116-9.","Ray A","Indian J Exp Biol","1993","1993/02/01","","",""
"8388455","Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice","Welch SP.","J Pharmacol Exp Ther. 1993 May;265(2):633-40.","Welch SP","J Pharmacol Exp Ther","1993","1993/05/01","","",""
"8388406","Evidence for an opioid inhibitory effect on T cell proliferation","Manfredi B, Sacerdote P, Bianchi M, Locatelli L, Veljic-Radulovic J, Panerai AE.","J Neuroimmunol. 1993 Apr;44(1):43-8. doi: 10.1016/0165-5728(93)90266-2.","Manfredi B","J Neuroimmunol","1993","1993/04/01","","","10.1016/0165-5728(93)90266-2"
"8388303","L-arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway","Kawabata A, Umeda N, Takagi H.","Br J Pharmacol. 1993 May;109(1):73-9. doi: 10.1111/j.1476-5381.1993.tb13533.x.","Kawabata A","Br J Pharmacol","1993","1993/05/01","PMC2175590","","10.1111/j.1476-5381.1993.tb13533.x"
"8388301","Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors","Morrone LA, Romanelli L, Amico MC, Valeri P.","Br J Pharmacol. 1993 May;109(1):48-52. doi: 10.1111/j.1476-5381.1993.tb13529.x.","Morrone LA","Br J Pharmacol","1993","1993/05/01","PMC2175595","","10.1111/j.1476-5381.1993.tb13529.x"
"8388299","Effects of the kappa-opioid agonist U50,488 on parturition in rats","Douglas AJ, Clarke G, MacMillan SJ, Bull PM, Neumann I, Way SA, Wright DM, McGrory BG, Russell JA.","Br J Pharmacol. 1993 May;109(1):251-8. doi: 10.1111/j.1476-5381.1993.tb13561.x.","Douglas AJ","Br J Pharmacol","1993","1993/05/01","PMC2175571","","10.1111/j.1476-5381.1993.tb13561.x"
"8388215","The design of delta-selective opioid receptor antagonists","Portoghese PS.","Farmaco. 1993 Feb;48(2):243-51.","Portoghese PS","Farmaco","1993","1993/02/01","","",""
"8387662","Narcotic receptor blockade and its effect on the analgesic response to placebo and ibuprofen after oral surgery","Hersh EV, Ochs H, Quinn P, MacAfee K, Cooper SA, Barasch A.","Oral Surg Oral Med Oral Pathol. 1993 May;75(5):539-46. doi: 10.1016/0030-4220(93)90219-t.","Hersh EV","Oral Surg Oral Med Oral Pathol","1993","1993/05/01","","","10.1016/0030-4220(93)90219-t"
"8387138","Spinal delta 2 but not delta 1 opioid receptors are involved in intracerebroventricular beta-endorphin-induced antinociception in the mouse","Tseng LF, Collins KA, Portoghese PS.","Life Sci. 1993;52(19):PL211-5. doi: 10.1016/0024-3205(93)90062-8.","Tseng LF","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90062-8"
"8387056","Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex","De Sarro G, Trimarchi GR, Sinopoli S, Masuda Y, De Sarro A.","Gen Pharmacol. 1993 Mar;24(2):439-47. doi: 10.1016/0306-3623(93)90330-z.","De Sarro G","Gen Pharmacol","1993","1993/03/01","","","10.1016/0306-3623(93)90330-z"
"8386234","Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains","Pick CG, Nejat RJ, Pasternak GW.","J Pharmacol Exp Ther. 1993 Apr;265(1):166-71.","Pick CG","J Pharmacol Exp Ther","1993","1993/04/01","","",""
"8386091","Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice","Kamei J, Iwamoto Y, Suzuki T, Nagase H, Misawa M, Kasuya Y.","Eur J Pharmacol. 1993 Mar 30;234(1):117-20. doi: 10.1016/0014-2999(93)90714-s.","Kamei J","Eur J Pharmacol","1993","1993/03/30","","","10.1016/0014-2999(93)90714-s"
"8385747","The actions of the kappa 1 opioid agonist U-50,488 on presynaptic nerve terminals of the chick ciliary ganglion","Fletcher GH, Chiappinelli VA.","Neuroscience. 1993 Mar;53(1):239-50. doi: 10.1016/0306-4522(93)90302-v.","Fletcher GH","Neuroscience","1993","1993/03/01","","","10.1016/0306-4522(93)90302-v"
"8384567","Thermodynamic parameters for [D-Pen2,5]enkephalin at delta-opioid receptors in the mouse isolated vas deferens","Raffa RB, Wild KD, Mosberg HI, Porreca F.","Eur J Pharmacol. 1993 Feb 15;244(3):231-8. doi: 10.1016/0922-4106(93)90148-3.","Raffa RB","Eur J Pharmacol","1993","1993/02/15","","","10.1016/0922-4106(93)90148-3"
"8384517","Effects of opiates on neuronal development in the rat cerebral cortex","Seatriz JV, Hammer RP Jr.","Brain Res Bull. 1993;30(5-6):523-7. doi: 10.1016/0361-9230(93)90078-p.","Seatriz JV","Brain Res Bull","1993","1993/01/01","","","10.1016/0361-9230(93)90078-p"
"8384509","[3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors","Contreras PC, Tam L, Drower E, Rafferty MF.","Brain Res. 1993 Feb 26;604(1-2):160-4. doi: 10.1016/0006-8993(93)90363-r.","Contreras PC","Brain Res","1993","1993/02/26","","","10.1016/0006-8993(93)90363-r"
"8384252","kappa-Opioid agonist modulation of [3H]thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnover","Barg J, Belcheva MM, Rowiński J, Coscia CJ.","J Neurochem. 1993 Apr;60(4):1505-11. doi: 10.1111/j.1471-4159.1993.tb03314.x.","Barg J","J Neurochem","1993","1993/04/01","PMC2586989","NIHMS73193","10.1111/j.1471-4159.1993.tb03314.x"
"8383858","Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats","Koch JE, Bodnar RJ.","Physiol Behav. 1993 Mar;53(3):603-5. doi: 10.1016/0031-9384(93)90160-h.","Koch JE","Physiol Behav","1993","1993/03/01","","","10.1016/0031-9384(93)90160-h"
"8383850","Opioid antagonists and butorphanol dependence","Jaw SP, Hoskins B, Ho IK.","Pharmacol Biochem Behav. 1993 Mar;44(3):497-500. doi: 10.1016/0091-3057(93)90158-p.","Jaw SP","Pharmacol Biochem Behav","1993","1993/03/01","","","10.1016/0091-3057(93)90158-p"
"8383804","Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells","Carter BD, Medzihradsky F.","Mol Pharmacol. 1993 Mar;43(3):465-73.","Carter BD","Mol Pharmacol","1993","1993/03/01","","",""
"8383738","Involvement of delta 2 opioid receptors in the development of morphine dependence in mice","Miyamoto Y, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1993 Mar;264(3):1141-5.","Miyamoto Y","J Pharmacol Exp Ther","1993","1993/03/01","","",""
"8383568","Quantitative light microscopic localization of [3H]naltrindole binding sites in the rat brain","Drower EJ, Dorn CR, Markos CS, Unnerstall JR, Rafferty MF, Contreras PC.","Brain Res. 1993 Jan 29;602(1):138-42. doi: 10.1016/0006-8993(93)90253-j.","Drower EJ","Brain Res","1993","1993/01/29","","","10.1016/0006-8993(93)90253-j"
"8383499","Dissociation of interference with the speed and accuracy of escape produced by inescapable shock","Maier SF, Minor TR.","Behav Neurosci. 1993 Feb;107(1):139-46. doi: 10.1037//0735-7044.107.1.139.","Maier SF","Behav Neurosci","1993","1993/02/01","","","10.1037//0735-7044.107.1.139"
"8383271","7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord","Sofuoglu M, Portoghese PS, Takemori AE.","Life Sci. 1993;52(8):769-75. doi: 10.1016/0024-3205(93)90240-4.","Sofuoglu M","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90240-4"
"8383266","Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice","Miyamoto Y, Takemori AE.","Life Sci. 1993;52(12):1039-44. doi: 10.1016/0024-3205(93)90196-a.","Miyamoto Y","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90196-a"
"8383062","Cocaine-like discriminative stimulus properties of the delta-selective opioid receptor agonist, [D-Pen2,L-Pen5]enkephalin, in the rat","Ukai M, Mori E, Kameyama T.","Eur J Pharmacol. 1993 Jan 26;231(1):143-4. doi: 10.1016/0014-2999(93)90696-f.","Ukai M","Eur J Pharmacol","1993","1993/01/26","","","10.1016/0014-2999(93)90696-f"
"8382637","Effects of dopamine and kappa opioid receptors on fetal responsiveness to perioral stimuli","Robinson SR, Moody CA, Spear LP, Smotherman WP.","Dev Psychobiol. 1993 Jan;26(1):37-50. doi: 10.1002/dev.420260104.","Robinson SR","Dev Psychobiol","1993","1993/01/01","","","10.1002/dev.420260104"
"8382386","Immunosuppression by delta opioid receptor antagonist","Arakawa K, Akami T, Okamoto M, Akioka K, Nakai I, Oka T, Nagase H.","Transplant Proc. 1993 Feb;25(1 Pt 1):738-40.","Arakawa K","Transplant Proc","1993","1993/02/01","","",""
"8382329","Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation","Reid LD, Hubbell CL, Glaccum MB, Bilsky EJ, Portoghese PS, Porreca F.","Life Sci. 1993;52(9):PL67-71. doi: 10.1016/0024-3205(93)90084-g.","Reid LD","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90084-g"
"8382281","Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens","Wild KD, Carlisi VJ, Mosberg HI, Bowen WD, Portoghese PS, Sultana M, Takemori AE, Hruby VJ, Porreca F.","J Pharmacol Exp Ther. 1993 Feb;264(2):831-8.","Wild KD","J Pharmacol Exp Ther","1993","1993/02/01","","",""
"8382278","The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats","Dosaka-Akita K, Tortella FC, Holaday JW, Long JB.","J Pharmacol Exp Ther. 1993 Feb;264(2):631-7. doi: 10.21236/ada263043.","Dosaka-Akita K","J Pharmacol Exp Ther","1993","1993/02/01","","","10.21236/ada263043"
"8381698","17-Beta-estradiol and progesterone modulate an intrinsic opioid analgesic system","Dawson-Basoa MB, Gintzler AR.","Brain Res. 1993 Jan 22;601(1-2):241-5. doi: 10.1016/0006-8993(93)91716-6.","Dawson-Basoa MB","Brain Res","1993","1993/01/22","","","10.1016/0006-8993(93)91716-6"
"8381696","Electrophysiological actions of delta opioids in CA1 of the rat hippocampal slice are mediated by one delta receptor subtype","Watson GB, Lanthorn TH.","Brain Res. 1993 Jan 22;601(1-2):129-35. doi: 10.1016/0006-8993(93)91703-u.","Watson GB","Brain Res","1993","1993/01/22","","","10.1016/0006-8993(93)91703-u"
"8381547","Opioid agonist properties of two oxime derivatives of naltrexone, NPC 831 and NPC 836","DeHaven-Hudkins DL, Komer KM, Peterson JA, Mavunkel BJ, Rzeszotarski WJ.","Pharmacol Biochem Behav. 1993 Jan;44(1):45-50. doi: 10.1016/0091-3057(93)90279-3.","DeHaven-Hudkins DL","Pharmacol Biochem Behav","1993","1993/01/01","","","10.1016/0091-3057(93)90279-3"
"8381356","Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I","Cheng PY, Wu D, Decena J, Soong Y, McCabe S, Szeto HH.","Eur J Pharmacol. 1993 Jan 5;230(1):85-8. doi: 10.1016/0014-2999(93)90413-c.","Cheng PY","Eur J Pharmacol","1993","1993/01/05","","","10.1016/0014-2999(93)90413-c"
"8381004","Relationship between kappa 1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes","Konkoy CS, Childers SR.","Biochem Pharmacol. 1993 Jan 7;45(1):207-16. doi: 10.1016/0006-2952(93)90394-c.","Konkoy CS","Biochem Pharmacol","1993","1993/01/07","","","10.1016/0006-2952(93)90394-c"
"8380771","Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release","Acquas E, Meloni M, Di Chiara G.","Eur J Pharmacol. 1993 Jan 12;230(2):239-41. doi: 10.1016/0014-2999(93)90809-v.","Acquas E","Eur J Pharmacol","1993","1993/01/12","","","10.1016/0014-2999(93)90809-v"
"8380614","A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic kappa address element to the delta antagonist, natrindole: 5'-[N2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists","Olmsted SL, Takemori AE, Portoghese PS.","J Med Chem. 1993 Jan 8;36(1):179-80. doi: 10.1021/jm00053a025.","Olmsted SL","J Med Chem","1993","1993/01/08","","","10.1021/jm00053a025"
"8380178","Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography","Carson RE, Channing MA, Blasberg RG, Dunn BB, Cohen RM, Rice KC, Herscovitch P.","J Cereb Blood Flow Metab. 1993 Jan;13(1):24-42. doi: 10.1038/jcbfm.1993.6.","Carson RE","J Cereb Blood Flow Metab","1993","1993/01/01","","","10.1038/jcbfm.1993.6"
"8374794","Effect of diabetes on the antinociceptive effect of beta-endorphin","Kamei J, Kawashima N, Hitosugi H, Misawa M, Nagase H, Kasuya Y.","Brain Res. 1993 Aug 13;619(1-2):76-80. doi: 10.1016/0006-8993(93)91597-l.","Kamei J","Brain Res","1993","1993/08/13","","","10.1016/0006-8993(93)91597-l"
"8374774","Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice","Funada M, Suzuki T, Narita M, Misawa M, Nagase H.","Brain Res. 1993 Aug 13;619(1-2):163-72. doi: 10.1016/0006-8993(93)91608-u.","Funada M","Brain Res","1993","1993/08/13","","","10.1016/0006-8993(93)91608-u"
"8371146","The role of endogenous opioids as mediators of the hypothermic effects of intrathecally administered calcium and calcitonin gene-related peptide in mice","Smith FL, Welch SP, Dombrowski DS, Dewey WL.","J Pharmacol Exp Ther. 1993 Sep;266(3):1407-15.","Smith FL","J Pharmacol Exp Ther","1993","1993/09/01","","",""
"8371142","Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys","Negus SS, Butelman ER, Al Y, Woods JH.","J Pharmacol Exp Ther. 1993 Sep;266(3):1355-63.","Negus SS","J Pharmacol Exp Ther","1993","1993/09/01","","",""
"8368401","Central interferon-alpha inhibits natural killer cytotoxicity through sympathetic innervation","Take S, Mori T, Katafuchi T, Hori T.","Am J Physiol. 1993 Aug;265(2 Pt 2):R453-9. doi: 10.1152/ajpregu.1993.265.2.R453.","Take S","Am J Physiol","1993","1993/08/01","","","10.1152/ajpregu.1993.265.2.R453"
"8361330","Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages","Rojavin M, Szabo I, Bussiere JL, Rogers TJ, Adler MW, Eisenstein TK.","Life Sci. 1993;53(12):997-1006. doi: 10.1016/0024-3205(93)90122-j.","Rojavin M","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90122-j"
"8360887","Synthesis and kappa-opioid antagonist selectivity of a norbinaltorphimine congener. Identification of the address moiety required for kappa-antagonist activity","Lin CE, Takemori AE, Portoghese PS.","J Med Chem. 1993 Aug 6;36(16):2412-5. doi: 10.1021/jm00068a020.","Lin CE","J Med Chem","1993","1993/08/06","","","10.1021/jm00068a020"
"8355569","Naltrexone treatment attenuates the inhibitory effect of nicotine treatment on serum LH in rats","Hodson CA, Davenport A, Price G, Burden HW.","Life Sci. 1993;53(10):839-46. doi: 10.1016/0024-3205(93)90506-x.","Hodson CA","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90506-x"
"8352362","Treatment of flashbacks with naltrexone","Bills LJ, Kreisler K.","Am J Psychiatry. 1993 Sep;150(9):1430. doi: 10.1176/ajp.150.9.1430a.","Bills LJ","Am J Psychiatry","1993","1993/09/01","","","10.1176/ajp.150.9.1430a"
"8340312","Naltrexone and fluoxetine in Prader-Willi syndrome","Benjamin E, Buot-Smith T.","J Am Acad Child Adolesc Psychiatry. 1993 Jul;32(4):870-3. doi: 10.1097/00004583-199307000-00025.","Benjamin E","J Am Acad Child Adolesc Psychiatry","1993","1993/07/01","","","10.1097/00004583-199307000-00025"
"8336863","Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease","Fulghesu AM, Lanzone A, Cucinelli F, Caruso A, Mancuso S.","Obstet Gynecol. 1993 Aug;82(2):191-7.","Fulghesu AM","Obstet Gynecol","1993","1993/08/01","","",""
"8310788","Opioid receptors-mediated respiratory effects and antinociception after S(+)-ketamine","Latasch L, Freye E.","Acta Anaesthesiol Belg. 1993;44(3):93-102.","Latasch L","Acta Anaesthesiol Belg","1993","1993/01/01","","",""
"8309961","Opioid modulation of amphetamine-stimulated dopamine release and concentration in rat striatal slices","Kolta MG, Bardo MT.","Pharmacol Biochem Behav. 1993 Dec;46(4):819-25. doi: 10.1016/0091-3057(93)90207-a.","Kolta MG","Pharmacol Biochem Behav","1993","1993/12/01","","","10.1016/0091-3057(93)90207-a"
"8309960","Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimine","Paronis CA, Waddell AB, Holtzman SG.","Pharmacol Biochem Behav. 1993 Dec;46(4):813-7. doi: 10.1016/0091-3057(93)90206-9.","Paronis CA","Pharmacol Biochem Behav","1993","1993/12/01","","","10.1016/0091-3057(93)90206-9"
"8309954","Sex differences in the antinociceptive effects of the enkephalinase inhibitor, SCH 34826","Kavaliers M, Innes DG.","Pharmacol Biochem Behav. 1993 Dec;46(4):777-80. doi: 10.1016/0091-3057(93)90200-d.","Kavaliers M","Pharmacol Biochem Behav","1993","1993/12/01","","","10.1016/0091-3057(93)90200-d"
"8309345","Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain","Búzás B, Izenwasser S, Portoghese PS, Cox BM.","Life Sci. 1994;54(7):PL101-6. doi: 10.1016/0024-3205(94)00412-9.","Búzás B","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00412-9"
"8301596","Delta-1 opioid receptor dependence of acute hypoxic adaptation","Mayfield KP, D'Alecy LG.","J Pharmacol Exp Ther. 1994 Jan;268(1):74-7.","Mayfield KP","J Pharmacol Exp Ther","1994","1994/01/01","","",""
"8301589","Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities","France CP, Medzihradsky F, Woods JH.","J Pharmacol Exp Ther. 1994 Jan;268(1):47-58.","France CP","J Pharmacol Exp Ther","1994","1994/01/01","","",""
"8300813","The effect of nalmefene on pulsatile secretion of luteinizing hormone and prolactin in men","Graves GR, Kennedy TG, Weick RF, Casper RF.","Hum Reprod. 1993 Oct;8(10):1598-603. doi: 10.1093/oxfordjournals.humrep.a137898.","Graves GR","Hum Reprod","1993","1993/10/01","","","10.1093/oxfordjournals.humrep.a137898"
"8300189","A monoclonal anti-idiotypic antibody to opioid receptors labels desipramine-induced opioid binding sites on rat C6 glioma cells and attenuates thymidine incorporation into DNA","Barg J, Belcheva MM, Levy R, McHale RJ, McLachlan JA, Johnson FE, Coscia CJ, Vogel Z.","Glia. 1994 Jan;10(1):10-5. doi: 10.1002/glia.440100103.","Barg J","Glia","1994","1994/01/01","","","10.1002/glia.440100103"
"8295712","DAMGO ([D-Ala2,NMePhe4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L- Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouse","Ukai M, Toyoshi T, Kameyama T.","Neuropharmacology. 1993 Oct;32(10):1019-24. doi: 10.1016/0028-3908(93)90067-d.","Ukai M","Neuropharmacology","1993","1993/10/01","","","10.1016/0028-3908(93)90067-d"
"8294223","Treatment of idiopathic erectile dysfunction in men with the opiate antagonist naltrexone--a double-blind study","Brennemann W, Stitz B, Van Ahlen H, Brensing KA, Klingmüller D.","J Androl. 1993 Nov-Dec;14(6):407-10.","Brennemann W","J Androl","1993","1993/11/01","","",""
"8292252","Arousal following intra-preoptic area administration of naltrexone, ICI 174864 or nor-BNI in hibernating ground squirrels","Yu LC, Cai YP.","Behav Brain Res. 1993 Oct 21;57(1):31-5. doi: 10.1016/0166-4328(93)90058-x.","Yu LC","Behav Brain Res","1993","1993/10/21","","","10.1016/0166-4328(93)90058-x"
"8290669","Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children","Ernst M, Devi L, Silva RR, Gonzalez NM, Small AM, Malone RP, Campbell M.","Psychopharmacol Bull. 1993;29(2):221-7.","Ernst M","Psychopharmacol Bull","1993","1993/01/01","","",""
"8289586","Blood luteinizing hormone and prolactin concentrations in response to naltrexone challenge: studies on rats with diabetes induced by different doses of streptozotocin","Yogev L, Yavetz H, Gottreich A, Oppenheim D, Homonnai ZT, Paz G.","Life Sci. 1994;54(4):261-6. doi: 10.1016/0024-3205(94)00815-9.","Yogev L","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00815-9"
"8287898","Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine","Jones DN, Bowen WD, Portoghese PS, Holtzman SG.","Eur J Pharmacol. 1993 Nov 9;249(2):167-77. doi: 10.1016/0014-2999(93)90429-l.","Jones DN","Eur J Pharmacol","1993","1993/11/09","","","10.1016/0014-2999(93)90429-l"
"8287897","Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats","Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y.","Eur J Pharmacol. 1993 Nov 9;249(2):161-5. doi: 10.1016/0014-2999(93)90428-k.","Kamei J","Eur J Pharmacol","1993","1993/11/09","","","10.1016/0014-2999(93)90428-k"
"8287195","Neurophysiological evidence for increased kappa opioidergic control of spinal cord neurons in rats with unilateral inflammation at the ankle","Stiller RU, Grubb BD, Schaible HG.","Eur J Neurosci. 1993 Nov 1;5(11):1520-7. doi: 10.1111/j.1460-9568.1993.tb00220.x.","Stiller RU","Eur J Neurosci","1993","1993/11/01","","","10.1111/j.1460-9568.1993.tb00220.x"
"8284832","Nalmefene in the treatment of interstitial cystitis","Stone NN.","Urol Clin North Am. 1994 Feb;21(1):101-6.","Stone NN","Urol Clin North Am","1994","1994/02/01","","",""
"8282676","Naltrexone in autistic children: behavioral symptoms and attentional learning","Campbell M, Anderson LT, Small AM, Adams P, Gonzalez NM, Ernst M.","J Am Acad Child Adolesc Psychiatry. 1993 Nov;32(6):1283-91. doi: 10.1097/00004583-199311000-00024.","Campbell M","J Am Acad Child Adolesc Psychiatry","1993","1993/11/01","","","10.1097/00004583-199311000-00024"
"8282012","delta-Opioid receptor-mediated regulation of central dopaminergic neurons in the rat","Manzanares J, Durham RA, Lookingland KJ, Moore KE.","Eur J Pharmacol. 1993 Nov 2;249(1):107-12. doi: 10.1016/0014-2999(93)90668-8.","Manzanares J","Eur J Pharmacol","1993","1993/11/02","","","10.1016/0014-2999(93)90668-8"
"8280394","Ultrasonic vocalizations are elicited from rat pups in the home cage by pentylenetetrazol and U50,488, but not naltrexone","Carden SE, Bortot AT, Hofer MA.","Behav Neurosci. 1993 Oct;107(5):851-9. doi: 10.1037//0735-7044.107.5.851.","Carden SE","Behav Neurosci","1993","1993/10/01","","","10.1037//0735-7044.107.5.851"
"8280345","Naltrexone-buprenorphine interactions: effects on cocaine self-administration","Mello NK, Lukas SE, Mendelson JH, Drieze J.","Neuropsychopharmacology. 1993 Nov;9(3):211-24. doi: 10.1038/npp.1993.57.","Mello NK","Neuropsychopharmacology","1993","1993/11/01","","","10.1038/npp.1993.57"
"8278442","Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants","Shaw WN.","Pharmacol Biochem Behav. 1993 Nov;46(3):653-9. doi: 10.1016/0091-3057(93)90557-a.","Shaw WN","Pharmacol Biochem Behav","1993","1993/11/01","","","10.1016/0091-3057(93)90557-a"
"8276957","Pulsatile administration of gonadotrophin releasing hormone and oral administration of naltrexone in hypothalamic amenorrhoea","Leyendecker G, Waibel-Treber S, Wildt L.","Hum Reprod. 1993 Nov;8 Suppl 2:184-8. doi: 10.1093/humrep/8.suppl_2.184.","Leyendecker G","Hum Reprod","1993","1993/11/01","","","10.1093/humrep/8.suppl_2.184"
"8276953","Opiate antagonist treatment of ovarian failure","Wildt L, Sir-Petermann T, Leyendecker G, Waibel-Treber S, Rabenbauer B.","Hum Reprod. 1993 Nov;8 Suppl 2:168-74. doi: 10.1093/humrep/8.suppl_2.168.","Wildt L","Hum Reprod","1993","1993/11/01","","","10.1093/humrep/8.suppl_2.168"
"8276060","Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole","Heidbreder C, Goldberg SR, Shippenberg TS.","Eur J Pharmacol. 1993 Oct 19;243(2):123-7. doi: 10.1016/0014-2999(93)90370-w.","Heidbreder C","Eur J Pharmacol","1993","1993/10/19","","","10.1016/0014-2999(93)90370-w"
"8275903","[Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone]","Leboyer M, Bouvard MP, Launay JM, Recasens C, Plumet MH, Waller-Perotte D, Tabuteau F, Bondoux D, Dugas M.","Encephale. 1993 Mar-Apr;19(2):95-102.","Leboyer M","Encephale","1993","1993/03/01","","",""
"8275346","Opioid antagonist-induced receptor upregulation: effects of concurrent agonist administration","Yoburn BC, Duttaroy A, Shah S, Davis T.","Brain Res Bull. 1994;33(2):237-40. doi: 10.1016/0361-9230(94)90259-3.","Yoburn BC","Brain Res Bull","1994","1994/01/01","","","10.1016/0361-9230(94)90259-3"
"8275060","A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa","Mitchell JE, Raymond N, Specker S.","Int J Eat Disord. 1993 Nov;14(3):229-47. doi: 10.1002/1098-108x(199311)14:3<229::aid-eat2260140302>3.0.co;2-x.","Mitchell JE","Int J Eat Disord","1993","1993/11/01","","","10.1002/1098-108x(199311)14:3<229::aid-eat2260140302>3.0.co;2-x"
"8267120","Buprenorphine for benzodiazepine-abusing heroin addicts","KOSTEN TR.","Am J Psychiatry. 1994 Jan;151(1):151. doi: 10.1176/ajp.151.1.151a.","KOSTEN TR","Am J Psychiatry","1994","1994/01/01","","","10.1176/ajp.151.1.151a"
"8265703","Opioidergic manipulations affect intake of 3% NaCl in sodium-deficient rats","Hubbell CL, McCutcheon NB.","Pharmacol Biochem Behav. 1993 Oct;46(2):473-6. doi: 10.1016/0091-3057(93)90382-4.","Hubbell CL","Pharmacol Biochem Behav","1993","1993/10/01","","","10.1016/0091-3057(93)90382-4"
"8263790","Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys","Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH.","J Pharmacol Exp Ther. 1993 Dec;267(3):1269-76.","Butelman ER","J Pharmacol Exp Ther","1993","1993/12/01","","",""
"8258763","Haight-Ashbury free clinics' drug detoxification protocols--Part 2: Opioid blockade","Galloway G, Hayner G.","J Psychoactive Drugs. 1993 Jul-Sep;25(3):251-2. doi: 10.1080/02791072.1993.10472276.","Galloway G","J Psychoactive Drugs","1993","1993/07/01","","","10.1080/02791072.1993.10472276"
"8257409","Effects of endorphin blocking on conditioned SCR in humans","Merckelbach H, Arntz A, de Jong P, Schouten E.","Behav Res Ther. 1993 Nov;31(8):775-9. doi: 10.1016/0005-7967(93)90008-i.","Merckelbach H","Behav Res Ther","1993","1993/11/01","","","10.1016/0005-7967(93)90008-i"
"8255904","Naloxone-induced analgesia: involvement of kappa-opiate receptors","Bianchi M, Panerai AE.","Pharmacol Biochem Behav. 1993 Sep;46(1):145-8. doi: 10.1016/0091-3057(93)90331-m.","Bianchi M","Pharmacol Biochem Behav","1993","1993/09/01","","","10.1016/0091-3057(93)90331-m"
"8253111","Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively","Takemori AE, Portoghese PS.","Eur J Pharmacol. 1993 Sep 28;242(2):145-50. doi: 10.1016/0014-2999(93)90074-r.","Takemori AE","Eur J Pharmacol","1993","1993/09/28","","","10.1016/0014-2999(93)90074-r"
"8252387","Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats","Kiefel JM, Rossi GC, Bodnar RJ.","Brain Res. 1993 Oct 8;624(1-2):151-61. doi: 10.1016/0006-8993(93)90073-v.","Kiefel JM","Brain Res","1993","1993/10/08","","","10.1016/0006-8993(93)90073-v"
"8247256","Binding in vivo of selective mu and delta opioid agonists: localization by autoradiography","Mokhtari M, Tafani JA, Zajac JM.","Neuropeptides. 1993 Sep;25(3):183-91. doi: 10.1016/0143-4179(93)90101-f.","Mokhtari M","Neuropeptides","1993","1993/09/01","","","10.1016/0143-4179(93)90101-f"
"8246672","Differential antagonism by naltrindole-5'-isothiocyanate on [3H]DSLET and [3H]DPDPE binding to striatal slices of mice","Chakrabarti S, Sultana M, Portoghese PS, Takemori AE.","Life Sci. 1993;53(23):1761-5. doi: 10.1016/0024-3205(93)90163-w.","Chakrabarti S","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90163-w"
"8246236","Possible contribution of a glutathione conjugate to the long-duration action of beta-funaltrexamine","Larson DL, Hua M, Takemori AE, Portoghese PS.","J Med Chem. 1993 Nov 12;36(23):3669-73. doi: 10.1021/jm00075a023.","Larson DL","J Med Chem","1993","1993/11/12","","","10.1021/jm00075a023"
"8246164","Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice","Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH.","J Pharmacol Exp Ther. 1993 Nov;267(2):888-95.","Comer SD","J Pharmacol Exp Ther","1993","1993/11/01","","",""
"8246162","A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration","Dykstra LA, Schoenbaum GM, Yarbrough J, McNutt R, Chang KJ.","J Pharmacol Exp Ther. 1993 Nov;267(2):875-82.","Dykstra LA","J Pharmacol Exp Ther","1993","1993/11/01","","",""
"8246161","Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors","Comer SD, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH.","J Pharmacol Exp Ther. 1993 Nov;267(2):866-74.","Comer SD","J Pharmacol Exp Ther","1993","1993/11/01","","",""
"8237607","Morphine-induced modulation of immune status: evidence for opioid receptor mediation and compartment specificity","Lysle DT, Coussons ME, Watts VJ, Bennett EH, Dykstra LA.","Adv Exp Med Biol. 1993;335:53-9. doi: 10.1007/978-1-4615-2980-4_8.","Lysle DT","Adv Exp Med Biol","1993","1993/01/01","","","10.1007/978-1-4615-2980-4_8"
"8236504","Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapy","Lissoni P, Meregalli S, Fossati V, Barni S, Tancini G, Barigozzi P, Frigerio F.","Tumori. 1993 Jun 30;79(3):198-201.","Lissoni P","Tumori","1993","1993/06/30","","",""
"8234900","Effects of the enkephalin analog (D-Met2,Pro5)-enkephalinamide on alpha-melanocyte-stimulating hormone secretion","Carr JA, Saland LC, Samora A, Tejeda D.","Regul Pept. 1993 Sep 3;47(2):141-50. doi: 10.1016/0167-0115(93)90418-8.","Carr JA","Regul Pept","1993","1993/09/03","","","10.1016/0167-0115(93)90418-8"
"8234022","Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis","Saksida LM, Galea LA, Kavaliers M.","Peptides. 1993 Jul-Aug;14(4):763-5. doi: 10.1016/0196-9781(93)90110-3.","Saksida LM","Peptides","1993","1993/07/01","","","10.1016/0196-9781(93)90110-3"
"8232225","Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides","Liu-Chen LY, Chen C, Phillips CA.","Mol Pharmacol. 1993 Oct;44(4):749-56.","Liu-Chen LY","Mol Pharmacol","1993","1993/10/01","","",""
"8229781","Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections","Martin TJ, Dworkin SI, Smith JE.","J Pharmacol Exp Ther. 1993 Oct;267(1):506-14.","Martin TJ","J Pharmacol Exp Ther","1993","1993/10/01","","",""
"8229762","Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets","Levier DG, Brown RD, McCay JA, Fuchs BA, Harris LS, Munson AE.","J Pharmacol Exp Ther. 1993 Oct;267(1):357-63.","Levier DG","J Pharmacol Exp Ther","1993","1993/10/01","","",""
"8229759","Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine","Walker EA, Young AM.","J Pharmacol Exp Ther. 1993 Oct;267(1):322-30.","Walker EA","J Pharmacol Exp Ther","1993","1993/10/01","","",""
"8229750","Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase","Côté TE, Izenwasser S, Weems HB.","J Pharmacol Exp Ther. 1993 Oct;267(1):238-44.","Côté TE","J Pharmacol Exp Ther","1993","1993/10/01","","",""
"8229746","Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves","Kapusta DR, Obih JC.","J Pharmacol Exp Ther. 1993 Oct;267(1):197-204.","Kapusta DR","J Pharmacol Exp Ther","1993","1993/10/01","","",""
"8228982","Interacting presynaptic kappa-opioid and GABAA receptors modulate dopamine release from rat striatal synaptosomes","Ronken E, Mulder AH, Schoffelmeer AN.","J Neurochem. 1993 Nov;61(5):1634-9. doi: 10.1111/j.1471-4159.1993.tb09797.x.","Ronken E","J Neurochem","1993","1993/11/01","","","10.1111/j.1471-4159.1993.tb09797.x"
"8228955","Naltrexone abuse and risk of suicide","Lerner AG, Sigal M, Gelkopf M.","J Nerv Ment Dis. 1993 Nov;181(11):706-7. doi: 10.1097/00005053-199311000-00012.","Lerner AG","J Nerv Ment Dis","1993","1993/11/01","","","10.1097/00005053-199311000-00012"
"8226493","Cholinergic and opioid involvement in release of growth hormone during exercise and recovery","Thompson DL, Weltman JY, Rogol AD, Metzger DL, Veldhuis JD, Weltman A.","J Appl Physiol (1985). 1993 Aug;75(2):870-8. doi: 10.1152/jappl.1993.75.2.870.","Thompson DL","J Appl Physiol (1985)","1993","1993/08/01","","","10.1152/jappl.1993.75.2.870"
"8225078","[Prevention of heroin reabuse--value of naltrexone]","Porat S, Shufman EN, Witztum E.","Harefuah. 1993 Aug;125(3-4):115-9.","Porat S","Harefuah","1993","1993/08/01","","",""
"8224200","Delta opioid receptor mediates phospholipase C activation via Gi in Xenopus oocytes","Miyamae T, Fukushima N, Misu Y, Ueda H.","FEBS Lett. 1993 Nov 1;333(3):311-4. doi: 10.1016/0014-5793(93)80677-m.","Miyamae T","FEBS Lett","1993","1993/11/01","","","10.1016/0014-5793(93)80677-m"
"8223952","Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodium","Wild KD, Fang L, McNutt RW, Chang KJ, Toth G, Borsodi A, Yamamura HI, Porreca F.","Eur J Pharmacol. 1993 Aug 15;246(3):289-92. doi: 10.1016/0922-4106(93)90044-a.","Wild KD","Eur J Pharmacol","1993","1993/08/15","","","10.1016/0922-4106(93)90044-a"
"8223936","Antinociceptive activity of intrathecal ketorolac is blocked by the kappa-opioid receptor antagonist, nor-binaltorphimine","Uphouse LA, Welch SP, Ward CR, Ellis EF, Embrey JP.","Eur J Pharmacol. 1993 Sep 21;242(1):53-8. doi: 10.1016/0014-2999(93)90009-7.","Uphouse LA","Eur J Pharmacol","1993","1993/09/21","","","10.1016/0014-2999(93)90009-7"
"8223892","Restraint stress potentiates analgesia induced by 5'-N-ethylcarboxamidoadenosine: comparison with morphine","Woolfolk DR, Holtzman SG.","Eur J Pharmacol. 1993 Aug 3;239(1-3):177-82. doi: 10.1016/0014-2999(93)90991-p.","Woolfolk DR","Eur J Pharmacol","1993","1993/08/03","","","10.1016/0014-2999(93)90991-p"
"8223888","Effects of nor-binaltorphimine on butorphanol dependence","Jaw SP, Makimura M, Hoskins B, Ho IK.","Eur J Pharmacol. 1993 Aug 3;239(1-3):133-40. doi: 10.1016/0014-2999(93)90986-r.","Jaw SP","Eur J Pharmacol","1993","1993/08/03","","","10.1016/0014-2999(93)90986-r"
"8221115","Multiple opioid system involvement in the mediation of parasitic-infection induced analgesia","Kavaliers M, Colwell DD.","Brain Res. 1993 Oct 1;623(2):316-20. doi: 10.1016/0006-8993(93)91445-x.","Kavaliers M","Brain Res","1993","1993/10/01","","","10.1016/0006-8993(93)91445-x"
"8221101","Differential effects of specific delta and kappa opioid receptor antagonists on the bidirectional dose-dependent effect of systemic naloxone in arthritic rats, an experimental model of persistent pain","Cattaneo I, Kayser V, Guilbaud G.","Brain Res. 1993 Oct 1;623(2):201-7. doi: 10.1016/0006-8993(93)91428-u.","Cattaneo I","Brain Res","1993","1993/10/01","","","10.1016/0006-8993(93)91428-u"
"8220323","Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice","Tokuyama S, Takahashi M, Kaneto H.","Biol Pharm Bull. 1993 Aug;16(8):774-7. doi: 10.1248/bpb.16.774.","Tokuyama S","Biol Pharm Bull","1993","1993/08/01","","","10.1248/bpb.16.774"
"8214728","Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes","Wittels B, Glosten B, Faure EA, Moawad AH, Ismail M, Hibbard J, Amundsen L, Binstock W, Senal JA, Cox SM, et al.","Anesth Analg. 1993 Nov;77(5):925-32. doi: 10.1213/00000539-199311000-00009.","Wittels B","Anesth Analg","1993","1993/11/01","","","10.1213/00000539-199311000-00009"
"8210609","Cessation of long-term naltrexone therapy and self-injury: a case study","Crews WD Jr, Bonaventura S, Rowe FB, Bonsie D.","Res Dev Disabil. 1993 Jul-Aug;14(4):331-40. doi: 10.1016/0891-4222(93)90026-g.","Crews WD Jr","Res Dev Disabil","1993","1993/07/01","","","10.1016/0891-4222(93)90026-g"
"8208774","Acute sensitization to opioid antagonists","White-Gbadebo D, Holtzman SG.","Pharmacol Biochem Behav. 1994 Mar;47(3):559-66. doi: 10.1016/0091-3057(94)90159-7.","White-Gbadebo D","Pharmacol Biochem Behav","1994","1994/03/01","","","10.1016/0091-3057(94)90159-7"
"8208759","Amphetamine-induced modification of quinine palatability: analysis by the taste reactivity test","Parker L, Leeb K.","Pharmacol Biochem Behav. 1994 Mar;47(3):413-20. doi: 10.1016/0091-3057(94)90137-6.","Parker L","Pharmacol Biochem Behav","1994","1994/03/01","","","10.1016/0091-3057(94)90137-6"
"8206107","Antinociceptive effect of L-arginine in diabetic mice","Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.","Eur J Pharmacol. 1994 Mar 11;254(1-2):113-7. doi: 10.1016/0014-2999(94)90377-8.","Kamei J","Eur J Pharmacol","1994","1994/03/11","","","10.1016/0014-2999(94)90377-8"
"8205479","The role of multiple opioid receptors in the potentiation of reward by food restriction","Carr KD, Papadouka V.","Brain Res. 1994 Mar 14;639(2):253-60. doi: 10.1016/0006-8993(94)91738-8.","Carr KD","Brain Res","1994","1994/03/14","","","10.1016/0006-8993(94)91738-8"
"8202334","Naltrexone must not be considered a real therapy in functional hypothalamic amenorrhea. The results of a double blind controlled study","Manieri C, Musso MC, Marolda AR, Pastorino R, Ferrarotti M, Fornengo R, Isolato G, Messina M.","Panminerva Med. 1993 Dec;35(4):214-7.","Manieri C","Panminerva Med","1993","1993/12/01","","",""
"8202214","Effect of a peripheral and a central acting opioid antagonist on the testicular response to stress in rats","Akinbami MA, Taylor MF, Collins DC, Mann DR.","Neuroendocrinology. 1994 Apr;59(4):343-8. doi: 10.1159/000126676.","Akinbami MA","Neuroendocrinology","1994","1994/04/01","","","10.1159/000126676"
"8201839","Identification of a human delta opioid receptor: cloning and expression","Knapp RJ, Malatynska E, Fang L, Li X, Babin E, Nguyen M, Santoro G, Varga EV, Hruby VJ, Roeske WR, et al.","Life Sci. 1994;54(25):PL463-9. doi: 10.1016/0024-3205(94)90138-4.","Knapp RJ","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)90138-4"
"8201610","Coping styles, opioid blockade, and cardiovascular response to stress","Bruehl S, McCubbin JA, Wilson JF, Montgomery T, Ibarra P, Carlson CR.","J Behav Med. 1994 Feb;17(1):25-40. doi: 10.1007/BF01856880.","Bruehl S","J Behav Med","1994","1994/02/01","","","10.1007/BF01856880"
"8200424","Antitussive effect of [Met5]enkephalin-Arg6-Phe7 in mice","Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.","Eur J Pharmacol. 1994 Mar 3;253(3):293-6. doi: 10.1016/0014-2999(94)90205-4.","Kamei J","Eur J Pharmacol","1994","1994/03/03","","","10.1016/0014-2999(94)90205-4"
"8196487","Differential mediation of cold water swim stress-induced antinociception by delta-opioid receptor subtypes in diabetic mice","Kamei J, Iwamoto Y, Hitosugi H, Misawa M, Nagase H, Kasuya Y.","Life Sci. 1994;54(23):PL425-30. doi: 10.1016/0024-3205(94)90127-9.","Kamei J","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)90127-9"
"8193252","Advances in induction of ovulation","Franks S, Gilling-Smith C.","Curr Opin Obstet Gynecol. 1994 Apr;6(2):136-40.","Franks S","Curr Opin Obstet Gynecol","1994","1994/04/01","","",""
"8192843","Hypoalgesia in response to sensitization during acute noise stress","Helmstetter FJ, Bellgowan PS.","Behav Neurosci. 1994 Feb;108(1):177-85. doi: 10.1037//0735-7044.108.1.177.","Helmstetter FJ","Behav Neurosci","1994","1994/02/01","","","10.1037//0735-7044.108.1.177"
"8190015","Opioid antagonist modulation of rat heart development","McLaughlin PJ.","Life Sci. 1994;54(19):1423-31. doi: 10.1016/0024-3205(94)00597-4.","McLaughlin PJ","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00597-4"
"8182708","Structure-activity relationship of N17'-substituted norbinaltorphimine congeners. Role of the N17' basic group in the interaction with a putative address subsite on the kappa opioid receptor","Portoghese PS, Lin CE, Farouz-Grant F, Takemori AE.","J Med Chem. 1994 May 13;37(10):1495-500. doi: 10.1021/jm00036a015.","Portoghese PS","J Med Chem","1994","1994/05/13","","","10.1021/jm00036a015"
"8182537","Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice","Carr DJ, Gerak LR, France CP.","J Pharmacol Exp Ther. 1994 May;269(2):693-8.","Carr DJ","J Pharmacol Exp Ther","1994","1994/05/01","","",""
"8182525","Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade","Hodges BL, Gagnon MJ, Gillespie TR, Breneisen JR, O'Leary DF, Hara S, Quock RM.","J Pharmacol Exp Ther. 1994 May;269(2):596-600.","Hodges BL","J Pharmacol Exp Ther","1994","1994/05/01","","",""
"8180837","The role of multiple opioid receptors in the maintenance of stimulation-induced feeding","Papadouka V, Carr KD.","Brain Res. 1994 Mar 7;639(1):42-8. doi: 10.1016/0006-8993(94)91762-0.","Papadouka V","Brain Res","1994","1994/03/07","","","10.1016/0006-8993(94)91762-0"
"8180809","Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice","Saucier DM, Kavaliers M.","Brain Res. 1994 Feb 21;637(1-2):292-6. doi: 10.1016/0006-8993(94)91247-5.","Saucier DM","Brain Res","1994","1994/02/21","","","10.1016/0006-8993(94)91247-5"
"8180802","The effect of selective opioid antagonists on butorphanol-induced feeding","Levine AS, Grace M, Portoghese PS, Billington CJ.","Brain Res. 1994 Feb 21;637(1-2):242-8. doi: 10.1016/0006-8993(94)91239-4.","Levine AS","Brain Res","1994","1994/02/21","","","10.1016/0006-8993(94)91239-4"
"8178651","Influence of selective opiate antagonists on striatal acetylcholine and dopamine release","Lendvai B, Sándor NT, Sándor A.","Acta Physiol Hung. 1993;81(1):19-28.","Lendvai B","Acta Physiol Hung","1993","1993/01/01","","",""
"8173956","Differential modulation of angiotensin II and hypertonic saline-induced drinking by opioid receptor subtype antagonists in rats","Ruegg H, Hahn B, Koch JE, Bodnar RJ.","Brain Res. 1994 Jan 28;635(1-2):203-10. doi: 10.1016/0006-8993(94)91440-0.","Ruegg H","Brain Res","1994","1994/01/28","","","10.1016/0006-8993(94)91440-0"
"8173139","Naltrexone in the treatment of alcohol dependence","O'Mara NB, Wesley LC.","Ann Pharmacother. 1994 Feb;28(2):210-11.","O'Mara NB","Ann Pharmacother","1994","1994/02/01","","",""
"8172458","Area tempestas modulates the behavioural responses to nociceptive stimuli in rats","Massotti M, D'Amore A, Lorenzini P, Brusa L.","Ann Ist Super Sanita. 1993;29(3):401-7.","Massotti M","Ann Ist Super Sanita","1993","1993/01/01","","",""
"8172457","Opioids and corticosteroids involvement in the regulation of the neocortical spindling episodes in DBA/2J mice","Capasso A, Di Giannuario A, Loizzo A, Palazzesi S, Cutrufo C, Pieretti S, Sorrentino L.","Ann Ist Super Sanita. 1993;29(3):395-400.","Capasso A","Ann Ist Super Sanita","1993","1993/01/01","","",""
"8171046","Serum prolactin response to ether stress in diabetic rats: opiate system contribution","Yogev L, Yavetz H, Gottreich A, Oppenheim D, Homonnai ZT, Paz G.","Proc Soc Exp Biol Med. 1994 Mar;205(3):248-52. doi: 10.3181/00379727-205-43704.","Yogev L","Proc Soc Exp Biol Med","1994","1994/03/01","","","10.3181/00379727-205-43704"
"8163362","A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder","Glover H.","Isr J Psychiatry Relat Sci. 1993;30(4):255-63.","Glover H","Isr J Psychiatry Relat Sci","1993","1993/01/01","","",""
"8161296","Naltrexone and alcohol dependence: some methodological issues","Andrade C, Rao NS.","Arch Gen Psychiatry. 1994 Apr;51(4):335-6. doi: 10.1001/archpsyc.1994.03950040079013.","Andrade C","Arch Gen Psychiatry","1994","1994/04/01","","","10.1001/archpsyc.1994.03950040079013"
"8159267","Impaired supersensitivity to morphine following chronic naltrexone treatment in senescent rats","Neisewander JL, Nonneman AJ, Rowlett JK, Bardo MT.","Neurobiol Aging. 1994 Jan-Feb;15(1):91-7. doi: 10.1016/0197-4580(94)90148-1.","Neisewander JL","Neurobiol Aging","1994","1994/01/01","","","10.1016/0197-4580(94)90148-1"
"8157053","Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo","Vanderah T, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Hruby VJ, Haaseth RC, Matsunaga TO, Porreca F.","Eur J Pharmacol. 1994 Feb 3;252(2):133-7. doi: 10.1016/0014-2999(94)90588-6.","Vanderah T","Eur J Pharmacol","1994","1994/02/03","","","10.1016/0014-2999(94)90588-6"
"8156397","mu-Opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis","Matsumoto M, Yoshioka M, Togashi H, Hirokami M, Tochihara M, Ikeda T, Smith CB, Saito H.","Brain Res. 1994 Feb 4;636(1):1-8. doi: 10.1016/0006-8993(94)90169-4.","Matsumoto M","Brain Res","1994","1994/02/04","","","10.1016/0006-8993(94)90169-4"
"8154874","Rett syndrome: controlled study of an oral opiate antagonist, naltrexone","Percy AK, Glaze DG, Schultz RJ, Zoghbi HY, Williamson D, Frost JD Jr, Jankovic JJ, del Junco D, Skender M, Waring S, et al.","Ann Neurol. 1994 Apr;35(4):464-70. doi: 10.1002/ana.410350415.","Percy AK","Ann Neurol","1994","1994/04/01","","","10.1002/ana.410350415"
"8149991","The decompensatory phase of acute hypovolaemia in rabbits involves a central delta 1-opioid receptor","Ludbrook J, Ventura S.","Eur J Pharmacol. 1994 Jan 24;252(1):113-6. doi: 10.1016/0014-2999(94)90582-7.","Ludbrook J","Eur J Pharmacol","1994","1994/01/24","","","10.1016/0014-2999(94)90582-7"
"8149982","Involvement of delta 1-opioid receptor antagonism in the antitussive effect of delta-opioid receptor antagonists","Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y.","Eur J Pharmacol. 1994 Jan 14;251(2-3):291-4. doi: 10.1016/0014-2999(94)90411-1.","Kamei J","Eur J Pharmacol","1994","1994/01/14","","","10.1016/0014-2999(94)90411-1"
"8138952","Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice","Smith PB, Welch SP, Martin BR.","J Pharmacol Exp Ther. 1994 Mar;268(3):1381-7.","Smith PB","J Pharmacol Exp Ther","1994","1994/03/01","","",""
"8137875","Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice","Kamei J, Iwamoto Y, Suzuki T, Misawa M, Kasuya Y, Nagase H, Okutomi T, Soma G, Mizuno D.","Eur J Pharmacol. 1994 Jan 4;251(1):95-8. doi: 10.1016/0014-2999(94)90448-0.","Kamei J","Eur J Pharmacol","1994","1994/01/04","","","10.1016/0014-2999(94)90448-0"
"8136623","Dependence on tramadol","Ehrenreich H, Poser W.","Clin Investig. 1993 Dec;72(1):76. doi: 10.1007/BF00231123.","Ehrenreich H","Clin Investig","1993","1993/12/01","","","10.1007/BF00231123"
"8135389","Efficacy of methylnaltrexone versus naloxone for reversal of morphine-induced depression of hypoxic ventilatory response","Amin HM, Sopchak AM, Foss JF, Esposito BF, Roizen MF, Camporesi EM.","Anesth Analg. 1994 Apr;78(4):701-5. doi: 10.1213/00000539-199404000-00015.","Amin HM","Anesth Analg","1994","1994/04/01","","","10.1213/00000539-199404000-00015"
"8132037","Characterization of the mu-opioid receptors on SH-SY5Y cells using beta-funaltrexamine (beta-FNA) and naloxonazine","Elliott J, Smart D, Traynor JR, Lambert DG.","Biochem Soc Trans. 1993 Nov;21(4):469S. doi: 10.1042/bst021469s.","Elliott J","Biochem Soc Trans","1993","1993/11/01","","","10.1042/bst021469s"
"8131071","The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate neurochemistry","Wiertelak EP, Yang HY, Mooney-Heiberger K, Maier SF, Watkins LR.","Brain Res. 1994 Jan 21;634(2):214-26. doi: 10.1016/0006-8993(94)91924-0.","Wiertelak EP","Brain Res","1994","1994/01/21","","","10.1016/0006-8993(94)91924-0"
"8131061","The effect of norbinaltorphimine, beta-funaltrexamine and naltrindole on NPY-induced feeding","Kotz CM, Grace MK, Billington CJ, Levine AS.","Brain Res. 1993 Dec 24;631(2):325-8. doi: 10.1016/0006-8993(93)91552-4.","Kotz CM","Brain Res","1993","1993/12/24","","","10.1016/0006-8993(93)91552-4"
"8127459","[Naltrexone in the therapeutic relation in cases of opioid abuse and dependence]","Liffredo C, Gallino G.","Minerva Med. 1993 Dec;84(12):687-92.","Liffredo C","Minerva Med","1993","1993/12/01","","",""
"8126697","Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety","Portoghese PS, Sultana M, Moe ST, Takemori AE.","J Med Chem. 1994 Mar 4;37(5):579-85. doi: 10.1021/jm00031a006.","Portoghese PS","J Med Chem","1994","1994/03/04","","","10.1021/jm00031a006"
"8122294","Gas chromatography/tandem mass spectrometry measurement of delta 9-tetrahydrocannabinol, naltrexone, and their active metabolites in plasma","Nelson CC, Fraser MD, Wilfahrt JK, Foltz RL.","Ther Drug Monit. 1993 Dec;15(6):557-62. doi: 10.1097/00007691-199312000-00019.","Nelson CC","Ther Drug Monit","1993","1993/12/01","","","10.1097/00007691-199312000-00019"
"8120180","Involvement of opioid peptides from casein on reticular motility and digesta passage in steers","Kil SJ, Froetschel MA.","J Dairy Sci. 1994 Jan;77(1):111-23. doi: 10.3168/jds.S0022-0302(94)76934-4.","Kil SJ","J Dairy Sci","1994","1994/01/01","","","10.3168/jds.S0022-0302(94)76934-4"
"8120161","Naltrexone has no hepatotoxic effects in a self-injurious patient with chronic hepatitis","Hetrick WP, Krutzik MN, Taylor DV, Sandman CA, Rusu L, Martinazzi VP.","J Clin Psychopharmacol. 1993 Dec;13(6):453-4.","Hetrick WP","J Clin Psychopharmacol","1993","1993/12/01","","",""
"8118700","The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm","Lê AD, Poulos CX, Quan B, Chow S.","Brain Res. 1993 Dec 10;630(1-2):330-2. doi: 10.1016/0006-8993(93)90672-a.","Lê AD","Brain Res","1993","1993/12/10","","","10.1016/0006-8993(93)90672-a"
"8117237","Interaction of beta-endorphin and GABAergic drugs in the regulation of memory storage","Castellano C, Introini-Collison IB, McGaugh JL.","Behav Neural Biol. 1993 Sep;60(2):123-8. doi: 10.1016/0163-1047(93)90215-4.","Castellano C","Behav Neural Biol","1993","1993/09/01","","","10.1016/0163-1047(93)90215-4"
"8115422","Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (-)-lobeline in the rat brainstem","Hamann SR, Martin WR.","Pharmacol Biochem Behav. 1994 Jan;47(1):197-201. doi: 10.1016/0091-3057(94)90131-7.","Hamann SR","Pharmacol Biochem Behav","1994","1994/01/01","","","10.1016/0091-3057(94)90131-7"
"8114013","Opioids regulation of human chorionic gonadotropin release from trophoblast tissue is mediated by gonadotropin releasing hormone","Cemerikic B, Zamah R, Ahmed MS.","J Pharmacol Exp Ther. 1994 Feb;268(2):971-7.","Cemerikic B","J Pharmacol Exp Ther","1994","1994/02/01","","",""
"8113996","Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity","Fang L, Knapp RJ, Horvath R, Matsunaga TO, Haaseth RC, Hruby VJ, Porreca F, Yamamura HI.","J Pharmacol Exp Ther. 1994 Feb;268(2):836-46.","Fang L","J Pharmacol Exp Ther","1994","1994/02/01","","",""
"8113981","Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat","Stewart PE, Hammond DL.","J Pharmacol Exp Ther. 1994 Feb;268(2):701-8.","Stewart PE","J Pharmacol Exp Ther","1994","1994/02/01","","",""
"8113979","Delta-1 opioid agonist acutely increases hypoxic tolerance","Mayfield KP, D'Alecy LG.","J Pharmacol Exp Ther. 1994 Feb;268(2):683-8.","Mayfield KP","J Pharmacol Exp Ther","1994","1994/02/01","","",""
"8112506","Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat","Bhargava HN, Matwyshyn GA, Reddy PL, Veeranna.","Gen Pharmacol. 1993 Nov;24(6):1351-7. doi: 10.1016/0306-3623(93)90418-w.","Bhargava HN","Gen Pharmacol","1993","1993/11/01","","","10.1016/0306-3623(93)90418-w"
"8112488","Repeated exposure of rat pups to isolation attenuates isolation-induced ultrasonic vocalization rates: reversal with naltrexone","Goodwin GA, Molina VA, Spear LP.","Dev Psychobiol. 1994 Jan;27(1):53-64. doi: 10.1002/dev.420270106.","Goodwin GA","Dev Psychobiol","1994","1994/01/01","","","10.1002/dev.420270106"
"8109774","Comparison of potency and duration of action of nalmefene and naloxone","Glass PS, Jhaveri RM, Smith LR.","Anesth Analg. 1994 Mar;78(3):536-41. doi: 10.1213/00000539-199403000-00021.","Glass PS","Anesth Analg","1994","1994/03/01","","","10.1213/00000539-199403000-00021"
"8105790","Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients","Rapaport MH, Wolkowitz O, Kelsoe JR, Pato C, Konicki PE, Pickar D.","Neuropsychopharmacology. 1993 Sep;9(2):111-5. doi: 10.1038/npp.1993.49.","Rapaport MH","Neuropsychopharmacology","1993","1993/09/01","","","10.1038/npp.1993.49"
"8103909","Regulatory role of enteric kappa opioid receptors in human colonic motility","Chamouard P, Klein A, Martin E, Adloff M, Angel F.","Life Sci. 1993;53(14):1149-56. doi: 10.1016/0024-3205(93)90551-d.","Chamouard P","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90551-d"
"8103800","The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein","Lawrence DM, Bidlack JM.","J Pharmacol Exp Ther. 1993 Sep;266(3):1678-83.","Lawrence DM","J Pharmacol Exp Ther","1993","1993/09/01","","",""
"8103315","Role of increase of opioid receptors in granulocyte CD11b/CD18 dysfunction","Mazzone A, Ricevuti G, Pasotti D, Fossati G, Mazzucchelli I, Cavigliano P, Lecchini S, Frigo G, Notario A.","Ann N Y Acad Sci. 1993 Jun 23;685:770-3. doi: 10.1111/j.1749-6632.1993.tb35941.x.","Mazzone A","Ann N Y Acad Sci","1993","1993/06/23","","","10.1111/j.1749-6632.1993.tb35941.x"
"8102969","Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice","Itoh J, Ukai M, Kameyama T.","Eur J Pharmacol. 1993 Jun 4;236(3):341-5. doi: 10.1016/0014-2999(93)90469-x.","Itoh J","Eur J Pharmacol","1993","1993/06/04","","","10.1016/0014-2999(93)90469-x"
"8101007","Opioid antagonists: indirect antagonism of morphine analgesia by spinal dynorphin A","Aksu F, Holmes BB, Fujimoto JM.","Pharmacol Biochem Behav. 1993 Jun;45(2):409-18. doi: 10.1016/0091-3057(93)90258-u.","Aksu F","Pharmacol Biochem Behav","1993","1993/06/01","","","10.1016/0091-3057(93)90258-u"
"8101006","Endogenous dynorphin modulates calcium-mediated antinociception in mice","Smith FL, Dewey WL.","Pharmacol Biochem Behav. 1993 Jun;45(2):383-91. doi: 10.1016/0091-3057(93)90255-r.","Smith FL","Pharmacol Biochem Behav","1993","1993/06/01","","","10.1016/0091-3057(93)90255-r"
"8100519","A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation","Lambert PD, Wilding JP, al-Dokhayel AA, Bohuon C, Comoy E, Gilbey SG, Bloom SR.","Endocrinology. 1993 Jul;133(1):29-32. doi: 10.1210/endo.133.1.8100519.","Lambert PD","Endocrinology","1993","1993/07/01","","","10.1210/endo.133.1.8100519"
"8099201","Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus","Wagner JJ, Terman GW, Chavkin C.","Nature. 1993 Jun 3;363(6428):451-4. doi: 10.1038/363451a0.","Wagner JJ","Nature","1993","1993/06/03","PMC2096733","NIHMS34331","10.1038/363451a0"
"8098678","Effects of opioid receptors antagonists administration to suprachiasmatic nucleus on hibernation of ground squirrels Citellus dauricus","Yu LC, Cai YP.","Comp Biochem Physiol C. 1993 Feb;104(2):249-52.","Yu LC","Comp Biochem Physiol C","1993","1993/02/01","","",""
"8097387","Mu- vs. delta-opioid influence on respiratory and sleep behavior during development","Moss IR, Scott SC, Inman JD.","Am J Physiol. 1993 Apr;264(4 Pt 2):R754-60. doi: 10.1152/ajpregu.1993.264.4.R754.","Moss IR","Am J Physiol","1993","1993/04/01","","","10.1152/ajpregu.1993.264.4.R754"
"8096421","The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine","Randich A, Robertson JD, Willingham T.","Brain Res. 1993 Feb 19;603(2):186-200. doi: 10.1016/0006-8993(93)91237-m.","Randich A","Brain Res","1993","1993/02/19","","","10.1016/0006-8993(93)91237-m"
"8092339","Naltrexone-induced alterations in human ethanol intoxication","Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H.","Am J Psychiatry. 1994 Oct;151(10):1463-7. doi: 10.1176/ajp.151.10.1463.","Swift RM","Am J Psychiatry","1994","1994/10/01","","","10.1176/ajp.151.10.1463"
"8090284","Multiple opiate receptor subtypes are involved in the stimulation of growth hormone release by beta-endorphin in female rats","Janik J, Klosterman S, Parman R, Callahan P.","Neuroendocrinology. 1994 Jul;60(1):69-75. doi: 10.1159/000126721.","Janik J","Neuroendocrinology","1994","1994/07/01","","","10.1159/000126721"
"8090073","Effect of chronic exposure to naltrexone and opioid selective agonists on G protein mRNA levels in the rat nervous system","Rubino T, Massi P, Patrini G, Venier I, Giagnoni G, Parolaro D.","Brain Res Mol Brain Res. 1994 Jun;23(4):333-7. doi: 10.1016/0169-328x(94)90243-7.","Rubino T","Brain Res Mol Brain Res","1994","1994/06/01","","","10.1016/0169-328x(94)90243-7"
"8085012","Luteinizing hormone regulators: luteinizing hormone releasing hormone analogs, estrogens, opiates, and estrogen-opiate hybrids","Kolb VM.","Prog Drug Res. 1994;42:39-52. doi: 10.1007/978-3-0348-7153-2_3.","Kolb VM","Prog Drug Res","1994","1994/01/01","","","10.1007/978-3-0348-7153-2_3"
"8084898","Kappa opioid effects on fetal behavior: central administration of U50,488","Petrov ES, Varlinskaya EI, Robinson SR, Smotherman WP, de Costa BR, Rice KC.","Physiol Behav. 1994 Jul;56(1):175-82. doi: 10.1016/0031-9384(94)90276-3.","Petrov ES","Physiol Behav","1994","1994/07/01","","","10.1016/0031-9384(94)90276-3"
"8082873","Effect of naltrexone treatment on insulin secretion, insulin action and postprandial thermogenesis in obesity","Vettor R, Macor C, Rossi E, De Palo C, Ruggeri A, Cobelli C, Federspil G.","Horm Metab Res. 1994 Apr;26(4):188-94. doi: 10.1055/s-2007-1000809.","Vettor R","Horm Metab Res","1994","1994/04/01","","","10.1055/s-2007-1000809"
"8082700","Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats","Diop L, Rivière PJ, Pascaud X, Dassaud M, Junien JL.","Eur J Pharmacol. 1994 May 12;257(1-2):181-7. doi: 10.1016/0014-2999(94)90710-2.","Diop L","Eur J Pharmacol","1994","1994/05/12","","","10.1016/0014-2999(94)90710-2"
"8082697","Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol","Jaw SP, Makimura M, Oh KW, Hoskins B, Ho IK.","Eur J Pharmacol. 1994 May 12;257(1-2):153-60. doi: 10.1016/0014-2999(94)90707-2.","Jaw SP","Eur J Pharmacol","1994","1994/05/12","","","10.1016/0014-2999(94)90707-2"
"8082032","Naltrexone administration effects on regional brain monoamines in developing rats","De Cabo C, Colado MI, Pujol A, Martín MI, Viveros MP.","Brain Res Bull. 1994;34(4):395-406. doi: 10.1016/0361-9230(94)90036-1.","De Cabo C","Brain Res Bull","1994","1994/01/01","","","10.1016/0361-9230(94)90036-1"
"8080893","The efficacy of naltrexone in preventing reabuse of heroin after detoxification","Shufman EN, Porat S, Witztum E, Gandacu D, Bar-Hamburger R, Ginath Y.","Biol Psychiatry. 1994 Jun 15;35(12):935-45. doi: 10.1016/0006-3223(94)91240-8.","Shufman EN","Biol Psychiatry","1994","1994/06/15","","","10.1016/0006-3223(94)91240-8"
"8058754","Agonists and antagonists bind to different domains of the cloned kappa opioid receptor","Kong H, Raynor K, Yano H, Takeda J, Bell GI, Reisine T.","Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8042-6. doi: 10.1073/pnas.91.17.8042.","Kong H","Proc Natl Acad Sci U S A","1994","1994/08/16","PMC44541","","10.1073/pnas.91.17.8042"
"8057400","Effects of opiates on blood rheology","Galante A, De Luca A, Pietroiusti A, Tiratterra F, Benincasa E, Domenici B, Baldelli C, Valenzi C.","J Toxicol Clin Toxicol. 1994;32(4):411-7. doi: 10.3109/15563659409011042.","Galante A","J Toxicol Clin Toxicol","1994","1994/01/01","","","10.3109/15563659409011042"
"8056738","Effects of the opiate antagonist, naltrexone, on binging antecedents and plasma beta-endorphin concentrations","Chatoor I, Herman BH, Hartzler J.","J Am Acad Child Adolesc Psychiatry. 1994 Jun;33(5):748-52. doi: 10.1097/00004583-199406000-00016.","Chatoor I","J Am Acad Child Adolesc Psychiatry","1994","1994/06/01","","","10.1097/00004583-199406000-00016"
"8055740","A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation","Legarda JJ, Gossop M.","Drug Alcohol Depend. 1994 Apr;35(2):91-3. doi: 10.1016/0376-8716(94)90115-5.","Legarda JJ","Drug Alcohol Depend","1994","1994/04/01","","","10.1016/0376-8716(94)90115-5"
"8046996","Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice","Rady JJ, Takemori AE, Portoghese PS, Fujimoto JM.","Life Sci. 1994;55(8):603-9. doi: 10.1016/0024-3205(94)00486-2.","Rady JJ","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00486-2"
"8042002","Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice","Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.","Res Commun Chem Pathol Pharmacol. 1994 Apr;84(1):105-10.","Kamei J","Res Commun Chem Pathol Pharmacol","1994","1994/04/01","","",""
"8040164","Naltrexone in infantile autism","Black SL.","J Autism Dev Disord. 1994 Apr;24(2):236-9. doi: 10.1007/BF02172101.","Black SL","J Autism Dev Disord","1994","1994/04/01","","","10.1007/BF02172101"
"8037885","Behavioral effects of kappa-opioid-receptor stimulation on neonatal rats","Kehoe P, Boylan CB.","Behav Neurosci. 1994 Apr;108(2):418-23. doi: 10.1037//0735-7044.108.2.418.","Kehoe P","Behav Neurosci","1994","1994/04/01","","","10.1037//0735-7044.108.2.418"
"8035657","Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors","Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.","Life Sci. 1994;55(6):PL121-6. doi: 10.1016/0024-3205(94)90062-0.","Kamei J","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)90062-0"
"8035333","Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice","Miyamoto Y, Bowen WD, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1994 Jul;270(1):37-9.","Miyamoto Y","J Pharmacol Exp Ther","1994","1994/07/01","","",""
"8035318","The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice","Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR.","J Pharmacol Exp Ther. 1994 Jul;270(1):219-27.","Smith PB","J Pharmacol Exp Ther","1994","1994/07/01","","",""
"8034384","The efficacy of controlled trials of alcohol misuse treatments in maintaining abstinence: a meta-analysis","Agosti V.","Int J Addict. 1994 Apr;29(6):759-69. doi: 10.3109/10826089409047908.","Agosti V","Int J Addict","1994","1994/04/01","","","10.3109/10826089409047908"
"8034071","Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome","Cagnacci A, Soldani R, Paoletti AM, Falqui A, Melis GB.","Fertil Steril. 1994 Aug;62(2):269-72. doi: 10.1016/s0015-0282(16)56877-0.","Cagnacci A","Fertil Steril","1994","1994/08/01","","","10.1016/s0015-0282(16)56877-0"
"8033761","Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts","Navaratnam V, Jamaludin A, Raman N, Mohamed M, Mansor SM.","Drug Alcohol Depend. 1994 Feb;34(3):231-6. doi: 10.1016/0376-8716(94)90161-9.","Navaratnam V","Drug Alcohol Depend","1994","1994/02/01","","","10.1016/0376-8716(94)90161-9"
"8032878","Lack of catecholamine involvement in the increased luteinizing hormone release due to blockade of kappa-opioid receptors in the medial basal hypothalamus during midpregnancy in the rat","Zhen S, Gallo RV.","Brain Res. 1994 Apr 11;642(1-2):178-84. doi: 10.1016/0006-8993(94)90920-2.","Zhen S","Brain Res","1994","1994/04/11","","","10.1016/0006-8993(94)90920-2"
"8032166","Treatment of alcoholism as a chronic disorder","O'Brien CP.","EXS. 1994;71:349-59.","O'Brien CP","EXS","1994","1994/01/01","","",""
"8032147","Neuropeptides and alcohol addiction in monkeys","van Ree JM, Kornet M, Goosen C.","EXS. 1994;71:165-74. doi: 10.1007/978-3-0348-7330-7_17.","van Ree JM","EXS","1994","1994/01/01","","","10.1007/978-3-0348-7330-7_17"
"8029291","Naltrexone, serotonin receptor subtype antagonists, and carbohydrate intake in rats","Islam AK, Dougherty T, Koch JE, Bodnar RJ.","Pharmacol Biochem Behav. 1994 May;48(1):193-201. doi: 10.1016/0091-3057(94)90516-9.","Islam AK","Pharmacol Biochem Behav","1994","1994/05/01","","","10.1016/0091-3057(94)90516-9"
"8029266","TRIMU-5, a mu 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis","Eisenberg RM.","Pharmacol Biochem Behav. 1994 Apr;47(4):943-6. doi: 10.1016/0091-3057(94)90300-x.","Eisenberg RM","Pharmacol Biochem Behav","1994","1994/04/01","","","10.1016/0091-3057(94)90300-x"
"8028443","Delta antagonist and kappa agonist activity of Naltriben: evidence for differential kappa interaction with the delta 1 and delta 2 opioid receptor subtypes","Stewart PE, Holper EM, Hammond DL.","Life Sci. 1994;55(4):PL79-84. doi: 10.1016/0024-3205(94)00738-1.","Stewart PE","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00738-1"
"8026736","Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat","Reddy PL, Veeranna, Matwyshyn GA, Thorat SN, Bhargava HN.","Gen Pharmacol. 1994 Mar;25(2):355-61. doi: 10.1016/0306-3623(94)90066-3.","Reddy PL","Gen Pharmacol","1994","1994/03/01","","","10.1016/0306-3623(94)90066-3"
"8026700","Effects of naltrexone pellet implantation on morphine tolerance and physical dependence in the rat","Bhargava HN, Matwyshyn GA, Gerk PM, Bozek PS, Bailey MD, Ko KH, Simko RJ, Thorat SN.","Gen Pharmacol. 1994 Jan;25(1):149-55. doi: 10.1016/0306-3623(94)90025-6.","Bhargava HN","Gen Pharmacol","1994","1994/01/01","","","10.1016/0306-3623(94)90025-6"
"8026550","Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum","Schmidt N, Brune K, Geisslinger G.","Eur J Pharmacol. 1994 Apr 1;255(1-3):245-7. doi: 10.1016/0014-2999(94)90105-8.","Schmidt N","Eur J Pharmacol","1994","1994/04/01","","","10.1016/0014-2999(94)90105-8"
"8025568","Characterization of opioid binding sites in the neural and intermediate lobe of the rat pituitary gland by quantitative receptor autoradiography","Boersma CJ, Pool CW, Van Heerikhuize JJ, Van Leeuwen FW.","J Neuroendocrinol. 1994 Feb;6(1):47-56. doi: 10.1111/j.1365-2826.1994.tb00554.x.","Boersma CJ","J Neuroendocrinol","1994","1994/02/01","","","10.1111/j.1365-2826.1994.tb00554.x"
"8024608","Microwave irradiation affects radial-arm maze performance in the rat","Lai H, Horita A, Guy AW.","Bioelectromagnetics. 1994;15(2):95-104. doi: 10.1002/bem.2250150202.","Lai H","Bioelectromagnetics","1994","1994/01/01","","","10.1002/bem.2250150202"
"8021929","Synthesis and delta-opioid receptor antagonist activity of a naltrindole analogue with a regioisomeric indole moiety","Portoghese PS, Ohkawa S, Moe ST, Takemori AE.","J Med Chem. 1994 Jun 10;37(12):1886-8. doi: 10.1021/jm00038a019.","Portoghese PS","J Med Chem","1994","1994/06/10","","","10.1021/jm00038a019"
"8021928","N-benzylnaltrindoles as long-acting delta-opioid receptor antagonists","Korlipara VL, Takemori AE, Portoghese PS.","J Med Chem. 1994 Jun 10;37(12):1882-5. doi: 10.1021/jm00038a018.","Korlipara VL","J Med Chem","1994","1994/06/10","","","10.1021/jm00038a018"
"8019773","Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole","Derrien M, Durieux C, Roques BP.","Br J Pharmacol. 1994 Mar;111(3):956-60. doi: 10.1111/j.1476-5381.1994.tb14832.x.","Derrien M","Br J Pharmacol","1994","1994/03/01","PMC1910081","","10.1111/j.1476-5381.1994.tb14832.x"
"8018739","A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR","Azatian A, Papiasvilli A, Joseph H.","J Addict Dis. 1994;13(1):35-52. doi: 10.1300/J069v13n01_04.","Azatian A","J Addict Dis","1994","1994/01/01","","","10.1300/J069v13n01_04"
"8015716","Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors","Kamei J, Iwamoto Y, Hitosugi H, Misawa M, Nagase H, Kasuya Y.","Neurosci Lett. 1994 Jan 3;165(1-2):141-3. doi: 10.1016/0304-3940(94)90729-3.","Kamei J","Neurosci Lett","1994","1994/01/03","","","10.1016/0304-3940(94)90729-3"
"8012749","An unusual reaction to opioid blockade with naltrexone in a case of post-traumatic stress disorder","Ibarra P, Bruehl SP, McCubbin JA, Carlson CR, Wilson JF, Norton JA, Montgomery TB.","J Trauma Stress. 1994 Apr;7(2):303-9. doi: 10.1007/BF02102950.","Ibarra P","J Trauma Stress","1994","1994/04/01","","","10.1007/BF02102950"
"8005254","The opioid agonist codeine and antagonist naltrexone do not affect voluntary suppression of capsaicin induced cough in healthy subjects","Hutchings HA, Eccles R.","Eur Respir J. 1994 Apr;7(4):715-9. doi: 10.1183/09031936.94.07040715.","Hutchings HA","Eur Respir J","1994","1994/04/01","","","10.1183/09031936.94.07040715"
"8004769","Evidence that weaning stimulates the developmental expression of a delta-opioid receptor subtype in the rat","Kitchen I, Crook TJ, Muhammad BY, Hill RG.","Brain Res Dev Brain Res. 1994 Mar 18;78(1):147-50. doi: 10.1016/0165-3806(94)90020-5.","Kitchen I","Brain Res Dev Brain Res","1994","1994/03/18","","","10.1016/0165-3806(94)90020-5"
"8003769","Morphine-induced decreases in in vivo antibody responses","Lockwood LL, Silbert LH, Fleshner M, Laudenslager ML, Watkins LR, Maier SF.","Brain Behav Immun. 1994 Mar;8(1):24-36. doi: 10.1006/brbi.1994.1003.","Lockwood LL","Brain Behav Immun","1994","1994/03/01","","","10.1006/brbi.1994.1003"
"8002285","Quaternary naltrexone: its immunomodulatory activity and interaction with brain delta and kappa opioid receptors","Janković BD, Radulović J.","Immunopharmacology. 1994 Sep-Oct;28(2):105-12. doi: 10.1016/0162-3109(94)90026-4.","Janković BD","Immunopharmacology","1994","1994/09/01","","","10.1016/0162-3109(94)90026-4"
"7996538","Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6 alpha- and 6 beta-naltrexol","Nelson TD, Davis RD, Nelson WL.","J Med Chem. 1994 Dec 9;37(25):4270-7. doi: 10.1021/jm00051a003.","Nelson TD","J Med Chem","1994","1994/12/09","","","10.1021/jm00051a003"
"7996463","Antinociceptive and response rate-altering effects of kappa opioid agonists, spiradoline, enadoline and U69,593, alone and in combination with opioid antagonists in squirrel monkeys","Pitts RC, Dykstra LA.","J Pharmacol Exp Ther. 1994 Dec;271(3):1501-8.","Pitts RC","J Pharmacol Exp Ther","1994","1994/12/01","","",""
"7996417","Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists","Noble F, Smadja C, Roques BP.","J Pharmacol Exp Ther. 1994 Dec;271(3):1127-34.","Noble F","J Pharmacol Exp Ther","1994","1994/12/01","","",""
"7991069","The effects of protection by D-Pen2-D-Pen5-enkephalin or D-Ala2-NMePhe4-Gly-ol-enkephalin against beta-chlornaltrexamine in the spinal cord on the antinociception induced by beta-endorphin administered intracerebroventricularly in the mouse","Suh HW, Lim JS, Song DK, Kim YH, Tseng LF.","Neuropeptides. 1994 Aug;27(2):143-9. doi: 10.1016/0143-4179(94)90055-8.","Suh HW","Neuropeptides","1994","1994/08/01","","","10.1016/0143-4179(94)90055-8"
"7988653","Antitussive effect of dihydroetorphine in mice","Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y.","Eur J Pharmacol. 1994 Aug 1;260(2-3):257-9. doi: 10.1016/0014-2999(94)90347-6.","Kamei J","Eur J Pharmacol","1994","1994/08/01","","","10.1016/0014-2999(94)90347-6"
"7988361","The effect of chronic naltrexone pretreatment on associative vs. non-associative morphine tolerance","Azorlosa JL.","Drug Alcohol Depend. 1994 Aug;36(1):65-7. doi: 10.1016/0376-8716(94)90011-6.","Azorlosa JL","Drug Alcohol Depend","1994","1994/08/01","","","10.1016/0376-8716(94)90011-6"
"7983232","Lack of hepatotoxicity with naltrexone treatment","Sax DS, Kornetsky C, Kim A.","J Clin Pharmacol. 1994 Sep;34(9):898-901. doi: 10.1002/j.1552-4604.1994.tb04002.x.","Sax DS","J Clin Pharmacol","1994","1994/09/01","","","10.1002/j.1552-4604.1994.tb04002.x"
"7982926","Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor","Xue JC, Chen C, Zhu J, Kunapuli S, DeRiel JK, Yu L, Liu-Chen LY.","J Biol Chem. 1994 Dec 2;269(48):30195-9.","Xue JC","J Biol Chem","1994","1994/12/02","","",""
"7982463","Beta-funaltrexamine blockade of opioid-induced inhibition of somatostatin secretion from rat stomach","McIntosh C, Yago V, Kwok YN.","Eur J Pharmacol. 1994 Jul 11;259(3):331-4. doi: 10.1016/0014-2999(94)90663-7.","McIntosh C","Eur J Pharmacol","1994","1994/07/11","","","10.1016/0014-2999(94)90663-7"
"7981474","Maternal behaviour in sheep and its neuroendocrine regulation","Keverne EB, Kendrick KM.","Acta Paediatr Suppl. 1994 Jun;397:47-56. doi: 10.1111/j.1651-2227.1994.tb13265.x.","Keverne EB","Acta Paediatr Suppl","1994","1994/06/01","","","10.1111/j.1651-2227.1994.tb13265.x"
"7981473","Brain opioids and mother-infant social motivation","Panksepp J, Nelson E, Siviy S.","Acta Paediatr Suppl. 1994 Jun;397:40-6.","Panksepp J","Acta Paediatr Suppl","1994","1994/06/01","","",""
"7970193","Species difference in the modulatory effect of kappa agonist on 5-HT release from ground squirrel and rat hippocampus","Cui Y, Lee T, Wang LC.","Neurosci Lett. 1994 Jul 4;175(1-2):126-8. doi: 10.1016/0304-3940(94)91095-2.","Cui Y","Neurosci Lett","1994","1994/07/04","","","10.1016/0304-3940(94)91095-2"
"7969822","Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors","Collin E, Mauborgne A, Bourgoin S, Benoliel JJ, Hamon M, Cesselin F.","Neuropeptides. 1994 Jul;27(1):75-83. doi: 10.1016/0143-4179(94)90018-3.","Collin E","Neuropeptides","1994","1994/07/01","","","10.1016/0143-4179(94)90018-3"
"7969211","Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease","Rascol O, Fabre N, Blin O, Poulik J, Sabatini U, Senard JM, Ané M, Montastruc JL, Rascol A.","Mov Disord. 1994 Jul;9(4):437-40. doi: 10.1002/mds.870090410.","Rascol O","Mov Disord","1994","1994/07/01","","","10.1002/mds.870090410"
"7968211","The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesia","Shah S, Davis T, Yoburn BC.","Life Sci. 1994;55(19):1451-8. doi: 10.1016/0024-3205(94)00685-7.","Shah S","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00685-7"
"7966919","From the National Institutes of Health","Gordis E.","JAMA. 1994 Dec 14;272(22):1733. doi: 10.1001/jama.272.22.1733.","Gordis E","JAMA","1994","1994/12/14","","","10.1001/jama.272.22.1733"
"7965818","In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats","Walker EA, Makhay MM, House JD, Young AM.","J Pharmacol Exp Ther. 1994 Nov;271(2):959-68.","Walker EA","J Pharmacol Exp Ther","1994","1994/11/01","","",""
"7965787","Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice","Burke TF, Woods JH, Lewis JW, Medzihradsky F.","J Pharmacol Exp Ther. 1994 Nov;271(2):715-21.","Burke TF","J Pharmacol Exp Ther","1994","1994/11/01","","",""
"7960495","Handling during suckling alters rat behavior but does not reverse the deleterious effects of undernutrition on naltrexone-induced inhibition of exploratory activity","Rocha JB, de Mello CF.","Int J Vitam Nutr Res. 1994;64(2):152-6.","Rocha JB","Int J Vitam Nutr Res","1994","1994/01/01","","",""
"7953760","Naltrexone induces down- and upregulation of delta opioid receptors in rat brain regions","Belcheva MM, Barg J, Mchale R, Coscia CJ.","Brain Res Bull. 1994;35(1):69-72. doi: 10.1016/0361-9230(94)90218-6.","Belcheva MM","Brain Res Bull","1994","1994/01/01","","","10.1016/0361-9230(94)90218-6"
"7953755","Deficits in shock-induced freezing and naltrexone enhancement of freezing in fawn hooded rats","Calcagnetti DJ, Schechter MD.","Brain Res Bull. 1994;35(1):37-40. doi: 10.1016/0361-9230(94)90213-5.","Calcagnetti DJ","Brain Res Bull","1994","1994/01/01","","","10.1016/0361-9230(94)90213-5"
"7950982","Evidence for chemical differentiation of delta opioid receptor subtypes by the sulfhydryl reagent N-ethylmaleimide","Tam L, Rafferty MF.","Receptor. 1994 Summer;4(2):81-91.","Tam L","Receptor","1994","1994/01/01","","",""
"7948733","Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2","Wilkes BC, Schiller PW.","Biopolymers. 1994 Sep;34(9):1213-9. doi: 10.1002/bip.360340909.","Wilkes BC","Biopolymers","1994","1994/09/01","","","10.1002/bip.360340909"
"7946257","Opioid antagonist effects on self-injury in adults with mental retardation: response form and location as determinants of medication effects","Thompson T, Hackenberg T, Cerutti D, Baker D, Axtell S.","Am J Ment Retard. 1994 Jul;99(1):85-102.","Thompson T","Am J Ment Retard","1994","1994/07/01","","",""
"7941781","Differential modulation of behavioral responses by [D-Ala2, NMePhe4, Gly-ol]enkephalin, [D-Ala2] deltorphin II and [D-Pen2, L-Pen5]enkephalin in the mouse","Ukai M, Toyoshi T, Mizutani M, Sasaki Y, Kameyama T.","Nihon Shinkei Seishin Yakurigaku Zasshi. 1994 Jun;14(3):161-8.","Ukai M","Nihon Shinkei Seishin Yakurigaku Zasshi","1994","1994/06/01","","",""
"7941780","Opioid peptides selective for receptor types modulate cocaine-induced behavioral responses in mice","Ukai M, Mizutani M, Kameyama T.","Nihon Shinkei Seishin Yakurigaku Zasshi. 1994 Jun;14(3):153-9.","Ukai M","Nihon Shinkei Seishin Yakurigaku Zasshi","1994","1994/06/01","","",""
"7938126","Opioid antagonist modulation of DNA synthesis in mouse tongue epithelium is circadian dependent","Zagon IS, Wu Y, McLaughlin PJ.","Pharmacol Biochem Behav. 1994 Jul;48(3):709-14. doi: 10.1016/0091-3057(94)90337-9.","Zagon IS","Pharmacol Biochem Behav","1994","1994/07/01","","","10.1016/0091-3057(94)90337-9"
"7938116","Nalorphine as a stimulus in drug discrimination learning: assessment of the role of mu- and kappa-receptor subtypes","Smurthwaite ST, Riley AL.","Pharmacol Biochem Behav. 1994 Jul;48(3):635-42. doi: 10.1016/0091-3057(94)90325-5.","Smurthwaite ST","Pharmacol Biochem Behav","1994","1994/07/01","","","10.1016/0091-3057(94)90325-5"
"7936103","Participation of opioid receptor types on post-tetanic twitch inhibition in isolated guinea-pig ileal longitudinal muscle","Ozaki M, Miyamoto Y, Kishioka S, Masuda Y, Yamamoto H.","Neuropharmacology. 1994 May;33(5):671-9. doi: 10.1016/0028-3908(94)90173-2.","Ozaki M","Neuropharmacology","1994","1994/05/01","","","10.1016/0028-3908(94)90173-2"
"7934637","The role of delta-opioid receptor subtypes in cocaine- and methamphetamine-induced place preferences","Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H.","Life Sci. 1994;55(17):PL339-44. doi: 10.1016/0024-3205(94)00774-8.","Suzuki T","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00774-8"
"7934309","The involvement of opioid delta receptor in restraint-induced antinociception in mice","Wong CL.","Methods Find Exp Clin Pharmacol. 1994 Jun;16(5):309-13.","Wong CL","Methods Find Exp Clin Pharmacol","1994","1994/06/01","","",""
"7932212","Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys","France CP, Gerak LR.","J Pharmacol Exp Ther. 1994 Sep;270(3):992-9.","France CP","J Pharmacol Exp Ther","1994","1994/09/01","","",""
"7932161","A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity","Freier DO, Fuchs BA.","J Pharmacol Exp Ther. 1994 Sep;270(3):1127-33.","Freier DO","J Pharmacol Exp Ther","1994","1994/09/01","","",""
"7932149","Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys","Negus SS, Butelman ER, Chang KJ, DeCosta B, Winger G, Woods JH.","J Pharmacol Exp Ther. 1994 Sep;270(3):1025-34.","Negus SS","J Pharmacol Exp Ther","1994","1994/09/01","","",""
"7931552","Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons","Moises HC, Rusin KI, Macdonald RL.","J Neurosci. 1994 Oct;14(10):5903-16. doi: 10.1523/JNEUROSCI.14-10-05903.1994.","Moises HC","J Neurosci","1994","1994/10/01","PMC6577010","","10.1523/JNEUROSCI.14-10-05903.1994"
"7931548","Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cells","Barg J, Belcheva MM, Zimlichman R, Levy R, Saya D, McHale RJ, Johnson FE, Coscia CJ, Vogel Z.","Version 2. J Neurosci. 1994 Oct;14(10):5858-64. doi: 10.1523/JNEUROSCI.14-10-05858.1994.","Barg J","J Neurosci","1994","1994/10/01","PMC2504522","NIHMS57738","10.1523/JNEUROSCI.14-10-05858.1994"
"7928111","Metastasis and neuroendocrine system in stressed mice","Giraldi T, Perissin L, Zorzet S, Rapozzi V, Rodani MG.","Int J Neurosci. 1994 Jan-Feb;74(1-4):265-78. doi: 10.3109/00207459408987245.","Giraldi T","Int J Neurosci","1994","1994/01/01","","","10.3109/00207459408987245"
"7927646","Receptor-mediated regulation of neuropeptide gene expression in astrocytes","Schwartz JP, Nishiyama N, Wilson D, Taniwaki T.","Glia. 1994 Jun;11(2):185-90. doi: 10.1002/glia.440110212.","Schwartz JP","Glia","1994","1994/06/01","","","10.1002/glia.440110212"
"7926497","The kappa agonist fedotozine modulates colonic distention-induced inhibition of gastric motility and emptying in dogs","Gué M, Junien JL, Buéno L.","Gastroenterology. 1994 Nov;107(5):1327-34. doi: 10.1016/0016-5085(94)90534-7.","Gué M","Gastroenterology","1994","1994/11/01","","","10.1016/0016-5085(94)90534-7"
"7922530","Behavioral effects of lipopolysaccharide in rats: involvement of endogenous opioids","Yirmiya R, Rosen H, Donchin O, Ovadia H.","Brain Res. 1994 Jun 13;648(1):80-6. doi: 10.1016/0006-8993(94)91908-9.","Yirmiya R","Brain Res","1994","1994/06/13","","","10.1016/0006-8993(94)91908-9"
"7922523","Effect of opioid antagonism on beta-endorphin processing and proopiomelanocortin-peptide release in the hypothalamus","Jaffe SB, Sobieszczyk S, Wardlaw SL.","Brain Res. 1994 Jun 13;648(1):24-31. doi: 10.1016/0006-8993(94)91900-3.","Jaffe SB","Brain Res","1994","1994/06/13","","","10.1016/0006-8993(94)91900-3"
"7915312","Pharmacological characterization of dynorphin A (1-17)-induced effects on spinal cord-evoked potentials","Ristic H, Isaac L.","J Pharmacol Exp Ther. 1994 Aug;270(2):534-9.","Ristic H","J Pharmacol Exp Ther","1994","1994/08/01","","",""
"7914889","Semiparametric models for antagonistic drug interactions","Troconiz IF, Sheiner LB, Verotta D.","J Appl Physiol (1985). 1994 May;76(5):2224-33. doi: 10.1152/jappl.1994.76.5.2224.","Troconiz IF","J Appl Physiol (1985)","1994","1994/05/01","","","10.1152/jappl.1994.76.5.2224"
"7913954","Kappa opioids inhibit induction of long-term potentiation in the dentate gyrus of the guinea pig hippocampus","Terman GW, Wagner JJ, Chavkin C.","J Neurosci. 1994 Aug;14(8):4740-7. doi: 10.1523/JNEUROSCI.14-08-04740.1994.","Terman GW","J Neurosci","1994","1994/08/01","PMC6577189","","10.1523/JNEUROSCI.14-08-04740.1994"
"7913047","Cardiovascular responses to intra-hippocampal dynorphin A-(1-8) in spontaneously hypertensive rats","Wang JQ, Ingenito AJ.","Eur J Pharmacol. 1994 Apr 11;256(1):57-64. doi: 10.1016/0014-2999(94)90616-5.","Wang JQ","Eur J Pharmacol","1994","1994/04/11","","","10.1016/0014-2999(94)90616-5"
"7912425","Comparative effects of intrahippocampal injection of dynorphin A(1-8), dynorphin A(1-13), dynorphin A(1-17), U-50,488H, and dynorphin B on blood pressure and heart rate in spontaneously hypertensive and normotensive Wistar-Kyoto rats","Wang JQ, Ingenito AJ.","Peptides. 1994 Jan;15(1):125-32. doi: 10.1016/0196-9781(94)90180-5.","Wang JQ","Peptides","1994","1994/01/01","","","10.1016/0196-9781(94)90180-5"
"7912273","Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat","Guirimand F, Strimbu-Gozariu M, Willer JC, Le Bars D.","J Pharmacol Exp Ther. 1994 Jun;269(3):1007-20.","Guirimand F","J Pharmacol Exp Ther","1994","1994/06/01","","",""
"7911987","Electrophysiological studies on the spinal roles of endogenous opioids in carrageenan inflammation","Stanfa LC, Dickenson AH.","Pain. 1994 Feb;56(2):185-91. doi: 10.1016/0304-3959(94)90093-0.","Stanfa LC","Pain","1994","1994/02/01","","","10.1016/0304-3959(94)90093-0"
"7911578","Central administration of the endopeptidase 24.15 inhibitor cFP-AAF-pAB suggests dynorphin as the endogenous ligand underlying behavioral effects of milk in the fetal rat","Smotherman WP, Robinson SR, Varlinskaya EI, Petrov ES, Orlowski M, de Costa BR, Rice KC.","Pharmacol Biochem Behav. 1994 Mar;47(3):715-9. doi: 10.1016/0091-3057(94)90178-3.","Smotherman WP","Pharmacol Biochem Behav","1994","1994/03/01","","","10.1016/0091-3057(94)90178-3"
"7910928","Etonitazene-induced antinociception in mu1 opioid receptor deficient CXBK mice: evidence for a role for mu2 receptors in supraspinal antinociception","Connelly CD, Martinez RP, Schupsky JJ, Porreca F, Raffa RB.","Life Sci. 1994;54(21):PL369-74. doi: 10.1016/0024-3205(94)90037-x.","Connelly CD","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)90037-x"
"7910769","Cardiovascular effects of microinjection of dynorphin-A(1-8) into the hippocampus in conscious, spontaneously hypertensive and normotensive Wistar-Kyoto rats","Wang JQ, Ingenito AJ.","Clin Exp Hypertens. 1994 Mar;16(2):229-43. doi: 10.3109/10641969409067951.","Wang JQ","Clin Exp Hypertens","1994","1994/03/01","","","10.3109/10641969409067951"
"7909142","Neurochemical evidence that estrogen-induced suppression of kappa-opioid-receptor-mediated regulation of tuberoinfundibular dopaminergic neurons is prolactin-independent","Wagner EJ, Manzanares J, Moore KE, Lookingland KJ.","Neuroendocrinology. 1994 Mar;59(3):197-201. doi: 10.1159/000126659.","Wagner EJ","Neuroendocrinology","1994","1994/03/01","","","10.1159/000126659"
"7908805","[Effect of naloxone and naltrexone on the postprandial energy expenditure and endocrine pancreas response to a mixed meal in essential obesity]","Signorini AM, Fondelli C, Garosi G, Borgogni L, Tanganelli I, Gragnoli G.","Boll Soc Ital Biol Sper. 1993 Jul-Aug;69(7-8):447-52.","Signorini AM","Boll Soc Ital Biol Sper","1993","1993/07/01","","",""
"7908722","Blockade of morphine reward through the activation of kappa-opioid receptors in mice","Funada M, Suzuki T, Narita M, Misawa M, Nagase H.","Neuropharmacology. 1993 Dec;32(12):1315-23. doi: 10.1016/0028-3908(93)90026-y.","Funada M","Neuropharmacology","1993","1993/12/01","","","10.1016/0028-3908(93)90026-y"
"7908601","Opioid receptor antagonist nalmefene stereospecifically inhibits glutamate release during global cerebral ischemia","Graham SH, Shimizu H, Newman A, Weinstein P, Faden AI.","Brain Res. 1993 Dec 31;632(1-2):346-50. doi: 10.1016/0006-8993(93)91175-r.","Graham SH","Brain Res","1993","1993/12/31","","","10.1016/0006-8993(93)91175-r"
"7906352","Sequential use of opioid antagonists and agonists in Tourette's syndrome","McConville BJ, Norman AB, Fogelson MH, Erenberg G.","Lancet. 1994 Mar 5;343(8897):601. doi: 10.1016/s0140-6736(94)91553-9.","McConville BJ","Lancet","1994","1994/03/05","","","10.1016/s0140-6736(94)91553-9"
"7904531","The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat","Lambert PD, Wilding JP, al-Dokhayel AA, Gilbey SG, Bloom SR.","Brain Res. 1993 Nov 26;629(1):146-8. doi: 10.1016/0006-8993(93)90493-7.","Lambert PD","Brain Res","1993","1993/11/26","","","10.1016/0006-8993(93)90493-7"
"7904217","Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities","Aman MG.","Ann Clin Psychiatry. 1993 Sep;5(3):171-88. doi: 10.3109/10401239309148981.","Aman MG","Ann Clin Psychiatry","1993","1993/09/01","","","10.3109/10401239309148981"
"7903457","Dynorphin A(1-17) mediates midazolam antagonism of morphine antinociception in mice","Rady JJ, Fujimoto JM.","Pharmacol Biochem Behav. 1993 Oct;46(2):331-9. doi: 10.1016/0091-3057(93)90361-v.","Rady JJ","Pharmacol Biochem Behav","1993","1993/10/01","","","10.1016/0091-3057(93)90361-v"
"7903391","Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats","Comer SD, Lac ST, Curtis LK, Carroll ME.","J Pharmacol Exp Ther. 1993 Dec;267(3):1470-7.","Comer SD","J Pharmacol Exp Ther","1993","1993/12/01","","",""
"7902813","Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists","Devine DP, Leone P, Wise RA.","Eur J Pharmacol. 1993 Oct 12;243(1):55-64. doi: 10.1016/0014-2999(93)90167-g.","Devine DP","Eur J Pharmacol","1993","1993/10/12","","","10.1016/0014-2999(93)90167-g"
"7902680","Inhibiting a spinal dynorphin A component enhances intrathecal morphine antinociception in mice","Holmes BB, Fujimoto JM.","Anesth Analg. 1993 Dec;77(6):1166-73. doi: 10.1213/00000539-199312000-00015.","Holmes BB","Anesth Analg","1993","1993/12/01","","","10.1213/00000539-199312000-00015"
"7902584","kappa-Opioid receptors also increase potassium conductance","Grudt TJ, Williams JT.","Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11429-32. doi: 10.1073/pnas.90.23.11429.","Grudt TJ","Proc Natl Acad Sci U S A","1993","1993/12/01","PMC47996","","10.1073/pnas.90.23.11429"
"7902369","Opioid antagonist affects behavioral effects of exposure in vivo","Arntz A, Merckelbach H, de Jong P.","J Consult Clin Psychol. 1993 Oct;61(5):865-70. doi: 10.1037//0022-006x.61.5.865.","Arntz A","J Consult Clin Psychol","1993","1993/10/01","","","10.1037//0022-006x.61.5.865"
"7902288","The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs","Brent PJ, Chahl LA, Cantarell PA, Kavanagh C.","Eur J Pharmacol. 1993 Sep 14;241(2-3):149-56. doi: 10.1016/0014-2999(93)90196-o.","Brent PJ","Eur J Pharmacol","1993","1993/09/14","","","10.1016/0014-2999(93)90196-o"
"7902011","Mechanism of action of CCK in avian gastroduodenal motility: evidence for nitric oxide involvement","Martinez V, Jimenez M, Goñalons E, Vergara P.","Am J Physiol. 1993 Nov;265(5 Pt 1):G842-50. doi: 10.1152/ajpgi.1993.265.5.G842.","Martinez V","Am J Physiol","1993","1993/11/01","","","10.1152/ajpgi.1993.265.5.G842"
"7901877","Recent developments in alcoholism:opioid peptides","Froehlich JC, Li TK.","Recent Dev Alcohol. 1993;11:187-205.","Froehlich JC","Recent Dev Alcohol","1993","1993/01/01","","",""
"7901396","Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency","Walker EA, Butelman ER, DeCosta BR, Woods JH.","J Pharmacol Exp Ther. 1993 Oct;267(1):280-6.","Walker EA","J Pharmacol Exp Ther","1993","1993/10/01","","",""
"7901389","Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens","Izenwasser S, Búzás B, Cox BM.","J Pharmacol Exp Ther. 1993 Oct;267(1):145-52.","Izenwasser S","J Pharmacol Exp Ther","1993","1993/10/01","","",""
"7900916","Role of endogenous central opioid mechanisms in maintenance of body sodium balance","Kapusta DR, Obih JC.","Am J Physiol. 1995 Mar;268(3 Pt 2):R723-30. doi: 10.1152/ajpregu.1995.268.3.R723.","Kapusta DR","Am J Physiol","1995","1995/03/01","","","10.1152/ajpregu.1995.268.3.R723"
"7899479","Influence of hypertension development on rat tail artery responses to opioid peptides","Wong SC, Ingenito AJ.","Pharmacology. 1995 Jan;50(1):40-50. doi: 10.1159/000139265.","Wong SC","Pharmacology","1995","1995/01/01","","","10.1159/000139265"
"7898778","Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat","Ossipov MH, Kovelowski CJ, Vanderah T, Porreca F.","Neurosci Lett. 1994 Nov 7;181(1-2):9-12. doi: 10.1016/0304-3940(94)90548-7.","Ossipov MH","Neurosci Lett","1994","1994/11/07","","","10.1016/0304-3940(94)90548-7"
"7898771","U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats","Maisonneuve IM, Archer S, Glick SD.","Neurosci Lett. 1994 Nov 7;181(1-2):57-60. doi: 10.1016/0304-3940(94)90559-2.","Maisonneuve IM","Neurosci Lett","1994","1994/11/07","","","10.1016/0304-3940(94)90559-2"
"7896657","Case study: paradoxical response to naltrexone treatment of self-injurious behavior","Benjamin S, Seek A, Tresise L, Price E, Gagnon M.","J Am Acad Child Adolesc Psychiatry. 1995 Feb;34(2):238-42. doi: 10.1097/00004583-199502000-00020.","Benjamin S","J Am Acad Child Adolesc Psychiatry","1995","1995/02/01","","","10.1097/00004583-199502000-00020"
"7896655","Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study","Kolmen BK, Feldman HM, Handen BL, Janosky JE.","J Am Acad Child Adolesc Psychiatry. 1995 Feb;34(2):223-31. doi: 10.1097/00004583-199502000-00018.","Kolmen BK","J Am Acad Child Adolesc Psychiatry","1995","1995/02/01","","","10.1097/00004583-199502000-00018"
"7895030","Streptozotocin-induced diabetes produces a naltrexone-reversible lowering of self-stimulation threshold","Carr KD.","Brain Res. 1994 Nov 21;664(1-2):211-4. doi: 10.1016/0006-8993(94)91973-9.","Carr KD","Brain Res","1994","1994/11/21","","","10.1016/0006-8993(94)91973-9"
"7894264","Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse","Przewłocka B, Machelska H, Lasoń W.","Eur Neuropsychopharmacol. 1994 Dec;4(4):527-33. doi: 10.1016/0924-977x(94)90302-6.","Przewłocka B","Eur Neuropsychopharmacol","1994","1994/12/01","","","10.1016/0924-977x(94)90302-6"
"7891351","The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure","Joseph DB, Bidlack JM.","J Pharmacol Exp Ther. 1995 Mar;272(3):970-6.","Joseph DB","J Pharmacol Exp Ther","1995","1995/03/01","","",""
"7891343","Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation","Pol O, Planas E, Puig MM.","J Pharmacol Exp Ther. 1995 Mar;272(3):1271-6.","Pol O","J Pharmacol Exp Ther","1995","1995/03/01","","",""
"7891340","Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking","Flores LR, Wahl SM, Bayer BM.","J Pharmacol Exp Ther. 1995 Mar;272(3):1246-51.","Flores LR","J Pharmacol Exp Ther","1995","1995/03/01","","",""
"7891326","Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats","Martin TJ, Dworkin SI, Smith JE.","J Pharmacol Exp Ther. 1995 Mar;272(3):1135-40.","Martin TJ","J Pharmacol Exp Ther","1995","1995/03/01","","",""
"7890130","Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians","Gillberg C.","Dev Med Child Neurol. 1995 Mar;37(3):239-45. doi: 10.1111/j.1469-8749.1995.tb11998.x.","Gillberg C","Dev Med Child Neurol","1995","1995/03/01","","","10.1111/j.1469-8749.1995.tb11998.x"
"7890042","kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments","Avidor-Reiss T, Zippel R, Levy R, Saya D, Ezra V, Barg J, Matus-Leibovitch N, Vogel Z.","FEBS Lett. 1995 Mar 13;361(1):70-4. doi: 10.1016/0014-5793(95)00154-2.","Avidor-Reiss T","FEBS Lett","1995","1995/03/13","","","10.1016/0014-5793(95)00154-2"
"7887206","[Impulsive behaviors in opiate-dependent subjects treated with naltrexone]","Pérez de los Cobos J, Pinet C, Ribalta E, Trujols J, Casas M.","Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1994 Nov-Dec;22(6):254-60.","Pérez de los Cobos J","Actas Luso Esp Neurol Psiquiatr Cienc Afines","1994","1994/11/01","","",""
"7886089","Effects of the delta-opioid agonist, [D-Pen2,D-Pen5]-enkephalin, on fetal lamb EEG","Szeto HH, Cheng PY, Wu DL, Soong Y.","Pharmacol Biochem Behav. 1994 Dec;49(4):795-800. doi: 10.1016/0091-3057(94)90225-9.","Szeto HH","Pharmacol Biochem Behav","1994","1994/12/01","","","10.1016/0091-3057(94)90225-9"
"7885192","Long-term sensitization to the behavioral effects of naltrexone is associated with regionally specific changes in the number of mu and delta opioid receptors in rat brain","Marley RJ, Shimosato K, Gewiss M, Thorndike E, Goldberg SR, Schindler CW.","Life Sci. 1995;56(10):767-74. doi: 10.1016/0024-3205(95)00007-s.","Marley RJ","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)00007-s"
"7885084","[USA approves of a new drug that decreases the craving for alcohol]","Wirschubsky ZG.","Lakartidningen. 1995 Mar 8;92(10):1005.","Wirschubsky ZG","Lakartidningen","1995","1995/03/08","","",""
"7883843","Prolonged opioid blockade does not influence luteinizing hormone modifications of the follicular and luteal menstrual phases","Cagnacci A, Paoletti AM, Soldani R, Tuveri F, Melis GB.","J Clin Endocrinol Metab. 1995 Mar;80(3):860-3. doi: 10.1210/jcem.80.3.7883843.","Cagnacci A","J Clin Endocrinol Metab","1995","1995/03/01","","","10.1210/jcem.80.3.7883843"
"7880010","[Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal]","Patricio LD, Miguel N.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:28-30.","Patricio LD","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7871070","Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay","Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH.","Psychopharmacology (Berl). 1994 Jul;115(3):311-9. doi: 10.1007/BF02245071.","Broadbear JH","Psychopharmacology (Berl)","1994","1994/07/01","","","10.1007/BF02245071"
"7870983","Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice","Narita M, Suzuki T, Funada M, Misawa M, Nagase H.","Psychopharmacology (Berl). 1993;111(4):423-6. doi: 10.1007/BF02253531.","Narita M","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02253531"
"7870973","Norbinaltorphimine blocks the feeding but not the reinforcing effect of lateral hypothalamic electrical stimulation","Carr KD, Papadouka V, Wolinsky TD.","Psychopharmacology (Berl). 1993;111(3):345-50. doi: 10.1007/BF02244951.","Carr KD","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02244951"
"7870955","Heroin self-administration in rats under a progressive ratio schedule of reinforcement","Roberts DC, Bennett SA.","Psychopharmacology (Berl). 1993;111(2):215-8. doi: 10.1007/BF02245526.","Roberts DC","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02245526"
"7870937","Effect of clonidine on the responsiveness of infant rats to maternal stimuli","Hansen S.","Psychopharmacology (Berl). 1993;111(1):78-84. doi: 10.1007/BF02257410.","Hansen S","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02257410"
"7870900","Pharmacological specificity of enhanced sensitivity to naltrexone in rats","Schindler CW, Goldberg SR, Katz JL.","Psychopharmacology (Berl). 1993;110(1-2):60-8. doi: 10.1007/BF02246951.","Schindler CW","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02246951"
"7870894","Antagonism of the morphine-induced Straub tail reaction by kappa-opioid receptor activation in mice","Narita M, Suzuki T, Misawa M, Nagase H.","Psychopharmacology (Berl). 1993;110(1-2):254-6. doi: 10.1007/BF02246982.","Narita M","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02246982"
"7865894","Both T cells and macrophages are targets of kappa-opioid-induced immunosuppression","Guan L, Townsend R, Eisenstein TK, Adler MW, Rogers TJ.","Brain Behav Immun. 1994 Sep;8(3):229-40. doi: 10.1006/brbi.1994.1021.","Guan L","Brain Behav Immun","1994","1994/09/01","","","10.1006/brbi.1994.1021"
"7865893","Electrical stimulation of the dorsal midbrain periaqueductal gray suppresses peripheral blood natural killer cell activity","Demetrikopoulos MK, Siegel A, Schleifer SJ, Obedi J, Keller SE.","Brain Behav Immun. 1994 Sep;8(3):218-28. doi: 10.1006/brbi.1994.1020.","Demetrikopoulos MK","Brain Behav Immun","1994","1994/09/01","","","10.1006/brbi.1994.1020"
"7865139","Treatment of alcoholism as a chronic disorder","O'Brien CP.","Alcohol. 1994 Nov-Dec;11(6):433-7. doi: 10.1016/0741-8329(94)90063-9.","O'Brien CP","Alcohol","1994","1994/11/01","","","10.1016/0741-8329(94)90063-9"
"7862883","Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release","Spanagel R, Almeida OF, Bartl C, Shippenberg TS.","Psychopharmacology (Berl). 1994 Jun;115(1-2):121-7. doi: 10.1007/BF02244761.","Spanagel R","Psychopharmacology (Berl)","1994","1994/06/01","","","10.1007/BF02244761"
"7862859","Pharmacological analysis of the rate-decreasing effects of mu and kappa opioids in pigeons","Mattox AJ, Picker MJ, Dykstra LA.","Psychopharmacology (Berl). 1994 Jan;113(3-4):457-62. doi: 10.1007/BF02245223.","Mattox AJ","Psychopharmacology (Berl)","1994","1994/01/01","","","10.1007/BF02245223"
"7862822","Delta-opiod receptor-mediated forced swimming stress-induced antinociception in the formalin test","Kamei J, Hitosugi H, Misawa M, Nagase H, Kasuya Y.","Psychopharmacology (Berl). 1993;113(1):15-8. doi: 10.1007/BF02244327.","Kamei J","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02244327"
"7862713","GABA receptor-linked chloride channels and the behavioral effects of naltrexone in rats","Gewiss MV, Marley RJ, Thorndike EB, Goldberg SR, Schindler CW.","Pharmacol Biochem Behav. 1994 Nov;49(3):589-97. doi: 10.1016/0091-3057(94)90074-4.","Gewiss MV","Pharmacol Biochem Behav","1994","1994/11/01","","","10.1016/0091-3057(94)90074-4"
"7862634","Identification of kappa opioid receptors in the immune system by indirect immunofluorescence","Lawrence DM, el-Hamouly W, Archer S, Leary JF, Bidlack JM.","Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1062-6. doi: 10.1073/pnas.92.4.1062.","Lawrence DM","Proc Natl Acad Sci U S A","1995","1995/02/14","PMC42637","","10.1073/pnas.92.4.1062"
"7861658","Blockade of delta-opioid receptors prevents morphine-induced place preference in mice","Suzuki T, Yoshiike M, Mizoguchi H, Kamei J, Misawa M, Nagase H.","Jpn J Pharmacol. 1994 Sep;66(1):131-7. doi: 10.1254/jjp.66.131.","Suzuki T","Jpn J Pharmacol","1994","1994/09/01","","","10.1254/jjp.66.131"
"7855202","Ultrasounds emitted by female rats during agonistic interactions: effects of morphine and naltrexone","Haney M, Miczek KA.","Psychopharmacology (Berl). 1994 Apr;114(3):441-8. doi: 10.1007/BF02249334.","Haney M","Psychopharmacology (Berl)","1994","1994/04/01","","","10.1007/BF02249334"
"7855177","The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice","Kamei J, Kawashima N, Iwamoto Y, Suzuki T, Nagase H, Misawa M, Kasuya Y.","Psychopharmacology (Berl). 1993;113(2):167-71. doi: 10.1007/BF02245693.","Kamei J","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02245693"
"7853350","Isothiocyanate-substituted benzyl ether opioid receptor ligands derived from 6 beta-naltrexol","Davis RD, Nelson WL.","J Med Chem. 1995 Feb 3;38(3):570-9. doi: 10.1021/jm00003a020.","Davis RD","J Med Chem","1995","1995/02/03","","","10.1021/jm00003a020"
"7853332","7'-Substituted amino acid conjugates of naltrindole. Hydrophilic groups as determinants of selective antagonism of delta 1 opioid receptor-mediated antinociception in mice","Portoghese PS, Farouz-Grant F, Sultana M, Takemori AE.","J Med Chem. 1995 Feb 3;38(3):402-7. doi: 10.1021/jm00003a002.","Portoghese PS","J Med Chem","1995","1995/02/03","","","10.1021/jm00003a002"
"7853168","Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist","Pakarinen ED, Woods JH, Moerschbaecher JM.","J Pharmacol Exp Ther. 1995 Feb;272(2):552-9.","Pakarinen ED","J Pharmacol Exp Ther","1995","1995/02/01","","",""
"7852517","Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemic women","Matera C, Freda PU, Ferin M, Wardlaw SL.","J Clin Endocrinol Metab. 1995 Feb;80(2):540-5. doi: 10.1210/jcem.80.2.7852517.","Matera C","J Clin Endocrinol Metab","1995","1995/02/01","","","10.1210/jcem.80.2.7852517"
"7852157","Use of naltrexone for treatment of psychogenically induced dermatoses in five zoo animals","Kenny DE.","J Am Vet Med Assoc. 1994 Oct 1;205(7):1021-3.","Kenny DE","J Am Vet Med Assoc","1994","1994/10/01","","",""
"7851478","Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes","Spanagel R, Almeida OF, Shippenberg TS.","Eur J Pharmacol. 1994 Oct 24;264(2):157-62. doi: 10.1016/0014-2999(94)00449-8.","Spanagel R","Eur J Pharmacol","1994","1994/10/24","","","10.1016/0014-2999(94)00449-8"
"7850467","A permissive role of corticosterone in an opioid form of stress-induced analgesia: blockade of opiate analgesia is not due to stress-induced hormone release","Sutton LC, Fleshner M, Mazzeo R, Maier SF, Watkins LR.","Brain Res. 1994 Nov 7;663(1):19-29. doi: 10.1016/0006-8993(94)90458-8.","Sutton LC","Brain Res","1994","1994/11/07","","","10.1016/0006-8993(94)90458-8"
"7847604","Changes in transaminases over the course of a 12-week, double-blind nalmefene trial in a 38-year-old female subject","Salvato FR, Mason BJ.","Alcohol Clin Exp Res. 1994 Oct;18(5):1187-9. doi: 10.1111/j.1530-0277.1994.tb00102.x.","Salvato FR","Alcohol Clin Exp Res","1994","1994/10/01","","","10.1111/j.1530-0277.1994.tb00102.x"
"7847600","A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence","Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E.","Alcohol Clin Exp Res. 1994 Oct;18(5):1162-7. doi: 10.1111/j.1530-0277.1994.tb00098.x.","Mason BJ","Alcohol Clin Exp Res","1994","1994/10/01","","","10.1111/j.1530-0277.1994.tb00098.x"
"7845553","Effect of selective mu 1, mu 2 and delta 2 opioid receptor agonists on gastric functions in the rat","Improta G, Broccardo M.","Neuropharmacology. 1994 Aug;33(8):977-81. doi: 10.1016/0028-3908(94)90155-4.","Improta G","Neuropharmacology","1994","1994/08/01","","","10.1016/0028-3908(94)90155-4"
"7844861","From the Food and Drug Administration","Nightingale SL.","JAMA. 1995 Feb 22;273(8):613. doi: 10.1001/jama.273.8.613.","Nightingale SL","JAMA","1995","1995/02/22","","","10.1001/jama.273.8.613"
"7843855","OHM3295: a fentanyl-related 4-heteroanilido piperidine with analgesic effects but not suppressive effects on splenic NK activity in mice","Carr DJ, Baker ML, Holmes C, Brockunier LL, Bagley JR, France CP.","Int J Immunopharmacol. 1994 Oct;16(10):835-44. doi: 10.1016/0192-0561(94)90057-4.","Carr DJ","Int J Immunopharmacol","1994","1994/10/01","","","10.1016/0192-0561(94)90057-4"
"7838911","Naloxone pretreatment blocks acute morphine-induced sensitization to naltrexone","White-Gbadebo D, Holtzman S.","Psychopharmacology (Berl). 1994 Mar;114(2):225-8. doi: 10.1007/BF02244840.","White-Gbadebo D","Psychopharmacology (Berl)","1994","1994/03/01","","","10.1007/BF02244840"
"7836903","Opioid peptides and testicular activity in the lizard Podarcis s. sicula Raf","Ciarcia G, Facchinetti F, Vallarino M, Pestarino M, Paolucci M, Cardone A, Fasano S, Pierantoni R, Genazzani AR.","J Endocrinol. 1994 Dec;143(3):565-71. doi: 10.1677/joe.0.1430565.","Ciarcia G","J Endocrinol","1994","1994/12/01","","","10.1677/joe.0.1430565"
"7831456","Naltrexone plasma levels, clinical response and effect on weight in autistic children","Gonzalez NM, Campbell M, Small AM, Shay J, Bluhm LD, Adams PB, Foltz RL.","Psychopharmacol Bull. 1994;30(2):203-8.","Gonzalez NM","Psychopharmacol Bull","1994","1994/01/01","","",""
"7829663","Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement","Coussons-Read ME, Dykstra LA, Lysle DT.","J Neuroimmunol. 1994 Dec;55(2):135-42. doi: 10.1016/0165-5728(94)90003-5.","Coussons-Read ME","J Neuroimmunol","1994","1994/12/01","","","10.1016/0165-5728(94)90003-5"
"7829285","Naltrexone attenuates the antiparkinsonian effects of picoTesla range magnetic fields","Sandyk R, Iacono RP.","Int J Neurosci. 1994 Sep;78(1-2):111-22. doi: 10.3109/00207459408986050.","Sandyk R","Int J Neurosci","1994","1994/09/01","","","10.3109/00207459408986050"
"7824591","Differing mechanisms for proactive effects of intermittent and single shock on gastric ulceration","Overmier JB, Murison R.","Physiol Behav. 1994 Nov;56(5):913-9. doi: 10.1016/0031-9384(94)90323-9.","Overmier JB","Physiol Behav","1994","1994/11/01","","","10.1016/0031-9384(94)90323-9"
"7821355","Attenuation of the discriminative stimulus properties of cocaine by delta-opioid receptor antagonists","Suzuki T, Mori T, Funada M, Misawa M, Nagase H.","Eur J Pharmacol. 1994 Sep 22;263(1-2):207-11. doi: 10.1016/0014-2999(94)90544-4.","Suzuki T","Eur J Pharmacol","1994","1994/09/22","","","10.1016/0014-2999(94)90544-4"
"7821354","Morphine-induced straub tail response: mediated by central mu2-opioid receptor","Nath C, Gupta MB, Patnaik GK, Dhawan KN.","Eur J Pharmacol. 1994 Sep 22;263(1-2):203-5. doi: 10.1016/0014-2999(94)90543-6.","Nath C","Eur J Pharmacol","1994","1994/09/22","","","10.1016/0014-2999(94)90543-6"
"7820634","Central opioid receptor subtype mediation of isoproterenol-induced drinking in rats","Glass MJ, Hahn B, Joseph A, Bodnar RJ.","Brain Res. 1994 Sep 19;657(1-2):310-4. doi: 10.1016/0006-8993(94)90982-2.","Glass MJ","Brain Res","1994","1994/09/19","","","10.1016/0006-8993(94)90982-2"
"7816875","Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 2. 2-deoxy-D-glucose","Schaefer LA, Koch JE, Bodnar RJ.","Pharmacol Biochem Behav. 1994 Sep;49(1):205-11. doi: 10.1016/0091-3057(94)90477-4.","Schaefer LA","Pharmacol Biochem Behav","1994","1994/09/01","","","10.1016/0091-3057(94)90477-4"
"7816874","Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 1. Food deprivation","Hobbs DJ, Koch JE, Bodnar RJ.","Pharmacol Biochem Behav. 1994 Sep;49(1):197-204. doi: 10.1016/0091-3057(94)90476-6.","Hobbs DJ","Pharmacol Biochem Behav","1994","1994/09/01","","","10.1016/0091-3057(94)90476-6"
"7816344","Effects of diabetes on spontaneous locomotor activity in mice","Kamei J, Saitoh A, Iwamoto Y, Funada M, Suzuki T, Misawa M, Nagase H, Kasuya Y.","Neurosci Lett. 1994 Aug 29;178(1):69-72. doi: 10.1016/0304-3940(94)90292-5.","Kamei J","Neurosci Lett","1994","1994/08/29","","","10.1016/0304-3940(94)90292-5"
"7816343","Effects of diabetes on the morphine-induced Straub tail reaction in mice","Kamei J, Ohsawa M, Misawa M, Nagase H, Kasuya Y.","Neurosci Lett. 1994 Aug 29;178(1):66-8. doi: 10.1016/0304-3940(94)90291-7.","Kamei J","Neurosci Lett","1994","1994/08/29","","","10.1016/0304-3940(94)90291-7"
"7815347","Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation","Law PY, Bergsbaken C.","J Pharmacol Exp Ther. 1995 Jan;272(1):322-32.","Law PY","J Pharmacol Exp Ther","1995","1995/01/01","","",""
"7815100","Differential effects of methionine enkephalin on the growth of brain tumor cells","Lee YS, Wurster RD.","J Neurooncol. 1994;19(1):11-5. doi: 10.1007/BF01051044.","Lee YS","J Neurooncol","1994","1994/01/01","","","10.1007/BF01051044"
"7813576","Delta-opioid receptor agonists inhibit neuromuscular transmission in human colon","Chamouard P, Rohr S, Meyer C, Baumann R, Angel F.","Eur J Pharmacol. 1994 Sep 1;262(1-2):33-9. doi: 10.1016/0014-2999(94)90025-6.","Chamouard P","Eur J Pharmacol","1994","1994/09/01","","","10.1016/0014-2999(94)90025-6"
"7809540","[Effect of chronic blockade of the opiodergic receptor on insulin resistance in a hyperandrogenic woman]","Sir T, López G, Alba F, Cipriano A, Candía M, Castillo T, Devoto L.","Rev Med Chil. 1994 Apr;122(4):441-7.","Sir T","Rev Med Chil","1994","1994/04/01","","",""
"7806698","A naltrexone-induced increase in insulin requirement","Marrazzi MA, Jacober S, Luby ED.","J Clin Psychopharmacol. 1994 Oct;14(5):363-5.","Marrazzi MA","J Clin Psychopharmacol","1994","1994/10/01","","",""
"7806598","Opiate antagonists for the treatment of schizophrenia","Welch EB, Thompson DF.","J Clin Pharm Ther. 1994 Oct;19(5):279-83. doi: 10.1111/j.1365-2710.1994.tb00814.x.","Welch EB","J Clin Pharm Ther","1994","1994/10/01","","","10.1111/j.1365-2710.1994.tb00814.x"
"7805771","Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine","Elliott J, Smart D, Lambert DG, Traynor JR.","Eur J Pharmacol. 1994 Aug 16;268(3):447-50. doi: 10.1016/0922-4106(94)90072-8.","Elliott J","Eur J Pharmacol","1994","1994/08/16","","","10.1016/0922-4106(94)90072-8"
"7796321","Effect of diabetes on the morphine-induced inhibition of gastrointestinal transit","Kamei J, Ohsawa M, Misawa M, Nagase H, Kasuya Y.","Nihon Shinkei Seishin Yakurigaku Zasshi. 1995 Apr;15(2):165-9.","Kamei J","Nihon Shinkei Seishin Yakurigaku Zasshi","1995","1995/04/01","","",""
"7791961","Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat","Briski KP, Vogel KL.","Neuropeptides. 1995 Mar;28(3):175-81. doi: 10.1016/0143-4179(95)90113-2.","Briski KP","Neuropeptides","1995","1995/03/01","","","10.1016/0143-4179(95)90113-2"
"7791117","mu-, delta- and kappa-opiate receptors mediate antinociception in the rat tail flick test following noxious thermal stimulation of one hindpaw","Pitcher GM, Yashpal K, Coderre TJ, Henry JL.","J Pharmacol Exp Ther. 1995 Jun;273(3):1428-33.","Pitcher GM","J Pharmacol Exp Ther","1995","1995/06/01","","",""
"7791074","Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition","Liu-Chen LY, Yang HH, Li S, Adams JU.","J Pharmacol Exp Ther. 1995 Jun;273(3):1047-56.","Liu-Chen LY","J Pharmacol Exp Ther","1995","1995/06/01","","",""
"7781680","Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine","Yuan CS, Foss JF, Moss J.","Eur J Pharmacol. 1995 Mar 24;276(1-2):107-11. doi: 10.1016/0014-2999(95)00018-g.","Yuan CS","Eur J Pharmacol","1995","1995/03/24","","","10.1016/0014-2999(95)00018-g"
"7777181","Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats","Przewłocka B, Lasoń W, Machelska H, van Luijtelaar G, Coenen A, Przewłocki R.","Neurosci Lett. 1995 Feb 17;186(2-3):131-4. doi: 10.1016/0304-3940(95)11303-e.","Przewłocka B","Neurosci Lett","1995","1995/02/17","","","10.1016/0304-3940(95)11303-e"
"7775160","Morphine inhibits the development of allogeneic immune responses in mouse lymph node","Maity R, Mukherjee R, Skolnick P.","Immunopharmacology. 1995 Mar;29(2):175-83. doi: 10.1016/0162-3109(94)00058-n.","Maity R","Immunopharmacology","1995","1995/03/01","","","10.1016/0162-3109(94)00058-n"
"7775156","Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice","Carpenter GW, Carr DJ.","Immunopharmacology. 1995 Mar;29(2):129-40. doi: 10.1016/0162-3109(94)00052-h.","Carpenter GW","Immunopharmacology","1995","1995/03/01","","","10.1016/0162-3109(94)00052-h"
"7774673","Evidence that beta-endorphin is an agonist at bovine pineal delta-opioid receptors","Aloyo VJ, Pazdalski PS.","Eur J Pharmacol. 1995 Feb 15;288(3):295-301. doi: 10.1016/0922-4106(95)90041-1.","Aloyo VJ","Eur J Pharmacol","1995","1995/02/15","","","10.1016/0922-4106(95)90041-1"
"7774657","Antinociceptive effect of dihydroetorphine in diabetic mice","Kamei J, Suzuki T, Misawa M, Nagase H, Kasuya Y.","Eur J Pharmacol. 1995 Feb 24;275(1):109-13. doi: 10.1016/0014-2999(95)00013-b.","Kamei J","Eur J Pharmacol","1995","1995/02/24","","","10.1016/0014-2999(95)00013-b"
"7773532","Unexpected prosecretory action component of loperamide at mu-opioid receptors in the guinea-pig colonic mucosa in vitro","Kromer W.","Br J Pharmacol. 1995 Feb;114(4):739-44. doi: 10.1111/j.1476-5381.1995.tb13266.x.","Kromer W","Br J Pharmacol","1995","1995/02/01","PMC1510207","","10.1111/j.1476-5381.1995.tb13266.x"
"7759336","Complications with the use of carfentanil citrate and xylazine hydrochloride to immobilize domestic horses","Shaw ML, Carpenter JW, Leith DE.","J Am Vet Med Assoc. 1995 Mar 15;206(6):833-6.","Shaw ML","J Am Vet Med Assoc","1995","1995/03/15","","",""
"7752296","Clonidine and opiate receptor antagonists in the treatment of heroin addiction","Gerra G, Marcato A, Caccavari R, Fontanesi B, Delsignore R, Fertonani G, Avanzini P, Rustichelli P, Passeri M.","J Subst Abuse Treat. 1995 Jan-Feb;12(1):35-41.","Gerra G","J Subst Abuse Treat","1995","1995/01/01","","",""
"7751946","Endogenous opioids regulate long-term potentiation of synaptic inhibition in the dentate gyrus of rat hippocampus","Xie CW, Lewis DV.","J Neurosci. 1995 May;15(5 Pt 2):3788-95. doi: 10.1523/JNEUROSCI.15-05-03788.1995.","Xie CW","J Neurosci","1995","1995/05/01","PMC6578250","","10.1523/JNEUROSCI.15-05-03788.1995"
"7751426","Evaluation of diurnal variation in fentanyl clearance","Gupta SK, Southam MA, Hwang SS.","J Clin Pharmacol. 1995 Feb;35(2):159-62. doi: 10.1002/j.1552-4604.1995.tb05005.x.","Gupta SK","J Clin Pharmacol","1995","1995/02/01","","","10.1002/j.1552-4604.1995.tb05005.x"
"7749752","Long-term exposure to opioid antagonists up-regulates prodynorphin gene expression in rat brain","Romualdi P, Lesa G, Donatini A, Ferri S.","Brain Res. 1995 Feb 20;672(1-2):42-7. doi: 10.1016/0006-8993(94)01379-v.","Romualdi P","Brain Res","1995","1995/02/20","","","10.1016/0006-8993(94)01379-v"
"7746508","Assessment of endogenous enkephalins efficacy in the hot plate test in mice: comparative study with morphine","Noble F, Roques BP.","Neurosci Lett. 1995 Feb 9;185(2):75-8. doi: 10.1016/0304-3940(94)11228-b.","Noble F","Neurosci Lett","1995","1995/02/09","","","10.1016/0304-3940(94)11228-b"
"7746270","kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes","Ma GH, Miller RJ, Kuznetsov A, Philipson LH.","Mol Pharmacol. 1995 May;47(5):1035-40.","Ma GH","Mol Pharmacol","1995","1995/05/01","","",""
"7745028","Chronic naltrexone treatment induces desensitization of the luteinizing hormone pulse generator for opioid blockade in hyperprolactinemic patients","de Wit W, Schoute E, Schoemaker J.","J Clin Endocrinol Metab. 1995 May;80(5):1739-42. doi: 10.1210/jcem.80.5.7745028.","de Wit W","J Clin Endocrinol Metab","1995","1995/05/01","","","10.1210/jcem.80.5.7745028"
"7740068","Neonatally administered naltrexone affects several behavioral responses in adult rats of both genders","de Cabo de la Vega C, Pujol A, Paz Viveros M.","Pharmacol Biochem Behav. 1995 Feb;50(2):277-86. doi: 10.1016/0091-3057(94)00314-9.","de Cabo de la Vega C","Pharmacol Biochem Behav","1995","1995/02/01","","","10.1016/0091-3057(94)00314-9"
"7740050","CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101","Dauge V, Corringer PJ, Roques BP.","Pharmacol Biochem Behav. 1995 Feb;50(2):133-9. doi: 10.1016/0091-3057(94)00246-f.","Dauge V","Pharmacol Biochem Behav","1995","1995/02/01","","","10.1016/0091-3057(94)00246-f"
"7737308","A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test","Noble F, Blommaert A, Fournié-Zaluski MC, Roques BP.","Eur J Pharmacol. 1995 Jan 24;273(1-2):145-51. doi: 10.1016/0014-2999(94)00688-4.","Noble F","Eur J Pharmacol","1995","1995/01/24","","","10.1016/0014-2999(94)00688-4"
"7735342","Binge eating disorder: response to naltrexone","Marrazzi MA, Markham KM, Kinzie J, Luby ED.","Int J Obes Relat Metab Disord. 1995 Feb;19(2):143-5.","Marrazzi MA","Int J Obes Relat Metab Disord","1995","1995/02/01","","",""
"7733405","Opioid growth factor modulates corneal epithelial outgrowth in tissue culture","Zagon IS, Sassani JW, McLaughlin PJ.","Am J Physiol. 1995 Apr;268(4 Pt 2):R942-50. doi: 10.1152/ajpregu.1995.268.4.R942.","Zagon IS","Am J Physiol","1995","1995/04/01","","","10.1152/ajpregu.1995.268.4.R942"
"7732604","The effects of naltrexone in autistic children: report of two cases","Akkök F.","Turk J Pediatr. 1995 Jan-Mar;37(1):19-23.","Akkök F","Turk J Pediatr","1995","1995/01/01","","",""
"7731019","Electrophilic N-benzylnaltrindoles as delta opioid receptor-selective antagonists","Korlipara VL, Takemori AE, Portoghese PS.","J Med Chem. 1995 Apr 14;38(8):1337-43. doi: 10.1021/jm00008a012.","Korlipara VL","J Med Chem","1995","1995/04/14","","","10.1021/jm00008a012"
"7729641","Increased opioid binding to peripheral white blood cells in a rat model of acute cholestasis","Lang ME, Jourd'Heuil D, Meddings JB, Swain MG.","Gastroenterology. 1995 May;108(5):1479-86. doi: 10.1016/0016-5085(95)90697-5.","Lang ME","Gastroenterology","1995","1995/05/01","","","10.1016/0016-5085(95)90697-5"
"7716485","I get no kick from CH3CH2OH","Nemecek S.","Sci Am. 1995 Apr;272(4):24, 26. doi: 10.1038/scientificamerican0495-24b.","Nemecek S","Sci Am","1995","1995/04/01","","","10.1038/scientificamerican0495-24b"
"7715840","The increase in morphine antinociceptive potency produced by carrageenan-induced hindpaw inflammation is blocked by naltrindole, a selective delta-opioid antagonist","Ossipov MH, Kovelowski CJ, Porreca F.","Neurosci Lett. 1995 Jan 30;184(3):173-6. doi: 10.1016/0304-3940(94)11199-s.","Ossipov MH","Neurosci Lett","1995","1995/01/30","","","10.1016/0304-3940(94)11199-s"
"7714789","SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist","Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC, Porreca F.","J Pharmacol Exp Ther. 1995 Apr;273(1):359-66.","Bilsky EJ","J Pharmacol Exp Ther","1995","1995/04/01","","",""
"7714138","Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome","Lanzone A, Fulghesu AM, Guido M, Ciampelli M, Caruso A, Mancuso S.","Hum Reprod. 1994 Dec;9(12):2242-6. doi: 10.1093/oxfordjournals.humrep.a138430.","Lanzone A","Hum Reprod","1994","1994/12/01","","","10.1093/oxfordjournals.humrep.a138430"
"7714013","The contribution of delta 1- and delta 2-opioid receptors to hypoxia-induced pial artery dilation in the newborn pig","Armstead WM.","J Cereb Blood Flow Metab. 1995 May;15(3):539-46. doi: 10.1038/jcbfm.1995.67.","Armstead WM","J Cereb Blood Flow Metab","1995","1995/05/01","","","10.1038/jcbfm.1995.67"
"7713356","A lack of supersensitivity to opioid receptor agonists following chronic spinal opioid receptor antagonist administration in the rat","Keck BJ, Stafinsky JL, Uram M, Crisp T.","Gen Pharmacol. 1995 Jan;26(1):161-8. doi: 10.1016/0306-3623(94)00154-f.","Keck BJ","Gen Pharmacol","1995","1995/01/01","","","10.1016/0306-3623(94)00154-f"
"7713149","Opioid effects on spinal [3H]5-hydroxytryptamine release are not related to their antinociceptive action","Monroe PJ, Kradel BK, Smith DL, Smith DJ.","Eur J Pharmacol. 1995 Jan 5;272(1):51-6. doi: 10.1016/0014-2999(94)00623-f.","Monroe PJ","Eur J Pharmacol","1995","1995/01/05","","","10.1016/0014-2999(94)00623-f"
"7708177","Clinical case report: opiate antagonist and event-related desynchronization in 2 autistic boys","Lensing P, Schimke H, Klimesch W, Pap V, Szemes G, Klingler D, Panksepp J.","Neuropsychobiology. 1995;31(1):16-23. doi: 10.1159/000119167.","Lensing P","Neuropsychobiology","1995","1995/01/01","","","10.1159/000119167"
"7705968","Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity","Garza HH Jr, Prakash O, Carr DJ.","Int J Immunopharmacol. 1994 Dec;16(12):1061-70. doi: 10.1016/0192-0561(94)90086-8.","Garza HH Jr","Int J Immunopharmacol","1994","1994/12/01","","","10.1016/0192-0561(94)90086-8"
"7701033","SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine","van Dyck CH, Rosen MI, Thomas HM, McMahon TJ, Wallace EA, O'Connor PG, Sullivan M, Krystal JH, Hoffer PB, Woods SW, et al.","Psychiatry Res. 1994 Dec;55(4):181-91. doi: 10.1016/0925-4927(94)90013-2.","van Dyck CH","Psychiatry Res","1994","1994/12/01","","","10.1016/0925-4927(94)90013-2"
"7700837","GRF-induced feeding: evidence for protein selectivity and opiate involvement","Dickson PR, Vaccarino FJ.","Peptides. 1994;15(8):1343-52. doi: 10.1016/0196-9781(94)90107-4.","Dickson PR","Peptides","1994","1994/01/01","","","10.1016/0196-9781(94)90107-4"
"7700561","Activation of mu-opioid receptor modulates GABAA receptor-mediated currents in isolated spinal dorsal horn neurons","Wang RA, Randić M.","Neurosci Lett. 1994 Oct 24;180(2):109-13. doi: 10.1016/0304-3940(94)90499-5.","Wang RA","Neurosci Lett","1994","1994/10/24","","","10.1016/0304-3940(94)90499-5"
"7700253","Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes","Henry DJ, Grandy DK, Lester HA, Davidson N, Chavkin C.","Mol Pharmacol. 1995 Mar;47(3):551-7.","Henry DJ","Mol Pharmacol","1995","1995/03/01","","",""
"7699567","Evidence for functional delta-opiate receptors in the rat intestine","Hancock DL, Coupar IM.","J Pharm Pharmacol. 1994 Oct;46(10):805-8. doi: 10.1111/j.2042-7158.1994.tb03734.x.","Hancock DL","J Pharm Pharmacol","1994","1994/10/01","","","10.1111/j.2042-7158.1994.tb03734.x"
"7698213","Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat","Diop L, Rivière PJ, Pascaud X, Junien JL.","Eur J Pharmacol. 1994 Dec 12;271(1):65-71. doi: 10.1016/0014-2999(94)90265-8.","Diop L","Eur J Pharmacol","1994","1994/12/12","","","10.1016/0014-2999(94)90265-8"
"7698193","Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis","Milanés MV, Vargas ML, Martín MI.","Eur J Pharmacol. 1994 Dec 12;271(1):103-9. doi: 10.1016/0014-2999(94)90270-4.","Milanés MV","Eur J Pharmacol","1994","1994/12/12","","","10.1016/0014-2999(94)90270-4"
"7697383","Analysis of central opioid receptor subtype antagonism of hypotonic and hypertonic saline intake in water-deprived rats","Bodnar RJ, Glass MJ, Koch JE.","Brain Res Bull. 1995;36(3):293-300. doi: 10.1016/0361-9230(94)00205-f.","Bodnar RJ","Brain Res Bull","1995","1995/01/01","","","10.1016/0361-9230(94)00205-f"
"7696612","Antisense oligodeoxynucleotide to the CCKB receptor produces naltrindole- and [Leu5]enkephalin antiserum-sensitive enhancement of morphine antinociception","Vanderah TW, Lai J, Yamamura HI, Porreca F.","Neuroreport. 1994 Dec 20;5(18):2601-5. doi: 10.1097/00001756-199412000-00049.","Vanderah TW","Neuroreport","1994","1994/12/20","","","10.1097/00001756-199412000-00049"
"7694913","Effect of naltrexone on alcohol ""high"" in alcoholics","Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP.","Am J Psychiatry. 1995 Apr;152(4):613-5. doi: 10.1176/ajp.152.4.613.","Volpicelli JR","Am J Psychiatry","1995","1995/04/01","","","10.1176/ajp.152.4.613"
"7694857","Antinociceptive evaluation of 14 beta-(bromoacetamido)-7,8-dihydro- N(cyclopropylmethyl)-normorphinone in mice","Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM.","Eur J Pharmacol. 1993 Aug 24;240(2-3):201-6. doi: 10.1016/0014-2999(93)90899-s.","Jiang Q","Eur J Pharmacol","1993","1993/08/24","","","10.1016/0014-2999(93)90899-s"
"7693299","Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats","Benjamin D, Grant ER, Pohorecky LA.","Brain Res. 1993 Sep 3;621(1):137-40. doi: 10.1016/0006-8993(93)90309-b.","Benjamin D","Brain Res","1993","1993/09/03","","","10.1016/0006-8993(93)90309-b"
"7690585","Endogenous opioids and excessive alcohol consumption","Gianoulakis C.","J Psychiatry Neurosci. 1993 Jul;18(4):148-56.","Gianoulakis C","J Psychiatry Neurosci","1993","1993/07/01","PMC1188524","",""
"7690399","Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies","Devine DP, Leone P, Pocock D, Wise RA.","J Pharmacol Exp Ther. 1993 Sep;266(3):1236-46.","Devine DP","J Pharmacol Exp Ther","1993","1993/09/01","","",""
"7689107","Simultaneous measurement of opiate-induced histamine release in the periaqueductal gray and opiate antinociception: an in vivo microdialysis study","Barke KE, Hough LB.","J Pharmacol Exp Ther. 1993 Aug;266(2):934-42.","Barke KE","J Pharmacol Exp Ther","1993","1993/08/01","","",""
"7686748","Expression of functional delta opioid receptors in Xenopus oocytes","Tamir M, Kushner L.","Biochem Biophys Res Commun. 1993 Jun 30;193(3):1224-31. doi: 10.1006/bbrc.1993.1756.","Tamir M","Biochem Biophys Res Commun","1993","1993/06/30","","","10.1006/bbrc.1993.1756"
"7686388","Chronic treatment of newborn rats with naltrexone alters astrocyte production of nerve growth factor","Mitsuo K, Schwartz JP.","J Mol Neurosci. 1993 Spring;4(1):21-8. doi: 10.1007/BF02736687.","Mitsuo K","J Mol Neurosci","1993","1993/01/01","","","10.1007/BF02736687"
"7685383","Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone","Lysle DT, Coussons ME, Watts VJ, Bennett EH, Dykstra LA.","J Pharmacol Exp Ther. 1993 Jun;265(3):1071-8.","Lysle DT","J Pharmacol Exp Ther","1993","1993/06/01","","",""
"7684340","The modulation of placental lactogen release by opioids: a role for extracellular calcium","Petit A, Gallo-Payet N, Bellabarba D, Lehoux JG, Bélisle S.","Mol Cell Endocrinol. 1993 Jan;90(2):165-70. doi: 10.1016/0303-7207(93)90148-d.","Petit A","Mol Cell Endocrinol","1993","1993/01/01","","","10.1016/0303-7207(93)90148-d"
"7682680","Formalin-induced nociceptive responses in diabetic mice","Kamei J, Hitosugi H, Kasuya Y.","Neurosci Lett. 1993 Jan 12;149(2):161-4. doi: 10.1016/0304-3940(93)90761-9.","Kamei J","Neurosci Lett","1993","1993/01/12","","","10.1016/0304-3940(93)90761-9"
"7681005","Norbinaltorphimine protection against N-methyl-D-aspartic acid-induced convulsions and mortality","Shukla VK, Lemaire S.","Eur J Pharmacol. 1993 Feb 9;231(2):293-6. doi: 10.1016/0014-2999(93)90463-r.","Shukla VK","Eur J Pharmacol","1993","1993/02/09","","","10.1016/0014-2999(93)90463-r"
"7679737","Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers","Preston KL, Bigelow GE.","J Pharmacol Exp Ther. 1993 Feb;264(2):813-23.","Preston KL","J Pharmacol Exp Ther","1993","1993/02/01","","",""
"7673105","Opiates and alcohol self-administration in animals","Ulm RR, Volpicelli JR, Volpicelli LA.","J Clin Psychiatry. 1995;56 Suppl 7:5-14.","Ulm RR","J Clin Psychiatry","1995","1995/01/01","","",""
"7673104","Naltrexone in the treatment of alcoholism: predicting response to naltrexone","Volpicelli JR, Clay KL, Watson NT, O'Brien CP.","J Clin Psychiatry. 1995;56 Suppl 7:39-44.","Volpicelli JR","J Clin Psychiatry","1995","1995/01/01","","",""
"7673102","Effect of naltrexone on human alcohol consumption","Swift RM.","J Clin Psychiatry. 1995;56 Suppl 7:24-9.","Swift RM","J Clin Psychiatry","1995","1995/01/01","","",""
"7668157","Delta opioid agonists inhibit proliferation of highlypurified murine CD4+ and CD8+ T-cells","Shahabi NA, Sharp BM.","Adv Exp Med Biol. 1995;373:29-36. doi: 10.1007/978-1-4615-1951-5_5.","Shahabi NA","Adv Exp Med Biol","1995","1995/01/01","","","10.1007/978-1-4615-1951-5_5"
"7668141","Mouse strain differences in in vivo and in vitro immunosuppressive effects of opioids","Eisenstein TK, Meissler JJ Jr, Bussiere JL, Rogers TJ, Geller EB, Adler MW.","Adv Exp Med Biol. 1995;373:115-21. doi: 10.1007/978-1-4615-1951-5_16.","Eisenstein TK","Adv Exp Med Biol","1995","1995/01/01","","","10.1007/978-1-4615-1951-5_16"
"7667382","Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity","Yoburn BC, Shah S, Chan K, Duttaroy A, Davis T.","Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):535-9. doi: 10.1016/0091-3057(94)00375-s.","Yoburn BC","Pharmacol Biochem Behav","1995","1995/06/01","","","10.1016/0091-3057(94)00375-s"
"7667374","Effects of restraint stress and intra-ventral tegmental area injections of morphine and methyl naltrexone on the discriminative stimulus effects of heroin in the rat","Shaham Y, Stewart J.","Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):491-8. doi: 10.1016/0091-3057(95)00015-o.","Shaham Y","Pharmacol Biochem Behav","1995","1995/06/01","","","10.1016/0091-3057(95)00015-o"
"7667357","Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids","Broadbent J, Gaspard TM, Dworkin SI.","Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):379-85. doi: 10.1016/0091-3057(94)00408-b.","Broadbent J","Pharmacol Biochem Behav","1995","1995/06/01","","","10.1016/0091-3057(94)00408-b"
"7664811","Blockade of the antinociceptive activity of centrally administered ketorolac by nor-binaltorphimine","Tripathi A, Welch SP.","Eur J Pharmacol. 1995 May 4;278(1):27-32. doi: 10.1016/0014-2999(95)00091-x.","Tripathi A","Eur J Pharmacol","1995","1995/05/04","","","10.1016/0014-2999(95)00091-x"
"7657850","A bioequivalence study of oral controlled-release morphine using naltrexone blockade","Kaiko RF, Grandy RP, Reder RF, Goldenheim PD, Sackler RS.","J Clin Pharmacol. 1995 May;35(5):499-504. doi: 10.1002/j.1552-4604.1995.tb04094.x.","Kaiko RF","J Clin Pharmacol","1995","1995/05/01","","","10.1002/j.1552-4604.1995.tb04094.x"
"7654128","Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies","Willemsen-Swinkels SH, Buitelaar JK, Nijhof GJ, van England H.","Arch Gen Psychiatry. 1995 Sep;52(9):766-73. doi: 10.1001/archpsyc.1995.03950210060011.","Willemsen-Swinkels SH","Arch Gen Psychiatry","1995","1995/09/01","","","10.1001/archpsyc.1995.03950210060011"
"7651622","Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats","Koch JE, Glass MJ, Cooper ML, Bodnar RJ.","Neuroscience. 1995 Jun;66(4):951-7. doi: 10.1016/0306-4522(95)00001-y.","Koch JE","Neuroscience","1995","1995/06/01","","","10.1016/0306-4522(95)00001-y"
"7643909","The antinociception induced by beta-endorphin administered intrathecally is mediated by the activation of mu- and kappa-opioid receptors in the rat","Tseng LF, Henneberry B, Collins KA.","Naunyn Schmiedebergs Arch Pharmacol. 1995 May;351(5):464-8. doi: 10.1007/BF00171036.","Tseng LF","Naunyn Schmiedebergs Arch Pharmacol","1995","1995/05/01","","","10.1007/BF00171036"
"7637475","Naltrexone in alcohol dependence","Volpicelli JR.","Lancet. 1995 Aug 19;346(8973):456. doi: 10.1016/s0140-6736(95)91316-5.","Volpicelli JR","Lancet","1995","1995/08/19","","","10.1016/s0140-6736(95)91316-5"
"7636735","Cold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acidA receptors","Killian P, Holmes BB, Takemori AE, Portoghese PS, Fujimoto JM.","J Pharmacol Exp Ther. 1995 Aug;274(2):730-4.","Killian P","J Pharmacol Exp Ther","1995","1995/08/01","","",""
"7636731","Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes","Kamei J, Ohsawa M, Saitoh A, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y.","J Pharmacol Exp Ther. 1995 Aug;274(2):700-6.","Kamei J","J Pharmacol Exp Ther","1995","1995/08/01","","",""
"7635178","mu- and delta-opioid receptor-mediated contractile effects on rat aortic vascular smooth muscle","Parra L, Pérez-Vizcaíno F, Alsasua A, Martín MI, Tamargo J.","Eur J Pharmacol. 1995 Apr 13;277(1):99-105. doi: 10.1016/0014-2999(95)00067-u.","Parra L","Eur J Pharmacol","1995","1995/04/13","","","10.1016/0014-2999(95)00067-u"
"7634105","Naltrexone gains alcoholism indication","","Am J Health Syst Pharm. 1995 Apr 15;52(8):778. doi: 10.1093/ajhp/52.8.778.","","Am J Health Syst Pharm","1995","1995/04/15","","","10.1093/ajhp/52.8.778"
"7629089","Characterization of irreversible binding of beta-funaltrexamine to the cloned rat mu opioid receptor","Chen C, Xue JC, Zhu J, Chen YW, Kunapuli S, Kim de Riel J, Yu L, Liu-Chen LY.","J Biol Chem. 1995 Jul 28;270(30):17866-70. doi: 10.1074/jbc.270.30.17866.","Chen C","J Biol Chem","1995","1995/07/28","","","10.1074/jbc.270.30.17866"
"7627682","Opiate antagonists for recurrent self-injurious behavior in three mentally retarded adults","Buzan RD, Dubovsky SL, Treadway JT, Thomas M.","Psychiatr Serv. 1995 May;46(5):511-2. doi: 10.1176/ps.46.5.511.","Buzan RD","Psychiatr Serv","1995","1995/05/01","","","10.1176/ps.46.5.511"
"7624831","NMDA antagonists and clonidine block c-fos expression during morphine withdrawal","Rasmussen K, Brodsky M, Inturrisi CE.","Synapse. 1995 May;20(1):68-74. doi: 10.1002/syn.890200110.","Rasmussen K","Synapse","1995","1995/05/01","","","10.1002/syn.890200110"
"7620885","Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats","Cole JL, Leventhal L, Pasternak GW, Bowen WD, Bodnar RJ.","Brain Res. 1995 Apr 24;678(1-2):168-76. doi: 10.1016/0006-8993(95)00181-o.","Cole JL","Brain Res","1995","1995/04/24","","","10.1016/0006-8993(95)00181-o"
"7617680","Maternal naltrexone prevents morphological and behavioral alterations induced in rats by prenatal stress","Keshet GI, Weinstock M.","Pharmacol Biochem Behav. 1995 Mar;50(3):413-9. doi: 10.1016/0091-3057(94)00289-u.","Keshet GI","Pharmacol Biochem Behav","1995","1995/03/01","","","10.1016/0091-3057(94)00289-u"
"7616430","Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization","Sala M, Braida D, Colombo M, Groppetti A, Sacco S, Gori E, Parenti M.","J Pharmacol Exp Ther. 1995 Jul;274(1):450-7.","Sala M","J Pharmacol Exp Ther","1995","1995/07/01","","",""
"7616395","Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys","France CP, Gerak LR, Flynn D, Winger GD, Medzihradsky F, Bagley JR, Brockunier LL, Woods JH.","J Pharmacol Exp Ther. 1995 Jul;274(1):17-28.","France CP","J Pharmacol Exp Ther","1995","1995/07/01","","",""
"7616334","Primary care-based ambulatory opioid detoxification: the results of a clinical trial","O'Connor PG, Waugh ME, Carroll KM, Rounsaville BJ, Diagkogiannis IA, Schottenfeld RS.","J Gen Intern Med. 1995 May;10(5):255-60. doi: 10.1007/BF02599882.","O'Connor PG","J Gen Intern Med","1995","1995/05/01","","","10.1007/BF02599882"
"7615787","Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action","Kotz CM, Grace MK, Briggs J, Levine AS, Billington CJ.","J Clin Invest. 1995 Jul;96(1):163-70. doi: 10.1172/JCI118017.","Kotz CM","J Clin Invest","1995","1995/07/01","PMC185185","","10.1172/JCI118017"
"7614260","Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor","Carr DJ, Carpenter GW.","Neuroimmunomodulation. 1995 Jan-Feb;2(1):44-53. doi: 10.1159/000096847.","Carr DJ","Neuroimmunomodulation","1995","1995/01/01","","","10.1159/000096847"
"7608262","Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea","Couzinet B, Young J, Brailly S, Chanson P, Schaison G.","J Clin Endocrinol Metab. 1995 Jul;80(7):2102-7. doi: 10.1210/jcem.80.7.7608262.","Couzinet B","J Clin Endocrinol Metab","1995","1995/07/01","","","10.1210/jcem.80.7.7608262"
"7605911","Human delta opioid receptor: a stable cell line for functional studies of opioids","Malatynska E, Wang Y, Knapp RJ, Santoro G, Li X, Waite S, Roeske WR, Yamamura HI.","Neuroreport. 1995 Mar 7;6(4):613-6.","Malatynska E","Neuroreport","1995","1995/03/07","","",""
"7605635","L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells","Simmons ML, Terman GW, Gibbs SM, Chavkin C.","Neuron. 1995 Jun;14(6):1265-72. doi: 10.1016/0896-6273(95)90273-2.","Simmons ML","Neuron","1995","1995/06/01","","","10.1016/0896-6273(95)90273-2"
"7604756","Possible evidence of angiotensin II and endogenous opioid modulation of novelty-induced rearing in the rat","Ajayi AA, Ukponmwan OE.","Afr J Med Med Sci. 1994 Sep;23(3):287-90.","Ajayi AA","Afr J Med Med Sci","1994","1994/09/01","","",""
"7603392","Naltrexone for alcohol dependence","","Med Lett Drugs Ther. 1995 Jul 21;37(953):64-6.","","Med Lett Drugs Ther","1995","1995/07/21","","",""
"7603296","Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice","Suzuki T, Tsuji M, Mori T, Misawa M, Endoh T, Nagase H.","Life Sci. 1995;57(2):155-68. doi: 10.1016/0024-3205(95)00256-6.","Suzuki T","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)00256-6"
"7591518","Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats","Xue JC, Yu YX, Han JS, Jen MF.","Int J Neurosci. 1995 May;82(1-2):83-93. doi: 10.3109/00207459508994292.","Xue JC","Int J Neurosci","1995","1995/05/01","","","10.3109/00207459508994292"
"7589640","Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea","Genazzani AD, Petraglia F, Gastaldi M, Volpogni C, Gamba O, Genazzani AR.","Fertil Steril. 1995 Nov;64(5):951-6. doi: 10.1016/s0015-0282(16)57908-4.","Genazzani AD","Fertil Steril","1995","1995/11/01","","","10.1016/s0015-0282(16)57908-4"
"7588425","Melatonin modifies prolactin release induced by opiate antagonists in male rats","Shacoori V, Saiag B, Rault B.","Endocr Res. 1995 Aug;21(3):545-53. doi: 10.1080/07435809509030472.","Shacoori V","Endocr Res","1995","1995/08/01","","","10.1080/07435809509030472"
"7588256","Inhibition of luteinizing hormone-releasing hormone secretion by delta-opioid agonists in GT1-1 neuronal cells","Maggi R, Pimpinelli F, Martini L, Piva F.","Endocrinology. 1995 Nov;136(11):5177-81. doi: 10.1210/endo.136.11.7588256.","Maggi R","Endocrinology","1995","1995/11/01","","","10.1210/endo.136.11.7588256"
"7583704","Treatment of neurotoxic side effects of interferon-alpha with naltrexone","Valentine AD, Meyers CA, Talpaz M.","Cancer Invest. 1995;13(6):561-6. doi: 10.3109/07357909509024923.","Valentine AD","Cancer Invest","1995","1995/01/01","","","10.3109/07357909509024923"
"7583338","CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone","Brodsky M, Elliott K, Hynansky A, Inturrisi CE.","Brain Res Bull. 1995;38(2):135-41. doi: 10.1016/0361-9230(95)00079-t.","Brodsky M","Brain Res Bull","1995","1995/01/01","","","10.1016/0361-9230(95)00079-t"
"7583248","Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-fed rats","Leventhal L, Kirkham TC, Cole JL, Bodnar RJ.","Brain Res. 1995 Jul 10;685(1-2):205-10. doi: 10.1016/0006-8993(95)00385-4.","Leventhal L","Brain Res","1995","1995/07/10","","","10.1016/0006-8993(95)00385-4"
"7582612","A different opinion regarding the use of opiate antagonists in PTSD: comments on ""An unusual reaction to opioid blockade with naltrexone in a case of post-traumatic stress disorder""","Glover H.","J Trauma Stress. 1995 Jul;8(3):483-9. doi: 10.1007/BF02102972.","Glover H","J Trauma Stress","1995","1995/07/01","","","10.1007/BF02102972"
"7581169","Synthesis of radioiodinated naltrindole analogues: ligands for studies of delta opioid receptors","Kinter CM, Lever JR.","Nucl Med Biol. 1995 Jul;22(5):599-606. doi: 10.1016/0969-8051(94)00149-e.","Kinter CM","Nucl Med Biol","1995","1995/07/01","","","10.1016/0969-8051(94)00149-e"
"7569550","[Clinical use of naltrexone]","Manzanares J.","Rev Med Univ Navarra. 1995 Apr-Jun;40(2):78-84.","Manzanares J","Rev Med Univ Navarra","1995","1995/04/01","","",""
"7568632","Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys","Vermeulen RJ, Drukarch B, Sahadat MC, Goosen C, Schoffelmeer AN, Wolters EC, Stoof JC.","Psychopharmacology (Berl). 1995 Apr;118(4):451-9. doi: 10.1007/BF02245946.","Vermeulen RJ","Psychopharmacology (Berl)","1995","1995/04/01","","","10.1007/BF02245946"
"7568440","Body temperature, motor activity, and feeding behavior of mice treated with beta-chlornaltrexamine","Kozak W, Conn CA, Kluger MJ.","Physiol Behav. 1995 Aug;58(2):353-62. doi: 10.1016/0031-9384(95)00067-s.","Kozak W","Physiol Behav","1995","1995/08/01","","","10.1016/0031-9384(95)00067-s"
"7568427","Nitrous oxide induces feeding in the nondeprived rat that is antagonized by naltrexone","Czech DA.","Physiol Behav. 1995 Aug;58(2):251-5. doi: 10.1016/0031-9384(95)00057-p.","Czech DA","Physiol Behav","1995","1995/08/01","","","10.1016/0031-9384(95)00057-p"
"7566508","Effects of mu opioid agonist and antagonist on neurological outcome following traumatic brain injury in the rat","Lyeth BG, Jiang JY, Gong QZ, Hamm RJ, Young HF.","Neuropeptides. 1995 Jul;29(1):11-9. doi: 10.1016/0143-4179(95)90051-9.","Lyeth BG","Neuropeptides","1995","1995/07/01","","","10.1016/0143-4179(95)90051-9"
"7565300","Nalmefene--a long-acting injectable opioid antagonist","","Med Lett Drugs Ther. 1995 Oct 27;37(960):97-8.","","Med Lett Drugs Ther","1995","1995/10/27","","",""
"7564899","Effect of naltrindole on the development of physical dependence on morphine in mice: a behavioral and biochemical study","Suzuki T, Tsuji M, Mori T, Misawa M, Nagase H.","Life Sci. 1995;57(17):PL247-52. doi: 10.1016/0024-3205(95)02139-a.","Suzuki T","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)02139-a"
"7564893","CCB, a novel specific kappa opioid agonist, which discriminates between opioid and sigma 1 recognition sites","Ronsisvalle G, Prezzavento O, Pasquinucci L, Marrazzo A, Vittorio F, Gomez-Vidal JA, Carboni L, Spampinato S.","Life Sci. 1995;57(16):1487-95. doi: 10.1016/0024-3205(95)02120-8.","Ronsisvalle G","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)02120-8"
"7564358","Electrophysiological demonstration and activation of mu-opioid receptors in the rabbit sinoatrial node","Saeki T, Nishimura M, Sato N, Fujinami T, Watanabe Y.","J Cardiovasc Pharmacol. 1995 Jul;26(1):160-8. doi: 10.1097/00005344-199507000-00025.","Saeki T","J Cardiovasc Pharmacol","1995","1995/07/01","","","10.1097/00005344-199507000-00025"
"7563422","Capture of wood bison (Bison bison athabascae) using carfentanil-based mixtures","Haigh JC, Gates CC.","J Wildl Dis. 1995 Jan;31(1):37-42. doi: 10.7589/0090-3558-31.1.37.","Haigh JC","J Wildl Dis","1995","1995/01/01","","","10.7589/0090-3558-31.1.37"
"7562596","Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids","Yaksh TL, Malmberg AB, Ro S, Schiller P, Goodman M.","J Pharmacol Exp Ther. 1995 Oct;275(1):63-72.","Yaksh TL","J Pharmacol Exp Ther","1995","1995/10/01","","",""
"7562504","Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone","Hammond DL, Stewart PE, Littell L.","J Pharmacol Exp Ther. 1995 Sep;274(3):1317-24.","Hammond DL","J Pharmacol Exp Ther","1995","1995/09/01","","",""
"7557255","Antinociceptive effects of clebopride in the mouse","Bittencourt SC, De Lima TC, Morato GS.","Gen Pharmacol. 1995 Sep;26(5):1083-7. doi: 10.1016/0306-3623(94)00262-l.","Bittencourt SC","Gen Pharmacol","1995","1995/09/01","","","10.1016/0306-3623(94)00262-l"
"7557249","Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase","Bhargava HN.","Gen Pharmacol. 1995 Sep;26(5):1049-53. doi: 10.1016/0306-3623(94)00271-n.","Bhargava HN","Gen Pharmacol","1995","1995/09/01","","","10.1016/0306-3623(94)00271-n"
"7556409","Effects of kappa-opioid receptor agonists on stimulated phosphoinositide hydrolysis in rat kidney","Mosaddeghi M, Kapusta DR, Minor LD, Duan N, Paul D.","Eur J Pharmacol. 1995 May 26;289(3):411-7. doi: 10.1016/0922-4106(95)90149-3.","Mosaddeghi M","Eur J Pharmacol","1995","1995/05/26","","","10.1016/0922-4106(95)90149-3"
"7556397","Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia","Schäfer M, Imai Y, Uhl GR, Stein C.","Eur J Pharmacol. 1995 Jun 12;279(2-3):165-9. doi: 10.1016/0014-2999(95)00150-j.","Schäfer M","Eur J Pharmacol","1995","1995/06/12","","","10.1016/0014-2999(95)00150-j"
"7552334","Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease","Maneuf YP, Mitchell IJ, Crossman AR, Woodruff GN, Brotchie JM.","Brain Res. 1995 Jun 12;683(1):102-8. doi: 10.1016/0006-8993(95)00358-w.","Maneuf YP","Brain Res","1995","1995/06/12","","","10.1016/0006-8993(95)00358-w"
"7552272","Kappa opioid inhibition of morphine and cocaine self-administration in rats","Glick SD, Maisonneuve IM, Raucci J, Archer S.","Brain Res. 1995 May 29;681(1-2):147-52. doi: 10.1016/0006-8993(95)00306-b.","Glick SD","Brain Res","1995","1995/05/29","","","10.1016/0006-8993(95)00306-b"
"7548949","Exposure to stable flies reduces spatial learning in mice: involvement of endogenous opioid systems","Kavaliers M, Colwell DD.","Med Vet Entomol. 1995 Jul;9(3):300-6. doi: 10.1111/j.1365-2915.1995.tb00138.x.","Kavaliers M","Med Vet Entomol","1995","1995/07/01","","","10.1111/j.1365-2915.1995.tb00138.x"
"7541509","Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine","Hjorth SA, Thirstrup K, Grandy DK, Schwartz TW.","Mol Pharmacol. 1995 Jun;47(6):1089-94.","Hjorth SA","Mol Pharmacol","1995","1995/06/01","","",""
"7537820","The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat","Chen L, Gu Y, Huang LY.","J Physiol. 1995 Feb 1;482 ( Pt 3)(Pt 3):575-81. doi: 10.1113/jphysiol.1995.sp020541.","Chen L","J Physiol","1995","1995/02/01","PMC1157783","","10.1113/jphysiol.1995.sp020541"
"7536308","The formalin-induced expression of tachykinin peptide and neurokinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration","McCarson KE, Krause JE.","Neuroscience. 1995 Feb;64(3):729-39. doi: 10.1016/0306-4522(94)00442-8.","McCarson KE","Neuroscience","1995","1995/02/01","","","10.1016/0306-4522(94)00442-8"
"7535484","Neurotrophic factors in diabetic neuropathy","Crain SM.","Trends Neurosci. 1995 Jan;18(1):15-6. doi: 10.1016/0166-2236(95)93944-s.","Crain SM","Trends Neurosci","1995","1995/01/01","","","10.1016/0166-2236(95)93944-s"
"7535119","Ca2+ channel inhibition by kappa opioid receptors expressed in Xenopus oocytes","Kaneko S, Fukuda K, Yada N, Akaike A, Mori Y, Satoh M.","Neuroreport. 1994 Dec 20;5(18):2506-8. doi: 10.1097/00001756-199412000-00025.","Kaneko S","Neuroreport","1994","1994/12/20","","","10.1097/00001756-199412000-00025"
"7530918","Opioids and nitric oxide contribute to hypoxia-induced pial arterial vasodilation in newborn pigs","Armstead WM.","Am J Physiol. 1995 Jan;268(1 Pt 2):H226-32. doi: 10.1152/ajpheart.1995.268.1.H226.","Armstead WM","Am J Physiol","1995","1995/01/01","","","10.1152/ajpheart.1995.268.1.H226"
"7526302","Species and age-dependent differences of functional coupling between opioid delta-receptor and G-proteins and possible involvement of protein kinase C in striatal membranes","Fukushima N, Ueda H, Hayashi C, Katayama T, Miyamae T, Misu Y.","Neurosci Lett. 1994 Jul 18;176(1):55-8. doi: 10.1016/0304-3940(94)90870-2.","Fukushima N","Neurosci Lett","1994","1994/07/18","","","10.1016/0304-3940(94)90870-2"
"7521022","Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain","Goettl VM, Larson AA.","Neuroscience. 1994 May;60(2):375-82. doi: 10.1016/0306-4522(94)90251-8.","Goettl VM","Neuroscience","1994","1994/05/01","","","10.1016/0306-4522(94)90251-8"
"7518322","Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice","Thorat SN, Barjavel MJ, Matwyshyn GA, Bhargava HN.","Brain Res. 1994 Apr 11;642(1-2):153-9. doi: 10.1016/0006-8993(94)90917-2.","Thorat SN","Brain Res","1994","1994/04/11","","","10.1016/0006-8993(94)90917-2"
"7514974","Managing illicit drug use. A practical guide","Wodak A.","Drugs. 1994 Mar;47(3):446-57. doi: 10.2165/00003495-199447030-00005.","Wodak A","Drugs","1994","1994/03/01","","","10.2165/00003495-199447030-00005"
"7514185","Beta-endorphin concentrations in brain areas and peritoneal macrophages in rats susceptible and resistant to experimental allergic encephalomyelitis: a possible relationship between tumor necrosis factor alpha and opioids in the disease","Panerai AE, Radulovic J, Monastra G, Manfredi B, Locatelli L, Sacerdote P.","J Neuroimmunol. 1994 May;51(2):169-76. doi: 10.1016/0165-5728(94)90078-7.","Panerai AE","J Neuroimmunol","1994","1994/05/01","","","10.1016/0165-5728(94)90078-7"
"7513375","Modulation of substance P-ergic system in the rat spinal cord by an opioid antagonist","Igwe OJ.","Brain Res Mol Brain Res. 1994 Feb;21(3-4):263-73. doi: 10.1016/0169-328x(94)90257-7.","Igwe OJ","Brain Res Mol Brain Res","1994","1994/02/01","","","10.1016/0169-328x(94)90257-7"
"7511201","Spinal co-administration of peptide substance P antagonist increases antinociceptive effect of the opioid peptide biphalin","Misterek K, Maszczynska I, Dorociak A, Gumulka SW, Carr DB, Szyfelbein SK, Lipkowski AW.","Life Sci. 1994;54(14):939-44. doi: 10.1016/0024-3205(94)00494-3.","Misterek K","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00494-3"
"7504777","Regulation of substance P receptor system in rat striatum by chronic naltrexone treatment","Igwe OJ.","Brain Res Mol Brain Res. 1993 Oct;20(1-2):40-50. doi: 10.1016/0169-328x(93)90108-2.","Igwe OJ","Brain Res Mol Brain Res","1993","1993/10/01","","","10.1016/0169-328x(93)90108-2"
"7503254","Role of endogenous opioids and serotonin in the hemodynamic response to hemorrhage during hypoxia","Resta TC, Resta JM, Walker BR.","Am J Physiol. 1995 Nov;269(5 Pt 2):H1597-606. doi: 10.1152/ajpheart.1995.269.5.H1597.","Resta TC","Am J Physiol","1995","1995/11/01","","","10.1152/ajpheart.1995.269.5.H1597"
"7501658","The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference","Krishnan-Sarin S, Portoghese PS, Li TK, Froehlich JC.","Pharmacol Biochem Behav. 1995 Sep;52(1):153-9. doi: 10.1016/0091-3057(95)00080-g.","Krishnan-Sarin S","Pharmacol Biochem Behav","1995","1995/09/01","","","10.1016/0091-3057(95)00080-g"
"7501275","Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice","Kamei J, Saitoh A, Kasuya Y.","Neurosci Lett. 1995 Aug 25;196(3):169-72. doi: 10.1016/0304-3940(95)11867-v.","Kamei J","Neurosci Lett","1995","1995/08/25","","","10.1016/0304-3940(95)11867-v"
"7498274","Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task","Hiramatsu M, Sasaki M, Kameyama T.","Eur J Pharmacol. 1995 Aug 25;282(1-3):185-91. doi: 10.1016/0014-2999(95)00330-n.","Hiramatsu M","Eur J Pharmacol","1995","1995/08/25","","","10.1016/0014-2999(95)00330-n"
"7498254","The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine","Shippenberg TS, Heidbreder C.","Eur J Pharmacol. 1995 Jun 23;280(1):55-61. doi: 10.1016/0014-2999(95)00185-n.","Shippenberg TS","Eur J Pharmacol","1995","1995/06/23","","","10.1016/0014-2999(95)00185-n"
"7496798","Effects of naltrexone on morphine-induced tolerance and physical dependence and changes in cellular immune function in mice","Bhargava HN, House RV, Thorat SN, Thomas PT.","Brain Res. 1995 Aug 28;690(1):121-6. doi: 10.1016/0006-8993(95)00612-t.","Bhargava HN","Brain Res","1995","1995/08/28","","","10.1016/0006-8993(95)00612-t"
"7494457","Opioid mu- and kappa-receptor mediate phospholipase C activation through Gi1 in Xenopus oocytes","Ueda H, Miyamae T, Fukushima N, Takeshima H, Fukuda K, Sasaki Y, Misu Y.","Brain Res Mol Brain Res. 1995 Aug;32(1):166-70. doi: 10.1016/0169-328x(95)00077-6.","Ueda H","Brain Res Mol Brain Res","1995","1995/08/01","","","10.1016/0169-328x(95)00077-6"
"7493620","Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy","Keïta H, Kayser V, Guilbaud G.","Eur J Pharmacol. 1995 Apr 24;277(2-3):275-80. doi: 10.1016/0014-2999(95)00122-2.","Keïta H","Eur J Pharmacol","1995","1995/04/24","","","10.1016/0014-2999(95)00122-2"
"7493617","The in vitro pharmacological characterization of naloxone benzoylhydrazone","Berzetei-Gurske IP, White A, Polgar W, DeCosta BR, Pasternak GW, Toll L.","Eur J Pharmacol. 1995 Apr 24;277(2-3):257-63. doi: 10.1016/0014-2999(95)00088-3.","Berzetei-Gurske IP","Eur J Pharmacol","1995","1995/04/24","","","10.1016/0014-2999(95)00088-3"
"7493616","Spinal delta 2-, but not delta 1-, mu-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat","Tseng LF, Tsai JH, Collins KA, Portoghese PS.","Eur J Pharmacol. 1995 Apr 24;277(2-3):251-6. doi: 10.1016/0014-2999(95)00084-x.","Tseng LF","Eur J Pharmacol","1995","1995/04/24","","","10.1016/0014-2999(95)00084-x"
"7489325","A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity","Caroleo MC, Arbitrio M, Melchiorri D, Nisticò G.","Neuroimmunomodulation. 1994 Mar-Apr;1(2):141-7. doi: 10.1159/000097148.","Caroleo MC","Neuroimmunomodulation","1994","1994/03/01","","","10.1159/000097148"
"7488736","Cocaine self-administration and naltrindole, a delta-selective opioid antagonist","Reid LD, Glick SD, Menkens KA, French ED, Bilsky EJ, Porreca F.","Neuroreport. 1995 Jul 10;6(10):1409-12. doi: 10.1097/00001756-199507100-00012.","Reid LD","Neuroreport","1995","1995/07/10","","","10.1097/00001756-199507100-00012"
"7480550","The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference","Krishnan-Sarin S, Jing SL, Kurtz DL, Zweifel M, Portoghese PS, Li TK, Froehlich JC.","Psychopharmacology (Berl). 1995 Jul;120(2):177-85. doi: 10.1007/BF02246191.","Krishnan-Sarin S","Psychopharmacology (Berl)","1995","1995/07/01","","","10.1007/BF02246191"
"7479836","Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment","Crain SM, Shen KF.","Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10540-4. doi: 10.1073/pnas.92.23.10540.","Crain SM","Proc Natl Acad Sci U S A","1995","1995/11/07","PMC40647","","10.1073/pnas.92.23.10540"
"7479344","Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF","Kontinen VK, Kalso EA.","Peptides. 1995;16(5):973-7. doi: 10.1016/0196-9781(95)00068-u.","Kontinen VK","Peptides","1995","1995/01/01","","","10.1016/0196-9781(95)00068-u"
"7478234","Tonic modulation of neurotransmitter release in the guinea-pig myenteric plexus: effect of mu and kappa opioid receptor blockade and of chronic sympathetic denervation","Cosentino M, Marino F, De Ponti F, Giaroni C, Somaini L, Leoni O, Lecchini S, Frigo G.","Neurosci Lett. 1995 Jul 21;194(3):185-8. doi: 10.1016/0304-3940(95)11757-n.","Cosentino M","Neurosci Lett","1995","1995/07/21","","","10.1016/0304-3940(95)11757-n"
"7477965","Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain","Tao R, Auerbach SB.","Neuroscience. 1995 Sep;68(2):553-61. doi: 10.1016/0306-4522(95)00154-b.","Tao R","Neuroscience","1995","1995/09/01","","","10.1016/0306-4522(95)00154-b"
"7477762","Characterization of the opioid receptor subtypes mediating the negative inotropic effects of DAMGO, DPDPE and U-50, 488H in isolated human right atria strips","Llobell F, Laorden ML.","Neuropeptides. 1995 Aug;29(2):115-9. doi: 10.1016/0143-4179(95)90094-2.","Llobell F","Neuropeptides","1995","1995/08/01","","","10.1016/0143-4179(95)90094-2"
"7476895","Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate","Yabaluri N, Medzihradsky F.","Mol Pharmacol. 1995 Oct;48(4):690-5.","Yabaluri N","Mol Pharmacol","1995","1995/10/01","","",""
"7475895","Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig","Culpepper-Morgan JA, Holt PR, LaRoche D, Kreek MJ.","Life Sci. 1995;56(14):1187-92. doi: 10.1016/0024-3205(95)00057-d.","Culpepper-Morgan JA","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)00057-d"
"7475809","Naltrexone in alcohol dependence","Brewer C.","Lancet. 1995 Nov 18;346(8986):1374. doi: 10.1016/s0140-6736(95)92393-4.","Brewer C","Lancet","1995","1995/11/18","","","10.1016/s0140-6736(95)92393-4"
"7465612","The effects of opiate antagonists on the discriminative stimulus properties of ethanol","Altshuler HL, Applebaum E, Shippenberg TS.","Pharmacol Biochem Behav. 1981 Jan;14(1):97-100. doi: 10.1016/0091-3057(81)90109-x.","Altshuler HL","Pharmacol Biochem Behav","1981","1981/01/01","","","10.1016/0091-3057(81)90109-x"
"7464456","Repeated administration of naltrexone produces tolerance to naloxone-induced hyperalgesia","Pilcher CW.","Life Sci. 1980 Nov 17;27(20):1905-9. doi: 10.1016/0024-3205(80)90437-3.","Pilcher CW","Life Sci","1980","1980/11/17","","","10.1016/0024-3205(80)90437-3"
"7461877","The treatment of heroin addiction: naltrexone alone and with behavior therapy","Callahan EJ, Rawson RA, McCleave B, Arias R, Glazer M, Liberman RP.","Int J Addict. 1980 Aug;15(6):795-807. doi: 10.3109/10826088009040057.","Callahan EJ","Int J Addict","1980","1980/08/01","","","10.3109/10826088009040057"
"7452507","Operant analysis of human heroin self-administration and the effects of naltrexone","Mello NK, Mendelson JH, Kuehnle JC, Sellers MS.","J Pharmacol Exp Ther. 1981 Jan;216(1):45-54.","Mello NK","J Pharmacol Exp Ther","1981","1981/01/01","","",""
"7442939","Interactions between naltrexone and non-opiate drugs evaluated by schedule-controlled behavior","Harris RA, Snell D.","Neuropharmacology. 1980 Nov;19(11):1087-93. doi: 10.1016/0028-3908(80)90106-9.","Harris RA","Neuropharmacology","1980","1980/11/01","","","10.1016/0028-3908(80)90106-9"
"7441501","Stereoselectivity of the stimulus effects of morphine and cyclazocine in the squirrel monkey","Teal JJ, Holtzman SG.","J Pharmacol Exp Ther. 1980 Nov;215(2):369-76.","Teal JJ","J Pharmacol Exp Ther","1980","1980/11/01","","",""
"7428332","Antinociceptive comparison of quipazine and morphine","Minnema DJ, DeWitt L, Rosecrans JA.","Commun Psychopharmacol. 1980;4(2):115-20.","Minnema DJ","Commun Psychopharmacol","1980","1980/01/01","","",""
"7422689","Pro- and anticonvulsant action of morphine in rats","Urca G, Frenk H.","Pharmacol Biochem Behav. 1980 Sep;13(3):343-7. doi: 10.1016/0091-3057(80)90237-3.","Urca G","Pharmacol Biochem Behav","1980","1980/09/01","","","10.1016/0091-3057(80)90237-3"
"7414330","Endorphin-mediated increases in pain threshold during pregnancy","Gintzler AR.","Science. 1980 Oct 10;210(4466):193-5. doi: 10.1126/science.7414330.","Gintzler AR","Science","1980","1980/10/10","","","10.1126/science.7414330"
"7400959","Heroin and naltrexone effects on pituitary-gonadal hormones in man: interaction of steroid feedback effects, tolerance and supersensitivity","Mendelson JH, Ellingboe J, Kuehnle JC, Mello NK.","J Pharmacol Exp Ther. 1980 Sep;214(3):503-6.","Mendelson JH","J Pharmacol Exp Ther","1980","1980/09/01","","",""
"7395603","Alterations of evoked potentials link research in attention dysfunction to peptide response symptoms of schizophrenia","Davis GC, Buchsbaum MS, Bunney WE Jr.","Adv Biochem Psychopharmacol. 1980;22:473-87.","Davis GC","Adv Biochem Psychopharmacol","1980","1980/01/01","","",""
"7379964","Naltrexone influence on hibernation","Kromer W.","Experientia. 1980 May 15;36(5):581-2. doi: 10.1007/BF01965814.","Kromer W","Experientia","1980","1980/05/15","","","10.1007/BF01965814"
"7378834","Self-administration of D-Ala2-Met-enkephalinamide at hypothalamic self-stimulation sites","Olds ME, Williams KN.","Brain Res. 1980 Jul 21;194(1):155-70. doi: 10.1016/0006-8993(80)91325-6.","Olds ME","Brain Res","1980","1980/07/21","","","10.1016/0006-8993(80)91325-6"
"7367458","Effects of heroin and naltrexone on plasma prolactin levels in man","Ellingboe J, Mendelson JH, Kuehnle JC.","Pharmacol Biochem Behav. 1980 Jan;12(1):163-5. doi: 10.1016/0091-3057(80)90431-1.","Ellingboe J","Pharmacol Biochem Behav","1980","1980/01/01","","","10.1016/0091-3057(80)90431-1"
"7365688","The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit","Taylor SM, Rodgers RM, Lynn RK, Gerber N.","J Pharmacol Exp Ther. 1980 May;213(2):289-99.","Taylor SM","J Pharmacol Exp Ther","1980","1980/05/01","","",""
"7359340","Discriminative stimulus effects of cyclazocine in the rat","Teal JJ, Holtzman SG.","J Pharmacol Exp Ther. 1980 Mar;212(3):368-76.","Teal JJ","J Pharmacol Exp Ther","1980","1980/03/01","","",""
"7357808","The naloxone test for opiate dependence","Judson BA, Himmelberger DU, Goldstein A.","Clin Pharmacol Ther. 1980 Apr;27(4):492-501. doi: 10.1038/clpt.1980.69.","Judson BA","Clin Pharmacol Ther","1980","1980/04/01","","","10.1038/clpt.1980.69"
"7340503","Naltrexone: a short-term treatment for opiate dependence","Greenstein RA, O'Brien CP, McLellan AT, Woody GE, Grabowski J, Long M, Coyle-Perkins G, Vittor A.","Am J Drug Alcohol Abuse. 1981;8(3):291-300. doi: 10.3109/00952998109009554.","Greenstein RA","Am J Drug Alcohol Abuse","1981","1981/01/01","","","10.3109/00952998109009554"
"7330080","The clinical use of clonidine in outpatient detoxification from opiates","Washton AM, Resnick RB.","Prog Clin Biol Res. 1981;71:277-84.","Washton AM","Prog Clin Biol Res","1981","1981/01/01","","",""
"7329205","Naltrexone partially inhibits the estrogen-induced increase in prolactin secretion and anterior pituitary weight","Ahmed HH, Van Vugt DA, Ruiz de Galarreta CM, Fanjul LF, Meites J.","Life Sci. 1981 Dec 28;29(26):2757-62. doi: 10.1016/0024-3205(81)90535-x.","Ahmed HH","Life Sci","1981","1981/12/28","","","10.1016/0024-3205(81)90535-x"
"7323217","Effect of morphine on rectal temperature after acute and chronic treatment in the rat","Numan R, Lal H.","Prog Neuropsychopharmacol. 1981;5(4):363-71. doi: 10.1016/0364-7722(81)90087-4.","Numan R","Prog Neuropsychopharmacol","1981","1981/01/01","","","10.1016/0364-7722(81)90087-4"
"7318888","Naltrexone effects on food-and codeine-maintained responding in rhesus monkeys","Herling S.","Eur J Pharmacol. 1981 Jul 17;73(1):41-9. doi: 10.1016/0014-2999(81)90143-6.","Herling S","Eur J Pharmacol","1981","1981/07/17","","","10.1016/0014-2999(81)90143-6"
"7318681","Multiple family therapy and naltrexone in the treatment of opiate dependence","Anton RF, Hogan I, Jalali B, Riordan CE, Kleber HD.","Drug Alcohol Depend. 1981 Sep;8(2):157-68. doi: 10.1016/0376-8716(81)90110-1.","Anton RF","Drug Alcohol Depend","1981","1981/09/01","","","10.1016/0376-8716(81)90110-1"
"7312906","Naltrexone and the tail flick reflex","Advokat C.","Pharmacol Biochem Behav. 1981 Nov;15(5):677-80. doi: 10.1016/0091-3057(81)90003-4.","Advokat C","Pharmacol Biochem Behav","1981","1981/11/01","","","10.1016/0091-3057(81)90003-4"
"7301882","Effects of chronic administration of naltrexone on appetitive behaviors of rats","Lang IM, Strahlendorf JC, Strahlendorf HK, Barnes CD.","Prog Clin Biol Res. 1981;68:197-207.","Lang IM","Prog Clin Biol Res","1981","1981/01/01","","",""
"7300562","Inhibitory effects of dorsal horn and excitant effects of ventral horn intraspinal microinjections of norepinephrine and serotonin in the cat","Bell JA, Matsumiya T.","Life Sci. 1981 Oct 12;29(15):1507-14. doi: 10.1016/0024-3205(81)90250-2.","Bell JA","Life Sci","1981","1981/10/12","","","10.1016/0024-3205(81)90250-2"
"7297627","Stimulation of the mesencephalic central gray increases blood prolactin in ovariectomized rats","Johnson JH, Swajkoski AR, Anderhub L.","Exp Neurol. 1981 Nov;74(2):419-29. doi: 10.1016/0014-4886(81)90180-1.","Johnson JH","Exp Neurol","1981","1981/11/01","","","10.1016/0014-4886(81)90180-1"
"7297411","Aversive effects of naltrexone in subjects not dependent on opiates","Hollister LE, Johnson K, Boukhabza D, Gillespie HK.","Drug Alcohol Depend. 1981 Aug;8(1):37-41. doi: 10.1016/0376-8716(81)90084-3.","Hollister LE","Drug Alcohol Depend","1981","1981/08/01","","","10.1016/0376-8716(81)90084-3"
"7291246","Blockade by naltrexone of analgesia produced by stimulation of the dorsal raphe nucleus","Swajkoski AR, Mayer DJ, Johnson JH.","Pharmacol Biochem Behav. 1981 Sep;15(3):419-23. doi: 10.1016/0091-3057(81)90272-0.","Swajkoski AR","Pharmacol Biochem Behav","1981","1981/09/01","","","10.1016/0091-3057(81)90272-0"
"7291235","Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet","Apfelbaum M, Mandenoff A.","Pharmacol Biochem Behav. 1981 Jul;15(1):89-91. doi: 10.1016/0091-3057(81)90344-0.","Apfelbaum M","Pharmacol Biochem Behav","1981","1981/07/01","","","10.1016/0091-3057(81)90344-0"
"7291218","Suppression of drinking by naloxone in rats homo- and heterozygous for diabetes insipidus","Brown DR, Holtzman SG.","Pharmacol Biochem Behav. 1981 Jul;15(1):109-14. doi: 10.1016/0091-3057(81)90347-6.","Brown DR","Pharmacol Biochem Behav","1981","1981/07/01","","","10.1016/0091-3057(81)90347-6"
"7290360","The anorexic effect of naltrexone is independent of its suppressant effect on water intake","Lowy MT, Yim GK.","Neuropharmacology. 1981 Sep;20(9):883-6. doi: 10.1016/0028-3908(81)90082-4.","Lowy MT","Neuropharmacology","1981","1981/09/01","","","10.1016/0028-3908(81)90082-4"
"7284781","Opiate antagonists: central sites of action in suppressing water intake of the rat","Brown DR, Holtzman SG.","Brain Res. 1981 Sep 28;221(2):432-6. doi: 10.1016/0006-8993(81)90796-4.","Brown DR","Brain Res","1981","1981/09/28","","","10.1016/0006-8993(81)90796-4"
"7268445","Long-term stress-induced analgesia and activation of the opiate system","Grau JW, Hyson RL, Maier SF, Madden J 4th, Barchas JD.","Science. 1981 Sep 18;213(4514):1409-11. doi: 10.1126/science.7268445.","Grau JW","Science","1981","1981/09/18","","","10.1126/science.7268445"
"7250068","Naltrexone-induced LH release in ovariectomized estrogen-primed rats","Higuchi T, Kawakami M.","Endocrinol Jpn. 1981 Feb;28(1):45-50. doi: 10.1507/endocrj1954.28.45.","Higuchi T","Endocrinol Jpn","1981","1981/02/01","","","10.1507/endocrj1954.28.45"
"7242242","Enhancement of apomorphine-induced climbing in mice by reversible and irreversible narcotic antagonist drugs","Quock RM, Lucas TS.","Life Sci. 1981 Mar 23;28(12):1421-4. doi: 10.1016/0024-3205(81)90417-3.","Quock RM","Life Sci","1981","1981/03/23","","","10.1016/0024-3205(81)90417-3"
"7232665","Clinical pharmacology of mixed agonist-antagonist drugs [proceedings]","Jasinski DR.","Psychopharmacol Bull. 1981 Jan;17(1):85-6.","Jasinski DR","Psychopharmacol Bull","1981","1981/01/01","","",""
"7232659","Supersensitivity to the behavioral effects of opiate antagonists [proceedings]","Spealman RD, Kelleher RT, Morse WH, Goldberg SR.","Psychopharmacol Bull. 1981 Jan;17(1):54-6.","Spealman RD","Psychopharmacol Bull","1981","1981/01/01","","",""
"7232476","Methadone reduces sexual performances and sexual motivation in the male Syrian golden hamster","Murphy MR.","Pharmacol Biochem Behav. 1981 Apr;14(4):561-7. doi: 10.1016/0091-3057(81)90317-8.","Murphy MR","Pharmacol Biochem Behav","1981","1981/04/01","","","10.1016/0091-3057(81)90317-8"
"7231051","Narcotic antagonists attenuate drinking induced by water deprivation in a primate","Brown DR, Holtzman SG.","Life Sci. 1981 Mar 16;28(11):1287-94. doi: 10.1016/0024-3205(81)90455-0.","Brown DR","Life Sci","1981","1981/03/16","","","10.1016/0024-3205(81)90455-0"
"7229996","Opiate regulation of angiotensin-induced drinking and vasopressin release","Summy-Long JY, Keil LC, Deen K, Severs WB.","J Pharmacol Exp Ther. 1981 Jun;217(3):630-7.","Summy-Long JY","J Pharmacol Exp Ther","1981","1981/06/01","","",""
"7229971","Three-choice drug discrimination in the rat: morphine, cyclazocine and saline","White JM, Holtzman SG.","J Pharmacol Exp Ther. 1981 May;217(2):254-62.","White JM","J Pharmacol Exp Ther","1981","1981/05/01","","",""
"7215432","Suppression of drinking by naloxone in the rat: a further characterization","Brown DR, Holtzman SG.","Eur J Pharmacol. 1981 Jan 29;69(3):331-40. doi: 10.1016/0014-2999(81)90479-9.","Brown DR","Eur J Pharmacol","1981","1981/01/29","","","10.1016/0014-2999(81)90479-9"
"7205651","Disposition of morphine in rat brain: relationship to biological activity","Plomp GJ, Maes RA, van Ree JM.","J Pharmacol Exp Ther. 1981 Apr;217(1):181-8.","Plomp GJ","J Pharmacol Exp Ther","1981","1981/04/01","","",""
"7205644","Effects of naltrexone dose and history of naltrexone exposure on food- and codeine-maintained responding in rhesus monkeys","Herling S.","J Pharmacol Exp Ther. 1981 Apr;217(1):105-13.","Herling S","J Pharmacol Exp Ther","1981","1981/04/01","","",""
"7205630","Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons","Goldberg SR, Morse WH, Goldberg DM.","J Pharmacol Exp Ther. 1981 Mar;216(3):500-9.","Goldberg SR","J Pharmacol Exp Ther","1981","1981/03/01","","",""
"7203820","Reduced behavioral activity due to opiate blockade: relations to stress","Roth KA, Katz RJ, Schmaltz K, Sibel M.","Int J Neurosci. 1981;12(1):59-62. doi: 10.3109/00207458108990673.","Roth KA","Int J Neurosci","1981","1981/01/01","","","10.3109/00207458108990673"
"7202485","Lack of effect of choline and narcotic antagonists upon apomorphine discrimination","Schechter MD.","Eur J Pharmacol. 1980 Nov 21;68(2):187-91. doi: 10.1016/0014-2999(80)90320-9.","Schechter MD","Eur J Pharmacol","1980","1980/11/21","","","10.1016/0014-2999(80)90320-9"
"7202207","Tetrahydroisoquinoline and opioid substrates of alcohol actions","Altshuler HL, Shippenberg TS.","Prog Clin Biol Res. 1982;90:329-44.","Altshuler HL","Prog Clin Biol Res","1982","1982/01/01","","",""
"7200037","Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists","Russell J, Bass P, Goldberg LI, Schuster CR, Merz H.","Eur J Pharmacol. 1982 Mar 12;78(3):255-61. doi: 10.1016/0014-2999(82)90026-7.","Russell J","Eur J Pharmacol","1982","1982/03/12","","","10.1016/0014-2999(82)90026-7"
"7198791","Involvement of opioid peptides in the inhibition of oxytocin release by heat stress in lactating mice","Haldar J, Bade V.","Proc Soc Exp Biol Med. 1981 Oct;168(1):10-4. doi: 10.3181/00379727-168-41227.","Haldar J","Proc Soc Exp Biol Med","1981","1981/10/01","","","10.3181/00379727-168-41227"
"7195937","Naltrexone effects on morphine and food self-administration in morphine-dependent rhesus monkeys","Mello NK, Mendelson JH, Bree MP.","J Pharmacol Exp Ther. 1981 Aug;218(2):550-7.","Mello NK","J Pharmacol Exp Ther","1981","1981/08/01","","",""
"7195448","Effects of narcotic antagonists on L-dopa reversal of reserpine-induced catalepsy and blepharoptosis in mice","Namba MM, Quock RM, Malone MH.","Life Sci. 1981 Apr 6;28(14):1629-36. doi: 10.1016/0024-3205(81)90318-0.","Namba MM","Life Sci","1981","1981/04/06","","","10.1016/0024-3205(81)90318-0"
"7195052","The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings]","Valentino RJ, Herling S, Woods JH.","Psychopharmacol Bull. 1981 Jan;17(1):51-4.","Valentino RJ","Psychopharmacol Bull","1981","1981/01/01","","",""
"7192404","Behavioural and endocrine effects of naltrexone in male talapoin monkeys","Meller RE, Keverne EB, Herbert J.","Pharmacol Biochem Behav. 1980 Nov;13(5):663-72. doi: 10.1016/0091-3057(80)90010-6.","Meller RE","Pharmacol Biochem Behav","1980","1980/11/01","","","10.1016/0091-3057(80)90010-6"
"7191065","Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate","Snead OC 3rd, Bearden LJ.","Neurology. 1980 Aug;30(8):832-8. doi: 10.1212/wnl.30.8.832.","Snead OC 3rd","Neurology","1980","1980/08/01","","","10.1212/wnl.30.8.832"
"7190698","Narcotic antagonist potentiation of L-DOPA in the reversal of reserpine induced catalepsy","Namba MM, Quock RM, Malone MH.","Proc West Pharmacol Soc. 1980;23:285-9.","Namba MM","Proc West Pharmacol Soc","1980","1980/01/01","","",""
"7188963","Blockade of ovulation by methadone in the rat: a central nervous system-mediated acute effect","Johnson JH, Rosecrans JA.","J Pharmacol Exp Ther. 1980 Apr;213(1):110-3.","Johnson JH","J Pharmacol Exp Ther","1980","1980/04/01","","",""
"7181582","Cardiac and autonomic nervous system effects of L-alphacetylmethadol (LAAM)","Langley AE, Lehman TM, Kirlangitis J, Zeid R.","Arch Int Pharmacodyn Ther. 1982 Oct;259(2):250-8.","Langley AE","Arch Int Pharmacodyn Ther","1982","1982/10/01","","",""
"7178183","Interaction between nicotine and endogenous opioid mechanisms in the unanesthetized dog","Kamerling SG, Wettstein JG, Sloan JW, Su TP, Martin WR.","Pharmacol Biochem Behav. 1982 Oct;17(4):733-40. doi: 10.1016/0091-3057(82)90355-0.","Kamerling SG","Pharmacol Biochem Behav","1982","1982/10/01","","","10.1016/0091-3057(82)90355-0"
"7177344","Chronic administration of naltrexone alters central catecholamine levels but not the development of hypertension in spontaneously hypertensive rats","Strahlendorf JC, Strahlendorf HK, McKown-Pulliam R, Hughes MJ, Lang IM.","Neuropharmacology. 1982 Nov;21(11):1195-8. doi: 10.1016/0028-3908(82)90179-4.","Strahlendorf JC","Neuropharmacology","1982","1982/11/01","","","10.1016/0028-3908(82)90179-4"
"7171079","Complementary marital roles of male heroin addicts: evolution and intervention tactics","Kosten TR, Jalali B, Kleber HD.","Am J Drug Alcohol Abuse. 1982-1983;9(2):155-69. doi: 10.3109/00952998209002619.","Kosten TR","Am J Drug Alcohol Abuse","1982","1982/01/01","","","10.3109/00952998209002619"
"7167863","Palatability-induced drinking after administration of morphine, naltrexone and diazepam in the non-deprived rat","Cooper SJ.","Subst Alcohol Actions Misuse. 1982;3(5):259-66.","Cooper SJ","Subst Alcohol Actions Misuse","1982","1982/01/01","","",""
"7166139","Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers","Judson BA, Goldstein A.","Drug Alcohol Depend. 1982 Oct-Nov;10(2-3):269-82. doi: 10.1016/0376-8716(82)90021-7.","Judson BA","Drug Alcohol Depend","1982","1982/10/01","","","10.1016/0376-8716(82)90021-7"
"7162354","Potentiation by naltrexone of d-amphetamine-induced behavioral suppression and its reversal by clonidine","Fossom LH, Sparber SB.","Life Sci. 1982 Dec 20;31(25):2827-35. doi: 10.1016/0024-3205(82)90672-5.","Fossom LH","Life Sci","1982","1982/12/20","","","10.1016/0024-3205(82)90672-5"
"7150691","Data acquisition system used in studying naltrexone and behavior of primates","Mast RT, Hydinger-Macdonald MJ, Crowley TJ.","Biomed Sci Instrum. 1982;18:37-44.","Mast RT","Biomed Sci Instrum","1982","1982/01/01","","",""
"7145041","Analysis of the interaction of naltrexone with eating following adrenergic and cholinergic stimulation of the hypothalamus","Chance WT, Finkelstein JA, van Lammeren FM, Fischer JE.","Neuropharmacology. 1982 Sep;21(9):929-32. doi: 10.1016/0028-3908(82)90086-7.","Chance WT","Neuropharmacology","1982","1982/09/01","","","10.1016/0028-3908(82)90086-7"
"7145032","Effects of opiate antagonists and of morphine on chlordiazepoxide-induced hyperdipsia in the water-deprived rat","Cooper SJ.","Neuropharmacology. 1982 Oct;21(10):1013-7. doi: 10.1016/0028-3908(82)90115-0.","Cooper SJ","Neuropharmacology","1982","1982/10/01","","","10.1016/0028-3908(82)90115-0"
"7143239","Development of tolerance to the effects of morphine on luteinizing hormone secretion as a function of castration in the male rat","Cicero TJ, Meyer ER, Schmoeker PF.","J Pharmacol Exp Ther. 1982 Dec;223(3):784-9.","Cicero TJ","J Pharmacol Exp Ther","1982","1982/12/01","","",""
"7138234","Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy","Charney DS, Riordan CE, Kleber HD, Murburg M, Braverman P, Sternberg DE, Heninger GR, Redmond DE.","Arch Gen Psychiatry. 1982 Nov;39(11):1327-32. doi: 10.1001/archpsyc.1982.04290110077013.","Charney DS","Arch Gen Psychiatry","1982","1982/11/01","","","10.1001/archpsyc.1982.04290110077013"
"7132574","Endogenous opiates and stress ulceration","Morley JE, Levine AS, Silvis SE.","Life Sci. 1982 Aug 16;31(7):693-9. doi: 10.1016/0024-3205(82)90771-8.","Morley JE","Life Sci","1982","1982/08/16","","","10.1016/0024-3205(82)90771-8"
"7122510","Investigations of the preferential reduction in drinking behavior of opiate antagonists","Lang IM, Strahlendorf JC, Strahlendorf HK, Lutherer LO, Barnes CD.","Proc West Pharmacol Soc. 1982;25:293-7.","Lang IM","Proc West Pharmacol Soc","1982","1982/01/01","","",""
"7119946","A clinical guide to the diagnosis and treatment of heroin-related sexual dysfunction","Smith DE, Moser C, Wesson DR, Apter M, Buxton ME, Davison JV, Orgel M, Buffum J.","J Psychoactive Drugs. 1982 Jan-Jun;14(1-2):91-9. doi: 10.1080/02791072.1982.10471916.","Smith DE","J Psychoactive Drugs","1982","1982/01/01","","","10.1080/02791072.1982.10471916"
"7111349","The effects of chronic administration of naltrexone on appetite and water exchange in rats","Lang IM, Strahlendorf JC, Strahlendorf HK, Lutherer LO, Barnes CD.","Pharmacol Biochem Behav. 1982 Jun;16(6):909-13. doi: 10.1016/0091-3057(82)90043-0.","Lang IM","Pharmacol Biochem Behav","1982","1982/06/01","","","10.1016/0091-3057(82)90043-0"
"7111345","A comparison of the effects of opiate antagonists on operant and ingestive behavior","Sanger DJ, McCarthy PS.","Pharmacol Biochem Behav. 1982 Jun;16(6):1013-5. doi: 10.1016/0091-3057(82)90063-6.","Sanger DJ","Pharmacol Biochem Behav","1982","1982/06/01","","","10.1016/0091-3057(82)90063-6"
"7109840","Effects of yohimbine and naltrexone in counteraction of the morphine Straub tail and the amphetamine-potentiated morphine Straub tail in mice","Blumberg H, Slovak DM.","Life Sci. 1982 Jun 14;30(24):2115-21. doi: 10.1016/0024-3205(82)90454-4.","Blumberg H","Life Sci","1982","1982/06/14","","","10.1016/0024-3205(82)90454-4"
"7109826","Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity","Bianchi G, Fiocchi R, Tavani A, Manara L.","Life Sci. 1982 May 31;30(22):1875-83. doi: 10.1016/0024-3205(82)90467-2.","Bianchi G","Life Sci","1982","1982/05/31","","","10.1016/0024-3205(82)90467-2"
"7108900","Narcotic antagonistic potency of bivalent ligands which contain beta-naltrexamine. Evidence for bridging between proximal recognition sites","Erez M, Takemori AE, Portoghese PS.","J Med Chem. 1982 Jul;25(7):847-9. doi: 10.1021/jm00349a016.","Erez M","J Med Chem","1982","1982/07/01","","","10.1021/jm00349a016"
"7100917","Hypotensive effect of fasting: possible involvement of the sympathetic nervous system and endogenous opiates","Einhorn D, Young JB, Landberg L.","Science. 1982 Aug 20;217(4561):727-9. doi: 10.1126/science.7100917.","Einhorn D","Science","1982","1982/08/20","","","10.1126/science.7100917"
"7097642","Effects of opiate antagonists on early pregnancy and pseudopregnancy in mice","Nieder GL, Corder CN.","J Reprod Fertil. 1982 Jul;65(2):341-6. doi: 10.1530/jrf.0.0650341.","Nieder GL","J Reprod Fertil","1982","1982/07/01","","","10.1530/jrf.0.0650341"
"7089582","Adrenal medullary enkephalin-like peptides may mediate opioid stress analgesia","Lewis JW, Tordoff MG, Sherman JE, Liebeskind JC.","Science. 1982 Aug 6;217(4559):557-9. doi: 10.1126/science.7089582.","Lewis JW","Science","1982","1982/08/06","","","10.1126/science.7089582"
"7089032","Opiate modification of amygdaloid-kindled seizures in rats","Stone WS, Eggleton CE, Berman RF.","Pharmacol Biochem Behav. 1982 May;16(5):751-6. doi: 10.1016/0091-3057(82)90230-1.","Stone WS","Pharmacol Biochem Behav","1982","1982/05/01","","","10.1016/0091-3057(82)90230-1"
"7085584","Outpatient opiate detoxification with clonidine","Washton AM, Resnick RB.","J Clin Psychiatry. 1982 Jun;43(6 Pt 2):39-41.","Washton AM","J Clin Psychiatry","1982","1982/06/01","","",""
"7079321","Tail pinch behavior and analgesia in diabetic mice","Levine AS, Morley JE, Wilcox G, Brown DM, Handwerger BS.","Physiol Behav. 1982 Jan;28(1):39-43. doi: 10.1016/0031-9384(82)90098-1.","Levine AS","Physiol Behav","1982","1982/01/01","","","10.1016/0031-9384(82)90098-1"
"7065829","Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome","Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H.","Arch Gen Psychiatry. 1982 Feb;39(2):151-6. doi: 10.1001/archpsyc.1982.04290020021004.","Rounsaville BJ","Arch Gen Psychiatry","1982","1982/02/01","","","10.1001/archpsyc.1982.04290020021004"
"7062259","Opiates and thermoregulation in mice. II. Effects of opiate antagonists","Rosow CE, Miller JM, Poulsen-Burke J, Cochin J.","J Pharmacol Exp Ther. 1982 Mar;220(3):464-7.","Rosow CE","J Pharmacol Exp Ther","1982","1982/03/01","","",""
"7061693","Effect of endogenous opioid blockade on the amplitude and frequency of pulsatile luteinizing hormone secretion in normal men","Ellingboe J, Veldhuis JD, Mendelson JH, Kuehnle JC, Mello NK.","J Clin Endocrinol Metab. 1982 Apr;54(4):854-7. doi: 10.1210/jcem-54-4-854.","Ellingboe J","J Clin Endocrinol Metab","1982","1982/04/01","","","10.1210/jcem-54-4-854"
"7060629","Opiate antagonists stimulate ruminal motility of conscious goats","Maas CL.","Eur J Pharmacol. 1982 Jan 8;77(1):71-4. doi: 10.1016/0014-2999(82)90539-8.","Maas CL","Eur J Pharmacol","1982","1982/01/08","","","10.1016/0014-2999(82)90539-8"
"7057394","Characterization of vasopressin analgesia","Berkowitz BA, Sherman S.","J Pharmacol Exp Ther. 1982 Feb;220(2):329-34.","Berkowitz BA","J Pharmacol Exp Ther","1982","1982/02/01","","",""
"7047964","Drinking, but not feeding, is opiate-sensitive in hamsters","Lowy MT, Yim GK.","Life Sci. 1982 May 10;30(19):1639-44. doi: 10.1016/0024-3205(82)90496-9.","Lowy MT","Life Sci","1982","1982/05/10","","","10.1016/0024-3205(82)90496-9"
"7042396","Limitations on the antagonistic actions of opioid antagonists","Young AM, Woods JH.","Fed Proc. 1982 May;41(7):2333-8.","Young AM","Fed Proc","1982","1982/05/01","","",""
"7037459","Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys","Woods JH, Young AM, Herling S.","Fed Proc. 1982 Feb;41(2):221-7.","Woods JH","Fed Proc","1982","1982/02/01","","",""
"7023894","Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison","Judson BA, Carney TM, Goldstein A.","Drug Alcohol Depend. 1981 Jul;7(4):325-46. doi: 10.1016/0376-8716(81)90049-1.","Judson BA","Drug Alcohol Depend","1981","1981/07/01","","","10.1016/0376-8716(81)90049-1"
"7017107","Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey","Hein DW, Young AM, Herling S, Woods JH.","J Pharmacol Exp Ther. 1981 Jul;218(1):7-15.","Hein DW","J Pharmacol Exp Ther","1981","1981/07/01","","",""
"6993656","Narcotic discrimination in pigeons","Herling S, Coale EH Jr, Valentino RJ, Hein DW, Woods JH.","J Pharmacol Exp Ther. 1980 Jul;214(1):139-46.","Herling S","J Pharmacol Exp Ther","1980","1980/07/01","","",""
"6993401","Naltrexone in chronic schizophrenia. Results of a clinical trial","Ragheb M, Berney S, Ban T.","Int Pharmacopsychiatry. 1980;15(1):1-5. doi: 10.1159/000468408.","Ragheb M","Int Pharmacopsychiatry","1980","1980/01/01","","","10.1159/000468408"
"6978757","Failure of narcotic antagonist to alter electroacupuncture modification of halothane anaesthesia in the dog","Tay AA, Tseng CK, Pace NL, Wong KC, Hong-Goka BC.","Can Anaesth Soc J. 1982 May;29(3):231-5. doi: 10.1007/BF03007122.","Tay AA","Can Anaesth Soc J","1982","1982/05/01","","","10.1007/BF03007122"
"6961864","Endorphin levels in opioid-dependent human subjects: a longitudinal study","O'Brien CP, Terenius L, Wahlström A, McLellan AT, Krivoy W.","Ann N Y Acad Sci. 1982;398:377-87. doi: 10.1111/j.1749-6632.1982.tb39509.x.","O'Brien CP","Ann N Y Acad Sci","1982","1982/01/01","","","10.1111/j.1749-6632.1982.tb39509.x"
"6961861","Activation of opioid-containing systems during gestation","Gintzler AR.","Ann N Y Acad Sci. 1982;398:302-7. doi: 10.1111/j.1749-6632.1982.tb39502.x.","Gintzler AR","Ann N Y Acad Sci","1982","1982/01/01","","","10.1111/j.1749-6632.1982.tb39502.x"
"6927049","Quantitative determination of 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN), naltrexone, and 6 beta-naltrexol in human plasma, red blood cells, saliva, and urine by gas liquid chromatography","Verebey K, De Pace A, Jukofsky D, Volavka JV, Mulé SJ.","J Anal Toxicol. 1980 Jan-Feb;4(1):33-7. doi: 10.1093/jat/4.1.33.","Verebey K","J Anal Toxicol","1980","1980/01/01","","","10.1093/jat/4.1.33"
"6891739","Effects of beta-chlornaltrexamine on separation distress in chicks","Panksepp J, Siviy S, Normansell L, White K, Bishop P.","Life Sci. 1982 Nov 15-22;31(20-21):2387-90. doi: 10.1016/0024-3205(82)90163-1.","Panksepp J","Life Sci","1982","1982/11/15","","","10.1016/0024-3205(82)90163-1"
"6891063","Effects of opiate antagonists on social and aggressive behavior of isolated mice","Puglisi-Allegra S, Oliverio A, Mandel P.","Pharmacol Biochem Behav. 1982 Oct;17(4):691-4. doi: 10.1016/0091-3057(82)90347-1.","Puglisi-Allegra S","Pharmacol Biochem Behav","1982","1982/10/01","","","10.1016/0091-3057(82)90347-1"
"6890239","Tolerance to and physical dependence on N-allylnormetazocine (NANM) in chronic spinal dogs","Martin WR, Eades CG, Gilbert PE, Thompson JA.","Subst Alcohol Actions Misuse. 1980;1(3):269-79.","Martin WR","Subst Alcohol Actions Misuse","1980","1980/01/01","","",""
"6889739","Central regulation of intestinal function: morphine withdrawal diarrhea","Schreier WA, Burks TF.","Proc West Pharmacol Soc. 1982;25:151-4.","Schreier WA","Proc West Pharmacol Soc","1982","1982/01/01","","",""
"6889416","Acquisition of brightness discrimination in the rat is impaired by opiates with psychotomimetic properties","Tang AH, Franklin SR.","Pharmacol Biochem Behav. 1983 Jun;18(6):873-7. doi: 10.1016/s0091-3057(83)80008-2.","Tang AH","Pharmacol Biochem Behav","1983","1983/06/01","","","10.1016/s0091-3057(83)80008-2"
"6883119","Anticonvulsant effects of stress: role of endogenous opioids","Oliverio A, Castellano C, Puglisi-Allegra S.","Brain Res. 1983 Jul 18;271(1):193-5. doi: 10.1016/0006-8993(83)91385-9.","Oliverio A","Brain Res","1983","1983/07/18","","","10.1016/0006-8993(83)91385-9"
"6883097","Involvement of central muscarinic cholinergic mechanisms in opioid stress analgesia","Lewis JW, Cannon JT, Liebeskind JC.","Brain Res. 1983 Jul 4;270(2):289-93. doi: 10.1016/0006-8993(83)90603-0.","Lewis JW","Brain Res","1983","1983/07/04","","","10.1016/0006-8993(83)90603-0"
"6875851","Naltrexone effects on plasma vasopressin concentration elevated and lowered by various stimuli","Rosella-Dampman LM, Keil LC, Chee O, Summy-Long JY.","J Pharmacol Exp Ther. 1983 Aug;226(2):373-81.","Rosella-Dampman LM","J Pharmacol Exp Ther","1983","1983/08/01","","",""
"6867737","Naltrexone modulates tumor response in mice with neuroblastoma","Zagon IS, McLaughlin PJ.","Science. 1983 Aug 12;221(4611):671-3. doi: 10.1126/science.6867737.","Zagon IS","Science","1983","1983/08/12","","","10.1126/science.6867737"
"6843792","Effects of chronic antenatal and postnatal administration of narcotics on naloxone-induced anorexia in preweanling rats","Aroyewun OO, Barr GA.","Neuropharmacology. 1983 Mar;22(3):329-36. doi: 10.1016/0028-3908(83)90248-4.","Aroyewun OO","Neuropharmacology","1983","1983/03/01","","","10.1016/0028-3908(83)90248-4"
"6843791","Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat","Cooper SJ.","Neuropharmacology. 1983 Mar;22(3):323-8. doi: 10.1016/0028-3908(83)90247-2.","Cooper SJ","Neuropharmacology","1983","1983/03/01","","","10.1016/0028-3908(83)90247-2"
"6843782","Effects of naloxone and its quarternary analogue on stimulation-induced feeding","Carr KD, Simon EJ.","Neuropharmacology. 1983 Jan;22(1):127-30. doi: 10.1016/0028-3908(83)90272-1.","Carr KD","Neuropharmacology","1983","1983/01/01","","","10.1016/0028-3908(83)90272-1"
"6835979","Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone","Critcher EC, Lin CI, Patel J, Myers RD.","Pharmacol Biochem Behav. 1983 Feb;18(2):225-9. doi: 10.1016/0091-3057(83)90367-2.","Critcher EC","Pharmacol Biochem Behav","1983","1983/02/01","","","10.1016/0091-3057(83)90367-2"
"6831119","Stereospecific enhancement of evoked release of brain acetylcholine by narcotic antagonists","Jhamandas K, Sutak M.","Br J Pharmacol. 1983 Feb;78(2):433-40. doi: 10.1111/j.1476-5381.1983.tb09408.x.","Jhamandas K","Br J Pharmacol","1983","1983/02/01","PMC2044700","","10.1111/j.1476-5381.1983.tb09408.x"
"6827900","Cardiovascular effects of naloxone, naltrexone and morphine in the squirrel monkey","Byrd LD.","Life Sci. 1983 Jan 24;32(4):391-8. doi: 10.1016/0024-3205(83)90085-1.","Byrd LD","Life Sci","1983","1983/01/24","","","10.1016/0024-3205(83)90085-1"
"6813889","Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey","Holtzman SG.","Psychopharmacology (Berl). 1982;77(4):295-300. doi: 10.1007/BF00432758.","Holtzman SG","Psychopharmacology (Berl)","1982","1982/01/01","","","10.1007/BF00432758"
"6811941","Naltrexone and psychotherapy","Stone-Washton N, Resnick RB, Washton AM.","NIDA Res Monogr. 1982 Apr;41:505-7.","Stone-Washton N","NIDA Res Monogr","1982","1982/04/01","","",""
"6798611","Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat","Ruffing DM, Domino EF.","Psychopharmacology (Berl). 1981;75(3):226-30. doi: 10.1007/BF00432428.","Ruffing DM","Psychopharmacology (Berl)","1981","1981/01/01","","","10.1007/BF00432428"
"6791204","Assessment of naltrexone in the treatment of schizophrenia","Gitlin MJ, Gerner RH, Rosenblatt M.","Psychopharmacology (Berl). 1981;74(1):51-3. doi: 10.1007/BF00431756.","Gitlin MJ","Psychopharmacology (Berl)","1981","1981/01/01","","","10.1007/BF00431756"
"6791198","Threshold differences for naloxone and naltrexone in the hypothalamus and midbrain using fixed ratio brain self-stimulation in rats","Schaefer GJ, Michael RP.","Psychopharmacology (Berl). 1981;74(1):17-22. doi: 10.1007/BF00431750.","Schaefer GJ","Psychopharmacology (Berl)","1981","1981/01/01","","","10.1007/BF00431750"
"6791016","A comparative study of the oral, intravenous, and subcutaneous administration of 3H-naltrexone to normal male volunteers","Perez-Reyes M, Wall ME.","NIDA Res Monogr. 1981;28:93-101.","Perez-Reyes M","NIDA Res Monogr","1981","1981/01/01","","",""
"6791015","Pharmacological evaluation of narcotic antagonist delivery systems in rhesus monkeys","Harrigan SE, Downs DA.","NIDA Res Monogr. 1981;28:77-92.","Harrigan SE","NIDA Res Monogr","1981","1981/01/01","","",""
"6791014","Background on animal testing in the drug delivery systems program","Dewey WL.","NIDA Res Monogr. 1981;28:69-76.","Dewey WL","NIDA Res Monogr","1981","1981/01/01","","",""
"6791013","Analytical methods for quantitative and qualitative analysis of naltrexone and metabolites in biological fluids","Wall ME, Brine DR.","NIDA Res Monogr. 1981;28:52-65.","Wall ME","NIDA Res Monogr","1981","1981/01/01","","",""
"6791012","Quantitative determination of naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN) in human plasma, red blood cells, saliva and urine by gas liquid chromatography","Verebey K.","NIDA Res Monogr. 1981;28:36-51.","Verebey K","NIDA Res Monogr","1981","1981/01/01","","",""
"6791011","Historical perspective on the chemistry and development of naltrexone","Archer S.","NIDA Res Monogr. 1981;28:3-10.","Archer S","NIDA Res Monogr","1981","1981/01/01","","",""
"6791010","Solid solutions as long-acting naltrexone delivery systems","Olsen JL.","NIDA Res Monogr. 1981;28:265-71.","Olsen JL","NIDA Res Monogr","1981","1981/01/01","","",""
"6791009","An improved long-acting delivery system for narcotic antagonists","Misra AL, Pontani RB.","NIDA Res Monogr. 1981;28:254-64.","Misra AL","NIDA Res Monogr","1981","1981/01/01","","",""
"6791008","An electron-capture gas chromatographic assay for naltrexone in biological fluids","Reuning RH, Ashcraft SB, Morrison BE.","NIDA Res Monogr. 1981;28:25-35.","Reuning RH","NIDA Res Monogr","1981","1981/01/01","","",""
"6791006","Use of synthetic polypeptides in the preparation of biodegradable delivery systems for narcotic antagonists","Sidman KR, Schwope AD, Steber WD, Rudolph SE.","NIDA Res Monogr. 1981;28:214-31.","Sidman KR","NIDA Res Monogr","1981","1981/01/01","","",""
"6791005","Development of drug delivery systems for use in treatment of narcotic addiction","Sharon AC, Wise DL.","NIDA Res Monogr. 1981;28:194-213.","Sharon AC","NIDA Res Monogr","1981","1981/01/01","","",""
"6791004","A review of parenteral sustained-release naltrexone systems","Olsen JL, Kincl FA.","NIDA Res Monogr. 1981;28:187-93.","Olsen JL","NIDA Res Monogr","1981","1981/01/01","","",""
"6791003","Pharmacokinetic quantitation of naltrexone release from several sustained-release delivery systems","Reuning RH, Liao SH, Staubus AE.","NIDA Res Monogr. 1981;28:172-84.","Reuning RH","NIDA Res Monogr","1981","1981/01/01","","",""
"6791002","Overview of human pharmacokinetics of naltrexone","Licko V.","NIDA Res Monogr. 1981;28:161-71.","Licko V","NIDA Res Monogr","1981","1981/01/01","","",""
"6791001","The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics","Verebey K.","NIDA Res Monogr. 1981;28:147-58.","Verebey K","NIDA Res Monogr","1981","1981/01/01","","",""
"6791000","Treatment of heroin-dependent persons with antagonists: current status","Renault PF.","NIDA Res Monogr. 1981;28:11-22.","Renault PF","NIDA Res Monogr","1981","1981/01/01","","",""
"6790999","The metabolism of naltrexone in man","Wall ME, Brine DR, Perez-Reyes M.","NIDA Res Monogr. 1981;28:105-31.","Wall ME","NIDA Res Monogr","1981","1981/01/01","","",""
"6790998","Narcotic antagonists: naltrexone pharmacochemistry and sustained-release preparations","","NIDA Res Monogr. 1981;28:1-273.","","NIDA Res Monogr","1981","1981/01/01","","",""
"6783917","Psychotherapy and naltrexone in opioid dependence","Resnick RB, Washton AM, Stone-Washton N.","NIDA Res Monogr. 1981 Feb;34:109-15.","Resnick RB","NIDA Res Monogr","1981","1981/02/01","","",""
"6783916","Clonidine hydrochloride detoxification from methadone treatments: the value of naltrexone aftercare","Rawson RA, Washton AM, Resnick RB, Tennant FS Jr.","NIDA Res Monogr. 1981 Feb;34:101-8.","Rawson RA","NIDA Res Monogr","1981","1981/02/01","","",""
"6774622","Opiate use and sexual function","Mirin SM, Meyer RE, Mendelson JH, Ellingboe J.","Am J Psychiatry. 1980 Aug;137(8):909-15. doi: 10.1176/ajp.137.8.909.","Mirin SM","Am J Psychiatry","1980","1980/08/01","","","10.1176/ajp.137.8.909"
"6771774","Stimulus effects of morphine in the monkey: quantitative analysis of antagonism","Teal JJ, Holtzman SG.","Pharmacol Biochem Behav. 1980 Apr;12(4):587-93. doi: 10.1016/0091-3057(80)90193-8.","Teal JJ","Pharmacol Biochem Behav","1980","1980/04/01","","","10.1016/0091-3057(80)90193-8"
"6768078","Effects of heroin self-administration on cigarette smoking","Mello NK, Mendelson JH, Sellers ML, Kuehnle JC.","Psychopharmacology (Berl). 1980 Jan;67(1):45-52. doi: 10.1007/BF00427594.","Mello NK","Psychopharmacology (Berl)","1980","1980/01/01","","","10.1007/BF00427594"
"6767889","Alteration of ethanol self-administration by naltrexone","Altshuler HL, Phillips PE, Feinhandler DA.","Life Sci. 1980 Mar 3;26(9):679-88. doi: 10.1016/0024-3205(80)90257-x.","Altshuler HL","Life Sci","1980","1980/03/03","","","10.1016/0024-3205(80)90257-x"
"6760771","Naloxone and naltrexone in mental illness and tardive dyskinesia","Volavka J, Anderson B, Koz G.","Ann N Y Acad Sci. 1982;398:97-102. doi: 10.1111/j.1749-6632.1982.tb39480.x.","Volavka J","Ann N Y Acad Sci","1982","1982/01/01","","","10.1111/j.1749-6632.1982.tb39480.x"
"6760769","Phencyclidine-like discriminative stimulus properties of psychotomimetic opioids","Holtzman SG.","Ann N Y Acad Sci. 1982;398:230-40. doi: 10.1111/j.1749-6632.1982.tb39497.x.","Holtzman SG","Ann N Y Acad Sci","1982","1982/01/01","","","10.1111/j.1749-6632.1982.tb39497.x"
"6755122","Ethanol inhibits the naloxone-induced release of luteinizing hormone-releasing hormone from the hypothalamus of the male rat","Cicero TJ, Newman KS, Gerrity M, Schmoeker PF, Bell RD.","Life Sci. 1982 Oct 11;31(15):1587-96. doi: 10.1016/0024-3205(82)90050-9.","Cicero TJ","Life Sci","1982","1982/10/11","","","10.1016/0024-3205(82)90050-9"
"6738824","Effects of naloxone and naltrexone on drug-induced hypothermia in mice","Weiss J, Thompson ML, Shuster L.","Neuropharmacology. 1984 May;23(5):483-9. doi: 10.1016/0028-3908(84)90019-4.","Weiss J","Neuropharmacology","1984","1984/05/01","","","10.1016/0028-3908(84)90019-4"
"6738790","Naltrexone effects on pituitary neurointermediate lobe and median eminence","Saland LC, Reyes E, Ortiz E.","Neurochem Res. 1984 Feb;9(2):207-17. doi: 10.1007/BF00964168.","Saland LC","Neurochem Res","1984","1984/02/01","","","10.1007/BF00964168"
"6737235","Electrochemical chromatographic determinations of morphine antagonists in biological fluids, with applications","Derendorf H, El-Din A, El-Koussi A, Garrett ER.","J Pharm Sci. 1984 May;73(5):621-4. doi: 10.1002/jps.2600730510.","Derendorf H","J Pharm Sci","1984","1984/05/01","","","10.1002/jps.2600730510"
"6722534","Naloxone improves, and morphine exacerbates, experimental shock induced by release of endogenous histamine by compound 48/80","Amir S.","Brain Res. 1984 Apr 9;297(1):187-90. doi: 10.1016/0006-8993(84)90558-4.","Amir S","Brain Res","1984","1984/04/09","","","10.1016/0006-8993(84)90558-4"
"6718461","Pharmacological profile of wet-dog shaking induced by electrical stimulation of the fornix in rats","Slater P.","Pharmacol Res Commun. 1984 Mar;16(3):273-80. doi: 10.1016/s0031-6989(84)80110-1.","Slater P","Pharmacol Res Commun","1984","1984/03/01","","","10.1016/s0031-6989(84)80110-1"
"6716270","Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat","Koob GF, Pettit HO, Ettenberg A, Bloom FE.","J Pharmacol Exp Ther. 1984 May;229(2):481-6.","Koob GF","J Pharmacol Exp Ther","1984","1984/05/01","","",""
"6709679","Opiate antagonists reverse the hypoactivity associated with systemic anaphylaxis in mice","Amir S.","Pharmacol Biochem Behav. 1984 Mar;20(3):483-5. doi: 10.1016/0091-3057(84)90290-9.","Amir S","Pharmacol Biochem Behav","1984","1984/03/01","","","10.1016/0091-3057(84)90290-9"
"6709677","Latent inhibition in the aversion to oral methadone","Lynch MR, Porter JH, Rosecrans JA.","Pharmacol Biochem Behav. 1984 Mar;20(3):467-72. doi: 10.1016/0091-3057(84)90287-9.","Lynch MR","Pharmacol Biochem Behav","1984","1984/03/01","","","10.1016/0091-3057(84)90287-9"
"6703387","Addiction and anesthesiology","Spiegelman WG, Saunders L, Mazze RI.","Anesthesiology. 1984 Apr;60(4):335-41. doi: 10.1097/00000542-198404000-00009.","Spiegelman WG","Anesthesiology","1984","1984/04/01","","","10.1097/00000542-198404000-00009"
"6697193","Opiate and non-opiate analgesia induced by inescapable tail-shock: effects of dorsolateral funiculus lesions and decerebration","Watkins LR, Drugan R, Hyson RL, Moye TB, Ryan SM, Mayer DJ, Maier SF.","Brain Res. 1984 Jan 23;291(2):325-36. doi: 10.1016/0006-8993(84)91265-4.","Watkins LR","Brain Res","1984","1984/01/23","","","10.1016/0006-8993(84)91265-4"
"6694998","Effect of naltrexone on food intake and hoarding in white-footed mice (Peromyscus)","Tannenbaum MG, Pivorun EB.","Pharmacol Biochem Behav. 1984 Jan;20(1):35-7. doi: 10.1016/0091-3057(84)90096-0.","Tannenbaum MG","Pharmacol Biochem Behav","1984","1984/01/01","","","10.1016/0091-3057(84)90096-0"
"6691146","Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity","Shavit Y, Lewis JW, Terman GW, Gale RP, Liebeskind JC.","Science. 1984 Jan 13;223(4632):188-90. doi: 10.1126/science.6691146.","Shavit Y","Science","1984","1984/01/13","","","10.1126/science.6691146"
"6686324","Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth","Lewis JW, Shavit Y, Terman GW, Nelson LR, Gale RP, Liebeskind JC.","Peptides. 1983 Sep-Oct;4(5):635-8. doi: 10.1016/0196-9781(83)90010-4.","Lewis JW","Peptides","1983","1983/09/01","","","10.1016/0196-9781(83)90010-4"
"6686142","Spinal antagonism of tolerance and dependence induced by systemically administered morphine","Delander GE, Takemori AE.","Eur J Pharmacol. 1983 Oct 14;94(1-2):35-42. doi: 10.1016/0014-2999(83)90439-9.","Delander GE","Eur J Pharmacol","1983","1983/10/14","","","10.1016/0014-2999(83)90439-9"
"6684293","Use of the novel irreversible opiate antagonist, beta-chlornaltrexamine, in the estimation of the normorphine affinity constant in naive and morphine tolerant guinea-pig ilea","Porreca F, Burks TF.","Proc West Pharmacol Soc. 1983;26:295-7.","Porreca F","Proc West Pharmacol Soc","1983","1983/01/01","","",""
"6682490","Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives","Brown DR, Robertson MJ, Goldberg LI.","Neuropharmacology. 1983 Mar;22(3):317-21. doi: 10.1016/0028-3908(83)90246-0.","Brown DR","Neuropharmacology","1983","1983/03/01","","","10.1016/0028-3908(83)90246-0"
"6682230","A preliminary description of acute physical dependence on morphine in the vervet monkey","Krystal JH, Redmond DE Jr.","Pharmacol Biochem Behav. 1983 Feb;18(2):289-91. doi: 10.1016/0091-3057(83)90379-9.","Krystal JH","Pharmacol Biochem Behav","1983","1983/02/01","","","10.1016/0091-3057(83)90379-9"
"6681633","Prolonged excretion of morphine in rats during protracted abstinence: lack of effect of naltrexone","Jones AW, Neri A, Anggård E.","J Pharmacol Exp Ther. 1983 Feb;224(2):419-23.","Jones AW","J Pharmacol Exp Ther","1983","1983/02/01","","",""
"6681632","Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons","Valentino RJ, Herling S, Woods JH.","J Pharmacol Exp Ther. 1983 Feb;224(2):307-13.","Valentino RJ","J Pharmacol Exp Ther","1983","1983/02/01","","",""
"6668313","Determination of naloxone in blood by high-performance liquid chromatography","Asali LA, Nation RL, Brown KF.","J Chromatogr. 1983 Dec 9;278(2):329-35. doi: 10.1016/s0378-4347(00)84792-1.","Asali LA","J Chromatogr","1983","1983/12/09","","","10.1016/s0378-4347(00)84792-1"
"6667710","Proanaphylactic action of morphine is mediated through a central cholinergic mechanism","Amir S.","Eur J Pharmacol. 1983 Nov 11;95(1-2):117-9. doi: 10.1016/0014-2999(83)90274-1.","Amir S","Eur J Pharmacol","1983","1983/11/11","","","10.1016/0014-2999(83)90274-1"
"6665302","Nalmefene: quantitation of a new narcotic antagonist in human plasma using high performance-liquid chromatography with electrochemical detection","Hsiao J, Dixon R.","Res Commun Chem Pathol Pharmacol. 1983 Dec;42(3):449-54.","Hsiao J","Res Commun Chem Pathol Pharmacol","1983","1983/12/01","","",""
"6662195","Analgesic effect of prolactin: possible mechanism of action","Ramaswamy S, Pillai NP, Bapna JS.","Eur J Pharmacol. 1983 Dec 9;96(1-2):171-3. doi: 10.1016/0014-2999(83)90548-4.","Ramaswamy S","Eur J Pharmacol","1983","1983/12/09","","","10.1016/0014-2999(83)90548-4"
"6657726","Inhibition of morphine-induced analgesia and locomotor activity in strains of mice: a comparison of long-acting opiate antagonists","Frischknecht HR, Siegfried B, Riggio G, Waser PG.","Pharmacol Biochem Behav. 1983 Dec;19(6):939-44. doi: 10.1016/0091-3057(83)90395-7.","Frischknecht HR","Pharmacol Biochem Behav","1983","1983/12/01","","","10.1016/0091-3057(83)90395-7"
"6655565","Discriminative stimulus effects of dextrorphan in pigeons","Herling S, Solomon RE, Woods JH.","J Pharmacol Exp Ther. 1983 Dec;227(3):723-31.","Herling S","J Pharmacol Exp Ther","1983","1983/12/01","","",""
"6653389","Predictors of favorable outcome following naltrexone treatment","Greenstein RA, Evans BD, McLellan AT, O'Brien CP.","Drug Alcohol Depend. 1983 Oct;12(2):173-80. doi: 10.1016/0376-8716(83)90042-x.","Greenstein RA","Drug Alcohol Depend","1983","1983/10/01","","","10.1016/0376-8716(83)90042-x"
"6646353","Morphine antagonizes pentobarbital-induced anesthesia","Horita A, Carino MA, Yamawaki S.","Neuropharmacology. 1983 Oct;22(10):1183-6. doi: 10.1016/0028-3908(83)90078-3.","Horita A","Neuropharmacology","1983","1983/10/01","","","10.1016/0028-3908(83)90078-3"
"6640516","Opioid antagonists inhibit the growth of metastatic murine neuroblastoma","Zagon IS, McLaughlin PJ.","Cancer Lett. 1983 Nov;21(1):89-94. doi: 10.1016/0304-3835(83)90087-3.","Zagon IS","Cancer Lett","1983","1983/11/01","","","10.1016/0304-3835(83)90087-3"
"6640302","Interaction of the opiate antagonist, naltrexone methyl bromide, with the acetylcholine receptor system of the motor end-plate","Argentieri TM, McArdle JJ.","Brain Res. 1983 Oct 31;277(2):377-9. doi: 10.1016/0006-8993(83)90950-2.","Argentieri TM","Brain Res","1983","1983/10/31","","","10.1016/0006-8993(83)90950-2"
"6637740","Naltrexone and clonidine: alternatives to methadone","Ginzburg HM.","Am Fam Physician. 1983 Nov;28(5):100, 102.","Ginzburg HM","Am Fam Physician","1983","1983/11/01","","",""
"6634902","Patterns of drinking in the rat following the administration of opiate antagonists","Cooper SJ, Holtzman SG.","Pharmacol Biochem Behav. 1983 Sep;19(3):505-11. doi: 10.1016/0091-3057(83)90127-2.","Cooper SJ","Pharmacol Biochem Behav","1983","1983/09/01","","","10.1016/0091-3057(83)90127-2"
"6634889","Opiate antagonists, morphine and spatial memory in rats","Beatty WW.","Pharmacol Biochem Behav. 1983 Sep;19(3):397-401. doi: 10.1016/0091-3057(83)90108-9.","Beatty WW","Pharmacol Biochem Behav","1983","1983/09/01","","","10.1016/0091-3057(83)90108-9"
"6634886","Abolition of conditioned heart-rate responses in rabbits following central administration of [N-MePhe3, D-Pro4] morphiceptin","Lavond DG, Mauk MD, Madden J 4th, Barchas JD, Thompson RF.","Pharmacol Biochem Behav. 1983 Aug;19(2):379-82. doi: 10.1016/0091-3057(83)90069-2.","Lavond DG","Pharmacol Biochem Behav","1983","1983/08/01","","","10.1016/0091-3057(83)90069-2"
"6634872","Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats","McLaughlin CL, Baile CA.","Pharmacol Biochem Behav. 1983 Aug;19(2):235-40. doi: 10.1016/0091-3057(83)90045-x.","McLaughlin CL","Pharmacol Biochem Behav","1983","1983/08/01","","","10.1016/0091-3057(83)90045-x"
"6633822","Role of endorphins in endotoxin-induced hyperglycaemia in mice","Amir S, Harel M.","Neuropharmacology. 1983 Sep;22(9):1117-9. doi: 10.1016/0028-3908(83)90033-3.","Amir S","Neuropharmacology","1983","1983/09/01","","","10.1016/0028-3908(83)90033-3"
"6619824","Family denial as a prognostic factor in opiate addict treatment outcome","Kosten TR, Jalali B, Hogan I, Kleber HD.","J Nerv Ment Dis. 1983 Oct;171(10):611-6. doi: 10.1097/00005053-198310000-00004.","Kosten TR","J Nerv Ment Dis","1983","1983/10/01","","","10.1097/00005053-198310000-00004"
"6612331","Increased brain size and cellular content in infant rats treated with an opiate antagonist","Zagon IS, McLaughlin PJ.","Science. 1983 Sep 16;221(4616):1179-80. doi: 10.1126/science.6612331.","Zagon IS","Science","1983","1983/09/16","","","10.1126/science.6612331"
"6607339","An antiabsorptive basis for precipitated withdrawal diarrhea in morphine-dependent rats","Chang EB, Brown DR, Field M, Miller RJ.","J Pharmacol Exp Ther. 1984 Feb;228(2):364-9.","Chang EB","J Pharmacol Exp Ther","1984","1984/02/01","","",""
"6583447","Neurohormonal modulation of natural resistance to a murine lymphoma","Greenberg AH, Dyck DG, Sandler LS, Pohajdak B, Dresel KM, Grant D.","J Natl Cancer Inst. 1984 Mar;72(3):653-9.","Greenberg AH","J Natl Cancer Inst","1984","1984/03/01","","",""
"6578730","Endorphins in endotoxin-induced hyperglycemia in mice","Amir S, Harel M.","Arch Toxicol Suppl. 1983;6:261-5. doi: 10.1007/978-3-642-69083-9_48.","Amir S","Arch Toxicol Suppl","1983","1983/01/01","","","10.1007/978-3-642-69083-9_48"
"6547224","The effects of intrathecal morphine and naltrexone on autotomy in sciatic nerve sectioned rats","Wiesenfeld-Hallin Z.","Pain. 1984 Mar;18(3):267-78. doi: 10.1016/0304-3959(84)90821-2.","Wiesenfeld-Hallin Z","Pain","1984","1984/03/01","","","10.1016/0304-3959(84)90821-2"
"6543435","Opioid involvement in hypertension induced by short-term isolation","Fuentes JA, Borrell J, Naranjo JR.","Clin Exp Hypertens A. 1984;6(10-11):2041-4. doi: 10.3109/10641968409046124.","Fuentes JA","Clin Exp Hypertens A","1984","1984/01/01","","","10.3109/10641968409046124"
"6543398","The behavioural depression of hippocampal kindled rats is attenuated by subcutaneous and intracerebroventricular naltrexone","Cottrell GA, Nyakas C, Bohus B.","Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(4-6):673-6. doi: 10.1016/0278-5846(84)90035-6.","Cottrell GA","Prog Neuropsychopharmacol Biol Psychiatry","1984","1984/01/01","","","10.1016/0278-5846(84)90035-6"
"6543246","Endogenous opiates and stress. Behavioral activation elicited in the rat and effects of naltrexone, diprenorphine and morphine","Katz RJ, Manik CP.","Neuropharmacology. 1984 Dec;23(12A):1425-30. doi: 10.1016/0028-3908(84)90084-4.","Katz RJ","Neuropharmacology","1984","1984/12/01","","","10.1016/0028-3908(84)90084-4"
"6541122","Do testicular opiates regulate Leydig cell function?","Gerendai I, Shaha C, Thau R, Bardin CW.","Endocrinology. 1984 Oct;115(4):1645-7. doi: 10.1210/endo-115-4-1645.","Gerendai I","Endocrinology","1984","1984/10/01","","","10.1210/endo-115-4-1645"
"6541075","A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin","Summy-Long JY, Miller DS, Rosella-Dampman LM, Hartman RD, Emmert SE.","Brain Res. 1984 Sep 10;309(2):362-6.","Summy-Long JY","Brain Res","1984","1984/09/10","","",""
"6540897","A rapid, quantitative in vivo assay for narcotic antagonists","Katovich MJ, Simpkins JW, Song IC, Bodor N, Tuttle R.","Subst Alcohol Actions Misuse. 1984;5(2):87-95.","Katovich MJ","Subst Alcohol Actions Misuse","1984","1984/01/01","","",""
"6540590","Effects of naltrexone and signaling inescapable electric shock on nociception and gastric lesions in rats","Guile MN, McCutcheon NB.","Behav Neurosci. 1984 Aug;98(4):695-702. doi: 10.1037//0735-7044.98.4.695.","Guile MN","Behav Neurosci","1984","1984/08/01","","","10.1037//0735-7044.98.4.695"
"6539667","Stress induced alteration of opiate withdrawal","Manik CP, Katz RJ.","Drug Alcohol Depend. 1984 May;13(3):311-4. doi: 10.1016/0376-8716(84)90071-1.","Manik CP","Drug Alcohol Depend","1984","1984/05/01","","","10.1016/0376-8716(84)90071-1"
"6539142","Chronic stress enhances apomorphine-induced stereotyped behavior in mice: involvement of endogenous opioids","Cabib S, Puglisi-Allegra S, Oliverio A.","Brain Res. 1984 Apr 23;298(1):138-40. doi: 10.1016/0006-8993(84)91156-9.","Cabib S","Brain Res","1984","1984/04/23","","","10.1016/0006-8993(84)91156-9"
"6538628","Effects of naltrexone on plasma corticosterone in opiate-naive rats: a central action","Eisenberg RM.","Life Sci. 1984 Mar 19;34(12):1185-91. doi: 10.1016/0024-3205(84)90091-2.","Eisenberg RM","Life Sci","1984","1984/03/19","","","10.1016/0024-3205(84)90091-2"
"6529975","The effect of spontaneous seizures on pentylenetetrazole and maximum electroshock induced seizures in the Mongolian gerbil","Lee RJ, Lomax P.","Eur J Pharmacol. 1984 Oct 30;106(1):91-6. doi: 10.1016/0014-2999(84)90681-2.","Lee RJ","Eur J Pharmacol","1984","1984/10/30","","","10.1016/0014-2999(84)90681-2"
"6529627","Effects of centrally administered naloxone on phrenic nerve activity","Wilson BA, Eldridge FL, Millhorn DE, Waldrop TG, Klingler LE.","Brain Res. 1984 Dec 24;324(2):366-8. doi: 10.1016/0006-8993(84)90051-9.","Wilson BA","Brain Res","1984","1984/12/24","","","10.1016/0006-8993(84)90051-9"
"6522309","Methadone and naltrexone in the treatment of heroin dependence","Greenstein RA, Resnick RB, Resnick E.","Psychiatr Clin North Am. 1984 Dec;7(4):671-9.","Greenstein RA","Psychiatr Clin North Am","1984","1984/12/01","","",""
"6520774","Nalmefene: radioimmunoassay for a new opioid antagonist","Dixon R, Hsiao J, Taaffe W, Hahn E, Tuttle R.","J Pharm Sci. 1984 Nov;73(11):1645-6. doi: 10.1002/jps.2600731141.","Dixon R","J Pharm Sci","1984","1984/11/01","","","10.1002/jps.2600731141"
"6519154","Naloxone protein binding in adult and foetal plasma","Asali LA, Brown KF.","Eur J Clin Pharmacol. 1984;27(4):459-63. doi: 10.1007/BF00549595.","Asali LA","Eur J Clin Pharmacol","1984","1984/01/01","","","10.1007/BF00549595"
"6505691","Intrinsic mechanisms of pain inhibition: activation by stress","Terman GW, Shavit Y, Lewis JW, Cannon JT, Liebeskind JC.","Science. 1984 Dec 14;226(4680):1270-7. doi: 10.1126/science.6505691.","Terman GW","Science","1984","1984/12/14","","","10.1126/science.6505691"
"6499910","Naltrexone-reversible effects of flunitrazepam on locomotor activity and passive avoidance behaviour in mice","Castellano C, Filibeck U, Pavone F.","Eur J Pharmacol. 1984 Sep 3;104(1-2):111-6. doi: 10.1016/0014-2999(84)90376-5.","Castellano C","Eur J Pharmacol","1984","1984/09/03","","","10.1016/0014-2999(84)90376-5"
"6494208","Locomotor activity and opiate effects in male and female hamsters","Schnur P, Barela P.","Pharmacol Biochem Behav. 1984 Sep;21(3):369-74. doi: 10.1016/s0091-3057(84)80097-0.","Schnur P","Pharmacol Biochem Behav","1984","1984/09/01","","","10.1016/s0091-3057(84)80097-0"
"6494192","Footshock induced hyperthermia","Pechnick RN, Morgan MJ, Liebeskind JC.","Proc West Pharmacol Soc. 1984;27:519-22.","Pechnick RN","Proc West Pharmacol Soc","1984","1984/01/01","","",""
"6488691","Kinetics of a naltrexone sustained-release preparation","Chiang CN, Hollister LE, Kishimoto A, Barnett G.","Clin Pharmacol Ther. 1984 Nov;36(5):704-8. doi: 10.1038/clpt.1984.243.","Chiang CN","Clin Pharmacol Ther","1984","1984/11/01","","","10.1038/clpt.1984.243"
"6486774","Ventromedial and lateral hypothalamic injections of naloxone or naltrexone suppress the acute food intake of food-deprived rats","Thornhill JA, Saunders W.","Appetite. 1984 Mar;5(1):25-30. doi: 10.1016/s0195-6663(84)80046-x.","Thornhill JA","Appetite","1984","1984/03/01","","","10.1016/s0195-6663(84)80046-x"
"6482651","Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity","Charney DS, Redmond DE Jr, Galloway MP, Kleber HD, Heninger GR, Murberg M, Roth RH.","Life Sci. 1984 Sep 17;35(12):1263-72. doi: 10.1016/0024-3205(84)90097-3.","Charney DS","Life Sci","1984","1984/09/17","","","10.1016/0024-3205(84)90097-3"
"6479015","Naltrexone treatment of heroin addiction: one-year follow-up","Judson BA, Goldstein A.","Drug Alcohol Depend. 1984 Jul;13(4):357-65. doi: 10.1016/0376-8716(84)90003-6.","Judson BA","Drug Alcohol Depend","1984","1984/07/01","","","10.1016/0376-8716(84)90003-6"
"6475891","Strategies to improve compliance with narcotic antagonists","Kosten TR, Kleber HD.","Am J Drug Alcohol Abuse. 1984;10(2):249-66. doi: 10.3109/00952998409002784.","Kosten TR","Am J Drug Alcohol Abuse","1984","1984/01/01","","","10.3109/00952998409002784"
"6475888","The index of choice: indications of methadone patients' selection of naltrexone treatment","Singleton EG, Sherman MF, Bigelow GE.","Am J Drug Alcohol Abuse. 1984;10(2):209-21. doi: 10.3109/00952998409002781.","Singleton EG","Am J Drug Alcohol Abuse","1984","1984/01/01","","","10.3109/00952998409002781"
"6473168","Derivatives of beta-casomorphins with high analgesic potency","Matthies H, Stark H, Hartrodt B, Ruethrich HL, Spieler HT, Barth A, Neubert K.","Peptides. 1984 May-Jun;5(3):463-70. doi: 10.1016/0196-9781(84)90070-6.","Matthies H","Peptides","1984","1984/05/01","","","10.1016/0196-9781(84)90070-6"
"6469938","Reproductive toxicity and teratology evaluations of naltrexone","Christian MS.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):7-10.","Christian MS","J Clin Psychiatry","1984","1984/09/01","","",""
"6469937","Naltrexone treatment in a jail work-release program","Brahen LS, Henderson RK, Capone T, Kordal N.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):49-52.","Brahen LS","J Clin Psychiatry","1984","1984/09/01","","",""
"6469936","Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience","Ling W, Wesson DR.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):46-8.","Ling W","J Clin Psychiatry","1984","1984/09/01","","",""
"6469935","Clinical experience with naltrexone in suburban opioid addicts","Tennant FS Jr, Rawson RA, Cohen AJ, Mann A.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):42-5.","Tennant FS Jr","J Clin Psychiatry","1984","1984/09/01","","",""
"6469934","Naltrexone induction: psychologic and pharmacologic strategies","Kleber HD, Kosten TR.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):29-38.","Kleber HD","J Clin Psychiatry","1984","1984/09/01","","",""
"6469933","Naltrexone: a clinical perspective","Greenstein RA, Arndt IC, McLellan AT, O'Brien CP, Evans B.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):25-8.","Greenstein RA","J Clin Psychiatry","1984","1984/09/01","","",""
"6469932","Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration","Meyer MC, Straughn AB, Lo MW, Schary WL, Whitney CC.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):15-9.","Meyer MC","J Clin Psychiatry","1984","1984/09/01","","",""
"6469931","Physiologic and morphologic changes and incidence of neoplasms in mice and rats fed naltrexone HCl for 24 months","Rosenkrantz H.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):11-4.","Rosenkrantz H","J Clin Psychiatry","1984","1984/09/01","","",""
"6443393","Effects of b-FNA in drug-naive and morphine-dependent rhesus monkeys","Gmerek D, Woods JH.","NIDA Res Monogr. 1984;55:99-105.","Gmerek D","NIDA Res Monogr","1984","1984/01/01","","",""
"6443380","Assessment and extinction of conditioned withdrawal-like responses in an integrated treatment for opiate dependence","Childress AR, McLellan AT, O'Brien CP.","NIDA Res Monogr. 1984;55:202-10.","Childress AR","NIDA Res Monogr","1984","1984/01/01","","",""
"6443377","Naltrexone in addicted physicians and business executives","Washton AM, Gold MS, Pottash AC.","NIDA Res Monogr. 1984;55:185-90.","Washton AM","NIDA Res Monogr","1984","1984/01/01","","",""
"6440184","Acute effects of naloxone and naltrexone, but lack of delayed effects, on exploratory behavior in the rat","Koek W, Slangen JL.","Psychopharmacology (Berl). 1984;84(3):383-7. doi: 10.1007/BF00555217.","Koek W","Psychopharmacology (Berl)","1984","1984/01/01","","","10.1007/BF00555217"
"6439410","[Opiate antagonists]","Sonka K.","Cas Lek Cesk. 1984 Oct 19;123(42):1265-9.","Sonka K","Cas Lek Cesk","1984","1984/10/19","","",""
"6436825","Naloxone and naltrexone block the gastrointestinal effects of TRH and MK-212","Horita A, Carino MA, Fatherazi S, Lai H, Pae YS.","Proc West Pharmacol Soc. 1984;27:385-6.","Horita A","Proc West Pharmacol Soc","1984","1984/01/01","","",""
"6434974","Five-year follow-up of opiate addicts with naltrexone and behavior therapy","Rawson RA, Tennant FS Jr.","NIDA Res Monogr. 1984 Mar;49:289-95.","Rawson RA","NIDA Res Monogr","1984","1984/03/01","","",""
"6434972","Abstinence treatments for opiate addicts: therapeutic community or naltrexone?","Arndt I, McLellan AT, O'Brien CP.","NIDA Res Monogr. 1984 Mar;49:275-81.","Arndt I","NIDA Res Monogr","1984","1984/03/01","","",""
"6433331","Potentiation of foot shock analgesia by thyrotropin releasing hormone","Butler PD, Bodnar RJ.","Peptides. 1984 May-Jun;5(3):635-9. doi: 10.1016/0196-9781(84)90095-0.","Butler PD","Peptides","1984","1984/05/01","","","10.1016/0196-9781(84)90095-0"
"6431449","Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions","Marks-Kaufman R, Balmagiya T, Gross E.","Pharmacol Biochem Behav. 1984 Jun;20(6):911-6. doi: 10.1016/0091-3057(84)90016-9.","Marks-Kaufman R","Pharmacol Biochem Behav","1984","1984/06/01","","","10.1016/0091-3057(84)90016-9"
"6429197","Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man","Veldhuis JD, Rogol AD, Samojlik E, Ertel NH.","J Clin Invest. 1984 Jul;74(1):47-55. doi: 10.1172/JCI111417.","Veldhuis JD","J Clin Invest","1984","1984/07/01","PMC425183","","10.1172/JCI111417"
"6424632","Effects of opiate antagonists on hormones and behavior of male and female rhesus monkeys","Abbott DH, Holman SD, Berman M, Neff DA, Goy RW.","Arch Sex Behav. 1984 Feb;13(1):1-25. doi: 10.1007/BF01542974.","Abbott DH","Arch Sex Behav","1984","1984/02/01","","","10.1007/BF01542974"
"6422028","Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system","Reuning RH, Liao SH, Staubus AE, Ashcraft SB, Downs DA, Harrigan SE, Wiley JN, Wise DL.","J Pharmacokinet Biopharm. 1983 Aug;11(4):369-87. doi: 10.1007/BF01058956.","Reuning RH","J Pharmacokinet Biopharm","1983","1983/08/01","","","10.1007/BF01058956"
"6419179","Antinociceptive effects of thyrotrophin-releasing hormone and its analogues in the rat periaqueductal grey region","Webster VA, Griffiths EC, Slater P.","Neurosci Lett. 1983 Nov 21;42(1):67-70. doi: 10.1016/0304-3940(83)90423-8.","Webster VA","Neurosci Lett","1983","1983/11/21","","","10.1016/0304-3940(83)90423-8"
"6415729","Facilitation of hot-plate response learning by pre- and posttraining naltrexone administration","Messing RB, Rijk H, Rigter H.","Psychopharmacology (Berl). 1983;81(1):33-6. doi: 10.1007/BF00439270.","Messing RB","Psychopharmacology (Berl)","1983","1983/01/01","","","10.1007/BF00439270"
"6410281","Opioid antagonists: do they have a role in treatment programs?","O'Brien CP, Greenstein RA, Evans B, Woody GE, Arndt R.","NIDA Res Monogr. 1983 Apr;43:71-8.","O'Brien CP","NIDA Res Monogr","1983","1983/04/01","","",""
"6410276","Recent advances in opiate detoxification: clonidine and lofexidine","Washton AM, Resnick RB.","NIDA Res Monogr. 1983 Apr;43:44-50.","Washton AM","NIDA Res Monogr","1983","1983/04/01","","",""
"6410264","Predictors of favorable outcome following naltrexone treatment","Greenstein RA, Evans BD, McLellan AT, O'Brien CP.","NIDA Res Monogr. 1983 Apr;43:294-301.","Greenstein RA","NIDA Res Monogr","1983","1983/04/01","","",""
"6408661","Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids","White JM, Holtzman SG.","Psychopharmacology (Berl). 1983;80(1):1-9. doi: 10.1007/BF00427484.","White JM","Psychopharmacology (Berl)","1983","1983/01/01","","","10.1007/BF00427484"
"6408390","High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization","Craviso GL, Musacchio JM.","Mol Pharmacol. 1983 May;23(3):619-28.","Craviso GL","Mol Pharmacol","1983","1983/05/01","","",""
"6407041","Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice","Kiianmaa K, Hoffman PL, Tabakoff B.","Psychopharmacology (Berl). 1983;79(4):291-4. doi: 10.1007/BF00433403.","Kiianmaa K","Psychopharmacology (Berl)","1983","1983/01/01","","","10.1007/BF00433403"
"6403960","Effects of naloxone and naltrexone on the increased water intake and drinking duration in phenobarbitone-treated rats","Cooper SJ, McGivern H.","Psychopharmacology (Berl). 1983;79(1):25-8. doi: 10.1007/BF00433011.","Cooper SJ","Psychopharmacology (Berl)","1983","1983/01/01","","","10.1007/BF00433011"
"6394130","New insights and treatments: opiate withdrawal and cocaine addiction","Gold MS, Dackis CA.","Clin Ther. 1984;7(1):6-21.","Gold MS","Clin Ther","1984","1984/01/01","","",""
"6388274","The physiology of opiate hedonic effects and the role of opioids in motivated behavior","Carr KD.","Adv Alcohol Subst Abuse. 1984 Spring;3(3):5-18. doi: 10.1300/J251v03n03_02.","Carr KD","Adv Alcohol Subst Abuse","1984","1984/01/01","","","10.1300/J251v03n03_02"
"6388273","The sequential use of clonidine and naltrexone in the treatment of opiate addicts","Gold MS, Dackis CA, Washton AM.","Adv Alcohol Subst Abuse. 1984 Spring;3(3):19-39. doi: 10.1300/J251v03n03_03.","Gold MS","Adv Alcohol Subst Abuse","1984","1984/01/01","","","10.1300/J251v03n03_03"
"6386494","Narcotic discrimination in pigeons: antagonism by naltrexone","Herling S, Valentino RJ, Solomon RE, Woods JH.","Eur J Pharmacol. 1984 Oct 1;105(1-2):137-42. doi: 10.1016/0014-2999(84)90657-5.","Herling S","Eur J Pharmacol","1984","1984/10/01","","","10.1016/0014-2999(84)90657-5"
"6381473","Use of naltrexone to extinguish opioid-conditioned responses","O'Brien CP, Childress AR, McLellan AT, Ternes J, Ehrman RN.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):53-6.","O'Brien CP","J Clin Psychiatry","1984","1984/09/01","","",""
"6374352","Endogenous opiate involvement in acute and chronic stress-induced changes in plasma LH concentrations in the male rat","Briski KP, Quigley K, Meites J.","Life Sci. 1984 Jun 18;34(25):2485-93. doi: 10.1016/0024-3205(84)90285-6.","Briski KP","Life Sci","1984","1984/06/18","","","10.1016/0024-3205(84)90285-6"
"6363990","Effect of phosphoramidon - a selective enkephalinase inhibitor - on nociception and behaviour","Rupreht J, Ukponmwan OE, Admiraal PV, Dzoljic MR.","Neurosci Lett. 1983 Nov 11;41(3):331-5. doi: 10.1016/0304-3940(83)90472-x.","Rupreht J","Neurosci Lett","1983","1983/11/11","","","10.1016/0304-3940(83)90472-x"
"6359093","The role of endorphins in opiate addiction, opiate withdrawal, and recovery","Gold MS, Rea WS.","Psychiatr Clin North Am. 1983 Sep;6(3):489-520.","Gold MS","Psychiatr Clin North Am","1983","1983/09/01","","",""
"6352139","Clinical pharmacokinetics of narcotic agonist-antagonist drugs","Bullingham RE, McQuay HJ, Moore RA.","Clin Pharmacokinet. 1983 Jul-Aug;8(4):332-43. doi: 10.2165/00003088-198308040-00004.","Bullingham RE","Clin Pharmacokinet","1983","1983/07/01","","","10.2165/00003088-198308040-00004"
"6347117","Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxification","Judson BA, Goldstein A, Inturrisi CE.","Arch Gen Psychiatry. 1983 Aug;40(8):834-40. doi: 10.1001/archpsyc.1983.01790070024003.","Judson BA","Arch Gen Psychiatry","1983","1983/08/01","","","10.1001/archpsyc.1983.01790070024003"
"6338330","Minireview. Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behavior","Cooper SJ.","Life Sci. 1983 Mar 7;32(10):1043-51. doi: 10.1016/0024-3205(83)90108-x.","Cooper SJ","Life Sci","1983","1983/03/07","","","10.1016/0024-3205(83)90108-x"
"6330766","Opioid antagonism of electroshock-induced seizures","Puglisi-Allegra S, Castellano C, Csányl V, Dóka A, Oliverio A.","Pharmacol Biochem Behav. 1984 May;20(5):767-9. doi: 10.1016/0091-3057(84)90197-7.","Puglisi-Allegra S","Pharmacol Biochem Behav","1984","1984/05/01","","","10.1016/0091-3057(84)90197-7"
"6330764","Behavioral activity of a short chain ACTH analog","Drago F, Continella G, Scapagnini U.","Pharmacol Biochem Behav. 1984 May;20(5):689-95. doi: 10.1016/0091-3057(84)90186-2.","Drago F","Pharmacol Biochem Behav","1984","1984/05/01","","","10.1016/0091-3057(84)90186-2"
"6330761","Stress and sucrose hyperphagia: role of endogenous opiates","Bertiere MC, Sy TM, Baigts F, Mandenoff A, Apfelbaum M.","Pharmacol Biochem Behav. 1984 May;20(5):675-9. doi: 10.1016/0091-3057(84)90183-7.","Bertiere MC","Pharmacol Biochem Behav","1984","1984/05/01","","","10.1016/0091-3057(84)90183-7"
"6330479","Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat","Koenig JI, Mayfield MA, McCann SM, Krulich L.","Life Sci. 1984 May 7;34(19):1829-37. doi: 10.1016/0024-3205(84)90676-3.","Koenig JI","Life Sci","1984","1984/05/07","","","10.1016/0024-3205(84)90676-3"
"6329589","Review of naltrexone, a long-acting opiate antagonist","Crabtree BL.","Clin Pharm. 1984 May-Jun;3(3):273-80.","Crabtree BL","Clin Pharm","1984","1984/05/01","","",""
"6329467","Endogenous opioids mediate ECS-induced catalepsy at supraspinal levels","Frenk H, Stein BE.","Brain Res. 1984 Jun 11;303(1):109-12. doi: 10.1016/0006-8993(84)90216-6.","Frenk H","Brain Res","1984","1984/06/11","","","10.1016/0006-8993(84)90216-6"
"6328530","Visualization of opiate receptor upregulation by light microscopy autoradiography","Tempel A, Gardner EL, Zukin RS.","Proc Natl Acad Sci U S A. 1984 Jun;81(12):3893-7. doi: 10.1073/pnas.81.12.3893.","Tempel A","Proc Natl Acad Sci U S A","1984","1984/06/01","PMC345328","","10.1073/pnas.81.12.3893"
"6328153","Naltrexone prevents footshock-induced performance deficit in rats","McCubbin JA, Kizer JS, Lipton MA.","Life Sci. 1984 May 21;34(21):2057-66. doi: 10.1016/0024-3205(84)90370-9.","McCubbin JA","Life Sci","1984","1984/05/21","","","10.1016/0024-3205(84)90370-9"
"6326965","Nonspecific convulsions are induced by morphine but not D-Ala2-methionine-enkephalinamide at cortical sites","Frenk H, Watkins LR, Miller J, Mayer DJ.","Brain Res. 1984 May 7;299(1):51-9. doi: 10.1016/0006-8993(84)90787-x.","Frenk H","Brain Res","1984","1984/05/07","","","10.1016/0006-8993(84)90787-x"
"6326151","Multiple opioid receptors in endotoxic shock: evidence for delta involvement and mu-delta interactions in vivo","D'Amato R, Holaday JW.","Proc Natl Acad Sci U S A. 1984 May;81(9):2898-901. doi: 10.1073/pnas.81.9.2898.","D'Amato R","Proc Natl Acad Sci U S A","1984","1984/05/01","PMC345180","","10.1073/pnas.81.9.2898"
"6324770","Affinity chromatography of solubilized opioid binding sites using CH-Sepharose modified with a new naltrexone derivative","Gioannini TL, Howard A, Hiller JM, Simon EJ.","Biochem Biophys Res Commun. 1984 Mar 15;119(2):624-9. doi: 10.1016/s0006-291x(84)80295-8.","Gioannini TL","Biochem Biophys Res Commun","1984","1984/03/15","","","10.1016/s0006-291x(84)80295-8"
"6323369","Pulsatile secretion of gonadotropins and prolactin in male marathon runners. Relation to the endogenous opiate system","Rogol AD, Veldhuis JD, Williams FA, Johnson ML.","J Androl. 1984 Jan-Feb;5(1):21-7. doi: 10.1002/j.1939-4640.1984.tb00773.x.","Rogol AD","J Androl","1984","1984/01/01","","","10.1002/j.1939-4640.1984.tb00773.x"
"6322365","Effects of chronic naltrexone on amphetamine locomotor activity","Ng Cheong Ton MJ, Blair R, Holmes L, Amit Z.","Subst Alcohol Actions Misuse. 1983;4(4):331-6.","Ng Cheong Ton MJ","Subst Alcohol Actions Misuse","1983","1983/01/01","","",""
"6321207","ICI 154,129, a delta-opioid receptor antagonist raises seizure threshold in rats","Tortella FC, Robles LE, Holaday JW, Cowan A.","Eur J Pharmacol. 1984 Jan 13;97(1-2):141-4. doi: 10.1016/0014-2999(84)90523-5.","Tortella FC","Eur J Pharmacol","1984","1984/01/13","","","10.1016/0014-2999(84)90523-5"
"6321203","Effect of beta-FNA on opiate receptor binding: preliminary evidence for two types of mu receptors","Rothman RB, Bowen WD, Schumacher UK, Pert CB.","Eur J Pharmacol. 1983 Nov 11;95(1-2):147-8. doi: 10.1016/0014-2999(83)90282-0.","Rothman RB","Eur J Pharmacol","1983","1983/11/11","","","10.1016/0014-2999(83)90282-0"
"6320316","Body temperature effects of opioids administered into the periaqueductal grey area of rat brain","Widdowson PS, Griffiths EC, Slater P.","Regul Pept. 1983 Nov;7(3):259-67. doi: 10.1016/0167-0115(83)90019-8.","Widdowson PS","Regul Pept","1983","1983/11/01","","","10.1016/0167-0115(83)90019-8"
"6319931","Repeated administration of naltrexone and diprenorphine decreases food intake and body weight in squirrel monkeys","Herman BH, Holtzman SG.","Life Sci. 1984 Jan 2;34(1):1-12. doi: 10.1016/0024-3205(84)90324-2.","Herman BH","Life Sci","1984","1984/01/02","","","10.1016/0024-3205(84)90324-2"
"6319928","Evidence from opiate binding studies that heroin acts through its metabolites","Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, Simon EJ.","Life Sci. 1983;33 Suppl 1:773-6. doi: 10.1016/0024-3205(83)90616-1.","Inturrisi CE","Life Sci","1983","1983/01/01","","","10.1016/0024-3205(83)90616-1"
"6319921","Multiple opioid receptors: evidence for mu-delta binding site interactions in endotoxic shock","Holaday JW, D'Amato RJ.","Life Sci. 1983;33 Suppl 1:703-6. doi: 10.1016/0024-3205(83)90599-4.","Holaday JW","Life Sci","1983","1983/01/01","","","10.1016/0024-3205(83)90599-4"
"6319914","Evidence for delta-receptor involvement in the post-ictal antinociceptive responses to electroconvulsive shock in rats","Belenky GL, Gelinas-Sorell D, Kenner JR, Holaday JW.","Life Sci. 1983;33 Suppl 1:583-5. doi: 10.1016/0024-3205(83)90570-2.","Belenky GL","Life Sci","1983","1983/01/01","","","10.1016/0024-3205(83)90570-2"
"6319895","Quaternary derivatives of narcotic antagonists: stereochemical requirements at the chiral nitrogen for in vitro and in vivo activity","Bianchetti A, Nisato D, Sacilotto R, Dragonetti M, Picerno N, Tarantino A, Manara L, Angel LM, Simon EJ.","Life Sci. 1983;33 Suppl 1:415-8. doi: 10.1016/0024-3205(83)90530-1.","Bianchetti A","Life Sci","1983","1983/01/01","","","10.1016/0024-3205(83)90530-1"
"6319107","New and experimental therapeutic roles for naloxone and related opioid antagonists","McNicholas LF, Martin WR.","Drugs. 1984 Jan;27(1):81-93. doi: 10.2165/00003495-198427010-00004.","McNicholas LF","Drugs","1984","1984/01/01","","","10.2165/00003495-198427010-00004"
"6318895","Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat","Bardo MT, Bhatnagar RK, Gebhart GF.","Brain Res. 1983 Dec 19;289(1-2):223-34. doi: 10.1016/0006-8993(83)90023-9.","Bardo MT","Brain Res","1983","1983/12/19","","","10.1016/0006-8993(83)90023-9"
"6316371","Multi-dimensional analyses of behavior in mice treated with morphine, endorphins and [des-tyrosine1]-gamma-endorphin","Kameyama T, Ukai M.","Pharmacol Biochem Behav. 1983 Oct;19(4):671-7. doi: 10.1016/0091-3057(83)90343-x.","Kameyama T","Pharmacol Biochem Behav","1983","1983/10/01","","","10.1016/0091-3057(83)90343-x"
"6316064","Naltrexone modulates growth in infant rats","Zagon IS, McLaughlin PJ.","Life Sci. 1983 Dec 12;33(24):2449-54. doi: 10.1016/0024-3205(83)90639-2.","Zagon IS","Life Sci","1983","1983/12/12","","","10.1016/0024-3205(83)90639-2"
"6315775","Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man","Veldhuis JD, Rogol AD, Johnson ML.","J Clin Invest. 1983 Dec;72(6):2031-40. doi: 10.1172/JCI111168.","Veldhuis JD","J Clin Invest","1983","1983/12/01","PMC437044","","10.1172/JCI111168"
"6314208","Morphine exacerbates anaphylactic shock in mice by stimulating central opiate receptors","Amir S.","Neurosci Lett. 1983 Sep 30;40(2):169-74. doi: 10.1016/0304-3940(83)90297-5.","Amir S","Neurosci Lett","1983","1983/09/30","","","10.1016/0304-3940(83)90297-5"
"6314167","Effect of chronic naltrexone and methadone administration on brain immunoreactive beta-endorphin in the rat","Ragavan VV, Wardlaw SL, Kreek MJ, Frantz AG.","Neuroendocrinology. 1983 Oct;37(4):266-8. doi: 10.1159/000123556.","Ragavan VV","Neuroendocrinology","1983","1983/10/01","","","10.1159/000123556"
"6313736","Do alpha-adrenergic mechanisms regulate spontaneous or opiate-modulated pulsatile luteinizing hormone secretion in man?","Veldhuis JD, Rogol AD, Williams FA, Johnson ML.","J Clin Endocrinol Metab. 1983 Dec;57(6):1292-6. doi: 10.1210/jcem-57-6-1292.","Veldhuis JD","J Clin Endocrinol Metab","1983","1983/12/01","","","10.1210/jcem-57-6-1292"
"6313397","Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog","Vaupel DB.","Eur J Pharmacol. 1983 Sep 2;92(3-4):269-74. doi: 10.1016/0014-2999(83)90297-2.","Vaupel DB","Eur J Pharmacol","1983","1983/09/02","","","10.1016/0014-2999(83)90297-2"
"6312042","Different receptor sites mediate opioid agonism and antagonism","Portoghese PS, Takemori AE.","J Med Chem. 1983 Oct;26(10):1341-3. doi: 10.1021/jm00364a001.","Portoghese PS","J Med Chem","1983","1983/10/01","","","10.1021/jm00364a001"
"6310750","An opiate binding site in the rat brain is highly selective for 4,5-epoxymorphinans","Grevel J, Sadée W.","Science. 1983 Sep 16;221(4616):1198-201. doi: 10.1126/science.6310750.","Grevel J","Science","1983","1983/09/16","","","10.1126/science.6310750"
"6310295","Testosterone does not influence opiate binding sites in the male rat brain","Cicero TJ, Newman KS, Meyer ER.","Life Sci. 1983 Sep 26;33(13):1231-9. doi: 10.1016/0024-3205(83)90003-6.","Cicero TJ","Life Sci","1983","1983/09/26","","","10.1016/0024-3205(83)90003-6"
"6310111","Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels","Sayre LM, Larson DL, Fries DS, Takemori AE, Portoghese PS.","J Med Chem. 1983 Sep;26(9):1229-35. doi: 10.1021/jm00363a005.","Sayre LM","J Med Chem","1983","1983/09/01","","","10.1021/jm00363a005"
"6309428","beta-endorphin acting on the brainstem is involved in the antihypertensive action of clonidine and alpha-methyldopa in rats","Ramirez-Gonzalez MD, Tchakarov L, Mosqueda Garcia R, Kunos G.","Circ Res. 1983 Aug;53(2):150-7. doi: 10.1161/01.res.53.2.150.","Ramirez-Gonzalez MD","Circ Res","1983","1983/08/01","","","10.1161/01.res.53.2.150"
"6308767","Normalizing effect of an adrenocorticotropic hormone (4-9) analog ORG 2766 on disturbed social behavior in rats","Niesink RJ, van Ree JM.","Science. 1983 Sep 2;221(4614):960-2. doi: 10.1126/science.6308767.","Niesink RJ","Science","1983","1983/09/02","","","10.1126/science.6308767"
"6308695","Opiate antagonists overcome the learned helplessness effect but impair competent escape performance","Whitehouse WG, Walker J, Margules DL, Bersh PJ.","Physiol Behav. 1983 May;30(5):731-4. doi: 10.1016/0031-9384(83)90170-1.","Whitehouse WG","Physiol Behav","1983","1983/05/01","","","10.1016/0031-9384(83)90170-1"
"6306614","ACTH1-39 but not naltrexone produces biphasic effects on locomotor activity","Blair R, Galina ZH, Sutherland C, Amit Z.","Peptides. 1983 Jan-Feb;4(1):117-20. doi: 10.1016/0196-9781(83)90177-8.","Blair R","Peptides","1983","1983/01/01","","","10.1016/0196-9781(83)90177-8"
"6303805","Naltrexone blocks the response-latency increasing effects but not the discriminative effects of diazepam in rats","Herling S.","Eur J Pharmacol. 1983 Mar 18;88(1):121-4. doi: 10.1016/0014-2999(83)90400-4.","Herling S","Eur J Pharmacol","1983","1983/03/18","","","10.1016/0014-2999(83)90400-4"
"6302425","Naltrexone-sensitive behavioral actions of the ACTH 4-9 analog (Org 2766)","Fekete M, Drago F, Van Ree JM, Bohus B, Wiegant VM, De Wied D.","Life Sci. 1983 May 9;32(19):2193-204. doi: 10.1016/0024-3205(83)90417-4.","Fekete M","Life Sci","1983","1983/05/09","","","10.1016/0024-3205(83)90417-4"
"6301847","Determination of the relative involvement of mu-opioid receptors in opioid-induced depression of respiratory rate by use of beta-funaltrexamine","Ward SJ, Takemori AE.","Eur J Pharmacol. 1983 Jan 28;87(1):1-6. doi: 10.1016/0014-2999(83)90043-2.","Ward SJ","Eur J Pharmacol","1983","1983/01/28","","","10.1016/0014-2999(83)90043-2"
"6300933","Opiate-receptor blockade reduces voluntary running but not self-stimulation in hamsters","Potter CD, Borer KT, Katz RJ.","Pharmacol Biochem Behav. 1983 Feb;18(2):217-23. doi: 10.1016/0091-3057(83)90366-0.","Potter CD","Pharmacol Biochem Behav","1983","1983/02/01","","","10.1016/0091-3057(83)90366-0"
"6300721","Blockade of morphine dependence-related enhancement of secretory protein synthesis in the pons-medulla and striatum-septum by naltrexone","Retz KC, Steele WJ.","Neuropharmacology. 1983 Feb;22(2):183-9. doi: 10.1016/0028-3908(83)90007-2.","Retz KC","Neuropharmacology","1983","1983/02/01","","","10.1016/0028-3908(83)90007-2"
"6299472","Regulation of opiate receptors in mouse brain: arcuate nuclear lesion induces receptor up-regulation and supersensitivity to opiates","Simantov R, Amir S.","Brain Res. 1983 Feb 28;262(1):168-71. doi: 10.1016/0006-8993(83)90483-3.","Simantov R","Brain Res","1983","1983/02/28","","","10.1016/0006-8993(83)90483-3"
"6299458","Analgesia induced by electroconvulsive shock: brain enkephalins may mediate tolerance but not the induction of analgesia","Urca G, Nof A, Weissman BA, Sarne Y.","Brain Res. 1983 Feb 7;260(2):271-7. doi: 10.1016/0006-8993(83)90680-7.","Urca G","Brain Res","1983","1983/02/07","","","10.1016/0006-8993(83)90680-7"
"6299265","Naloxone enhancement of memory processes: effects of other opiate antagonists","Gallagher M.","Behav Neural Biol. 1982 Aug;35(4):375-82. doi: 10.1016/s0163-1047(82)91020-2.","Gallagher M","Behav Neural Biol","1982","1982/08/01","","","10.1016/s0163-1047(82)91020-2"
"6298835","Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey","Locke KW, Brown DR, Holtzman SG.","Pharmacol Biochem Behav. 1982 Dec;17(6):1275-9. doi: 10.1016/0091-3057(82)90133-2.","Locke KW","Pharmacol Biochem Behav","1982","1982/12/01","","","10.1016/0091-3057(82)90133-2"
"6298834","Hibernation ""trigger"": opioid-like inhibitory action on brain function of the monkey","Oeltgen PR, Walsh JW, Hamann SR, Randall DC, Spurrier WA, Myers RD.","Pharmacol Biochem Behav. 1982 Dec;17(6):1271-4. doi: 10.1016/0091-3057(82)90132-0.","Oeltgen PR","Pharmacol Biochem Behav","1982","1982/12/01","","","10.1016/0091-3057(82)90132-0"
"6297359","Role of opioid peptides in disorders of attention in psychopathology","Buchsbaum MS, Reus VI, Davis GC, Holcomb HH, Cappelletti J, Silberman E.","Ann N Y Acad Sci. 1982;398:352-65. doi: 10.1111/j.1749-6632.1982.tb39506.x.","Buchsbaum MS","Ann N Y Acad Sci","1982","1982/01/01","","","10.1111/j.1749-6632.1982.tb39506.x"
"6296898","Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems","Ettenberg A, Pettit HO, Bloom FE, Koob GF.","Psychopharmacology (Berl). 1982;78(3):204-9. doi: 10.1007/BF00428151.","Ettenberg A","Psychopharmacology (Berl)","1982","1982/01/01","","","10.1007/BF00428151"
"6296572","Reduction in opiate receptor reserve in morphine tolerant guinea pig ilea","Chavkin C, Goldstein A.","Life Sci. 1982 Oct 18-25;31(16-17):1687-90. doi: 10.1016/0024-3205(82)90186-2.","Chavkin C","Life Sci","1982","1982/10/18","","","10.1016/0024-3205(82)90186-2"
"6296358","Relative involvement of receptor subtypes in opioid-induced inhibition of gastrointestinal transit in mice","Ward SJ, Takemori AE.","J Pharmacol Exp Ther. 1983 Feb;224(2):359-63.","Ward SJ","J Pharmacol Exp Ther","1983","1983/02/01","","",""
"6296330","Protection of opiate receptors in NG108-15 against modification by N-ethylmaleimide","Mullikin-Kilpatrick D, Larsen NE, Blume AJ.","J Neurosci. 1983 Jan;3(1):145-52. doi: 10.1523/JNEUROSCI.03-01-00145.1983.","Mullikin-Kilpatrick D","J Neurosci","1983","1983/01/01","PMC6564592","","10.1523/JNEUROSCI.03-01-00145.1983"
"6295778","Improved assays for the assessment of kappa- and delta-properties of opioid ligands","Ward SJ, Portoghese PS, Takemori AE.","Eur J Pharmacol. 1982 Nov 19;85(2):163-70. doi: 10.1016/0014-2999(82)90461-7.","Ward SJ","Eur J Pharmacol","1982","1982/11/19","","","10.1016/0014-2999(82)90461-7"
"6295552","Opiate and non-opiate aspects of morphine induced seizures","Frenk H, Liban A, Balamuth R, Urca G.","Brain Res. 1982 Dec 16;253(1-2):253-61. doi: 10.1016/0006-8993(82)90692-8.","Frenk H","Brain Res","1982","1982/12/16","","","10.1016/0006-8993(82)90692-8"
"6294686","Enhancement of osmotic- and hypovolemic-induced drinking by chlordiazepoxide in rats is blocked by naltrexone","Cooper SJ.","Pharmacol Biochem Behav. 1982 Nov;17(5):921-5. doi: 10.1016/0091-3057(82)90473-7.","Cooper SJ","Pharmacol Biochem Behav","1982","1982/11/01","","","10.1016/0091-3057(82)90473-7"
"6294682","Extent and control of shock affects naltrexone sensitivity of stress-induced analgesia and reactivity to morphine","Hyson RL, Ashcraft LJ, Drugan RC, Grau JW, Maier SF.","Pharmacol Biochem Behav. 1982 Nov;17(5):1019-25. doi: 10.1016/0091-3057(82)90488-9.","Hyson RL","Pharmacol Biochem Behav","1982","1982/11/01","","","10.1016/0091-3057(82)90488-9"
"6294168","Involvement of both adrenergic and cholinergic receptors in the cardiovascular effects of naloxone during hemorrhagic hypotension in the conscious rabbit","Schadt JC, York DH.","J Auton Nerv Syst. 1982 Sep;6(2):237-51. doi: 10.1016/0165-1838(82)90054-6.","Schadt JC","J Auton Nerv Syst","1982","1982/09/01","","","10.1016/0165-1838(82)90054-6"
"6292636","Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment","Tempel A, Zukin RS, Gardner EL.","Life Sci. 1982 Sep 20-27;31(12-13):1401-4. doi: 10.1016/0024-3205(82)90391-5.","Tempel A","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90391-5"
"6292615","Opioid agonist and antagonist bivalent ligands as receptor probes","Portoghese PS, Ronsisvalle G, Larson DL, Yim CB, Sayre LM, Takemori AE.","Life Sci. 1982 Sep 20-27;31(12-13):1283-6. doi: 10.1016/0024-3205(82)90362-9.","Portoghese PS","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90362-9"
"6292420","Synthesis and pharmacology of metabolically stable tert-butyl ethers of morphine and levorphanol","Mohacsi E, Leimgruber W, Baruth H.","J Med Chem. 1982 Oct;25(10):1264-6. doi: 10.1021/jm00352a037.","Mohacsi E","J Med Chem","1982","1982/10/01","","","10.1021/jm00352a037"
"6291701","beta-Endorphin alters dopamine uptake by the dopamine neurons of the hypothalamus and striatum","George SR, Van Loon GR.","Brain Res. 1982 Sep 30;248(2):293-303. doi: 10.1016/0006-8993(82)90587-x.","George SR","Brain Res","1982","1982/09/30","","","10.1016/0006-8993(82)90587-x"
"6291068","Intraseptally injected opiate agents: effects on morphine-induced behaviour of cats","Megens AA, Cools AR.","Pharmacol Biochem Behav. 1982 Aug;17(2):297-304. doi: 10.1016/0091-3057(82)90084-3.","Megens AA","Pharmacol Biochem Behav","1982","1982/08/01","","","10.1016/0091-3057(82)90084-3"
"6290924","Release of prolactin in response to microinjection of morphine into mesencephalic dorsal raphe nucleus","Johnson JH.","Neuroendocrinology. 1982;35(3):169-72. doi: 10.1159/000123376.","Johnson JH","Neuroendocrinology","1982","1982/01/01","","","10.1159/000123376"
"6290184","D-Ala2-Met-enkephalinamide, a potent opioid peptide, alters pituitary-adrenocortical secretion in rats","De Souza EB, Van Loon GR.","Endocrinology. 1982 Nov;111(5):1483-90. doi: 10.1210/endo-111-5-1483.","De Souza EB","Endocrinology","1982","1982/11/01","","","10.1210/endo-111-5-1483"
"6289965","Naltrexone-induced opiate receptor supersensitivity","Zukin RS, Sugarman JR, Fitz-Syage ML, Gardner EL, Zukin SR, Gintzler AR.","Brain Res. 1982 Aug 12;245(2):285-92. doi: 10.1016/0006-8993(82)90811-3.","Zukin RS","Brain Res","1982","1982/08/12","","","10.1016/0006-8993(82)90811-3"
"6289627","Affinity labeling and purification of the opiate receptor from rat brain","Bidlack JM, Abood LG, Munemitsu SM, Archer S, Gala D, Kreilick RW.","Adv Biochem Psychopharmacol. 1982;33:301-9.","Bidlack JM","Adv Biochem Psychopharmacol","1982","1982/01/01","","",""
"6289119","Methadone-induced endorphin dysfunction in addicts","Gold MS, Pottash AC, Extein I, Martin D, Kleber HD.","NIDA Res Monogr. 1982 Apr;41:476-82.","Gold MS","NIDA Res Monogr","1982","1982/04/01","","",""
"6289026","Naltrexone, opiate addiction, and endorphins","Gold MS, Dackis CA, Pottash AL, Sternbach HH, Annitto WJ, Martin D, Dackis MP.","Med Res Rev. 1982 Jul-Sep;2(3):211-46. doi: 10.1002/med.2610020302.","Gold MS","Med Res Rev","1982","1982/07/01","","","10.1002/med.2610020302"
"6288945","Potential affinity labels for the opiate receptor based on fentanyl and related compounds","Maryanoff BE, Simon EJ, Gioannini T, Gorissen H.","J Med Chem. 1982 Aug;25(8):913-9. doi: 10.1021/jm00350a006.","Maryanoff BE","J Med Chem","1982","1982/08/01","","","10.1021/jm00350a006"
"6288413","Naltrexone-insensitive facilitation and naltrexone-sensitive inhibition of passive avoidance behavior of the ACTH-(4-9) analog (ORG 2766) are located in two different parts of the molecule","Fekete M, De Wied D.","Eur J Pharmacol. 1982 Jul 16;81(3):441-8. doi: 10.1016/0014-2999(82)90109-1.","Fekete M","Eur J Pharmacol","1982","1982/07/16","","","10.1016/0014-2999(82)90109-1"
"6287349","Opiate, enkephalin, and endorphin analgesia: relations to a single subpopulation of opiate receptors","Pasternak GW.","Neurology. 1981 Oct;31(10):1311-5. doi: 10.1212/wnl.31.10.1311.","Pasternak GW","Neurology","1981","1981/10/01","","","10.1212/wnl.31.10.1311"
"6286325","Pharmacological profiles of beta-funaltrexamine (beta-FNA) and beta-chlornaltrexamine (beta-CNA) on the mouse vas deferens preparation","Ward SJ, Portoghese PS, Takemori AE.","Eur J Pharmacol. 1982 Jun 4;80(4):377-84. doi: 10.1016/0014-2999(82)90083-8.","Ward SJ","Eur J Pharmacol","1982","1982/06/04","","","10.1016/0014-2999(82)90083-8"
"6281840","Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat","Snell D, Harris RA.","Psychopharmacology (Berl). 1982;76(2):177-81. doi: 10.1007/BF00435274.","Snell D","Psychopharmacology (Berl)","1982","1982/01/01","","","10.1007/BF00435274"
"6281826","Endogenous opioids interact in stress-induced hyperglycemia in mice","Amir S, Bernstein M.","Physiol Behav. 1982 Mar;28(3):575-7. doi: 10.1016/0031-9384(82)90156-1.","Amir S","Physiol Behav","1982","1982/03/01","","","10.1016/0031-9384(82)90156-1"
"6281084","Stimulus properties of opioids with mixed agonist and antagonist activity","Holtzman SG.","Fed Proc. 1982 May;41(7):2328-32.","Holtzman SG","Fed Proc","1982","1982/05/01","","",""
"6280208","Opiate antagonists stimulate affiliative behaviour in monkeys","Fabre-Nys C, Meller RE, Keverne EB.","Pharmacol Biochem Behav. 1982 Apr;16(4):653-9. doi: 10.1016/0091-3057(82)90432-4.","Fabre-Nys C","Pharmacol Biochem Behav","1982","1982/04/01","","","10.1016/0091-3057(82)90432-4"
"6280206","Antagonism of morphine-induced behavioral suppression by opiate receptor alkylators","Messing RB, Portoghese PS, Takemori AE, Sparber SB.","Pharmacol Biochem Behav. 1982 Apr;16(4):621-6. doi: 10.1016/0091-3057(82)90426-9.","Messing RB","Pharmacol Biochem Behav","1982","1982/04/01","","","10.1016/0091-3057(82)90426-9"
"6280203","Effects of naloxone and naltrexone on locomotor activity in C57BL/6 and DBA/2 mice","Castellano C, Puglisi-Allegra S.","Pharmacol Biochem Behav. 1982 Apr;16(4):561-3. doi: 10.1016/0091-3057(82)90415-4.","Castellano C","Pharmacol Biochem Behav","1982","1982/04/01","","","10.1016/0091-3057(82)90415-4"
"6278352","Stereospecific accumulation of dihydromorphine and naltrexone by corpus striatal slices of morphine-dependent mice","Oishi R, Takemori AE.","Neuropharmacology. 1982 Jan;21(1):57-61. doi: 10.1016/0028-3908(82)90211-8.","Oishi R","Neuropharmacology","1982","1982/01/01","","","10.1016/0028-3908(82)90211-8"
"6278127","Naltrexone improves survival rate and cardiovascular function in canine hemorrhagic shock","Gurll NJ, Reynolds DG, Vargish T, Lechner R.","J Pharmacol Exp Ther. 1982 Mar;220(3):625-8.","Gurll NJ","J Pharmacol Exp Ther","1982","1982/03/01","","",""
"6277426","Effect of naltrexone on regional brain oxygen consumption in the cat","Grandison L, Buchweitz E, Weiss HR.","Brain Res. 1982 Feb 11;233(2):369-79. doi: 10.1016/0006-8993(82)91209-4.","Grandison L","Brain Res","1982","1982/02/11","","","10.1016/0006-8993(82)91209-4"
"6276733","Pain sensitivity and endorphins in functional psychoses","Davis GC, Buchsbaum MS.","Mod Probl Pharmacopsychiatry. 1981;17:97-108. doi: 10.1159/000402408.","Davis GC","Mod Probl Pharmacopsychiatry","1981","1981/01/01","","","10.1159/000402408"
"6276726","Action of naloxone and naltrexone in different types of psychoses","Volavka J.","Mod Probl Pharmacopsychiatry. 1981;17:202-12. doi: 10.1159/000402416.","Volavka J","Mod Probl Pharmacopsychiatry","1981","1981/01/01","","","10.1159/000402416"
"6276546","Common anionic receptor site hypothesis: its relevance to the antagonist action of naloxone","Kobylecki RJ, Carling RW, Lord JA, Smith CF, Lane AC.","J Med Chem. 1982 Feb;25(2):116-20. doi: 10.1021/jm00344a005.","Kobylecki RJ","J Med Chem","1982","1982/02/01","","","10.1021/jm00344a005"
"6272677","ACTH-induced grooming involves high-affinity opiate receptors","Dunn AJ, Childers SR, Kramarcy NR, Villiger JW.","Behav Neural Biol. 1981 Jan;31(1):105-9. doi: 10.1016/s0163-1047(81)91178-x.","Dunn AJ","Behav Neural Biol","1981","1981/01/01","","","10.1016/s0163-1047(81)91178-x"
"6272240","Naltrexone reduces weight gain, alters ""beta-endorphin"", and reduces insulin output from pancreatic islets of genetically obese mice","Recant L, Voyles NR, Luciano M, Pert CB.","Peptides. 1980 Winter;1(4):309-13. doi: 10.1016/0196-9781(80)90008-x.","Recant L","Peptides","1980","1980/01/01","","","10.1016/0196-9781(80)90008-x"
"6272086","Scatchard analysis of opiate receptor binding","Fischel SV, Medzihradsky F.","Mol Pharmacol. 1981 Sep;20(2):269-79.","Fischel SV","Mol Pharmacol","1981","1981/09/01","","",""
"6272084","Two different modifications of the neuroblastoma X glioma hybrid opiate receptors induced by N-ethylmaleimide","Larsen NE, Mullikin-Kilpatrick D, Blume AJ.","Mol Pharmacol. 1981 Sep;20(2):255-62.","Larsen NE","Mol Pharmacol","1981","1981/09/01","","",""
"6272048","Effects of beta-endorphin fragments on plasma levels of vasopressin","van Wimersma Greidanus TB, van Ree JM, Goedemans HJ, van Dam AF, Andringa-Bakker EA, de Wied D.","Life Sci. 1981 Aug 24;29(8):783-8. doi: 10.1016/0024-3205(81)90033-3.","van Wimersma Greidanus TB","Life Sci","1981","1981/08/24","","","10.1016/0024-3205(81)90033-3"
"6271831","Levonantradol-induced inhibition of acetylcholine turnover in rat hippocampus and striatum","Costa E, Cheney DL, Murray TF.","J Clin Pharmacol. 1981 Aug-Sep;21(S1):256S-261S. doi: 10.1002/j.1552-4604.1981.tb02603.x.","Costa E","J Clin Pharmacol","1981","1981/08/01","","","10.1002/j.1552-4604.1981.tb02603.x"
"6271598","Effects of opioid peptides on thermoregulation","Clark WG.","Fed Proc. 1981 Nov;40(13):2754-9.","Clark WG","Fed Proc","1981","1981/11/01","","",""
"6271322","In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions","Dum JE, Herz A.","Br J Pharmacol. 1981 Nov;74(3):627-33. doi: 10.1111/j.1476-5381.1981.tb10473.x.","Dum JE","Br J Pharmacol","1981","1981/11/01","PMC2071750","","10.1111/j.1476-5381.1981.tb10473.x"
"6270541","Irreversible inactivation of the opiate receptors in the neuroblastoma x glioma hybrid NG108-15 by chlornaltrexamine","Fantozzi R, Mullikin-Kilpatrick D, Blume AJ.","Mol Pharmacol. 1981 Jul;20(1):8-15.","Fantozzi R","Mol Pharmacol","1981","1981/07/01","","",""
"6268381","Gamma-melanotropin and brain function","van Ree JM, Bohus B, Csontos KM, Gispen WH, Greven HM, Nijkamp FP, Opmeer FA, de Rotte GA, van Wimersma Greidanus TB, Witter A, de Wied D.","Ciba Found Symp. 1981;81:263-76. doi: 10.1002/9780470720646.ch15.","van Ree JM","Ciba Found Symp","1981","1981/01/01","","","10.1002/9780470720646.ch15"
"6268235","Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain","Kosterlitz HW, Paterson SJ, Robson LE.","Br J Pharmacol. 1981 Aug;73(4):939-49. doi: 10.1111/j.1476-5381.1981.tb08749.x.","Kosterlitz HW","Br J Pharmacol","1981","1981/08/01","PMC2071481","","10.1111/j.1476-5381.1981.tb08749.x"
"6267469","Current status of preclinical research on disposition, pharmacokinetics, and metabolism of naltrexone","Misra AL.","NIDA Res Monogr. 1981;28:132-46.","Misra AL","NIDA Res Monogr","1981","1981/01/01","","",""
"6267391","Seasonal variation in the apparent number of binding sites for 3H-opioid agonists and antagonists","Codd EE, Byrne WL.","Life Sci. 1981 Jun 8;28(23):2577-83. doi: 10.1016/0024-3205(81)90714-1.","Codd EE","Life Sci","1981","1981/06/08","","","10.1016/0024-3205(81)90714-1"
"6266844","Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats","Tulunay FC, Ayhan IH, Portoghese PS, Takemori AE.","Eur J Pharmacol. 1981 Mar 12;70(2):219-24. doi: 10.1016/0014-2999(81)90217-x.","Tulunay FC","Eur J Pharmacol","1981","1981/03/12","","","10.1016/0014-2999(81)90217-x"
"6266608","Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy","Urca G, Yitzhaky J, Frenk H.","Brain Res. 1981 Aug 31;219(2):385-96. doi: 10.1016/0006-8993(81)90301-2.","Urca G","Brain Res","1981","1981/08/31","","","10.1016/0006-8993(81)90301-2"
"6266433","The role of opioid peptides in memory and learning","Izquierdo I, Dias RD, Souza DO, Carrasco MA, Elisabetsky E, Perry ML.","Behav Brain Res. 1980 Dec;1(6):451-68. doi: 10.1016/0166-4328(80)90001-7.","Izquierdo I","Behav Brain Res","1980","1980/12/01","","","10.1016/0166-4328(80)90001-7"
"6264340","Chronic lithium administration alters the interaction between opiate antagonists and opiate receptors in vivo","Amir S, Simantov R.","Neuropharmacology. 1981 Jun;20(6):587-91. doi: 10.1016/0028-3908(81)90212-4.","Amir S","Neuropharmacology","1981","1981/06/01","","","10.1016/0028-3908(81)90212-4"
"6264311","Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus","Chavkin C, Goldstein A.","Nature. 1981 Jun 18;291(5816):591-3. doi: 10.1038/291591a0.","Chavkin C","Nature","1981","1981/06/18","","","10.1038/291591a0"
"6263637","The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone","Takemori AE, Larson DL, Portoghese PS.","Eur J Pharmacol. 1981 Apr 9;70(4):445-51. doi: 10.1016/0014-2999(81)90355-1.","Takemori AE","Eur J Pharmacol","1981","1981/04/09","","","10.1016/0014-2999(81)90355-1"
"6262493","Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists","Valentino RJ, Herling S, Woods JH, Medzihradsky F, Merz H.","J Pharmacol Exp Ther. 1981 Jun;217(3):652-9.","Valentino RJ","J Pharmacol Exp Ther","1981","1981/06/01","","",""
"6262485","Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists","Iwamoto ET.","J Pharmacol Exp Ther. 1981 May;217(2):451-60.","Iwamoto ET","J Pharmacol Exp Ther","1981","1981/05/01","","",""
"6261273","ACTH mediation of learned fear: blockade by naloxone and naltrexone","Concannon JT, Riccio DC, Maloney R, McKelvey J.","Physiol Behav. 1980 Dec;25(6):977-9. doi: 10.1016/0031-9384(80)90320-0.","Concannon JT","Physiol Behav","1980","1980/12/01","","","10.1016/0031-9384(80)90320-0"
"6259471","Isolation of selective 3H-chlornaltrexamine-bound complexes, possible opioid receptor components in brains of mice","Caruso TP, Larson DL, Portoghese PS, Takemori AE.","Life Sci. 1980 Dec 1;27(22):2063-9. doi: 10.1016/0024-3205(80)90485-3.","Caruso TP","Life Sci","1980","1980/12/01","","","10.1016/0024-3205(80)90485-3"
"6259220","Opiate antagonists and long-term analgesic reaction induced by inescapable shock in rats","Maier SF, Davies S, Grau JW, Jackson RL, Morrison DH, Moye T, Madden J 4th, Barchas JD.","J Comp Physiol Psychol. 1980 Dec;94(6):1172-83. doi: 10.1037/h0077743.","Maier SF","J Comp Physiol Psychol","1980","1980/12/01","","","10.1037/h0077743"
"6256633","Emerging concepts concerning drug abuse","Martin WR.","NIDA Res Monogr. 1980 Mar;30:278-85.","Martin WR","NIDA Res Monogr","1980","1980/03/01","","",""
"6256182","Discriminative stimulus effects of prototype opiate receptor agonists in monkeys","Teal JJ, Holtzman SG.","Eur J Pharmacol. 1980 Nov 7;68(1):1-10. doi: 10.1016/0014-2999(80)90053-9.","Teal JJ","Eur J Pharmacol","1980","1980/11/07","","","10.1016/0014-2999(80)90053-9"
"6255487","Opioid peptides and their receptors","Kosterlitz HW.","Prog Biochem Pharmacol. 1980;16:3-10. doi: 10.1016/b978-0-08-028021-9.50005-8.","Kosterlitz HW","Prog Biochem Pharmacol","1980","1980/01/01","","","10.1016/b978-0-08-028021-9.50005-8"
"6254782","Inhibition of growth in young mice treated with pentazocine: reversal by naltrexone","Wassef NM, Smith AA.","Eur J Pharmacol. 1980 Aug 29;66(2-3):155-60. doi: 10.1016/0014-2999(80)90138-7.","Wassef NM","Eur J Pharmacol","1980","1980/08/29","","","10.1016/0014-2999(80)90138-7"
"6254356","The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone","Schecter A.","Am J Drug Alcohol Abuse. 1980;7(1):1-18. doi: 10.3109/00952998009028406.","Schecter A","Am J Drug Alcohol Abuse","1980","1980/01/01","","","10.3109/00952998009028406"
"6252794","Influence of morphine and naltrexone on the intraocular pressure of conscious cynomolgus monkeys (Macaca fascicularis)","Hahnenberger RW.","Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980;214(1):27-31. doi: 10.1007/BF00414533.","Hahnenberger RW","Albrecht Von Graefes Arch Klin Exp Ophthalmol","1980","1980/01/01","","","10.1007/BF00414533"
"6252015","Opiate receptors may mediate the suppressive but not the excitatory action of ACTH on motor activity in rats","Amir S, Galina ZH, Blair R, Brown ZW, Amit Z.","Eur J Pharmacol. 1980 Sep 5;66(4):307-13. doi: 10.1016/0014-2999(80)90463-x.","Amir S","Eur J Pharmacol","1980","1980/09/05","","","10.1016/0014-2999(80)90463-x"
"6250102","Autoanalgesia: opiate and non-opiate mechanisms","Chance WT.","Neurosci Biobehav Rev. 1980 Spring;4(1):55-67. doi: 10.1016/0149-7634(80)90025-1.","Chance WT","Neurosci Biobehav Rev","1980","1980/01/01","","","10.1016/0149-7634(80)90025-1"
"6249450","Depressant and excitant effects of intraspinal microinjections of morphine and methionine-enkephalin in the cat","Bell JA, Sharpe LG, Berry JN.","Brain Res. 1980 Sep 8;196(2):455-65. doi: 10.1016/0006-8993(80)90409-6.","Bell JA","Brain Res","1980","1980/09/08","","","10.1016/0006-8993(80)90409-6"
"6248627","Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats","Farsang C, Ramirez-Gonzalez MD, Mucci L, Kunos G.","J Pharmacol Exp Ther. 1980 Jul;214(1):203-8.","Farsang C","J Pharmacol Exp Ther","1980","1980/07/01","","",""
"6247596","Electroacupuncture analgesia is mediated by stereospecific opiate receptors and is reversed by antagonists of type I receptors","Cheng RS, Pomeranz BH.","Life Sci. 1980 Feb 25;26(8):631-8. doi: 10.1016/0024-3205(80)90239-8.","Cheng RS","Life Sci","1980","1980/02/25","","","10.1016/0024-3205(80)90239-8"
"6247594","Location and characterization of opiate receptors regulating pituitary secretion","Grandison L, Fratta W, Guidotti A.","Life Sci. 1980 May 12;26(19):1633-42. doi: 10.1016/0024-3205(80)90367-7.","Grandison L","Life Sci","1980","1980/05/12","","","10.1016/0024-3205(80)90367-7"
"6247214","The effects of opiate agonists on growth hormone and prolactin release in rats","Shaar CJ, Clemens JA.","Fed Proc. 1980 Jun;39(8):2539-43.","Shaar CJ","Fed Proc","1980","1980/06/01","","",""
"6246747","Opiate receptors: problems of definition and characterization","Terenius L.","Adv Biochem Psychopharmacol. 1980;21:321-8.","Terenius L","Adv Biochem Psychopharmacol","1980","1980/01/01","","",""
"6245423","Effects of pentazocine and other opiates on shock detection in the rat: involvement of opiate and dopamine receptors","Hernández LL, Appel JB.","Psychopharmacology (Berl). 1980 Feb;67(2):155-63. doi: 10.1007/BF00431971.","Hernández LL","Psychopharmacology (Berl)","1980","1980/02/01","","","10.1007/BF00431971"
"6245210","A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities","Portoghese PS, Larson DL, Sayre LM, Fries DS, Takemori AE.","J Med Chem. 1980 Mar;23(3):233-4. doi: 10.1021/jm00177a002.","Portoghese PS","J Med Chem","1980","1980/03/01","","","10.1021/jm00177a002"
"6244551","Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors","Smith JR, Simon EJ.","Proc Natl Acad Sci U S A. 1980 Jan;77(1):281-4. doi: 10.1073/pnas.77.1.281.","Smith JR","Proc Natl Acad Sci U S A","1980","1980/01/01","PMC348253","","10.1073/pnas.77.1.281"
"6244390","Naloxone-induced increases in serum luteinizing hormone in the male: mechanisms of action","Cicero TJ, Wilcox CE, Bell RD, Meyer ER.","J Pharmacol Exp Ther. 1980 Mar;212(3):573-8.","Cicero TJ","J Pharmacol Exp Ther","1980","1980/03/01","","",""
"6209395","Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand","Koolpe GA, Nelson WL, Gioannini TL, Angel L, Simon EJ.","J Med Chem. 1984 Dec;27(12):1718-23. doi: 10.1021/jm00378a032.","Koolpe GA","J Med Chem","1984","1984/12/01","","","10.1021/jm00378a032"
"6207431","Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine","France CP, Jacobson AE, Woods JH.","NIDA Res Monogr. 1984 Mar;49:136-42.","France CP","NIDA Res Monogr","1984","1984/03/01","","",""
"6206224","Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine","France CP, Jacobson AE, Woods JH.","J Pharmacol Exp Ther. 1984 Sep;230(3):652-7.","France CP","J Pharmacol Exp Ther","1984","1984/09/01","","",""
"6201940","Effects of beta-endorphin and its fragments on inhibitory avoidance behavior in rats","Kovàcs GL, Bohus B, De Wied D.","Psychoneuroendocrinology. 1983;8(4):411-9. doi: 10.1016/0306-4530(83)90020-3.","Kovàcs GL","Psychoneuroendocrinology","1983","1983/01/01","","","10.1016/0306-4530(83)90020-3"
"6197313","Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses","Giles T, Sander G, Merz H.","Eur J Pharmacol. 1983 Nov 25;95(3-4):247-52. doi: 10.1016/0014-2999(83)90641-6.","Giles T","Eur J Pharmacol","1983","1983/11/25","","","10.1016/0014-2999(83)90641-6"
"6196793","Substance P enhancement of passive and active avoidance conditioning in mice","Schlesinger K, Lipsitz DU, Peck PL, Pelleymounter MA, Stewart JM, Chase TN.","Pharmacol Biochem Behav. 1983 Oct;19(4):655-61. doi: 10.1016/0091-3057(83)90341-6.","Schlesinger K","Pharmacol Biochem Behav","1983","1983/10/01","","","10.1016/0091-3057(83)90341-6"
"6192235","Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level","Hylden JL, Wilcox GL.","J Pharmacol Exp Ther. 1983 Aug;226(2):398-404.","Hylden JL","J Pharmacol Exp Ther","1983","1983/08/01","","",""
"6184003","A case of episodic flushing and organic psychosis: reversal by opiate antagonists","Goldstein DJ, Keiser HR.","Ann Intern Med. 1983 Jan;98(1):30-4. doi: 10.7326/0003-4819-98-1-30.","Goldstein DJ","Ann Intern Med","1983","1983/01/01","","","10.7326/0003-4819-98-1-30"
"6183549","Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice","Ramabadran K.","Life Sci. 1982 Sep 20-27;31(12-13):1253-6. doi: 10.1016/0024-3205(82)90355-1.","Ramabadran K","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90355-1"
"6176696","Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines","Hahn EF, Carroll-Buatti M, Pasternak GW.","J Neurosci. 1982 May;2(5):572-6. doi: 10.1523/JNEUROSCI.02-05-00572.1982.","Hahn EF","J Neurosci","1982","1982/05/01","PMC6564265","","10.1523/JNEUROSCI.02-05-00572.1982"
"6166807","Peripheral sympatholytic effects of 1-alpha-acetylmethadol","Stickney JL, Eikenburg DC.","J Cardiovasc Pharmacol. 1981 Mar-Apr;3(2):369-80. doi: 10.1097/00005344-198103000-00014.","Stickney JL","J Cardiovasc Pharmacol","1981","1981/03/01","","","10.1097/00005344-198103000-00014"
"6162947","Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine","Caruso TP, Larson DL, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1980 Jun;213(3):539-44.","Caruso TP","J Pharmacol Exp Ther","1980","1980/06/01","","",""
"6161013","Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine","Larson AA, Armstrong MJ.","Eur J Pharmacol. 1980 Nov 7;68(1):25-31. doi: 10.1016/0014-2999(80)90056-4.","Larson AA","Eur J Pharmacol","1980","1980/11/07","","","10.1016/0014-2999(80)90056-4"
"6156240","Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones","Pasternak GW, Hahn EF.","J Med Chem. 1980 Jun;23(6):674-6. doi: 10.1021/jm00180a019.","Pasternak GW","J Med Chem","1980","1980/06/01","","","10.1021/jm00180a019"
"6151208","Antagonism of the discriminative effects of ethylketazocine, cyclazocine, and nalorphine in macaques","Young AM, Stephens KR.","Psychopharmacology (Berl). 1984;84(3):356-61. doi: 10.1007/BF00555213.","Young AM","Psychopharmacology (Berl)","1984","1984/01/01","","","10.1007/BF00555213"
"6150815","Naltrexone disposition in man after subcutaneous administration","Wall ME, Perez-Reyes M, Brine DR, Cook CE.","Drug Metab Dispos. 1984 Nov-Dec;12(6):677-82.","Wall ME","Drug Metab Dispos","1984","1984/11/01","","",""
"6150086","The role of opioid receptor sub-types in tifluadom-induced feeding","Jackson HC, Sewell RD.","J Pharm Pharmacol. 1984 Oct;36(10):683-6. doi: 10.1111/j.2042-7158.1984.tb04843.x.","Jackson HC","J Pharm Pharmacol","1984","1984/10/01","","","10.1111/j.2042-7158.1984.tb04843.x"
"6148913","Which opioid receptor mechanism modulates feeding?","Morley JE, Levine AS, Gosnell BA, Billington CJ.","Appetite. 1984 Mar;5(1):61-8. doi: 10.1016/s0195-6663(84)80051-3.","Morley JE","Appetite","1984","1984/03/01","","","10.1016/s0195-6663(84)80051-3"
"6147336","Neurotransmitters and biphasic respiratory response to hypoxia","Long WA, Lawson EE.","J Appl Physiol Respir Environ Exerc Physiol. 1984 Jul;57(1):213-22. doi: 10.1152/jappl.1984.57.1.213.","Long WA","J Appl Physiol Respir Environ Exerc Physiol","1984","1984/07/01","","","10.1152/jappl.1984.57.1.213"
"6147020","[Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases]","Bakharev VD, Tikhomirov SM.","Sov Med. 1984;(6):50-3.","Bakharev VD","Sov Med","1984","1984/01/01","","",""
"6146706","Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques","Schulz R, Wüster M, Herz A.","J Pharmacol Exp Ther. 1984 Jul;230(1):200-4.","Schulz R","J Pharmacol Exp Ther","1984","1984/07/01","","",""
"6146699","Is the hypothermic effect of alpha-methyldopa mediated by opioid peptides?","Sitsen JM, Nijkamp FP.","J Pharm Pharmacol. 1984 Jul;36(7):481-3. doi: 10.1111/j.2042-7158.1984.tb04433.x.","Sitsen JM","J Pharm Pharmacol","1984","1984/07/01","","","10.1111/j.2042-7158.1984.tb04433.x"
"6141501","Opioid peptides and seizures in the spontaneously epileptic Mongolian gerbil","Lee RJ, Bajorek JG, Lomax P.","Life Sci. 1983;33 Suppl 1:567-70. doi: 10.1016/0024-3205(83)90566-0.","Lee RJ","Life Sci","1983","1983/01/01","","","10.1016/0024-3205(83)90566-0"
"6141278","Opioid receptor selectivity of dynorphin gene products","James IF, Fischli W, Goldstein A.","J Pharmacol Exp Ther. 1984 Jan;228(1):88-93.","James IF","J Pharmacol Exp Ther","1984","1984/01/01","","",""
"6136987","Evidence for a role of the ventro-medial posterior hypothalamus in nociceptive processes in the rat","Millan MJ, Przewłocki R, Millan MH, Herz A.","Pharmacol Biochem Behav. 1983 Jun;18(6):901-7. doi: 10.1016/s0091-3057(83)80013-6.","Millan MJ","Pharmacol Biochem Behav","1983","1983/06/01","","","10.1016/s0091-3057(83)80013-6"
"6136392","Opiate receptor pharmacology: mixed agonist/antagonist narcotics","Hameroff SR.","Contemp Anesth Pract. 1983;7:27-43.","Hameroff SR","Contemp Anesth Pract","1983","1983/01/01","","",""
"6135144","Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency","Cox BM, Chavkin C.","Mol Pharmacol. 1983 Jan;23(1):36-43.","Cox BM","Mol Pharmacol","1983","1983/01/01","","",""
"6133288","Effects of three narcotic antagonists (naltrexone, diprenorphine, and S-20682) on blood pressure, heart rate and electrical cortical activity","Freye E, Hartung E, Schenk GK.","Pharmacology. 1983;26(2):110-6. doi: 10.1159/000137792.","Freye E","Pharmacology","1983","1983/01/01","","","10.1159/000137792"
"6131962","Naltrexone metabolism and sustained release following administration of an insoluble complex to rhesus monkeys and guinea-pigs","Macgregor TR, Drum MA, Harrigan SE, Wiley JN, Reuning RH.","J Pharm Pharmacol. 1983 Jan;35(1):38-42. doi: 10.1111/j.2042-7158.1983.tb04260.x.","Macgregor TR","J Pharm Pharmacol","1983","1983/01/01","","","10.1111/j.2042-7158.1983.tb04260.x"
"6131119","Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice","Ward SJ, Takemori AE.","J Pharmacol Exp Ther. 1983 Mar;224(3):525-30.","Ward SJ","J Pharmacol Exp Ther","1983","1983/03/01","","",""
"6130527","Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin","James IF, Chavkin C, Goldstein A.","Proc Natl Acad Sci U S A. 1982 Dec;79(23):7570-4. doi: 10.1073/pnas.79.23.7570.","James IF","Proc Natl Acad Sci U S A","1982","1982/12/01","PMC347382","","10.1073/pnas.79.23.7570"
"6130451","Application of an irreversible opiate antagonist (beta-FNA, beta-funal-trexamine) to demonstrate dynorphin selectivity for K-opioid sites","Huidobro-Toro JP, Yoshimura K, Way EL.","Life Sci. 1982 Nov 29;31(22):2409-16. doi: 10.1016/0024-3205(82)90744-5.","Huidobro-Toro JP","Life Sci","1982","1982/11/29","","","10.1016/0024-3205(82)90744-5"
"6129982","Opioid peptides inhibit intestinal transit in the rat by a central mechanism","Galligan JJ, Burks TF.","Eur J Pharmacol. 1982 Nov 5;85(1):61-8. doi: 10.1016/0014-2999(82)90424-1.","Galligan JJ","Eur J Pharmacol","1982","1982/11/05","","","10.1016/0014-2999(82)90424-1"
"6129881","Prevention of late fentanyl-induced respiratory depression after the injection of opiate antagonists naltrexone and S-20682: comparison with naloxone","Freye E, Hartung E, Kaliebe S.","Br J Anaesth. 1983 Jan;55(1):71-7. doi: 10.1093/bja/55.1.71.","Freye E","Br J Anaesth","1983","1983/01/01","","","10.1093/bja/55.1.71"
"6129686","[Narcotic withdrawal syndrome. Therapeutic methods]","Cerdeño Impuesto V.","Rev Clin Esp. 1982 Oct 15;167(1):65-9.","Cerdeño Impuesto V","Rev Clin Esp","1982","1982/10/15","","",""
"6128656","Selectivity of dynorphin for kappa opioid receptors","James IF, Chavkin C, Goldstein A.","Life Sci. 1982 Sep 20-27;31(12-13):1331-4. doi: 10.1016/0024-3205(82)90374-5.","James IF","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90374-5"
"6128653","Relative involvement of receptor subtypes in opioid-induced inhibition of intestinal motility in mice","Ward SJ, Takemori AE.","Life Sci. 1982 Sep 20-27;31(12-13):1267-70. doi: 10.1016/0024-3205(82)90358-7.","Ward SJ","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90358-7"
"6121872","Suppression of ethanol consumption by MET-enkephalin in rats","Ho AK, Rossi N.","J Pharm Pharmacol. 1982 Feb;34(2):118-9. doi: 10.1111/j.2042-7158.1982.tb04199.x.","Ho AK","J Pharm Pharmacol","1982","1982/02/01","","","10.1111/j.2042-7158.1982.tb04199.x"
"6121523","Naloxone: analeptic action unrelated to opiate receptor antagonism?","Kraynack BJ, Gintautas JG.","Anesthesiology. 1982 Apr;56(4):251-3.","Kraynack BJ","Anesthesiology","1982","1982/04/01","","",""
"6121047","Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine","Slizgi GR, Ludens JH.","J Pharmacol Exp Ther. 1982 Mar;220(3):585-91.","Slizgi GR","J Pharmacol Exp Ther","1982","1982/03/01","","",""
"6121045","Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine","Ward SJ, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1982 Mar;220(3):494-8.","Ward SJ","J Pharmacol Exp Ther","1982","1982/03/01","","",""
"6120359","Anorexic effects of naltrexone in man","Sternbach HA, Annitto W, Pottash AL, Gold MS.","Lancet. 1982 Feb 13;1(8268):388-9. doi: 10.1016/s0140-6736(82)91407-6.","Sternbach HA","Lancet","1982","1982/02/13","","","10.1016/s0140-6736(82)91407-6"
"6116207","Effects of naltrexone and prolyl-leucyl-glycinamide on drug-induced tremor and rigidity in the rat","Dickinson SL, Slater P, Longman DA.","Neuropharmacology. 1981 Aug;20(8):757-62. doi: 10.1016/0028-3908(81)90225-2.","Dickinson SL","Neuropharmacology","1981","1981/08/01","","","10.1016/0028-3908(81)90225-2"
"6115930","The in vitro pharmacology of D-Met2,Pro5-enkephalinamide","Rónai AZ, Berzétei IP, Bajusz S, Székely JI.","J Pharm Pharmacol. 1981 Aug;33(8):534-5. doi: 10.1111/j.2042-7158.1981.tb13854.x.","Rónai AZ","J Pharm Pharmacol","1981","1981/08/01","","","10.1111/j.2042-7158.1981.tb13854.x"
"6114837","Metabolism and disposition of naltrexone in man after oral and intravenous administration","Wall ME, Brine DR, Perez-Reyes M.","Drug Metab Dispos. 1981 Jul-Aug;9(4):369-75.","Wall ME","Drug Metab Dispos","1981","1981/07/01","","",""
"6110766","Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior","Harris RA.","J Pharmacol Exp Ther. 1980 Jun;213(3):497-503.","Harris RA","J Pharmacol Exp Ther","1980","1980/06/01","","",""
"6109606","Metabolism and choleretic effect of naltrexone in the isolated perfused rat liver","Rodgers RM, Taylor SM, Dickinson RG, Ilias AM, Lynn RK, Gerber N.","Drug Metab Dispos. 1980 Nov-Dec;8(6):390-6.","Rodgers RM","Drug Metab Dispos","1980","1980/11/01","","",""
"6108466","Clonidine versus methadone for opiate detoxification","Washton AM, Resnick RB.","Lancet. 1980 Dec 13;2(8207):1297. doi: 10.1016/s0140-6736(80)92356-9.","Washton AM","Lancet","1980","1980/12/13","","","10.1016/s0140-6736(80)92356-9"
"6107698","Clonidine and opiate withdrawal","Gold MS, Pottash AL, Extein I, Kleber HD.","Lancet. 1980 Nov 15;2(8203):1078-9. doi: 10.1016/s0140-6736(80)92295-3.","Gold MS","Lancet","1980","1980/11/15","","","10.1016/s0140-6736(80)92295-3"
"6107608","Anti-endorphin effects of methadone","Gold MS, Pottash AL, Extein I, Kleber HD.","Lancet. 1980 Nov 1;2(8201):972-3. doi: 10.1016/s0140-6736(80)92125-x.","Gold MS","Lancet","1980","1980/11/01","","","10.1016/s0140-6736(80)92125-x"
"6107224","The stimulatory effect of morphine on reduction of naltrexone to 6 alpha-naltrexol in the guinea pig","Roerig SC, Fujimoto JM, Wang RI.","Drug Metab Dispos. 1980 Sep-Oct;8(5):295-9.","Roerig SC","Drug Metab Dispos","1980","1980/09/01","","",""
"6106678","Core temperature changes following administration of naloxone and naltrexone to rats exposed to hot and cold ambient temperatures. Evidence for the physiological role of endorphins in hot and cold acclimatization","Thornhill JA, Cooper KE, Veale WL.","J Pharm Pharmacol. 1980 Jun;32(6):427-30. doi: 10.1111/j.2042-7158.1980.tb12958.x.","Thornhill JA","J Pharm Pharmacol","1980","1980/06/01","","","10.1111/j.2042-7158.1980.tb12958.x"
"6101980","Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors","Kosterlitz HW, Lord JA, Paterson SJ, Waterfield AA.","Br J Pharmacol. 1980 Feb;68(2):333-42. doi: 10.1111/j.1476-5381.1980.tb10422.x.","Kosterlitz HW","Br J Pharmacol","1980","1980/02/01","PMC2043928","","10.1111/j.1476-5381.1980.tb10422.x"
"6101080","Opioid effects in developing rat vas deferens","Rónai AZ, Berzétei IP, Kurgyis J.","Cell Mol Neurobiol. 1981 Dec;1(4):335-42. doi: 10.1007/BF00716268.","Rónai AZ","Cell Mol Neurobiol","1981","1981/12/01","","","10.1007/BF00716268"
"6100022","Modulation of the pulsatile release of biologically active luteinizing hormone by endogenous opiates","Veldhuis JD, Rogol AD, Johnson ML, Dufau ML.","Ann N Y Acad Sci. 1984;438:485-9. doi: 10.1111/j.1749-6632.1984.tb38313.x.","Veldhuis JD","Ann N Y Acad Sci","1984","1984/01/01","","","10.1111/j.1749-6632.1984.tb38313.x"
"6099871","Opiate receptor upregulation and functional supersensitivity","Zukin RS, Tempel A, Gardner EL.","NIDA Res Monogr. 1984;54:146-61.","Zukin RS","NIDA Res Monogr","1984","1984/01/01","","",""
"6099514","Effects of full and partial kappa agonists and mu agonists on urine output of normally hydrated rats","Leander JD.","Neuropeptides. 1984 Dec;5(1-3):283-6. doi: 10.1016/0143-4179(84)90083-0.","Leander JD","Neuropeptides","1984","1984/12/01","","","10.1016/0143-4179(84)90083-0"
"6099513","Chronic blockade of opiate receptors: influence on reproduction and body weight in female rats","Pfeiffer DG, Nikolarakis KE, Pfeiffer A.","Neuropeptides. 1984 Dec;5(1-3):279-82. doi: 10.1016/0143-4179(84)90082-9.","Pfeiffer DG","Neuropeptides","1984","1984/12/01","","","10.1016/0143-4179(84)90082-9"
"6099490","Acute and persistent effects of beta-funaltrexamine on the binding and agonist potencies of opioids in the myenteric plexus of the guinea-pig ileum","McKnight AT, Paterson SJ, Corbett AD, Kosterlitz HW.","Neuropeptides. 1984 Dec;5(1-3):169-72. doi: 10.1016/0143-4179(84)90054-4.","McKnight AT","Neuropeptides","1984","1984/12/01","","","10.1016/0143-4179(84)90054-4"
"6099488","Comparison of ""selective"" opiate receptor antagonists on the isolated mouse vas deferens","Smith CB, Bennett-Kelly L, Woods JH.","Neuropeptides. 1984 Dec;5(1-3):161-4. doi: 10.1016/0143-4179(84)90052-0.","Smith CB","Neuropeptides","1984","1984/12/01","","","10.1016/0143-4179(84)90052-0"
"6099471","Chronic naloxone increases opiate binding in SHR and WKY rats","Hahn EF.","Neurochem Res. 1984 Dec;9(12):1749-56. doi: 10.1007/BF00968085.","Hahn EF","Neurochem Res","1984","1984/12/01","","","10.1007/BF00968085"
"6098896","Ethanol-opioid interaction in mice","Tamborska E, Kotlińska J, Langwiński R.","Pol J Pharmacol Pharm. 1984 Jul-Aug;36(4):337-44.","Tamborska E","Pol J Pharmacol Pharm","1984","1984/07/01","","",""
"6095280","Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus","Chavkin C, Goldstein A.","Proc Natl Acad Sci U S A. 1984 Nov;81(22):7253-7. doi: 10.1073/pnas.81.22.7253.","Chavkin C","Proc Natl Acad Sci U S A","1984","1984/11/01","PMC392117","","10.1073/pnas.81.22.7253"
"6094248","3-[18F]Acetylcyclofoxy: a useful probe for the visualization of opiate receptors in living animals","Pert CB, Danks JA, Channing MA, Eckelman WC, Larson SM, Bennett JM, Burke TR Jr, Rice KC.","FEBS Lett. 1984 Nov 19;177(2):281-6. doi: 10.1016/0014-5793(84)81300-9.","Pert CB","FEBS Lett","1984","1984/11/19","","","10.1016/0014-5793(84)81300-9"
"6094203","Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists","Takemori AE, Portoghese PS.","Eur J Pharmacol. 1984 Sep 3;104(1-2):101-4. doi: 10.1016/0014-2999(84)90374-1.","Takemori AE","Eur J Pharmacol","1984","1984/09/03","","","10.1016/0014-2999(84)90374-1"
"6093942","Hyperthermic response of the cat to intraventricular injection of the opioid delta-receptor agonist D-Ala2-D-Leu5-enkephalin","Pang IH, Bernardini GL, Clark WG.","Brain Res Bull. 1984 Aug;13(2):263-8. doi: 10.1016/0361-9230(84)90127-8.","Pang IH","Brain Res Bull","1984","1984/08/01","","","10.1016/0361-9230(84)90127-8"
"6093484","Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare","Rawson RA, Washton AM, Resnick RB, Tennant FS Jr.","Adv Alcohol Subst Abuse. 1984 Spring;3(3):41-9. doi: 10.1300/J251v03n03_04.","Rawson RA","Adv Alcohol Subst Abuse","1984","1984/01/01","","","10.1300/J251v03n03_04"
"6093153","Effects of ethanol and naltrexone on free-operant avoidance behavior in rats","Galizio M, Smaltz SC, Spencer BA.","Pharmacol Biochem Behav. 1984 Sep;21(3):423-9. doi: 10.1016/s0091-3057(84)80105-7.","Galizio M","Pharmacol Biochem Behav","1984","1984/09/01","","","10.1016/s0091-3057(84)80105-7"
"6093137","Mu and delta opioid receptor interactions in a rat model of drug induced seizures","Tortella FC, Holaday JW.","Proc West Pharmacol Soc. 1984;27:435-7.","Tortella FC","Proc West Pharmacol Soc","1984","1984/01/01","","",""
"6092898","Opiate-receptor interactions on single locus coeruleus neurones","Williams JT, North RA.","Mol Pharmacol. 1984 Nov;26(3):489-97.","Williams JT","Mol Pharmacol","1984","1984/11/01","","",""
"6092812","Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth","Zagon IS, McLaughlin PJ.","Life Sci. 1984 Nov 12;35(20):2057-64. doi: 10.1016/0024-3205(84)90563-0.","Zagon IS","Life Sci","1984","1984/11/12","","","10.1016/0024-3205(84)90563-0"
"6092607","Role of spinal mu opioid receptors in the development of morphine tolerance and dependence","DeLander GE, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1984 Oct;231(1):91-6.","DeLander GE","J Pharmacol Exp Ther","1984","1984/10/01","","",""
"6091160","Cold water stress analgesia in rats: differential effects of naltrexone","Girardot MN, Holloway FA.","Physiol Behav. 1984 Apr;32(4):547-55. doi: 10.1016/0031-9384(84)90308-1.","Girardot MN","Physiol Behav","1984","1984/04/01","","","10.1016/0031-9384(84)90308-1"
"6091150","Counteraction by naltrexone of stress-induced inhibition of TSH release: role of noradrenergic system","Briski K, Quigley K, Meites J.","Proc Soc Exp Biol Med. 1984 Nov;177(2):354-9. doi: 10.3181/00379727-177-41956.","Briski K","Proc Soc Exp Biol Med","1984","1984/11/01","","","10.3181/00379727-177-41956"
"6090835","Antagonism of diazepam-induced feeding in rats by antisera to opioid peptides","González Y, Fernández-Tomé MP, Sánchez-Franco F, del Río J.","Life Sci. 1984 Sep 24;35(13):1423-9. doi: 10.1016/0024-3205(84)90401-6.","González Y","Life Sci","1984","1984/09/24","","","10.1016/0024-3205(84)90401-6"
"6090834","Enhancement of opiate-induced depressions in serum luteinizing hormone levels by the prior administration of naloxone in the male rat","Cicero TJ, Owens DP, Schmoeker PF, Meyer ER.","Life Sci. 1984 Sep 17;35(12):1321-8. doi: 10.1016/0024-3205(84)90104-8.","Cicero TJ","Life Sci","1984","1984/09/17","","","10.1016/0024-3205(84)90104-8"
"6090663","Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues","Sayre LM, Larson DL, Takemori AE, Portoghese PS.","J Med Chem. 1984 Oct;27(10):1325-35. doi: 10.1021/jm00376a018.","Sayre LM","J Med Chem","1984","1984/10/01","","","10.1021/jm00376a018"
"6090179","Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds","Isenberg KE, Cicero TJ.","Eur J Pharmacol. 1984 Aug 3;103(1-2):57-63. doi: 10.1016/0014-2999(84)90189-4.","Isenberg KE","Eur J Pharmacol","1984","1984/08/03","","","10.1016/0014-2999(84)90189-4"
"6088697","Effect of beta-FNA on opiate delta receptor binding","Rothman RB, Schumacher UK, Pert CB.","J Neurochem. 1984 Oct;43(4):1197-200. doi: 10.1111/j.1471-4159.1984.tb12861.x.","Rothman RB","J Neurochem","1984","1984/10/01","","","10.1111/j.1471-4159.1984.tb12861.x"
"6088469","The role of the National Institute on Drug Abuse in the development of naltrexone","Ginzburg HM, Glass WJ.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):4-6.","Ginzburg HM","J Clin Psychiatry","1984","1984/09/01","","",""
"6088468","Naltrexone in addicted business executives and physicians","Washton AM, Pottash AC, Gold MS.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):39-41.","Washton AM","J Clin Psychiatry","1984","1984/09/01","","",""
"6088467","Endocrine and metabolic effects of opiate antagonists","Atkinson RL.","J Clin Psychiatry. 1984 Sep;45(9 Pt 2):20-4.","Atkinson RL","J Clin Psychiatry","1984","1984/09/01","","",""
"6087062","Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer","Zagon IS, McLaughlin PJ.","Life Sci. 1984 Jul 23;35(4):409-16. doi: 10.1016/0024-3205(84)90651-9.","Zagon IS","Life Sci","1984","1984/07/23","","","10.1016/0024-3205(84)90651-9"
"6086361","Stereospecificity of 4,5-epoxymorphinan binding to the lambda site in rat brain","Yu VC, Jacobson AE, Rice KC, Sadée W.","Eur J Pharmacol. 1984 May 18;101(1-2):161-2. doi: 10.1016/0014-2999(84)90045-1.","Yu VC","Eur J Pharmacol","1984","1984/05/18","","","10.1016/0014-2999(84)90045-1"
"6084846","Social influences on sex differences in the behavior and endocrine state of talapoin monkeys","Keverne EB, Eberhart JA, Yodyingyuad U, Abbott DH.","Prog Brain Res. 1984;61:331-47. doi: 10.1016/s0079-6123(08)64445-3.","Keverne EB","Prog Brain Res","1984","1984/01/01","","","10.1016/s0079-6123(08)64445-3"
"4467728","Clinical use of naltrexone (EN-1639A): Part I: Safety and efficacy in pilot studies","Schecter AJ, Friedman JG, Grossman DJ.","Am J Drug Alcohol Abuse. 1974;1(2):253-69. doi: 10.3109/00952997409040871.","Schecter AJ","Am J Drug Alcohol Abuse","1974","1974/01/01","","","10.3109/00952997409040871"
"4095190","Effects of opiate antagonists on feeding and spontaneous locomotion in deer","Plotka ED, Morley JE, Levine AS, Seal US.","Physiol Behav. 1985 Dec;35(6):965-9. doi: 10.1016/0031-9384(85)90267-7.","Plotka ED","Physiol Behav","1985","1985/12/01","","","10.1016/0031-9384(85)90267-7"
"4095181","Hormonal mediation of the analgesia produced by food deprivation","Hamm RJ, Knisely JS, Watson A, Lyeth BG, Bossut DF.","Physiol Behav. 1985 Dec;35(6):879-82. doi: 10.1016/0031-9384(85)90254-9.","Hamm RJ","Physiol Behav","1985","1985/12/01","","","10.1016/0031-9384(85)90254-9"
"4094718","Neonatal exposure to naltrexone affects morphine sensitivity and facilitates sexual behaviour in female rats","Meyerson BJ, Berg M.","Neurosci Lett. 1985 Dec 18;62(3):323-7. doi: 10.1016/0304-3940(85)90569-5.","Meyerson BJ","Neurosci Lett","1985","1985/12/18","","","10.1016/0304-3940(85)90569-5"
"4084815","Dexamethasone differentially alters naltrexone effects on vasopressin and oxytocin release during tail electroshock","Rosella-Dampman LM, Summy-Long JY.","Brain Res Bull. 1985 Dec;15(6):587-93. doi: 10.1016/0361-9230(85)90208-4.","Rosella-Dampman LM","Brain Res Bull","1985","1985/12/01","","","10.1016/0361-9230(85)90208-4"
"4084183","Effects of opiate antagonists on spatial memory in young and aged rats","Gallagher M, Bostock E, King R.","Behav Neural Biol. 1985 Nov;44(3):374-85. doi: 10.1016/s0163-1047(85)90688-0.","Gallagher M","Behav Neural Biol","1985","1985/11/01","","","10.1016/s0163-1047(85)90688-0"
"4080766","Effects of opioid antagonists and their quaternary derivatives on locomotor activity and fixed ratio responding for brain self-stimulation in rats","Schaefer GJ, Michael RP.","Pharmacol Biochem Behav. 1985 Nov;23(5):797-802. doi: 10.1016/0091-3057(85)90074-7.","Schaefer GJ","Pharmacol Biochem Behav","1985","1985/11/01","","","10.1016/0091-3057(85)90074-7"
"4080758","Intracerebroventricular drug administration in pigeons","France CP, Adams JU, Woods JH.","Pharmacol Biochem Behav. 1985 Nov;23(5):731-6. doi: 10.1016/0091-3057(85)90063-2.","France CP","Pharmacol Biochem Behav","1985","1985/11/01","","","10.1016/0091-3057(85)90063-2"
"4075082","Acute effects of morphine on neurochemical estimates of activity of incertohypothalamic dopaminergic neurons in the male rat","Lookingland KJ, Moore KE.","Brain Res. 1985 Dec 2;348(2):205-12. doi: 10.1016/0006-8993(85)90438-x.","Lookingland KJ","Brain Res","1985","1985/12/02","","","10.1016/0006-8993(85)90438-x"
"4070418","Placenta ingestion enhances opiate analgesia in rats","Kristal MB, Thompson AC, Grishkat HL.","Physiol Behav. 1985 Oct;35(4):481-6. doi: 10.1016/0031-9384(85)90127-1.","Kristal MB","Physiol Behav","1985","1985/10/01","","","10.1016/0031-9384(85)90127-1"
"4070392","Quaternary naltrexone reverses morphine-induced behaviors","Mickley GA, Stevens KE, Galbraith JA.","Physiol Behav. 1985 Aug;35(2):249-53. doi: 10.1016/0031-9384(85)90345-2.","Mickley GA","Physiol Behav","1985","1985/08/01","","","10.1016/0031-9384(85)90345-2"
"4070326","Intraseptal morphine potentiates pentobarbital narcosis and hypothermia in the rat","Fatherazi S, Lai H, Kazi S, Horita A.","Pharmacol Biochem Behav. 1985 Oct;23(4):505-7. doi: 10.1016/0091-3057(85)90409-5.","Fatherazi S","Pharmacol Biochem Behav","1985","1985/10/01","","","10.1016/0091-3057(85)90409-5"
"4067601","d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatment","van Kammen DP, Schulz SC.","J Neural Transm. 1985;64(1):35-43. doi: 10.1007/BF01259343.","van Kammen DP","J Neural Transm","1985","1985/01/01","","","10.1007/BF01259343"
"4064907","Clinical evaluation of a naltrexone sustained-release preparation","Chiang CN, Hollister LE, Gillespie HK, Foltz RL.","Drug Alcohol Depend. 1985 Sep;16(1):1-8. doi: 10.1016/0376-8716(85)90076-6.","Chiang CN","Drug Alcohol Depend","1985","1985/09/01","","","10.1016/0376-8716(85)90076-6"
"4063057","Effects of ethanol and naltrexone on aggressive display in the siamese fighting fish, Betta splendens","Galizio M, Woodard RL, Keith J.","Alcohol. 1985 Sep-Oct;2(5):637-40. doi: 10.1016/0741-8329(85)90138-7.","Galizio M","Alcohol","1985","1985/09/01","","","10.1016/0741-8329(85)90138-7"
"4059587","Effect of oral nalmefene, an opiate-receptor antagonist, on meal-stimulated gastric acid secretion and serum gastrin concentration in man","Feldman M, Moore L, Walsh JH.","Regul Pept. 1985 Jul;11(3):245-50. doi: 10.1016/0167-0115(85)90056-4.","Feldman M","Regul Pept","1985","1985/07/01","","","10.1016/0167-0115(85)90056-4"
"4059307","Asymmetric behavior induced by enkephalinergic agents in the basal ganglia","Geula C, Asdourian D.","Pharmacol Biochem Behav. 1985 Aug;23(2):207-13. doi: 10.1016/0091-3057(85)90558-1.","Geula C","Pharmacol Biochem Behav","1985","1985/08/01","","","10.1016/0091-3057(85)90558-1"
"4057080","Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon","France CP, Woods JH.","J Pharmacol Exp Ther. 1985 Nov;235(2):442-7.","France CP","J Pharmacol Exp Ther","1985","1985/11/01","","",""
"4057078","Effects of quaternary naltrexone and chlordiazepoxide in squirrel monkeys with enhanced sensitivity to the behavioral effects of naltrexone","Warren PH, Morse WH.","J Pharmacol Exp Ther. 1985 Nov;235(2):412-7.","Warren PH","J Pharmacol Exp Ther","1985","1985/11/01","","",""
"4057071","Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies","Gmerek DE, Woods JH.","J Pharmacol Exp Ther. 1985 Nov;235(2):296-301.","Gmerek DE","J Pharmacol Exp Ther","1985","1985/11/01","","",""
"4054212","beta-Funaltrexamine (beta-FNA) and neural tumor response in mice","Zagon IS, McLaughlin PJ, Takemori AE, Portoghese PS.","Eur J Pharmacol. 1985 Oct 8;116(1-2):165-9. doi: 10.1016/0014-2999(85)90198-0.","Zagon IS","Eur J Pharmacol","1985","1985/10/08","","","10.1016/0014-2999(85)90198-0"
"4045722","Effects of buprenorphine on shock titration in squirrel monkeys","Dykstra LA.","J Pharmacol Exp Ther. 1985 Oct;235(1):20-5.","Dykstra LA","J Pharmacol Exp Ther","1985","1985/10/01","","",""
"4043225","Cross-tolerance between morphine- and bombesin-induced inhibition of intestinal transit in rats","Gmerek DE, Ryan JP, Cowan A.","Eur J Pharmacol. 1985 Aug 15;114(2):175-80. doi: 10.1016/0014-2999(85)90625-9.","Gmerek DE","Eur J Pharmacol","1985","1985/08/15","","","10.1016/0014-2999(85)90625-9"
"4042525","Effects of long-term therapy with naltrexone on body weight in obesity","Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL.","Clin Pharmacol Ther. 1985 Oct;38(4):419-22. doi: 10.1038/clpt.1985.197.","Atkinson RL","Clin Pharmacol Ther","1985","1985/10/01","","","10.1038/clpt.1985.197"
"4041065","Narcotic antagonist potentiation of apomorphine drug effect: a stereospecific, centrally mediated drug action","Quock RM, Kouchich FJ, Fries DS.","Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(3):239-43. doi: 10.1016/0278-5846(85)90086-7.","Quock RM","Prog Neuropsychopharmacol Biol Psychiatry","1985","1985/01/01","","","10.1016/0278-5846(85)90086-7"
"4040246","Naltrexone antagonizes the biobehavioral adaptation to cold water stress in rats","Girardot MN, Holloway FA.","Pharmacol Biochem Behav. 1985 May;22(5):769-79. doi: 10.1016/0091-3057(85)90526-x.","Girardot MN","Pharmacol Biochem Behav","1985","1985/05/01","","","10.1016/0091-3057(85)90526-x"
"4039802","Effects of naloxone and other opiate antagonists on blood-ethanol concentration in acutely-ethanol-intoxicated rats","Badawy AA, Aliyu SU.","Neuropeptides. 1985 Feb;5(4-6):341-4. doi: 10.1016/0143-4179(85)90023-x.","Badawy AA","Neuropeptides","1985","1985/02/01","","","10.1016/0143-4179(85)90023-x"
"4039067","Hyperthermia in the rat from handling stress blocked by naltrexone injected into the preoptic-anterior hypothalamus","Pae YS, Lai H, Horita A.","Pharmacol Biochem Behav. 1985 Feb;22(2):337-9. doi: 10.1016/0091-3057(85)90400-9.","Pae YS","Pharmacol Biochem Behav","1985","1985/02/01","","","10.1016/0091-3057(85)90400-9"
"4039002","Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs","Holtzman SG.","J Pharmacol Exp Ther. 1985 Apr;233(1):80-6.","Holtzman SG","J Pharmacol Exp Ther","1985","1985/04/01","","",""
"4033357","Narcotic antagonist-induced hypotension in the spontaneously hypertensive rat","Quock RM, Kouchich FJ, Vaughn LK, Fries DS.","Life Sci. 1985 Sep 2;37(9):819-26. doi: 10.1016/0024-3205(85)90516-8.","Quock RM","Life Sci","1985","1985/09/02","","","10.1016/0024-3205(85)90516-8"
"4033351","Changes in LH and prolactin levels in diabetic male rats and the role of the opiate system in the control of their secretion","Yogev L, Gottriech A, Timan B, Homonnai ZT, Paz GF.","Life Sci. 1985 Sep 16;37(11):993-9. doi: 10.1016/0024-3205(85)90587-9.","Yogev L","Life Sci","1985","1985/09/16","","","10.1016/0024-3205(85)90587-9"
"4031019","Endogenous opiates participate in the regulation of pulsatile luteinizing hormone release in an unopposed estrogen milieu: studies in estrogen-replaced, gonadectomized patients with testicular feminization","Veldhuis JD, Rogol AD, Perez-Palacios G, Stumpf P, Kitchin JD, Dufau ML.","J Clin Endocrinol Metab. 1985 Oct;61(4):790-3. doi: 10.1210/jcem-61-4-790.","Veldhuis JD","J Clin Endocrinol Metab","1985","1985/10/01","","","10.1210/jcem-61-4-790"
"4023023","Effects of opioids and phencyclidine in combination with naltrexone on the acquisition and performance of response sequences in monkeys","Moerschbaecher JM, Thompson DM, Winsauer PJ.","Pharmacol Biochem Behav. 1985 Jun;22(6):1061-9. doi: 10.1016/0091-3057(85)90317-x.","Moerschbaecher JM","Pharmacol Biochem Behav","1985","1985/06/01","","","10.1016/0091-3057(85)90317-x"
"4018136","Prolactin analgesia: tolerance and cross-tolerance with morphine","Ramaswamy S, Viswanathan S, Bapna JS.","Eur J Pharmacol. 1985 May 28;112(1):123-5. doi: 10.1016/0014-2999(85)90248-1.","Ramaswamy S","Eur J Pharmacol","1985","1985/05/28","","","10.1016/0014-2999(85)90248-1"
"4011730","Opioid antagonist-induced regulation of organ development","Zagon IS, McLaughlin PJ.","Physiol Behav. 1985 Apr;34(4):507-11. doi: 10.1016/0031-9384(85)90041-1.","Zagon IS","Physiol Behav","1985","1985/04/01","","","10.1016/0031-9384(85)90041-1"
"4009506","Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure","France CP, Woods JH.","J Pharmacol Exp Ther. 1985 Jul;234(1):81-9.","France CP","J Pharmacol Exp Ther","1985","1985/07/01","","",""
"4009482","Chronic stress, aging and morphine analgesia: chronic stress affects the reactivity to morphine in young mature but not old rats","Girardot MN, Holloway FA.","J Pharmacol Exp Ther. 1985 Jun;233(3):545-53.","Girardot MN","J Pharmacol Exp Ther","1985","1985/06/01","","",""
"4005545","Evidence of a supraspinal opioid analgesic mechanism engaged by lateral hypothalamic electrical stimulation","Carr KD, Uysal S.","Brain Res. 1985 May 27;335(1):55-62. doi: 10.1016/0006-8993(85)90275-6.","Carr KD","Brain Res","1985","1985/05/27","","","10.1016/0006-8993(85)90275-6"
"4000407","Hot-plate learning in mice is unaltered by immediate post-training administration of naloxone, naltrexone or morphine","Rodgers RJ, Randall J, Pittock F.","Neuropharmacology. 1985 Apr;24(4):333-6. doi: 10.1016/0028-3908(85)90140-6.","Rodgers RJ","Neuropharmacology","1985","1985/04/01","","","10.1016/0028-3908(85)90140-6"
"3991774","Stereospecific reduction by narcotic antagonists of clonidine-induced food intake","Katz NL, Schlemmer RF Jr, Waller DP.","Pharmacol Biochem Behav. 1985 Apr;22(4):649-51. doi: 10.1016/0091-3057(85)90290-4.","Katz NL","Pharmacol Biochem Behav","1985","1985/04/01","","","10.1016/0091-3057(85)90290-4"
"3991759","Naltrexone's influence on neurobehavioral development","Zagon IS, McLaughlin PJ.","Pharmacol Biochem Behav. 1985 Mar;22(3):441-8. doi: 10.1016/0091-3057(85)90046-2.","Zagon IS","Pharmacol Biochem Behav","1985","1985/03/01","","","10.1016/0091-3057(85)90046-2"
"3991756","Naltrexone fails to suppress spontaneous locomotor activity in hamsters","Lowy MT, Sangiah S, Yim GK.","Pharmacol Biochem Behav. 1985 Mar;22(3):399-401. doi: 10.1016/0091-3057(85)90039-5.","Lowy MT","Pharmacol Biochem Behav","1985","1985/03/01","","","10.1016/0091-3057(85)90039-5"
"3990510","Morphine decreases 3H-norepinephrine release and increases endogenous norepinephrine levels in the isolated cat superior cervical ganglion","Martínez AE, Adler-Graschinsky E.","Life Sci. 1985 Apr 29;36(17):1679-85. doi: 10.1016/0024-3205(85)90371-6.","Martínez AE","Life Sci","1985","1985/04/29","","","10.1016/0024-3205(85)90371-6"
"3986523","Antagonism of brain opioid peptide action reduces hibernation bout duration","Beckman AL, Llados-Eckman C.","Brain Res. 1985 Mar 4;328(2):201-5. doi: 10.1016/0006-8993(85)91030-3.","Beckman AL","Brain Res","1985","1985/03/04","","","10.1016/0006-8993(85)91030-3"
"3981418","Pharmacokinetics of morphine and its surrogates V: Naltrexone and naltrexone conjugate pharmacokinetics in the dog as a function of dose","Garrett ER, el-Koussi A el-D.","J Pharm Sci. 1985 Jan;74(1):50-6. doi: 10.1002/jps.2600740114.","Garrett ER","J Pharm Sci","1985","1985/01/01","","","10.1002/jps.2600740114"
"3979972","Naltrexone facilitation of sexual receptivity in the rat","Allen DL, Renner KJ, Luine VN.","Horm Behav. 1985 Mar;19(1):98-103. doi: 10.1016/0018-506x(85)90010-8.","Allen DL","Horm Behav","1985","1985/03/01","","","10.1016/0018-506x(85)90010-8"
"3971145","Contralateral circling induced by tegmental morphine: anatomical localization, pharmacological specificity, and phenomenology","Holmes LJ, Wise RA.","Brain Res. 1985 Feb 4;326(1):19-26. doi: 10.1016/0006-8993(85)91380-0.","Holmes LJ","Brain Res","1985","1985/02/04","","","10.1016/0006-8993(85)91380-0"
"3969057","Naltrexone for opioid addiction","","Med Lett Drugs Ther. 1985 Feb 1;27(680):11-2.","","Med Lett Drugs Ther","1985","1985/02/01","","",""
"3958962","Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat","Yoburn BC, Cohen AH, Inturrisi CE.","J Pharmacol Exp Ther. 1986 Apr;237(1):126-30.","Yoburn BC","J Pharmacol Exp Ther","1986","1986/04/01","","",""
"3951334","Naltrexone blocks the post-shock increase of ethanol consumption","Volpicelli JR, Davis MA, Olgin JE.","Life Sci. 1986 Mar 3;38(9):841-7. doi: 10.1016/0024-3205(86)90601-6.","Volpicelli JR","Life Sci","1986","1986/03/03","","","10.1016/0024-3205(86)90601-6"
"3950006","Psychosocial factors in outcome in two opiate addiction treatments","Grey C, Osborn E, Reznikoff M.","J Clin Psychol. 1986 Jan;42(1):185-9. doi: 10.1002/1097-4679(198601)42:1<185::aid-jclp2270420132>3.0.co;2-w.","Grey C","J Clin Psychol","1986","1986/01/01","","","10.1002/1097-4679(198601)42:1<185::aid-jclp2270420132>3.0.co;2-w"
"3947710","Effect of naltrexone on mood and cognitive functioning among overweight men","Hatsukami DK, Mitchell JE, Morley JE, Morgan SF, Levine AS.","Biol Psychiatry. 1986 Mar;21(3):293-300. doi: 10.1016/0006-3223(86)90050-8.","Hatsukami DK","Biol Psychiatry","1986","1986/03/01","","","10.1016/0006-3223(86)90050-8"
"3947698","Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts","Kosten TR, Kreek MJ, Ragunath J, Kleber HD.","Biol Psychiatry. 1986 Feb;21(2):217-20. doi: 10.1016/0006-3223(86)90150-2.","Kosten TR","Biol Psychiatry","1986","1986/02/01","","","10.1016/0006-3223(86)90150-2"
"3946804","Prolonged antagonism of opioid action with intravenous nalmefene in man","Gal TJ, DiFazio CA.","Anesthesiology. 1986 Feb;64(2):175-80. doi: 10.1097/00000542-198602000-00008.","Gal TJ","Anesthesiology","1986","1986/02/01","","","10.1097/00000542-198602000-00008"
"3943269","Nalmefene: intravenous safety and kinetics of a new opioid antagonist","Dixon R, Howes J, Gentile J, Hsu HB, Hsiao J, Garg D, Weidler D, Meyer M, Tuttle R.","Clin Pharmacol Ther. 1986 Jan;39(1):49-53. doi: 10.1038/clpt.1986.9.","Dixon R","Clin Pharmacol Ther","1986","1986/01/01","","","10.1038/clpt.1986.9"
"3941402","Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats","Gmerek DE, Cowan A, Woods JH.","J Pharmacol Exp Ther. 1986 Jan;236(1):8-13.","Gmerek DE","J Pharmacol Exp Ther","1986","1986/01/01","","",""
"3941353","Treatment of experimental stroke with opiate antagonists. Effects on neurological function, infarct size, and survival","Baskin DS, Hosobuchi Y, Grevel JC.","J Neurosurg. 1986 Jan;64(1):99-103. doi: 10.3171/jns.1986.64.1.0099.","Baskin DS","J Neurosurg","1986","1986/01/01","","","10.3171/jns.1986.64.1.0099"
"3931155","Naltrexone: no effect on simian social and motor behavior","Crowley TJ, Macdonald MJ, Zerbe G.","Psychopharmacology (Berl). 1985;87(2):250-1. doi: 10.1007/BF00431818.","Crowley TJ","Psychopharmacology (Berl)","1985","1985/01/01","","","10.1007/BF00431818"
"3927336","Central and peripheral contributions of endogenous opioid systems to nutrient selection in rats","Marks-Kaufman R, Plager A, Kanarek RB.","Psychopharmacology (Berl). 1985;85(4):414-8. doi: 10.1007/BF00429656.","Marks-Kaufman R","Psychopharmacology (Berl)","1985","1985/01/01","","","10.1007/BF00429656"
"3923525","Effects of morphine, naltrexone, and dextrorphan in untreated and morphine-treated pigeons","France CP, Woods JH.","Psychopharmacology (Berl). 1985;85(3):377-82. doi: 10.1007/BF00428205.","France CP","Psychopharmacology (Berl)","1985","1985/01/01","","","10.1007/BF00428205"
"3921389","Blockade by naloxone and naltrexone of the TRH-induced stimulation of colonic transit in the rabbit","Horita A, Carino MA, Pae YS.","Eur J Pharmacol. 1985 Feb 5;108(3):289-93. doi: 10.1016/0014-2999(85)90451-0.","Horita A","Eur J Pharmacol","1985","1985/02/05","","","10.1016/0014-2999(85)90451-0"
"3916036","Direct inhibition of gonadotroph function by opiates","Blank MS, Fabbri A, Catt KJ, Dufau ML.","Trans Assoc Am Physicians. 1985;98:1-9.","Blank MS","Trans Assoc Am Physicians","1985","1985/01/01","","",""
"3908352","A controlled trial of naltrexone in obese humans","Malcolm R, O'Neil PM, Sexauer JD, Riddle FE, Currey HS, Counts C.","Int J Obes. 1985;9(5):347-53.","Malcolm R","Int J Obes","1985","1985/01/01","","",""
"3908340","Psychotherapy/counseling for opiate addicts: strategies for use in different treatment settings","Rounsaville BJ, Kleber HD.","Int J Addict. 1985 Jun-Jul;20(6-7):869-96. doi: 10.3109/10826088509047757.","Rounsaville BJ","Int J Addict","1985","1985/06/01","","","10.3109/10826088509047757"
"3903533","Multiple, single-dose naltrexone administrations fail to effect overall cognitive functioning and plasma cortisol in individuals with probable Alzheimer's disease","Pomara N, Roberts R, Rhiew HB, Stanley M, Gershon S.","Neurobiol Aging. 1985 Fall;6(3):233-6. doi: 10.1016/0197-4580(85)90055-7.","Pomara N","Neurobiol Aging","1985","1985/01/01","","","10.1016/0197-4580(85)90055-7"
"3901041","REM sleep deprivation decreases the grooming and shaking behaviour induced by enkephalinase inhibitor or opiate withdrawal","Ukponmwan OE, vd Poel-Heisterkamp AL, Dzoljic MR.","Pharmacol Biochem Behav. 1985 Sep;23(3):385-9. doi: 10.1016/0091-3057(85)90010-3.","Ukponmwan OE","Pharmacol Biochem Behav","1985","1985/09/01","","","10.1016/0091-3057(85)90010-3"
"3896411","Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men","Maggio CA, Presta E, Bracco EF, Vasselli JR, Kissileff HR, Pfohl DN, Hashim SA.","Brain Res Bull. 1985 Jun;14(6):657-61. doi: 10.1016/0361-9230(85)90115-7.","Maggio CA","Brain Res Bull","1985","1985/06/01","","","10.1016/0361-9230(85)90115-7"
"3892216","Enhancement of colonic motor response to feeding by central endogenous opiates in the dog","Fioramonti J, Buéno L, Fargeas MJ.","Life Sci. 1985 Jul 1;36(26):2509-14. doi: 10.1016/0024-3205(85)90147-x.","Fioramonti J","Life Sci","1985","1985/07/01","","","10.1016/0024-3205(85)90147-x"
"3891654","Antinociceptive models displaying peripheral opioid activity","Smith TW, Follenfant RL, Ferreira SH.","Int J Tissue React. 1985;7(1):61-7.","Smith TW","Int J Tissue React","1985","1985/01/01","","",""
"3888577","Behavioral pharmacology of buprenorphine","Mello NK, Mendelson JH.","Drug Alcohol Depend. 1985 Feb;14(3-4):283-303. doi: 10.1016/0376-8716(85)90062-6.","Mello NK","Drug Alcohol Depend","1985","1985/02/01","","","10.1016/0376-8716(85)90062-6"
"3888575","Historical introduction and review of chemistry","Harris LS, May EL.","Drug Alcohol Depend. 1985 Feb;14(3-4):227-32. doi: 10.1016/0376-8716(85)90058-4.","Harris LS","Drug Alcohol Depend","1985","1985/02/01","","","10.1016/0376-8716(85)90058-4"
"3843739","Exposure to a cat produces opioid analgesia in rats","Lester LS, Fanselow MS.","Behav Neurosci. 1985 Aug;99(4):756-9. doi: 10.1037//0735-7044.99.4.756.","Lester LS","Behav Neurosci","1985","1985/08/01","","","10.1037//0735-7044.99.4.756"
"3843737","Shock controllability and opioid substrates of escape performance and nociception: differential effects of peripherally and centrally acting naltrexone","Whitehouse WG, Blustein JE, Walker J, Bersh PJ, Margules DL.","Behav Neurosci. 1985 Aug;99(4):717-33. doi: 10.1037//0735-7044.99.4.717.","Whitehouse WG","Behav Neurosci","1985","1985/08/01","","","10.1037//0735-7044.99.4.717"
"3843728","Odors released by stressed rats produce opioid analgesia in unstressed rats","Fanselow MS.","Behav Neurosci. 1985 Jun;99(3):589-92. doi: 10.1037//0735-7044.99.3.589.","Fanselow MS","Behav Neurosci","1985","1985/06/01","","","10.1037//0735-7044.99.3.589"
"3843718","Effect of age and long-term stress experience on adaptation to stress analgesia in mature rats: role of opioids","Girardot MN, Holloway FA.","Behav Neurosci. 1985 Jun;99(3):411-22. doi: 10.1037//0735-7044.99.3.411.","Girardot MN","Behav Neurosci","1985","1985/06/01","","","10.1037//0735-7044.99.3.411"
"3843301","Shock controllability and the nature of stress-induced analgesia","Drugan RC, Ader DN, Maier SF.","Behav Neurosci. 1985 Oct;99(5):791-801. doi: 10.1037//0735-7044.99.5.791.","Drugan RC","Behav Neurosci","1985","1985/10/01","","","10.1037//0735-7044.99.5.791"
"3842024","Unexpected effects of nalmefene, a new opiate antagonist, on the hypothalamic-pituitary-gonadal axis in the male rat","Limonta P, Bardin CW, Hahn EF, Thau RB.","Steroids. 1985 Dec;46(6):955-65. doi: 10.1016/s0039-128x(85)80003-9.","Limonta P","Steroids","1985","1985/12/01","","","10.1016/s0039-128x(85)80003-9"
"3838691","Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates","Watkins LR, Kinscheck IB, Kaufman EF, Miller J, Frenk H, Mayer DJ.","Brain Res. 1985 Feb 18;327(1-2):181-90. doi: 10.1016/0006-8993(85)91512-4.","Watkins LR","Brain Res","1985","1985/02/18","","","10.1016/0006-8993(85)91512-4"
"3832903","Naltrexone: its clinical utility","Ginzburg HM.","Adv Alcohol Subst Abuse. 1985 Fall-1986 Winter;5(1-2):83-101. doi: 10.1300/J251v05n01_07.","Ginzburg HM","Adv Alcohol Subst Abuse","1985","1985/01/01","","","10.1300/J251v05n01_07"
"3828120","[Activity of naloxone and naltrexone on the development of the morphine withdrawal syndrome]","Piccinelli D, de Feo G, Mazzanti G.","Boll Soc Ital Biol Sper. 1986 Oct 30;62(10):1221-8.","Piccinelli D","Boll Soc Ital Biol Sper","1986","1986/10/30","","",""
"3828119","[Naloxone and naltrexone antagonism of various central effects of morphine]","Piccinelli D, de Feo G, Mazzanti G.","Boll Soc Ital Biol Sper. 1986 Oct 30;62(10):1213-20.","Piccinelli D","Boll Soc Ital Biol Sper","1986","1986/10/30","","",""
"3826875","Investigation into the use of narcotic antagonists in the treatment of a stereotypic behavior pattern (crib-biting) in the horse","Dodman NH, Shuster L, Court MH, Dixon R.","Am J Vet Res. 1987 Feb;48(2):311-9.","Dodman NH","Am J Vet Res","1987","1987/02/01","","",""
"3826024","Psychosocial adjustment, modality choice, and outcome in naltrexone versus methadone treatment","Osborn E, Grey C, Reznikoff M.","Am J Drug Alcohol Abuse. 1986;12(4):383-8. doi: 10.3109/00952998609016877.","Osborn E","Am J Drug Alcohol Abuse","1986","1986/01/01","","","10.3109/00952998609016877"
"3823199","Ingestion of amniotic fluid enhances opiate analgesia in rats","Kristal MB, Thompson AC, Abbott P.","Physiol Behav. 1986;38(6):809-15. doi: 10.1016/0031-9384(86)90047-8.","Kristal MB","Physiol Behav","1986","1986/01/01","","","10.1016/0031-9384(86)90047-8"
"3821370","Naloxone, naltrexone and body temperature","Eikelboom R.","Life Sci. 1987 Mar 16;40(11):1027-32. doi: 10.1016/0024-3205(87)90563-7.","Eikelboom R","Life Sci","1987","1987/03/16","","","10.1016/0024-3205(87)90563-7"
"3818993","Treatment of chronic anorexia nervosa with opiate blockade","Luby ED, Marrazzi MA, Kinzie J.","J Clin Psychopharmacol. 1987 Feb;7(1):52-3. doi: 10.1097/00004714-198702000-00026.","Luby ED","J Clin Psychopharmacol","1987","1987/02/01","","","10.1097/00004714-198702000-00026"
"3814350","Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey","Myers RD, Borg S, Mossberg R.","Alcohol. 1986 Nov-Dec;3(6):383-8. doi: 10.1016/0741-8329(86)90058-3.","Myers RD","Alcohol","1986","1986/11/01","","","10.1016/0741-8329(86)90058-3"
"3808218","Loss of estradiol-positive feedback action on LH release during prepubertal period in rats treated postnatally with an opiate antagonist","Lira SA, Phipps DW Jr, Sarkar DK.","Neuroendocrinology. 1986;44(3):331-7. doi: 10.1159/000124665.","Lira SA","Neuroendocrinology","1986","1986/01/01","","","10.1159/000124665"
"3801871","Effect of withdrawal from chronic naltrexone on regional cerebral oxygen consumption in the cat","Buchweitz E, Weiss HR.","Brain Res. 1986 Nov 12;397(2):308-14. doi: 10.1016/0006-8993(86)90632-3.","Buchweitz E","Brain Res","1986","1986/11/12","","","10.1016/0006-8993(86)90632-3"
"3801750","Naltrexone: helping the heroin user to get clean and stay clean","Brewer C.","Br J Hosp Med. 1986 Dec;36(6):401.","Brewer C","Br J Hosp Med","1986","1986/12/01","","",""
"3794740","Cognitive effects of high-dose naltrexone in patients with probable Alzheimer's disease","Knopman DS, Hartman M.","J Neurol Neurosurg Psychiatry. 1986 Nov;49(11):1321-2. doi: 10.1136/jnnp.49.11.1321-a.","Knopman DS","J Neurol Neurosurg Psychiatry","1986","1986/11/01","PMC1029087","","10.1136/jnnp.49.11.1321-a"
"3794708","Low-level microwave irradiations affect central cholinergic activity in the rat","Lai H, Horita A, Chou CK, Guy AW.","J Neurochem. 1987 Jan;48(1):40-5. doi: 10.1111/j.1471-4159.1987.tb13124.x.","Lai H","J Neurochem","1987","1987/01/01","","","10.1111/j.1471-4159.1987.tb13124.x"
"3790639","High-dose naltrexone therapy and dietary counseling for obesity","Mitchell JE, Morley JE, Levine AS, Hatsukami D, Gannon M, Pfohl D.","Biol Psychiatry. 1987 Jan;22(1):35-42. doi: 10.1016/0006-3223(87)90127-2.","Mitchell JE","Biol Psychiatry","1987","1987/01/01","","","10.1016/0006-3223(87)90127-2"
"3785509","Prenatal exposure to ethanol potentiates morphine-induced hypothermia in adult rats","Nelson LR, Lewis JW, Kokka N, Branch BJ, Taylor AN.","Neurobehav Toxicol Teratol. 1986 Sep-Oct;8(5):469-74.","Nelson LR","Neurobehav Toxicol Teratol","1986","1986/09/01","","",""
"3785506","The effect of trichloroethylene on male sexual behavior: possible opioid role","Nelson JL, Zenick H.","Neurobehav Toxicol Teratol. 1986 Sep-Oct;8(5):441-5.","Nelson JL","Neurobehav Toxicol Teratol","1986","1986/09/01","","",""
"3780414","Pharmacologic and reinforcing properties of phencyclidine and the enantiomers of N-allylnormetazocine in the dog","Vaupel DB, Risner ME, Shannon HE.","Drug Alcohol Depend. 1986 Oct;18(2):173-94. doi: 10.1016/0376-8716(86)90050-5.","Vaupel DB","Drug Alcohol Depend","1986","1986/10/01","","","10.1016/0376-8716(86)90050-5"
"3774822","Naltrexone blocks the effects of prenatal stress on sexual behavior differentiation in male rats","Ward OB, Monaghan EP, Ward IL.","Pharmacol Biochem Behav. 1986 Sep;25(3):573-6. doi: 10.1016/0091-3057(86)90143-7.","Ward OB","Pharmacol Biochem Behav","1986","1986/09/01","","","10.1016/0091-3057(86)90143-7"
"3768031","Effect of morphine treatment and withdrawal on endogenous methionine- and leucine-enkephalin levels in primate brain","Elsworth JD, Redmond DE Jr, Roth RH.","Biochem Pharmacol. 1986 Oct 1;35(19):3415-7. doi: 10.1016/0006-2952(86)90447-8.","Elsworth JD","Biochem Pharmacol","1986","1986/10/01","","","10.1016/0006-2952(86)90447-8"
"3767162","Erectile function and naltrexone","Goldstein JA.","Ann Intern Med. 1986 Nov;105(5):799. doi: 10.7326/0003-4819-105-5-799_1.","Goldstein JA","Ann Intern Med","1986","1986/11/01","","","10.7326/0003-4819-105-5-799_1"
"3763665","Variable interval schedules of timeout from avoidance: effects of ethanol, naltrexone, and CGS 8216","Galizio M, Perone M, Spencer BA.","Pharmacol Biochem Behav. 1986 Aug;25(2):439-48. doi: 10.1016/0091-3057(86)90021-3.","Galizio M","Pharmacol Biochem Behav","1986","1986/08/01","","","10.1016/0091-3057(86)90021-3"
"3762878","Naltrexone inhibits the persistent spasmodic dyskinesia induced by chronic intraperitoneal administration of iminodipropionitrile (IDPN)","Cadet JL, Braun TL.","Neuropeptides. 1986 Jul;8(1):87-91. doi: 10.1016/0143-4179(86)90069-7.","Cadet JL","Neuropeptides","1986","1986/07/01","","","10.1016/0143-4179(86)90069-7"
"3762313","The analgesia produced by food deprivation in 4-month old, 14-month old, and 24-month old rats","Hamm RJ, Knisely JS.","Life Sci. 1986 Oct 27;39(17):1509-15. doi: 10.1016/0024-3205(86)90380-2.","Hamm RJ","Life Sci","1986","1986/10/27","","","10.1016/0024-3205(86)90380-2"
"3760220","Retention and outcome in a narcotic antagonist treatment program","Capone T, Brahen L, Condren R, Kordal N, Melchionda R, Peterson M.","J Clin Psychol. 1986 Sep;42(5):825-33. doi: 10.1002/1097-4679(198609)42:5<825::aid-jclp2270420526>3.0.co;2-b.","Capone T","J Clin Psychol","1986","1986/09/01","","","10.1002/1097-4679(198609)42:5<825::aid-jclp2270420526>3.0.co;2-b"
"3759744","Influence of endogenous opioids on the response of selected hormones to exercise in humans","Farrell PA, Gustafson AB, Garthwaite TL, Kalkhoff RK, Cowley AW Jr, Morgan WP.","J Appl Physiol (1985). 1986 Sep;61(3):1051-7. doi: 10.1152/jappl.1986.61.3.1051.","Farrell PA","J Appl Physiol (1985)","1986","1986/09/01","","","10.1152/jappl.1986.61.3.1051"
"3749218","Effect of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine","Kirkham TC, Blundell JE.","Pharmacol Biochem Behav. 1986 Jul;25(1):123-8. doi: 10.1016/0091-3057(86)90241-8.","Kirkham TC","Pharmacol Biochem Behav","1986","1986/07/01","","","10.1016/0091-3057(86)90241-8"
"3741602","Comparison of the effects of morphine and immobilization stress on discrimination performance of rats","Grilly DM, Gowans GC.","Behav Neurosci. 1986 Aug;100(4):512-24. doi: 10.1037//0735-7044.100.4.512.","Grilly DM","Behav Neurosci","1986","1986/08/01","","","10.1037//0735-7044.100.4.512"
"3733981","Determination of 6-beta-naltrexol and naltrexone by bonded-phase adsorption thin-layer chromatography","Verebey K, Alarazi J, Lehrer M, Mulé SJ.","J Chromatogr. 1986 May 28;378(1):261-6. doi: 10.1016/s0378-4347(00)80723-9.","Verebey K","J Chromatogr","1986","1986/05/28","","","10.1016/s0378-4347(00)80723-9"
"3732628","Opioid-mediation of separation distress in 10-day-old rats: reversal of stress with maternal stimuli","Kehoe P, Blass EM.","Dev Psychobiol. 1986 Jul;19(4):385-98. doi: 10.1002/dev.420190410.","Kehoe P","Dev Psychobiol","1986","1986/07/01","","","10.1002/dev.420190410"
"3728712","An opioid antagonist, naltrexone, reduces preference for sucrose in humans","Fantino M, Hosotte J, Apfelbaum M.","Am J Physiol. 1986 Jul;251(1 Pt 2):R91-6. doi: 10.1152/ajpregu.1986.251.1.R91.","Fantino M","Am J Physiol","1986","1986/07/01","","","10.1152/ajpregu.1986.251.1.R91"
"3728193","The effect of multiple family therapy on addict family functioning: a pilot study","Kosten TR, Hogan I, Jalali B, Steidl J, Kleber HD.","Adv Alcohol Subst Abuse. 1986 Spring;5(3):51-62. doi: 10.1300/J251v05n03_04.","Kosten TR","Adv Alcohol Subst Abuse","1986","1986/01/01","","","10.1300/J251v05n03_04"
"3723392","Effects of naltrexone on intravenous cocaine self-administration in rats during food satiation and deprivation","Carroll ME, Lac ST, Walker MJ, Kragh R, Newman T.","J Pharmacol Exp Ther. 1986 Jul;238(1):1-7.","Carroll ME","J Pharmacol Exp Ther","1986","1986/07/01","","",""
"3722068","Role of endogenous opiates in hypoxic ventilatory response in the newborn primate","Mayock DE, LaFramboise WA, Guthrie RD, Standaert TA, Woodrum DE.","J Appl Physiol (1985). 1986 Jun;60(6):2015-9. doi: 10.1152/jappl.1986.60.6.2015.","Mayock DE","J Appl Physiol (1985)","1986","1986/06/01","","","10.1152/jappl.1986.60.6.2015"
"3720824","Effects of beta-funaltrexamine (beta-FNA) on morphine dependence in rats and monkeys","Aceto MD, Dewey WL, Portoghese PS, Takemori AE.","Eur J Pharmacol. 1986 Apr 29;123(3):387-93. doi: 10.1016/0014-2999(86)90713-2.","Aceto MD","Eur J Pharmacol","1986","1986/04/29","","","10.1016/0014-2999(86)90713-2"
"3720659","Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation","Hartman RD, Rosella-Dampman LM, Emmert SE, Summy-Long JY.","Endocrinology. 1986 Jul;119(1):1-11. doi: 10.1210/endo-119-1-1.","Hartman RD","Endocrinology","1986","1986/07/01","","","10.1210/endo-119-1-1"
"3719314","Endogenous analgesia in the pregnant rat: an artifact of weight-dependent measures?","Dahl JL, Silva BW, Baker TB, Tiffany ST.","Brain Res. 1986 May 14;373(1-2):316-23. doi: 10.1016/0006-8993(86)90346-x.","Dahl JL","Brain Res","1986","1986/05/14","","","10.1016/0006-8993(86)90346-x"
"3717421","The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone","Charney DS, Heninger GR, Kleber HD.","Am J Psychiatry. 1986 Jul;143(7):831-7. doi: 10.1176/ajp.143.7.831.","Charney DS","Am J Psychiatry","1986","1986/07/01","","","10.1176/ajp.143.7.831"
"3713432","Evidence for a central but not adrenal, opioid mediation in hypertension induced by brief isolation in the rat","Naranjo JR, Urdín MC, Borrell J, Fuentes JA.","Life Sci. 1986 May 26;38(21):1923-30. doi: 10.1016/0024-3205(86)90221-3.","Naranjo JR","Life Sci","1986","1986/05/26","","","10.1016/0024-3205(86)90221-3"
"3711987","Opioid antagonist (naltrexone) modulation of cerebellar development: histological and morphometric studies","Zagon IS, McLaughlin PJ.","J Neurosci. 1986 May;6(5):1424-32. doi: 10.1523/JNEUROSCI.06-05-01424.1986.","Zagon IS","J Neurosci","1986","1986/05/01","PMC6568545","","10.1523/JNEUROSCI.06-05-01424.1986"
"3708367","Sodium-dependent, high-affinity choline uptake in hippocampus and frontal cortex of the rat affected by acute restraint stress","Lai H, Zabawska J, Horita A.","Brain Res. 1986 May 7;372(2):366-9. doi: 10.1016/0006-8993(86)91146-7.","Lai H","Brain Res","1986","1986/05/07","","","10.1016/0006-8993(86)91146-7"
"3708354","Opioid and non-opioid stress analgesia from cold water swim: importance of stress severity","Terman GW, Morgan MJ, Liebeskind JC.","Brain Res. 1986 Apr 30;372(1):167-71. doi: 10.1016/0006-8993(86)91472-1.","Terman GW","Brain Res","1986","1986/04/30","","","10.1016/0006-8993(86)91472-1"
"3701917","Loperamide: evidence for a centrally mediated opioid effect on rumen motility in conscious goats and sheep","Maas CL, van Duin CT, van Miert AS.","J Vet Pharmacol Ther. 1986 Mar;9(1):63-70. doi: 10.1111/j.1365-2885.1986.tb00013.x.","Maas CL","J Vet Pharmacol Ther","1986","1986/03/01","","","10.1111/j.1365-2885.1986.tb00013.x"
"3701789","Crystal structures of alpha- and beta-funaltrexamine: conformational requirement of the fumaramate moiety in the irreversible blockage of mu opioid receptors","Griffin JF, Larson DL, Portoghese PS.","J Med Chem. 1986 May;29(5):778-83. doi: 10.1021/jm00155a031.","Griffin JF","J Med Chem","1986","1986/05/01","","","10.1021/jm00155a031"
"3700983","Environmentally-induced analgesia: age-related differences in a hormonally-mediated, nonopioid system","Hamm RJ, Knisely JS, Watson A.","J Gerontol. 1986 May;41(3):336-41. doi: 10.1093/geronj/41.3.336.","Hamm RJ","J Gerontol","1986","1986/05/01","","","10.1093/geronj/41.3.336"
"3698906","The effects of opioid receptor antagonists suggest that testicular opiates regulate Sertoli and Leydig cell function in the neonatal rat","Gerendai I, Shaha C, Gunsalus GL, Bardin CW.","Endocrinology. 1986 May;118(5):2039-44. doi: 10.1210/endo-118-5-2039.","Gerendai I","Endocrinology","1986","1986/05/01","","","10.1210/endo-118-5-2039"
"3690365","Effects of opiate antagonist treatment into either the periaqueductal grey or nucleus accumbens on heroin-induced locomotor activation","Vaccarino FJ, Corrigall WA.","Brain Res Bull. 1987 Nov;19(5):545-9. doi: 10.1016/0361-9230(87)90071-2.","Vaccarino FJ","Brain Res Bull","1987","1987/11/01","","","10.1016/0361-9230(87)90071-2"
"3687898","Relationship of marital structure and interactions to opiate abuse relapse","Kosten TR, Jalali B, Steidl JH, Kleber HD.","Am J Drug Alcohol Abuse. 1987;13(4):387-99. doi: 10.3109/00952998709001523.","Kosten TR","Am J Drug Alcohol Abuse","1987","1987/01/01","","","10.3109/00952998709001523"
"3687888","The antecedents and benefits of achieving abstinence in opioid addicts: a 2.5-year follow-up study","Rounsaville BJ, Kosten TR, Kleber HD.","Am J Drug Alcohol Abuse. 1987;13(3):213-29. doi: 10.3109/00952998709001511.","Rounsaville BJ","Am J Drug Alcohol Abuse","1987","1987/01/01","","","10.3109/00952998709001511"
"3687878","Clonidine and naltrexone in the outpatient treatment of heroin withdrawal","Kleber HD, Topazian M, Gaspari J, Riordan CE, Kosten T.","Am J Drug Alcohol Abuse. 1987;13(1-2):1-17. doi: 10.3109/00952998709001497.","Kleber HD","Am J Drug Alcohol Abuse","1987","1987/01/01","","","10.3109/00952998709001497"
"3683083","Hypotensive effect of naloxone on high blood pressure induced by stress in the rat","Florentino A, Jiménez I, Naranjo JR, Urdín MC, Fuentes JA.","Life Sci. 1987 Nov 30;41(22):2445-53. doi: 10.1016/0024-3205(87)90670-9.","Florentino A","Life Sci","1987","1987/11/30","","","10.1016/0024-3205(87)90670-9"
"3682088","Immobilization of white-tailed deer by etorphine and xylazine and its antagonism by nalmefene and yohimbine","Kreeger TJ, Plotka ED, Seal US.","J Wildl Dis. 1987 Oct;23(4):619-24. doi: 10.7589/0090-3558-23.4.619.","Kreeger TJ","J Wildl Dis","1987","1987/10/01","","","10.7589/0090-3558-23.4.619"
"3680614","A panic attack precipitated by opiate blockade--a case study","Luby ED, Marrazzi MA.","J Clin Psychopharmacol. 1987 Oct;7(5):361-2. doi: 10.1097/00004714-198710000-00025.","Luby ED","J Clin Psychopharmacol","1987","1987/10/01","","","10.1097/00004714-198710000-00025"
"3680580","Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist","Dixon R, Gentile J, Hsu HB, Hsiao J, Howes J, Garg D, Weidler D.","J Clin Pharmacol. 1987 Mar;27(3):233-9. doi: 10.1002/j.1552-4604.1987.tb02191.x.","Dixon R","J Clin Pharmacol","1987","1987/03/01","","","10.1002/j.1552-4604.1987.tb02191.x"
"3678618","Ontogeny of an endogenous, nonopioid and hormonally mediated analgesic system","Hamm RJ, Knisely JS.","Dev Psychobiol. 1987 Sep;20(5):539-48. doi: 10.1002/dev.420200507.","Hamm RJ","Dev Psychobiol","1987","1987/09/01","","","10.1002/dev.420200507"
"3678057","Naltrexone in the management of seizures associated with Rett syndrome","Thompson DF, Thompson GD.","Drug Intell Clin Pharm. 1987 Nov;21(11):874.","Thompson DF","Drug Intell Clin Pharm","1987","1987/11/01","","",""
"3676787","Antagonism of endogenous opioids modulates memory processing","Flood JF, Cherkin A, Morley JE.","Brain Res. 1987 Oct 6;422(2):218-34. doi: 10.1016/0006-8993(87)90929-2.","Flood JF","Brain Res","1987","1987/10/06","","","10.1016/0006-8993(87)90929-2"
"3676713","Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat","Mucha RF.","Brain Res. 1987 Aug 25;418(2):214-20. doi: 10.1016/0006-8993(87)90088-6.","Mucha RF","Brain Res","1987","1987/08/25","","","10.1016/0006-8993(87)90088-6"
"3675853","Strain differences in reversal of conditional analgesia by opioid antagonists","Helmstetter FJ, Fanselow MS.","Behav Neurosci. 1987 Oct;101(5):735-7. doi: 10.1037//0735-7044.101.5.735.","Helmstetter FJ","Behav Neurosci","1987","1987/10/01","","","10.1037//0735-7044.101.5.735"
"3671810","Naltrexone in treatment of self injurious behavior: a clinical study","Szymanski L, Kedesdy J, Sulkes S, Cutler A, Stevens-Our P.","Res Dev Disabil. 1987;8(2):179-90. doi: 10.1016/0891-4222(87)90002-3.","Szymanski L","Res Dev Disabil","1987","1987/01/01","","","10.1016/0891-4222(87)90002-3"
"3671362","Antagonism by nalmefene of systemic and intrathecal morphine-induced analgesia in mice","Roerig SC, Arteau C, Fujimoto JM.","Proc Soc Exp Biol Med. 1987 Nov;186(2):234-9. doi: 10.3181/00379727-186-42609.","Roerig SC","Proc Soc Exp Biol Med","1987","1987/11/01","","","10.3181/00379727-186-42609"
"3666034","Immediate and long-term effects of opiate antagonists on postictal behaviour following amygdala kindling in the rat","Cottrell GA, Bohus B.","Eur J Pharmacol. 1987 Sep 23;141(3):417-21. doi: 10.1016/0014-2999(87)90559-0.","Cottrell GA","Eur J Pharmacol","1987","1987/09/23","","","10.1016/0014-2999(87)90559-0"
"3659111","The role of endogenous opioids in footshock-induced hyperthermia","Pechnick RN, Morgan MJ.","Pharmacol Biochem Behav. 1987 Sep;28(1):95-100. doi: 10.1016/0091-3057(87)90018-9.","Pechnick RN","Pharmacol Biochem Behav","1987","1987/09/01","","","10.1016/0091-3057(87)90018-9"
"3659093","Heroin self-administration: effects of antagonist treatment in lateral hypothalamus","Corrigall WA.","Pharmacol Biochem Behav. 1987 Aug;27(4):693-700. doi: 10.1016/0091-3057(87)90196-1.","Corrigall WA","Pharmacol Biochem Behav","1987","1987/08/01","","","10.1016/0091-3057(87)90196-1"
"3656096","Improvement of the oral bioavailability of naltrexone in dogs: a prodrug approach","Hussain MA, Koval CA, Myers MJ, Shami EG, Shefter E.","J Pharm Sci. 1987 May;76(5):356-8. doi: 10.1002/jps.2600760503.","Hussain MA","J Pharm Sci","1987","1987/05/01","","","10.1002/jps.2600760503"
"3653249","Interaction of narcotic antagonist naltrexone with nicotinic acetylcholine receptor","Oliveira L, Madsen BW, Kapai N, Sherby SM, Swanson KL, Eldefrawi ME, Albuquerque EX.","Eur J Pharmacol. 1987 Aug 21;140(3):331-42. doi: 10.1016/0014-2999(87)90290-1.","Oliveira L","Eur J Pharmacol","1987","1987/08/21","","","10.1016/0014-2999(87)90290-1"
"3639451","Tailor made for the job?","Brewer C.","Nurs Times. 1986 Aug 27-Sep 2;82(35):42-3.","Brewer C","Nurs Times","1986","1986/08/02","","",""
"3628520","Effect of naltrexone on food intake, hunger, and satiety in obese men","Spiegel TA, Stunkard AJ, Shrager EE, O'Brien CP, Morrison MF, Stellar E.","Physiol Behav. 1987;40(2):135-41. doi: 10.1016/0031-9384(87)90198-3.","Spiegel TA","Physiol Behav","1987","1987/01/01","","","10.1016/0031-9384(87)90198-3"
"3628295","Analgesic properties of lithium","Yirmiya R, Lieblich I, Garcia J, Liebeskind JC.","Proc West Pharmacol Soc. 1987;30:303-6.","Yirmiya R","Proc West Pharmacol Soc","1987","1987/01/01","","",""
"3628278","Intrathecal beta-funaltrexamine (beta-FNA) is a long acting agonist in the mouse abdominal stretch test","Heyman JS, Porreca F.","Proc West Pharmacol Soc. 1987;30:209-10.","Heyman JS","Proc West Pharmacol Soc","1987","1987/01/01","","",""
"3620936","Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine","Kalivas PW, Abhold R.","Brain Res. 1987 Jun 30;414(2):339-48. doi: 10.1016/0006-8993(87)90015-1.","Kalivas PW","Brain Res","1987","1987/06/30","","","10.1016/0006-8993(87)90015-1"
"3620774","The pros and cons of naltrexone detoxification","Cook CC, Lipsedge MS.","Br J Hosp Med. 1987 Jul;38(1):79-80.","Cook CC","Br J Hosp Med","1987","1987/07/01","","",""
"3615545","The effects of opioid antagonists on ingestive behavior in the domestic fowl","McCormack JF, Denbow DM.","Pharmacol Biochem Behav. 1987 May;27(1):25-33. doi: 10.1016/0091-3057(87)90472-2.","McCormack JF","Pharmacol Biochem Behav","1987","1987/05/01","","","10.1016/0091-3057(87)90472-2"
"3613837","Nitrous oxide-induced hypothermia in the rat","Quock RM, Panek RW, Kouchich FJ, Rosenthal MA.","Life Sci. 1987 Aug 10;41(6):683-90. doi: 10.1016/0024-3205(87)90447-4.","Quock RM","Life Sci","1987","1987/08/10","","","10.1016/0024-3205(87)90447-4"
"3612524","Morphine, saline and naltrexone discrimination in morphine-treated pigeons","France CP, Woods JH.","J Pharmacol Exp Ther. 1987 Jul;242(1):195-202.","France CP","J Pharmacol Exp Ther","1987","1987/07/01","","",""
"3609906","[Clinical experiences with naltrexone]","Huber JC.","Gynakol Rundsch. 1987;27 Suppl 1:47-55.","Huber JC","Gynakol Rundsch","1987","1987/01/01","","",""
"3607463","Endogenous opioid systems regulate cell proliferation in the developing rat brain","Zagon IS, McLaughlin PJ.","Brain Res. 1987 May 26;412(1):68-72. doi: 10.1016/0006-8993(87)91440-5.","Zagon IS","Brain Res","1987","1987/05/26","","","10.1016/0006-8993(87)91440-5"
"3605414","Interaction between thioridazine and naltrexone","Maany I, O'Brien CP, Woody G.","Am J Psychiatry. 1987 Jul;144(7):966. doi: 10.1176/ajp.144.7.966b.","Maany I","Am J Psychiatry","1987","1987/07/01","","","10.1176/ajp.144.7.966b"
"3601009","Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons","France CP, Adams JU, Woods JH.","Neuropharmacology. 1987 Jun;26(6):541-8. doi: 10.1016/0028-3908(87)90145-6.","France CP","Neuropharmacology","1987","1987/06/01","","","10.1016/0028-3908(87)90145-6"
"3600195","Opiate system involvement in the control of LH secretion in diabetic and normoglycemic male rats","Yogev L, Gottreich A, Brezner E, Paz GF, Homonnai ZT.","Life Sci. 1987 Aug 3;41(5):585-90. doi: 10.1016/0024-3205(87)90411-5.","Yogev L","Life Sci","1987","1987/08/03","","","10.1016/0024-3205(87)90411-5"
"3595494","[Effects of the opiate antagonists naloxone and naltrexone on the body temperature of rats]","Iakimova K.","Eksp Med Morfol. 1987;26(1):23-7.","Iakimova K","Eksp Med Morfol","1987","1987/01/01","","",""
"3594229","Spinal cord mediation of the opioid analgesia of pregnancy","Sander HW, Gintzler AR.","Brain Res. 1987 Apr 7;408(1-2):389-93. doi: 10.1016/0006-8993(87)90412-4.","Sander HW","Brain Res","1987","1987/04/07","","","10.1016/0006-8993(87)90412-4"
"3593812","Naltrexone and dysphoria: a double-blind placebo controlled trial","Malcolm R, O'Neil PM, Von JM, Dickerson PC.","Biol Psychiatry. 1987 Jun;22(6):710-6. doi: 10.1016/0006-3223(87)90202-2.","Malcolm R","Biol Psychiatry","1987","1987/06/01","","","10.1016/0006-3223(87)90202-2"
"3592007","Naltrexone treatment for postconcussional syndrome","Tennant FS Jr, Wild J.","Am J Psychiatry. 1987 Jun;144(6):813-4. doi: 10.1176/ajp.144.6.813.","Tennant FS Jr","Am J Psychiatry","1987","1987/06/01","","","10.1176/ajp.144.6.813"
"3589443","[New supportive therapy with naltrexone. Care of heroin addiction in the United States]","Rimailho A.","Rev Prat. 1987 May 21;37(29):1751-5.","Rimailho A","Rev Prat","1987","1987/05/21","","",""
"3586751","[Naltrexone]","San Molina L.","Med Clin (Barc). 1987 Apr 11;88(14):556-8.","San Molina L","Med Clin (Barc)","1987","1987/04/11","","",""
"3580888","Evidence for opioid and non-opioid forms of stress-induced analgesia in the snail, Cepaea nemoralis","Kavaliers M.","Brain Res. 1987 Apr 28;410(1):111-5. doi: 10.1016/s0006-8993(87)80029-x.","Kavaliers M","Brain Res","1987","1987/04/28","","","10.1016/s0006-8993(87)80029-x"
"3580701","Naltrexone in the treatment of opiate dependence","Wells B.","Br J Hosp Med. 1987 May;37(5):469-70.","Wells B","Br J Hosp Med","1987","1987/05/01","","",""
"3575497","Effects of naltrexone on learning and performance of conditional fear-induced freezing and opioid analgesia","Helmstetter FJ, Fanselow MS.","Physiol Behav. 1987;39(4):501-5. doi: 10.1016/0031-9384(87)90380-5.","Helmstetter FJ","Physiol Behav","1987","1987/01/01","","","10.1016/0031-9384(87)90380-5"
"3575366","Effects of naloxone and naltrexone on meal patterns of freely-feeding rats","Kirkham TC, Blundell JE.","Pharmacol Biochem Behav. 1987 Mar;26(3):515-20. doi: 10.1016/0091-3057(87)90158-4.","Kirkham TC","Pharmacol Biochem Behav","1987","1987/03/01","","","10.1016/0091-3057(87)90158-4"
"3575365","Interactions between sucrose, pain and isolation distress","Blass E, Fitzgerald E, Kehoe P.","Pharmacol Biochem Behav. 1987 Mar;26(3):483-9. doi: 10.1016/0091-3057(87)90153-5.","Blass E","Pharmacol Biochem Behav","1987","1987/03/01","","","10.1016/0091-3057(87)90153-5"
"3572784","Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons","Kalivas PW, Duffy P.","J Pharmacol Exp Ther. 1987 Apr;241(1):204-12.","Kalivas PW","J Pharmacol Exp Ther","1987","1987/04/01","","",""
"3571432","Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea","Wildt L, Leyendecker G.","J Clin Endocrinol Metab. 1987 Jun;64(6):1334-5. doi: 10.1210/jcem-64-6-1334.","Wildt L","J Clin Endocrinol Metab","1987","1987/06/01","","","10.1210/jcem-64-6-1334"
"3563109","Effects of naltrexone in postnatal rats on the recovery of disturbed brain and lymphatic tissues after X-irradiation or ethylnitrosourea treatment in utero","Schmahl WG, Plendl J, Reinöhl-Kompa S.","Res Commun Chem Pathol Pharmacol. 1987 Jan;55(1):89-99.","Schmahl WG","Res Commun Chem Pathol Pharmacol","1987","1987/01/01","","",""
"3562485","Differential effects of CGS 8216 and naltrexone on ingestional behaviour","Kirkham TC, Barber DJ, Heath RW, Cooper SJ.","Pharmacol Biochem Behav. 1987 Jan;26(1):145-51. doi: 10.1016/0091-3057(87)90547-8.","Kirkham TC","Pharmacol Biochem Behav","1987","1987/01/01","","","10.1016/0091-3057(87)90547-8"
"3562324","Endogenous opioids and opiate antagonists modulate the blood pressure of the spontaneously hypertensive rat","Levin ER, Mills S, Weber MA.","Peptides. 1986 Nov-Dec;7(6):977-81. doi: 10.1016/0196-9781(86)90124-5.","Levin ER","Peptides","1986","1986/11/01","","","10.1016/0196-9781(86)90124-5"
"3559988","Evaluation of the receptor selectivities of opioid drugs by investigating the block of their effect on urine output by beta-funaltrexamine","Hayes AG, Skingle M, Tyers MB.","J Pharmacol Exp Ther. 1987 Mar;240(3):984-8.","Hayes AG","J Pharmacol Exp Ther","1987","1987/03/01","","",""
"3559457","Variable-interval schedules of timeout from avoidance: effects of chlordiazepoxide, CGS 8216, morphine, and naltrexone","Galizio M, Perone M.","J Exp Anal Behav. 1987 Jan;47(1):115-26. doi: 10.1901/jeab.1987.47-115.","Galizio M","J Exp Anal Behav","1987","1987/01/01","PMC1348301","","10.1901/jeab.1987.47-115"
"3559033","Preliminary observations on naltrexone for treatment of Alzheimer's type dementia","Tennant FS Jr.","J Am Geriatr Soc. 1987 Apr;35(4):369-70. doi: 10.1111/j.1532-5415.1987.tb04654.x.","Tennant FS Jr","J Am Geriatr Soc","1987","1987/04/01","","","10.1111/j.1532-5415.1987.tb04654.x"
"3557806","Treatment of antidepressant-resistant bulimia with naltrexone","Jonas JM, Gold MS.","Int J Psychiatry Med. 1986-1987;16(4):305-9. doi: 10.2190/0cmp-4xxh-3641-nrdw.","Jonas JM","Int J Psychiatry Med","1986","1986/01/01","","","10.2190/0cmp-4xxh-3641-nrdw"
"3553834","The role of naltrexone in the management of drug abuse","Ginzburg HM, MacDonald MG.","Med Toxicol. 1987 Mar-Apr;2(2):83-92. doi: 10.1007/BF03260007.","Ginzburg HM","Med Toxicol","1987","1987/03/01","","","10.1007/BF03260007"
"3548443","Failure of nalmefene and estrogen to improve memory in Alzheimer's disease","Weiss BL.","Am J Psychiatry. 1987 Mar;144(3):386-7. doi: 10.1176/ajp.144.3.aj1443386.","Weiss BL","Am J Psychiatry","1987","1987/03/01","","","10.1176/ajp.144.3.aj1443386"
"3541052","Naltrexone and Alzheimer's disease","Serby M, Resnick R, Jordan B, Adler J, Corwin J, Rotrosen JP.","Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):587-90. doi: 10.1016/0278-5846(86)90028-x.","Serby M","Prog Neuropsychopharmacol Biol Psychiatry","1986","1986/01/01","","","10.1016/0278-5846(86)90028-x"
"3539980","Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans","Givens JR, Kurtz BR, Kitabchi AE, Bittle JB, Karas JG, Mitchell JA, Howes JF.","J Clin Endocrinol Metab. 1987 Feb;64(2):377-82. doi: 10.1210/jcem-64-2-377.","Givens JR","J Clin Endocrinol Metab","1987","1987/02/01","","","10.1210/jcem-64-2-377"
"3533370","Prolonged blockade of opioid effect with oral nalmefene","Gal TJ, DiFazio CA, Dixon R.","Clin Pharmacol Ther. 1986 Nov;40(5):537-42. doi: 10.1038/clpt.1986.220.","Gal TJ","Clin Pharmacol Ther","1986","1986/11/01","","","10.1038/clpt.1986.220"
"3529831","Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory","Agren H.","Acta Psychiatr Scand Suppl. 1986;327:91-113.","Agren H","Acta Psychiatr Scand Suppl","1986","1986/01/01","","",""
"3524388","Stressor controllability and stress-induced analgesia","Maier SF.","Ann N Y Acad Sci. 1986;467:55-72. doi: 10.1111/j.1749-6632.1986.tb14618.x.","Maier SF","Ann N Y Acad Sci","1986","1986/01/01","","","10.1111/j.1749-6632.1986.tb14618.x"
"3524387","Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress analgesia","Fanselow MS.","Ann N Y Acad Sci. 1986;467:40-54. doi: 10.1111/j.1749-6632.1986.tb14617.x.","Fanselow MS","Ann N Y Acad Sci","1986","1986/01/01","","","10.1111/j.1749-6632.1986.tb14617.x"
"3521663","Naltrexone: useful tool in the treatment of heroin users: a review of the literature","Santos EF.","Bol Asoc Med P R. 1986 Mar;78(3):95-8.","Santos EF","Bol Asoc Med P R","1986","1986/03/01","","",""
"3520602","Opioid and non-opioid components of insulin-induced feeding","Si EC, Bryant HU, Yim GK.","Pharmacol Biochem Behav. 1986 Apr;24(4):899-903. doi: 10.1016/0091-3057(86)90434-x.","Si EC","Pharmacol Biochem Behav","1986","1986/04/01","","","10.1016/0091-3057(86)90434-x"
"3518492","Effect of endorphins on heart rate and blood pressure in adult dogs","Haddad GG, Jeng HJ, Lai TL.","Am J Physiol. 1986 May;250(5 Pt 2):H796-805. doi: 10.1152/ajpheart.1986.250.5.H796.","Haddad GG","Am J Physiol","1986","1986/05/01","","","10.1152/ajpheart.1986.250.5.H796"
"3517031","Role of endogenous opiates in pubertal maturation: opposing actions of naltrexone in prepubertal and late pubertal boys","Mauras N, Veldhuis JD, Rogol AD.","J Clin Endocrinol Metab. 1986 Jun;62(6):1256-63. doi: 10.1210/jcem-62-6-1256.","Mauras N","J Clin Endocrinol Metab","1986","1986/06/01","","","10.1210/jcem-62-6-1256"
"3508536","Coupling of naltrexone to biodegradable poly(alpha-amino acids)","Negishi N, Bennett DB, Cho CS, Jeong SY, Van Heeswijk WA, Feijen J, Kim SW.","Pharm Res. 1987 Aug;4(4):305-10. doi: 10.1023/a:1016493103302.","Negishi N","Pharm Res","1987","1987/08/01","","","10.1023/a:1016493103302"
"3504387","Endogenous opioids and post-ictal increase in seizure threshold in Mongolian gerbils","Frey HH.","Epilepsy Res. 1987 Mar;1(2):121-5. doi: 10.1016/0920-1211(87)90017-9.","Frey HH","Epilepsy Res","1987","1987/03/01","","","10.1016/0920-1211(87)90017-9"
"3492352","Pargyline and naltrexone fail to antagonize the gustatory avoidance response induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","DeVito MJ, Wagner GC.","Drug Alcohol Depend. 1986 Nov;18(3):293-9. doi: 10.1016/0376-8716(86)90060-8.","DeVito MJ","Drug Alcohol Depend","1986","1986/11/01","","","10.1016/0376-8716(86)90060-8"
"3489902","Naltrexone induces melanocyte-stimulating hormone release and degenerative changes in pituitary innervation in amphibians","Saland LC, Comunas F, Maez D.","Neuropeptides. 1986 Aug-Sep;8(2):133-41. doi: 10.1016/0143-4179(86)90040-5.","Saland LC","Neuropeptides","1986","1986/08/01","","","10.1016/0143-4179(86)90040-5"
"3481242","Naltrexone decreases self-injurious behavior","Herman BH, Hammock MK, Arthur-Smith A, Egan J, Chatoor I, Werner A, Zelnik N.","Ann Neurol. 1987 Oct;22(4):550-2. doi: 10.1002/ana.410220419.","Herman BH","Ann Neurol","1987","1987/10/01","","","10.1002/ana.410220419"
"3459065","Primary care of parenteral substance abusers","Williams A.","Nurse Pract. 1986 Jun;11(6):17, 20, 25 passim.","Williams A","Nurse Pract","1986","1986/06/01","","",""
"3454671","Naltrexone in organic bulimia: a preliminary report","Childs A.","Brain Inj. 1987 Jul-Sep;1(1):49-55. doi: 10.3109/02699058709034444.","Childs A","Brain Inj","1987","1987/07/01","","","10.3109/02699058709034444"
"3453207","Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity","Shavit Y, Martin FC, Yirmiya R, Ben-Eliyahu S, Terman GW, Weiner H, Gale RP, Liebeskind JC.","Brain Behav Immun. 1987 Dec;1(4):318-28. doi: 10.1016/0889-1591(87)90034-1.","Shavit Y","Brain Behav Immun","1987","1987/12/01","","","10.1016/0889-1591(87)90034-1"
"3446373","Kappa-selective opiate antagonist nor-binaltorphimine improves outcome after traumatic spinal cord injury in rats","Faden AI, Takemori AE, Portoghese PS.","Cent Nerv Syst Trauma. 1987;4(4):227-37. doi: 10.1089/cns.1987.4.227.","Faden AI","Cent Nerv Syst Trauma","1987","1987/01/01","","","10.1089/cns.1987.4.227"
"3435737","Endogenous opioid effect on breathing during normoxia and hypoxia in developing swine","Moss IR, Sugarman LM, Goode DL.","Biol Neonate. 1987;52(6):337-46. doi: 10.1159/000242729.","Moss IR","Biol Neonate","1987","1987/01/01","","","10.1159/000242729"
"3429408","Effects of narcotic antagonists on self-injurious behavior: a single case study","Bernstein GA, Hughes JR, Mitchell JE, Thompson T.","J Am Acad Child Adolesc Psychiatry. 1987 Nov;26(6):886-9.","Bernstein GA","J Am Acad Child Adolesc Psychiatry","1987","1987/11/01","","",""
"3427441","Chronic antagonist infusion does not increase morphine antinociception in rat spinal cord","Stevens CW, Yaksh TL.","Brain Res. 1987 Nov 10;425(2):388-90. doi: 10.1016/0006-8993(87)90527-0.","Stevens CW","Brain Res","1987","1987/11/10","","","10.1016/0006-8993(87)90527-0"
"3426795","Long-term analgesic reaction in attacked mice","Siegfried B, Frischknecht HR, Riggio G, Waser PG.","Behav Neurosci. 1987 Dec;101(6):797-805. doi: 10.1037//0735-7044.101.6.797.","Siegfried B","Behav Neurosci","1987","1987/12/01","","","10.1037//0735-7044.101.6.797"
"3420162","Evidence for the involvement of central opioidergic systems in L-tyrosine methyl ester-induced analgesia in the rat","Ramarao P, Bhargava HN.","Pharmacology. 1988;37(1):1-7. doi: 10.1159/000138407.","Ramarao P","Pharmacology","1988","1988/01/01","","","10.1159/000138407"
"3416994","Hypothalamo-hypophyseal-gonadal function in the rat following administration of the novel and selective D-1 agonist CY 208-243","Siegel RA, Markó M.","Experientia. 1988 Sep 15;44(9):764-6. doi: 10.1007/BF01959157.","Siegel RA","Experientia","1988","1988/09/15","","","10.1007/BF01959157"
"3410777","Use of a narcotic antagonist (nalmefene) to suppress self-mutilative behavior in a stallion","Dodman NH, Shuster L, Court MH, Patel J.","J Am Vet Med Assoc. 1988 Jun 1;192(11):1585-6.","Dodman NH","J Am Vet Med Assoc","1988","1988/06/01","","",""
"3409950","Irreversible binding of [3H]beta-funaltrexamine to brain slices of morphine-tolerant and -dependent mice","Takahashi M, Portoghese PS, Takemori AE.","Eur J Pharmacol. 1988 May 10;149(3):205-12. doi: 10.1016/0014-2999(88)90650-4.","Takahashi M","Eur J Pharmacol","1988","1988/05/10","","","10.1016/0014-2999(88)90650-4"
"3402532","Hippocampal kindling-induced after-discharge and behavioural depression: immediate and long-term attenuation by opiate antagonists","Cottrell GA, Nyakas C, Bohus B.","Eur J Pharmacol. 1988 May 20;150(1-2):1-8. doi: 10.1016/0014-2999(88)90743-1.","Cottrell GA","Eur J Pharmacol","1988","1988/05/20","","","10.1016/0014-2999(88)90743-1"
"3401731","Electroacupuncture suppression of a nociceptive reflex is potentiated by two repeated electroacupuncture treatments: the first opioid effect potentiates a second non-opioid effect","Pomeranz B, Warma N.","Brain Res. 1988 Jun 14;452(1-2):232-6. doi: 10.1016/0006-8993(88)90028-5.","Pomeranz B","Brain Res","1988","1988/06/14","","","10.1016/0006-8993(88)90028-5"
"3401730","Electroacupuncture suppresses a nociceptive reflex: naltrexone prevents but does not reverse this effect","Pomeranz B, Bibic L.","Brain Res. 1988 Jun 14;452(1-2):227-31. doi: 10.1016/0006-8993(88)90027-3.","Pomeranz B","Brain Res","1988","1988/06/14","","","10.1016/0006-8993(88)90027-3"
"3395362","Comparative evaluation of different pathways for the liver toxicity of morphine using freshly isolated hepatocytes","Ohno Y, Nagamatsu K, Kawanishi T, Ikebuchi H, Terao T, Takanaka A.","Biochem Pharmacol. 1988 Jul 15;37(14):2862-3. doi: 10.1016/0006-2952(88)90052-4.","Ohno Y","Biochem Pharmacol","1988","1988/07/15","","","10.1016/0006-2952(88)90052-4"
"3387517","Naltrexone in infantile autism","Campbell M, Adams P, Small AM, Tesch LM, Curren EL.","Psychopharmacol Bull. 1988;24(1):135-9.","Campbell M","Psychopharmacol Bull","1988","1988/01/01","","",""
"3382815","Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers","Vining E, Kosten TR, Kleber HD.","Br J Addict. 1988 May;83(5):567-75. doi: 10.1111/j.1360-0443.1988.tb02576.x.","Vining E","Br J Addict","1988","1988/05/01","","","10.1111/j.1360-0443.1988.tb02576.x"
"3379357","Effects of treatment with the opioid antagonists naloxone and naltrexone on LH secretion and on sexual maturation in immature female rats","Meijs-Roelofs HM, Kramer P.","J Endocrinol. 1988 May;117(2):237-43. doi: 10.1677/joe.0.1170237.","Meijs-Roelofs HM","J Endocrinol","1988","1988/05/01","","","10.1677/joe.0.1170237"
"3379356","Induction of LH hypersecretion in cyclic rats during the afternoon of oestrus by oestrogen in conjunction with progesterone antagonism or opioidergic blockade","Lustig RH, Pfaff DW, Fishman J.","J Endocrinol. 1988 May;117(2):229-35. doi: 10.1677/joe.0.1170229.","Lustig RH","J Endocrinol","1988","1988/05/01","","","10.1677/joe.0.1170229"
"3375139","Effects of hemorrhage and opiate antagonists on adrenal release of neuropeptides in cats","Gaumann DM, Yaksh TL.","Peptides. 1988 Mar-Apr;9(2):393-405. doi: 10.1016/0196-9781(88)90275-6.","Gaumann DM","Peptides","1988","1988/03/01","","","10.1016/0196-9781(88)90275-6"
"3374808","Naltrexone blocks the enhancing effect of novel experiences on performance in memory tests in humans","Chaves ML, Bizzi JW, Palmini AL, Izquierdo I.","Neuropsychologia. 1988;26(3):491-4. doi: 10.1016/0028-3932(88)90102-9.","Chaves ML","Neuropsychologia","1988","1988/01/01","","","10.1016/0028-3932(88)90102-9"
"3372681","Alcohol effects on naltrexone-induced stimulation of pituitary, adrenal, and gonadal hormones during the early follicular phase of the menstrual cycle","Teoh SK, Mendelson JH, Mello NK, Skupny A.","J Clin Endocrinol Metab. 1988 Jun;66(6):1181-6. doi: 10.1210/jcem-66-6-1181.","Teoh SK","J Clin Endocrinol Metab","1988","1988/06/01","","","10.1210/jcem-66-6-1181"
"3371560","Prenatal antagonism of stress by naltrexone administration: early and long-lasting effects on emotional behaviors in mice","D'Amato FR, Castellano C, Ammassari-Teule M, Oliverio A.","Dev Psychobiol. 1988 Apr;21(3):283-92. doi: 10.1002/dev.420210309.","D'Amato FR","Dev Psychobiol","1988","1988/04/01","","","10.1002/dev.420210309"
"3370463","Regional brain glucose uptake in genetically diabetic C57BL/KsJ mice: modulation by the opiate antagonist, nalmefene","Garris DR, Michel ME.","Brain Res. 1988 Apr 5;445(2):262-7. doi: 10.1016/0006-8993(88)91188-2.","Garris DR","Brain Res","1988","1988/04/05","","","10.1016/0006-8993(88)91188-2"
"3370455","Effect of chronic naltrexone administration and its withdrawal on the regional activity of neurons that contain norepinephrine, dopamine and serotonin","Sharma TR, Chan WC, Gintzler AR.","Brain Res. 1988 Mar 1;442(2):379-86. doi: 10.1016/0006-8993(88)91530-2.","Sharma TR","Brain Res","1988","1988/03/01","","","10.1016/0006-8993(88)91530-2"
"3369583","Idiosyncratic reaction to naltrexone augmented by thioridazine","Malcolm R, Gabel T, Morton A.","Am J Psychiatry. 1988 Jun;145(6):773-4. doi: 10.1176/ajp.145.6.aj1456773.","Malcolm R","Am J Psychiatry","1988","1988/06/01","","","10.1176/ajp.145.6.aj1456773"
"3367315","Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism","Faden AI, Sacksen I, Noble LJ.","J Pharmacol Exp Ther. 1988 May;245(2):742-8.","Faden AI","J Pharmacol Exp Ther","1988","1988/05/01","","",""
"3362942","Effect of morphine and nalmefene on energy balance in diabetic and non-diabetic rats","Levine AS, Grace M, Billington CJ, Gosnell BA, Krahn DD, Brown DM, Morley JE.","Pharmacol Biochem Behav. 1988 Mar;29(3):495-500. doi: 10.1016/0091-3057(88)90010-x.","Levine AS","Pharmacol Biochem Behav","1988","1988/03/01","","","10.1016/0091-3057(88)90010-x"
"3359284","Peripheral versus intracerebroventricular administration of quaternary naltrexone and the enhancement of Pavlovian conditioning","Fanselow MS, Calcagnetti DJ, Helmstetter FJ.","Brain Res. 1988 Mar 15;444(1):147-52. doi: 10.1016/0006-8993(88)90921-3.","Fanselow MS","Brain Res","1988","1988/03/15","","","10.1016/0006-8993(88)90921-3"
"3353441","Protection by opioids against gastric lesions caused by necrotizing agents","Ferri S, Speroni E, Candeletti S, Cavicchini E, Romualdi P, Govoni P, Marchini M.","Pharmacology. 1988;36(2):140-4. doi: 10.1159/000138371.","Ferri S","Pharmacology","1988","1988/01/01","","","10.1159/000138371"
"3350993","Naltrexone: lack of effect on hepatic enzymes","Brahen LS, Capone TJ, Capone DM.","J Clin Pharmacol. 1988 Jan;28(1):64-70. doi: 10.1002/j.1552-4604.1988.tb03102.x.","Brahen LS","J Clin Pharmacol","1988","1988/01/01","","","10.1002/j.1552-4604.1988.tb03102.x"
"3350581","Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism","Maestroni GJ, Conti A, Pierpaoli W.","Immunology. 1988 Mar;63(3):465-9.","Maestroni GJ","Immunology","1988","1988/03/01","PMC1454741","",""
"3346838","Phencyclidine-like discriminative stimulus effects of the stereoisomers of alpha- and beta-cyclazocine in rats","Slifer BL, Balster RL.","J Pharmacol Exp Ther. 1988 Feb;244(2):606-12.","Slifer BL","J Pharmacol Exp Ther","1988","1988/02/01","","",""
"3346837","Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons","France CP, Woods JH.","J Pharmacol Exp Ther. 1988 Feb;244(2):599-605.","France CP","J Pharmacol Exp Ther","1988","1988/02/01","","",""
"3346833","Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine","Yaksh TL, Harty GJ.","J Pharmacol Exp Ther. 1988 Feb;244(2):501-7.","Yaksh TL","J Pharmacol Exp Ther","1988","1988/02/01","","",""
"3339293","Opioidergic modulation of the oestradiol-induced LH surge in the rat: roles of ovarian steroids","Lustig RH, Pfaff DW, Fishman J.","J Endocrinol. 1988 Jan;116(1):55-69. doi: 10.1677/joe.0.1160055.","Lustig RH","J Endocrinol","1988","1988/01/01","","","10.1677/joe.0.1160055"
"3336001","Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats","Moerschbaecher JM, Devia C, Brocklehurst C.","J Pharmacol Exp Ther. 1988 Jan;244(1):237-46.","Moerschbaecher JM","J Pharmacol Exp Ther","1988","1988/01/01","","",""
"3335997","Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates","Simpkins JW, Smulkowski M, Dixon R, Tuttle R.","J Pharmacol Exp Ther. 1988 Jan;244(1):195-205.","Simpkins JW","J Pharmacol Exp Ther","1988","1988/01/01","","",""
"3329169","Naltrexone does not affect adrenal steroidogenesis in women with hirsutism/oligomenorrhea","Jackson JA, Wincek TJ, Pliego JF.","Henry Ford Hosp Med J. 1987;35(4):194-7.","Jackson JA","Henry Ford Hosp Med J","1987","1987/01/01","","",""
"3308215","Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism","Maestroni GJ, Conti A, Pierpaoli W.","Clin Exp Immunol. 1987 May;68(2):384-91.","Maestroni GJ","Clin Exp Immunol","1987","1987/05/01","PMC1542725","",""
"3302207","Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine","Dykstra LA, Gmerek DE, Winger G, Woods JH.","J Pharmacol Exp Ther. 1987 Aug;242(2):421-7.","Dykstra LA","J Pharmacol Exp Ther","1987","1987/08/01","","",""
"3297022","Pathophysiological relationships between the biological and immunological activities of luteinizing hormone","Dufau ML, Veldhuis JD.","Baillieres Clin Endocrinol Metab. 1987 Feb;1(1):153-76. doi: 10.1016/s0950-351x(87)80057-5.","Dufau ML","Baillieres Clin Endocrinol Metab","1987","1987/02/01","","","10.1016/s0950-351x(87)80057-5"
"3285899","Loss of the cortisol response to naltrexone in Alzheimer's disease","Pomara N, Stanley M, Rhiew HB, Bagne CA, Deptula D, Galloway MP, Tanimoto K, Verebey K, Tamminga CA.","Biol Psychiatry. 1988 Apr 1;23(7):726-33. doi: 10.1016/0006-3223(88)90057-1.","Pomara N","Biol Psychiatry","1988","1988/04/01","","","10.1016/0006-3223(88)90057-1"
"3276498","Effects of opioid peptides on aldosterone production: stimulatory effect of leu-enkephalin","Bruzzone ME, Marusic ET.","Endocrinology. 1988 Feb;122(2):402-6. doi: 10.1210/endo-122-2-402.","Bruzzone ME","Endocrinology","1988","1988/02/01","","","10.1210/endo-122-2-402"
"3267398","Environmentally induced analgesia: age-related decline in a neurally mediated, nonopioid system","Hamm RJ, Knisely JS.","Psychol Aging. 1986 Sep;1(3):195-201. doi: 10.1037//0882-7974.1.3.195.","Hamm RJ","Psychol Aging","1986","1986/09/01","","","10.1037//0882-7974.1.3.195"
"3266082","Shock-induced modulation of lymphocyte responsiveness and natural killer activity: differential mechanisms of induction","Cunnick JE, Lysle DT, Armfield A, Rabin BS.","Brain Behav Immun. 1988 Jun;2(2):102-13. doi: 10.1016/0889-1591(88)90011-6.","Cunnick JE","Brain Behav Immun","1988","1988/06/01","","","10.1016/0889-1591(88)90011-6"
"3252685","Fluctuations of succinic dehydrogenase during morphine tolerance, dependence and withdrawals in the spinal cord and medulla oblongata of mice","Josephjohn K, Sood PP.","Acta Neurol Belg. 1988 Nov-Dec;88(5):281-9.","Josephjohn K","Acta Neurol Belg","1988","1988/11/01","","",""
"3252262","Neonatal naltrexone treatment: effects on sexual and exploratory behavior in male and female rats","Meyerson BJ, Berg M, Johansson B.","Pharmacol Biochem Behav. 1988 Sep;31(1):63-7. doi: 10.1016/0091-3057(88)90312-7.","Meyerson BJ","Pharmacol Biochem Behav","1988","1988/09/01","","","10.1016/0091-3057(88)90312-7"
"3252031","Morphine effects on locus ceruleus neurons are dependent on the state of arousal and availability of external stimuli: studies in anesthetized and unanesthetized rats","Valentino RJ, Wehby RG.","J Pharmacol Exp Ther. 1988 Mar;244(3):1178-86.","Valentino RJ","J Pharmacol Exp Ther","1988","1988/03/01","","",""
"3251596","Apomorphine markedly potentiates naltrexone-induced hypodipsia in the rat","Ukai M, Nakayama S, Kameyama T.","Brain Res. 1988 Jun 7;451(1-2):357-60. doi: 10.1016/0006-8993(88)90784-6.","Ukai M","Brain Res","1988","1988/06/07","","","10.1016/0006-8993(88)90784-6"
"3250670","Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique","Brewer C, Rezae H, Bailey C.","Br J Psychiatry. 1988 Sep;153:340-3. doi: 10.1192/bjp.153.3.340.","Brewer C","Br J Psychiatry","1988","1988/09/01","","","10.1192/bjp.153.3.340"
"3247293","Naltrexone-3-salicylate (a prodrug of naltrexone): synthesis and pharmacokinetics in dogs","Hussain MA, Shefter E.","Pharm Res. 1988 Feb;5(2):113-5. doi: 10.1023/a:1015944302567.","Hussain MA","Pharm Res","1988","1988/02/01","","","10.1023/a:1015944302567"
"3245848","Internally standardized method for the determination of nalbuphine in human plasma by means of high performance liquid chromatography with electrochemical coulometric detection","Wetzelsberger N, Lücker PW, Erking W.","Arzneimittelforschung. 1988 Dec;38(12):1768-71.","Wetzelsberger N","Arzneimittelforschung","1988","1988/12/01","","",""
"3241666","Comparison of the oxytocin response to water-deprivation, hyperosmolarity and administration of morphine or naltrexone in lactating and virgin female rats","Evans RG, Olley JE.","Neurosci Lett. 1988 Nov 22;94(1-2):177-81. doi: 10.1016/0304-3940(88)90291-1.","Evans RG","Neurosci Lett","1988","1988/11/22","","","10.1016/0304-3940(88)90291-1"
"3224281","Mediation of serotonin-induced analgesia by the 5HT2 receptor in the pentobarbital anesthetized mouse model","Banks WA, Kastin AJ, Trentman TL, Haynes HS, Johnson BG, Galina ZH.","Brain Res Bull. 1988 Dec;21(6):887-91. doi: 10.1016/0361-9230(88)90022-6.","Banks WA","Brain Res Bull","1988","1988/12/01","","","10.1016/0361-9230(88)90022-6"
"3219609","Endogenous opioid systems and neural cancer: transmission and scanning electron microscopic studies of murine neuroblastoma in tissue culture","Zagon IS.","Brain Res Bull. 1988 Nov;21(5):777-84. doi: 10.1016/0361-9230(88)90046-9.","Zagon IS","Brain Res Bull","1988","1988/11/01","","","10.1016/0361-9230(88)90046-9"
"3216959","Reversal by beta-funaltrexamine and 16-methyl cyprenorphine of the antinociceptive effects of opioid agonists in the mouse and guinea-pig","Hayes AG, Birch PJ.","Neuropharmacology. 1988 Aug;27(8):813-6. doi: 10.1016/0028-3908(88)90096-2.","Hayes AG","Neuropharmacology","1988","1988/08/01","","","10.1016/0028-3908(88)90096-2"
"3215726","Naltrexone suppresses abnormal sexual behavior in Tourette's syndrome","Sandyk R.","Int J Neurosci. 1988 Nov;43(1-2):107-10. doi: 10.3109/00207458808985786.","Sandyk R","Int J Neurosci","1988","1988/11/01","","","10.3109/00207458808985786"
"3211978","Morphine preexposure attenuates the aversive properties of opiates without preexposure to the aversive properties","Martin GM, Bechara A, van der Kooy D.","Pharmacol Biochem Behav. 1988 Jul;30(3):687-92. doi: 10.1016/0091-3057(88)90085-8.","Martin GM","Pharmacol Biochem Behav","1988","1988/07/01","","","10.1016/0091-3057(88)90085-8"
"3211915","The effect of tetrahydropapaveroline and naltrexone on voluntary ethanol ingestion in rats","Oster L, Martinez TT.","Proc West Pharmacol Soc. 1988;31:277-9.","Oster L","Proc West Pharmacol Soc","1988","1988/01/01","","",""
"3211905","Clonidine activates a cholinergic hippocampal theta rhythm in the rat","Yabase M, Chinn C, Horita A.","Proc West Pharmacol Soc. 1988;31:213-4.","Yabase M","Proc West Pharmacol Soc","1988","1988/01/01","","",""
"3210007","Chronic naltrexone suppresses platelet aggregation induced by adrenaline and 5-hydroxytryptamine in former heroin addicts","García-Sevilla JA, Ulibarri I, Giralt MT, Areso P, Oliveros RG, Gutiérrez M.","J Neural Transm. 1988;73(2):157-60. doi: 10.1007/BF01243386.","García-Sevilla JA","J Neural Transm","1988","1988/01/01","","","10.1007/BF01243386"
"3204249","The effects of nalmefene, a potent oral opiate antagonist, on exercise-induced bronchospasm","Christopher MA, Wyzan D, Harman E, Hendeles L.","J Allergy Clin Immunol. 1988 Dec;82(6):1037-41. doi: 10.1016/0091-6749(88)90141-8.","Christopher MA","J Allergy Clin Immunol","1988","1988/12/01","","","10.1016/0091-6749(88)90141-8"
"3202818","Naltrexone-reversible pain suppression in the isolated attacking mouse","Siegfried B, Frischknecht HR.","Behav Neural Biol. 1988 Nov;50(3):354-60. doi: 10.1016/s0163-1047(88)91082-5.","Siegfried B","Behav Neural Biol","1988","1988/11/01","","","10.1016/s0163-1047(88)91082-5"
"3202224","Behavioral evidence for cholecystokinin-opiate interactions in neonatal rats","Weller A, Blass EM.","Am J Physiol. 1988 Dec;255(6 Pt 2):R901-7. doi: 10.1152/ajpregu.1988.255.6.R901.","Weller A","Am J Physiol","1988","1988/12/01","","","10.1152/ajpregu.1988.255.6.R901"
"3192459","Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs","Dodman NH, Shuster L, White SD, Court MH, Parker D, Dixon R.","J Am Vet Med Assoc. 1988 Oct 1;193(7):815-9.","Dodman NH","J Am Vet Med Assoc","1988","1988/10/01","","",""
"3188932","Evaluation of the anti-arrhythmic potency of naltrexone in the isolated ischaemic rat heart","Liu XL, Mok CP, Lee YS, Wong TM.","Zhongguo Yao Li Xue Bao. 1988 Jan;9(1):40-3.","Liu XL","Zhongguo Yao Li Xue Bao","1988","1988/01/01","","",""
"3179728","Effects of naltrexone on nucleus accumbens, lateral hypothalamic and ventral tegmental self-stimulation rate-frequency functions","West TE, Wise RA.","Brain Res. 1988 Oct 11;462(1):126-33. doi: 10.1016/0006-8993(88)90594-x.","West TE","Brain Res","1988","1988/10/11","","","10.1016/0006-8993(88)90594-x"
"3178891","Stress- and morphine-induced elevations of plasma and tissue cholesterol in mice: reversal by naltrexone","Bryant HU, Kuta CC, Story JA, Yim GK.","Biochem Pharmacol. 1988 Oct 1;37(19):3777-80. doi: 10.1016/0006-2952(88)90415-7.","Bryant HU","Biochem Pharmacol","1988","1988/10/01","","","10.1016/0006-2952(88)90415-7"
"3174777","Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration","Corrigall WA, Vaccarino FJ.","Pharmacol Biochem Behav. 1988 Jun;30(2):443-50. doi: 10.1016/0091-3057(88)90478-9.","Corrigall WA","Pharmacol Biochem Behav","1988","1988/06/01","","","10.1016/0091-3057(88)90478-9"
"3174740","Dissociation of the opioid and nonopioid effects of cyclazocine","Calligaro D, Young GA, Khazan N.","Pharmacol Biochem Behav. 1988 May;30(1):163-7.","Calligaro D","Pharmacol Biochem Behav","1988","1988/05/01","","",""
"3165970","Gilles de la Tourette's syndrome associated with chronic schizophrenia","Sandyk R, Bamford CR.","Int J Neurosci. 1988 Jul;41(1-2):83-6. doi: 10.3109/00207458808985744.","Sandyk R","Int J Neurosci","1988","1988/07/01","","","10.3109/00207458808985744"
"3163711","Self-mutilation in Tourette's syndrome","Sandyk R.","J Child Neurol. 1988 Apr;3(2):147-8. doi: 10.1177/088307388800300215.","Sandyk R","J Child Neurol","1988","1988/04/01","","","10.1177/088307388800300215"
"3150786","Naltrexone effects on pituitary and gonadal hormones in male and female rhesus monkeys","Mello NK, Mendelson JH, Bree MP, Skupny A.","Pharmacol Biochem Behav. 1988 Nov;31(3):683-91. doi: 10.1016/0091-3057(88)90248-1.","Mello NK","Pharmacol Biochem Behav","1988","1988/11/01","","","10.1016/0091-3057(88)90248-1"
"3149772","Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys","Winslow JT, Miczek KA.","Psychopharmacology (Berl). 1988;96(4):493-9. doi: 10.1007/BF02180030.","Winslow JT","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF02180030"
"3147479","Effects of naltrexone, and d-amphetamine, and their interaction on the stimulus control of choice behavior of rats","Grilly DM, Gowans GC.","Psychopharmacology (Berl). 1988;96(1):73-80. doi: 10.1007/BF02431536.","Grilly DM","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF02431536"
"3147475","""Paradoxical"" analgesia induced by naloxone and naltrexone","Greeley JD, Lê AD, Poulos CX, Cappell H.","Psychopharmacology (Berl). 1988;96(1):36-9. doi: 10.1007/BF02431530.","Greeley JD","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF02431530"
"3147381","Conditioning phenomena and the problem of relapse in opioid addicts and alcoholics","Meyer RE.","NIDA Res Monogr. 1988;84:161-79.","Meyer RE","NIDA Res Monogr","1988","1988/01/01","","",""
"3147046","Opioid peptides and primary biliary cirrhosis","Thornton JR, Losowsky MS.","BMJ. 1988 Dec 10;297(6662):1501-4. doi: 10.1136/bmj.297.6662.1501.","Thornton JR","BMJ","1988","1988/12/10","PMC1835218","","10.1136/bmj.297.6662.1501"
"3144404","Early undernutrition blocks the effect of naltrexone on rat exploratory behavior","Rotta FT, Mello CF, Rocha JB, Souza DO.","Braz J Med Biol Res. 1988;21(2):305-12.","Rotta FT","Braz J Med Biol Res","1988","1988/01/01","","",""
"3143473","[Efficacy of the treatment of sleep apnea using naltrexone. A clinical, polygraphic and gasometric study]","Ferber C, Sanchez P, Lemoine P, Mouret J.","C R Acad Sci III. 1988;307(12):695-700.","Ferber C","C R Acad Sci III","1988","1988/01/01","","",""
"3140862","Antagonism of morphine-induced respiratory depression with nalmefene","Konieczko KM, Jones JG, Barrowcliffe MP, Jordan C, Altman DG.","Br J Anaesth. 1988 Sep;61(3):318-23. doi: 10.1093/bja/61.3.318.","Konieczko KM","Br J Anaesth","1988","1988/09/01","","","10.1093/bja/61.3.318"
"3129443","Sustained effects of opioid antagonism during the normal human luteal phase","Gindoff PR, Jewelewicz R, Hembree W, Wardlaw S, Ferin M.","J Clin Endocrinol Metab. 1988 May;66(5):1000-4. doi: 10.1210/jcem-66-5-1000.","Gindoff PR","J Clin Endocrinol Metab","1988","1988/05/01","","","10.1210/jcem-66-5-1000"
"3127853","Morphine induces delayed anorexia in rats","Leshem M.","Psychopharmacology (Berl). 1988;94(2):254-8. doi: 10.1007/BF00176855.","Leshem M","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF00176855"
"3125440","Naltrexone stimulation of pituitary, adrenal, and gonadal hormones during the luteal phase of the menstrual cycle: acute effects of alcohol","Mendelson JH, Mello NK, Lange U, Teoh SK, Skupny AS, Palmieri S, Ellingboe J.","NIDA Res Monogr. 1987;76:116-23.","Mendelson JH","NIDA Res Monogr","1987","1987/01/01","","",""
"3124142","Role of endogenous opioids on ventilation and chemical control of breathing in pentobarbitone-anesthetized rats","Mauser PJ, Chapman RW.","Pharmacology. 1987;35(6):317-26. doi: 10.1159/000138356.","Mauser PJ","Pharmacology","1987","1987/01/01","","","10.1159/000138356"
"3123965","Action of naltrexone on the sexual impairment of obese cafeteria rats","Mandenoff A, Bertière MC, Betoulle D, Apfelbaum M.","NIDA Res Monogr. 1986;75:489-92.","Mandenoff A","NIDA Res Monogr","1986","1986/01/01","","",""
"3123447","The effect of long-term opiate antagonist administration to pubertal boys","Kulin HE, Demers LM, Rogol AD, Veldhuis JD.","J Androl. 1987 Nov-Dec;8(6):374-7. doi: 10.1002/j.1939-4640.1987.tb00980.x.","Kulin HE","J Androl","1987","1987/11/01","","","10.1002/j.1939-4640.1987.tb00980.x"
"3121260","Naloxone and naltrexone. Application in COPD","Reents SB, Beck CA Jr.","Chest. 1988 Jan;93(1):217-9. doi: 10.1378/chest.93.1.217.","Reents SB","Chest","1988","1988/01/01","","","10.1378/chest.93.1.217"
"3114797","Analgesia and decrement in operant performance in socially defeated mice: selective cross-tolerance to morphine and antagonism by naltrexone","Miczek KA, Winslow JT.","Psychopharmacology (Berl). 1987;92(4):444-51. doi: 10.1007/BF00176476.","Miczek KA","Psychopharmacology (Berl)","1987","1987/01/01","","","10.1007/BF00176476"
"3107034","Beta-funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons","France CP, Woods JH.","Psychopharmacology (Berl). 1987;91(2):213-6. doi: 10.1007/BF00217065.","France CP","Psychopharmacology (Berl)","1987","1987/01/01","","","10.1007/BF00217065"
"3104950","Suppression of deprivation-induced water intake in the rat by opioid antagonists: central sites of action","Ukai M, Holtzman SG.","Psychopharmacology (Berl). 1987;91(3):279-84. doi: 10.1007/BF00518177.","Ukai M","Psychopharmacology (Berl)","1987","1987/01/01","","","10.1007/BF00518177"
"3092100","Naltrexone (Trexan): a review of hepatotoxicity issues","Verebey KG, Mulé SJ.","NIDA Res Monogr. 1986;67:73-81.","Verebey KG","NIDA Res Monogr","1986","1986/01/01","","",""
"3092099","Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage","Pfohl DN, Allen JI, Atkinson RL, Knopman DS, Malcolm RJ, Mitchell JE, Morley JE.","NIDA Res Monogr. 1986;67:66-72.","Pfohl DN","NIDA Res Monogr","1986","1986/01/01","","",""
"3092093","CSF endorphins in chronic opioid-dependent humans","O'Brien CP, Terenius LY, Nyberg F, McLellan AT.","NIDA Res Monogr. 1986;67:373-80.","O'Brien CP","NIDA Res Monogr","1986","1986/01/01","","",""
"3092091","Chronic naltrexone effect on cortisol","Kosten TR, Kreek MJ, Ragunath J, Kleber HD.","NIDA Res Monogr. 1986;67:362-5.","Kosten TR","NIDA Res Monogr","1986","1986/01/01","","",""
"3090442","Clinical investigations of drug effects in women","Mendelson JH, Mello NK.","NIDA Res Monogr. 1986;65:21-30.","Mendelson JH","NIDA Res Monogr","1986","1986/01/01","","",""
"3089534","Opiate withdrawal: inpatient versus outpatient programmes","Brewer C.","Br Med J (Clin Res Ed). 1986 Aug 9;293(6543):391. doi: 10.1136/bmj.293.6543.391-a.","Brewer C","Br Med J (Clin Res Ed)","1986","1986/08/09","PMC1341074","","10.1136/bmj.293.6543.391-a"
"3088658","An analysis of the paradoxical effect of morphine on runway speed and food consumption","Corrigall WA, Linseman MA, D'Onofrio RM, Lei H.","Psychopharmacology (Berl). 1986;89(3):327-33. doi: 10.1007/BF00174369.","Corrigall WA","Psychopharmacology (Berl)","1986","1986/01/01","","","10.1007/BF00174369"
"3088644","Possible mediation of catecholaminergic pathways in the antinociceptive effect of an extract of Cannabis sativa L","Ferri S, Cavicchini E, Romualdi P, Speroni E, Murari G.","Psychopharmacology (Berl). 1986;89(2):244-7. doi: 10.1007/BF00310637.","Ferri S","Psychopharmacology (Berl)","1986","1986/01/01","","","10.1007/BF00310637"
"3076856","Opiates, sleep and itch","Burch JR, Harrison PV.","Clin Exp Dermatol. 1988 Nov;13(6):418-9. doi: 10.1111/j.1365-2230.1988.tb00744.x.","Burch JR","Clin Exp Dermatol","1988","1988/11/01","","","10.1111/j.1365-2230.1988.tb00744.x"
"3067620","Opiate antagonist nalmefene inhibits ethanol-induced flushing in Asians: a preliminary study","Ho SB, DeMaster EG, Shafer RB, Levine AS, Morley JE, Go VL, Allen JI.","Alcohol Clin Exp Res. 1988 Oct;12(5):705-12. doi: 10.1111/j.1530-0277.1988.tb00269.x.","Ho SB","Alcohol Clin Exp Res","1988","1988/10/01","","","10.1111/j.1530-0277.1988.tb00269.x"
"3067243","Ethylketocyclazocine and bremazocine analgesia in neonatal rats","Helmstetter FJ, Calcagnetti DJ, Cramer CP, Fanselow MS.","Pharmacol Biochem Behav. 1988 Aug;30(4):817-21. doi: 10.1016/0091-3057(88)90105-0.","Helmstetter FJ","Pharmacol Biochem Behav","1988","1988/08/01","","","10.1016/0091-3057(88)90105-0"
"3048954","Clonidine and the treatment of the opiate withdrawal syndrome","Gossop M.","Drug Alcohol Depend. 1988 Jul;21(3):253-9. doi: 10.1016/0376-8716(88)90078-6.","Gossop M","Drug Alcohol Depend","1988","1988/07/01","","","10.1016/0376-8716(88)90078-6"
"3043289","Clinical trial of naltrexone in premenstrual syndrome","Chuong CJ, Coulam CB, Bergstralh EJ, O'Fallon WM, Steinmetz GI.","Obstet Gynecol. 1988 Sep;72(3 Pt 1):332-6.","Chuong CJ","Obstet Gynecol","1988","1988/09/01","","",""
"3041143","Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems","McLaughlin PJ, Zagon IS.","Life Sci. 1987 Sep 21;41(12):1465-72. doi: 10.1016/0024-3205(87)90711-9.","McLaughlin PJ","Life Sci","1987","1987/09/21","","","10.1016/0024-3205(87)90711-9"
"3040654","Appraising the instantaneous secretory rates of luteinizing hormone and testosterone in response to selective mu opiate receptor blockade in late pubertal boys","Mauras N, Rogol AD, Veldhuis JD.","J Androl. 1987 Jul-Aug;8(4):203-9. doi: 10.1002/j.1939-4640.1987.tb03304.x.","Mauras N","J Androl","1987","1987/07/01","","","10.1002/j.1939-4640.1987.tb03304.x"
"3040177","Endogenous opioids regulate dendritic growth and spine formation in developing rat brain","Hauser KF, McLaughlin PJ, Zagon IS.","Brain Res. 1987 Jul 21;416(1):157-61. doi: 10.1016/0006-8993(87)91509-5.","Hauser KF","Brain Res","1987","1987/07/21","","","10.1016/0006-8993(87)91509-5"
"3040023","Effects of restraint and naltrexone on the biphasic heart rate response to morphine in rats","Schwarz KS, Peris J, Cunningham CL.","Alcohol Drug Res. 1987;7(5-6):327-39.","Schwarz KS","Alcohol Drug Res","1987","1987/01/01","","",""
"3039272","Role of peripheral and central opioid activity in analgesia induced by restraint stress","Kelly SJ, Franklin KB.","Life Sci. 1987 Aug 10;41(6):789-94. doi: 10.1016/0024-3205(87)90460-7.","Kelly SJ","Life Sci","1987","1987/08/10","","","10.1016/0024-3205(87)90460-7"
"3039139","X-ray crystal structure of the opioid ligand naltrexonazine","Urbanczyk-Lipkowska Z, Lipkowski AW, Etter MC, Hahn EF, Pasternak GW, Portoghese PS.","J Med Chem. 1987 Aug;30(8):1489-94. doi: 10.1021/jm00391a035.","Urbanczyk-Lipkowska Z","J Med Chem","1987","1987/08/01","","","10.1021/jm00391a035"
"3038836","Brain opioids and autism: an updated analysis of possible linkages","Sahley TL, Panksepp J.","J Autism Dev Disord. 1987 Jun;17(2):201-16. doi: 10.1007/BF01495056.","Sahley TL","J Autism Dev Disord","1987","1987/06/01","","","10.1007/BF01495056"
"3038579","Diprenorphine has agonist activity at opioid kappa-receptors in the myenteric plexus of the guinea-pig ileum","Traynor JR, Corbett AD, Kosterlitz HW.","Eur J Pharmacol. 1987 May 7;137(1):85-9. doi: 10.1016/0014-2999(87)90185-3.","Traynor JR","Eur J Pharmacol","1987","1987/05/07","","","10.1016/0014-2999(87)90185-3"
"3038139","Exposure to novelty induces naltrexone-reversible analgesia in rats","Siegfried B, Netto CA, Izquierdo I.","Behav Neurosci. 1987 Jun;101(3):436-8. doi: 10.1037//0735-7044.101.3.436.","Siegfried B","Behav Neurosci","1987","1987/06/01","","","10.1037//0735-7044.101.3.436"
"3036838","Multiple interconvertible affinity states for the delta opioid agonist-receptor complex","Spain JW, Coscia CJ.","J Biol Chem. 1987 Jul 5;262(19):8948-51.","Spain JW","J Biol Chem","1987","1987/07/05","","",""
"3035177","Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives","Schoenecker JW, Takemori AE, Portoghese PS.","J Med Chem. 1987 Jun;30(6):1040-4. doi: 10.1021/jm00389a014.","Schoenecker JW","J Med Chem","1987","1987/06/01","","","10.1021/jm00389a014"
"3034303","The central representation of an aversive event maintains the opioid and nonopioid forms of analgesia","Grau JW.","Behav Neurosci. 1987 Apr;101(2):272-88. doi: 10.1037//0735-7044.101.2.272.","Grau JW","Behav Neurosci","1987","1987/04/01","","","10.1037//0735-7044.101.2.272"
"3033716","Naltrexone reverses a long term depressive effect of a toxic lithium injection on saccharin preference","Lieblich I, Yirmiya R.","Physiol Behav. 1987;39(4):547-50. doi: 10.1016/0031-9384(87)90388-x.","Lieblich I","Physiol Behav","1987","1987/01/01","","","10.1016/0031-9384(87)90388-x"
"3033246","Opioid agonist and antagonist activities of monofunctional nitrogen mustard analogues of beta-chlornaltrexamine","Schoenecker JW, Takemori AE, Portoghese PS.","J Med Chem. 1987 May;30(5):933-5. doi: 10.1021/jm00388a033.","Schoenecker JW","J Med Chem","1987","1987/05/01","","","10.1021/jm00388a033"
"3033213","Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands","Zimmerman DM, Leander JD, Reel JK, Hynes MD.","J Pharmacol Exp Ther. 1987 May;241(2):374-8.","Zimmerman DM","J Pharmacol Exp Ther","1987","1987/05/01","","",""
"3031743","Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats","Plotsky PM.","Regul Pept. 1986 Dec 30;16(3-4):235-42. doi: 10.1016/0167-0115(86)90022-4.","Plotsky PM","Regul Pept","1986","1986/12/30","","","10.1016/0167-0115(86)90022-4"
"3030873","Unidirectional interaction between thyrotropin releasing hormone and opiates at the level of their brain receptors","Das S, Bhargava HN.","Gen Pharmacol. 1987;18(1):99-102. doi: 10.1016/0306-3623(87)90178-9.","Das S","Gen Pharmacol","1987","1987/01/01","","","10.1016/0306-3623(87)90178-9"
"3030494","The pattern of [3H]cyclofoxy retention in rat brain after in vivo injection corresponds to the in vitro opiate receptor distribution","Ostrowski NL, Burke TR Jr, Rice KC, Pert A, Pert CB.","Brain Res. 1987 Feb 3;402(2):275-86. doi: 10.1016/0006-8993(87)90034-5.","Ostrowski NL","Brain Res","1987","1987/02/03","","","10.1016/0006-8993(87)90034-5"
"3030209","Delta receptors in the rat vas deferens","Smith CF, Carter A.","Arch Int Pharmacodyn Ther. 1986 Dec;284(2):181-92.","Smith CF","Arch Int Pharmacodyn Ther","1986","1986/12/01","","",""
"3027318","Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures","Tortella FC, Robles L, Mosberg HI.","J Pharmacol Exp Ther. 1987 Feb;240(2):571-7.","Tortella FC","J Pharmacol Exp Ther","1987","1987/02/01","","",""
"3027317","An analysis of naltrexone precipitated abstinence in morphine-dependent chronic spinal dogs","Martin WR, Gilbert PE, Jasinski DR, Martin CD.","J Pharmacol Exp Ther. 1987 Feb;240(2):565-70.","Martin WR","J Pharmacol Exp Ther","1987","1987/02/01","","",""
"3026683","The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogs","Liang CS, Imai N, Stone CK, Woolf PD, Kawashima S, Tuttle RR.","Circulation. 1987 Feb;75(2):443-51. doi: 10.1161/01.cir.75.2.443.","Liang CS","Circulation","1987","1987/02/01","","","10.1161/01.cir.75.2.443"
"3026544","Bremazocine is an agonist at kappa-opioid receptors and an antagonist at mu-opioid receptors in the guinea-pig myenteric plexus","Corbett AD, Kosterlitz HW.","Br J Pharmacol. 1986 Sep;89(1):245-9. doi: 10.1111/j.1476-5381.1986.tb11141.x.","Corbett AD","Br J Pharmacol","1986","1986/09/01","PMC1917028","","10.1111/j.1476-5381.1986.tb11141.x"
"3025902","Opioid elements in development of the spontaneous motility of chick embryos","Sedlácek J.","Physiol Bohemoslov. 1986;35(5):427-36.","Sedlácek J","Physiol Bohemoslov","1986","1986/01/01","","",""
"3025539","Selective proliferation of brain kappa opiate receptors in spontaneously hypertensive rats","Bhargava HN, Das S.","Life Sci. 1986 Dec 29;39(26):2593-600. doi: 10.1016/0024-3205(86)90114-1.","Bhargava HN","Life Sci","1986","1986/12/29","","","10.1016/0024-3205(86)90114-1"
"3025501","Modulation of murine neuroblastoma in nude mice by opioid antagonists","Zagon IS, McLaughlin PJ.","J Natl Cancer Inst. 1987 Jan;78(1):141-7. doi: 10.1093/jnci/78.1.141.","Zagon IS","J Natl Cancer Inst","1987","1987/01/01","","","10.1093/jnci/78.1.141"
"3024662","Effects of flunitrazepam on passive avoidance behaviour in mice subjected to immobilization stress or familiarized with the testing apparatus","Castellano C, Pavone F.","Behav Brain Res. 1986 Oct;22(1):91-5. doi: 10.1016/0166-4328(86)90084-7.","Castellano C","Behav Brain Res","1986","1986/10/01","","","10.1016/0166-4328(86)90084-7"
"3022745","Effects of the affinity ligands 14-beta-chloroacetylnaltrexone and 14-beta-bromoacetamidomorphine on [3H]-dihydromorphine binding sites in rat brain","Reichman M, Dirksen R, Abood LG, Gala D.","Biochem Pharmacol. 1986 Nov 15;35(22):3995-8. doi: 10.1016/0006-2952(86)90017-1.","Reichman M","Biochem Pharmacol","1986","1986/11/15","","","10.1016/0006-2952(86)90017-1"
"3022308","Potentiation of the propunishment, but not the convulsant action of the beta-carboline DMCM by naltrexone","Duka T, Stephens DN.","Pharmacol Biochem Behav. 1986 Sep;25(3):595-8. doi: 10.1016/0091-3057(86)90147-4.","Duka T","Pharmacol Biochem Behav","1986","1986/09/01","","","10.1016/0091-3057(86)90147-4"
"3022093","Evidence for coupling of the kappa opioid receptor to brain GTPase","Clark MJ, Levenson SD, Medzihradsky F.","Life Sci. 1986 Nov 10;39(19):1721-7. doi: 10.1016/0024-3205(86)90090-1.","Clark MJ","Life Sci","1986","1986/11/10","","","10.1016/0024-3205(86)90090-1"
"3021954","Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes","Tam SW, Liu-Chen LY.","J Pharmacol Exp Ther. 1986 Nov;239(2):351-7.","Tam SW","J Pharmacol Exp Ther","1986","1986/11/01","","",""
"3021476","Irreversible selective blockade of kappa-opioid receptors in the guinea-pig ileum","Sheehan MJ, Hayes AG, Tyers MB.","Eur J Pharmacol. 1986 Sep 23;129(1-2):19-24. doi: 10.1016/0014-2999(86)90331-6.","Sheehan MJ","Eur J Pharmacol","1986","1986/09/23","","","10.1016/0014-2999(86)90331-6"
"3020413","Affinity labels as probes for opioid receptor types and subtypes","Portoghese PS, Takemori AE.","NIDA Res Monogr. 1986;69:157-68.","Portoghese PS","NIDA Res Monogr","1986","1986/01/01","","",""
"3020332","Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion","Blank MS, Mann DR, Daugherty DT, Sridiran R, Murphy JR.","Life Sci. 1986 Oct 27;39(17):1493-99. doi: 10.1016/0024-3205(86)90378-4.","Blank MS","Life Sci","1986","1986/10/27","","","10.1016/0024-3205(86)90378-4"
"3020246","Irreversible blockage of opioid receptor types by ester homologues of beta-funaltrexamine","Schoenecker JW, Takemori AE, Portoghese PS.","J Med Chem. 1986 Oct;29(10):1868-71. doi: 10.1021/jm00160a013.","Schoenecker JW","J Med Chem","1986","1986/10/01","","","10.1021/jm00160a013"
"3020245","Synthesis and biological activity of analogues of beta-chlornaltrexamine and beta-funaltrexamine at opioid receptors","Portoghese PS, Rein MD, Takemori AE.","J Med Chem. 1986 Oct;29(10):1861-4. doi: 10.1021/jm00160a011.","Portoghese PS","J Med Chem","1986","1986/10/01","","","10.1021/jm00160a011"
"3020228","Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse","Yoburn BC, Nunes FA, Adler B, Pasternak GW, Inturrisi CE.","J Pharmacol Exp Ther. 1986 Oct;239(1):132-5.","Yoburn BC","J Pharmacol Exp Ther","1986","1986/10/01","","",""
"3019487","beta-Funaltrexamine (beta-FNA) and the regulation of body and brain development in rats","Zagon IS, McLaughlin PJ.","Brain Res Bull. 1986 Jul;17(1):5-9. doi: 10.1016/0361-9230(86)90155-3.","Zagon IS","Brain Res Bull","1986","1986/07/01","","","10.1016/0361-9230(86)90155-3"
"3018757","Involvement of brain opiate receptors in the immune-suppressive effect of morphine","Shavit Y, Depaulis A, Martin FC, Terman GW, Pechnick RN, Zane CJ, Gale RP, Liebeskind JC.","Proc Natl Acad Sci U S A. 1986 Sep;83(18):7114-7. doi: 10.1073/pnas.83.18.7114.","Shavit Y","Proc Natl Acad Sci U S A","1986","1986/09/01","PMC386663","","10.1073/pnas.83.18.7114"
"3018242","Synthesis and opioid antagonist potencies of naltrexamine bivalent ligands with conformationally restricted spacers","Portoghese PS, Ronsisvalle G, Larson DL, Takemori AE.","J Med Chem. 1986 Sep;29(9):1650-3. doi: 10.1021/jm00159a014.","Portoghese PS","J Med Chem","1986","1986/09/01","","","10.1021/jm00159a014"
"3018231","Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats","Locke KW, Holtzman SG.","J Pharmacol Exp Ther. 1986 Sep;238(3):997-1003.","Locke KW","J Pharmacol Exp Ther","1986","1986/09/01","","",""
"3018230","Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects","Locke KW, Holtzman SG.","J Pharmacol Exp Ther. 1986 Sep;238(3):990-6.","Locke KW","J Pharmacol Exp Ther","1986","1986/09/01","","",""
"3017514","Opioid antagonist-induced modulation of cerebral and hippocampal development: histological and morphometric studies","Zagon IS, McLaughlin PJ.","Brain Res. 1986 Aug;393(2):233-46. doi: 10.1016/0165-3806(86)90025-8.","Zagon IS","Brain Res","1986","1986/08/01","","","10.1016/0165-3806(86)90025-8"
"3017495","Reversal by beta-funaltrexamine of the antinociceptive effect of opioid agonists in the rat","Hayes AG, Skingle M, Tyers MB.","Br J Pharmacol. 1986 Aug;88(4):867-72. doi: 10.1111/j.1476-5381.1986.tb16260.x.","Hayes AG","Br J Pharmacol","1986","1986/08/01","PMC1917077","","10.1111/j.1476-5381.1986.tb16260.x"
"3016272","Activity of N-methyl-alpha- and -beta-funaltrexamine at opioid receptors","Mohamed MS, Larson DL, Takemori AE, Portoghese PS.","J Med Chem. 1986 Aug;29(8):1551-3. doi: 10.1021/jm00158a043.","Mohamed MS","J Med Chem","1986","1986/08/01","","","10.1021/jm00158a043"
"3016244","Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine","Ward SJ, LoPresti D, James DW.","J Pharmacol Exp Ther. 1986 Aug;238(2):625-31.","Ward SJ","J Pharmacol Exp Ther","1986","1986/08/01","","",""
"3015356","Phencyclidine-induced stereotyped behaviors after injection of ethylketocyclazocine, Mr 2266 and naltrexone in rats","Nabeshima T, Hiramatsu M, Kameyama T.","Brain Res. 1986 Jul 23;378(2):234-9. doi: 10.1016/0006-8993(86)90926-1.","Nabeshima T","Brain Res","1986","1986/07/23","","","10.1016/0006-8993(86)90926-1"
"3014973","Multiple endogenous opiate and non-opiate analgesia systems: evidence of their existence and clinical implications","Watkins LR, Mayer DJ.","Ann N Y Acad Sci. 1986;467:273-99. doi: 10.1111/j.1749-6632.1986.tb14635.x.","Watkins LR","Ann N Y Acad Sci","1986","1986/01/01","","","10.1111/j.1749-6632.1986.tb14635.x"
"3014971","Hyperalgesic functions of peripheral opiate receptors","van der Kooy D.","Ann N Y Acad Sci. 1986;467:154-68. doi: 10.1111/j.1749-6632.1986.tb14626.x.","van der Kooy D","Ann N Y Acad Sci","1986","1986/01/01","","","10.1111/j.1749-6632.1986.tb14626.x"
"3012488","Antinociceptive effects in rodents of the dipeptide Lys-Trp (Nps) and related compounds","Garcia-Lopez MT, Herranz R, Gonzalez-Muñiz R, Naranjo JR, De Ceballos ML, Del Rio J.","Peptides. 1986 Jan-Feb;7(1):39-43. doi: 10.1016/0196-9781(86)90058-6.","Garcia-Lopez MT","Peptides","1986","1986/01/01","","","10.1016/0196-9781(86)90058-6"
"3011007","Neurochemical correlates of opiate receptor regulation","Zukin RS, Tempel A.","Biochem Pharmacol. 1986 May 15;35(10):1623-7. doi: 10.1016/0006-2952(86)90314-x.","Zukin RS","Biochem Pharmacol","1986","1986/05/15","","","10.1016/0006-2952(86)90314-x"
"3010087","Effects of endogenous and exogenous opioids on splenic natural killer cell activity","Kraut RP, Greenberg AH.","Nat Immun Cell Growth Regul. 1986;5(1):28-40.","Kraut RP","Nat Immun Cell Growth Regul","1986","1986/01/01","","",""
"3009817","Investigation of the structural requirements for the kappa-selective opioid receptor antagonist, 6 beta,6 beta'-[ethylenebis(oxyethyleneimino)]bis[17-(cyclopropylmethyl)- 4,5 alpha-epoxymorphinan-3,14-diol] (TENA)","Botros S, Lipkowski AW, Takemori AE, Portoghese PS.","J Med Chem. 1986 May;29(5):874-6. doi: 10.1021/jm00155a048.","Botros S","J Med Chem","1986","1986/05/01","","","10.1021/jm00155a048"
"3009717","An assessment of the role of opioid receptors in the response to cannabimimetic drugs","Devane WA, Spain JW, Coscia CJ, Howlett AC.","J Neurochem. 1986 Jun;46(6):1929-35. doi: 10.1111/j.1471-4159.1986.tb08515.x.","Devane WA","J Neurochem","1986","1986/06/01","","","10.1111/j.1471-4159.1986.tb08515.x"
"3009251","Environmentally induced analgesia: ontogeny of a nonopioid system","Knisely JS, Hamm RJ.","Dev Psychobiol. 1986 Jan;19(1):27-36. doi: 10.1002/dev.420190104.","Knisely JS","Dev Psychobiol","1986","1986/01/01","","","10.1002/dev.420190104"
"3009150","Inhibition of luteinizing hormone release by morphine and endogenous opiates in cultured pituitary cells","Blank MS, Fabbri A, Catt KJ, Dufau ML.","Endocrinology. 1986 May;118(5):2097-101. doi: 10.1210/endo-118-5-2097.","Blank MS","Endocrinology","1986","1986/05/01","","","10.1210/endo-118-5-2097"
"3007777","Naltrexone","Kleber HD.","J Subst Abuse Treat. 1985;2(2):117-22. doi: 10.1016/0740-5472(85)90036-4.","Kleber HD","J Subst Abuse Treat","1985","1985/01/01","","","10.1016/0740-5472(85)90036-4"
"3006087","Use of naltrexone as a provocative test for hypothalamic-pituitary hormone function","Mendelson JH, Mello NK, Cristofaro P, Skupny A, Ellingboe J.","Pharmacol Biochem Behav. 1986 Feb;24(2):309-13. doi: 10.1016/0091-3057(86)90356-4.","Mendelson JH","Pharmacol Biochem Behav","1986","1986/02/01","","","10.1016/0091-3057(86)90356-4"
"3004996","[3H]beta-funaltrexamine binds covalently to brain opioid receptors","Tam SW, Nickolson VJ, Liu-Chen LY.","Eur J Pharmacol. 1985 Dec 17;119(3):259-60. doi: 10.1016/0014-2999(85)90307-3.","Tam SW","Eur J Pharmacol","1985","1985/12/17","","","10.1016/0014-2999(85)90307-3"
"3003626","Pharmacological evidence for a protective role of the endogenous opioid system on electroshock-induced seizures in the mouse","Puglisi-Allegra S, Cabib S, Oliverio A.","Neurosci Lett. 1985 Dec 4;62(2):241-7. doi: 10.1016/0304-3940(85)90362-3.","Puglisi-Allegra S","Neurosci Lett","1985","1985/12/04","","","10.1016/0304-3940(85)90362-3"
"3002317","Effect of beta-funaltrexamine on retention of passive-avoidance conditioning","Gallagher M.","Behav Neural Biol. 1985 Nov;44(3):499-502. doi: 10.1016/s0163-1047(85)90976-8.","Gallagher M","Behav Neural Biol","1985","1985/11/01","","","10.1016/s0163-1047(85)90976-8"
"3002205","A radiolabeled-ligand-binding technique for the characterization of opioid receptors in the intact mouse vas deferens","Cicero TJ, Bell RD.","Anal Biochem. 1985 Oct;150(1):67-75. doi: 10.1016/0003-2697(85)90441-5.","Cicero TJ","Anal Biochem","1985","1985/10/01","","","10.1016/0003-2697(85)90441-5"
"3001432","[Enkephalinergic regulation of cardiovascular centers]","Laubie M, Schmitt H.","J Pharmacol. 1985;16 Suppl 2:69-94.","Laubie M","J Pharmacol","1985","1985/01/01","","",""
"3001233","Effect of naltrexone on senile dementia of the Alzheimer type","Hyman BT, Eslinger PJ, Damasio AR.","J Neurol Neurosurg Psychiatry. 1985 Nov;48(11):1169-71. doi: 10.1136/jnnp.48.11.1169.","Hyman BT","J Neurol Neurosurg Psychiatry","1985","1985/11/01","PMC1028579","","10.1136/jnnp.48.11.1169"
"3000523","Analgesic effects of mu antagonists after naloxone non-reversible stress-induced analgesia","Sacerdote P, Mantegazza P, Panerai AE.","Brain Res. 1985 Dec 16;359(1-2):34-8. doi: 10.1016/0006-8993(85)91409-x.","Sacerdote P","Brain Res","1985","1985/12/16","","","10.1016/0006-8993(85)91409-x"
"3000501","Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine","Hayes AG, Sheehan MJ, Tyers MB.","Br J Pharmacol. 1985 Dec;86(4):899-904. doi: 10.1111/j.1476-5381.1985.tb11112.x.","Hayes AG","Br J Pharmacol","1985","1985/12/01","PMC1916625","","10.1111/j.1476-5381.1985.tb11112.x"
"2999724","Central effects of growth hormone-releasing factor (GRF) on intestinal motility in dogs: involvement of dopaminergic receptors","Bueno L, Fioramonti J, Primi MP.","Peptides. 1985 May-Jun;6(3):403-7. doi: 10.1016/0196-9781(85)90104-4.","Bueno L","Peptides","1985","1985/05/01","","","10.1016/0196-9781(85)90104-4"
"2999408","Hybromet: a ligand for purifying opioid receptors","Archer S, Michael J, Osei-Gyimah P, Seyed-Mozaffari A, Zukin RS, Maneckjee R, Simon EJ, Gioannini TL.","J Med Chem. 1985 Dec;28(12):1950-3. doi: 10.1021/jm00150a032.","Archer S","J Med Chem","1985","1985/12/01","","","10.1021/jm00150a032"
"2999106","Purification of an active opioid-binding protein from bovine striatum","Gioannini TL, Howard AD, Hiller JM, Simon EJ.","J Biol Chem. 1985 Dec 5;260(28):15117-21.","Gioannini TL","J Biol Chem","1985","1985/12/05","","",""
"2998381","Differential up-regulation of microsomal and synaptic membrane mu opioid receptors","Moudy AM, Spain JW, Coscia CJ.","Biochem Biophys Res Commun. 1985 Oct 30;132(2):735-41. doi: 10.1016/0006-291x(85)91194-5.","Moudy AM","Biochem Biophys Res Commun","1985","1985/10/30","","","10.1016/0006-291x(85)91194-5"
"2997887","N-(3-Fluoropropyl)-N-normetazocine, a potentially useful opiate antagonist for opiate receptor studies with positron emission tomography (PET)","Feliu AL, Holland MJ, Carr KD, Fowler JS, Simon EJ.","Res Commun Chem Pathol Pharmacol. 1985 Sep;49(3):323-36.","Feliu AL","Res Commun Chem Pathol Pharmacol","1985","1985/09/01","","",""
"2997824","Characterization of the discriminative stimulus effects of centrally administered morphine in the rat","Locke KW, Holtzman SG.","Psychopharmacology (Berl). 1985;87(1):1-6. doi: 10.1007/BF00431767.","Locke KW","Psychopharmacology (Berl)","1985","1985/01/01","","","10.1007/BF00431767"
"2997654","Are delta-opioid receptors involved in the regulation of food and water intake?","Jackson HC, Sewell RD.","Neuropharmacology. 1985 Sep;24(9):885-8. doi: 10.1016/0028-3908(85)90040-1.","Jackson HC","Neuropharmacology","1985","1985/09/01","","","10.1016/0028-3908(85)90040-1"
"2997642","An opiate receptor-associated aminopeptidase that degrades enkephalins","Hui KS, Gioannini T, Hui M, Simon EJ, Lajtha A.","Neurochem Res. 1985 Aug;10(8):1047-58. doi: 10.1007/BF00965880.","Hui KS","Neurochem Res","1985","1985/08/01","","","10.1007/BF00965880"
"2997614","Opioids and development: new lessons from old problems","Zagon IS.","NIDA Res Monogr. 1985;60:58-77.","Zagon IS","NIDA Res Monogr","1985","1985/01/01","","",""
"2997432","Receptors for opioid peptides in the guinea-pig ileum","Takemori AE, Portoghese PS.","J Pharmacol Exp Ther. 1985 Nov;235(2):389-92.","Takemori AE","J Pharmacol Exp Ther","1985","1985/11/01","","",""
"2996912","Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels","Hayes AG, Stewart BR.","Eur J Pharmacol. 1985 Oct 8;116(1-2):75-9. doi: 10.1016/0014-2999(85)90186-4.","Hayes AG","Eur J Pharmacol","1985","1985/10/08","","","10.1016/0014-2999(85)90186-4"
"2995741","Differential effects of morphine on the rates of dopamine turnover in the neural and intermediate lobes of the rat pituitary gland","Lookingland KJ, Moore KE.","Life Sci. 1985 Sep 30;37(13):1225-9. doi: 10.1016/0024-3205(85)90134-1.","Lookingland KJ","Life Sci","1985","1985/09/30","","","10.1016/0024-3205(85)90134-1"
"2995111","Changes in responsiveness to mu and kappa opiates following a series of convulsions","Mansour A, Valenstein ES.","Exp Neurol. 1985 Oct;90(1):224-37. doi: 10.1016/0014-4886(85)90055-x.","Mansour A","Exp Neurol","1985","1985/10/01","","","10.1016/0014-4886(85)90055-x"
"2993609","Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors","Portoghese PS, Larson DL, Yim CB, Sayre LM, Ronsisvalle G, Lipkowski AW, Takemori AE, Rice KC, Tam SW.","J Med Chem. 1985 Sep;28(9):1140-1. doi: 10.1021/jm00147a002.","Portoghese PS","J Med Chem","1985","1985/09/01","","","10.1021/jm00147a002"
"2993171","Radiosynthesis of [18F]3-acetylcyclofoxy: a high affinity opiate antagonist","Channing MA, Eckelman WC, Bennett JM, Burke TR Jr, Rice KC.","Int J Appl Radiat Isot. 1985 Jun;36(6):429-33. doi: 10.1016/0020-708x(85)90204-2.","Channing MA","Int J Appl Radiat Isot","1985","1985/06/01","","","10.1016/0020-708x(85)90204-2"
"2992669","Pre-incubation of guinea-pig myenteric plexus with beta-funaltrexamine: discrepancy between binding assays and bioassays","Corbett AD, Kostelitz HW, McKnight AT, Paterson SJ, Robson LE.","Br J Pharmacol. 1985 Jul;85(3):665-73. doi: 10.1111/j.1476-5381.1985.tb10562.x.","Corbett AD","Br J Pharmacol","1985","1985/07/01","PMC1916526","","10.1111/j.1476-5381.1985.tb10562.x"
"2992300","Naltrexone-induced dysphoria in former opioid addicts","Crowley TJ, Wagner JE, Zerbe G, Macdonald M.","Am J Psychiatry. 1985 Sep;142(9):1081-4. doi: 10.1176/ajp.142.9.1081.","Crowley TJ","Am J Psychiatry","1985","1985/09/01","","","10.1176/ajp.142.9.1081"
"2991949","Opiate antagonism reduces placentophagia and pup cleaning by parturient rats","Mayer AD, Faris PL, Komisaruk BR, Rosenblatt JS.","Pharmacol Biochem Behav. 1985 Jun;22(6):1035-44. doi: 10.1016/0091-3057(85)90314-4.","Mayer AD","Pharmacol Biochem Behav","1985","1985/06/01","","","10.1016/0091-3057(85)90314-4"
"2991795","Castration affects male rat brain opiate receptor content","Hahn EF, Fishman J.","Neuroendocrinology. 1985 Jul;41(1):60-3. doi: 10.1159/000124154.","Hahn EF","Neuroendocrinology","1985","1985/07/01","","","10.1159/000124154"
"2991684","The anticonvulsant effects of DADLE are primarily mediated by activation of delta opioid receptors: interactions between delta and mu receptor antagonists","Tortella FC, Robles L, Holaday JW.","Life Sci. 1985 Aug 12;37(6):497-503. doi: 10.1016/0024-3205(85)90461-8.","Tortella FC","Life Sci","1985","1985/08/12","","","10.1016/0024-3205(85)90461-8"
"2991678","Binding of a new opiate antagonist, nalmefene, to rat brain membranes","Michel ME, Bolger G, Weissman BA.","Methods Find Exp Clin Pharmacol. 1985 Apr;7(4):175-7.","Michel ME","Methods Find Exp Clin Pharmacol","1985","1985/04/01","","",""
"2991346","Comparative anatomo-functional imaging of two neuroreceptors and glucose metabolism: a PET study performed in the living baboon","Larson SM, Di Chiro G.","J Comput Assist Tomogr. 1985 Jul-Aug;9(4):676-81. doi: 10.1097/00004728-198507010-00003.","Larson SM","J Comput Assist Tomogr","1985","1985/07/01","","","10.1097/00004728-198507010-00003"
"2989632","Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment","Yoburn BC, Goodman RR, Cohen AH, Pasternak GW, Inturrisi CE.","Life Sci. 1985 Jun 17;36(24):2325-32. doi: 10.1016/0024-3205(85)90322-4.","Yoburn BC","Life Sci","1985","1985/06/17","","","10.1016/0024-3205(85)90322-4"
"2989500","Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists","Eisenberg RM.","J Pharmacol Exp Ther. 1985 Jun;233(3):863-9.","Eisenberg RM","J Pharmacol Exp Ther","1985","1985/06/01","","",""
"2989428","Effects of 5,5'-dithiobis-(2-nitrobenzoic acid) on opiate binding to both the membrane-bound receptor and the partially purified opiate receptor","Nozaki M, Cho TM.","J Neurochem. 1985 Aug;45(2):461-4. doi: 10.1111/j.1471-4159.1985.tb04010.x.","Nozaki M","J Neurochem","1985","1985/08/01","","","10.1111/j.1471-4159.1985.tb04010.x"
"2987990","Multi-dimensional analyses of behavior in mice treated with naltrexone","Ukai M, Kameyama T.","Physiol Behav. 1985 Feb;34(2):311-3. doi: 10.1016/0031-9384(85)90121-0.","Ukai M","Physiol Behav","1985","1985/02/01","","","10.1016/0031-9384(85)90121-0"
"2987740","Effects of opiates on urine output in the water-loaded rat and reversal by beta-funaltrexamine","Skingle M, Hayes AG, Tyers MB.","Neuropeptides. 1985 Feb;5(4-6):433-6. doi: 10.1016/0143-4179(85)90047-2.","Skingle M","Neuropeptides","1985","1985/02/01","","","10.1016/0143-4179(85)90047-2"
"2986883","Effect of sodium chloride on opiate receptor binding in spontaneously hypertensive rats: dependence on age","Hahn EF.","Clin Exp Hypertens A. 1985;7(1):123-37. doi: 10.3109/10641968509074758.","Hahn EF","Clin Exp Hypertens A","1985","1985/01/01","","","10.3109/10641968509074758"
"2986002","Opposite motivational effects of endogenous opioids in brain and periphery","Bechara A, van der Kooy D.","Nature. 1985 Apr 11-17;314(6011):533-4. doi: 10.1038/314533a0.","Bechara A","Nature","1985","1985/04/11","","","10.1038/314533a0"
"2984700","Chronic naltrexone treatment increases the heroin-produced facilitation of self-stimulation","Schenk S, Nawiesniak E.","Pharmacol Biochem Behav. 1985 Feb;22(2):175-7. doi: 10.1016/0091-3057(85)90373-9.","Schenk S","Pharmacol Biochem Behav","1985","1985/02/01","","","10.1016/0091-3057(85)90373-9"
"2984501","Prolonged in vivo antagonism of central mu- and delta-opioid receptor activity by beta-funal trexamine","Dray A, Nunan L, Wire W.","Life Sci. 1985 Apr 8;36(14):1353-8. doi: 10.1016/0024-3205(85)90040-2.","Dray A","Life Sci","1985","1985/04/08","","","10.1016/0024-3205(85)90040-2"
"2984010","Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA)","Ward SJ, Fries DS, Larson DL, Portoghese PS, Takemori AE.","Eur J Pharmacol. 1985 Jan 8;107(3):323-30. doi: 10.1016/0014-2999(85)90257-2.","Ward SJ","Eur J Pharmacol","1985","1985/01/08","","","10.1016/0014-2999(85)90257-2"
"2983171","TENA, a selective kappa opioid receptor antagonist","Portoghese PS, Takemori AE.","Life Sci. 1985 Feb 25;36(8):801-5. doi: 10.1016/0024-3205(85)90202-4.","Portoghese PS","Life Sci","1985","1985/02/25","","","10.1016/0024-3205(85)90202-4"
"2982011","Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation","Tempel A, Gardner EL, Zukin RS.","J Pharmacol Exp Ther. 1985 Feb;232(2):439-44.","Tempel A","J Pharmacol Exp Ther","1985","1985/02/01","","",""
"2981129","Nontolerance to the opioid antagonism of naltrexone","Kleber HD, Kosten TR, Gaspari J, Topazian M.","Biol Psychiatry. 1985 Jan;20(1):66-72. doi: 10.1016/0006-3223(85)90136-2.","Kleber HD","Biol Psychiatry","1985","1985/01/01","","","10.1016/0006-3223(85)90136-2"
"2981076","Possible delta receptor mediation of the effect of beta-endorphin on luteinizing hormone (LH) release, but not on prolactin (PRL) release, in the ovariectomized rat","Wiesner JB, Koenig JI, Krulich L, Moss RL.","Endocrinology. 1985 Jan;116(1):475-7. doi: 10.1210/endo-116-1-475.","Wiesner JB","Endocrinology","1985","1985/01/01","","","10.1210/endo-116-1-475"
"2976353","[Naltrexone, opiate antagonist, in the therapy of drug dependence]","Cugurra F.","Clin Ter. 1988 Nov 15;127(3):173-80.","Cugurra F","Clin Ter","1988","1988/11/15","","",""
"2974555","[Naloxone and naltrexone in the treatment of chronic obstructive bronchopneumopathies]","Caillaud D, Bedu M, Coudert J, Molina C.","Presse Med. 1988 Oct 29;17(38):2036.","Caillaud D","Presse Med","1988","1988/10/29","","",""
"2974485","Comparisons of descending pain inhibitory pathways activated by beta-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice","Roerig SC, Fujimoto JM, Tseng LF.","J Pharmacol Exp Ther. 1988 Dec;247(3):1107-13.","Roerig SC","J Pharmacol Exp Ther","1988","1988/12/01","","",""
"2970012","The role of beta-endorphin in respiratory disorders in man","Dewey W, Morris D, Brase D, Myer E.","NIDA Res Monogr. 1988;81:181-7.","Dewey W","NIDA Res Monogr","1988","1988/01/01","","",""
"2969457","Behavioral significance of opioid peptides in relation to hippocampal function","Gallagher M.","NIDA Res Monogr. 1988;82:118-32.","Gallagher M","NIDA Res Monogr","1988","1988/01/01","","",""
"2966856","Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice","Suh HH, Tseng LF.","J Pharmacol Exp Ther. 1988 May;245(2):587-93.","Suh HH","J Pharmacol Exp Ther","1988","1988/05/01","","",""
"2961881","Antagonism by naltrexone of the hypotension and bradycardia induced by alpha-methyldopa in conscious normotensive rats","van Giersbergen PL, de Jong W.","J Pharmacol Exp Ther. 1988 Jan;244(1):341-7.","van Giersbergen PL","J Pharmacol Exp Ther","1988","1988/01/01","","",""
"2961585","The effect of opioids on rat plasma atrial natriuretic peptide","Vollmar AM, Arendt RM, Schulz R.","Eur J Pharmacol. 1987 Nov 17;143(3):315-21. doi: 10.1016/0014-2999(87)90455-9.","Vollmar AM","Eur J Pharmacol","1987","1987/11/17","","","10.1016/0014-2999(87)90455-9"
"2960478","Effect of naltrexone on ethanol-provoked flushing in Oriental and white subjects","Wilkin JK, Hazelrigg EJ.","Clin Pharmacol Ther. 1987 Nov;42(5):582-7. doi: 10.1038/clpt.1987.200.","Wilkin JK","Clin Pharmacol Ther","1987","1987/11/01","","","10.1038/clpt.1987.200"
"2956960","Opiate addiction and plasma beta-endorphin-like immunoreactivity: methadone maintained, recently detoxified and early naltrexone treated ex-addicts","Cushman P, Morris D, Adams M, Dewey W.","Alcohol Drug Res. 1987;7(5-6):533-40.","Cushman P","Alcohol Drug Res","1987","1987/01/01","","",""
"2953335","Effect of novel experiences on retention of inhibitory avoidance behavior in mice: the influence of previous exposure to the same or another experience","Izquierdo I, McGaugh JL.","Behav Neural Biol. 1987 Mar;47(2):109-15. doi: 10.1016/s0163-1047(87)90201-9.","Izquierdo I","Behav Neural Biol","1987","1987/03/01","","","10.1016/s0163-1047(87)90201-9"
"2950531","Mating produced analgesia in the Syrian hamster","Cruz-Morales SE, Noble RG.","Physiol Behav. 1986;38(5):601-6. doi: 10.1016/0031-9384(86)90252-0.","Cruz-Morales SE","Physiol Behav","1986","1986/01/01","","","10.1016/0031-9384(86)90252-0"
"2947253","Influence of nalmefene on energy balance and glucose regulation in Zucker rats","McLaughlin CL, Baile CA, Gingerich RL, Michel ME.","Physiol Behav. 1986;37(6):899-908.","McLaughlin CL","Physiol Behav","1986","1986/01/01","","",""
"2946562","Effect of naltrexone on apnea of prematurity and on plasma beta-endorphin-like immunoreactivity","MacDonald MG, Moss IR, Kefale GG, Ginzburg HM, Fink RJ, Chin L.","Dev Pharmacol Ther. 1986;9(5):301-9. doi: 10.1159/000457108.","MacDonald MG","Dev Pharmacol Ther","1986","1986/01/01","","","10.1159/000457108"
"2944913","The effects of naltrexone, an oral beta-endorphin antagonist, in children with the Prader-Willi syndrome","Zlotkin SH, Fettes IM, Stallings VA.","J Clin Endocrinol Metab. 1986 Nov;63(5):1229-32. doi: 10.1210/jcem-63-5-1229.","Zlotkin SH","J Clin Endocrinol Metab","1986","1986/11/01","","","10.1210/jcem-63-5-1229"
"2944564","Arcuate nucleus lesions reduce opioid stress-induced analgesia (SIA) and enhance non-opioid SIA in rats","Kelsey JE, Hoerman WA 4th, Kimball LD 3rd, Radack LS, Carter MV.","Brain Res. 1986 Sep 24;382(2):278-90. doi: 10.1016/0006-8993(86)91337-5.","Kelsey JE","Brain Res","1986","1986/09/24","","","10.1016/0006-8993(86)91337-5"
"2944026","Morphine or capsaicin administration alters the secretion of beta-endorphin into the hypophysial portal vasculature of the rat","Koenig JI, Meltzer HY, Gudelsky GA.","Neuroendocrinology. 1986;43(5):611-7. doi: 10.1159/000124589.","Koenig JI","Neuroendocrinology","1986","1986/01/01","","","10.1159/000124589"
"2942391","The effect of beta-endorphin on biogenic amines, insulin, and glucagon levels in the hepatic portal circulation of normal and pancreatectomized dogs","Hussain MN, Kikuchi K, Cukerman E, Sirek A, Sirek OV.","Endocrinology. 1986 Aug;119(2):685-90. doi: 10.1210/endo-119-2-685.","Hussain MN","Endocrinology","1986","1986/08/01","","","10.1210/endo-119-2-685"
"2941636","A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts","Kosten TR, Kreek MJ, Ragunath J, Kleber HD.","Life Sci. 1986 Jul 7;39(1):55-9. doi: 10.1016/0024-3205(86)90437-6.","Kosten TR","Life Sci","1986","1986/07/07","","","10.1016/0024-3205(86)90437-6"
"2939305","Pro-opiomelanocortin-derived peptides in the testis: evidence for a possible role in Leydig and Sertoli cell function","Boitani C, Chen CL, Margioris AN, Gerendai I, Morris PL, Bardin CW.","Med Biol. 1986;63(5-6):251-8.","Boitani C","Med Biol","1986","1986/01/01","","",""
"2938937","The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine","Koenig JI, Meltzer HY, Devane GD, Gudelsky GA.","Endocrinology. 1986 Jun;118(6):2534-9. doi: 10.1210/endo-118-6-2534.","Koenig JI","Endocrinology","1986","1986/06/01","","","10.1210/endo-118-6-2534"
"2938932","Opioid-mediated cardiovascular effects of clonidine in spontaneously hypertensive rats: elimination by neonatal treatment with monosodium glutamate","Mosqueda-Garcia R, Eskay R, Zamir N, Palkovits M, Kunos G.","Endocrinology. 1986 May;118(5):1814-22. doi: 10.1210/endo-118-5-1814.","Mosqueda-Garcia R","Endocrinology","1986","1986/05/01","","","10.1210/endo-118-5-1814"
"2938524","High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications","Yaksh TL, Harty GJ, Onofrio BM.","Anesthesiology. 1986 May;64(5):590-7. doi: 10.1097/00000542-198605000-00008.","Yaksh TL","Anesthesiology","1986","1986/05/01","","","10.1097/00000542-198605000-00008"
"2936929","Endorphins in primate hemorrhagic shock: beneficial action of opiate antagonists","McIntosh TK, Palter M, Grasberger R, Vezina R, Gerstein L, Yeston N, Egdahl RH.","J Surg Res. 1986 Mar;40(3):265-75. doi: 10.1016/0022-4804(86)90160-5.","McIntosh TK","J Surg Res","1986","1986/03/01","","","10.1016/0022-4804(86)90160-5"
"2935140","Pharmacological evidence of a central effect of naltrexone, morphine, and beta-endorphin and a peripheral effect of met- and leu-enkephalin on retention of an inhibitory response in mice","Introini IB, McGaugh JL, Baratti CM.","Behav Neural Biol. 1985 Nov;44(3):434-46. doi: 10.1016/s0163-1047(85)90832-5.","Introini IB","Behav Neural Biol","1985","1985/11/01","","","10.1016/s0163-1047(85)90832-5"
"2934749","Opioid modulation of feeding behavior following repeated exposure to forced swimming exercise in male rats","Davis JM, Lamb DR, Yim GK, Malven PV.","Pharmacol Biochem Behav. 1985 Nov;23(5):709-14. doi: 10.1016/0091-3057(85)90059-0.","Davis JM","Pharmacol Biochem Behav","1985","1985/11/01","","","10.1016/0091-3057(85)90059-0"
"2934748","Opioid modulation of feeding behavior following forced swimming exercise in male rats","Davis JM, Lamb DR, Lowy MT, Yim GK, Malven PV.","Pharmacol Biochem Behav. 1985 Nov;23(5):701-7. doi: 10.1016/0091-3057(85)90058-9.","Davis JM","Pharmacol Biochem Behav","1985","1985/11/01","","","10.1016/0091-3057(85)90058-9"
"2934599","Effect of CNS-active drugs on TRH-induced prolactin release","Hylka VW, Forman LJ, Sonntag WE, Meites J.","Life Sci. 1986 Jan 6;38(1):51-7. doi: 10.1016/0024-3205(86)90274-2.","Hylka VW","Life Sci","1986","1986/01/06","","","10.1016/0024-3205(86)90274-2"
"2927249","Role of opioid antagonists in treating intravenous cocaine abuse","Kosten TR, Kleber HD, Morgan C.","Life Sci. 1989;44(13):887-92. doi: 10.1016/0024-3205(89)90589-4.","Kosten TR","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90589-4"
"2925898","Endogenous opioid systems and the regulation of dendritic growth and spine formation","Hauser KF, McLaughlin PJ, Zagon IS.","J Comp Neurol. 1989 Mar 1;281(1):13-22. doi: 10.1002/cne.902810103.","Hauser KF","J Comp Neurol","1989","1989/03/01","","","10.1002/cne.902810103"
"2925573","Naltrexone in autistic children: an acute open dose range tolerance trial","Campbell M, Overall JE, Small AM, Sokol MS, Spencer EK, Adams P, Foltz RL, Monti KM, Perry R, Nobler M, et al.","J Am Acad Child Adolesc Psychiatry. 1989 Mar;28(2):200-6. doi: 10.1097/00004583-198903000-00009.","Campbell M","J Am Acad Child Adolesc Psychiatry","1989","1989/03/01","","","10.1097/00004583-198903000-00009"
"2923679","Impaired learning of classically conditioned bradycardia in rats following fourth ventricle administration of D-Ala2-methionine-enkephalinamide","Harris GC, Fitzgerald RD.","Behav Neurosci. 1989 Feb;103(1):77-83. doi: 10.1037//0735-7044.103.1.77.","Harris GC","Behav Neurosci","1989","1989/02/01","","","10.1037//0735-7044.103.1.77"
"2923666","Determinants of the nature of environmentally induced hypoalgesia","Maier SF.","Behav Neurosci. 1989 Feb;103(1):131-43. doi: 10.1037//0735-7044.103.1.131.","Maier SF","Behav Neurosci","1989","1989/02/01","","","10.1037//0735-7044.103.1.131"
"2918471","Environmental determinants of enhanced sensitivity to the behavioral effects of naltrexone","Warren PH, Morse WH.","J Pharmacol Exp Ther. 1989 Feb;248(2):546-51.","Warren PH","J Pharmacol Exp Ther","1989","1989/02/01","","",""
"2912237","More on idiosyncratic reaction to naltrexone","Malcolm R, Gabel T, Morton A.","Am J Psychiatry. 1989 Jan;146(1):124-5.","Malcolm R","Am J Psychiatry","1989","1989/01/01","","",""
"2909555","Influence of antiopioids on luteinizing hormone pulsatility in aging men","Vermeulen A, Deslypere JP, Kaufman JM.","J Clin Endocrinol Metab. 1989 Jan;68(1):68-72. doi: 10.1210/jcem-68-1-68.","Vermeulen A","J Clin Endocrinol Metab","1989","1989/01/01","","","10.1210/jcem-68-1-68"
"2907750","Estimated membrane structure and receptor subtype selection of an opioid alkaloid-peptide hybrid","Schwyzer R.","Int J Pept Protein Res. 1988 Dec;32(6):476-83. doi: 10.1111/j.1399-3011.1988.tb01378.x.","Schwyzer R","Int J Pept Protein Res","1988","1988/12/01","","","10.1111/j.1399-3011.1988.tb01378.x"
"2902643","Codeine produces a cholinergically mediated analeptic effect in rats and rabbits","Horita A, Carino MA, Chinn C.","Pharmacol Biochem Behav. 1988 May;30(1):115-8. doi: 10.1016/0091-3057(88)90432-7.","Horita A","Pharmacol Biochem Behav","1988","1988/05/01","","","10.1016/0091-3057(88)90432-7"
"2901674","Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice","Bansinath M, Bhargava HN.","Neuropharmacology. 1988 Apr;27(4):433-7. doi: 10.1016/0028-3908(88)90153-0.","Bansinath M","Neuropharmacology","1988","1988/04/01","","","10.1016/0028-3908(88)90153-0"
"2901483","Pharmacological mechanisms of action of flupirtine: a novel, centrally acting, nonopioid analgesic evaluated by its discriminative effects in the rat","Swedberg MD, Shannon HE, Nickel B, Goldberg SR.","J Pharmacol Exp Ther. 1988 Sep;246(3):1067-74.","Swedberg MD","J Pharmacol Exp Ther","1988","1988/09/01","","",""
"2900318","Naltrexone and the behavioural action of clonidine in normotensive and spontaneously hypertensive rats","van den Buuse M, Henneveld H, de Jong W.","J Pharm Pharmacol. 1988 Apr;40(4):298-300. doi: 10.1111/j.2042-7158.1988.tb05252.x.","van den Buuse M","J Pharm Pharmacol","1988","1988/04/01","","","10.1111/j.2042-7158.1988.tb05252.x"
"2899160","High doses of L-naloxone but neither D-naloxone nor beta-funaltrexamine prevent hyperthermia-induced seizures in rat pups","Laorden ML, Miralles FS, Puig MM.","J Pharm Pharmacol. 1988 Mar;40(3):223-4. doi: 10.1111/j.2042-7158.1988.tb05229.x.","Laorden ML","J Pharm Pharmacol","1988","1988/03/01","","","10.1111/j.2042-7158.1988.tb05229.x"
"2895254","Effects on naltrexone on infantile autism","Leboyer M, Bouvard MP, Dugas M.","Lancet. 1988 Mar 26;1(8587):715. doi: 10.1016/s0140-6736(88)91525-5.","Leboyer M","Lancet","1988","1988/03/26","","","10.1016/s0140-6736(88)91525-5"
"2894229","An examination of the opiate receptor subtypes labeled by [3H]cycloFOXY: an opiate antagonist suitable for positron emission tomography","Rothman RB, McLean S.","Biol Psychiatry. 1988 Mar 1;23(5):435-58. doi: 10.1016/0006-3223(88)90016-9.","Rothman RB","Biol Psychiatry","1988","1988/03/01","","","10.1016/0006-3223(88)90016-9"
"2893982","Biological evaluation of compounds for their physical dependence potential and abuse liability. X. Drug testing programs of the Committee on Problems of Drug Dependence, Inc. (1986)","Jacobson AE.","NIDA Res Monogr. 1987;76:370-91.","Jacobson AE","NIDA Res Monogr","1987","1987/01/01","","",""
"2890074","An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice","Morley JE, Flood JF.","Life Sci. 1987 Nov 2;41(18):2157-65. doi: 10.1016/0024-3205(87)90534-0.","Morley JE","Life Sci","1987","1987/11/02","","","10.1016/0024-3205(87)90534-0"
"2889994","Naltrexone and bulimic symptoms","Igoin-Apfelbaum L, Apfelbaum M.","Lancet. 1987 Nov 7;2(8567):1087-8. doi: 10.1016/s0140-6736(87)91513-3.","Igoin-Apfelbaum L","Lancet","1987","1987/11/07","","","10.1016/s0140-6736(87)91513-3"
"2883290","Intravenous kinetics and metabolism of [15,16-3H]naltrexonium methiodide in the rat","Misra AL, Pontani RB, Vadlamani NL.","J Pharm Pharmacol. 1987 Mar;39(3):225-7. doi: 10.1111/j.2042-7158.1987.tb06254.x.","Misra AL","J Pharm Pharmacol","1987","1987/03/01","","","10.1111/j.2042-7158.1987.tb06254.x"
"2882401","Effects of beta-chlornaltrexamine on food intake, body weight and opioid-induced feeding","Gosnell BA, Grace M, Levine AS.","Life Sci. 1987 Apr 13;40(15):1459-67. doi: 10.1016/0024-3205(87)90377-8.","Gosnell BA","Life Sci","1987","1987/04/13","","","10.1016/0024-3205(87)90377-8"
"2882399","Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists","Portoghese PS, Lipkowski AW, Takemori AE.","Life Sci. 1987 Mar 30;40(13):1287-92. doi: 10.1016/0024-3205(87)90585-6.","Portoghese PS","Life Sci","1987","1987/03/30","","","10.1016/0024-3205(87)90585-6"
"2881357","[Frequency as the cardinal determinant for electroacupuncture analgesia to be reversed by opioid antagonists]","Han JS, Ding XZ, Fan SG.","Sheng Li Xue Bao. 1986 Oct;38(5):475-82.","Han JS","Sheng Li Xue Bao","1986","1986/10/01","","",""
"2881149","Blood pressure monitoring at home for rapid opioid withdrawal with clonidine and naltrexone","Brewer C.","Lancet. 1987 Mar 14;1(8533):621. doi: 10.1016/s0140-6736(87)90253-4.","Brewer C","Lancet","1987","1987/03/14","","","10.1016/s0140-6736(87)90253-4"
"2876373","The role of drugs in the treatment of opioid addicts","Peachey JE.","Med J Aust. 1986 Oct 20;145(8):395-9.","Peachey JE","Med J Aust","1986","1986/10/20","","",""
"2875765","The role of the mediobasal arcuate hypothalamus in relation to opioid systems in the control of ingestive behaviour in the rat","Millan MJ, Millan MH, Reid LD, Herz A.","Brain Res. 1986 Aug 27;381(1):29-42. doi: 10.1016/0006-8993(86)90686-4.","Millan MJ","Brain Res","1986","1986/08/27","","","10.1016/0006-8993(86)90686-4"
"2875491","Role of pituitary and related neuropeptides in alcoholism and pharmacodependence","Van Ree JM.","Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(2):219-28. doi: 10.1016/0278-5846(86)90076-x.","Van Ree JM","Prog Neuropsychopharmacol Biol Psychiatry","1986","1986/01/01","","","10.1016/0278-5846(86)90076-x"
"2871535","Progesterone substitutes: cGMP mediation","Whalen RE, Lauber AH.","Neurosci Biobehav Rev. 1986 Spring;10(1):47-53. doi: 10.1016/0149-7634(86)90032-1.","Whalen RE","Neurosci Biobehav Rev","1986","1986/01/01","","","10.1016/0149-7634(86)90032-1"
"2871452","Naltrexone and hepatotoxicity","Mitchell JE.","Lancet. 1986 May 24;1(8491):1215. doi: 10.1016/s0140-6736(86)91196-7.","Mitchell JE","Lancet","1986","1986/05/24","","","10.1016/s0140-6736(86)91196-7"
"2870933","[3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain","Young EA, Walker JM, Lewis ME, Houghten RA, Woods JH, Akil H.","Eur J Pharmacol. 1986 Mar 4;121(3):355-65. doi: 10.1016/0014-2999(86)90256-6.","Young EA","Eur J Pharmacol","1986","1986/03/04","","","10.1016/0014-2999(86)90256-6"
"2870306","Naltrexone reverses bulimic symptoms","Jonas JM, Gold MS.","Lancet. 1986 Apr 5;1(8484):807. doi: 10.1016/s0140-6736(86)91822-2.","Jonas JM","Lancet","1986","1986/04/05","","","10.1016/s0140-6736(86)91822-2"
"2869440","Opiate antagonists do not alter neuronal responses to stimulation of opioid-containing pathways in rat hippocampus","Chavkin C, Bloom FE.","Neuropeptides. 1986 Jan;7(1):19-22. doi: 10.1016/0143-4179(86)90074-0.","Chavkin C","Neuropeptides","1986","1986/01/01","","","10.1016/0143-4179(86)90074-0"
"2869149","Aversive therapies for substance abuse: do they work?","McLellan AT, Childress AR.","J Subst Abuse Treat. 1985;2(3):187-91. doi: 10.1016/0740-5472(85)90051-0.","McLellan AT","J Subst Abuse Treat","1985","1985/01/01","","","10.1016/0740-5472(85)90051-0"
"2868465","Chronic desipramine attenuates morphine analgesia","O'Neill KA, Valentino D.","Pharmacol Biochem Behav. 1986 Jan;24(1):155-8. doi: 10.1016/0091-3057(86)90061-4.","O'Neill KA","Pharmacol Biochem Behav","1986","1986/01/01","","","10.1016/0091-3057(86)90061-4"
"2867174","Effect of beta-funaltrexamine on opioid side-effects produced by morphine and U-50, 488H","Hayes AG, Skingle M, Tyers MB.","J Pharm Pharmacol. 1985 Nov;37(11):841-3. doi: 10.1111/j.2042-7158.1985.tb04985.x.","Hayes AG","J Pharm Pharmacol","1985","1985/11/01","","","10.1111/j.2042-7158.1985.tb04985.x"
"2867051","Behavioral therapies for substance abuse","Childress AR, McLellan AT, O'Brien CP.","Int J Addict. 1985 Jun-Jul;20(6-7):947-69. doi: 10.3109/10826088509047760.","Childress AR","Int J Addict","1985","1985/06/01","","","10.3109/10826088509047760"
"2867050","Pharmacological advances in addiction treatment","Preston KL, Bigelow GE.","Int J Addict. 1985 Jun-Jul;20(6-7):845-67. doi: 10.3109/10826088509047756.","Preston KL","Int J Addict","1985","1985/06/01","","","10.3109/10826088509047756"
"2865342","Stereospecific opiate-binding sites occur in coated vesicles","Bennett DB, Spain JW, Laskowski MB, Roth BL, Coscia CJ.","J Neurosci. 1985 Nov;5(11):3010-5. doi: 10.1523/JNEUROSCI.05-11-03010.1985.","Bennett DB","J Neurosci","1985","1985/11/01","PMC6565169","","10.1523/JNEUROSCI.05-11-03010.1985"
"2865117","An analysis of naltrexone and naloxone's possible agonistic actions in the dog","Wettstein JG, Martin WR.","Drug Alcohol Depend. 1985 Aug;15(4):353-60. doi: 10.1016/0376-8716(85)90013-4.","Wettstein JG","Drug Alcohol Depend","1985","1985/08/01","","","10.1016/0376-8716(85)90013-4"
"2864100","Non-dopaminergic mechanisms in the turning behavior evoked by intranigral opiates","Morelli M, Di Chiara G.","Brain Res. 1985 Aug 26;341(2):350-9. doi: 10.1016/0006-8993(85)91074-1.","Morelli M","Brain Res","1985","1985/08/26","","","10.1016/0006-8993(85)91074-1"
"2862958","Simultaneous quantitation of norepinephrine, dopamine and serotonin in brain during and following chronic naltrexone administration","Baron SA, Testa FM, Gintzler AR.","Brain Res. 1985 Aug 5;340(1):192-8. doi: 10.1016/0006-8993(85)90794-2.","Baron SA","Brain Res","1985","1985/08/05","","","10.1016/0006-8993(85)90794-2"
"2860592","Treatment of stroke with opiate antagonists--effects of exogenous antagonists and dynorphin 1-13","Baskin DS, Kuroda H, Hosobuchi Y, Lee NM.","Neuropeptides. 1985 Feb;5(4-6):307-10. doi: 10.1016/0143-4179(85)90014-9.","Baskin DS","Neuropeptides","1985","1985/02/01","","","10.1016/0143-4179(85)90014-9"
"2859972","Drug discrimination studies","Holtzman SG.","Drug Alcohol Depend. 1985 Feb;14(3-4):263-82. doi: 10.1016/0376-8716(85)90061-4.","Holtzman SG","Drug Alcohol Depend","1985","1985/02/01","","","10.1016/0376-8716(85)90061-4"
"2859565","Analeptic effect of opiate receptor agonists in rabbits","Yamawaki S, Carino MA, Horita A.","Neurosci Lett. 1985 Mar 22;55(1):61-4. doi: 10.1016/0304-3940(85)90312-x.","Yamawaki S","Neurosci Lett","1985","1985/03/22","","","10.1016/0304-3940(85)90312-x"
"2859095","Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region","Chavkin C, Henriksen SJ, Siggins GR, Bloom FE.","Brain Res. 1985 Apr 8;331(2):366-70. doi: 10.1016/0006-8993(85)91565-3.","Chavkin C","Brain Res","1985","1985/04/08","","","10.1016/0006-8993(85)91565-3"
"2855850","Ligands for imaging opioid receptors in conscious humans by positron emission tomography (PET)","Newman A, Channing M, Finn R, Dunn B, Simpson N, Carson R, Ostrowski N, Cohen R, Burke T, Larson S, et al.","NIDA Res Monogr. 1988;90:117-21.","Newman A","NIDA Res Monogr","1988","1988/01/01","","",""
"2855268","Chronic stress attenuation of alpha 2-adrenoceptor reactivity is reversed by naltrexone","Cancela LM, Volosin M, Molina VA.","Pharmacol Biochem Behav. 1988 Sep;31(1):33-5. doi: 10.1016/0091-3057(88)90307-3.","Cancela LM","Pharmacol Biochem Behav","1988","1988/09/01","","","10.1016/0091-3057(88)90307-3"
"2855240","Inhibition by opioid agonists and enhancement by antagonists of the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: evidence for the functional role of opioid receptors","Kimura T, Katoh M, Satoh S.","J Pharmacol Exp Ther. 1988 Mar;244(3):1098-102.","Kimura T","J Pharmacol Exp Ther","1988","1988/03/01","","",""
"2855239","Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats","Di Chiara G, Imperato A.","J Pharmacol Exp Ther. 1988 Mar;244(3):1067-80.","Di Chiara G","J Pharmacol Exp Ther","1988","1988/03/01","","",""
"2855098","X-ray diffraction studies of enkephalins and opiates","Griffin JF, Smith GD.","NIDA Res Monogr. 1988;87:41-59.","Griffin JF","NIDA Res Monogr","1988","1988/01/01","","",""
"2853839","A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitro","Rothman RB, Bykov V, Reid A, De Costa BR, Newman AH, Jacobson AE, Rice KC.","Neuropeptides. 1988 Oct;12(3):181-7. doi: 10.1016/0143-4179(88)90052-2.","Rothman RB","Neuropeptides","1988","1988/10/01","","","10.1016/0143-4179(88)90052-2"
"2853675","Cardiovascular responses to kappa opioid agonists in intact and adrenal demedullated rats","Gulati A, Bhargava HN.","Eur J Pharmacol. 1988 Nov 1;156(2):247-57. doi: 10.1016/0014-2999(88)90328-7.","Gulati A","Eur J Pharmacol","1988","1988/11/01","","","10.1016/0014-2999(88)90328-7"
"2853405","Assessment of endogenous opioid mediation in stress-induced hypercholesterolemia in the rat","Bryant HU, Story JA, Yim GK.","Psychosom Med. 1988 Nov-Dec;50(6):576-85. doi: 10.1097/00006842-198811000-00003.","Bryant HU","Psychosom Med","1988","1988/11/01","","","10.1097/00006842-198811000-00003"
"2853070","Recovery from opioid receptor alkylation: social conflict analgesia and brain [3H]etorphine binding in beta-chlornaltrexamine-treated mice","Lazega D, Frischknecht HR, Waser PG, Siegfried B.","Eur J Pharmacol. 1988 Oct 18;155(3):333-7. doi: 10.1016/0014-2999(88)90525-0.","Lazega D","Eur J Pharmacol","1988","1988/10/18","","","10.1016/0014-2999(88)90525-0"
"2853057","Lack of evidence for epsilon-opioid receptors in the rat vas deferens","Sheehan MJ, Hayes AG, Tyers MB.","Eur J Pharmacol. 1988 Sep 23;154(3):237-45. doi: 10.1016/0014-2999(88)90197-5.","Sheehan MJ","Eur J Pharmacol","1988","1988/09/23","","","10.1016/0014-2999(88)90197-5"
"2852377","Evidence for opioid mechanisms in the behavioral effects of nicotine","Corrigall WA, Herling S, Coen KM.","Psychopharmacology (Berl). 1988;96(1):29-35. doi: 10.1007/BF02431529.","Corrigall WA","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF02431529"
"2851847","Emergence and development of stress-induced analgesia and concomitant behavioral changes in mice exposed to social conflict","Frischknecht HR, Siegfried B.","Physiol Behav. 1988;44(3):383-8. doi: 10.1016/0031-9384(88)90041-8.","Frischknecht HR","Physiol Behav","1988","1988/01/01","","","10.1016/0031-9384(88)90041-8"
"2851638","Influence of neonatal opioid blockade or injections of gonadotrophin-releasing hormone on the timing of puberty in female rats: correlation of opioid effects with occupation of hypothalamic mu-opioid receptors","Landymore KM, Wilkinson M.","J Endocrinol. 1988 Dec;119(3):447-52. doi: 10.1677/joe.0.1190447.","Landymore KM","J Endocrinol","1988","1988/12/01","","","10.1677/joe.0.1190447"
"2851350","Estimation of opioid receptor agonist dissociation constants with beta-chlornaltrexamine, an irreversible ligand which also displays agonism","Leff P, Dougall IG.","Br J Pharmacol. 1988 Sep;95(1):234-40. doi: 10.1111/j.1476-5381.1988.tb16569.x.","Leff P","Br J Pharmacol","1988","1988/09/01","PMC1854139","","10.1111/j.1476-5381.1988.tb16569.x"
"2850923","Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice","Leander JD.","Eur J Pharmacol. 1988 Jul 14;151(3):457-61. doi: 10.1016/0014-2999(88)90543-2.","Leander JD","Eur J Pharmacol","1988","1988/07/14","","","10.1016/0014-2999(88)90543-2"
"2850500","Pharmacological modifications of cocaine and opioid self-administration","Winger G.","NIDA Res Monogr. 1988;88:125-36.","Winger G","NIDA Res Monogr","1988","1988/01/01","","",""
"2850212","Kappa antagonist properties of buprenorphine in the shock titration procedure","Negus SS, Dykstra LA.","Eur J Pharmacol. 1988 Oct 26;156(1):77-86. doi: 10.1016/0014-2999(88)90149-5.","Negus SS","Eur J Pharmacol","1988","1988/10/26","","","10.1016/0014-2999(88)90149-5"
"2850091","Spinal kappa-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a kappa-selective antagonist","Sander HW, Portoghese PS, Gintzler AR.","Brain Res. 1988 Dec 6;474(2):343-7. doi: 10.1016/0006-8993(88)90448-9.","Sander HW","Brain Res","1988","1988/12/06","","","10.1016/0006-8993(88)90448-9"
"2849725","Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: neurochemical and behavioral evidence","Bardo MT, Neisewander JL, Ennis RB.","Neuropharmacology. 1988 Nov;27(11):1103-9. doi: 10.1016/0028-3908(88)90004-4.","Bardo MT","Neuropharmacology","1988","1988/11/01","","","10.1016/0028-3908(88)90004-4"
"2849679","Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats","Takemori AE, Schwartz MM, Portoghese PS.","J Pharmacol Exp Ther. 1988 Dec;247(3):971-4.","Takemori AE","J Pharmacol Exp Ther","1988","1988/12/01","","",""
"2849042","Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes","Costa T, Klinz FJ, Vachon L, Herz A.","Mol Pharmacol. 1988 Dec;34(6):744-54.","Costa T","Mol Pharmacol","1988","1988/12/01","","",""
"2848424","Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor","Segal IS, Vickery RG, Walton JK, Doze VA, Maze M.","Anesthesiology. 1988 Dec;69(6):818-23. doi: 10.1097/00000542-198812000-00004.","Segal IS","Anesthesiology","1988","1988/12/01","","","10.1097/00000542-198812000-00004"
"2847074","Mu but not delta opioid receptor stimulation intensifies kainic acid-induced neurotoxicity in rat hippocampus","Lason W, Simpson JN, McGinty JF.","Neuropeptides. 1988 Aug-Sep;12(2):89-94. doi: 10.1016/0143-4179(88)90036-4.","Lason W","Neuropeptides","1988","1988/08/01","","","10.1016/0143-4179(88)90036-4"
"2847072","Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanisms","Danks JA, Tortella FC, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW, Rothman RB.","Neuropharmacology. 1988 Sep;27(9):965-74. doi: 10.1016/0028-3908(88)90125-6.","Danks JA","Neuropharmacology","1988","1988/09/01","","","10.1016/0028-3908(88)90125-6"
"2846978","Central pharmacological activity of a quaternary ammonium compound in streptozotocin diabetic mice","Quock RM, Ishii MM, Emmanouil DE.","Life Sci. 1988;43(17):1411-7. doi: 10.1016/0024-3205(88)90308-6.","Quock RM","Life Sci","1988","1988/01/01","","","10.1016/0024-3205(88)90308-6"
"2846819","beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence","Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW.","J Pharmacol Exp Ther. 1988 Nov;247(2):405-16.","Rothman RB","J Pharmacol Exp Ther","1988","1988/11/01","","",""
"2846401","Effects and mechanism of action of lithium chloride on gastric acid secretion in rats","Guglietta A, Irons BJ, Lazarus LH, Sivam SP.","Gastroenterology. 1988 Dec;95(6):1454-9. doi: 10.1016/s0016-5085(88)80062-3.","Guglietta A","Gastroenterology","1988","1988/12/01","","","10.1016/s0016-5085(88)80062-3"
"2846315","Effects of beta-funaltrexamine on ingestive behaviors in the rat","Ukai M, Holtzman SG.","Eur J Pharmacol. 1988 Aug 24;153(2-3):161-5. doi: 10.1016/0014-2999(88)90602-4.","Ukai M","Eur J Pharmacol","1988","1988/08/24","","","10.1016/0014-2999(88)90602-4"
"2845604","Centrally mediated opioid induced depression of hepatic glutathione: effects of intracerebroventricular administration of mu, kappa, sigma and delta agonists","James RC, Wessinger WD, Roberts SM, Millner GC, Paule MG.","Toxicology. 1988 Oct;51(2-3):267-79. doi: 10.1016/0300-483x(88)90155-2.","James RC","Toxicology","1988","1988/10/01","","","10.1016/0300-483x(88)90155-2"
"2845219","Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE","Yoburn BC, Luke MC, Pasternak GW, Inturrisi CE.","Life Sci. 1988;43(16):1319-24. doi: 10.1016/0024-3205(88)90587-5.","Yoburn BC","Life Sci","1988","1988/01/01","","","10.1016/0024-3205(88)90587-5"
"2845215","Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone","Luke MC, Hahn EF, Price M, Pasternak GW.","Life Sci. 1988;43(15):1249-56. doi: 10.1016/0024-3205(88)90215-9.","Luke MC","Life Sci","1988","1988/01/01","","","10.1016/0024-3205(88)90215-9"
"2844617","Opioid components of the clockwork that governs luteinizing hormone and prolactin release in male rats","Almeida OF, Nikolarakis KE, Webley GE, Herz A.","FASEB J. 1988 Oct;2(13):2874-7. doi: 10.1096/fasebj.2.13.2844617.","Almeida OF","FASEB J","1988","1988/10/01","","","10.1096/fasebj.2.13.2844617"
"2844315","Endogenous opioids in cerebrospinal fluid of opioid-dependent humans","O'Brien CP, Terenius LY, Nyberg F, McLellan AT, Eriksson I.","Biol Psychiatry. 1988 Oct;24(6):649-62. doi: 10.1016/0006-3223(88)90139-4.","O'Brien CP","Biol Psychiatry","1988","1988/10/01","","","10.1016/0006-3223(88)90139-4"
"2841709","The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone","Jonas JM, Gold MS.","Psychiatry Res. 1988 May;24(2):195-9. doi: 10.1016/0165-1781(88)90062-5.","Jonas JM","Psychiatry Res","1988","1988/05/01","","","10.1016/0165-1781(88)90062-5"
"2840610","Opioid gene expression in rat striatum is modulated via opioid receptors: evidence from localized receptor inactivation","Morris BJ, Höllt V, Herz A.","Neurosci Lett. 1988 Jun 17;89(1):80-4. doi: 10.1016/0304-3940(88)90484-3.","Morris BJ","Neurosci Lett","1988","1988/06/17","","","10.1016/0304-3940(88)90484-3"
"2840175","Endogenous opioid systems and neural development: ultrastructural studies in the cerebellar cortex of infant and weanling rats","Hess GD, Zagon IS.","Brain Res Bull. 1988 Apr;20(4):473-8. doi: 10.1016/0361-9230(88)90137-2.","Hess GD","Brain Res Bull","1988","1988/04/01","","","10.1016/0361-9230(88)90137-2"
"2839666","Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs","Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM.","J Pharmacol Exp Ther. 1988 Jul;246(1):282-6.","Werling LL","J Pharmacol Exp Ther","1988","1988/07/01","","",""
"2839664","Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays","Takemori AE, Ho BY, Naeseth JS, Portoghese PS.","J Pharmacol Exp Ther. 1988 Jul;246(1):255-8.","Takemori AE","J Pharmacol Exp Ther","1988","1988/07/01","","",""
"2839637","Duration of occupancy of opiate receptors by naltrexone","Lee MC, Wagner HN Jr, Tanada S, Frost JJ, Bice AN, Dannals RF.","J Nucl Med. 1988 Jul;29(7):1207-11.","Lee MC","J Nucl Med","1988","1988/07/01","","",""
"2838632","Only one pharmacophore is required for the kappa opioid antagonist selectivity of norbinaltorphimine","Portoghese PS, Nagase H, Takemori AE.","J Med Chem. 1988 Jul;31(7):1344-7. doi: 10.1021/jm00402a015.","Portoghese PS","J Med Chem","1988","1988/07/01","","","10.1021/jm00402a015"
"2837233","Effect of ethanol on the binding of conformationally rigid and labile ligands of opioid receptors to rat brain membranes","Bhargava HN, Rapaka RS, Renugopalakrishnan V.","Biochem Pharmacol. 1988 Jun 1;37(11):2279-83. doi: 10.1016/0006-2952(88)90593-x.","Bhargava HN","Biochem Pharmacol","1988","1988/06/01","","","10.1016/0006-2952(88)90593-x"
"2836824","Stress-induced hypokinesia is facilitated by ACTH-(7-10)","Wolterink G, Van Ree JM.","Peptides. 1988 Mar-Apr;9(2):277-82. doi: 10.1016/0196-9781(88)90260-4.","Wolterink G","Peptides","1988","1988/03/01","","","10.1016/0196-9781(88)90260-4"
"2836152","Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence","Gonzalez JP, Brogden RN.","Drugs. 1988 Mar;35(3):192-213. doi: 10.2165/00003495-198835030-00002.","Gonzalez JP","Drugs","1988","1988/03/01","","","10.2165/00003495-198835030-00002"
"2832857","Milk-induced analgesia and comforting in 10-day-old rats: opioid mediation","Blass EM, Fitzgerald E.","Pharmacol Biochem Behav. 1988 Jan;29(1):9-13. doi: 10.1016/0091-3057(88)90266-3.","Blass EM","Pharmacol Biochem Behav","1988","1988/01/01","","","10.1016/0091-3057(88)90266-3"
"2832604","Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity","Portoghese PS, Nagase H, Lipkowski AW, Larson DL, Takemori AE.","J Med Chem. 1988 Apr;31(4):836-41. doi: 10.1021/jm00399a026.","Portoghese PS","J Med Chem","1988","1988/04/01","","","10.1021/jm00399a026"
"2832195","Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist","Portoghese PS, Sultana M, Takemori AE.","Eur J Pharmacol. 1988 Jan 27;146(1):185-6. doi: 10.1016/0014-2999(88)90502-x.","Portoghese PS","Eur J Pharmacol","1988","1988/01/27","","","10.1016/0014-2999(88)90502-x"
"2831700","Naltrexone treatment of bulimia: clinical and theoretical findings linking eating disorders and substance abuse","Jonas JM, Gold MS.","Adv Alcohol Subst Abuse. 1987;7(1):29-37.","Jonas JM","Adv Alcohol Subst Abuse","1987","1987/01/01","","",""
"2831695","Respiratory and neuroendocrine responses of piglets to hypoxia during postnatal development","Moss IR, Runold M, Dahlin I, Fredholm BB, Nyberg F, Lagercrantz H.","Acta Physiol Scand. 1987 Dec;131(4):533-41. doi: 10.1111/j.1748-1716.1987.tb08273.x.","Moss IR","Acta Physiol Scand","1987","1987/12/01","","","10.1111/j.1748-1716.1987.tb08273.x"
"2831515","Autoradiographic evidence for two classes of mu opioid binding sites in rat brain using [125I]FK33824","Rothman RB, Jacobson AE, Rice KC, Herkenham M.","Peptides. 1987 Nov-Dec;8(6):1015-21. doi: 10.1016/0196-9781(87)90130-6.","Rothman RB","Peptides","1987","1987/11/01","","","10.1016/0196-9781(87)90130-6"
"2831341","Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat","Fox DA, Burks TF.","J Pharmacol Exp Ther. 1988 Feb;244(2):456-62.","Fox DA","J Pharmacol Exp Ther","1988","1988/02/01","","",""
"2831070","Norbinaltorphimine: antagonist profile at kappa opioid receptors","Birch PJ, Hayes AG, Sheehan MJ, Tyers MB.","Eur J Pharmacol. 1987 Dec 15;144(3):405-8. doi: 10.1016/0014-2999(87)90397-9.","Birch PJ","Eur J Pharmacol","1987","1987/12/15","","","10.1016/0014-2999(87)90397-9"
"2830943","Reduced saccharin preference in CXBK (opioid receptor-deficient) mice","Yirmiya R, Lieblich I, Liebeskind JC.","Brain Res. 1988 Jan 12;438(1-2):339-42. doi: 10.1016/0006-8993(88)91360-1.","Yirmiya R","Brain Res","1988","1988/01/12","","","10.1016/0006-8993(88)91360-1"
"2830531","Role of the spinal cord in the development of opiate tolerance and dependence","Takemori AE, DeLander GE, Portoghese PS.","NIDA Res Monogr. 1987;76:42-5.","Takemori AE","NIDA Res Monogr","1987","1987/01/01","","",""
"2830524","New approaches to the evaluation of opioid agonists and antagonists upon the isolated, electrically stimulated mouse vas deferens preparation","Smith CB.","NIDA Res Monogr. 1987;76:288-94.","Smith CB","NIDA Res Monogr","1987","1987/01/01","","",""
"2830520","Potentiation of pentobarbital sleeping time by the acute and chronic administration of morphine","Pechnick RN, Terman GW, Liebeskind JC.","NIDA Res Monogr. 1987;76:233-9.","Pechnick RN","NIDA Res Monogr","1987","1987/01/01","","",""
"2829049","The role of opiate receptors in the potentiation of pentobarbital sleeping time by the acute and chronic administration of opiates","Pechnick RN, Terman GW.","Neuropharmacology. 1987 Nov;26(11):1589-93. doi: 10.1016/0028-3908(87)90006-2.","Pechnick RN","Neuropharmacology","1987","1987/11/01","","","10.1016/0028-3908(87)90006-2"
"2829013","Cross-protection of mu and delta opioid receptors in the mouse vas deferens","Sheehan MJ, Hayes AG, Tyers MB.","NIDA Res Monogr. 1986;75:85-8.","Sheehan MJ","NIDA Res Monogr","1986","1986/01/01","","",""
"2828993","Opioid analgesia in the mouse: evidence for multiple receptors using beta-FNA","Sánchez-Blázquez P, Garzón J.","NIDA Res Monogr. 1986;75:465-8.","Sánchez-Blázquez P","NIDA Res Monogr","1986","1986/01/01","","",""
"2828990","Stereochemistry of novel delta selective opiate antagonists","Kolb VM, Hua DH, Duax WL.","NIDA Res Monogr. 1986;75:45-8.","Kolb VM","NIDA Res Monogr","1986","1986/01/01","","",""
"2827704","Retention impairment by posttraining epinephrine: role of state dependency and of endogenous opioid mechanisms","Izquierdo I, McGaugh JL.","Behav Neurosci. 1987 Dec;101(6):778-81. doi: 10.1037//0735-7044.101.6.778.","Izquierdo I","Behav Neurosci","1987","1987/12/01","","","10.1037//0735-7044.101.6.778"
"2826950","Effects of stress and beta-funal trexamine pretreatment on morphine analgesia and opioid binding in rats","Adams JU, Andrews JS, Hiller JM, Simon EJ, Holtzman SG.","Life Sci. 1987 Dec 28;41(26):2835-44. doi: 10.1016/0024-3205(87)90430-9.","Adams JU","Life Sci","1987","1987/12/28","","","10.1016/0024-3205(87)90430-9"
"2826178","Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography","Rothman RB, McLean S, Bykov V, Lessor RA, Jacobson AE, Rice KC, Holaday JW.","Eur J Pharmacol. 1987 Oct 6;142(1):73-81. doi: 10.1016/0014-2999(87)90655-8.","Rothman RB","Eur J Pharmacol","1987","1987/10/06","","","10.1016/0014-2999(87)90655-8"
"2825222","Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine","Bardo MT, Neisewander JL.","Pharmacol Biochem Behav. 1987 Oct;28(2):267-73. doi: 10.1016/0091-3057(87)90224-3.","Bardo MT","Pharmacol Biochem Behav","1987","1987/10/01","","","10.1016/0091-3057(87)90224-3"
"2825220","Peripheral receptors mediate the aversive conditioning effects of morphine in the rat","Bechara A, Zito KA, van der Kooy D.","Pharmacol Biochem Behav. 1987 Oct;28(2):219-25. doi: 10.1016/0091-3057(87)90218-8.","Bechara A","Pharmacol Biochem Behav","1987","1987/10/01","","","10.1016/0091-3057(87)90218-8"
"2825200","Opiate receptors and the endorphin-mediated cardiovascular effects of clonidine in rats: evidence for hypertension-induced mu-subtype to delta-subtype changes","Mosqueda-Garcia R, Kunos G.","Proc Natl Acad Sci U S A. 1987 Dec;84(23):8637-41. doi: 10.1073/pnas.84.23.8637.","Mosqueda-Garcia R","Proc Natl Acad Sci U S A","1987","1987/12/01","PMC299601","","10.1073/pnas.84.23.8637"
"2825063","[3H]cyclofoxy, a ligand suitable for positron emission tomography, labels mu and kappa opioid receptors","McLean S, Rice KC, Lessor R, Rothman RB.","Neuropeptides. 1987 Oct;10(3):235-9. doi: 10.1016/0143-4179(87)90073-4.","McLean S","Neuropeptides","1987","1987/10/01","","","10.1016/0143-4179(87)90073-4"
"2824980","Cellular mechanisms of opioid tolerance: studies in single brain neurons","Christie MJ, Williams JT, North RA.","Mol Pharmacol. 1987 Nov;32(5):633-8.","Christie MJ","Mol Pharmacol","1987","1987/11/01","","",""
"2824758","Effects of kappa agonists and dexoxadrol on the acquisition of conditional discriminations in monkeys","Moerschbaecher JM, Brocklehurst C, Devia C, Faust WB.","J Pharmacol Exp Ther. 1987 Nov;243(2):737-44.","Moerschbaecher JM","J Pharmacol Exp Ther","1987","1987/11/01","","",""
"2823970","Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice","Heyman JS, Mulvaney SA, Mosberg HI, Porreca F.","Brain Res. 1987 Sep 8;420(1):100-8. doi: 10.1016/0006-8993(87)90244-7.","Heyman JS","Brain Res","1987","1987/09/08","","","10.1016/0006-8993(87)90244-7"
"2823789","The impairment of retention induced by pentylenetetrazol in mice may be mediated by a release of opioid peptides in the brain","Baratti CM.","Behav Neural Biol. 1987 Sep;48(2):183-96. doi: 10.1016/s0163-1047(87)90724-2.","Baratti CM","Behav Neural Biol","1987","1987/09/01","","","10.1016/s0163-1047(87)90724-2"
"2823167","Buprenorphine has potent kappa opioid receptor antagonist activity","Leander JD.","Neuropharmacology. 1987 Sep;26(9):1445-7. doi: 10.1016/0028-3908(87)90112-2.","Leander JD","Neuropharmacology","1987","1987/09/01","","","10.1016/0028-3908(87)90112-2"
"2823089","Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine","Liu-Chen LY, Phillips CA.","Mol Pharmacol. 1987 Sep;32(3):321-9.","Liu-Chen LY","Mol Pharmacol","1987","1987/09/01","","",""
"2822908","Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice","Takemori AE, Portoghese PS.","J Pharmacol Exp Ther. 1987 Oct;243(1):91-4.","Takemori AE","J Pharmacol Exp Ther","1987","1987/10/01","","",""
"2822439","Effects of beta-funaltrexamine on radiolabeled opioid binding","Recht LD, Pasternak GW.","Eur J Pharmacol. 1987 Aug 11;140(2):209-14. doi: 10.1016/0014-2999(87)90807-7.","Recht LD","Eur J Pharmacol","1987","1987/08/11","","","10.1016/0014-2999(87)90807-7"
"2821555","Quaternary naltrexone reveals the central mediation of conditional opioid analgesia","Calcagnetti DJ, Helmstetter FJ, Fanselow MS.","Pharmacol Biochem Behav. 1987 Jul;27(3):529-31. doi: 10.1016/0091-3057(87)90360-1.","Calcagnetti DJ","Pharmacol Biochem Behav","1987","1987/07/01","","","10.1016/0091-3057(87)90360-1"
"2821554","Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesia","Yoburn BC, Truesdell LS, Kest B, Inturrisi CE, Bodnar RJ.","Pharmacol Biochem Behav. 1987 Jul;27(3):525-7. doi: 10.1016/0091-3057(87)90359-5.","Yoburn BC","Pharmacol Biochem Behav","1987","1987/07/01","","","10.1016/0091-3057(87)90359-5"
"2820832","Multiple opiate receptors and pharmacological response to morphine in rats maintained on diets differing in protein concentration","Bhargava HN, Bansinath M, Das S, Matwyshyn GA.","Gen Pharmacol. 1987;18(5):505-12. doi: 10.1016/0306-3623(87)90071-1.","Bhargava HN","Gen Pharmacol","1987","1987/01/01","","","10.1016/0306-3623(87)90071-1"
"2820433","Does the blockade of opioid receptors influence the development of ethanol dependence?","Kotlińska J, Langwiński R.","Alcohol Alcohol. 1987;22(2):117-9.","Kotlińska J","Alcohol Alcohol","1987","1987/01/01","","",""
"2819908","Adrenalectomy and the anorectic effects of benzodiazepine inverse agonists and opiate antagonists in rats fed a palatable diet","Cooper SJ, Kirkham TC.","Physiol Behav. 1987;40(4):479-82. doi: 10.1016/0031-9384(87)90033-3.","Cooper SJ","Physiol Behav","1987","1987/01/01","","","10.1016/0031-9384(87)90033-3"
"2813479","Central vs. peripheral mediation of opioid effects on alcohol consumption in free-feeding rats","Linseman MA.","Pharmacol Biochem Behav. 1989 Jun;33(2):407-13. doi: 10.1016/0091-3057(89)90523-6.","Linseman MA","Pharmacol Biochem Behav","1989","1989/06/01","","","10.1016/0091-3057(89)90523-6"
"2813473","Discriminative stimulus properties of the mixed agonist-antagonist pentazocine in the rat using two-choice discrete-trial avoidance paradigm","Ukai M, Nakayama S, Hamada T, Kameyama T.","Pharmacol Biochem Behav. 1989 Jun;33(2):355-9. doi: 10.1016/0091-3057(89)90513-3.","Ukai M","Pharmacol Biochem Behav","1989","1989/06/01","","","10.1016/0091-3057(89)90513-3"
"2810122","Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol","De Vry J, Donselaar I, Van Ree JM.","J Pharmacol Exp Ther. 1989 Nov;251(2):735-40.","De Vry J","J Pharmacol Exp Ther","1989","1989/11/01","","",""
"2796595","Stress-induced decrease of 3-methoxytyramine in the nucleus accumbens of the mouse is prevented by naltrexone pretreatment","Cabib S, Oliverio A, Puglisi-Allegra S.","Life Sci. 1989;45(12):1031-7. doi: 10.1016/0024-3205(89)90159-8.","Cabib S","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90159-8"
"2795130","The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine","Bechara A, van der Kooy D.","J Neurosci. 1989 Oct;9(10):3400-9. doi: 10.1523/JNEUROSCI.09-10-03400.1989.","Bechara A","J Neurosci","1989","1989/10/01","PMC6569914","","10.1523/JNEUROSCI.09-10-03400.1989"
"2782866","Responses of lean and obese subjects to preloads, deprivation, and palatability","Spiegel TA, Shrager EE, Stellar E.","Appetite. 1989 Aug;13(1):45-69. doi: 10.1016/0195-6663(89)90026-3.","Spiegel TA","Appetite","1989","1989/08/01","","","10.1016/0195-6663(89)90026-3"
"2780781","Interactions between pentazocine and tripelennamine on autonomic and nociceptive measures in the dog","Vaupel DB.","Pharmacol Biochem Behav. 1989 May;33(1):245-51. doi: 10.1016/0091-3057(89)90457-7.","Vaupel DB","Pharmacol Biochem Behav","1989","1989/05/01","","","10.1016/0091-3057(89)90457-7"
"2780774","Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats","Cooper SJ, Turkish S.","Pharmacol Biochem Behav. 1989 May;33(1):17-20. doi: 10.1016/0091-3057(89)90422-x.","Cooper SJ","Pharmacol Biochem Behav","1989","1989/05/01","","","10.1016/0091-3057(89)90422-x"
"2780578","Chronic naltrexone enhances acquisition of the radial maze task in rats","Spain JW, Newsom GC.","Proc West Pharmacol Soc. 1989;32:141-2.","Spain JW","Proc West Pharmacol Soc","1989","1989/01/01","","",""
"2779401","[Naltrexone and prevention of opiate dependence relapse. An Italian experience]","Cibin M, Gentile N, Ferri M, Gallimberti L.","Minerva Psichiatr. 1989 Apr-Jun;30(2):93-8.","Cibin M","Minerva Psichiatr","1989","1989/04/01","","",""
"2779356","Taste aversion involving central opioid antagonism is potentiated in morphine-dependent rats","Mucha RF.","Life Sci. 1989;45(8):671-8. doi: 10.1016/0024-3205(89)90084-2.","Mucha RF","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90084-2"
"2776584","Comparison of high-dose opioid antagonist effects on ovine fetal cardiovascular function","Dunlap CE 3rd, Valego NK, Rose JC.","Dev Pharmacol Ther. 1989;13(1):28-37. doi: 10.1159/000457578.","Dunlap CE 3rd","Dev Pharmacol Ther","1989","1989/01/01","","","10.1159/000457578"
"2769591","Autism: psychobiological perspectives","Dalton ST, Howell CC.","J Child Adolesc Psychiatr Ment Health Nurs. 1989 Jul-Sep;2(3):92-6. doi: 10.1111/j.1744-6171.1989.tb00367.x.","Dalton ST","J Child Adolesc Psychiatr Ment Health Nurs","1989","1989/07/01","","","10.1111/j.1744-6171.1989.tb00367.x"
"2765984","Opioid modulation of feeding and drinking in fowls","Savory CJ, Gentle MJ, Yeomans MR.","Br Poult Sci. 1989 Jun;30(2):379-92. doi: 10.1080/00071668908417159.","Savory CJ","Br Poult Sci","1989","1989/06/01","","","10.1080/00071668908417159"
"2757588","Place avoidance learning and stress-induced analgesia in the attacked mouse: role of endogenous opioids","Siegfried B, Frischknecht HR.","Behav Neural Biol. 1989 Jul;52(1):95-107. doi: 10.1016/s0163-1047(89)90206-9.","Siegfried B","Behav Neural Biol","1989","1989/07/01","","","10.1016/s0163-1047(89)90206-9"
"2756529","Perturbation of glutathione by a central action of morphine","Skoulis NP, James RC, Harbison RD, Roberts SM.","Toxicology. 1989 Aug;57(3):287-302. doi: 10.1016/0300-483x(89)90117-0.","Skoulis NP","Toxicology","1989","1989/08/01","","","10.1016/0300-483x(89)90117-0"
"2755921","Effects of acute morphine administration on noradrenaline turnover and metabolism in various brain parts of control and handled rats","Attila LM.","Pharmacol Toxicol. 1989 Feb;64(2):202-9. doi: 10.1111/j.1600-0773.1989.tb00631.x.","Attila LM","Pharmacol Toxicol","1989","1989/02/01","","","10.1111/j.1600-0773.1989.tb00631.x"
"2755454","Urine testing in impaired physicians","Croughan J, Sanders K.","Mo Med. 1989 Jun;86(6):341-2.","Croughan J","Mo Med","1989","1989/06/01","","",""
"2752295","Opiate antagonists and self-stimulation: extinction-like response patterns suggest selective reward deficit","Trujillo KA, Belluzzi JD, Stein L.","Brain Res. 1989 Jul 17;492(1-2):15-28. doi: 10.1016/0006-8993(89)90884-6.","Trujillo KA","Brain Res","1989","1989/07/17","","","10.1016/0006-8993(89)90884-6"
"2752072","Opiate antagonist treatment reinstates estrous cycles in middle-aged persistent-estrous rats","Field EA, Kuhn CM.","Biol Reprod. 1989 Apr;40(4):714-9. doi: 10.1095/biolreprod40.4.714.","Field EA","Biol Reprod","1989","1989/04/01","","","10.1095/biolreprod40.4.714"
"2749256","The periaqueductal gray matter mediates opiate-induced immunosuppression","Weber RJ, Pert A.","Science. 1989 Jul 14;245(4914):188-90. doi: 10.1126/science.2749256.","Weber RJ","Science","1989","1989/07/14","","","10.1126/science.2749256"
"2747414","Delayed suppression of serum luteinizing hormone after naloxone treatment in neonatal female rats","Field EA, Kuhn CM.","Life Sci. 1989;44(26):2025-32. doi: 10.1016/0024-3205(89)90348-2.","Field EA","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90348-2"
"2746710","Naltrexone treatment--the problem of patient acceptance","Fram DH, Marmo J, Holden R.","J Subst Abuse Treat. 1989;6(2):119-22. doi: 10.1016/0740-5472(89)90039-1.","Fram DH","J Subst Abuse Treat","1989","1989/01/01","","","10.1016/0740-5472(89)90039-1"
"2745952","Codeine-induced abdominal pain","Wilkinson JE.","J Emerg Med. 1989 May-Jun;7(3):292. doi: 10.1016/0736-4679(89)90365-x.","Wilkinson JE","J Emerg Med","1989","1989/05/01","","","10.1016/0736-4679(89)90365-x"
"2745760","Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis","Monroe EW.","J Am Acad Dermatol. 1989 Jul;21(1):135-6. doi: 10.1016/s0190-9622(89)80353-6.","Monroe EW","J Am Acad Dermatol","1989","1989/07/01","","","10.1016/s0190-9622(89)80353-6"
"2744078","Flupirtine antinociception in the dog is primarily mediated by nonopioid supraspinal mechanisms","Vaupel DB, Nickel B, Becketts K.","Eur J Pharmacol. 1989 Mar 29;162(3):447-56. doi: 10.1016/0014-2999(89)90335-x.","Vaupel DB","Eur J Pharmacol","1989","1989/03/29","","","10.1016/0014-2999(89)90335-x"
"2743133","Repeated noise exposure affects muscarinic cholinergic receptors in the rat brain","Lai H, Carino MA, Wen YF.","Brain Res. 1989 May 29;488(1-2):361-4. doi: 10.1016/0006-8993(89)90731-2.","Lai H","Brain Res","1989","1989/05/29","","","10.1016/0006-8993(89)90731-2"
"2743108","Locus ceruleus discharge characteristics of morphine-dependent rats: effects of naltrexone","Valentino RJ, Wehby RG.","Brain Res. 1989 May 29;488(1-2):126-34. doi: 10.1016/0006-8993(89)90701-4.","Valentino RJ","Brain Res","1989","1989/05/29","","","10.1016/0006-8993(89)90701-4"
"2737720","Opioids in the systemic hemodynamic and renal responses to stress in spontaneously hypertensive rats","Kapusta DR, Jones SY, DiBona GF.","Hypertension. 1989 Jun;13(6 Pt 2):808-16. doi: 10.1161/01.hyp.13.6.808.","Kapusta DR","Hypertension","1989","1989/06/01","","","10.1161/01.hyp.13.6.808"
"2734323","Effects of a low dose of naltrexone on glucose-induced allesthesia and hunger in humans","Melchior JC, Fantino M, Rozen R, Igoin L, Rigaud D, Apfelbaum M.","Pharmacol Biochem Behav. 1989 Jan;32(1):117-21. doi: 10.1016/0091-3057(89)90219-0.","Melchior JC","Pharmacol Biochem Behav","1989","1989/01/01","","","10.1016/0091-3057(89)90219-0"
"2732944","Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen","Lux F, Han YH, Brase DA, Dewey WL.","J Pharmacol Exp Ther. 1989 Jun;249(3):688-93.","Lux F","J Pharmacol Exp Ther","1989","1989/06/01","","",""
"2730746","A naturalistic analytic study of veterans using naltrexone in Puerto Rico","Santos EF.","Bol Asoc Med P R. 1989 Apr;81(4):134-6.","Santos EF","Bol Asoc Med P R","1989","1989/04/01","","",""
"2728958","False positive urine drug screens from quinine in tonic water","Swift RM, Griffiths W, Cammera P.","Addict Behav. 1989;14(2):213-5. doi: 10.1016/0306-4603(89)90051-8.","Swift RM","Addict Behav","1989","1989/01/01","","","10.1016/0306-4603(89)90051-8"
"2727018","Effects of naloxone and naltrexone on memory consolidation in CD1 mice: involvement of GABAergic mechanisms","Castellano C, Introini-Collison IB, Pavone F, McGaugh JL.","Pharmacol Biochem Behav. 1989 Feb;32(2):563-7. doi: 10.1016/0091-3057(89)90197-4.","Castellano C","Pharmacol Biochem Behav","1989","1989/02/01","","","10.1016/0091-3057(89)90197-4"
"2721334","Effects of acute administration of naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children","Herman BH, Hammock MK, Arthur-Smith A, Kuehl K, Appelgate K.","Dev Pharmacol Ther. 1989;12(3):118-27.","Herman BH","Dev Pharmacol Ther","1989","1989/01/01","","",""
"2717513","Isolation of a novel morphinan 3-O-diglucuronide metabolite from dog urine","Dixon R, Hsiao J, Hsu HB, Smulkowski M, Tze-Ming-Chan, Pramanik B, Morton J.","Pharm Res. 1989 Jan;6(1):28-32. doi: 10.1023/a:1015818316854.","Dixon R","Pharm Res","1989","1989/01/01","","","10.1023/a:1015818316854"
"2716954","Comparison of the duration of action of nalmefene and naloxone on the hypothalamic-pituitary axis of the rhesus monkey","VanVugt DA, Webb MY, Reid RL.","Neuroendocrinology. 1989 Mar;49(3):275-80. doi: 10.1159/000125128.","VanVugt DA","Neuroendocrinology","1989","1989/03/01","","","10.1159/000125128"
"2715440","Naltrexone for neurotic excoriations","Smith KC, Pittelkow MR.","J Am Acad Dermatol. 1989 May;20(5 Pt 1):860-1. doi: 10.1016/s0190-9622(89)80130-6.","Smith KC","J Am Acad Dermatol","1989","1989/05/01","","","10.1016/s0190-9622(89)80130-6"
"2714161","Role for opioid peptides in self-injurious behavior: dissociation from autonomic nervous system functioning","Herman BH, Hammock MK, Egan J, Arthur-Smith A, Chatoor I, Werner A.","Dev Pharmacol Ther. 1989;12(2):81-9.","Herman BH","Dev Pharmacol Ther","1989","1989/01/01","","",""
"2702921","A multicentre study to introduce naltrexone for opiate dependence in Spain","García-Alonso F, Gutierrez M, San L, Bedate J, Forteza-Rei J, Rodríguez-Artalejo F, Palop R, López-Alvarez M, Pérez de los Cobos JC, Cami J.","Drug Alcohol Depend. 1989 Apr;23(2):117-21. doi: 10.1016/0376-8716(89)90016-1.","García-Alonso F","Drug Alcohol Depend","1989","1989/04/01","","","10.1016/0376-8716(89)90016-1"
"2701318","Naltrexone in federal probationers","Metzger DS, Cornish J, Woody GE, McLellan AT, Druley P, O'Brien CP.","NIDA Res Monogr. 1989;95:465-6.","Metzger DS","NIDA Res Monogr","1989","1989/01/01","","",""
"2685041","Immunomodulatory effects of footshock in the rat","Jessop JJ, West GL, Sobotka TJ.","J Neuroimmunol. 1989 Dec;25(2-3):241-9. doi: 10.1016/0165-5728(89)90142-2.","Jessop JJ","J Neuroimmunol","1989","1989/12/01","","","10.1016/0165-5728(89)90142-2"
"2681168","Prospects for a rational pharmacotherapy of alcoholism","Meyer RE.","J Clin Psychiatry. 1989 Nov;50(11):403-12.","Meyer RE","J Clin Psychiatry","1989","1989/11/01","","",""
"2676563","Intracerebroventricular N-ethylmaleimide differentially reduces supraspinal opioid analgesia in mice","Sánchez-Blázquez P, Ulibarri I, Garzón J.","Eur J Pharmacol. 1989 Jul 18;166(2):193-200. doi: 10.1016/0014-2999(89)90059-9.","Sánchez-Blázquez P","Eur J Pharmacol","1989","1989/07/18","","","10.1016/0014-2999(89)90059-9"
"2675644","Rapid detoxification from opioid dependence","Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD.","Am J Psychiatry. 1989 Oct;146(10):1349. doi: 10.1176/ajp.146.10.1349a.","Kosten TR","Am J Psychiatry","1989","1989/10/01","","","10.1176/ajp.146.10.1349a"
"2671240","The implication of opiates in the glucocorticoid-mediated inhibition of LH secretion in rats","Belhadj H, de Besi L, Bardin CW, Thau RB.","J Endocrinol. 1989 Aug;122(2):451-6. doi: 10.1677/joe.0.1220451.","Belhadj H","J Endocrinol","1989","1989/08/01","","","10.1677/joe.0.1220451"
"2666229","[Naltrexone]","Schifano F, Murri R, Gava R.","G Clin Med. 1989 May;70(5):379-84.","Schifano F","G Clin Med","1989","1989/05/01","","",""
"2662222","Inhibition of drinking by naltrexone in the rat: interaction with the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride","Ukai M, Nakayama S, Kameyama T.","Pharmacol Biochem Behav. 1989 Mar;32(3):651-5. doi: 10.1016/0091-3057(89)90012-9.","Ukai M","Pharmacol Biochem Behav","1989","1989/03/01","","","10.1016/0091-3057(89)90012-9"
"2662135","[Hypothalamic dysfunction. 2 cases: the contribution of nuclear magnetic resonance, therapeutic trial of naltrexone]","Loeuille GA, de Parscau L, Ythier H, Beaufrere B, Chatelain P, François R.","Pediatrie. 1989;44(3):203-12.","Loeuille GA","Pediatrie","1989","1989/01/01","","",""
"2656781","A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia","Mitchell JE, Christenson G, Jennings J, Huber M, Thomas B, Pomeroy C, Morley J.","J Clin Psychopharmacol. 1989 Apr;9(2):94-7. doi: 10.1097/00004714-198904000-00004.","Mitchell JE","J Clin Psychopharmacol","1989","1989/04/01","","","10.1097/00004714-198904000-00004"
"2655671","Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis","Barrett RP, Feinstein C, Hole WT.","Am J Ment Retard. 1989 May;93(6):644-51.","Barrett RP","Am J Ment Retard","1989","1989/05/01","","",""
"2645889","Duration of antagonistic effects of nalmefene and naloxone in opiate-induced sedation for emergency department procedures","Barsan WG, Seger D, Danzl DF, Ling LJ, Bartlett R, Buncher R, Bryan C.","Am J Emerg Med. 1989 Mar;7(2):155-61. doi: 10.1016/0735-6757(89)90128-9.","Barsan WG","Am J Emerg Med","1989","1989/03/01","","","10.1016/0735-6757(89)90128-9"
"2641056","NIDA's Medication Development Program--1989","Schuster CR, Snyder M.","NIDA Res Monogr. 1989;95:64-73.","Schuster CR","NIDA Res Monogr","1989","1989/01/01","","",""
"2641028","A dose run-up and safety evaluation of nalmefene HCl in human volunteers","Fudala PJ, Johnson RE, Heishman SJ, Cone EJ, Henningfield JE.","NIDA Res Monogr. 1989;95:451-2.","Fudala PJ","NIDA Res Monogr","1989","1989/01/01","","",""
"2640973","Naltrexone discrimination in morphine-treated monkeys","France CP, Woods JH.","NIDA Res Monogr. 1989;95:298-9.","France CP","NIDA Res Monogr","1989","1989/01/01","","",""
"2636709","Activation of brainstem endorphinergic neurons causes cardiovascular depression and facilitates baroreflex bradycardia","Mastrianni JA, Palkovits M, Kunos G.","Neuroscience. 1989;33(3):559-66. doi: 10.1016/0306-4522(89)90408-9.","Mastrianni JA","Neuroscience","1989","1989/01/01","","","10.1016/0306-4522(89)90408-9"
"2635083","[Naltrexone in narcolepsy. Initial experience]","Sonka K, Roth B, Posmurová M.","Cesk Neurol Neurochir. 1989 Oct;52(6):429-31.","Sonka K","Cesk Neurol Neurochir","1989","1989/10/01","","",""
"2629740","Naltrexone and clonidine in heroin withdrawal treatment","Drummond DC, Turkington D.","Br J Psychiatry. 1989 Apr;154:571-2. doi: 10.1192/bjp.154.4.571.","Drummond DC","Br J Psychiatry","1989","1989/04/01","","","10.1192/bjp.154.4.571"
"2624962","[The opiate antagonist, naltrexone, in the treatment of anovulation and premenstrual syndrome]","Presl J, Divila F.","Cesk Gynekol. 1989 Nov;54(9):710-2.","Presl J","Cesk Gynekol","1989","1989/11/01","","",""
"2624852","Advancement of first ovulation by the opioid antagonist naltrexone","Meijs-Roelofs HM, Kramer P.","Biol Reprod. 1989 Nov;41(5):842-7. doi: 10.1095/biolreprod41.5.842.","Meijs-Roelofs HM","Biol Reprod","1989","1989/11/01","","","10.1095/biolreprod41.5.842"
"2622523","Caerulein-induced antinociception: interaction with morphine and opioid antagonists in the rat","Rattray M, Jordan CC, de Belleroche J.","Neuropeptides. 1989 Nov-Dec;14(4):263-8. doi: 10.1016/0143-4179(89)90055-3.","Rattray M","Neuropeptides","1989","1989/11/01","","","10.1016/0143-4179(89)90055-3"
"2618077","Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans","Kotake AN, Kuwahara SK, Burton E, McCoy CE, Goldberg LI.","Xenobiotica. 1989 Nov;19(11):1247-54. doi: 10.3109/00498258909043176.","Kotake AN","Xenobiotica","1989","1989/11/01","","","10.3109/00498258909043176"
"2616603","Effect of naltrexone on relaxation induced by flank pressure in pigs","Grandin T, Dodman N, Shuster L.","Pharmacol Biochem Behav. 1989 Aug;33(4):839-42. doi: 10.1016/0091-3057(89)90479-6.","Grandin T","Pharmacol Biochem Behav","1989","1989/08/01","","","10.1016/0091-3057(89)90479-6"
"2601582","Possible dopaminergic system involvement in LH and PRL responses to naltrexone treatment","Yogev L, Gottreich A, Homonnai ZT, Paz GF.","Life Sci. 1989;45(24):2343-9. doi: 10.1016/0024-3205(89)90116-1.","Yogev L","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90116-1"
"2598056","Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis","Rasmussen K, Aghajanian GK.","Brain Res. 1989 Dec 29;505(2):346-50. doi: 10.1016/0006-8993(89)91466-2.","Rasmussen K","Brain Res","1989","1989/12/29","","","10.1016/0006-8993(89)91466-2"
"2598052","Effects of intracerebroventricular infusions of naltrexone and phentolamine on central and peripheral oxytocin release and on maternal behaviour induced by vaginocervical stimulation in the ewe","Kendrick KM, Keverne EB.","Brain Res. 1989 Dec 29;505(2):329-32. doi: 10.1016/0006-8993(89)91462-5.","Kendrick KM","Brain Res","1989","1989/12/29","","","10.1016/0006-8993(89)91462-5"
"2594167","Naltrexone blocks nicotine-induced prolactin release","Flores CM, Hulihan-Giblin BA, Kellar KJ.","Neuropharmacology. 1989 Nov;28(11):1287-90. doi: 10.1016/0028-3908(89)90225-6.","Flores CM","Neuropharmacology","1989","1989/11/01","","","10.1016/0028-3908(89)90225-6"
"2592592","Reversal of self-abusive behavior with naltrexone","Lienemann J, Walker FD.","J Clin Psychopharmacol. 1989 Dec;9(6):448-9. doi: 10.1097/00004714-198912000-00022.","Lienemann J","J Clin Psychopharmacol","1989","1989/12/01","","","10.1097/00004714-198912000-00022"
"2589564","Naltrexone for treatment of self-injury","Lienemann J, Walker F.","Am J Psychiatry. 1989 Dec;146(12):1639-40. doi: 10.1176/ajp.146.12.1639b.","Lienemann J","Am J Psychiatry","1989","1989/12/01","","","10.1176/ajp.146.12.1639b"
"2588819","Simultaneous identification and quantification of several opiates and derivatives by capillary gas chromatography and nitrogen selective detection","Kintz P, Mangin P, Lugnier AA, Chaumont AJ.","Z Rechtsmed. 1989;103(1):57-62. doi: 10.1007/BF01255847.","Kintz P","Z Rechtsmed","1989","1989/01/01","","","10.1007/BF01255847"
"2587611","Suppression of juvenile social behavior requires antagonism of central opioid systems","Jalowiec JE, Calcagnetti DJ, Fanselow MS.","Pharmacol Biochem Behav. 1989 Jul;33(3):697-700. doi: 10.1016/0091-3057(89)90409-7.","Jalowiec JE","Pharmacol Biochem Behav","1989","1989/07/01","","","10.1016/0091-3057(89)90409-7"
"2582304","Chloroacryloyl amides and alpha-methylenelactones from naltrexone, oxymorphone and fentanyl","Archer S, Michael J, Michael M, Simon EJ, Abdelhamid EM, Nelson WL, Koolpe GA.","Neuropeptides. 1985 Feb;5(4-6):395-8. doi: 10.1016/0143-4179(85)90037-x.","Archer S","Neuropeptides","1985","1985/02/01","","","10.1016/0143-4179(85)90037-x"
"2578990","The narcotic antagonist naltrexone has a biphasic effect on the nicotinic acetylcholine receptor","Madsen BW, Albuquerque EX.","FEBS Lett. 1985 Mar 11;182(1):20-4. doi: 10.1016/0014-5793(85)81145-5.","Madsen BW","FEBS Lett","1985","1985/03/11","","","10.1016/0014-5793(85)81145-5"
"2577060","Some central effects of opioid antagonists. Part I","Skorupska M, Langwiński R.","Pol J Pharmacol Pharm. 1989 Sep-Oct;41(5):401-11.","Skorupska M","Pol J Pharmacol Pharm","1989","1989/09/01","","",""
"2576452","Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramine","Benkelfat C, Aulakh CS, Bykov V, Rice KC, De Costa BR, Rothman RB.","J Pharm Pharmacol. 1989 Dec;41(12):865-7. doi: 10.1111/j.2042-7158.1989.tb06390.x.","Benkelfat C","J Pharm Pharmacol","1989","1989/12/01","","","10.1111/j.2042-7158.1989.tb06390.x"
"2576140","Mechanisms involved in the respiratory depressant actions of nicotine in anesthetized rats","Sloan JW, Martin WR, Bostwick M.","Pharmacol Biochem Behav. 1989 Nov;34(3):559-64. doi: 10.1016/0091-3057(89)90558-3.","Sloan JW","Pharmacol Biochem Behav","1989","1989/11/01","","","10.1016/0091-3057(89)90558-3"
"2576139","The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat","Crisp T, Stafinsky JL, Boja JW, Schechter MD.","Pharmacol Biochem Behav. 1989 Nov;34(3):497-501. doi: 10.1016/0091-3057(89)90547-9.","Crisp T","Pharmacol Biochem Behav","1989","1989/11/01","","","10.1016/0091-3057(89)90547-9"
"2575491","Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys","Reuning RH, Ashcraft SB, Wiley JN, Morrison BE.","Drug Metab Dispos. 1989 Nov-Dec;17(6):583-9.","Reuning RH","Drug Metab Dispos","1989","1989/11/01","","",""
"2574738","Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17)","Fujimoto JM, Rady JJ.","J Pharmacol Exp Ther. 1989 Dec;251(3):1045-52.","Fujimoto JM","J Pharmacol Exp Ther","1989","1989/12/01","","",""
"2571452","Schistosomiasis: role of endogenous opioids in suppression of gonadal steroid secretion","Isseroff H, Sylvester PW, Bessette CL, Jones PL, Fisher WG, Rynkowski TA, Gregor KR.","Comp Biochem Physiol A Comp Physiol. 1989;94(1):41-5. doi: 10.1016/0300-9629(89)90781-0.","Isseroff H","Comp Biochem Physiol A Comp Physiol","1989","1989/01/01","","","10.1016/0300-9629(89)90781-0"
"2571391","Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine","Long JB, Rigamonti DD, de Costa B, Rice KC, Martinez-Arizala A.","Brain Res. 1989 Sep 11;497(1):155-62. doi: 10.1016/0006-8993(89)90982-7.","Long JB","Brain Res","1989","1989/09/11","","","10.1016/0006-8993(89)90982-7"
"2571138","Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and beta-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus","Lipa SM, Kavaliers M, Ossenkopp KP.","Peptides. 1989 May-Jun;10(3):493-7. doi: 10.1016/0196-9781(89)90134-4.","Lipa SM","Peptides","1989","1989/05/01","","","10.1016/0196-9781(89)90134-4"
"2571107","Hypothermia elicited by some prodynorphin-derived peptides: opioid and non-opioid actions","Cavicchini E, Candeletti S, Spampinato S, Ferri S.","Neuropeptides. 1989 Jul;14(1):45-50. doi: 10.1016/0143-4179(89)90033-4.","Cavicchini E","Neuropeptides","1989","1989/07/01","","","10.1016/0143-4179(89)90033-4"
"2570868","Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide","Fanselow MS, Calcagnetti DJ, Helmstetter FJ.","J Pharmacol Exp Ther. 1989 Sep;250(3):825-30.","Fanselow MS","J Pharmacol Exp Ther","1989","1989/09/01","","",""
"2570759","Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin","Maestroni GJ, Conti A.","Int J Immunopharmacol. 1989;11(4):333-40. doi: 10.1016/0192-0561(89)90078-7.","Maestroni GJ","Int J Immunopharmacol","1989","1989/01/01","","","10.1016/0192-0561(89)90078-7"
"2569405","Spinal beta-endorphin analgesia involves an interaction with local monoaminergic systems","Crisp T, Stafinsky JL, Hess JE, Uram M.","Eur J Pharmacol. 1989 Jan 31;160(2):211-7. doi: 10.1016/0014-2999(89)90493-7.","Crisp T","Eur J Pharmacol","1989","1989/01/31","","","10.1016/0014-2999(89)90493-7"
"2569217","Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated","Bals-Kubik R, Herz A, Shippenberg TS.","Psychopharmacology (Berl). 1989;98(2):203-6. doi: 10.1007/BF00444692.","Bals-Kubik R","Psychopharmacology (Berl)","1989","1989/01/01","","","10.1007/BF00444692"
"2568626","The involvement of opioid peptides in stress-induced analgesia in the slug Arion ater","Dalton LM, Widdowson PS.","Peptides. 1989 Jan-Feb;10(1):9-13. doi: 10.1016/0196-9781(89)90067-3.","Dalton LM","Peptides","1989","1989/01/01","","","10.1016/0196-9781(89)90067-3"
"2568475","Effects of opioid agonists on urine production in neonatal rats","Jackson HC, Kitchen I.","J Pharm Pharmacol. 1989 Apr;41(4):281-3. doi: 10.1111/j.2042-7158.1989.tb06455.x.","Jackson HC","J Pharm Pharmacol","1989","1989/04/01","","","10.1111/j.2042-7158.1989.tb06455.x"
"2568435","Lack of mixed agonist-antagonist properties of [Gln8-Gly31]-beta h-EP-Gly-Gly-NH2 and [Arg9,19,24,28,29]-beta h-EP in the rat vas deferens neuroeffector junction: studies with naloxone, beta-funaltrexamine and ICI 174,864","Valenzuela R, Li CH, Huidobro-Toro JP.","J Pharm Pharmacol. 1989 Feb;41(2):92-6. doi: 10.1111/j.2042-7158.1989.tb06400.x.","Valenzuela R","J Pharm Pharmacol","1989","1989/02/01","","","10.1111/j.2042-7158.1989.tb06400.x"
"2566949","Fentanyl produces cholinergically-mediated analeptic and EEG arousal effects in rats","Horita A, Carino MA, Chinn C.","Neuropharmacology. 1989 May;28(5):481-6. doi: 10.1016/0028-3908(89)90083-x.","Horita A","Neuropharmacology","1989","1989/05/01","","","10.1016/0028-3908(89)90083-x"
"2565240","Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect","Sánchez-Blázquez P, Garzón J.","Eur J Pharmacol. 1989 Jan 2;159(1):9-23. doi: 10.1016/0014-2999(89)90038-1.","Sánchez-Blázquez P","Eur J Pharmacol","1989","1989/01/02","","","10.1016/0014-2999(89)90038-1"
"2561836","Delta opioid receptor selective alkaloid agonists and antagonists","Woods JH, DeCosta B, Jacobson AE, Rice KC, Medzihradsky F, Smith CB, Comer S, France CP, Winger G.","NIDA Res Monogr. 1989;95:300-1.","Woods JH","NIDA Res Monogr","1989","1989/01/01","","",""
"2561827","Mu antagonist and kappa agonist properties of b-funaltrexamine (b-FNA): long lasting spinal antinociception","Jiang Q, Heyman JS, Porreca F.","NIDA Res Monogr. 1989;95:199-205.","Jiang Q","NIDA Res Monogr","1989","1989/01/01","","",""
"2561826","Site-directed affinity ligands as tools to study the phenomenology and mechanisms of morphine-induced upregulation of opioid receptors","Rothman RB, Long JB, Bykov V, Rice KC, Holaday JW.","NIDA Res Monogr. 1989;95:192-8.","Rothman RB","NIDA Res Monogr","1989","1989/01/01","","",""
"2561526","Evidence for the presence of disulfide bridges in opioid receptors essential for ligand binding. Possible role in receptor activation","Gioannini TL, Liu YF, Park YH, Hiller JM, Simon EJ.","J Mol Recognit. 1989 Jul;2(1):44-8. doi: 10.1002/jmr.300020107.","Gioannini TL","J Mol Recognit","1989","1989/07/01","","","10.1002/jmr.300020107"
"2561015","[Atrial natriuretic peptide response to physical exercise is inhibited by an antagonist of the opioid receptors]","Lartigue M, Louisy F, Habrioux G, Guezennec CY, Galen FX.","Pathol Biol (Paris). 1989 Sep;37(7):831-5.","Lartigue M","Pathol Biol (Paris)","1989","1989/09/01","","",""
"2560207","Effects of opiate agonists and an antagonist on food intake and brain neurotransmitters in normophagic and obese ""cafeteria"" rats","Robert JJ, Orosco M, Rouch C, Jacquot C, Cohen Y.","Pharmacol Biochem Behav. 1989 Nov;34(3):577-83. doi: 10.1016/0091-3057(89)90561-3.","Robert JJ","Pharmacol Biochem Behav","1989","1989/11/01","","","10.1016/0091-3057(89)90561-3"
"2559974","Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions","Evans RG, Ludbrook J, Van Leeuwen AF.","J Physiol. 1989 Dec;419:15-31. doi: 10.1113/jphysiol.1989.sp017858.","Evans RG","J Physiol","1989","1989/12/01","PMC1189993","","10.1113/jphysiol.1989.sp017858"
"2559854","Chronic opioid antagonist treatment: assessment of receptor upregulation","Yoburn BC, Sierra V, Lutfy K.","Eur J Pharmacol. 1989 Nov 7;170(3):193-200. doi: 10.1016/0014-2999(89)90539-6.","Yoburn BC","Eur J Pharmacol","1989","1989/11/07","","","10.1016/0014-2999(89)90539-6"
"2559353","Exploring delta-receptor function using the selective opioid antagonist naltrindole","Jackson HC, Ripley TL, Nutt DJ.","Neuropharmacology. 1989 Dec;28(12):1427-30. doi: 10.1016/0028-3908(89)90022-1.","Jackson HC","Neuropharmacology","1989","1989/12/01","","","10.1016/0028-3908(89)90022-1"
"2559274","Lack of effect of the opioid antagonist, naltrexone, on the in situ growth of C-1300, N1E-115 and NS206 murine neuroblastoma tumor cell lines","Horn PT, Mirkin BL.","Life Sci. 1989;45(26):2539-45. doi: 10.1016/0024-3205(89)90237-3.","Horn PT","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90237-3"
"2558895","Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats","Fukagawa Y, Katz JL, Suzuki T.","Eur J Pharmacol. 1989 Oct 24;170(1-2):47-51. doi: 10.1016/0014-2999(89)90132-5.","Fukagawa Y","Eur J Pharmacol","1989","1989/10/24","","","10.1016/0014-2999(89)90132-5"
"2558367","Endogenous opioid peptides in the control of food intake in cats","Bado A, Rozé C, Lewin MJ, Dubrasquet M.","Peptides. 1989 Sep-Oct;10(5):967-71. doi: 10.1016/0196-9781(89)90177-0.","Bado A","Peptides","1989","1989/09/01","","","10.1016/0196-9781(89)90177-0"
"2558265","Kappa opioid receptors of human placental villi modulate acetylcholine release","Ahmed MS, Schoof T, Zhou DH, Quarles C.","Life Sci. 1989;45(25):2383-93. doi: 10.1016/0024-3205(89)90001-5.","Ahmed MS","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90001-5"
"2557287","From theory to practice: the planned treatment of drug users. Interview by Stanley Einstein","Woody G.","Int J Addict. 1989 Jul;24(7):675-706. doi: 10.3109/10826088909047306.","Woody G","Int J Addict","1989","1989/07/01","","","10.3109/10826088909047306"
"2557223","Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists","Heyman JS, Jiang Q, Rothman RB, Mosberg HI, Porreca F.","Eur J Pharmacol. 1989 Oct 4;169(1):43-52. doi: 10.1016/0014-2999(89)90815-7.","Heyman JS","Eur J Pharmacol","1989","1989/10/04","","","10.1016/0014-2999(89)90815-7"
"2557144","The role of aberrant hypothalamic opiatergic function in generating polycystic ovaries in the rat","Carriere PD, Farookhi R, Brawer JR.","Can J Physiol Pharmacol. 1989 Aug;67(8):896-901. doi: 10.1139/y89-140.","Carriere PD","Can J Physiol Pharmacol","1989","1989/08/01","","","10.1139/y89-140"
"2556617","Effects of the selective kappa opioid antagonist, nor-binaltorphimine, on electrically-elicited feeding in the rat","Carr KD, Bak TH, Simon EJ, Portoghese PS.","Life Sci. 1989;45(19):1787-92. doi: 10.1016/0024-3205(89)90518-3.","Carr KD","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90518-3"
"2556507","Identification of morphine- and cyclic AMP-regulated phosphoproteins (MARPPs) in the locus coeruleus and other regions of rat brain: regulation by acute and chronic morphine","Guitart X, Nestler EJ.","J Neurosci. 1989 Dec;9(12):4371-87. doi: 10.1523/JNEUROSCI.09-12-04371.1989.","Guitart X","J Neurosci","1989","1989/12/01","PMC6569648","","10.1523/JNEUROSCI.09-12-04371.1989"
"2556199","Delta-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones","Sullivan AF, Dickenson AH, Roques BP.","Br J Pharmacol. 1989 Nov;98(3):1039-49. doi: 10.1111/j.1476-5381.1989.tb14636.x.","Sullivan AF","Br J Pharmacol","1989","1989/11/01","PMC1854772","","10.1111/j.1476-5381.1989.tb14636.x"
"2555877","The therapeutic efficacy of opiate antagonists in hemorrhagic shock","Reynolds DG, Gurll NJ, Holaday JW, Lechner RB.","Resuscitation. 1989 Dec;18(2-3):243-51. doi: 10.1016/0300-9572(89)90026-9.","Reynolds DG","Resuscitation","1989","1989/12/01","","","10.1016/0300-9572(89)90026-9"
"2555188","Influence of endogenous opioids on atrial natriuretic factor release during exercise in man","Louisy F, Guezennec CY, Lartigue M, Aldigier JC, Galen FX.","Eur J Appl Physiol Occup Physiol. 1989;59(1-2):34-8. doi: 10.1007/BF02396577.","Louisy F","Eur J Appl Physiol Occup Physiol","1989","1989/01/01","","","10.1007/BF02396577"
"2555131","Rate-sensitive glucocorticoid feedback inhibition of adrenocorticotropin and beta-endorphin/beta-lipotropin secretion in rats","De Souza EB, Van Loon GR.","Endocrinology. 1989 Dec;125(6):2927-34. doi: 10.1210/endo-125-6-2927.","De Souza EB","Endocrinology","1989","1989/12/01","","","10.1210/endo-125-6-2927"
"2554190","Opioid systems in the amygdala can serve as substrate for the behavioral effects of the ACTH-(4-9) analog ORG 2766","Wolterink G, Van Ree JM.","Neuropeptides. 1989 Aug-Sep;14(2):129-36. doi: 10.1016/0143-4179(89)90070-x.","Wolterink G","Neuropeptides","1989","1989/08/01","","","10.1016/0143-4179(89)90070-x"
"2553926","A mu-specific opioid peptide agonist increases excitability of pyramidal neurons in untreated and receptor up-regulated hippocampus","Moudy AM, Coscia CJ, Laskowski MB.","J Pharmacol Exp Ther. 1989 Nov;251(2):536-42.","Moudy AM","J Pharmacol Exp Ther","1989","1989/11/01","","",""
"2553917","Effects of chronic morphine administration on the mu and delta opioid responses in the CA1 region of the rat hippocampus","Wimpey TL, Opheim KE, Chavkin C.","J Pharmacol Exp Ther. 1989 Nov;251(2):405-11.","Wimpey TL","J Pharmacol Exp Ther","1989","1989/11/01","","",""
"2553059","Ontogeny of noradrenergic effects on ultrasonic vocalizations in rat pups","Kehoe P, Harris JC.","Behav Neurosci. 1989 Oct;103(5):1099-107. doi: 10.1037//0735-7044.103.5.1099.","Kehoe P","Behav Neurosci","1989","1989/10/01","","","10.1037//0735-7044.103.5.1099"
"2552732","Effects of opioid receptor antagonists on morphine-induced stupor in rabbits","Fiserová M, Metys J.","Act Nerv Super (Praha). 1989 Jun;31(2):131-2.","Fiserová M","Act Nerv Super (Praha)","1989","1989/06/01","","",""
"2552241","A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalin","Vaughn LK, Knapp RJ, Toth G, Wan YP, Hruby VJ, Yamamura HI.","Life Sci. 1989;45(11):1001-8. doi: 10.1016/0024-3205(89)90154-9.","Vaughn LK","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90154-9"
"2551454","Participation of opiate receptors located in the nucleus tractus solitarii in the hypotension induced by alpha-methyldopa","Van Giersbergen PL, Roording P, de Lang H, de Jong W.","Brain Res. 1989 Sep 25;498(1):154-8. doi: 10.1016/0006-8993(89)90412-5.","Van Giersbergen PL","Brain Res","1989","1989/09/25","","","10.1016/0006-8993(89)90412-5"
"2550943","In vitro comparison of efficacies of ""full"" kappa opioid agonists","Wire WS, Kramer TH, Burks TF.","Proc West Pharmacol Soc. 1989;32:177-81.","Wire WS","Proc West Pharmacol Soc","1989","1989/01/01","","",""
"2550623","Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys","France CP, Woods JH.","J Pharmacol Exp Ther. 1989 Sep;250(3):937-43.","France CP","J Pharmacol Exp Ther","1989","1989/09/01","","",""
"2550622","Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys","France CP, Morse WH.","J Pharmacol Exp Ther. 1989 Sep;250(3):928-36.","France CP","J Pharmacol Exp Ther","1989","1989/09/01","","",""
"2550615","Inhibition of vagal transmission by cardiac sympathetic nerve stimulation in the dog: possible involvement of opioid receptor","Koyanagawa H, Musha T, Kanda A, Kimura T, Satoh S.","J Pharmacol Exp Ther. 1989 Sep;250(3):1092-6.","Koyanagawa H","J Pharmacol Exp Ther","1989","1989/09/01","","",""
"2549557","Naltrexone potentiates glycemic responses during stress and epinephrine challenge in genetically obese mice","McCubbin JA, Surwit RS, Kuhn CM, Cochrane C, Feinglos MN.","Psychosom Med. 1989 Jul-Aug;51(4):441-8. doi: 10.1097/00006842-198907000-00007.","McCubbin JA","Psychosom Med","1989","1989/07/01","","","10.1097/00006842-198907000-00007"
"2549147","Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes","Carr DJ, DeCosta BR, Kim CH, Jacobson AE, Guarcello V, Rice KC, Blalock JE.","J Endocrinol. 1989 Jul;122(1):161-8. doi: 10.1677/joe.0.1220161.","Carr DJ","J Endocrinol","1989","1989/07/01","","","10.1677/joe.0.1220161"
"2548676","Beta-funaltrexamine disrupts the day-night rhythm of nociception in mice","Kavaliers M.","Brain Res Bull. 1989 May;22(5):783-5. doi: 10.1016/0361-9230(89)90020-8.","Kavaliers M","Brain Res Bull","1989","1989/05/01","","","10.1016/0361-9230(89)90020-8"
"2548533","Procedures that produce context-specific tolerance to morphine in rats also produce context-specific withdrawal","Falls WA, Kelsey JE.","Behav Neurosci. 1989 Aug;103(4):842-9. doi: 10.1037//0735-7044.103.4.842.","Falls WA","Behav Neurosci","1989","1989/08/01","","","10.1037//0735-7044.103.4.842"
"2548531","Effects of opiate antagonists and their quaternary analogues on nucleus accumbens self-stimulation","Trujillo KA, Belluzzi JD, Stein L.","Behav Brain Res. 1989 Jun 1;33(2):181-8. doi: 10.1016/s0166-4328(89)80049-x.","Trujillo KA","Behav Brain Res","1989","1989/06/01","","","10.1016/s0166-4328(89)80049-x"
"2547002","Effects of selective opioid-receptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat","Cover PO, Buckingham JC.","J Endocrinol. 1989 May;121(2):213-20. doi: 10.1677/joe.0.1210213.","Cover PO","J Endocrinol","1989","1989/05/01","","","10.1677/joe.0.1210213"
"2546089","MU and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice","Michael-Titus A, Dourmap N, Costentin J.","Neuropeptides. 1989 May-Jun;13(4):235-42. doi: 10.1016/0143-4179(89)90076-0.","Michael-Titus A","Neuropeptides","1989","1989/05/01","","","10.1016/0143-4179(89)90076-0"
"2546087","Involvement of opioid and dopaminergic systems in isolation-induced pinning and social grooming of young rats","Niesink RJ, Van Ree JM.","Neuropharmacology. 1989 Apr;28(4):411-8. doi: 10.1016/0028-3908(89)90038-5.","Niesink RJ","Neuropharmacology","1989","1989/04/01","","","10.1016/0028-3908(89)90038-5"
"2544904","Novelty-induced place preference behavior in rats: effects of opiate and dopaminergic drugs","Bardo MT, Neisewander JL, Pierce RC.","Pharmacol Biochem Behav. 1989 Mar;32(3):683-9. doi: 10.1016/0091-3057(89)90018-x.","Bardo MT","Pharmacol Biochem Behav","1989","1989/03/01","","","10.1016/0091-3057(89)90018-x"
"2544207","Modulation of appetitively and aversively motivated behavior by the kappa opioid antagonist MR2266","Fanselow MS, Calcagnetti DJ, Helmstetter FJ.","Behav Neurosci. 1989 Jun;103(3):663-72. doi: 10.1037//0735-7044.103.3.663.","Fanselow MS","Behav Neurosci","1989","1989/06/01","","","10.1037//0735-7044.103.3.663"
"2543996","Endorphins in male impotence: evidence for naltrexone stimulation of erectile activity in patient therapy","Fabbri A, Jannini EA, Gnessi L, Moretti C, Ulisse S, Franzese A, Lazzari R, Fraioli F, Frajese G, Isidori A.","Psychoneuroendocrinology. 1989;14(1-2):103-11. doi: 10.1016/0306-4530(89)90059-0.","Fabbri A","Psychoneuroendocrinology","1989","1989/01/01","","","10.1016/0306-4530(89)90059-0"
"2543480","Long-lasting effects of naltrexone, an opioid receptor antagonist, on cell proliferation in developing rat forebrain","Schmahl W, Funk R, Miaskowski U, Plendl J.","Brain Res. 1989 May 8;486(2):297-300. doi: 10.1016/0006-8993(89)90515-5.","Schmahl W","Brain Res","1989","1989/05/08","","","10.1016/0006-8993(89)90515-5"
"2542985","Up-regulation of opiate receptors following chronic naltrexone treatment in mature and aged male and female rats","Neisewander JL, Rowlett JK, Nonneman AJ, Bardo MT.","Prog Clin Biol Res. 1989;292:471-6.","Neisewander JL","Prog Clin Biol Res","1989","1989/01/01","","",""
"2542355","Naloxone antagonism of corticotropin-releasing hormone stimulation of prolactin secretion in rhesus monkeys","Vanvugt DA, Webb MY, Reid RL.","J Clin Endocrinol Metab. 1989 Jun;68(6):1060-6. doi: 10.1210/jcem-68-6-1060.","Vanvugt DA","J Clin Endocrinol Metab","1989","1989/06/01","","","10.1210/jcem-68-6-1060"
"2541864","Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia","Yoburn BC, Paul D, Azimuddin S, Lutfy K, Sierra V.","Brain Res. 1989 Apr 17;485(1):176-8. doi: 10.1016/0006-8993(89)90680-x.","Yoburn BC","Brain Res","1989","1989/04/17","","","10.1016/0006-8993(89)90680-x"
"2541848","Estimation of affinities and efficacies for kappa-receptor agonists in guinea-pig ileum","Leff P, Dougall IG.","Br J Pharmacol. 1989 Mar;96(3):702-6. doi: 10.1111/j.1476-5381.1989.tb11871.x.","Leff P","Br J Pharmacol","1989","1989/03/01","PMC1854379","","10.1111/j.1476-5381.1989.tb11871.x"
"2540993","Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites","Rothman RB, Bykov V, Long JB, Brady LS, Jacobson AE, Rice KC, Holaday JW.","Eur J Pharmacol. 1989 Jan 24;160(1):71-82. doi: 10.1016/0014-2999(89)90655-9.","Rothman RB","Eur J Pharmacol","1989","1989/01/24","","","10.1016/0014-2999(89)90655-9"
"2540873","Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors","Zagon IS, McLaughlin PJ.","Brain Res. 1989 Feb 20;480(1-2):16-28. doi: 10.1016/0006-8993(89)91562-x.","Zagon IS","Brain Res","1989","1989/02/20","","","10.1016/0006-8993(89)91562-x"
"2540341","Paradoxical and subtype-specific effects of opiate antagonists on the expression of opioid receptors in rat brain cultures","Barg J, Levy R, Simantov R.","J Neurosci Res. 1989 Mar;22(3):322-30. doi: 10.1002/jnr.490220312.","Barg J","J Neurosci Res","1989","1989/03/01","","","10.1002/jnr.490220312"
"2539919","Adrenal vein catecholamines and met-enkephalin during staged hemorrhage and naltrexone administration in cats","Gaumann DM, Yaksh TL, Dousa MK, Tyce GM.","Circ Shock. 1989 Feb;27(2):139-54.","Gaumann DM","Circ Shock","1989","1989/02/01","","",""
"2539839","Conditioned opioid release in ten-day-old rats","Kehoe P, Blass EM.","Behav Neurosci. 1989 Apr;103(2):423-8. doi: 10.1037//0735-7044.103.2.423.","Kehoe P","Behav Neurosci","1989","1989/04/01","","","10.1037//0735-7044.103.2.423"
"2539457","Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys","Bergman J, Warren PH.","J Pharmacol Exp Ther. 1989 Mar;248(3):1102-8.","Bergman J","J Pharmacol Exp Ther","1989","1989/03/01","","",""
"2539453","Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand","Holtzman SG.","J Pharmacol Exp Ther. 1989 Mar;248(3):1054-62.","Holtzman SG","J Pharmacol Exp Ther","1989","1989/03/01","","",""
"2538689","Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model","Tortella FC, Echevarria E, Lipkowski AW, Takemori AE, Portoghese PS, Holaday JW.","Life Sci. 1989;44(10):661-5. doi: 10.1016/0024-3205(89)90470-0.","Tortella FC","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90470-0"
"2538562","Relationship between opioid-receptor occupancy and stimulation of low-Km GTPase in brain membranes","Clark MJ, Nordby GL, Medzihradsky F.","J Neurochem. 1989 Apr;52(4):1162-9. doi: 10.1111/j.1471-4159.1989.tb01862.x.","Clark MJ","J Neurochem","1989","1989/04/01","","","10.1111/j.1471-4159.1989.tb01862.x"
"2538171","[Effect of opiate receptor agonists and antagonists on maternal aggression in rats]","Kosenkova NS, Poshivalov VP.","Biull Eksp Biol Med. 1989 Feb;107(2):207-9.","Kosenkova NS","Biull Eksp Biol Med","1989","1989/02/01","","",""
"2537485","Analgesia produced by normal doses of opioid antagonists alone and in combination with morphine","Vaccarino AL, Tasker RA, Melzack R.","Pain. 1989 Jan;36(1):103-9. doi: 10.1016/0304-3959(89)90117-6.","Vaccarino AL","Pain","1989","1989/01/01","","","10.1016/0304-3959(89)90117-6"
"2536002","Possible involvement of brain opioid peptides in clonidine-induced hypotension in spontaneously hypertensive rats","van Giersbergen PL, Tierney SA, Wiegant VM, de Jong W.","Hypertension. 1989 Jan;13(1):83-90. doi: 10.1161/01.hyp.13.1.83.","van Giersbergen PL","Hypertension","1989","1989/01/01","","","10.1161/01.hyp.13.1.83"
"2535799","Physiologic and plasma hormone correlates of survival in endotoxic dogs: effects of opiate antagonists","Murray MJ, Offord KP, Yaksh TL.","Crit Care Med. 1989 Jan;17(1):39-47.","Murray MJ","Crit Care Med","1989","1989/01/01","","",""
"2534967","Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats","Mocchetti I, Ritter A, Costa E.","J Mol Neurosci. 1989;1(1):33-8. doi: 10.1007/BF02896854.","Mocchetti I","J Mol Neurosci","1989","1989/01/01","","","10.1007/BF02896854"
"2527243","Increase in plasma melatonin, beta-endorphin, and cortisol after a 28.5-mile mountain race: relationship to performance and lack of effect of naltrexone","Strassman RJ, Appenzeller O, Lewy AJ, Qualls CR, Peake GT.","J Clin Endocrinol Metab. 1989 Sep;69(3):540-5. doi: 10.1210/jcem-69-3-540.","Strassman RJ","J Clin Endocrinol Metab","1989","1989/09/01","","","10.1210/jcem-69-3-540"
"2522577","Regional brain glucose utilization during and following chronic naltrexone administration: preliminary observations in rat brain","Dow-Edwards DL, Milhorat TH, Freed LA, Gintzler AR.","Life Sci. 1989;44(8):571-7. doi: 10.1016/0024-3205(89)90619-x.","Dow-Edwards DL","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90619-x"
"2513390","Restricted exposure of mice to primer pheromones coincident with prolactin surges blocks pregnancy by changing hypothalamic dopamine release","Rosser AE, Remfry CJ, Keverne EB.","J Reprod Fertil. 1989 Nov;87(2):553-9. doi: 10.1530/jrf.0.0870553.","Rosser AE","J Reprod Fertil","1989","1989/11/01","","","10.1530/jrf.0.0870553"
"2509710","Role of endogenous opiates in the modulation of gonadotropin secretion in infant monkeys (Macaca mulatta): effects of naltrexone","Osborn RG, Fuller GB, Hobson WC, Reyes FI, Faiman C.","J Med Primatol. 1989;18(5):405-14.","Osborn RG","J Med Primatol","1989","1989/01/01","","",""
"2502793","Effects of prior saline-morphine discrimination by pigeons on three-way discrimination including two morphine doses","Gauvin DV, Young AM.","Psychopharmacology (Berl). 1989;98(2):222-30. doi: 10.1007/BF00444695.","Gauvin DV","Psychopharmacology (Berl)","1989","1989/01/01","","","10.1007/BF00444695"
"2498922","Relationship between behavioral and nociceptive changes in attacked mice: effects of opiate antagonists","Frischknecht HR, Siegfried B.","Psychopharmacology (Berl). 1989;97(2):160-2. doi: 10.1007/BF00442241.","Frischknecht HR","Psychopharmacology (Berl)","1989","1989/01/01","","","10.1007/BF00442241"
"2489237","Novel inhibitors of enkephalin-degrading enzymes. I: Inhibitors of enkephalinase by penicillins","Williams PS, Sewell RD, Smith HJ, Gonzalez JP.","J Enzyme Inhib. 1989;3(2):91-101. doi: 10.3109/14756368909030368.","Williams PS","J Enzyme Inhib","1989","1989/01/01","","","10.3109/14756368909030368"
"2482981","Evidence of single dose opioid dependence in 12- to 14-day-old chicken embryos","Bronson ME, Sparber SB.","Pharmacol Biochem Behav. 1989 Dec;34(4):705-9. doi: 10.1016/0091-3057(89)90262-1.","Bronson ME","Pharmacol Biochem Behav","1989","1989/12/01","","","10.1016/0091-3057(89)90262-1"
"2482511","Phosphodiesterase inhibitors potentiate opiate-antagonist discrimination by morphine-dependent rats","Holtzman SG.","Pharmacol Biochem Behav. 1989 Aug;33(4):875-9. doi: 10.1016/0091-3057(89)90485-1.","Holtzman SG","Pharmacol Biochem Behav","1989","1989/08/01","","","10.1016/0091-3057(89)90485-1"
"2482096","Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB/c mice","Solvason HB, Hiramoto RN, Ghanta VK.","Brain Behav Immun. 1989 Sep;3(3):247-62. doi: 10.1016/0889-1591(89)90040-8.","Solvason HB","Brain Behav Immun","1989","1989/09/01","","","10.1016/0889-1591(89)90040-8"
"2477388","Simultaneous extraction and chromatographic analysis of morphine, dilaudid, naltrexone and naloxone in biological fluids by high-performance liquid chromatography with electrochemical detection","O'Connor EF, Cheng SW, North WG.","J Chromatogr. 1989 Jun 30;491(1):240-7. doi: 10.1016/s0378-4347(00)82839-x.","O'Connor EF","J Chromatogr","1989","1989/06/30","","","10.1016/s0378-4347(00)82839-x"
"2477090","Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats","Beilin B, Martin FC, Shavit Y, Gale RP, Liebeskind JC.","Brain Behav Immun. 1989 Jun;3(2):129-37. doi: 10.1016/0889-1591(89)90013-5.","Beilin B","Brain Behav Immun","1989","1989/06/01","","","10.1016/0889-1591(89)90013-5"
"2475628","Opioid agonist and antagonist activities of peripherally selective derivatives of naltrexamine and oxymorphamine","Botros S, Lipkowski AW, Larson DL, Stark PA, Takemori AE, Portoghese PS.","J Med Chem. 1989 Sep;32(9):2068-71. doi: 10.1021/jm00129a009.","Botros S","J Med Chem","1989","1989/09/01","","","10.1021/jm00129a009"
"2473408","Modulation of [3H]DAGO binding by substance P (SP) and SP fragments in the mouse brain and spinal cord via MU1 interactions","Krumins SA, Kim DC, Seybold VS, Larson AA.","Neuropeptides. 1989 May-Jun;13(4):225-33. doi: 10.1016/0143-4179(89)90075-9.","Krumins SA","Neuropeptides","1989","1989/05/01","","","10.1016/0143-4179(89)90075-9"
"2471910","Evidence for a model of activation of central sigma systems","Iwamoto ET.","Life Sci. 1989;44(21):1547-54. doi: 10.1016/0024-3205(89)90448-7.","Iwamoto ET","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90448-7"
"2463689","Beta-endorphin disregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis","Sandman CA.","Synapse. 1988;2(3):193-9. doi: 10.1002/syn.890020304.","Sandman CA","Synapse","1988","1988/01/01","","","10.1002/syn.890020304"
"2462628","Action of naloxone on myenteric neurons removed from morphine-treated guinea pigs","Cherubini E, North RA, Tokimasa T.","J Pharmacol Exp Ther. 1988 Dec;247(3):830-8.","Cherubini E","J Pharmacol Exp Ther","1988","1988/12/01","","",""
"2459370","Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans","Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE.","J Pharmacol Exp Ther. 1988 Oct;247(1):47-53.","Bickel WK","J Pharmacol Exp Ther","1988","1988/10/01","","",""
"2441221","Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist","Galetta S, Hahn EF, Nishimura S, Pasternak GW.","Life Sci. 1987 Aug 10;41(6):783-7. doi: 10.1016/0024-3205(87)90459-0.","Galetta S","Life Sci","1987","1987/08/10","","","10.1016/0024-3205(87)90459-0"
"2434113","High-pressure liquid chromatographic method for the determination of hydromorphone in human plasma with electrochemical detection","Wetzelsberger N, Lücker PW, Erking W.","Arzneimittelforschung. 1986 Nov;36(11):1707-10.","Wetzelsberger N","Arzneimittelforschung","1986","1986/11/01","","",""
"2419770","Agonist-antagonist properties of fluorescent opioid probes in the guinea-pig myenteric plexus-longitudinal muscle preparation","Koman A, Einarsson M, Terenius L.","Naunyn Schmiedebergs Arch Pharmacol. 1985 Dec;331(4):355-8. doi: 10.1007/BF00500819.","Koman A","Naunyn Schmiedebergs Arch Pharmacol","1985","1985/12/01","","","10.1007/BF00500819"
"2416909","Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones","Hahn EF, Nishimura S, Goodman RR, Pasternak GW.","J Pharmacol Exp Ther. 1985 Dec;235(3):839-45.","Hahn EF","J Pharmacol Exp Ther","1985","1985/12/01","","",""
"2412252","Endorphins, immune function, and cancer","Morley JE, Kay N, Allen J, Moon T, Billington CJ.","Psychopharmacol Bull. 1985;21(3):485-8.","Morley JE","Psychopharmacol Bull","1985","1985/01/01","","",""
"2409281","10-Ketonaltrexone and 10-ketooxymorphone","Archer S, Seyed-Mozaffari A, Ward S, Kosterlitz HW, Paterson SJ, McKnight AT, Corbett AD.","J Med Chem. 1985 Jul;28(7):974-6. doi: 10.1021/jm00145a024.","Archer S","J Med Chem","1985","1985/07/01","","","10.1021/jm00145a024"
"2409280","Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone","Koolpe GA, Nelson WL, Gioannini TL, Angel L, Appelmans N, Simon EJ.","J Med Chem. 1985 Jul;28(7):949-57. doi: 10.1021/jm00145a018.","Koolpe GA","J Med Chem","1985","1985/07/01","","","10.1021/jm00145a018"
"2405152","Enhanced sensitivity to behavioral effects of naltrexone in rats","Schindler CW, Wu XZ, Su TP, Goldberg SR, Katz JL.","J Pharmacol Exp Ther. 1990 Jan;252(1):8-14.","Schindler CW","J Pharmacol Exp Ther","1990","1990/01/01","","",""
"2399258","Luteinizing hormone secretion as a response to a second naltrexone administration","Yogev L, Gottreich A, Homonnai ZT, Yavetz H, Paz GF.","Proc Soc Exp Biol Med. 1990 Oct;195(1):22-5. doi: 10.3181/00379727-195-43105.","Yogev L","Proc Soc Exp Biol Med","1990","1990/10/01","","","10.3181/00379727-195-43105"
"2395121","Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys","Mello NK, Mendelson JH, Bree MP, Lukas SE.","J Pharmacol Exp Ther. 1990 Sep;254(3):926-39.","Mello NK","J Pharmacol Exp Ther","1990","1990/09/01","","",""
"2377653","Opiate antagonists enhance the working memory of rats in the radial maze","Canli T, Cook RG, Miczek KA.","Pharmacol Biochem Behav. 1990 Jul;36(3):521-5. doi: 10.1016/0091-3057(90)90250-l.","Canli T","Pharmacol Biochem Behav","1990","1990/07/01","","","10.1016/0091-3057(90)90250-l"
"2371923","Peripheral and central opioid activity in the analgesic potency of morphine","Arrigo-Reina R.","Agents Actions. 1990 Apr;30(1-2):210-2. doi: 10.1007/BF01969040.","Arrigo-Reina R","Agents Actions","1990","1990/04/01","","","10.1007/BF01969040"
"2361487","Naltrexone normalizes the suppression but not the surge of delta 5-3 beta-hydroxysteroid dehydrogenase activity in Leydig cells of stressed rat fetuses","Ward IL, Ward OB, Hayden T, Weisz J, Orth JM.","Endocrinology. 1990 Jul;127(1):88-92. doi: 10.1210/endo-127-1-88.","Ward IL","Endocrinology","1990","1990/07/01","","","10.1210/endo-127-1-88"
"2360733","Preparation of oral naltrexone solution","Abboud TK.","Anesthesiology. 1990 Jul;73(1):190-1. doi: 10.1097/00000542-199007000-00034.","Abboud TK","Anesthesiology","1990","1990/07/01","","","10.1097/00000542-199007000-00034"
"2356889","Treatment of patients with self-injurious behavior","Favazza AR.","Am J Psychiatry. 1990 Jul;147(7):954-5. doi: 10.1176/ajp.147.7.aj1477954.","Favazza AR","Am J Psychiatry","1990","1990/07/01","","","10.1176/ajp.147.7.aj1477954"
"2338644","Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats","Adams JU, Holtzman SG.","J Pharmacol Exp Ther. 1990 May;253(2):483-9.","Adams JU","J Pharmacol Exp Ther","1990","1990/05/01","","",""
"2338367","Naltrexone for heroin addiction: encouraging results from Italy","Schifano F, Marra R.","Int J Clin Pharmacol Ther Toxicol. 1990 Apr;28(4):144-6.","Schifano F","Int J Clin Pharmacol Ther Toxicol","1990","1990/04/01","","",""
"2337771","Pain thresholds are elevated during pseudopregnancy","Gintzler AR, Bohan MC.","Brain Res. 1990 Jan 22;507(2):312-6. doi: 10.1016/0006-8993(90)90288-m.","Gintzler AR","Brain Res","1990","1990/01/22","","","10.1016/0006-8993(90)90288-m"
"2335769","Role of fear in mediating shuttle escape learning deficit produced by inescapable shock","Maier SF.","J Exp Psychol Anim Behav Process. 1990 Apr;16(2):137-49.","Maier SF","J Exp Psychol Anim Behav Process","1990","1990/04/01","","",""
"2331579","Alpha-methyldopa induces a naltrexone-insensitive antinociception and hypomotility in rats","van Giersbergen PL, van Duinkerken E, Sweep CG, Wiegant VM, van Ree JM, de Jong W.","Br J Pharmacol. 1990 Mar;99(3):467-72. doi: 10.1111/j.1476-5381.1990.tb12951.x.","van Giersbergen PL","Br J Pharmacol","1990","1990/03/01","PMC1917362","","10.1111/j.1476-5381.1990.tb12951.x"
"2329076","Naltrexone for treatment of acral lick dermatitis in dogs","White SD.","J Am Vet Med Assoc. 1990 Apr 1;196(7):1073-6.","White SD","J Am Vet Med Assoc","1990","1990/04/01","","",""
"2325830","Effects of the enkephalinase inhibitor SCH 34826 on the sleep-waking cycle and EEG activity in the rat","Trampus M, Conti A, Marzanatti M, Monopoli A, Ongini E.","Neuropharmacology. 1990 Mar;29(3):199-205. doi: 10.1016/0028-3908(90)90002-9.","Trampus M","Neuropharmacology","1990","1990/03/01","","","10.1016/0028-3908(90)90002-9"
"2323312","Opioid antagonist challenges in buprenorphine maintained patients","Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD.","Drug Alcohol Depend. 1990 Feb;25(1):73-8. doi: 10.1016/0376-8716(90)90144-4.","Kosten TR","Drug Alcohol Depend","1990","1990/02/01","","","10.1016/0376-8716(90)90144-4"
"2320705","Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats","Adams JU, Holtzman SG.","Psychopharmacology (Berl). 1990;100(4):451-8. doi: 10.1007/BF02243995.","Adams JU","Psychopharmacology (Berl)","1990","1990/01/01","","","10.1007/BF02243995"
"2319301","Chronic naltrexone treatment increases expression of preproenkephalin and preprotachykinin mRNA in discrete brain regions","Tempel A, Kessler JA, Zukin RS.","J Neurosci. 1990 Mar;10(3):741-7. doi: 10.1523/JNEUROSCI.10-03-00741.1990.","Tempel A","J Neurosci","1990","1990/03/01","PMC6570123","","10.1523/JNEUROSCI.10-03-00741.1990"
"2315439","Effects of nalmefene on feeding in humans. Dissociation of hunger and palatability","Yeomans MR, Wright P, Macleod HA, Critchley JA.","Psychopharmacology (Berl). 1990;100(3):426-32. doi: 10.1007/BF02244618.","Yeomans MR","Psychopharmacology (Berl)","1990","1990/01/01","","","10.1007/BF02244618"
"2315372","Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solution","Calcagnetti DJ, Calcagnetti RL, Fanselow MS.","Pharmacol Biochem Behav. 1990 Jan;35(1):69-73. doi: 10.1016/0091-3057(90)90206-w.","Calcagnetti DJ","Pharmacol Biochem Behav","1990","1990/01/01","","","10.1016/0091-3057(90)90206-w"
"2314151","Antagonism of fentanyl-induced respiratory depression with nalmefene","Moore LR, Bikhazi GB, Tuttle RR, Weidler DJ.","Methods Find Exp Clin Pharmacol. 1990 Jan-Feb;12(1):29-35.","Moore LR","Methods Find Exp Clin Pharmacol","1990","1990/01/01","","",""
"2310500","The effects of naltrexone on cadmium-induced increases in oral ethanol self-administration","Nation JR, Horger BA, Pugh CK, Bratton GR, Rowe LD.","Alcohol. 1990 Jan-Feb;7(1):17-20. doi: 10.1016/0741-8329(90)90054-g.","Nation JR","Alcohol","1990","1990/01/01","","","10.1016/0741-8329(90)90054-g"
"2308280","Staying off the merry go round: prescribing habits for recovering patients","Eames B.","J S C Med Assoc. 1990 Jan;86(1):42-5.","Eames B","J S C Med Assoc","1990","1990/01/01","","",""
"2304946","Pharmacological regulation of striatal prodynorphin peptides","Trujillo KA, Akil H.","Prog Clin Biol Res. 1990;328:223-6.","Trujillo KA","Prog Clin Biol Res","1990","1990/01/01","","",""
"2291844","Drugs to decrease alcohol drinking","Sinclair JD.","Ann Med. 1990;22(5):357-62. doi: 10.3109/07853899009147920.","Sinclair JD","Ann Med","1990","1990/01/01","","","10.3109/07853899009147920"
"2279977","Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment","Knabe R, Schulz P, Richard J.","J Autism Dev Disord. 1990 Dec;20(4):591-3. doi: 10.1007/BF02216064.","Knabe R","J Autism Dev Disord","1990","1990/12/01","","","10.1007/BF02216064"
"2279687","Antagonism of the acute pharmacological actions of morphine by panax ginseng extract","Ramarao P, Bhargava HN.","Gen Pharmacol. 1990;21(6):877-80. doi: 10.1016/0306-3623(90)90448-u.","Ramarao P","Gen Pharmacol","1990","1990/01/01","","","10.1016/0306-3623(90)90448-u"
"2277810","Actions of the opioid antagonist, nalmefene, and congeners on reperfusion cardiac arrhythmias and regional left coronary blood flow","Caldwell RW, Nagarajan R, Chryssanthis A, Tuttle RR.","Pharmacology. 1990;41(3):161-6. doi: 10.1159/000138713.","Caldwell RW","Pharmacology","1990","1990/01/01","","","10.1159/000138713"
"2277720","Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia","Joris J, Costello A, Dubner R, Hargreaves KM.","Pain. 1990 Oct;43(1):95-103. doi: 10.1016/0304-3959(90)90054-h.","Joris J","Pain","1990","1990/10/01","","","10.1016/0304-3959(90)90054-h"
"2274471","The lack of effect of opioid agonists and antagonists on some acute effects of ethanol","Kotlińska J, Langwiński R.","Pol J Pharmacol Pharm. 1990 Mar-Apr;42(2):129-35.","Kotlińska J","Pol J Pharmacol Pharm","1990","1990/03/01","","",""
"2272363","Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats","Kamei J, Tanihara H, Kasuya Y.","Eur J Pharmacol. 1990 Oct 9;187(2):281-6. doi: 10.1016/0014-2999(90)90014-w.","Kamei J","Eur J Pharmacol","1990","1990/10/09","","","10.1016/0014-2999(90)90014-w"
"2271928","Phenylephrine-induced antinociception: investigations of potential neural and endocrine bases","Watkins LR, Thurston CL, Fleshner M.","Brain Res. 1990 Oct 1;528(2):273-84. doi: 10.1016/0006-8993(90)91668-7.","Watkins LR","Brain Res","1990","1990/10/01","","","10.1016/0006-8993(90)91668-7"
"2266785","The molecular basis of cannabinoid activity","Makriyannis A, Rapaka RS.","Life Sci. 1990;47(24):2173-84. doi: 10.1016/0024-3205(90)90147-j.","Makriyannis A","Life Sci","1990","1990/01/01","","","10.1016/0024-3205(90)90147-j"
"2253041","Effects of noise on high-affinity choline uptake in the frontal cortex and hippocampus of the rat are blocked by intracerebroventricular injection of corticotropin-releasing factor antagonist","Lai H, Carino MA.","Brain Res. 1990 Sep 17;527(2):354-8. doi: 10.1016/0006-8993(90)91159-e.","Lai H","Brain Res","1990","1990/09/17","","","10.1016/0006-8993(90)91159-e"
"2251341","[D-Pen2, D-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice","Murray CW, Cowan A.","Psychopharmacology (Berl). 1990;102(3):425-6. doi: 10.1007/BF02244117.","Murray CW","Psychopharmacology (Berl)","1990","1990/01/01","","","10.1007/BF02244117"
"2244979","Context-specific morphine withdrawal in rats: duration and effects of clonidine","Kelsey JE, Aranow JS, Matthews RT.","Behav Neurosci. 1990 Oct;104(5):704-10. doi: 10.1037//0735-7044.104.5.704.","Kelsey JE","Behav Neurosci","1990","1990/10/01","","","10.1037//0735-7044.104.5.704"
"2243594","Opioid antagonist (naltrexone) stimulation of cell proliferation in human and animal neuroblastoma and human fibrosarcoma cells in culture","Zagon IS, McLaughlin PJ.","Neuroscience. 1990;37(1):223-6. doi: 10.1016/0306-4522(90)90207-k.","Zagon IS","Neuroscience","1990","1990/01/01","","","10.1016/0306-4522(90)90207-k"
"2243351","Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment","Ahtee L, Attila LM, Carlson KR.","J Pharmacol Exp Ther. 1990 Nov;255(2):803-8.","Ahtee L","J Pharmacol Exp Ther","1990","1990/11/01","","",""
"2243336","Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats","Faden AI, Shirane R, Chang LH, James TL, Lemke M, Weinstein PR.","J Pharmacol Exp Ther. 1990 Nov;255(2):451-8.","Faden AI","J Pharmacol Exp Ther","1990","1990/11/01","","",""
"2243332","Suppressive effects of morphine pellet implants on in vivo parameters of immune function","Bryant HU, Roudebush RE.","J Pharmacol Exp Ther. 1990 Nov;255(2):410-4.","Bryant HU","J Pharmacol Exp Ther","1990","1990/11/01","","",""
"2230942","Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats","Vink R, McIntosh TK, Rhomhanyi R, Faden AI.","J Neurosci. 1990 Nov;10(11):3524-30. doi: 10.1523/JNEUROSCI.10-11-03524.1990.","Vink R","J Neurosci","1990","1990/11/01","PMC6570099","","10.1523/JNEUROSCI.10-11-03524.1990"
"2230659","Defeat-induced hypoalgesia in the rat: effects of conditioned odors, naltrexone, and extinction","Williams JL, Worland PD, Smith MG.","J Exp Psychol Anim Behav Process. 1990 Oct;16(4):345-57.","Williams JL","J Exp Psychol Anim Behav Process","1990","1990/10/01","","",""
"2221131","BBB transport and rapid tissue binding of cyclofoxy: comparison of active and inactive enantiomers","Kawai R, Sawada Y, Channing M, Newman AH, Rice KC, Blasberg RG.","Am J Physiol. 1990 Oct;259(4 Pt 2):H1278-87. doi: 10.1152/ajpheart.1990.259.4.H1278.","Kawai R","Am J Physiol","1990","1990/10/01","","","10.1152/ajpheart.1990.259.4.H1278"
"2219678","Reversal of oxymorphone sedation by naloxone, nalmefene, and butorphanol","Dyson DH, Doherty T, Anderson GI, McDonell WN.","Vet Surg. 1990 Sep-Oct;19(5):398-403. doi: 10.1111/j.1532-950x.1990.tb01217.x.","Dyson DH","Vet Surg","1990","1990/09/01","","","10.1111/j.1532-950x.1990.tb01217.x"
"2212165","Nalmefene and pruritus","Harrison PV.","J Am Acad Dermatol. 1990 Sep;23(3 Pt 1):530. doi: 10.1016/s0190-9622(08)81120-6.","Harrison PV","J Am Acad Dermatol","1990","1990/09/01","","","10.1016/s0190-9622(08)81120-6"
"2207296","Pharmacokinetics of morphine and its surrogates. XI: Effect of simultaneously administered naltrexone and morphine on the pharmacokinetics and pharmacodynamics of each in the dog","Langguth P, Khan PJ, Garrett ER.","Biopharm Drug Dispos. 1990 Jul;11(5):419-44. doi: 10.1002/bdd.2510110507.","Langguth P","Biopharm Drug Dispos","1990","1990/07/01","","","10.1002/bdd.2510110507"
"2205964","[Naltrexone. An opioid antagonist to support the drug-free state in previous opioid addicts having stopped the habit]","Jepsen PW.","Ugeskr Laeger. 1990 Sep 3;152(36):2546-9.","Jepsen PW","Ugeskr Laeger","1990","1990/09/03","","",""
"2205128","Prophylactic oral naltrexone with intrathecal morphine for cesarean section: effects on adverse reactions and analgesia","Abboud TK, Lee K, Zhu J, Reyes A, Afrasiabi A, Mantilla M, Steffens Z, Chai M.","Anesth Analg. 1990 Oct;71(4):367-70. doi: 10.1213/00000539-199010000-00008.","Abboud TK","Anesth Analg","1990","1990/10/01","","","10.1213/00000539-199010000-00008"
"2197054","Clinical toxicology of drugs used in the treatment of opiate dependency","Fraser AD.","Clin Lab Med. 1990 Jun;10(2):375-86.","Fraser AD","Clin Lab Med","1990","1990/06/01","","",""
"2196621","Naltrexone in autistic children: a double-blind and placebo-controlled study","Campbell M, Anderson LT, Small AM, Locascio JJ, Lynch NS, Choroco MC.","Psychopharmacol Bull. 1990;26(1):130-5.","Campbell M","Psychopharmacol Bull","1990","1990/01/01","","",""
"2189867","A case report of naltrexone treatment of self-injury and social withdrawal in autism","Walters AS, Barrett RP, Feinstein C, Mercurio A, Hole WT.","J Autism Dev Disord. 1990 Jun;20(2):169-76. doi: 10.1007/BF02284716.","Walters AS","J Autism Dev Disord","1990","1990/06/01","","","10.1007/BF02284716"
"2187266","[Naltrexone--an effective aid in the psychosocial rehabilitation process of former opiate dependent patients]","Ladewig D.","Ther Umsch. 1990 Mar;47(3):247-50.","Ladewig D","Ther Umsch","1990","1990/03/01","","",""
"2186640","Cerebrovascular transport of [125I]quinuclidinyl benzilate, [3H]cyclofoxy, and [14C]iodoantipyrine","Sawada Y, Hiraga S, Patlak CS, Ito K, Pettigrew KD, Blasberg RG.","Am J Physiol. 1990 May;258(5 Pt 2):H1585-98. doi: 10.1152/ajpheart.1990.258.5.H1585.","Sawada Y","Am J Physiol","1990","1990/05/01","","","10.1152/ajpheart.1990.258.5.H1585"
"2178593","Comparison of the neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia","Yum SW, Faden AI.","Arch Neurol. 1990 Mar;47(3):277-81. doi: 10.1001/archneur.1990.00530030043014.","Yum SW","Arch Neurol","1990","1990/03/01","","","10.1001/archneur.1990.00530030043014"
"2178480","Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use","Lingham T, Perlanski E, Grupp LA.","Alcohol Clin Exp Res. 1990 Feb;14(1):92-9. doi: 10.1111/j.1530-0277.1990.tb00453.x.","Lingham T","Alcohol Clin Exp Res","1990","1990/02/01","","","10.1111/j.1530-0277.1990.tb00453.x"
"2178026","Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation","Yoburn BC, Sierra V, Lutfy K.","Brain Res. 1990 Oct 8;529(1-2):143-8. doi: 10.1016/0006-8993(90)90821-r.","Yoburn BC","Brain Res","1990","1990/10/08","","","10.1016/0006-8993(90)90821-r"
"2177196","In vivo and in vitro investigation of naltrindole, a delta-opioid antagonist","Ayres EA, Davis P, Burks TF.","Proc West Pharmacol Soc. 1990;33:55-63.","Ayres EA","Proc West Pharmacol Soc","1990","1990/01/01","","",""
"2176431","Role of opioid receptors in the long-lasting blood pressure depression after electric muscle stimulation in the hind leg of the rat","Hoffmann P, Delle M, Thorén P.","Acta Physiol Scand. 1990 Oct;140(2):191-8. doi: 10.1111/j.1748-1716.1990.tb08991.x.","Hoffmann P","Acta Physiol Scand","1990","1990/10/01","","","10.1111/j.1748-1716.1990.tb08991.x"
"2175793","Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine","Adams JU, Paronis CA, Holtzman SG.","J Pharmacol Exp Ther. 1990 Dec;255(3):1027-32.","Adams JU","J Pharmacol Exp Ther","1990","1990/12/01","","",""
"2175293","Hepatobiliary effects of morphine are mediated in the brain","Hurwitz A, Looney G, Sullins M, Ben-Zvi Z.","Hepatology. 1990 Dec;12(6):1406-12. doi: 10.1002/hep.1840120623.","Hurwitz A","Hepatology","1990","1990/12/01","","","10.1002/hep.1840120623"
"2174749","Reduced microvascular adrenergic receptor activity due to opioids in endotoxin shock","Baker CH, Sutton ET, Zhou Z, Reynolds DG.","Circ Shock. 1990 Oct;32(2):101-12.","Baker CH","Circ Shock","1990","1990/10/01","","",""
"2174676","Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures","Peterson PK, Sharp BM, Gekker G, Portoghese PS, Sannerud K, Balfour HH Jr.","AIDS. 1990 Sep;4(9):869-73. doi: 10.1097/00002030-199009000-00006.","Peterson PK","AIDS","1990","1990/09/01","","","10.1097/00002030-199009000-00006"
"2173760","Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers","Kawai R, Sawada Y, Channing M, Dunn B, Newman AH, Rice KC, Blasberg RG.","J Pharmacol Exp Ther. 1990 Nov;255(2):826-35.","Kawai R","J Pharmacol Exp Ther","1990","1990/11/01","","",""
"2173759","Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress","Parsons CG, Herz A.","J Pharmacol Exp Ther. 1990 Nov;255(2):795-802.","Parsons CG","J Pharmacol Exp Ther","1990","1990/11/01","","",""
"2173747","Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors","Giordano AL, Nock B, Cicero TJ.","J Pharmacol Exp Ther. 1990 Nov;255(2):536-40.","Giordano AL","J Pharmacol Exp Ther","1990","1990/11/01","","",""
"2172870","Perinatal opiate treatment delays growth of cortical dendrites","Ricalde AA, Hammer RP Jr.","Neurosci Lett. 1990 Jul 31;115(2-3):137-43. doi: 10.1016/0304-3940(90)90444-e.","Ricalde AA","Neurosci Lett","1990","1990/07/31","","","10.1016/0304-3940(90)90444-e"
"2172827","Opioid antagonists: structure activity relationships","Zimmerman DM, Leander JD.","NIDA Res Monogr. 1990;96:50-60.","Zimmerman DM","NIDA Res Monogr","1990","1990/01/01","","",""
"2172675","Differential effect of opioids on immunoglobulin production by lymphocytes isolated from Peyer's patches and spleen","Carr DJ, Radulescu RT, deCosta BR, Rice KC, Blalock JE.","Life Sci. 1990;47(12):1059-69. doi: 10.1016/0024-3205(90)90479-b.","Carr DJ","Life Sci","1990","1990/01/01","","","10.1016/0024-3205(90)90479-b"
"2172466","Modulation of opioid receptor binding by cis and trans fatty acids","Remmers AE, Nordby GL, Medzihradsky F.","J Neurochem. 1990 Dec;55(6):1993-2000. doi: 10.1111/j.1471-4159.1990.tb05787.x.","Remmers AE","J Neurochem","1990","1990/12/01","","","10.1111/j.1471-4159.1990.tb05787.x"
"2171723","Blockade of opioid receptors with naltrexone inhibits thyrotropin increase after noise stress but does not prevent the decrease caused by immobilization","Armario A, Marti O, Gavalda A, Jolin T.","Brain Res Bull. 1990 Aug;25(2):347-9. doi: 10.1016/0361-9230(90)90082-b.","Armario A","Brain Res Bull","1990","1990/08/01","","","10.1016/0361-9230(90)90082-b"
"2170791","Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo","Qi JA, Mosberg HI, Porreca F.","Life Sci. 1990;47(11):PL43-7. doi: 10.1016/0024-3205(90)90545-3.","Qi JA","Life Sci","1990","1990/01/01","","","10.1016/0024-3205(90)90545-3"
"2170723","Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia","Takahashi M, Senda T, Tokuyama S, Kaneto H.","Jpn J Pharmacol. 1990 Aug;53(4):487-94. doi: 10.1254/jjp.53.487.","Takahashi M","Jpn J Pharmacol","1990","1990/08/01","","","10.1254/jjp.53.487"
"2169936","Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats","Kitchen I, Pinker SR.","Br J Pharmacol. 1990 Aug;100(4):685-8. doi: 10.1111/j.1476-5381.1990.tb14076.x.","Kitchen I","Br J Pharmacol","1990","1990/08/01","PMC1917588","","10.1111/j.1476-5381.1990.tb14076.x"
"2169561","""Paradoxical"" analgesia and aggravated morphine dependence induced by opioid antagonists","Suzuki T, Fukagawa Y, Misawa M, Nagase H.","Life Sci. 1990;47(6):515-21. doi: 10.1016/0024-3205(90)90611-t.","Suzuki T","Life Sci","1990","1990/01/01","","","10.1016/0024-3205(90)90611-t"
"2169423","Stereoselectivity and subtype of the opiate receptor involved in stress-induced hypertension","Jiménez I, Iglesias T, Fuentes JA.","Eur J Pharmacol. 1990 Jun 21;182(1):155-60. doi: 10.1016/0014-2999(90)90505-z.","Jiménez I","Eur J Pharmacol","1990","1990/06/21","","","10.1016/0014-2999(90)90505-z"
"2169364","A lack of potency for the delta-opioid antagonist naltrindole after microinjection into the rostral ventrolateral medulla of rabbits","Morilak D, Drolet G, Chalmers J.","Clin Exp Pharmacol Physiol. 1990 Jul;17(7):527-30. doi: 10.1111/j.1440-1681.1990.tb01353.x.","Morilak D","Clin Exp Pharmacol Physiol","1990","1990/07/01","","","10.1111/j.1440-1681.1990.tb01353.x"
"2167107","An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior","Sandman CA, Barron JL, Colman H.","Am J Ment Retard. 1990 Jul;95(1):93-102.","Sandman CA","Am J Ment Retard","1990","1990/07/01","","",""
"2166788","Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice","Song ZH, Takemori AE.","J Pharmacol Exp Ther. 1990 Aug;254(2):363-8.","Song ZH","J Pharmacol Exp Ther","1990","1990/08/01","","",""
"2166728","Effects of short-term stimulation of serotoninergic pathways on the pulsatile secretion of luteinizing hormone in the absence and presence of acute opiate-receptor blockage","Urban RJ, Veldhuis JD.","J Androl. 1990 May-Jun;11(3):227-32.","Urban RJ","J Androl","1990","1990/05/01","","",""
"2166675","Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex","Heijna MH, Padt M, Hogenboom F, Portoghese PS, Mulder AH, Schoffelmeer AN.","Eur J Pharmacol. 1990 Jun 8;181(3):267-78. doi: 10.1016/0014-2999(90)90088-n.","Heijna MH","Eur J Pharmacol","1990","1990/06/08","","","10.1016/0014-2999(90)90088-n"
"2166280","Deltorphin, a naturally occurring peptide with high selectivity for delta opioid receptors, improves memory consolidation in two inbred strains of mice","Pavone F, Populin R, Castellano C, Kreil G, Melchiorri P.","Peptides. 1990 May-Jun;11(3):591-4. doi: 10.1016/0196-9781(90)90063-b.","Pavone F","Peptides","1990","1990/05/01","","","10.1016/0196-9781(90)90063-b"
"2164191","Effect of subtype-selective opioid receptor blockers on nitrous oxide antinociception in rats","Quock RM, Walczak CK, Henry RJ, Chen DC.","Pharmacol Res. 1990 May-Jun;22(3):351-7. doi: 10.1016/1043-6618(90)90733-t.","Quock RM","Pharmacol Res","1990","1990/05/01","","","10.1016/1043-6618(90)90733-t"
"2164174","Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain","Davenport KE, Houdi AA, Van Loon GR.","Neurosci Lett. 1990 May 18;113(1):40-6. doi: 10.1016/0304-3940(90)90491-q.","Davenport KE","Neurosci Lett","1990","1990/05/18","","","10.1016/0304-3940(90)90491-q"
"2164093","Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey","Dykstra LA.","J Pharmacol Exp Ther. 1990 Jul;254(1):245-52.","Dykstra LA","J Pharmacol Exp Ther","1990","1990/07/01","","",""
"2163849","Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens","Porreca F, LoPresti D, Ward SJ.","Eur J Pharmacol. 1990 Apr 10;179(1-2):129-39. doi: 10.1016/0014-2999(90)90410-8.","Porreca F","Eur J Pharmacol","1990","1990/04/10","","","10.1016/0014-2999(90)90410-8"
"2162954","Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice","Suh HH, Tseng LF.","J Pharmacol Exp Ther. 1990 Jun;253(3):981-6.","Suh HH","J Pharmacol Exp Ther","1990","1990/06/01","","",""
"2162953","Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment","Groppetti A, Ceresoli G, Mandelli V, Parenti M.","J Pharmacol Exp Ther. 1990 Jun;253(3):950-6.","Groppetti A","J Pharmacol Exp Ther","1990","1990/06/01","","",""
"2162542","Spinal paralysis and catalepsy induced by intrathecal injection of opioid agonists","Frenk H, Miller J, Johannessen JN, Mayer DJ.","Pharmacol Biochem Behav. 1990 Jun;36(2):243-7. doi: 10.1016/0091-3057(90)90398-2.","Frenk H","Pharmacol Biochem Behav","1990","1990/06/01","","","10.1016/0091-3057(90)90398-2"
"2162533","Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain","Rothman RB, Bykov V, de Costa BR, Jacobson AE, Rice KC, Brady LS.","Peptides. 1990 Mar-Apr;11(2):311-31. doi: 10.1016/0196-9781(90)90088-m.","Rothman RB","Peptides","1990","1990/03/01","","","10.1016/0196-9781(90)90088-m"
"2162494","The ontogeny of opioid receptors mediating opiate-induced feeding in rats","Capuano CA, Leibowitz SF, Barr GA.","Neuropharmacology. 1990 May;29(5):433-7. doi: 10.1016/0028-3908(90)90164-m.","Capuano CA","Neuropharmacology","1990","1990/05/01","","","10.1016/0028-3908(90)90164-m"
"2162182","Socially mediated reduction of isolation distress in rat pups is blocked by naltrexone but not by Ro 15-1788","Carden SE, Hofer MA.","Behav Neurosci. 1990 Jun;104(3):457-63. doi: 10.1037//0735-7044.104.3.457.","Carden SE","Behav Neurosci","1990","1990/06/01","","","10.1037//0735-7044.104.3.457"
"2162022","Peripheral opioid receptors mediating antinociception in inflammation. Activation by endogenous opioids and role of the pituitary-adrenal axis","Parsons CG, Członkowski A, Stein C, Herz A.","Pain. 1990 Apr;41(1):81-93. doi: 10.1016/0304-3959(90)91112-v.","Parsons CG","Pain","1990","1990/04/01","","","10.1016/0304-3959(90)91112-v"
"2161588","Drugs of abuse--opiates","Ling W, Wesson DR.","West J Med. 1990 May;152(5):565-72.","Ling W","West J Med","1990","1990/05/01","PMC1002412","",""
"2161243","Role of supraspinal systems in environmentally induced antinociception: effect of spinalization and decerebration on brief shock-induced and long shock-induced antinociception","Meagher MW, Grau JW, King RA.","Behav Neurosci. 1990 Apr;104(2):328-38. doi: 10.1037//0735-7044.104.2.328.","Meagher MW","Behav Neurosci","1990","1990/04/01","","","10.1037//0735-7044.104.2.328"
"2161111","Central but not peripheral opiate receptor blockade prolonged pituitary-adrenal responses to stress","Odio M, Brodish A.","Pharmacol Biochem Behav. 1990 Apr;35(4):963-9. doi: 10.1016/0091-3057(90)90386-v.","Odio M","Pharmacol Biochem Behav","1990","1990/04/01","","","10.1016/0091-3057(90)90386-v"
"2160624","Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism","Bayer BM, Daussin S, Hernandez M, Irvin L.","Neuropharmacology. 1990 Apr;29(4):369-74. doi: 10.1016/0028-3908(90)90096-a.","Bayer BM","Neuropharmacology","1990","1990/04/01","","","10.1016/0028-3908(90)90096-a"
"2160538","Design of peptidomimetic delta opioid receptor antagonists using the message-address concept","Portoghese PS, Sultana M, Takemori AE.","J Med Chem. 1990 Jun;33(6):1714-20. doi: 10.1021/jm00168a028.","Portoghese PS","J Med Chem","1990","1990/06/01","","","10.1021/jm00168a028"
"2160532","Naltrindole 5'-isothiocyanate: a nonequilibrium, highly selective delta opioid receptor antagonist","Portoghese PS, Sultana M, Takemori AE.","J Med Chem. 1990 Jun;33(6):1547-8. doi: 10.1021/jm00168a004.","Portoghese PS","J Med Chem","1990","1990/06/01","","","10.1021/jm00168a004"
"2158483","Interaction of naltrexone with postnatal administration of testosterone and estrogen on neurobehavioral sexual differentiation in rats","McGivern RF, Henschel DM.","Horm Behav. 1990 Mar;24(1):20-39. doi: 10.1016/0018-506x(90)90024-r.","McGivern RF","Horm Behav","1990","1990/03/01","","","10.1016/0018-506x(90)90024-r"
"2158355","Naltrexone attenuates self-injurious behavior in mentally retarded subjects","Kars H, Broekema W, Glaudemans-van Gelderen I, Verhoeven WM, van Ree JM.","Biol Psychiatry. 1990 Apr 1;27(7):741-6. doi: 10.1016/0006-3223(90)90589-t.","Kars H","Biol Psychiatry","1990","1990/04/01","","","10.1016/0006-3223(90)90589-t"
"2157601","Mediation of nitrous oxide analgesia in mice by spinal and supraspinal kappa-opioid receptors","Quock RM, Best JA, Chen DC, Vaughn LK, Portoghese PS, Takemori AE.","Eur J Pharmacol. 1990 Jan 3;175(1):97-100. doi: 10.1016/0014-2999(90)90158-3.","Quock RM","Eur J Pharmacol","1990","1990/01/03","","","10.1016/0014-2999(90)90158-3"
"2156986","Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice","Qi JA, Heyman JS, Sheldon RJ, Koslo RJ, Porreca F.","J Pharmacol Exp Ther. 1990 Mar;252(3):1006-11.","Qi JA","J Pharmacol Exp Ther","1990","1990/03/01","","",""
"2156522","Stress-induced suppression of natural killer cell cytotoxicity in the rat: a naltrexone-insensitive paradigm","Ben-Eliyahu S, Yirmiya R, Shavit Y, Liebeskind JC.","Behav Neurosci. 1990 Feb;104(1):235-8. doi: 10.1037//0735-7044.104.1.235.","Ben-Eliyahu S","Behav Neurosci","1990","1990/02/01","","","10.1037//0735-7044.104.1.235"
"2156273","Opioid inhibition of kainic acid-induced scratching: mediation by mu and sigma but not delta and kappa receptors","Kellstein DE, Coghill RC, Frenk H, Bossut DF, Mayer DJ.","Pharmacol Biochem Behav. 1990 Jan;35(1):1-5. doi: 10.1016/0091-3057(90)90195-n.","Kellstein DE","Pharmacol Biochem Behav","1990","1990/01/01","","","10.1016/0091-3057(90)90195-n"
"2156055","Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone","France CP, de Costa BR, Jacobson AE, Rice KC, Woods JH.","J Pharmacol Exp Ther. 1990 Feb;252(2):600-4.","France CP","J Pharmacol Exp Ther","1990","1990/02/01","","",""
"2155673","High-dose oral naltrexone: aversive response in drug-naive rat","Mucha RF.","Biol Psychiatry. 1990 Mar 1;27(5):543-5. doi: 10.1016/0006-3223(90)90445-8.","Mucha RF","Biol Psychiatry","1990","1990/03/01","","","10.1016/0006-3223(90)90445-8"
"2155039","Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats","Islam AK, Bodnar RJ.","Brain Res. 1990 Feb 5;508(2):293-6. doi: 10.1016/0006-8993(90)90410-d.","Islam AK","Brain Res","1990","1990/02/05","","","10.1016/0006-8993(90)90410-d"
"2154822","Selectivity profile of nor-binaltorphimine and ICI-197,067 in guinea pig brain","Magnan J, Tiberi M.","Prog Clin Biol Res. 1990;328:73-6.","Magnan J","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154821","Isolation of kappa opioid receptor with an aminoethyl-nor-binaltorphimine (AE-norBNI) affinity column","Song ZH, Barbas DP, Portoghese PS, Takemori AE.","Prog Clin Biol Res. 1990;328:69-72.","Song ZH","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154820","Nor-binaltorphimine is a reversible, noncompetitive opioid antagonist in the mouse vas deferens with high affinity for kappa receptors in monkey brain membranes","Smith CB, Medzihradsky F, Hollingsworth PJ, DeCosta B, Rice KC, Woods JH.","Prog Clin Biol Res. 1990;328:65-8.","Smith CB","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154819","[3H] beta-funaltrexamine ([3H] beta-FNA) binds irreversibly to mu opioid receptors in the rat brain: autoradiographic study","Liu-Chen LY, Li SX, Rohrbach KW, Lewis ME.","Prog Clin Biol Res. 1990;328:61-4.","Liu-Chen LY","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154818","Kinetic studies on binding of [3H] beta-funaltrexamine ([3H] beta-FNA) to mu opioid receptors","Liu-Chen LY, Li S, Holowecky O, Tallarida RJ.","Prog Clin Biol Res. 1990;328:57-60.","Liu-Chen LY","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154815","Effects of chronic treatment with specific antagonists on analgesia and physical dependence on morphine in rats","Fukagawa Y, Suzuki T, Misawa M, Nagase H.","Prog Clin Biol Res. 1990;328:527-30.","Fukagawa Y","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154813","Physical dependence on morphine using the mu receptor deficient CXBK mouse","Suzuki T, Misawa M.","Prog Clin Biol Res. 1990;328:519-22.","Suzuki T","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154806","Supraspinal analgesic action of pentazocine in mice","Nagase H, Narita M, Suzuki T, Misawa M.","Prog Clin Biol Res. 1990;328:465-8.","Nagase H","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154800","5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers","Schmidhammer H, Leander JD, Mayer-Valkanover K, Nussbaumer C, Schmidt C, Schoepp DD, Schratz A, Walla-Kugler M.","Prog Clin Biol Res. 1990;328:41-4.","Schmidhammer H","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154786","Effect of nor-binaltorphimine on the behavior of mice and rats receiving multiple injections of U-50,488","Cowan A, Murray CW.","Prog Clin Biol Res. 1990;328:303-6.","Cowan A","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154783","Cardiovascular action of methionine enkephalin (met-enkephalin) in conscious and anesthetized rabbits","Rhee HM, Lee SY.","Prog Clin Biol Res. 1990;328:291-4.","Rhee HM","Prog Clin Biol Res","1990","1990/01/01","","",""
"2154672","Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor","Liu-Chen LY, Li SX, Tallarida RJ.","Mol Pharmacol. 1990 Feb;37(2):243-50.","Liu-Chen LY","Mol Pharmacol","1990","1990/02/01","","",""
"2154288","Opioid antagonist eliminates the stress-induced impairment of long-term potentiation (LTP)","Shors TJ, Levine S, Thompson RF.","Brain Res. 1990 Jan 8;506(2):316-8. doi: 10.1016/0006-8993(90)91270-q.","Shors TJ","Brain Res","1990","1990/01/08","","","10.1016/0006-8993(90)91270-q"
"2153984","Suppression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent","Bayer BM, Hernandez M, Irvin L.","Prog Clin Biol Res. 1990;325:273-82.","Bayer BM","Prog Clin Biol Res","1990","1990/01/01","","",""
"2153826","Conjugate addition ligands of opioid antagonists. Methacrylate esters and ethers of 6 alpha- and 6 beta-naltrexol","Olsen LD, Klein P, Nelson WL, Yao YH, Simon EJ.","J Med Chem. 1990 Feb;33(2):737-41. doi: 10.1021/jm00164a043.","Olsen LD","J Med Chem","1990","1990/02/01","","","10.1021/jm00164a043"
"2153801","Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals","Vaupel DB, Cone EJ, Johnson RE, Su TP.","J Pharmacol Exp Ther. 1990 Jan;252(1):225-34.","Vaupel DB","J Pharmacol Exp Ther","1990","1990/01/01","","",""
"2153388","Naltrexone potentiates 4-aminopyridine seizures in the rat","Mihály A, Bencsik K, Solymosi T.","J Neural Transm Gen Sect. 1990;79(1-2):59-67. doi: 10.1007/BF01251001.","Mihály A","J Neural Transm Gen Sect","1990","1990/01/01","","","10.1007/BF01251001"
"2149618","Effects of sufentanil and naltrexone on adrenal vein catecholamines and neuropeptides during splanchnic nerve stimulation in cats","Gaumann DM, Yaksh TL, Tyce GM.","Synapse. 1990;6(4):392-4. doi: 10.1002/syn.890060411.","Gaumann DM","Synapse","1990","1990/01/01","","","10.1002/syn.890060411"
"2140609","Negative allesthesia and decreased endogenous opiate system activity in anorexia nervosa","Melchior JC, Rigaud D, Colas-Linhart N, Rozen R, Fantino M, Apfelbaum M.","Pharmacol Biochem Behav. 1990 Apr;35(4):885-8. doi: 10.1016/0091-3057(90)90375-r.","Melchior JC","Pharmacol Biochem Behav","1990","1990/04/01","","","10.1016/0091-3057(90)90375-r"
"2137699","Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups","Winslow JT, Insel TR.","Neuropsychopharmacology. 1990 Feb;3(1):51-9.","Winslow JT","Neuropsychopharmacology","1990","1990/02/01","","",""
"2137676","The role of pituitary beta-endorphin in mediating corticotropin-releasing factor-induced antinociception","Hargreaves KM, Flores CM, Dionne RA, Mueller GP.","Am J Physiol. 1990 Feb;258(2 Pt 1):E235-42. doi: 10.1152/ajpendo.1990.258.2.E235.","Hargreaves KM","Am J Physiol","1990","1990/02/01","","","10.1152/ajpendo.1990.258.2.E235"
"2137320","Naltrexone therapy of apnea in children with elevated cerebrospinal fluid beta-endorphin","Myer EC, Morris DL, Brase DA, Dewey WL, Zimmerman AW.","Ann Neurol. 1990 Jan;27(1):75-80. doi: 10.1002/ana.410270112.","Myer EC","Ann Neurol","1990","1990/01/01","","","10.1002/ana.410270112"
"2136215","Chronic pretreatment with naltrexone facilitates acquisition of intravenous cocaine self-administration in rats","Ramsey NF, van Ree JM.","Eur Neuropsychopharmacol. 1990 Nov;1(1):55-61. doi: 10.1016/0924-977x(90)90012-y.","Ramsey NF","Eur Neuropsychopharmacol","1990","1990/11/01","","","10.1016/0924-977x(90)90012-y"
"2122343","Naltrexone in functional hypothalamic amenorrhea and in the normal luteal phase","Remorgida V, Venturini PL, Anserini P, Salerno E, De Cecco L.","Obstet Gynecol. 1990 Dec;76(6):1115-20.","Remorgida V","Obstet Gynecol","1990","1990/12/01","","",""
"2120527","Effects of opioid blockade with nalmefene in older impotent men","Billington CJ, Shafer RB, Morley JE.","Life Sci. 1990;47(9):799-805. doi: 10.1016/0024-3205(90)90552-3.","Billington CJ","Life Sci","1990","1990/01/01","","","10.1016/0024-3205(90)90552-3"
"2115910","Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates","Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ.","J Neurosci. 1990 Jul;10(7):2308-17. doi: 10.1523/JNEUROSCI.10-07-02308.1990.","Rasmussen K","J Neurosci","1990","1990/07/01","PMC6570391","","10.1523/JNEUROSCI.10-07-02308.1990"
"2107826","Independence of benzodiazepine and opiate action in the suppression of isolation distress in rat pups","Carden SE, Hofer MA.","Behav Neurosci. 1990 Feb;104(1):160-6. doi: 10.1037//0735-7044.104.1.160.","Carden SE","Behav Neurosci","1990","1990/02/01","","","10.1037//0735-7044.104.1.160"
"2105673","Prophylactic oral naltrexone with epidural morphine: effect on adverse reactions and ventilatory responses to carbon dioxide","Abboud TK, Afrasiabi A, Davidson J, Zhu J, Reyes A, Khoo N, Steffens Z.","Anesthesiology. 1990 Feb;72(2):233-7.","Abboud TK","Anesthesiology","1990","1990/02/01","","",""
"2098653","[The role of opioid antagonists in the treatment of obesity. Results of a clinical trial with naltrexone]","Novi RF, Lamberto M, Visconti P, Maurino M, Ardizzone A, Mantovan M, Meluzzi A, Francesetti G, Molinatti GM.","Minerva Endocrinol. 1990 Apr-Jun;15(2):121-3.","Novi RF","Minerva Endocrinol","1990","1990/04/01","","",""
"2097456","[Clonidine-naltrexone: a new technic for the detoxification of opiate addicts]","Oliveros SC, Caballero L, Iruela LM.","Med Clin (Barc). 1990 Nov 10;95(16):627-9.","Oliveros SC","Med Clin (Barc)","1990","1990/11/10","","",""
"2095291","Diazepam inhibits retroactive interference of memory in humans: pretreatment with naltrexone does not alter this effect","Chaves ML, Pezzin S, Jardim CP, Izquierdo I.","Braz J Med Biol Res. 1990;23(5):417-21.","Chaves ML","Braz J Med Biol Res","1990","1990/01/01","","",""
"2087483","Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preference","Bilsky EJ, Marglin SH, Reid LD.","Pharmacol Biochem Behav. 1990 Nov;37(3):425-31. doi: 10.1016/0091-3057(90)90007-5.","Bilsky EJ","Pharmacol Biochem Behav","1990","1990/11/01","","","10.1016/0091-3057(90)90007-5"
"2087144","Brain opioid peptides may participate in the reversal of pentylenetetrazol-induced amnesia","Baratti CM, de Erausquin GA, Faiman CP.","Methods Find Exp Clin Pharmacol. 1990 Sep;12(7):451-6.","Baratti CM","Methods Find Exp Clin Pharmacol","1990","1990/09/01","","",""
"2085738","Cats produce analgesia in rats on the tail-flick test: naltrexone sensitivity is determined by the nociceptive test stimulus","Lichtman AH, Fanselow MS.","Brain Res. 1990 Nov 12;533(1):91-4. doi: 10.1016/0006-8993(90)91800-v.","Lichtman AH","Brain Res","1990","1990/11/12","","","10.1016/0006-8993(90)91800-v"
"2081263","Conformational search in enkephalin analogues containing a disulfide bond","Froimowitz M.","Biopolymers. 1990;30(11-12):1011-25. doi: 10.1002/bip.360301103.","Froimowitz M","Biopolymers","1990","1990/01/01","","","10.1002/bip.360301103"
"2069733","Prenatal ethanol exposure and opiatergic influence on puberty in the female rat","Creighton-Taylor JA, Rudeen PK.","Alcohol. 1991 May-Jun;8(3):187-91. doi: 10.1016/0741-8329(91)90790-4.","Creighton-Taylor JA","Alcohol","1991","1991/05/01","","","10.1016/0741-8329(91)90790-4"
"2057542","Involvement of endogenous opioid mechanisms in the interaction between stress and ethanol","Trudeau LE, Aragon CM, Amit Z.","Psychopharmacology (Berl). 1991;103(3):425-9. doi: 10.1007/BF02244299.","Trudeau LE","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02244299"
"2053647","Naltrexone challenge for hypercortisolemic pseudodementia","Lipschitz A.","Am J Psychiatry. 1991 Jul;148(7):953. doi: 10.1176/ajp.148.7.953a.","Lipschitz A","Am J Psychiatry","1991","1991/07/01","","","10.1176/ajp.148.7.953a"
"2053636","Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates","Loimer N, Lenz K, Schmid R, Presslich O.","Am J Psychiatry. 1991 Jul;148(7):933-5. doi: 10.1176/ajp.148.7.933.","Loimer N","Am J Psychiatry","1991","1991/07/01","","","10.1176/ajp.148.7.933"
"2046475","Opiate antagonist binding sites in discrete brain regions of spontaneously hypertensive and normotensive Wistar-Kyoto rats","Rahmani NH, Gulati A, Bhargava HN.","Life Sci. 1991;48(26):2499-504. doi: 10.1016/0024-3205(91)90604-a.","Rahmani NH","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90604-a"
"2045062","Long-term opiate receptor antagonism in a patient with panhypopituitarism: effects on appetite, prolactin and demand for vasopressin","Kraft K, Vetter H.","Horm Metab Res. 1991 Feb;23(2):74-5. doi: 10.1055/s-2007-1003617.","Kraft K","Horm Metab Res","1991","1991/02/01","","","10.1055/s-2007-1003617"
"2029727","Regulation of proenkephalin A gene expression in aggregating fetal rat brain cells","Simantov R, Höllt V.","Cell Mol Neurobiol. 1991 Apr;11(2):245-51. doi: 10.1007/BF00769037.","Simantov R","Cell Mol Neurobiol","1991","1991/04/01","","","10.1007/BF00769037"
"2029712","Negative chronotropic but no antiarrhythmic effect of (+)- and (-)-naloxone in rats and guinea pigs","Kaschube M, Brasch H.","Cardiovasc Res. 1991 Mar;25(3):230-4. doi: 10.1093/cvr/25.3.230.","Kaschube M","Cardiovasc Res","1991","1991/03/01","","","10.1093/cvr/25.3.230"
"2022315","Inhibition of calcium mobilization is an early event in opiate-induced immunosuppression","Sei Y, McIntyre T, Fride E, Yoshimoto K, Skolnick P, Arora PK.","FASEB J. 1991 May;5(8):2194-9. doi: 10.1096/fasebj.5.8.2022315.","Sei Y","FASEB J","1991","1991/05/01","","","10.1096/fasebj.5.8.2022315"
"2017444","Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine","Calcagnetti DJ, Holtzman SG.","Pharmacol Biochem Behav. 1991 Jan;38(1):185-90. doi: 10.1016/0091-3057(91)90608-5.","Calcagnetti DJ","Pharmacol Biochem Behav","1991","1991/01/01","","","10.1016/0091-3057(91)90608-5"
"2012619","Naltrexone pretreatment blocks microwave-induced changes in central cholinergic receptors","Lai H, Carino MA, Wen YF, Horita A, Guy AW.","Bioelectromagnetics. 1991;12(1):27-33. doi: 10.1002/bem.2250120105.","Lai H","Bioelectromagnetics","1991","1991/01/01","","","10.1002/bem.2250120105"
"2008865","Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects","Alger SA, Schwalberg MD, Bigaouette JM, Michalek AV, Howard LJ.","Am J Clin Nutr. 1991 Apr;53(4):865-71. doi: 10.1093/ajcn/53.4.865.","Alger SA","Am J Clin Nutr","1991","1991/04/01","","","10.1093/ajcn/53.4.865"
"2007323","Human pharmacology and abuse potential of nalmefene","Fudala PJ, Heishman SJ, Henningfield JE, Johnson RE.","Clin Pharmacol Ther. 1991 Mar;49(3):300-6. doi: 10.1038/clpt.1991.32.","Fudala PJ","Clin Pharmacol Ther","1991","1991/03/01","","","10.1038/clpt.1991.32"
"2006244","Increased sensitivity to rate-altering and discriminative stimulus effects of morphine following continuous exposure to naltrexone","Young AM, Mattox SR, Doty MD.","Psychopharmacology (Berl). 1991;103(1):67-73. doi: 10.1007/BF02244076.","Young AM","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02244076"
"2002750","The influence of alpha-fluoromethylhistidine and histamine receptor antagonists on the beta-endorphin-induced corticosterone response","Turoń M, Tytoń J, Bugajski J.","Life Sci. 1991;48(12):1191-8. doi: 10.1016/0024-3205(91)90458-n.","Turoń M","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90458-n"
"1981690","Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin","Dixon DM, Traynor JR.","Br J Pharmacol. 1990 Nov;101(3):674-8. doi: 10.1111/j.1476-5381.1990.tb14139.x.","Dixon DM","Br J Pharmacol","1990","1990/11/01","PMC1917763","","10.1111/j.1476-5381.1990.tb14139.x"
"1980130","Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism","Bakshi R, Newman AH, Faden AI.","J Neurosci. 1990 Dec;10(12):3793-800. doi: 10.1523/JNEUROSCI.10-12-03793.1990.","Bakshi R","J Neurosci","1990","1990/12/01","PMC6570042","","10.1523/JNEUROSCI.10-12-03793.1990"
"1976787","The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors","Rogers H, Hayes AG, Birch PJ, Traynor JR, Lawrence AJ.","J Pharm Pharmacol. 1990 May;42(5):358-9. doi: 10.1111/j.2042-7158.1990.tb05428.x.","Rogers H","J Pharm Pharmacol","1990","1990/05/01","","","10.1111/j.2042-7158.1990.tb05428.x"
"1976029","Local enkephalins tonically modulate dopamine release in the striatum: a microdialysis study","Dourmap N, Michael-Titus A, Costentin J.","Brain Res. 1990 Jul 30;524(1):153-5. doi: 10.1016/0006-8993(90)90505-6.","Dourmap N","Brain Res","1990","1990/07/30","","","10.1016/0006-8993(90)90505-6"
"1974646","Tonic opioid inhibition of the pressor region of the rostral ventrolateral medulla of rabbits is mediated by delta receptors","Morilak DA, Drolet G, Chalmers J.","J Pharmacol Exp Ther. 1990 Aug;254(2):671-6.","Morilak DA","J Pharmacol Exp Ther","1990","1990/08/01","","",""
"1973627","Chronic naltrexone infusion: effects on innervation of rat neurointermediate lobe","Saland LC, Reyes E, Samora A, Gutierrez L.","Brain Res Bull. 1990 Jun;24(6):779-86. doi: 10.1016/0361-9230(90)90140-u.","Saland LC","Brain Res Bull","1990","1990/06/01","","","10.1016/0361-9230(90)90140-u"
"1973268","Reflex peristalsis in the guinea pig isolated ileum is endogenously controlled by kappa opioid receptors","Kromer W.","Naunyn Schmiedebergs Arch Pharmacol. 1990 May;341(5):450-4. doi: 10.1007/BF00176339.","Kromer W","Naunyn Schmiedebergs Arch Pharmacol","1990","1990/05/01","","","10.1007/BF00176339"
"1971712","Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration","Summy-Long JY, Rosella-Dampman LM, McLemore GL, Koehler E.","Neuroendocrinology. 1990 Apr;51(4):376-84. doi: 10.1159/000125364.","Summy-Long JY","Neuroendocrinology","1990","1990/04/01","","","10.1159/000125364"
"1971432","Clonidine, administered intracerebroventricularly in mice, produces an anti-analgesic effect which may be mediated spinally by dynorphin A (1-17)","Fujimoto JM, Arts KS.","Neuropharmacology. 1990 Apr;29(4):351-8. doi: 10.1016/0028-3908(90)90093-7.","Fujimoto JM","Neuropharmacology","1990","1990/04/01","","","10.1016/0028-3908(90)90093-7"
"1968257","Characterisation of opioid binding sites using selective antagonists","Lawrence AJ, Traynor JR.","Prog Clin Biol Res. 1990;328:121-4.","Lawrence AJ","Prog Clin Biol Res","1990","1990/01/01","","",""
"1967925","Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury","Faden AI.","Ann Neurol. 1990 Jan;27(1):67-74. doi: 10.1002/ana.410270111.","Faden AI","Ann Neurol","1990","1990/01/01","","","10.1002/ana.410270111"
"1967391","Rapid transition from methadone maintenance to naltrexone","Loimer N, Lenz K, Presslich O, Schmid R.","Lancet. 1990 Jan 13;335(8681):111. doi: 10.1016/0140-6736(90)90576-q.","Loimer N","Lancet","1990","1990/01/13","","","10.1016/0140-6736(90)90576-q"
"1965769","A study of central opioid receptor involvement in nitrous oxide analgesia in mice","Chen DC, Quock RM.","Anesth Prog. 1990 Jul;37(4):181-5.","Chen DC","Anesth Prog","1990","1990/07/01","PMC2148669","",""
"1965750","Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations","Lee C, Rodgers RJ.","Psychopharmacology (Berl). 1990;102(4):507-13. doi: 10.1007/BF02247133.","Lee C","Psychopharmacology (Berl)","1990","1990/01/01","","","10.1007/BF02247133"
"1965514","beta-Funaltrexamine antagonizes the analgesic effects of mu and kappa agonists in the formalin test","Abbott FV.","Pharmacol Biochem Behav. 1990 Dec;37(4):713-6. doi: 10.1016/0091-3057(90)90553-t.","Abbott FV","Pharmacol Biochem Behav","1990","1990/12/01","","","10.1016/0091-3057(90)90553-t"
"1965042","Pharmacologic profile of NPC 168 (naltrexone phenyl oxime), a novel compound with activity at opioid receptors","DeHaven-Hudkins DL, Brostrom PA, Allen JT, Lesko LJ, Ferkany JW, Kaplita PV, Mavunkel BJ, Rzeszotarski WJ, Steranka LR.","Pharmacol Biochem Behav. 1990 Nov;37(3):497-504. doi: 10.1016/0091-3057(90)90019-e.","DeHaven-Hudkins DL","Pharmacol Biochem Behav","1990","1990/11/01","","","10.1016/0091-3057(90)90019-e"
"1964913","The anticonvulsant action of CI-977, a selective kappa-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex","Singh L, Vass CA, Hunter JC, Woodruff GN, Hughes J.","Eur J Pharmacol. 1990 Dec 4;191(3):477-80. doi: 10.1016/0014-2999(90)94183-x.","Singh L","Eur J Pharmacol","1990","1990/12/04","","","10.1016/0014-2999(90)94183-x"
"1964843","Conditional hypoalgesia is attenuated by naltrexone applied to the periaqueductal gray","Helmstetter FJ, Landeira-Fernandez J.","Brain Res. 1990 Dec 24;537(1-2):88-92. doi: 10.1016/0006-8993(90)90343-a.","Helmstetter FJ","Brain Res","1990","1990/12/24","","","10.1016/0006-8993(90)90343-a"
"1964536","Electric muscle stimulation in the spontaneously hypertensive rat induces a post-stimulatory reduction in activity: role of different opioid receptors","Hoffmann P, Skarphedinsson JO, Thorén P.","Acta Physiol Scand. 1990 Dec;140(4):507-14. doi: 10.1111/j.1748-1716.1990.tb09027.x.","Hoffmann P","Acta Physiol Scand","1990","1990/12/01","","","10.1111/j.1748-1716.1990.tb09027.x"
"1964530","The effects of mu, delta- and kappa-opioid receptor antagonists on the pain threshold increase following muscle stimulation in the rat","Hoffmann P, Carlsson S, Thorén P.","Acta Physiol Scand. 1990 Nov;140(3):353-8. doi: 10.1111/j.1748-1716.1990.tb09009.x.","Hoffmann P","Acta Physiol Scand","1990","1990/11/01","","","10.1111/j.1748-1716.1990.tb09009.x"
"1964442","The effects of opioid and benzodiazepine antagonists on dam-induced reductions in rat pup isolation distress","Carden SE, Hofer MA.","Dev Psychobiol. 1990 Dec;23(8):797-808. doi: 10.1002/dev.420230804.","Carden SE","Dev Psychobiol","1990","1990/12/01","","","10.1002/dev.420230804"
"1963685","Functional reactivity of different central opioid receptor systems following clomipramine treatments","Ukponmwan OE, Murugaiah KD.","Pharmacol Res. 1990 Nov-Dec;22(6):691-9. doi: 10.1016/s1043-6618(05)80095-7.","Ukponmwan OE","Pharmacol Res","1990","1990/11/01","","","10.1016/s1043-6618(05)80095-7"
"1963567","Nor-binaltorphimine decreases deprivation and opioid-induced feeding","Levine AS, Grace M, Billington CJ, Portoghese PS.","Brain Res. 1990 Nov 26;534(1-2):60-4. doi: 10.1016/0006-8993(90)90112-o.","Levine AS","Brain Res","1990","1990/11/26","","","10.1016/0006-8993(90)90112-o"
"1963562","Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine","Arjune D, Bodnar RJ.","Brain Res. 1990 Nov 26;534(1-2):313-6. doi: 10.1016/0006-8993(90)90147-4.","Arjune D","Brain Res","1990","1990/11/26","","","10.1016/0006-8993(90)90147-4"
"1963479","Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors","Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW.","Neuropharmacology. 1990 Sep;29(9):805-10. doi: 10.1016/0028-3908(90)90153-i.","Rothman RB","Neuropharmacology","1990","1990/09/01","","","10.1016/0028-3908(90)90153-i"
"1963340","Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions","Arjune D, Standifer KM, Pasternak GW, Bodnar RJ.","Brain Res. 1990 Dec 3;535(1):101-9. doi: 10.1016/0006-8993(90)91828-5.","Arjune D","Brain Res","1990","1990/12/03","","","10.1016/0006-8993(90)91828-5"
"1963258","[Maintenance treatment for opiate dependence at a naltrexone clinic]","López-Ibor Aliño JJ, Pérez de los Cobos JC, Ochoa E, Hernández Herreros M.","Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1990 Sep-Oct;18(5):296-305.","López-Ibor Aliño JJ","Actas Luso Esp Neurol Psiquiatr Cienc Afines","1990","1990/09/01","","",""
"1963196","The opioid receptor selectivity for trimebutine in isolated tissues experiments and receptor binding studies","Kaneto H, Takahashi M, Watanabe J.","J Pharmacobiodyn. 1990 Jul;13(7):448-53. doi: 10.1248/bpb1978.13.448.","Kaneto H","J Pharmacobiodyn","1990","1990/07/01","","","10.1248/bpb1978.13.448"
"1963149","Long-acting agonist and antagonist activities of naltrexamine bivalent ligands in mice","Takemori AE, Yim CB, Larson DL, Portoghese PS.","Eur J Pharmacol. 1990 Sep 21;186(2-3):285-8. doi: 10.1016/0014-2999(90)90445-c.","Takemori AE","Eur J Pharmacol","1990","1990/09/21","","","10.1016/0014-2999(90)90445-c"
"1955812","Variable-ratio schedules of timeout from avoidance: effects of d-amphetamine and morphine","Galizio M, Allen AR.","J Exp Anal Behav. 1991 Sep;56(2):193-203. doi: 10.1901/jeab.1991.56-193.","Galizio M","J Exp Anal Behav","1991","1991/09/01","PMC1323097","","10.1901/jeab.1991.56-193"
"1952921","Opioids and feeding reward","Kirkham TC.","Appetite. 1991 Aug;17(1):74-5. doi: 10.1016/0195-6663(91)90089-b.","Kirkham TC","Appetite","1991","1991/08/01","","","10.1016/0195-6663(91)90089-b"
"1946579","Opioid-dependent behaviors in infant rats: effects of prenatal exposure to ethanol","Kehoe P, Shoemaker W.","Pharmacol Biochem Behav. 1991 Jun;39(2):389-94. doi: 10.1016/0091-3057(91)90197-a.","Kehoe P","Pharmacol Biochem Behav","1991","1991/06/01","","","10.1016/0091-3057(91)90197-a"
"1943057","Analysis of naltrexone and 6-beta-naltrexol in plasma and urine by gas chromatography/negative ion chemical ionization mass spectrometry","Monti KM, Foltz RL, Chinn DM.","J Anal Toxicol. 1991 May-Jun;15(3):136-40. doi: 10.1093/jat/15.3.136.","Monti KM","J Anal Toxicol","1991","1991/05/01","","","10.1093/jat/15.3.136"
"1939481","Determination of naltrexone and 6 beta-naltrexol in plasma by high-performance liquid chromatography with coulometric detection","Zuccaro P, Altieri I, Betto P, Pacifici R, Ricciarello G, Pini LA, Sternieri E, Pichini S.","J Chromatogr. 1991 Jul 5;567(2):485-90. doi: 10.1016/0378-4347(91)80156-7.","Zuccaro P","J Chromatogr","1991","1991/07/05","","","10.1016/0378-4347(91)80156-7"
"1926426","Protective effect of nalmefene and naloxone on the ischemically damaged small bowel","Lopez J, Naujokat P, Xavier R, Walters W, Toledo-Pereyra LH.","Transplant Proc. 1991 Oct;23(5):2448-9.","Lopez J","Transplant Proc","1991","1991/10/01","","",""
"1926416","Role of opioid antagonists in the rat liver ischemia model","Naujokat P, Xavier R, Lopez J, Walters W, Toledo-Pereyra LH.","Transplant Proc. 1991 Oct;23(5):2426-7.","Naujokat P","Transplant Proc","1991","1991/10/01","","",""
"1924644","Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys","Kornet M, Goosen C, Van Ree JM.","Psychopharmacology (Berl). 1991;104(3):367-76. doi: 10.1007/BF02246038.","Kornet M","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02246038"
"1920119","Effect of morphine administration on rat liver metallothionein and zinc metabolism","Hidalgo J, Giralt M, Garvey JS, Armario A.","J Pharmacol Exp Ther. 1991 Oct;259(1):274-8.","Hidalgo J","J Pharmacol Exp Ther","1991","1991/10/01","","",""
"1919542","Pharmacological blocking agents for treating substance abuse","Kosten TA, Kosten TR.","J Nerv Ment Dis. 1991 Oct;179(10):583-92. doi: 10.1097/00005053-199110000-00001.","Kosten TA","J Nerv Ment Dis","1991","1991/10/01","","","10.1097/00005053-199110000-00001"
"1916993","Sympathoadrenal control by paraventricular hypothalamic beta-endorphin in hypertension","Jin CB, Rockhold RW.","Hypertension. 1991 Oct;18(4):503-15. doi: 10.1161/01.hyp.18.4.503.","Jin CB","Hypertension","1991","1991/10/01","","","10.1161/01.hyp.18.4.503"
"1912753","Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts","San L, Pomarol G, Peri JM, Olle JM, Cami J.","Br J Addict. 1991 Aug;86(8):983-90. doi: 10.1111/j.1360-0443.1991.tb01859.x.","San L","Br J Addict","1991","1991/08/01","","","10.1111/j.1360-0443.1991.tb01859.x"
"1908558","Sustained release injectable naltrexone microcapsules","Nuwayser ES, DeRoo DJ, Balskovich PD, Tsuk AG.","NIDA Res Monogr. 1990;105:532-3.","Nuwayser ES","NIDA Res Monogr","1990","1991/01/01","","",""
"1901524","Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress: role of beta-endorphin, prolactin and naltrexone","Tejwani GA, Gudehithlu KP, Hanissian SH, Gienapp IE, Whitacre CC, Malarkey WB.","Carcinogenesis. 1991 Apr;12(4):637-41. doi: 10.1093/carcin/12.4.637.","Tejwani GA","Carcinogenesis","1991","1991/04/01","","","10.1093/carcin/12.4.637"
"1899421","Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone","Kremer JA, Borm G, Schellekens LA, Thomas CM, Rolland R.","J Clin Endocrinol Metab. 1991 Feb;72(2):294-300. doi: 10.1210/jcem-72-2-294.","Kremer JA","J Clin Endocrinol Metab","1991","1991/02/01","","","10.1210/jcem-72-2-294"
"1893253","Electroacupuncture analgesia in naive rats: effects of brainstem and spinal cord lesions, and role of pituitary-adrenal axis","Bossut DF, Mayer DJ.","Brain Res. 1991 May 17;549(1):52-8. doi: 10.1016/0006-8993(91)90598-p.","Bossut DF","Brain Res","1991","1991/05/17","","","10.1016/0006-8993(91)90598-p"
"1893252","Electroacupuncture analgesia in rats: naltrexone antagonism is dependent on previous exposure","Bossut DF, Mayer DJ.","Brain Res. 1991 May 17;549(1):47-51. doi: 10.1016/0006-8993(91)90597-o.","Bossut DF","Brain Res","1991","1991/05/17","","","10.1016/0006-8993(91)90597-o"
"1893251","Electroacupuncture in rats: evidence for naloxone and naltrexone potentiation of analgesia","Bossut DF, Huang ZS, Sun SL, Mayer DJ.","Brain Res. 1991 May 17;549(1):36-46. doi: 10.1016/0006-8993(91)90596-n.","Bossut DF","Brain Res","1991","1991/05/17","","","10.1016/0006-8993(91)90596-n"
"1883251","Lower pleasantness of palatable foods in nalmefene-treated human volunteers","Yeomans MR, Wright P.","Appetite. 1991 Jun;16(3):249-59. doi: 10.1016/0195-6663(91)90062-w.","Yeomans MR","Appetite","1991","1991/06/01","","","10.1016/0195-6663(91)90062-w"
"1876736","[Epidural morphine and naltrexone: withdrawal syndrome]","Aguilar JL, Blanco D, Montes A, Llorente C, Vidal F.","Rev Esp Anestesiol Reanim. 1991 Mar-Apr;38(2):127-8.","Aguilar JL","Rev Esp Anestesiol Reanim","1991","1991/03/01","","",""
"1876660","Opiate antagonists reduce cocaine but not nicotine self-administration","Corrigall WA, Coen KM.","Psychopharmacology (Berl). 1991;104(2):167-70. doi: 10.1007/BF02244173.","Corrigall WA","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02244173"
"1876146","Effects of naltrexone on cocaine self-administration by rhesus monkey","Mello NK, Kamien JB, Mendelson JH, Lukas SE.","NIDA Res Monogr. 1990;105:617-8.","Mello NK","NIDA Res Monogr","1990","1991/01/01","","",""
"1875998","Preclinical evaluation of the effects of buprenorphine, naltrexone and desipramine on cocaine self-administration","Mello NK.","NIDA Res Monogr. 1990;105:189-95.","Mello NK","NIDA Res Monogr","1990","1991/01/01","","",""
"1875996","Use of naltrexone for the diagnosis and treatment of reproductive hormone disorders in women","Mendelson JH, Mello NK, Teoh SK, Ellingboe J.","NIDA Res Monogr. 1990;105:161-7.","Mendelson JH","NIDA Res Monogr","1990","1991/01/01","","",""
"1875787","Endothelin-1-induced nociception","Raffa RB, Schupsky JJ, Martinez RP, Jacoby HI.","Life Sci. 1991;49(11):PL61-5. doi: 10.1016/0024-3205(91)90252-7.","Raffa RB","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90252-7"
"1874537","Effects of stress on immune responsiveness, gastric ulcerogenesis and plasma corticosterone in rats: modulation by diazepam and naltrexone","Ray A, Mediratta PK, Puri S, Sen P.","Indian J Exp Biol. 1991 Mar;29(3):233-6.","Ray A","Indian J Exp Biol","1991","1991/03/01","","",""
"1865357","Naltrexone modulation of nicotinic acetylcholine receptor activity","Le Dain AC, Madsen BW, Edeson RO.","J Pharmacol Exp Ther. 1991 Aug;258(2):551-8.","Le Dain AC","J Pharmacol Exp Ther","1991","1991/08/01","","",""
"1864831","Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children","Panksepp J, Lensing P.","J Autism Dev Disord. 1991 Jun;21(2):243-9. doi: 10.1007/BF02284764.","Panksepp J","J Autism Dev Disord","1991","1991/06/01","","","10.1007/BF02284764"
"1862786","Treatment of heroin addicts using buprenorphine","Kosten TR, Morgan C, Kleber HD.","Am J Drug Alcohol Abuse. 1991 Jun;17(2):119-28. doi: 10.3109/00952999108992815.","Kosten TR","Am J Drug Alcohol Abuse","1991","1991/06/01","","","10.3109/00952999108992815"
"1860042","Periaqueductal gray stimulation produces a spinally mediated, opioid antinociception for the inflamed hindpaw of the rat","Morgan MM, Gold MS, Liebeskind JC, Stein C.","Brain Res. 1991 Apr 5;545(1-2):17-23. doi: 10.1016/0006-8993(91)91264-2.","Morgan MM","Brain Res","1991","1991/04/05","","","10.1016/0006-8993(91)91264-2"
"1858956","Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans","Bertino M, Beauchamp GK, Engelman K.","Am J Physiol. 1991 Jul;261(1 Pt 2):R59-63. doi: 10.1152/ajpregu.1991.261.1.R59.","Bertino M","Am J Physiol","1991","1991/07/01","","","10.1152/ajpregu.1991.261.1.R59"
"1857843","[Naloxone and naltrexone in the therapy of advanced COPD]","Foresti V, De Filippi G, Casati O, Zubani R, Scolari N.","Recenti Prog Med. 1991 Apr;82(4):230-2.","Foresti V","Recenti Prog Med","1991","1991/04/01","","",""
"1851915","Comparison of naloxonazine and beta-funaltrexamine antagonism of mu 1 and mu 2 opioid actions","Pick CG, Paul D, Pasternak GW.","Life Sci. 1991;48(21):2005-11. doi: 10.1016/0024-3205(91)90155-5.","Pick CG","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90155-5"
"1851846","Role of spacer and address components in peptidomimetic delta opioid receptor antagonists related to naltrindole","Portoghese PS, Nagase H, MaloneyHuss KE, Lin CE, Takemori AE.","J Med Chem. 1991 May;34(5):1715-20. doi: 10.1021/jm00109a027.","Portoghese PS","J Med Chem","1991","1991/05/01","","","10.1021/jm00109a027"
"1851837","Systemic administration of (Tyr-D-Ser(O-tert-butyl)-Gly-Phe-Leu-Thr(O-tert-butyl), a highly selective delta opioid agonist, induces mu receptor-mediated analgesia in mice","Baamonde A, Daugé V, Gacel G, Roques BP.","J Pharmacol Exp Ther. 1991 May;257(2):767-73.","Baamonde A","J Pharmacol Exp Ther","1991","1991/05/01","","",""
"1851833","Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes","Sofuoglu M, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1991 May;257(2):676-80.","Sofuoglu M","J Pharmacol Exp Ther","1991","1991/05/01","","",""
"1850249","Antitumor activity of naltrexone and correlation with steroid hormone receptors","Abou-Issa H, Tejwani GA.","Biochem Biophys Res Commun. 1991 Mar 15;175(2):625-30. doi: 10.1016/0006-291x(91)91611-f.","Abou-Issa H","Biochem Biophys Res Commun","1991","1991/03/15","","","10.1016/0006-291x(91)91611-f"
"1850136","Effects of selective opiate antagonists on morphine-induced hyperalgesia in domestic fowl","Sufka KJ, Hughes RA, Giordano J.","Pharmacol Biochem Behav. 1991 Jan;38(1):49-54. doi: 10.1016/0091-3057(91)90588-s.","Sufka KJ","Pharmacol Biochem Behav","1991","1991/01/01","","","10.1016/0091-3057(91)90588-s"
"1849995","Role of the spacer in conferring kappa opioid receptor selectivity to bivalent ligands related to norbinaltorphimine","Portoghese PS, Garzon-Aburbeh A, Nagase H, Lin CE, Takemori AE.","J Med Chem. 1991 Apr;34(4):1292-6. doi: 10.1021/jm00108a008.","Portoghese PS","J Med Chem","1991","1991/04/01","","","10.1021/jm00108a008"
"1849435","Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist","Walker MJ, Lê AD, Poulos CX, Cappell H.","Brain Res. 1991 Jan 11;538(2):181-6. doi: 10.1016/0006-8993(91)90427-w.","Walker MJ","Brain Res","1991","1991/01/11","","","10.1016/0006-8993(91)90427-w"
"1848633","Antagonism of morphine antinociception by intrathecally administered corticotropin-releasing factor in mice","Song ZH, Takemori AE.","J Pharmacol Exp Ther. 1991 Mar;256(3):909-12.","Song ZH","J Pharmacol Exp Ther","1991","1991/03/01","","",""
"1848341","Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist NOR-binaltorphimine","Manzanares J, Lookingland KJ, LaVigne SD, Moore KE.","Life Sci. 1991;48(12):1143-9. doi: 10.1016/0024-3205(91)90451-g.","Manzanares J","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90451-g"
"1847702","Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studies","Sawada Y, Kawai R, McManaway M, Otsuki H, Rice KC, Patlak CS, Blasberg RG.","J Cereb Blood Flow Metab. 1991 Mar;11(2):183-203. doi: 10.1038/jcbfm.1991.51.","Sawada Y","J Cereb Blood Flow Metab","1991","1991/03/01","","","10.1038/jcbfm.1991.51"
"1847202","The role of opioid receptor density in morphine tolerance","Lutfy K, Yoburn BC.","J Pharmacol Exp Ther. 1991 Feb;256(2):575-80.","Lutfy K","J Pharmacol Exp Ther","1991","1991/02/01","","",""
"1846414","Pharmacodynamic and pharmacokinetic actions of ketocyclazocine enantiomers in the dog: absence of sigma- or phencyclidine-like activity","Vaupel DB, Cone EJ.","J Pharmacol Exp Ther. 1991 Jan;256(1):211-21.","Vaupel DB","J Pharmacol Exp Ther","1991","1991/01/01","","",""
"1846076","Activation of mu opioid receptors inhibits transient high- and low-threshold Ca2+ currents, but spares a sustained current","Schroeder JE, Fischbach PS, Zheng D, McCleskey EW.","Neuron. 1991 Jan;6(1):13-20. doi: 10.1016/0896-6273(91)90117-i.","Schroeder JE","Neuron","1991","1991/01/01","","","10.1016/0896-6273(91)90117-i"
"1837256","[Use of naltrexone in the treatment of opiate addicts. Efficacy and indications for type categories]","Faro G, Jarre P, Martucci M, Sargiotto A, Eandi M.","Clin Ter. 1991 Nov 15-30;139(3-4):93-9.","Faro G","Clin Ter","1991","1991/11/15","","",""
"1836972","Opiate antagonists inhibit feeding induced by 8-OH-DPAT: possible mediation in the nucleus accumbens","Fletcher PJ.","Brain Res. 1991 Sep 27;560(1-2):260-7. doi: 10.1016/0006-8993(91)91241-r.","Fletcher PJ","Brain Res","1991","1991/09/27","","","10.1016/0006-8993(91)91241-r"
"1832640","NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal","Rasmussen K, Fuller RW, Stockton ME, Perry KW, Swinford RM, Ornstein PL.","Eur J Pharmacol. 1991 May 2;197(1):9-16. doi: 10.1016/0014-2999(91)90358-w.","Rasmussen K","Eur J Pharmacol","1991","1991/05/02","","","10.1016/0014-2999(91)90358-w"
"1832578","Protection by U-50,488H against beta-chlornaltrexamine antagonism of nitrous oxide antinociception in mice","Quock RM, Mueller J.","Brain Res. 1991 May 17;549(1):162-4. doi: 10.1016/0006-8993(91)90615-3.","Quock RM","Brain Res","1991","1991/05/17","","","10.1016/0006-8993(91)90615-3"
"1831247","Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes","Crowley WR, Parker SL, Armstrong WE, Wang W, Grosvenor CE.","Neuroendocrinology. 1991 May;53(5):493-502. doi: 10.1159/000125763.","Crowley WR","Neuroendocrinology","1991","1991/05/01","","","10.1159/000125763"
"1824589","Morphine-induced thymic hypoplasia is glucocorticoid-dependent","Sei Y, Yoshimoto K, McIntyre T, Skolnick P, Arora PK.","J Immunol. 1991 Jan 1;146(1):194-8.","Sei Y","J Immunol","1991","1991/01/01","","",""
"1816567","Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats","Ramsey NF, van Ree JM.","Pharmacol Biochem Behav. 1991 Dec;40(4):807-10. doi: 10.1016/0091-3057(91)90090-o.","Ramsey NF","Pharmacol Biochem Behav","1991","1991/12/01","","","10.1016/0091-3057(91)90090-o"
"1809731","In vivo enhancement of NK cell activity with met-enkephalin and glycyl-glutamine: their possible role in the conditioned response","Ghanta VK, Rogers CF, Hsueh CM, Hiramoto NS, Soong SJ, Hiramoto RN.","Int J Neurosci. 1991 Nov;61(1-2):135-43. doi: 10.3109/00207459108986281.","Ghanta VK","Int J Neurosci","1991","1991/11/01","","","10.3109/00207459108986281"
"1803028","Comparison of a serotonin antagonist, opioid antagonist, and TRH analog for the acute treatment of experimental spinal trauma","Puniak MA, Freeman GM, Agresta CA, Van Newkirk L, Barone CA, Salzman SK.","J Neurotrauma. 1991 Fall;8(3):193-203. doi: 10.1089/neu.1991.8.193.","Puniak MA","J Neurotrauma","1991","1991/01/01","","","10.1089/neu.1991.8.193"
"1797032","Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage","Hubbell CL, Marglin SH, Spitalnic SJ, Abelson ML, Wild KD, Reid LD.","Alcohol. 1991 Sep-Oct;8(5):355-67. doi: 10.1016/0741-8329(91)90573-f.","Hubbell CL","Alcohol","1991","1991/09/01","","","10.1016/0741-8329(91)90573-f"
"1788334","Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouse","Ayres EA, Parkhurst DN, Fang S, Kramer TH, Hruby VJ, Burks TF.","Proc West Pharmacol Soc. 1991;34:477-84.","Ayres EA","Proc West Pharmacol Soc","1991","1991/01/01","","",""
"1787550","Experience with clonidine-naltrexone for rapid opiate detoxification","Senft RA.","J Subst Abuse Treat. 1991;8(4):257-9. doi: 10.1016/0740-5472(91)90048-f.","Senft RA","J Subst Abuse Treat","1991","1991/01/01","","","10.1016/0740-5472(91)90048-f"
"1786649","The development of stimulation-produced analgesia (SPA) in the rat","van Praag H, Frenk H.","Brain Res Dev Brain Res. 1991 Dec 17;64(1-2):71-6. doi: 10.1016/0165-3806(91)90210-a.","van Praag H","Brain Res Dev Brain Res","1991","1991/12/17","","","10.1016/0165-3806(91)90210-a"
"1780350","Effect of naltrexone upon self-injurious behavior, learning and activity: a case study","Taylor DV, Hetrick WP, Neri CL, Touchette P, Barron JL, Sandman CA.","Pharmacol Biochem Behav. 1991 Sep;40(1):79-82. doi: 10.1016/0091-3057(91)90324-u.","Taylor DV","Pharmacol Biochem Behav","1991","1991/09/01","","","10.1016/0091-3057(91)90324-u"
"1780340","Failure of naltrexone to affect the pleasantness or intake of food","Hetherington MM, Vervaet N, Blass E, Rolls BJ.","Pharmacol Biochem Behav. 1991 Sep;40(1):185-90. doi: 10.1016/0091-3057(91)90343-z.","Hetherington MM","Pharmacol Biochem Behav","1991","1991/09/01","","","10.1016/0091-3057(91)90343-z"
"1780271","Research note: naloxone inhibits drinking in the chick induced by angiotensin II","Firman JD, Volmert RF.","Poult Sci. 1991 Sep;70(9):2010-2. doi: 10.3382/ps.0702010.","Firman JD","Poult Sci","1991","1991/09/01","","","10.3382/ps.0702010"
"1771218","Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration","Rasmussen K, Krystal JH, Aghajanian GK.","Psychopharmacology (Berl). 1991;105(4):508-12. doi: 10.1007/BF02244371.","Rasmussen K","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02244371"
"1769708","Splenic immunomodulation with swimming-induced stress in rats","Ferry A, Weill B, Amiridis I, Laziry F, Rieu M.","Immunol Lett. 1991 Aug;29(3):261-4. doi: 10.1016/0165-2478(91)90180-i.","Ferry A","Immunol Lett","1991","1991/08/01","","","10.1016/0165-2478(91)90180-i"
"1762065","Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration","Weber SJ, Greene DL, Sharma SD, Yamamura HI, Kramer TH, Burks TF, Hruby VJ, Hersh LB, Davis TP.","J Pharmacol Exp Ther. 1991 Dec;259(3):1109-17.","Weber SJ","J Pharmacol Exp Ther","1991","1991/12/01","","",""
"1761473","Occlusion pressure response to inspiratory flow-resistive loading in anesthetized swine","Segal BS, Inman JG, Moss IR.","J Appl Physiol (1985). 1991 Nov;71(5):1774-9. doi: 10.1152/jappl.1991.71.5.1774.","Segal BS","J Appl Physiol (1985)","1991","1991/11/01","","","10.1152/jappl.1991.71.5.1774"
"1758728","Respiratory responses of piglets to hypercapnia during postnatal development: effects of opioids","Segal BS, Inman JD, Moss IR.","Pediatr Pulmonol. 1991;11(2):113-9. doi: 10.1002/ppul.1950110207.","Segal BS","Pediatr Pulmonol","1991","1991/01/01","","","10.1002/ppul.1950110207"
"1749459","Naltrexone does not reverse the inhibitory effect of chronic restraint on gonadotropin secretion in the intact male rat","González-Quijano MI, Ariznavarreta C, Martín AI, Treguerres JA, López-Calderón A.","Neuroendocrinology. 1991 Nov;54(5):447-53. doi: 10.1159/000125933.","González-Quijano MI","Neuroendocrinology","1991","1991/11/01","","","10.1159/000125933"
"1746587","Antiretroviral activity of naloxone and naltrexone","Mahayni H, Minor JR.","Am J Hosp Pharm. 1991 Nov;48(11):2480-1.","Mahayni H","Am J Hosp Pharm","1991","1991/11/01","","",""
"1745703","Chronic opioids impair acquisition of both radial maze and Y-maze choice escape","Spain JW, Newsom GC.","Psychopharmacology (Berl). 1991;105(1):101-6. doi: 10.1007/BF02316870.","Spain JW","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02316870"
"1745104","Antagonism of acute cocaine toxicity by buprenorphine","Shukla VK, Goldfrank LR, Turndorf H, Bansinath M.","Life Sci. 1991;49(25):1887-93. doi: 10.1016/0024-3205(91)90289-n.","Shukla VK","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90289-n"
"1740170","Effects of naloxone and naltrexone on receptive and proceptive behaviors in female rats","Saito TR, Aoki S, Hokao R, Amao H, Wakafuji Y, Sugiyama M, Takahashi KW.","Jikken Dobutsu. 1992 Jan;41(1):75-7. doi: 10.1538/expanim1978.41.1_75.","Saito TR","Jikken Dobutsu","1992","1992/01/01","","","10.1538/expanim1978.41.1_75"
"1731036","Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation","Ayesta FJ, Ableitner A, Emmett-Oglesby MW, Herz A, Shippenberg TS.","J Pharmacol Exp Ther. 1992 Jan;260(1):168-74.","Ayesta FJ","J Pharmacol Exp Ther","1992","1992/01/01","","",""
"1723601","Opposite effects of naltrexone on ETOH intake by Syracuse high and low avoidance rats","Iso H, Brush FR.","Alcohol. 1991 Nov-Dec;8(6):443-8. doi: 10.1016/s0741-8329(91)90085-b.","Iso H","Alcohol","1991","1991/11/01","","","10.1016/s0741-8329(91)90085-b"
"1721687","In vivo tonic inhibition of spinal substance P (-like material) release by endogenous opioid(s) acting at delta receptors","Collin E, Mauborgne A, Bourgoin S, Chantrel D, Hamon M, Cesselin F.","Neuroscience. 1991;44(3):725-31. doi: 10.1016/0306-4522(91)90091-2.","Collin E","Neuroscience","1991","1991/01/01","","","10.1016/0306-4522(91)90091-2"
"1720510","Voltage-clamp experiments reveal receptor type-dependent modulation of chloride secretion in the guinea pig colonic mucosa by intestinal opioids","Kromer W.","Naunyn Schmiedebergs Arch Pharmacol. 1991 Sep;344(3):360-7. doi: 10.1007/BF00183012.","Kromer W","Naunyn Schmiedebergs Arch Pharmacol","1991","1991/09/01","","","10.1007/BF00183012"
"1701330","Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain","Hayward MD, Duman RS, Nestler EJ.","Brain Res. 1990 Aug 20;525(2):256-66. doi: 10.1016/0006-8993(90)90872-9.","Hayward MD","Brain Res","1990","1990/08/20","","","10.1016/0006-8993(90)90872-9"
"1698098","Development of enzymatically degradable protective coatings for use in triggered drug delivery systems: derivatized starch hydrogels","Heller J, Pangburn SH, Roskos KV.","Biomaterials. 1990 Jul;11(5):345-50. doi: 10.1016/0142-9612(90)90112-4.","Heller J","Biomaterials","1990","1990/07/01","","","10.1016/0142-9612(90)90112-4"
"1697078","Chronic morphine administration augments benzodiazepine binding and GABAA receptor function","Lopez F, Miller LG, Thompson ML, Schatzki A, Chesley S, Greenblatt DJ, Shader RI.","Psychopharmacology (Berl). 1990;101(4):545-9. doi: 10.1007/BF02244235.","Lopez F","Psychopharmacology (Berl)","1990","1990/01/01","","","10.1007/BF02244235"
"1694028","Substance P modulation of DAMGO binding in the brain of CXBK and Swiss-Webster mice","Krumins SA, Kim DC, Larson AA.","Peptides. 1990 Mar-Apr;11(2):281-5. doi: 10.1016/0196-9781(90)90083-h.","Krumins SA","Peptides","1990","1990/03/01","","","10.1016/0196-9781(90)90083-h"
"1687763","EEG evidence that morphine and an enkephalin analog cross the blood-brain barrier","Kastin AJ, Pearson MA, Banks WA.","Pharmacol Biochem Behav. 1991 Dec;40(4):771-4. doi: 10.1016/0091-3057(91)90084-f.","Kastin AJ","Pharmacol Biochem Behav","1991","1991/12/01","","","10.1016/0091-3057(91)90084-f"
"1687708","E-2078, a potent, selective and stable dynorphin analog with preferential activity for the kappa-opioid receptor subtype on the mouse vas deferens neuroeffector junction","Valenzuela R, Tachibana S, Huidobro-Toro JP.","Peptides. 1991 Nov-Dec;12(6):1211-4. doi: 10.1016/0196-9781(91)90196-v.","Valenzuela R","Peptides","1991","1991/11/01","","","10.1016/0196-9781(91)90196-v"
"1687169","MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids","Bilsky EJ, Hubbell CL, Delconte JD, Reid LD.","Pharmacol Biochem Behav. 1991 Oct;40(2):443-7. doi: 10.1016/0091-3057(91)90577-o.","Bilsky EJ","Pharmacol Biochem Behav","1991","1991/10/01","","","10.1016/0091-3057(91)90577-o"
"1686930","Differential effects of selective opioid peptide antagonists on the acquisition of pavlovian fear conditioning","Fanselow MS, Kim JJ, Young SL, Calcagnetti DJ, DeCola JP, Helmstetter FJ, Landeira-Fernandez J.","Peptides. 1991 Sep-Oct;12(5):1033-7. doi: 10.1016/0196-9781(91)90056-u.","Fanselow MS","Peptides","1991","1991/09/01","","","10.1016/0196-9781(91)90056-u"
"1686854","Effects of long-term treatment with naltrexone on hepatic enzyme activity","Pini LA, Ferretti C, Trenti T, Ferrari A, Sternieri E.","Drug Metabol Drug Interact. 1991;9(2):161-74. doi: 10.1515/dmdi.1991.9.2.161.","Pini LA","Drug Metabol Drug Interact","1991","1991/01/01","","","10.1515/dmdi.1991.9.2.161"
"1686589","[D-Ala2,NMePhe4,Gly-ol5]enkephalin, but not [D-Pen2,L-Pen5]enkephalin, specifically inhibits behaviors induced by the dopamine D2 agonist RU 24213","Toyoshi T, Ukai M, Kameyama T.","Eur J Pharmacol. 1991 Aug 16;201(1):41-6. doi: 10.1016/0014-2999(91)90320-p.","Toyoshi T","Eur J Pharmacol","1991","1991/08/16","","","10.1016/0014-2999(91)90320-p"
"1686100","Serotonin contributes to the spinal antinociceptive effects of morphine","Crisp T, Stafinsky JL, Uram M, Perni VC, Weaver MF, Spanos LJ.","Pharmacol Biochem Behav. 1991 Jul;39(3):591-5. doi: 10.1016/0091-3057(91)90133-m.","Crisp T","Pharmacol Biochem Behav","1991","1991/07/01","","","10.1016/0091-3057(91)90133-m"
"1685523","Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the rat","Jackson HC, Nutt DJ.","J Pharm Pharmacol. 1991 Sep;43(9):640-3. doi: 10.1111/j.2042-7158.1991.tb03554.x.","Jackson HC","J Pharm Pharmacol","1991","1991/09/01","","","10.1111/j.2042-7158.1991.tb03554.x"
"1685449","Effect of opioid receptor antagonists on vasodilator nerve actions in the perfused rat mesentery","Li YJ, Duckles SP.","Eur J Pharmacol. 1991 Nov 12;204(3):323-8. doi: 10.1016/0014-2999(91)90859-o.","Li YJ","Eur J Pharmacol","1991","1991/11/12","","","10.1016/0014-2999(91)90859-o"
"1685349","Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism","Rochford J, Godin C, Henry JL.","Brain Res. 1991 Nov 22;565(1):67-77. doi: 10.1016/0006-8993(91)91737-l.","Rochford J","Brain Res","1991","1991/11/22","","","10.1016/0006-8993(91)91737-l"
"1681781","A controlled trial of propoxyphene and naltrexone in patients with Tourette's syndrome","Kurlan R, Majumdar L, Deeley C, Mudholkar GS, Plumb S, Como PG.","Ann Neurol. 1991 Jul;30(1):19-23. doi: 10.1002/ana.410300105.","Kurlan R","Ann Neurol","1991","1991/07/01","","","10.1002/ana.410300105"
"1678526","Opioid mu and delta receptor antagonists reduce wet dog shaking elicited by perforant path stimulation","Mitchell CL, Barnes MI, Hudson PM, Hong JS.","Pharmacol Biochem Behav. 1991 Apr;38(4):801-5. doi: 10.1016/0091-3057(91)90245-w.","Mitchell CL","Pharmacol Biochem Behav","1991","1991/04/01","","","10.1016/0091-3057(91)90245-w"
"1678525","Effects of dexfenfluramine and opioid peptides, alone or in combination, on food intake and brain serotonin turnover in rats","Robert JJ, Orosco M, Rouch C, Cohen Y, Jacquot C.","Pharmacol Biochem Behav. 1991 Apr;38(4):775-80. doi: 10.1016/0091-3057(91)90241-s.","Robert JJ","Pharmacol Biochem Behav","1991","1991/04/01","","","10.1016/0091-3057(91)90241-s"
"1678297","U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals","Gannon RL, Terrian DM.","Brain Res. 1991 May 10;548(1-2):242-7. doi: 10.1016/0006-8993(91)91127-m.","Gannon RL","Brain Res","1991","1991/05/10","","","10.1016/0006-8993(91)91127-m"
"1677606","Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region","Stevens KE, Shiotsu G, Stein L.","Brain Res. 1991 Apr 5;545(1-2):8-16. doi: 10.1016/0006-8993(91)91263-z.","Stevens KE","Brain Res","1991","1991/04/05","","","10.1016/0006-8993(91)91263-z"
"1677542","mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides","Gunion MW, Rosenthal MJ, Morley JE, Miller S, Zib B, Butler B, Moore RD.","Am J Physiol. 1991 Jul;261(1 Pt 2):R70-81. doi: 10.1152/ajpregu.1991.261.1.R70.","Gunion MW","Am J Physiol","1991","1991/07/01","","","10.1152/ajpregu.1991.261.1.R70"
"1677015","Opioid antagonist impedes exposure","Merluzzi TV, Taylor CB, Boltwood M, Götestam KG.","J Consult Clin Psychol. 1991 Jun;59(3):425-30. doi: 10.1037//0022-006x.59.3.425.","Merluzzi TV","J Consult Clin Psychol","1991","1991/06/01","","","10.1037//0022-006x.59.3.425"
"1676337","Effects of dynorphin A(1-13) and of fragments of beta-endorphin on blood pressure and heart rate of anesthetized rats","van Giersbergen PL, de Lang H, de Jong W.","Can J Physiol Pharmacol. 1991 Mar;69(3):327-33. doi: 10.1139/y91-050.","van Giersbergen PL","Can J Physiol Pharmacol","1991","1991/03/01","","","10.1139/y91-050"
"1675608","Naltrexone-sensitizing effects of centrally administered morphine and opioid peptides","Adams JU, Holtzman SG.","Eur J Pharmacol. 1991 Jan 25;193(1):67-73. doi: 10.1016/0014-2999(91)90201-z.","Adams JU","Eur J Pharmacol","1991","1991/01/25","","","10.1016/0014-2999(91)90201-z"
"1675463","Use of medication in pervasive developmental disorders","Sloman L.","Psychiatr Clin North Am. 1991 Mar;14(1):165-82.","Sloman L","Psychiatr Clin North Am","1991","1991/03/01","","",""
"1672725","Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception","Song ZH, Takemori AE.","Life Sci. 1991;48(15):1447-53. doi: 10.1016/0024-3205(91)90181-a.","Song ZH","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90181-a"
"1672378","Separate neural mechanisms mediate sufentanil-induced pupillary responses in the cat","Sharpe LG.","J Pharmacol Exp Ther. 1991 Mar;256(3):845-9.","Sharpe LG","J Pharmacol Exp Ther","1991","1991/03/01","","",""
"1671100","Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice","Nakazawa T, Furuya Y, Kaneko T, Yamatsu K.","J Pharmacol Exp Ther. 1991 Jan;256(1):76-81.","Nakazawa T","J Pharmacol Exp Ther","1991","1991/01/01","","",""
"1669442","Novel inhibitors of enkephalin-degrading enzymes. III: 4-Carboxymethylamino-4-oxo-3 (phenylamino) butanoic acids as enkephalinase inhibitors","Patel A, Smith HJ, Sewell RD.","J Enzyme Inhib. 1991;5(2):133-49. doi: 10.3109/14756369109069066.","Patel A","J Enzyme Inhib","1991","1991/01/01","","","10.3109/14756369109069066"
"1667901","Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists","Baumann MH, Rabii J.","Brain Res. 1991 Dec 20;567(2):224-30. doi: 10.1016/0006-8993(91)90799-2.","Baumann MH","Brain Res","1991","1991/12/20","","","10.1016/0006-8993(91)90799-2"
"1666682","Opioid mediation of odor preferences induced by sugar and fat in 6-day-old rats","Shide DJ, Blass EM.","Physiol Behav. 1991 Nov;50(5):961-6. doi: 10.1016/0031-9384(91)90422-k.","Shide DJ","Physiol Behav","1991","1991/11/01","","","10.1016/0031-9384(91)90422-k"
"1666046","Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception","Liu-Chen LY, Li SX, Wheeler-Aceto H, Cowan A.","Eur J Pharmacol. 1991 Oct 15;203(2):195-202. doi: 10.1016/0014-2999(91)90715-3.","Liu-Chen LY","Eur J Pharmacol","1991","1991/10/15","","","10.1016/0014-2999(91)90715-3"
"1665794","Behavioural effects of deltorphins in rats","Negri L, Noviello V, Angelucci F.","Eur J Pharmacol. 1991 Dec 17;209(3):163-8. doi: 10.1016/0014-2999(91)90165-m.","Negri L","Eur J Pharmacol","1991","1991/12/17","","","10.1016/0014-2999(91)90165-m"
"1665789","Modulation of mu-mediated antitussive activity in rats by a delta agonist","Kamei J, Tanihara H, Kasuya Y.","Eur J Pharmacol. 1991 Oct 2;203(1):153-6. doi: 10.1016/0014-2999(91)90807-3.","Kamei J","Eur J Pharmacol","1991","1991/10/02","","","10.1016/0014-2999(91)90807-3"
"1665188","Analysis of neurotransmitter receptors mediating changes in LH release induced by electrical stimulation of the dorsal raphe nucleus in the rat","Johnson JH, Kitts CS.","J Neurosci Res. 1991 Aug;29(4):520-6. doi: 10.1002/jnr.490290412.","Johnson JH","J Neurosci Res","1991","1991/08/01","","","10.1002/jnr.490290412"
"1664330","Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine","Takahashi M, Senda T, Kaneto H.","Eur J Pharmacol. 1991 Aug 6;200(2-3):293-7. doi: 10.1016/0014-2999(91)90585-e.","Takahashi M","Eur J Pharmacol","1991","1991/08/06","","","10.1016/0014-2999(91)90585-e"
"1664272","An enkephalinergic mechanism involved in amygdaloid suppression of affective defence behavior elicited from the midbrain periaqueductal gray in the cat","Shaikh MB, Lu CL, Siegel A.","Brain Res. 1991 Sep 13;559(1):109-17. doi: 10.1016/0006-8993(91)90293-5.","Shaikh MB","Brain Res","1991","1991/09/13","","","10.1016/0006-8993(91)90293-5"
"1663414","Beta-funaltrexamine (beta-FNA) decreases deprivation and opioid-induced feeding","Levine AS, Grace M, Billington CJ.","Brain Res. 1991 Oct 25;562(2):281-4. doi: 10.1016/0006-8993(91)90632-6.","Levine AS","Brain Res","1991","1991/10/25","","","10.1016/0006-8993(91)90632-6"
"1661859","Evaluation of the sites of opioid influence on anterior pituitary hormone secretion using a quaternary opiate antagonist","Simpkins JW, Swager D, Millard WJ.","Neuroendocrinology. 1991 Oct;54(4):384-90. doi: 10.1159/000125918.","Simpkins JW","Neuroendocrinology","1991","1991/10/01","","","10.1159/000125918"
"1661103","kappa-Opioid antagonist improves cellular bioenergetics and recovery after traumatic brain injury","Vink R, Portoghese PS, Faden AI.","Am J Physiol. 1991 Dec;261(6 Pt 2):R1527-32. doi: 10.1152/ajpregu.1991.261.6.R1527.","Vink R","Am J Physiol","1991","1991/12/01","","","10.1152/ajpregu.1991.261.6.R1527"
"1660758","DAGO ([D-Ala2,N-Me-Phe4,Gly-ol]enkephalin) specifically reverses apomorphine-induced increase in rearing and grooming behaviors in the mouse","Ukai M, Toyoshi T, Kameyama T.","Brain Res. 1991 Aug 23;557(1-2):77-82. doi: 10.1016/0006-8993(91)90118-f.","Ukai M","Brain Res","1991","1991/08/23","","","10.1016/0006-8993(91)90118-f"
"1659130","In vitro effect of high doses of morphine on Con A induced lymphokine production","Jessop JJ, Taplits MS.","Adv Exp Med Biol. 1991;288:179-87. doi: 10.1007/978-1-4684-5925-8_20.","Jessop JJ","Adv Exp Med Biol","1991","1991/01/01","","","10.1007/978-1-4684-5925-8_20"
"1658817","Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor","Arjune D, Bowen WD, Bodnar RJ.","Pharmacol Biochem Behav. 1991 Jun;39(2):429-36. doi: 10.1016/0091-3057(91)90203-e.","Arjune D","Pharmacol Biochem Behav","1991","1991/06/01","","","10.1016/0091-3057(91)90203-e"
"1658509","Cross-tolerance studies in the spinal cord of beta-FNA-treated mice provides further evidence for delta opioid receptor subtypes","Sofuoglu M, Portoghese PS, Takemori AE.","Life Sci. 1991;49(19):PL153-6. doi: 10.1016/0024-3205(91)90397-t.","Sofuoglu M","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90397-t"
"1658309","Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat","Drower EJ, Stapelfeld A, Rafferty MF, de Costa BR, Rice KC, Hammond DL.","J Pharmacol Exp Ther. 1991 Nov;259(2):725-31.","Drower EJ","J Pharmacol Exp Ther","1991","1991/11/01","","",""
"1658308","Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues","James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ.","J Pharmacol Exp Ther. 1991 Nov;259(2):712-8.","James MK","J Pharmacol Exp Ther","1991","1991/11/01","","",""
"1657291","Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats","Omote K, Kitahata LM, Nakatani K, Collins JG.","Brain Res. 1991 Jul 19;554(1-2):299-303. doi: 10.1016/0006-8993(91)90204-9.","Omote K","Brain Res","1991","1991/07/19","","","10.1016/0006-8993(91)90204-9"
"1657224","Opiate receptor antagonists for delusions of parasitosis","Botschev C, Müller N.","Biol Psychiatry. 1991 Sep 1;30(5):530-1. doi: 10.1016/0006-3223(91)90322-d.","Botschev C","Biol Psychiatry","1991","1991/09/01","","","10.1016/0006-3223(91)90322-d"
"1656303","In vitro depressant effects of U-54494A, an anticonvulsant related to kappa opioids, in the hippocampus","Proietti ML, Scotti de Carolis A, Frank C, Zeng YC, Sagratella S.","Neuropharmacology. 1991 Jun;30(6):637-42. doi: 10.1016/0028-3908(91)90084-o.","Proietti ML","Neuropharmacology","1991","1991/06/01","","","10.1016/0028-3908(91)90084-o"
"1656025","Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone","Belcheva MM, Barg J, McHale RJ, Gao XM, Chuang DM, Coscia CJ.","J Pharmacol Exp Ther. 1991 Oct;259(1):302-9.","Belcheva MM","J Pharmacol Exp Ther","1991","1991/10/01","","",""
"1655470","Evaluation of receptor mechanism mediating fentanyl analgesia and toxicity","Jang Y, Yoburn BC.","Eur J Pharmacol. 1991 May 17;197(2-3):135-41. doi: 10.1016/0014-2999(91)90512-o.","Jang Y","Eur J Pharmacol","1991","1991/05/17","","","10.1016/0014-2999(91)90512-o"
"1654574","Isolation-induced vocalization in Wistar rat pups is not increased by naltrexone","Carden SE, Hofer MA.","Physiol Behav. 1991 Jun;49(6):1279-82. doi: 10.1016/0031-9384(91)90363-s.","Carden SE","Physiol Behav","1991","1991/06/01","","","10.1016/0031-9384(91)90363-s"
"1654389","Resolution of biphasic binding of the opioid antagonist naltrexone in brain membranes","Remmers AE, Medzihradsky F.","J Neurochem. 1991 Oct;57(4):1265-9. doi: 10.1111/j.1471-4159.1991.tb08288.x.","Remmers AE","J Neurochem","1991","1991/10/01","","","10.1111/j.1471-4159.1991.tb08288.x"
"1653084","Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats","Hoffman DC, West TE, Wise RA.","Brain Res. 1991 Jun 7;550(2):205-12. doi: 10.1016/0006-8993(91)91319-v.","Hoffman DC","Brain Res","1991","1991/06/07","","","10.1016/0006-8993(91)91319-v"
"1652797","Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex","Rothman RB, Bykov V, Mahboubi A, Long JB, Jiang Q, Porreca F, de Costa BR, Jacobson AE, Rice KC, Holaday JW.","Synapse. 1991 Jun;8(2):86-99. doi: 10.1002/syn.890080203.","Rothman RB","Synapse","1991","1991/06/01","","","10.1002/syn.890080203"
"1652662","Footshock- and psychological-stress prevent the development of tolerance to spinal but not supraspinal morphine","Takahashi M, Kaneto H.","Jpn J Pharmacol. 1991 Jun;56(2):121-6. doi: 10.1254/jjp.56.121.","Takahashi M","Jpn J Pharmacol","1991","1991/06/01","","","10.1254/jjp.56.121"
"1652143","Role of central versus peripheral opioid receptors in analgesia induced by repeated administration of opioid antagonists","Walker MJ, Lê AD, Poulos CX, Cappell H.","Psychopharmacology (Berl). 1991;104(2):164-6. doi: 10.1007/BF02244172.","Walker MJ","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02244172"
"1652048","Opioids regulate the release of human chorionic gonadotropin hormone from trophoblast tissue","Cemerikic B, Cheng J, Agbas A, Ahmed MS.","Life Sci. 1991;49(11):813-24. doi: 10.1016/0024-3205(91)90246-8.","Cemerikic B","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90246-8"
"1651519","Dissociation of opioid receptor upregulation and functional supersensitivity","Chang SC, Lutfy K, Sierra V, Yoburn BC.","Pharmacol Biochem Behav. 1991 Apr;38(4):853-9. doi: 10.1016/0091-3057(91)90253-x.","Chang SC","Pharmacol Biochem Behav","1991","1991/04/01","","","10.1016/0091-3057(91)90253-x"
"1651391","The opioid activity and receptor selectivity of fluorinated Leu5 enkephalin analogues in vitro and in vivo","Watanabe J, Tokuyama S, Takahashi M, Kaneto H, Maeda M, Kawasaki K, Taguchi T, Kobayashi Y, Yamamoto Y, Shimokawa K.","J Pharmacobiodyn. 1991 Feb;14(2):101-5. doi: 10.1248/bpb1978.14.101.","Watanabe J","J Pharmacobiodyn","1991","1991/02/01","","","10.1248/bpb1978.14.101"
"1650833","Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists","Mjanger E, Yaksh TL.","J Pharmacol Exp Ther. 1991 Aug;258(2):544-50.","Mjanger E","J Pharmacol Exp Ther","1991","1991/08/01","","",""
"1650830","Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects","France CP, Winger G, Medzihradsky F, Seggel MR, Rice KC, Woods JH.","J Pharmacol Exp Ther. 1991 Aug;258(2):502-10.","France CP","J Pharmacol Exp Ther","1991","1991/08/01","","",""
"1650277","Effects of parabrachial opioid antagonism on stimulation-induced feeding","Carr KD, Aleman DO, Bak TH, Simon EJ.","Brain Res. 1991 Apr 5;545(1-2):283-6. doi: 10.1016/0006-8993(91)91298-f.","Carr KD","Brain Res","1991","1991/04/05","","","10.1016/0006-8993(91)91298-f"
"1649751","Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats","Adamson WT, Windh RT, Blackford S, Kuhn CM.","Endocrinology. 1991 Aug;129(2):959-64. doi: 10.1210/endo-129-2-959.","Adamson WT","Endocrinology","1991","1991/08/01","","","10.1210/endo-129-2-959"
"1649665","Kappa-opioid antagonist strongly attenuates drinking of genetically polydipsic mice","Katafuchi T, Hattori Y, Nagatomo I, Koizumi K.","Brain Res. 1991 Apr 12;546(1):1-7. doi: 10.1016/0006-8993(91)91152-q.","Katafuchi T","Brain Res","1991","1991/04/12","","","10.1016/0006-8993(91)91152-q"
"1649664","Endogenous opioids regulate cell proliferation in the retina of developing rat","Isayama T, McLaughlin PJ, Zagon IS.","Brain Res. 1991 Mar 22;544(1):79-85. doi: 10.1016/0006-8993(91)90887-2.","Isayama T","Brain Res","1991","1991/03/22","","","10.1016/0006-8993(91)90887-2"
"1649420","Endogenous opioids tonically inhibit the depressor neurones in the caudal ventrolateral medulla of rabbits: mediation through delta- and kappa-receptors","Drolet G, Morilak DA, Chalmers J.","Neuropharmacology. 1991 Apr;30(4):383-90. doi: 10.1016/0028-3908(91)90064-i.","Drolet G","Neuropharmacology","1991","1991/04/01","","","10.1016/0028-3908(91)90064-i"
"1649297","Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice","Abdelhamid EE, Sultana M, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1991 Jul 1;258(1):299-303.","Abdelhamid EE","J Pharmacol Exp Ther","1991","1991/07/01","","",""
"1648745","Modifications of social conflict-induced analgesic and activity responses in male mice receiving chronic opioid agonist and antagonist treatments","Teskey GC, Kavaliers M.","Pharmacol Biochem Behav. 1991 Mar;38(3):485-93. doi: 10.1016/0091-3057(91)90002-j.","Teskey GC","Pharmacol Biochem Behav","1991","1991/03/01","","","10.1016/0091-3057(91)90002-j"
"1648619","Persistent binding of fatty acyl derivatives of naltrexamine to opioid receptors","Portoghese PS, Garzon-Aburbeh A, Larson DL.","J Med Chem. 1991 Jul;34(7):1966-9. doi: 10.1021/jm00111a007.","Portoghese PS","J Med Chem","1991","1991/07/01","","","10.1021/jm00111a007"
"1648248","Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area","Calenco-Choukroun G, Daugé V, Gacel G, Féger J, Roques BP.","Psychopharmacology (Berl). 1991;103(4):493-502. doi: 10.1007/BF02244249.","Calenco-Choukroun G","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02244249"
"1648136","An approach to the design of receptor-type-selective non-peptide antagonists of peptidergic receptors: delta opioid antagonists","Portoghese PS.","J Med Chem. 1991 Jun;34(6):1757-62. doi: 10.1021/jm00110a001.","Portoghese PS","J Med Chem","1991","1991/06/01","","","10.1021/jm00110a001"
"1647539","Differential effects of selective mu-, kappa- and delta-opioid antagonists on electroshock seizure threshold in mice","Jackson HC, Nutt DJ.","Psychopharmacology (Berl). 1991;103(3):380-3. doi: 10.1007/BF02244293.","Jackson HC","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02244293"
"1647294","The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine","Witkin JM, Johnson RE, Jaffe JH, Goldberg SR, Grayson NA, Rice KC, Katz JL.","Drug Alcohol Depend. 1991 Mar;27(2):177-84. doi: 10.1016/0376-8716(91)90037-y.","Witkin JM","Drug Alcohol Depend","1991","1991/03/01","","","10.1016/0376-8716(91)90037-y"
"1646998","Upregulation of the opioid receptor complex by the chronic administration of morphine: a biochemical marker related to the development of tolerance and dependence","Rothman RB, Long JB, Bykov V, Xu H, Jacobson AE, Rice KC, Holaday JW.","Peptides. 1991 Jan-Feb;12(1):151-60. doi: 10.1016/0196-9781(91)90182-o.","Rothman RB","Peptides","1991","1991/01/01","","","10.1016/0196-9781(91)90182-o"
"1646967","Effect of naltrexone on stress-induced bioactive prolactin release in aging male rats","Briski KP, Sylvester PW.","Neurobiol Aging. 1991 Mar-Apr;12(2):145-9. doi: 10.1016/0197-4580(91)90053-m.","Briski KP","Neurobiol Aging","1991","1991/03/01","","","10.1016/0197-4580(91)90053-m"
"1646826","Regional brain measurement of Bmax and KD with the opiate antagonist cyclofoxy: equilibrium studies in the conscious rat","Kawai R, Carson RE, Dunn B, Newman AH, Rice KC, Blasberg RG.","J Cereb Blood Flow Metab. 1991 Jul;11(4):529-44. doi: 10.1038/jcbfm.1991.102.","Kawai R","J Cereb Blood Flow Metab","1991","1991/07/01","","","10.1038/jcbfm.1991.102"
"1646379","Effects of chronic postnatal opioid receptor blockade by naltrexone upon proliferation capacity in the prenatally X-irradiated brain of the rat","Schmahl W, Miaskowski U.","Neurotoxicol Teratol. 1991 Jan-Feb;13(1):37-42. doi: 10.1016/0892-0362(91)90025-r.","Schmahl W","Neurotoxicol Teratol","1991","1991/01/01","","","10.1016/0892-0362(91)90025-r"
"1646325","Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice","Horan P, de Costa BR, Rice KC, Porreca F.","J Pharmacol Exp Ther. 1991 Jun;257(3):1154-61.","Horan P","J Pharmacol Exp Ther","1991","1991/06/01","","",""
"1646319","Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes","Jiang Q, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F.","J Pharmacol Exp Ther. 1991 Jun;257(3):1069-75.","Jiang Q","J Pharmacol Exp Ther","1991","1991/06/01","","",""
"1646295","(D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens","Longoni R, Spina L, Mulas A, Carboni E, Garau L, Melchiorri P, Di Chiara G.","J Neurosci. 1991 Jun;11(6):1565-76. doi: 10.1523/JNEUROSCI.11-06-01565.1991.","Longoni R","J Neurosci","1991","1991/06/01","PMC6575425","","10.1523/JNEUROSCI.11-06-01565.1991"
"1645834","Pentazocine-induced biphasic analgesia in mice","Suzuki T, Narita M, Misawa M, Nagase H.","Life Sci. 1991;48(19):1827-35. doi: 10.1016/0024-3205(91)90238-7.","Suzuki T","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90238-7"
"1645609","Autoradiographic study of irreversible binding of [3H]beta-funaltrexamine to opioid receptors in the rat forebrain: comparison with mu and delta receptor distribution","Liu-Chen LY, Li SX, Lewis ME.","Brain Res. 1991 Mar 29;544(2):235-42. doi: 10.1016/0006-8993(91)90059-5.","Liu-Chen LY","Brain Res","1991","1991/03/29","","","10.1016/0006-8993(91)90059-5"
"1645433","A monoclonal anti-idiotypic antibody to mu and delta opioid receptors","Coscia CJ, Szücs M, Barg J, Belcheva MM, Bem WT, Khoobehi K, Donnigan TA, Juszczak R, McHale RJ, Hanley MR, et al.","Brain Res Mol Brain Res. 1991 Mar;9(4):299-306. doi: 10.1016/0169-328x(91)90076-a.","Coscia CJ","Brain Res Mol Brain Res","1991","1991/03/01","","","10.1016/0169-328x(91)90076-a"
"1632606","Opioid modulation of alcohol intake in monkeys by low doses of naltrexone and morphine","Kornet M, Goosen C, Van Ree JM.","Ann N Y Acad Sci. 1992 Jun 28;654:469-71. doi: 10.1111/j.1749-6632.1992.tb26002.x.","Kornet M","Ann N Y Acad Sci","1992","1992/06/28","","","10.1111/j.1749-6632.1992.tb26002.x"
"1621484","Ovulation induction with a single-blind treatment regimen comparing naltrexone, placebo and clomiphene citrate in women with secondary amenorrhea","Armeanu MC, Moss RJ, Schoemaker J.","Acta Endocrinol (Copenh). 1992 May;126(5):410-5. doi: 10.1530/acta.0.1260410.","Armeanu MC","Acta Endocrinol (Copenh)","1992","1992/05/01","","","10.1530/acta.0.1260410"
"1618268","Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats","Kogan JH, Nestler EJ, Aghajanian GK.","Eur J Pharmacol. 1992 Jan 28;211(1):47-53. doi: 10.1016/0014-2999(92)90261-2.","Kogan JH","Eur J Pharmacol","1992","1992/01/28","","","10.1016/0014-2999(92)90261-2"
"1605487","Metastasis and neuroendocrine system in stressed mice","Giraldi T, Perissin L, Zorzet S, Rapozzi V.","Ann N Y Acad Sci. 1992 Apr 15;650:297-301. doi: 10.1111/j.1749-6632.1992.tb49140.x.","Giraldi T","Ann N Y Acad Sci","1992","1992/04/15","","","10.1111/j.1749-6632.1992.tb49140.x"
"1605469","Opioid modulation of immunoglobulin production by lymphocytes isolated from Peyer's patches and spleen","Carr DJ, Radulescu RT, DeCosta BR, Rice KC, Blalock JE.","Ann N Y Acad Sci. 1992 Apr 15;650:125-7. doi: 10.1111/j.1749-6632.1992.tb49108.x.","Carr DJ","Ann N Y Acad Sci","1992","1992/04/15","","","10.1111/j.1749-6632.1992.tb49108.x"
"1604425","Feedback inhibition of met-enkephalin release from the rat spinal cord in vivo","Collin E, Bourgoin S, Mantelet S, Hamon M, Cesselin F.","Synapse. 1992 May;11(1):76-84. doi: 10.1002/syn.890110110.","Collin E","Synapse","1992","1992/05/01","","","10.1002/syn.890110110"
"1601640","Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility","Bayer BM, Gastonguay MR, Hernandez MC.","Immunopharmacology. 1992 Mar-Apr;23(2):117-24. doi: 10.1016/0162-3109(92)90035-b.","Bayer BM","Immunopharmacology","1992","1992/03/01","","","10.1016/0162-3109(92)90035-b"
"1596095","Naltrexone and Tourette's syndrome","Erenberg G, Lederman RJ.","Ann Neurol. 1992 May;31(5):574. doi: 10.1002/ana.410310521.","Erenberg G","Ann Neurol","1992","1992/05/01","","","10.1002/ana.410310521"
"1592876","Progesterone inhibits the estrogen-induced gonadotropin surge in the rhesus monkey independent of endogenous opiates","Van Vugt DA, Heisler LE, Reid RL.","J Clin Endocrinol Metab. 1992 Jun;74(6):1312-9. doi: 10.1210/jcem.74.6.1592876.","Van Vugt DA","J Clin Endocrinol Metab","1992","1992/06/01","","","10.1210/jcem.74.6.1592876"
"1584835","Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms","Parker LA, Rennie M.","Pharmacol Biochem Behav. 1992 Mar;41(3):559-65. doi: 10.1016/0091-3057(92)90373-n.","Parker LA","Pharmacol Biochem Behav","1992","1992/03/01","","","10.1016/0091-3057(92)90373-n"
"1580165","Effects of opioid antagonism with naltrexone on pulsatile luteinizing hormone secretion in women with hypothalamic amenorrhea in basal conditions and after discontinuation of treatment with pulsatile LHRH","Armeanu MC, Lambalk CB, Berkhout GM, Schoemaker J.","Gynecol Endocrinol. 1992 Mar;6(1):3-12. doi: 10.3109/09513599209081000.","Armeanu MC","Gynecol Endocrinol","1992","1992/03/01","","","10.3109/09513599209081000"
"1573974","Apparent pA2 value of naltrexone is not changed in rats following continuous exposure to morphine or naloxone","Paronis CA, Holtzman SG.","Life Sci. 1992;50(19):1407-16. doi: 10.1016/0024-3205(92)90259-r.","Paronis CA","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90259-r"
"1571600","Beta-endorphin blunts phosphatidylinositol formation during in vitro activation of isolated human lymphocytes: preliminary report","Chiappelli F, Nguyen L, Bullington R, Fahey JL.","Brain Behav Immun. 1992 Mar;6(1):1-10. doi: 10.1016/0889-1591(92)90054-r.","Chiappelli F","Brain Behav Immun","1992","1992/03/01","","","10.1016/0889-1591(92)90054-r"
"1568861","A naltrexone double blind placebo controlled study in Israel","Lerner A, Sigal M, Bacalu A, Shiff R, Burganski I, Gelkopf M.","Isr J Psychiatry Relat Sci. 1992;29(1):36-43.","Lerner A","Isr J Psychiatry Relat Sci","1992","1992/01/01","","",""
"1564630","Exogenous melatonin modifies the circadian rhythm but does not increase the level of some immune parameters in the chicken","Skwarło-Sońta K, Thaela MJ, Midura M, Lech B, Głuchowska B, Drela N, Kozłowska E, Kowalczyk R.","J Pineal Res. 1992 Jan;12(1):27-34. doi: 10.1111/j.1600-079x.1992.tb00022.x.","Skwarło-Sońta K","J Pineal Res","1992","1992/01/01","","","10.1111/j.1600-079x.1992.tb00022.x"
"1555686","Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment","Armeanu MC, Berkhout GM, Schoemaker J.","Fertil Steril. 1992 Apr;57(4):762-70. doi: 10.1016/s0015-0282(16)54956-5.","Armeanu MC","Fertil Steril","1992","1992/04/01","","","10.1016/s0015-0282(16)54956-5"
"1552818","Opioidergic modulation of cocaine conditioned place preferences","Bilsky EJ, Montegut MJ, Delong CL, Reid LD.","Life Sci. 1992;50(14):PL85-90. doi: 10.1016/0024-3205(92)90105-x.","Bilsky EJ","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90105-x"
"1548976","Estrogenic effects of the new opioid antagonist naltrexone-estrone azine on pituitary luteinizing hormone secretion in ovariectomized rats","Armeanu MC, van Dieten JA, Kolb VM, Schoemaker J, de Koning J.","Life Sci. 1992;50(13):913-21. doi: 10.1016/0024-3205(92)90168-o.","Armeanu MC","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90168-o"
"1539079","Naloxone as a stimulus in drug discrimination learning: generalization to other opiate antagonists","Smurthwaite ST, Kautz MA, Geter B, Riley AL.","Pharmacol Biochem Behav. 1992 Jan;41(1):43-7. doi: 10.1016/0091-3057(92)90056-l.","Smurthwaite ST","Pharmacol Biochem Behav","1992","1992/01/01","","","10.1016/0091-3057(92)90056-l"
"1535707","Characterization of intrathecal vasopressin-induced antinociception, scratching behavior, and motor suppression","Thurston CL, Campbell IG, Culhane ES, Carstens E, Watkins LR.","Peptides. 1992 Jan-Feb;13(1):17-25. doi: 10.1016/0196-9781(92)90135-p.","Thurston CL","Peptides","1992","1992/01/01","","","10.1016/0196-9781(92)90135-p"
"1528943","Effects of beta-funaltrexamine on butorphanol dependence","Oh KW, Makimura M, Jaw SP, Hoskins B, Ho IK.","Pharmacol Biochem Behav. 1992 May;42(1):29-34. doi: 10.1016/0091-3057(92)90441-h.","Oh KW","Pharmacol Biochem Behav","1992","1992/05/01","","","10.1016/0091-3057(92)90441-h"
"1527096","The effect of lipase on the release of naltrexone from triglyceride-coated cellulose acetate phthalate microspheres","Tefft JA, Roskos KV, Heller J.","J Biomed Mater Res. 1992 Jun;26(6):713-24. doi: 10.1002/jbm.820260603.","Tefft JA","J Biomed Mater Res","1992","1992/06/01","","","10.1002/jbm.820260603"
"1517538","Differential effects of morphine and naltrexone on the antibody response in various mouse strains","Bussiere JL, Adler MW, Rogers TJ, Eisenstein TK.","Immunopharmacol Immunotoxicol. 1992;14(3):657-73. doi: 10.3109/08923979209005416.","Bussiere JL","Immunopharmacol Immunotoxicol","1992","1992/01/01","","","10.3109/08923979209005416"
"1513848","Naltrexone, serotonin receptor subtype antagonists, and glucoprivic intake: 2. Insulin","Koch JE, Beczkowska IW, Bodnar RJ.","Pharmacol Biochem Behav. 1992 Aug;42(4):671-80. doi: 10.1016/0091-3057(92)90013-6.","Koch JE","Pharmacol Biochem Behav","1992","1992/08/01","","","10.1016/0091-3057(92)90013-6"
"1513847","Naltrexone, serotonin receptor subtype antagonists, and glucoprivic intake: 1. 2-Deoxy-D-glucose","Beczkowska IW, Koch JE, Bodnar RJ.","Pharmacol Biochem Behav. 1992 Aug;42(4):661-70. doi: 10.1016/0091-3057(92)90012-5.","Beczkowska IW","Pharmacol Biochem Behav","1992","1992/08/01","","","10.1016/0091-3057(92)90012-5"
"1511272","The central effect of methionine-enkephalin on NK cell activity","Hsueh CM, Hiramoto RN, Ghanta VK.","Brain Res. 1992 Apr 24;578(1-2):142-8. doi: 10.1016/0006-8993(92)90241-z.","Hsueh CM","Brain Res","1992","1992/04/24","","","10.1016/0006-8993(92)90241-z"
"1499694","Analgesic and aversive effects of naloxone in BALB/c mice","Vaccarino AL, Plamondon H, Melzack R.","Exp Neurol. 1992 Aug;117(2):216-8. doi: 10.1016/0014-4886(92)90130-i.","Vaccarino AL","Exp Neurol","1992","1992/08/01","","","10.1016/0014-4886(92)90130-i"
"1499660","Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine","Suzuki T, Narita M, Takahashi Y, Misawa M, Nagase H.","Eur J Pharmacol. 1992 Mar 17;213(1):91-7. doi: 10.1016/0014-2999(92)90237-x.","Suzuki T","Eur J Pharmacol","1992","1992/03/17","","","10.1016/0014-2999(92)90237-x"
"1499659","Naltrindole retards tolerance development to morphine-induced effects on EEG and EEG power spectra","Stamidis H, Young GA.","Eur J Pharmacol. 1992 Mar 17;213(1):9-16. doi: 10.1016/0014-2999(92)90226-t.","Stamidis H","Eur J Pharmacol","1992","1992/03/17","","","10.1016/0014-2999(92)90226-t"
"1498948","Naltrexone in chronic negative schizophrenia","Marchesi GF, Santone G, Cotani P, Giordano A, Chelli F.","Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:56A-57A. doi: 10.1097/00002826-199201001-00031.","Marchesi GF","Clin Neuropharmacol","1992","1992/01/01","","","10.1097/00002826-199201001-00031"
"1497864","Clinical effects of naltrexone on autistic behavior","Zingarelli G, Ellman G, Hom A, Wymore M, Heidorn S, Chicz-DeMet A.","Am J Ment Retard. 1992 Jul;97(1):57-63.","Zingarelli G","Am J Ment Retard","1992","1992/07/01","","",""
"1491416","Ostrich (Struthio camelus) immobilisation using carfentanil and xylazine and reversal with yohimbine and naltrexone","Raath JP, Quandt SK, Malan JH.","J S Afr Vet Assoc. 1992 Dec;63(4):138-40.","Raath JP","J S Afr Vet Assoc","1992","1992/12/01","","",""
"1487543","Opiate antagonists and eating behavior in humans: a review","de Zwaan M, Mitchell JE.","J Clin Pharmacol. 1992 Dec;32(12):1060-72.","de Zwaan M","J Clin Pharmacol","1992","1992/12/01","","",""
"1482275","[Treatment with naltrexone in opiate dependents: 2 years' follow-up]","Ochoa E, Arias F, Somoza JC, López-Ibor JJ.","Arch Neurobiol (Madr). 1992 Sep-Oct;55(5):224-7.","Ochoa E","Arch Neurobiol (Madr)","1992","1992/09/01","","",""
"1478264","Chronic naltrexone treatment of rats: effects on gastrointestinal opioid peptide content","McIntosh CH, Law S, Bakich V.","Eur J Pharmacol. 1992 Nov 17;223(2-3):117-22. doi: 10.1016/0014-2999(92)94829-k.","McIntosh CH","Eur J Pharmacol","1992","1992/11/17","","","10.1016/0014-2999(92)94829-k"
"1478260","Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine","Noble F, Turcaud S, Fournié-Zaluski MC, Roques BP.","Eur J Pharmacol. 1992 Nov 13;223(1):83-9. doi: 10.1016/0014-2999(92)90821-k.","Noble F","Eur J Pharmacol","1992","1992/11/13","","","10.1016/0014-2999(92)90821-k"
"1475289","Opioid modulation of thermal dehydration-induced thirst in rats","Barney CC, Morrison CM, Renkema LA, Vergoth C.","Pharmacol Biochem Behav. 1992 Dec;43(4):1065-70. doi: 10.1016/0091-3057(92)90482-u.","Barney CC","Pharmacol Biochem Behav","1992","1992/12/01","","","10.1016/0091-3057(92)90482-u"
"1471698","Effects of chronic nocturnal opiate antagonism on the menstrual cycle","Brzyski RG, Viniegra A, Archer DF.","Am J Obstet Gynecol. 1992 Dec;167(6):1780-4. doi: 10.1016/0002-9378(92)91775-6.","Brzyski RG","Am J Obstet Gynecol","1992","1992/12/01","","","10.1016/0002-9378(92)91775-6"
"1467831","L-leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia","Kawabata A, Nishimura Y, Takagi H.","Br J Pharmacol. 1992 Dec;107(4):1096-101. doi: 10.1111/j.1476-5381.1992.tb13413.x.","Kawabata A","Br J Pharmacol","1992","1992/12/01","PMC1907944","","10.1111/j.1476-5381.1992.tb13413.x"
"1462806","[Detoxification treatment with naltrexone in opiate dependence]","Ochoa Mangado E, López-Ibor Aliño JJ, Pérez de los Cobos Peris JC, Cebollada Gracia A.","Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1992 Sep-Oct;20(5):215-29.","Ochoa Mangado E","Actas Luso Esp Neurol Psiquiatr Cienc Afines","1992","1992/09/01","","",""
"1447490","Effects of opioid receptor blockade on luteinizing hormone (LH) pulses and interpulse LH concentrations in normal women during the early phase of the menstrual cycle","Evans WS, Weltman JY, Johnson ML, Weltman A, Veldhuis JD, Rogol AD.","J Endocrinol Invest. 1992 Jul-Aug;15(7):525-31. doi: 10.1007/BF03348799.","Evans WS","J Endocrinol Invest","1992","1992/07/01","","","10.1007/BF03348799"
"1445971","Intravenous cocaine challenges during naltrexone maintenance: a preliminary study","Kosten T, Silverman DG, Fleming J, Kosten TA, Gawin FH, Compton M, Jatlow P, Byck R.","Biol Psychiatry. 1992 Sep 15;32(6):543-8. doi: 10.1016/0006-3223(92)90223-m.","Kosten T","Biol Psychiatry","1992","1992/09/15","","","10.1016/0006-3223(92)90223-m"
"1444726","Naltrexone and coping skills therapy for alcohol dependence. A controlled study","O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B.","Arch Gen Psychiatry. 1992 Nov;49(11):881-7. doi: 10.1001/archpsyc.1992.01820110045007.","O'Malley SS","Arch Gen Psychiatry","1992","1992/11/01","","","10.1001/archpsyc.1992.01820110045007"
"1435974","Clinical parallels of chronic drug self-administration models for treatment evaluation","Mendelson JH, Mello NK.","NIDA Res Monogr. 1992;119:170-4.","Mendelson JH","NIDA Res Monogr","1992","1992/01/01","","",""
"1435090","Centrally acting endogenous hypotensive substances in rats subjected to endotoxic shock","Xu T, Wang T, Han JS.","Life Sci. 1992;51(23):1817-21. doi: 10.1016/0024-3205(92)90053-r.","Xu T","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90053-r"
"1431829","Naltrexone abuse potential","Lerner AG, Sigal M, Bocalu A, Gelkopf M.","J Nerv Ment Dis. 1992 Nov;180(11):734-5. doi: 10.1097/00005053-199211000-00012.","Lerner AG","J Nerv Ment Dis","1992","1992/11/01","","","10.1097/00005053-199211000-00012"
"1425962","Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole","Menkens K, Bilsky EJ, Wild KD, Portoghese PS, Reid LD, Porreca F.","Eur J Pharmacol. 1992 Aug 25;219(2):345-6. doi: 10.1016/0014-2999(92)90319-y.","Menkens K","Eur J Pharmacol","1992","1992/08/25","","","10.1016/0014-2999(92)90319-y"
"1414352","Naltrexone open trial with a 5-year-old-boy. A social rebound reaction","Lensing P, Klingler D, Lampl C, Leboyer M, Bouvard M, Plumet MH, Panksepp J.","Acta Paedopsychiatr. 1992;55(3):169-73.","Lensing P","Acta Paedopsychiatr","1992","1992/01/01","","",""
"1410149","Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction","Stewart J, Wise RA.","Psychopharmacology (Berl). 1992;108(1-2):79-84. doi: 10.1007/BF02245289.","Stewart J","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02245289"
"1409913","Naltrexone-sensitive analgesia following exposure of mice to 2450-MHz radiofrequency radiation","Maillefer RH, Quock RM.","Physiol Behav. 1992 Sep;52(3):511-4. doi: 10.1016/0031-9384(92)90339-4.","Maillefer RH","Physiol Behav","1992","1992/09/01","","","10.1016/0031-9384(92)90339-4"
"1406906","Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone","Kosten TR, Morgan C, Kleber HD.","NIDA Res Monogr. 1992;121:101-19.","Kosten TR","NIDA Res Monogr","1992","1992/01/01","","",""
"1403211","Ambulatory opiate detoxification and primary care: a role for the primary care physician","O'Connor PG, Waugh ME, Schottenfeld RS, Diakogiannis IA, Rounsaville BJ.","J Gen Intern Med. 1992 Sep-Oct;7(5):532-4. doi: 10.1007/BF02599459.","O'Connor PG","J Gen Intern Med","1992","1992/09/01","","","10.1007/BF02599459"
"1396104","Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone","Dykstra LA, Doty P, Johnson AB, Picker MJ.","Drug Alcohol Depend. 1992 Aug;30(3):227-34. doi: 10.1016/0376-8716(92)90056-i.","Dykstra LA","Drug Alcohol Depend","1992","1992/08/01","","","10.1016/0376-8716(92)90056-i"
"1385166","Identification of a novel receptor mediating substance P-induced behavior in the mouse","Mousseau DD, Sun X, Larson AA.","Eur J Pharmacol. 1992 Jul 7;217(2-3):197-201. doi: 10.1016/0014-2999(92)90849-y.","Mousseau DD","Eur J Pharmacol","1992","1992/07/07","","","10.1016/0014-2999(92)90849-y"
"1380394","N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies","Bakshi R, Ni RX, Faden AI.","Brain Res. 1992 May 15;580(1-2):255-64. doi: 10.1016/0006-8993(92)90952-6.","Bakshi R","Brain Res","1992","1992/05/15","","","10.1016/0006-8993(92)90952-6"
"1364844","Alkylation with beta-funaltrexamine suggests differences between mu-opioid receptor systems in guinea-pig brain and myenteric-plexus","Franklin TG, Traynor JR.","Br J Pharmacol. 1991 Mar;102(3):718-22. doi: 10.1111/j.1476-5381.1991.tb12239.x.","Franklin TG","Br J Pharmacol","1991","1991/03/01","PMC1917925","","10.1111/j.1476-5381.1991.tb12239.x"
"1362519","Effects of the opiates on the paraventricular nucleus in genetically polydipsic mice","Nagatomo I, Katafuchi T, Koizumi K.","Brain Res. 1992 Dec 11;598(1-2):23-32. doi: 10.1016/0006-8993(92)90163-4.","Nagatomo I","Brain Res","1992","1992/12/11","","","10.1016/0006-8993(92)90163-4"
"1361992","Effect of mu-, kappa-, and delta-selective opioid agonists on thermoregulation in the rat","Handler CM, Geller EB, Adler MW.","Pharmacol Biochem Behav. 1992 Dec;43(4):1209-16. doi: 10.1016/0091-3057(92)90504-9.","Handler CM","Pharmacol Biochem Behav","1992","1992/12/01","","","10.1016/0091-3057(92)90504-9"
"1359112","Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation","Derrick BE, Rodriguez SB, Lieberman DN, Martinez JL Jr.","J Pharmacol Exp Ther. 1992 Nov;263(2):725-33.","Derrick BE","J Pharmacol Exp Ther","1992","1992/11/11","","",""
"1357708","Kappa opioid receptor activity modulates memory for peck-avoidance training in the 2-day-old chick","Colombo PJ, Martinez JL Jr, Bennett EL, Rosenzweig MR.","Psychopharmacology (Berl). 1992;108(1-2):235-40. doi: 10.1007/BF02245314.","Colombo PJ","Psychopharmacology (Berl)","1992","1992/01/11","","","10.1007/BF02245314"
"1356252","Endogenous opioids may be involved in idazoxan-induced food intake","Jackson HC, Griffin IJ, Nutt DJ.","Neuropharmacology. 1992 Aug;31(8):771-6. doi: 10.1016/0028-3908(92)90040-v.","Jackson HC","Neuropharmacology","1992","1992/08/01","","","10.1016/0028-3908(92)90040-v"
"1355851","Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum","Zadina JE, Kastin AJ, Kersh D, Wyatt A.","Life Sci. 1992;51(11):869-85. doi: 10.1016/0024-3205(92)90615-v.","Zadina JE","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90615-v"
"1355735","Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors","Maguire P, Tsai N, Kamal J, Cometta-Morini C, Upton C, Loew G.","Eur J Pharmacol. 1992 Mar 24;213(2):219-25. doi: 10.1016/0014-2999(92)90685-w.","Maguire P","Eur J Pharmacol","1992","1992/03/24","","","10.1016/0014-2999(92)90685-w"
"1354563","Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro","Pinnock RD.","Brain Res. 1992 Jun 26;583(1-2):237-46. doi: 10.1016/s0006-8993(10)80029-0.","Pinnock RD","Brain Res","1992","1992/06/26","","","10.1016/s0006-8993(10)80029-0"
"1354161","Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice","Toyoshi T, Ukai M, Kameyama T.","Eur J Pharmacol. 1992 Mar 17;213(1):25-30. doi: 10.1016/0014-2999(92)90228-v.","Toyoshi T","Eur J Pharmacol","1992","1992/03/17","","","10.1016/0014-2999(92)90228-v"
"1354010","Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels","Watkins LR, Wiertelak EP, Maier SF.","Brain Res. 1992 Jun 5;582(1):1-9. doi: 10.1016/0006-8993(92)90310-6.","Watkins LR","Brain Res","1992","1992/06/05","","","10.1016/0006-8993(92)90310-6"
"1352026","Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord","Song SH, Takemori AE.","Life Sci. 1992;51(2):107-11. doi: 10.1016/0024-3205(92)90003-8.","Song SH","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90003-8"
"1350068","Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin","Flores CM, Hulihan-Giblin BA, Hornby PJ, Lumpkin MD, Kellar KJ.","Neuroendocrinology. 1992 May;55(5):519-28. doi: 10.1159/000126176.","Flores CM","Neuroendocrinology","1992","1992/05/01","","","10.1159/000126176"
"1349645","Centrally mediated cardiovascular actions of dynorphin A(1-8) on rat hippocampal formation","Wang JQ, Ingenito AJ.","J Pharmacol Exp Ther. 1992 May;261(2):678-85.","Wang JQ","J Pharmacol Exp Ther","1992","1992/05/01","","",""
"1349191","Endopeptidase 24.15 inhibition and opioid antinociception","Kest B, Orlowski M, Bodnar RJ.","Psychopharmacology (Berl). 1992;106(3):408-16. doi: 10.1007/BF02245427.","Kest B","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02245427"
"1348537","Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17)","Holmes BB, Fujimoto JM.","J Pharmacol Exp Ther. 1992 Apr;261(1):146-53.","Holmes BB","J Pharmacol Exp Ther","1992","1992/04/01","","",""
"1347952","Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone","Bertalmio AJ, Woods JH.","Psychopharmacology (Berl). 1992;106(2):189-94. doi: 10.1007/BF02801971.","Bertalmio AJ","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02801971"
"1347943","Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","Spanagel R, Herz A, Shippenberg TS.","Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2046-50. doi: 10.1073/pnas.89.6.2046.","Spanagel R","Proc Natl Acad Sci U S A","1992","1992/03/15","PMC48593","","10.1073/pnas.89.6.2046"
"1345943","Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus","Wagner JJ, Caudle RM, Chavkin C.","J Neurosci. 1992 Jan;12(1):132-41. doi: 10.1523/JNEUROSCI.12-01-00132.1992.","Wagner JJ","J Neurosci","1992","1992/01/01","PMC6575691","","10.1523/JNEUROSCI.12-01-00132.1992"
"1345670","Brief report: a double-blind study of naltrexone in infantile autism","Leboyer M, Bouvard MP, Launay JM, Tabuteau F, Waller D, Dugas M, Kerdelhue B, Lensing P, Panksepp J.","J Autism Dev Disord. 1992 Jun;22(2):309-19. doi: 10.1007/BF01058158.","Leboyer M","J Autism Dev Disord","1992","1992/06/01","","","10.1007/BF01058158"
"1345133","Naltrexone in the treatment of alcohol dependence","Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP.","Arch Gen Psychiatry. 1992 Nov;49(11):876-80. doi: 10.1001/archpsyc.1992.01820110040006.","Volpicelli JR","Arch Gen Psychiatry","1992","1992/11/01","","","10.1001/archpsyc.1992.01820110040006"
"1342427","[Ovulation induction by the chronic administration of naltrexone in a patient with secondary hypothalamic amenorrhea]","Sir T, Alba F, Rivera J, Kohen P, Devoto L.","Rev Chil Obstet Ginecol. 1992;57(1):39-43.","Sir T","Rev Chil Obstet Ginecol","1992","1992/01/01","","",""
"1342010","The involvement of pineal gland and melatonin in immunity and aging: II. Thyrotropin-releasing hormone and melatonin forestall involution and promote reconstitution of the thymus in anterior hypothalamic area (AHA)-lesioned mice","Lesnikov VA, Korneva EA, Dall'ara A, Pierpaoli W.","Int J Neurosci. 1992 Jan;62(1-2):141-53. doi: 10.3109/00207459108999767.","Lesnikov VA","Int J Neurosci","1992","1992/01/01","","","10.3109/00207459108999767"
"1341721","Role of pineal melatonin and melatonin-induced-immuno-opioids in murine leukemogenesis","Conti A, Haran-Ghera N, Maestroni GJ.","Med Oncol Tumor Pharmacother. 1992;9(2):87-92. doi: 10.1007/BF02989659.","Conti A","Med Oncol Tumor Pharmacother","1992","1992/01/01","","","10.1007/BF02989659"
"1337857","Effects of naltrindole and nor-binaltorphimine treatment on antinociception induced by sub-acute selective mu opioid receptor blockade","Walker MJ, Le AD, Poulos CX.","Brain Res. 1992 Dec 25;599(2):204-8. doi: 10.1016/0006-8993(92)90392-m.","Walker MJ","Brain Res","1992","1992/12/25","","","10.1016/0006-8993(92)90392-m"
"1337380","Interaction of opioid peptides and other drugs with multiple delta ncx binding sites in rat brain: further evidence for heterogeneity","Xu H, Partilla JS, de Costa BR, Rice KC, Rothman RB.","Peptides. 1992 Nov-Dec;13(6):1207-13. doi: 10.1016/0196-9781(92)90030-7.","Xu H","Peptides","1992","1992/11/01","","","10.1016/0196-9781(92)90030-7"
"1336751","On the mechanism of the interaction of ketamine and halothane in vitro","Bansinath M, Warner W, Tang CK, Turndorf H, Puig MM.","Gen Pharmacol. 1992 Nov;23(6):1183-7. doi: 10.1016/0306-3623(92)90309-8.","Bansinath M","Gen Pharmacol","1992","1992/11/01","","","10.1016/0306-3623(92)90309-8"
"1336747","The noradrenergic component contributing to spinal fentanyl-induced antinociception is supraspinally mediated","Crisp T, Stafinsky JL, Perni VC, Uram M.","Gen Pharmacol. 1992 Nov;23(6):1087-91. doi: 10.1016/0306-3623(92)90291-q.","Crisp T","Gen Pharmacol","1992","1992/11/01","","","10.1016/0306-3623(92)90291-q"
"1335562","Involvement of opioid receptors in nucleus tractus solitarii in modulating endotoxic hypotension in rats","Xu T, Wang T, Han J.","Neurosci Lett. 1992 Oct 26;146(1):72-4. doi: 10.1016/0304-3940(92)90175-7.","Xu T","Neurosci Lett","1992","1992/10/26","","","10.1016/0304-3940(92)90175-7"
"1335557","Opioid receptors mediating antinociception from beta-endorphin and morphine in the periaqueductal gray","Smith DJ, Robertson B, Monroe PJ, Taylor DA, Leedham JA, Cabral JD.","Neuropharmacology. 1992 Nov;31(11):1137-50. doi: 10.1016/0028-3908(92)90010-m.","Smith DJ","Neuropharmacology","1992","1992/11/01","","","10.1016/0028-3908(92)90010-m"
"1335271","Morphine- and naltrexone-induced modification of palatability: analysis by the taste reactivity test","Parker LA, Maier S, Rennie M, Crebolder J.","Behav Neurosci. 1992 Dec;106(6):999-1010. doi: 10.1037//0735-7044.106.6.999.","Parker LA","Behav Neurosci","1992","1992/12/01","","","10.1037//0735-7044.106.6.999"
"1335078","O3-(2-carbomethoxyallyl) ethers of opioid ligands derived from oxymorphone, naltrexone, etorphine, diprenorphine, norbinaltorphimine, and naltrindole. Unexpected O3-dealkylation in the opioid radioligand displacement assay","Klein P, Nelson WL.","J Med Chem. 1992 Nov 27;35(24):4589-94. doi: 10.1021/jm00102a012.","Klein P","J Med Chem","1992","1992/11/27","","","10.1021/jm00102a012"
"1334774","Ontogeny of zeta (zeta), the opioid growth factor receptor, in the rat brain","Zagon IS, Gibo DM, McLaughlin PJ.","Brain Res. 1992 Nov 20;596(1-2):149-56. doi: 10.1016/0006-8993(92)91542-m.","Zagon IS","Brain Res","1992","1992/11/20","","","10.1016/0006-8993(92)91542-m"
"1334765","The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity","Leyton M, Stewart J.","Brain Res. 1992 Oct 23;594(1):56-74. doi: 10.1016/0006-8993(92)91029-e.","Leyton M","Brain Res","1992","1992/10/23","","","10.1016/0006-8993(92)91029-e"
"1334456","PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy","Theodore WH, Carson RE, Andreasen P, Zametkin A, Blasberg R, Leiderman DB, Rice K, Newman A, Channing M, Dunn B, et al.","Epilepsy Res. 1992 Nov;13(2):129-39. doi: 10.1016/0920-1211(92)90068-5.","Theodore WH","Epilepsy Res","1992","1992/11/01","","","10.1016/0920-1211(92)90068-5"
"1334271","Aerobic fitness and opioidergic inhibition of cardiovascular stress reactivity","McCubbin JA, Cheung R, Montgomery TB, Bulbulian R, Wilson JF.","Psychophysiology. 1992 Nov;29(6):687-97. doi: 10.1111/j.1469-8986.1992.tb02047.x.","McCubbin JA","Psychophysiology","1992","1992/11/01","","","10.1111/j.1469-8986.1992.tb02047.x"
"1334238","Opioid receptor antagonist affinity ligands: 6 beta-bromoacetamido-6-desoxynaltrexone and 6 beta-thioglycolamido-6-desoxynaltrexone","Manda S, Lerner-Marmarosh N, Hashmi M, Abood LG.","Neurochem Res. 1992 Dec;17(12):1191-4. doi: 10.1007/BF00968398.","Manda S","Neurochem Res","1992","1992/12/01","","","10.1007/BF00968398"
"1333541","The pruritus of cholestasis and the opioid system","Jones EA, Bergasa NV.","JAMA. 1992 Dec 16;268(23):3359-62.","Jones EA","JAMA","1992","1992/12/16","","",""
"1333085","Diprenorphine as a stimulus in drug discrimination learning","Smurthwaite ST, Riley AL.","Pharmacol Biochem Behav. 1992 Nov;43(3):839-46. doi: 10.1016/0091-3057(92)90416-d.","Smurthwaite ST","Pharmacol Biochem Behav","1992","1992/11/01","","","10.1016/0091-3057(92)90416-d"
"1333013","Opioid agonist and antagonist activities of morphindoles related to naltrindole","Portoghese PS, Larson DL, Sultana M, Takemori AE.","J Med Chem. 1992 Nov 13;35(23):4325-9. doi: 10.1021/jm00101a009.","Portoghese PS","J Med Chem","1992","1992/11/13","","","10.1021/jm00101a009"
"1332851","Mu- and kappa-opiate receptor control of prolactin secretion in rats: ontogeny and interaction with serotonin","Blackford SP, Little PJ, Kuhn CM.","Endocrinology. 1992 Dec;131(6):2891-7. doi: 10.1210/endo.131.6.1332851.","Blackford SP","Endocrinology","1992","1992/12/01","","","10.1210/endo.131.6.1332851"
"1332097","Differential impact of naltrexone on luteinizing hormone release during single versus repetitive exposure to restraint stress","Briski KP, Sylvester PW.","Psychoneuroendocrinology. 1992 May-Jul;17(2-3):125-33. doi: 10.1016/0306-4530(92)90051-8.","Briski KP","Psychoneuroendocrinology","1992","1992/05/01","","","10.1016/0306-4530(92)90051-8"
"1331999","Mu-delta opioid interactions. II: Beta-FNA inhibits DPDPE-induced increases in morphine EEG and EEG spectral power","Stamidis H, Young GA.","Peptides. 1992 Jul-Aug;13(4):755-60. doi: 10.1016/0196-9781(92)90183-4.","Stamidis H","Peptides","1992","1992/07/01","","","10.1016/0196-9781(92)90183-4"
"1331455","Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes","Portoghese PS, Sultana M, Nelson WL, Klein P, Takemori AE.","J Med Chem. 1992 Oct 30;35(22):4086-91. doi: 10.1021/jm00100a014.","Portoghese PS","J Med Chem","1992","1992/10/30","","","10.1021/jm00100a014"
"1330622","Chronic d-amphetamine inhibits opioid receptor antagonist-induced supersensitivity","Duttaroy A, Billings B, Candido J, Yoburn BC.","Eur J Pharmacol. 1992 Oct 20;221(2-3):211-5. doi: 10.1016/0014-2999(92)90703-7.","Duttaroy A","Eur J Pharmacol","1992","1992/10/20","","","10.1016/0014-2999(92)90703-7"
"1330549","The delta receptor is involved in sufentanil-induced respiratory depression--opioid subreceptors mediate different effects","Freye E, Latasch L, Portoghese PS.","Eur J Anaesthesiol. 1992 Nov;9(6):457-62.","Freye E","Eur J Anaesthesiol","1992","1992/11/01","","",""
"1330187","Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats","Crook TJ, Kitchen I, Hill RG.","Br J Pharmacol. 1992 Oct;107(2):573-6. doi: 10.1111/j.1476-5381.1992.tb12785.x.","Crook TJ","Br J Pharmacol","1992","1992/10/01","PMC1907854","","10.1111/j.1476-5381.1992.tb12785.x"
"1329399","[Opiate hypothesis of the origin of early childhood autism and sequelae for psychopharmacotherapy]","Lensing P, Klingler D, Panksepp J, Huber M, Saria A, Hackenberg B, Adam H.","Z Kinder Jugendpsychiatr. 1992 Sep;20(3):185-96.","Lensing P","Z Kinder Jugendpsychiatr","1992","1992/09/01","","",""
"1328845","Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells","Belcheva MM, Barg J, Gloeckner C, Gao XM, Chuang DM, Coscia CJ.","Mol Pharmacol. 1992 Sep;42(3):445-52.","Belcheva MM","Mol Pharmacol","1992","1992/09/01","","",""
"1328733","The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference","Suzuki T, Shiozaki Y, Masukawa Y, Misawa M, Nagase H.","Jpn J Pharmacol. 1992 Apr;58(4):435-42. doi: 10.1254/jjp.58.435.","Suzuki T","Jpn J Pharmacol","1992","1992/04/01","","","10.1254/jjp.58.435"
"1328610","Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB)","Malmberg AB, Yaksh TL.","J Pharmacol Exp Ther. 1992 Oct;263(1):264-75.","Malmberg AB","J Pharmacol Exp Ther","1992","1992/10/01","","",""
"1328606","Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain","Schoffelmeer AN, De Vries TJ, Hogenboom F, Hruby VJ, Portoghese PS, Mulder AH.","J Pharmacol Exp Ther. 1992 Oct;263(1):20-4.","Schoffelmeer AN","J Pharmacol Exp Ther","1992","1992/10/01","","",""
"1327826","A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone","Portoghese PS, Sultana M, Nagase H, Takemori AE.","Eur J Pharmacol. 1992 Jul 21;218(1):195-6. doi: 10.1016/0014-2999(92)90167-3.","Portoghese PS","Eur J Pharmacol","1992","1992/07/21","","","10.1016/0014-2999(92)90167-3"
"1327813","delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites","Sofuoglu M, Portoghese PS, Takemori AE.","Eur J Pharmacol. 1992 Jun 5;216(2):273-7. doi: 10.1016/0014-2999(92)90370-j.","Sofuoglu M","Eur J Pharmacol","1992","1992/06/05","","","10.1016/0014-2999(92)90370-j"
"1327807","Long term kappa-opioid receptor blockade following nor-binaltorphimine","Jones DN, Holtzman SG.","Eur J Pharmacol. 1992 May 14;215(2-3):345-8. doi: 10.1016/0014-2999(92)90055-9.","Jones DN","Eur J Pharmacol","1992","1992/05/14","","","10.1016/0014-2999(92)90055-9"
"1327717","The effect of blockade of kappa-opioid receptors in the medial basal hypothalamus and medial preoptic area on luteinizing hormone release during midpregnancy in the rat","Zhen S, Gallo RV.","Endocrinology. 1992 Oct;131(4):1650-6. doi: 10.1210/endo.131.4.1327717.","Zhen S","Endocrinology","1992","1992/10/01","","","10.1210/endo.131.4.1327717"
"1327422","Effect of selective opiate antagonists on striatal acetylcholine and dopamine release","Sandor NT, Lendvai B, Vizi ES.","Brain Res Bull. 1992 Sep-Oct;29(3-4):369-73. doi: 10.1016/0361-9230(92)90070-e.","Sandor NT","Brain Res Bull","1992","1992/09/01","","","10.1016/0361-9230(92)90070-e"
"1327383","Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193-195","Poole S, Bristow AF, Lorenzetti BB, Das RE, Smith TW, Ferreira SH.","Br J Pharmacol. 1992 Jun;106(2):489-92. doi: 10.1111/j.1476-5381.1992.tb14361.x.","Poole S","Br J Pharmacol","1992","1992/06/01","PMC1907488","","10.1111/j.1476-5381.1992.tb14361.x"
"1327126","A photoactivatable naltrexone derivative labels glycoproteins of different molecular weight corresponding to the mu- and kappa-opioid receptors","Mejean A, Hawkinson J, Guthapfel R, Goeldner M, Hirth C.","Biochemistry. 1992 Oct 13;31(40):9685-93. doi: 10.1021/bi00155a023.","Mejean A","Biochemistry","1992","1992/10/13","","","10.1021/bi00155a023"
"1326932","Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo","Endoh T, Matsuura H, Tanaka C, Nagase H.","Arch Int Pharmacodyn Ther. 1992 Mar-Apr;316:30-42.","Endoh T","Arch Int Pharmacodyn Ther","1992","1992/03/01","","",""
"1326632","Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice","Smith FL, Dewey WL.","J Pharmacol Exp Ther. 1992 Sep;262(3):995-1003.","Smith FL","J Pharmacol Exp Ther","1992","1992/09/01","","",""
"1326622","Clocinnamox: a novel, systemically-active, irreversible opioid antagonist","Comer SD, Burke TF, Lewis JW, Woods JH.","J Pharmacol Exp Ther. 1992 Sep;262(3):1051-6.","Comer SD","J Pharmacol Exp Ther","1992","1992/09/01","","",""
"1326621","Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice","Pick CG, Paul D, Pasternak GW.","J Pharmacol Exp Ther. 1992 Sep;262(3):1044-50.","Pick CG","J Pharmacol Exp Ther","1992","1992/09/01","","",""
"1326619","Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole","Cheng PY, Wu DL, Decena J, Cheng Y, McCabe S, Szeto HH.","J Pharmacol Exp Ther. 1992 Sep;262(3):1004-10.","Cheng PY","J Pharmacol Exp Ther","1992","1992/09/01","","",""
"1326441","Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective delta-opioid receptor agonist","Kalso EA, Sullivan AF, McQuay HJ, Dickenson AH.","Eur J Pharmacol. 1992 May 27;216(1):97-101. doi: 10.1016/0014-2999(92)90214-o.","Kalso EA","Eur J Pharmacol","1992","1992/05/27","","","10.1016/0014-2999(92)90214-o"
"1325358","Antinociception after intracerebroventricular administration of naltrindole in the mouse","Stapelfeld A, Hammond DL, Rafferty MF.","Eur J Pharmacol. 1992 Apr 22;214(2-3):273-6. doi: 10.1016/0014-2999(92)90129-r.","Stapelfeld A","Eur J Pharmacol","1992","1992/04/22","","","10.1016/0014-2999(92)90129-r"
"1325355","Pentobarbital attenuates antinociception induced by i.c.v. morphine but not beta-endorphin in the mouse","Tseng LF, Tang RR.","Eur J Pharmacol. 1992 Apr 22;214(2-3):175-80. doi: 10.1016/0014-2999(92)90116-l.","Tseng LF","Eur J Pharmacol","1992","1992/04/22","","","10.1016/0014-2999(92)90116-l"
"1325057","Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation","Candido J, Lutfy K, Billings B, Sierra V, Duttaroy A, Inturrisi CE, Yoburn BC.","Pharmacol Biochem Behav. 1992 Aug;42(4):685-92. doi: 10.1016/0091-3057(92)90015-8.","Candido J","Pharmacol Biochem Behav","1992","1992/08/01","","","10.1016/0091-3057(92)90015-8"
"1324087","Effects of diabetes on stress-induced analgesia in mice","Kamei J, Kawashima N, Ohhashi Y, Kasuya Y.","Brain Res. 1992 May 15;580(1-2):180-4. doi: 10.1016/0006-8993(92)90942-3.","Kamei J","Brain Res","1992","1992/05/15","","","10.1016/0006-8993(92)90942-3"
"1324030","Modulation of immune status by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids","Lysle DT, Luecken LJ, Maslonek KA.","Brain Behav Immun. 1992 Jun;6(2):179-88. doi: 10.1016/0889-1591(92)90017-i.","Lysle DT","Brain Behav Immun","1992","1992/06/01","","","10.1016/0889-1591(92)90017-i"
"1323802","Sexual differences in kappa opioid receptor-mediated regulation of tuberoinfundibular dopaminergic neurons","Manzanares J, Wagner EJ, LaVigne SD, Lookingland KJ, Moore KE.","Neuroendocrinology. 1992 Mar;55(3):301-7. doi: 10.1159/000126129.","Manzanares J","Neuroendocrinology","1992","1992/03/01","","","10.1159/000126129"
"1323656","Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors","Jones DN, Holtzman SG.","J Pharmacol Exp Ther. 1992 Aug;262(2):638-45.","Jones DN","J Pharmacol Exp Ther","1992","1992/08/01","","",""
"1323508","Delta opioid receptors mediate seizures produced by intrahippocampal injection of ala-deltorphin in rats","De Sarro GB, Marra R, Spagnolo C, Nisticò G.","Funct Neurol. 1992 May-Jun;7(3):235-8.","De Sarro GB","Funct Neurol","1992","1992/05/01","","",""
"1323369","Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels","Watkins LR, Wiertelak EP, Maier SF.","Brain Res. 1992 Jun 5;582(1):10-21. doi: 10.1016/0006-8993(92)90311-v.","Watkins LR","Brain Res","1992","1992/06/05","","","10.1016/0006-8993(92)90311-v"
"1321982","Modulation of kappa-mediated antitussive activity in rats by a delta-agonist","Kamei J, Tanihara H, Kasuya Y.","Res Commun Chem Pathol Pharmacol. 1992 Jun;76(3):375-8.","Kamei J","Res Commun Chem Pathol Pharmacol","1992","1992/06/01","","",""
"1321710","The possible mechanism of action of ethanol on rat thymus","Budec M, Cirić O, Koko V, Aŝanin R.","Drug Alcohol Depend. 1992 Jun;30(2):181-5. doi: 10.1016/0376-8716(92)90024-7.","Budec M","Drug Alcohol Depend","1992","1992/06/01","","","10.1016/0376-8716(92)90024-7"
"1321363","Ex vivo determination of opiate antagonist binding at mu-opioid ([3H]-DAGO) receptors in hypothalamic micropunches from maturing female rats: comparison between SDZ 210-096 and nalmefene","Landymore KM, Giles A, Wilkinson M.","Neuropeptides. 1992 Mar;21(3):175-82. doi: 10.1016/0143-4179(92)90042-u.","Landymore KM","Neuropeptides","1992","1992/03/01","","","10.1016/0143-4179(92)90042-u"
"1320440","Opiate receptor blockade by naltrexone and mood state after acute physical activity","Daniel M, Martin AD, Carter J.","Br J Sports Med. 1992 Jun;26(2):111-5. doi: 10.1136/bjsm.26.2.111.","Daniel M","Br J Sports Med","1992","1992/06/01","PMC1478917","","10.1136/bjsm.26.2.111"
"1320121","Electrophilic opioid ligands. Oxygen tethered alpha-methylene-gamma-lactone, acrylate, isothiocyanate, and epoxide derivatives of 6 beta-naltrexol","Dasher WE, Klein P, Nelson WL.","J Med Chem. 1992 Jun 26;35(13):2374-84. doi: 10.1021/jm00091a005.","Dasher WE","J Med Chem","1992","1992/06/26","","","10.1021/jm00091a005"
"1319586","Reduction of learned helplessness by central administration of quaternary naltrexone","Blustein JE, Whitehouse WG, Calcagnetti DJ, Troisi JR, Margules DL, Bersh PJ.","Physiol Behav. 1992 May;51(5):1075-8. doi: 10.1016/0031-9384(92)90095-j.","Blustein JE","Physiol Behav","1992","1992/05/01","","","10.1016/0031-9384(92)90095-j"
"1319338","Naloxone-induced analgesia in diabetic mice","Kamei J, Kawashima N, Kasuya Y.","Eur J Pharmacol. 1992 Jan 21;210(3):339-41. doi: 10.1016/0014-2999(92)90424-3.","Kamei J","Eur J Pharmacol","1992","1992/01/21","","","10.1016/0014-2999(92)90424-3"
"1319015","Hypothermic effect of D-Ala-deltorphin II, a selective delta opioid receptor agonist","Broccardo M, Improta G.","Neurosci Lett. 1992 May 25;139(2):209-12. doi: 10.1016/0304-3940(92)90554-k.","Broccardo M","Neurosci Lett","1992","1992/05/25","","","10.1016/0304-3940(92)90554-k"
"1318671","Selective naltrexone-derived opioid receptor antagonists","Takemori AE, Portoghese PS.","Annu Rev Pharmacol Toxicol. 1992;32:239-69. doi: 10.1146/annurev.pa.32.040192.001323.","Takemori AE","Annu Rev Pharmacol Toxicol","1992","1992/01/01","","","10.1146/annurev.pa.32.040192.001323"
"1318215","The mu-opioid activity of kappa-opioid receptor agonist compounds in the guinea pig ileum","Berzetei-Gurske IP, Toll L.","Eur J Pharmacol. 1992 Mar 3;212(2-3):283-6. doi: 10.1016/0014-2999(92)90345-5.","Berzetei-Gurske IP","Eur J Pharmacol","1992","1992/03/03","","","10.1016/0014-2999(92)90345-5"
"1318206","Maintenance of acute morphine tolerance in mice by selective blockage of kappa opioid receptors with norbinaltorphimine","Sofuoglu M, Portoghese PS, Takemori AE.","Eur J Pharmacol. 1992 Jan 14;210(2):159-62. doi: 10.1016/0014-2999(92)90666-r.","Sofuoglu M","Eur J Pharmacol","1992","1992/01/14","","","10.1016/0014-2999(92)90666-r"
"1318204","The electrophysiological effects of opioid receptor-selective antagonists on sheep Purkinje fibres","McIntosh M, Kane K, Parratt J.","Eur J Pharmacol. 1992 Jan 7;210(1):45-51. doi: 10.1016/0014-2999(92)90650-s.","McIntosh M","Eur J Pharmacol","1992","1992/01/07","","","10.1016/0014-2999(92)90650-s"
"1318203","Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia","McIntosh M, Kane K, Parratt J.","Eur J Pharmacol. 1992 Jan 7;210(1):37-44. doi: 10.1016/0014-2999(92)90649-o.","McIntosh M","Eur J Pharmacol","1992","1992/01/07","","","10.1016/0014-2999(92)90649-o"
"1317498","Activation of the zinc finger encoding gene krox-20 in adult rat brain: comparison with zif268","Bhat RV, Worley PF, Cole AJ, Baraban JM.","Brain Res Mol Brain Res. 1992 Apr;13(3):263-6. doi: 10.1016/0169-328x(92)90034-9.","Bhat RV","Brain Res Mol Brain Res","1992","1992/04/01","","","10.1016/0169-328x(92)90034-9"
"1317189","Kappa opioid mediation of fetal responses to milk","Smotherman WP, Robinson SR.","Behav Neurosci. 1992 Apr;106(2):396-407. doi: 10.1037//0735-7044.106.2.396.","Smotherman WP","Behav Neurosci","1992","1992/04/01","","","10.1037//0735-7044.106.2.396"
"1317026","Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release","Collin E, Bourgoin S, Ferhat L, Hamon M, Cesselin F.","Neurosci Lett. 1992 Jan 6;134(2):238-42. doi: 10.1016/0304-3940(92)90525-c.","Collin E","Neurosci Lett","1992","1992/01/06","","","10.1016/0304-3940(92)90525-c"
"1315940","A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro","Pinnock RD.","Neuroscience. 1992;47(1):87-94. doi: 10.1016/0306-4522(92)90123-j.","Pinnock RD","Neuroscience","1992","1992/01/01","","","10.1016/0306-4522(92)90123-j"
"1315896","Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone","Takemori AE, Sultana M, Nagase H, Portoghese PS.","Life Sci. 1992;50(20):1491-5. doi: 10.1016/0024-3205(92)90138-f.","Takemori AE","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90138-f"
"1315863","Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem","Hamann SR, Martin WR.","J Pharmacol Exp Ther. 1992 May;261(2):707-15.","Hamann SR","J Pharmacol Exp Ther","1992","1992/05/01","","",""
"1315182","Effects of naloxone and nalmefene in rat spinal cord injury induced by the ventral compression technique","Benzel EC, Khare V, Fowler MR.","J Spinal Disord. 1992 Mar;5(1):75-7. doi: 10.1097/00002517-199203000-00009.","Benzel EC","J Spinal Disord","1992","1992/03/01","","","10.1097/00002517-199203000-00009"
"1314443","Immunosuppressive effect of delta-opioid receptor antagonist on xenogeneic mixed lymphocyte reaction","Arakawa K, Akami T, Okamoto M, Nakajima H, Mitsuo M, Nakai I, Oka T, Nagase H, Matsumoto S.","Transplant Proc. 1992 Apr;24(2):696-7.","Arakawa K","Transplant Proc","1992","1992/04/01","","",""
"1314442","The immunosuppressive effect of delta-opioid receptor antagonist on rat renal allograft survival","Arakawa K, Akami T, Okamoto M, Oka T, Nagase H, Matsumoto S.","Transplantation. 1992 Apr;53(4):951-3.","Arakawa K","Transplantation","1992","1992/04/01","","",""
"1313589","Modulation by naltrexone of stress-induced changes in humoral immune responsiveness and gastric mucosal integrity in rats","Ray A, Mediratta PK, Sen P.","Physiol Behav. 1992 Feb;51(2):293-6. doi: 10.1016/0031-9384(92)90143-p.","Ray A","Physiol Behav","1992","1992/02/01","","","10.1016/0031-9384(92)90143-p"
"1313587","The effects of continuous naltrexone infusions on diet preferences are modulated by adaptation to the diets","Gosnell BA, Krahn DD.","Physiol Behav. 1992 Feb;51(2):239-44. doi: 10.1016/0031-9384(92)90136-p.","Gosnell BA","Physiol Behav","1992","1992/02/01","","","10.1016/0031-9384(92)90136-p"
"1313136","An opioid growth factor regulates the replication of microorganisms","Zagon IS, McLaughlin PJ.","Life Sci. 1992;50(16):1179-87. doi: 10.1016/0024-3205(92)90461-w.","Zagon IS","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90461-w"
"1313133","Characterization of [3H]naltrindole binding to delta opioid receptors in rat brain","Yamamura MS, Horvath R, Toth G, Otvos F, Malatynska E, Knapp RJ, Porreca F, Hruby VJ, Yamamura HI.","Life Sci. 1992;50(16):PL119-24. doi: 10.1016/0024-3205(92)90464-z.","Yamamura MS","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90464-z"
"1312164","Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test","Horan P, Taylor J, Yamamura HI, Porreca F.","J Pharmacol Exp Ther. 1992 Mar;260(3):1237-43.","Horan P","J Pharmacol Exp Ther","1992","1992/03/01","","",""
"1311454","Effects of [D-Ala2, D-Leu5]enkephalin and [D-Pen2, L-Pen5]enkephalin on apomorphine-induced motor activity in the mouse","Ukai M, Toyoshi T, Kameyama T.","Pharmacol Biochem Behav. 1992 Jan;41(1):171-6. doi: 10.1016/0091-3057(92)90078-t.","Ukai M","Pharmacol Biochem Behav","1992","1992/01/01","","","10.1016/0091-3057(92)90078-t"
"1311082","Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells","Maneckjee R, Minna JD.","Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1169-73. doi: 10.1073/pnas.89.4.1169.","Maneckjee R","Proc Natl Acad Sci U S A","1992","1992/02/15","PMC48410","","10.1073/pnas.89.4.1169"
"1310737","Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype","Mattia A, Farmer SC, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Bowen WD, Porreca F.","J Pharmacol Exp Ther. 1992 Feb;260(2):518-25.","Mattia A","J Pharmacol Exp Ther","1992","1992/02/01","","",""
"1310130","Enhanced sensitivity to naltrexone is associated with an up-regulation in GABA receptor function","Schindler CW, Marley RJ, Goldberg SR.","Life Sci. 1992;50(4):PL1-6. doi: 10.1016/0024-3205(92)90341-l.","Schindler CW","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90341-l"
"1309877","Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment","Craft RM, Dykstra LA.","J Pharmacol Exp Ther. 1992 Jan;260(1):334-42.","Craft RM","J Pharmacol Exp Ther","1992","1992/01/01","","",""
"1309876","Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output","Craft RM, Dykstra LA.","J Pharmacol Exp Ther. 1992 Jan;260(1):327-33.","Craft RM","J Pharmacol Exp Ther","1992","1992/01/01","","",""
"1307841","[The role of endogenous opioids in modulation of immunosuppression in fish]","Faisal M, Chiappelli F, Ahmed II, Cooper EL, Weiner H.","Schriftenr Ver Wasser Boden Lufthyg. 1992;89:785-99.","Faisal M","Schriftenr Ver Wasser Boden Lufthyg","1992","1992/01/01","","",""
"1305637","Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity","Janković BD, Radulović J.","Int J Neurosci. 1992 Nov-Dec;67(1-4):241-70. doi: 10.3109/00207459208994788.","Janković BD","Int J Neurosci","1992","1992/11/01","","","10.3109/00207459208994788"
"1295310","Erythrocytes as carriers of new anti-opioid prodrugs: in vitro studies","Noël-Hocquet S, Jabbouri S, Lazar S, Maunier JC, Guillaumet G, Ropars C.","Adv Exp Med Biol. 1992;326:215-21. doi: 10.1007/978-1-4615-3030-5_27.","Noël-Hocquet S","Adv Exp Med Biol","1992","1992/01/01","","","10.1007/978-1-4615-3030-5_27"
"1295034","Comparison of the neurochemistry of the endogenous opioid systems in two brainstem pain-processing centers","al-Rodhan NR, Yaksh TL, Kelly PJ.","Stereotact Funct Neurosurg. 1992;59(1-4):15-9. doi: 10.1159/000098910.","al-Rodhan NR","Stereotact Funct Neurosurg","1992","1992/01/01","","","10.1159/000098910"
"1291596","Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women","Botticelli G, Bacchi Modena A, Bresciani D, Villa P, Aguzzoli L, Florio P, Nappi RE, Petraglia F, Genazzani AR.","J Endocrinol Invest. 1992 Dec;15(11):839-47. doi: 10.1007/BF03348817.","Botticelli G","J Endocrinol Invest","1992","1992/12/01","","","10.1007/BF03348817"
"1283972","Morphine induces an increase in extracellular serotonin in the rat diencephalon","Grauer SM, Tao R, Auerbach SB.","Brain Res. 1992 Dec 25;599(2):277-82. doi: 10.1016/0006-8993(92)90402-u.","Grauer SM","Brain Res","1992","1992/12/25","","","10.1016/0006-8993(92)90402-u"
"1283803","Perinatal morphine exposure alters peptidergic development in the striatum","Tenconi B, Donadoni ML, Finco C, Germani E, Malosio ML, Di Giulio AM, Mantegazza P, Gorio A.","Int J Dev Neurosci. 1992 Dec;10(6):517-26. doi: 10.1016/0736-5748(92)90052-2.","Tenconi B","Int J Dev Neurosci","1992","1992/12/01","","","10.1016/0736-5748(92)90052-2"
"1281527","Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord","Collin E, Mauborgne A, Bourgoin S, Mantelet S, Ferhat L, Hamon M, Cesselin F.","Neuroscience. 1992 Nov;51(2):347-55. doi: 10.1016/0306-4522(92)90319-w.","Collin E","Neuroscience","1992","1992/11/01","","","10.1016/0306-4522(92)90319-w"
"1279654","Involvement of opioid mechanisms in peripheral motor control of detrusor muscle","Berggren A, Rubenson A, Sillén U.","Pharmacol Toxicol. 1992 Sep;71(3 Pt 1):179-84. doi: 10.1111/j.1600-0773.1992.tb00541.x.","Berggren A","Pharmacol Toxicol","1992","1992/09/01","","","10.1111/j.1600-0773.1992.tb00541.x"
"1271953","Opiate receptor: irreversible inactivation by an alkylating local anesthetic","Craviso GL, Musacchio JM.","Life Sci. 1976 Apr 15;18(8):821-7. doi: 10.1016/0024-3205(76)90007-2.","Craviso GL","Life Sci","1976","1976/04/15","","","10.1016/0024-3205(76)90007-2"
"1265343","An evaluation of the hot plate technique to study narcotic antagonists","Heilman RD, Gray MI, Chen RP, Hahn EF, Fishman J.","Res Commun Chem Pathol Pharmacol. 1976 Apr;13(4):635-47.","Heilman RD","Res Commun Chem Pathol Pharmacol","1976","1976/04/01","","",""
"1259524","Heroin addiction. Sequential treatment employing pharmacologic supports","Goldstein A.","Arch Gen Psychiatry. 1976 Mar;33(3):353-8. doi: 10.1001/archpsyc.1976.01770030061009.","Goldstein A","Arch Gen Psychiatry","1976","1976/03/01","","","10.1001/archpsyc.1976.01770030061009"
"1258715","Use of narcotic (opiate) antagonists","Calesnick B.","Am Fam Physician. 1976 Mar;13(3):158-9.","Calesnick B","Am Fam Physician","1976","1976/03/01","","",""
"1254668","Quantitative determination of naltrexone and beta-naltrexol in human plasma using electron detection","Verebey K, Kogan MJ, DePace A, Mulé SJ.","J Chromatogr. 1976 Apr 7;118(3):331-5. doi: 10.1016/s0021-9673(00)82170-6.","Verebey K","J Chromatogr","1976","1976/04/07","","","10.1016/s0021-9673(00)82170-6"
"1241971","Development of injectable microcapsules for use in the treatment of narcotic addiction","Thies C.","Natl Inst Drug Abuse Res Monogr Ser. 1975;(4):19-20.","Thies C","Natl Inst Drug Abuse Res Monogr Ser","1975","1975/01/01","","",""
"1241970","Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction","Schwope AD, Wise DL, Howes JF.","Natl Inst Drug Abuse Res Monogr Ser. 1975;(4):13-8.","Schwope AD","Natl Inst Drug Abuse Res Monogr Ser","1975","1975/01/01","","",""
"1241097","Lactic/glycolic acid polymers as narcotic antagonist delivery systems","Schwope AD, Wise DL, Howes JF.","Life Sci. 1975 Dec 15;17(12):1877-85. doi: 10.1016/0024-3205(75)90473-7.","Schwope AD","Life Sci","1975","1975/12/15","","","10.1016/0024-3205(75)90473-7"
"1234983","Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists","Sidman KR, Arnold DL, Steber WD, Nelsen L, Granchelli FE, Strong P, Sheth SG.","Natl Inst Drug Abuse Res Monogr Ser. 1975;(4):33-8.","Sidman KR","Natl Inst Drug Abuse Res Monogr Ser","1975","1975/01/01","","",""
"1234982","Sustained release of naltrexone from glyceride implants","Sullivan MF, Kalkward DR.","Natl Inst Drug Abuse Res Monogr Ser. 1975;(4):27-32.","Sullivan MF","Natl Inst Drug Abuse Res Monogr Ser","1975","1975/01/01","","",""
"1234981","Long-acting narcotic antagonist complexes","Gray AP, Guardina WJ.","Natl Inst Drug Abuse Res Monogr Ser. 1975;(4):21-6.","Gray AP","Natl Inst Drug Abuse Res Monogr Ser","1975","1975/01/01","","",""
"1227303","Naltrexone study guidelines: good vehicle--wrong destination","Brahen LS.","Am J Drug Alcohol Abuse. 1975;2(3-4):451-3. doi: 10.3109/00952997509005669.","Brahen LS","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005669"
"1227302","Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program","Schecter A, Kauders F.","Am J Drug Alcohol Abuse. 1975;2(3-4):443-9. doi: 10.3109/00952997509005668.","Schecter A","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005668"
"1227301","Clinical use of naltrexone (EN 1639 A). Part II: experience with the first 50 patients in a New York City treatment clinic","Schecter A.","Am J Drug Alcohol Abuse. 1975;2(3-4):433-42. doi: 10.3109/00952997509005667.","Schecter A","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005667"
"1227300","The clinical usefulness of narcotic antagonists: preliminary findings on the use of naltrexone","Lewis DC.","Am J Drug Alcohol Abuse. 1975;2(3-4):403-15. doi: 10.3109/00952997509005665.","Lewis DC","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005665"
"1227298","Clinical experience with naltrexone","O'Brien CP, Greenstein RA, Mintz J, Woody GE.","Am J Drug Alcohol Abuse. 1975;2(3-4):365-77. doi: 10.3109/00952997509005662.","O'Brien CP","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005662"
"1227297","Naltrexone pharmacology, pharmacokinetics, and metabolism: current status","Verebey K, Mulé SJ.","Am J Drug Alcohol Abuse. 1975;2(3-4):357-63. doi: 10.3109/00952997509005661.","Verebey K","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005661"
"1227291","On the role of chemotherapy in the treatment of heroin addiction","Goldstein A.","Am J Drug Alcohol Abuse. 1975;2(3-4):279-88. doi: 10.3109/00952997509005653.","Goldstein A","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005653"
"1212020","Influence of catecholaminergic agents on narcotic binding in brain","Cicero TJ, Wilcox CE, Meyer ER, Michael H.","Arch Int Pharmacodyn Ther. 1975 Dec;218(2):221-30.","Cicero TJ","Arch Int Pharmacodyn Ther","1975","1975/12/01","","",""
"1201850","A unit for delivering multiple drug treatment and prevention services","","Hosp Community Psychiatry. 1975 Oct;26(10):663-6.","","Hosp Community Psychiatry","1975","1975/10/01","","",""
"1197924","Acetylcholine storage and its stabilization by morphine","Nogrady T, Dimaio J.","Res Commun Chem Pathol Pharmacol. 1975 Nov;12(3):425-31.","Nogrady T","Res Commun Chem Pathol Pharmacol","1975","1975/11/01","","",""
"1196002","Comparative in vivo distribution of opiate agonists and antagonists by means of double isotope techniques","Fishman J, Hahn EF, Norton BI.","Life Sci. 1975 Oct 10;17(7):1119-25. doi: 10.1016/0024-3205(75)90333-1.","Fishman J","Life Sci","1975","1975/10/10","","","10.1016/0024-3205(75)90333-1"
"1188187","Isolation and identification of a new metabolite of naltrexone in human blood and urine","Verebely K, Chedekel MA, Mule SJ, Rosenthal D.","Res Commun Chem Pathol Pharmacol. 1975 Sep;12(1):67-84.","Verebely K","Res Commun Chem Pathol Pharmacol","1975","1975/09/01","","",""
"1181122","Treatment of heroin dependence with naltrexone","Martin WR.","Curr Psychiatr Ther. 1975;15:157-61.","Martin WR","Curr Psychiatr Ther","1975","1975/01/01","","",""
"1088899","Clinical efficacy of naltrexone: a one year follow up","Resnick R, Aronoff M, Lonborg G, Kestenbaum R, Kauders F, Washton A, Hough G.","NIDA Res Monogr. 1976 Sep;(9):114-7. doi: 10.1037/e497452006-021.","Resnick R","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-021"
"1088898","Narcotic antagonists: naltrexone progress report: foreword","Jaffe J.","NIDA Res Monogr. 1976 Sep;(9):v-vii.","Jaffe J","NIDA Res Monogr","1976","1976/09/01","","",""
"1071365","Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states","Ho AK, Chen RC.","Ann N Y Acad Sci. 1976;281:297-310. doi: 10.1111/j.1749-6632.1976.tb27940.x.","Ho AK","Ann N Y Acad Sci","1976","1976/01/01","","","10.1111/j.1749-6632.1976.tb27940.x"
"1036502","Correlation between analgesia and the decrease of acetylcholine turnover rate in cortex and hippocampus elicited by morphine, meperidine, viminol R2 and azidomorphine","Zsilla G, Cheney DL, Racagni G, Costa E.","J Pharmacol Exp Ther. 1976 Dec;199(3):662-8.","Zsilla G","J Pharmacol Exp Ther","1976","1976/12/01","","",""
"1004531","The development of sustained action preparations of narcotic antagonists","Willette RE.","NIDA Res Monogr. 1976 Sep;(9):31-4.","Willette RE","NIDA Res Monogr","1976","1976/09/01","","",""
"1004530","The theoretical basis of narcotic addiction treatment with narcotic antagonists","Wikler A.","NIDA Res Monogr. 1976 Sep;(9):119-22. doi: 10.1037/e497452006-022.","Wikler A","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-022"
"1004529","An analysis of naltrexone use--its efficacy, safety and potential","Landsberg R, Taintor Z, Plumb M, Amico L, Wicks N.","NIDA Res Monogr. 1976 Sep;(9):106-13. doi: 10.1037/e497452006-020.","Landsberg R","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-020"
"999987","Short-term effects of naltrexone in 155 heroin ex-addicts","Volavka J, Resnick RB, Kestenbaum RS, Freedman AM.","Biol Psychiatry. 1976 Dec;11(6):679-85.","Volavka J","Biol Psychiatry","1976","1976/12/01","","",""
"999452","Psychopathology and mood during heroin use: acute vs chronic effects","Mirin SM, Meyer RE, McNamee HB.","Arch Gen Psychiatry. 1976 Dec;33(12):1503-8. doi: 10.1001/archpsyc.1976.01770120107011.","Mirin SM","Arch Gen Psychiatry","1976","1976/12/01","","","10.1001/archpsyc.1976.01770120107011"
"996000","Ethanol preference in the hamster: effects of morphine sulfate and naltrexone, a long-acting morphine antagonist","Ross D, Hartmann RJ, Geller I.","Proc West Pharmacol Soc. 1976;19:326-30.","Ross D","Proc West Pharmacol Soc","1976","1976/01/01","","",""
"982058","Nitrous oxide ""analgesia"": resemblance to opiate action","Berkowitz BA, Ngai SH, Finck AD.","Science. 1976 Nov 26;194(4268):967-8. doi: 10.1126/science.982058.","Berkowitz BA","Science","1976","1976/11/26","","","10.1126/science.982058"
"978296","Ring C conformation of 6beta-naltrexol and 6alpha-naltrexol. Evidence from proton and carbon-13 nuclear magnetic resonance","Brine GA, Praskash D, Hart CK, Kotchmar DJ, Moreland CG, Carroll FI.","J Org Chem. 1976 Oct 15;41(21):3445-8. doi: 10.1021/jo00883a027.","Brine GA","J Org Chem","1976","1976/10/15","","","10.1021/jo00883a027"
"977685","Determination of naloxone and naltrexone as perfluoroalkyl ester derivatives by electron-capture gas-liquid chromatography","Sams RA, Malspeis L.","J Chromatogr. 1976 Oct 13;125(2):409-20. doi: 10.1016/s0021-9673(00)83372-5.","Sams RA","J Chromatogr","1976","1976/10/13","","","10.1016/s0021-9673(00)83372-5"
"974367","Morphine-naloxone interaction in the central cholinergic system: the influence of subcortical lesioning and electrical stimulation","Jhamandas K, Sutak M.","Br J Pharmacol. 1976 Sep;58(1):101-7. doi: 10.1111/j.1476-5381.1976.tb07697.x.","Jhamandas K","Br J Pharmacol","1976","1976/09/01","PMC1667128","","10.1111/j.1476-5381.1976.tb07697.x"
"967234","Development of Chronomers tm for narcotic antagonists","Capozza RC, Schmitt EE, Seńdelbeck LR.","Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan;(4):39-42.","Capozza RC","Natl Inst Drug Abuse Res Monogr Ser","1976","1976/01/01","","",""
"967233","Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists","Sidman KR, Arnold DL, Steber WD, Nelsen L, Granchelli FE, Strong P, Sheth SG.","Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan;(4):33-8.","Sidman KR","Natl Inst Drug Abuse Res Monogr Ser","1976","1976/01/01","","",""
"967232","Sustained release of naltrexone from glyceride implants","Sullivan MF, Kalkwarf DR.","Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan;(4):27-32.","Sullivan MF","Natl Inst Drug Abuse Res Monogr Ser","1976","1976/01/01","","",""
"967231","Long-acting narcotic antagonist complexes","Gray AP, Guardina WJ.","Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan;(4):21-6.","Gray AP","Natl Inst Drug Abuse Res Monogr Ser","1976","1976/01/01","","",""
"967230","Development of injectable microcapsules for use in the treatment of narcotic addiction","Thies C.","Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan;(4):19-20.","Thies C","Natl Inst Drug Abuse Res Monogr Ser","1976","1976/01/01","","",""
"964342","Inhibition of nucleic acid synthesis in the regenerating limb of salamanders treated with a DL-methadone or narcotic antagonists","Hui FW, Krikun E, Hirsh EM, Blaiklock RG, Smith AA.","Exp Neurol. 1976 Oct;53(1):267-73. doi: 10.1016/0014-4886(76)90296-x.","Hui FW","Exp Neurol","1976","1976/10/01","","","10.1016/0014-4886(76)90296-x"
"959310","The structure-action relationship and kinetics of some naloxone and naltrexone derivatives","Vizi ES, Foldes FF, Rich J, Knoll J.","Pharmacology. 1976;14(1):76-85. doi: 10.1159/000136582.","Vizi ES","Pharmacology","1976","1976/01/01","","","10.1159/000136582"
"954353","Naltrexone: disposition, metabolism, and effects after acute and chronic dosing","Verebey K, Volavka J, Mulé SJ, Resnick RB.","Clin Pharmacol Ther. 1976 Sep;20(3):315-28. doi: 10.1002/cpt1976203315.","Verebey K","Clin Pharmacol Ther","1976","1976/09/01","","","10.1002/cpt1976203315"
"945438","Reinstatement of precipitated narcotic withdrawal hypothermia in the rat","Ary M, Lomax P.","Life Sci. 1976 Jun 1;18(11):1199-202. doi: 10.1016/0024-3205(76)90193-4.","Ary M","Life Sci","1976","1976/06/01","","","10.1016/0024-3205(76)90193-4"
"945347","The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE.","J Pharmacol Exp Ther. 1976 Jun;197(3):517-32.","Martin WR","J Pharmacol Exp Ther","1976","1976/06/01","","",""
"944026","A behavioral paradigm for the evaluation of narcotic antagonists","Meyer RE, Mirin SM, Altman JL, McNamee HB.","Arch Gen Psychiatry. 1976 Mar;33(3):371-7. doi: 10.1001/archpsyc.1976.01770030073011.","Meyer RE","Arch Gen Psychiatry","1976","1976/03/01","","","10.1001/archpsyc.1976.01770030073011"
"943794","Comparison of withdrawal precipitating properties of various morphine antagonists and partial agonists in relation to their stereospecific binding to brain homogenates","Bläsig J, Höllt V, Herz A, Paschelke G.","Psychopharmacologia. 1976;46(1):41-51. doi: 10.1007/BF00421548.","Bläsig J","Psychopharmacologia","1976","1976/01/01","","","10.1007/BF00421548"
"935974","Pharmacotherapy of opiate addiction","Swanson DA.","S Afr Med J. 1976 May 22;50(22):857-9.","Swanson DA","S Afr Med J","1976","1976/05/22","","",""
"927009","Effects of acute and chronic morphine and narcotic antagonists on brain energy metabolism","King LJ, Minnema KH, Cash C.","Life Sci. 1977 Nov 15;21(10):1465-74. doi: 10.1016/0024-3205(77)90201-6.","King LJ","Life Sci","1977","1977/11/15","","","10.1016/0024-3205(77)90201-6"
"920847","An oral opiate antagonist in chronic schizophrenia: a pilot study","Mielke DH, Gallant DM.","Am J Psychiatry. 1977 Dec;134(12):1430-1. doi: 10.1176/ajp.134.12.1430.","Mielke DH","Am J Psychiatry","1977","1977/12/01","","","10.1176/ajp.134.12.1430"
"911218","Naltrexone and cyclazocine. A controlled treatment study","Brahen LS, Capone T, Wiechert V, Desiderio D.","Arch Gen Psychiatry. 1977 Oct;34(10):1181-4. doi: 10.1001/archpsyc.1977.01770220063007.","Brahen LS","Arch Gen Psychiatry","1977","1977/10/01","","","10.1001/archpsyc.1977.01770220063007"
"909610","Inhibition of acetylcholine turnover in rat hippocampus by intraseptal injections of beta-endorphin and morphine","Moroni F, Cheney DL, Costa E.","Naunyn Schmiedebergs Arch Pharmacol. 1977 Sep;299(2):149-53. doi: 10.1007/BF00498556.","Moroni F","Naunyn Schmiedebergs Arch Pharmacol","1977","1977/09/01","","","10.1007/BF00498556"
"905632","Estimation of the systemic availability and other pharmacokinetic parameters of naltrexone in man after acute and chronic oral administration","Kogan MJ, Verebey K, Mule SJ.","Res Commun Chem Pathol Pharmacol. 1977 Sep;18(1):29-34.","Kogan MJ","Res Commun Chem Pathol Pharmacol","1977","1977/09/01","","",""
"894682","Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexone","Jiang JB, Hanson RN, Portoghese PS, Takemori AE.","J Med Chem. 1977 Aug;20(8):1100-2. doi: 10.1021/jm00218a023.","Jiang JB","J Med Chem","1977","1977/08/01","","","10.1021/jm00218a023"
"881456","Quantitative determination of naltrexone and naltrexone prodrugs by electron-capture gas-liquid chromatography","Burce GL, Bhat HB, Sokoloski T.","J Chromatogr. 1977 Jul 21;137(2):323-32. doi: 10.1016/s0021-9673(00)81355-2.","Burce GL","J Chromatogr","1977","1977/07/21","","","10.1016/s0021-9673(00)81355-2"
"880876","Naltrexone treatment of opiate-dependent persons","Hollister LE, Schwin RL, Kasper P.","Drug Alcohol Depend. 1977 May;2(3):203-9. doi: 10.1016/0376-8716(77)90027-8.","Hollister LE","Drug Alcohol Depend","1977","1977/05/01","","","10.1016/0376-8716(77)90027-8"
"865620","beta endorphin inhibits ACh turnover in nuclei of rat brain","Moroni F, Cheney DL, Costa E.","Nature. 1977 May 19;267(5608):267-8. doi: 10.1038/267267a0.","Moroni F","Nature","1977","1977/05/19","","","10.1038/267267a0"
"853872","Antagonism of the effects of pentobarbital in the chronic spinal dog by naltrexone","Gilbert PE, Martin WR.","Life Sci. 1977 Apr 15;20(8):1401-6. doi: 10.1016/0024-3205(77)90368-x.","Gilbert PE","Life Sci","1977","1977/04/15","","","10.1016/0024-3205(77)90368-x"
"849672","Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone","Resnick RB, Kestenbaum RS, Washton A, Poole D.","Clin Pharmacol Ther. 1977 Apr;21(4):409-13. doi: 10.1002/cpt1977214409.","Resnick RB","Clin Pharmacol Ther","1977","1977/04/01","","","10.1002/cpt1977214409"
"844498","Beta-endorphin and male sexual behavior","Meyerson BJ, Terenius L.","Eur J Pharmacol. 1977 Mar 21;42(2):191-2. doi: 10.1016/0014-2999(77)90359-4.","Meyerson BJ","Eur J Pharmacol","1977","1977/03/21","","","10.1016/0014-2999(77)90359-4"
"844495","The effect of the narcotic antagonists naloxone, naltrexone and nalorphine on spinal cord C-fiber reflexes evoked by electrical stimulation or radiant heat","Bell JA, Martin WR.","Eur J Pharmacol. 1977 Mar 21;42(2):147-54. doi: 10.1016/0014-2999(77)90354-5.","Bell JA","Eur J Pharmacol","1977","1977/03/21","","","10.1016/0014-2999(77)90354-5"
"834360","Constant rate infusion of deuterated phosphorylcholine to measure the effects of morphine on acetylcholine turnover rate in specific nuclei of rat brain","Zsilla G, Racagni G, Cheney DL, Costa E.","Neuropharmacology. 1977 Jan;16(1):25-30. doi: 10.1016/0028-3908(77)90042-9.","Zsilla G","Neuropharmacology","1977","1977/01/01","","","10.1016/0028-3908(77)90042-9"
"828467","Evaluation of narcotic and narcotic antagonist interactions in primates","Killam KF Jr, Brocco MJ, Robinson CA.","Ann N Y Acad Sci. 1976;281:331-5. doi: 10.1111/j.1749-6632.1976.tb27943.x.","Killam KF Jr","Ann N Y Acad Sci","1976","1976/01/01","","","10.1111/j.1749-6632.1976.tb27943.x"
"828465","Disposition of narcotics and narcotic antagonists","Inturrisi CE.","Ann N Y Acad Sci. 1976;281:273-87. doi: 10.1111/j.1749-6632.1976.tb27938.x.","Inturrisi CE","Ann N Y Acad Sci","1976","1976/01/01","","","10.1111/j.1749-6632.1976.tb27938.x"
"827709","Testing of drug delivery systems for use in the treatment of narcotic addiction","Reuning RH, Malspeis L, Frank S, Notari RE.","Natl Inst Drug Abuse Res Monogr Ser. 1975;(4):43-5.","Reuning RH","Natl Inst Drug Abuse Res Monogr Ser","1975","1975/01/01","","",""
"826950","Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone","Shannon HE, Holtzman SG.","Psychopharmacology (Berl). 1976 Nov 10;50(2):119-24. doi: 10.1007/BF00430479.","Shannon HE","Psychopharmacology (Berl)","1976","1976/11/10","","","10.1007/BF00430479"
"826824","Preclinical toxicity studies of naltrexone","Braude MC, Morrison JM.","NIDA Res Monogr. 1976 Sep;(9):16-26. doi: 10.1037/e497452006-006.","Braude MC","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-006"
"823438","Testing of drug delivery systems for use in the treatment of narcotic addiction","Reuning RH, Malspeis L, Frank S, Notari RE.","Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan;(4):43-5.","Reuning RH","Natl Inst Drug Abuse Res Monogr Ser","1976","1976/01/01","","",""
"822483","Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat","Malspeis L, Ludden TM, Bathala MS, Morrison BE, Feller DR, Reuning RH.","Res Commun Chem Pathol Pharmacol. 1976 Jul;14(3):393-406.","Malspeis L","Res Commun Chem Pathol Pharmacol","1976","1976/07/01","","",""
"822446","[Precipitation and prevention of abstinence in acutely morphinized rats and mice: comparisons between naloxone, naltrexone, and diprenorphine (author's transl)]","Tremblay E, Colombel MC, Jacob J.","Psychopharmacology (Berl). 1976 Aug 26;49(1):41-8.","Tremblay E","Psychopharmacology (Berl)","1976","1976/08/26","","",""
"821786","Assessment of CNS drug activity in rhesus monkeys by analysis of the EEG","Gehrmann JE, Killam KF Jr.","Fed Proc. 1976 Sep;35(11):2258-63.","Gehrmann JE","Fed Proc","1976","1976/09/01","","",""
"819644","Tritiated naltrexone binding in plasma from several species and tissue distribution in mice","Ludden TM, Malspeis L, Baggot JD, Sokoloski TD, Frank SG, Reuning RH.","J Pharm Sci. 1976 May;65(5):712-6. doi: 10.1002/jps.2600650521.","Ludden TM","J Pharm Sci","1976","1976/05/01","","","10.1002/jps.2600650521"
"810832","Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol","Malspeis L, Bathala MS, Ludden TM, Bhat HB, Frank SG, Sokoloski TD, Morrison BE, Reuning RH.","Res Commun Chem Pathol Pharmacol. 1975 Sep;12(1):43-65.","Malspeis L","Res Commun Chem Pathol Pharmacol","1975","1975/09/01","","",""
"794728","Use of narcotic antagonists (naltrexone) in an addiction treatment program","Lewis D, Hersch R, Black R, Mayer J.","NIDA Res Monogr. 1976 Sep;(9):99-105. doi: 10.1037/e497452006-019.","Lewis D","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-019"
"794727","Narcotic antagonist treatment of the criminal justice patient-institutional vs outpatient-including a 24 hour detox naltrexone induction regimen with oral medication","Brahen L, Wiechert V, Capone T.","NIDA Res Monogr. 1976 Sep;(9):93-8. doi: 10.1037/e497452006-018.","Brahen L","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-018"
"794726","Clinical experiences with naltrexone in 370 detoxified addicts","Thomas M, Kauders F, Harris M, Cooperstein J, Hough G, Resnick R.","NIDA Res Monogr. 1976 Sep;(9):88-92. doi: 10.1037/e497452006-017.","Thomas M","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-017"
"794725","Factors influencing success in an antagonistic treatment program","Parwatikar S, Crawford J, Nelkupa JV, De Gracia C.","NIDA Res Monogr. 1976 Sep;(9):77-81.","Parwatikar S","NIDA Res Monogr","1976","1976/09/01","","",""
"794724","Comments and findings from a naltrexone double blind study","Keegan J, Lavenduski C, Schooff K.","NIDA Res Monogr. 1976 Sep;(9):74-6. doi: 10.1037/e497452006-014.","Keegan J","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-014"
"794723","Naltrexone in methadone maintenance patients electing to become ""drug free""","Haas N, Ling W, Holmes E, Blakis M, Litaker M.","NIDA Res Monogr. 1976 Sep;(9):70-3. doi: 10.1037/e497452006-013.","Haas N","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-013"
"794722","Patient response to naltrexone: issues of acceptance, treatment effects, and frequency of administration","Curran S, Savage C.","NIDA Res Monogr. 1976 Sep;(9):67-9. doi: 10.1037/e497452006-012.","Curran S","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-012"
"794721","Varying clinical contexts for administering naltrexone","Hurzeler M, Gerwirtz D, Kleber H.","NIDA Res Monogr. 1976 Sep;(9):48-66. doi: 10.1037/e497452006-011.","Hurzeler M","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-011"
"794720","Philosophy and status of NAS CENA study","Hollister LE.","NIDA Res Monogr. 1976 Sep;(9):45-7. doi: 10.1037/e497452006-010.","Hollister LE","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-010"
"794719","Evolution of the National Academy of Sciences study of naltrexone","Kaim SC.","NIDA Res Monogr. 1976 Sep;(9):37-44. doi: 10.1037/e497452006-009.","Kaim SC","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-009"
"794718","Naltrexone bibliography","","NIDA Res Monogr. 1976 Sep;(9):176-8.","","NIDA Res Monogr","1976","1976/09/01","","",""
"794717","Interim report on clinic intake and safety data collected from 17 NIDA-funded naltrexone studies","Bradford A, Hurley F, Golondzowski O, Dorrier C.","NIDA Res Monogr. 1976 Sep;(9):163-71.","Bradford A","NIDA Res Monogr","1976","1976/09/01","","",""
"794716","Comparison of two naltrexone treatment programs: naltrexone alone versus naltrexone plus behavior therapy","Callahan E, Rawson R, Glazer M, McCleave B, Arias R.","NIDA Res Monogr. 1976 Sep;(9):150-7. doi: 10.1037/e497452006-026.","Callahan E","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-026"
"794715","Clinical experience with naltrexone in a behavioral research study: an interim report","Greenstein R, O'Brien C, Mintz J, Woody G, Hanna N.","NIDA Res Monogr. 1976 Sep;(9):141-9. doi: 10.1037/e497452006-025.","Greenstein R","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-025"
"794713","Narcotic antagonists: naltrexone progress report: introduction","Renault PF.","NIDA Res Monogr. 1976 Sep;(9):1-3.","Renault PF","NIDA Res Monogr","1976","1976/09/01","","",""
"787798","Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction","Schwope AD, Wise DL, Howes JF.","Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan;(4):13-8.","Schwope AD","Natl Inst Drug Abuse Res Monogr Ser","1976","1976/01/01","","",""
"775969","Experiences with Naltrexone in Buffalo","Taintor Z, Landsberg R, Wicks N.","Am J Drug Alcohol Abuse. 1975;2(3-4):391-401. doi: 10.3109/00952997509005664.","Taintor Z","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005664"
"773586","Naltrexone: physiological and psychological effects of single doses","Gritz ER, Shiffman SM, Jarvik ME, Schlesinger J, Charuvastra VC.","Clin Pharmacol Ther. 1976 Jun;19(6):773-6. doi: 10.1002/cpt1976196773.","Gritz ER","Clin Pharmacol Ther","1976","1976/06/01","","","10.1002/cpt1976196773"
"762657","Pharmacokinetics of naloxone and naltrexone in the dog","Pace NL, Parrish RG, Lieberman MM, Wong KC, Blatnick RA.","J Pharmacol Exp Ther. 1979 Feb;208(2):254-6.","Pace NL","J Pharmacol Exp Ther","1979","1979/02/01","","",""
"762651","On the regulation of gamma-aminobutyric acid neurons in caudatus, pallidus and nigra: effects of opioids and dopamine agonists","Moroni F, Peralta E, Cheney DL, Costa E.","J Pharmacol Exp Ther. 1979 Feb;208(2):190-4.","Moroni F","J Pharmacol Exp Ther","1979","1979/02/01","","",""
"755620","Alteration of ethanol effects by opiate antagonists","Harris RA, Erickson CK.","Curr Alcohol. 1979;5:17-28.","Harris RA","Curr Alcohol","1979","1979/01/01","","",""
"755381","Craving in heroin addicts maintained on the opiate antagonist naltrexone","Sideroff SI, Charuvastra VC, Jarvik ME.","Am J Drug Alcohol Abuse. 1978;5(4):415-23. doi: 10.3109/00952997809007017.","Sideroff SI","Am J Drug Alcohol Abuse","1978","1978/01/01","","","10.3109/00952997809007017"
"747177","Controlled clinical study of naltrexone side effects comparing first-day doses and maintenance regimens","Brahen LS, Capone T, Heller RC, Linden SL, Landy HJ, Lewis MJ.","Am J Drug Alcohol Abuse. 1978;5(2):235-45. doi: 10.3109/00952997809028001.","Brahen LS","Am J Drug Alcohol Abuse","1978","1978/01/01","","","10.3109/00952997809028001"
"747176","Naltrexone and conventionality","Suffet F, Remine DC 2nd, Taleporos E, Brotman R.","Am J Drug Alcohol Abuse. 1978;5(2):221-33. doi: 10.3109/00952997809028000.","Suffet F","Am J Drug Alcohol Abuse","1978","1978/01/01","","","10.3109/00952997809028000"
"740012","Detection of alkylating agents by the analysis of amino acid residues in hemoglobin and urine. 1. The in vivo and in vitro effects of ethyl methanesulfonate, methyl methanesulfonate, hycanthone methanesulfonate, and naltrexone","Truong L, Ward JB Jr, Legator MS.","Mutat Res. 1978 Dec;54(3):271-81. doi: 10.1016/0165-1161(78)90017-1.","Truong L","Mutat Res","1978","1978/12/01","","","10.1016/0165-1161(78)90017-1"
"734225","Carbon-13 nuclear magnetic resonance identification of 2-hydroxy-3-O-methyl-6beta-naltrexol as a minor naltrexone metabolite","Brine GA, Brine DR, Welch CD, Bondeson VC, Carroll FI.","Res Commun Chem Pathol Pharmacol. 1978 Dec;22(3):455-64.","Brine GA","Res Commun Chem Pathol Pharmacol","1978","1978/12/01","","",""
"733832","Effects of opiates on the discriminative stimulus properties of dopamine agonists","Hernandez LL, Holohean AM, Appel JB.","Pharmacol Biochem Behav. 1978 Oct;9(4):459-63. doi: 10.1016/0091-3057(78)90041-2.","Hernandez LL","Pharmacol Biochem Behav","1978","1978/10/01","","","10.1016/0091-3057(78)90041-2"
"733827","Discriminative effects of morphine in the pigeon","Järbe TU.","Pharmacol Biochem Behav. 1978 Oct;9(4):411-6. doi: 10.1016/0091-3057(78)90032-1.","Järbe TU","Pharmacol Biochem Behav","1978","1978/10/01","","","10.1016/0091-3057(78)90032-1"
"730406","Narcotic antagonist treatment: clinical experience with naltrexone","Lewis DC, Mayer J, Hersch RG, Black R.","Int J Addict. 1978 Aug;13(6):961-73. doi: 10.3109/10826087809039316.","Lewis DC","Int J Addict","1978","1978/08/01","","","10.3109/10826087809039316"
"723970","Genotype dependent response of morphine and methionine-enkephalin on the electrically induced contractions of the mouse vas deferens","Berti F, Bruno F, Omini C, Racagni G.","Naunyn Schmiedebergs Arch Pharmacol. 1978 Oct;305(1):5-8. doi: 10.1007/BF00496999.","Berti F","Naunyn Schmiedebergs Arch Pharmacol","1978","1978/10/01","","","10.1007/BF00496999"
"714975","Effects of repeated injections of naltrexone on antagonism of rate decreases by morphine in the pigeon","Smith JB.","Pharmacol Biochem Behav. 1978 Aug;9(2):265-7. doi: 10.1016/0091-3057(78)90176-4.","Smith JB","Pharmacol Biochem Behav","1978","1978/08/01","","","10.1016/0091-3057(78)90176-4"
"692825","Behavioral effects of chronic narcotic antagonist administration of infant rats","Paul L, Diaz J, Bailey B.","Neuropharmacology. 1978 Aug;17(8):655-7. doi: 10.1016/0028-3908(78)90163-6.","Paul L","Neuropharmacology","1978","1978/08/01","","","10.1016/0028-3908(78)90163-6"
"688025","Midbrain raphe mediation of the narcotic blockade of ovulation","Maughan GT, Johnson JH, Rosecrans JA.","Brain Res. 1978 Oct 27;155(2):413-7. doi: 10.1016/0006-8993(78)91040-5.","Maughan GT","Brain Res","1978","1978/10/27","","","10.1016/0006-8993(78)91040-5"
"682114","Naltrexone, morphine and cocaine interactions in mice and rats","Blumberg H, Ikeda C.","J Pharmacol Exp Ther. 1978 Aug;206(2):303-10.","Blumberg H","J Pharmacol Exp Ther","1978","1978/08/01","","",""
"674824","The identification and measurement of two new metabolites of naltrexone in human urine","Cone EJ, Gorodetzky CW, Darwin WD, Carroll FI, Brine GA, Welch CD.","Res Commun Chem Pathol Pharmacol. 1978 Jun;20(3):413-33.","Cone EJ","Res Commun Chem Pathol Pharmacol","1978","1978/06/01","","",""
"672425","Stereospecific aversive property of narcotic antagonists in morphine-free rats","Stolerman IP, Pilcher CW, D'Mello GD.","Life Sci. 1978 May 15;22(19):1755-62. doi: 10.1016/0024-3205(78)90628-8.","Stolerman IP","Life Sci","1978","1978/05/15","","","10.1016/0024-3205(78)90628-8"
"663407","Plasma corticosteroid levels in rats maintained on a long-acting naltrexone delivery system","Misra AL, Pontani RB, Vadlamani NL.","Res Commun Chem Pathol Pharmacol. 1978 Apr;20(1):43-50.","Misra AL","Res Commun Chem Pathol Pharmacol","1978","1978/04/01","","",""
"660528","Central and peripheral actions of morphine on intestinal transit","Stewart JJ, Weisbrodt NW, Burks TF.","J Pharmacol Exp Ther. 1978 Jun;205(3):547-55.","Stewart JJ","J Pharmacol Exp Ther","1978","1978/06/01","","",""
"658129","Inhibition by d,l-methadone of RNA and protein synthesis in neonatal mice: antagonism by naloxone or naltrexone","Hui FW, Krikun E, Smith AA.","Eur J Pharmacol. 1978 May 1;49(1):87-93. doi: 10.1016/0014-2999(78)90225-x.","Hui FW","Eur J Pharmacol","1978","1978/05/01","","","10.1016/0014-2999(78)90225-x"
"645364","Prlonged drug release from multiple emulsions","Brodin AF, Kavaliunas DR, Frank SG.","Acta Pharm Suec. 1978;15(1):1-12.","Brodin AF","Acta Pharm Suec","1978","1978/01/01","","",""
"626239","Possible withdrawal from endogeneous opiates in schizophrenics","Gitlin M, Rosenblatt M.","Am J Psychiatry. 1978 Mar;135(3):377-8. doi: 10.1176/ajp.135.3.377.","Gitlin M","Am J Psychiatry","1978","1978/03/01","","","10.1176/ajp.135.3.377"
"591144","Prospects, problems, side effects, and safety of narcotic antagonists","Resnick RB.","Int J Addict. 1977 Oct;12(7):863-7. doi: 10.3109/10826087709027256.","Resnick RB","Int J Addict","1977","1977/10/01","","","10.3109/10826087709027256"
"574545","Discriminative stimulus effects of naltrexone in the morphine-dependent rat","Gellert VF, Holtzman SG.","J Pharmacol Exp Ther. 1979 Dec;211(3):596-605.","Gellert VF","J Pharmacol Exp Ther","1979","1979/12/01","","",""
"570272","EEG and other effects of naltrexone and heroin in man","Volavka J, James B, Reker D, Mallya A, Cho D, Pevnick J.","Pharmakopsychiatr Neuropsychopharmakol. 1979 Jan;12(1):79-85. doi: 10.1055/s-0028-1094597.","Volavka J","Pharmakopsychiatr Neuropsychopharmakol","1979","1979/01/01","","","10.1055/s-0028-1094597"
"567585","The effects of naltrexone on the development of physical dependence on morphine","Bhargava HN.","Eur J Pharmacol. 1978 Aug 1;50(3):193-202. doi: 10.1016/0014-2999(78)90351-5.","Bhargava HN","Eur J Pharmacol","1978","1978/08/01","","","10.1016/0014-2999(78)90351-5"
"564769","The pharmacology of thebaine in the chronic spinal dog","Gilbert PE, Martin WR.","Drug Alcohol Depend. 1978 Mar;3(2):139-42. doi: 10.1016/0376-8716(78)90027-3.","Gilbert PE","Drug Alcohol Depend","1978","1978/03/01","","","10.1016/0376-8716(78)90027-3"
"563313","Dissociation of increased 5-hydroxyindoleacetic acid levels and physical dependence: the effects of naloxone","Laska FJ, Fennessy MR.","Clin Exp Pharmacol Physiol. 1977 Nov-Dec;4(6):515-23. doi: 10.1111/j.1440-1681.1977.tb02681.x.","Laska FJ","Clin Exp Pharmacol Physiol","1977","1977/11/01","","","10.1111/j.1440-1681.1977.tb02681.x"
"562763","Differentiation between opioid peptides by naltrexone","Rónai AZ, Berzétei I, Bajusz S.","Eur J Pharmacol. 1977 Oct 15;45(4):393-4. doi: 10.1016/0014-2999(77)90281-3.","Rónai AZ","Eur J Pharmacol","1977","1977/10/15","","","10.1016/0014-2999(77)90281-3"
"561312","Stability of Met-enkephalin content in brain structures of morphine-dependent or foot shock-stressed rats","Fratta W, Yang HY, Hong J, Costa E.","Nature. 1977 Aug 4;268(5619):452-3. doi: 10.1038/268452a0.","Fratta W","Nature","1977","1977/08/04","","","10.1038/268452a0"
"551319","Chronic naltrexone administration reverses the suppressive effect of crowding on body weight gain in rats","Amir S, Galina HZ, Amit Z.","Neuropharmacology. 1979 Nov;18(11):905-7. doi: 10.1016/0028-3908(79)90089-3.","Amir S","Neuropharmacology","1979","1979/11/01","","","10.1016/0028-3908(79)90089-3"
"550130","Behavioral effects of perinatal naltrexone exposure: a preliminary investigation","Harry GJ, Rosecrans JA.","Pharmacol Biochem Behav. 1979;11 Suppl:19-22.","Harry GJ","Pharmacol Biochem Behav","1979","1979/01/01","","",""
"539577","Effects of contingent payment on compliance with a naltrexone regimen","Grabowski J, O'Brien CP, Greenstein R, Ternes J, Long M, Steinberg-Donato S.","Am J Drug Alcohol Abuse. 1979;6(3):355-65. doi: 10.3109/00952997909001724.","Grabowski J","Am J Drug Alcohol Abuse","1979","1979/01/01","","","10.3109/00952997909001724"
"530471","Stress induced grooming in the rat--an endorphin mediated syndrome","Katz RJ, Roth KA.","Neurosci Lett. 1979 Jul;13(2):209-12. doi: 10.1016/0304-3940(79)90043-0.","Katz RJ","Neurosci Lett","1979","1979/07/01","","","10.1016/0304-3940(79)90043-0"
"523496","Suppressant effects of naltrexone on water intake in rats","Frenk H, Rosen JB.","Pharmacol Biochem Behav. 1979 Oct;11(4):387-90. doi: 10.1016/0091-3057(79)90112-6.","Frenk H","Pharmacol Biochem Behav","1979","1979/10/01","","","10.1016/0091-3057(79)90112-6"
"522615","Inhibition of drug metabolism by chronically administered naltrexone","Lehman TM, Pyati P, Peterson GR.","Life Sci. 1979 Oct 29;25(18):1591-600. doi: 10.1016/0024-3205(79)90442-9.","Lehman TM","Life Sci","1979","1979/10/29","","","10.1016/0024-3205(79)90442-9"
"522608","Increased amphetamine potency following chronic naltrexone administration in rats","Amir S, Blair R, Amit Z.","Life Sci. 1979 Oct 15;25(16):1407-12. doi: 10.1016/0024-3205(79)90418-1.","Amir S","Life Sci","1979","1979/10/15","","","10.1016/0024-3205(79)90418-1"
"517492","Measurement of urine temperature as an alternative to observed urination in a narcotic treatment program","Judson BA, Himmelberger DU, Goldstein A.","Am J Drug Alcohol Abuse. 1979;6(2):197-205. doi: 10.3109/00952997909007045.","Judson BA","Am J Drug Alcohol Abuse","1979","1979/01/01","","","10.3109/00952997909007045"
"517491","The double-blind crossover trial design: how good is it for psychoactive drugs?","Brahen LS, Capone T, Wojak JC.","Am J Drug Alcohol Abuse. 1979;6(2):189-96. doi: 10.3109/00952997909007044.","Brahen LS","Am J Drug Alcohol Abuse","1979","1979/01/01","","","10.3109/00952997909007044"
"515087","Plasma and semen kinetics of naltrexone in the rabbit","Taylor SM, Rodgers RM, Lynn RK, Gerber N.","Proc West Pharmacol Soc. 1979;22:455-61.","Taylor SM","Proc West Pharmacol Soc","1979","1979/01/01","","",""
"510393","Enhanced analgesic effects of stress following chronic administration of naltrexone in rats","Amir S, Amit Z.","Eur J Pharmacol. 1979 Oct 26;59(1-2):137-40. doi: 10.1016/0014-2999(79)90036-0.","Amir S","Eur J Pharmacol","1979","1979/10/26","","","10.1016/0014-2999(79)90036-0"
"510378","Autoanalgesia: acquisition, blockade and relationship to opiate binding","Chance WT, White AC, Krynock GM, Rosecrans JA.","Eur J Pharmacol. 1979 Oct 15;58(4):461-8. doi: 10.1016/0014-2999(79)90317-0.","Chance WT","Eur J Pharmacol","1979","1979/10/15","","","10.1016/0014-2999(79)90317-0"
"496053","Studies of the possible role of brain endorphins in pentobarbital anesthesia and toxicity in mice","Bhargava HN.","Anesthesiology. 1979 Nov;51(5):398-401. doi: 10.1097/00000542-197911000-00006.","Bhargava HN","Anesthesiology","1979","1979/11/01","","","10.1097/00000542-197911000-00006"
"485705","Acute effects of opiate agonists, partial agonists and antagonists on brain monoamines in the rat","Fennessy MR, Laska FJ.","Arch Int Pharmacodyn Ther. 1979 Mar;238(1):60-70.","Fennessy MR","Arch Int Pharmacodyn Ther","1979","1979/03/01","","",""
"481705","GABAergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by delta 9-tetrahydrocannabinol","Revuelta AV, Cheney DL, Wood PL, Costa E.","Neuropharmacology. 1979 Jun;18(6):525-30. doi: 10.1016/0028-3908(79)90095-9.","Revuelta AV","Neuropharmacology","1979","1979/06/01","","","10.1016/0028-3908(79)90095-9"
"477732","Comparison of binding of [3H]-methionine-enkephalin, [3H]-naltrexone and [3H]-dihydromorphine in the mouse vas deferens and the myenteric plexus and brain of the ginea pig","Leslie FM, Kosterlitz HW.","Eur J Pharmacol. 1979 Jul 1;56(4):379-83. doi: 10.1016/0014-2999(79)90269-3.","Leslie FM","Eur J Pharmacol","1979","1979/07/01","","","10.1016/0014-2999(79)90269-3"
"465866","The effect of intracerebroventricular administration of methionine-enkephalin on the stress-induced secretion of corticosterone in mice","Gibson A, Ginsburg M, Hall M, Hart SL.","Br J Pharmacol. 1979 Jun;66(2):164-6. doi: 10.1111/j.1476-5381.1979.tb13660.x.","Gibson A","Br J Pharmacol","1979","1979/06/01","PMC2043635","","10.1111/j.1476-5381.1979.tb13660.x"
"461486","Facilitation by opiate antagonists of sexual performance in the male rat","Myers BM, Baum MJ.","Pharmacol Biochem Behav. 1979 Apr;10(4):615-8. doi: 10.1016/0091-3057(79)90242-9.","Myers BM","Pharmacol Biochem Behav","1979","1979/04/01","","","10.1016/0091-3057(79)90242-9"
"461479","Evidence supporting lack of discriminative stimulus properties of a combination of naltrexone and morphine","Järbe TU, Loman P, Swedberg MD.","Pharmacol Biochem Behav. 1979 Apr;10(4):493-7. doi: 10.1016/0091-3057(79)90223-5.","Järbe TU","Pharmacol Biochem Behav","1979","1979/04/01","","","10.1016/0091-3057(79)90223-5"
"441097","Opiate modification of intracranial self-stimulation in the rat","Weibel SL, Wolf HH.","Pharmacol Biochem Behav. 1979 Jan;10(1):71-8. doi: 10.1016/0091-3057(79)90171-0.","Weibel SL","Pharmacol Biochem Behav","1979","1979/01/01","","","10.1016/0091-3057(79)90171-0"
"440006","Effects of morphine and beta-endorphin on basal and elevated plasma levels of alpha-MSH and vasopressin","van Wimersma Greidanus TB, Thody TJ, Verspaget H, de Rotte GA, Goedemans HJ, Croiset G, van Ree JM.","Life Sci. 1979 Feb 12;24(7):579-85. doi: 10.1016/0024-3205(79)90153-x.","van Wimersma Greidanus TB","Life Sci","1979","1979/02/12","","","10.1016/0024-3205(79)90153-x"
"439005","Nitrous oxide stimulation of locomotor activity: evidence for an opiate-like behavioral effect","Hynes MD, Berkowitz BA.","J Pharmacol Exp Ther. 1979 May;209(2):304-8.","Hynes MD","J Pharmacol Exp Ther","1979","1979/05/01","","",""
"437945","Naltrexone antagonism of exploration in the rat","Katz RJ.","Int J Neurosci. 1979;9(1):49-51.","Katz RJ","Int J Neurosci","1979","1979/01/01","","",""
"424476","Endogenous opioid peptides and the control of pain","Kosterlitz HW.","Psychol Med. 1979 Feb;9(1):1-4. doi: 10.1017/s0033291700021498.","Kosterlitz HW","Psychol Med","1979","1979/02/01","","","10.1017/s0033291700021498"
"421447","Narcotic antagonists in the treatment of opioid dependence: review and commentary","Resnick RB, Schuyten-Resnick E, Washton AM.","Compr Psychiatry. 1979 Mar-Apr;20(2):116-25. doi: 10.1016/0010-440x(79)90042-7.","Resnick RB","Compr Psychiatry","1979","1979/03/01","","","10.1016/0010-440x(79)90042-7"
"420348","Withdrawal from endogenous opiates","Julius DA.","Am J Psychiatry. 1979 Mar;136(3):358-9. doi: 10.1176/ajp.136.3.358.","Julius DA","Am J Psychiatry","1979","1979/03/01","","","10.1176/ajp.136.3.358"
"418355","Conditioning effects of narcotics in humans","O'Brien CP, Testa T, Ternes J, Greenstein R.","NIDA Res Monogr. 1978;(18):67-71. doi: 10.1037/e497412006-011.","O'Brien CP","NIDA Res Monogr","1978","1978/01/01","","","10.1037/e497412006-011"
"413904","Continuous intravenous naltrexone effects on morphine self-administration in rhesus monkeys","Harrigan SE, Downs DA.","J Pharmacol Exp Ther. 1978 Feb;204(2):481-6.","Harrigan SE","J Pharmacol Exp Ther","1978","1978/02/01","","",""
"393928","Failure of beta-endorphin antiserum, naloxone, and naltrexone to alter physiologic growth hormone and insulin secretion","Tannenbaum GS, Panerai AE, Friesen HG.","Life Sci. 1979 Dec 3;25(23):1983-90. doi: 10.1016/0024-3205(79)90602-7.","Tannenbaum GS","Life Sci","1979","1979/12/03","","","10.1016/0024-3205(79)90602-7"
"374068","Endogenous opioids participate in the regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone","Cicero TJ, Schainker BA, Meyer ER.","Endocrinology. 1979 May;104(5):1286-91. doi: 10.1210/endo-104-5-1286.","Cicero TJ","Endocrinology","1979","1979/05/01","","","10.1210/endo-104-5-1286"
"369432","Clinical pharmacology of narcotic antagonists","O'Brien CP, Greenstein R, Ternes J, Woody GE.","Ann N Y Acad Sci. 1978;311:232-40. doi: 10.1111/j.1749-6632.1978.tb16779.x.","O'Brien CP","Ann N Y Acad Sci","1978","1978/01/01","","","10.1111/j.1749-6632.1978.tb16779.x"
"365122","Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists","","Arch Gen Psychiatry. 1978 Mar;35(3):335-40.","","Arch Gen Psychiatry","1978","1978/03/01","","",""
"338517","Methadone maintenance and narcotic blocking drugs. Appendix","Wikler A.","Int J Addict. 1977 Oct;12(7):869-81. doi: 10.3109/10826087709027257.","Wikler A","Int J Addict","1977","1977/10/01","","","10.3109/10826087709027257"
"298339","Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone","Davis GC, Buchsbaum MS, van Kammen DP, Bunney WE Jr.","Psychiatry Res. 1979 Jul;1(1):61-9. doi: 10.1016/0165-1781(79)90029-5.","Davis GC","Psychiatry Res","1979","1979/07/01","","","10.1016/0165-1781(79)90029-5"
"283722","Clinical outcome with naltrexone","Resnick RB, Washton AM.","Ann N Y Acad Sci. 1978;311:241-7. doi: 10.1111/j.1749-6632.1978.tb16780.x.","Resnick RB","Ann N Y Acad Sci","1978","1978/01/01","","","10.1111/j.1749-6632.1978.tb16780.x"
"252920","Treatment of heroin-dependent persons with antagonists: current status","Renault PF.","Bull Narc. 1978 Apr-Jun;30(2):21-9.","Renault PF","Bull Narc","1978","1978/04/01","","",""
"239958","A gas-liquid chromatographic method for the determination of naltrexone and beta-naltrexol in human urine","Verebely K, Mulé SJ, Jukofsky D.","J Chromatogr. 1975 Aug 20;111(1):141-8. doi: 10.1016/s0021-9673(01)80155-2.","Verebely K","J Chromatogr","1975","1975/08/20","","","10.1016/s0021-9673(01)80155-2"
"232441","Brain opiate receptor concentrations are increased in adult spontaneously hypertensive rats","Martucci CP, Hahn EF.","Endocr Res Commun. 1979;6(4):291-7. doi: 10.1080/07435807909061108.","Martucci CP","Endocr Res Commun","1979","1979/01/01","","","10.1080/07435807909061108"
"231991","Psychiatric implications of endorphin research","Mackay AV.","Br J Psychiatry. 1979 Nov;135:470-3. doi: 10.1192/bjp.135.5.470.","Mackay AV","Br J Psychiatry","1979","1979/11/01","","","10.1192/bjp.135.5.470"
"228671","Changes in rat brain opiate receptor content upon castration and testosterone replacement","Hahn EF, Fishman J.","Biochem Biophys Res Commun. 1979 Oct 12;90(3):819-23. doi: 10.1016/0006-291x(79)91901-6.","Hahn EF","Biochem Biophys Res Commun","1979","1979/10/12","","","10.1016/0006-291x(79)91901-6"
"226864","Stereospecific opiate binding in bovine adrenal medulla","Chavkin C, Cox BM, Goldstein A.","Mol Pharmacol. 1979 May;15(3):751-3.","Chavkin C","Mol Pharmacol","1979","1979/05/01","","",""
"226215","Alterations in brain opiate receptors in Parkinson's disease","Reisine TD, Rossor M, Spokes E, Iversen LL, Yamamura HI.","Brain Res. 1979 Sep 14;173(2):378-82. doi: 10.1016/0006-8993(79)90642-5.","Reisine TD","Brain Res","1979","1979/09/14","","","10.1016/0006-8993(79)90642-5"
"224675","Hormonal and other effects of naltrexone in normal men","Volavka J, Mallya A, Bauman J, Pevnick J, Cho D, Reker D, James B, Dornbush R.","Adv Exp Med Biol. 1979;116:291-305. doi: 10.1007/978-1-4684-3503-0_17.","Volavka J","Adv Exp Med Biol","1979","1979/01/01","","","10.1007/978-1-4684-3503-0_17"
"220890","Research and development of naltrexone: a new narcotic antagonist","Julius DA.","Am J Psychiatry. 1979 Jun;136(6):782-6. doi: 10.1176/ajp.136.6.782.","Julius DA","Am J Psychiatry","1979","1979/06/01","","","10.1176/ajp.136.6.782"
"220407","Naloxone and naltrexone: actions and interactions at an opiate drug receptor on frog skeletal muscle fibers","Frank GB, Marwaha J.","J Pharmacol Exp Ther. 1979 Jun;209(3):382-8.","Frank GB","J Pharmacol Exp Ther","1979","1979/06/01","","",""
"219728","Failure of naloxone and naltrexone to antagonize halothane anesthesia in the dog","Pace NL, Wong KC.","Anesth Analg. 1979 Jan-Feb;58(1):36-9.","Pace NL","Anesth Analg","1979","1979/01/01","","",""
"219434","Effects of naltrexone on mood and neuroendocrine function in normal adult males","Mendelson JH, Ellingboe J, Keuhnle JC, Mello NK.","Psychoneuroendocrinology. 1978 Oct;3(3-4):231-6. doi: 10.1016/0306-4530(78)90013-6.","Mendelson JH","Psychoneuroendocrinology","1978","1978/10/01","","","10.1016/0306-4530(78)90013-6"
"219179","Differential sensitivity to morphine-induced analgesia and motor activity in two inbred strains of mice: behavioral and biochemical correlations","Racagni G, Bruno F, Iuliano E, Paoletti R.","J Pharmacol Exp Ther. 1979 Apr;209(1):111-6.","Racagni G","J Pharmacol Exp Ther","1979","1979/04/01","","",""
"218233","Studies on membrane-bound opiate receptors","Simon EJ.","Prog Clin Biol Res. 1979;27:51-62.","Simon EJ","Prog Clin Biol Res","1979","1979/01/01","","",""
"218109","The development of sustained action preparations of narcotic antagonists","Willette RE.","NIDA Res Monogr. 1978;(19):333-9.","Willette RE","NIDA Res Monogr","1978","1978/01/01","","",""
"218108","Naltrexone in the treatment of opiate dependence","Resnick RB, Washton AM, Thomas MA, Kestenbaum RS.","NIDA Res Monogr. 1978;(19):321-32.","Resnick RB","NIDA Res Monogr","1978","1978/01/01","","",""
"218107","Update of naltrexone treatment","O'Brien CP, Greenstein R, Woody GE.","NIDA Res Monogr. 1978;(19):315-20.","O'Brien CP","NIDA Res Monogr","1978","1978/01/01","","",""
"218106","A history of the development of narcotic antagonists for the treatment of narcotic addiction","Martin WR.","NIDA Res Monogr. 1978;(19):296-300.","Martin WR","NIDA Res Monogr","1978","1978/01/01","","",""
"218009","Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties","Portoghese PS, Larson DL, Jiang JB, Caruso TP, Takemori AE.","J Med Chem. 1979 Feb;22(2):168-73. doi: 10.1021/jm00188a008.","Portoghese PS","J Med Chem","1979","1979/02/01","","","10.1021/jm00188a008"
"216330","Some observations on the opiate peptides and schizophrenia","Watson SJ, Akil H, Berger PA, Barchas JD.","Arch Gen Psychiatry. 1979 Jan;36(1):35-41. doi: 10.1001/archpsyc.1979.01780010041004.","Watson SJ","Arch Gen Psychiatry","1979","1979/01/01","","","10.1001/archpsyc.1979.01780010041004"
"215744","Opiate receptor agonists as modulators of gamma-aminobutyric acid turnover in the nucleus caudatus, globus pallidus and substantia nigra of the rat","Moroni F, Cheney DL, Peralta E, Costa E.","J Pharmacol Exp Ther. 1978 Dec;207(3):870-7.","Moroni F","J Pharmacol Exp Ther","1978","1978/12/01","","",""
"211530","Permanent alterations of central opiate systems as a result of chronic opiate antagonism during infancy in rats","Diaz J, Paul L, Frenk H, Bailey B.","Proc West Pharmacol Soc. 1978;21:377-9.","Diaz J","Proc West Pharmacol Soc","1978","1978/01/01","","",""
"211360","Decrease of cyclic GMP in cerebellum by intrastriatal D-Ala2-met-enkephalinamide","Biggio G, Corda MG, Casu M, Gessa GL.","Life Sci. 1978 Jul 24;23(4):335-9. doi: 10.1016/0024-3205(78)90017-6.","Biggio G","Life Sci","1978","1978/07/24","","","10.1016/0024-3205(78)90017-6"
"210831","Phospholipid changes in synaptic membranes by lipolytic enzymes and subsequent restoration of opiate binding with phosphatidylserine","Abood LG, Salem N, MacNeil M, Butler M.","Biochim Biophys Acta. 1978 Jul 25;530(1):35-46. doi: 10.1016/0005-2760(78)90124-8.","Abood LG","Biochim Biophys Acta","1978","1978/07/25","","","10.1016/0005-2760(78)90124-8"
"209185","6beta-[N,N-Bis(2-chloroethyl)amino]-17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan(chlornaltrexamine) a potent opioid receptor alkylating agent with ultralong narcotic antagonist actitivty","Portoghese PS, Larson DL, Jiang JB, Takemori AE, Caruso TP.","J Med Chem. 1978 Jul;21(7):598-9. doi: 10.1021/jm00205a002.","Portoghese PS","J Med Chem","1978","1978/07/01","","","10.1021/jm00205a002"
"206109","Participation of hypothalamic endorphins in the control of prolactin release","Guidotti A, Grandison L.","Adv Biochem Psychopharmacol. 1978;18:191-8.","Guidotti A","Adv Biochem Psychopharmacol","1978","1978/01/01","","",""
"205867","Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides","Blume AJ.","Proc Natl Acad Sci U S A. 1978 Apr;75(4):1713-7. doi: 10.1073/pnas.75.4.1713.","Blume AJ","Proc Natl Acad Sci U S A","1978","1978/04/01","PMC392409","","10.1073/pnas.75.4.1713"
"204766","Behavioral and electrophysiological effects of peptides related to lipotropin (beta-LPH)","de Wied D, Bohus B, van Ree JM, Urban I.","J Pharmacol Exp Ther. 1978 Mar;204(3):570-80.","de Wied D","J Pharmacol Exp Ther","1978","1978/03/01","","",""
"203494","In vivo receptor occupation by opiates and correlation to the pharmacological effect","Höllt V, Herz A.","Fed Proc. 1978 Feb;37(2):158-61.","Höllt V","Fed Proc","1978","1978/02/01","","",""
"202879","Phospholipase A inhibition of opiate receptor binding can be reversed by albumin","Lin HK, Simon EJ.","Nature. 1978 Jan 26;271(5643):383-4. doi: 10.1038/271383a0.","Lin HK","Nature","1978","1978/01/26","","","10.1038/271383a0"
"201861","Regulation of prolactin release by endogenous opiates","Grandison L, Guidotti A.","Nature. 1977 Nov 24;270(5635):357-9. doi: 10.1038/270357a0.","Grandison L","Nature","1977","1977/11/24","","","10.1038/270357a0"
"201577","Methadone maintenance and narcotic blocking drugs","Wikler A.","Int J Addict. 1977 Oct;12(7):851-6. doi: 10.3109/10826087709027254.","Wikler A","Int J Addict","1977","1977/10/01","","","10.3109/10826087709027254"
"200967","Stimulus effects of delta(9)-THC and its interaction with naltrexone and catecholamine blockers in rats","Järbe TU, Ohlin GC.","Psychopharmacology (Berl). 1977 Oct 20;54(2):193-5. doi: 10.1007/BF00426779.","Järbe TU","Psychopharmacology (Berl)","1977","1977/10/20","","","10.1007/BF00426779"
"200250","[Receptor occupation and pharmacological activity as demonstrated on opiates (author's transl)]","Herz A, Höllt V.","Arzneimittelforschung. 1977;27(96):1865-7.","Herz A","Arzneimittelforschung","1977","1977/01/01","","",""
"198833","Opioid peptides and opiates differ in receptor selectivity","Terenius L.","Psychoneuroendocrinology. 1977;2(1):53-8. doi: 10.1016/0306-4530(77)90031-2.","Terenius L","Psychoneuroendocrinology","1977","1977/01/01","","","10.1016/0306-4530(77)90031-2"
"194170","Behavioural dissociation of the enkephalinergic systems of nucleus accumbens and nucleus caudatus","Dill RE, Costa E.","Neuropharmacology. 1977 May;16(5):323-6. doi: 10.1016/0028-3908(77)90068-5.","Dill RE","Neuropharmacology","1977","1977/05/01","","","10.1016/0028-3908(77)90068-5"
"189354","Recent progress in research on narcotic antagonists","Archer S, Michne WF.","Prog Drug Res. 1976;20:45-100. doi: 10.1007/978-3-0348-7094-8_3.","Archer S","Prog Drug Res","1976","1976/01/01","","","10.1007/978-3-0348-7094-8_3"
"189228","On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists","Biggio G, Guidotti A, Costa E.","Naunyn Schmiedebergs Arch Pharmacol. 1977 Jan;296(2):117-21. doi: 10.1007/BF00508462.","Biggio G","Naunyn Schmiedebergs Arch Pharmacol","1977","1977/01/01","","","10.1007/BF00508462"
"188138","Endogenous opiate receptor ligand: electrically induced release in the guinea pig ileum","Puig MM, Gascon P, Craviso GL, Musacchio JM.","Science. 1977 Jan 28;195(4276):419-20. doi: 10.1126/science.188138.","Puig MM","Science","1977","1977/01/28","","","10.1126/science.188138"
"187943","NIDA's naltrexone research program","Julius D.","NIDA Res Monogr. 1976 Sep;(9):5-11. doi: 10.1037/e497452006-004.","Julius D","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-004"
"187942","The effects of naltrexone in the chronic spinal dog and acute spinal cat; possible interaction with naturally-occurring morphine-like agonists","Martin W, Bell J, Gilbert P, Sloan J, Thompson J.","NIDA Res Monogr. 1976 Sep;(9):27-30. doi: 10.1037/e497452006-007.","Martin W","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-007"
"187941","Naltrexone in the management of heroin addiction: critique of the rationale","Goldstein A.","NIDA Res Monogr. 1976 Sep;(9):158-61.","Goldstein A","NIDA Res Monogr","1976","1976/09/01","","",""
"187940","Limitations of an extinction approach to narcotic antagonist treatment","Meyer R, Randall R, Barrington C, Mirin S, Greenberg I.","NIDA Res Monogr. 1976 Sep;(9):123-35. doi: 10.1037/e497452006-023.","Meyer R","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-023"
"186283","A method for site selectivity analysis applied to opiate receptors","Terenius L, Wahlstrom A.","Eur J Pharmacol. 1976 Dec;40(2):241-8. doi: 10.1016/0014-2999(76)90058-3.","Terenius L","Eur J Pharmacol","1976","1976/12/01","","","10.1016/0014-2999(76)90058-3"
"186159","Ontological development of opiate receptors in rodent brain","Clendeninn NJ, Petraitis M, Simon EJ.","Brain Res. 1976 Dec 10;118(1):157-60. doi: 10.1016/0006-8993(76)90852-0.","Clendeninn NJ","Brain Res","1976","1976/12/10","","","10.1016/0006-8993(76)90852-0"
"185061","Naltrexone-induced hypothermia in the rat","Ary M, Chesarek W, Sorensen SM, Lomax P.","Eur J Pharmacol. 1976 Oct;39(2):215-20. doi: 10.1016/0014-2999(76)90129-1.","Ary M","Eur J Pharmacol","1976","1976/10/01","","","10.1016/0014-2999(76)90129-1"
"184055","Aftercare on narcotic antagonists: prospects and problems","Rawlins M, Randall M.","Int J Addict. 1976;11(3):501-11. doi: 10.3109/10826087609056166.","Rawlins M","Int J Addict","1976","1976/01/01","","","10.3109/10826087609056166"
"184054","Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study","Altman JL, Meyer RE, Mirin SM, McNamee HB.","Int J Addict. 1976;11(3):485-99. doi: 10.3109/10826087609056165.","Altman JL","Int J Addict","1976","1976/01/01","","","10.3109/10826087609056165"
"184053","Analysis and modification of opiate reinforcement","Meyer RE, McNamee HB, Mirin SM, Altman JL.","Int J Addict. 1976;11(3):467-84. doi: 10.3109/10826087609056164.","Meyer RE","Int J Addict","1976","1976/01/01","","","10.3109/10826087609056164"
"179316","The clinical usefulness of narcotic antagonists: implications of behavioral research","Meyer RE, Mirin SM, Altman JL.","Am J Drug Alcohol Abuse. 1975;2(3-4):417-32. doi: 10.3109/00952997509005666.","Meyer RE","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005666"
"158518","Genetic screening of compounds used in drug abuse treatment. I. Naltrexone hydrochloride","Brusick D, Matheson D, Jagannath D, Braude M, Brockman H.","Drug Chem Toxicol. 1978;1(2):103-35. doi: 10.3109/01480547809034430.","Brusick D","Drug Chem Toxicol","1978","1978/01/01","","","10.3109/01480547809034430"
"152622","Effect of an opiate antagonist on movement disorders","Nutt JG, Rosin AJ, Eisler T, Calne DB, Chase TN.","Arch Neurol. 1978 Dec;35(12):810-1. doi: 10.1001/archneur.1978.00500360034006.","Nutt JG","Arch Neurol","1978","1978/12/01","","","10.1001/archneur.1978.00500360034006"
"121360","Modification of treatment compliance as a function of contingent payment manipulations","Grabowski J, O'Brien CP, Greenstein R, Long M, Steinberg-Donato S, Ternes J.","NIDA Res Monogr. 1979;27:402-8.","Grabowski J","NIDA Res Monogr","1979","1979/01/01","","",""
"121347","Heroin and naltrexone effects on pituitary-gonadal hormones in man: tolerance and supersensitivity","Mendelson JH, Ellingboe J, Kuehnle J, Mello NK.","NIDA Res Monogr. 1979;27:302-8.","Mendelson JH","NIDA Res Monogr","1979","1979/01/01","","",""
"121346","Naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol plasma levels in schizophrenic patients after large oral doses of naltrexone","Verebey K, Mulé SJ.","NIDA Res Monogr. 1979;27:296-301.","Verebey K","NIDA Res Monogr","1979","1979/01/01","","",""
"121339","Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal","Washton AM, Resnick RB, Rawson RA.","NIDA Res Monogr. 1979;27:233-9.","Washton AM","NIDA Res Monogr","1979","1979/01/01","","",""
"121328","Narcotic drug discriminations by rhesus monkeys and pigeons","Woods JH, Herling S, Valentino RJ, Hein DW, Coale EH Jr.","NIDA Res Monogr. 1979;27:128-34.","Woods JH","NIDA Res Monogr","1979","1979/01/01","","",""
"118856","Behavioral methods for the assessment of alcohol tolerance and dependence","Altshuler HL.","Drug Alcohol Depend. 1979 May-Jul;4(3-4):333-46. doi: 10.1016/0376-8716(79)90017-6.","Altshuler HL","Drug Alcohol Depend","1979","1979/05/01","","","10.1016/0376-8716(79)90017-6"
"117373","Naltrexone and behavior therapy for heroin addiction","Rawson RA, Glazer M, Callahan EJ, Liberman RP.","NIDA Res Monogr. 1979 Jun;(25):26-43. doi: 10.1037/e497382006-005.","Rawson RA","NIDA Res Monogr","1979","1979/06/01","","","10.1037/e497382006-005"
"112621","Prevention by naltrexone of tolerance to the rate-decreasing effects of morphine on schedule-controlled responding in the pigeon","Smith JB.","Psychopharmacology (Berl). 1979 May 8;63(1):49-54. doi: 10.1007/BF00426921.","Smith JB","Psychopharmacology (Berl)","1979","1979/05/08","","","10.1007/BF00426921"
"108682","Opiate antagonists can inhibit mammary tumor growth in rats","Aylsworth CF, Hodson CA, Meites J.","Proc Soc Exp Biol Med. 1979 May;161(1):18-20. doi: 10.3181/00379727-161-40479.","Aylsworth CF","Proc Soc Exp Biol Med","1979","1979/05/01","","","10.3181/00379727-161-40479"
"108382","Plasma naltrexone kinetics after intravenous bolus administration in dogs and monkeys","Reuning RH, Batra VK, Ludden TM, Jao MY, Morrison BE, McCarthy DA, Harrigan SE, Ashcraft SB, Sams RA, Bathala MS, Staubus AE, Malspeis L.","J Pharm Sci. 1979 Apr;68(4):411-6. doi: 10.1002/jps.2600680405.","Reuning RH","J Pharm Sci","1979","1979/04/01","","","10.1002/jps.2600680405"
"107446","Evidence for a mutagenic effect of the narcotic antagonist, naltrexone, in germ cells of Drosophila","Zimmering S.","Mutat Res. 1979 Feb;66(2):129-31. doi: 10.1016/0165-1218(79)90056-9.","Zimmering S","Mutat Res","1979","1979/02/01","","","10.1016/0165-1218(79)90056-9"
"106298","The future of naltrexone","Renault PF.","NIDA Res Monogr. 1978;(19):340-5.","Renault PF","NIDA Res Monogr","1978","1978/01/01","","",""
"106297","Naltrexone: the clinical investigator's dilemma","Ling W.","NIDA Res Monogr. 1978;(19):308-14.","Ling W","NIDA Res Monogr","1978","1978/01/01","","",""
"106296","Historical trends in naltrexone research","Julius DA.","NIDA Res Monogr. 1978;(19):301-7.","Julius DA","NIDA Res Monogr","1978","1978/01/01","","",""
"101850","Heroin self-administration: an operant analysis","Mendelson JH, Mello NK.","NIDA Res Monogr. 1978 Jul;(20):128-48.","Mendelson JH","NIDA Res Monogr","1978","1978/07/01","","",""
"98797","Morphine as a discriminative cue in gerbils: drug generalization and antagonism","Järbe TU, Rollenhagen C.","Psychopharmacology (Berl). 1978 Jul 19;58(3):271-5. doi: 10.1007/BF00427390.","Järbe TU","Psychopharmacology (Berl)","1978","1978/07/19","","","10.1007/BF00427390"
"97713","Aversiveness of oral methadone in rats","Chipkin RE, Rosecrans JA.","Psychopharmacology (Berl). 1978 May 31;57(3):303-10. doi: 10.1007/BF00426755.","Chipkin RE","Psychopharmacology (Berl)","1978","1978/05/31","","","10.1007/BF00426755"
"95036","Conditioned drug responses to naturalistic stimuli","Ternes JW, O'Brien CP, Grabowski J, Wellerstein H, Jordan-Hayes J.","NIDA Res Monogr. 1979;27:282-8.","Ternes JW","NIDA Res Monogr","1979","1979/01/01","","",""
"95035","Unreinforced self-injections: effects on rituals and outcome in heroin addicts","O'Brien CP, Greenstein R, Ternes J, McLellan AT, Grabowski J.","NIDA Res Monogr. 1979;27:275-81.","O'Brien CP","NIDA Res Monogr","1979","1979/01/01","","",""
"86208","Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity","Caruso TP, Takemori AE, Larson DL, Portoghese PS.","Science. 1979 Apr 20;204(4390):316-8. doi: 10.1126/science.86208.","Caruso TP","Science","1979","1979/04/20","","","10.1126/science.86208"
"66306","Orientation of the oxygen atom at C-6 as a determinant of agonistic activity in the oxymorphone series","Ronai AZ, Foldes FF, Hahn EF, Fishman J.","J Pharmacol Exp Ther. 1977 Mar;200(3):496-500.","Ronai AZ","J Pharmacol Exp Ther","1977","1977/03/01","","",""
"63915","Naltrexone in a behavioral treatment program","O'Brien C, Greenstein R.","NIDA Res Monogr. 1976 Sep;(9):136-40. doi: 10.1037/e497452006-024.","O'Brien C","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-024"
"56258","Preliminary characterization of enzymes for reduction of naloxone and naltrexone in rabbit and chicken liver","Roerig S, Fujimoto JM, Wang RI, Pollock SH, Lange D.","Drug Metab Dispos. 1976 Jan-Feb;4(1):53-8.","Roerig S","Drug Metab Dispos","1976","1976/01/01","","",""
"56139","Letter: Treatment of accidental naltrexone-induced withdrawal","Volavka J, Resnick RB.","Am J Psychiatry. 1976 Feb;133(2):233. doi: 10.1176/ajp.133.2.233a.","Volavka J","Am J Psychiatry","1976","1976/02/01","","","10.1176/ajp.133.2.233a"
"42280","GABA turnover as a tool to explore the function of GABA-ergic synapses: physiological and pharmacological studies","Moroni F.","Adv Exp Med Biol. 1979;123:189-204. doi: 10.1007/978-1-4899-5199-1_11.","Moroni F","Adv Exp Med Biol","1979","1979/01/01","","","10.1007/978-1-4899-5199-1_11"
"33396","Kinetic studies in isolated organs: tools to design analgesic peptides and to analyze their receptor effects","Rónai AZ, Berzétei I, Székely JI, Gráf L, Bajusz S.","Pharmacology. 1979;18(1):18-24. doi: 10.1159/000137225.","Rónai AZ","Pharmacology","1979","1979/01/01","","","10.1159/000137225"
"31527","Analeptic and antianaleptic effects of naloxone and naltrexone in rabbits","Horita A, Carino MA.","Life Sci. 1978 Oct 23;23(16):1681-6. doi: 10.1016/0024-3205(78)90466-6.","Horita A","Life Sci","1978","1978/10/23","","","10.1016/0024-3205(78)90466-6"
"30814","Opiate-receptor mediated changes in monoamine synthesis in rat brain","Garcia-Sevilla JA, Ahtee L, Magnusson T, Carlsson A.","J Pharm Pharmacol. 1978 Oct;30(10):613-21. doi: 10.1111/j.2042-7158.1978.tb13342.x.","Garcia-Sevilla JA","J Pharm Pharmacol","1978","1978/10/01","","","10.1111/j.2042-7158.1978.tb13342.x"
"27943","Drug release from o/w/o multiple emulsion systems","Brodin AF, Frank SG.","Acta Pharm Suec. 1978;15(2):111-8.","Brodin AF","Acta Pharm Suec","1978","1978/01/01","","",""
"27776","[The treatment of drug-dependence (author's transl)]","Ladewig D.","Schweiz Rundsch Med Prax. 1978 Jun 27;67(26):957-65.","Ladewig D","Schweiz Rundsch Med Prax","1978","1978/06/27","","",""
"26754","An improved long-acting delivery system for narcotic antagonists","Misra AL, Pontani RB.","J Pharm Pharmacol. 1978 May;30(5):325-6. doi: 10.1111/j.2042-7158.1978.tb13244.x.","Misra AL","J Pharm Pharmacol","1978","1978/05/01","","","10.1111/j.2042-7158.1978.tb13244.x"
"26554","Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigs","Ludden TM, Bathala MS, Malspeis L, Drum MA, Reuning RH.","Drug Metab Dispos. 1978 May-Jun;6(3):321-8.","Ludden TM","Drug Metab Dispos","1978","1978/05/01","","",""
"13306","Development of Chronomers for narcotic antagonists","Capozza RC, Schmitt EE, Sendelbeck LR.","Natl Inst Drug Abuse Res Monogr Ser. 1975;(4):39-42.","Capozza RC","Natl Inst Drug Abuse Res Monogr Ser","1975","1975/01/01","","",""
"11501","Behavioral effects of narcotic analgesics administered alone or in combination with narcotic antagonists","Hartmann RJ, Geller I.","Proc West Pharmacol Soc. 1976;19:243-7.","Hartmann RJ","Proc West Pharmacol Soc","1976","1976/01/01","","",""
"10147","The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat","Dayton HE, Inturrisi CE.","Drug Metab Dispos. 1976 Sep-Oct;4(5):474-8.","Dayton HE","Drug Metab Dispos","1976","1976/09/01","","",""
"6708","Accumulation of cGMP in striatum of rats injected with narcotic analgesics: antagonism by naltrexone","Racagni G, Zsilla G, Guidotti A, Costa E.","J Pharm Pharmacol. 1976 Mar;28(3):258-60. doi: 10.1111/j.2042-7158.1976.tb04146.x.","Racagni G","J Pharm Pharmacol","1976","1976/03/01","","","10.1111/j.2042-7158.1976.tb04146.x"
"6233","Disposition of (15,16-3H)naltrexone in the central nervous system of the rat","Misra AL, Bloch R, Vardy J, Mulé SJ, Verebely K.","Drug Metab Dispos. 1976 May-Jun;4(3):276-80.","Misra AL","Drug Metab Dispos","1976","1976/05/01","","",""
